PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Do, T; Page, JE; Walker, S				Do, Truc; Page, Julia E.; Walker, Suzanne			Uncovering the activities, biological roles, and regulation of bacterial cell wall hydrolases and tailoring enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						peptidoglycan; Lipid II; hydrolase; teichoic acid; acetyltransferase; antibiotics; cell wall biochemistry; LytR-CpsA-Psr ligases; peptidoglycan hydrolase regulators; peptidoglycan hydrolase; O-acetyltransferase; antibiotic development	PENICILLIN-BINDING PROTEINS; PEPTIDOGLYCAN CROSS-LINKING; STAPHYLOCOCCUS-AUREUS; LIPID-II; BACILLUS-SUBTILIS; LINKED PEPTIDOGLYCAN; ESCHERICHIA-COLI; UNDECAPRENYL PHOSPHATE; WIDESPREAD FAMILY; MUREIN HYDROLASE	Bacteria account for 1000-fold more biomass than humans. They vary widely in shape and size. The morphological diversity of bacteria is due largely to the different peptidoglycan-based cell wall structures that encase bacterial cells. Although the basic structure of peptidoglycan is highly conserved, consisting of long glycan strands that are cross-linked by short peptide chains, the mature cell wall is chemically diverse. Peptidoglycan hydrolases and cell wall?tailoring enzymes that regulate glycan strand length, the degree of cross-linking, and the addition of other modifications to peptidoglycan are central in determining the final architecture of the bacterial cell wall. Historically, it has been difficult to biochemically characterize these enzymes that act on peptidoglycan because suitable peptidoglycan substrates were inaccessible. In this review, we discuss fundamental aspects of bacterial cell wall synthesis, describe the regulation and diverse biochemical and functional activities of peptidoglycan hydrolases, and highlight recently developed methods to make and label defined peptidoglycan substrates. We also review how access to these substrates has now enabled biochemical studies that deepen our understanding of how bacterial cell wall enzymes cooperate to build a mature cell wall. Such improved understanding is critical to the development of new antibiotics that disrupt cell wall biogenesis, a process essential to the survival of bacteria.	[Do, Truc; Page, Julia E.; Walker, Suzanne] Harvard Med Sch, Dept Microbiol, HIM Rm 1013,4 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walker, S (corresponding author), Harvard Med Sch, Dept Microbiol, HIM Rm 1013,4 Blackfan Circle, Boston, MA 02115 USA.	suzanne_walker@hms.harvard.edu		Page, Julia/0000-0002-9884-2382; Do, Truc/0000-0001-7212-0296	National Institutes of Health [R01 GM076710, R01 AI148752, T32GM007753]; National Science Foundation graduate research fellowship [DGE1144152]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grants R01 GM076710 and R01 AI148752 (to S. W.), T32GM007753 (to J. E. P.), and a National Science Foundation graduate research fellowship under Grant DGE1144152 (to T. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Arai R, 2012, J BIOL CHEM, V287, P44736, DOI 10.1074/jbc.M112.414763; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Auer GK, 2017, BIOCHEMISTRY-US, V56, P3710, DOI 10.1021/acs.biochem.7b00346; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Barreteau H, 2009, J CHROMATOGR B, V877, P213, DOI 10.1016/j.jchromb.2008.12.010; Bartual SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4842; Began J, 2020, EMBO J, V39, DOI 10.15252/embj.2019102935; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; BERNADSKY G, 1994, J BACTERIOL, V176, P5225, DOI 10.1128/JB.176.17.5225-5232.1994; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chan YGY, 2016, J BACTERIOL, V198, P1123, DOI 10.1128/JB.00983-15; Chan YGY, 2014, J BIOL CHEM, V289, P15680, DOI 10.1074/jbc.M114.567669; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; Crow A, 2017, P NATL ACAD SCI USA, V114, P12572, DOI 10.1073/pnas.1712153114; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Do T, 2020, NAT MICROBIOL, V5, P291, DOI 10.1038/s41564-019-0632-1; Dobihal GS, 2019, ELIFE, V8, DOI 10.7554/eLife.52088; Dominguez-Cuevas P, 2013, MOL MICROBIOL, V89, P1084, DOI 10.1111/mmi.12335; Egan AJF, 2017, FEBS J, V284, P851, DOI 10.1111/febs.13959; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Escobar CA, 2018, ANAL BIOCHEM, V543, P162, DOI 10.1016/j.ab.2017.12.016; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Garcia-Heredia A, 2018, ELIFE, V7, DOI 10.7554/eLife.37243; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Gonzalez-Delgado LS, 2020, NAT CHEM BIOL, V16, P24, DOI 10.1038/s41589-019-0393-4; Hanson BR, 2012, CURR OPIN MICROBIOL, V15, P204, DOI 10.1016/j.mib.2011.12.011; Hashimoto M, 2012, J BACTERIOL, V194, P796, DOI 10.1128/JB.05569-11; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Huang LY, 2014, ANGEW CHEM INT EDIT, V53, P8060, DOI 10.1002/anie.201402313; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kim SJ, 2015, BBA-BIOMEMBRANES, V1848, P350, DOI 10.1016/j.bbamem.2014.05.031; KRAUSE RM, 1957, J EXP MED, V106, P365, DOI 10.1084/jem.106.3.365; Lazar K, 2002, CURR OPIN CHEM BIOL, V6, P786, DOI 10.1016/S1367-5931(02)00355-1; Lebar MD, 2013, J AM CHEM SOC, V135, P4632, DOI 10.1021/ja312510m; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; Lee M, 2017, ANGEW CHEM INT EDIT, V56, P2735, DOI 10.1002/anie.201611279; Lee W, 2016, J AM CHEM SOC, V138, P100, DOI 10.1021/jacs.5b11807; Lerner TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002524; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lupoli TJ, 2009, J AM CHEM SOC, V131, P18230, DOI 10.1021/ja908916z; Mavrici D, 2014, P NATL ACAD SCI USA, V111, P8037, DOI 10.1073/pnas.1321812111; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Meier EL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006999; Meisner J, 2013, MOL MICROBIOL, V89, P1069, DOI 10.1111/mmi.12330; Men HB, 1998, J AM CHEM SOC, V120, P2484, DOI 10.1021/ja974221p; Mitkowski P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42435-z; Moynihan PJ, 2014, J BIOL CHEM, V289, P16748, DOI 10.1074/jbc.M114.567388; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Perlstein DL, 2007, J AM CHEM SOC, V129, P12674, DOI 10.1021/ja075965y; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Popham DL, 1999, J BACTERIOL, V181, P126, DOI 10.1128/JB.181.1.126-132.1999; Qiao Y, 2017, NAT CHEM BIOL, V13, P793, DOI 10.1038/nchembio.2388; Qiao Y, 2014, J AM CHEM SOC, V136, P14678, DOI 10.1021/ja508147s; Radkov AD, 2018, ANNU REV BIOCHEM, V87, P991, DOI 10.1146/annurev-biochem-062917-012921; Rajagopal M, 2017, CURR TOP MICROBIOL, V404, P1, DOI 10.1007/82_2015_5021; Rather P, 2013, BBA-BIOMEMBRANES, V1828, P2849, DOI 10.1016/j.bbamem.2013.03.012; Rausch M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09356-x; Rebets Y, 2014, ACS CHEM BIOL, V9, P459, DOI 10.1021/cb4006744; Reichmann NT, 2019, NAT MICROBIOL, V4, P1368, DOI 10.1038/s41564-019-0437-2; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Rohs PDA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007726; Rued BE, 2019, MBIO, V10, DOI 10.1128/mBio.02622-18; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schaefer K, 2018, J AM CHEM SOC, V140, P2442, DOI 10.1021/jacs.7b13551; Schaefer K, 2017, NAT CHEM BIOL, V13, P396, DOI 10.1038/nchembio.2302; Scherer K, 2013, BBA-BIOMEMBRANES, V1828, P2628, DOI 10.1016/j.bbamem.2013.07.014; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schloss PD, 2016, MBIO, V7, DOI 10.1128/mBio.00201-16; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Schwartz B, 2001, J AM CHEM SOC, V123, P11638, DOI 10.1021/ja0166848; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Sham LT, 2013, MBIO, V4, DOI 10.1128/mBio.00431-13; Sham LT, 2011, P NATL ACAD SCI USA, V108, pE1061, DOI 10.1073/pnas.1108323108; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Singh SK, 2015, P NATL ACAD SCI USA, V112, P10956, DOI 10.1073/pnas.1507760112; SMITH TJ, 1995, J BACTERIOL, V177, P3855, DOI 10.1128/jb.177.13.3855-3862.1995; Srisuknimit V, 2017, J AM CHEM SOC, V139, P9791, DOI 10.1021/jacs.7b04881; Sychantha D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02332; Sychantha D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006667; Taguchi A, 2019, CURR OPIN CHEM BIOL, V53, P44, DOI 10.1016/j.cbpa.2019.07.009; Taguchi A, 2019, NAT MICROBIOL, V4, P587, DOI 10.1038/s41564-018-0345-x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2011, CURR OPIN MICROBIOL, V14, P698, DOI 10.1016/j.mib.2011.10.003; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; VanNieuwenhze MS, 2002, J AM CHEM SOC, V124, P3656, DOI 10.1021/ja017386d; Vermassen A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00331; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2012, MOL MICROBIOL, V86, P1031, DOI 10.1111/mmi.12059; Wang TSA, 2011, J AM CHEM SOC, V133, P8528, DOI 10.1021/ja2028712; Wang YB, 2017, J AM CHEM SOC, V139, P13596, DOI 10.1021/jacs.7b06820; Welsh MA, 2019, J AM CHEM SOC, V141, P12994, DOI 10.1021/jacs.9b06358; Welsh MA, 2017, J AM CHEM SOC, V139, P17727, DOI 10.1021/jacs.7b10170; Wheeler R, 2015, MBIO, V6, DOI 10.1128/mBio.00660-15; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Yamamoto H, 2008, MOL MICROBIOL, V70, P168, DOI 10.1111/j.1365-2958.2008.06398.x; Yang DC, 2016, MICROBIOL MOL BIOL R, V80, P187, DOI 10.1128/MMBR.00031-15; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108; Ye XY, 2001, J AM CHEM SOC, V123, P3155, DOI 10.1021/ja010028q; Young KD, 2007, CURR OPIN MICROBIOL, V10, P596, DOI 10.1016/j.mib.2007.09.009; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yunck R, 2016, MOL MICROBIOL, V99, P700, DOI 10.1111/mmi.13258; Zhao H, 2017, MOL MICROBIOL, V106, P847, DOI 10.1111/mmi.13853; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	129	36	36	7	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3347	3361		10.1074/jbc.REV119.010155	http://dx.doi.org/10.1074/jbc.REV119.010155			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974163	Green Published, hybrid			2022-12-28	WOS:000519597300036
J	Pajarillo, E; Rizor, A; Son, DS; Aschner, M; Lee, E				Pajarillo, Edward; Rizor, Asha; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; Parkinson disease; neurodegeneration; neurodegenerative disease; neurotoxin; dopaminergic neurons; neuron restrictive silencer factor (NRSF); neurotoxicity; RE1-silencing transcription factor (REST); Tyrosine Hydroxylase	RESTRICTIVE SILENCER FACTOR; OXIDATIVE STRESS; TAMOXIFEN PROTECT; PROMOTER ACTIVITY; NUCLEAR RECEPTOR; IN-VIVO; EXPRESSION; NRSF; REPRESSOR; NRSF/REST	Dopaminergic functions are important for various biological activities, and their impairment leads to neurodegeneration, a hallmark of Parkinson's disease (PD). Chronic manganese (Mn) exposure causes the neurological disorder manganism, presenting symptoms similar to those of PD. Emerging evidence has linked the transcription factor RE1-silencing transcription factor (REST) to PD and also Alzheimer's disease. But REST's role in dopaminergic neurons is unclear. Here, we investigated whether REST protects dopaminergic neurons against Mn-induced toxicity and enhances expression of the dopamine-synthesizing enzyme tyrosine hydroxylase (TH). We report that REST binds to RE1 consensus sites in the TH gene promoter, stimulates TH transcription, and increases TH mRNA and protein levels in dopaminergic cells. REST binding to the TH promoter recruited the epigenetic modifier cAMP-response element-binding protein?binding protein/p300 and thereby up-regulated TH expression. REST relieved Mn-induced repression of TH promoter activity, mRNA, and protein levels and also reduced Mn-induced oxidative stress, inflammation, and apoptosis in dopaminergic neurons. REST reduced Mn-induced proinflammatory cytokines, including tumor necrosis factor ?, interleukin 1? (IL-1?), IL-6, and interferon ?. Moreover, REST inhibited the Mn-induced proapoptotic proteins Bcl-2?associated X protein (Bax) and death-associated protein 6 (Daxx) and attenuated an Mn-induced decrease in the antiapoptotic proteins Bcl-2 and Bcl-xL. REST also enhanced the expression of antioxidant proteins, including catalase, NF-E2?related factor 2 (Nrf2), and heme oxygenase 1 (HO-1). Our findings indicate that REST activates TH expression and thereby protects neurons against Mn-induced toxicity and neurological disorders associated with dopaminergic neurodegeneration.	[Pajarillo, Edward; Rizor, Asha; Lee, Eunsook] Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10461 USA	State University System of Florida; Florida A&M University; Meharry Medical College; Yeshiva University	Lee, E (corresponding author), Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32301 USA.	eunsook.lee@famu.edu	Pajarillo, Edward Alain/ABF-9202-2021	Pajarillo, Edward Alain/0000-0002-5044-7607; aschner, michael/0000-0002-2619-1656	National Institutes of Health Research [R01 ES024756, U54 MD007582, NCI SC1 CA200519, R01 ES10563, R01 ES07331, 1R21 ES025415]	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Research Grants R01 ES024756, U54 MD007582, NCI SC1 CA200519, R01 ES10563, R01 ES07331, and 1R21 ES025415. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Abramovitz L, 2008, J BIOL CHEM, V283, P110, DOI 10.1074/jbc.M707366200; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alsulimani HH, 2015, TOX RESEARCH, V31, P347, DOI 10.5487/TR.2015.31.4.347; Aouacheria A, 2017, NEUROCHEM INT, V109, P141, DOI 10.1016/j.neuint.2017.04.009; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; BECK KD, 1991, J NEUROCHEM, V57, P527, DOI 10.1111/j.1471-4159.1991.tb03782.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BEROD A, 1982, BRAIN RES, V240, P235, DOI 10.1016/0006-8993(82)90219-0; Blasco H, 2017, CAN J NEUROL SCI, V44, P90, DOI 10.1017/cjn.2016.284; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; COULON JF, 1990, J NEUROCHEM, V55, P1412, DOI 10.1111/j.1471-4159.1990.tb03154.x; Doan KV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12733; Harischandra DS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00654; Hwang JY, 2018, CURR OPIN NEUROBIOL, V48, P193, DOI 10.1016/j.conb.2017.12.008; Isaev NK, 2018, REV NEUROSCIENCE, V29, P233, DOI 10.1515/revneuro-2017-0051; Johnson J, 2018, NEUROTOXICOLOGY, V64, P230, DOI 10.1016/j.neuro.2017.06.007; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Kawamura M, 2019, NEUROSCI LETT, V699, P59, DOI 10.1016/j.neulet.2019.01.042; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kim HS, 2001, J NEUROCHEM, V76, P280, DOI 10.1046/j.1471-4159.2001.00044.x; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210248; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kirn SM, 2006, BIOCHEM BIOPH RES CO, V346, P426, DOI 10.1016/j.bbrc.2006.05.142; Kumasaka MY, 2017, NEUROTOX RES, V32, P661, DOI 10.1007/s12640-017-9783-0; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lim J, 2000, MOL CELL BIOCHEM, V212, P51, DOI 10.1023/A:1007148719497; Lim J, 2015, NEUROREPORT, V26, P380, DOI 10.1097/WNR.0000000000000356; Lin KH, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110765; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Menezes JA, 2014, NEUROTOXICOLOGY, V45, P293, DOI 10.1016/j.neuro.2013.09.006; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Moreno-Gonzalez G, 2008, BIOSCIENCE REP, V28, P177, DOI 10.1042/BSR20080058; Murai K, 2004, NUCLEIC ACIDS RES, V32, P3180, DOI 10.1093/nar/gkh550; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Palm K, 1998, J NEUROSCI, V18, P1280; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Popichak KA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1349-4; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Qi YP, 1997, J NEUROSCI, V17, P1217; Qi ZP, 2019, TOXICOL IND HEALTH, V35, P211, DOI 10.1177/0748233719825720; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Seth KA, 2001, J BIOL CHEM, V276, P13917, DOI 10.1074/jbc.M007745200; Shimojo M, 2004, LIFE SCI, V74, P2213, DOI 10.1016/j.lfs.2003.08.045; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Stredrick DL, 2004, NEUROTOXICOLOGY, V25, P543, DOI 10.1016/j.neuro.2003.08.006; Suo HY, 2015, NEUROPHARMACOLOGY, V99, P67, DOI 10.1016/j.neuropharm.2015.07.015; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Wang P, 2014, EUR NEUROL, V72, P249, DOI 10.1159/000363515; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Yoo JY, 2001, BIOCHEM BIOPH RES CO, V283, P928, DOI 10.1006/bbrc.2001.4857; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Zhang DH, 2011, TOXICOL APPL PHARM, V254, P65, DOI 10.1016/j.taap.2010.03.023; Zhang K, 2017, BIOL TRACE ELEM RES, V180, P297, DOI 10.1007/s12011-017-0992-4; Zhang ZP, 2017, TOXICOL APPL PHARM, V336, P94, DOI 10.1016/j.taap.2017.10.011; Zhao YG, 2017, MOL NEUROBIOL, V54, P541, DOI 10.1007/s12035-015-9658-4	73	15	15	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3040	3054		10.1074/jbc.RA119.011446	http://dx.doi.org/10.1074/jbc.RA119.011446			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001620	Green Published, hybrid			2022-12-28	WOS:000519597300014
J	Janiszewska, M; Primi, MC; Izard, T				Janiszewska, Michalina; Primi, Marina Candido; Izard, Tina			Cell adhesion in cancer: Beyond the migration of single cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						integrin; cadherin; cell adhesion; cancer; cancer biology; cell adhesion molecules; cancer stem cells; collective migration; epithelial-mesenchymal transition; integrin; organoids; targeted treatment	CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; BREAST-CANCER; BETA-1-INTEGRIN DELETION; CLINICAL-SIGNIFICANCE; COLLECTIVE INVASION; NEURITE OUTGROWTH; N-CADHERIN	Homeostasis in healthy tissues strongly relies on cell-to-cell adhesion and cell-to-extracellular matrix interactions. For instance, normal epithelial cells maintain tissue structure by adhering to each other and to the extracellular matrix. The proteins that mediate these distinct interactions are collectively called cell adhesion molecules and are divided into four major groups: cadherins, integrins, selectins, and immunoglobulins. They not only physically anchor cells, but also critically integrate signaling between the extracellular microenvironment and cells. These signals include biochemical cues, as adhesion proteins can both act as ligand-activated receptors and activate mechanotransduction triggered by changes in the physical environment. Molecular mechanisms related to cell adhesion signaling have been extensively studied, especially because mutations and changes in expression of these proteins, particularly cadherins and integrins, are frequently associated with diseases ranging from developmental intellectual disability to cancer. In fact, two major hallmarks of cancer, loss of cell-to-cell adhesion and anchorage-independent growth, are both dependent on cell adhesion molecules. Despite many studies elucidating the relationships between malignant transformation and metastasis and cellular adhesion processes, several areas still await exploration. Here, we highlight recently discovered roles of adhesion molecules in collective cancer cell migration and discuss the utility of three-dimensional models in studying cell-cell adhesion. We also describe recent therapeutic approaches targeting adhesion molecules.	[Janiszewska, Michalina] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Primi, Marina Candido; Izard, Tina] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Janiszewska, M (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.	mjaniszewska@scripps.edu	Primi, Marina Candido/G-4549-2014	Primi, Marina Candido/0000-0001-8760-7486	National Institutes of Health; Department of Defense; State of Florida	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); State of Florida	Supported by National Institutes of Health grant and by start-up funds provided to The Scripps Research Institute by the State of Florida. To whom correspondence should be addressed. E-mail: mjaniszewska@scripps.edu.; Supported by National Institutes of Health Grants, the Department of Defense, and start-up funds provided to The Scripps Research Institute by the State of Florida.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Aksorn N, 2019, ANTICANCER RES, V39, P541, DOI 10.21873/anticanres.13146; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bachmann M, 2019, PHYSIOL REV, V99, P1655, DOI 10.1152/physrev.00036.2018; Banyard J, 2015, CONNECT TISSUE RES, V56, P403, DOI 10.3109/03008207.2015.1060970; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen S, 2003, J IMMUNOL, V170, P2695, DOI 10.4049/jimmunol.170.5.2695; Cooper J, 2019, CANCER CELL, V35, P347, DOI 10.1016/j.ccell.2019.01.007; Corn PG, 2000, CLIN CANCER RES, V6, P4243; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; De Pascalis C, 2017, MOL BIOL CELL, V28, P1833, DOI 10.1091/mbc.E17-03-0134; Ding M, 2017, ONCOL LETT, V14, P6327, DOI 10.3892/ol.2017.7030; Dong YW, 2018, J AM CHEM SOC, V140, P16264, DOI 10.1021/jacs.8b10021; Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6; Elsamany S, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0096-3; Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045; Freemont AJ, 1996, J CLIN PATHOL-CL MOL, V49, pM321; Friedl P, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a029199; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; GEIGER B, 1987, J CELL SCI, P251; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Harjunpaa H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01078; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; Hong SK, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0924-8; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Huang LM, 2019, EXP CELL RES, V378, P1, DOI 10.1016/j.yexcr.2019.02.012; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Jia DY, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050725; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Klein D, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00367; Ko KS, 2001, J CELL SCI, V114, P1155; Kon E, 2019, ELIFE, V8, DOI 10.7554/eLife.47673; Kroger C, 2019, P NATL ACAD SCI USA, V116, P7353, DOI 10.1073/pnas.1812876116; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; Larsson AM, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0976-0; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; Lou YY, 2016, CLIN CANCER RES, V22, P3630, DOI 10.1158/1078-0432.CCR-15-1434; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Melki JR, 2000, BLOOD, V95, P3208; Mitjans F, 2000, INT J CANCER, V87, P716, DOI 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.3.CO;2-I; MITJANS F, 1995, J CELL SCI, V108, P2825; Moh MC, 2009, CELL ADHES MIGR, V3, P334, DOI 10.4161/cam.3.4.9246; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Mrozik KM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4845-0; Mui KL, 2016, J CELL SCI, V129, P1093, DOI 10.1242/jcs.183699; Murlidhar V, 2017, CANCER RES, V77, P5194, DOI 10.1158/0008-5472.CAN-16-2072; O'Day S, 2011, BRIT J CANCER, V105, P346, DOI 10.1038/bjc.2011.183; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Padmanaban V, 2019, NATURE, V573, P439, DOI 10.1038/s41586-019-1526-3; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Peng H, 2019, EBIOMEDICINE, V46, P105, DOI 10.1016/j.ebiom.2019.07.002; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qian X, 2014, ONCOGENE, V33, P3411, DOI 10.1038/onc.2013.310; Raab-Westphal S, 2017, CANCERS, V9, DOI 10.3390/cancers9090110; Sartori A, 2019, CANCERS, V11, DOI 10.3390/cancers11040531; Schwartz MA, 2001, J CELL SCI, V114, P2553; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shashikanth N, 2015, J BIOL CHEM, V290, P21749, DOI 10.1074/jbc.M115.657098; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turaga Soumya M, 2016, CNS Oncol, V5, P251, DOI 10.2217/cns-2016-0015; Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x; Valenzuela-Iglesias A, 2019, MOL CANCER RES, V17, P1195, DOI 10.1158/1541-7786.MCR-18-0048; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wai Wong Chee, 2012, Int J Cell Biol, V2012, P340296, DOI 10.1155/2012/340296; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Windisch R, 2019, CANCERS, V11, DOI 10.3390/cancers11030311; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	109	160	169	40	119	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2495	2505		10.1074/jbc.REV119.007759	http://dx.doi.org/10.1074/jbc.REV119.007759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31937589	Green Published, hybrid			2022-12-28	WOS:000517330200029
J	Jaskolka, MC; Kane, PM				Jaskolka, Michael C.; Kane, Patricia M.			Interaction between the yeast RAVE complex and Vph1-containing V-o sectors is a central glucose-sensitive interaction required for V-ATPase reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; vacuole; vacuolar acidification; yeast; organellar pH homeostasis; glucose signaling; protein-protein interaction; proton pump; rabconnectin-3; RAVE complex	H+-ATPASE; PH HOMEOSTASIS; VACUOLAR; SUBUNIT; GENE; ACIDIFICATION; PURIFICATION; INHIBITION; REGULATOR; ENCODES	The yeast vacuolar H+-ATPase (V-ATPase) of budding yeast (Saccharomyces cerevisiae) is regulated by reversible disassembly. Disassembly inhibits V-ATPase activity under low-glucose conditions by releasing peripheral V-1 subcomplexes from membrane-bound V-o subcomplexes. V-ATPase reassembly and reactivation requires intervention of the conserved regulator of H+-ATPase of vacuoles and endosomes (RAVE) complex, which binds to cytosolic V-1 subcomplexes and assists reassembly with integral membrane V-o complexes. Consistent with its role, the RAVE complex itself is reversibly recruited to the vacuolar membrane by glucose, but the requirements for its recruitment are not understood. We demonstrate here that RAVE recruitment to the membrane does not require an interaction with V-1. Glucose-dependent RAVE localization to the vacuolar membrane required only intact V-o complexes containing the Vph1 subunit, suggesting that the RAVE-V-o interaction is glucose-dependent. We identified a short conserved sequence in the center of the RAVE subunit Rav1 that is essential for the interaction with Vph1 in vivo and in vitro. Mutations in this region resulted in the temperature- and pH-dependent growth phenotype characteristic of rav? mutants. However, this region did not account for glucose sensitivity of the Rav1-Vph1 interaction. We quantitated glucose-dependent localization of a GFP-tagged RAVE subunit to the vacuolar membrane in several mutants previously implicated in altering V-ATPase assembly state or glucose-induced assembly. RAVE localization did not correlate with V-ATPase assembly levels reported previously in these mutants, highlighting both the catalytic nature of RAVE's role in V-ATPase assembly and the likelihood of glucose signaling to RAVE independently of V-1.	[Jaskolka, Michael C.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Jaskolka, Michael/0000-0003-2341-0750	National Institutes of Health [R01 GM127364]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 GM127364 (to P. M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Deprez MA, 2018, MICROB CELL, V5, P119, DOI 10.15698/mic2018.03.618; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Henderson KA, 2014, ELIFE, V3, DOI 10.7554/eLife.03504; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Ho B, 2018, CELL SYST, V6, P192, DOI 10.1016/j.cels.2017.12.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Liu Y, 2017, DIABETES, V66, P1521, DOI 10.2337/db16-0727; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sharma S, 2019, J BIOL CHEM, V294, P6439, DOI 10.1074/jbc.RA119.007577; Sherman F., 1982, METHODS YEAST GENETI; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wilms T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006835; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001	41	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2259	2269		10.1074/jbc.RA119.011522	http://dx.doi.org/10.1074/jbc.RA119.011522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31941791	Green Published, hybrid			2022-12-28	WOS:000517330200010
J	Shin, NY; Yamazaki, H; Beniash, E; Yang, X; Margolis, SS; Pugach, MK; Simmer, JP; Margolis, HC				Shin, Nah-Young; Yamazaki, Hajime; Beniash, Elia; Yang, Xu; Margolis, Seth S.; Pugach, Megan K.; Simmer, James P.; Margolis, Henry C.			Amelogenin phosphorylation regulates tooth enamel formation by stabilizing a transient amorphous mineral precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; tooth; tooth development; extracellular matrix protein; phosphorylation; amelogenesis; amelogenin; dental enamel; knock-in mouse model	CALCIUM-PHOSPHATE FORMATION; OCTACALCIUM PHOSPHATE; MATRIX PROTEINS; FINE-STRUCTURE; MICE DISPLAY; AMELOBLASTIN; IMPERFECTA; DEFECTS; MMP20; CELL	Dental enamel comprises interwoven arrays of extremely long and narrow crystals of carbonated hydroxyapatite called enamel rods. Amelogenin (AMELX) is the predominant extracellular enamel matrix protein and plays an essential role in enamel formation (amelogenesis). Previously, we have demonstrated that full-length AMELX forms higher-order supramolecular assemblies that regulate ordered mineralization in vitro, as observed in enamel rods. Phosphorylation of the sole AMELX phosphorylation site (Ser-16) in vitro greatly enhances its capacity to stabilize amorphous calcium phosphate (ACP), the first mineral phase formed in developing enamel, and prevents apatitic crystal formation. To test our hypothesis that AMELX phosphorylation is critical for amelogenesis, we generated and characterized a hemizygous knockin (KI) mouse model with a phosphorylation-defective Ser-16 to Ala-16 substitution in AMELX. Using EM analysis, we demonstrate that in the absence of phosphorylated AMELX, KI enamel lacks enamel rods, the hallmark component of mammalian enamel, and, unlike WT enamel, appears to be composed of less organized arrays of shorter crystals oriented normal to the dentinoenamel junction. KI enamel also exhibited hypoplasia and numerous surface defects, whereas heterozygous enamel displayed highly variable mosaic structures with both KI and WT features. Importantly, ACP-to-apatitic crystal transformation occurred significantly faster in KI enamel. Secretory KI ameloblasts also lacked Tomes' processes, consistent with the absence of enamel rods, and underwent progressive cell pathology throughout enamel development. In conclusion, AMELX phosphorylation plays critical mechanistic roles in regulating ACP-phase transformation and enamel crystal growth, and in maintaining ameloblast integrity and function during amelogenesis.	[Shin, Nah-Young; Yamazaki, Hajime; Pugach, Megan K.; Margolis, Henry C.] Forsyth Inst, Cambridge, MA 02142 USA; [Shin, Nah-Young; Yamazaki, Hajime; Pugach, Megan K.; Margolis, Henry C.] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Yamazaki, Hajime; Beniash, Elia; Yang, Xu] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Oral Biol, Pittsburgh, PA 15213 USA; [Margolis, Henry C.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Periodont & Prevent Dent, Pittsburgh, PA 15213 USA; [Margolis, Seth S.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Shin, Nah-Young] Boston Childrens Hosp, Dept Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Shin, Nah-Young] Harvard Med Sch, Dana Farber Canc Inst, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Margolis, HC (corresponding author), Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Periodont & Prevent Dent, Pittsburgh, PA 15213 USA.	hmargolis@pitt.edu		Simmer, James/0000-0002-7192-6105; Yamazaki, Hajime/0000-0002-5138-4142	National Institutes of Health NIDCR Grant R21-dental enamel formation [DE023425]; The Forsyth Institute; University of Pittsburgh School of Dental Medicine	National Institutes of Health NIDCR Grant R21-dental enamel formation; The Forsyth Institute; University of Pittsburgh School of Dental Medicine(University of Pittsburgh)	This work was supported by National Institutes of Health NIDCR Grant R21-dental enamel formation, through the use of knockout and DE023425 (to H. C. M.), The Forsyth Institute, and the University of Pittsburgh School of Dental Medicine. The authors declare that they have no conflicts of interest with the contents of this article.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aichmayer B, 2005, J STRUCT BIOL, V151, P239, DOI 10.1016/j.jsb.2005.06.007; Bajaj D, 2009, BIOMATERIALS, V30, P4037, DOI 10.1016/j.biomaterials.2009.04.017; Baldassarri M, 2008, J DENT RES, V87, P645, DOI 10.1177/154405910808700711; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2011, CELLS TISSUES ORGANS, V194, P222, DOI 10.1159/000324205; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Chan HC, 2010, J DENT RES, V89, P695, DOI 10.1177/0022034510365662; Connelly C, 2016, COLLOID SURFACE B, V148, P377, DOI 10.1016/j.colsurfb.2016.09.010; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Cui JX, 2017, ELIFE, V6, DOI 10.7554/eLife.23990; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Fang PA, 2013, J STRUCT BIOL, V183, P250, DOI 10.1016/j.jsb.2013.05.011; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; FRANKLIN DL, 1991, J ANAT, V174, P103; Fukae M, 1998, CONNECT TISSUE RES, V39, P123, DOI 10.3109/03008209809023918; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gallon V, 2013, J STRUCT BIOL, V183, P239, DOI 10.1016/j.jsb.2013.03.014; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089303; Hu YY, 2016, MOL GENET GENOM MED, V4, P641, DOI 10.1002/mgg3.252; Hu YY, 2011, EUR J ORAL SCI, V119, P217, DOI 10.1111/j.1600-0722.2011.00859.x; KALLENBACH E, 1973, TISSUE CELL, V5, P501, DOI 10.1016/S0040-8166(73)80041-2; KALLENBACH E, 1977, AM J ANAT, V148, P479, DOI 10.1002/aja.1001480406; Kwak SY, 2016, J DENT RES, V95, P1511, DOI 10.1177/0022034516662814; Kwak SY, 2014, CONNECT TISSUE RES, V55, P21, DOI 10.3109/03008207.2014.923853; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Le Norcy E, 2011, J DENT RES, V90, P1091, DOI 10.1177/0022034511411301; Le Norcy E, 2011, EUR J ORAL SCI, V119, P97, DOI 10.1111/j.1600-0722.2011.00900.x; LEBLOND CP, 1979, J DENT RES, V58, P950, DOI 10.1177/00220345790580024901; Lignon G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00267; Ma P, 2016, J DENT RES, V95, P1408, DOI 10.1177/0022034516661513; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Margolis H. C., 2010, AMELOGENINS MULTIFAC, P133, DOI 10.2174/978160805171711001010133; Margolis HC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00339; Masica DL, 2011, J PHYS CHEM C, V115, P13775, DOI 10.1021/jp202965h; Mazumder P, 2016, J DENT RES, V95, P1042, DOI 10.1177/0022034516645389; Mazumder P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00274; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694; Nanci A, 2007, 10 CATES ORAL HISTOL; Nishikawa S, 2017, J ORAL BIOSCI, V59, P197, DOI 10.1016/j.job.2017.07.002; Ohyama Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27784; Paine CT, 1998, CONNECT TISSUE RES, V38, P257, DOI 10.3109/03008209809017046; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Pugach MK, 2010, J DENT RES, V89, P165, DOI 10.1177/0022034509358392; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; Robinson C, 2003, CONNECT TISSUE RES, V44, P65, DOI 10.1080/03008200390152115; Robinson C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00405; Shin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086774; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Skobe Z, 2006, EUR J ORAL SCI, V114, P338, DOI 10.1111/j.1600-0722.2006.00305.x; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2019, J ANAT, V235, P912, DOI 10.1111/joa.13053; Smith CEL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00435; Tao JH, 2007, J PHYS CHEM B, V111, P13410, DOI 10.1021/jp0732918; Verdelis K, 2016, MATRIX BIOL, V52-54, P246, DOI 10.1016/j.matbio.2016.01.003; Wald T, 2017, P NATL ACAD SCI USA, V114, pE1641, DOI 10.1073/pnas.1615334114; Wang SK, 2013, J BONE MINER RES, V28, P2508, DOI 10.1002/jbmr.1990; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wiedemann-Bidlack FB, 2011, J STRUCT BIOL, V173, P250, DOI 10.1016/j.jsb.2010.11.006; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Xia Y, 2016, MATRIX BIOL, V52-54, P198, DOI 10.1016/j.matbio.2015.11.005; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P206, DOI 10.1111/j.1600-0722.2011.00866.x; Yamazaki H, 2019, J DENT RES, V98, P468, DOI 10.1177/0022034518823537; Yamazaki H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00450; Zalzal SF, 2008, MATRIX BIOL, V27, P352, DOI 10.1016/j.matbio.2008.01.003	85	26	27	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1943	1959		10.1074/jbc.RA119.010506	http://dx.doi.org/10.1074/jbc.RA119.010506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919099	Green Published, hybrid			2022-12-28	WOS:000517128200014
J	Neff, RA; Flinspach, M; Gibbs, A; Shih, AY; Minassian, NA; Liu, Y; Fellows, R; Libiger, O; Young, S; Pennington, MW; Hunter, MJ; Wickenden, AD				Neff, Robert A.; Flinspach, Mack; Gibbs, Alan; Shih, Amy Y.; Minassian, Natali A.; Liu, Yi; Fellows, Ross; Libiger, Ondrej; Young, Stephanie; Pennington, Michael W.; Hunter, Michael J.; Wickenden, Alan D.			Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa(v)1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; peptide biosynthesis; molecular modeling; pain; neurotoxin; analgesic; antagonist; Na(v)1.2; Na(v)1.7; spider toxin	CHRONIC PAIN; UNITED-STATES; SCN9A; POLYMORPHISM; PREVALENCE; ANTAGONIST; MUTATIONS; NA(V)1.7; CURRENTS; POTENCY	Pain is a significant public health burden in the United States, and current treatment approaches rely heavily on opioids, which often have limited efficacy and can lead to addiction. In humans, functional loss of the voltage-gated sodium channel Na(v)1.7 leads to pain insensitivity without deficits in the central nervous system. Accordingly, discovery of a selective Na(v)1.7 antagonist should provide an analgesic without abuse liability and an improved side-effect profile. Huwentoxin-IV, a component of tarantula venom, potently blocks sodium channels and is an attractive scaffold for engineering a Na(v)1.7-selective molecule. To define the functional impact of alterations in huwentoxin-IV sequence, we produced a library of 373 point mutants and tested them for Na(v)1.7 and Na(v)1.2 activity. We then combined favorable individual changes to produce combinatorial mutants that showed further improvements in Na(v)1.7 potency (E1N, E4D, Y33W, Q34S-Na(v)1.7 pIC(50) = 8.1 +/- 0.08) and increased selectivity over other Na-v isoforms (E1N, R26K, Q34S, G36I, Na(v)1.7 pIC(50) = 7.2 +/- 0.1, Na(v)1.2 pIC(50) = 6.1 +/- 0.18, Na(v)1.3 pIC(50) = 6.4 +/- 1.0), Na(v)1.4 is inactive at 3 mu m, and Na(v)1.5 is inactive at 10 mu m. We also substituted noncoded amino acids at select positions in huwentoxin-IV. Based on these results, we identify key determinants of huwentoxin's Na(v)1.7 inhibition and propose a model for huwentoxin-IV's interaction with Na(v)1.7. These findings uncover fundamental features of huwentoxin involved in Na(v)1.7 blockade, provide a foundation for additional optimization of this molecule, and offer a basis for the development of a safe and effective analgesic.	[Neff, Robert A.; Minassian, Natali A.; Liu, Yi] Janssen Res & Dev LLC, Neurosci Discovery, San Diego, CA 92121 USA; [Flinspach, Mack; Fellows, Ross; Hunter, Michael J.] Janssen Res & Dev LLC, Biol Res, San Diego, CA 92121 USA; [Shih, Amy Y.] Janssen Res & Dev LLC, Discovery Chem Computat Chem, San Diego, CA 92121 USA; [Libiger, Ondrej; Young, Stephanie] Janssen Res & Dev LLC, Translat Med & Early Dev Stat, San Diego, CA 92121 USA; [Wickenden, Alan D.] Janssen Res & Dev LLC, Mol & Cellular Pharmacol, San Diego, CA 92121 USA; [Gibbs, Alan] Janssen Res & Dev LLC, Struct Biol, Spring House, PA 19477 USA; [Pennington, Michael W.] Peptides Int Inc, Louisville, KY 40299 USA; [Flinspach, Mack] Takeda Pharmaceut LLC, Struct Biol & Biophys, 9625 Towne Ctr Dr, San Diego, CA 92121 USA; [Minassian, Natali A.] Neurocrine Biosci Inc, Vitro Pharmacol, 12780 El Camino Real, San Diego, CA 92130 USA; [Fellows, Ross] Eli Lilly & Co, BioTDR, Prot Optimizat, Lilly Technol Ctr North, Bldg 314,1223 W Morris St,Gate 1,Dock 314, Indianapolis, IN 46221 USA; [Pennington, Michael W.] AmbioPharm Inc, 1024 Dittman Court, North Augusta, SC 29842 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Neurocrine Biosciences; Eli Lilly	Neff, RA (corresponding author), Janssen Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	rneff@its.jnj.com		Neff, Robert/0000-0002-7550-4348; pennington, michael/0000-0001-5446-3447	Janssen Research and Development, LLC	Janssen Research and Development, LLC	This work was funded by Janssen Research and Development, LLC. R. A. N., A. G., A. Y. S., Y. L., O. L., S. Y., M. J. H., and A. D. W. are all employees of Janssen Research & Development, LLC. M. F. is an employee of Takeda Pharmaceuticals, LLC. N. A. M. is an employee of Neurocrine Biosciences, Inc. R. F. is an employee of Eli Lilly & Co. M. W. P. is an employee of AmbioPharm, Inc.	Agwa AJ, 2017, BBA-BIOMEMBRANES, V1859, P835, DOI 10.1016/j.bbamem.2017.01.020; [Anonymous], 2019, SCHROD REL 2019 3; [Anonymous], 2019, WHOS CANC PAIN LADD; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Center for Behavioral Health Statistics and Quality, 2016, 2015 NAT SURV DRUG U; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Deng MC, 2013, TOXICON, V71, P57, DOI 10.1016/j.toxicon.2013.05.015; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; Eckert W., 2013, [PCT Int. Appl., PCT Int. Appl., WO], Patent No. 2013173706; Eckert W. F. M., 2013, Patent US, Patent No. 2013041572; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Emery EC, 2015, J NEUROSCI, V35, P7674, DOI 10.1523/JNEUROSCI.3935-14.2015; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Flinspach M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39662; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Israel MR, 2017, ADV PHARMACOL, V79, P67, DOI 10.1016/bs.apha.2017.01.004; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Maher MP, 2007, J BIOMOL SCREEN, V12, P656, DOI 10.1177/1087057107302113; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pinheiro J. B. D., 2019, R LANGUAGE ENV STAT; Rahnama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173551; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Release S., 2020, MAESTRO DESMOND INTE; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Robinson SD, 2017, EXPERT REV PROTEOMIC, V14, P931, DOI 10.1080/14789450.2017.1377613; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2014, MOL PHARMACOL, V86, P159, DOI 10.1124/mol.114.092338; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xu H, 2019, CELL, V176, P1238, DOI 10.1016/j.cell.2019.01.047; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	40	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1315	1327		10.1074/jbc.RA119.011318	http://dx.doi.org/10.1074/jbc.RA119.011318			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31871053	Green Published, Bronze			2022-12-28	WOS:000513822300012
J	Schatzman, SS; Peterson, RL; Teka, M; He, BX; Cabelli, DE; Cormack, BP; Culotta, VC				Schatzman, Sabrina S.; Peterson, Ryan L.; Teka, Mieraf; He, Bixi; Cabelli, Diane E.; Cormack, Brendan P.; Culotta, Valeria C.			Copper-only superoxide dismutase enzymes and iron starvation stress in Candida fungal pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide dismutase (SOD); copper; reactive oxygen species (ROS); superoxide ion; Candida albicans; Candida auris; Candida tropicalis; oxidative stress; SOD4; virulence factor	OXIDATIVE STRESS; CELL-WALL; PLASMA-MEMBRANE; NADPH OXIDASES; ALBICANS; PROTEINS; HOMEOSTASIS; ACTIVATION; MECHANISM; CHAPERONE	Copper (Cu)-only superoxide dismutases (SOD) represent a newly characterized class of extracellular SODs important for virulence of several fungal pathogens. Previous studies of the Cu-only enzyme SOD5 from the opportunistic fungal pathogen Candida albicans have revealed that the active-site structure and Cu binding of SOD5 strongly deviate from those of Cu/Zn-SODs in its animal hosts, making Cu-only SODs a possible target for future antifungal drug design. C. albicans also expresses a Cu-only SOD4 that is highly similar in sequence to SOD5, but is poorly characterized. Here, we compared the biochemical, biophysical, and cell biological properties of C. albicans SOD4 and SOD5. Analyzing the recombinant proteins, we found that, similar to SOD5, Cu-only SOD4 can react with superoxide at rates approaching diffusion limits. Both SODs were monomeric and they exhibited similar binding affinities for their Cu cofactor. In C. albicans cultures, SOD4 and SOD5 were predominantly cell wall proteins. Despite these similarities, the SOD4 and SOD5 genes strongly differed in transcriptional regulation. SOD5 was predominantly induced during hyphal morphogenesis, together with a fungal burst in reactive oxygen species. Conversely, SOD4 expression was specifically up-regulated by iron (Fe) starvation and controlled by the Fe-responsive transcription factor SEF1. Interestingly, Candida tropicalis and the emerging fungal pathogen Candida auris contain a single SOD5-like SOD rather than a pair, and in both fungi, this SOD was induced by Fe starvation. This unexpected link between Fe homeostasis and extracellular Cu-SODs may help many fungi adapt to Fe-limited conditions of their hosts.	[Schatzman, Sabrina S.; Peterson, Ryan L.; Teka, Mieraf; He, Bixi; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Cabelli, Diane E.] Brookhaven Natl Labs, Dept Chem, Upton, NY 11973 USA; [Cormack, Brendan P.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Energy (DOE); Brookhaven National Laboratory; Johns Hopkins University	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculott1@jhu.edu		Schatzman, Sabrina/0000-0002-6645-5601	National Institutes of Health [RO1 AI119949, RO1 GM50016, T32 GM080189, F32 GM112320, 5R01AI046223]; United States Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences [DE-SC0012704]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE))	This work was supported by National Institutes of Health Grants RO1 AI119949 (to V. C. C.), RO1 GM50016 (to V. C. C.), T32 GM080189 (to S. S.), F32 GM112320 (to R. L. P.), and 5R01AI046223 (to B. P. C.), and United States Department of Energy (DOE) Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences Contract DE-SC0012704 to Brookhaven National Laboratories. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Bresgen N, 2015, BIOMOLECULES, V5, P808, DOI 10.3390/biom5020808; Broxton CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168400; Brunke S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004356; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; Castells-Roca L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148204; Castells-Roca L, 2011, MOL MICROBIOL, V81, P232, DOI 10.1111/j.1365-2958.2011.07689.x; Chakravarti A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170649; Chatterjee S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1863-z; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chi MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149548; CUDD A, 1982, J BIOL CHEM, V257, P1443; Datta KK, 2016, OMICS, V20, P239, DOI 10.1089/omi.2015.0197; De Freitas JM, 2000, J BIOL CHEM, V275, P11645, DOI 10.1074/jbc.275.16.11645; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frieman MB, 2004, MICROBIOL-SGM, V150, P3105, DOI 10.1099/mic.0.27420-0; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, J BIOL INORG CHEM, V19, P595, DOI 10.1007/s00775-013-1045-x; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; Hameed S, 2008, FEMS YEAST RES, V8, P744, DOI 10.1111/j.1567-1364.2008.00394.x; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; HIROSE J, 1982, ARCH BIOCHEM BIOPHYS, V218, P179, DOI 10.1016/0003-9861(82)90334-4; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Lackey E, 2013, EUKARYOT CELL, V12, P1356, DOI 10.1128/EC.00164-13; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P1589, DOI 10.1021/bi992822i; Larkin E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02396-16, 10.1128/AAC.02396-16]; Leaden L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02014; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Li F, 2015, FUNGAL GENET BIOL, V81, P160, DOI 10.1016/j.fgb.2014.09.006; Li LF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005147; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Mancera E, 2015, G3-GENES GENOM GENET, V5, P849, DOI 10.1534/g3.115.017566; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Mizusawa M, 2017, J CLIN MICROBIOL, V55, P638, DOI 10.1128/JCM.02202-16; Munoz JF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07779-6; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nguyen N, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00149-17, 10.1128/mspheredirect.00149-17]; Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Oberegger H, 2000, FEBS LETT, V485, P113, DOI 10.1016/S0014-5793(00)02206-7; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Peterson RL, 2016, J BIOL CHEM, V291, P20911, DOI 10.1074/jbc.M116.748251; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Robinett NG, 2019, J BIOL CHEM, V294, P2700, DOI 10.1074/jbc.RA118.007095; Robinett NG, 2018, J BIOL CHEM, V293, P4636, DOI 10.1074/jbc.TM117.000182; Rohm M, 2013, MOL MICROBIOL, V87, P132, DOI 10.1111/mmi.12087; Rossi DCP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006763; Schatzman SS, 2018, ACS INFECT DIS, V4, P893, DOI 10.1021/acsinfecdis.8b00026; Schmidt PJ, 1999, J BIOL CHEM, V274, P36952, DOI 10.1074/jbc.274.52.36952; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigle HC, 2005, J ANTIMICROB CHEMOTH, V55, P663, DOI 10.1093/jac/dki089; Sorgo AG, 2013, MICROBIOL-SGM, V159, P1673, DOI 10.1099/mic.0.065599-0; Sorgo AG, 2013, FEMS MICROBIOL LETT, V338, P10, DOI 10.1111/1574-6968.12049; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Spreghini E, 2003, EUKARYOT CELL, V2, P746, DOI 10.1128/EC.2.4.746-755.2003; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Urban C, 2005, MOL MICROBIOL, V57, P1318, DOI 10.1111/j.1365-2958.2005.04771.x; Watters MK, 2018, G3-GENES GENOM GENET, V8, P1439, DOI 10.1534/g3.118.200112; Wu YQ, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy057; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Yue HZ, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0187-x; Zarnowski R, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006872	86	11	12	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					570	583		10.1074/jbc.RA119.011084	http://dx.doi.org/10.1074/jbc.RA119.011084			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806705	Green Published, hybrid			2022-12-28	WOS:000507373600024
J	Singh, SK; Plieskatt, J; Chourasia, BK; Singh, V; Bolscher, JM; Dechering, KJ; Adu, B; Lopez-Mendez, B; Kaviraj, S; Locke, E; King, CR; Theisen, M				Singh, Susheel K.; Plieskatt, Jordan; Chourasia, Bishwanath Kumar; Singh, Vandana; Bolscher, Judith M.; Dechering, Koen J.; Adu, Bright; Lopez-Mendez, Blanca; Kaviraj, Swarnendu; Locke, Emily; King, C. Richter; Theisen, Michael			The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; parasite; protein expression; vaccine development; chromatography; immunogenicity; protein folding; circumsporozoite protein; Lactococcus lactis; Plasmodium falciparum	RTS,S/AS01 MALARIA VACCINE; PHASE-3 TRIAL; T-CELLS; SPOROZOITES; ANTIBODIES; EPITOPE; IMMUNOGENICITY; TRANSMISSION; EXPRESSION; PROTECTION	The Plasmodium falciparum circumsporozoite protein (PfCSP) is a sporozoite surface protein whose role in sporozoite motility and cell invasion has made it the leading candidate for a pre-erythrocytic malaria vaccine. However, production of high yields of soluble recombinant PfCSP, including its extensive NANP and NVDP repeats, has proven problematic. Here, we report on the development and characterization of a secreted, soluble, and stable full-length PfCSP (containing 4 NVDP and 38 NANP repeats) produced in the Lactococcus lactis expression system. The recombinant full-length PfCSP, denoted PfCSP4/38, was produced initially with a histidine tag and purified by a simple two-step procedure. Importantly, the recombinant PfCSP4/38 retained a conformational epitope for antibodies as confirmed by both in vivo and in vitro characterizations. We characterized this complex protein by HPLC, light scattering, MS analysis, differential scanning fluorimetry, CD, SDS-PAGE, and immunoblotting with conformation-dependent and -independent mAbs, which confirmed it to be both pure and soluble. Moreover, we found that the recombinant protein is stable at both frozen and elevated-temperature storage conditions. When we used L. lactis?derived PfCSP4/38 to immunize mice, it elicited high levels of functional antibodies that had the capacity to modify sporozoite motility in vitro. We concluded that the reported yield, purity, results of biophysical analyses, and stability of PfCSP4/38 warrant further consideration of using the L. lactis system for the production of circumsporozoite proteins for preclinical and clinical applications in malaria vaccine development.	[Singh, Susheel K.; Chourasia, Bishwanath Kumar; Singh, Vandana; Theisen, Michael] Statens Serum Inst, Dept Congenital Disorders, Artillerivej 5, DK-2300 Copenhagen, Denmark; [Singh, Susheel K.; Chourasia, Bishwanath Kumar; Singh, Vandana; Theisen, Michael] Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Lopez-Mendez, Blanca] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Singh, Susheel K.; Chourasia, Bishwanath Kumar; Singh, Vandana; Theisen, Michael] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Plieskatt, Jordan; Locke, Emily; King, C. Richter] PATHs Malaria Vaccine Initiat, Washington, DC 20001 USA; [Bolscher, Judith M.; Dechering, Koen J.] TropIQ Hlth Sci, NL-6534 AT Nijmegen, Netherlands; [Adu, Bright] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Kaviraj, Swarnendu] Gennova Biopharmaceut Ltd, Pune 411057, Maharashtra, India	Statens Serum Institut; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Ghana	Theisen, M (corresponding author), Statens Serum Inst, Dept Congenital Disorders, Artillerivej 5, DK-2300 Copenhagen, Denmark.	mth@ssi.dk	Adu, Bright/ABA-8631-2020	Adu, Bright/0000-0002-3622-2137; Singh, Vandana/0000-0002-8243-1343; Singh, Susheel K/0000-0003-1670-6246; Plieskatt, Jordan/0000-0002-2333-7234; Theisen, Michael/0000-0003-4412-1392	PATH's Malaria Vaccine Initiative [OPP1108403]; Bill & Melinda Gates Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research	PATH's Malaria Vaccine Initiative; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novo Nordisk Foundation Center for Protein Research	This work was funded by PATH's Malaria Vaccine Initiative under Grant OPP1108403 from the Bill & Melinda Gates Foundation and in part by Grant NNF14CC0001 from the Novo Nordisk Foundation Center for Protein Research. The authors declare that they have no conflicts of interest with the contents of this article.	Adu B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1146-4; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Barry Aissata, 2018, Wellcome Open Res, V3, P159, DOI 10.12688/wellcomeopenres.14932.1; Behet MC, 2018, INFECT IMMUN, V86, DOI [10.1128/iai.00920-17, 10.1128/IAI.00920-17]; Boes A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1328-0; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; DOROSARIO VE, 1989, T ROY SOC TROP MED H, V83, P305, DOI 10.1016/0035-9203(89)90481-1; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Espinosa DA, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0011-y; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Gosling R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001994; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Kana IH, 2017, J INFECT DIS, V215, P623, DOI 10.1093/infdis/jiw617; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kedees MH, 2002, EXP PARASITOL, V101, P64, DOI 10.1016/S0014-4894(02)00030-9; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Kurtovic L, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1054-2; Lousada-Dietrich S, 2011, VACCINE, V29, P3284, DOI 10.1016/j.vaccine.2011.02.022; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Noe AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107764; NUSSENZWEIG RS, 1989, REV INFECT DIS, V11, pS579; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Schwenk R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111020; Singh SK, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0902-2; Singh SK, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0710-0; Singh SK, 2015, VACCINE, V33, P1981, DOI 10.1016/j.vaccine.2015.02.040; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Theisen M, 2004, VACCINE, V22, P1188, DOI 10.1016/j.vaccine.2003.09.017; Theisen M, 2017, EXPERT REV VACCINES, V16, P907, DOI 10.1080/14760584.2017.1355246; Theisen M, 2014, VACCINE, V32, P2623, DOI 10.1016/j.vaccine.2014.03.020; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; World Health Organization, 2018, WORLD MAL REP 2018; YOUNG JF, 1985, SCIENCE, V228, P958, DOI 10.1126/science.2988125; Zhao JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161607	49	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					403	414		10.1074/jbc.RA119.011268	http://dx.doi.org/10.1074/jbc.RA119.011268			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31792057	Green Published, hybrid			2022-12-28	WOS:000507373600012
J	Deeb, SK; Guzik-Lendrum, S; Jeffrey, JD; Gilbert, SP				Deeb, Stephanie K.; Guzik-Lendrum, Stephanie; Jeffrey, Jasper D.; Gilbert, Susan P.			The ability of the kinesin-2 heterodimer KIF3AC to navigate microtubule networks is provided by the KIF3A motor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; fluorescence; intracellular trafficking; kinesin; microtubule; neuron; molecular motor; processivity; single-molecule biophysics; TIRF microscopy	LEFT-RIGHT ASYMMETRY; TUG-OF-WAR; SUPERFAMILY PROTEIN; TRANSPORT; SUBUNIT; FAMILY; INTERSECTIONS; COORDINATION; MECHANISMS; EXPRESSION	Heterodimeric kinesin family member KIF3AC is a mammalian kinesin-2 that is highly expressed in the central nervous system and has been implicated in intracellular transport. KIF3AC is unusual in that the motility characteristics of KIF3C when expressed as a homodimer are exceeding slow, whereas homodimeric KIF3AA, as well as KIF3AC, have much faster ATPase kinetics and single molecule velocities. Heterodimeric KIF3AC and homodimeric KIF3AA and KIF3CC are processive, although the run length of KIF3AC exceeds that of KIF3AA and KIF3CC. KIF3C is of particular interest because it exhibits a signature 25-residue insert of glycine and serine residues in loop L11 of its motor domain, and this insert is not present in any other kinesin, suggesting that it confers specific properties to mammalian heterodimeric KIF3AC. To gain a better understanding of the mechanochemical potential of KIF3AC, we pursued a single molecule study to characterize the navigation ability of KIF3AC, KIF3AA, and KIF3CC when encountering microtubule intersections. The results show that all three motors exhibited a preference to remain on the same microtubule when approaching an intersection from the top microtubule, and the majority of track switches occurred from the bottom microtubule onto the top microtubule. Heterodimeric KIF3AC and homodimeric KIF3AA displayed a similar likelihood of switching tracks (36.1 and 32.3%, respectively). In contrast, KIF3CC detached at intersections (67.7%) rather than switch tracks. These results indicate that it is the properties of KIF3A that contribute largely to the ability of KIF3AC to switch microtubule tracks to navigate intersections.	[Deeb, Stephanie K.; Guzik-Lendrum, Stephanie; Jeffrey, Jasper D.; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	sgilbert@rpi.edu			National Institutes of Health [R37-GM054141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37-GM054141 (to S. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Arpag G, 2019, BIOPHYS J, V116, P1115, DOI 10.1016/j.bpj.2019.01.036; Bensel B. M. W., 2019, STRAIN DEPENDENT KIN, P793075, DOI [10.1101/793075, DOI 10.1101/793075]; Bensel BM, 2017, P NATL ACAD SCI USA, V114, pE4281, DOI 10.1073/pnas.1701482114; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Bergman JP, 2018, P NATL ACAD SCI USA, V115, P537, DOI 10.1073/pnas.1707936115; Conway L, 2012, P NATL ACAD SCI USA, V109, P20814, DOI 10.1073/pnas.1209304109; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Engelke MF, 2019, CURR BIOL, V29, P1137, DOI 10.1016/j.cub.2019.02.043; Feng QZ, 2018, BIOPHYS J, V114, P400, DOI 10.1016/j.bpj.2017.11.016; Ferro LS, 2019, ELIFE, V8, DOI 10.7554/eLife.48629; Gao Y, 2018, BIOPHYS J, V114, P2900, DOI 10.1016/j.bpj.2018.05.010; Gilbert SP, 2018, J BIOL CHEM, V293, P4510, DOI 10.1074/jbc.R117.001324; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guzik-Lendrum S, 2017, BIOPHYS J, V113, P1845, DOI 10.1016/j.bpj.2017.09.015; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2017, TRAFFIC, V18, P304, DOI 10.1111/tra.12478; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Navone F, 2001, J NEUROCHEM, V77, P741, DOI 10.1046/j.1471-4159.2001.00277.x; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Osunbayo O, 2015, BIOPHYS J, V108, P1480, DOI 10.1016/j.bpj.2015.02.016; Prevo B, 2017, FEBS J, V284, P2905, DOI 10.1111/febs.14068; Quinn SM, 2018, J BIOL CHEM, V293, P13389, DOI 10.1074/jbc.RA118.002767; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Ross JL, 2008, BIOPHYS J, V94, P3115, DOI 10.1529/biophysj.107.120014; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Silverman MA, 2010, CYTOSKELETON, V67, P784, DOI 10.1002/cm.20487; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Woll KA, 2018, J BIOL CHEM, V293, P11283, DOI 10.1074/jbc.RA118.002182; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang R, 2019, TRAFFIC, V20, P851, DOI 10.1111/tra.12692; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970	55	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20070	20083		10.1074/jbc.RA119.010725	http://dx.doi.org/10.1074/jbc.RA119.010725			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748411	Green Published, hybrid			2022-12-28	WOS:000505005800020
J	Ugbode, C; Fort-Aznar, L; Sweeney, ST				Ugbode, Chris; Fort-Aznar, Laura; Sweeney, Sean T.			Leaky endosomes push tau over the seed limit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PATHOLOGY	The inter- and intracellular propagation of aggregated proteins like tau is emerging as a central mechanism behind progression of various neurodegenerative diseases. The steps by which tau aggregates and propagates is currently unclear. Chen et al. now combine a cell-based model of tau aggregation with a CRISPR interference (CRISPRi) genetic screen to identify components of the endosomal sorting complex required for transport (ESCRT) machinery as mediators of intracellular propagation of tau aggregates. These findings reveal a role for endolysosomal integrity in blocking tau propagation.	[Ugbode, Chris; Fort-Aznar, Laura; Sweeney, Sean T.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of York - UK	Sweeney, ST (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	sean.sweeney@york.ac.uk	Fort-Aznar, Laura/AAF-1908-2021	Ugbode, Christopher/0000-0002-6023-8294; Sweeney, Sean/0000-0003-2673-9578; Fort-Aznar, Laura/0000-0002-3869-7494	BBSRC [BB/I01179X/1] Funding Source: UKRI; Motor Neurone Disease Association [SWEENEY/OCT15/884-792] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Motor Neurone Disease Association		Anding AL, 2018, CURR BIOL, V28, P287, DOI 10.1016/j.cub.2017.11.064; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brion JP, 1998, EUR NEUROL, V40, P130, DOI 10.1159/000007969; Chen JJ, 2019, J BIOL CHEM, V294, P18952, DOI 10.1074/jbc.RA119.009432; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Skowyra ML, 2018, SCIENCE, V360, P49, DOI 10.1126/science.aar5078; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Takada Leonel T., 2015, Dement. neuropsychol., V9, P219, DOI [10.1590/1980-57642015dn93000003, 10.1590/1980-57642015DN93000003]	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					18967	18968		10.1074/jbc.H119.011687	http://dx.doi.org/10.1074/jbc.H119.011687			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836670	Green Published, hybrid			2022-12-28	WOS:000516527800002
J	Spiering, MJ				Spiering, Martin J.			Tor comes to the fore in autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PHOSPHATIDYLINOSITOL KINASE HOMOLOG; YEAST; MUTANTS					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohsumi Y., 2016, COMMUNICATION   1207; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Thorburn A, 2018, J BIOL CHEM, V293, P5425, DOI 10.1074/jbc.R117.810739; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yamamoto H, 2015, J BIOL CHEM, V290, P29506, DOI 10.1074/jbc.M115.684233	13	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18519	18520		10.1074/jbc.CL119.011710	http://dx.doi.org/10.1074/jbc.CL119.011710			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31784480	Green Published, hybrid			2022-12-28	WOS:000505547900045
J	Bharadwaj, VS; Knott, BC; Stahlberg, J; Beckham, GT; Crowley, MF				Bharadwaj, Vivek S.; Knott, Brandon C.; Stahlberg, Jerry; Beckham, Gregg T.; Crowley, Michael F.			The hydrolysis mechanism of a GH45 cellulase and its potential relation to lytic transglycosylase and expansin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; cellulase; molecular dynamics; enzyme mechanism; cellulose; expansins; GH45; lytic transglycosylases; QM; MM; transition path sampling	MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CELL-WALL; PEPTIDOGLYCAN BINDING; HUMICOLA INSOLENS; ENDOGLUCANASE V; CELLOBIOHYDROLASE; CHARMM; SIMULATIONS; SUBSTRATE	Family 45 glycoside hydrolases (GH45) are endoglucanases that are integral to cellulolytic secretomes, and their ability to break down cellulose has been successfully exploited in textile and detergent industries. In addition to their industrial relevance, understanding the molecular mechanism of GH45-catalyzed hydrolysis is of fundamental importance because of their structural similarity to cell wall?modifying enzymes such as bacterial lytic transglycosylases (LTs) and expansins present in bacteria, plants, and fungi. Our understanding of the catalytic itinerary of GH45s has been incomplete because a crystal structure with substrate spanning the ?1 to +1 subsites is currently lacking. Here we constructed and validated a putative Michaelis complex in silico and used it to elucidate the hydrolytic mechanism in a GH45, Cel45A from the fungus Humicola insolens, via unbiased simulation approaches. These molecular simulations revealed that the solvent-exposed active-site architecture results in lack of coordination for the hydroxymethyl group of the substrate at the ?1 subsite. This lack of coordination imparted mobility to the hydroxymethyl group and enabled a crucial hydrogen bond with the catalytic acid during and after the reaction. This suggests the possibility of a nonhydrolytic reaction mechanism when the catalytic base aspartic acid is missing, as is the case in some LTs (murein transglycosylase A) and expansins. We calculated reaction free energies and demonstrate the thermodynamic feasibility of the hydrolytic and nonhydrolytic reaction mechanisms. Our results provide molecular insights into the hydrolysis mechanism in HiCel45A, with possible implications for elucidating the elusive catalytic mechanism in LTs and expansins.	[Bharadwaj, Vivek S.; Knott, Brandon C.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, S-75007 Uppsala, Sweden	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Swedish University of Agricultural Sciences	Crowley, MF (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.; Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; michael.crowley@nrel.gov	; Stahlberg, Jerry/D-4163-2013	Bharadwaj, Vivek/0000-0001-5851-9807; Knott, Brandon/0000-0003-3414-3897; Stahlberg, Jerry/0000-0003-4059-8580; Hart, Gerald/0000-0001-7812-4351	Department of Energy [DE-AC36-08GO28308]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Department of Energy(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was authored in part by the Alliance for Sustainable Energy, LLC, the manager and operator of the National Renewable Energy Laboratory for the Department of Energy under Contract DE-AC36-08GO28308. We are also grateful for access to and use of National Renewable Energy Laboratory Computational Sciences resources (Peregrine and Eagle), supported by the Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; Barnett CB, 2011, J AM CHEM SOC, V133, P19474, DOI 10.1021/ja206842j; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biarnes X, 2011, J AM CHEM SOC, V133, P20301, DOI 10.1021/ja207113e; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burgin T, 2019, REACT CHEM ENG, V4, P402, DOI 10.1039/c8re00240a; Byun B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22527-y; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case D., 2017, AMBER 16 AMBERTOOLS1; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fibriansah G, 2012, BIOCHEMISTRY-US, V51, P9164, DOI 10.1021/bi300900t; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Godoy AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21798-9; Grossfield A., WHAM WEIGHTED HISTOG; Hynninen AP, 2014, J COMPUT CHEM, V35, P406, DOI 10.1002/jcc.23501; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Lee M, 2016, ACS CHEM BIOL, V11, P1525, DOI 10.1021/acschembio.6b00194; Mayes HB, 2016, CHEM SCI, V7, P5955, DOI 10.1039/c6sc00571c; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Peters B, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2409924; Peters B, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2748396; Peters B, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2234477; Peters B, 2016, ANNU REV PHYS CHEM, V67, P669, DOI 10.1146/annurev-physchem-040215-112215; Peters B, 2010, MOL SIMULAT, V36, P1265, DOI 10.1080/08927020903536382; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Quay DHX, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0039-z; Rasmussen G., 1995, EPO Patent, Patent No. [531372B1, 531372]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schulein M., 1998, ACS SYM SER, V687, P66, DOI [10.1021/BK-1998-0687.CH006, DOI 10.1021/BK-1998-0687.CH006]; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Thompson AJ, 2012, ANGEW CHEM INT EDIT, V51, P10997, DOI 10.1002/anie.201205338; van Straaten KE, 2007, J BIOL CHEM, V282, P21197, DOI 10.1074/jbc.M701818200; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Williams AH, 2018, J BIOL CHEM, V293, P6000, DOI 10.1074/jbc.RA117.001095; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103	63	11	11	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4477	4487		10.1074/jbc.RA119.011406	http://dx.doi.org/10.1074/jbc.RA119.011406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32054684	Green Published, hybrid			2022-12-28	WOS:000524499700010
J	Pitsawong, W; Chenprakhon, P; Dhammaraj, T; Medhanavyn, D; Sucharitakul, J; Tongsook, C; van Berkel, WJH; Chaiyen, P; Miller, AF				Pitsawong, Warintra; Chenprakhon, Pirom; Dhammaraj, Taweesak; Medhanavyn, Dheeradhach; Sucharitakul, Jeerus; Tongsook, Chanakan; van Berkel, Willem J. H.; Chaiyen, Pimchai; Miller, Anne-Frances			Tuning of pK(a) values activates substrates in flavin-dependent aromatic hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; flavoprotein; enzyme mechanism; enzyme kinetics; nuclear magnetic resonance (NMR); 19F NMR; flavin-dependent monooxygenase; pKa tuning	P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; PARA-HYDROXYBENZOATE HYDROXYLASE; OXYGENASE COMPONENT; F-19 NMR; 3-HYDROXYBENZOATE 6-HYDROXYLASE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; FREE-ENERGY; PROTON; MONOOXYGENASE	Hydroxylation of substituted phenols by flavin-dependent monooxygenases is the first step of their biotransformation in various microorganisms. The reaction is thought to proceed via electrophilic aromatic substitution, catalyzed by enzymatic deprotonation of substrate, in single-component hydroxylases that use flavin as a cofactor (group A). However, two-component hydroxylases (group D), which use reduced flavin as a co-substrate, are less amenable to spectroscopic investigation. Herein, we employed F-19 NMR in conjunction with fluorinated substrate analogs to directly measure pK(a) values and to monitor protein events in hydroxylase active sites. We found that the single-component monooxygenase 3-hydroxybenzoate 6-hydroxylase (3HB6H) depresses the pK(a) of the bound substrate analog 4-fluoro-3-hydroxybenzoate (4F3HB) by 1.6 pH units, consistent with previously proposed mechanisms. F-19 NMR was applied anaerobically to the two-component monooxygenase 4-hydroxyphenylacetate 3-hydroxylase (HPAH), revealing depression of the pK(a) of 3-fluoro-4-hydroxyphenylacetate by 2.5 pH units upon binding to the C-2 component of HPAH. F-19 NMR also revealed a pK(a) of 8.7 ? 0.05 that we attributed to an active-site residue involved in deprotonating bound substrate, and assigned to His-120 based on studies of protein variants. Thus, in both types of hydroxylases, we confirmed that binding favors the phenolate form of substrate. The 9 and 14 kJ/mol magnitudes of the effects for 3HB6H and HPAH-C-2, respectively, are consistent with pK(a) tuning by one or more H-bonding interactions. Our implementation of F-19 NMR in anaerobic samples is applicable to other two-component flavin-dependent hydroxylases and promises to expand our understanding of their catalytic mechanisms.	[Pitsawong, Warintra; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Chenprakhon, Pirom] Mahidol Univ, Inst Innovat Learning, Salaya 73170, Nakhon Pathom, Thailand; [Dhammaraj, Taweesak] Mahasarakham Univ, Fac Pharm, Maha Sarakham 44150, Thailand; [Medhanavyn, Dheeradhach] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Medhanavyn, Dheeradhach] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10300, Thailand; [Tongsook, Chanakan] Silpakorn Univ, Fac Sci, Dept Chem, Amphoe Muang 730000, Nakhon Pathom, Thailand; [van Berkel, Willem J. H.] Wageningen Univ & Res, Lab Food Chem, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands; [Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol, Sch Biomol Sci & Engn, 555 Moo 1 Payupnai, Wangchan 21210, Rayong, Thailand; [Pitsawong, Warintra] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA	University of Kentucky; Mahidol University; Mahasarakham University; Mahidol University; Mahidol University; Chulalongkorn University; Silpakorn University; Wageningen University & Research; Vidyasirimedhi Institute of Science & Technology; Brandeis University	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, 555 Moo 1 Payupnai, Wangchan 21210, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th; afmill3r2@gmail.com	van Berkel, Willem J.H./O-2431-2014; Dhammaraj, Taweesak/GYJ-3406-2022; pitsawong, warintra/G-1760-2018	van Berkel, Willem J.H./0000-0002-6551-2782; Chenprakhon, Pirom/0000-0002-5927-6920; pitsawong, warintra/0000-0001-5438-1783	Center for Pharmaceutical Development, National Science Foundation [I/UCRC IIP-1540011]; Research Challenge Trust Fund Fellowship; National Science Foundation, Chemistry of Life Processes [CHE-1808433]; Thailand Research Fund [RTA5980001, MRG6180156, RSA5980062]; Thailand Science Research and Innovation Global Partnership Program; Vidyasirimedhi Institute of Science and Technology (VISTEC)	Center for Pharmaceutical Development, National Science Foundation; Research Challenge Trust Fund Fellowship; National Science Foundation, Chemistry of Life Processes(National Science Foundation (NSF)); Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Science Research and Innovation Global Partnership Program; Vidyasirimedhi Institute of Science and Technology (VISTEC)	This work was supported by the Vice President for Research of the University of Kentucky, the Center for Pharmaceutical Development, National Science Foundation Grant I/UCRC IIP-1540011 (to A.-F. M.), a Research Challenge Trust Fund Fellowship (to W. P.), the National Science Foundation, Chemistry of Life Processes Grant CHE-1808433 (to A.-F. M.), the Thailand Research Fund grant RTA5980001, Thailand Science Research and Innovation Global Partnership Program and Vidyasirimedhi Institute of Science and Technology (VISTEC) (to P. Chaiyen), and Thailand Research Fund Grants MRG6180156 (to P. Chenprakhon) and RSA5980062 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Arunima, 2005, MAGN RESON CHEM, V43, P132, DOI 10.1002/mrc.1520; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Benitez AR, 2019, ACS CATAL, V9, P3633, DOI 10.1021/acscatal.8b04575; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chenprakhon P, 2019, PROTEIN SCI, V28, P8, DOI 10.1002/pro.3525; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dhammaraj T, 2016, ACS CHEM BIOL, V11, P2889, DOI 10.1021/acschembio.6b00402; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; Dockrey SAB, 2018, NAT CHEM, V10, P119, DOI [10.1038/NCHEM.2879, 10.1038/nchem.2879]; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; DUGAD LB, 1988, BIOCHEMISTRY-US, V27, P4310, DOI 10.1021/bi00412a018; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; ESCHRICH K, 1993, EUR J BIOCHEM, V216, P137, DOI 10.1111/j.1432-1033.1993.tb18125.x; Everill P, 2012, J AM CHEM SOC, V134, P2348, DOI 10.1021/ja210091q; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Fersht A., 1985, ENZYME STRUCTURE MEC, P174; Gerig J.T., 2003, BIOPHYSICS TXB ONLIN, P1; GERIG JT, 1994, PROG NUCL MAG RES SP, V26, P293, DOI 10.1016/0079-6565(94)80009-X; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1980, J BIOL CHEM, V255, P4189; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Jadan AP, 2004, ADV SYNTH CATAL, V346, P367, DOI 10.1002/adsc.200303146; Kahyaoglu A, 2002, PROTEIN SCI, V11, P965, DOI 10.1110/ps.3890102; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; PEELEN S, 1993, EUR J BIOCHEM, V218, P345, DOI 10.1111/j.1432-1033.1993.tb18383.x; Perrin D. D., 1983, BUFFERS PH METAL ION, P159; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimviriyakul P, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01482e; Pinthong C, 2017, PROCESS BIOCHEM, V63, P122, DOI 10.1016/j.procbio.2017.08.006; Ridder L, 2003, J PHYS CHEM B, V107, P2118, DOI 10.1021/jp026213n; Ridder L, 2000, J AM CHEM SOC, V122, P8728, DOI 10.1021/ja0007814; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Salopek-Sondi B, 2002, PROTEIN ENG, V15, P855, DOI 10.1093/protein/15.11.855; Sanders LK, 2001, J PHYS CHEM A, V105, P8098, DOI 10.1021/jp011114f; SHOUN H, 1979, J BIOL CHEM, V254, P899; Spencer RGS, 2000, J MAGN RESON, V142, P120, DOI 10.1006/jmre.1999.1925; Stockman BJ, 2008, J AM CHEM SOC, V130, P5870, DOI 10.1021/ja801588u; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2016, FEBS J, V283, P860, DOI 10.1111/febs.13636; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sucharitakul J, 2012, BIOCHEMISTRY-US, V51, P4309, DOI 10.1021/bi201823c; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700632; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; Tozawa K, 1996, FEBS LETT, V397, P122, DOI 10.1016/S0014-5793(96)01155-6; Tweedy SE, 2019, J PHYS CHEM B, V123, P8065, DOI 10.1021/acs.jpcb.9b08178; VALCOUR AA, 1986, J MAGN RESON, V66, P536, DOI 10.1016/0022-2364(86)90197-6; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANBERKEL WJH, 1989, EUR J BIOCHEM, V179, P307; VERVOORT J, 1992, EUR J BIOCHEM, V206, P479, DOI 10.1111/j.1432-1033.1992.tb16950.x; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Wang XY, 2018, THEOR CHEM ACC, V137, DOI 10.1007/s00214-018-2278-0; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Zhu YG, 2013, J AM CHEM SOC, V135, P18750, DOI 10.1021/ja410513g	75	6	6	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3965	3981		10.1074/jbc.RA119.011884	http://dx.doi.org/10.1074/jbc.RA119.011884			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014994	Green Published, hybrid			2022-12-28	WOS:000527704400021
J	Pang, HM; Wang, XD; Zhao, SQ; Xi, W; Lv, JL; Qin, JW; Zhao, Q; Che, YZ; Chen, LY; Li, SJ				Pang, Huimin; Wang, Xudong; Zhao, Shiqun; Xi, Wang; Lv, Jili; Qin, Jiwei; Zhao, Qing; Che, Yongzhe; Chen, Liangyi; Li, Shu Jie			Loss of the voltage-gated proton channel Hv1 decreases insulin secretion and leads to hyperglycemia and glucose intolerance in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin secretion; pancreatic islet; ?-cell; glucose metabolism; homeostasis; diabetes; Hv1; voltage-gated proton channel	BETA-CELL DYSFUNCTION; SUPEROXIDE-PRODUCTION; GRANULE DYNAMICS; INTRACELLULAR PH; EXOCYTOSIS; MECHANISMS; RELEASE; PROTEIN; MOUSE	Insulin secretion by pancreatic islet ?-cells is regulated by glucose levels and is accompanied by proton generation. The voltage-gated proton channel Hv1 is present in pancreatic ?-cells and extremely selective for protons. However, whether Hv1 is involved in insulin secretion is unclear. Here we demonstrate that Hv1 promotes insulin secretion of pancreatic ?-cells and glucose homeostasis. Hv1-deficient mice displayed hyperglycemia and glucose intolerance because of reduced insulin secretion but retained normal peripheral insulin sensitivity. Moreover, Hv1 loss contributed much more to severe glucose intolerance as the mice got older. Islets of Hv1-deficient and heterozygous mice were markedly deficient in glucose- and K+-induced insulin secretion. In perifusion assays, Hv1 deletion dramatically reduced the first and second phase of glucose-stimulated insulin secretion. Islet insulin and proinsulin content was reduced, and histological analysis of pancreas slices revealed an accompanying modest reduction of ?-cell mass in Hv1 knockout mice. EM observations also indicated a reduction in insulin granule size, but not granule number or granule docking, in Hv1-deficient mice. Mechanistically, Hv1 loss limited the capacity for glucose-induced membrane depolarization, accompanied by a reduced ability of glucose to raise Ca2+ levels in islets, as evidenced by decreased durations of individual calcium oscillations. Moreover, Hv1 expression was significantly reduced in pancreatic ?-cells from streptozotocin-induced diabetic mice, indicating that Hv1 deficiency is associated with ?-cell dysfunction and diabetes. We conclude that Hv1 regulates insulin secretion and glucose homeostasis through a mechanism that depends on intracellular Ca2+ levels and membrane depolarization.	[Pang, Huimin; Wang, Xudong; Xi, Wang; Lv, Jili; Qin, Jiwei; Zhao, Qing; Li, Shu Jie] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Dept Biophys,Sch Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Zhao, Shiqun; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Che, Yongzhe] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Nankai University; Peking University; Nankai University	Chen, LY; Li, SJ (corresponding author), Nankai Univ, Minist Educ, Key Lab Bioact Mat, Dept Biophys,Sch Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	lychen@pku.edu.cn; shujieli@nankai.edu.cn			National Natural Science Foundation of China [31271464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Natural Science Foundation of China Grant 31271464. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barg S, 2001, J CELL SCI, V114, P2145; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CERASI E, 1975, DIABETOLOGIA, V11, P1, DOI 10.1007/BF00422811; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Gunawardana SC, 2002, DIABETES, V51, P105, DOI 10.2337/diabetes.51.1.105; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LINDSTROM P, 1984, BIOCHEM J, V218, P887, DOI 10.1042/bj2180887; LINDSTROM P, 1986, BIOCHEM J, V239, P199, DOI 10.1042/bj2390199; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nunemaker CS, 2006, AM J PHYSIOL-ENDOC M, V290, pE523, DOI 10.1152/ajpendo.00392.2005; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; PACE CS, 1983, AM J PHYSIOL, V244, pE3, DOI 10.1152/ajpendo.1983.244.1.E3; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Qureshi FM, 2015, CELL CALCIUM, V57, P366, DOI 10.1016/j.ceca.2015.03.002; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; TAGUCHI N, 1995, ENDOCRINOLOGY, V136, P3942, DOI 10.1210/en.136.9.3942; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070550; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhao AZ, 2010, DIABETES, V59, P2522, DOI 10.2337/db09-1719; Zhao Q, 2015, BIOCHEM BIOPH RES CO, V468, P746, DOI 10.1016/j.bbrc.2015.11.027	40	6	6	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3601	3613		10.1074/jbc.RA119.010489	http://dx.doi.org/10.1074/jbc.RA119.010489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31949049	hybrid, Green Published			2022-12-28	WOS:000527725300019
J	Capell-Hattam, IM; Sharpe, LJ; Qian, L; Hart-Smith, G; Prabhu, AV; Brown, AJ				Capell-Hattam, Isabelle M.; Sharpe, Laura J.; Qian, Lydia; Hart-Smith, Gene; Prabhu, Anika V.; Brown, Andrew J.			Twin enzymes, divergent control: The cholesterogenic enzymes DHCR14 and LBR are differentially regulated transcriptionally and post-translationally	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; endoplasmic reticulum-associated protein degradation (ERAD); protein degradation; enzyme degradation; DHCR14; LBR; TM7SF2	LAMIN-B RECEPTOR; MEIOSIS-ACTIVATING STEROLS; 3-BETA-HYDROXYSTEROL DELTA(14)-REDUCTASE; SQUALENE MONOOXYGENASE; UBIQUITIN LIGASES; REDUCTASE; TM7SF2; DEGRADATION; MUTATIONS; DYSPLASIA	Cholesterol synthesis is a tightly regulated process, both transcriptionally and post-translationally. Transcriptional control of cholesterol synthesis is relatively well-understood. However, of the ?20 enzymes in cholesterol biosynthesis, post-translational regulation has only been examined for a small number. Three of the four sterol reductases in cholesterol production, 7-dehydrocholesterol reductase (DHCR7), 14-dehydrocholesterol reductase (DHCR14), and lamin-B receptor (LBR), share evolutionary ties with a high level of sequence homology and predicted structural homology. DHCR14 and LBR uniquely share the same ?-14 reductase activity in cholesterol biosynthesis, yet little is known about their post-translational regulation. We have previously identified specific modes of post-translational control of DHCR7, but it is unknown whether these regulatory mechanisms are shared by DHCR14 and LBR. Using CHO-7 cells stably expressing epitope-tagged DHCR14 or LBR, we investigated the post-translational regulation of these enzymes. We found that DHCR14 and LBR undergo differential post-translational regulation, with DHCR14 being rapidly turned over, triggered by cholesterol and other sterol intermediates, whereas LBR remained stable. DHCR14 is degraded via the ubiquitin-proteasome system, and we identified several DHCR14 and DHCR7 putative interaction partners, including a number of E3 ligases that modulate DHCR14 levels. Interestingly, we found that gene expression across an array of human tissues showed a negative relationship between the C14-sterol reductases; one enzyme or the other tends to be predominantly expressed in each tissue. Overall, our findings indicate that whereas LBR tends to be the constitutively active C14-sterol reductase, DHCR14 levels are tunable, responding to the local cellular demands for cholesterol.	[Capell-Hattam, Isabelle M.; Sharpe, Laura J.; Qian, Lydia; Hart-Smith, Gene; Prabhu, Anika V.; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Hart-Smith, Gene] Macquarie Univ, Dept Mol Sci, Macquarie Pk, NSW 2109, Australia	University of New South Wales Sydney; Macquarie University	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Hart-Smith, Gene/0000-0003-3907-0367; Prabhu, Anika/0000-0002-3809-1716; Capell-Hattam, Isabelle M/0000-0002-0902-0062; Sharpe, Laura/0000-0002-9896-294X	Australian Research Council [DP170101178]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP170101178 to (A. J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Byskov AG, 1999, J EXP ZOOL, V285, P237, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;237::AID-JEZ6&gt;3.0.CO;2-S; Byskov AG, 1998, J MOL MED-JMM, V76, P818, DOI 10.1007/s001090050286; Chen L, 2019, J LIPID RES, V60, P1765, DOI 10.1194/jlr.RA119000201; Chua NK, 2019, BIOCHEM J, V476, P2545, DOI 10.1042/BCJ20190418; Chua NK, 2019, J BIOL CHEM, V294, P8134, DOI 10.1074/jbc.RA119.007798; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Clayton P, 2010, NUCLEUS-PHILA, V1, P354, DOI 10.4161/nucl.1.4.12435; Cohen TV, 2008, HUM MOL GENET, V17, P2921, DOI 10.1093/hmg/ddn191; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hart-Smith G, 2012, J AM SOC MASS SPECTR, V23, P124, DOI 10.1007/s13361-011-0273-y; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; KIM CK, 1995, BBA-LIPID LIPID MET, V1259, P39, DOI 10.1016/0005-2760(95)00128-Y; Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liokatis S, 2012, J BIOL CHEM, V287, P1032, DOI 10.1074/jbc.M111.281303; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Platt FM, 2014, ANNU REV GENOM HUM G, V15, P173, DOI 10.1146/annurev-genom-091212-153412; Prabhu AV, 2017, J STEROID BIOCHEM, V165, P363, DOI 10.1016/j.jsbmb.2016.08.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prakash A, 2002, J BIOSCIENCES, V27, P105, DOI 10.1007/BF02703766; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Scott NA, 2020, BIOCHEM J, V477, P541, DOI 10.1042/BCJ20190647; Sharpe LJ, 2019, J BIOL CHEM, V294, P2436, DOI 10.1074/jbc.RA118.005069; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Smith DL, 2018, ANAL CHEM, V90, P9101, DOI 10.1021/acs.analchem.8b01525; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Tsai PL, 2016, ELIFE, V5, DOI 10.7554/eLife.16011; Wassif CA, 2007, HUM MOL GENET, V16, P1176, DOI 10.1093/hmg/ddm065; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	60	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2850	2865		10.1074/jbc.RA119.011323	http://dx.doi.org/10.1074/jbc.RA119.011323			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31911440	Green Published, hybrid			2022-12-28	WOS:000519969100026
J	Sircar, G; Bhowmik, M; Sarkar, RK; Najafi, N; Dasgupta, A; Focke-Tejkl, M; Flicker, S; Mittermann, I; Valenta, R; Bhattacharya, K; Bhattacharya, SG				Sircar, Gaurab; Bhowmik, Moumita; Sarkar, Rajat Kanti; Najafi, Nazanin; Dasgupta, Angira; Focke-Tejkl, Margarete; Flicker, Sabine; Mittermann, Irene; Valenta, Rudolf; Bhattacharya, Kashinath; Bhattacharya, Swati Gupta			Molecular characterization of a fungal cyclophilin allergen Rhi o 2 and elucidation of antigenic determinants responsible for IgE?cross-reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; allergen; immunoglobulin E (IgE); epitope mapping; cyclophilin; fungi; Rhi o 2	CRYSTAL-STRUCTURE; CROSS-REACTIVITY; IDENTIFICATION; POLLEN; FAMILY; PURIFICATION; EXPRESSION; SPECTRUM; EPITOPE	Cyclophilins are structurally conserved pan-allergens showing extensive cross-reactivity. So far, no precise information on cross-reactive IgE-epitopes of cyclophilins is available. Here, an 18-kDa IgE-reactive cyclophilin (Rhi o 2) was purified from Rhizopus oryzae, an indoor mold causing allergic sensitization. Based on LC-MS/MS-derived sequences of natural Rhi o 2, the full-length cDNA was cloned, and expressed as recombinant (r) allergen. Purified rRhi o 2 displayed IgE-reactivity and basophil degranulation with sera from all cyclophilin-positive patients. The melting curve of properly folded rRhi o 2 showed partial refolding after heat denaturation. The allergen displayed monomeric functional peptidyl-prolyl cis-trans isomerase (PPIase) activity. In IgE-inhibition assays, rRhi o 2 exhibited extensive cross-reactivity with various other cyclophilins reported as allergens from diverse sources including its homologous human autoantigen. By generating a series of deletion mutants, a conserved 69-residue (Asn(81)-Asn(149)) fragment at C terminus of Rhi o 2 was identified as crucial for IgE-recognition and cross-reactivity. Grafting of the Asn(81)-Asn(149) fragment within the primary structure of yeast cyclophilin CPR1 by replacing its homologous sequence resulted in a hybrid molecule with structural folds similar to Rhi o 2. The IgE-reactivity and allergenic activity of the hybrid cyclophilin were greater than that of CPR1. Therefore, the Asn(81)-Asn(149) fragment can be considered as the site of IgE recognition of Rhi o 2. Hence, Rhi o 2 serves as a candidate antigen for the molecular diagnosis of mold allergy, and determination of a major cross-reactive IgE-epitope has clinical potential for the design of next-generation immunotherapeutics against cyclophilin-induced allergies.	[Sircar, Gaurab; Sarkar, Rajat Kanti; Bhattacharya, Kashinath] Visva Bharati, Dept Bot, Santini Ketan 731235, W Bengal, India; [Sircar, Gaurab; Bhowmik, Moumita; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India; [Najafi, Nazanin; Focke-Tejkl, Margarete; Flicker, Sabine; Mittermann, Irene; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiologyinfectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Dasgupta, Angira] BR Singh Hosp, Dept Chest Med, Kolkata 700014, India; [Dasgupta, Angira] Ctr Med Educ & Res, Kolkata 700014, India; [Valenta, Rudolf] NRC Inst Immunol FMBA Russia, Moscow 115478, Russia; [Valenta, Rudolf] Sechenov First Moscow State Med Univ, Dept Clin Immunol & Allergy, Moscow 119146, Russia	Visva Bharati University; Department of Science & Technology (India); Bose Institute; Medical University of Vienna; NRC Institute of Immunology FMBA of Russia; Sechenov First Moscow State Medical University	Sircar, G; Bhattacharya, K (corresponding author), Visva Bharati, Dept Bot, Santini Ketan 731235, W Bengal, India.; Sircar, G; Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India.	sircar.gaurab1@gmail.com; kashinathb23@rediffmail.com; swati@jcbose.ac.in		Flicker, Sabine/0000-0003-4768-8693; Focke, Margarete/0000-0003-3433-5071; Valenta, Rudolf/0000-0001-5944-3365; Sircar, Gaurab/0000-0002-9067-4564	Wellcome Trust/DBT India Alliance through an Early Career Fellowship [IA/E/17/1/503696]; European Academy of Allergy and Clinical Immunology (EAACI); Dept. of Science and Technology, Government of India through Institutional Plan Project-1; Austrian Science Fund (FWF); Megagrant of the Government of the Russian Federation [14.W03.31.0024]; Biomay AG, Vienna, Austria; Viravaxx, Vienna, Austria;  [F4605];  [F4607];  [P29991]	Wellcome Trust/DBT India Alliance through an Early Career Fellowship(Wellcome Trust DBT India Alliance); European Academy of Allergy and Clinical Immunology (EAACI); Dept. of Science and Technology, Government of India through Institutional Plan Project-1; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Megagrant of the Government of the Russian Federation; Biomay AG, Vienna, Austria; Viravaxx, Vienna, Austria; ; ; 	This work was supported by Wellcome Trust/DBT India Alliance Grant IA/E/17/1/503696 through an Early Career Fellowship (to G. S.) and a fellowship from European Academy of Allergy and Clinical Immunology (EAACI) (to G. S.), Dept. of Science and Technology, Government of India through Institutional Plan Project-1 (to S. G. B.), in part by Grant F4605 (to R. V.), F4607 (to S. F.) and P29991 (to M. F.-T.), Austrian Science Fund (FWF), and a Megagrant of the Government of the Russian Federation under Grant 14.W03.31.0024 (to R. V.). Rudolf Valenta has received research grants from Biomay AG, Vienna, Austria, and Viravaxx, Vienna, Austria, and serves as a consultant for Viravaxx.	Adams B, 2005, J BIOL CHEM, V280, P24308, DOI 10.1074/jbc.M500990200; Agarwal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114745; An S, 2013, MOL CELL PROTEOMICS, V12, P1818, DOI 10.1074/mcp.M112.027136; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Cadot P, 2006, MOL IMMUNOL, V43, P226, DOI 10.1016/j.molimm.2005.02.001; Cadot P, 2000, J ALLERGY CLIN IMMUN, V105, P286, DOI 10.1016/S0091-6749(00)90078-2; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Ciprandi G, 2017, IMMUNOBIOLOGY, V222, P726, DOI 10.1016/j.imbio.2017.01.006; Crameri R, 1996, J EXP MED, V184, P265, DOI 10.1084/jem.184.1.265; Dey D, 2019, AEROBIOLOGIA, V35, P15, DOI 10.1007/s10453-018-9534-6; Dey D, 2019, INT ARCH ALLERGY IMM, V178, P60, DOI 10.1159/000492584; Dey D, 2016, BBA-PROTEINS PROTEOM, V1864, P869, DOI 10.1016/j.bbapap.2016.03.012; Fluckiger S, 2002, EUR J IMMUNOL, V32, P10, DOI 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I; Fujita C, 2001, INT ARCH ALLERGY IMM, V125, P44, DOI 10.1159/000053795; Gattinger P, 2019, EBIOMEDICINE, V39, P33, DOI 10.1016/j.ebiom.2018.12.002; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; Ghosh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138992; Glaser AG, 2006, BIOCHEM J, V396, P41, DOI 10.1042/BJ20051708; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; Kaur G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136692; Kawano S, 2013, PROTEIN J, V32, P386, DOI 10.1007/s10930-013-9496-z; Limacher A, 2006, STRUCTURE, V14, P185, DOI 10.1016/j.str.2005.10.015; Linhart B, 2015, J IMMUNOL, V194, P4008, DOI 10.4049/jimmunol.1400402; Mittermann I, 2004, CURR OPIN ALLERGY CL, V4, P367, DOI 10.1097/00130832-200410000-00007; Mittermann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156077; Pomes A, 2020, ALLERGY, V75, P9, DOI 10.1111/all.13993; Pomes A, 2018, MOL IMMUNOL, V100, P3, DOI 10.1016/j.molimm.2018.03.003; Roesner LM, 2016, J IMMUNOL, V196, P3245, DOI 10.4049/jimmunol.1500351; Roy D, 2003, BIOCHEM BIOPH RES CO, V307, P422, DOI 10.1016/S0006-291X(03)01193-8; Ruethers T, 2018, MOL IMMUNOL, V100, P28, DOI 10.1016/j.molimm.2018.04.008; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Sarkar MB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00823; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sircar G, 2016, J BIOL CHEM, V291, P18016, DOI 10.1074/jbc.M116.732032; Sircar G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144547; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Twaroch TE, 2015, ALLERGY ASTHMA IMMUN, V7, P205, DOI 10.4168/aair.2015.7.3.205; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Welter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065116; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Williams BJ, 2016, PROTEOMICS, V16, P2284, DOI 10.1002/pmic.201500492	46	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2736	2748		10.1074/jbc.RA119.011659	http://dx.doi.org/10.1074/jbc.RA119.011659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31882546	hybrid, Green Published			2022-12-28	WOS:000519969100018
J	Jobin, PG; Solis, N; Machado, Y; Bell, PA; Rai, SK; Kwon, NH; Kim, S; Overall, CM; Butler, GS				Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Rai, Simran K.; Kwon, Nam Hoon; Kim, Sunghoon; Overall, Christopher M.; Butler, Georgina S.			Moonlighting matrix metalloproteinase substrates: Enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multifunctional protein; aminoacyl tRNA synthetase; proteolysis; matrix metalloproteinase (MMP); inflammation; toll-like receptor (TLR); macrophage; innate immunity; moonlighting proteins	NF-KAPPA-B; MASS-SPECTROMETRY; DIADENOSINE POLYPHOSPHATES; MULTISYNTHETASE COMPLEX; NEUTROPHIL APOPTOSIS; CYTOKINE ACTIVITIES; CRYSTAL-STRUCTURE; POTENTIAL ROLE; IDENTIFICATION; PROTEINS	Tyrosyl-tRNA synthetase ligates tyrosine to its cognate tRNA in the cytoplasm, but it can also be secreted through a noncanonical pathway. We found that extracellular tyrosyl-tRNA synthetase (YRS) exhibited proinflammatory activities. In addition to acting as a monocyte/macrophage chemoattractant, YRS initiated signaling through Toll-like receptor 2 (TLR2) resulting in NF-?B activation and release of tumor necrosis factor ? (TNF?) and multiple chemokines, including MIP-1?/?, CXCL8 (IL8), and CXCL1 (KC) from THP1 monocyte and peripheral blood mononuclear cell?derived macrophages. Furthermore, YRS up-regulated matrix metalloproteinase (MMP) activity in a TNF?-dependent manner in M0 macrophages. Because MMPs process a variety of intracellular proteins that also exhibit extracellular moonlighting functions, we profiled 10 MMPs for YRS cleavage and identified 55 cleavage sites by amino-terminal oriented mass spectrometry of substrates (ATOMS) positional proteomics and Edman degradation. Stable proteoforms resulted from cleavages near the start of the YRS C-terminal EMAPII domain. All of the MMPs tested cleaved at ADS(386)?(LYV)-L-387 and VSG(405)?(406)LVQ, generating 43- and 45-kDa fragments. The highest catalytic efficiency for YRS was demonstrated by MMP7, which is highly expressed by monocytes and macrophages, and by neutrophil-specific MMP8. MMP-cleaved YRS enhanced TLR2 signaling, increased TNF? secretion from macrophages, and amplified monocyte/macrophage chemotaxis compared with unprocessed YRS. The cleavage of YRS by MMP8, but not MMP7, was inhibited by tyrosine, a substrate of the YRS aminoacylation reaction. Overall, the proinflammatory activity of YRS is enhanced by MMP cleavage, which we suggest forms a feed-forward mechanism to promote inflammation.	[Jobin, Parker G.; Overall, Christopher M.] Univ British Columbia, Fac Dent, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Rai, Simran K.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Fac Dent, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Solis, Nestor; Machado, Yoan; Bell, Peter A.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Rai, Simran K.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V5T 4S6, Canada; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Seoul National University (SNU); Seoul National University (SNU)	Overall, CM (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall,Rm 4-401, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Butler, Georgina/GQP-7553-2022; Machado, Yoan/D-9429-2016	Butler, Georgina/0000-0003-1172-1578; Machado, Yoan/0000-0002-8251-3744; Jobin, Parker/0000-0001-5852-7890	Canadian Institutes of Health Research (CIHR) Foundation Grant [FDN-148408]; CIHR [MOP-111055]; Canada Foundation for Innovation [31059]; Michael Smith Foundation for Health Research [IN-NPG-00105]; University of British Columbia (UBC) 4-year doctoral fellowship; CIHR Vanier Canada graduate scholarship; Centre for Blood Research graduate award; Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship; Australian Early Career Fellowship; Canadian MSFHR Research Trainee Fellowship	Canadian Institutes of Health Research (CIHR) Foundation Grant(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia (UBC) 4-year doctoral fellowship; CIHR Vanier Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); Centre for Blood Research graduate award; Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship; Australian Early Career Fellowship; Canadian MSFHR Research Trainee Fellowship	This work was supported by Canadian Institutes of Health Research (CIHR) Foundation Grant FDN-148408 (to C. M. O.), CIHR Grant MOP-111055 (to C. M. O. and G. S. B.), Canada Foundation for Innovation Grant 31059 (to C. M. O.), and the Michael Smith Foundation for Health Research to establish the British Columbia Proteomics Network Grant IN-NPG-00105 (to C. M. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by University of British Columbia (UBC) 4-year doctoral fellowship, CIHR Vanier Canada graduate scholarship, a Centre for Blood Research graduate award, and a Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship.; Recipient of an Australian Early Career Fellowship.; Recipients of a Canadian MSFHR Research Trainee Fellowship.	Abbey SR, 2018, J DENT RES, V97, P338, DOI 10.1177/0022034517736054; Ahn YH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.191; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAXI MD, 1995, J PHARMACOL TOX MET, V33, P121, DOI 10.1016/1056-8719(94)00127-P; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200; Casas-Tinto S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10022; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Doucet A, 2011, METHOD ENZYMOL, V501, P275, DOI 10.1016/B978-0-12-385950-1.00013-4; Doucet A, 2011, METHODS MOL BIOL, V753, P273, DOI 10.1007/978-1-61779-148-2_18; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dufour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04717-4; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Eckhard U, 2015, DATA BRIEF, V5, P542, DOI 10.1016/j.dib.2015.10.003; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Eckhard U, 2015, J PROTEOME RES, V14, P3568, DOI 10.1021/acs.jproteome.5b00579; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Gasmi L, 1996, BRIT J HAEMATOL, V95, P637, DOI 10.1046/j.1365-2141.1996.d01-1960.x; Geisler S, 2015, PTERIDINES, V26, P31, DOI 10.1515/pterid-2014-0015; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Jankowski J, 2003, ARTERIOSCL THROM VAS, V23, P1231, DOI 10.1161/01.ATV.0000075913.00428.FD; Jobin PG, 2019, J BIOL CHEM, V294, P12866, DOI 10.1074/jbc.RA119.009584; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Jovanovic A, 1996, PFLUG ARCH EUR J PHY, V431, P800, DOI 10.1007/BF02253848; Kanaji T, 2018, P NATL ACAD SCI USA, V115, pEB228, DOI 10.1073/pnas.1807000115; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Lee HC, 2019, J VIROL, V93, DOI 10.1128/JVI.01291-18; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Marcus K, 2000, ELECTROPHORESIS, V21, P2622, DOI 10.1002/1522-2683(20000701)21:13<2622::AID-ELPS2622>3.0.CO;2-3; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Mistry P, 2015, P NATL ACAD SCI USA, V112, P5455, DOI 10.1073/pnas.1422576112; Nakajima H., 1990, ANN NY ACAD SCI, V613, p734 ? 737, DOI [10.1111/j.1749-6632.1990.tb18255.x2076013, DOI 10.1111/J.1749-6632.1990.TB18255.X2076013]; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; Park SR, 2018, CELL DEATH DIFFER, V25, P2023, DOI 10.1038/s41418-018-0099-2; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Planesse C, 2015, CYTOKINE, V73, P190, DOI 10.1016/j.cyto.2015.01.028; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; Prudova A, 2014, BLOOD, V124, pE49, DOI 10.1182/blood-2014-04-569640; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ruiz S, 1999, J LEUKOCYTE BIOL, V66, P416, DOI 10.1002/jlb.66.3.416; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Tshori S, 2014, TOP CURR CHEM, V344, P189, DOI 10.1007/128_2013_426; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004	88	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2186	2202		10.1074/jbc.RA119.010486	http://dx.doi.org/10.1074/jbc.RA119.010486			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31771979	Green Published, hybrid			2022-12-28	WOS:000517330200004
J	Qi, YF; Wang, XM; Lei, P; Li, HM; Yan, LR; Zhao, J; Meng, JJ; Shao, JX; An, LJ; Yu, F; Liu, XY				Qi, Yafei; Wang, Xiaomin; Lei, Pei; Li, Huimin; Yan, Liru; Zhao, Jun; Meng, Jingjing; Shao, Jingxia; An, Lijun; Yu, Fei; Liu, Xiayan			The chloroplast metalloproteases VAR2 and EGY1 act synergistically to regulate chloroplast development in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; chloroplast; metalloprotease; photosynthesis; protein complex; EGY1; AMOS1; enhancer of variegation; leaf variegation; VAR2; AtFtsH2	THYLAKOID FTSH PROTEASE; PHOTOSYSTEM-II REPAIR; VAR2-MEDIATED LEAF VARIEGATION; MUTATIONS; TRANSLATION; BIOGENESIS; SUPPRESS; FAMILY; LOCUS; PHOTOINHIBITION	Chloroplast development and photosynthesis require the proper assembly and turnover of photosynthetic protein complexes. Chloroplasts harbor a repertoire of proteases to facilitate proteostasis and development. We have previously used an Arabidopsis leaf variegation mutant, yellow variegated2 (var2), defective in thylakoid FtsH protease complexes, as a tool to dissect the genetic regulation of chloroplast development. Here, we report a new genetic enhancer mutant of var2, enhancer of variegation3?1 (evr3?1). We confirm that EVR3 encodes a chloroplast metalloprotease, reported previously as ethylene-dependent gravitropism-deficient and yellow-green1 (EGY1)/ammonium overly sensitive1 (AMOS1). We observed that mutations in EVR3/EGY1/AMOS1 cause more severe leaf variegation in var2?5 and synthetic lethality in var2?4. Using a modified blue-native PAGE system, we reveal abnormal accumulations of photosystem I, photosystem II, and light-harvesting antenna complexes in EVR3/EGY1/AMOS1 mutants. Moreover, we discover distinct roles of VAR2 and EVR3/EGY1/AMOS1 in the turnover of photosystem II reaction center under high light stress. In summary, our findings indicate that two chloroplast metalloproteases, VAR2/AtFtsH2 and EVR3/EGY1/AMOS1, function coordinately to regulate chloroplast development and reveal new roles of EVR3/EGY1/AMOS1 in regulating chloroplast proteostasis in Arabidopsis.	Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Liu, XY (corresponding author), 22 Xinong Rd, Yangling 712100, Shaanxi, Peoples R China.	xiayanliu@gmail.com			National Natural Science Foundation of China [31741010, 31770205, 31870268]; Fundamental Research Funds for the Central Universities [2452018152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31741010 (to Y. Q.), 31770205 (to X. L.), and 31870268 (to F. Y.) and by Fundamental Research Funds for the Central Universities 2452018152 (to Y. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam Z, 2011, PLANT CELL, V23, P3745, DOI 10.1105/tpc.111.087239; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Barry CS, 2012, PLANT PHYSIOL, V159, P1086, DOI 10.1104/pp.112.197483; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chi W, 2012, BBA-BIOENERGETICS, V1817, P239, DOI 10.1016/j.bbabio.2011.05.014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Costanzo M, 2019, CELL, V177, P85, DOI 10.1016/j.cell.2019.01.033; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Hu FH, 2015, PLANT PHYSIOL, V168, P1066, DOI 10.1104/pp.15.00549; Jarvi S, 2015, BBA-BIOENERGETICS, V1847, P900, DOI 10.1016/j.bbabio.2015.01.006; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Kato Y, 2007, PLANT PHYSIOL, V144, P952, DOI 10.1104/pp.107.099002; Kato Y, 2009, PLANT PHYSIOL, V151, P1790, DOI 10.1104/pp.109.146589; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li BH, 2012, PLANT PHYSIOL, V160, P2040, DOI 10.1104/pp.112.206508; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Liu SY, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00295; Liu XY, 2013, J INTEGR PLANT BIOL, V55, P979, DOI 10.1111/jipb.12078; Liu XY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-287; Liu XY, 2010, PLANT PHYSIOL, V154, P1588, DOI 10.1104/pp.110.164111; Malnoe A, 2014, PLANT CELL, V26, P373, DOI 10.1105/tpc.113.120113; Murata N, 2009, PHOTOSYNTH RES, V99, P155, DOI 10.1007/s11120-008-9389-8; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Nishimura K, 2017, MOL PLANT, V10, P4, DOI 10.1016/j.molp.2016.08.005; Nishimura K, 2016, PLANT PHYSIOL, V171, P2280, DOI 10.1104/pp.16.00330; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Putarjunan A, 2013, PHOTOSYNTH RES, V116, P437, DOI 10.1007/s11120-013-9855-9; Qi YF, 2016, PHOTOSYNTH RES, V127, P355, DOI 10.1007/s11120-015-0195-9; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT PHYSIOL, V152, P1263, DOI 10.1104/pp.109.150722; Taylor NL, 2009, J PROTEOMICS, V72, P367, DOI 10.1016/j.jprot.2008.11.006; Wang F, 2017, MOL PLANT, V10, P99, DOI 10.1016/j.molp.2016.09.012; Wang RJ, 2018, PLANT PHYSIOL, V176, P804, DOI 10.1104/pp.17.00673; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu FW, 2016, PLANT PHYSIOL, V172, P1200, DOI 10.1104/pp.16.00786; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Yu F, 2011, MOL PLANT, V4, P229, DOI 10.1093/mp/ssq074; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zhang S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01308; Zheng MD, 2016, PLANT PHYSIOL, V172, P1117, DOI 10.1104/pp.15.02040; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	52	9	10	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1036	1046		10.1074/jbc.RA119.011853	http://dx.doi.org/10.1074/jbc.RA119.011853			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31836664	Green Published, hybrid			2022-12-28	WOS:000509949300012
J	Krishnan, A; Kloehn, J; Lunghi, M; Soldati-Favre, D				Krishnan, Aarti; Kloehn, Joachim; Lunghi, Matteo; Soldati-Favre, Dominique			Vitamin and cofactor acquisition in apicomplexans: Synthesis versus salvage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						parasite metabolism; metabolomics; vitamin; Toxoplasma gondii; Plasmodium; parasitology; cofactor; Cryptosporidium; metabolic pathway; nutrient acquisition; Apicomplexa	PARASITE TOXOPLASMA-GONDII; HEME-BIOSYNTHESIS PATHWAY; DE-NOVO SYNTHESIS; PLASMODIUM-FALCIPARUM; MALARIA PARASITE; SHIKIMATE PATHWAY; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; LIPOIC ACID; INTRAERYTHROCYTIC STAGES	The Apicomplexa phylum comprises diverse parasitic organisms that have evolved from a free-living ancestor. These obligate intracellular parasites exhibit versatile metabolic capabilities reflecting their capacity to survive and grow in different hosts and varying niches. Determined by nutrient availability, they either use their biosynthesis machineries or largely depend on their host for metabolite acquisition. Because vitamins cannot be synthesized by the mammalian host, the enzymes required for their synthesis in apicomplexan parasites represent a large repertoire of potential therapeutic targets. Here, we review recent advances in metabolic reconstruction and functional studies coupled to metabolomics that unravel the interplay between biosynthesis and salvage of vitamins and cofactors in apicomplexans. A particular emphasis is placed on Toxoplasma gondii, during both its acute and latent stages of infection.	[Krishnan, Aarti; Kloehn, Joachim; Lunghi, Matteo; Soldati-Favre, Dominique] Univ Geneva CMU, Fac Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland	University of Geneva	Soldati-Favre, D (corresponding author), Univ Geneva CMU, Fac Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Dominique.Soldati-Favre@unige.ch		Kloehn, Joachim/0000-0002-6366-8599; Krishnan, Aarti/0000-0002-7936-4442; Soldati-Favre, Dominique/0000-0003-4156-2109; lunghi, matteo/0000-0002-9338-9929	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [695596]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under Grant Agreement 695596 (to J. K. and M. L.).	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2003, NUTR BIOCH VITAMINS; Augagneur Y, 2013, J BIOL CHEM, V288, P20558, DOI 10.1074/jbc.M113.482992; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Beckett D, 2005, J NUTR BIOCHEM, V16, P411, DOI 10.1016/j.jnutbio.2005.03.019; BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0; Beri D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37816-9; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Burgess SL, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00101-17; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Cabello-Donayre M, 2020, CELL MOL LIFE SCI, V77, P1827, DOI 10.1007/s00018-019-03258-3; Caldelari R, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2968-7; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; Cassera MB, 2004, J BIOL CHEM, V279, P51749, DOI 10.1074/jbc.M408360200; Chan XWA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3060; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chiappino-Pepe A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005397; Choby JE, 2016, J MOL BIOL, V428, P3408, DOI 10.1016/j.jmb.2016.03.018; Chugh M, 2013, P NATL ACAD SCI USA, V110, P5392, DOI 10.1073/pnas.1218412110; Ciulli A, 2007, J BIOL CHEM, V282, P8487, DOI 10.1074/jbc.M611171200; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; Daberkow RL, 2003, J NUTR, V133, P2703, DOI 10.1093/jn/133.9.2703; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; de Villiers M, 2017, ACS INFECT DIS, V3, P527, DOI 10.1021/acsinfecdis.7b00024; de Villiers M, 2014, FEBS J, V281, P4731, DOI 10.1111/febs.13013; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Driscoll TP, 2017, MBIO, V8, DOI [10.1128/mbio.00859-17, 10.1128/mBio.00859-17]; DUBEY JP, 1988, AM J VET RES, V49, P910; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Falkard B, 2013, CELL MICROBIOL, V15, P1585, DOI 10.1111/cmi.12137; Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Fleige T, 2010, MICROBES INFECT, V12, P253, DOI 10.1016/j.micinf.2009.12.010; Garten M, 2018, NAT MICROBIOL, V3, P1090, DOI 10.1038/s41564-018-0222-7; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Goldberg DE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006511; Gunther S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005510; Hammoudi PM, 2018, MOL MICROBIOL, V109, P225, DOI 10.1111/mmi.13981; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hart RJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00260; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hehl AB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1225-x; Heinberg A, 2015, ANN NY ACAD SCI, V1342, P10, DOI 10.1111/nyas.12662; Hellgren O, 2018, PARASITOLOGY, V145, P1084, DOI 10.1017/S0031182017002219; Hoegl A, 2018, NAT CHEM, V10, P1234, DOI 10.1038/s41557-018-0144-2; Hung SS, 2011, TRENDS PARASITOL, V27, P131, DOI 10.1016/j.pt.2010.11.003; Hyde JE, 2005, ACTA TROP, V94, P191, DOI 10.1016/j.actatropica.2005.04.002; Jaffe EK, 2011, J BIOL CHEM, V286, P15298, DOI 10.1074/jbc.M111.226225; Jalovecka M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00248; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Ke HJ, 2014, J BIOL CHEM, V289, P34827, DOI 10.1074/jbc.M114.615831; Keeling PJ, 1999, NATURE, V397, P219, DOI 10.1038/16618; Kehrer J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005734; Knockel J, 2007, MOL BIOCHEM PARASIT, V152, P108, DOI 10.1016/j.molbiopara.2006.12.005; Knockel J, 2012, BIOCHEM J, V443, P397, DOI 10.1042/BJ20111542; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kronenberger T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/108516; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Mageed SN, 2014, ANTIMICROB AGENTS CH, V58, P6345, DOI 10.1128/AAC.02640-14; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Mather MW, 2019, TRENDS PARASITOL, V35, P176, DOI 10.1016/j.pt.2019.01.010; Matz JM, 2019, CELL REP, V26, P356, DOI 10.1016/j.celrep.2018.12.062; MEHLHORN H, 1984, ADV PARASIT, V23, P37, DOI 10.1016/S0065-308X(08)60285-7; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Muller IB, 2010, TRENDS PARASITOL, V26, P35, DOI 10.1016/j.pt.2009.10.006; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004406; Muller S, 2007, TRENDS PARASITOL, V23, P112, DOI 10.1016/j.pt.2007.01.009; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Nitzsche R, 2016, J BIOL CHEM, V291, P126, DOI 10.1074/jbc.M114.624619; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; O'Hara JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094061; O'Hara SP, 2011, MICROBES INFECT, V13, P721, DOI 10.1016/j.micinf.2011.03.008; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; PALM D, 1990, BIOCHEMISTRY-US, V29, P1099, DOI 10.1021/bi00457a001; Peek J, 2014, MOL BIOCHEM PARASIT, V194, P16, DOI 10.1016/j.molbiopara.2014.04.002; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; Polonais V, 2010, BIOL CELL, V102, P435, DOI 10.1042/BC20100005; Rajgopal A, 2001, BBA-MOL BASIS DIS, V1537, P175, DOI 10.1016/S0925-4439(01)00073-4; Ramakrishnan S, 2015, MOL MICROBIOL, V97, P64, DOI 10.1111/mmi.13010; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Read M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-351; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Rizopoulos Z, 2016, INFECT IMMUN, V84, P3252, DOI 10.1128/IAI.00148-16; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Salcedo-Sora JE, 2011, J BIOL CHEM, V286, P44659, DOI 10.1074/jbc.M111.286054; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Shanmugam D, 2010, J BIOL CHEM, V285, P22122, DOI 10.1074/jbc.M110.107243; Sherling ES, 2016, FEMS MICROBIOL REV, V40, P701, DOI 10.1093/femsre/fuw016; Shukla A, 2018, INT J PARASITOL, V48, P955, DOI 10.1016/j.ijpara.2018.05.013; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sigala PA, 2015, ELIFE, V4, DOI 10.7554/eLife.09143; Sinai AP, 1997, J CELL SCI, V110, P2117; Song C, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.62; Srinivasan B, 2015, NAT CHEM BIOL, V11, P784, DOI [10.1038/nchembio.1906, 10.1038/NCHEMBIO.1906]; Stanway RR, 2019, CELL, V179, P1112, DOI 10.1016/j.cell.2019.10.030; Subramanian VS, 2003, J BIOL CHEM, V278, P3976, DOI 10.1074/jbc.M210717200; Sugi T, 2017, MBIO, V8, DOI [10.1128/mBio.01289-17, 10.1128/mbio.01289-17]; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Thomsen-Zieger N, 2003, FEBS LETT, V547, P80, DOI 10.1016/S0014-5793(03)00673-2; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI 10.1016/j.pt.2016.05.010; Tjhin ET, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006918; Tonhosolo R, 2005, BIOCHEM J, V392, P117, DOI 10.1042/BJ20050441; Tripodi Karina E J, 2011, Enzyme Res, V2011, P873230, DOI 10.4061/2011/873230; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Tymoshenko S, 2013, BRIEF FUNCT GENOMICS, V12, P316, DOI 10.1093/bfgp/elt017; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VANDEKAMP JL, 1995, NUTR RES, V15, P415, DOI 10.1016/0271-5317(95)00009-7; von Delft F, 2003, STRUCTURE, V11, P985, DOI 10.1016/S0969-2126(03)00158-8; von Delft F, 2001, STRUCTURE, V9, P439, DOI 10.1016/S0969-2126(01)00604-9; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111; Wrenger C, 2008, BRAZ J MED BIOL RES, V41, P82, DOI 10.1590/S0100-879X2008005000006; Wrenger C, 2006, BIOL CHEM, V387, P41, DOI 10.1515/BC.2006.007; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; ZEREZ CR, 1990, BLOOD, V75, P1705; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472; Zilles JL, 2000, J BACTERIOL, V182, P5606, DOI 10.1128/JB.182.19.5606-5610.2000	137	12	12	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					701	714		10.1074/jbc.AW119.008150	http://dx.doi.org/10.1074/jbc.AW119.008150			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31767680	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000508382900003
J	Sugishima, M; Wada, K; Fukuyama, K; Yamamoto, K				Sugishima, Masakazu; Wada, Kei; Fukuyama, Keiichi; Yamamoto, Ken			Crystal structure of phytochromobilin synthase in complex with biliverdin IX?, a key enzyme in the biosynthesis of phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; photoreceptor; enzyme mechanism; enzyme structure; plant biochemistry; ferredoxin-dependent bilin reductase; tetrapyrrole	DEPENDENT BILIN REDUCTASES; CHROMOPHORE-BINDING DOMAIN; FERREDOXIN OXIDOREDUCTASE; PHYCOCYANOBILIN; BACTERIOPHYTOCHROME; MECHANISM; HY2; REDUCTION; DEFICIENT; INSIGHTS	Phytochromobilin (P?B) is a red/far-red light sensory pigment in plant phytochrome. P?B synthase is a ferredoxin-dependent bilin reductase (FDBR) that catalyzes the site-specific reduction of bilins, which are sensory and photosynthesis pigments, and produces P?B from biliverdin, a heme-derived linear tetrapyrrole pigment. Here, we determined the crystal structure of tomato P?B synthase in complex with biliverdin at 1.95 ? resolution. The overall structure of tomato P?B synthase was similar to those of other FDBRs, except for the addition of a long C-terminal loop and short helices. The structure further revealed that the C-terminal loop is part of the biliverdin-binding pocket and that two basic residues in the C-terminal loop form salt bridges with the propionate groups of biliverdin. This suggested that the C-terminal loop is involved in the interaction with ferredoxin and biliverdin. The configuration of biliverdin bound to tomato P?B synthase differed from that of biliverdin bound to other FDBRs, and its orientation in P?B synthase was inverted relative to its orientation in the other FDBRs. Structural and enzymatic analyses disclosed that two aspartic acid residues, Asp-123 and Asp-263, form hydrogen bonds with water molecules and are essential for the site-specific A-ring reduction of biliverdin. On the basis of these observations and enzymatic assays with a V121A P?B synthase variant, we propose the following mechanistic product release mechanism: P?B synthase-catalyzed stereospecific reduction produces 2(R)-P?B, which when bound to P?B synthase collides with the side chain of Val-121, releasing 2(R)-P?B from the synthase.	[Sugishima, Masakazu; Yamamoto, Ken] Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 8300011, Japan; [Wada, Kei] Univ Miyazaki, Dept Med Sci, Miyazaki 8891692, Japan; [Fukuyama, Keiichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	Kurume University; University of Miyazaki; Osaka University	Sugishima, M (corresponding author), Kurume Univ, Sch Med, Dept Med Biochem, Kurume, Fukuoka 8300011, Japan.	sugishima_masakazu@med.kurume-u.ac.jp	Sugishima, Masakazu/M-2773-2019; Sugishima, Masakazu/B-1049-2010	Sugishima, Masakazu/0000-0002-0840-4929; Sugishima, Masakazu/0000-0002-0840-4929; Wada, Kei/0000-0001-7631-4151	Japan Society for the Promotion of Science KAKENHI Grant [19K06515]; Japan Science and Technology Agency-Mirai Program Grant [JPMJMI17EH]; Japan Agency for Medical Research and Development [JP18am0101070, 1365, 1733]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency-Mirai Program Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was partially supported by Japan Society for the Promotion of Science KAKENHI Grant 19K06515 (to M. S.), the Japan Science and Technology Agency-Mirai Program Grant JPMJMI17EH (to K. W.), and the Platform Project for Supporting Drug Discovery and Life Science Research, Basis for Supporting Innovative Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development under Grant JP18am0101070 (support numbers 1365 and 1733). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Chiu FY, 2010, J BIOL CHEM, V285, P5056, DOI 10.1074/jbc.M109.075747; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2010, J BIOL CHEM, V285, P1000, DOI 10.1074/jbc.M109.055632; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; KENDRICK RE, 1994, EUPHYTICA, V79, P227, DOI 10.1007/BF00022523; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; LAGARIAS JC, 1989, P NATL ACAD SCI USA, V86, P5778, DOI 10.1073/pnas.86.15.5778; Ledermann B, 2018, FEBS J, V285, P339, DOI 10.1111/febs.14341; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Muramoto T, 2005, PLANT CELL PHYSIOL, V46, P661, DOI 10.1093/pcp/pci062; Rockwell NC, 2017, NEW PHYTOL, V214, P1145, DOI 10.1111/nph.14422; Schafer E, 2002, EMBO REP, V3, P1042, DOI 10.1093/embo-reports/kvf222; Sommerkamp JA, 2019, J BIOL CHEM, V294, P13889, DOI 10.1074/jbc.RA119.009306; Sugishima M, 2019, CURR OPIN STRUC BIOL, V59, P73, DOI 10.1016/j.sbi.2019.03.005; Sugishima M, 2010, J MOL BIOL, V402, P879, DOI 10.1016/j.jmb.2010.08.021; Sugishima M, 2009, J MOL BIOL, V389, P376, DOI 10.1016/j.jmb.2009.04.017; Terry MJ, 1996, J BIOL CHEM, V271, P21681, DOI 10.1074/jbc.271.35.21681; Tu SL, 2008, J BIOL CHEM, V283, P27555, DOI 10.1074/jbc.M803761200; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Unno M., 2013, INTEGRATING APPROACH, P47; Unno M, 2015, J AM CHEM SOC, V137, P5452, DOI 10.1021/jacs.5b00645; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104	37	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					771	782		10.1074/jbc.RA119.011431	http://dx.doi.org/10.1074/jbc.RA119.011431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31822504	Green Published, hybrid			2022-12-28	WOS:000508382900009
J	Nicklow, EE; Sevier, CS				Nicklow, Erin E.; Sevier, Carolyn S.			Activity of the yeast cytoplasmic Hsp70 nucleotide-exchange factor Fes1 is regulated by reversible methionine oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat-shock protein (Hsp70); chaperone; methionine; redox regulation; post-translational modification (PTM); reactive oxygen species (ROS); Fes1; methionine oxidation; methionine sulfoxide reductase; nucleotide-exchange factor (NEF)	SACCHAROMYCES-CEREVISIAE; SULFOXIDE REDUCTASES; MITOCHONDRIAL HSP70; ANTIOXIDANT DEFENSE; STRUCTURAL-ANALYSIS; OXIDIZED PROTEINS; ATP-BINDING; HSPBP1; RESIDUES; HSP110	Cells employ a vast network of regulatory pathways to manage intracellular levels of reactive oxygen species (ROS). An effectual means used by cells to control these regulatory systems are sulfur-based redox switches, which consist of protein cysteine or methionine residues that become transiently oxidized when intracellular ROS levels increase. Here, we describe a methionine-based oxidation event involving the yeast cytoplasmic Hsp70 co-chaperone Fes1. We show that Fes1 undergoes reversible methionine oxidation during excessively-oxidizing cellular conditions, and we map the site of this oxidation to a cluster of three methionine residues in the Fes1 core domain. Making use of recombinant proteins and a variety of in vitro assays, we establish that oxidation inhibits Fes1 activity and, correspondingly, alters Hsp70 activity. Moreover, we demonstrate in vitro and in cells that Fes1 oxidation is reversible and is regulated by the cytoplasmic methionine sulfoxide reductase Mxr1 (MsrA) and a previously unidentified cytoplasmic pool of the reductase Mxr2 (MsrB). We speculate that inactivation of Fes1 activity during excessively-oxidizing conditions may help maintain protein-folding homeostasis in a suboptimal cellular folding environment. The characterization of Fes1 oxidation during cellular stress provides a new perspective as to how the activities of the cytoplasmic Hsp70 chaperones may be attuned by fluctuations in cellular ROS levels and provides further insight into how cells use methionine-based redox switches to sense and respond to oxidative stress.	[Nicklow, Erin E.; Sevier, Carolyn S.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Sevier, CS (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	css224@cornell.edu		Sevier, Carolyn/0000-0003-3245-6988	National Institutes of Health [R01 GM105958, T32 GM008500]; Cornell Schwartz Research Fund Award; Cornell Presidential Life Science Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Schwartz Research Fund Award; Cornell Presidential Life Science Fellowship	This work was supported by National Institutes of Health Grant R01 GM105958 and a Cornell Schwartz Research Fund Award (to C. S. S.) and a Cornell Presidential Life Science Fellowship and National Institutes of Health Training Grant T32 GM008500 (to E. E. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Achilli C, 2015, BIOFACTORS, V41, P135, DOI 10.1002/biof.1214; Adams A., 1997, METHODS IN YEAST GEN; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Allu PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21083-9; Allu PK, 2015, MOL BIOL CELL, V26, P406, DOI 10.1091/mbc.E14-09-1371; Bracher A., 2015, NETWORKING CHAPERONE, V78; Brachmann CB, 1998, YEAST, V14, P115; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brodsky J. L., 2007, NETWORKING CHAPERONE; Chin D, 1996, J BIOL CHEM, V271, P30465, DOI 10.1074/jbc.271.48.30465; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dragovic Z, 2006, BIOL CHEM, V387, P1593, DOI 10.1515/BC.2006.198; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; Gennaris A, 2015, NATURE, V528, P409, DOI 10.1038/nature15764; Ghesquiere B, 2014, MASS SPECTROM REV, V33, P147, DOI 10.1002/mas.21386; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Gowda NKC, 2018, NAT STRUCT MOL BIOL, V25, P83, DOI 10.1038/s41594-017-0008-2; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Harndahl U, 2001, BBA-PROTEIN STRUCT M, V1545, P227, DOI 10.1016/S0167-4838(00)00280-6; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsieh YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01409-9; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kampinga HH, 2019, CELL STRESS CHAPERON, V24, P7, DOI 10.1007/s12192-018-0948-4; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kato M, 2019, CELL, V177, P711, DOI 10.1016/j.cell.2019.02.044; Kaya A, 2010, BIOCHEMISTRY-US, V49, P8618, DOI 10.1021/bi100908v; Kettern N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016398; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Klont F, 2018, ANAL CHEM, V90, P5405, DOI 10.1021/acs.analchem.8b00600; Kominek J, 2013, GENOME BIOL EVOL, V5, P2460, DOI 10.1093/gbe/evt192; Kumar S, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008219; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Lin SX, 2017, SCIENCE, V355, P597, DOI 10.1126/science.aal3316; LINDE S, 1990, J CHROMATOGR-BIOMED, V530, P29, DOI 10.1016/S0378-4347(00)82299-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marada A, 2013, MOL BIOL CELL, V24, P692, DOI 10.1091/mbc.E12-10-0719; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Mayer MP, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0183; McClellan AJ, 2000, GENETICS, V156, P501; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Needham PG, 2015, J MOL BIOL, V427, P2948, DOI 10.1016/j.jmb.2015.04.010; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Siegenthaler KD, 2017, ELIFE, V6, DOI 10.7554/eLife.24141; SIKORSKI RS, 1989, GENETICS, V122, P19; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Swiderek KM, 1998, ELECTROPHORESIS, V19, P989, DOI 10.1002/elps.1150190614; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Valverde H, 2019, BIOINFORMATICS, V35, P4849, DOI 10.1093/bioinformatics/btz462; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Watson AA, 1998, BIOCHEMISTRY-US, V37, P12700, DOI 10.1021/bi9810757; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	76	12	12	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					552	569		10.1074/jbc.RA119.010125	http://dx.doi.org/10.1074/jbc.RA119.010125			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806703	hybrid, Green Published			2022-12-28	WOS:000507373600023
J	Xiao, YL; Matsuda, I; Inoue, M; Sasahara, T; Hoshi, M; Ishii, Y				Xiao, Yiling; Matsuda, Isamu; Inoue, Masafumi; Sasahara, Tomoya; Hoshi, Minako; Ishii, Yoshitaka			NMR-based site-resolved profiling of ?-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); amyloid; solid state NMR; protein misfolding; structural biology; oligomer; Alzheimer disease; neurodegeneration; protein aggregation; amylospheroid (ASPD); fibrillization; neurotoxic protein; spherical amyloid assembly (SPA); Abeta42	A-BETA OLIGOMER; SOLID-STATE NMR; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; CHEMICAL-SHIFTS; MOLECULAR-BASIS; PROTEIN; BRAIN; INTERMEDIATE; ARCHITECTURE	Increasing evidence highlights the central role of neurotoxic oligomers of the 42-residue-long ?-amyloid (A?42) in Alzheimer's disease (AD). However, very limited information is available on the structural transition from oligomer to fibril, particularly for pathologically relevant amyloids. To the best of our knowledge, we present here the first site-specific structural characterization of A?42 misfolding, from toxic oligomeric assembly yielding a similar conformation to an AD-associated A?42 oligomer, into a fibril. Transmission EM (TEM) analysis revealed that a spherical amyloid assembly (SPA) of A?42 with a 15.6 ? 2.1-nm diameter forms in a ?30-?m A?42 solution after a ?10-h incubation at 4 ?C, followed by a slow conversion into fibril at ?180 h. Immunological analysis suggested that the SPA has a surface structure similar to that of amylospheroid (ASPD), a patient-derived toxic A? oligomer, which had a diameter of 10?15 nm in negative-stain TEM. Solid-state NMR analyses indicated that the SPA structure involves a ?-loop-? motif, which significantly differed from the triple-? motif observed for the A?42 fibril. The comparison of the C-13 chemical shifts of SPA with those of the fibril prepared in the above conditions and interstrand distance measurements suggested a large conformational change involving rearrangements of intermolecular ?-sheet into in-register parallel ?-sheet during the misfolding. A comparison of the SPA and ASPD C-13 chemical shifts indicated that SPA is structurally similar to the ASPD relevant to AD. These observations provide insights into the architecture and key structural transitions of amyloid oligomers relevant for AD pathology.	[Xiao, Yiling; Matsuda, Isamu; Ishii, Yoshitaka] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Matsuda, Isamu; Ishii, Yoshitaka] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Inoue, Masafumi; Sasahara, Tomoya] Kyoto Univ, Grad Sch Med, TAO Hlth Life Pharma Co Ltd, Med Pharma Collaborat Bldg, Kyoto 6068501, Japan; [Inoue, Masafumi] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Syst Pathol Neurol Disorders,Chuo Ku, 1-757 Asahimachidori, Niigata 9518585, Japan; [Sasahara, Tomoya; Hoshi, Minako] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat, Dept Brain & Neurodegenerat Dis Res, Kobe, Hyogo 6500047, Japan; [Hoshi, Minako] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068501, Japan; [Ishii, Yoshitaka] RIKEN, RIKEN SPring 8 Ctr RSC, NMR Sci & Dev Div, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tokyo Institute of Technology; Kyoto University; Niigata University; Institute for Biomedical Research & Innovation (IBRI); Kyoto University; RIKEN	Ishii, Y (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.; Ishii, Y (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan.; Ishii, Y (corresponding author), RIKEN, RIKEN SPring 8 Ctr RSC, NMR Sci & Dev Div, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ishii@bio.titech.ac.jp	Matsuda, Isamu/GXZ-7907-2022; Xiao, Yiling/ABC-5970-2021; Ishii, Yoshitaka/F-4558-2014	Matsuda, Isamu/0000-0002-3032-8934; Xiao, Yiling/0000-0002-4548-4833; Ishii, Yoshitaka/0000-0002-7724-6469; jing shang, ya wen/0000-0002-2553-053X	National Institutes of Health [U01 GM098033, R01 GM098033]; JST-Mirai, Japan [JPMJMI17A2]; Japan Society for the Promotion of Science (SSPS) KAKENHI Grant [17H04055]; JSPS KAKENHI [JP15K21772]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JST-Mirai, Japan; Japan Society for the Promotion of Science (SSPS) KAKENHI Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The initial part of this work was supported primarily by National Institutes of Health Grants U01 GM098033 and R01 GM098033 (to Y. I.). This work was also supported by JST-Mirai, Japan, Program Grant JPMJMI17A2 (to Y. I.) and Japan Society for the Promotion of Science (SSPS) KAKENHI Grant 17H04055 (to M. H.). The instruments employed in this work were supported in part by JSPS KAKENHI Grant JP15K21772 (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amar F, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2021; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Ishii Y, 2001, CHEM PHYS, V266, P231, DOI 10.1016/S0301-0104(01)00250-6; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Ohnishi T, 2015, P NATL ACAD SCI USA, V112, pE4465, DOI 10.1073/pnas.1421182112; Opazo P, 2018, CELL REP, V23, P3137, DOI 10.1016/j.celrep.2018.05.036; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sahoo BR, 2018, CHEM COMMUN, V54, P12883, DOI 10.1039/c8cc07921h; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yang T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0100-y; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	51	11	11	4	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					458	467		10.1074/jbc.RA119.008522	http://dx.doi.org/10.1074/jbc.RA119.008522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771980	Green Published, hybrid			2022-12-28	WOS:000507373600016
J	Chen, H; Previero, A; Deutscher, MP				Chen, Hua; Previero, Angelica; Deutscher, Murray P.			A novel mechanism of ribonuclease regulation: GcvB and Hfq stabilize the mRNA that encodes RNase BN/Z during exponential phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease; mRNA decay; bacteria; post-transcriptional regulation; RNA; growth-phase regulation; mRNA stability; regulatory RNA	ESCHERICHIA-COLI; ANTISENSE RNAS; BN/RNASE Z; E. COLI; 6S RNA; PROTEIN; GENE; IDENTIFICATION; TRANSCRIPTION; ACETYLATION	RNase BN, the Escherichia coli RNase Z family member, plays a limited role in tRNA metabolism, in contrast to most other organisms. However, RNase BN does act on 6S RNA, the global transcription regulator, degrading it in exponential-phase cells and maintaining it at low levels during this phase of growth. RNase BN levels decrease in stationary-phase cells, leading to elevation of 6S RNA and subsequent regulation of RNA polymerase. These findings were the first indication that RNase BN itself is growth phase?regulated. Here, we analyze the mechanism of this regulation of RNase BN. We find that RNase BN decreases in stationary phase because its mRNA becomes unstable, due primarily to its degradation by RNase E. However, in exponential-phase cells rbn mRNA is stabilized due to binding by the sRNA, GcvB, and the protein, Hfq, which reduce cleavage by RNase E. Because the amount of GcvB decreases in stationary phase, rbn mRNA is less protected and becomes increasingly unstable resulting in reduction in the amount of RNase BN. The small RNA-dependent, positive regulation of RNase BN in exponential-phase cells is the first example of this novel mechanism for RNase regulation.	[Chen, Hua; Previero, Angelica; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu		chen, hua/0000-0001-8838-1095	National Institutes of Health [GM016317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The National Institutes of Health Grant GM016317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Barria C., 2016, STRESS ENV CONTROL G, P174; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Bilusic I, 2014, RNA BIOL, V11, P641, DOI 10.4161/rna.29299; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; Cech GM, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00036; Chen H, 2016, J BIOL CHEM, V291, P26435, DOI 10.1074/jbc.M116.757450; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deutscher MP, 2015, FEMS MICROBIOL REV, V39, P350, DOI 10.1093/femsre/fuv012; Deutscher MP, 2015, RNA, V21, P597, DOI 10.1261/rna.049692.115; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Dutta T, 2018, GENE, V656, P60, DOI 10.1016/j.gene.2018.02.068; Dutta T, 2013, J BIOL CHEM, V288, P30636, DOI 10.1074/jbc.M113.514570; Dutta T, 2012, J BIOL CHEM, V287, P35747, DOI 10.1074/jbc.M112.407403; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; JAIN C, 1993, GENE, V133, P99, DOI 10.1016/0378-1119(93)90231-Q; Kavita K, 2018, CURR OPIN MICROBIOL, V42, P53, DOI 10.1016/j.mib.2017.10.014; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kushner SR, 2015, RNA, V21, P673, DOI 10.1261/rna.049700.115; Lalaouna D, 2019, MOL MICROBIOL, V111, P473, DOI 10.1111/mmi.14168; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Melamed S, 2016, MOL CELL, V63, P884, DOI 10.1016/j.molcel.2016.07.026; Miller J. H, 1972, EXPT MOL GENETICS; Miyakoshi M, 2015, EMBO J, V34, P1478, DOI 10.15252/embj.201490546; Mohanty BK, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0011-2017; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P115, DOI 10.1099/mic.0.023432-0; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Song LM, 2016, NUCLEIC ACIDS RES, V44, P1979, DOI 10.1093/nar/gkw053; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wang X, 2015, P NATL ACAD SCI USA, V112, P7581, DOI 10.1073/pnas.1424683112; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001	47	10	11	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19997	20008		10.1074/jbc.RA119.011367	http://dx.doi.org/10.1074/jbc.RA119.011367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31744883	hybrid, Green Published			2022-12-28	WOS:000505005800015
J	Contreras-Baeza, Y; Sandoval, PY; Alarcon, R; Galaz, A; Cortes-Molina, F; Alegria, K; Baeza-Lehnert, F; Arce-Molina, R; Guequen, A; Flores, CA; San Martin, A; Barros, LF				Contreras-Baeza, Yasna; Sandoval, Pamela Y.; Alarcon, Romina; Galaz, Alex; Cortes-Molina, Francisca; Alegria, Karin; Baeza-Lehnert, Felipe; Arce-Molina, Robinson; Guequen, Anita; Flores, Carlos A.; San Martin, Alejandro; Felipe Barros, L.			Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; pyruvate; transporter; cancer; macrophage; Michaelis-Menten; monocarboxylate transporter	PLASMA-MEMBRANE; CELL; INHIBITOR; PH; ASTROCYTES; MODULATION; EXPRESSION; HYPOXIA; GLUCOSE; CD147	Monocarboxylate transporter 4 (MCT4) is an H+-coupled symporter highly expressed in metastatic tumors and at inflammatory sites undergoing hypoxia or the Warburg effect. At these sites, extracellular lactate contributes to malignancy and immune response evasion. Intriguingly, at 30?40 mm, the reported K-m of MCT4 for lactate is more than 1 order of magnitude higher than physiological or even pathological lactate levels. MCT4 is not thought to transport pyruvate. Here we have characterized cell lactate and pyruvate dynamics using the FRET sensors Laconic and Pyronic. Dominant MCT4 permeability was demonstrated in various cell types by pharmacological means and by CRISPR/Cas9-mediated deletion. Respective K-m values for lactate uptake were 1.7, 1.2, and 0.7 mm in MDA-MB-231 cells, macrophages, and HEK293 cells expressing recombinant MCT4. In MDA-MB-231 cells MCT4 exhibited a K-m for pyruvate of 4.2 mm, as opposed to >150 mm reported previously. Parallel assays with the pH-sensitive dye 2?,7?-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) indicated that previous K-m estimates based on substrate-induced acidification were severely biased by confounding pH-regulatory mechanisms. Numerical simulation using revised kinetic parameters revealed that MCT4, but not the related transporters MCT1 and MCT2, endows cells with the ability to export lactate in high-lactate microenvironments. In conclusion, MCT4 is a high-affinity lactate transporter with physiologically relevant affinity for pyruvate.	[Contreras-Baeza, Yasna; Sandoval, Pamela Y.; Alarcon, Romina; Galaz, Alex; Cortes-Molina, Francisca; Alegria, Karin; Baeza-Lehnert, Felipe; Arce-Molina, Robinson; Guequen, Anita; Flores, Carlos A.; San Martin, Alejandro; Felipe Barros, L.] Ctr Estudios Cient, Ctr Estudios Cient, Arturo Prat 514, Valdivia 5110466, Chile; [Alarcon, Romina; Baeza-Lehnert, Felipe; Arce-Molina, Robinson] Univ Austral Chile, Valdivia 5110566, Chile	Universidad Austral de Chile	San Martin, A; Barros, LF (corresponding author), Ctr Estudios Cient, Ctr Estudios Cient, Arturo Prat 514, Valdivia 5110466, Chile.	aalejo@cecs.cl; fbarros@cecs.cl	Cortes, Francisca/AAV-9485-2020; Sandoval, Pamela Y./AAL-8719-2020	Sandoval, Pamela Y./0000-0002-6514-3980; San Martin, Alejandro/0000-0002-5608-5117; Flores, Carlos/0000-0002-3813-1909	Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	We thank Karen Everett for critical reading of the manuscript and Jose ' Sarmiento (Universidad Austral de Chile) for help with confocal microscopy of MCT4 in human macrophages. We thank Drs. Brandon Faubert and Ralph J. DeBerardinis (Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX) for a generous gift of the MCT4-Lenti-CRISPR_V2 construct. The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT.	Baeza-Lehnert F, 2019, CELL METAB, V29, P668, DOI 10.1016/j.cmet.2018.11.005; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; BONANNO JA, 1990, CURR EYE RES, V9, P707, DOI 10.3109/02713689008999587; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CLAYCOMB WC, 1971, DEV BIOL, V24, P413, DOI 10.1016/0012-1606(71)90089-3; Contreras-Baeza Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224527; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P173; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Delgado MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19595-5; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong CS, 2016, CELL REP, V14, P1590, DOI 10.1016/j.celrep.2016.01.057; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Moreau A, 2011, FUND CLIN PHARMACOL, V25, P743, DOI 10.1111/j.1472-8206.2010.00913.x; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Park SJ, 2018, AM J CANCER RES, V8, P1967; Peetz J, 2015, PFLUG ARCH EUR J PHY, V467, P1469, DOI 10.1007/s00424-014-1594-z; Placais PY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15510; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; RACKER E, 1972, AM SCI, V60, P56; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; Russell DG, 2019, NAT REV IMMUNOL, V19, P291, DOI 10.1038/s41577-019-0124-9; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Sasaki S, 2016, DRUG METAB PHARMACOK, V31, P218, DOI 10.1016/j.dmpk.2016.03.004; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Tan Z, 2015, J BIOL CHEM, V290, P46, DOI 10.1074/jbc.M114.603589; Theparambil SM, 2014, J NEUROSCI, V34, P1148, DOI 10.1523/JNEUROSCI.2377-13.2014; Tobar N, 2017, J CELL PHYSIOL, V232, P136, DOI 10.1002/jcp.25398; Tosco M, 2000, AM J PHYSIOL-REG I, V278, pR1190, DOI 10.1152/ajpregu.2000.278.5.R1190; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Walenta S, 2000, CANCER RES, V60, P916; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [10.1158/jcr.1925.148, DOI 10.1158/JCR.1925.148]; Weber B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020396; WIDDAS WF, 1954, J PHYSIOL-LONDON, V125, P163, DOI 10.1113/jphysiol.1954.sp005148; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	53	60	62	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20135	20147		10.1074/jbc.RA119.009093	http://dx.doi.org/10.1074/jbc.RA119.009093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719150	Green Published, hybrid			2022-12-28	WOS:000505005800025
J	Reiding, KR; Franc, V; Huitema, MG; Brouwer, E; Heeringa, P; Heck, AJR				Reiding, Karli R.; Franc, Vojtech; Huitema, Minke G.; Brouwer, Elisabeth; Heeringa, Peter; Heck, Albert J. R.			Neutrophil myeloperoxidase harbors distinct site-specific peculiarities in its glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; MPO; neutrophil; glycosylation; mannose-6-phosphate (M6P); mass spectrometry (MS); autoimmune disease; anti-neutrophil cytoplasmic autoantibody (ANCA); glycoproteomics; paucimannose; self-antigen; phosphomannose	RAY CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; AZUROPHILIC GRANULES; PROTEINS; PROPEPTIDE; VASCULITIS	Anti-neutrophil cytoplasmic autoantibodies (ANCAs) are directed against lysosomal components of neutrophils. ANCAs directed to proteinase 3 and myeloperoxidase (MPO) in particular are associated with distinct forms of small vessel vasculitides. MPO is an abundant neutrophil-derived heme protein that is part of the antimicrobial defense system. The protein is typically present in the azurophilic granules of neutrophils, but a large portion may also enter the extracellular space. It remains unclear why MPO is frequently the target of antibody-mediated autoimmune responses. MPO is a homodimeric glycoprotein, posttranslationally modified with complex sugars at specific sites. Glycosylation can strongly influence protein function, affecting its folding, receptor interaction, and backbone accessibility. MPO potentially can be heavily modified as it harbors 5 putative N-glycosylation sites (10 in the mature dimer). Although considered important for MPO structure and function, the full scope and relative abundance of the glycans attached to MPO is unknown. Here, combining bottom-up glycoproteomics and native MS approaches, we structurally characterized MPO from neutrophils of healthy human donors. We quantified the relative occupancy levels of the glycans at each of the five sites and observed complex heterogeneity and site-specific glycosylation. In particular, we detected glycosylation phenotypes uncommon for glycoproteins in the extracellular space, such as a high abundance of phosphorylated high-mannose species and severely truncated small glycans having the size of paucimannose or smaller. We hypothesize that the atypical glycosylation pattern found on MPO might contribute to its specific processing and presentation as a self-antigen by antigen-presenting cells.	[Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Huitema, Minke G.; Brouwer, Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 AB Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands	Utrecht University; Utrecht University; University of Groningen; University of Groningen	Reiding, KR (corresponding author), Padualaan 8, NL-3584 CH Utrecht, Netherlands.	k.r.reiding@uu.nl	Heck, Albert/D-7098-2011; Brouwer, Elisabeth/AAL-9029-2020; Heeringa, Peter/A-6008-2009	Heck, Albert/0000-0002-2405-4404; Brouwer, Elisabeth/0000-0002-5652-4423; Heeringa, Peter/0000-0001-8684-763X; Franc, Vojtech/0000-0003-4114-2382	NWO TOP-Punt Grant [718.015.003]; European Union's Horizon 2020 Research and Innovation Program [668036]	NWO TOP-Punt Grant; European Union's Horizon 2020 Research and Innovation Program	This work was supported by the NWO TOP-Punt Grant 718.015.003 (to A.J.R.H.) and the European Union's Horizon 2020 Research and Innovation Program under Grant 668036 (RELENT). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; [Anonymous], PYMOL MOL GRAPH SYST; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Bossuyt X, 2017, NAT REV RHEUMATOL, V13, P683, DOI 10.1038/nrrheum.2017.140; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Caval T, 2019, MOL CELL PROTEOMICS, V18, P16, DOI 10.1074/mcp.RA118.000967; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Cornec D, 2016, NAT REV RHEUMATOL, V12, P570, DOI 10.1038/nrrheum.2016.123; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gao YP, 2017, ONCOTARGET, V8, P7420, DOI 10.18632/oncotarget.14558; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Heeringa P, 1997, AM J PATHOL, V151, P131; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lee LY, 2016, J PROTEOME RES, V15, P3904, DOI 10.1021/acs.jproteome.6b00438; Lin YH, 2018, J PROTEOME RES, V17, P2861, DOI 10.1021/acs.jproteome.8b00318; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; NAUSEEF WM, 1983, J CLIN INVEST, V71, P1297, DOI 10.1172/JCI110880; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Potel CM, 2019, ANAL CHEM, V91, P5542, DOI 10.1021/acs.analchem.9b00734; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Reiding KR, 2018, TRAC-TREND ANAL CHEM, V108, P260, DOI 10.1016/j.trac.2018.09.007; Rosati S, 2014, NAT PROTOC, V9, P967, DOI 10.1038/nprot.2014.057; Roth AJ, 2013, J CLIN INVEST, V123, P1773, DOI 10.1172/JCI65292; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Thaysen-Andersen M, 2015, J BIOL CHEM, V290, P8789, DOI 10.1074/jbc.M114.631622; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van der Geest KSM, 2018, RHEUMATOLOGY, V57, P1332, DOI 10.1093/rheumatology/kex367; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang J, 2018, NEPHROLOGY, V23, P46, DOI 10.1111/nep.12926; Woods R.J., 2005, GLYCAM WEB; Yang Y, 2017, MABS-AUSTIN, V9, P638, DOI 10.1080/19420862.2017.1290033; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13397; Yogalingam G, 2017, J BIOL CHEM, V292, P4255, DOI 10.1074/jbc.M116.739441; Yu JT, 2017, KIDNEY INT, V91, P1410, DOI 10.1016/j.kint.2016.12.012; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	43	24	24	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20233	20245		10.1074/jbc.RA119.011098	http://dx.doi.org/10.1074/jbc.RA119.011098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719144	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000505005800033
J	Grinter, R; Lithgow, T				Grinter, Rhys; Lithgow, Trevor			The structure of the bacterial iron?catecholate transporter Fiu suggests that it imports substrates via a two-step mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; X-ray crystallography; Escherichia coli (E; coli); protein structure; outer membrane; siderophore; bacterial outer membrane; ferric iron uptake (Fiu); iron acquisition; solute uptake; TonB-dependent transporter	OUTER-MEMBRANE PERMEABILITY; FERRIC-ENTEROBACTIN; CHROMOSOMAL GENES; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; IRON; SIDEROPHORE; PROTEIN; RECEPTOR; FEPA	The ferric iron uptake (Fiu) transporter from Escherichia coli functions in the transport of iron?catecholate complexes across the bacterial outer membrane, providing the bacterium with iron, which is essential for growth. Recently it has become clear that Fiu also represents a liability for E. coli because its activity allows import of antimicrobial compounds that mimic catecholate. This inadvertent import suggests the potential utility of antimicrobial catechol siderophore mimetics in managing bacterial infections. However, to fully exploit these compounds, a detailed understanding of the mechanism of transport through Fiu and related transporters is required. To address this question, we determined the crystal structure of Fiu at 2.1?2.9 ? and analyzed its function in E. coli. Through analysis of the Fiuo crystal structure, in combination with in silico docking and mutagenesis, we provide insight into how Fiu and related transporters bind catecholate in a surface-exposed cavity. Moreover, through determination of the structure of Fiu in multiple crystal states, we revealed the presence of a large, selectively gated cavity in the interior of this transporter. This chamber is large enough to accommodate the Fiu substrate and may allow import of substrates via a two-step mechanism. This would avoid channel formation through the transporter and inadvertent import of toxic molecules. As Fiu and its homologs are the targets of substrate-mimicking antibiotics, these results may assist in the development of these compounds.	[Grinter, Rhys] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; Monash University	Grinter, R (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	rhys.grinter@monash.edu		Grinter, Rhys/0000-0002-8195-5348	Australian Research Council [FL130100038]; National Health and Medical Research Council (NHMRC Program in Cellular Microbiology) [1092262]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC Program in Cellular Microbiology)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (FL130100038) and the National Health and Medical Research Council(NHMRCProgram in Cellular Microbiology, 1092262). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2012, P NATL ACAD SCI USA, V109, P4425, DOI 10.1073/pnas.1114224109; ARMSTRONG SK, 1990, J BIOL CHEM, V265, P14536; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bolam DN, 2018, CURR OPIN STRUC BIOL, V51, P35, DOI 10.1016/j.sbi.2018.03.001; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Brillet K, 2011, J AM CHEM SOC, V133, P16503, DOI 10.1021/ja205504z; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Calmettes C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8996; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chakraborty R, 2003, BIOMETALS, V16, P507, DOI 10.1023/A:1023485632520; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Cornelis P, 2009, ENV MICROBIOL REP, V1, P256, DOI 10.1111/j.1758-2229.2009.00041.x; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; CRITCHLEY IA, 1991, J ANTIMICROB CHEMOTH, V28, P377, DOI 10.1093/jac/28.3.377; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Destoumieux-Garzon D, 2006, BIOMETALS, V19, P181, DOI 10.1007/s10534-005-4452-9; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Ghequire MGK, 2017, MBIO, V8, DOI 10.1128/mBio.01961-16; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; Grinter R, 2019, IUCRJ, V6, P401, DOI 10.1107/S2052252519002926; Grinter R, 2014, MOL MICROBIOL, V93, P234, DOI 10.1111/mmi.12655; Grinter R, 2013, FEMS MICROBIOL LETT, V338, P1, DOI 10.1111/1574-6968.12011; HANTKE K, 1990, FEMS MICROBIOL LETT, V67, P5, DOI 10.1111/j.1574-6968.1990.tb13826.x; Hickman SJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14804; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Josts I, 2019, ELIFE, V8, DOI 10.7554/eLife.48528; Khan A, 2018, MICROBIOL RES, V212, P103, DOI 10.1016/j.micres.2017.10.012; King DT, 2016, PROTEIN SCI, V25, P787, DOI 10.1002/pro.2889; Kong HM, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111615; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Luscher A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00097-18, 10.1128/aac.00097-18]; Machuca A, 2007, LETT APPL MICROBIOL, V44, P7, DOI 10.1111/j.1472-765X.2006.02046.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Moynie L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11508-y; Moynie L, 2018, ELIFE, V7, DOI 10.7554/eLife.42270; Moynie L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02531-16; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; NIKAIDO H, 1990, J BACTERIOL, V172, P1361, DOI 10.1128/jb.172.3.1361-1367.1990; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIERCE JR, 1983, J BACTERIOL, V155, P330, DOI 10.1128/JB.155.1.330-336.1983; Portsmouth S, 2018, LANCET INFECT DIS, V18, P1319, DOI 10.1016/S1473-3099(18)30554-1; PUGSLEY AP, 1987, J GEN MICROBIOL, V133, P3505; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; REIKOFSKI J, 1992, BIOTECHNOL ADV, V10, P535, DOI 10.1016/0734-9750(92)91451-J; Saleem M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056746; Strahsburger E, 2005, ANTIMICROB AGENTS CH, V49, P3083, DOI 10.1128/AAC.49.7.3083-3086.2005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24648; van Delden C, 2013, ANTIMICROB AGENTS CH, V57, P2095, DOI 10.1128/AAC.02474-12; van den Berg B, 2015, P NATL ACAD SCI USA, V112, pE2991, DOI 10.1073/pnas.1424835112; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; White P, 2017, P NATL ACAD SCI USA, V114, P12051, DOI 10.1073/pnas.1713741114	70	7	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19523	19534		10.1074/jbc.RA119.011018	http://dx.doi.org/10.1074/jbc.RA119.011018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712312	Green Published, hybrid			2022-12-28	WOS:000504093200007
J	Chawla-Sarkar, M; Bauer, JA; Lupica, JA; Morrison, BH; Tang, Z; Oates, RK; Almasan, A; DiDonato, JA; Borden, EC; Lindner, DJ				Chawla-Sarkar, Mamta; Bauer, Joseph A.; Lupica, Joseph A.; Morrison, Bei H.; Tang, Zhuo; Oates, Rhonda K.; Almasan, Alex; DiDonato, Joseph A.; Borden, Ernest C.; Lindner, Daniel J.			RETRACTION: Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL (Retraction of Vol 294, Pg 39461, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Hazen, Stanley L/ABD-5845-2021; Lindner, Daniel/ABB-5440-2020	Lupica, Joseph/0000-0003-1476-037X				Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18518	18518		10.1074/jbc.W119.011721	http://dx.doi.org/10.1074/jbc.W119.011721			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31784479	Green Published, hybrid			2022-12-28	WOS:000505547900044
J	Hansen, LH; Madsen, TD; Goth, CK; Clausen, H; Chen, Y; Dzoyashvili, N; Iyer, SR; Sangaralingham, SJ; Burnett, JC; Rehfeld, JF; Vakhrushev, SY; Schjoldager, KT; Goetze, JP				Hansen, Lasse H.; Madsen, Thomas Daugbjerg; Goth, Christoffer K.; Clausen, Henrik; Chen, Yang; Dzoyashvili, Nina; Iyer, Seethalakshmi R.; Sangaralingham, S. Jeson; Burnett, John C., Jr.; Rehfeld, Jens F.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Goetze, Jens P.			Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor (vol 294, pg 12567, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Hansen, Lasse H.; Rehfeld, Jens F.; Goetze, Jens P.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hansen, LH (corresponding author), Univ Copenhagen, Rigshosp, Dept Clin Biochem, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark.		clausen, henrik/AAD-8016-2021; Vakhrushev, Sergey Y/A-7638-2014	Vakhrushev, Sergey Y/0000-0002-0418-5765				Hansen LH, 2019, J BIOL CHEM, V294, P12567, DOI 10.1074/jbc.RA119.008102	1	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18516	18516		10.1074/jbc.AAC119.011661	http://dx.doi.org/10.1074/jbc.AAC119.011661			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31784477	Green Published, hybrid			2022-12-28	WOS:000505547900042
J	De-Souza, EA; Pimentel, FSA; De-Queiroz, ALFV; Camara, H; Felix-Formiga, ML; Machado, CM; Pinto, S; Galina, A; Mori, MA; Montero-Lomeli, M; Masuda, CA				De-Souza, Evandro A.; Pimentel, Felipe S. A.; De-Queiroz, Ana Luiza F. V.; Camara, Henrique; Felix-Formiga, Mikaella L.; Machado, Caio M.; Pinto, Silas; Galina, Antonio; Mori, Marcelo A.; Montero-Lomeli, Monica; Masuda, Claudio A.			The yeast protein Ubx4p contributes to mitochondrial respiration and lithium?galactose?mediated activation of the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; galactose; mitochondria; endoplasmic reticulum stress (ER stress); endoplasmic reticulum?associated protein degradation (ERAD); Caenorhabditis elegans (C; elegans); ASPS-1; ASPSCR1; galactosemia; lithium	ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CALCIUM HOMEOSTASIS; ELECTRON-TRANSPORT; CA2+ HOMEOSTASIS; GENE-EXPRESSION; ER STRESS; LIFE-SPAN; LITHIUM	In the presence of galactose, lithium ions activate the unfolded protein response (UPR) by inhibiting phosphoglucomutase activity and causing the accumulation of galactose-related metabolites, including galactose-1-phosphate. These metabolites also accumulate in humans who have the disease classic galactosemia. Here, we demonstrate that Saccharomyces cerevisiae yeast strains harboring a deletion of UBX4, a gene encoding a partner of Cdc48p in the endoplasmic reticulum?associated degradation (ERAD) pathway, exhibit delayed UPR activation after lithium and galactose exposure because the deletion decreases galactose-1-phosphate levels. The delay in UPR activation did not occur in yeast strains in which key ERAD or proteasomal pathway genes had been disrupted, indicating that the ubx4? phenotype is ERAD-independent. We also observed that the ubx4? strain displays decreased oxygen consumption. The inhibition of mitochondrial respiration was sufficient to diminish galactose-1-phosphate levels and, consequently, affects UPR activation. Finally, we show that the deletion of the AMP-activated protein kinase ortholog?encoding gene SNF1 can restore the oxygen consumption rate in ubx4? strain, thereby reestablishing galactose metabolism, UPR activation, and cellular adaption to lithium?galactose challenge. Our results indicate a role for Ubx4p in yeast mitochondrial function and highlight that mitochondrial and endoplasmic reticulum functions are intertwined through galactose metabolism. These findings also shed new light on the mechanisms of lithium action and on the pathophysiology of galactosemia.	[De-Souza, Evandro A.; Pimentel, Felipe S. A.; De-Queiroz, Ana Luiza F. V.; Felix-Formiga, Mikaella L.; Machado, Caio M.; Montero-Lomeli, Monica; Masuda, Claudio A.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Galina, Antonio] Univ Fed Rio de Janeiro, Programa Bioquim & Biofis Celular, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Camara, Henrique; Pinto, Silas; Mori, Marcelo A.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual de Campinas	Masuda, CA (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	cmasuda@bioqmed.ufrj.br	de Souza, Evandro Araujo/G-3696-2014; Masuda, Claudio Akio/F-7214-2014	de Souza, Evandro Araujo/0000-0002-9080-3864; Masuda, Claudio Akio/0000-0002-0310-7108; Seixas, Felipe/0000-0002-4753-8612; Camara, Henrique/0000-0001-7300-1416; Pinto, Silas/0000-0003-0894-8915	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants [E-26/203.203/2015, E-26/010.000837/2016]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2017/01184-9, 17/04377-2, 17/01339-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship [E-26/200.790/2019]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship	This work was supported by research grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants E-26/203.203/2015 (to M. M.-L.) and E-26/010.000837/2016 (to C. A. M.); and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2017/01184-9 (to M. A. M.). This work was also supported in part by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico fellowships (to E. A. D.-S., F. S. A. P., A. L. F. V. D.-Q., C. M. M., and M. L. F.-F.), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro fellowship E-26/200.790/2019 (to E. A. D.-S.), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowships 17/04377-2 (to S. P.) and 17/01339-2 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiello DP, 2004, J BIOL CHEM, V279, P38495, DOI 10.1074/jbc.M400833200; Aiello DP, 2002, J BIOL CHEM, V277, P45751, DOI 10.1074/jbc.M208748200; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Balakrishnan B, 2016, BIOCHEM BIOPH RES CO, V470, P205, DOI 10.1016/j.bbrc.2016.01.036; Berry G. T., 2017, CLASSIC GALACTOSEMIA; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Bozaquel-Morais BL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169682; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; BRENNER S, 1974, GENETICS, V77, P71; Bro C, 2003, J BIOL CHEM, V278, P32141, DOI 10.1074/jbc.M304478200; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chien CY, 2013, J BIOL CHEM, V288, P37180, DOI 10.1074/jbc.M113.513598; CLARKE CF, 1991, J BIOL CHEM, V266, P16636; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Csutora P, 2005, AM J PHYSIOL-CELL PH, V289, pC58, DOI 10.1152/ajpcell.00464.2004; De-Souza EA, 2014, DIS MODEL MECH, V7, P55, DOI 10.1242/dmm.012641; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Ferreira JR, 2006, BIOCHEM BIOPH RES CO, V339, P30, DOI 10.1016/j.bbrc.2005.11.003; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Fu LW, 2000, J BIOL CHEM, V275, P5431, DOI 10.1074/jbc.275.8.5431; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Habtemichael E. N., 2019, INSULIN STIMULATED P, DOI [10.1101/817049, DOI 10.1101/817049]; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Izawa T, 2017, CELL, V171, P890, DOI 10.1016/j.cell.2017.10.002; Jelicic B, 2005, FEMS MICROBIOL LETT, V253, P207, DOI 10.1016/j.femsle.2005.09.033; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Knupp J, 2019, CELL DEATH DIFFER, V26, P487, DOI 10.1038/s41418-018-0133-4; Lai K, 2014, FUTURE MED CHEM, V6, P1003, DOI [10.4155/fmc.14.43, 10.4155/FMC.14.43]; Li Y, 2010, MOL MICROBIOL, V78, P414, DOI 10.1111/j.1365-2958.2010.07343.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado CM, 2017, BBA-MOL BASIS DIS, V1863, P1403, DOI 10.1016/j.bbadis.2017.02.014; Madsen L, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-31; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Martensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y; Masuda CA, 2001, J BIOL CHEM, V276, P37794; Masuda CA, 2008, FEMS YEAST RES, V8, P1245, DOI 10.1111/j.1567-1364.2008.00440.x; Mizuno T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005491; Nagy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070410; Nicastro R, 2015, BBA-MOL CELL RES, V1853, P1615, DOI 10.1016/j.bbamcr.2015.03.014; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Osman C, 2015, P NATL ACAD SCI USA, V112, pE947, DOI 10.1073/pnas.1501737112; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pinto S, 2018, REDOX BIOL, V18, P84, DOI 10.1016/j.redox.2018.06.006; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rendon OZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04564-3; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Simoes T, 2018, ELIFE, V7, DOI 10.7554/eLife.30015; Slepak TI, 2007, MOL GENET METAB, V92, P78, DOI 10.1016/j.ymgme.2007.06.005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Torelli NQ, 2015, FREE RADICAL BIO MED, V81, P30, DOI 10.1016/j.freeradbiomed.2014.12.025; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Wu ZY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0615-3; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200	69	1	1	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3773	3782		10.1074/jbc.RA119.011271	http://dx.doi.org/10.1074/jbc.RA119.011271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	31996377	Green Published, hybrid			2022-12-28	WOS:000527704400005
J	Okubo, T; Hayashi, R; Shibata, S; Kudo, Y; Ishikawa, Y; Inoue, S; Kobayashi, Y; Honda, A; Honma, Y; Kawasaki, S; Nishida, K				Okubo, Toru; Hayashi, Ryuhei; Shibata, Shun; Kudo, Yuji; Ishikawa, Yuki; Inoue, Saki; Kobayashi, Yuki; Honda, Ai; Honma, Yoichi; Kawasaki, Satoshi; Nishida, Kohji			Generation and validation of a PITX2?EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						paired-like homeodomain transcription factor 2 (PITX2); induced pluripotent stem cell (iPS cell) (iPSC); transcription activator?like effector nuclease (TALEN); regenerative medicine; stem cells; eye development; neural crest cell; periocular mesenchyme (POM); reporter gene	HOMEOBOX GENE PITX2; HUMAN IPS CELLS; NEURAL CREST; ANTERIOR SEGMENT; ANGIOGENIC PRIVILEGE; OCULAR DEVELOPMENT; DIFFERENTIATION; EYE; MORPHOGENESIS; TRANSCRIPTION	PITX2 (Paired-like homeodomain transcription factor 2) plays important roles in asymmetric development of the internal organs and symmetric development of eye tissues. During eye development, cranial neural crest cells migrate from the neural tube and form the periocular mesenchyme (POM). POM cells differentiate into several ocular cell types, such as corneal endothelial cells, keratocytes, and some ocular mesenchymal cells. In this study, we used transcription activator?like effector nuclease technology to establish a human induced pluripotent stem cell (hiPSC) line expressing a fluorescent reporter gene from the PITX2 promoter. Using homologous recombination, we heterozygously inserted a PITX2?IRES2?EGFP sequence downstream of the stop codon in exon 8 of PITX2. Cellular pluripotency was monitored with alkaline phosphatase and immunofluorescence staining of pluripotency markers, and the hiPSC line formed normal self-formed ectodermal autonomous multizones. Using a combination of previously reported methods, we induced PITX2 in the hiPSC line and observed simultaneous EGFP and PITX2 expression, as indicated by immunoblotting and immunofluorescence staining. PITX2 mRNA levels were increased in EGFP-positive cells, which were collected by cell sorting, and marker gene expression analysis of EGFP-positive cells induced in self-formed ectodermal autonomous multizones revealed that they were genuine POM cells. Moreover, after 2 days of culture, EGFP-positive cells expressed the PITX2 protein, which co-localized with forkhead box C1 (FOXC1) protein in the nucleus. We anticipate that the PITX2?EGFP hiPSC reporter cell line established and validated here can be utilized to isolate POM cells and to analyze PITX2 expression during POM cell induction.	[Okubo, Toru; Hayashi, Ryuhei; Shibata, Shun; Kudo, Yuji; Honma, Yoichi] Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hayashi, Ryuhei; Ishikawa, Yuki; Inoue, Saki; Kobayashi, Yuki; Honda, Ai; Kawasaki, Satoshi; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nishida, Kohji] Osaka Univ, Integrated Frontier Res Med Sci Div, Inst Open & Transdisciplinary Res Initiat, Suita, Osaka 5650871, Japan; [Okubo, Toru; Shibata, Shun; Kudo, Yuji; Honma, Yoichi] Rohto Pharmaceut Co Ltd, Basic Res Dev Div, Osaka 5448666, Japan	Osaka University; Osaka University; Osaka University; Rohto Pharmaceutical Co Ltd	Hayashi, R (corresponding author), Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ryuhei.hayashi@ophthal.med.osaka-u.ac.jp	Hayashi, Ryuhei/AAW-4737-2020	Hayashi, Ryuhei/0000-0002-4699-8617; Okubo, Toru/0000-0001-7483-8576; Shibata, Shun/0000-0002-9081-1370	Project for the Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development	Project for the Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development	This work was supported in part by the Project for the Realization of Regenerative Medicine of the Japan Agency for Medical Research and Development. R. H. is affiliated with the endowed chair of Rohto Pharmaceutical Co., Ltd. T. O., S. S., Y. Kudo, and Y. H. are employees of Rohto Pharmaceutical Co., Ltd.	Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Campione M, 1999, DEVELOPMENT, V126, P1225; Chen LS, 2016, INVEST OPHTH VIS SCI, V57, P1072, DOI 10.1167/iovs.15-18103; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Franco D, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4040016; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Gage PJ, 2014, DEV DYNAM, V243, P1391, DOI 10.1002/dvdy.24165; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Hall B.K., 2009, NEURAL CREST NEURAL, P159, DOI [10.1006/dbio.1998.9175., DOI 10.1006/DBIO.1998.9175]; Hayashi R, 2017, NAT PROTOC, V12, P683, DOI 10.1038/nprot.2017.007; Hayashi R, 2016, NATURE, V531, P376, DOI 10.1038/nature17000; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kimura Masashi, 2014, Hum Genome Var, V1, P14005, DOI 10.1038/hgv.2014.5; Kobayashi Y, 2017, STEM CELL RES, V25, P256, DOI 10.1016/j.scr.2017.10.015; Langenberg T, 2008, DEV DYNAM, V237, P1645, DOI 10.1002/dvdy.21577; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lovatt M, 2018, DIFFERENTIATION, V99, P62, DOI 10.1016/j.diff.2017.11.003; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; McMahon C, 2009, DEV BIOL, V332, P287, DOI 10.1016/j.ydbio.2009.05.577; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mimura S, 2016, INT J DEV BIOL, V60, P21, DOI 10.1387/ijdb.160040mk; Nishizawa M, 2016, CELL STEM CELL, V19, P341, DOI 10.1016/j.stem.2016.06.019; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Roy O, 2015, INVEST OPHTH VIS SCI, V56, P1228, DOI 10.1167/iovs.14-16166; Seifi M, 2016, ACTA OPHTHALMOL, V94, pE571, DOI 10.1111/aos.13030; Seo S, 2017, INVEST OPHTH VIS SCI, V58, P1368, DOI 10.1167/iovs.16-21217; Shiratori H, 2006, DEVELOPMENT, V133, P3015, DOI 10.1242/dev.02470; Suh H, 2002, DEVELOPMENT, V129, P329; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Welsh IC, 2013, DEV CELL, V26, P629, DOI 10.1016/j.devcel.2013.07.019; Williams AL, 2015, BIRTH DEFECTS RES C, V105, P87, DOI 10.1002/bdrc.21095	33	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3456	3465		10.1074/jbc.RA119.010713	http://dx.doi.org/10.1074/jbc.RA119.010713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32034090	Green Published, hybrid			2022-12-28	WOS:000527725300008
J	Toldi, V; Szabo, A; Sahin-Toth, M				Toldi, Vanda; Szabo, Andras; Sahin-Toth, Miklos			Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; protease; protease inhibitor; trypsin; trypsinogen; chymotrypsin C; mesotrypsin	CATIONIC TRYPSINOGEN; PANCREATITIS; PROTEINS; PROTEASE; AUTOACTIVATION; DETERMINANTS; PURIFICATION; EXPRESSION; CLEAVAGE; AFFINITY	Mesotrypsin is an unusual human trypsin isoform with inhibitor resistance and the ability to degrade trypsin inhibitors. Degradation of the protective serine protease inhibitor Kazal type 1 (SPINK1) by mesotrypsin in the pancreas may contribute to the pathogenesis of pancreatitis. Here we tested the hypothesis that the regulatory digestive protease chymotrypsin C (CTRC) mitigates the harmful effects of mesotrypsin by cleaving the autolysis loop. As human trypsins are post-translationally sulfated in the autolysis loop, we also assessed the effect of this modification. We found that mesotrypsin cleaved in the autolysis loop by CTRC exhibited catalytic impairment on short peptides due to a 10-fold increase in K-m, it digested ?-casein poorly and bound soybean trypsin inhibitor with 10-fold decreased affinity. Importantly, CTRC-cleaved mesotrypsin degraded SPINK1 with markedly reduced efficiency. Sulfation increased mesotrypsin activity but accelerated CTRC-mediated cleavage of the autolysis loop and did not protect against the detrimental effect of CTRC cleavage. The observations indicate that CTRC-mediated cleavage of the autolysis loop in mesotrypsin decreases protease activity and thereby protects the pancreas against unwanted SPINK1 degradation. The findings expand the role of CTRC as a key defense mechanism against pancreatitis through regulation of intrapancreatic trypsin activity.	[Toldi, Vanda; Szabo, Andras] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Egyet Ter 1,Life Sci Bldg 3-109, H-4032 Debrecen, Hungary; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Sahin-Toth, Miklos] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA	University of Debrecen; Boston University; University of California System; University of California Los Angeles	Szabo, A (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Egyet Ter 1,Life Sci Bldg 3-109, H-4032 Debrecen, Hungary.; Sahin-Toth, M (corresponding author), MacDonald Res Labs, 675 Charles E Young Dr South,Rm 2220, Los Angeles, CA 90095 USA.	andrasszabo@med.unideb.hu; msahintoth@mednet.ucla.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Toldi, Vanda/0000-0002-0446-027X; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01 DK058088]; National Research, Development and Innovation Office of Hungary [PD120960, FK127942]; European Union; European Social Fund; University of Debrecen OTKA Bridge Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [BO/00514/19/5];  [EFOP-3.6.3-VEKOP-16-2017-00009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office of Hungary; European Union(European Commission); European Social Fund(European Social Fund (ESF)); University of Debrecen OTKA Bridge Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This work was supported by National Institutes of Health Grant R01 DK058088 (to M. S.-T.), National Research, Development and Innovation Office of Hungary Grants PD120960 and FK127942, EFOP-3.6.3-VEKOP-16-2017-00009 project co-financed by the European Union and the European Social Fund, the University of Debrecen OTKA Bridge Fund, and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences Grant BO/00514/19/5 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; GUILLIN MC, 1992, SEMIN THROMB HEMOST, V18, P224, DOI 10.1055/s-2007-1002428; GUY O, 1978, BIOCHEMISTRY-US, V17, P1669, DOI 10.1021/bi00602a014; Hegyi E, 2017, DIGEST DIS SCI, V62, P1692, DOI 10.1007/s10620-017-4601-3; Jancso Z, 2016, J BIOL CHEM, V291, P12897, DOI 10.1074/jbc.M116.725374; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Lasher D, 2019, AM J GASTROENTEROL, V114, P974, DOI 10.14309/ajg.0000000000000051; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Sabharwal AK, 1997, J BIOL CHEM, V272, P22037, DOI 10.1074/jbc.272.35.22037; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Szabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102063; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3447	3455		10.1074/jbc.RA120.012526	http://dx.doi.org/10.1074/jbc.RA120.012526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32014997	Green Published, hybrid			2022-12-28	WOS:000527725300007
J	Baek, Y; Kim, J; Ahn, J; Jo, I; Hong, S; Ryu, S; Ha, NC				Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul			Structure and function of the hypochlorous acid?induced flavoprotein RclA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavoprotein; copper; crystal structure; nicotinamide adenine dinucleotide (NADH); disulfide; oxidative stress; macrophage; flavoprotein disulfide reductase; hypochlorous acid; innate immune response; oxygen; RclA	X-RAY; TRANSCRIPTION FACTOR; REDUCTASE; PROTEIN; MECHANISMS; OXIDATION; OXIDASE; HG2+	In response to microbial invasion, the animal immune system generates hypochlorous acid (HOCl) that kills microorganisms in the oxidative burst. HOCl toxicity is amplified in the phagosome through import of the copper cation (Cu2+). In Escherichia coli and Salmonella, the transcriptional regulator RclR senses HOCl stress and induces expression of the RclA, -B, and -C proteins involved in bacterial defenses against oxidative stress. However, the structures and biochemical roles of the Rcl proteins remain to be elucidated. In this study, we first examined the role of the flavoprotein disulfide reductase (FDR) RclA in the survival of Salmonella in macrophage phagosomes, finding that RclA promotes Salmonella survival in macrophage vacuoles containing sublethal HOCl levels. To clarify the molecular mechanism, we determined the crystal structure of RclA from E. coli at 2.9 ? resolution. This analysis revealed that the structure of homodimeric RclA is similar to those of typical FDRs, exhibiting two conserved cysteine residues near the flavin ring of the cofactor flavin adenine dinucleotide (FAD). Of note, we observed that Cu2+ accelerated RclA-mediated oxidation of NADH, leading to a lowering of oxygen levels in vitro. Compared with the RclA WT enzyme, substitution of the conserved cysteine residues lowered the specificity to Cu2+ or substantially increased the production of superoxide anion in the absence of Cu2+. We conclude that RclA-mediated lowering of oxygen levels could contribute to the inhibition of oxidative bursts in phagosomes. Our study sheds light on the molecular basis for how bacteria can survive HOCl stress in macrophages.	[Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Ctr Food Safety & Toxicol, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea; [Baek, Yeongjin; Kim, Jinwoo; Ahn, Jinsook; Jo, Inseong; Hong, Seokho; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, CALS, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ha, NC (corresponding author), Seoul Natl Univ, Ctr Food Safety & Toxicol, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea.	hanc210@snu.ac.kr	Hong, Seokho/AGZ-9428-2022; Jo, Inseong/AGY-9957-2022; Ahn, Jinsook/AAE-5827-2022	Hong, Seokho/0000-0003-4603-8445; Jo, Inseong/0000-0002-7964-4751; Kim, Jinwoo/0000-0002-3397-1247	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) [710012-03-1HD120]; National Research Foundation of Korea [NRF-2017R1A2B2003992]; Korean Government (MSIT) [NRF-2019M3E5D6063871]; ARC Program - Ministry of Agriculture, Food, and Rural Affairs	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MSIT)(Korean Government); ARC Program - Ministry of Agriculture, Food, and Rural Affairs	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) Grant 710012-03-1HD120, the ARC Program (to N. C. H.) funded by the Ministry of Agriculture, Food, and Rural Affairs, National Research Foundation of Korea Grant NRF-2017R1A2B2003992 (to N. C. H.), and by Korean Government (MSIT) Grant NRF-2019M3E5D6063871.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Angiulli G, 2015, BBA-GEN SUBJECTS, V1850, P1891, DOI 10.1016/j.bbagen.2015.05.022; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Derke RM., 2019, MICROBIOLOGY, DOI [10.1101/690669, DOI 10.1101/690669]; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jo I, 2019, P NATL ACAD SCI USA, V116, P3740, DOI 10.1073/pnas.1811509116; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Ledwidge R, 2005, BIOCHEMISTRY-US, V44, P11402, DOI 10.1021/bi050519d; 신웅희, 2014, Biodesign, V2, P1; Lian P, 2014, BIOCHEMISTRY-US, V53, P7211, DOI 10.1021/bi500608u; LIOCHEV SI, 1992, ARCH BIOCHEM BIOPHYS, V294, P403, DOI 10.1016/0003-9861(92)90703-Y; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; Murakami K, 2014, BIOMETALS, V27, P551, DOI 10.1007/s10534-014-9731-x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park Suk-Youl, 2017, Biodesign, V5, P30; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; RAY S, 1989, J BIOSCIENCE, V14, P173, DOI 10.1007/BF02703169; RENNEX D, 1994, FEBS LETT, V355, P220, DOI 10.1016/0014-5793(94)01180-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; WEISS SJ, 1982, LAB INVEST, V47, P5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827	36	9	9	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3202	3212		10.1074/jbc.RA119.011530	http://dx.doi.org/10.1074/jbc.RA119.011530			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988242	hybrid, Green Published			2022-12-28	WOS:000519597300025
J	Bogenhagen, DF; Haley, JD				Bogenhagen, Daniel F.; Haley, John D.			Pulse-chase SILAC?based analyses reveal selective oversynthesis and rapid turnover of mitochondrial protein components of respiratory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial respiratory chain complex; protein assembly; proteomics; protein synthesis; protein dynamics; NADH dehydrogenase; oxidative phosphorylation system; stable isotope labeling with amino acids in cell culture (SILAC); mitochondrial biogenesis; respiratory complex assembly; protein turnover	ACYL-CARRIER PROTEIN; SUBUNIT; ARCHITECTURE; TRANSLATION; BIOGENESIS; SYNTHASE	Mammalian mitochondria assemble four complexes of the respiratory chain (RCI, RCIII, RCIV, and RCV) by combining 13 polypeptides synthesized within mitochondria on mitochondrial ribosomes (mitoribosomes) with over 70 polypeptides encoded in nuclear DNA, translated on cytoplasmic ribosomes, and imported into mitochondria. We have previously observed that mitoribosome assembly is inefficient because some mitoribosomal proteins are produced in excess, but whether this is the case for other mitochondrial assemblies such as the RCs is unclear. We report here that pulse-chase stable isotope labeling with amino acids in cell culture (SILAC) is a valuable technique to study RC assembly because it can reveal considerable differences in the assembly rates and efficiencies of the different complexes. The SILAC analyses of HeLa cells indicated that assembly of RCV, comprising F-1/F-o-ATPase, is rapid with little excess subunit synthesis, but that assembly of RCI (i.e. NADH dehydrogenase) is far less efficient, with dramatic oversynthesis of numerous proteins, particularly in the matrix-exposed N and Q domains. Unassembled subunits were generally degraded within 3 h. We also observed differential assembly kinetics for individual complexes that were immunoprecipitated with complex-specific antibodies. Immunoprecipitation with an antibody that recognizes the ND1 subunit of RCI co-precipitated a number of proteins implicated in FeS cluster assembly and newly synthesized ubiquinol-cytochrome c reductase Rieske iron-sulfur polypeptide 1 (UQCRFS1), the Rieske FeS protein in RCIII, reflecting some coordination between RCI and RCIII assemblies. We propose that pulse-chase SILAC labeling is a useful tool for studying rates of protein complex assembly and degradation.	[Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Haley, John D.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Haley, John D.] SUNY Stony Brook, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu		Haley, John/0000-0002-0283-6413; Bogenhagen, Daniel/0000-0002-9993-2574	National Institutes of Health [1R01 GM112790, PI-15-151]; United Mitochondrial Disease Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation	This work was supported by National Institutes of Health Grant 1R01 GM112790 and by Research Grant PI-15-151 (to D. F. B.) from the United Mitochondrial Disease Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bogenhagen DF, 2018, CELL REP, V22, P1935, DOI 10.1016/j.celrep.2018.01.066; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Boniecki MT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01497-1; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Dibley MG, 2020, MOL CELL PROTEOMICS, V19, P65, DOI 10.1074/mcp.RA119.001784; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; HUBER PJ, 1973, ANN STAT, V1, P799, DOI 10.1214/aos/1176342503; Isaac RS, 2018, ANNU REV GENET, V52, P511, DOI 10.1146/annurev-genet-120417-031709; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036; Nowinski SM, 2018, CURR BIOL, V28, pR1212, DOI 10.1016/j.cub.2018.08.022; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Snider J, 2019, ADV EXP MED BIOL, V1140, P575, DOI 10.1007/978-3-030-15950-4_34; Stoldt S, 2018, NAT CELL BIOL, V20, P528, DOI 10.1038/s41556-018-0090-7; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zong S, 2018, CELL RES, V28, P1026, DOI 10.1038/s41422-018-0071-1	37	24	24	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2544	2554		10.1074/jbc.RA119.011791	http://dx.doi.org/10.1074/jbc.RA119.011791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974161	hybrid, Green Published			2022-12-28	WOS:000519969100001
J	Gao, DT; Ashraf, MZ; Zhang, LF; Kar, N; Byzova, TV; Podrez, EA				Gao, Detao; Ashraf, Mohammad Z.; Zhang, Lifang; Kar, Niladri; Byzova, Tatiana V.; Podrez, Eugene A.			Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization, in vivo detection, and functional implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high-density lipoprotein (HDL); apolipoprotein; oxidative stress; atherosclerosis; cardiovascular disease; phospholipid metabolism; lipid metabolism; cholesterol efflux; cross-linking; oxidized phospholipid-apoprotein adduct; oxidized phospholipids	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; COVALENT MODIFICATIONS; PROTEIN ADDUCTS; ARTERY WALL; FOAM CELLS; OXIDATION; MYELOPEROXIDASE; EFFLUX	Apolipoprotein A-I (apoA-I) is cross-linked and dysfunctional in human atheroma. Although multiple mechanisms of apoA-I cross-linking have been demonstrated in vitro, the in vivo mechanisms of cross-linking are not well-established. We have recently demonstrated the highly selective and efficient modification of high-density lipoprotein (HDL) apoproteins by endogenous oxidized phospholipids (oxPLs), including ?-ketoalkenal phospholipids. In the current study, we report that ?-ketoalkenal phospholipids effectively cross-link apoproteins in HDL. We further demonstrate that cross-linking impairs the cholesterol efflux mediated by apoA-I or HDL3 in vitro and in vivo. Using LC-MS/MS analysis, we analyzed the pattern of apoprotein cross-linking in isolated human HDL either by synthetic ?-ketoalkenal phospholipids or by oxPLs generated during HDL oxidation in plasma by the physiologically relevant MPO-H2O2-NO2? system. We found that five histidine residues in helices 5?8 of apoA-I are preferably cross-linked by oxPLs, forming stable pyrrole adducts with lysine residues in the helices 3?4 of another apoA-I or in the central domain of apoA-II. We also identified cross-links of apoA-I and apoA-II with two minor HDL apoproteins, apoA-IV and apoE. We detected a similar pattern of apoprotein cross-linking in oxidized murine HDL. We further detected oxPL cross-link adducts of HDL apoproteins in plasma and aorta of hyperlipidemic LDLR?/? mice, including cross-link adducts of apoA-I His-165?apoA-I Lys-93, apoA-I His-154?apoA-I Lys-105, apoA-I His-154?apoA-IV Lys-149, and apoA-II Lys-30?apoE His-227. These findings suggest an important mechanism that contributes to the loss of HDL's atheroprotective function in vivo.	[Gao, Detao; Ashraf, Mohammad Z.; Zhang, Lifang; Kar, Niladri; Podrez, Eugene A.] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA; [Byzova, Tatiana V.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Ashraf, Mohammad Z.] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India; [Kar, Niladri] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Jamia Millia Islamia; Cleveland Clinic Foundation	Podrez, EA (corresponding author), 9500 Euclid Ave,NB5-87, Cleveland, OH 44195 USA.	podreze@ccf.org			National Institutes of Health [HL145536, HL077213, HL073311, HL126738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL145536 (to T. V. B.) and HL077213, HL073311, and HL126738 (to E. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisvert WA, 1999, ARTERIOSCL THROM VAS, V19, P525, DOI 10.1161/01.ATV.19.3.525; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; CHACKO GK, 1988, J LIPID RES, V29, P319; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Choi J, 2011, BIOORGAN MED CHEM, V19, P580, DOI 10.1016/j.bmc.2010.10.058; Codreanu SG, 2012, METHODS MOL BIOL, V803, P77, DOI 10.1007/978-1-61779-364-6_7; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Feingold KR, 2016, CURR OPIN LIPIDOL, V27, P521, DOI 10.1097/MOL.0000000000000333; Gao DT, 2018, FREE RADICAL BIO MED, V115, P57, DOI 10.1016/j.freeradbiomed.2017.11.012; Gao DT, 2014, ANAL CHEM, V86, P1254, DOI 10.1021/ac4035949; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Gao X, 2008, J MOL BIOL, V376, P997, DOI 10.1016/j.jmb.2007.12.030; Gillard BK, 2005, BIOCHEMISTRY-US, V44, P471, DOI 10.1021/bi048591j; He Y, 2019, MOL CELL PROTEOMICS, V18, P854, DOI 10.1074/mcp.RA118.000878; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jayaraman S, 2008, BIOCHEMISTRY-US, V47, P3875, DOI 10.1021/bi7023783; Kim HYH, 2009, MOL CELL PROTEOMICS, V8, P2080, DOI 10.1074/mcp.M900121-MCP200; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; Miller YI, 1996, ARCH BIOCHEM BIOPHYS, V326, P252, DOI 10.1006/abbi.1996.0073; Montine TJ, 1996, J NEUROPATH EXP NEUR, V55, P202, DOI 10.1097/00005072-199602000-00009; MOREL DW, 1994, BIOCHEM BIOPH RES CO, V200, P408, DOI 10.1006/bbrc.1994.1464; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Namiri-Kalantari R, 2015, BIOFACTORS, V41, P153, DOI 10.1002/biof.1205; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2010, CLIN EXP PHARMACOL P, V37, P719, DOI 10.1111/j.1440-1681.2010.05380.x; Pollard RD, 2016, BIOCHEMISTRY-US, V55, P4971, DOI 10.1021/acs.biochem.6b00347; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; SAKAI M, 1992, FEBS LETT, V314, P199, DOI 10.1016/0014-5793(92)80974-L; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; SHOUKRY MI, 1994, BBA-LIPID LIPID MET, V1210, P355, DOI 10.1016/0005-2760(94)90240-2; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Valiyaveettil M, 2008, BLOOD, V111, P1962, DOI 10.1182/blood-2007-08-107813; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	50	7	8	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1973	1984		10.1074/jbc.RA119.008445	http://dx.doi.org/10.1074/jbc.RA119.008445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31907281	Green Published, hybrid			2022-12-28	WOS:000517128200016
J	Steidle, EA; Morrissette, VA; Fujimaki, K; Chong, L; Resnick, AC; Capaldi, AP; Rolfes, RJ				Steidle, Elizabeth A.; Morrissette, Victoria A.; Fujimaki, Kotaro; Chong, Lucy; Resnick, Adam C.; Capaldi, Andrew P.; Rolfes, Ronda J.			The InsP(7) phosphatase Siw14 regulates inositol pyrophosphate levels to control localization of the general stress response transcription factor Msn2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; stress response; transcription regulation; gene expression; yeast genetics; inositol pyrophosphate; MSN2; SIW14	PROTEIN-TYROSINE PHOSPHATASES; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; NUCLEAR-LOCALIZATION; SIGNALING PATHWAY; HYDROGEN-PEROXIDE; CELL-GROWTH; HEAT-SHOCK; GENOMICS; PENTAKISPHOSPHATE	The environmental stress response (ESR) is critical for cell survival. Yeast cells unable to synthesize inositol pyrophosphates (PP-InsPs) are unable to induce the ESR. We recently discovered a diphosphoinositol pentakisphosphate (PP-InsP(5)) phosphatase in Saccharomyces cerevisiae encoded by SIW14. Yeast strains deleted for SIW14 have increased levels of PP-InsPs. We hypothesized that strains with high inositol pyrophosphate levels will have an increased stress response. We examined the response of the siw14? mutant to heat shock, nutrient limitation, osmotic stress, and oxidative treatment using cell growth assays and found increased resistance to each. Transcriptional responses to oxidative and osmotic stresses were assessed using microarray and reverse transcriptase quantitative PCR. The ESR was partially induced in the siw14? mutant strain, consistent with the increased stress resistance, and the mutant strain further induced the ESR in response to oxidative and osmotic stresses. The levels of PP-InsPs increased in WT cells under oxidative stress but not under hyperosmotic stress, and they were high and unchanging in the mutant. Phosphatase activity of Siw14 was inhibited by oxidation that was reversible. To determine how altered PP-InsP levels affect the ESR, we performed epistasis experiments with mutations in rpd3 and msn2/4 combined with siw14?. We show that mutations in msn2? and msn4?, but not rpd3, are epistatic to siw14? by assessing growth under oxidative stress conditions and expression of CTT1. Msn2-GFP nuclear localization was increased in the siw14?. These data support a model in which the modulation of PP-InsPs influence the ESR through general stress response transcription factors Msn2/4.	[Steidle, Elizabeth A.; Morrissette, Victoria A.; Rolfes, Ronda J.] Georgetown Univ, Dept Biol, Reiss Sci Bldg 406, Washington, DC 20057 USA; [Fujimaki, Kotaro; Capaldi, Andrew P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Chong, Lucy; Resnick, Adam C.] Childrens Hosp Philadelphia, Div Neurosurg, Colket Translat Res, Philadelphia, PA 19104 USA; [Steidle, Elizabeth A.] Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Chong, Lucy] CA Inst Technol, Div Biol & Biol Engn, Broad Ctr, 1200 East Calif Blvd, Pasadena, CA 91125 USA	Georgetown University; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yeshiva University; Albert Einstein College of Medicine	Rolfes, RJ (corresponding author), Georgetown Univ, Dept Biol, Reiss Sci Bldg 406, Washington, DC 20057 USA.	rolfesr@georgetown.edu		Chong, Lucy/0000-0002-5858-9984	Georgetown Pilot Grant; National Institutes of Health [R01GM097329]; National Science Foundation CAREER Grant [MCB-1253809]; GradGov Research Project Award	Georgetown Pilot Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Grant(National Science Foundation (NSF)); GradGov Research Project Award	This work was supported by a Georgetown Pilot Grant (to R. J. R.), a GradGov Research Project Award (to V. A. M.), National Institutes of Health Grant R01GM097329 (to A. P. C.), and National Science Foundation CAREER Grant MCB-1253809 (to A. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AkhavanAghdam Z, 2016, ELIFE, V5, DOI 10.7554/eLife.18458; Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; ALI N, 1995, BIOCHEM J, V310, P279, DOI 10.1042/bj3100279; Altintas A, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov101; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Brachmann CB, 1998, YEAST, V14, P115; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Choi K, 2005, CELL SIGNAL, V17, P1533, DOI 10.1016/j.cellsig.2005.03.021; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Garay E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004168; Gasch AP, 2003, TOP CURR GENET, V1, P11; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Ghosh AK, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov093; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hallett JEH, 2014, GENETICS, V198, P773, DOI 10.1534/genetics.114.168369; Hasan R, 2002, MOL MICROBIOL, V45, P233, DOI 10.1046/j.1365-2958.2002.03011.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jarolim S, 2013, G3-GENES GENOM GENET, V3, P2321, DOI 10.1534/g3.113.007971; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; Laha D, 2015, PLANT CELL, V27, P1082, DOI 10.1105/tpc.114.135160; Lee P, 2013, FEBS LETT, V587, P3648, DOI 10.1016/j.febslet.2013.10.004; Lev S, 2015, MBIO, V6, DOI 10.1128/mBio.00531-15; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23927; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Martins D, 2014, REDOX BIOL, V2, P308, DOI 10.1016/j.redox.2013.12.019; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Miles S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003854; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morpheus, 2019, ON LIN HEAT MAP GEN; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Norman KL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007493; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Pereira C, 2013, FOLIA MICROBIOL, V58, P81, DOI 10.1007/s12223-012-0186-6; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Sadeh A, 2011, MOL BIOL CELL, V22, P3127, DOI 10.1091/mbc.E10-12-1007; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thota SG, 2015, J BIOSCIENCES, V40, P593, DOI 10.1007/s12038-015-9549-x; Tremblay A, 2002, MOL CELL BIOL, V22, P4792, DOI 10.1128/MCB.22.13.4792-4802.2002; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wang HC, 2018, J BIOL CHEM, V293, P6905, DOI 10.1074/jbc.RA117.001670; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Weissgerber TL, 2017, J BIOL CHEM, V292, P20592, DOI 10.1074/jbc.RA117.000147; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wickner RB, 2017, P NATL ACAD SCI USA, V114, pE8402, DOI 10.1073/pnas.1714361114; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Worley J, 2013, CELL REP, V3, P1476, DOI 10.1016/j.celrep.2013.03.043; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	73	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2043	2056		10.1074/jbc.RA119.012148	http://dx.doi.org/10.1074/jbc.RA119.012148			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31848224	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000517128200022
J	Peluso, G; Tian, E; Abusleme, L; Munemasa, T; Mukaibo, T; Ten Hagen, KG				Peluso, Gabriella; Tian, E.; Abusleme, Loreto; Munemasa, Takashi; Mukaibo, Taro; Ten Hagen, Kelly G.			Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; glycosylation; microbiome; bone; glycosyltransferase; Galnt3; hyperphosphatemic familial tumoral calcinosis (HFTC); Muc10; O-glycosylation; saliva; salivary protein; glycan; post-translational modification; submandibular gland	POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; O-GLYCOSYLATION; UDP-GALNAC; SALIVARY MUCIN; DROSOPHILA; HEALTH; EXPRESSION; SECRETION; MEMBERS; FAMILY	The importance of the microbiome in health and its disruption in disease is continuing to be elucidated. However, the multitude of host and environmental factors that influence the microbiome are still largely unknown. Here, we examined UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 (Galnt3)-deficient mice, which serve as a model for the disease hyperphosphatemic familial tumoral calcinosis (HFTC). In HFTC, loss of GALNT3 activity in the bone is thought to lead to altered glycosylation of the phosphate-regulating hormone fibroblast growth factor 23 (FGF23), resulting in hyperphosphatemia and subdermal calcified tumors. However, GALNT3 is expressed in other tissues in addition to bone, suggesting that systemic loss could result in other pathologies. Using semiquantitative real-time PCR, we found that Galnt3 is the major O-glycosyltransferase expressed in the secretory cells of salivary glands. Additionally, 16S rRNA gene sequencing revealed that the loss of Galnt3 resulted in changes in the structure, composition, and stability of the oral microbiome. Moreover, we identified the major secreted salivary mucin, Muc10, as an in vivo substrate of Galnt3. Given that mucins and their O-glycans are known to interact with various microbes, our results suggest that loss of Galnt3 decreases glycosylation of Muc10, which alters the composition and stability of the oral microbiome. Considering that oral findings have been documented in HFTC patients, our study suggests that investigating GALNT3-mediated changes in the oral microbiome may be warranted.	[Peluso, Gabriella; Tian, E.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA; [Munemasa, Takashi; Mukaibo, Taro] NIDCR, Secretory Mech & Dysfunct Sect, NIH, Bethesda, MD 20892 USA; [Abusleme, Loreto] Univ Chile, Lab Oral Microbiol, Fac Dent, Santiago 8380544, Chile; [Abusleme, Loreto] Univ Chile, Lab Craniofacial Translat Res, Fac Dent, Santiago 8380544, Chile; [Munemasa, Takashi; Mukaibo, Taro] Kyushu Dent Univ, Div Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka 8038580, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidad de Chile; Universidad de Chile; Kyushu Dental University	Ten Hagen, KG (corresponding author), Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov	Mukaibo, Taro/AAR-9429-2020	Mukaibo, Taro/0000-0002-3650-9250; Abusleme, Loreto/0000-0002-7210-1236	Intramural Research Program of the NIDCR, National Institutes of Health [Z01-DE000713, ZIA-DE000738]; NIDCR Veterinary Resources Core Grant [ZIC DE000740-05]; NIDCR Imaging Core Grant [DE000750-01]; Chilean National Fund for Scientific and Technologic Development (FONDECYT) [11180505]	Intramural Research Program of the NIDCR, National Institutes of Health; NIDCR Veterinary Resources Core Grant; NIDCR Imaging Core Grant; Chilean National Fund for Scientific and Technologic Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Intramural Research Program of the NIDCR, National Institutes of Health, Grants Z01-DE000713 (to K. G. T. H.) and ZIA-DE000738 (to James E. Melvin). This research was also supported in part by the NIDCR Veterinary Resources Core Grant ZIC DE000740-05, the NIDCR Imaging Core Grant DE000750-01, and Chilean National Fund for Scientific and Technologic Development (FONDECYT) Grant 11180505 (to L. A). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abusleme L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2655; Abusleme L, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122061; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cross BW, 2018, CELL IMMUNOL, V333, P19, DOI 10.1016/j.cellimm.2018.08.008; Culp DJ, 2015, J BIOL CHEM, V290, P2993, DOI 10.1074/jbc.M114.597906; DENNY PA, 1982, HISTOCHEM J, V14, P403, DOI 10.1007/BF01011852; DENNY PA, 1980, CARBOHYD RES, V87, P265, DOI 10.1016/S0008-6215(00)85213-1; Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797; Frenkel ES, 2017, ISME J, V11, P1286, DOI 10.1038/ismej.2016.200; Frenkel ES, 2015, APPL ENVIRON MICROB, V81, P332, DOI 10.1128/AEM.02573-14; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gao N, 2016, AM J PHYSIOL-GASTR L, V311, pG74, DOI 10.1152/ajpgi.00060.2016; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; GRESIK EW, 1975, CELL TISSUE RES, V157, P411; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Heo SM, 2013, INFECT IMMUN, V81, P1364, DOI 10.1128/IAI.00825-12; Hoare A, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.BAD-0006-2016; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kiessling LL, 2013, CHEM SOC REV, V42, P4476, DOI 10.1039/c3cs60097a; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lamont RJ, 2018, NAT REV MICROBIOL, V16, P745, DOI 10.1038/s41579-018-0089-x; Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; LIGTENBERG AJM, 1992, INFECT IMMUN, V60, P3878, DOI 10.1128/IAI.60.9.3878-3884.1992; Miyazaki T, 2013, HISTOCHEM CELL BIOL, V139, P339, DOI 10.1007/s00418-012-1031-3; Moshier A, 1996, CURR MICROBIOL, V33, P200, DOI 10.1007/s002849900100; Moutsopoulos NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004698; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Rosier BT, 2018, J DENT RES, V97, P371, DOI 10.1177/0022034517742139; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wenzel UA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100217; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613; Zhang LP, 2017, J BIOL CHEM, V292, P21231, DOI 10.1074/jbc.M117.809848; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhou YJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r1	62	9	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1411	1425		10.1074/jbc.RA119.009807	http://dx.doi.org/10.1074/jbc.RA119.009807			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31882545	Bronze, Green Published			2022-12-28	WOS:000513822300023
J	Ahmed, I; Roy, BC; Jakulla, LUMR; Subramaniam, D; Dandawate, P; Anant, S; Sampath, V; Umar, S				Ahmed, Ishfaq; Roy, Badal Chandra; Jakulla, Laxmi Uma Maheswar Rao; Subramaniam, Dharmalingam; Dandawate, Prasad; Anant, Shrikant; Sampath, Venkatesh; Umar, Shahid			Infection-induced signals generated at the plasma membrane epigenetically regulate Wnt signaling in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt; beta-catenin; Notch pathway; cancer stem cells; bacterial pathogenesis; microRNA (miRNA); Citrobacter rodentium; Fzd10; LRP5; LRP6; miR-153?3p; ?-catenin; Notch; cancer stem cells; inflammation; bacterial infection	HYPERPLASIA AND/OR COLITIS; CANCER STEM-CELLS; KAPPA-B ACTIVITY; BETA-CATENIN; HUMAN COLON; CITROBACTER-RODENTIUM; BACTERIAL-INFECTION; COLORECTAL-CANCER; ACTIVATION; PATHWAY	Wnt signaling regulates immunomodulatory functions during infection and inflammation. Employing NCCIT and HCT116 cells, having high endogenous Wnt signaling, we observed elevated levels of low-density lipoprotein receptor?related protein 5/6 (LRP5/6) and Frizzled class receptor 10 (FZD10) and increases in ?-catenin, doublecortin-like kinase 1 (DCLK1), CD44 molecule (CD44), and aldehyde dehydrogenase 1 family member A1 (ALDH1A1). siRNA-induced knockdown of these receptors antagonized TOPflash reporter activity and spheroid growth in vitro and elevated Wnt-inhibitory factor 1 (WIF1) activity. Elevated mRNA and protein levels of LRP5/6 and FZD10 paralleled expression of WNT2b and WNT4 in colonic crypts at days 6 and 12 post-infection with Citrobacter rodentium (CR) and tended to decline at days 20?34. The CR mutant escV or the tankyrase inhibitor XAV939 attenuated these responses. A three-dimensional organoid assay in colonic crypts isolated from CR-infected mice revealed elevated levels of LRP5/6 and FZD10 and ?-catenin co-localization with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2). Co-immunoprecipitation in the membrane fraction revealed that axin associates with LRP5/6 in CR-infected crypts, and this association was correlated with increased ?-catenin. Colon tumors from either CR-infected ApcP(Min/+) or azoxymethane/dextran sodium sulfate (AOM/DSS)-treated mice had high LRP5/6 or FZD10 levels, and chronic Notch blockade through the ?-secretase inhibitor dibenzazepine down-regulated LRP5/6 and FZD10 expression. In CR-responsive CT-26 cells, siRNA-induced LRP5/6 or FZD10 knockdown antagonized TOPflash reporter activity. Elevated miR-153-3p levels correlated with LRP5/6 and FZD10, and miR-153-3p sequestration via a plasmid-based miR inhibitor system attenuated Wnt signaling. We conclude that infection-induced signals from the plasma membrane epigenetically regulate Wnt signaling.	[Ahmed, Ishfaq; Roy, Badal Chandra; Jakulla, Laxmi Uma Maheswar Rao; Umar, Shahid] Univ Kansas, Med Ctr, Dept Surg, 3901 Rainbow Blvd,4028 Wahl Hall East, Kansas City, KS 66160 USA; [Subramaniam, Dharmalingam; Dandawate, Prasad; Anant, Shrikant] Univ Kansas, Dept Canc Biol, Med Ctr, Kansas City, KS 66160 USA; [Sampath, Venkatesh] Childrens Mercy Hosp, Div Neonatol, Kansas City, MO 64108 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital	Umar, S (corresponding author), Univ Kansas, Med Ctr, Dept Surg, 3901 Rainbow Blvd,4028 Wahl Hall East, Kansas City, KS 66160 USA.	sumar@kumc.edu	Anant, Shrikant/AAF-8020-2020	Dandawate, Prasad/0000-0002-1141-3703; Subramaniam, Dharmalingam/0000-0002-2710-485X	National Institutes of Health [R01CA185322, R01DK117296-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01CA185322 (to S. U.) and R01DK117296-01A1 (to V. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed I, 2013, AM J PHYSIOL-GASTR L, V304, pG356, DOI 10.1152/ajpgi.00372.2012; Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Bai J, 2015, J IMMUNOL, V194, P4185, DOI 10.4049/jimmunol.1403196; Barrila J, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00282-18; Cao H, 2016, GENE THER, V23, P527, DOI 10.1038/gt.2016.22; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; Chandrakesan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079432; Chandrakesan P, 2012, INFECT IMMUN, V80, P753, DOI 10.1128/IAI.06101-11; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; de Voer RM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005880; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hua HW, 2015, ONCOTARGET, V6, P3840, DOI 10.18632/oncotarget.2927; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kessler M, 2012, AM J PATHOL, V180, P186, DOI 10.1016/j.ajpath.2011.09.015; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lu R, 2012, AM J PHYSIOL-GASTR L, V303, pG1113, DOI 10.1152/ajpgi.00453.2011; Luo T, 2016, INFECT IMMUN, V84, P686, DOI 10.1128/IAI.01289-15; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Morgenstern Y, 2017, EMBO J, V36, P3046, DOI 10.15252/embj.201696253; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mughini-Gras L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189721; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Munro MJ, 2018, J CLIN PATHOL, V71, P110, DOI 10.1136/jclinpath-2017-204739; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagaoka T, 2013, CELL SIGNAL, V25, P178, DOI 10.1016/j.cellsig.2012.09.024; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Ricci-Vitiani L, 2009, J MOL MED, V87, P1097, DOI 10.1007/s00109-009-0518-4; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Roy BC, 2015, ONCOGENE, V34, P4519, DOI 10.1038/onc.2014.386; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Sun DY, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0203-6; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Wang Y, 2013, LAB CHIP, V13, P4625, DOI 10.1039/c3lc50813g; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhao XS, 2016, ONCOTARGET, V7, P48321, DOI 10.18632/oncotarget.10220; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	60	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1021	1035		10.1074/jbc.RA119.010285	http://dx.doi.org/10.1074/jbc.RA119.010285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31836665	Green Published, hybrid			2022-12-28	WOS:000509949300011
J	Rahfeld, P; Withers, SG				Rahfeld, Peter; Withers, Stephen G.			Toward universal donor blood: Enzymatic conversion of A and B to O type	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						blood; glycosidase; transplantation; antigen; glycobiology; ABO blood group system; blood transfusion; blood types; glycoside hydrolase; universal donor blood; human; enzymatically converted blood; oligosaccharide epitope; carbohydrate antigen; fucosyl galactose H-antigen; glycan	ALPHA-N-ACETYLGALACTOSAMINIDASE; ENDO-BETA-GALACTOSIDASE; GROUP-A; CHEMICAL BASIS; ANTIGEN; CELLS; ERYTHROCYTES; PURIFICATION; EXPRESSION; TRANSFUSIONS	Transfusion of blood, or more commonly red blood cells (RBCs), is integral to health care systems worldwide but requires careful matching of blood types to avoid serious adverse consequences. Of the four main blood types, A, B, AB, and O, only O can be given to any patient. This universal donor O-type blood is crucial for emergency situations where time or resources for typing are limited, so it is often in short supply. A and B blood differ from the O type in the presence of an additional sugar antigen (GalNAc and Gal, respectively) on the core H-antigen found on O-type RBCs. Thus, conversion of A, B, and AB RBCs to O-type RBCs should be achievable by removal of that sugar with an appropriate glycosidase. The first demonstration of a B-to-O conversion by Goldstein in 1982 required massive amounts of enzyme but enabled proof-of-principle transfusions without adverse effects in humans. New ?-galactosidases and ?-N-acetylgalactosaminidases were identified by screening bacterial libraries in 2007, allowing improved conversion of B and the first useful conversions of A-type RBCs, although under constrained conditions. In 2019, screening of a metagenomic library derived from the feces of an AB donor enabled discovery of a significantly more efficient two-enzyme system, involving a GalNAc deacetylase and a galactosaminidase, for A conversion. This promising system works well both in standard conditions and in whole blood. We discuss remaining challenges and opportunities for the use of such enzymes in blood conversion and organ transplantation.	[Rahfeld, Peter; Withers, Stephen G.] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Rahfeld, Peter; Withers, Stephen G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Withers, Stephen G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Withers, Stephen G/I-7229-2019	Withers, Stephen G/0000-0002-6722-5701	Canadian Institutes for Health Research; Deutsche Akademie der Naturforscher Leopoldina	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Akademie der Naturforscher Leopoldina	This work was supported by the Canadian Institutes for Health Research and the Deutsche Akademie der Naturforscher Leopoldina. The authors are named inventors on a patent submission by the University of British Columbia regarding enzymes that may be used for removal of A-antigens from red blood cells.	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Bakunina IY, 2002, BIOCHEMISTRY-MOSCOW+, V67, P689, DOI 10.1023/A:1016106623655; BREMER EG, 1984, J BIOL CHEM, V259, P4773; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Chapanian R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5683; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1984, BIOCHEM BIOPH RES CO, V124, P523, DOI 10.1016/0006-291X(84)91585-7; Clausen H., 2004, European Patent, Patent No. [1436387A2, 1436387]; Cohen M, 2009, BLOOD, V114, P3668, DOI 10.1182/blood-2009-06-227041; Daniels G, 2010, TRANSFUSION, V50, P281, DOI 10.1111/j.1537-2995.2009.02456.x; DONALD ASR, 1981, EUR J BIOCHEM, V120, P243, DOI 10.1111/j.1432-1033.1981.tb05695.x; Durand JK, 2010, LABMEDICINE, V41, P53, DOI 10.1309/LM0MICLH4GG3QNDC; ECONOMID.J, 1967, VOX SANG, V12, P321, DOI 10.1111/j.1423-0410.1967.tb03362.x; Fernandes Heloise Pöckel, 2011, Rev. Bras. Hematol. Hemoter., V33, P297, DOI 10.5581/1516-8484.20110080; Gao HW, 2016, BLOOD TRANSFUS-ITALY, V14, P168, DOI 10.2450/2015.0010-15; Gao HW, 2014, BLOOD TRANSFUS-ITALY, V12, P61, DOI 10.2450/2013.0023-13; Gao HW, 2013, ARTIF CELL NANOMED B, V41, P32, DOI 10.3109/10731199.2012.724422; Garratty G, 2008, VOX SANG, V94, P87, DOI 10.1111/j.1423-0410.2007.01003.x; GERBAL A, 1975, VOX SANG, V28, P398, DOI 10.1111/j.1423-0410.1975.tb02787.x; GOLDSTEIN J, 1982, SCIENCE, V215, P168, DOI 10.1126/science.6274021; Goldstein J, 1989, Transfus Med Rev, V3, P206, DOI 10.1016/S0887-7963(89)70080-8; HAKOMORI S, 1972, BIOCHEM BIOPH RES CO, V49, P1061, DOI 10.1016/0006-291X(72)90320-8; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HARPAZ N, 1975, ARCH BIOCHEM BIOPHYS, V170, P676, DOI 10.1016/0003-9861(75)90164-2; HATA J, 1992, BIOCHEM INT, V28, P77; Hoskins LC, 2001, TRANSFUSION, V41, P908, DOI 10.1046/j.1537-2995.2001.41070908.x; Hsieh HY, 2003, PROTEIN EXPRES PURIF, V32, P309, DOI 10.1016/j.pep.2003.08.007; Hsieh HY, 2000, IUBMB LIFE, V50, P91, DOI 10.1080/713803702; IZUMI K, 1992, BIOCHIM BIOPHYS ACTA, V1116, P72, DOI 10.1016/0304-4165(92)90130-M; Jeyakanthan M, 2016, AM J TRANSPLANT, V16, P1548, DOI 10.1111/ajt.13625; Jeyakanthan M, 2015, AM J TRANSPLANT, V15, P2602, DOI 10.1111/ajt.13328; Judd WJ, 1996, TRANSFUS MED REV, V10, P111, DOI 10.1016/S0887-7963(96)80087-3; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Kobayashi T, 2007, TRANSPLANTATION, V83, P1284, DOI 10.1097/01.tp.0000260634.85690.c4; Kobayashi T, 2009, TRANSPL IMMUNOL, V20, P132, DOI 10.1016/j.trim.2008.09.007; Kruskall MS, 2000, TRANSFUSION, V40, P1290, DOI 10.1046/j.1537-2995.2000.40111290.x; Kwan DH, 2015, GLYCOBIOLOGY, V25, P806, DOI 10.1093/glycob/cwv031; Kwan DH, 2015, J AM CHEM SOC, V137, P5695, DOI 10.1021/ja5116088; Landry D., 2002, United States Patent, Patent No. [US20020072104A1, 2002007210]; LANDSTEINER KARL, 1940, PROC SOC EXP BIOL AND MED, V43, P223; Laxmi V., 2017, BCC RES REP, V1, P1; LENNY L, 1980, TRANSFUSION, V20, P618; LENNY LL, 1991, BLOOD, V77, P1383; LENNY LL, 1994, TRANSFUSION, V34, P209, DOI 10.1046/j.1537-2995.1994.34394196617.x; Lenny LL, 1995, TRANSFUSION, V35, P899, DOI 10.1046/j.1537-2995.1995.351196110892.x; LEVY GN, 1980, J BIOL CHEM, V255, P1737; Li L, 2015, AM J HEMATOL, V90, P1165, DOI 10.1002/ajh.24211; Liu QYP, 2008, J BIOL CHEM, V283, P8545, DOI 10.1074/jbc.M709020200; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Makivuokko H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-94; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; MOLLICONE R, 1995, TRANSFUS CLIN BIOL, V2, P235, DOI 10.1016/S1246-7820(05)80089-8; Olsson ML, 2008, BRIT J HAEMATOL, V140, P3, DOI 10.1111/j.1365-2141.2007.06839.x; Olsson ML, 2004, TRANSFUS CLIN BIOL, V11, P33, DOI 10.1016/j.tracli.2003.12.002; Quraishy N, 2016, ADV CLIN CHEM, V77, P221, DOI 10.1016/bs.acc.2016.06.006; Rahfeld P, 2019, NAT MICROBIOL, V4, P1475, DOI 10.1038/s41564-019-0469-7; REGE VP, 1963, NATURE, V200, P532, DOI 10.1038/200532a0; ROSENFIELD RE, 1973, P NATL ACAD SCI USA, V70, P1303, DOI 10.1073/pnas.70.5.1303; Rydberg L, 2007, TRANSPLANTATION, V84, pS10, DOI 10.1097/01.tp.0000296017.44394.e2; Senior M, 2018, NAT BIOTECHNOL, V36, P488, DOI 10.1038/nbt.4157; Simmons DP, 2015, HEMATOL ONCOL CLIN N, V29, P429, DOI 10.1016/j.hoc.2015.01.003; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Weinstock C, 2014, BLOOD TRANSFUS-ITALY, V12, P3, DOI 10.2450/2013.0192-13; Yee J, 2016, ADV CHRONIC KIDNEY D, V23, P277, DOI 10.1053/j.ackd.2016.08.001; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; Zhu A, 1996, PROTEIN EXPRES PURIF, V8, P456, DOI 10.1006/prep.1996.0124	68	13	14	10	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					325	334		10.1074/jbc.REV119.008164	http://dx.doi.org/10.1074/jbc.REV119.008164			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31792054	hybrid, Green Published			2022-12-28	WOS:000507373600005
J	Lentzsch, AM; Yao, J; Russell, R; Lambowitz, AM				Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.			Template-switching mechanism of a group II intron-encoded reverse transcriptase and its implications for biological function and RNA-Seq	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; DNA sequencing; enzyme kinetics; retrovirus; reverse transcription; RNA; RNA virus; structure?function; transposable element (TE); viral polymerase; group II intron reverse transcriptase; non-templated nucleotide addition; RNA sequencing; RNA-dependent RNA polymerase; thermostable group II intron reverse transcriptase	NONTEMPLATED NUCLEOTIDE ADDITION; SYNTHESIS DE-NOVO; CDNA SYNTHESIS; MITOCHONDRIAL PLASMIDS; MAURICEVILLE PLASMID; DNA; RETROTRANSPOSON; RECOMBINATION; REPLICATION; NEUROSPORA	The reverse transcriptases (RTs) encoded by mobile group II introns and other non-LTR retroelements differ from retroviral RTs in being able to template-switch efficiently from the 5? end of one template to the 3? end of another with little or no complementarity between the donor and acceptor templates. Here, to establish a complete kinetic framework for the reaction and to identify conditions that more efficiently capture acceptor RNAs or DNAs, we used a thermostable group II intron RT (TGIRT; GsI?IIC RT) that can template switch directly from synthetic RNA template/DNA primer duplexes having either a blunt end or a 3?-DNA overhang end. We found that the rate and amplitude of template switching are optimal from starter duplexes with a single nucleotide 3?-DNA overhang complementary to the 3? nucleotide of the acceptor RNA, suggesting a role for nontemplated nucleotide addition of a complementary nucleotide to the 3? end of cDNAs synthesized from natural templates. Longer 3?-DNA overhangs progressively decreased the template-switching rate, even when complementary to the 3? end of the acceptor template. The reliance on only a single bp with the 3? nucleotide of the acceptor together with discrimination against mismatches and the high processivity of group II intron RTs enable synthesis of full-length DNA copies of nucleic acids beginning directly at their 3? end. We discuss the possible biological functions of the template-switching activity of group II intron- and other non-LTR retroelement?encoded RTs, as well as the optimization of this activity for adapter addition in RNA- and DNA-Seq protocols.	[Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Oncol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Oncol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu		Lambowitz, Alan/0000-0001-6036-2423	National Institutes of Health [R01 GM37949, R35 GM131777]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131777, R01GM037949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM37949 (to A. M. Lambowitz) and R35 GM131777 (to R. R.). Thermostable group II intron reverse transcriptase enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas and East Tennessee State University to InGex, LLC. A. M. Lambowitz, some former and present members of the Lambowitz laboratory, and the University of Texas are minority equity holders in InGex, LLC, and receive royalty payments from the sale of TGIRT enzymes and kits employing TGIRT template-switching activity for RNA-seq adapter addition and from the sublicensing of intellectual property to other companies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; Baidyaroy D, 2012, FUNGAL BIOL-UK, V116, P919, DOI 10.1016/j.funbio.2012.06.003; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Brenlla A, 2014, NUCLEIC ACIDS RES, V42, P2555, DOI 10.1093/nar/gkt1149; Buzdin AA, 2004, CELL MOL LIFE SCI, V61, P2046, DOI 10.1007/s00018-004-4041-z; Chen B, 1997, J MOL BIOL, V271, P311, DOI 10.1006/jmbi.1997.1185; Chiang CC, 1997, MOL CELL BIOL, V17, P4526, DOI 10.1128/MCB.17.8.4526; CHIANG CC, 1994, MOL CELL BIOL, V14, P6419, DOI 10.1128/MCB.14.10.6419; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; COLLINS RA, 1981, CELL, V24, P443, DOI 10.1016/0092-8674(81)90335-4; Coros CJ, 2008, RNA, V14, P2634, DOI 10.1261/rna.1247608; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Galligan Jeffrey T., 2007, V7, P163, DOI 10.1007/7171_2007_098; George JA, 1996, GENETICS, V142, P853; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KENNELL JC, 1994, MOL CELL BIOL, V14, P3094, DOI 10.1128/MCB.14.5.3094; Khadgi BB, 2019, NUCLEIC ACIDS RES, V47, P8708, DOI 10.1093/nar/gkz673; KUIPER MTR, 1988, CELL, V55, P693, DOI 10.1016/0092-8674(88)90228-0; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luczkowiak J, 2018, J BIOL CHEM, V293, P13351, DOI 10.1074/jbc.RA118.004324; Malik O, 2017, NUCLEIC ACIDS RES, V45, P10190, DOI 10.1093/nar/gkx720; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mohr G, 2018, J MOL BIOL, V430, P2760, DOI 10.1016/j.jmb.2018.06.019; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Moldovan JB, 2019, P NATL ACAD SCI USA, V116, P20612, DOI 10.1073/pnas.1805404116; Motea EA, 2010, BBA-PROTEINS PROTEOM, V1804, P1151, DOI 10.1016/j.bbapap.2009.06.030; Nottingham RM, 2016, RNA, V22, P597, DOI 10.1261/rna.055558.115; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Oz-Gleenberg I, 2012, FEBS J, V279, P1894, DOI 10.1111/j.1742-4658.2012.08570.x; Oz-Gleenberg I, 2012, FEBS J, V279, P142, DOI 10.1111/j.1742-4658.2011.08406.x; Oz-Gleenberg I, 2011, NUCLEIC ACIDS RES, V39, P1042, DOI 10.1093/nar/gkq786; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Qin Y, 2016, RNA, V22, P111, DOI 10.1261/rna.054809.115; Raper AT, 2018, CHEM REV, V118, P6000, DOI 10.1021/acs.chemrev.7b00685; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Ritchie AJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0069-9; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Song HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04217-5; Stamos JL, 2017, MOL CELL, V68, P926, DOI 10.1016/j.molcel.2017.10.024; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WANG H, 1993, CELL, V75, P1071, DOI 10.1016/0092-8674(93)90317-J; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; White TB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002534; Wu DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09064-w; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44457-z; Yu Y, 2017, NEW PHYTOL, V216, P1002, DOI 10.1111/nph.14834; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	67	10	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19764	19784		10.1074/jbc.RA119.011337	http://dx.doi.org/10.1074/jbc.RA119.011337			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712313	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000504093200024
J	Fang, C; Li, T; Li, Y; Xu, GJ; Deng, QW; Chen, YJ; Hou, YN; Lee, HC; Zhao, YJ				Fang, Cheng; Li, Ting; Li, Ying; Xu, Guan Jie; Deng, Qi Wen; Chen, Ya Jie; Hou, Yun Nan; Lee, Hon Cheung; Zhao, Yong Juan			CD38 produces nicotinic acid adenine dinucleotide phosphate in the lysosome (vol 293, pg 8151, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Zhao, Yongjuan/AAS-9919-2021					Fang C, 2018, J BIOL CHEM, V293, P8151, DOI 10.1074/jbc.RA118.002113	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19447	19447		10.1074/jbc.AAC119.011919	http://dx.doi.org/10.1074/jbc.AAC119.011919			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836674	hybrid, Green Published			2022-12-28	WOS:000516527800042
J	Hayes, JA; Hilbert, BJ; Gaubitz, C; Stone, NP; Kelch, BA				Hayes, Janelle A.; Hilbert, Brendan J.; Gaubitz, Christl; Stone, Nicholas P.; Kelch, Brian A.			A thermophilic phage uses a small terminase protein with a fixed helix?turn?helix geometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-EM; bacteriophage; DNA-binding protein; molecular motor; thermophile; DNA packaging; DNA recognition; helix?turn?helix domain; small terminase; viral motor	CRYSTAL-STRUCTURE; DNA-RECOGNITION; LARGE SUBUNIT; INITIATION; ATPASE; BACTERIOPHAGE-P22; COMPONENT; SEQUENCE; FEATURES; COMPLEX	Tailed bacteriophages use a DNA-packaging motor to encapsulate their genome during viral particle assembly. The small terminase (TerS) component of this DNA-packaging machinery acts as a molecular matchmaker that recognizes both the viral genome and the main motor component, the large terminase (TerL). However, how TerS binds DNA and the TerL protein remains unclear. Here we identified gp83 of the thermophilic bacteriophage P74-26 as the TerS protein. We found that TerS(P76-26) oligomerizes into a nonamer that binds DNA, stimulates TerL ATPase activity, and inhibits TerL nuclease activity. A cryo-EM structure of TerS(P76-26) revealed that it forms a ring with a wide central pore and radially arrayed helix?turn?helix domains. The structure further showed that these helix?turn?helix domains, which are thought to bind DNA by wrapping the double helix around the ring, are rigidly held in an orientation distinct from that seen in other TerS proteins. This rigid arrangement of the putative DNA-binding domain imposed strong constraints on how TerS(P76-26) can bind DNA. Finally, the TerS(P76-26) structure lacked the conserved C-terminal ?-barrel domain used by other TerS proteins for binding TerL. This suggests that a well-ordered C-terminal ?-barrel domain is not required for TerS(P76-26) to carry out its matchmaking function. Our work highlights a thermophilic system for studying the role of small terminase proteins in viral maturation and presents the structure of TerS(P76-26), revealing key differences between this thermophilic phage and its mesophilic counterparts.	[Hayes, Janelle A.; Hilbert, Brendan J.; Gaubitz, Christl; Stone, Nicholas P.; Kelch, Brian A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Kelch, BA (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	brian.kelch@umassmed.edu		Gaubitz, Christl/0000-0002-6047-9282	Pew Charitable Trusts [00027337]; National Science Foundation [1817338]	Pew Charitable Trusts; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Pew Charitable Trusts Grant 00027337 (to B. A. K.) and the National Science Foundation Grant 1817338 (to B. A. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; CASJENS S, 1987, J MOL BIOL, V194, P411, DOI 10.1016/0022-2836(87)90671-1; CASJENS S, 1992, J MOL BIOL, V227, P1086, DOI 10.1016/0022-2836(92)90523-M; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feiss M, 2012, ADV EXP MED BIOL, V726, P489, DOI 10.1007/978-1-4614-0980-9_22; Gao S, 2016, NUCLEIC ACIDS RES, V44, P4425, DOI 10.1093/nar/gkw184; Gao S, 2011, J BIOL CHEM, V286, P3944, DOI 10.1074/jbc.M110.196907; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Greive SJ, 2016, NUCLEIC ACIDS RES, V44, P776, DOI 10.1093/nar/gkv1467; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; Hilbert BJ, 2017, NUCLEIC ACIDS RES, V45, P3591, DOI 10.1093/nar/gkw1356; Hilbert BJ, 2015, P NATL ACAD SCI USA, V112, pE3792, DOI 10.1073/pnas.1506951112; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Kelley DS, 2016, MBIO, V7, DOI 10.1128/mBio.01537-16; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mastronarde D.N, 2003, MICROSC MICROANAL, V9, P1182, DOI [10.1017/S1431927603445911, DOI 10.1017/S1431927603445911]; McNally R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-3; Minakhin L, 2008, J MOL BIOL, V378, P468, DOI 10.1016/j.jmb.2008.02.018; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Stone NP, 2018, STRUCTURE, V26, P936, DOI 10.1016/j.str.2018.04.008; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; van Duijn E, 2010, J AM SOC MASS SPECTR, V21, P971, DOI 10.1016/j.jasms.2009.12.010; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000592; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	46	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3783	3793		10.1074/jbc.RA119.012224	http://dx.doi.org/10.1074/jbc.RA119.012224			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014998	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000527704400006
J	Murugina, NE; Budikhina, AS; Dagil, YA; Maximchik, PV; Balyasova, LS; Murugin, VV; Melnikov, MV; Sharova, VS; Nikolaeva, AM; Chkadua, GZ; Pinegin, BV; Pashenkov, MV				Murugina, Nina E.; Budikhina, Anna S.; Dagil, Yulia A.; Maximchik, Polina, V; Balyasova, Lyudmila S.; Murugin, Vladimir V.; Melnikov, Mikhail, V; Sharova, Viktoriya S.; Nikolaeva, Anna M.; Chkadua, Georgy Z.; Pinegin, Boris, V; Pashenkov, Mikhail, V			Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; dendritic cell; glucose metabolism; Nod-like receptor (NLR); cytokine; unfolded protein response (UPR); 2-deoxy-d-glucose; metabolic reprogramming; NOD1; NOD2; glycolysis; muramyl peptides	P70 S6 KINASE; SUCCINATE-DEHYDROGENASE; DENDRITIC CELL; PROTEIN-KINASE; MESSENGER-RNA; INFLAMMATORY MACROPHAGES; SIGNALING AXIS; METABOLISM; PHOSPHORYLATION; BACTERIAL	Upon activation with pathogen-associated molecular patterns, metabolism of macrophages and dendritic cells is shifted from oxidative phosphorylation to aerobic glycolysis, which is considered important for proinflammatory cytokine production. Fragments of bacterial peptidoglycan (muramyl peptides) activate innate immune cells through nucleotide-binding oligomerization domain (NOD) 1 and/or NOD2 receptors. Here, we show that NOD1 and NOD2 agonists induce early glycolytic reprogramming of human monocyte-derived macrophages (MDM), which is similar to that induced by the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide. This glycolytic reprogramming depends on Akt kinases, independent of mTOR complex 1 and is efficiently inhibited by 2-deoxy-d-glucose (2-DG) or by glucose starvation. 2-DG inhibits proinflammatory cytokine production by MDM and monocyte-derived dendritic cells activated by NOD1 or TLR4 agonists, except for tumor necrosis factor production by MDM, which is inhibited initially, but augmented 4 h after addition of agonists and later. However, 2-DG exerts these effects by inducing unfolded protein response rather than by inhibiting glycolysis. By contrast, glucose starvation does not cause unfolded protein response and, in normoxic conditions, only marginally affects proinflammatory cytokine production triggered through NOD1 or TLR4. In hypoxia mimicked by treating MDM with oligomycin (a mitochondrial ATP synthase inhibitor), both 2-DG and glucose starvation strongly suppress tumor necrosis factor and interleukin-6 production and compromise cell viability. In summary, the requirement of glycolytic reprogramming for proinflammatory cytokine production in normoxia is not obvious, and effects of 2-DG on cytokine responses should be interpreted cautiously. In hypoxia, however, glycolysis becomes critical for cytokine production and cell survival.	[Murugina, Nina E.; Budikhina, Anna S.; Dagil, Yulia A.; Balyasova, Lyudmila S.; Murugin, Vladimir V.; Melnikov, Mikhail, V; Nikolaeva, Anna M.; Pinegin, Boris, V; Pashenkov, Mikhail, V] Fed Med Biol Agcy Russia, Inst Immunol, Lab Clin Immunol, Natl Res Ctr, Kashirskoe Shosse 24, Moscow 115522, Russia; [Maximchik, Polina, V] Lomonosov Moscow State Univ, Fac Fundamental Med, Leninskie Gory 1, Moscow 119991, Russia; [Melnikov, Mikhail, V] Pirogov Russian Natl Res Med Univ, Dept Neurol Neurosurg & Med Genet, Ostrovityanova St 1, Moscow 117997, Russia; [Sharova, Viktoriya S.] Russian Acad Sci, Koltsov Inst Dev Biol, Vavilova St 26, Moscow 119334, Russia; [Nikolaeva, Anna M.] Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1, Moscow 119991, Russia; [Chkadua, Georgy Z.] Minist Hlth Russian Federat, NN Blokhin Natl Med Res Ctr Oncol, Lab Expt Diagnost & Biotherapy Tumors, Kashirskoe Shosse 24 Bldg 2, Moscow 115522, Russia	NRC Institute of Immunology FMBA of Russia; Lomonosov Moscow State University; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University; Ministry of Health of the Russian Federation	Pashenkov, MV (corresponding author), Fed Med Biol Agcy Russia, Inst Immunol, Lab Clin Immunol, Natl Res Ctr, Kashirskoe Shosse 24, Moscow 115522, Russia.	mvpashenkov@yandex.ru	Pashenkov, Mikhail/AAU-8034-2020; Melnikov, Mikhail/AAO-4544-2020	Murugina, Nina/0000-0001-7000-5729; Pashenkov, Mikhail/0000-0002-6995-1790	Russian Science Foundation [16-15-10314]; Russian Science Foundation [19-15-13011] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation Grant 16-15-10314 (to N. E. M., A. S. B., Y. A. D., L. S. B., V. V. M., M. V. M., V. S. S., A. M. N., B. V. P., and M. V. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balendran A, 1999, J BIOL CHEM, V274, P37400, DOI 10.1074/jbc.274.52.37400; Boyd S, 2015, J MED CHEM, V58, P3611, DOI 10.1021/acs.jmedchem.5b00352; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dagil YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160784; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Diskin C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00270; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Fortin CF, 2013, J LEUKOCYTE BIOL, V94, P693, DOI 10.1189/jlb.0113012; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Hahn EL, 2000, SHOCK, V13, P253, DOI 10.1097/00024382-200004000-00001; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00426; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Idrovo JP, 2016, J SURG RES, V200, P242, DOI 10.1016/j.jss.2015.06.059; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jiang H, 2016, J IMMUNOL, V197, P2880, DOI 10.4049/jimmunol.1600474; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Kager L, 2010, THER CLIN RISK MANAG, V6, P279; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014399; Liu ZY, 2015, MOL MED, V21, P937, DOI 10.2119/molmed.2015.00198; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Maximchik P, 2018, FEBS J, V285, P4590, DOI 10.1111/febs.14687; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Meshcheryakova E, 2007, VACCINE, V25, P4515, DOI 10.1016/j.vaccine.2007.04.006; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; MILLER ES, 1993, BRAIN BEHAV IMMUN, V7, P317, DOI 10.1006/brbi.1993.1031; Millet P, 2016, J IMMUNOL, V196, P2541, DOI 10.4049/jimmunol.1501345; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Na YR, 2016, J IMMUNOL, V197, P4101, DOI 10.4049/jimmunol.1600745; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pashenkov MV, 2017, J IMMUNOL, V198, P1638, DOI 10.4049/jimmunol.1600467; Pashenkov MV, 2010, INT IMMUNOPHARMACOL, V10, P875, DOI 10.1016/j.intimp.2010.04.025; Rogatzki MJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00022; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Smith JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00422; Stienstra R, 2017, CELL METAB, V26, P142, DOI 10.1016/j.cmet.2017.06.001; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tang GM, 2017, ONCOTARGET, V8, P97977, DOI 10.18632/oncotarget.20105; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tawakol A, 2015, ARTERIOSCL THROM VAS, V35, P1463, DOI 10.1161/ATVBAHA.115.305551; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Yen YT, 2013, SURGERY, V153, P689, DOI 10.1016/j.surg.2012.11.021; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	77	9	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3099	3114		10.1074/jbc.RA119.010589	http://dx.doi.org/10.1074/jbc.RA119.010589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005665	hybrid, Green Published			2022-12-28	WOS:000519597300018
J	Hwang, SH; Bang, S; Kim, W; Chung, J				Hwang, Sun-Hong; Bang, Sunhoe; Kim, Wonho; Chung, Jongkyeong			Von Hippel?Lindau tumor suppressor (VHL) stimulates TOR signaling by interacting with phosphoinositide 3-kinase (PI3K)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; target of rapamycin (TOR); metabolic regulation; S6 kinase; phosphatidylinositide 3-kinase (PI 3-kinase); cell size; nutrient sensing; p110; von Hippel?Lindau (VHL)	HYPOXIA-INDUCIBLE FACTORS; COMPLEX GENE-PRODUCTS; PROTEIN-KINASE B; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CELL-GROWTH; MTOR; PHOSPHORYLATION; ACTIVATION; RAPAMYCIN	Cell growth is positively controlled by the phosphoinositide 3-kinase (PI3K)?target of rapamycin (TOR) signaling pathway under conditions of abundant growth factors and nutrients. To discover additional mechanisms that regulate cell growth, here we performed RNAi-based mosaic analyses in the Drosophila fat body, the primary metabolic organ in the fly. Unexpectedly, the knockdown of the Drosophila von Hippel?Lindau (VHL) gene markedly decreased cell size and body size. These cell growth phenotypes induced by VHL loss of function were recovered by activation of TOR signaling in Drosophila. Consistent with the genetic interactions between VHL and the signaling components of PI3K?TOR pathway in Drosophila, we observed that VHL loss of function in mammalian cells causes decreased phosphorylation of ribosomal protein S6 kinase and Akt, which represent the main activities of this pathway. We further demonstrate that VHL activates TOR signaling by directly interacting with the p110 catalytic subunit of PI3K. On the basis of the evolutionarily conserved regulation of PI3K?TOR signaling by VHL observed here, we propose that VHL plays an important role in the regulation and maintenance of proper cell growth in metazoans.	[Hwang, Sun-Hong; Bang, Sunhoe; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Hwang, Sun-Hong; Bang, Sunhoe; Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, 1 Gwanak Ro, Seoul 08826, South Korea.	jkc@snu.ac.kr			Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI17C0328]; BK21 Plus Program from the Ministry of Education of the Republic of Korea; Global Ph.D. Fellowship Program from National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of the Republic of Korea	Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health Welfare; BK21 Plus Program from the Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); Global Ph.D. Fellowship Program from National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of the Republic of Korea(National Research Foundation of Korea)	This work was supported by Grant HI17C0328 from the Korea Health Technology R&D project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (to J. C.); funds from the BK21 Plus Program from the Ministry of Education of the Republic of Korea (to S.-H. H., S. B., and J. C.); and by the Global Ph.D. Fellowship Program from National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning of the Republic of Korea (to S.-H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim E, 2017, MOL CELLS, V40, P315, DOI 10.14348/molcells.2017.0066; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JA, 2018, MOL CELLS, V41, P264, DOI 10.14348/molcells.2018.0076; Kim W, 2017, DEV CELL, V42, P363, DOI 10.1016/j.devcel.2017.07.020; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Koh HY, 2018, MOL CELLS, V41, P881, DOI 10.14348/molcells.2018.0247; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kucejova B, 2011, MOL CANCER RES, V9, P1255, DOI 10.1158/1541-7786.MCR-11-0302; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mans DA, 2008, EXP CELL RES, V314, P1229, DOI 10.1016/j.yexcr.2007.12.020; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Niswender KD, 2003, J HISTOCHEM CYTOCHEM, V51, P275, DOI 10.1177/002215540305100302; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pignoni F, 1997, DEVELOPMENT, V124, P271; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thoma CR, 2007, CELL CYCLE, V6, P1809, DOI 10.4161/cc.6.15.4518; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; van den Heuvel CNAM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00117; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	76	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2336	2347		10.1074/jbc.RA119.011596	http://dx.doi.org/10.1074/jbc.RA119.011596			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31959630	hybrid, Green Published			2022-12-28	WOS:000517330200016
J	Murthy, AC; Fawzi, NL				Murthy, Anastasia C.; Fawzi, Nicolas L.			The (un)structural biology of biomolecular liquid-liquid phase separation using NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						intrinsically disordered protein; structural biology; heterogeneous nuclear ribonucleoprotein (hnRNP); nuclear magnetic resonance (NMR); protein-protein interaction; liquid-liquid phase separation; RNA-binding proteins	C-TERMINAL DOMAIN; RNA-POLYMERASE-II; DISORDERED PROTEINS; SECONDARY STRUCTURE; ATOMIC-RESOLUTION; FUS; BINDING; RELAXATION; GRANULES; STATES	Liquid-liquid phase separation (LLPS) of proteins and nucleic acids is a phenomenon that underlies membraneless compartmentalization of the cell. The underlying molecular interactions that underpin biomolecular LLPS have been of increased interest due to the importance of membraneless organelles in facilitating various biological processes and the disease association of several of the proteins that mediate LLPS. Proteins that are able to undergo LLPS often contain intrinsically disordered regions and remain dynamic in solution. Solution-state NMR spectroscopy has emerged as a leading structural technique to characterize protein LLPS due to the variety and specificity of information that can be obtained about intrinsically disordered sequences. This review discusses practical aspects of studying LLPS by NMR, summarizes recent work on the molecular aspects of LLPS of various protein systems, and discusses future opportunities for characterizing the molecular details of LLPS to modulate phase separation.	[Murthy, Anastasia C.] Brown Univ, Grad Program Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Fawzi, Nicolas L.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Fawzi, Nicolas L.] Brown Univ, Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Fawzi, NL (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.; Fawzi, NL (corresponding author), Brown Univ, Robert J & Nancy D Carney Inst Brain Sci, Providence, RI 02912 USA.	nicolas_fawzi@brown.edu	Fawzi, Nicolas/E-2555-2013	Fawzi, Nicolas/0000-0001-5483-0577; Murthy, Anastasia/0000-0002-2490-697X	NIGMS, National Institutes of Health [R01GM118530, T32GM007601]; Human Frontier Science Program [RGP0045/2018]; National Science Foundation [1644760, 1845734]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF))	This work was supported by NIGMS, National Institutes of Health, Grant R01GM118530 (to N. L. F.), Human Frontier Science Program Grant RGP0045/2018 (to N. L. F.), and National Science Foundation Grant 1845734 (to N. L. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by NIGMS, National Institutes of Health, Training Grant T32GM007601 (to the MCB graduate program at Brown University) and National Science Foundation Graduate Fellowship 1644760.	Ackermann BE, 2019, ANGEW CHEM INT EDIT, V58, P6300, DOI 10.1002/anie.201901141; Amaya J, 2018, J BIOL CHEM, V293, P19522, DOI 10.1074/jbc.RA118.005120; Ambadipudi S, 2019, CHEM SCI, V10, P6503, DOI 10.1039/c9sc00531e; Anthis NJ, 2015, Q REV BIOPHYS, V48, P35, DOI 10.1017/S0033583514000122; Banerjee PR, 2017, ANGEW CHEM INT EDIT, V56, P11354, DOI 10.1002/anie.201703191; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Brady JP, 2017, P NATL ACAD SCI USA, V114, pE8194, DOI 10.1073/pnas.1706197114; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Conicella A. E., 2019, TDP 43 ALPHA HELICAL, DOI [10.1101/640615, DOI 10.1101/640615]; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Damman R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12402-3; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; Debelouchina GT, 2017, Q REV BIOPHYS, V50, DOI 10.1017/S0033583517000051; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gibbs E, 2020, J MAGN RESON, V310, DOI 10.1016/j.jmr.2019.106646; Gibbs EB, 2017, ARCH BIOCHEM BIOPHYS, V628, P57, DOI 10.1016/j.abb.2017.05.008; Janke AM, 2018, BIOCHEMISTRY-US, V57, P2549, DOI 10.1021/acs.biochem.7b00310; Jensen MR, 2013, CURR OPIN STRUC BIOL, V23, P426, DOI 10.1016/j.sbi.2013.02.007; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim TH, 2019, SCIENCE, V365, P825, DOI 10.1126/science.aax4240; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Krzeminski M, 2013, BIOINFORMATICS, V29, P398, DOI 10.1093/bioinformatics/bts701; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Libich DS, 2013, P NATL ACAD SCI USA, V110, P11361, DOI 10.1073/pnas.1305715110; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Muiznieks LD, 2018, J MOL BIOL, V430, P4741, DOI 10.1016/j.jmb.2018.06.010; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Murthy AC, 2019, NAT STRUCT MOL BIOL, V26, P637, DOI 10.1038/s41594-019-0250-x; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Reichheld SE, 2017, P NATL ACAD SCI USA, V114, pE4408, DOI 10.1073/pnas.1701877114; Ryan VH, 2019, TRENDS NEUROSCI, V42, P693, DOI 10.1016/j.tins.2019.08.005; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Shorter J, 2019, J BIOL CHEM, V294, P7113, DOI 10.1074/jbc.REV119.007944; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tsang B, 2019, P NATL ACAD SCI USA, V116, P4218, DOI 10.1073/pnas.1814385116; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Turner AL, 2018, P NATL ACAD SCI USA, V115, P11964, DOI 10.1073/pnas.1805943115; Ukmar-Godec T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10792-y; Vernon RM, 2019, CURR OPIN STRUC BIOL, V58, P88, DOI 10.1016/j.sbi.2019.05.016; Wheeler R. J., 2019, SMALL MOL MODULATING, DOI [10.1101/721001, DOI 10.1101/721001]; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Yuwen TR, 2018, J AM CHEM SOC, V140, P2115, DOI 10.1021/jacs.7b09576	54	39	40	8	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2375	2384		10.1074/jbc.REV119.009847	http://dx.doi.org/10.1074/jbc.REV119.009847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31911439	Green Published, hybrid			2022-12-28	WOS:000517330200019
J	Hara, K; Iida, N; Tamafune, R; Ohashi, E; Sakurai, H; Ishikawa, Y; Hishiki, A; Hashimoto, H				Hara, Kodai; Iida, Nao; Tamafune, Ryota; Ohashi, Eiji; Sakurai, Hitomi; Ishikawa, Yoshinobu; Hishiki, Asami; Hashimoto, Hiroshi			Structure of the RAD9-RAD1-HUS1 checkpoint clamp bound to RHINO sheds light on the other side of the DNA clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; structural biology; proliferating cell nuclear antigen (PCNA); checkpoint control; protein structure; protein complex; 9-1-1; DNA clamp; crystal structure; DNA damage checkpoint; protein-protein interaction	CRYSTAL-STRUCTURE; PCNA; COMPLEX	DNA clamp, a highly conserved ring-shaped protein, binds dsDNA within its central pore. Also, DNA clamp interacts with various nuclear proteins on its front, thereby stimulating their enzymatic activities and biological functions. It has been assumed that the DNA clamp is a functionally single-faced ring from bacteria to humans. Here, we report the crystal structure of the heterotrimeric RAD9-RAD1-HUS1 (9-1-1) checkpoint clamp bound to a peptide of RHINO, a recently identified cancer-related protein that interacts with 9-1-1 and promotes activation of the DNA damage checkpoint. This is the first structure of 9-1-1 bound to its partner. The structure reveals that RHINO is unexpectedly bound to the edge and around the back of the 9-1-1 ring through specific interactions with the RAD1 subunit of 9-1-1. Our finding indicates that 9-1-1 is a functionally double-faced DNA clamp.	[Hara, Kodai; Iida, Nao; Tamafune, Ryota; Sakurai, Hitomi; Ishikawa, Yoshinobu; Hishiki, Asami; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Yada 52-1, Shizuoka, Shizuoka 4228002, Japan; [Ohashi, Eiji] Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan	University of Shizuoka; Kyushu University	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; hara, kodai/0000-0002-1586-6312; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants [25291017, 16H04755, 17H06014, 15K18491, 17K07314]; Collaborated Research Program [VFCR-14-02]	Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants; Collaborated Research Program	This work was supported by Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants 25291017, 16H04755, and 17H06014 (to H. H.) and Grants 15K18491 and 17K07314 (to K. H.) and by the Collaborated Research Program as the Visiting Fellow of the Institute for Protein Research, Osaka University, VFCR-14-02 (to H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Eichinger CS, 2011, TRENDS BIOCHEM SCI, V36, P563, DOI 10.1016/j.tibs.2011.08.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelch BA, 2016, BIOPOLYMERS, V105, P532, DOI 10.1002/bip.22827; Kim JW, 2010, INT J ONCOL, V37, P861, DOI 10.3892/ijo_00000737; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lindsey-Boltz LA, 2015, CELL CYCLE, V14, P99, DOI 10.4161/15384101.2014.967076; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ohashi E, 2017, ADV EXP MED BIOL, V1042, P135, DOI 10.1007/978-981-10-6955-0_7; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Venclovas C, 2002, PROTEIN SCI, V11, P2403, DOI 10.1110/ps.0214302; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Yao NNY, 2016, CRIT REV BIOCHEM MOL, V51, P135, DOI 10.3109/10409238.2015.1125845	25	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					899	904		10.1074/jbc.AC119.011816	http://dx.doi.org/10.1074/jbc.AC119.011816			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31776186	Green Published, hybrid			2022-12-28	WOS:000509949300001
J	Laursen, KB; Kashyap, V; Scandura, J; Gudas, LJ				Laursen, Kristian B.; Kashyap, Vasundhra; Scandura, Joseph; Gudas, Lorraine J.			An alternative retinoic acid-responsive Stra6 promoter regulated in response to retinol deficiency (vol 290, pg 4356, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					898	898		10.1074/jbc.AAC119.012410	http://dx.doi.org/10.1074/jbc.AAC119.012410			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953251	Green Published, hybrid			2022-12-28	WOS:000508382900020
J	Liu, K; Tang, MX; Jin, HW; Liu, QZ; He, LJ; Zhu, H; Liu, XX; Han, XM; Li, Y; Zhang, LB; Tang, J; Pu, WJ; Lv, Z; Wang, HX; Ji, HB; Zhou, B				Liu, Kuo; Tang, Muxue; Jin, Hengwei; Liu, Qiaozhen; He, Lingjuan; Zhu, Huan; Liu, Xiuxiu; Han, Ximeng; Li, Yan; Zhang, Libo; Tang, Juan; Pu, Wenjuan; Lv, Zan; Wang, Haixiao; Ji, Hongbin; Zhou, Bin			Triple-cell lineage tracing by a dual reporter on a single allele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung; lung injury; cardiomyocyte; cardiovascular; stem cells; regeneration; development; bronchioalveolar stem cells (BASCs); Cre-loxP; Dre-rox; heart development; lineage tracing	STEM-CELLS; LUNG EPITHELIUM; CRE; RECOMBINASE; PROGENITORS; ALVEOLAR; SYSTEM; AIRWAY; MODEL; IDENTIFICATION	Genetic lineage tracing is widely used to study organ development and tissue regeneration. Multicolor reporters are a powerful platform for simultaneously tracking discrete cell populations. Here, combining Dre-rox and Cre-loxP systems, we generated a new dual-recombinase reporter system, called Rosa26 traffic light reporter (R26-TLR), to monitor red, green, and yellow fluorescence. Using this new reporter system with the three distinct fluorescent reporters combined on one allele, we found that the readouts of the two recombinases Cre and Dre simultaneously reflect Cre(+)Dre(?), Cre(?)Dre(+), and Cre(+)Dre(+) cell lineages. As proof of principle, we show specific labeling in three distinct progenitor/stem cell populations, including club cells, AT2 cells, and bronchoalveolar stem cells, in Sftpc-DreER;Scgb1a1-CreER;R26-TLR mice. By using this new dual-recombinase reporter system, we simultaneously traced the cell fate of these three distinct cell populations during lung repair and regeneration, providing a more comprehensive picture of stem cell function in distal airway repair and regeneration. We propose that this new reporter system will advance developmental and regenerative research by facilitating a more sophisticated genetic approach to studying in vivo cell fate plasticity.	[Liu, Kuo; Tang, Muxue; Jin, Hengwei; Liu, Qiaozhen; He, Lingjuan; Zhu, Huan; Liu, Xiuxiu; Han, Ximeng; Li, Yan; Zhang, Libo; Tang, Juan; Pu, Wenjuan; Lv, Zan; Wang, Haixiao; Ji, Hongbin; Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Inst Biochem & Cell B, Shanghai 200031, Peoples R China; [Liu, Kuo; Han, Ximeng; Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Zhou, Bin] 320 Yueyang Rd,Life Sci Res Bldg,A-2112, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhou, B (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Inst Biochem & Cell B, Shanghai 200031, Peoples R China.; Zhou, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhou, B (corresponding author), 320 Yueyang Rd,Life Sci Res Bldg,A-2112, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn		Zhu, Huan/0000-0002-0731-2547	National Key Research and Development Program of China [2018YFA0108100, 2019YFA0110400, 2018YFA0107900, 2016YFC1300600, 2017YFC1001303]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16010507, XDB19000000]; National Science Foundation of China [31730112, 91639302, 31625019, 91849202, 81761138040, 81872241, 31701292, 31922032]	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grants 2018YFA0108100, 2019YFA0110400, 2018YFA0107900, 2016YFC1300600, and 2017YFC1001303; Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA16010507 and XDB19000000; and National Science Foundation of China Grants 31730112, 91639302, 31625019, 91849202, 81761138040, 81872241, 31701292, and 31922032. The authors declare that they have no conflicts of interest with the contents of this article.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12422; Glenny RW, 2011, J APPL PHYSIOL, V110, P1119, DOI 10.1152/japplphysiol.01293.2010; Gonzalez G, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.303; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jiang M, 2017, NATURE, V550, P529, DOI 10.1038/nature24269; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Liu K, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167775; Liu QZ, 2019, NAT GENET, V51, P728, DOI 10.1038/s41588-019-0346-6; Liu QZ, 2014, CELL RES, V24, P1367, DOI 10.1038/cr.2014.125; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lynch TJ, 2018, CELL STEM CELL, V22, P653, DOI 10.1016/j.stem.2018.03.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mirkovic J, 2015, J PATHOL, V236, P265, DOI 10.1002/path.4533; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Salwig I, 2019, EMBO J, V38, DOI 10.15252/embj.2019102099; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tata A, 2018, CELL STEM CELL, V22, P668, DOI 10.1016/j.stem.2018.03.018; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Yang EJ, 2015, MODERN PATHOL, V28, P994, DOI 10.1038/modpathol.2015.54; Yang Y, 2018, DEV CELL, V44, P752, DOI 10.1016/j.devcel.2018.03.001; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zepp JA, 2019, NAT REV MOL CELL BIO, V20, P551, DOI 10.1038/s41580-019-0141-3; Zhang H, 2017, CELL RES, V27, P1157, DOI 10.1038/cr.2017.103; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhao H, 2019, CURR OPIN CELL BIOL, V61, P101, DOI 10.1016/j.ceb.2019.07.004; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	52	12	12	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					690	700		10.1074/jbc.RA119.011349	http://dx.doi.org/10.1074/jbc.RA119.011349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31771978	Green Published, hybrid			2022-12-28	WOS:000508382900002
J	Wang, SF; Crisman, L; Miller, J; Datta, I; Gulbranson, DR; Tian, Y; Yin, Q; Yu, HJ; Shen, JS				Wang, Shifeng; Crisman, Lauren; Miller, Jessica; Datta, Ishara; Gulbranson, Daniel R.; Tian, Yuan; Yin, Qian; Yu, Haijia; Shen, Jingshi			Inducible Exoc7/Exo70 knockout reveals a critical role of the exocyst in insulin-regulated GLUT4 exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; membrane fusion; membrane protein; membrane trafficking; vesicles; glucose transporter type 4 (GLUT4); CRISPR genome editing; exocyst; exocyst complex component 7 (Exoc7); insulin signaling	SECRETORY VESICLES; STRUCTURAL BASIS; ESSENTIAL GENES; GLUCOSE-UPTAKE; SUBUNIT SEC6; MEMBRANE; SNARE; COMPLEX; FUSION; TRAFFICKING	Insulin promotes glucose uptake by triggering the translocation of glucose transporter type 4 (GLUT4) from intracellular vesicles to the plasma membrane through exocytosis. GLUT4 exocytosis is a vesicle fusion event involving fusion of GLUT4-containing vesicles with the plasma membrane. For GLUT4 vesicle fusion to occur, GLUT4 vesicles must first be tethered to the plasma membrane. A key tethering factor in exocytosis is a heterooctameric protein complex called the exocyst. The role of the exocyst in GLUT4 exocytosis, however, remains incompletely understood. Here we first systematically analyzed data from a genome-scale CRISPR screen in HeLa cells that targeted virtually all known genes in the human genome, including 12 exocyst genes. The screen recovered only a subset of the exocyst genes, including exocyst complex component 7 (Exoc7/Exo70). Other exocyst genes, however, were not isolated in the screen, likely because of functional redundancy. Our findings suggest that selection of an appropriate exocyst gene is critical for genetic studies of exocyst functions. Next we developed an inducible adipocyte genome editing system that enabled Exoc7 gene deletion in adipocytes without interfering with adipocyte differentiation. We observed that insulin-stimulated GLUT4 exocytosis was markedly inhibited in Exoc7 KO adipocytes. Insulin signaling, however, remained intact in these KO cells. These results indicate that the exocyst plays a critical role in insulin-stimulated GLUT4 exocytosis in adipocytes. We propose that the strategy outlined in this work could be instrumental in genetically dissecting other membrane-trafficking pathways in adipocytes.	[Wang, Shifeng; Crisman, Lauren; Miller, Jessica; Datta, Ishara; Gulbranson, Daniel R.; Yu, Haijia; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Shifeng] Beijing Univ Chinese Med, Dept Chinese Med Informat Sci, Beijing 102488, Peoples R China; [Tian, Yuan; Yin, Qian] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Tian, Yuan; Yin, Qian] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Yu, Haijia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China	University of Colorado System; University of Colorado Boulder; Beijing University of Chinese Medicine; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Nanjing Normal University	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Gulbranson, Daniel/AAE-4338-2020; Gulbranson, Daniel/AAE-4807-2020; Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; Wang, Shifeng/0000-0002-1663-1312; Datta, Ishara/0000-0002-4493-5487; Yin, Qian/0000-0002-8481-150X	National Institutes of Health [GM088759, DK095367, GM126960, AI108793]; American Diabetes Association basic science award; Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine; American Heart Association predoctoral fellowship; Undergraduate Research Opportunities Program at University of Colorado Boulder; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI108793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367, R56DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R35GM126960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association basic science award(American Diabetes Association); Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine; American Heart Association predoctoral fellowship(American Heart Association); Undergraduate Research Opportunities Program at University of Colorado Boulder; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants DK095367 (to J. S.), GM126960 (to J. S.), and AI108793 (Q. Y.); an American Diabetes Association basic science award (to J. S.); a fellowship from the Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine (to S. W.); National Institutes of Health Institutional Predoctoral Training Grant GM088759 (to L. C.), an American Heart Association predoctoral fellowship (to D. R. G.), and a fellowship from the Undergraduate Research Opportunities Program at University of Colorado Boulder (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07467-5; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Blot Vincent, 2008, V457, P347, DOI 10.1007/978-1-59745-261-8-26; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Dubuke ML, 2015, J BIOL CHEM, V290, P28245, DOI 10.1074/jbc.M115.673806; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gulbranson DR, 2019, DEV CELL, V50, P436, DOI 10.1016/j.devcel.2019.06.013; Gulbranson DR, 2017, P NATL ACAD SCI USA, V114, pE8224, DOI 10.1073/pnas.1712176114; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Heider MR, 2016, NAT STRUCT MOL BIOL, V23, P59, DOI 10.1038/nsmb.3146; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Inoue M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120289; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kioumourtzoglou D, 2015, J CELL SCI, V128, P2423, DOI 10.1242/jcs.166561; Lepore DM, 2018, TRENDS BIOCHEM SCI, V43, P714, DOI 10.1016/j.tibs.2018.06.012; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; Mei KR, 2018, NAT STRUCT MOL BIOL, V25, P139, DOI 10.1038/s41594-017-0016-2; Menasche Bridget L, 2019, Curr Protoc Cell Biol, V82, pe68, DOI 10.1002/cpcb.68; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Polgar N, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031401; Rai A, 2016, ELIFE, V5, DOI 10.7554/eLife.18675; Rivera-Molina F, 2013, J CELL BIOL, V201, P673, DOI 10.1083/jcb.201212103; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2015, BIOCHEM BIOPH RES CO, V465, P601, DOI 10.1016/j.bbrc.2015.08.069; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen D, 2013, J CELL BIOL, V202, P509, DOI 10.1083/jcb.201211148; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Skorobogatko Y, 2018, P NATL ACAD SCI USA, V115, P7819, DOI 10.1073/pnas.1801050115; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Yue P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14236	69	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19988	19996		10.1074/jbc.RA119.010821	http://dx.doi.org/10.1074/jbc.RA119.010821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740584	hybrid, Green Published			2022-12-28	WOS:000505005800014
J	Tarpey, MD; Amorese, AJ; Balestrieri, NP; Fisher-Wellman, KH; Spangenburg, EE				Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.			Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; muscle physiology; bioenergetics; electron transport system (ETS); mitochondrial metabolism; anthracycline drug; doxorubicin; mitochondriopathy; muscle wasting; myotoxicity	ATP HYDROLYSIS EQUILIBRIA; SARCOPLASMIC-RETICULUM; ADENYLATE KINASE; CREATINE-KINASE; CALCIUM-RELEASE; CANCER; CA2+; CHEMOTHERAPY; CARDIOTOXICITY; DYSFUNCTION	Doxorubicin is an anthracycline-based chemotherapeutic that causes myotoxicity with symptoms persisting beyond treatment. Patients experience muscle pain, weakness, fatigue, and atrophy, but the underlying mechanisms are poorly understood. Studies investigating doxorubicin-induced myotoxicity have reported disrupted mitochondrial function. Mitochondria are responsible for regulating both cellular energy status and Ca2+ handling, both of which impact contractile function. Moreover, loss of mitochondrial integrity may initiate muscle atrophy. Skeletal muscle mitochondrial dysregulation may therefore contribute to an overall loss of skeletal muscle quality and performance that may be mitigated by appropriately targeted mitochondrial therapies. We therefore assessed the impact of doxorubicin on muscle performance and applied a multiplexed assay platform to diagnose alterations in mitochondrial respiratory control. Mice received a clinically relevant dose of doxorubicin delivered systemically and were euthanized 72 h later. We measured extensor digitorum longus and soleus muscle forces, fatigue, and contractile kinetics in vitro, along with Ca2+ uptake in isolated sarcoplasmic reticulum. Isolated skeletal muscle mitochondria were used for real-time respirometry or frozen for protein content and activity assays. Doxorubicin impaired muscle performance, which was indicated by reduced force production, fatigue resistance, and sarcoplasmic reticulum?Ca2+ uptake, which were associated with a substrate-independent reduction in respiration and membrane potential but no changes in the NAD(P)H/NAD(P)(+) redox state. Protein content and dehydrogenase activity results corroborated these findings, indicating that doxorubicin-induced mitochondrial impairments are located upstream of ATP synthase within the electron transport system. Collectively, doxorubicin-induced lesions likely span mitochondrial complexes I?IV, providing potential targets for alleviating doxorubicin myotoxicity.	[Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, East Carolina Diabet & Obes Inst, 115 Heart Dr, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA.; Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, East Carolina Diabet & Obes Inst, 115 Heart Dr, Greenville, NC 27834 USA.	spangenburge14@ecu.edu			National Institutes of Health [R01AR06660]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01AR06660 (to E. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASAYAMA J, 1992, CARDIOVASC RES, V26, P371, DOI 10.1093/cvr/26.4.371; Bonifati DM, 2000, CANCER CHEMOTH PHARM, V46, P517, DOI 10.1007/s002800000175; Bredahl EC, 2017, NUTR CANCER, V69, P607, DOI 10.1080/01635581.2017.1295089; Bredahl EC, 2016, MED SCI SPORT EXER, V48, P1468, DOI 10.1249/MSS.0000000000000926; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cappetta D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1521020; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Cunha-Oliveira T, 2018, TOXICOL APPL PHARM, V348, P1, DOI 10.1016/j.taap.2018.04.009; Fabris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139070; Fisher-Wellman KH, 2018, CELL REP, V24, P3593, DOI 10.1016/j.celrep.2018.08.091; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gammella E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00025; Gilliam LAA, 2016, AM J PHYSIOL-ENDOC M, V311, pE293, DOI 10.1152/ajpendo.00540.2015; Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849; Hydock DS, 2011, ANTICANCER RES, V31, P2023; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jacobsen PB, 1999, J PAIN SYMPTOM MANAG, V18, P233, DOI 10.1016/S0885-3924(99)00082-2; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; Koopman WJH, 2003, AM J PHYSIOL-CELL PH, V285, pC1263, DOI 10.1152/ajpcell.00097.2003; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LOIRAT MJ, 1988, BIOSCIENCE REP, V8, P369, DOI 10.1007/BF01115228; McLaughlin KL, 2018, BIOCHEM BIOPH RES CO, V504, P742, DOI 10.1016/j.bbrc.2018.09.022; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; OBRIEN PJ, 1990, MOL CELL BIOCHEM, V94, P113, DOI 10.1007/BF00214118; Olson RD, 2000, TOXICOL APPL PHARM, V169, P168, DOI 10.1006/taap.2000.9065; ONDRIAS K, 1990, CIRC RES, V67, P1167, DOI 10.1161/01.RES.67.5.1167; PAWELCZYK T, 1992, BIOCHEM J, V288, P369, DOI 10.1042/bj2880369; Rossi AE, 2009, EXERC SPORT SCI REV, V37, P29, DOI 10.1097/JES.0b013e3181911fa4; SAKS VA, 1994, MOL CELL BIOCHEM, V133, P155, DOI 10.1007/BF01267954; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schmidt CA, 2017, J VASC SURG, V65, P1504, DOI 10.1016/j.jvs.2016.04.041; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Simunek T, 2009, PHARMACOL REP, V61, P154; Sin TK, 2016, J GERONTOL A-BIOL, V71, P730, DOI 10.1093/gerona/glv175; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Stone P, 1999, BRIT J CANCER, V79, P1479, DOI 10.1038/sj.bjc.6690236; Tarpey MD, 2019, J PHYSIOL-LONDON, V597, P869, DOI 10.1113/JP276863; Tarpey MD, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0160-3; Teague WE, 1996, J EXP BIOL, V199, P509; Tozer RG, 2008, ANTIOXID REDOX SIGN, V10, P395, DOI 10.1089/ars.2007.1919; Tupling R, 2001, AM J PHYSIOL-ENDOC M, V281, pE224, DOI 10.1152/ajpendo.2001.281.2.E224; van Norren K, 2009, BRIT J CANCER, V100, P311, DOI 10.1038/sj.bjc.6604858; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Xu XX, 2005, MOL PHARMACOL, V68, P261, DOI 10.1124/mol.105.013383; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711	52	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19709	19722		10.1074/jbc.RA119.008426	http://dx.doi.org/10.1074/jbc.RA119.008426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690631	Green Published, hybrid			2022-12-28	WOS:000504093200020
J	Kohri, N; Akizawa, H; Iisaka, S; Bai, H; Yanagawa, Y; Takahashi, M; Komatsu, M; Kawai, M; Nagano, M; Kawahara, M				Kohri, Nanami; Akizawa, Hiroki; Iisaka, Sakie; Bai, Hanako; Yanagawa, Yojiro; Takahashi, Masashi; Komatsu, Masaya; Kawai, Masahito; Nagano, Masashi; Kawahara, Manabu			Trophectoderm regeneration to support full-term development in the inner cell mass isolated from bovine blastocyst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						blastocyst; cattle; embryo; gene expression; Hippo pathway; inner cell mass; mouse; protein-protein interaction; trophectoderm; yes-associated protein	EARLY LINEAGE SEGREGATION; PRIMITIVE ENDODERM; TROPHOBLAST DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE TROPHECTODERM; EXPRESSION; FATE; PREIMPLANTATION; DIFFERENTIATION; POLARITY	Which comes first: tissue structure or cell differentiation? While different cell types establish distinct structures delineating the in- and outside of an embryo, they progressively become specified by the blastocyst stage, when two types of cell lineages are formed: inner cell mass (ICM) and trophectoderm (TE). This inside-outside aspect can be experimentally converted by the isolation of the ICM from a blastocyst, leading to a posteriori externalization of the blastomeres composing the outermost layer of the ICM. Here, we investigated the totipotency of isolated mouse and bovine ICMs to determine whether they are competent for TE regeneration. Surprisingly, a calf was generated from the bovine isolated ICM with re-formed blastocoel (re-iICM), but no mouse re-iICMs developed to term. To further explore the cause of difference in developmental competency between the mouse and bovine re-iICMs, we investigated the SOX17 protein expression that is a representative molecular marker of primitive endoderm. The localization pattern of SOX17 was totally different between mouse and bovine embryos. Particularly, the ectopic SOX17 localization in the TE might be associated with lethality of mouse re-iICMs. Meanwhile, transcriptome sequencing revealed that some of the bovine re-iICMs showed transcriptional patterns of TE-specific genes similar to those of whole blastocysts. Our findings suggest that TE regeneration competency is maintained longer in bovine ICMs than in mouse ICMs and provide evidence that the ICM/TE cell fate decision is influenced by structural determinants, including positional information of each blastomere in mammalian embryos.	[Kohri, Nanami; Akizawa, Hiroki; Iisaka, Sakie; Bai, Hanako; Takahashi, Masashi; Komatsu, Masaya; Kawahara, Manabu] Hokkaido Univ, Res Fac Agr, Lab Anim Breeding & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan; [Yanagawa, Yojiro; Nagano, Masashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Theriogenol, Sapporo, Hokkaido 0600818, Japan; [Kawai, Masahito] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Shizunai Livestock Farm, Sapporo, Hokkaido 0560141, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kawahara, M (corresponding author), Hokkaido Univ, Grad Sch Agr, Lab Anim Breeding & Reprod, Sapporo, Hokkaido 0608589, Japan.	k-hara@anim.agr.hokudai.ac.jp	Akizawa, Hiroki/GYD-4542-2022; Bai, Hanako/K-4769-2019	Bai, Hanako/0000-0001-9940-1880; Akizawa, Hiroki/0000-0003-1091-5629; Nagano, Masashi/0000-0002-1890-6842	Japan Society for the Promotion of Science [18H02321, 17J03585]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) to Manabu K (grant number, 18H02321) and Grant-in-Aid for JSPS Fellows to N.K. (No., 17J03585) from the Japan Society for the Promotion of Science.	Akizawa H, 2018, REPRODUCTION, V155, P563, DOI 10.1530/REP-18-0043; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Aono A, 2013, THERIOGENOLOGY, V79, P1146, DOI 10.1016/j.theriogenology.2013.02.009; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Boroviak T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0541; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Cao ZB, 2015, DEVELOPMENT, V142, P1606, DOI 10.1242/dev.120238; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng XX, 2016, DEV GROWTH DIFFER, V58, P327, DOI 10.1111/dgd.12276; Clements D, 2000, MECH DEVELOP, V99, P65, DOI 10.1016/S0925-4773(00)00476-7; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gwatkin R. B. L, 2008, REPRODUCTION, V7, P99; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; Home P, 2017, DEVELOPMENT, V144, P876, DOI 10.1242/dev.145318; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; HYAFIL F, 1980, CELL, V21, P927, DOI 10.1016/0092-8674(80)90456-0; Isaji Y, 2013, J REPROD DEVELOP, V59, P196, DOI 10.1262/jrd.2012-156; Jang JW, 2017, ONCOGENE, V36, P999, DOI 10.1038/onc.2016.266; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; Katagiri S, 2006, ANIM REPROD SCI, V95, P54, DOI 10.1016/j.anireprosci.2005.09.001; Kawahara M, 2015, SCI REP, V5, P1; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kishigami S, 2006, FEBS LETT, V580, P1801, DOI 10.1016/j.febslet.2006.02.036; Krawchuk D, 2013, DEV BIOL, V384, P65, DOI 10.1016/j.ydbio.2013.09.023; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kurowski A, 2019, DEV BIOL, V446, P94, DOI 10.1016/j.ydbio.2018.12.008; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Lilly AJ, 2017, SEMIN CELL DEV BIOL, V63, P50, DOI 10.1016/j.semcdb.2016.07.021; Lorthongpanich C, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127803; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Mallol A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120033; Mitalipov S, 2009, ADV BIOCHEM ENG BIOT, V114, P185, DOI 10.1007/10_2008_45; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ogura A, 2012, PHILOS T R SOC B, V4, P13; PIERCE GB, 1988, AM J PATHOL, V132, P356; QUINN P, 1985, FERTIL STERIL, V44, P493; Quinn P, 2004, REPRODUCTION, V66, P161; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sasaki H, 2017, DEV GROWTH DIFFER, V59, P12, DOI 10.1111/dgd.12335; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; Simmet K, 2018, CELL CYCLE, V17, P1688, DOI 10.1080/15384101.2018.1496747; Simmet K, 2018, P NATL ACAD SCI USA, V115, P2770, DOI 10.1073/pnas.1718833115; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Whitten W. K, 1956, NATURE, V12, P260; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wigger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15427-0; Yamazaki W, 2016, J BIOL CHEM, V291, P20924, DOI 10.1074/jbc.M116.744144; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	64	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19209	19223		10.1074/jbc.RA119.010746	http://dx.doi.org/10.1074/jbc.RA119.010746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31704705	Green Published, hybrid			2022-12-28	WOS:000516527800021
J	Stanly, TA; Fritzsche, M; Banerji, S; Shrestha, D; Schneider, F; Eggeling, C; Jackson, DG				Stanly, Tess A.; Fritzsche, Marco; Banerji, Suneale; Shrestha, Dilip; Schneider, Falk; Eggeling, Christian; Jackson, David G.			The cortical actin network regulates avidity-dependent binding of hyaluronan by the lymphatic vessel endothelial receptor LYVE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; fluorescence recovery after photobleaching (FRAP); fluorescence correlation spectroscopy (FCS); confocal microscopy; membrane biophysics; leukocyte; hyaluronan; endothelial cell; dendritic cell; receptor; stimulated emission depletion (STED) microscopy; immune system; membrane receptor dynamics; STED-FCS; lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1); sFCS	PLASMA-MEMBRANE; CD44; CELLS; CYTOSKELETON; DIFFUSION; PROTEINS; DYNAMICS; DIFFERENTIATION; POLYMERIZATION; TRANSMIGRATION	Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) mediates the docking and entry of dendritic cells to lymphatic vessels through selective adhesion to its ligand hyaluronan in the leukocyte surface glycocalyx. To bind hyaluronan efficiently, LYVE-1 must undergo surface clustering, a process that is induced efficiently by the large cross-linked assemblages of glycosaminoglycan present within leukocyte pericellular matrices but is induced poorly by the shorter polymer alone. These properties suggested that LYVE-1 may have limited mobility in the endothelial plasma membrane, but no biophysical investigation of these parameters has been carried out to date. Here, using super-resolution fluorescence microscopy and spectroscopy combined with biochemical analyses of the receptor in primary lymphatic endothelial cells, we provide the first evidence that LYVE-1 dynamics are indeed restricted by the submembranous actin network. We show that actin disruption not only increases LYVE-1 lateral diffusion but also enhances hyaluronan-binding activity. However, unlike the related leukocyte HA receptor CD44, which uses ERM and ankyrin motifs within its cytoplasmic tail to bind actin, LYVE-1 displays little if any direct interaction with actin, as determined by co-immunoprecipitation. Instead, as shown by super-resolution stimulated emission depletion microscopy in combination with fluorescence correlation spectroscopy, LYVE-1 diffusion is restricted by transient entrapment within submembranous actin corrals. These results point to an actin-mediated constraint on LYVE-1 clustering in lymphatic endothelium that tunes the receptor for selective engagement with hyaluronan assemblages in the glycocalyx that are large enough to cross-bridge the corral-bound LYVE-1 molecules and thereby facilitate leukocyte adhesion and transmigration.	[Stanly, Tess A.; Fritzsche, Marco; Banerji, Suneale; Shrestha, Dilip; Schneider, Falk; Eggeling, Christian; Jackson, David G.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Human Immunol Unit, Oxford OX3 9DS, England; [Stanly, Tess A.] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Oxford OX3 9DS, England; [Fritzsche, Marco] Univ York, Dept Biol, York Biomed Res Inst, York YO10 5DD, N Yorkshire, England; [Eggeling, Christian] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Eggeling, Christian] Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany; [Eggeling, Christian] Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Oxford; University of York - UK; University of Oxford; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena	Eggeling, C; Jackson, DG (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Med Res Council, Human Immunol Unit, Oxford OX3 9DS, England.; Eggeling, C (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.; Eggeling, C (corresponding author), Leibniz Inst Photon Technol eV, Albert Einstein Str 9, D-07745 Jena, Germany.; Eggeling, C (corresponding author), Friedrich Schiller Univ Jena, Inst Appl Opt & Biophys, Max Wien Pl 4, D-07743 Jena, Germany.	christian.eggeling@rdm.ox.ac.uk; david.jackson@imm.ox.ac.uk		Schneider, Falk/0000-0003-0502-9139; Eggeling, Christian/0000-0002-3698-5599; Fritzsche, Marco/0000-0002-8712-7471	Wolfson Foundation [18272]; Medical Research Council (MRC) [MC_UU_12010, G090-2418, MC_UU_00008/2, MC_UU_12025]; MRC/BBSRC/ESPRC [MR/K01577X/1]; Wellcome Trust [104924/14/Z/14, 100262Z/12/Z, 098274/Z/12/Z, 091911, 107457/Z/15/Z]; Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse") [3162113987-SFB 1278]; Newton-Katip Celebi Institutional Links [352333122]; University of Oxford (EPA Cephalosporin Fund); University of Oxford (John Fell Fund); MRC [MC_UU_00008/2, MC_U137884182, MC_UU_12010/2, MC_UU_00008/9, G0902418] Funding Source: UKRI	Wolfson Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/BBSRC/ESPRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse")(German Research Foundation (DFG)); Newton-Katip Celebi Institutional Links; University of Oxford (EPA Cephalosporin Fund); University of Oxford (John Fell Fund); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wolfson Foundation Grant 18272; the Medical Research Council (MRC) (MC_UU_12010/unit programs, G090-2418, MC_UU_00008/2, and MC_UU_12025); MRC/BBSRC/ESPRC Grant MR/K01577X/1; Wellcome Trust Grants 104924/14/Z/14, 100262Z/12/Z, and 098274/Z/12/Z and Strategic Award 091911 (107457/Z/15/Z, Advanced Micron Bioimaging Unit); the Deutsche Forschungsgemeinschaft (Research Unit 1905, Jena Excellence Cluster "Balance of the Microverse," project no. 3162113987-SFB 1278 (project C05)); Newton-Katip Celebi Institutional Links Grant 352333122; and internal University of Oxford funding (EPA Cephalosporin Fund and John Fell Fund). The authors declare that they have no conflicts of interest with the contents of this article.	Andreoli D, 2015, SCI REP-UK, V5, DOI [10.1038/srep10347, 10.1038/srep11454]; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; [Anonymous], [No title captured]; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Chojnacki J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00515-6; Clarke JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068978; Clausen MP, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa52a1; Clausen MP, 2015, METHODS, V88, P67, DOI 10.1016/j.ymeth.2015.06.017; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dubacheva GV, 2015, P NATL ACAD SCI USA, V112, P5579, DOI 10.1073/pnas.1500622112; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Eghiaian F, 2015, BIOPHYS J, V108, P1330, DOI 10.1016/j.bpj.2015.01.016; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Fritzsche M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501337; Fritzsche M, 2015, NAT PROTOC, V10, P660, DOI 10.1038/nprot.2015.042; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Fujiwara TK, 2016, MOL BIOL CELL, V27, P1101, DOI 10.1091/mbc.E15-04-0186; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Jackson DG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00471; Jackson DG, 2019, MATRIX BIOL, V78-79, P219, DOI 10.1016/j.matbio.2018.02.001; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; Machan R, 2016, BIOPHYS J, V111, P152, DOI 10.1016/j.bpj.2016.06.001; Mao S Y, 1999, Methods Mol Biol, V115, P35; Mattila PK, 2016, J CELL BIOL, V212, P267, DOI 10.1083/jcb.201504137; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; Schneider F, 2018, ACS NANO, V12, P8540, DOI 10.1021/acsnano.8b04080; Schneider F, 2017, MOL BIOL CELL, V28, P1507, DOI 10.1091/mbc.E16-07-0536; Shelby SA, 2013, BIOPHYS J, V105, P2343, DOI 10.1016/j.bpj.2013.09.049; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Staaf E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai9200; Stanly TA, 2016, BIOL OPEN, V5, P1343, DOI 10.1242/bio.019943; Torreno-Pina JA, 2016, P NATL ACAD SCI USA, V113, pE772, DOI 10.1073/pnas.1514530113; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Vaahtomeri K, 2017, CELL REP, V19, P902, DOI 10.1016/j.celrep.2017.04.027; Vieira JM, 2018, J CLIN INVEST, V128, P3402, DOI 10.1172/JCI97192; Waithe D, 2018, METHODS, V140, P62, DOI 10.1016/j.ymeth.2017.09.010; Waithe D, 2016, BIOINFORMATICS, V32, P958, DOI 10.1093/bioinformatics/btv687; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	68	6	6	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5036	5050		10.1074/jbc.RA119.011992	http://dx.doi.org/10.1074/jbc.RA119.011992			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32034091	Green Published, hybrid			2022-12-28	WOS:000526887000025
J	Newman, JA; Aitkenhead, H; Gavard, AE; Rota, IA; Handel, AE; Hollander, GA; Gileadi, O				Newman, Joseph A.; Aitkenhead, Hazel; Gavard, Angeline E.; Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.; Gileadi, Opher			The crystal structure of human forkhead box N1 in complex with DNA reveals the structural basis for forkhead box family specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA?protein interaction; immunodeficiency; transcription factor; crystal structure; gene regulation; forkhead box N1; thymus	BINDING-SPECIFICITY; DOMAIN; RECOGNITION; METHYLATION; PROTEIN; MOUSE	Forkhead box N1 (FOXN1) is a member of the forkhead box family of transcription factors and plays an important role in thymic epithelial cell differentiation and development. FOXN1 mutations in humans and mice give rise to the ?nude? phenotype, which is marked by athymia. FOXN1 belongs to a subset of the FOX family that recognizes an alternative forkhead-like (FHL) consensus sequence (GACGC) that is different from the more widely recognized forkhead (FKH) sequence RYAAAYA (where R is purine, and Y is pyrimidine). Here, we present the FOXN1 structure in complex with DNA containing an FHL motif at 1.6 ? resolution, in which the DNA sequence is recognized by a mixture of direct and water-mediated contacts provided by residues in an ?-helix inserted in the DNA major groove (the recognition helix). Comparisons with the structure of other FOX family members revealed that the FKH and FHL DNA sequences are bound in two distinct modes, with partially different registers for the protein DNA contacts. We identified a single alternative rotamer within the recognition helix itself as an important determinant of DNA specificity and found protein sequence features in the recognition helix that could be used to predict the specificity of other FOX family members. Finally, we demonstrate that the C-terminal region of FOXN1 is required for high-affinity DNA binding and that FOXN1 has a significantly reduced affinity for DNA that contains 5?-methylcytosine, which may have implications for the role of FOXN1 in thymic involution.	[Newman, Joseph A.; Aitkenhead, Hazel; Gavard, Angeline E.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.] Univ Oxford, Dept Paediat, Oxford OX3 9DS, England; [Rota, Ioanna A.; Handel, Adam E.; Hollander, Georg A.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Handel, Adam E.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Hollander, Georg A.] Univ Basel, Dept Biomed, Paediat Immunol, CH-4056 Basel, Switzerland; [Hollander, Georg A.] Univ Childrens Hosp Basel, CH-4056 Basel, Switzerland; [Aitkenhead, Hazel] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Basel; University of Basel; University of Oxford; Wellcome Centre for Human Genetics	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; Handel, Adam/0000-0001-8385-6346; Hollander, Georg/0000-0002-8790-0874	Structural Genomics Consortium [1097737]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen; Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Grants [106169/ZZ14/Z, 211944/Z/18/Z]	Structural Genomics Consortium(University of Toronto); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA; MSD; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Grants	This work was supported in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, InnFovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766, Janssen, Merck KGaA, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Grants 106169/ZZ14/Z (to I. A. R., A. E. H., and G. A. H.) and 211944/Z/18/Z (to J. A. N., H. A., A. E. G., and O. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams EJ, 2019, NATURE, V571, P408, DOI 10.1038/s41586-019-1318-9; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boura E, 2010, ACTA CRYSTALLOGR D, V66, P1351, DOI 10.1107/S0907444910042228; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Ignat'eva E. L., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P76; Jackson Brian C., 2010, Human Genomics, V4, P345; Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaestner KH, 2000, GENE DEV, V14, P142; Li J, 2017, BIOCHEMISTRY-US, V56, P3745, DOI 10.1021/acs.biochem.7b00211; Littler DR, 2010, NUCLEIC ACIDS RES, V38, P4527, DOI 10.1093/nar/gkq194; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Parolia A, 2019, NATURE, V571, P413, DOI 10.1038/s41586-019-1347-4; Rogers JM, 2019, MOL CELL, V74, P245, DOI 10.1016/j.molcel.2019.01.019; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsai KL, 2006, J BIOL CHEM, V281, P17400, DOI 10.1074/jbc.M600478200; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zampieri M, 2015, MECH AGEING DEV, V151, P60, DOI 10.1016/j.mad.2015.02.002; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	32	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2948	2958		10.1074/jbc.RA119.010365	http://dx.doi.org/10.1074/jbc.RA119.010365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31914405	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000519597300007
J	Sandoval, DR; Toledo, AG; Painter, CD; Tota, EM; Sheikh, MO; West, AMV; Frank, MM; Wells, L; Xu, D; Bicknell, R; Corbett, KD; Esko, JD				Sandoval, Daniel R.; Toledo, Alejandro Gomez; Painter, Chelsea D.; Tota, Ember M.; Sheikh, M. Osman; West, Alan M., V; Frank, Martin M.; Wells, Lance; Xu, Ding; Bicknell, Roy; Corbett, Kevin D.; Esko, Jeffrey D.			Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteomics; heparin-binding protein; heparin; heparan sulfate; endothelium; vascular biology; glycosaminoglycan; extracellular matrix; C-type lectin 14a (CLEC14A); LPHAMS	LAMININ ALPHA-4 CHAIN; GROWTH-FACTOR; MOLECULAR-CLONING; LYMPHOCYTE CHEMOATTRACTANT; SPROUTING ANGIOGENESIS; EPITHELIN PRECURSOR; TERMINAL DOMAIN; RECEPTOR; AFFINITY; GLYCOSAMINOGLYCANS	Animal cells express heparan sulfate proteoglycans that perform many important cellular functions by way of heparan sulfate?protein interactions. The identification of membrane heparan sulfate?binding proteins is challenging because of their low abundance and the need for extensive enrichment. Here, we report a proteomics workflow for the identification and characterization of membrane-anchored and extracellular proteins that bind heparan sulfate. The technique is based on limited proteolysis of live cells in the absence of denaturation and fixation, heparin-affinity chromatography, and high-resolution LC-MS/MS, and we designate it LPHAMS. Application of LPHAMS to U937 monocytic and primary murine and human endothelial cells identified 55 plasma membrane, extracellular matrix, and soluble secreted proteins, including many previously unidentified heparin-binding proteins. The method also facilitated the mapping of the heparin-binding domains, making it possible to predict the location of the heparin-binding site. To validate the discovery feature of LPHAMS, we characterized one of the newly-discovered heparin-binding proteins, C-type lectin 14a (CLEC14A), a member of the C-type lectin family that modulates angiogenesis. We found that the C-type lectin domain of CLEC14A binds one-to-one to heparin with nanomolar affinity, and using molecular modeling and mutagenesis, we mapped its heparin-binding site. CLEC14A physically interacted with other glycosaminoglycans, including endothelial heparan sulfate and chondroitin sulfate E, but not with neutral or sialylated oligosaccharides. The LPHAMS technique should be applicable to other cells and glycans and provides a way to expand the repertoire of glycan-binding proteins for further study.	[Sandoval, Daniel R.; Toledo, Alejandro Gomez; Painter, Chelsea D.; Corbett, Kevin D.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Sandoval, Daniel R.; Painter, Chelsea D.; West, Alan M., V] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Tota, Ember M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sheikh, M. Osman; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Frank, Martin M.] Biognos AB, S-41705 Gothenburg, Sweden; [Xu, Ding] Univ Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA; [Bicknell, Roy] Univ Birmingham, Coll Med & Dent, Birmingham B15 2TT, W Midlands, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Birmingham	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Esko, JD (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu		Bicknell, Roy/0000-0002-0941-8919; Frank, Martin/0000-0002-1006-6746; Sheikh, Mohammed/0000-0002-9481-8318; Corbett, Kevin/0000-0001-5854-2388; Wells, Lance/0000-0003-4956-5363	Program of Excellence in Glycoscience from the National Institutes of Health [P01 HL107150, P01 HL131474]; National Institutes of Health [R01 AR070179, R01 GM104141, P41 GM103490]	Program of Excellence in Glycoscience from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Program of Excellence in Glycoscience Grants P01 HL107150 and P01 HL131474 from the National Institutes of Health (to J. D. E.), a supplement to Grant P01 HL131474 (to D.R.S.), and National Institutes of Health Grants R01 AR070179 (to D. X.), R01 GM104141 (to K. D. C.), and P41 GM103490 (to L. W.). The University of California, San Diego, and J. D. E. have a financial interest in TEGA Therapeutics, Inc. J. D. E. and the University of California, San Diego, may financially benefit from this interest if the company is successful in marketing its products (recombinant heparan sulfate) that are related to this research. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angel PM, 2007, RAPID COMMUN MASS SP, V21, P674, DOI 10.1002/rcm.2874; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Beckman M, 2009, FEBS J, V276, P7343, DOI 10.1111/j.1742-4658.2009.07444.x; BENECKY MJ, 1988, BIOCHEMISTRY-US, V27, P7565, DOI 10.1021/bi00419a058; BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cummings RD., 2017, ESSENTIALS GLYCOBIOL, Vpp, P435, DOI DOI 10.1101/GLYCOBIOLOGY.3E.034; DIXIT VM, 1984, J BIOL CHEM, V259, P100; EHRLICH HJ, 1991, BIOCHEMISTRY-US, V30, P1021, DOI 10.1021/bi00218a020; FLODGAARD H, 1991, EUR J BIOCHEM, V197, P535, DOI 10.1111/j.1432-1033.1991.tb15942.x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Holtz AM, 2015, J CELL BIOL, V209, P739, DOI 10.1083/jcb.201411024; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11118-y; Joo EJ, 2005, GLYCOBIOLOGY, V15, P1, DOI 10.1093/glycob/cwh132; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan KA, 2017, ONCOGENE, V36, P6097, DOI 10.1038/onc.2017.214; Khan KA, 2019, FEBS J, V286, P3299, DOI 10.1111/febs.14985; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kim TK, 2018, MOL ONCOL, V12, P356, DOI 10.1002/1878-0261.12169; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Ledoux D, 2003, FEBS LETT, V537, P23, DOI 10.1016/S0014-5793(03)00064-4; Lee S, 2017, J CLIN INVEST, V127, P457, DOI 10.1172/JCI85145; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Menoret A, 2000, J IMMUNOL METHODS, V237, P119, DOI 10.1016/S0022-1759(00)00137-X; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Noy PJ, 2016, FASEB J, V30, P2311, DOI 10.1096/fj.201500122R; Nunes QM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217633; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; Olaya-Abril A, 2014, J PROTEOMICS, V97, P164, DOI 10.1016/j.jprot.2013.03.035; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rho SS, 2011, BIOCHEM BIOPH RES CO, V404, P103, DOI 10.1016/j.bbrc.2010.11.075; Riera M, 1999, MOL CELL BIOCHEM, V191, P97, DOI 10.1023/A:1006810311743; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh A, 2019, GLYCOBIOLOGY, V29, P515, DOI 10.1093/glycob/cwz027; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Sue SC, 2004, J MOL BIOL, V343, P1365, DOI 10.1016/j.jmb.2004.09.014; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xu D, 2011, J BIOL CHEM, V286, P41736, DOI 10.1074/jbc.M111.299685; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Yamashita H, 2004, J MOL BIOL, V335, P1145, DOI 10.1016/j.jmb.2003.11.047; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Yip CW, 2014, CARCINOGENESIS, V35, P2485, DOI 10.1093/carcin/bgu164; Yu WH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006093; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang B, 2014, J CLIN INVEST, V124, P209, DOI 10.1172/JCI71090; Zhang X, 2018, P NATL ACAD SCI USA, V115, P3828, DOI 10.1073/pnas.1720859115; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746	98	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2804	2821		10.1074/jbc.RA119.011639	http://dx.doi.org/10.1074/jbc.RA119.011639			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31964714	Green Published, hybrid			2022-12-28	WOS:000519969100023
J	Wang, L; Cheng, N; Wang, P; Li, J; Jia, AN; Li, WY; Zhang, N; Yin, YX; Tong, L; Wei, Q; Liu, GW; Li, ZM; Luo, J				Wang, Lu; Cheng, Na; Wang, Ping; Li, Jing; Jia, Anna; Li, Wenying; Zhang, Nan; Yin, Yanxia; Tong, Li; Wei, Qun; Liu, Guangwei; Li, Zhimei; Luo, Jing			A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcineurin; NFAT transcription factor; enzyme inhibitor; cytokine; cellular immune response	ACTIVATED T-CELLS; NUCLEAR FACTOR; AIRWAY INFLAMMATION; GENE-EXPRESSION; CYCLOSPORINE-A; INHIBITION; PHOSPHATASE; IDENTIFICATION; CALCIUM; PATHWAY	The calcineurin/nuclear factor of activated T cell (CN/NFAT) signaling pathway plays a critical role in the immune response. Therefore, inhibition of the CN/NFAT pathway is an important target for inflammatory disease. The conserved PXIXIT and LXVP motifs of CN substrates and targeting proteins have been recognized. Based on the affinity ability and inhibitory effect of these docking sequences on CN, we designed a bioactive peptide (named pep3) against the CN/NFAT interaction, which has two binding sites derived from the RCAN1-PXIXIT motif and the NFATc1-LXVP motif. The shortest linker between the two binding sites in pep3 is derived from A238L, a physiological binding partner of CN. Microscale thermophoresis revealed that pep3 has two docking sites on CN. Pep3 also has the most potent inhibitory effect on CN. It is suggested that pep3 contains an NFATc1-LXVP?substrate recognition motif and RCAN1-PXIXIT?mediated anchoring to CN. Expression of this peptide significantly suppresses CN/NFAT signaling. Cell-permeable 11-arginine?modified pep3 (11R-pep3) blocks the NFAT downstream signaling pathway. Intranasal administration of the 11R-pep3 peptide inhibits airway inflammation in an ovalbumin-induced asthma model. Our results suggest that pep3 is promising as an immunosuppressive agent and can be used in topical remedies.	[Wang, Lu; Cheng, Na; Wang, Ping; Li, Jing; Jia, Anna; Li, Wenying; Zhang, Nan; Yin, Yanxia; Tong, Li; Wei, Qun; Liu, Guangwei; Luo, Jing] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol,Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China; [Li, Zhimei] Capital Med Univ, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China; [Li, Jing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60635 USA	Beijing Normal University; Capital Medical University; University of Chicago	Li, ZM (corresponding author), Capital Med Univ, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China.; Luo, J (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, 19 Xinjiekouwaidajie, Beijing 100875, Peoples R China.	lizm1211@163.com; luojing@bnu.edu.cn		LI, Jing/0000-0003-3277-6818	National Nature Science Foundation of China [81373389, 31700695]; research fund for China Association Against Epilepsy-UCB program [2017010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for China Association Against Epilepsy-UCB program	This work was supported by National Nature Science Foundation of China Project Grants 81373389 (to J. L.) and 31700695 (to Y. Y.) and the research fund for China Association Against Epilepsy-UCB program 2017010. The authors declare that they have no conflicts of interest with the contents of this article.	Abrams CC, 2008, VIROLOGY, V374, P477, DOI 10.1016/j.virol.2008.01.005; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Mulero MC, 2010, ANAL BIOCHEM, V398, P99, DOI 10.1016/j.ab.2009.10.045; Choi JM, 2012, IMMUNOL LETT, V143, P170, DOI 10.1016/j.imlet.2012.01.016; FUKUDA T, 1995, ANN ALLERG ASTHMA IM, V75, P65; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; Li CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14275; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; Lunding LP, 2015, J IMMUNOL, V194, P5615, DOI 10.4049/jimmunol.1402529; Luo J, 2008, BRAIN RES BULL, V76, P464, DOI 10.1016/j.brainresbull.2007.12.005; Luo J, 2014, HUM MOL GENET, V23, P6567, DOI 10.1093/hmg/ddu377; Ma B, 2015, J NEUROSCI, V35, P10799, DOI 10.1523/JNEUROSCI.2455-14.2015; Ma YP, 2015, INT J BIOL MACROMOL, V72, P254, DOI 10.1016/j.ijbiomac.2014.08.042; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02934-3; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roh SS, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/781425; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Slupe AM, 2013, J BIOL CHEM, V288, P12353, DOI 10.1074/jbc.M113.459677; Song RW, 2017, BIOCHIMIE, V142, P158, DOI 10.1016/j.biochi.2017.09.002; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Wei Q, 1997, BIOCHEM MOL BIOL INT, V41, P169; WEI Q, 1988, J BIOL CHEM, V263, P19541; Zhao YN, 2016, BIOCHIMIE, V127, P50, DOI 10.1016/j.biochi.2016.04.011	36	9	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2760	2770		10.1074/jbc.RA119.010254	http://dx.doi.org/10.1074/jbc.RA119.010254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31941790	Green Published, hybrid			2022-12-28	WOS:000519969100020
J	Song, XZ; Akasaka, H; Wang, H; Abbasgholizadeh, R; Shin, JH; Zang, FL; Chen, JY; Logsdon, CD; Maitra, A; Bean, AJ; Wang, HM				Song, Xianzhou; Akasaka, Hironari; Wang, Hua; Abbasgholizadeh, Reza; Shin, Ji-Hyun; Zang, Fenglin; Chen, Jiayi; Logsdon, Craig D.; Maitra, Anirban; Bean, Andrew J.; Wang, Huamin			Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic cancer; endocytosis; receptor tyrosine kinase; ubiquitylation (ubiquitination); protein degradation; tumor suppressor gene; Axl; c-Cbl; Gas6; HPK1; kinase signaling	CASPASE-MEDIATED CLEAVAGE; GENE-EXPRESSION; DEGRADATION; GROWTH; CELLS; ADENOCARCINOMA; OVEREXPRESSION; BAFILOMYCIN-A1; METASTASIS; ACTIVATION	The oncogenic receptor tyrosine kinase AXL is overexpressed in cancer and plays an important role in carcinomas of multiple organs. However, the mechanisms of AXL overexpression in cancer remain unclear. In this study, using HEK293T, Panc-1, and Panc-28 cells and samples of human pancreatic intraepithelial neoplasia (PanIN), along with several biochemical approaches and immunofluorescence microscopy analyses, we sought to investigate the mechanisms that regulate AXL over-expression in pancreatic ductal adenocarcinoma (PDAC). We found that AXL interacts with hematopoietic progenitor kinase 1 (HPK1) and demonstrate that HPK1 down-regulates AXL and decreases its half-life. The HPK1-mediated AXL degradation was inhibited by the endocytic pathway inhibitors leupeptin, bafilomycin A1, and monensin. HPK1 accelerated the movement of AXL from the plasma membrane to endosomes in pancreatic cancer cells treated with the AXL ligand growth arrest-specific 6 (GAS6). Moreover, HPK1 increased the binding of AXL to the Cbl proto-oncogene (c-Cbl); promoted AXL ubiquitination; decreased AXL-mediated signaling, including phospho-AKT and phospho-ERK signaling; and decreased the invasion capability of PDAC cells. Importantly, we show that AXL expression inversely correlates with HPK1 expression in human PanINs and that patients whose tumors have low HPK1 and high AXL expression levels have shorter survival than those with low AXL or high HPK1 expression (p < 0.001). Our results suggest that HPK1 is a tumor suppressor that targets AXL for degradation via the endocytic pathway. HPK1 loss of function may contribute to AXL overexpression and thereby enhance AXL-dependent downstream signaling and tumor invasion in PDAC.	[Song, Xianzhou; Akasaka, Hironari; Abbasgholizadeh, Reza; Shin, Ji-Hyun; Zang, Fenglin; Chen, Jiayi; Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Houston, TX 77030 USA; [Wang, Hua] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Maitra, Anirban; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Bean, Andrew J.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, HM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Unit 085, 1515 Holcombe Blvd, Houston, TX 77030 USA.	hmwang@mdanderson.org	Chen, Jiayi/GZM-5106-2022		National Institutes of Health [1R01 CA196941, 1R01CA195651]; Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center	This work was supported by National Institutes of Health Grants 1R01 CA196941 and 1R01CA195651 and the Khalifa Bin Zayed Al Nahyan Foundation Institute for Pancreatic Cancer Research at University of Texas M. D. Anderson Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745670; Are M, 2017, J SURG ONCOL, V115, P637, DOI 10.1002/jso.24585; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goyette MA, 2018, CELL REP, V23, P1476, DOI 10.1016/j.celrep.2018.04.019; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Hernandez S, 2018, CELL REP, V25, P80, DOI 10.1016/j.celrep.2018.09.012; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; HYMAN C, 1983, J CELL BIOL, V96, P1316, DOI 10.1083/jcb.96.5.1316; Kariolis MS, 2017, J CLIN INVEST, V127, P183, DOI 10.1172/JCI85610; Kirane A, 2015, CANCER RES, V75, P3699, DOI 10.1158/0008-5472.CAN-14-2887-T; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Leconet W, 2014, ONCOGENE, V33, P5405, DOI 10.1038/onc.2013.487; Leconet W, 2017, CLIN CANCER RES, V23, P2806, DOI 10.1158/1078-0432.CCR-16-1316; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Ludwig KF, 2018, CANCER RES, V78, P246, DOI 10.1158/0008-5472.CAN-17-1973; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Meric F, 2002, CLIN CANCER RES, V8, P361; Moody G, 2016, INT J CANCER, V139, P1340, DOI 10.1002/ijc.30180; Moore RH, 1999, J CELL SCI, V112, P329; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Skinner HD, 2017, CLIN CANCER RES, V23, P2713, DOI 10.1158/1078-0432.CCR-16-2586; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tsou AP, 1998, GENOMICS, V50, P331, DOI 10.1006/geno.1998.5338; Tveten K, 2009, ACTA BIOCH BIOPH SIN, V41, P246, DOI 10.1093/abbs/gmp008; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Wang H, 2016, SEMIN CANCER BIOL, V36, P88, DOI 10.1016/j.semcancer.2015.09.004; Wang H, 2014, J BIOL CHEM, V289, P4009, DOI 10.1074/jbc.M113.520106; Wang H, 2009, CANCER RES, V69, P1063, DOI 10.1158/0008-5472.CAN-08-1751; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Wu CW, 2002, ANTICANCER RES, V22, P1071; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang G, 2018, CLIN CANCER RES, V24, P4771, DOI 10.1158/1078-0432.CCR-17-2773; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	54	7	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2348	2358		10.1074/jbc.RA119.012186	http://dx.doi.org/10.1074/jbc.RA119.012186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31959629	Green Published, hybrid			2022-12-28	WOS:000517330200017
J	Xu, R; Ritz, BK; Wang, YK; Huang, JC; Zhao, C; Gong, KZ; Liu, XN; Du, JH				Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Zhao, Chen; Gong, Kaizheng; Liu, Xinnong; Du, Jianhai			The retina and retinal pigment epithelium differ in nitrogen metabolism and are metabolically connected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; nitrogen metabolism; retinal metabolism; mitochondrial metabolism; amino acid	MITOCHONDRIAL PYRUVATE CARRIER; NERVOUS-TISSUE; GLIAL-CELLS; TCA CYCLE; GLUTAMATE; AMMONIA; TRANSPORT; NEURONS; PATHWAY; GLUCOSE	Defects in energy metabolism in either the retina or the immediately adjacent retinal pigment epithelium (RPE) underlie retinal degeneration, but the metabolic dependence between retina and RPE remains unclear. Nitrogen-containing metabolites such as amino acids are essential for energy metabolism. Here, we found that N-15-labeled ammonium is predominantly assimilated into glutamine in both the retina and RPE/choroid ex vivo. [N-15]Ammonium tracing in vivo show that, like the brain, the retina can synthesize asparagine from ammonium, but RPE/choroid and the liver cannot. However, unless present at toxic concentrations, ammonium cannot be recycled into glutamate in the retina and RPE/choroid. Tracing with N-15-labeled amino acids show that the retina predominantly uses aspartate transaminase for de novo synthesis of glutamate, glutamine, and aspartate, whereas RPE uses multiple transaminases to utilize and synthesize amino acids. Retina consumes more leucine than RPE, but little leucine is catabolized. The synthesis of serine and glycine is active in RPE but limited in the retina. RPE, but not the retina, uses alanine as mitochondrial substrates through mitochondrial pyruvate carrier. However, when the mitochondrial pyruvate carrier is inhibited, alanine may directly enter the retinal mitochondria but not those of RPE. In conclusion, our results demonstrate that the retina and RPE differ in nitrogen metabolism and highlight that the RPE supports retinal metabolism through active amino acid metabolism.	[Xu, Rong] Yangzhou Univ, Affiliated Hosp, Cent Lab, Yangzhou 225012, Jiangsu, Peoples R China; [Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Du, Jianhai] West Virginia Univ, Dept Ophthalmol, Morgantown, WV 26506 USA; [Xu, Rong; Ritz, Brianna K.; Wang, Yekai; Huang, Jiancheng; Du, Jianhai] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Huang, Jiancheng; Zhao, Chen] Fudan Univ, Inst Eye, Eye & ENT Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Gong, Kaizheng; Liu, Xinnong] Yangzhou Univ, Affiliated Hosp, Dept Cardiol, Yangzhou 225012, Jiangsu, Peoples R China; [Liu, Xinnong] Yangzhou Univ, Affiliated Hosp, Dept Gen Surg, Yangzhou 225012, Jiangsu, Peoples R China	Yangzhou University; West Virginia University; West Virginia University; Fudan University; Yangzhou University; Yangzhou University	Liu, XN (corresponding author), 368 Hanjiang Middle Rd, Yangzhou 225012, Jiangsu, Peoples R China.; Du, JH (corresponding author), WVU Eye Inst, One Med Ctr Dr,POB 9193, Morgantown, WV 26505 USA.	yzyyxhk@163.com; jianhai.du@wvumedicine.org		Du, Jianhai/0000-0002-2019-8128	National Institutes of Health [EY026030]; Retina Research Foundation; Yanzhou University International Academic Exchange Fund Studentship; Yangzhou University International Academic Exchange Fund Grant [XKYCX18_130]; West Virginia University Summer Undergraduate Vision Research Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; Yanzhou University International Academic Exchange Fund Studentship; Yangzhou University International Academic Exchange Fund Grant; West Virginia University Summer Undergraduate Vision Research Fellowship	This work was supported by National Institutes of Health Grant EY026030 (to J. D.) and by the Retina Research Foundation (to J. D.). This work was also supported in part by a Yanzhou University International Academic Exchange Fund Studentship (to R. X.), the Yangzhou University International Academic Exchange Fund Grant XKYCX18_130 (to R. X.), and a West Virginia University Summer Undergraduate Vision Research Fellowship (to B. K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; AMES A, 1980, J NEUROCHEM, V35, P131; Ames A 3rd, 1980, Neurochem Int, V1C, P393, DOI 10.1016/0197-0186(80)90075-3; Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Bowman CE, 2016, MOL CELL BIOL, V36, P2089, DOI 10.1128/MCB.00166-16; Bringmann A, 1998, J BRAIN RES, V39, P193; Brown EE, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101201; Bui BV, 2009, J NEUROCHEM, V111, P589, DOI 10.1111/j.1471-4159.2009.06354.x; Chao JR, 2017, J BIOL CHEM, V292, P12895, DOI 10.1074/jbc.M117.788422; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Coles JA, 1996, J PHYSIOL-LONDON, V495, P305, DOI 10.1113/jphysiol.1996.sp021595; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; Felszeghy S, 2019, REDOX BIOL, V20, P1, DOI 10.1016/j.redox.2018.09.011; Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, pAMD41, DOI 10.1167/iovs.18-24289; Franco TMA, 2017, ACS CHEM BIOL, V12, P1235, DOI 10.1021/acschembio.7b00142; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Grenell A, 2019, P NATL ACAD SCI USA, V116, P3530, DOI 10.1073/pnas.1812941116; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Lieth E, 2001, J NEUROCHEM, V76, P1712, DOI 10.1046/j.1471-4159.2001.00156.x; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Lomelino CL, 2017, J BIOL CHEM, V292, P19952, DOI 10.1074/jbc.R117.819060; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Millard P, 2019, BIOINFORMATICS, V35, P4484, DOI 10.1093/bioinformatics/btz209; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; PARKS JM, 1976, J NEUROCHEM, V27, P987, DOI 10.1111/j.1471-4159.1976.tb00301.x; PEREZSALA D, 1986, J BIOL CHEM, V261, P13969; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799; Singh C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129398; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Tompkins SC, 2019, CELL REP, V28, P2608, DOI 10.1016/j.celrep.2019.07.098; Uhlmann S, 2003, GRAEF ARCH CLIN EXP, V241, P451, DOI 10.1007/s00417-003-0639-3; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Venkatesh A, 2015, J CLIN INVEST, V125, P1446, DOI 10.1172/JCI79766; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; Yam M, 2019, J BIOL CHEM, V294, P10278, DOI 10.1074/jbc.RA119.007983; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zaganas I, 2013, METAB BRAIN DIS, V28, P127, DOI 10.1007/s11011-013-9382-6; Zhang LJ, 2016, HUM MOL GENET, V25, P4244, DOI 10.1093/hmg/ddw256; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhu SY, 2018, EXP EYE RES, V174, P113, DOI 10.1016/j.exer.2018.05.032	60	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2324	2335		10.1074/jbc.RA119.011727	http://dx.doi.org/10.1074/jbc.RA119.011727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953322	Green Published, hybrid			2022-12-28	WOS:000517330200015
J	Chen, KY; Brychta, RJ; Sater, ZA; Cassimatis, TM; Cero, C; Fletcher, LA; Israni, NS; Johnson, JW; Lea, HJ; Linderman, JD; O'Mara, AE; Zhu, KY; Cypess, AM				Chen, Kong Y.; Brychta, Robert J.; Abdul Sater, Zahraa; Cassimatis, Thomas M.; Cero, Cheryl; Fletcher, Laura A.; Israni, Nikita S.; Johnson, James W.; Lea, Hannah J.; Linderman, Joyce D.; O'Mara, Alana E.; Zhu, Kenneth Y.; Cypess, Aaron M.			Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						adipocyte; adrenergic receptor; energy metabolism; imaging; pharmacology; obesity; energy expenditure; metabolic disorder; sympathomimetic; thermogenesis	BROWN ADIPOSE-TISSUE; LOW ENVIRONMENTAL-TEMPERATURE; DIET-INDUCED THERMOGENESIS; MASSIVE WEIGHT-LOSS; BETA(3)-ADRENERGIC RECEPTOR; SKELETAL-MUSCLE; METABOLIC ADAPTATION; ADRENERGIC-RECEPTOR; NONSHIVERING THERMOGENESIS; COLD-EXPOSURE	The current obesity pandemic results from a physiological imbalance in which energy intake chronically exceeds energy expenditure (EE), and prevention and treatment strategies remain generally ineffective. Approaches designed to increase EE have been informed by decades of experiments in rodent models designed to stimulate adaptive thermogenesis, a long-term increase in metabolism, primarily induced by chronic cold exposure. At the cellular level, thermogenesis is achieved through increased rates of futile cycling, which are observed in several systems, most notably the regulated uncoupling of oxidative phosphorylation from ATP generation by uncoupling protein 1, a tissue-specific protein present in mitochondria of brown adipose tissue (BAT). Physiological activation of BAT and other organ thermogenesis occurs through ?-adrenergic receptors (AR), and considerable effort over the past 5 decades has been directed toward developing AR agonists capable of safely achieving a net negative energy balance while avoiding unwanted cardiovascular side effects. Recent discoveries of other BAT futile cycles based on creatine and succinate have provided additional targets. Complicating the current and developing pharmacological-, cold-, and exercise-based methods to increase EE is the emerging evidence for strong physiological drives toward restoring lost weight over the long term. Future studies will need to address technical challenges such as how to accurately measure individual tissue thermogenesis in humans; how to safely activate BAT and other organ thermogenesis; and how to sustain a negative energy balance over many years of treatment.	[Chen, Kong Y.; Brychta, Robert J.; Abdul Sater, Zahraa; Cassimatis, Thomas M.; Cero, Cheryl; Fletcher, Laura A.; Israni, Nikita S.; Johnson, James W.; Lea, Hannah J.; Linderman, Joyce D.; O'Mara, Alana E.; Zhu, Kenneth Y.; Cypess, Aaron M.] NIDDK, Diabet Endocrinol & Obes Branch, Intramural Res Program, NIH, Bldg 10 CRC,Rm 5-5752,10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chen, KY (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, Intramural Res Program, NIH, Bldg 10 CRC,Rm 5-5752,10 Ctr Dr, Bethesda, MD 20892 USA.; Cypess, AM (corresponding author), Bldg 10 CRC,Rm 6-3950,10 Ctr Dr, Bethesda, MD 20892 USA.	kong.chen@nih.gov; aaron.cypess@nih.gov	Johnson, James/GXZ-5047-2022; Chen, Kong/L-6972-2017	Johnson, James/0000-0003-1658-244X; Cero, Cheryl/0000-0003-0513-8669; Brychta, Robert/0000-0001-9491-7968; Zhu, Kenneth/0000-0002-9335-2691; Chen, Kong/0000-0002-0306-1904	National Institutes of Health Intramural Research Program of the NIDDK [DK075112, DK075115, DK075116, DK071013, DK071014]	National Institutes of Health Intramural Research Program of the NIDDK	This work was supported by National Institutes of Health Intramural Research Program of the NIDDK Grants DK075112, DK075115, DK075116, DK071013, and DK071014. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreu-Vieira G, 2015, MOL METAB, V4, P461, DOI 10.1016/j.molmet.2015.03.001; ANDERSEN KL, 1960, J APPL PHYSIOL, V15, P649, DOI 10.1152/jappl.1960.15.4.649; [Anonymous], [No title captured]; Arch JRS, 2011, THER ADV ENDOCRINOL, V2, P59, DOI 10.1177/2042018811398517; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; ASTRUP A, 1985, AM J CLIN NUTR, V42, P83, DOI 10.1093/ajcn/42.1.83; Astrup A, 2004, OBES RES, V12, p167S, DOI 10.1038/oby.2004.284; ASTRUP A, 1984, CLIN SCI, V66, P179, DOI 10.1042/cs0660179; Astrup A., 1993, INT J OBES RELAT MET, V17; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462; Benedict FG, 1938, VITAL ENERGETICS STU; Bengtsson T, 2000, BIOCHEM J, V347, P643, DOI 10.1042/0264-6021:3470643; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bertholet AM, 2017, BIOCHIMIE, V134, P28, DOI 10.1016/j.biochi.2016.10.013; Biton V, 2003, CNS DRUGS, V17, P781, DOI 10.2165/00023210-200317110-00002; Blondin DP, 2018, HAND CLINIC, V156, P153, DOI 10.1016/B978-0-444-63912-7.00010-2; Blondin DP, 2015, J PHYSIOL-LONDON, V593, P701, DOI 10.1113/jphysiol.2014.283598; Blundell JE, 2012, DIS MODEL MECH, V5, P608, DOI 10.1242/dmm.009837; Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; BRODY S., 1932, Relation between basal metabolism and mature body-weight in different species of mammals and birds., P89; Brychta RJ, 2017, EUR J CLIN NUTR, V71, P345, DOI 10.1038/ejcn.2016.223; Brychta RJ, 2019, J CLIN ENDOCR METAB, V104, P4865, DOI 10.1210/jc.2019-00728; BUSKIRK ER, 1960, AM J CLIN NUTR, V8, P602, DOI 10.1093/ajcn/8.5.602; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Carey AL, 2015, DIABETOLOGIA, V58, P1045, DOI 10.1007/s00125-015-3543-6; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chen KY, 2016, CELL METAB, V24, P210, DOI 10.1016/j.cmet.2016.07.014; Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Clapham JC, 2007, DIABETES OBES METAB, V9, P259, DOI 10.1111/j.1463-1326.2006.00608.x; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; DALY PA, 1993, INT J OBESITY, V17, pS73; de Jong JMA, 2017, AM J PHYSIOL-ENDOC M, V312, pE508, DOI 10.1152/ajpendo.00437.2016; Din MU, 2016, EUR J NUCL MED MOL I, V43, P1878, DOI 10.1007/s00259-016-3364-y; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Dodgson SJ, 2000, EPILEPSIA, V41, pS35, DOI 10.1111/j.1528-1157.2000.tb06047.x; Doucet E, 2018, OBES REV, V19, P36, DOI 10.1111/obr.12783; DUBOIS EF, 1952, J NUTR, V48, P257, DOI 10.1093/jn/48.2.257; DULLOO AG, 1993, INT J OBESITY, V17, pS35; Dulloo AG, 2002, INT J OBESITY, V26, P590, DOI 10.1038/sj/ijo/0802036; DULLOO AG, 1986, INT J OBESITY, V10, P467; DULLOO AG, 1991, INT J OBESITY, V15, P317; DULLOO AG, 1989, NUTRITION, V5, P7; Evans BA, 2019, BRIT J PHARMACOL, V176, P2416, DOI 10.1111/bph.14631; Eyolfson DA, 2001, EUR J APPL PHYSIOL, V84, P100, DOI 10.1007/s004210000329; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510; Fischer AW, 2016, AM J PHYSIOL-ENDOC M, V311, pE202, DOI 10.1152/ajpendo.00093.2016; Fisher JP, 2009, AUTON NEUROSCI-BASIC, V148, P5, DOI 10.1016/j.autneu.2009.02.003; Fleming JW, 2013, ANN PHARMACOTHER, V47, P1007, DOI [10.1345/aph.1R779, 10.1345/aph.1r779]; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Fraum TJ, 2019, CELL METAB, V30, P212, DOI 10.1016/j.cmet.2019.05.019; Gadde KM, 2018, J AM COLL CARDIOL, V71, P69, DOI 10.1016/j.jacc.2017.11.011; Galgani JE, 2010, BRIT J NUTR, V103, P38, DOI 10.1017/S0007114509991358; Geiser F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00842; Geisler JG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030280; Gifford A, 2016, AM J PHYSIOL-ENDOC M, V311, pE95, DOI 10.1152/ajpendo.00482.2015; GLAUSER S C, 1970, Archives of Environmental Health, V20, P377; Goldberg GR, 1998, BRIT J NUTR, V80, P141, DOI 10.1017/S0007114598001044; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; GREEN DE, 1981, P NATL ACAD SCI-BIOL, V78, P5344, DOI 10.1073/pnas.78.9.5344; Gryder DS, 2003, J NEUROSCI, V23, P7069, DOI 10.1523/JNEUROSCI.23-18-07069.2003; Guth Eve, 2014, JAMA, V312, P974, DOI 10.1001/jama.2014.10929; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Haman Francois, 2017, Temperature (Austin), V4, P217, DOI 10.1080/23328940.2017.1328999; Hardy JD, 1937, P NATL ACAD SCI USA, V23, P624, DOI 10.1073/pnas.23.12.624; Herrero AI, 2002, NEUROPHARMACOLOGY, V42, P210, DOI 10.1016/S0028-3908(01)00171-X; Heymsfield SB, 2012, OBES REV, V13, P1001, DOI 10.1111/j.1467-789X.2012.01019.x; HOCH FL, 1973, ANESTHESIOLOGY, V38, P237, DOI 10.1097/00000542-197303000-00007; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Hollstein T, 2019, AM J CLIN NUTR, V110, P593, DOI 10.1093/ajcn/nqz062; HORTON TJ, 1991, INT J OBESITY, V15, P359; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jespersen NZ, 2019, MOL METAB, V24, P30, DOI 10.1016/j.molmet.2019.03.005; Jiang CY, 2017, ONCOTARGET, V8, P75114, DOI 10.18632/oncotarget.20540; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P2489, DOI 10.1210/jc.2012-1444; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Jordan J, 2014, J HYPERTENS, V32, P1178, DOI 10.1097/HJH.0000000000000145; JOY RJT, 1963, J APPL PHYSIOL, V18, P1209, DOI 10.1152/jappl.1963.18.6.1209; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kerns JC, 2017, OBESITY, V25, P1838, DOI 10.1002/oby.21986; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Knuth ND, 2014, OBESITY, V22, P2563, DOI 10.1002/oby.20900; Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x; Larson CJ, 2019, HANDB EXP PHARMACOL, V251, P381, DOI 10.1007/164_2018_184; Lee P, 2011, INT J OBESITY, V35, P1395, DOI 10.1038/ijo.2010.284; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lee TA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-78; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938; Lewis KH, 2019, OBESITY, V27, P591, DOI 10.1002/oby.22430; Li LS, 1996, DIABETOLOGIA, V39, P857, DOI 10.1007/s001250050521; Loh RKC, 2019, DIABETES OBES METAB, V21, P276, DOI 10.1111/dom.13516; Lopez M, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12996; Lopez M, 2017, PHARMACOL THERAPEUT, V178, P109, DOI 10.1016/j.pharmthera.2017.03.014; Lotfi K, 2015, OBESITY, V23, pS11, DOI 10.1002/oby.21095; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; LUPIEN JR, 1988, PHARMACOL BIOCHEM BE, V29, P33, DOI 10.1016/0091-3057(88)90269-9; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; MacPherson REK, 2014, AM J PHYSIOL-ENDOC M, V307, pE563, DOI 10.1152/ajpendo.00287.2014; MARETTE A, 1989, AM J PHYSIOL, V257, pC714, DOI 10.1152/ajpcell.1989.257.4.C714; Marlatt KL, 2018, AM J PHYSIOL-REG I, V315, pR479, DOI 10.1152/ajpregu.00443.2017; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; McKemy David D., 2007, P177; MCNAIR E, 1983, PHARMACOL BIOCHEM BE, V18, P341, DOI 10.1016/0091-3057(83)90451-3; Melanson EL, 2013, MED SCI SPORT EXER, V45, P1600, DOI 10.1249/MSS.0b013e31828ba942; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Molnar D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Napolitano G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011245; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2735, DOI 10.1271/bbb.65.2735; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ong FJ, 2018, CLIN SCI, V132, P1039, DOI 10.1042/CS20170276; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PASQUALI R, 1985, INT J OBESITY, V9, P93; Pergolizzi JV, 2018, J CLIN PHARM THER, V43, P313, DOI 10.1111/jcpt.12679; Perna MK, 2016, AMINO ACIDS, V48, P2057, DOI 10.1007/s00726-016-2291-3; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Piaggi P, 2019, OBESITY, V27, P691, DOI 10.1002/oby.22456; Presby DM, 2019, AM J PHYSIOL-ENDOC M, V316, pE977, DOI 10.1152/ajpendo.00543.2018; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RANDLE PJ, 1963, LANCET, V1, P785; RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; RENNIE DW, 1962, J APPL PHYSIOL, V17, P326, DOI 10.1152/jappl.1962.17.2.326; Revelli JP, 1997, J CLIN INVEST, V100, P1098, DOI 10.1172/JCI119620; Richard D, 2002, INT J OBESITY, V26, P344, DOI 10.1038/sj.ijo.0801873; Richard D, 2000, NUTRITION, V16, P961, DOI 10.1016/S0899-9007(00)00452-4; Robert VA, 2009, J INFECT DIS, V200, P1623, DOI 10.1086/644642; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Roth JV, 2009, ANESTH ANALG, V109, P1695, DOI 10.1213/ANE.0b013e3181b763ae; Rubner M., 1883, Z BIOL, V19, P535; Sacco E, 2012, THER ADV UROL, V4, P315, DOI 10.1177/1756287212457114; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schena G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040357; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Seoane-Collazo P, 2014, ENDOCRINOLOGY, V155, P1679, DOI 10.1210/en.2013-1839; Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206; Sharma AM, 2001, HYPERTENSION, V37, P250, DOI 10.1161/01.HYP.37.2.250; Shekelle P, 2002, PHYTOMEDICINE, V9, P78; Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537; Shuldiner AR, 1996, LANCET, V348, P1584, DOI 10.1016/S0140-6736(05)66197-1; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Swift RW, 1932, J NUTR, V5, P213, DOI 10.1093/jn/5.3.213; Swift RW, 1932, J NUTR, V5, P227, DOI 10.1093/jn/5.3.227; Thomas DM, 2012, OBES REV, V13, P835, DOI 10.1111/j.1467-789X.2012.01012.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; TULP OL, 1986, COMP BIOCHEM PHYS C, V85, P17; Ueta CB, 2012, J ENDOCRINOL, V214, P359, DOI 10.1530/JOE-12-0155; van der Lans AAJJ, 2014, AM J PHYSIOL-REG I, V307, pR103, DOI 10.1152/ajpregu.00021.2014; Vanderbeld B, 2000, BIOCHEM CELL BIOL, V78, P537, DOI 10.1139/o00-075; Vansal SS, 1999, BIOCHEM PHARMACOL, V58, P807, DOI 10.1016/S0006-2952(99)00152-5; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x; WAGERSRDAR SA, 1984, PHYSIOL BEHAV, V32, P389, DOI 10.1016/0031-9384(84)90252-X; Wang JL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01855-z; WATANABE T, 1994, LIFE SCI, V54, P369, DOI 10.1016/0024-3205(94)00793-4; Weinstein LS, 2014, HORM METAB RES, V46, P841, DOI 10.1055/s-0034-1387798; Weir G, 2018, CELL METAB, V27, P1348, DOI 10.1016/j.cmet.2018.04.020; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; WELLMAN PJ, 1986, PHARMACOL BIOCHEM BE, V24, P1605, DOI 10.1016/0091-3057(86)90493-4; Welly RJ, 2016, MED SCI SPORT EXER, V48, P1688, DOI 10.1249/MSS.0000000000000964; West JB, 2013, AM J PHYSIOL-LUNG C, V305, pL775, DOI 10.1152/ajplung.00228.2013; White HS, 2000, EPILEPSIA, V41, pS17, DOI 10.1111/j.1528-1157.2000.tb06042.x; White HS, 1997, EPILEPSIA, V38, pS9, DOI 10.1111/j.1528-1157.1997.tb04523.x; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Winslow CEA, 1937, AM J PHYSIOL, V120, P1; WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zhang L, 2017, MAGN RESON MED, V78, P1070, DOI 10.1002/mrm.26506; Zhang L, 2017, INT J BIOL SCI, V13, P1152, DOI 10.7150/ijbs.20132; Zhang XL, 2000, EPILEPSIA, V41, pS52; Zoico E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00368	201	55	59	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1926	1942		10.1074/jbc.REV119.007363	http://dx.doi.org/10.1074/jbc.REV119.007363			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31914415	Green Published, hybrid			2022-12-28	WOS:000517128200013
J	Sizova, DV; Huang, JY; Akin, EJ; Estacion, M; Gomis-Perez, C; Waxman, SG; Dib-Hajj, SD				Sizova, Daria, V; Huang, Jianying; Akin, Elizabeth J.; Estacion, Mark; Gomis-Perez, Carolina; Waxman, Stephen G.; Dib-Hajj, Sulayman D.			A 49-residue sequence motif in the C terminus of Nav1.9 regulates trafficking of the channel to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; pain; electrophysiology; structural model; trafficking; functional expression; live imaging; Nav1; 9; nociception; sensory neurons; voltage clamp; channel trafficking	SODIUM-CHANNELS; GENE-TRANSFER; NA(V)1.9; MUTATION; NEURONS; PAIN; EXPRESSION; SITE; INSENSITIVITY; ACTIVATION	Genetic and functional studies have confirmed an important role for the voltage-gated sodium channel Nav1.9 in human pain disorders. However, low functional expression of Nav1.9 in heterologous systems (e.g. in human embryonic kidney 293 (HEK293) cells) has hampered studies of its biophysical and pharmacological properties and the development of high-throughput assays for drug development targeting this channel. The mechanistic basis for the low level of Nav1.9 currents in heterologous expression systems is not understood. Here, we implemented a multidisciplinary approach to investigate the mechanisms that govern functional Nav1.9 expression. Recombinant expression of a series of Nav1.9-Nav1.7 C-terminal chimeras in HEK293 cells identified a 49-amino-acid-long motif in the C terminus of the two channels that regulates expression levels of these chimeras. We confirmed the critical role of this motif in the context of a full-length channel chimera, Nav1.9-Ct49aa(Nav1.7), which displayed significantly increased current density in HEK293 cells while largely retaining the characteristic Nav1.9-gating properties. High-resolution live microscopy indicated that the newly identified C-terminal motif dramatically increases the number of channels on the plasma membrane of HEK293 cells. Molecular modeling results suggested that this motif is exposed on the cytoplasmic face of the folded C terminus, where it might interact with other channel partners. These findings reveal that a 49-residue-long motif in Nav1.9 regulates channel trafficking to the plasma membrane.	[Sizova, Daria, V; Huang, Jianying; Akin, Elizabeth J.; Estacion, Mark; Gomis-Perez, Carolina; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Yale Univ, Dept Neurol, New Haven, CT 06510 USA; [Sizova, Daria, V; Huang, Jianying; Akin, Elizabeth J.; Estacion, Mark; Gomis-Perez, Carolina; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Yale Univ, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Sizova, Daria, V; Huang, Jianying; Akin, Elizabeth J.; Estacion, Mark; Gomis-Perez, Carolina; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Waxman, SG; Dib-Hajj, SD (corresponding author), Vet Affairs Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res, 950 Campbell Ave, West Haven, CT 06516 USA.	stephen.waxman@yale.edu; sulayman.dib-hajj@yale.edu		Gomis-Perez, Carolina/0000-0002-6818-4403; Sizova, Daria/0000-0001-5471-6010	United States Department of Veterans Affairs Rehabilitation Research and Development Service [B9253-C]	United States Department of Veterans Affairs Rehabilitation Research and Development Service	This work was supported by Center Grant B9253-C from the United States Department of Veterans Affairs Rehabilitation Research and Development Service. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America with Yale University. The authors declare that they have no conflicts of interest with the contents of this article.	Akin EJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax4755; Akin EJ, 2016, BIOPHYS J, V111, P1235, DOI 10.1016/j.bpj.2016.08.016; Akin EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124397; Atkins JF, 2007, RNA, V13, P803, DOI 10.1261/rna.487907; Bennett DL, 2019, PHYSIOL REV, V99, P1079, DOI 10.1152/physrev.00052.2017; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Choi JS, 2004, FEBS LETT, V572, P256, DOI 10.1016/j.febslet.2004.07.047; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; Dash B, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0388-1; Dash B, 2018, MOL PAIN, V14, DOI 10.1177/1744806918788638;1744806918788638; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2019, ANNU REV NEUROSCI, V42, P87, DOI 10.1146/annurev-neuro-070918-050144; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2009, NAT PROTOC, V4, P1118, DOI 10.1038/nprot.2009.90; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Goral RO, 2015, PFLUG ARCH EUR J PHY, V467, P2423, DOI 10.1007/s00424-015-1709-1; Gorfe AA, 2012, ELS, DOI [10.1002/9780470015902.a0002615.pub2, DOI 10.1002/9780470015902.A0002615.PUB2]; Han CY, 2017, J NEUROL NEUROSUR PS, V88, P233, DOI 10.1136/jnnp-2016-313804; Han CY, 2015, NEUROMOL MED, V17, P158, DOI 10.1007/s12017-015-8347-9; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; Hockley JRF, 2014, PAIN, V155, P1962, DOI 10.1016/j.pain.2014.06.015; Huang JY, 2017, J CLIN INVEST, V127, P2805, DOI 10.1172/JCI92373; Huang JY, 2014, BRAIN, V137, P1627, DOI 10.1093/brain/awu079; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Leipold E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10049; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Lin ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161450; Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0; O'Donnell AM, 2016, J PEDIATR SURG, V51, P1458, DOI 10.1016/j.jpedsurg.2016.05.007; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Sole L, 2019, J NEUROSCI, V39, P4238, DOI 10.1523/JNEUROSCI.2771-18.2019; Vanoye CG, 2013, J GEN PHYSIOL, V141, P193, DOI 10.1085/jgp.201210919; Vijayaragavan K, 2004, FEBS LETT, V559, P39, DOI 10.1016/S0014-5793(04)00019-5; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woods CG, 2015, EUR J HUM GENET, V23, P561, DOI [10.1038/ejhg.2014.166, 10.1038/ejhg.2015.163]; Yang Y, 2016, J NEUROSCI, V36, P7511, DOI 10.1523/JNEUROSCI.0462-16.2016	46	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1077	1090		10.1074/jbc.RA119.011424	http://dx.doi.org/10.1074/jbc.RA119.011424			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31822564	Green Published, hybrid			2022-12-28	WOS:000509949300016
J	Han, H; Schubert, HL; McCullough, J; Monroe, N; Purdy, MD; Yeager, M; Sundquist, WI; Hill, CP				Han, Han; Schubert, Heidi L.; McCullough, John; Monroe, Nicole; Purdy, Michael D.; Yeager, Mark; Sundquist, Wesley I.; Hill, Christopher P.			Structure of spastin bound to a glutamate-rich peptide implies a hand-over-hand mechanism of substrate translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); protein structure; peptide interaction; cryo-electron microscopy; structure-function; microtubule severing mechanism; molecular machine	CRYO-EM; PROTEIN; TUBULIN; ELECTROSTATICS; RECOGNITION; ORIENTATION; VALIDATION; ATPASE; PORE	Many members of the AAA+ ATPase family function as hexamers that unfold their protein substrates. These AAA unfoldases include spastin, which plays a critical role in the architecture of eukaryotic cells by driving the remodeling and severing of microtubules, which are cytoskeletal polymers of tubulin subunits. Here, we demonstrate that a human spastin binds weakly to unmodified peptides from the C-terminal segment of human tubulin ?1A/B. A peptide comprising alternating glutamate and tyrosine residues binds more tightly, which is consistent with the known importance of glutamylation for spastin microtubule severing activity. A cryo-EM structure of the spastin-peptide complex at 4.2 ? resolution revealed an asymmetric hexamer in which five spastin subunits adopt a helical, spiral staircase configuration that binds the peptide within the central pore, whereas the sixth subunit of the hexamer is displaced from the peptide/substrate, as if transitioning from one end of the helix to the other. This configuration differs from a recently published structure of spastin from Drosophila melanogaster, which forms a six-subunit spiral without a transitioning subunit. Our structure resembles other recently reported AAA unfoldases, including the meiotic clade relative Vps4, and supports a model in which spastin utilizes a hand-over-hand mechanism of tubulin translocation and microtubule remodeling.	[Han, Han; Schubert, Heidi L.; McCullough, John; Monroe, Nicole; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Purdy, Michael D.; Yeager, Mark] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Ctr Membrane & Cell Physiol, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	Utah System of Higher Education; University of Utah; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.; Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu		McCullough, John/0000-0001-6836-4394; Schubert, Heidi/0000-0003-1762-8390	National Institutes of Health, NCI [P30CA042014]; National Institutes of Health [S10 OD018210]	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank James Fulcher and Michael Kay for the labeled E<INF>8</INF> peptide. The (EY)<INF>5</INF> peptide synthesis, sequencing of constructs, and validation of proteins was performed at the peptide synthesis, DNA sequencing, and MS core facilities at the University of Utah, which are supported by National Institutes of Health, NCI Grant P30CA042014. Mass spectrometry equipment in the Core was obtained through an National Institutes of Health Shared Instrumentation Grant S10 OD018210. Data processing and image reconstruction used the University of Utah Center for High Performance Computing.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alfieri C, 2018, NATURE, V559, P274, DOI 10.1038/s41586-018-0281-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; de la Pena AH, 2018, SCIENCE, V362, P1018, DOI 10.1126/science.aav0725; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong YC, 2019, NATURE, V565, P49, DOI 10.1038/s41586-018-0736-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fan XY, 2018, FEBS LETT, V592, P1625, DOI 10.1002/1873-3468.13075; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Han H, 2019, ELIFE, V8, DOI 10.7554/eLife.44071; Han H, 2019, BIOCHEM SOC T, V47, P37, DOI 10.1042/BST20180260; Han H, 2017, ELIFE, V6, DOI 10.7554/eLife.31324; Han H, 2015, J BIOL CHEM, V290, P13490, DOI 10.1074/jbc.M115.642355; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; McNally FJ, 2018, J CELL BIOL, V217, P4057, DOI 10.1083/jcb.201612104; Monroe N, 2017, ELIFE, V6, DOI 10.7554/eLife.24487; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Plaud C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033704; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Ripstein ZA, 2017, ELIFE, V6, DOI 10.7554/eLife.25754; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2019, CURR OPIN CELL BIOL, V56, P102, DOI 10.1016/j.ceb.2018.10.009; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sandate CR, 2019, NAT STRUCT MOL BIOL, V26, P671, DOI 10.1038/s41594-019-0257-3; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700325; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Vemu A, 2018, SCIENCE, V361, DOI 10.1126/science.aau1504; White KI, 2018, ELIFE, V7, DOI 10.7554/eLife.38888; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; Zehr E, 2017, NAT STRUCT MOL BIOL, V24, P717, DOI 10.1038/nsmb.3448; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	48	18	18	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					435	443		10.1074/jbc.AC119.009890	http://dx.doi.org/10.1074/jbc.AC119.009890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31767681	Green Published, hybrid			2022-12-28	WOS:000507373600014
J	Liu, C; Liang, B; Wang, QL; Wu, JL; Zou, MH				Liu, Chao; Liang, Bin; Wang, Qilong; Wu, Jiliang; Zou, Ming-Hui			Activation of AMP-activated protein kinase?1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and Survivin. (Withdrawal of Vol 285, Pg 15346, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491	1	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					671	671		10.1074/jbc.W119.012219	http://dx.doi.org/10.1074/jbc.W119.012219			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31924677	Green Published, hybrid			2022-12-28	WOS:000507373600036
J	Kuhlman, B				Kuhlman, Brian			Designing protein structures and complexes with the molecular modeling program Rosetta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DE-NOVO DESIGN; COMPUTATIONAL DESIGN; BISPECIFIC ANTIBODIES; STRUCTURE PREDICTION; ENERGY FUNCTION; GENERATION; DIVERSITY; STABILITY; BIOLOGY	Proteins perform an amazingly diverse set of functions in all aspects of life. Critical to the function of many proteins are the highly specific three-dimensional structures they adopt. For this reason, there is strong interest in learning how to rationally design proteins that adopt user-defined structures. Over the last 25 years, there has been significant progress in the field of computational protein design as rotamer-based sequence optimization protocols have enabled accurate design of protein tertiary and quaternary structure. In this award article, I will summarize how the molecular modeling program Rosetta is used to design new protein structures and describe how we have taken advantage of this capability to create proteins that have important applications in research and medicine. I will highlight three protein design stories: the use of protein interface design to create therapeutic bispecific antibodies, the engineering of light-inducible proteins that can be used to recruit proteins to specific locations in the cell, and the de novo design of new protein structures from pieces of naturally occurring proteins.	[Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu		Kuhlman, Brian/0000-0003-4907-9699	NIGMS, National Institutes of Health [R35GM131923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131923] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R35GM131923. Brian Kuhlman has financial interest in a company, Dualogics, that is commercializing the technology for making bispecific antibodies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; BETZ SF, 1993, CURR OPIN STRUC BIOL, V3, P601, DOI 10.1016/0959-440X(93)90090-8; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Froning KJ, 2017, PROTEIN SCI, V26, P2021, DOI 10.1002/pro.3240; Gainza P, 2016, CURR OPIN STRUC BIOL, V39, P16, DOI 10.1016/j.sbi.2016.03.006; Gainza-Cirauqui P, 2018, CURR OPIN BIOTECH, V52, P145, DOI 10.1016/j.copbio.2018.04.001; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Guffy SL, 2018, J CHEM INF MODEL, V58, P895, DOI 10.1021/acs.jcim.8b00060; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Jacobs TM, 2016, SCIENCE, V352, P687, DOI 10.1126/science.aad8036; Johnson HE, 2018, CURR OPIN BIOTECH, V52, P42, DOI 10.1016/j.copbio.2018.02.003; Kim DN, 2016, PROTEIN SCI, V25, P702, DOI 10.1002/pro.2869; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Krishnamurthy A, 2018, PHARMACOL THERAPEUT, V185, P122, DOI 10.1016/j.pharmthera.2017.12.002; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Labrijn AF, 2019, NAT REV DRUG DISCOV, V18, P585, DOI 10.1038/s41573-019-0028-1; Leaver-Fay A, 2016, STRUCTURE, V24, P641, DOI 10.1016/j.str.2016.02.013; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Lungu OI, 2012, CHEM BIOL, V19, P507, DOI 10.1016/j.chembiol.2012.02.006; Maguire JB, 2018, J CHEM THEORY COMPUT, V14, P2751, DOI 10.1021/acs.jctc.8b00033; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Murphy GS, 2012, STRUCTURE, V20, P1086, DOI 10.1016/j.str.2012.03.026; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Okumura M, 2018, ELIFE, V7, DOI 10.7554/eLife.36559; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu D., 2019, NAT METHODS, V7, P1010; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068; Yumerefendi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128443; Zimmerman SP, 2017, J CELL SCI, V130, P2971, DOI 10.1242/jcs.205948	50	11	11	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19436	19443		10.1074/jbc.AW119.008144	http://dx.doi.org/10.1074/jbc.AW119.008144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699898	Green Published, hybrid			2022-12-28	WOS:000516527800038
J	Bolten, M; Bernardini, JP; Mayor, T				Bolten, Marcel; Bernardini, Jonathan P.; Mayor, Thibault			Unfolding or aggregation, that is the question	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEASOME; RPN13	Cellular processes accompanying protein aggregation are diverse and entangled, making it difficult to investigate the underlying molecular processes in a time-resolved way. Gottlieb, Thompson, and colleagues address this shortcoming using a chemical biology approach to monitor ubiquitination within the first 10 min after the initiation of protein aggregation. Intriguingly, unfolding rather than aggregation seems to trigger the observed events. This work might provide a method to answer open questions regarding the regulation of the proteostasis network upon protein misfolding.	[Bolten, Marcel; Bernardini, Jonathan P.; Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, 2125 East Mall, Vancouver, BC V5T 1Z4, Canada	University of British Columbia	Mayor, T (corresponding author), Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, 2125 East Mall, Vancouver, BC V5T 1Z4, Canada.	mayor@mail.ubc.ca		Bernardini, Jonathan/0000-0002-5767-7624	Canadian Institute of Health Research (CIHR) [PJT-148489, PJT-159804]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research (CIHR) Grants PJT-148489 and PJT-159804. The authors declare that they have no conflicts of interest with the contents of this article.	Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chu BW, 2013, J BIOL CHEM, V288, P34575, DOI 10.1074/jbc.M113.499350; Galves M, 2019, TRENDS BIOCHEM SCI, V44, P872, DOI 10.1016/j.tibs.2019.04.007; Gottlieb CD, 2019, J BIOL CHEM, V294, P16511, DOI 10.1074/jbc.RA119.009654; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Miyazaki Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11689	7	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16525	16526		10.1074/jbc.H119.011242	http://dx.doi.org/10.1074/jbc.H119.011242			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31704773	Green Published, hybrid			2022-12-28	WOS:000501801900005
J	Hartman, Z; Geldenhuys, WJ; Agazie, YM				Hartman, Zachary; Geldenhuys, Werner J.; Agazie, Yehenew M.			A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; receptor tyrosine kinase; breast cancer; phosphatase; inhibitor; EGF signaling; EGFR; HER2; Peptide inhibitor; SHP2	PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; MOLECULAR-MECHANISM; AUTOMATED DOCKING; SH2 DOMAINS; INHIBITION; BREAST; CELLS; KINASE; TARGET	The Src homology phosphatase 2 (SHP2) is a cytoplasmic enzyme that mediates signaling induced by multiple receptor tyrosine kinases, including signaling by the epidermal growth factor receptor (EGFR) family (EGFR1?4 or the human homologs HER1?4). In EGFR (HER1) and EGFR2 (HER2) signaling, SHP2 increases the half-life of activated Ras by blocking recruitment of Ras GTPase-activating protein (RasGAP) to the plasma membrane through dephosphorylation of docking sites on the receptors. However, it is unclear how SHP2 selectively recognizes RasGAP-binding sites on EGFR and HER2. In this report, we show that SHP2-targeted pTyr residues exist in a specific amino acid context that allows selective binding. More specifically, we show that acidic residues N-terminal to the substrate pTyr in EGFR and HER2 mediate specific binding by the SHP2 active site, leading to blockade of RasGAP binding and optimal signaling by the two receptors. Molecular modeling studies revealed that a peptide derived from the region of pTyr(992)-EGFR packs well and makes stronger interactions with the SHP2 active site than with the SHP1 active site, suggesting a built-in mechanism that enables selective substrate recognition by SHP2. A phosphorylated form of this peptide inhibits SHP2 activity in vitro and EGFR and HER2 signaling in cells, suggesting inhibition of SHP2 protein tyrosine phosphatase activity by this peptide. Although we do not expect this peptide to be a strong inhibitor by itself, we foresee that the insights into SHP2 selectivity described here will be useful in future development of active-site small molecule-based inhibitors.	[Hartman, Zachary; Agazie, Yehenew M.] West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Geldenhuys, Werner J.] West Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Agazie, Yehenew M.] West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Agazie, YM (corresponding author), West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.; Agazie, YM (corresponding author), West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu			NCI, National Institute of Health [CA213996]; DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program	NCI, National Institute of Health; DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program(United States Department of Defense)	This work was supported by NCI, National Institute of Health Grant CA213996 (to Y. M. A.). This work was also supported in part by a predoctoral fellowship (to Z. H.) from the DOD-CDMRP (Department of Defense - Congressionally Directed Medical Research Program) Breast Cancer Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Borrelli A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020295; Cao M, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152621; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chen LW, 2010, BIOCHEM PHARMACOL, V80, P801, DOI 10.1016/j.bcp.2010.05.019; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Dardaei L, 2018, NAT MED, V24, P512, DOI 10.1038/nm.4497; Della Corte CM, 2019, EBIOMEDICINE, V39, P5, DOI 10.1016/j.ebiom.2018.12.008; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hartman Z, 2013, ONCOGENE, V32, P4169, DOI 10.1038/onc.2012.418; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Li J, 2009, EXP CELL RES, V315, P2284, DOI 10.1016/j.yexcr.2009.04.011; Matalkah F, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0659-z; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Morris GM, 2013, J CHEM INF MODEL, V53, P898, DOI 10.1021/ci300545a; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Sun X, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020395; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Vermeulen NPE, 2004, DRUG METAB REV, V36, P15; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; Wu JH, 2006, J BIOL CHEM, V281, P37758, DOI 10.1074/jbc.M605756200; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Yu ZH, 2011, BIOORG MED CHEM LETT, V21, P4238, DOI 10.1016/j.bmcl.2011.05.078; Zhang X, 2010, J MED CHEM, V53, P2482, DOI 10.1021/jm901645u; Zhao H, 2019, ONCOGENE, V38, P2275, DOI 10.1038/s41388-018-0574-8; Zhao H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1131-2; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200	46	12	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3563	3575		10.1074/jbc.RA119.011422	http://dx.doi.org/10.1074/jbc.RA119.011422			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024694	Green Published, hybrid			2022-12-28	WOS:000527725300016
J	Kumari, R; Kumar, R; Kumar, S; Singh, AK; Hanpude, P; Jangir, D; Maiti, TK				Kumari, Raniki; Kumar, Roshan; Kumar, Sanjay; Singh, Abhishek Kumar; Hanpude, Pranita; Jangir, Deepak; Maiti, Tushar Kanti			Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegeneration; Parkinson's disease; amyloid; protein aggregation; protein misfolding; Lewy body; neurotoxicity; OTU deubiquitinase ubiquitin aldehyde-binding 1 (OTUB1); otubain-1; pS129; alpha-synuclein	ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; COMPLEX-I; NEURONAL APOPTOSIS; CYSTEINE PROTEASES; SYNAPTIC DAMAGE; BINDING; BETA; UBIQUITINATION; ROTENONE	Parkinson's disease (PD) is a multifactorial malady and the second most common neurodegenerative disorder, characterized by loss of dopaminergic neurons in the midbrain. A hallmark of PD pathology is the formation of intracellular protein inclusions, termed Lewy bodies (LBs). Recent MS studies have shown that OTU deubiquitinase ubiquitin aldehyde-binding 1 (OTUB1), a deubiquitinating enzyme of the OTU family, is enriched together with ?-synuclein in LBs from individuals with PD and is also present in amyloid plaques associated with Alzheimer's disease. In the present study, using mammalian cell cultures and a PD mouse model, along with CD spectroscopy, atomic force microscopy, immunofluorescence-based imaging, and various biochemical assays, we demonstrate that after heat-induced protein aggregation, OTUB1 reacts strongly with both anti-A11 and anti-osteocalcin antibodies, detecting oligomeric, prefibrillar structures or fibrillar species of amyloidogenic proteins, respectively. Further, recombinant OTUB1 exhibited high thioflavin-T and Congo red binding and increased ?-sheet formation upon heat induction. The oligomeric OTUB1 aggregates were highly cytotoxic, characteristic of many amyloid proteins. OTUB1 formed inclusions in neuronal cells and co-localized with thioflavin S and with ?-synuclein during rotenone-induced stress. It also co-localized with the disease-associated variant pS129-?-synuclein in rotenone-exposed mouse brains. Interestingly, OTUB1 aggregates were also associated with severe cytoskeleton damage, rapid internalization inside the neuronal cells, and mitochondrial damage, all of which contribute to neurotoxicity. In conclusion, the results of our study indicate that OTUB1 may contribute to LB pathology through its amyloidogenic properties.	[Kumari, Raniki; Kumar, Roshan; Kumar, Sanjay; Singh, Abhishek Kumar; Hanpude, Pranita; Jangir, Deepak; Maiti, Tushar Kanti] NCR Biotech Sci Cluster, Funct Prote Lab, RCB, Faridabad 121001, India; [Kumari, Raniki] KIIT, Bhubaneswar 751024, Odisha, India; [Kumar, Roshan; Kumar, Sanjay] Manipal Acad Higher Educ, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT); Manipal Academy of Higher Education (MAHE)	Maiti, TK (corresponding author), NCR Biotech Sci Cluster, Funct Prote Lab, RCB, Faridabad 121001, India.	tkmaiti@rcb.res.in	Kumar, Sanjay/HGA-4133-2022; Kumari, Raniki/AAU-2541-2020	Kumar, Sanjay/0000-0002-6101-2334; Hanpude, Pranita/0000-0002-0103-2835; Kumari, Raniki/0000-0001-8902-1729; Maiti, Tushar/0000-0003-4721-827X; Jangir, Deepak Kumar/0000-0001-8838-3859	Regional Center for Biotechnology (Faridabad, India)	Regional Center for Biotechnology (Faridabad, India)	This work was supported by the core funding of the Regional Center for Biotechnology (Faridabad, India). The authors declare that they have no conflicts of interest with the contents of this article.	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; [Anonymous], 2018, MEDICINE, DOI DOI 10.1097/MD.0000000000010983; Arawaka S, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0452-6; Avidan-Shpalter C, 2006, AMYLOID, V13, P216, DOI 10.1080/13506120600960643; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bridi JC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00080; Canerina-Amaro A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00382; Chanez-Cardenas Maria Elena, 2012, J Biophys, V2012, P606172, DOI 10.1155/2012/606172; Chen YX, 2017, ONCOTARGET, V8, P11053, DOI 10.18632/oncotarget.14278; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Engelhardt Eliasz, 2017, Dement. neuropsychol., V11, P198, DOI 10.1590/1980-57642016dn11-020012; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Follmer C, 2015, J BIOL CHEM, V290, P27660, DOI 10.1074/jbc.M115.686584; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Fujikake N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00255; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Hadley KC, 2015, ELIFE, V4, DOI 10.7554/eLife.09579; Halliday M, 2014, J BIOL CHEM, V289, P19862, DOI 10.1074/jbc.R114.568477; Han XJ, 2017, MOL MED REP, V16, P4521, DOI 10.3892/mmr.2017.7203; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Huseby CJ, 2019, J BIOL CHEM, V294, P4728, DOI 10.1074/jbc.RA118.006943; Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92; Jin S, 2016, J BIOL CHEM, V291, P19590, DOI 10.1074/jbc.M115.691840; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Julien C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0634-x; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kevenaar JT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00044; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44558; Lee SJ, 2012, METHODS MOL BIOL, V849, P347, DOI 10.1007/978-1-61779-551-0_23; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Lipscomb IP, 2007, J GEN VIROL, V88, P2619, DOI 10.1099/vir.0.82228-0; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Magrinelli F, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9832839; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Mokhtar Sara H, 2013, Int J Alzheimers Dis, V2013, P910502, DOI 10.1155/2013/910502; Montoliu-Gaya L, 2018, MOL CELL NEUROSCI, V89, P49, DOI 10.1016/j.mcn.2018.03.015; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Ordonez DG, 2018, NEURON, V97, P108, DOI 10.1016/j.neuron.2017.11.036; Pasupala N, 2018, J BIOL CHEM, V293, P18285, DOI 10.1074/jbc.RA118.004677; Patke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064974; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Relini A, 2014, BIOMOLECULES, V4, P20, DOI 10.3390/biom4010020; Rodriguez EE, 2016, J BIOL INORG CHEM, V21, P691, DOI 10.1007/s00775-016-1376-5; Rui YF, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0261-z; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Singh SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7361613; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Takahashi H, 2001, NEUROPATHOLOGY, V21, P315, DOI 10.1046/j.1440-1789.2001.00403.x; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Toussi DN, 2016, MICROBES INFECT, V18, P627, DOI 10.1016/j.micinf.2016.06.001; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wang P, 2017, ACTA NEUROPATHOL, V133, P731, DOI 10.1007/s00401-016-1663-9; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu C, 2012, BIOPHYS J, V103, P550, DOI 10.1016/j.bpj.2012.07.008; Xia QW, 2008, FRONT BIOSCI-LANDMRK, V13, P3850; Xie LL, 2016, MOL CELL BIOCHEM, V422, P171, DOI 10.1007/s11010-016-2817-8; Xu L, 2017, NEUROPATHOLOGY, V37, P217, DOI 10.1111/neup.12366; Xu LJ, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1720621; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012; Zhou HH, 2018, ONCOGENE, V37, P3356, DOI 10.1038/s41388-018-0224-1	91	11	11	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3466	3484		10.1074/jbc.RA119.009546	http://dx.doi.org/10.1074/jbc.RA119.009546			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005664	Green Published, hybrid			2022-12-28	WOS:000527725300009
J	Luo, Y; Zhang, JX; Chen, L; Chen, SR; Chen, H; Zhang, GF; Pan, HL				Luo, Yi; Zhang, Jixiang; Chen, Lin; Chen, Shao-Rui; Chen, Hong; Zhang, Guangfen; Pan, Hui-Lin			Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pain; neurobiology; neurophysiology; neuroscience; synapse; dorsal root ganglion	MECHANICALLY EVOKED-RESPONSES; SPINAL NEURONS; RAT MODEL; METHYLATION; TRANSMISSION; ACTIVATION; INHIBITION; ANALGESIA; PROTEIN; PLASTICITY	Type 1 cannabinoid receptors (CB(1)Rs) are expressed in the dorsal root ganglion (DRG) and contribute to the analgesic effect of cannabinoids. However, the epigenetic mechanism regulating the expression of CB(1)Rs in neuropathic pain is unknown. G9a (encoded by the Ehmt2 gene), a histone 3 at lysine 9 methyltransferase, is a key chromatin regulator responsible for gene silencing. In this study, we determined G9a's role in regulating CB1R expression in the DRG and in CB1R-mediated analgesic effects in an animal model of neuropathic pain. We show that nerve injury profoundly reduced mRNA levels of CB(1)Rs but increased the expression of CB2 receptors in the rat DRG. ChIP results indicated increased enrichment of histone 3 at lysine 9 dimethylation, a G9a-catalyzed repressive histone mark, at the promoter regions of the CB1R genes. G9a inhibition in nerve-injured rats not only up-regulated the CB1R expression level in the DRG but also potentiated the analgesic effect of a CB1R agonist on nerve injury-induced pain hypersensitivity. Furthermore, in mice lacking Ehmt2 in DRG neurons, nerve injury failed to reduce CB1R expression in the DRG and to decrease the analgesic effect of the CB1R agonist. Moreover, nerve injury diminished the inhibitory effect of the CB1R agonist on synaptic glutamate release from primary afferent nerves to spinal cord dorsal horn neurons in WT mice but not in mice lacking Ehmt2 in DRG neurons. Our findings reveal that nerve injury diminishes the analgesic effect of CB1R agonists through G9a-mediated CB1R down-regulation in primary sensory neurons.	[Luo, Yi; Zhang, Jixiang; Chen, Lin; Chen, Shao-Rui; Chen, Hong; Zhang, Guangfen; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Luo, Yi] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan 430071, Hubei, Peoples R China; [Chen, Lin] Jianghan Univ, Sch Phys Educ, Wuhan 430056, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Wuhan University; Jianghan University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Zhang, Jixiang/0000-0002-1641-8650	National Institutes on Drug Abuse [DA041711]; National Institutes of Health [NS101880]; N. G. and Helen T. Hawkins Endowment	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment	This study was supported by National Institutes on Drug Abuse Grant DA041711 (to H.-L. P.), National Institutes of Health Grant NS101880, and by the N. G. and Helen T. Hawkins Endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Berman JS, 2004, PAIN, V112, P299, DOI 10.1016/j.pain.2004.09.013; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; D'Addario C, 2013, FEBS J, V280, P1905, DOI 10.1111/febs.12125; Deng MC, 2019, CELL MOL LIFE SCI, V76, P1889, DOI 10.1007/s00018-019-03047-y; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Garriga J, 2018, J NEUROSCI, V38, P6090, DOI 10.1523/JNEUROSCI.2616-17.2018; Gutierrez T, 2011, PAIN, V152, P1976, DOI 10.1016/j.pain.2011.03.038; Hauser W, 2018, EUR J PAIN, V22, P455, DOI 10.1002/ejp.1118; Herre M, 2019, CURR OPIN NEUROBIOL, V59, P79, DOI 10.1016/j.conb.2019.04.006; Herzberg U, 1997, NEUROSCI LETT, V221, P157, DOI 10.1016/S0304-3940(96)13308-5; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones MR, 2015, AM J CLIN EXP UROL, V3, P28; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Kelly S, 2003, EUR J NEUROSCI, V18, P2239, DOI 10.1046/j.1460-9568.2003.02957.x; Kelly S, 2003, EUR J PHARMACOL, V474, P209, DOI 10.1016/S0014-2999(03)02085-5; Kelly S, 2001, J NEUROPHYSIOL, V86, P3061, DOI 10.1152/jn.2001.86.6.3061; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Lotsch J, 2018, EUR J PAIN, V22, P471, DOI 10.1002/ejp.1148; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Morisset V, 2001, J NEUROPHYSIOL, V86, P40, DOI 10.1152/jn.2001.86.1.40; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Petrov RR, 2013, EUR J MED CHEM, V69, P881, DOI 10.1016/j.ejmech.2013.09.038; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Stockings E, 2018, PAIN, V159, P1932, DOI 10.1097/j.pain.0000000000001293; Sun J, 2019, J PHYSIOL-LONDON, V597, P1661, DOI 10.1113/JP277428; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Veress G, 2013, BRAIN STRUCT FUNCT, V218, P733, DOI 10.1007/s00429-012-0425-2; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wotherspoon G, 2005, NEUROSCIENCE, V135, P235, DOI 10.1016/j.neuroscience.2005.06.009; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang J., 2018, EPIGENETICS CHRONIC, P85; Zhang JX, 2018, J BIOL CHEM, V293, P19078, DOI 10.1074/jbc.RA118.005846; Zhang YH, 2016, J BIOL CHEM, V291, P8475, DOI 10.1074/jbc.M115.711812; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	63	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3553	3562		10.1074/jbc.RA119.011053	http://dx.doi.org/10.1074/jbc.RA119.011053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024693	Green Published, hybrid			2022-12-28	WOS:000527725300015
J	Park, JE; Brand, DD; Rosloniec, EF; Yi, AK; Stuart, JM; Kang, AH; Myers, LK				Park, Jeoung-Eun; Brand, David D.; Rosloniec, Edward F.; Yi, Ae-Kyung; Stuart, John M.; Kang, Andrew H.; Myers, Linda K.			Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; receptor; autoimmunity; collagen; inflammation; CD305; kinase signaling; leukocyte-associated immunoglobulin-like receptor 1; rheumatoid arthritis	IG-LIKE RECEPTOR-1; LAIR-1; COLLAGENS; INITIATION; TYROSINE; KINASES; DOMAIN	Multiple observations implicate T-cell dysregulation as a central event in the pathogenesis of rheumatoid arthritis. Here, we investigated mechanisms for suppressing T-cell activation via the inhibitory receptor leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1). To determine how LAIR-1 affects T-cell receptor (TCR) signaling, we compared 1) T cells from LAIR-1?sufficient and ?deficient mice, 2) Jurkat cells expressing either LAIR-1 mutants or C-terminal Src kinase (CSK) mutants, and 3) T cells from mice that contain a CSK transgene susceptible to chemical inhibition. Our results indicated that LAIR-1 engagement by collagen or by complement C1q (C1Q, which contains a collagen-like domain) inhibits TCR signaling by decreasing the phosphorylation of key components in the canonical T-cell signaling pathway, including LCK proto-oncogene SRC family tyrosine kinase (LCK), LYN proto-oncogene SRC family tyrosine kinase (LYN), ? chain of T-cell receptor?associated protein kinase 70 (ZAP-70), and three mitogen-activated protein kinases (extracellular signal?regulated kinase, c-Jun N-terminal kinase 1/2, and p38). The intracellular region of LAIR-1 contains two immunoreceptor tyrosine-based inhibition motifs that are both phosphorylated by LAIR-1 activation, and immunoprecipitation experiments revealed that Tyr-251 in LAIR-1 binds CSK. Using CRISPR/Cas9-mediated genome editing, we demonstrate that CSK is essential for the LAIR-1?induced inhibition of the human TCR signal transduction. T cells from mice that expressed a PP1 analog?sensitive form of CSK (CskAS) corroborated these findings, and we also found that Tyr-251 is critical for LAIR-1's inhibitory function. We propose that LAIR-1 activation may be a strategy for controlling inflammation and may offer a potential therapeutic approach for managing autoimmune diseases.	[Park, Jeoung-Eun; Brand, David D.; Rosloniec, Edward F.; Stuart, John M.; Kang, Andrew H.; Myers, Linda K.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Brand, David D.; Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol Biochem, Memphis, TN 38163 USA; [Brand, David D.; Rosloniec, Edward F.; Stuart, John M.; Kang, Andrew H.] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Myers, LK (corresponding author), Div Rheumatol, 956 Court Ave,Rm G326, Memphis, TN 38163 USA.	lmyers@uthsc.edu		Brand, David/0000-0002-9260-7963	U.S. Public Health Service [AR064825, AR069010, AR064723]; Department of Veterans Affairs; Arthritis Foundation	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Veterans Affairs(US Department of Veterans Affairs); Arthritis Foundation	This work was supported, in part, by U.S. Public Health Service Grants AR064825, AR069010, and AR064723 and program-directed funds from the Department of Veterans Affairs and the Arthritis Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agashe VV, 2018, J IMMUNOL, V201, P772, DOI 10.4049/jimmunol.1701753; Boraschi-Diaz I, 2018, BONE, V117, P23, DOI 10.1016/j.bone.2018.09.006; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Jin JY, 2018, CELL IMMUNOL, V331, P78, DOI 10.1016/j.cellimm.2018.05.011; Kim S, 2017, J IMMUNOL, V199, P2692, DOI 10.4049/jimmunol.1700271; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Maasho K, 2005, MOL IMMUNOL, V42, P1521, DOI 10.1016/j.molimm.2005.01.004; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Otahal P, 2011, BBA-MOL CELL RES, V1813, P367, DOI 10.1016/j.bbamcr.2010.12.003; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Son M, 2014, MOL MED, V20, P559, DOI 10.2119/molmed.2014.00185; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; Tang B, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4433; Tang XB, 2012, J IMMUNOL, V188, P548, DOI 10.4049/jimmunol.1102044; Verbrugge A, 2006, EUR J IMMUNOL, V36, P190, DOI 10.1002/eji.200535226; Zhang Y, 2014, CELL IMMUNOL, V287, P46, DOI 10.1016/j.cellimm.2013.12.005	31	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2239	2247		10.1074/jbc.RA119.011150	http://dx.doi.org/10.1074/jbc.RA119.011150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932281	Green Published, hybrid			2022-12-28	WOS:000517330200008
J	Sarkar, SK; Foo, ACY; Matyas, A; Asikhia, I; Kosenko, T; Goto, NK; Vergara-Jaque, A; Lagace, TA				Sarkar, Samantha K.; Foo, Alexander C. Y.; Matyas, Angela; Asikhia, Ikhuosho; Kosenko, Tanja; Goto, Natalie K.; Vergara-Jaque, Ariela; Lagace, Thomas A.			A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); low-density lipoprotein (LDL); lipoprotein metabolism; intrinsically disordered protein; conformational change; computer modeling; lipid metabolism; allosteric regulation; allostery; familial hypercholesterolemia; cholesterol regulation	SUBTILISIN/KEXIN TYPE 9; PROTEIN-STRUCTURE PREDICTION; OF-FUNCTION MUTATIONS; C-TERMINAL DOMAIN; LDL RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SECONDARY STRUCTURE; CHOLESTEROL LEVELS; MOLECULAR-BASIS; HUMAN PLASMA	Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a ligand of low-density lipoprotein (LDL) receptor (LDLR) that promotes LDLR degradation in late endosomes/lysosomes. In human plasma, 30?40% of PCSK9 is bound to LDL particles; however, the physiological significance of this interaction remains unknown. LDL binding in vitro requires a disordered N-terminal region in PCSK9's prodomain. Here, we report that peptides corresponding to a predicted amphipathic ?-helix in the prodomain N terminus adopt helical structure in a membrane-mimetic environment. This effect was greatly enhanced by an R46L substitution representing an atheroprotective PCSK9 loss-of-function mutation. A helix-disrupting proline substitution within the putative ?-helical motif in full-length PCSK9 lowered LDL binding affinity >5-fold. Modeling studies suggested that the transient ?-helix aligns multiple polar residues to interact with positively charged residues in the C-terminal domain. Gain-of-function PCSK9 mutations associated with familial hypercholesterolemia (FH) and clustered at the predicted interdomain interface (R469W, R496W, and F515L) inhibited LDL binding, which was completely abolished in the case of the R496W variant. These findings shed light on allosteric conformational changes in PCSK9 required for high-affinity binding to LDL particles. Moreover, the initial identification of FH-associated mutations that diminish PCSK9's ability to bind LDL reported here supports the notion that PCSK9-LDL association in the circulation inhibits PCSK9 activity.	[Sarkar, Samantha K.; Matyas, Angela; Asikhia, Ikhuosho; Kosenko, Tanja; Lagace, Thomas A.] Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4W7, Canada; [Foo, Alexander C. Y.; Goto, Natalie K.] Univ Ottawa, Fac Sci, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada; [Vergara-Jaque, Ariela] Univ Talca, Ctr Bioinformat & Mol Simulat, Talca 3460000, Chile; [Vergara-Jaque, Ariela] Millennium Nucleus Ion Channel Associated Dis MiN, Talca 3460000, Chile	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Universidad de Talca	Lagace, TA (corresponding author), Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, 40 Ruskin St,Rm H-4213, Ottawa, ON K1N 6N5, Canada.	tlagace@ottawaheart.ca	Vergara-Jaque, Ariela/AAJ-1645-2020; Goto, Natalie/AAO-7979-2020	Vergara-Jaque, Ariela/0000-0002-1236-013X; Goto, Natalie/0000-0003-4877-4884; Lagace, Thomas/0000-0002-6946-4212; Foo, Alexander/0000-0002-4331-2085	Heart and Stroke Foundation of Canada [G-15-0009352]; Canadian Institutes of Health Research (CIHR) [391063]; Pfizer ASPIRE Program; FONDECYT Research Initiation Grant [11170223]; Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pfizer ASPIRE Program; FONDECYT Research Initiation Grant; Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	This work was supported in part by Heart and Stroke Foundation of Canada Grant G-15-0009352, Canadian Institutes of Health Research (CIHR) Grant 391063, and the Pfizer ASPIRE Program (to T. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FONDECYT Research Initiation Grant 11170223. The Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD) is a Millennium Nucleus supported by the Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ahrens JB, 2017, CELL MOL LIFE SCI, V74, P3163, DOI 10.1007/s00018-017-2559-0; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chorba JS, 2018, J BIOL CHEM, V293, P1875, DOI 10.1074/jbc.RA117.000754; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; El Khoury P, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0684-8; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fazio S, 2017, J CLIN ENDOCR METAB, V102, P3340, DOI 10.1210/jc.2016-4043; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Galvan AM, 2019, J LIPID RES, V60, P71, DOI 10.1194/jlr.M087189; Geschwindner S, 2015, PROTEIN ENG DES SEL, V28, P117, DOI 10.1093/protein/gzv008; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Graham JM, 1996, ATHEROSCLEROSIS, V124, P125, DOI 10.1016/0021-9150(96)05797-8; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gustafsen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00568-7; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Hopkins PN, 2015, CIRC-CARDIOVASC GENE, V8, P823, DOI 10.1161/CIRCGENETICS.115.001129; Hori M, 2015, J CLIN ENDOCR METAB, V100, pE41, DOI 10.1210/jc.2014-3066; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaya E, 2017, ANATOL J CARDIOL, V18, P266, DOI 10.14744/AnatolJCardiol.2017.7654; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krois AS, 2016, P NATL ACAD SCI USA, V113, pE1853, DOI 10.1073/pnas.1602487113; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Nguyen MA, 2014, J LIPID RES, V55, P266, DOI 10.1194/jlr.M044156; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Romagnuolo R, 2015, J BIOL CHEM, V290, P11649, DOI 10.1074/jbc.M114.611988; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUMSEY SC, 1992, J LIPID RES, V33, P1551; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Schiele F, 2014, J MOL BIOL, V426, P843, DOI 10.1016/j.jmb.2013.11.011; SEGREST JP, 1992, J LIPID RES, V33, P141; Seidah NG, 2019, J MOL BIOL, V431, P904, DOI 10.1016/j.jmb.2019.01.015; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Stein EA, 2013, CIRCULATION, V127, P2372, DOI 10.1161/CIRCULATIONAHA.113.003360; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Tavori H, 2015, ATHEROSCLEROSIS, V238, P264, DOI 10.1016/j.atherosclerosis.2014.12.017; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Ultsch M, 2019, J MOL BIOL, V431, P885, DOI 10.1016/j.jmb.2018.11.025; Verbeek R, 2017, ARTERIOSCL THROM VAS, V37, P43, DOI 10.1161/ATVBAHA.116.307995; Wierod L, 2016, MOL GENET METAB REP, V9, P86, DOI 10.1016/j.ymgmr.2016.11.003; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	76	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2285	2298		10.1074/jbc.RA119.010221	http://dx.doi.org/10.1074/jbc.RA119.010221			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949048	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000517330200012
J	Nigam, AK; Li, JLG; Lall, K; Shi, D; Bush, KT; Bhatnagar, V; Abagyan, R; Nigam, SK				Nigam, Anisha K.; Li, Julia G.; Lall, Kaustubh; Shi, Da; Bush, Kevin T.; Bhatnagar, Vibha; Abagyan, Ruben; Nigam, Sanjay K.			Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; transporter; multidrug transporter; mouse; metabolomics; cheminformatics; machine-learning; organic anion transporter	ORGANIC ANION TRANSPORTERS; RENAL TRANSPORTERS; CHOROID-PLEXUS; UREMIC TOXINS; KNOCKOUT MICE; SLC22 FAMILY; KIDNEY; PATHWAYS; SYSTEMS; IDENTIFICATION	The multispecific organic anion transporters, OAT1 (SLC22A6) and OAT3 (SLC22A8), the main kidney elimination pathways for many common drugs, are often considered to have largely-redundant roles. However, whereas examination of metabolomics data from Oat-knockout mice (Oat1 and Oat3KO) revealed considerable overlap, over a hundred metabolites were increased in the plasma of one or the other of these knockout mice. Many of these relatively unique metabolites are components of distinct biochemical and signaling pathways, including those involving amino acids, lipids, bile acids, and uremic toxins. Cheminformatics, together with a ?logical? statistical and machine learning-based approach, identified a number of molecular features distinguishing these unique endogenous substrates. Compared with OAT1, OAT3 tends to interact with more complex substrates possessing more rings and chiral centers. An independent ?brute force? approach, analyzing all possible combinations of molecular features, supported the logical approach. Together, the results suggest the potential molecular basis by which OAT1 and OAT3 modulate distinct metabolic and signaling pathways in vivo. As suggested by the Remote Sensing and Signaling Theory, the analysis provides a potential mechanism by which ?multispecific? kidney proximal tubule transporters exert distinct physiological effects. Furthermore, a strong metabolite-based machine-learning classifier was able to successfully predict unique OAT1 versus OAT3 drugs; this suggests the feasibility of drug design based on knockout metabolomics of drug transporters. The approach can be applied to other SLC and ATP-binding cassette drug transporters to define their nonredundant physiological roles and for analyzing the potential impact of drug?metabolite interactions.	[Nigam, Anisha K.; Shi, Da; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Li, Julia G.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Lall, Kaustubh] Univ Calif San Diego, Dept Comp Engn, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Abagyan, R; Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ruben@ucsd.edu; snigam@ucsd.edu	Shi, Da/ABD-4722-2020	Shi, Da/0000-0002-1953-2299	NIDDK Grant [DK109392]; Eunice Kennedy Shriver NICHD Grant [HD090259]	NIDDK Grant; Eunice Kennedy Shriver NICHD Grant	This work was supported by NIDDK Grant DK109392 and Eunice Kennedy Shriver NICHD Grant HD090259 (to S. K. N.). R. A. is a founder of Molsoft LLC. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Almazroo OA, 2017, CLIN LIVER DIS, V21, P1, DOI 10.1016/j.cld.2016.08.001; An GH, 2014, DRUG METAB DISPOS, V42, P1357, DOI 10.1124/dmd.114.059337; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Demsar J, 2007, J BIOMED INFORM, V40, P661, DOI 10.1016/j.jbi.2007.03.010; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ivanyuk A, 2017, CLIN PHARMACOKINET, V56, P825, DOI 10.1007/s40262-017-0506-8; Jansen J, 2019, P NATL ACAD SCI USA, V116, P16105, DOI 10.1073/pnas.1821809116; Jelena D, 2019, COMP BIOCHEM PHYS B, V236, DOI 10.1016/j.cbpb.2019.110309; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kouznetsova VL, 2011, BIOORGAN MED CHEM, V19, P3320, DOI 10.1016/j.bmc.2011.04.045; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Liu HC, 2016, J PHARMACOL EXP THER, V359, P215, DOI 10.1124/jpet.116.232660; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lozano E, 2018, J PERS MED, V8, DOI 10.3390/jpm8020014; Martinez D, 2018, CLIN PHARMACOL THER, V104, P687, DOI 10.1002/cpt.1008; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Masereeuw R, 2010, PHARMACOL THERAPEUT, V126, P200, DOI 10.1016/j.pharmthera.2010.02.007; Matsson Par, 2015, In Silico Pharmacology, V3, P8, DOI 10.1186/s40203-015-0012-3; Morrissey KM, 2013, ANNU REV PHARMACOL, V53, P503, DOI 10.1146/annurev-pharmtox-011112-140317; Murray M, 2017, BRIT J PHARMACOL, V174, P1908, DOI 10.1111/bph.13785; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; O'Hagan S, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0198-y; O'Hagan S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00105; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Ritthoff O., 2001, LLWA 01; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Robertson EE, 2006, PHARMACOL THERAPEUT, V109, P399, DOI 10.1016/j.pharmthera.2005.07.005; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Stanley LA, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P527, DOI 10.1016/B978-0-12-802104-0.00027-5; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Ullrich KJ, 1997, J MEMBRANE BIOL, V158, P95, DOI 10.1007/s002329900247; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; VanWert AL, 2008, PHARM RES-DORDR, V25, P453, DOI 10.1007/s11095-007-9407-0; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Vriend J, 2019, BIOL CHEM, V400, P1347, DOI 10.1515/hsz-2018-0446; Wang X, 2018, TOXICOL SCI, V161, P321, DOI 10.1093/toxsci/kfx216; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	71	22	22	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1829	1842		10.1074/jbc.RA119.010729	http://dx.doi.org/10.1074/jbc.RA119.010729			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31896576	Green Published, hybrid			2022-12-28	WOS:000517128200005
J	Young, KZ; Lee, SJ; Zhang, XJ; Cartee, NMP; Torres, M; Keep, SG; Gabbireddy, SR; Fontana, JL; Qi, L; Wang, MM				Young, Kelly Z.; Lee, Soo Jung; Zhang, Xiaojie; Cartee, Naw May Pearl; Torres, Mauricio; Keep, Simon G.; Gabbireddy, Sairisheel R.; Fontana, Julia L.; Qi, Ling; Wang, Michael M.			NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch protein; vascular smooth muscle cells; proteolysis; protein processing; stroke; arteries; cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); cysteine residues; NOTCH3; small-vessel disease	AUTOSOMAL-DOMINANT ARTERIOPATHY; ASP-PRO BOND; SUBCORTICAL INFARCTS; NEUROPATHOLOGIC ASSESSMENT; AUTOCATALYTIC CLEAVAGE; ALZHEIMERS-DISEASE; RISK-FACTORS; LOW PH; CADASIL; MUTATIONS	The small-vessel disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) arises from mutations in the human gene encoding NOTCH3 and results in vascular smooth muscle cell degeneration, stroke, and dementia. However, the structural changes in NOTCH3 involved in CADASIL etiology are unclear. Here, we discovered site-specific fragmentation of NOTCH3 protein in pathologically affected vessels of human CADASIL-affected brains. EM-based experiments to pinpoint NOTCH3 localization in these brains indicated accumulation of NOTCH3 fragmentation products in the basement membrane, collagen fibers, and granular osmiophilic material within the cerebrovasculature. Using antibodies generated against a disease-linked neo-epitope found in degenerating vascular medium of CADASIL brains, we mapped the site of fragmentation to the NOTCH3 N terminus at the peptide bond joining Asp(80) and Pro(81). Cleavage at this site was predicted to separate the first epidermal growth factor (EGF)-like domain from the remainder of the protein. We found that the cleavage product from this fragmentation event is released into the conditioned medium of cells expressing recombinant NOTCH3 fragments. Mutagenesis of Pro(81) abolished the fragmentation, and low pH and reducing conditions enhanced NOTCH3 proteolysis. Furthermore, substitution of multiple cysteine residues of the NOTCH3 N terminus activated proteolytic release of the first EGF-like repeat, suggesting that the elimination of multiple disulfide bonds in NOTCH3 accelerates its fragmentation. These characteristics link the signature molecular genetic alterations present in individuals with CADASIL to a post-translational protein alteration in degenerating brain arteries. The cellular consequences of these pathological NOTCH3 fragments are an important area for future investigation.	[Young, Kelly Z.; Lee, Soo Jung; Zhang, Xiaojie; Cartee, Naw May Pearl; Keep, Simon G.; Gabbireddy, Sairisheel R.; Fontana, Julia L.; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Young, Kelly Z.; Torres, Mauricio; Qi, Ling; Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), 7725 Med Sci Bldg 2 Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu		Keep, Simon/0000-0002-4139-1672; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044; Young, Kelly/0000-0002-6714-7563; Qi, Ling/0000-0001-8229-0184	National Institutes of Health [NS099783, NS099160, R35GM130292, HL108842, T32-HL125242, T32 GM007863]; United States Department of Veterans Affairs [BX003855, BX003824]; Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; CADASIL Together We Have Hope	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; CADASIL Together We Have Hope	This study was supported by National Institutes of Health Grants NS099783 and NS099160 (to M. M. W.), R35GM130292 (to L. Q.), HL108842 (to S. G. K.; awarded to Dr. Jimo Borjigin), and T32-HL125242 and T32 GM007863 (to K. Z. Y.) and United States Department of Veterans Affairs Grants BX003855 and BX003824 (to M. M. W.). This work was also supported by the Frankel Cardiovascular Center Summer Undergraduate Fellowship Program (to J. L. F. and S. R. G.), CADASIL Together We Have Hope, and members of the international CADASIL communitywhomadedonations used in this study. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Arboleda-Velasquez JF, 2011, P NATL ACAD SCI USA, V108, pE128, DOI 10.1073/pnas.1101964108; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Caplan LR, 2015, J STROKE, V17, P2, DOI 10.5853/jos.2015.17.1.2; de Groot JC, 2000, ANN NEUROL, V47, P145; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dong HR, 2013, STROKE, V44, P1456, DOI 10.1161/STROKEAHA.111.000721; Dong HR, 2012, BRAIN RES, V1456, P64, DOI 10.1016/j.brainres.2012.03.037; Duering M, 2011, HUM MOL GENET, V20, P3256, DOI 10.1093/hmg/ddr237; Fairchild TA, 2001, J BIOL CHEM, V276, P26674, DOI 10.1074/jbc.M103647200; Ghezali L, 2018, ANN NEUROL, V84, P246, DOI 10.1002/ana.25284; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Ishiko A, 2006, ACTA NEUROPATHOL, V112, P333, DOI 10.1007/s00401-006-0116-2; Jackson C, 2005, BRAIN, V128, P2507, DOI 10.1093/brain/awh636; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kast J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0096-8; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lovendahl KN, 2018, ADV EXP MED BIOL, V1066, P47, DOI 10.1007/978-3-319-89512-3_3; Meng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044964; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Monet-Lepretre M, 2013, BRAIN, V136, P1830, DOI 10.1093/brain/awt092; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morris GP, 2018, ACTA NEUROPATHOL, V136, P663, DOI 10.1007/s00401-018-1918-8; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; Rutten JW, 2016, ANN CLIN TRANSL NEUR, V3, P844, DOI 10.1002/acn3.344; SEGALAS I, 1995, FEBS LETT, V371, P171, DOI 10.1016/0014-5793(95)00844-Y; Skribanek Z, 2002, J PEPT SCI, V8, P398, DOI 10.1002/psc.395; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; TUSZYNSKI MH, 1989, STROKE, V20, P990, DOI 10.1161/01.STR.20.8.990; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Zhang XJ, 2015, TRANSL STROKE RES, V6, P148, DOI 10.1007/s12975-014-0379-1; Zhang XJ, 2014, BRAIN RES, V1583, P230, DOI 10.1016/j.brainres.2014.08.018	45	8	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1960	1972		10.1074/jbc.RA119.007724	http://dx.doi.org/10.1074/jbc.RA119.007724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31901894	hybrid, Green Published			2022-12-28	WOS:000517128200015
J	Kinyamu, HK; Bennett, BD; Bushel, PR; Archer, TK				Kinyamu, H. Karimi; Bennett, Brian D.; Bushel, Pierre R.; Archer, Trevor K.			Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone modification; RNA polymerase II; proteasome; transcription; breast cancer	CARBOXYL-TERMINAL DOMAIN; POLYMERASE-II; TRANSCRIPTION ELONGATION; GLUCOCORTICOID-RECEPTOR; HISTONE MODIFICATIONS; PHOSPHORYLATION; UBIQUITIN; PROTEIN; CTD; H3K4ME3	Proteasome activity is required for diverse cellular processes, including transcriptional and epigenetic regulation. However, inhibiting proteasome activity can lead to an increase in transcriptional output that is correlated with enriched levels of trimethyl H3K4 and phosphorylated forms of RNA polymerase (Pol) II at the promoter and gene body. Here, we perform gene expression analysis and ChIP followed by sequencing (ChIP-seq) in MCF-7 breast cancer cells treated with the proteasome inhibitor MG132, and we further explore genome-wide effects of proteasome inhibition on the chromatin state and RNA Pol II transcription. Analysis of gene expression programs and chromatin architecture reveals that chemically inhibiting proteasome activity creates a distinct chromatin state, defined by spreading of the H3K4me3 mark into the gene bodies of differentially-expressed genes. The distinct H3K4me3 chromatin profile and hyperacetylated nucleosomes at transcription start sites establish a chromatin landscape that facilitates recruitment of Ser-5- and Ser-2-phosphorylated RNA Pol II. Subsequent transcriptional events result in diverse gene expression changes. Alterations of H3K36me3 levels in the gene body reflect productive RNA Pol II elongation of transcripts of genes that are induced, underscoring the requirement for proteasome activity at multiple phases of the transcriptional cycle. Finally, by integrating genomics data and pathway analysis, we find that the differential effects of proteasome inhibition on the chromatin state modulate genes that are fundamental for cancer cell survival. Together, our results uncover underappreciated downstream effects of proteasome inhibitors that may underlie targeting of distinct chromatin states and key steps of RNA Pol II-mediated transcription in cancer cells.	[Kinyamu, H. Karimi; Bennett, Brian D.; Archer, Trevor K.] NIEHS, Chromatin & Gene Express Sect, Epigenet & Stem Cell Biol Lab, NIH, Durham, NC 27709 USA; [Bennett, Brian D.] NIEHS, Integrat Bioinformat Support Grp, Epigenet & Stem Cell Biol Lab, Durham, NC 27709 USA; [Bushel, Pierre R.] NIEHS, Biostat & Computat Biol Branch, NIH, Durham, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Chromatin & Gene Express Sect, Epigenet & Stem Cell Biol Lab, NIH, Durham, NC 27709 USA.	archer1@niehs.nih.gov	kinyamu, Harriet/AAG-9069-2019; Archer, Trevor K/E-5191-2019	kinyamu, Harriet/0000-0002-2377-7408; Archer, Trevor K/0000-0001-7651-3644	Intramural Research Program NIEHS from the National Institutes of Health [Z01 ES071006-19]	Intramural Research Program NIEHS from the National Institutes of Health	This work was supported by the Intramural Research Program NIEHS Grant Z01 ES071006-19 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Cromm PM, 2017, ACS CENTRAL SCI, V3, P830, DOI 10.1021/acscentsci.7b00252; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Dai ZW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04426-y; Dhar SS, 2018, MOL CELL, V70, P825, DOI 10.1016/j.molcel.2018.04.028; Durairaj G, 2014, BIOMOLECULES, V4, P827, DOI 10.3390/biom4030827; Ebmeier CC, 2017, CELL REP, V20, P1173, DOI 10.1016/j.celrep.2017.07.021; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Erickson B, 2018, GENE DEV, V32, P1215, DOI 10.1101/gad.316810.118; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Fong N, 2017, MOL CELL, V66, P546, DOI 10.1016/j.molcel.2017.04.016; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fuchs SM, 2012, J BIOL CHEM, V287, P3249, DOI 10.1074/jbc.M111.273953; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gandolfi S, 2017, CANCER METAST REV, V36, P561, DOI 10.1007/s10555-017-9707-8; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Grosso AR, 2015, ELIFE, V4, DOI 10.7554/eLife.09214; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2000, GENE DEV, V14, P1048; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; Levenson AS, 1997, CANCER RES, V57, P3071; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Liang KW, 2018, CELL, V175, P766, DOI 10.1016/j.cell.2018.09.027; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Liu Y, 2013, CANCER RES, V73, P1308, DOI 10.1158/0008-5472.CAN-12-2489; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McCann TS, 2014, BIOMOLECULES, V4, P1026, DOI 10.3390/biom4041026; Meers MP, 2017, ELIFE, V6, DOI 10.7554/eLife.23249; Motosugi R, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00030; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; Proudfoot NJ, 2016, SCIENCE, V352, DOI 10.1126/science.aad9926; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sampathi S, 2019, NUCLEIC ACIDS RES, V47, P3921, DOI 10.1093/nar/gkz127; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Tan YL, 2018, MOL CELL, V71, P526, DOI 10.1016/j.molcel.2018.07.039; Taneja N, 2017, MOL CELL, V66, P50, DOI 10.1016/j.molcel.2017.02.006; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Trotter KW, 2012, METHODS MOL BIOL, V833, P89, DOI 10.1007/978-1-61779-477-3_6; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wallace AD, 2010, STEROIDS, V75, P1016, DOI 10.1016/j.steroids.2010.06.015; Wang JL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090118; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhao YT, 2018, GENOME RES, V28, P933, DOI 10.1101/gr.233775.117; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu K, 2017, NUCLEIC ACIDS RES, V45, P92, DOI 10.1093/nar/gkw814	92	5	5	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1271	1287		10.1074/jbc.RA119.011174	http://dx.doi.org/10.1074/jbc.RA119.011174			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31806706	Green Published, hybrid			2022-12-28	WOS:000513822300009
J	Mariuzza, RA; Agnihotri, P; Orban, J				Mariuzza, Roy A.; Agnihotri, Pragati; Orban, John			The structural basis of T-cell receptor (TCR) activation: An enduring enigma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						T-cell receptor (TCR); major histocompatibility complex (MHC); signal transduction; cryo-electron microscopy; nuclear magnetic resonance (NMR); molecular dynamics; mechanotransduction; allosteric regulation	INDUCED CONFORMATIONAL-CHANGE; BETA FG LOOP; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; MEMBRANE-BINDING; CD3-EPSILON-GAMMA; ALLOSTERY; COMPLEX; ZETA; SEGREGATION	T cells are critical for protective immune responses to pathogens and tumors. The T-cell receptor (TCR)?CD3 complex is composed of a diverse ?? TCR heterodimer noncovalently associated with the invariant CD3 dimers CD3??, CD3??, and CD3??. The TCR mediates recognition of antigenic peptides bound to MHC molecules (pMHC), whereas the CD3 molecules transduce activation signals to the T cell. Whereas much is known about downstream T-cell signaling pathways, the mechanism whereby TCR engagement by pMHC is first communicated to the CD3 signaling apparatus, a process termed early T-cell activation, remains largely a mystery. In this review, we examine the molecular basis for TCR activation in light of the recently determined cryoEM structure of a complete TCR?CD3 complex. This structure provides an unprecedented opportunity to assess various signaling models that have been proposed for the TCR. We review evidence from single-molecule and structural studies for force-induced conformational changes in the TCR?CD3 complex, for dynamically-driven TCR allostery, and for pMHC-induced structural changes in the transmembrane and cytoplasmic regions of CD3 subunits. We identify major knowledge gaps that must be filled in order to arrive at a comprehensive model of TCR activation that explains, at the molecular level, how pMHC-specific information is transmitted across the T-cell membrane to initiate intracellular signaling. An in-depth understanding of this process will accelerate the rational design of immunotherapeutic agents targeting the TCR?CD3 complex.	[Mariuzza, Roy A.; Agnihotri, Pragati; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Mariuzza, Roy A.; Agnihotri, Pragati] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mariuzza, RA; Orban, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu; jorban@umd.edu	Agnihotri, Pragati/AAA-3087-2019	Agnihotri, Pragati/0000-0003-3392-0594	National Institutes of Health [AI129893]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant AI129893 (to R. A. M. and J. O.).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Anthis NJ, 2015, Q REV BIOPHYS, V48, P35, DOI 10.1017/S0033583514000122; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Brazin KN, 2018, IMMUNITY, V49, P829, DOI 10.1016/j.immuni.2018.09.007; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Buckle AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02898; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chavent M, 2016, STRUCTURE, V24, P337, DOI 10.1016/j.str.2015.11.008; Connolly A, 2019, IMMUNOL REV, V291, P26, DOI 10.1111/imr.12769; Courtney AH, 2017, MOL CELL, V67, P498, DOI 10.1016/j.molcel.2017.06.024; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Guo XD, 2017, CELL RES, V27, P505, DOI 10.1038/cr.2017.42; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Jin ML, 2019, P NATL ACAD SCI USA, V116, P19513, DOI 10.1073/pnas.1903976116; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Knapp B, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007338; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Mallis RJ, 2019, J BIOMOL NMR, V73, P319, DOI 10.1007/s10858-019-00234-8; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; McLeish TCB, 2015, BIOPHYS J, V109, P1240, DOI 10.1016/j.bpj.2015.08.009; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Natarajan K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01657; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Puthenveetil R, 2019, J BIOL CHEM, V294, P15914, DOI 10.1074/jbc.REV119.009178; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Rangarajan S, 2018, J BIOL CHEM, V293, P15991, DOI 10.1074/jbc.RA118.003832; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Schamel WW, 2019, IMMUNOL REV, V291, P8, DOI 10.1111/imr.12788; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Swamy M, 2016, IMMUNITY, V44, P1091, DOI 10.1016/j.immuni.2016.04.011; Thonghin N, 2018, METHODS, V147, P176, DOI 10.1016/j.ymeth.2018.04.018; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Wu P, 2019, MOL CELL, V73, P1015, DOI 10.1016/j.molcel.2018.12.018; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	71	44	45	7	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					914	925		10.1074/jbc.REV119.009411	http://dx.doi.org/10.1074/jbc.REV119.009411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31848223	Green Published, hybrid			2022-12-28	WOS:000509949300003
J	Simon, MC; Reinbeck, AL; Wessel, C; Heindirk, J; Jelenik, T; Kaul, K; Arreguin-Cano, J; Strom, A; Blaut, M; Backhed, F; Burkart, V; Roden, M				Simon, Marie-Christine; Reinbeck, Anna Lena; Wessel, Corinna; Heindirk, Julia; Jelenik, Tomas; Kaul, Kirti; Arreguin-Cano, Juan; Strom, Alexander; Blaut, Michael; Backhed, Fredrik; Burkart, Volker; Roden, Michael			Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; autoimmune disease; glucose metabolism; insulin resistance; islet; microbiome; mitochondrial metabolism; type 1 diabetes; Toll-like receptor 4 (TLR4)	CHAIN FATTY-ACIDS; TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; INTESTINAL MICROBIOTA; INNATE IMMUNITY; SMOOTH-MUSCLE; RISK-FACTOR; FETUIN-A; TYPE-1; ACTIVATION	The rising prevalence of type 1 diabetes (T1D) over the past decades has been linked to lifestyle changes, but the underlying mechanisms are largely unknown. Recent findings point to gut-associated mechanisms in the control of T1D pathogenesis. In nonobese diabetic (NOD) mice, a model of T1D, diabetes development accelerates after deletion of the Toll-like receptor 4 (TLR4). We hypothesized that altered intestinal functions contribute to metabolic alterations, which favor accelerated diabetes development in TLR4-deficient (TLR4(?/?)) NOD mice. In 70?90-day-old normoglycemic (prediabetic) female NOD TLR4(+/+) and NOD TLR4(?/?) mice, gut morphology and microbiome composition were analyzed. Parameters of lipid metabolism, glucose homeostasis, and mitochondrial respiratory activity were measured in vivo and ex vivo. Compared with NOD TLR4(+/+) mice, NOD TLR4(?/?) animals showed lower muscle mass of the small intestine, higher abundance of Bacteroidetes, and lower Firmicutes in the large intestine, along with lower levels of circulating short-chain fatty acids (SCFA). These changes are associated with higher body weight, hyperlipidemia, and severe insulin and glucose intolerance, all occurring before the onset of diabetes. These mice also exhibited insulin resistance?related abnormalities of energy metabolism, such as lower total respiratory exchange rates and higher hepatic oxidative capacity. Distinct alterations of gut morphology and microbiota composition associated with reduction of circulating SCFA may contribute to metabolic disorders promoting the progression of insulin-deficient diabetes/T1D development.	[Simon, Marie-Christine; Reinbeck, Anna Lena; Wessel, Corinna; Heindirk, Julia; Jelenik, Tomas; Kaul, Kirti; Arreguin-Cano, Juan; Strom, Alexander; Burkart, Volker; Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Simon, Marie-Christine; Reinbeck, Anna Lena; Wessel, Corinna; Heindirk, Julia; Jelenik, Tomas; Kaul, Kirti; Arreguin-Cano, Juan; Strom, Alexander; Burkart, Volker; Roden, Michael] German Ctr Diabet Res DZD, D-85764 Munich, Germany; [Simon, Marie-Christine; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41348 Gothenburg, Sweden; [Simon, Marie-Christine; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, S-41348 Gothenburg, Sweden; [Blaut, Michael] German Inst Human Nutr, Dept Gastrointestinal Microbiol, D-14558 Potsdam, Germany; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Roden, Michael] Heinrich Heine Univ, Med Fac, Div Endocrinol & Diabetol, D-40225 Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); University of Gothenburg; University of Gothenburg; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Novo Nordisk Foundation; University of Copenhagen; Heinrich Heine University Dusseldorf	Roden, M (corresponding author), German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.; Roden, M (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.; Roden, M (corresponding author), Heinrich Heine Univ, Med Fac, Div Endocrinol & Diabetol, D-40225 Dusseldorf, Germany.	michael.roden@ddz.de	Simon, Marie-Christine/AAX-7883-2020; Backhed, Fredrik/ABE-6613-2020	Simon, Marie-Christine/0000-0001-6625-1265; Backhed, Fredrik/0000-0002-4871-8818; Arreguin Cano, Juan Antonio/0000-0003-1292-9880	Ministry for Culture and Science of the State of North Rhine-Westphalia (MKW and NRW); German Federal Ministry of Health (BMG); Federal Ministry for Research (BMBF); European Funds for Regional Development [EFRE-0400191]; EUREKA Eurostars-2 Grant [E! 113230 DIA-PEP]; German Science Foundation (DFG) [CRC/SFB 1116/2 B12]; Schmutzler Stiftung, Germany; German Diabetes Association (DDG); German Society for Mucosal Immunology and Microbiome (DGMIM); Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden	Ministry for Culture and Science of the State of North Rhine-Westphalia (MKW and NRW); German Federal Ministry of Health (BMG); Federal Ministry for Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Funds for Regional Development(European Commission); EUREKA Eurostars-2 Grant; German Science Foundation (DFG)(German Research Foundation (DFG)); Schmutzler Stiftung, Germany; German Diabetes Association (DDG); German Society for Mucosal Immunology and Microbiome (DGMIM); Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden	This work was supported by the Ministry for Culture and Science of the State of North Rhine-Westphalia (MKW and NRW); the German Federal Ministry of Health (BMG); the Federal Ministry for Research (BMBF) to the German Center for Diabetes Research (DZD e.V.); European Funds for Regional Development Grant EFRE-0400191; EUREKA Eurostars-2 Grant E! 113230 DIA-PEP; German Science Foundation (DFG) Grant CRC/SFB 1116/2 B12; the Schmutzler Stiftung, Germany; the German Diabetes Association (DDG); the German Society for Mucosal Immunology and Microbiome (DGMIM); and the Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden. The authors declare that they have no conflicts of interest with the contents of this article.	Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; Bister V, 2005, SCAND J GASTROENTERO, V40, P1413, DOI 10.1080/00365520510023918; Burghoff S, 2013, ARCH PHYSIOL BIOCHEM, V119, P39, DOI 10.3109/13813455.2012.755547; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Caputi V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00350; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Forcen R, 2015, NEUROGASTROENT MOTIL, V27, P1258, DOI 10.1111/nmo.12619; Fourlanos S, 2004, DIABETOLOGIA, V47, P1661, DOI 10.1007/s00125-004-1507-3; Gancheva S, 2018, PHYSIOL REV, V98, P1371, DOI 10.1152/physrev.00015.2017; Gancheva S, 2016, DIABETES, V65, P1849, DOI 10.2337/db16-0162; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Greiner TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110359; Gulden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075385; Harbison JE, 2019, PEDIATR DIABETES, V20, P574, DOI 10.1111/pedi.12865; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025792, 10.1371/journal.pone.0014764]; Jelenik T, 2014, DIABETES, V63, P3856, DOI 10.2337/db13-1794; Jialal I, 2012, DIABETES CARE, V35, P900, DOI 10.2337/dc11-2375; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kacerovsky M, 2011, J INTERN MED, V269, P189, DOI 10.1111/j.1365-2796.2010.02298.x; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Knip M, 2016, NAT REV ENDOCRINOL, V12, P154, DOI 10.1038/nrendo.2015.218; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liu Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00470; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Muller M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48775-0; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rumio C, 2006, J CELL PHYSIOL, V208, P47, DOI 10.1002/jcp.20632; Schallschmidt T, 2018, GENETICS, V210, P1527, DOI 10.1534/genetics.118.301578; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Uranga JA, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13047; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Verbeeten KC, 2011, DIABETIC MED, V28, P10, DOI 10.1111/j.1464-5491.2010.03160.x; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Weickert MO, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-90; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu P, 2007, DIABETES CARE, V30, P2314, DOI 10.2337/dc06-2389; Yin QR, 2017, CELL PHYSIOL BIOCHEM, V44, P2189, DOI 10.1159/000486024	58	18	19	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					969	980		10.1074/jbc.RA119.010816	http://dx.doi.org/10.1074/jbc.RA119.010816			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31822562	Green Published, hybrid			2022-12-28	WOS:000509949300007
J	Li, Z; Jiang, YY; Guengerich, FP; Ma, L; Li, SY; Zhang, W				Li, Zhong; Jiang, Yuanyuan; Guengerich, F. Peter; Ma, Li; Li, Shengying; Zhang, Wei			Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cytochrome P450; enzyme mechanism; protein engineering; metabolic engineering; substrate specificity; directed evolution; electron source engineering; ferredoxin; light activation; redox partner proteins; substrate engineering	SELF-SUFFICIENT CYTOCHROME-P450; FATTY-ACID HYDROXYLATION; DRIVEN DRUG-METABOLISM; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; P450 ENZYMES; ESCHERICHIA-COLI; STRUCTURAL BASIS; MECHANISTIC INSIGHTS; DIRECTED EVOLUTION	Cytochrome P450 enzymes (P450s) are broadly distributed among living organisms and play crucial roles in natural product biosynthesis, degradation of xenobiotics, steroid biosynthesis, and drug metabolism. P450s are considered as the most versatile biocatalysts in nature because of the vast variety of substrate structures and the types of reactions they catalyze. In particular, P450s can catalyze regio- and stereoselective oxidations of nonactivated C?H bonds in complex organic molecules under mild conditions, making P450s useful biocatalysts in the production of commodity pharmaceuticals, fine or bulk chemicals, bioremediation agents, flavors, and fragrances. Major efforts have been made in engineering improved P450 systems that overcome the inherent limitations of the native enzymes. In this review, we focus on recent progress of different strategies, including protein engineering, redox-partner engineering, substrate engineering, electron source engineering, and P450-mediated metabolic engineering, in efforts to more efficiently produce pharmaceuticals and other chemicals. We also discuss future opportunities for engineering and applications of the P450 systems.	[Li, Zhong; Jiang, Yuanyuan] Chinese Acad Sci, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Jiang, Yuanyuan] Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Jiang, Yuanyuan; Ma, Li; Li, Shengying; Zhang, Wei] Shandong Univ, State Key Lab Microbial Technol, Qingdao 266237, Shandong, Peoples R China; [Li, Zhong; Jiang, Yuanyuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Li, Shengying; Zhang, Wei] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Shandong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vanderbilt University; Qingdao National Laboratory for Marine Science & Technology	Zhang, W (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao 266237, Shandong, Peoples R China.; Zhang, W (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Shandong, Peoples R China.	zhang_wei@sdu.edu.cn	jiang, anyi/GPT-0379-2022	Zhang, Wei/0000-0001-9459-680X	National Key R&D Program of China [2019YFA0905400-04]; National Natural Science Foundation of China [31570030, 31600045, 31872729]; National Institutes of Health [R01 GM118122]; Qilu Youth Scholar Startup Funding of Shandong University; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS [SKLBNPC18242]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qilu Youth Scholar Startup Funding of Shandong University; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS(Chinese Academy of Sciences)	This work was supported by National Key R&D Program of China Grant 2019YFA0905400-04 (to W. Z.), National Natural Science Foundation of China Grants 31570030 (to W. Z.), 31600045 (to L. M.), and 31872729 (to S. L.); National Institutes of Health Grant R01 GM118122 (to F. P. G.); a Qilu Youth Scholar Startup Funding of Shandong University grant (to W. Z.); and the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS, Grant SKLBNPC18242 (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Ba L, 2013, BIOTECHNOL BIOENG, V110, P2815, DOI 10.1002/bit.24960; Ban JG, 2014, J IND MICROBIOL BIOT, V41, P879, DOI 10.1007/s10295-014-1432-5; Barriuso J, 2011, J AM CHEM SOC, V133, P8078, DOI 10.1021/ja201138v; Bate N, 1999, J IND MICROBIOL BIOT, V23, P118, DOI 10.1038/sj.jim.2900707; Bell SG, 2012, CHEM COMMUN, V48, P11692, DOI 10.1039/c2cc35968e; Belsare KD, 2017, PROTEIN ENG DES SEL, V30, P119, DOI 10.1093/protein/gzw072; Bernhardt R, 2014, APPL MICROBIOL BIOT, V98, P6185, DOI 10.1007/s00253-014-5767-7; Biggs BW, 2016, P NATL ACAD SCI USA, V113, P3209, DOI 10.1073/pnas.1515826113; Bistolas N, 2005, BIOSENS BIOELECTRON, V20, P2408, DOI 10.1016/j.bios.2004.11.023; Chen J, 2019, ACS CATAL, V9, P7350, DOI 10.1021/acscatal.9b02507; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Ciaramella A, 2017, REND LINCEI-SCI FIS, V28, P169, DOI 10.1007/s12210-016-0581-z; Cong ZQ, 2015, ACS CATAL, V5, P150, DOI 10.1021/cs501592f; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Dalber A, 2005, J INORG BIOCHEM, V99, P185, DOI 10.1016/j.jinorgbio.2004.09.018; Di Nardo G, 2012, INT J MOL SCI, V13, P15901, DOI 10.3390/ijms131215901; Ding Y, 2008, J AM CHEM SOC, V130, P5492, DOI 10.1021/ja710520q; Dodhia VR, 2006, J BIOL INORG CHEM, V11, P903, DOI 10.1007/s00775-006-0144-3; Du L, 2017, P NATL ACAD SCI USA, V114, pE5129, DOI 10.1073/pnas.1702317114; Du L, 2016, J BIOL CHEM, V291, P6583, DOI 10.1074/jbc.M115.695320; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; Fairhead M, 2005, J BIOL INORG CHEM, V10, P842, DOI 10.1007/s00775-005-0033-1; Fujii T, 2009, BIOSCI BIOTECH BIOCH, V73, P805, DOI 10.1271/bbb.80627; Fujii Y, 2011, BIOCHEM BIOPH RES CO, V404, P511, DOI 10.1016/j.bbrc.2010.12.013; Fujii Y, 2009, BIOCHEM BIOPH RES CO, V385, P170, DOI 10.1016/j.bbrc.2009.05.033; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gandomkar S, 2018, ANGEW CHEM INT EDIT, V57, P427, DOI 10.1002/anie.201710227; Girhard M, 2013, BIOTECHNOL APPL BIOC, V60, P111, DOI 10.1002/bab.1063; Guengerich FP, 2018, ACS CATAL, V8, P10964, DOI 10.1021/acscatal.8b03401; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Gumulya Y, 2018, NAT CATAL, V1, P878, DOI 10.1038/s41929-018-0159-5; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hayashi K, 2008, BIOCHEMISTRY-US, V47, P11964, DOI 10.1021/bi801222d; Hayashi K, 2010, FEBS J, V277, P3999, DOI 10.1111/j.1742-4658.2010.07791.x; HOSOBUCHI M, 1993, BIOTECHNOL BIOENG, V42, P815, DOI 10.1002/bit.260420705; Hsu PY, 1999, J BIOL CHEM, V274, P762, DOI 10.1074/jbc.274.2.762; Huang XN, 2019, ACS SYNTH BIOL, V8, P818, DOI 10.1021/acssynbio.8b00489; Ito S, 1999, ACTA CRYSTALLOGR D, V55, P1209, DOI 10.1107/S0907444999003716; Janocha S, 2016, CHEMBIOCHEM, V17, P852, DOI 10.1002/cbic.201500524; Jensen K, 2011, ACS CHEM BIOL, V6, P533, DOI 10.1021/cb100393j; Jiang YY, 2018, CHINESE J ORG CHEM, V38, P2307, DOI 10.6023/cjoc201805055; Johannes TW, 2007, BIOTECHNOL BIOENG, V96, P18, DOI 10.1002/bit.21168; Karasawa M, 2018, ANGEW CHEM INT EDIT, V57, P12264, DOI 10.1002/anie.201804924; Kawakami N, 2011, ANGEW CHEM INT EDIT, V50, P5315, DOI 10.1002/anie.201007975; KAWAUCHI H, 1994, BBA-GENE STRUCT EXPR, V1219, P179, DOI 10.1016/0167-4781(94)90266-6; Kern F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14881; Khatri Y, 2010, CHEM BIOL, V17, P1295, DOI 10.1016/j.chembiol.2010.10.010; KIDO T, 1979, J BIOL CHEM, V254, P1806; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Krishnan S, 2011, J PHYS CHEM B, V115, P8371, DOI 10.1021/jp201235m; Krishnan S, 2011, J AM CHEM SOC, V133, P1459, DOI 10.1021/ja108637s; Krishnan S, 2009, J AM CHEM SOC, V131, P16215, DOI 10.1021/ja9065317; Kulig JK, 2015, BIOORGAN MED CHEM, V23, P5603, DOI 10.1016/j.bmc.2015.07.025; Kumar S, 2003, J BIOL CHEM, V278, P17178, DOI 10.1074/jbc.M212515200; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Lee MJ, 2013, APPL ENVIRON MICROB, V79, P2253, DOI 10.1128/AEM.03722-12; Lewis JC, 2009, P NATL ACAD SCI USA, V106, P16550, DOI 10.1073/pnas.0908954106; Li QL, 2018, ORG LETT, V20, P4854, DOI 10.1021/acs.orglett.8b01997; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Liu WF, 2007, BIOTECHNOL ADV, V25, P369, DOI 10.1016/j.biotechadv.2007.03.002; Liu Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-28; Lowell AN, 2017, J AM CHEM SOC, V139, P7913, DOI 10.1021/jacs.7b02875; Lu C, 2018, ACS CATAL, V8, P5794, DOI 10.1021/acscatal.8b01313; Lu JS, 2015, ELECTROCHIM ACTA, V165, P36, DOI 10.1016/j.electacta.2015.02.183; Lu JS, 2014, CHEM COMMUN, V50, P13896, DOI 10.1039/c4cc06200k; Lu Y, 2007, J IND MICROBIOL BIOT, V34, P247, DOI 10.1007/s10295-006-0193-1; Ma L, 2015, APPL ENVIRON MICROB, V81, P6268, DOI 10.1128/AEM.01353-15; Ma NN, 2018, ANGEW CHEM INT EDIT, V57, P7628, DOI 10.1002/anie.201801592; Mak LH, 2010, ANAL CHEM, V82, P5357, DOI 10.1021/ac101072h; Matthews S, 2017, J BIOL CHEM, V292, P5128, DOI 10.1074/jbc.M116.762336; McLean KJ, 2015, ADV EXP MED BIOL, V851, P299, DOI 10.1007/978-3-319-16009-2_11; McLean KJ, 2015, P NATL ACAD SCI USA, V112, P2847, DOI 10.1073/pnas.1419028112; Meinhold P, 2006, ADV SYNTH CATAL, V348, P763, DOI 10.1002/adsc.200505465; Mellor SB, 2017, PHOTOSYNTH RES, V134, P329, DOI 10.1007/s11120-017-0364-0; Mellor SB, 2016, ACS CHEM BIOL, V11, P1862, DOI 10.1021/acschembio.6b00190; Menard A, 2012, CHEMBIOCHEM, V13, P2527, DOI 10.1002/cbic.201200524; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Mie Y, 2009, J AM CHEM SOC, V131, P6646, DOI 10.1021/ja809364r; Minas W, 1998, BIOTECHNOL PROGR, V14, P561, DOI 10.1021/bp980055t; Muhammed MT, 2019, CHEM BIOL DRUG DES, V93, P12, DOI 10.1111/cbdd.13388; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Nakamura K, 2001, ARCH BIOCHEM BIOPHYS, V395, P25, DOI 10.1006/abbi.2001.2569; Narayan ARH, 2015, NAT CHEM, V7, P653, DOI [10.1038/NCHEM.2285, 10.1038/nchem.2285]; Negretti S, 2014, J AM CHEM SOC, V136, P4901, DOI 10.1021/ja5016052; Nelson DR, 2018, BBA-PROTEINS PROTEOM, V1866, P141, DOI 10.1016/j.bbapap.2017.05.003; Nerimetla R, 2017, ACS CATAL, V7, P3446, DOI 10.1021/acscatal.6b03588; Nerimetla R, 2015, CHEM COMMUN, V51, P11681, DOI 10.1039/c5cc03364k; Tran NH, 2012, J INORG BIOCHEM, V115, P50, DOI 10.1016/j.jinorgbio.2012.05.012; Nielsen AZ, 2013, ACS SYNTH BIOL, V2, P308, DOI 10.1021/sb300128r; Otey CR, 2006, BIOTECHNOL BIOENG, V93, P494, DOI 10.1002/bit.20744; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Parikh A, 1999, BIOCHEMISTRY-US, V38, P5283, DOI 10.1021/bi990142+; Park JH, 2015, ANGEW CHEM INT EDIT, V54, P969, DOI 10.1002/anie.201410059; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; Polic V, 2017, ADV SYNTH CATAL, V359, P3983, DOI 10.1002/adsc.201700637; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Qi FF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04772-x; Lam Q, 2016, BBA-BIOENERGETICS, V1857, P589, DOI 10.1016/j.bbabio.2015.09.004; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roberts GA, 2003, J BIOL CHEM, V278, P48914, DOI 10.1074/jbc.M309630200; Robin A, 2011, BEILSTEIN J ORG CHEM, V7, P1494, DOI 10.3762/bjoc.7.173; Robin A, 2009, CHEM COMMUN, P2478, DOI 10.1039/b901716j; Rudolf JD, 2017, NAT PROD REP, V34, P1141, DOI 10.1039/c7np00034k; Sabbadin F, 2010, CHEMBIOCHEM, V11, P987, DOI 10.1002/cbic.201000104; Sadeghi SJ, 2013, BIOTECHNOL APPL BIOC, V60, P102, DOI 10.1002/bab.1086; Sadeghi SJ, 2011, BBA-PROTEINS PROTEOM, V1814, P237, DOI 10.1016/j.bbapap.2010.07.010; Sakaki T, 2012, BIOL PHARM BULL, V35, P844, DOI 10.1248/bpb.35.844; Sandberg M, 2002, BRIT J CLIN PHARMACO, V54, P423, DOI 10.1046/j.1365-2125.2002.01660.x; Sawayama AM, 2009, CHEM-EUR J, V15, P11723, DOI 10.1002/chem.200900643; Schmitz LM, 2019, BIOTECHNOL BIOENG, V116, P3469, DOI 10.1002/bit.27156; Schuckel J, 2012, CHEMBIOCHEM, V13, P2758, DOI 10.1002/cbic.201200572; Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007; Sevrioukova IF, 2011, ARCH BIOCHEM BIOPHYS, V507, P66, DOI 10.1016/j.abb.2010.08.022; Shalan H, 2018, BBA-PROTEINS PROTEOM, V1866, P80, DOI 10.1016/j.bbapap.2017.06.002; SHEPHARD EA, 1983, BIOCHEM J, V211, P333, DOI 10.1042/bj2110333; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Shoji O., 2007, ANGEW CHEM, V119, P3730, DOI DOI 10.1002/ANGE.200700068; Shoji O, 2017, ANGEW CHEM INT EDIT, V56, P10324, DOI 10.1002/anie.201703461; Shoji O, 2017, CHEM LETT, V46, P278, DOI 10.1246/cl.160963; Shoji O, 2015, ISR J CHEM, V55, P32, DOI 10.1002/ijch.201400096; Shoji O, 2014, J BIOL INORG CHEM, V19, P529, DOI 10.1007/s00775-014-1106-9; Shumyantseva VV, 2005, J INORG BIOCHEM, V99, P1051, DOI 10.1016/j.jinorgbio.2005.01.014; Sowden RJ, 2005, ORG BIOMOL CHEM, V3, P57, DOI 10.1039/b413068e; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; Sulistyaningdyah WT, 2005, APPL MICROBIOL BIOT, V67, P556, DOI 10.1007/s00253-004-1761-9; Sun CL, 2019, ORG LETT, V21, P1453, DOI 10.1021/acs.orglett.9b00208; Sun Y, 2017, J IND MICROBIOL BIOT, V44, P161, DOI 10.1007/s10295-016-1875-y; SUZUKI K, 1993, BIOCHIM BIOPHYS ACTA, V1203, P215, DOI 10.1016/0167-4838(93)90086-7; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; Taylor M, 2000, BIOCHEM BIOPH RES CO, V279, P708, DOI 10.1006/bbrc.2000.4002; Tosstorff A, 2014, J MOL CATAL B-ENZYM, V108, P51, DOI 10.1016/j.molcatb.2014.06.011; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; UHLMANN H, 1994, J BIOL CHEM, V269, P22557; Urlacher VB, 2004, APPL MICROBIOL BIOT, V64, P317, DOI 10.1007/s00253-003-1514-1; Urlacher VB, 2019, TRENDS BIOTECHNOL, V37, P882, DOI 10.1016/j.tibtech.2019.01.001; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Walgama C, 2015, ANAL CHEM, V87, P4712, DOI 10.1021/ac5044362; Wasalathanthri DP, 2012, ELECTROANAL, V24, P2049, DOI 10.1002/elan.201200373; Wei YF, 2018, CURR OPIN CHEM BIOL, V43, P1, DOI 10.1016/j.cbpa.2017.08.006; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wlodarczyk A, 2016, METAB ENG, V33, P1, DOI 10.1016/j.ymben.2015.10.009; Wong TS, 2004, BIOTECHNOL BIOENG, V85, P351, DOI 10.1002/bit.10896; Woodley JM, 2013, CURR OPIN CHEM BIOL, V17, P310, DOI 10.1016/j.cbpa.2013.03.017; Xu JK, 2019, CHEM-EUR J, V25, P6853, DOI 10.1002/chem.201806383; Xu LH, 2018, SYN SYST BIOTECHNO, V3, P283, DOI 10.1016/j.synbio.2018.10.001; Yasuda K, 2018, BBA-PROTEINS PROTEOM, V1866, P23, DOI 10.1016/j.bbapap.2017.05.014; Yasutake Y, 2010, J BIOL CHEM, V285, P31193, DOI 10.1074/jbc.M110.147009; Yu D, 2019, J AM CHEM SOC, V141, P5655, DOI 10.1021/jacs.9b01939; Zachos L, 2015, CHEM COMMUN, V51, P1918, DOI 10.1039/c4cc07276f; Zhang JD, 2011, J IND MICROBIOL BIOT, V38, P633, DOI 10.1007/s10295-010-0809-3; Zhang W, 2018, ACS CATAL, V8, P9992, DOI 10.1021/acscatal.8b02913; Zhang W, 2014, J AM CHEM SOC, V136, P3640, DOI 10.1021/ja4130302; Zhang XW, 2017, NAT PROD REP, V34, P1061, DOI 10.1039/c7np00028f; Zhao FL, 2016, BIOTECHNOL BIOENG, V113, P1787, DOI 10.1002/bit.25934; Zilly FE, 2009, CHEM COMMUN, P7152, DOI 10.1039/b913863c; Zuo R, 2016, BIOTECHNOL J, V11, P624, DOI 10.1002/biot.201500416	168	90	99	81	328	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					833	849		10.1074/jbc.REV119.008758	http://dx.doi.org/10.1074/jbc.REV119.008758			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31811088	Green Published, hybrid			2022-12-28	WOS:000508382900014
J	Ribeiro, AJM; Tyzack, JD; Borkakoti, N; Holliday, GL; Thornton, JM				Ribeiro, Antonio J. M.; Tyzack, Jonathan D.; Borkakoti, Neera; Holliday, Gemma L.; Thornton, Janet M.			A global analysis of function and conservation of catalytic residues in enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bioinformatics; enzyme catalysis; enzyme mechanism; enzyme mutation; amino acid; active site; catalytic residue; database; enzyme evolution; Mechanism and Catalytic Site Atlas (M-CSA); catalytic residue	SITE ATLAS; MECHANISMS; DATABASE; PREDICTION; COMPLEXITY; EVOLUTION; SEQUENCE; MACIE	The catalytic residues of an enzyme comprise the amino acids located in the active center responsible for accelerating the enzyme-catalyzed reaction. These residues lower the activation energy of reactions by performing several catalytic functions. Decades of enzymology research has established general themes regarding the roles of specific residues in these catalytic reactions, but it has been more difficult to explore these roles in a more systematic way. Here, we review the data on the catalytic residues of 648 enzymes, as annotated in the Mechanism and Catalytic Site Atlas (M-CSA), and compare our results with those in previous studies. We structured this analysis around three key properties of the catalytic residues: amino acid type, catalytic function, and sequence conservation in homologous proteins. As expected, we observed that catalysis is mostly accomplished by a small set of residues performing a limited number of catalytic functions. Catalytic residues are typically highly conserved, but to a smaller degree in homologues that perform different reactions or are nonenzymes (pseudoenzymes). Cross-analysis yielded further insights revealing which residues perform particular functions and how often. We obtained more detailed specificity rules for certain functions by identifying the chemical group upon which the residue acts. Finally, we show the mutation tolerance of the catalytic residues based on their roles. The characterization of the catalytic residues, their functions, and conservation, as presented here, is key to understanding the impact of mutations in evolution, disease, and enzyme design. The tools developed for this analysis are available at the M-CSA website and allow for user specific analysis of the same data.	[Ribeiro, Antonio J. M.; Tyzack, Jonathan D.; Borkakoti, Neera; Holliday, Gemma L.; Thornton, Janet M.] European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Holliday, Gemma L.] Med Discovery Catapult, Alderley Pk, Alderley Edge SK10 4TG, Cheshire, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Ribeiro, AJM (corresponding author), European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	ribeiro@ebi.ac.uk	Ribeiro, António J M/H-2474-2013	Ribeiro, António J M/0000-0002-2533-1231; Borkakoti, Nivedita/0000-0002-5878-1490; Tyzack, Jonathan/0000-0003-4827-9023; Holliday, Gemma/0000-0002-6731-6398; Thornton, Janet/0000-0003-0824-4096	EMBL	EMBL	This work was supported by EMBL.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Copley SD, 2015, TRENDS BIOCHEM SCI, V40, P72, DOI 10.1016/j.tibs.2014.12.004; Ebert MCCJC, 2017, CURR OPIN CHEM BIOL, V37, P89, DOI 10.1016/j.cbpa.2017.01.021; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fischer JD, 2010, J MOL BIOL, V403, P803, DOI 10.1016/j.jmb.2010.09.018; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Hochberg GKA, 2017, ANNU REV BIOPHYS, V46, P247, DOI 10.1146/annurev-biophys-070816-033631; Holliday GL, 2014, J MOL BIOL, V426, P2098, DOI 10.1016/j.jmb.2014.03.008; Holliday GL, 2012, NUCLEIC ACIDS RES, V40, pD783, DOI 10.1093/nar/gkr799; Holliday GL, 2011, FEBS J, V278, P3835, DOI 10.1111/j.1742-4658.2011.08190.x; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Holliday GL, 2005, BIOINFORMATICS, V21, P4315, DOI 10.1093/bioinformatics/bti693; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020; McDonald AG, 2014, FEBS J, V281, P583, DOI 10.1111/febs.12530; Miller M, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz818; Murphy JM, 2017, CURR OPIN STRUC BIOL, V47, P95, DOI 10.1016/j.sbi.2017.07.004; Nagano N, 2015, NUCLEIC ACIDS RES, V43, pD453, DOI 10.1093/nar/gku946; Nath N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003642; Nelson D. L., 2017, LEHNINGER PRINCIPLES, P246; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rahman SA, 2014, NAT METHODS, V11, P171, DOI [10.1038/NMETH.2803, 10.1038/nmeth.2803]; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Ribeiro AJM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat9797; Ribeiro AJM, 2018, NUCLEIC ACIDS RES, V46, pD618, DOI 10.1093/nar/gkx1012; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sillitoe I, 2019, NUCLEIC ACIDS RES, V47, pD280, DOI 10.1093/nar/gky1097; Song JN, 2018, J THEOR BIOL, V443, P125, DOI 10.1016/j.jtbi.2018.01.023; Zeymer C, 2018, ANNU REV BIOCHEM, V87, P131, DOI 10.1146/annurev-biochem-062917-012034; ZVELEBIL MJJM, 1988, PROTEIN ENG, V2, P127, DOI 10.1093/protein/2.2.127	40	36	37	9	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					314	324		10.1074/jbc.REV119.006289	http://dx.doi.org/10.1074/jbc.REV119.006289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31796628	Green Published, hybrid			2022-12-28	WOS:000507373600004
J	Liu, TT; Sun, QS; Liu, Y; Cen, S; Zhang, Q				Liu, Tingting; Sun, Qingsong; Liu, Yong; Cen, Shan; Zhang, Quan			The MOV10 helicase restricts hepatitis B virus replication by inhibiting viral reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis B virus (HBV; Hep B); DNA viruses; innate immunity; RNA helicase; viral replication; liver disease; Moloney leukemia virus 10 (MOV10); RNA silencing; viral reverse transcription; virus-host interactions	RNA HELICASE; GENE-PRODUCTS; EXPRESSION; INTEGRATION; APOBEC3G; COMPLEX	Interferons inhibit viruses by inducing antiviral protein expression. One of the interferon-induced antiviral proteins, human Moloney leukemia virus 10 (MOV10), a superfamily 1 RNA helicase, has been shown to inhibit retroviruses and several RNA viruses. However, it remains undetermined whether MOV10 also inhibits DNA viruses, including hepatitis B virus (HBV). Here, we report that MOV10 dramatically reduces the levels of intracellular HBV DNA, resulting in significant inhibition of both the HBV experimental strain and the clinical isolates. Mechanistic experiments revealed that MOV10 interacts with HBV RNA and blocks the early step of viral reverse transcription, thereby impairing viral DNA synthesis, without affecting viral gene expression and pregenomic RNA encapsidation. Moreover, mutation of the helicase domain of MOV10 caused loss of binding to HBV RNA and of the anti-HBV activity. Together, our results indicate that MOV10 restricts HBV replication, insights that may open new avenues to the development of anti-HBV therapeutics.	[Liu, Tingting] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Transfus Med,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Qingsong] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Emergency, Huaian 223301, Peoples R China; [Liu, Yong; Zhang, Quan] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yong; Zhang, Quan] Nanjing Univ, Sch Med, Affiliated Hosp, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Zhang, Quan] Nanjing Med Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing University; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Nanjing Medical University; Nanjing University	Cen, S (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.; Zhang, Q (corresponding author), 321 Zhong Shan Rd, Nanjing 210008, Jiangsu, Peoples R China.	shancen@imb.pumc.edu.cn; huanlezq44@126.com			National Natural Science Foundation of China [81602400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81602400. The authors declare that they have no conflicts of interest with the contents of this article.	Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; FALLOWS DA, 1995, J VIROL, V69, P3067, DOI 10.1128/JVI.69.5.3067-3073.1995; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Gregersen LH, 2014, MOL CELL, V54, P573, DOI 10.1016/j.molcel.2014.03.017; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Izumi T, 2013, J VIROL, V87, P11047, DOI 10.1128/JVI.02070-13; Ko C, 2014, J VIROL, V88, P13689, DOI 10.1128/JVI.02035-14; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li XY, 2013, J BIOL CHEM, V288, P21148, DOI 10.1074/jbc.M113.465856; Liu YH, 2015, J VIROL, V89, P2287, DOI 10.1128/JVI.02760-14; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Lu HL, 2013, J IMMUNOL, V191, P3264, DOI 10.4049/jimmunol.1300512; Ma YX, 2015, VIRUS RES, V197, P85, DOI 10.1016/j.virusres.2014.12.011; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Okuyama-Dobashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17047; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schultz U, 1999, J VIROL, V73, P5459, DOI 10.1128/JVI.73.7.5459-5465.1999; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wu S, 2017, J VIROL, V91, DOI 10.1128/JVI.00519-17; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhang H, 2016, HEPATOLOGY, V64, P1033, DOI 10.1002/hep.28698; Zhang JS, 2016, J VIROL, V90, P3966, DOI 10.1128/JVI.03137-15; Zhang Q, 2018, VIRUS RES, V255, P165, DOI 10.1016/j.virusres.2018.07.021	40	12	12	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19804	19813		10.1074/jbc.RA119.009435	http://dx.doi.org/10.1074/jbc.RA119.009435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31722967	Green Published, hybrid			2022-12-28	WOS:000504093200027
J	Dasari, TK; Geiger, R; Karki, R; Banoth, B; Sharma, BR; Gurung, P; Burton, A; Kanneganti, TD				Dasari, Tejasvi K.; Geiger, Rechel; Karki, Rajendra; Banoth, Balaji; Sharma, Bhesh Raj; Gurung, Prajwal; Burton, Amanda; Kanneganti, Thirumala-Devi			The nonreceptor tyrosine kinase SYK drives caspase-8/NLRP3 inflammasome-mediated autoinflammatory osteomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; spleen tyrosine kinase (Syk); NLRP3; caspase 1 (CASP1); autoimmunity; caspase-8; chronic multifocal osteomyelitis (cmo); chronic recurrent multifocal osteomyelitis (CRMO); IL-1?	NLRP3 INFLAMMASOME; SIGNALING PATHWAY; ACTIVATION; IL-1-BETA; PROTEIN; PHOSPHORYLATION; PATHOGENESIS; RECEPTORS; COMPLEX; PSTPIP2	Chronic recurrent multifocal osteomyelitis (CRMO) in humans can be modeled in Pstpip2(cmo) mice, which carry a missense mutation in the proline?serine?threonine phosphatase?interacting protein 2 (Pstpip2) gene. As cmo disease in mice, the experimental model analogous to human CRMO, is mediated specifically by IL-1? and not by IL-1?, delineating the molecular pathways contributing to pathogenic IL-1? production is crucial to developing targeted therapies. In particular, our earlier findings support redundant roles of NLR family pyrin domain-containing 3 (NLRP3) and caspase-1 with caspase-8 in instigating cmo. However, the signaling components upstream of caspase-8 and pro-IL-1? cleavage in Pstpip2(cmo) mice are not well-understood. Therefore, here we investigated the signaling pathways in these mice and discovered a central role of a nonreceptor tyrosine kinase, spleen tyrosine kinase (SYK), in mediating osteomyelitis. Using several mutant mouse strains, immunoblotting, and microcomputed tomography, we demonstrate that absent in melanoma 2 (AIM2), receptor-interacting serine/ threonine protein kinase 3 (RIPK3), and caspase recruitment domain?containing protein 9 (CARD9) are each dispensable for osteomyelitis induction in Pstpip2(cmo) mice, whereas genetic deletion of Syk completely abrogates the disease phenotype. We further show that SYK centrally mediates signaling upstream of caspase-1 and caspase-8 activation and principally up-regulates NF-?B and IL-1? signaling in Pstpip2(cmo) mice, thereby inducing cmo. These results provide a rationale for directly targeting SYK and its downstream signaling components in CRMO.	[Dasari, Tejasvi K.; Geiger, Rechel; Karki, Rajendra; Banoth, Balaji; Sharma, Bhesh Raj; Gurung, Prajwal; Burton, Amanda; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Ste E7004, Memphis, TN 38105 USA; [Dasari, Tejasvi K.] Baylor Coll Med, Sch Med, Houston, TX 77030 USA; [Gurung, Prajwal] Univ Iowa, Inflammat Program, Iowa City, IA 52241 USA	St Jude Children's Research Hospital; Baylor College of Medicine; University of Iowa	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Ste E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Karki, Rajendra/H-6647-2019; Banoth, Balaji/ABF-7350-2020; Sharma, Bhesh Raj/H-3782-2014	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Karki, Rajendra/0000-0003-4436-9128; Sharma, Bhesh Raj/0000-0003-3609-833X; Gurung, Prajwal/0000-0002-7451-9433; Banoth, Balaji/0000-0002-7467-2198	National Institutes of Health [CA163507, AR056296, AI124346, AI101935]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institutes of Health Grants CA163507, AR056296, AI124346, and AI101935 and by the American Lebanese Syrian Associated Charities (to T.-D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Chitu V, 2009, BLOOD, V114, P2497, DOI 10.1182/blood-2009-02-204925; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Drobek A, 2015, J IMMUNOL, V195, P3416, DOI 10.4049/jimmunol.1401494; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Gurung P, 2017, IMMUNITY, V46, P635, DOI 10.1016/j.immuni.2017.03.014; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Hofmann SR, 2017, CURR OSTEOPOROS REP, V15, P542, DOI 10.1007/s11914-017-0405-9; Jurik AG, 2004, SEMIN MUSCULOSKEL R, V8, P243, DOI 10.1055/s-2004-835364; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Li YJ, 2016, HEMATOLOGY, V21, P144, DOI 10.1179/1607845415Y.0000000029; Lin YC, 2015, J LEUKOCYTE BIOL, V97, P825, DOI 10.1189/jlb.3HI0814-371RR; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Sharma BR, 2019, CELL DEATH DIFFER, V26, P741, DOI 10.1038/s41418-018-0159-7; Stern SM, 2013, RHEUM DIS CLIN N AM, V39, P735, DOI 10.1016/j.rdc.2013.05.002; Tartey S, 2018, J CLIN INVEST, V128, P2042, DOI 10.1172/JCI98446; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Wagener M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00225	40	8	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3394	3400		10.1074/jbc.RA119.010623	http://dx.doi.org/10.1074/jbc.RA119.010623			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31719149	Green Published, hybrid			2022-12-28	WOS:000527725300001
J	Richter, AA; Kobus, S; Czech, L; Hoeppner, A; Zarzycki, J; Erb, TJ; Lauterbach, L; Dickschat, JS; Bremer, E; Smits, SHJ				Richter, Alexandra A.; Kobus, Stefanie; Czech, Laura; Hoeppner, Astrid; Zarzycki, Jan; Erb, Tobias J.; Lauterbach, Lukas; Dickschat, Jeroen S.; Bremer, Erhard; Smits, Sander H. J.			The architecture of the diaminobutyrate acetyltransferase active site provides mechanistic insight into the biosynthesis of the chemical chaperone ectoine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; crystal structure; enzyme; stress response; acetyltransferase; chemical chaperone; L-2; 4-diaminobutyrate; reaction mechanism; structural biology	COMPATIBLE SOLUTE HYDROXYECTOINE; ORGANIC OSMOLYTES; AMINO-ACID; IN-VITRO; PROTEIN; BACTERIA; STRESS; MUTANT; CRYSTALLIZATION; OSMOADAPTATION	Ectoine is a solute compatible with the physiologies of both prokaryotic and eukaryotic cells and is widely synthesized by bacteria as an osmotic stress protectant. Because it preserves functional attributes of proteins and macromolecular complexes, it is considered a chemical chaperone and has found numerous practical applications. However, the mechanism of its biosynthesis is incompletely understood. The second step in ectoine biosynthesis is catalyzed by l-2,4-diaminobutyrate acetyltransferase (EctA; EC 2.3.1.178), which transfers the acetyl group from acetyl-CoA to EctB-formed l-2,4-diaminobutyrate (DAB), yielding N-?-acetyl-l-2,4-diaminobutyrate (N-?-ADABA), the substrate of ectoine synthase (EctC). Here, we report the biochemical and structural characterization of the EctA enzyme from the thermotolerant bacterium Paenibacillus lautus (Pl). We found that (Pl)EctA forms a homodimer whose enzyme activity is highly regiospecific by producing N-?-ADABA but not the ectoine catabolic intermediate N-?-acetyl-l-2,4-diaminobutyric acid. High-resolution crystal structures of (Pl)EctA (at 1.2?2.2 ? resolution) (i) for its apo-form, (ii) in complex with CoA, (iii) in complex with DAB, (iv) in complex with both CoA and DAB, and (v) in the presence of the product N-?-ADABA were obtained. To pinpoint residues involved in DAB binding, we probed the structure-function relationship of (Pl)EctA by site-directed mutagenesis. Phylogenomics shows that EctA-type proteins from both Bacteria and Archaea are evolutionarily highly conserved, including catalytically important residues. Collectively, our biochemical and structural findings yielded detailed insights into the catalytic core of the EctA enzyme that laid the foundation for unraveling its reaction mechanism.	[Richter, Alexandra A.; Czech, Laura; Bremer, Erhard] Philipps Univ Marburg, Dept Biol, Lab Microbiol, Karl von Frisch Str 8, D-35043 Marburg, Germany; [Richter, Alexandra A.; Czech, Laura; Erb, Tobias J.; Bremer, Erhard] Philipps Univ Marburg, SYNMIKRO Res Ctr, D-35043 Marburg, Germany; [Kobus, Stefanie; Hoeppner, Astrid; Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Ctr Struct Studies, Dusseldorf, Germany; [Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Zarzycki, Jan; Erb, Tobias J.] Max Planck Inst Terr Microbiol, Dept Biochem & Synthet Metab, D-35043 Marburg, Germany; [Lauterbach, Lukas; Dickschat, Jeroen S.] Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany	Philipps University Marburg; Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Max Planck Society; University of Bonn	Bremer, E (corresponding author), Philipps Univ Marburg, Dept Biol, Lab Microbiol, Karl von Frisch Str 8, D-35043 Marburg, Germany.; Smits, SHJ (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	bremer@staff.uni-marburg.de; sander.smits@hhu.de	Czech, Laura/AAB-7425-2019	Zarzycki, Jan/0000-0002-6307-6497; Hoeppner, Astrid/0000-0002-7076-5936; Czech, Laura/0000-0001-7398-1186	Deutsche Forschungsgemeinschaft (DFG) [INST 160/621-1 FUGG]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We cordially acknowledge the staff of beamline P13 (DESY, EMBL, Hamburg, Germany) for kind and helpful support during crystal screening, and we are equally thankful to the staff of the ID23-1, ID29, ID30B, and ID30A-3 beamlines of the European Synchrotron Radiation Facility (Grenoble, France) for expertly providing synchrotron radiation facilities. We greatly appreciate the generous gift of ectoine by the bitop AG (Witten, Germany) for our study. We thank Jochen Sohn for excellent technical assistance during EctA protein overproduction and purification. We are thankful to Dr. Uwe Linne (Department of Chemistry, Philipps-University Marburg) for performing the MS analysis of recombinant (Pl)EctA proteins; access to the MS facilities of the Department of Chemistry of the PhilippsUniversity Marburg is gratefully acknowledged. We thank the Deutsche Forschungsgemeinschaft (DFG) for co-financing the SynaptG2Si mass spectrometer (Grant INST 160/621-1 FUGG to U. Linne and G. Bange). We appreciate the kind support of Lutz Schmitt (Institute of Biochemistry, University Dusseldorf) for this project. We are very grateful to Gert Bange for critical reading of the manuscript and many inspiring discussions. We particularly acknowledge and thank Alexander Lepak (SYNMIKRO Research Center, Philipps-University) for producing the video visualizing the predicted enzyme reaction mechanism of the L-2,4-diaminobutyrate acetyltransferase EctA.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], [No title captured]; Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; Booth IR, 2014, CURR OPIN MICROBIOL, V18, P16, DOI 10.1016/j.mib.2014.01.005; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Bownik A, 2016, ARH HIG RADA TOKSIKO, V67, P260, DOI 10.1515/aiht-2016-67-2837; Brands S, 2019, ARCH BIOCHEM BIOPHYS, V674, DOI 10.1016/j.abb.2019.108097; Bremer E, 2019, ANNU REV MICROBIOL, V73, P313, DOI 10.1146/annurev-micro-020518-115504; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruce H, 2012, ACTA CRYSTALLOGR F, V68, P1175, DOI 10.1107/S1744309112030023; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Czech L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36247-w; Czech L, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040177; Czech L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005163; Czech L, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01772-17; da Costa M. S., 1998, V61, P117; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Gunde-Cimerman N, 2018, FEMS MICROBIOL REV, V42, P353, DOI 10.1093/femsre/fuy009; Hahn MB, 2017, PHYS CHEM CHEM PHYS, V19, P25717, DOI 10.1039/c7cp02860a; Harding T, 2016, GENOME BIOL EVOL, V8, P2241, DOI 10.1093/gbe/evw152; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Herzog M, 2019, COLLOID SURFACE B, V178, P404, DOI 10.1016/j.colsurfb.2019.03.026; Hoppner A, 2014, J BIOL CHEM, V289, P29570, DOI 10.1074/jbc.M114.576769; Hoeppner A, 2014, ACTA CRYSTALLOGR F, V70, P493, DOI 10.1107/S2053230X14004798; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; INBAR L, 1988, J BIOL CHEM, V263, P16014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Kobus S, 2015, ACTA CRYSTALLOGR F, V71, P1027, DOI 10.1107/S2053230X15011115; Kolp S, 2006, BBA-PROTEINS PROTEOM, V1764, P1234, DOI 10.1016/j.bbapap.2006.04.015; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Kunte HJ, 2014, CURR BIOTECHNOL, V3, P10, DOI [10.2174/22115501113026660037, DOI 10.2174/22115501113026660037]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Manzanera M, 2004, FEMS MICROBIOL LETT, V233, P347, DOI 10.1016/j.femsle.2004.03.005; Mead DA, 2012, STAND GENOMIC SCI, V6, P366, DOI 10.4056/sigs.2605792; Meyer S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07441-z; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2011, METHOD ENZYMOL, P15, DOI 10.1016/B978-0-12-386905-0.00002-4; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Richter AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02811; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Sahin Erinc, 2012, Methods Mol Biol, V899, P403, DOI 10.1007/978-1-61779-921-1_25; Salvador M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01845; Schroter MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15512-4; Schulz A, 2017, ENVIRON MICROBIOL, V19, P4599, DOI 10.1111/1462-2920.13924; Schulz A, 2017, ENVIRON MICROBIOL, V19, P926, DOI 10.1111/1462-2920.13414; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Stadmiller SS, 2017, J MOL BIOL, V429, P1155, DOI 10.1016/j.jmb.2017.03.001; Stiller LM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040184; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Sun H, 2012, CRYOLETTERS, V33, P485; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Tramonti A, 2018, FEBS J, V285, P3925, DOI 10.1111/febs.14599; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; van den Berg J, 2017, NAT REV MICROBIOL, V15, P309, DOI 10.1038/nrmicro.2017.17; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wedeking A, 2014, CURR MED CHEM, V21, P2565, DOI 10.2174/0929867321666131228222730; Weinisch L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003892; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156; Widderich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151285; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yanykin DV, 2019, PHOTOSYNTH RES, V141, P165, DOI 10.1007/s11120-019-00617-w; Zaccai G, 2016, SCI REP-UK, V6, DOI 10.1038/srep31434	97	10	12	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2822	2838		10.1074/jbc.RA119.011277	http://dx.doi.org/10.1074/jbc.RA119.011277			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969391	Green Published, hybrid			2022-12-28	WOS:000519969100024
J	Chrissian, C; Camacho, E; Fu, MS; Prados-Rosales, R; Chatterjee, S; Cordero, RJB; Lodge, JK; Casadevall, A; Stark, RE				Chrissian, Christine; Camacho, Emma; Fu, Man Shun; Prados-Rosales, Rafael; Chatterjee, Subhasish; Cordero, Radames J. B.; Lodge, Jennifer K.; Casadevall, Arturo; Stark, Ruth E.			Melanin deposition in two Cryptococcus species depends on cell-wall composition and flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell wall; polysaccharide; nuclear magnetic resonance (NMR); solid state NMR; Cryptococcus; melanin; molecular structure; opportunistic pathogen; virulence factor	SOLID-STATE NMR; DEACETYLATED CHITINS CHITOSANS; VANCOUVER-ISLAND; NEOFORMANS; VIRULENCE; GATTII; MELANIZATION; OUTBREAK; POLYSACCHARIDE; BIOSYNTHESIS	Cryptococcus neoformans and Cryptococcus gattii are two species complexes in the large fungal genus Cryptococcus and are responsible for potentially lethal disseminated infections. These two complexes share several phenotypic traits, such as production of the protective compound melanin. In C. neoformans, the pigment associates with key cellular constituents that are essential for melanin deposition within the cell wall. Consequently, melanization is modulated by changes in cell-wall composition or ultrastructure. However, whether similar factors influence melanization in C. gattii is unknown. Herein, we used transmission EM, biochemical assays, and solid-state NMR spectroscopy of representative isolates and ?leaky melanin? mutant strains from each species complex to examine the compositional and structural factors governing cell-wall pigment deposition in C. neoformans and C. gattii. The principal findings were the following. 1) C. gattii R265 had an exceptionally high chitosan content compared with C. neoformans H99; a rich chitosan composition promoted homogeneous melanin distribution throughout the cell wall but did not increase the propensity of pigment deposition. 2) Strains from both species manifesting the leaky melanin phenotype had reduced chitosan content, which was compensated for by the production of lipids and other nonpolysaccharide constituents that depended on the species or mutation. 3) Changes in the relative rigidity of cell-wall chitin were associated with aberrant pigment retention, implicating cell-wall flexibility as an independent variable in cryptococcal melanin assembly. Overall, our results indicate that cell-wall composition and molecular architecture are critical factors for the anchoring and arrangement of melanin pigments in both C. neoformans and C. gattii species complexes.	[Chrissian, Christine; Chatterjee, Subhasish; Stark, Ruth E.] CUNY City Coll, Dept Chem & Biochem, MR 1024, New York, NY 10031 USA; [Chrissian, Christine; Chatterjee, Subhasish; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Chrissian, Christine; Stark, Ruth E.] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Stark, Ruth E.] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA; [Camacho, Emma; Fu, Man Shun; Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Prados-Rosales, Rafael] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10033 USA; [Prados-Rosales, Rafael] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth & Microbiol, E-28049 Madrid, Spain; [Lodge, Jennifer K.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Chatterjee, Subhasish] Columbia Univ, Dept Chem, Barnard Coll, New York, NY 10027 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Autonomous University of Madrid; Washington University (WUSTL); Columbia University	Stark, RE (corresponding author), CUNY City Coll, Dept Chem & Biochem, MR 1024, New York, NY 10031 USA.	rstark@ccny.cuny.edu	Prados-Rosales, Rafael/D-5840-2019; Chatterjee, Subhasish/AAT-6069-2020; Cordero, Radames JB/F-6912-2011	Prados-Rosales, Rafael/0000-0001-5964-0166; Chatterjee, Subhasish/0000-0003-1351-3537; Chrissian, Christine/0000-0003-2858-4864; Cordero, Radames JB/0000-0002-3026-7094; Stark, Ruth E/0000-0002-3132-4580	National Institutes of Health [R01-AI052733]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01-AI052733 (to A. C. and R. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the respon-sibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agustinho DP, 2019, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180040; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Baker LG, 2009, EUKARYOT CELL, V8, P1692, DOI 10.1128/EC.00227-09; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; BULL A T, 1970, Journal of General Microbiology, V63, P75; Camacho E, 2017, MICROBIOL-SGM, V163, P1540, DOI 10.1099/mic.0.000552; Casadevall A, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00103-17, 10.1128/msphere.00103-17]; Chatterjee S, 2018, J BIOL CHEM, V293, P20157, DOI 10.1074/jbc.RA118.005791; Chatterjee S, 2015, J BIOL CHEM, V290, P13779, DOI 10.1074/jbc.M114.618389; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chowdhary A, 2012, CRIT REV MICROBIOL, V38, P1, DOI 10.3109/1040841X.2011.606426; Cui JH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010061; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; EMMONS CW, 1955, AM J HYG, V62, P227, DOI 10.1093/oxfordjournals.aje.a119775; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Freij JB, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00946-17, 10.1128/iai.00946-17]; Gerstein AC, 2017, YEAST, V34, P143, DOI 10.1002/yea.3222; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Grifoll-Romero L, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10040352; Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y; HING AW, 1993, J MAGN RESON SER A, V103, P151, DOI 10.1006/jmra.1993.1146; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; Kwon-Chung KJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00357-16; Lam WC, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00644-19; Latge JP, 2014, CURR OPIN MICROBIOL, V20, P111, DOI 10.1016/j.mib.2014.05.009; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Liu L, 1999, INFECT IMMUN, V67, P108, DOI 10.1128/IAI.67.1.108-112.1999; May RC, 2016, NAT REV MICROBIOL, V14, P106, DOI 10.1038/nrmicro.2015.6; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Oh DX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23245; P?rez P., 2013, LAB PROTOCOLS FUNGAL, P175, DOI 10.1007/978-1-4614-2356-0_12; Perez Pilar, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.top079897; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; Quemeneur F, 2008, BIOMACROMOLECULES, V9, P396, DOI 10.1021/bm700943j; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1261, DOI 10.1128/JCM.34.5.1261-1263.1996; Stavenga DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049743; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tsirilakis K, 2012, MYCOPATHOLOGIA, V173, P83, DOI 10.1007/s11046-011-9483-x; VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S; VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2; Walker CA, 2010, EUKARYOT CELL, V9, P1329, DOI 10.1128/EC.00051-10; Walker L, 2018, MBIO, V9, DOI 10.1128/mBio.02383-17; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang Z, 1999, INFECT IMMUN, V67, P6619; Watson HR, 2009, BIOMACROMOLECULES, V10, P793, DOI 10.1021/bm8012814; Weinhold MX, 2009, CARBOHYD POLYM, V78, P678, DOI 10.1016/j.carbpol.2009.06.001; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; Williamson PR, 1998, J BACTERIOL, V180, P1570, DOI 10.1128/JB.180.6.1570-1572.1998; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang YC, 2012, J PHYS CHEM B, V116, P1579, DOI 10.1021/jp210043w; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	65	21	21	4	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1815	1828		10.1074/jbc.RA119.011949	http://dx.doi.org/10.1074/jbc.RA119.011949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31896575	Green Published, hybrid			2022-12-28	WOS:000517128200004
J	Srivastava, RK; Moliner, A; Lee, ES; Nickles, E; Sim, E; Liu, C; Schwarz, H; Ibanez, CF				Srivastava, Raj Kamal; Moliner, Annalena; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.			CD137 negatively affects ?browning? of white adipose tissue during cold exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue metabolism; adipocyte; adipogenesis; adipose tissue; adipokine; beige adipocyte; brite adipocyte; thermogenesis; UCP1	BEIGE; ADIPOCYTES; DISTINCT; MOUSE; CELL	Prolonged cold exposure stimulates the formation of brownlike adipocytes expressing UCP1 (uncoupling-protein-1) in subcutaneous white adipose tissue which, together with classical brown adipose tissue, contributes to maintaining body temperature in mammals through nonshivering thermogenesis. The mechanisms that regulate the formation of these cells, alternatively called beige or brite adipocytes, are incompletely understood. Here we report that mice lacking CD137, a cell surface protein used in several studies as a marker for beige adipocytes, showed elevated levels of thermogenic markers, including UCP1, increased numbers of beige adipocyte precursors, and expanded UCP1-expressing cell clusters in inguinal white adipose tissue after chronic cold exposure. CD137 knockout mice also showed enhanced cold resistance. These results indicate that CD137 functions as a negative regulator of ?browning? in white adipose tissue and call into question the use of this protein as a functional marker for beige adipocytes.	[Srivastava, Raj Kamal; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Srivastava, Raj Kamal; Moliner, Annalena; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Moliner, Annalena; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Ibanez, Carlos F.] Stellenbosch Univ, Stellenbosch Inst Adv Study, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Srivastava, Raj Kamal] Indira Gandhi Natl Tribal Univ, Amarkantak, India	National University of Singapore; National University of Singapore; Karolinska Institutet; Stellenbosch University; Indira Gandhi National Tribal University	Ibanez, CF (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore.; Ibanez, CF (corresponding author), Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore.; Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Ibanez, CF (corresponding author), Stellenbosch Univ, Stellenbosch Inst Adv Study, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa.	phscfi@nus.edu.sg	Srivastava, Raj Kamal/G-4853-2011	Srivastava, Raj Kamal/0000-0001-9328-146X; Sim, Eunice/0000-0002-0955-8807	Singapore National Medical Research Council [NMRC/CBRG/0107/2016, NMRC/BnB/018b/2015]; National University of Singapore; Swedish Research Council (Vetenskapsradet) [2016-01538]	Singapore National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	This work was supported by Singapore National Medical Research Council Grants NMRC/CBRG/0107/2016 (to C. F. I.) and NMRC/BnB/018b/2015 (to H. S.), National University of Singapore Aspiration Fund Partner (to C. F. I.), and Swedish Research Council (Vetenskapsradet) Grant 2016-01538 (to C. F. I.). The authors declare that they have no conflicts of interest with the contents of this article.	de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Dharmadhikari B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1113367; Garcia RA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0081-2; Guo TQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03245; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Igarashi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32803-6; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kim CS, 2011, DIABETES, V60, P3159, DOI 10.2337/db10-1805; Kim CS, 2010, ENDOCRINOLOGY, V151, P4725, DOI 10.1210/en.2010-0346; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sanchez-Gurmaches J, 2016, TRENDS CELL BIOL, V26, P313, DOI 10.1016/j.tcb.2016.01.004; SCHWARZ H, 1995, BLOOD, V85, P1043, DOI 10.1182/blood.V85.4.1043.bloodjournal8541043; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Thum E, 2009, FRONT BIOSCI-LANDMRK, V14, P4173, DOI 10.2741/3521; Ussar S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008490; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	21	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2034	2042		10.1074/jbc.AC119.011795	http://dx.doi.org/10.1074/jbc.AC119.011795			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919095	Green Published, hybrid			2022-12-28	WOS:000517128200021
J	Werner, MT; Wang, HX; Hamagami, N; Hsu, SC; Yano, JA; Stonestrom, AJ; Behera, V; Zong, YC; Mackay, JP; Blobel, GA				Werner, Michael T.; Wang, Hongxin; Hamagami, Nicole; Hsu, Sarah C.; Yano, Jennifer A.; Stonestrom, Aaron J.; Behera, Vivek; Zong, Yichen; Mackay, Joel P.; Blobel, Gerd A.			Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; transcription regulation; chromatin; protein structure; bromodomain-containing protein 4 (BRD4); bromodomain and extraterminal motif (BET) proteins; bromodomain-containing protein 2 (BRD2); bromodomain-containing protein 3 (BRD3); RNA polymerase II-associated factor (PAF)	HISTONE H4 RECOGNITION; P-TEFB; TRANSCRIPTIONAL ELONGATION; SELECTIVE-INHIBITION; DOSE-ESCALATION; 2ND BROMODOMAIN; CHROMATIN; DOMAIN; BRD4; MECHANISM	The widely expressed bromodomain and extraterminal motif (BET) proteins bromodomain-containing protein 2 (BRD2), BRD3, and BRD4 are multifunctional transcriptional regulators that bind acetylated chromatin via their conserved tandem bromodomains. Small molecules that target BET bromodomains are being tested for various diseases but typically do not discern between BET family members. Genomic distributions and protein partners of BET proteins have been described, but the basis for differences in BET protein function within a given lineage remains unclear. By establishing a gene knockout-rescue system in a Brd2-null erythroblast cell line, here we compared a series of mutant and chimeric BET proteins for their ability to modulate cell growth, differentiation, and gene expression. We found that the BET N-terminal halves bearing the bromodomains convey marked differences in protein stability but do not account for specificity in BET protein function. Instead, when BET proteins were expressed at comparable levels, their specificity was largely determined by the C-terminal half. Remarkably, a chimeric BET protein comprising the N-terminal half of the structurally similar short BRD4 isoform (BRD4S) and the C-terminal half of BRD2 functioned similarly to intact BRD2. We traced part of the BRD2-specific activity to a previously uncharacterized short segment predicted to harbor a coiled-coil (CC) domain. Deleting the CC segment impaired BRD2's ability to restore growth and differentiation, and the CC region functioned in conjunction with the adjacent ET domain to impart BRD2-like activity onto BRD4S. In summary, our results identify distinct BET protein domains that regulate protein turnover and biological activities.	[Werner, Michael T.; Wang, Hongxin; Hamagami, Nicole; Hsu, Sarah C.; Yano, Jennifer A.; Stonestrom, Aaron J.; Behera, Vivek; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Werner, Michael T.; Hsu, Sarah C.; Stonestrom, Aaron J.; Behera, Vivek; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zong, Yichen; Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Sydney	Werner, MT (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Blobel, GA (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr 316H, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	miwerner@pennmedicine.upenn.edu; blobel@email.chop.edu	Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Stonestrom, Aaron/0000-0002-0602-1158; Hamagami, Nicole/0000-0003-2063-7626	National Institutes of Health [R01DK054937, R37DK058044, T32HL007439, F30DK112573]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01DK054937 and R37DK058044 (to G. A. B.) and T32HL007439 and F30DK112573 (to M. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alsarraj J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080746; Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Andrieu GP, 2018, MOL CANCER RES, V16, P580, DOI 10.1158/1541-7786.MCR-17-0568; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Chen Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09257-z; Conrad RJ, 2017, MOL CELL, V67, P1001, DOI 10.1016/j.molcel.2017.07.025; Crowe BL, 2016, P NATL ACAD SCI USA, V113, P2086, DOI 10.1073/pnas.1516813113; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deeney JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151329; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Fontanals-Cirera B, 2017, MOL CELL, V68, P731, DOI 10.1016/j.molcel.2017.11.004; Fukazawa H, 2012, BIOL PHARM BULL, V35, P2064, DOI 10.1248/bpb.b12-00527; Garcia-Gutierrez P, 2012, J CELL SCI, V125, P3671, DOI 10.1242/jcs.105841; Guo N, 2000, J CELL SCI, V113, P3085; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hnilicova J, 2013, MOL BIOL CELL, V24, P3557, DOI 10.1091/mbc.E13-06-0303; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Izumikawa K, 2019, NUCLEIC ACIDS RES, V47, P10357, DOI 10.1093/nar/gkz747; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Khoueiry P, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0286-5; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lambert JP, 2019, MOL CELL, V73, P621, DOI 10.1016/j.molcel.2018.11.006; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Leroy G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r68; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luna-Pelaez N, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1792-x; Luna-Pelaez N, 2018, J MOL BIOL, V430, P1084, DOI 10.1016/j.jmb.2018.02.023; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muhar M, 2018, SCIENCE, V360, P800, DOI 10.1126/science.aao2793; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Olley G, 2018, NAT GENET, V50, P329, DOI 10.1038/s41588-018-0042-y; Paralkar VR, 2014, BLOOD, V123, P1927, DOI 10.1182/blood-2013-12-544494; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Smith SG, 2016, ACS CHEM BIOL, V11, P598, DOI 10.1021/acschembio.5b00831; Stonestrom Aaron J, 2016, Drug Discov Today Technol, V19, P23, DOI 10.1016/j.ddtec.2016.05.004; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taniguchi Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111849; Truebestein L, 2016, BIOESSAYS, V38, P903, DOI 10.1002/bies.201600062; Umehara T, 2010, FEBS LETT, V584, P3901, DOI 10.1016/j.febslet.2010.08.013; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Wai DCC, 2018, J BIOL CHEM, V293, P7160, DOI 10.1074/jbc.RA117.000678; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zhang Q, 2016, STRUCTURE, V24, P1201, DOI 10.1016/j.str.2016.04.019	72	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1898	1914		10.1074/jbc.RA119.010679	http://dx.doi.org/10.1074/jbc.RA119.010679			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31792058	hybrid, Green Published			2022-12-28	WOS:000517128200011
J	Shrestha, BK; Rasmussen, MS; Abudu, YP; Bruun, JA; Larsen, KB; Alemu, EA; Sjottem, E; Lamark, T; Johansen, T				Shrestha, Birendra Kumar; Rasmussen, Mads Skytte; Abudu, Yakubu Princely; Bruun, Jack-Ansgar; Larsen, Kenneth Bowitz; Alemu, Endalkachew A.; Sjottem, Eva; Lamark, Trond; Johansen, Terje			NIMA-related kinase 9-mediated phosphorylation of the microtubule-associated LC3B protein at Thr-50 suppresses selective autophagy of p62/sequestosome 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; protein kinase; MST1 (mammalian sterile 20-like kinase 1); MST2 (mammalian sterile 20-like kinase 2); protein-protein interaction; LC3B; LDS; LIR; NIMA-related kinase 9 (NEK9); serine; threonine kinase 3 (STK3)	STRUCTURAL BASIS; LIR MOTIF; ATG8; MECHANISM; P62/SQSTM1; DEGRADATION; MATURATION; PATHWAYS; BINDING; FAMILY	Human ATG8 family proteins (ATG8s) are active in all steps of the macroautophagy pathway, and their lipidation is essential for autophagosome formation. Lipidated ATG8s anchored to the outer surface of the phagophore serve as scaffolds for binding of other core autophagy proteins and various effector proteins involved in trafficking or fusion events, whereas those at the inner surface are needed for assembly of selective autophagy substrates. Their scaffolding role depends on specific interactions between the LC3-interacting region (LIR) docking site (LDS) in ATG8s and LIR motifs in various interaction partners. LC3B is phosphorylated at Thr-50 within the LDS by serine/threonine kinase (STK) 3 and STK4. Here, we identified LIR motifs in STK3 and atypical protein kinase C zeta (PKC zeta) and never in mitosis A (NIMA)-related kinase 9 (NEK9). All three kinases phosphorylated LC3B Thr-50 in vitro. A phospho-mimicking substitution of Thr-50 impaired binding of several LIR-containing proteins, such as ATG4B, FYVE, and coiled-coil domain-containing 1 (FYCO1), and autophagy cargo receptors p62/sequestosome 1 (SQSTM1) and neighbor of BRCA1 gene (NBR1). NEK9 knockdown or knockout enhanced degradation of the autophagy receptor and substrate p62. Of note, the suppression of p62 degradation was mediated by NEK9-mediated phosphorylation of LC3B Thr-50. Consistently, reconstitution of LC3B-KO cells with the phospho-mimicking T50E variant inhibited autophagic p62 degradation. PKC zeta knockdown did not affect autophagic p62 degradation, whereas STK3/4 knockouts inhibited autophagic p62 degradation independently of LC3B Thr-50 phosphorylation. Our findings suggest that NEK9 suppresses LC3B-mediated autophagy of p62 by phosphorylating Thr-50 within the LDS of LC3B.	[Shrestha, Birendra Kumar; Rasmussen, Mads Skytte; Abudu, Yakubu Princely; Bruun, Jack-Ansgar; Larsen, Kenneth Bowitz; Alemu, Endalkachew A.; Sjottem, Eva; Lamark, Trond; Johansen, Terje] UiT Arctic Univ Norway, Dept Med Biol, Mol Canc Res Grp, Fac Hlth Sci, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Johansen, T (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Mol Canc Res Grp, Fac Hlth Sci, N-9037 Tromso, Norway.	terje.johansen@uit.no	Abudu, Yakubu Princely/AAN-1792-2020; Johansen, Terje/N-2971-2015; Larsen, Kenneth/HDO-5510-2022; Johansen, Terje/AAY-1753-2021	Abudu, Yakubu Princely/0000-0002-8798-270X; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Shrestha, Birendra Kumar/0000-0002-8972-0308; Bruun, Jack-Ansgar/0000-0003-0614-2790; Sjottem, Eva/0000-0003-2668-1708	Research Council of Norway [214448, 249884]; Norwegian Cancer Society [71043-PR-2006-0320]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by FRIBIOMED Program Grant 214448 and TOP-PFORSK Program Grant 249884 of the Research Council of Norway and Norwegian Cancer Society Grant 71043-PR-2006-0320 (to T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Baisamy L, 2009, J BIOL CHEM, V284, P28232, DOI 10.1074/jbc.M109.054668; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Johansen T, 2017, METHOD ENZYMOL, V587, P143, DOI 10.1016/bs.mie.2016.10.023; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kumar S, 2018, J CELL BIOL, V217, P997, DOI 10.1083/jcb.201708039; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lamark T, 2017, ESSAYS BIOCHEM, V61, P609, DOI 10.1042/EBC20170035; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Luhr M, 2018, JOVE-J VIS EXP, DOI 10.3791/57971; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Maruyama Y, 2014, BIOCHEM BIOPH RES CO, V446, P309, DOI 10.1016/j.bbrc.2014.02.093; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Olsvik HL, 2015, J BIOL CHEM, V290, P29361, DOI 10.1074/jbc.M115.686915; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Qu LJ, 2016, BIOCHEM BIOPH RES CO, V470, P306, DOI 10.1016/j.bbrc.2016.01.059; Rasmussen MS, 2017, AUTOPHAGY, V13, P834, DOI 10.1080/15548627.2017.1287651; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Vaites LP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00392-17; von Muhlinen N, 2013, AUTOPHAGY, V9, P784, DOI 10.4161/auto.23698; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wen X, 2016, J MOL BIOL, V428, P1681, DOI 10.1016/j.jmb.2016.02.021; Wilkinson DS, 2015, MOL CELL, V57, P55, DOI 10.1016/j.molcel.2014.11.019; Wirth M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10059-6; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	66	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1240	1260		10.1074/jbc.RA119.010068	http://dx.doi.org/10.1074/jbc.RA119.010068			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31857374	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000513822300007
J	Werneck-de-Castro, JP; Blandino-Rosano, M; Hilfiker-Kleiner, D; Bernal-Mizrachi, E				Werneck-de-Castro, Joao Pedro; Blandino-Rosano, Manuel; Hilfiker-Kleiner, Denise; Bernal-Mizrachi, Ernesto			Glucose stimulates microRNA-199 expression in murine pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); beta-cell; pancreatic islet; glucose metabolism; pancreas; islet function; microRNA expression; miR-199	INSULIN-SECRETION; IDENTIFICATION; TRANSCRIPTION; MIR-199A; PATHWAY; CANCER; MTOR; PROLIFERATION; DYSFUNCTION; BIOGENESIS	MicroRNA 199 (miR-199) negatively impacts pancreatic beta-cell function and its expression is highly increased in islets from diabetic mice as well as in plasma of diabetic patients. Here we investigated how miR-199 expression is regulated in beta-cells by assessing expression of miR-199 precursors (primiR-199a1, primiR-199a2, and primiR-199b) and mature miR-199 (miR-199-3p and miR-199-5p) and promoter transcriptional activity assays in mouse islets and mouse insulinoma cells (MIN6) under different stimuli. We found that mouse islets equally express miR-199-3p and miR-199-5p. However, the primiRNA expression levels differed; although primiR-199a1 expression was about 30% greater than that of primiR-199a2, primiR-199b is barely detected in islets. We observed a 2-fold increase in primiR-199a1 and primiR-199a2 mRNA levels in mouse islets cultured in 10 mm glucose compared with 5.5 mm glucose. Similar responses to glucose were observed in MIN6 cells. Exposure to 30 mm KCl to induce membrane depolarization and calcium influx increased expression of primiR-199a2 but not of primiR-199a1 in MIN6 cells, indicating that calcium influx was involved. Transcriptional activity studies in MIN6 cells also revealed that primiR-199a2 promoter activity was enhanced by glucose and reduced by 2-deoxy-D-glucose-induced starvation. KCl and the potassium channel blocker tolbutamide also stimulated primiR-199a2 promoter activity. Calcium channel blockade by nifedipine reduced primiR-199a2 promoter activity in MIN6 cells, and diazoxide-mediated calcium influx inhibition blunted glucose up-regulation of miR-199-3p in islets. In conclusion, we uncover that glucose acutely up-regulates miR-199 family expression in beta-cells. Glucose metabolism and calcium influx are involved in primiR-199a2 expression but not primiR-199a1 expression.	[Werneck-de-Castro, Joao Pedro; Blandino-Rosano, Manuel; Bernal-Mizrachi, Ernesto] Univ Miami, Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Werneck-de-Castro, Joao Pedro; Bernal-Mizrachi, Ernesto] Miami Vet Affairs Hlth Care Syst, Miami, FL 33136 USA; [Hilfiker-Kleiner, Denise] Med Sch Hannover, Dept Cardiol & Angiol, D-30625 Hannover, Germany	University of Miami; Hannover Medical School	Bernal-Mizrachi, E (corresponding author), Univ Miami, Dept Endocrinol Diabet & Metab, Miami, FL 33009 USA.	ebernalm@med.miami.edu		Blandino-Rosano, Manuel/0000-0002-1712-8233; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930	National Institutes of Health [RO1-DK-084236]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RO1-DK-084236 (to E. B.-M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; Aranda JF, 2015, J CELL SCI, V128, P3197, DOI 10.1242/jcs.165233; Ardestani A, 2018, CELL METAB, V27, P314, DOI 10.1016/j.cmet.2017.11.004; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bijkerk R, 2019, NUCLEIC ACID THER, V29, P67, DOI 10.1089/nat.2018.0763; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Chakraborty C, 2013, CURR DRUG TARGETS, V14, P1110, DOI 10.2174/13894501113149990182; Cheong MW, 2015, J MOL MED, V93, P807, DOI 10.1007/s00109-015-1272-4; Dumortier O, 2014, DIABETES, V63, P3416, DOI 10.2337/db13-1431; Eliasson L, 2017, MOL CELL ENDOCRINOL, V456, P95, DOI 10.1016/j.mce.2017.02.043; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Eto K, 2007, J BIOL CHEM, V282, P5973, DOI 10.1074/jbc.M607288200; Eto K, 2006, ENDOCRINOLOGY, V147, P2923, DOI 10.1210/en.2005-1336; Filios SR, 2015, DIABETES, V64, P3631, DOI 10.2337/db15-0831; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fu JY, 2018, J CELL PHYSIOL, V233, P2292, DOI 10.1002/jcp.26101; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gu DN, 2017, CANCER LETT, V400, P69, DOI 10.1016/j.canlet.2017.04.020; Gu S, 2012, INT J MOL SCI, V13, P8449, DOI 10.3390/ijms13078449; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Josefsen K, 1999, DIABETOLOGIA, V42, P195, DOI 10.1007/s001250051139; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Roat R, 2017, AM J TRANSPLANT, V17, P992, DOI 10.1111/ajt.14073; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Sandovici I, 2013, CELL MOL LIFE SCI, V70, P1575, DOI 10.1007/s00018-013-1297-1; Sands WA, 2017, J PHYSIOL-LONDON, V595, P6383, DOI 10.1113/JP274334; Song GA, 2010, BIOL PHARM BULL, V33, P1822, DOI 10.1248/bpb.33.1822; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Webb GC, 2000, P NATL ACAD SCI USA, V97, P5773, DOI 10.1073/pnas.100126597; Wu D, 2013, INT J GYNECOL CANCER, V23, P1191, DOI 10.1097/IGC.0b013e31829ea779; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yan ST, 2014, MOL CELL BIOCHEM, V397, P45, DOI 10.1007/s11010-014-2170-8; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang AM, 2018, BIOCHEM BIOPH RES CO, V495, P1648, DOI 10.1016/j.bbrc.2017.12.028	49	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1261	1270		10.1074/jbc.RA119.010356	http://dx.doi.org/10.1074/jbc.RA119.010356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31882540	hybrid, Green Published			2022-12-28	WOS:000513822300008
J	Albuquerque-Wendt, A; Jacot, D; Pacheco, ND; Seegers, C; Zarnovican, P; Buettner, FFR; Bakker, H; Soldati-Favre, D; Routier, FH				Albuquerque-Wendt, Andreia; Jacot, Damien; Pacheco, Nicolas Dos Santos; Seegers, Carla; Zarnovican, Patricia; Buettner, Falk F. R.; Bakker, Hans; Soldati-Favre, Dominique; Routier, Francoise H.			C-Mannosylation of Toxoplasma gondii proteins promotes attachment to host cells and parasite virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; glycosyltransferase; endoplasmic reticulum (ER); Toxoplasma gondii; adhesin; thrombospondin; C-mannosylation; Thrombospondin type 1 repeat	GLIDING MOTILITY; MICRONEME DISCHARGE; TYPE-1 REPEATS; INVASION; MIC2; SECRETION; MANNOSYLTRANSFERASE; IDENTIFICATION; DETERMINANT; ADHESION	C-Mannosylation is a common modification of thrombospondin type 1 repeats present in metazoans and recently identified also in apicomplexan parasites. This glycosylation is mediated by enzymes of the DPY19 family that transfer ?-mannoses to tryptophan residues in the sequence WX2WX2C, which is part of the structurally essential tryptophan ladder. Here, deletion of the dpy19 gene in the parasite Toxoplasma gondii abolished C-mannosyltransferase activity and reduced levels of the micronemal protein MIC2. The loss of C-mannosyltransferase activity was associated with weakened parasite adhesion to host cells and with reduced parasite motility, host cell invasion, and parasite egress. Interestingly, the C-mannosyltransferase?deficient ?dpy19 parasites were strongly attenuated in virulence and induced protective immunity in mice. This parasite attenuation could not simply be explained by the decreased MIC2 level and strongly suggests that absence of C-mannosyltransferase activity leads to an insufficient level of additional proteins. In summary, our results indicate that T. gondii C-mannosyltransferase DPY19 is not essential for parasite survival, but is important for adhesion, motility, and virulence.	[Albuquerque-Wendt, Andreia; Seegers, Carla; Zarnovican, Patricia; Buettner, Falk F. R.; Bakker, Hans; Routier, Francoise H.] Hannover Med Sch, Dept Clin Biochem, OE4340, D-30625 Hannover, Germany; [Jacot, Damien; Pacheco, Nicolas Dos Santos; Soldati-Favre, Dominique] Univ Geneva, CMU, Dept Microbiol & Mol Med, CH-1206 Geneva, Switzerland; [Albuquerque-Wendt, Andreia] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England	Hannover Medical School; University of Geneva; University of Oxford	Routier, FH (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Bakker, Hans/AAA-1623-2020; Bakker, Hans/A-1787-2017; Wendt, Andreia/M-7835-2018	Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; Soldati-Favre, Dominique/0000-0003-4156-2109; Buettner, Falk/0000-0002-8468-1223; Dos Santos Pacheco, Nicolas/0000-0003-1959-194X; Routier, Francoise/0000-0002-7163-0590; Wendt, Andreia/0000-0001-5794-5417	European Community Initial training network GlycoPar (EU FP7) Grant [GA608295]; European Research Council (ERC), European Union's Horizon 2020 research and innovation programme Grant [695596]	European Community Initial training network GlycoPar (EU FP7) Grant; European Research Council (ERC), European Union's Horizon 2020 research and innovation programme Grant	This work was supported by European Community Initial training network GlycoPar (EU FP7) Grant GA608295 and the European Research Council (ERC), European Union's Horizon 2020 research and innovation programme Grant 695596 (to D. S.-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JC, 2000, DEV DYNAM, V218, P280; [Anonymous], [No title captured]; Bandini G, 2019, PARASITOLOGY, V146, P1755, DOI 10.1017/S0031182019000040; Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Bargieri D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004273; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cerede O, 2002, EMBO J, V21, P2526, DOI 10.1093/emboj/21.11.2526; Coppens I, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006893; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Dubois DJ, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13018; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gras Simon, 2017, Wellcome Open Res, V2, P32, DOI [10.12688/wellcomeopenres.11594.2, 10.12688/wellcomeopenres.11594.1]; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Harper JM, 2004, MOL BIOCHEM PARASIT, V134, P201, DOI 10.1016/j.molbiopara.2003.12.001; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2015, J BIOL CHEM, V290, P1432, DOI 10.1074/jbc.M114.613646; Huynh MH, 2014, INFECT IMMUN, V82, P4358, DOI 10.1128/IAI.01877-14; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kawase O, 2010, PARASITOL INT, V59, P211, DOI 10.1016/j.parint.2010.02.001; Khurana S, 2019, J BIOL CHEM, V294, P1541, DOI 10.1074/jbc.RA118.005357; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Liu Q, 2017, EXP PARASITOL, V176, P89, DOI 10.1016/j.exppara.2017.03.001; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Lopez-Gutierrez B, 2019, PARASITOLOGY, V146, P1767, DOI 10.1017/S0031182019001380; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Munte CE, 2008, FEBS J, V275, P1163, DOI 10.1111/j.1742-4658.2008.06277.x; Niwa Y, 2016, MOL BIOL CELL, V27, P744, DOI 10.1091/mbc.E15-06-0373; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rugarabamu G, 2015, MOL MICROBIOL, V97, P244, DOI 10.1111/mmi.13021; Saouros S, 2012, J BIOL CHEM, V287, P36029, DOI 10.1074/jbc.M112.389825; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Shcherbakova A, 2019, ELIFE, V8, DOI 10.7554/eLife.52978; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01795-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Siupka P, 2015, GENES IMMUN, V16, P405, DOI 10.1038/gene.2015.22; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Swearingen KE, 2019, J PROTEOME RES, V18, P652, DOI 10.1021/acs.jproteome.8b00638; Swearingen KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005791; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	64	6	7	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1066	1076		10.1074/jbc.RA119.010590	http://dx.doi.org/10.1074/jbc.RA119.010590			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31862733	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000509949300015
J	Magee, N; Zou, A; Ghosh, P; Ahamed, F; Delker, D; Zhang, YX				Magee, Nancy; Zou, An; Ghosh, Priyanka; Ahamed, Forkan; Delker, Don; Zhang, Yuxia			Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; inflammation; fibrosis; nuclear receptor; lipid metabolism; fatty liver disease; nonalcoholic steatohepatitis (NASH); RNA sequencing; small heterodimer partner (SHP); steatosis	NUCLEAR-RECEPTOR-SHP; FATTY LIVER-DISEASE; LEPTIN-DEFICIENT MICE; STELLATE CELLS; REGULATORY CASCADE; MURINE MODEL; PPAR-GAMMA; GENE; PROGRESSION; EXPRESSION	Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease worldwide and is characterized by steatosis, inflammation, and fibrosis. The molecular mechanisms underlying NASH development remain obscure. The nuclear receptor small heterodimer partner (Shp) plays a complex role in lipid metabolism and inflammation. Here, we sought to determine SHP's role in regulating steatosis and inflammation in NASH. Shp deletion in murine hepatocytes (Shp(Hep?/?)) resulted in massive infiltration of macrophages and CD4(+) T cells in the liver. Shp(Hep?/?) mice developed reduced steatosis, but surprisingly increased hepatic inflammation and fibrosis after being fed a high-fat, -cholesterol, and -fructose (HFCF) diet. RNA-Seq analysis revealed that pathways involved in inflammation and fibrosis are significantly activated in the liver of Shp(Hep?/?) mice fed a chow diet. After having been fed the HFCF diet, WT mice displayed up-regulated peroxisome proliferator-activated receptor ? (Pparg) signaling in the liver; however, this response was completely abolished in the Shp(Hep?/?) mice. In contrast, livers of Shp(Hep?/?) mice had consistent NF-?B activation. To further characterize the role of Shp specifically in the transition of steatosis to NASH, mice were fed the HFCF diet for 4 weeks, followed by Shp deletion. Surprisingly, Shp deletion after steatosis development exacerbated hepatic inflammation and fibrosis without affecting liver steatosis. Together, our results indicate that, depending on NASH stage, hepatic Shp plays an opposing role in steatosis and inflammation. Mechanistically, Shp deletion in hepatocytes activated NF-?B and impaired Pparg activation, leading to the dissociation of steatosis, inflammation, and fibrosis in NASH development.	[Magee, Nancy; Zou, An; Ghosh, Priyanka; Ahamed, Forkan; Zhang, Yuxia] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Delker, Don] Univ Utah, Dept Med, Sch Med, Salt Lake City, UT 84108 USA; [Zhang, Yuxia] Univ Kansas, Liver Ctr, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; Utah System of Higher Education; University of Utah; University of Kansas; University of Kansas Medical Center	Zhang, YX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.	lzhang5@kumc.edu		Ghosh, Priyanka/0000-0002-4666-7420	National Institutes of Health [R01DK119131, K22CA184146, P20GM103549, P30GM118247, P20GM103418, T32ES007079, UL1 TR002366]; KUMC Enhancement Award; American Association for the Study of Liver Diseases (AASLD) Bridging Award; American Cancer Society (ACS) [(IRG) 16-194-07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KUMC Enhancement Award; American Association for the Study of Liver Diseases (AASLD) Bridging Award; American Cancer Society (ACS)(American Cancer Society)	This work was supported by National Institutes of Health Grants R01DK119131, K22CA184146, P20GM103549, P30GM118247, P20GM103418, T32ES007079, and UL1 TR002366; a KUMC Enhancement Award; an American Association for the Study of Liver Diseases (AASLD) Bridging Award; and American Cancer Society (ACS) Institutional Research Grant (IRG) 16-194-07. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Olivos NE, 2015, ANN HEPATOL, V14, P487, DOI 10.1016/S1665-2681(19)31170-6; Akinrotimi O, 2017, HEPATOLOGY, V66, P1854, DOI 10.1002/hep.29305; Ali AH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.06; Benet M, 2015, MOL PHARMACOL, V87, P582, DOI 10.1124/mol.114.096313; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cipriani S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41055; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Ibrahim SH, 2016, HEPATOLOGY, V63, P731, DOI 10.1002/hep.28252; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Jung GS, 2015, LIVER INT, V35, P2233, DOI 10.1111/liv.12871; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Magee N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5170402; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Renga B, 2011, INFLAMM RES, V60, P577, DOI 10.1007/s00011-010-0306-1; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; Sanders KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36163-z; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Smalling RV, 2013, AM J PHYSIOL-GASTR L, V305, pG364, DOI 10.1152/ajpgi.00077.2013; Suh YH, 2004, J ENDOCRINOL, V183, P133, DOI 10.1677/joe.1.05675; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97; Zou A, 2018, J BIOL CHEM, V293, P8656, DOI 10.1074/jbc.RA117.001653	56	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					994	1008		10.1074/jbc.RA119.010233	http://dx.doi.org/10.1074/jbc.RA119.010233			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31831621	hybrid, Green Published			2022-12-28	WOS:000509949300009
J	Dai, GY; Yin, J; Li, KE; Chen, DK; Liu, Z; Bi, FC; Rong, C; Yao, N				Dai, Guang-Yi; Yin, Jian; Li, Kai-En; Chen, Ding-Kang; Liu, Zhe; Bi, Fang-Cheng; Rong, Chan; Yao, Nan			The Arabidopsis AtGCD3 protein is a glucosylceramidase that preferentially hydrolyzes long-acyl-chain glucosylceramides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; sphingolipid; ceramide; fatty acid; lipid metabolism; cell signaling; glucosylceramidase; plant biology; stress adaption	PLASMA-MEMBRANES; SPHINGOLIPIDS; IDENTIFICATION; GLUCOCEREBROSIDASE; BIOSYNTHESIS; ACCUMULATION; PERFORMANCE; METABOLISM; LEAF; GBA2	Cellular membranes contain many lipids, some of which, such as sphingolipids, have important structural and signaling functions. The common sphingolipid glucosylceramide (GlcCer) is present in plants, fungi, and animals. As a major plant sphingolipid, GlcCer is involved in the formation of lipid microdomains, and the regulation of GlcCer is key for acclimation to stress. Although the GlcCer biosynthetic pathway has been elucidated, little is known about GlcCer catabolism, and a plant GlcCer-degrading enzyme (glucosylceramidase (GCD)) has yet to be identified. Here, we identified AtGCD3, one of four Arabidopsis thaliana homologs of human nonlysosomal glucosylceramidase, as a plant GCD. We found that recombinant AtGCD3 has a low K-m for the fluorescent lipid C-6-NBD GlcCer and preferentially hydrolyzes long acyl-chain GlcCer purified from Arabidopsis leaves. Testing of inhibitors of mammalian glucosylceramidases revealed that a specific inhibitor of human ?-glucosidase 2, N-butyldeoxynojirimycin, inhibits AtGCD3 more effectively than does a specific inhibitor of human ?-glucosidase 1, conduritol ?-epoxide. We also found that Glu-499 and Asp-647 in AtGCD3 are vital for GCD activity. GFP-AtGCD3 fusion proteins mainly localized to the plasma membrane or the endoplasmic reticulum membrane. No obvious growth defects or changes in sphingolipid contents were observed in gcd3 mutants. Our results indicate that AtGCD3 is a plant glucosylceramidase that participates in GlcCer catabolism by preferentially hydrolyzing long-acyl-chain GlcCers.	[Dai, Guang-Yi; Yin, Jian; Li, Kai-En; Chen, Ding-Kang; Liu, Zhe; Bi, Fang-Cheng; Rong, Chan; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, State Key Lab Biocontrol, Guangzhou 510275, Peoples R China	Sun Yat Sen University	Yao, N (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, State Key Lab Biocontrol, Guangzhou 510275, Peoples R China.	yaonan@mail.sysu.edu.cn	yao, nan/F-2095-2011	yao, nan/0000-0002-2045-5462; dai, guangyi/0000-0002-1776-2904	National Natural Science Foundation of China [31570255, 31771357]; Natural Science Foundation of Guangdong Province [2017A030311005]; Sun Yat-sen University Project [33000-31143406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Sun Yat-sen University Project	This work was supported by National Natural Science Foundation of China Grants 31570255 and 31771357, Natural Science Foundation of Guangdong Province Grant 2017A030311005, and Sun Yat-sen University Project 33000-31143406. The authors declare that they have no conflicts of interest with the contents of this article.	Bi FC, 2014, PLANT CELL, V26, P3449, DOI 10.1105/tpc.114.127050; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; CAHOON EB, 1991, PLANT PHYSIOL, V95, P58, DOI 10.1104/pp.95.1.58; Charoenwattanasatien R, 2016, ACS CHEM BIOL, V11, P1891, DOI 10.1021/acschembio.6b00192; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cobucci-Ponzano B, 2010, J BIOL CHEM, V285, P20691, DOI 10.1074/jbc.M109.086470; DANIELS LB, 1981, CLIN CHIM ACTA, V115, P369, DOI 10.1016/0009-8981(81)90251-5; Ferrara MC, 2014, BBA-GEN SUBJECTS, V1840, P367, DOI 10.1016/j.bbagen.2013.09.022; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Luttgeharm KD, 2015, PHYTOCHEMISTRY, V115, P121, DOI 10.1016/j.phytochem.2015.02.019; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Markham JE, 2013, CURR OPIN PLANT BIOL, V16, P350, DOI 10.1016/j.pbi.2013.02.009; Massimo A, 2016, NEUROCHEM RES, V41, P210, DOI 10.1007/s11064-015-1763-2; Melser S, 2010, TRAFFIC, V11, P479, DOI 10.1111/j.1600-0854.2009.01030.x; Msanne J, 2015, PLANT J, V84, P188, DOI 10.1111/tpj.13000; Nagata M, 2017, P NATL ACAD SCI USA, V114, pE3285, DOI 10.1073/pnas.1618133114; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Tjellstrom H, 2010, FASEB J, V24, P1128, DOI 10.1096/fj.09-139410; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu JX, 2015, PLANT J, V81, P767, DOI 10.1111/tpj.12769; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807	38	8	8	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					717	728		10.1074/jbc.RA119.011274	http://dx.doi.org/10.1074/jbc.RA119.011274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31819005	hybrid, Green Published			2022-12-28	WOS:000508382900005
J	Ghosh, S; Kamble, NU; Verma, P; Salvi, P; Petla, BP; Roy, S; Rao, V; Hazra, A; Varshney, V; Kaur, H; Majee, M				Ghosh, Shraboni; Kamble, Nitin Uttam; Verma, Pooja; Salvi, Prafull; Petla, Bhanu Prakash; Roy, Shweta; Rao, Venkateswara; Hazra, Abhijit; Varshney, Vishal; Kaur, Harmeet; Majee, Manoj			Arabidopsis protein l-ISOASPARTYL METHYLTRANSFERASE repairs isoaspartyl damage to antioxidant enzymes and increases heat and oxidative stress tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant physiology; protein deamidation; plant biochemistry; reactive oxygen species (ROS); Arabidopsis; antioxidant enzyme; isoAsp; PIMT; protein repair; ROS	SEED VIGOR; SUPEROXIDE-DISMUTASE; ASPARTYL RESIDUES; LONGEVITY; ACCUMULATION; CHICKPEA; SURVIVAL; GENE; OVEREXPRESSION; TRANSCRIPTS	Stressful environments accelerate the formation of isoaspartyl (isoAsp) residues in proteins, which detrimentally affect protein structure and function. The enzyme PROTEIN l-ISOASPARTYL METHYLTRANSFERASE (PIMT) repairs other proteins by reverting deleterious isoAsp residues to functional aspartyl residues. PIMT function previously has been elucidated in seeds, but its role in plant survival under stress conditions remains undefined. Herein, we used molecular, biochemical, and genetic approaches, including protein overexpression and knockdown experiments, in Arabidopsis to investigate the role of PIMTs in plant growth and survival during heat and oxidative stresses. We demonstrate that these stresses increase isoAsp accumulation in plant proteins, that PIMT activity is essential for restricting isoAsp accumulation, and that both PIMT1 and PIMT2 play an important role in this restriction and Arabidopsis growth and survival. Moreover, we show that PIMT improves stress tolerance by facilitating efficient reactive oxygen species (ROS) scavenging by protecting the functionality of antioxidant enzymes from isoAsp-mediated damage during stress. Specifically, biochemical and MS/MS analyses revealed that antioxidant enzymes acquire deleterious isoAsp residues during stress, which adversely affect their catalytic activities, and that PIMT repairs the isoAsp residues and thereby restores antioxidant enzyme function. Collectively, our results suggest that the PIMT-mediated protein repair system is an integral part of the stress-tolerance mechanism in plants, in which PIMTs protect antioxidant enzymes that maintain proper ROS homeostasis against isoAsp-mediated damage in stressful environments.	[Ghosh, Shraboni; Kamble, Nitin Uttam; Verma, Pooja; Salvi, Prafull; Petla, Bhanu Prakash; Roy, Shweta; Rao, Venkateswara; Hazra, Abhijit; Varshney, Vishal; Kaur, Harmeet; Majee, Manoj] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Ghosh, Shraboni; Kamble, Nitin Uttam; Hazra, Abhijit; Varshney, Vishal] Univ Grant Commiss, Delhi, India; [Ghosh, Shraboni; Kamble, Nitin Uttam; Hazra, Abhijit; Varshney, Vishal] Govt India, CSIR, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Council of Scientific & Industrial Research (CSIR) - India	Majee, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	manojmajee@nipgr.ac.in	Kamble, Nitin Uttam/V-6238-2019; Petla, Bhanu/AAF-4598-2021; Salvi, Prafull/AAP-1007-2020	Kamble, Nitin Uttam/0000-0003-3862-9587; Petla, Bhanu/0000-0003-2012-0766; Salvi, Prafull/0000-0002-7834-8803; Majee, Manoj/0000-0002-9156-2951; Verma, Pooja/0000-0002-5985-2166; Ghosh, Shraboni/0000-0003-2198-4830	Department of Biotechnology [BT/PR8000/BRB/10/1210/2013]; Government of India; National Institute of Plant Genome Research	Department of Biotechnology; Government of India; National Institute of Plant Genome Research	This work was supported in part by Department of Biotechnology Grant BT/PR8000/BRB/10/1210/2013, the Government of India, and a core grant from the National Institute of Plant Genome Research. The authors declare that they have no conflicts of interest with the contents of this article.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Augustine R, 2013, PLANT BIOTECHNOL J, V11, P855, DOI 10.1111/pbi.12078; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dinkins RD, 2008, PLANT J, V55, P1, DOI 10.1111/j.1365-313X.2008.03471.x; GEIGER T, 1987, J BIOL CHEM, V262, P785; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Kaundal A., 2012, BIO-PROTOCOL, V2, P278, DOI [10.21769/BioProtoc.278, DOI 10.21769/BIOPROTOC.278]; Kaur H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00713; Kaur H, 2013, PLANTA, V237, P321, DOI 10.1007/s00425-012-1781-0; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; MUDGETT MB, 1993, BIOCHEMISTRY-US, V32, P11100, DOI 10.1021/bi00092a020; MUDGETT MB, 1994, J BIOL CHEM, V269, P25605; Nayak NR, 2013, PLANT CELL, V25, P2573, DOI 10.1105/tpc.113.113456; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Petla BP, 2016, NEW PHYTOL, V211, P627, DOI 10.1111/nph.13923; Salvi P, 2018, PLANT CELL PHYSIOL, V59, P155, DOI 10.1093/pcp/pcx170; Salvi P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35088; Thapar N, 2001, PLANT PHYSIOL, V125, P1023, DOI 10.1104/pp.125.2.1023; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Verma P, 2013, PLANT PHYSIOL, V161, P1141, DOI 10.1104/pp.112.206243; Verma P, 2010, PLANTA, V231, P329, DOI 10.1007/s00425-009-1050-z; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Wei YD, 2015, PLANT MOL BIOL, V89, P475, DOI 10.1007/s11103-015-0383-1; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Xu QL, 2004, PLANT PHYSIOL, V136, P2652, DOI 10.1104/pp.104.046094; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	40	15	16	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					783	799		10.1074/jbc.RA119.010779	http://dx.doi.org/10.1074/jbc.RA119.010779			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31831624	Green Published, hybrid			2022-12-28	WOS:000508382900010
J	Chaconas, G; Castellanos, M; Verhey, TB				Chaconas, George; Castellanos, Mildred; Verhey, Theodore B.			Changing of the guard: How the Lyme disease spirochete subverts the host immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bacterial genetics; bacterial pathogenesis; DNA mismatch repair; DNA recombination; genetic polymorphism; G-quadruplex; infectious disease; antigenic variation; Borrelia; Lyme disease; gene conversion	BURGDORFERI TELOMERE RESOLVASE; VLSE ANTIGENIC VARIATION; BORRELIA-BURGDORFERI; TRANSCRIPTIONAL REGULATION; PLASMODIUM-FALCIPARUM; LINEAR PLASMIDS; DNA; REPLICATION; SEQUENCE; RECOMBINATION	Lyme disease, also known as Lyme borreliosis, is the most common tick-transmitted disease in the Northern Hemisphere. The disease is caused by the bacterial spirochete Borrelia burgdorferi and other related Borrelia species. One of the many fascinating features of this unique pathogen is an elaborate system for antigenic variation, whereby the sequence of the surface-bound lipoprotein VlsE is continually modified through segmental gene conversion events. This perpetual changing of the guard allows the pathogen to remain one step ahead of the acquired immune response, enabling persistent infection. Accordingly, the vls locus is the most evolutionarily diverse genetic element in Lyme disease?causing borreliae. Small stretches of information are transferred from a series of silent cassettes in the vls locus to generate an expressed mosaic vlsE gene version that contains genetic information from several different silent cassettes, resulting in ?10(40) possible vlsE sequences. Yet, despite its extreme evolutionary flexibility, the locus has rigidly conserved structural features. These include a telomeric location of the vlsE gene, an inverse orientation of vlsE and the silent cassettes, the presence of nearly perfect inverted repeats of ?100 bp near the 5? end of vlsE, and an exceedingly high concentration of G runs in vlsE and the silent cassettes. We discuss the possible roles of these evolutionarily conserved features, highlight recent findings from several studies that have used next-generation DNA sequencing to unravel the switching process, and review advances in the development of a mini-vls system for genetic manipulation of the locus.	[Chaconas, George; Castellanos, Mildred; Verhey, Theodore B.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Chaconas, George] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Chaconas, George; Castellanos, Mildred; Verhey, Theodore B.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Chaconas, G (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada.	chaconas@ucalgary.ca		Verhey, Theodore/0000-0002-4292-0839	Canadian Institutes of Health Research Grant [PJT-153336]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant PJT-153336. The authors declare that they have no conflicts of interest with the contents of this article.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Alverson J, 2002, J BACTERIOL, V184, P6069, DOI 10.1128/JB.183.21.6069-6072.2002; Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Bandy NJ, 2014, J BACTERIOL, V196, P2396, DOI 10.1128/JB.01435-13; Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; Bankhead Troy, 2016, For Immunopathol Dis Therap, V7, P191, DOI 10.1615/ForumImmunDisTher.2017019625; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; Barbour AG, 2010, BORRELIA MOL BIOL HO, P327; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Beaurepaire C, 2007, MOL MICROBIOL, V63, P443, DOI 10.1111/j.1365-2958.2006.05533.x; Bikard D, 2010, MICROBIOL MOL BIOL R, V74, P570, DOI 10.1128/MMBR.00026-10; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Cahoon LA, 2013, J BACTERIOL, V195, P2255, DOI 10.1128/JB.02217-12; Cahoon LA, 2011, MOL MICROBIOL, V81, P1136, DOI 10.1111/j.1365-2958.2011.07773.x; Casjens SR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4597-x; Casjens SR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3553-5; Castellanos M, 2018, MOL MICROBIOL, V109, P710, DOI 10.1111/mmi.14071; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Chaconas G, 2010, ANNU REV MICROBIOL, V64, P185, DOI 10.1146/annurev.micro.112408.134037; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Crossland NA, 2018, AM J PATHOL, V188, P672, DOI 10.1016/j.ajpath.2017.11.005; Crowder CD, 2017, YALE J BIOL MED, V90, P195; Dahan D, 2018, NUCLEIC ACIDS RES, V46, P11847, DOI 10.1093/nar/gky1065; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; DELANGE AM, 1986, J VIROL, V59, P249, DOI 10.1128/JVI.59.2.249-259.1986; Devlin R, 2017, CURR GENET, V63, P441, DOI 10.1007/s00294-016-0662-7; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Eicken C, 2002, J BIOL CHEM, V277, P21691, DOI 10.1074/jbc.M201547200; Embers ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189071; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Glover L, 2013, CELL MICROBIOL, V15, P1984, DOI 10.1111/cmi.12215; HINNEBUSCH J, 1991, J BACTERIOL, V173, P7233, DOI 10.1128/jb.173.22.7233-7239.1991; HINNEBUSCH J, 1990, MOL MICROBIOL, V4, P811, DOI 10.1111/j.1365-2958.1990.tb00651.x; Hodzic E, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00442-19; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Huang SH, 2017, NUCLEIC ACIDS RES, V45, P1319, DOI 10.1093/nar/gkw1243; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Hudson CR, 2001, MOL MICROBIOL, V41, P229, DOI 10.1046/j.1365-2958.2001.02511.x; Jolivet-Gougeon A, 2011, J MED MICROBIOL, V60, P563, DOI 10.1099/jmm.0.024083-0; Kirkman LA, 2012, CURR OPIN MICROBIOL, V15, P456, DOI 10.1016/j.mib.2012.03.003; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0023-2014; Kolinjivadi AM, 2017, FEBS LETT, V591, P1083, DOI 10.1002/1873-3468.12556; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Lawrenz MB, 2004, INFECT IMMUN, V72, P6577, DOI 10.1128/IAI.72.11.6577-6585.2004; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Magunda PRH, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0806-4; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Margos G, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3804-5; McCulloch R, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0016-2014; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Norris S.J., 2010, BORRELIA MOL BIOL HO, P293; Norris SJ, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0038-2014; Obergfell KP, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0015-2014; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Polleys EJ, 2017, DNA REPAIR, V56, P156, DOI 10.1016/j.dnarep.2017.06.018; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Prucca CG, 2011, ANNU REV MICROBIOL, V65, P611, DOI 10.1146/annurev-micro-090110-102940; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Rogovskyy AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124268; Rogovskyy AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061226; Rotman E, 2016, J BACTERIOL, V198, P2470, DOI 10.1128/JB.00330-16; Gargantini PR, 2016, CURR OPIN MICROBIOL, V32, P52, DOI 10.1016/j.mib.2016.04.017; SAINTGIRONS I, 1991, RES MICROBIOL, V142, P711, DOI 10.1016/0923-2508(91)90085-O; Sannohe Y, 2010, CURR PROTOC NUCL ACI, DOI [10.1002/0471142700.nc1702s40, DOI 10.1002/0471142700.NC1702S40]; Saranathan N, 2019, TRENDS MICROBIOL, V27, P148, DOI 10.1016/j.tim.2018.08.011; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Seifert HS, 2018, ANNU REV MICROBIOL, V72, P49, DOI 10.1146/annurev-micro-090817-062629; Stanek G, 2018, FEMS MICROBIOL REV, V42, P233, DOI 10.1093/femsre/fux047; Steere AC, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.90; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sung SY, 2001, J BACTERIOL, V183, P5855, DOI 10.1128/JB.183.20.5855-5861.2001; Thakur RS, 2014, J BIOL CHEM, V289, P25112, DOI 10.1074/jbc.M114.563569; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Verhey TB, 2019, MOL MICROBIOL, V111, P750, DOI 10.1111/mmi.14189; Verhey TB, 2018, CELL REP, V23, P2595, DOI 10.1016/j.celrep.2018.04.117; Verhey TB, 2018, MOL MICROBIOL, V107, P104, DOI 10.1111/mmi.13873; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; Wahlgren M, 2017, NAT REV MICROBIOL, V15, P479, DOI 10.1038/nrmicro.2017.47; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	98	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					301	313		10.1074/jbc.REV119.008583	http://dx.doi.org/10.1074/jbc.REV119.008583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31753921	Green Published, hybrid			2022-12-28	WOS:000507373600003
J	Kollenstart, L; de Groot, AJL; Janssen, GMC; Cheng, X; Vreeken, K; Martino, F; Cote, J; van Veelen, PA; van Attikum, H				Kollenstart, Leonie; de Groot, Anton J. L.; Janssen, George M. C.; Cheng, Xue; Vreeken, Kees; Martino, Fabrizio; Cote, Jacques; van Veelen, Peter A.; van Attikum, Haico			Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone modification; gene transcription; post-translational modification (PTM); chromatin modification; crotonylation; Esa1-Yng2-Epl1 (Piccolo NuA4) complex; Gcn5-Ada (ADA) complex	POSTTRANSLATIONAL MODIFICATIONS; LYSINE SUCCINYLATION; METABOLIC-REGULATION; CRYSTAL-STRUCTURE; ACETYL-COENZYME; RECOGNITION; EXPRESSION; COMPLEXES; H3; H4	Histone post-translational modifications (PTMs) are critical for processes such as transcription. The more notable among these are the nonacetyl histone lysine acylation modifications such as crotonylation, butyrylation, and succinylation. However, the biological relevance of these PTMs is not fully understood because their regulation is largely unknown. Here, we set out to investigate whether the main histone acetyltransferases in budding yeast, Gcn5 and Esa1, possess crotonyltransferase activity. In vitro studies revealed that the Gcn5-Ada2-Ada3 (ADA) and Esa1-Yng2-Epl1 (Piccolo NuA4) histone acetyltransferase complexes have the capacity to crotonylate histones. Mass spectrometry analysis revealed that ADA and Piccolo NuA4 crotonylate lysines in the N-terminal tails of histone H3 and H4, respectively. Functionally, we show that crotonylation selectively affects gene transcription in vivo in a manner dependent on Gcn5 and Esa1. Thus, we identify the Gcn5- and Esa1-containing ADA and Piccolo NuA4 complexes as bona fide crotonyltransferases that promote crotonylation-dependent transcription.	[Kollenstart, Leonie; de Groot, Anton J. L.; Vreeken, Kees; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Janssen, George M. C.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Albinusdreef 2, NL-2333 ZC Leiden, Netherlands; [Cheng, Xue; Cote, Jacques] Laval Univ, Ctr Rech Ctr Hosp Univ Quebec Axe Oncol, Canc Res Ctr, St Patrick Res Grp Basic Oncol, Quebec City, PQ G1R 3S3, Canada; [Martino, Fabrizio] CSIC, Spanish Natl Res Council, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Laval University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	van Attikum, H (corresponding author), Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	h.van.attikum@lumc.nl	Cote, Jacques/I-8901-2014; van Attikum, Haico/A-4596-2010	Cote, Jacques/0000-0001-6751-555X; Janssen, George/0000-0001-9091-4030; van Veelen, Peter/0000-0002-7898-9408; Kollenstart, Leonie/0000-0003-3401-2512; Van Attikum, Haico/0000-0001-8590-0240	Canadian Institutes of Health Research (CIHR) [FDN-143314]; Investment Grant NWO Medium (ZonMw) [91116004]; ERC Consolidator grant [617485]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Investment Grant NWO Medium (ZonMw); ERC Consolidator grant(European Research Council (ERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant FDN-143314 (to J. C.), Investment Grant NWO Medium 91116004 (partly financed by ZonMw) (to P. A. v. V.), and an ERC Consolidator grant 617485 (to H. v. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Arnaudo N, 2013, NAT STRUCT MOL BIOL, V20, P1119, DOI 10.1038/nsmb.2641; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Bellush JM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0287; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Bos J, 2018, J AM CHEM SOC, V140, P4757, DOI 10.1021/jacs.7b13141; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Cobb J, 2010, METHODS MOL BIOL, V587, P113, DOI 10.1007/978-1-60327-355-8_8; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dantuma NP, 2016, EMBO J, V35, P6, DOI 10.15252/embj.201592595; Decker PV, 2008, GENETICS, V178, P1209, DOI 10.1534/genetics.107.080135; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Fu HF, 2018, STEM CELL REP, V11, P70, DOI 10.1016/j.stemcr.2018.05.003; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Goudarzi A, 2016, MOL CELL, V62, P169, DOI 10.1016/j.molcel.2016.03.014; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Kebede AF, 2017, NAT STRUCT MOL BIOL, V24, P1048, DOI 10.1038/nsmb.3490; Kelly RDW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32927-9; Klein BJ, 2017, STRUCTURE, V25, P650, DOI 10.1016/j.str.2017.02.003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Liu XG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.16; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Montgomery DC, 2015, CHEM BIOL, V22, P1030, DOI 10.1016/j.chembiol.2015.06.015; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Riss A, 2015, J BIOL CHEM, V290, P28997, DOI 10.1074/jbc.M115.668533; Rossetto D, 2014, EMBO J, V33, P1397, DOI 10.15252/embj.201386433; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simithy J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01384-9; Soltani J, 2009, FEMS MICROBIOL LETT, V298, P228, DOI 10.1111/j.1574-6968.2009.01723.x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vlaming H, 2016, ELIFE, V5, DOI 10.7554/eLife.18919; Wang Y, 2018, P NATL ACAD SCI USA, V115, P2365, DOI 10.1073/pnas.1717664115; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Wei W, 2017, CELL RES, V27, P898, DOI 10.1038/cr.2017.68; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Xiong XZ, 2016, NAT CHEM BIOL, V12, P1111, DOI [10.1038/nchembio.2218, 10.1038/NCHEMBIO.2218]; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zhang Q, 2016, STRUCTURE, V24, P1606, DOI 10.1016/j.str.2016.05.023; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao D, 2016, CELL RES, V26, P629, DOI 10.1038/cr.2016.49	57	34	34	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20122	20134		10.1074/jbc.RA119.010302	http://dx.doi.org/10.1074/jbc.RA119.010302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31699900	Green Published, hybrid			2022-12-28	WOS:000505005800024
J	Zhong, XT; Jagarlapudi, S; Weng, Y; Ly, M; Rouse, JC; McClure, K; Ishino, T; Zhang, Y; Sousa, E; Cohen, J; Tzvetkova, B; Cote, K; Scarcelli, JJ; Johnson, K; Palandra, J; Apgar, JR; Yaddanapudi, S; Gonzalez-Villalobos, RA; Opsahl, AC; Lam, K; Yao, Q; Duan, WL; Sievers, A; Zhou, J; Ferguson, D; D'Antona, A; Zollner, R; Zhu, HL; Kriz, R; Lin, L; Clerin, V				Zhong, Xiaotian; Jagarlapudi, Srinath; Weng, Yan; Ly, Mellisa; Rouse, Jason C.; McClure, Kim; Ishino, Tetsuya; Zhang, Yan; Sousa, Eric; Cohen, Justin; Tzvetkova, Boriana; Cote, Kaffa; Scarcelli, John J.; Johnson, Keith; Palandra, Joe; Apgar, James R.; Yaddanapudi, Suma; Gonzalez-Villalobos, Romer A.; Opsahl, Alan C.; Lam, Khetemenee; Yao, Qing; Duan, Weili; Sievers, Annette; Zhou, Jing; Ferguson, Darren; D'Antona, Aaron; Zollner, Richard; Zhu, Hongli L.; Kriz, Ron; Lin, Laura; Clerin, Valerie			Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); signal transduction; glycosidase; glycosylation; sialic acid; pharmacokinetics; acute kidney injury; Klotho; LacdiNAc; mammalian cell expression	CHINESE-HAMSTER OVARY; GROWTH-FACTOR 23; ALPHA-KLOTHO; N-ACETYLGALACTOSAMINE; MOLECULAR-CLONING; GLYCOSYLATION; RECEPTOR; LACDINAC; FGF23; BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE	The fortuitously discovered antiaging membrane protein ?Klotho (Klotho) is highly expressed in the kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD). Klotho functions as a co-receptor for fibroblast growth factor 23 (FGF23) signaling, whereas its shed extracellular domain, soluble Klotho (sKlotho), carrying glycosidase activity, is a humoral factor that regulates renal health. Low sKlotho in CKD is associated with disease progression, and sKlotho supplementation has emerged as a potential therapeutic strategy for managing CKD. Here, we explored the structure-function relationship and post-translational modifications of sKlotho variants to guide the future design of sKlotho-based therapeutics. Chinese hamster ovary (CHO)- and human embryonic kidney (HEK)-derived WT sKlotho proteins had varied activities in FGF23 co-receptor and ?-glucuronidase assays in vitro and distinct properties in vivo. Sialidase treatment of heavily sialylated CHO-sKlotho increased its co-receptor activity 3-fold, yet it remained less active than hyposialylated HEK-sKlotho. MS and glycopeptide-mapping analyses revealed that HEK-sKlotho is uniquely modified with an unusual N-glycan structure consisting of N,N?-di-N-acetyllactose diamine at multiple N-linked sites, one of which at Asn-126 was adjacent to a putative GalNAc transfer motif. Site-directed mutagenesis and structural modeling analyses directly implicated N-glycans in Klotho's protein folding and function. Moreover, the introduction of two catalytic glutamate residues conserved across glycosidases into sKlotho enhanced its glucuronidase activity but decreased its FGF23 co-receptor activity, suggesting that these two functions might be structurally divergent. These findings open up opportunities for rational engineering of pharmacologically enhanced sKlotho therapeutics for managing kidney disease.	[Zhong, Xiaotian; Weng, Yan; Ishino, Tetsuya; Zhang, Yan; Sousa, Eric; Cohen, Justin; Palandra, Joe; Apgar, James R.; Lam, Khetemenee; Yao, Qing; Duan, Weili; Sievers, Annette; Zhou, Jing; Ferguson, Darren; D'Antona, Aaron; Zollner, Richard; Zhu, Hongli L.; Kriz, Ron; Lin, Laura] Pfizer Worldwide Res, BioMed Design, Cambridge, MA 02139 USA; [Jagarlapudi, Srinath; McClure, Kim; Yaddanapudi, Suma; Gonzalez-Villalobos, Romer A.; Opsahl, Alan C.; Clerin, Valerie] Pfizer Worldwide Res, Internal Med, Cambridge, MA 02139 USA; [Ly, Mellisa; Rouse, Jason C.; Tzvetkova, Boriana; Cote, Kaffa; Johnson, Keith] Pfizer Inc, Analyt Res & Dev, Andover, MA 01810 USA; [Scarcelli, John J.] Pfizer Inc, Cell Line Dev Biotherapeut Pharmaceut Sci, Andover, MA 01810 USA; [Gonzalez-Villalobos, Romer A.] Janssen Res & Dev LLC, Cardiovasc & Metab Discovery, 4 Blackfan Circle, Boston, MA 02115 USA	Pfizer; Pfizer; Pfizer; Pfizer; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Zhong, XT; Clerin, V (corresponding author), Pfizer Worldwide R&D, 610 Main St, Cambridge, MA 02139 USA.	Xiaotian.Zhong@pfizer.com; Valerie.Clerin@pfizer.com		Apgar, James/0000-0002-4669-0188; Rouse, Jason/0000-0002-2721-7264				Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Bonar D, 2014, J BIOL CHEM, V289, P29677, DOI 10.1074/jbc.M114.596049; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Dalton GD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00323; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Erben RG, 2017, BONE, V100, P62, DOI 10.1016/j.bone.2016.09.010; Erben RG, 2016, MOL CELL ENDOCRINOL, V432, P66, DOI 10.1016/j.mce.2016.05.008; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; Grabner A, 2016, CURR OPIN NEPHROL HY, V25, P314, DOI 10.1097/MNH.0000000000000231; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Hu MC, 2014, CURR OPIN NEPHROL HY, V23, P331, DOI 10.1097/01.mnh.0000447024.97464.a3; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuro-o M, 2017, CLIN EXP NEPHROL, V21, P64, DOI 10.1007/s10157-016-1357-6; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lu X, 2017, KIDNEY DIS-BASEL, V3, P15, DOI 10.1159/000452880; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Mencke R, 2017, ADV DRUG DELIVER REV, V121, P85, DOI 10.1016/j.addr.2017.07.009; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mi YL, 2014, J BIOL CHEM, V289, P12157, DOI 10.1074/jbc.M113.544973; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nimtz M, 2004, BBA-GEN SUBJECTS, V1675, P71, DOI 10.1016/j.bbagen.2004.08.007; Palandra J, 2013, ANAL CHEM, V85, P5522, DOI 10.1021/ac4006765; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Radhakrishnan J, 2014, KIDNEY INT, V86, P246, DOI 10.1038/ki.2014.190; Rouse J.C., 2017, LC GC ONLINE, V15, P6; Sakan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086301; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Shang TQ, 2014, J PHARM SCI-US, V103, P1967, DOI 10.1002/jps.24004; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Varki A., 2017, ESSENTIALS GLYCOBIOL; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang MM, 2015, J BIOSCI BIOENG, V119, P657, DOI 10.1016/j.jbiosc.2014.11.008; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Yang K, 2015, J AM SOC NEPHROL, V26, P2434, DOI 10.1681/ASN.2014060543; Zhong XT, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2724; Zhong Xiaotian, 2013, Int J Cell Biol, V2013, P273086, DOI 10.1155/2013/273086; Zhong XT, 2013, J BIOL CHEM, V288, P1409, DOI 10.1074/jbc.M112.417717; Zhong XT, 2012, BIOTECHNOL BIOENG, V109, P1723, DOI 10.1002/bit.24448	70	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3115	3133		10.1074/jbc.RA119.012144	http://dx.doi.org/10.1074/jbc.RA119.012144			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005658	Green Published, hybrid			2022-12-28	WOS:000519597300019
J	Sastre, DE; Pulschen, AA; Basso, LGM; Pariente, JSB; Netto, CGCM; Machinandiarena, F; Albanesi, D; Navarro, MVAS; de Mendoza, D; Gueiros, FJ				Sastre, Diego E.; Pulschen, Andre A.; Basso, Luis G. M.; Pariente, Jhonathan S. Benites; Marques Netto, Caterina G. C.; Machinandiarena, Federico; Albanesi, Daniela; Navarro, Marcos V. A. S.; de Mendoza, Diego; Gueiros-Filho, Frederico J.			The phosphatidic acid pathway enzyme PlsX plays both catalytic and channeling roles in bacterial phospholipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycerophospholipid; Gram-positive bacteria; acyltransferase; membrane biogenesis; lipid binding protein; acylphosphate; PlsX; substrate channeling	BACILLUS-SUBTILIS; FATTY-ACID; MOLECULAR-PROPERTIES; STRUCTURAL-ANALYSIS; MEMBRANE; PROTEIN; BINDING; THIOESTERS; SITE	PlsX is the first enzyme in the pathway that produces phosphatidic acid in Gram-positive bacteria. It makes acylphosphate from acyl-acyl carrier protein (acyl-ACP) and is also involved in coordinating phospholipid and fatty acid biosyntheses. PlsX is a peripheral membrane enzyme in Bacillus subtilis, but how it associates with the membrane remains largely unknown. In the present study, using fluorescence microscopy, liposome sedimentation, differential scanning calorimetry, and acyltransferase assays, we determined that PlsX binds directly to lipid bilayers and identified its membrane anchoring moiety, consisting of a hydrophobic loop located at the tip of two amphipathic dimerization helices. To establish the role of the membrane association of PlsX in acylphosphate synthesis and in the flux through the phosphatidic acid pathway, we then created mutations and gene fusions that prevent PlsX's interaction with the membrane. Interestingly, phospholipid synthesis was severely hampered in cells in which PlsX was detached from the membrane, and results from metabolic labeling indicated that these cells accumulated free fatty acids. Because the same mutations did not affect PlsX transacylase activity, we conclude that membrane association is required for the proper delivery of PlsX's product to PlsY, the next enzyme in the phosphatidic acid pathway. We conclude that PlsX plays a dual role in phospholipid synthesis, acting both as a catalyst and as a chaperone protein that mediates substrate channeling into the pathway.	[Sastre, Diego E.; Pulschen, Andre A.; Pariente, Jhonathan S. Benites; Gueiros-Filho, Frederico J.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, SP, Brazil; [Basso, Luis G. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, BR-14040901 Ribeirao Preto, SP, Brazil; [Marques Netto, Caterina G. C.] Univ Fed Sao Carlos UFSCar, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario IBR, S2002LRK, Rosario, Santa Fe, Argentina; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Univ Nacl Rosario, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut, S2002LRK, Rosario, Santa Fe, Argentina; [Sastre, Diego E.; Navarro, Marcos V. A. S.] Univ Sao Paulo, Dept Biofis Mol, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, BR-13560970 Sao Carlos, SP, Brazil; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gueiros, FJ (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, SP, Brazil.; de Mendoza, D (corresponding author), Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario IBR, S2002LRK, Rosario, Santa Fe, Argentina.; de Mendoza, D (corresponding author), Univ Nacl Rosario, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut, S2002LRK, Rosario, Santa Fe, Argentina.	demendoza@ibr-conicet.gov.ar; fgueiros@iq.usp.br	Navarro, Marcos VAS/C-9141-2013; Basso, Luis GM/AAF-9872-2021; Gueiros-Filho, Frederico J./D-2160-2013; Basso, Luis GM/N-6692-2013; Netto, Caterina/M-9992-2014	Basso, Luis GM/0000-0003-1277-1008; Gueiros-Filho, Frederico J./0000-0001-5425-2439; Basso, Luis GM/0000-0003-1277-1008; Albanesi, Daniela/0000-0003-4380-9152; Netto, Caterina/0000-0002-3285-4129; Arashiro Pulschen, Andre/0000-0002-0139-3737; Benites Pariente, Jhonathan Stivins/0000-0001-6595-0478	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/05203-5]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2016-1594]; FAPESP [2014/13411-1, 2015/21583-0, 2014/00206-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2016/05203-5 (to F. J. G.-F.), Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2016-1594 (to D. d. M.), FAPESP Postdoctoral Fellowship Grant 2014/13411-1 (to D. E. S), FAPESP Grant 2015/21583-0 (to M. V. A. S. N), and FAPESP scholarship Grant 2014/00206-0 (to L. G. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams DW, 2015, EMBO J, V34, P491, DOI 10.15252/embj.201490177; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; DUBNAU D, 1969, J MOL BIOL, V45, P155, DOI 10.1016/0022-2836(69)90097-7; Gamsjaeger R, 2005, BIOCHEM J, V389, P665, DOI 10.1042/BJ20050156; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hara Y, 2008, GENES GENET SYST, V83, P433, DOI 10.1266/ggs.83.433; Jiang YP, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0562-8; Kim Y., 2009, Journal of Structural and Functional Genomics, V10, P157, DOI 10.1007/s10969-008-9052-9; Kohler P, 1997, J BACTERIOL, V179, P2060; Li ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01821-9; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Robertson RM, 2017, NAT STRUCT MOL BIOL, V24, P666, DOI 10.1038/nsmb.3436; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roggiani M, 2015, ANNU REV GENET, V49, P115, DOI 10.1146/annurev-genet-112414-054958; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sastre DE, 2020, J BIOL CHEM, V295, P2136, DOI 10.1074/jbc.RA119.011122; Sastre DE, 2016, MOL MICROBIOL, V100, P621, DOI 10.1111/mmi.13337; Takada H, 2014, MOL MICROBIOL, V91, P242, DOI 10.1111/mmi.12457; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weisiger RA, 2007, J MOL NEUROSCI, V33, P42, DOI 10.1007/s12031-007-0047-y; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018	35	4	4	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2148	2159		10.1074/jbc.RA119.011147	http://dx.doi.org/10.1074/jbc.RA119.011147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919098	Green Published, hybrid			2022-12-28	WOS:000517128200031
J	Tietz, S; Leuenberger, M; Hohner, R; Olson, AH; Fleming, GR; Kirchhoff, H				Tietz, Stefanie; Leuenberger, Michelle; Hohner, Ricarda; Olson, Alice H.; Fleming, Graham R.; Kirchhoff, Helmut			A proteoliposome-based system reveals how lipids control photosynthetic light harvesting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; membrane biophysics; membrane lipid; lipid-protein interaction; light-harvesting complex (antenna complex); lateral membrane pressure; non-bilayer lipid; non-photochemical quenching; proteoliposome; thylakoid membrane; monogalactosyldiacylglycerol; energy transduction; photosystem	TIME-RESOLVED FLUORESCENCE; CHLOROPHYLL-A/B-COMPLEX; MEMBRANE-PROTEINS; THYLAKOID MEMBRANES; CIRCULAR-DICHROISM; NONBILAYER LIPIDS; CRYSTAL-STRUCTURE; ANTENNA PROTEINS; MOLECULAR SWITCH; HIGHER-PLANTS	Integral membrane proteins are exposed to a complex and dynamic lipid environment modulated by nonbilayer lipids that can influence protein functions by lipid-protein interactions. The nonbilayer lipid monogalactosyldiacylglycerol (MGDG) is the most abundant lipid in plant photosynthetic thylakoid membranes, but its impact on the functionality of energy-converting membrane protein complexes is unknown. Here, we optimized a detergent-based reconstitution protocol to develop a proteoliposome technique that incorporates the major light-harvesting complex II (LHCII) into compositionally well-defined large unilamellar lipid bilayer vesicles to study the impact of MGDG on light harvesting by LHCII. Using steady-state fluorescence spectroscopy, CD spectroscopy, and time-correlated single-photon counting, we found that both chlorophyll fluorescence quantum yields and fluorescence lifetimes clearly indicate that the presence of MGDG in lipid bilayers switches LHCII from a light-harvesting to a more energy-quenching mode that dissipates harvested light into heat. It is hypothesized that in the in vitro system developed here, MGDG controls light harvesting of LHCII by modulating the hydrostatic lateral membrane pressure profile in the lipid bilayer sensed by LHCII-bound peripheral pigments.	[Tietz, Stefanie; Hohner, Ricarda; Olson, Alice H.; Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Leuenberger, Michelle; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Leuenberger, Michelle; Fleming, Graham R.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Tietz, Stefanie] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Hohner, Ricarda] WA State Univ, Sch Biol Sci, POB 644236, Pullman, WA 99164 USA	Washington State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Michigan State University	Kirchhoff, H (corresponding author), POB 646340, Pullman, WA 99164 USA.	kirchhh@wsu.edu	Kirchhoff, Helmut/AAN-6695-2020	Kirchhoff, Helmut/0000-0001-5874-3681	National Science Foundation [MCB1616982]; U.S. Department of Energy [DE-SC 0017160]; U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects [1005351, 0119]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC0205CH11231]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-AC03-76SF000098, FWP 449B]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB1616982; U.S. Department of Energy Grant DE-SC 0017160; and U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects 1005351 and 0119 (to H. K.). This work was also supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC0205CH11231 and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy Grants DE-AC03-76SF000098 and FWP 449B (to G. R. F). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar P, 2015, J BIOL CHEM, V290, P4877, DOI 10.1074/jbc.M114.607770; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Baczynski K, 2015, BIOCHIMIE, V118, P129, DOI 10.1016/j.biochi.2015.09.007; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROWSE J, 1981, BIOCHEM J, V196, P347, DOI 10.1042/bj1960347; BURKE JJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P252, DOI 10.1016/0003-9861(78)90031-0; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Chegeni FA, 2016, BBA-BIOENERGETICS, V1857, P1849, DOI 10.1016/j.bbabio.2016.09.004; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Crisafi E, 2017, BBA-BIOMEMBRANES, V1859, P40, DOI 10.1016/j.bbamem.2016.10.010; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Garab G, 2016, SUBCELL BIOCHEM, V86, P127, DOI 10.1007/978-3-319-25979-6_6; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; IDE JP, 1987, BIOCHIM BIOPHYS ACTA, V893, P349, DOI 10.1016/0005-2728(87)90056-9; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Joyard J, 1998, LIPIDS PHOTOSYNTHESI, P21, DOI DOI 10.1007/0-306-48087-5_; Karasawa A, 2013, J BIOL CHEM, V288, P29862, DOI 10.1074/jbc.M113.499327; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kirchhoff H, 2018, METHODS MOL BIOL, V1770, P305, DOI 10.1007/978-1-4939-7786-4_18; Klecker M, 2014, PLANT PHYSIOL, V165, P774, DOI 10.1104/pp.114.237990; Kruger TPJ, 2011, P NATL ACAD SCI USA, V108, P13516, DOI 10.1073/pnas.1105411108; Krumova SB, 2008, BBA-BIOMEMBRANES, V1778, P997, DOI 10.1016/j.bbamem.2008.01.004; KUHLBRANDT W, 1983, J CELL BIOL, V96, P1414, DOI 10.1083/jcb.96.5.1414; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Liguori N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Maatta S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00049; MCDONNEL A, 1980, J CELL BIOL, V84, P40, DOI 10.1083/jcb.84.1.40; Mirkovic T, 2017, CHEM REV, V117, P249, DOI 10.1021/acs.chemrev.6b00002; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muh F, 2010, J PHYS CHEM B, V114, P13517, DOI 10.1021/jp106323e; Natali A, 2016, J BIOL CHEM, V291, P16730, DOI 10.1074/jbc.M116.730101; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Novoderezhkin V, 2011, PHYS CHEM CHEM PHYS, V13, P17093, DOI 10.1039/c1cp21079c; Orsi M, 2013, FARADAY DISCUSS, V161, P249, DOI 10.1039/c2fd20110k; Palacios MA, 2002, J PHYS CHEM B, V106, P5782, DOI 10.1021/jp014078t; Palacios MA, 2006, PHOTOSYNTH RES, V88, P269, DOI 10.1007/s1120-006-9042-3; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Park S, 2018, J AM CHEM SOC, V140, P11965, DOI 10.1021/jacs.8b04844; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Seiwert D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05328-7; SPRAGUE SG, 1984, BIOCHIM BIOPHYS ACTA, V777, P306, DOI 10.1016/0005-2736(84)90433-4; van Eerden FJ, 2015, BBA-BIOMEMBRANES, V1848, P1319, DOI 10.1016/j.bbamem.2015.02.025; van Oort B, 2007, J PHYS CHEM B, V111, P7631, DOI 10.1021/jp070573z; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010	73	25	25	5	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1857	1866		10.1074/jbc.RA119.011707	http://dx.doi.org/10.1074/jbc.RA119.011707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31929108	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000517128200007
J	Karkhanis, V; Alinari, L; Ozer, HG; Chung, JH; Zhang, XL; Sif, S; Baiocchi, RA				Karkhanis, Vrajesh; Alinari, Lapo; Ozer, Hatice Gulcin; Chung, Jihyun; Zhang, Xiaoli; Sif, Said; Baiocchi, Robert A.			Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; lymphoma; Myc (c-Myc); cyclin D1; microRNA (miRNA); post-translational modification; gene regulation; cancer; histone deacetylase (HDAC); PRMT5	HISTONE; METHYLATION; PROLIFERATION; TRANSCRIPTION; PATHOGENESIS; INHIBITION; SURVIVAL; PATHWAY	Protein arginine methyltransferase-5 (PRMT5) is overexpressed in aggressive B-cell non-Hodgkin's lymphomas, including mantle cell lymphoma and diffuse large B-cell lymphoma, and supports constitutive expression of CYCLIN D1 and c-MYC. Here, we combined ChIP analysis with next-generation sequencing to identify microRNA (miRNA) genes that are targeted by PRMT5 in aggressive lymphoma cell lines. We identified enrichment of histone 3 dimethylation at Arg-8 (H3(Me2)R8) in the promoter regions of miR33b, miR96, and miR503. PRMT5 knockdown de-repressed transcription of all three miRNAs, accompanied by loss of recruitment of epigenetic repressor complexes containing PRMT5 and either histone deacetylase 2 (HDAC2) or HDAC3, enhanced binding of co-activator complexes containing p300 or CREB-binding protein (CBP), and increased acetylation of specific histones, including H2BK12, H3K9, H3K14, and H4K8 at the miRNA promoters. Re-expression of individual miRNAs in B-cell lymphoma cells down-regulated expression of PRMT5, CYCLIN D1, and c-MYC, which are all predicted targets of these miRNAs, and reduced lymphoma cell survival. Luciferase reporter assays with WT and mutant 3'UTRs of CYCLIN D1 and c-MYC mRNAs revealed that binding sites for miR33b, miR96, and miR503 are critical for translational regulation of the transcripts of these two genes. Our findings link altered PRMT5 expression to transcriptional silencing of tumor-suppressing miRNAs in lymphoma cells and reinforce PRMT5's relevance for promoting lymphoma cell growth and survival.	[Karkhanis, Vrajesh; Alinari, Lapo; Chung, Jihyun; Baiocchi, Robert A.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Ozer, Hatice Gulcin] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Zhang, Xiaoli] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Sif, Said] Qatar Univ, Dept Biol & Environm Sci, Coll Arts & Sci, POB 2713, Doha, Qatar	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Qatar University	Baiocchi, RA (corresponding author), Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA.; Sif, S (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Coll Arts & Sci, POB 2713, Doha, Qatar.	ssif@qu.edu.qa; robert.baiocchi@osumc.edu		Sif, Said/0000-0001-6268-1145	American Association for Cancer Research Basic Cancer Research Fellowship; Leukemia Lymphoma Society Mantle Cell Lymphoma Research Initiative [MCL7001-18]; National Institutes of Health NCI [P01 CA214274]; National Priorities Research Program (NPRP) from the National Research Fund (a member of Qatar Foundation) [8-617-3-13]	American Association for Cancer Research Basic Cancer Research Fellowship; Leukemia Lymphoma Society Mantle Cell Lymphoma Research Initiative; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Priorities Research Program (NPRP) from the National Research Fund (a member of Qatar Foundation)	This work was supported by the American Association for Cancer Research Basic Cancer Research Fellowship (to L. A.), the Leukemia Lymphoma Society Mantle Cell Lymphoma Research Initiative (MCL7001-18) (to R. A. B.), National Institutes of Health NCI Grant P01 CA214274 (to R. A. B. and L. A.), and National Priorities Research Program (NPRP) Grant 8-617-3-13 (to S. S. and R. A. B.) from the National Research Fund (a member of Qatar Foundation). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera NSI, 1998, AM J PATHOL, V153, P1969; Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Campo E, 2015, BLOOD, V125, P48, DOI 10.1182/blood-2014-05-521898; Chan WC, 1997, BLOOD, V89, P3909; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Chung JH, 2013, J BIOL CHEM, V288, P35534, DOI 10.1074/jbc.M113.510669; Copie-Bergman C, 2015, BLOOD, V126, P2466, DOI 10.1182/blood-2015-05-647602; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Hernandez L, 1999, LEUKEMIA, V13, P2087, DOI 10.1038/sj.leu.2401599; HOLM S, 1979, SCAND J STAT, V6, P65; Hu ZH, 2017, AM J SURG PATHOL, V41, P216, DOI 10.1097/PAS.0000000000000758; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jiang H, 2018, CANCER MED-US, V7, P869, DOI 10.1002/cam4.1360; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Klier M, 2008, LEUKEMIA, V22, P2097, DOI 10.1038/leu.2008.213; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2014, CANCER RES, V74, P6107, DOI 10.1158/0008-5472.CAN-14-0389; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oberley MJ, 2013, HISTOPATHOLOGY, V63, P499, DOI 10.1111/his.12207; Ott G, 2013, BLOOD, V122, P3884, DOI 10.1182/blood-2013-05-498329; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Sesques P, 2017, BLOOD, V129, P280, DOI 10.1182/blood-2016-02-636316; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Tian Z, 2012, BLOOD, V120, P3958, DOI 10.1182/blood-2012-01-401794; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; Wang D, 2014, MOL MED REP, V10, P3268, DOI 10.3892/mmr.2014.2591; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang Z, 2018, BREAST CANCER RES TR, V168, P531, DOI 10.1007/s10549-017-4597-6; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yi SH, 2015, ONCOTARGET, V6, P42362, DOI 10.18632/oncotarget.5705; Yin HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep18824; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	47	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1165	1180		10.1074/jbc.RA119.008742	http://dx.doi.org/10.1074/jbc.RA119.008742			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31822509	hybrid, Green Published			2022-12-28	WOS:000513822300001
J	Li, HT; Zhu, HY; Sarbeng, EB; Liu, QD; Tian, XL; Yang, Y; Lyons, C; Zhou, L; Liu, QL				Li, Hongtao; Zhu, Huanyu; Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Ying; Lyons, Charles; Zhou, Lei; Liu, Qinglian			An unexpected second binding site for polypeptide substrates is essential for Hsp70 chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; chaperone DnaK (DnaK); heat shock protein (HSP); peptide interaction; substrate specificity; protein folding; heat shock protein 70 (Hsp70); P2 site; peptide-binding site; TRP2 peptide	MOLECULAR CHAPERONES; PEPTIDE-BINDING; YEAST HSP110; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNAK DIMER; J-PROTEINS; DOMAIN; SPECIFICITY	Heat shock proteins of 70 kDa (Hsp70s) are ubiquitous and highly conserved molecular chaperones. They play multiple essential roles in assisting with protein folding and maintaining protein homeostasis. Their chaperone activity has been proposed to require several rounds of binding to and release of polypeptide substrates at the substrate-binding domain (SBD) of Hsp70s. All available structures have revealed a single substrate-binding site in the SBD that binds a single segment of an extended polypeptide of 3?4 residues. However, this well-established single peptide-binding site alone has made it difficult to explain the efficient chaperone activity of Hsp70s. In this study, using purified proteins and site-directed mutagenesis, along with fluorescence polarization and luciferase-refolding assays, we report the unexpected discovery of a second peptide-binding site in Hsp70s. More importantly, the biochemical analyses suggested that this novel binding site, named here P2, is essential for Hsp70 chaperone activity. Furthermore, cross-linking and mutagenesis studies indicated that this second binding site is in the SBD adjacent to the first binding site. Taken together, our results suggest that these two essential binding sites of Hsp70s cooperate in protein folding.	[Li, Hongtao; Zhu, Huanyu; Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Ying; Lyons, Charles; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Liu, Qingdai] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China	Virginia Commonwealth University; Tianjin University Science & Technology	Liu, QL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qliu3@vcu.edu			National Institutes of Health [R01GM098592, R21AI140006, 1R01GM109193]; Blick Scholar Award from VCU; American Heart Association [17GRNT33660506]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blick Scholar Award from VCU; American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants R01GM098592 and R21AI140006 (to Q. L.), a Blick Scholar Award from VCU (to Q. L.), and American Heart Association Grant 17GRNT33660506 (to Q. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Grant 1R01GM109193.	Alderson TR, 2016, STRUCTURE, V24, P1014, DOI 10.1016/j.str.2016.05.011; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Boysen M, 2019, MOL CELL, V74, P831, DOI 10.1016/j.molcel.2019.03.032; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Dahiya V, 2019, MOL CELL, V74, P816, DOI 10.1016/j.molcel.2019.03.026; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fernandez-Fernandez Maria Rosario, 2018, F1000Res, V7, DOI 10.12688/f1000research.15528.1; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Gumiero A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13563; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jiang YJ, 2019, SCIENCE, V365, P1313, DOI 10.1126/science.aax1280; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kampinga HH, 2019, CELL STRESS CHAPERON, V24, P7, DOI 10.1007/s12192-018-0948-4; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu Q., 2019, PROTEIN SCI, DOI [10.1002/pro.3725, DOI 10.1002/PRO.372531509306]; Liu QD, 2017, CELL STRESS CHAPERON, V22, P201, DOI 10.1007/s12192-016-0752-y; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2016, NATURE, V539, P361, DOI 10.1038/nature20470; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Fernandez-Fernandez MR, 2017, FEBS LETT, V591, P2648, DOI 10.1002/1873-3468.12751; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sarbeng EB, 2015, J BIOL CHEM, V290, P8849, DOI 10.1074/jbc.M114.596288; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; Wegele H, 2003, J CHROMATOGR B, V786, P109, DOI 10.1016/S1570-0232(02)00724-9; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Yan YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08450-4; Yang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01310-z; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	93	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					584	596		10.1074/jbc.RA119.009686	http://dx.doi.org/10.1074/jbc.RA119.009686			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806707	Green Published, hybrid			2022-12-28	WOS:000507373600025
J	Nematian-Ardestani, E; Abd-Wahab, F; Chatelain, FC; Sun, H; Schewe, M; Baukrowitz, T; Tucker, SJ				Nematian-Ardestani, Ehsan; Abd-Wahab, Firdaus; Chatelain, Franck C.; Sun, Han; Schewe, Marcus; Baukrowitz, Thomas; Tucker, Stephen J.			Selectivity filter instability dominates the low intrinsic activity of the TWIK-1 K2P K+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; potassium channel; gating; membrane biophysics; membrane protein	LEAK; MECHANISM; PORE; PERMEATION; GATE	Two-pore domain K+ (K2P) channels have many important physiological functions. However, the functional properties of the TWIK-1 (K2P1.1/KCNK1) K2P channel remain poorly characterized because heterologous expression of this ion channel yields only very low levels of functional activity. Several underlying reasons have been proposed, including TWIK-1 retention in intracellular organelles, inhibition by posttranslational sumoylation, a hydrophobic barrier within the pore, and a low open probability of the selectivity filter (SF) gate. By evaluating these potential mechanisms, we found that the latter dominates the low intrinsic functional activity of TWIK-1. Investigating this further, we observed that the low activity of the SF gate appears to arise from the inefficiency of K+ in stabilizing an active (i.e. conductive) SF conformation. In contrast, other permeant ion species, such as Rb+, NH4+, and Cs+, strongly promoted a pH-dependent activated conformation. Furthermore, many K2P channels are activated by membrane depolarization via an SF-mediated gating mechanism, but we found here that only very strong nonphysiological depolarization produces voltage-dependent activation of heterologously expressed TWIK-1. Remarkably, we also observed that TWIK-1 Rb+ currents are potently inhibited by intracellular K+ (IC50 = 2.8 mm). We conclude that TWIK-1 displays unique SF gating properties among the family of K2P channels. In particular, the apparent instability of the conductive conformation of the TWIK-1 SF in the presence of K+ appears to dominate the low levels of intrinsic functional activity observed when the channel is expressed at the cell surface.	[Nematian-Ardestani, Ehsan; Abd-Wahab, Firdaus; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Chatelain, Franck C.] Univ Cote dAzur, CNRS, Inst Pharmacol Mol & Cellulaire, Labex ICST, F-06560 Valbonne, France; [Sun, Han] Leibniz Forschungsinst Mol Pharmakol, Dept Struct Biol, D-13125 Berlin, Germany; [Schewe, Marcus; Baukrowitz, Thomas] Christian Albrechts Univ Kiel, Inst Physiol, D-24118 Kiel, Germany	University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Kiel	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk	Tucker, Stephen J./ABE-7468-2020; Tucker, Stephen J./ABE-6741-2020	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Baukrowitz, Thomas/0000-0003-4562-0505; CHATELAIN, Franck C./0000-0002-8426-8893; Sun, Han/0000-0002-1655-0838; Schewe, Marcus/0000-0002-6192-5651; Nematian-Ardestani, Ehsan/0000-0001-9674-6138	Biotechnology and Biological Sciences Research Council [BB/N000145/1]; Deutsche Forschungsgemeinschaft Research Group FOR 2518 DynIon; CNRS; King's scholarship from Malaysian government; BBSRC [BB/N000145/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft Research Group FOR 2518 DynIon(German Research Foundation (DFG)); CNRS(Centre National de la Recherche Scientifique (CNRS)); King's scholarship from Malaysian government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/N000145/1 (to E. N.-A. and S. J. T.), Deutsche Forschungsgemeinschaft Research Group FOR 2518 DynIon (to H. S., M. S., and T. B.), and CNRS. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a King's scholarship from the Malaysian government.	Aryal P, 2015, CHANNELS, V9, P44, DOI 10.4161/19336950.2014.981987; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Ben Soussia I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08710-3; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Bobak N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00640-8; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Chen HJ, 2014, TRENDS PHARMACOL SCI, V35, P461, DOI 10.1016/j.tips.2014.06.002; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Gada K, 2019, BRIT J PHARMACOL, V176, P256, DOI 10.1111/bph.14518; Goldstein SAN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002225; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hover S, 2016, J BIOL CHEM, V291, P3411, DOI 10.1074/jbc.M115.692673; Niemeyer MI, 2016, MOL PHARMACOL, V90, P309, DOI 10.1124/mol.116.103895; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Ma LQ, 2012, BIOPHYS J, V102, pL34, DOI 10.1016/j.bpj.2012.03.011; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nematian-Ardestani E, 2017, CHANNELS, V11, P482, DOI 10.1080/19336950.2017.1356955; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Schewe M, 2019, SCIENCE, V363, P875, DOI 10.1126/science.aav0569; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Tsukamoto H, 2018, J BIOL CHEM, V293, P6969, DOI 10.1074/jbc.RA118.001817; Yarishkin O, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0080-z; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					610	618		10.1074/jbc.RA119.010612	http://dx.doi.org/10.1074/jbc.RA119.010612			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806709	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000507373600027
J	Thalwieser, Z; Kiraly, N; Fonodi, M; Csortos, C; Boratko, A				Thalwieser, Zsofia; Kiraly, Nikolett; Fonodi, Marton; Csortos, Csilla; Boratko, Anita			Protein phosphatase 2A?mediated flotillin-1 dephosphorylation up-regulates endothelial cell migration and angiogenesis regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase 2 (PP2A); endothelial cell; angiogenesis; cell migration; phosphorylation	MEMBRANE; 2A; REGGIE-1/FLOTILLIN-2; LOCALIZATION; MICRODOMAINS; DOMAIN; PHOSPHORYLATION; OLIGOMERIZATION; IDENTIFICATION; CYTOSKELETON	Endothelial cells have key functions in endothelial barrier integrity and in responses to angiogenic signals that promote cell proliferation, cell migration, cytoskeletal reorganization, and formation of new blood vessels. These functions highly depend on protein?protein interactions in cell?cell junction and cell attachment complexes and on interactions with cytoskeletal proteins. Protein phosphatase 2A (PP2A) dephosphorylates several target proteins involved in cytoskeletal dynamics and cell adhesion. Our goal was to find new interacting and substrate proteins of the PP2A-B55? holoenzyme in bovine pulmonary endothelial cells. Using LC-MS/MS analysis, we identified flotillin-1 as a protein that binds recombinant GSH S-transferase?tagged PP2A-B55?. Immunoprecipitation experiments, proximity ligation assays, and immunofluorescent staining confirmed the interaction between these two endogenous proteins in endothelial cells. Originally, flotillins were described as regulatory proteins for axon regeneration, but they appear to function in many cellular processes, such as membrane receptor signaling, endocytosis, and cell adhesion. Ser(315) is a known PKC-targeted site in flotillin-1. Utilizing phosphomutants of flotillin-1 and the NanoBiT luciferase assay, we show here that phosphorylation/dephosphorylation of Ser(315) in flotillin-1 significantly affects its interaction with PP2A-B55? and that PP2A-B55? dephosphorylates phospho-Ser(315). Spreading, attachment, migration, and in vitro tube formation rates of S315A variant?overexpressing cells were faster than those of nontransfected or S315D-transfected cells. These results indicate that the PP2A?flotillin-1 interaction identified here affects major physiological activities of pulmonary endothelial cells.	[Thalwieser, Zsofia; Kiraly, Nikolett; Fonodi, Marton; Csortos, Csilla; Boratko, Anita] Univ Debrecen, Fac Med, Dept Med Chem, Egyet Ter 1, H-4032 Debrecen, Hungary	University of Debrecen	Boratko, A (corresponding author), Univ Debrecen, Fac Med, Dept Med Chem, Egyet Ter 1, H-4032 Debrecen, Hungary.	boratko@med.unideb.hu		Boratko, Anita/0000-0002-3099-6692	National Research, Development and Innovation Fund (NKFI) [PD116262]; New National Excellence Program of the Ministry of Human Capacities [UNKP-18-4, UNKP-19-4, UNKP-19-3]; Hungarian Academy of Sciences	National Research, Development and Innovation Fund (NKFI); New National Excellence Program of the Ministry of Human Capacities; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported National Research, Development and Innovation Fund (NKFI) Grant PD116262 (to A. B.), Grants UNKP-18-4, UNKP-19-4 (to A. B.), and UNKP-19-3 (to Z. T.), New National Excellence Program of the Ministry of Human Capacities, and a Bolyai Fellowship from the Hungarian Academy of Sciences (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bagchi S, 2015, METHODS MOL BIOL, V1318, P149, DOI 10.1007/978-1-4939-2742-5_15; Banning A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7040028; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; Bodin S, 2014, J CELL SCI, V127, P5139, DOI 10.1242/jcs.159764; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boratko A, 2017, BBA-MOL CELL RES, V1864, P431, DOI 10.1016/j.bbamcr.2016.12.001; Boratko A, 2015, INT J BIOCHEM CELL B, V69, P105, DOI 10.1016/j.biocel.2015.10.021; Boratko A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-2; Boratko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035595; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Edgar AJ, 2001, INT J BIOCHEM CELL B, V33, P53, DOI 10.1016/S1357-2725(00)00069-8; Fork C, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0439-4; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kasa A, 2013, MICROVASC RES, V89, P86, DOI 10.1016/j.mvr.2013.05.003; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Riento K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197401; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Tar K, 2004, J CELL BIOCHEM, V92, P534, DOI 10.1002/jcb.20036; Tar K, 2006, J CELL BIOCHEM, V98, P931, DOI 10.1002/jcb.20829; Waschke J, 2006, HISTOCHEM CELL BIOL, V126, P17, DOI 10.1007/s00418-005-0140-7; Weeks KL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004861; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	46	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20196	20206		10.1074/jbc.RA119.007980	http://dx.doi.org/10.1074/jbc.RA119.007980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753918	Green Published, hybrid			2022-12-28	WOS:000505005800030
J	Zhang, G; Chen, X; Qiu, FH; Zhu, FX; Lei, WJ; Nie, J				Zhang, Guo; Chen, Xia; Qiu, Fanghua; Zhu, Fengxin; Lei, Wenjing; Nie, Jing			RETRACTION: A novel interaction between the SH2 domain of signaling adaptor protein Nck-1 and the upstream regulator of the Rho family GTPase Rac1 engulfment and cell motility 1 (ELMO1) promotes Rac1 activation and cell motility (vol 289, pg 23112, 2014) (Retraction of Vol 289, Pg 23112, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Zhang G, 2014, J BIOL CHEM, V289, P23112, DOI 10.1074/jbc.M114.549550	1	0	0	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20262	20262		10.1074/jbc.W119.012036	http://dx.doi.org/10.1074/jbc.W119.012036			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31882523	Green Published, hybrid			2022-12-28	WOS:000505005800038
J	Ghorpade, DS; Kaveri, SV; Bayry, J; Balaji, KN				Ghorpade, Devram Sampat; Kaveri, Srini V.; Bayry, Jagadeesh; Balaji, Kithiganahalli Narayanaswamy			RETRACTION: Withdrawal: Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation. (Retraction of Vol 286, Pg 31347, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19449	19449		10.1074/jbc.W119.011943	http://dx.doi.org/10.1074/jbc.W119.011943			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836676	Green Published, hybrid			2022-12-28	WOS:000516527800044
J	Zhang, JY; Choi, EH; Tworak, A; Salom, D; Leinonen, H; Sander, CL; Hoang, TV; Handa, JT; Blackshaw, S; Palczewska, G; Kiser, PD; Palczewski, K				Zhang, Jianye; Choi, Elliot H.; Tworak, Aleksander; Salom, David; Leinonen, Henri; Sander, Christopher L.; Hoang, Thanh V.; Handa, James T.; Blackshaw, Seth; Palczewska, Grazyna; Kiser, Philip D.; Palczewski, Krzysztof			Photic generation of 11-cis-retinal in bovine retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzymatic photoisomerization; 11-cis-retinal; 13-cis-retinal; visual chromophore; RPE-retinal G protein-coupled receptor (RGR); retinal pigment epithelium-specific 65 kDa protein (RPE65); visible light; cellular retinaldehyde-binding protein (CRALBP); rhodopsin; cone opsin	COUPLED RECEPTOR OPSIN; ALL-TRANS-RETINOIDS; BINDING-PROTEIN; VISUAL CYCLE; VITAMIN-A; DARK-ADAPTATION; ISOMERIZATION; RHODOPSIN; RPE65; LIGHT	Photoisomerization of the 11-cis-retinal chromophore of rod and cone visual pigments to an all-trans configuration is the initiating event for vision in vertebrates. The regeneration of 11-cis-retinal, necessary for sustained visual function, is an endergonic process normally conducted by specialized enzyme systems. However, 11-cis-retinal also can be formed through reverse photoisomerization from all-trans-retinal. A non-visual opsin known as retinal pigment epithelium (RPE)-retinal G protein-coupled receptor (RGR) was previously shown to mediate visual chromophore regeneration in photic conditions, but conflicting results have cast doubt on its role as a photoisomerase. Here, we describe high-level production of 11-cis-retinal from RPE membranes stimulated by illumination at a narrow band of wavelengths. This activity was associated with RGR and enhanced by cellular retinaldehyde-binding protein (CRALBP), which binds the 11-cisretinal produced by RGR and prevents its reisomerization to all-trans-retinal. The activity was recapitulated with cells heterologously expressing RGR and with purified recombinant RGR. Using an RGR variant, K255A, we confirmed that a Schiff base linkage at Lys-255 is critical for substrate binding and isomerization. Single-cell RNA-Seq analysis of the retina and RPE tissue confirmed that RGR is expressed in human and bovine RPE and Muller glia, whereas mouse RGR is expressed in RPE, but not in Muller glia. These results provide key insights into the mechanisms of physiological retinoid photoisomerization and suggest a novel mechanism by which RGR, in concert with CRALBP, regenerates the visual chromophore in the RPE under sustained light conditions.	[Zhang, Jianye; Choi, Elliot H.; Tworak, Aleksander; Salom, David; Leinonen, Henri; Sander, Christopher L.; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Choi, Elliot H.; Sander, Christopher L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoang, Thanh V.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Handa, James T.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA; [Palczewska, Grazyna] Polgenix Inc, Dept Med Devices, 5171 Calif Ave,Suite 150, Irvine, CA 92617 USA; [Kiser, Philip D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA	University of California System; University of California Irvine; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA.	kpalczew@uci.edu	Leinonen, Henri/V-2684-2019; Sander, Christopher/GRR-4165-2022	Leinonen, Henri/0000-0002-0388-832X; Tworak, Aleksander/0000-0002-3256-8990; Palczewska, Grazyna/0000-0003-4030-4685; Salom, David/0000-0002-3208-1509; Sander, Christopher/0000-0002-1680-6637	NATIONAL EYE INSTITUTE [T32EY007157, R01EY027691, R24EY027283, R01EY020560] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY020560, R01 EY009339, U01 EY025451, R01 EY027691, T32 EY007157, R24 EY027283] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250, T32 GM008803] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albalat R, 2012, MOL BIOL EVOL, V29, P1461, DOI 10.1093/molbev/msr313; ALCHALEL A, 1975, J AM CHEM SOC, V97, P2161, DOI 10.1021/ja00841a029; Arno G, 2016, INVEST OPHTH VIS SCI, V57, P4806, DOI 10.1167/iovs.16-19687; BARRY B, 1982, J CELL BIOL, V94, P479, DOI 10.1083/jcb.94.2.479; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BERNSTEIN PS, 1986, BIOCHEMISTRY-US, V25, P6473, DOI 10.1021/bi00369a020; Bolze CS, 2014, J AM CHEM SOC, V136, P137, DOI 10.1021/ja411366w; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chance B, 1999, ADV ENZYMOL RAMB, V73, P1, DOI 10.1002/9780470123195.ch1; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Cook JD, 2017, J BIOL CHEM, V292, P21407, DOI [10.1074/jbc.M117.812701, 10.1074/jbc.m117.812701]; Crabb JW, 1998, METH MOL B, V89, P91; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FEX G, 1988, BIOCHIM BIOPHYS ACTA, V944, P249, DOI 10.1016/0005-2736(88)90438-5; FEX G, 1987, BIOCHIM BIOPHYS ACTA, V901, P255, DOI 10.1016/0005-2736(87)90122-2; Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Frederiksen R, 2016, J GEN PHYSIOL, V148, P1, DOI 10.1085/jgp.201511538; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HARA T, 1973, NATURE-NEW BIOL, V242, P39, DOI 10.1038/newbio242039a0; He MF, 2013, J CHROMATOGR A, V1271, P67, DOI 10.1016/j.chroma.2012.11.022; Hecht S, 1937, P NATL ACAD SCI USA, V23, P227, DOI 10.1073/pnas.23.4.227; Hofmann L, 2015, PROG RETIN EYE RES, V49, P46, DOI 10.1016/j.preteyeres.2015.07.004; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; JIANG MS, 1995, EXP EYE RES, V60, P401, DOI 10.1016/S0014-4835(05)80096-X; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kim EJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21104-7; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; NOY N, 1995, J LIPID RES, V36, P375; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Ortega JT, 2019, J BIOL CHEM, V294, P8101, DOI 10.1074/jbc.RA119.007808; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; OZAKI K, 1987, VISION RES, V27, P1057, DOI 10.1016/0042-6989(87)90020-4; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; RANDO RR, 1982, BIOCHEM BIOPH RES CO, V104, P430, DOI 10.1016/0006-291X(82)90655-6; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rodieck R.W., 1998, 1 STEPS SEEING; RUSHTON WAH, 1977, BIOPHYS STRUCT MECH, V3, P159, DOI 10.1007/BF00535812; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sahu B, 2015, J BIOL CHEM, V290, P27239, DOI 10.1074/jbc.M115.682096; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SHEN DW, 1994, BIOCHEMISTRY-US, V33, P13117, DOI 10.1021/bi00248a022; Shen P, 1999, BRAIN RES, V826, P157, DOI 10.1016/S0006-8993(99)01179-8; SHICHI H, 1974, J BIOL CHEM, V249, P6570; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Tao L, 1998, Mol Vis, V4, P25; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TERAKITA A, 1989, VISION RES, V29, P639, DOI 10.1016/0042-6989(89)90026-6; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Widjaja-Adhi M.A.K., 2018, FASEB J; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Yang M, 2002, J BIOL CHEM, V277, P3318, DOI 10.1074/jbc.M108946200; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950	90	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19137	19154		10.1074/jbc.RA119.011169	http://dx.doi.org/10.1074/jbc.RA119.011169			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694912	Green Published, hybrid			2022-12-28	WOS:000516527800016
J	Natarajan, K; Margulies, DH				Natarajan, Kannan; Margulies, David H.			Cutting antigenic peptides down to size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							AMINOPEPTIDASE; ERAP1	A critical step in antigen presentation is the degradative processing of peptides by aminopeptidases in the endoplasmic reticulum. It is unclear whether these enzymes act only on free peptides or on those bound to their major histocompatibility complex (MHC)-I?presenting molecules. A recent study examined the structure and biophysics of N-terminally extended peptides in complex with MHC-I, revealing the conformational adjustment of MHC to permit both binding of the peptide core and exposure of the peptide N terminus. These data suggest a mechanism by which aminopeptidase access is determined and offer an explanation for how longer peptides may be displayed at the cell surface.	[Natarajan, Kannan; Margulies, David H.] NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, 10 Ctr Dr,Bldg 10,Rm 11D12, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, 10 Ctr Dr,Bldg 10,Rm 11D12, Bethesda, MD 20892 USA.	dhm@nih.gov		Margulies, David/0000-0001-8530-7375	Intramural Research Program of NIAID, National Institutes of Health	Intramural Research Program of NIAID, National Institutes of Health	This work was supported by the Intramural Research Program of NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Li LN, 2019, J BIOL CHEM, V294, P18534, DOI 10.1074/jbc.RA119.010102; de Castro JAL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02463; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009	7	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18545	18546		10.1074/jbc.H119.011803	http://dx.doi.org/10.1074/jbc.H119.011803			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31811048	hybrid, Green Published			2022-12-28	WOS:000507618800004
J	Saini, AK; Maithal, K; Chand, P; Chowdhury, S; Vohra, R; Goyal, A; Dubey, GP; Chopra, P; Chandra, R; Tyagi, AK; Singh, Y; Tandon, V				Saini, Adesh Kumar; Maithal, Kapil; Chand, Prem; Chowdhury, Shantanu; Vohra, Reena; Goyal, Anita; Dubey, Gyanendra P.; Chopra, Puneet; Chandra, Ramesh; Tyagi, Anil K.; Singh, Yogendra; Tandon, Vibha			RETRACTION: Withdrawal: Nuclear localization and in situ DNA damage by Mycobacterium tuberculosis nucleoside-diphosphate kinase (Retraction of Vol 279, Pg 50142, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Saini, Reena V/ABA-6052-2020; Saini, Adesh/AAY-6016-2020	Saini, Adesh/0000-0002-5445-5786				Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200	1	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18949	18949		10.1074/jbc.W119.011773	http://dx.doi.org/10.1074/jbc.W119.011773			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31811049	Green Published, hybrid			2022-12-28	WOS:000507618800037
J	Ryan, JJ; Sprunger, ML; Holthaus, K; Shorter, J; Jackrel, ME				Ryan, Jeremy J.; Sprunger, Macy L.; Holthaus, Kayla; Shorter, James; Jackrel, Meredith E.			Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma (vol 294, pg 11286, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Ryan JJ, 2019, J BIOL CHEM, V294, P11286, DOI 10.1074/jbc.RA119.009494	2	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17707	17707		10.1074/jbc.AAC119.011523	http://dx.doi.org/10.1074/jbc.AAC119.011523			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31732685	Green Published, hybrid			2022-12-28	WOS:000503173500043
J	Ullah, K; Chen, SP; Lu, JQ; Wang, XH; Liu, Q; Zhang, Y; Long, YQ; Hu, ZH; Xu, GQ				Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Hu, Zhanhong; Xu, Guoqiang			The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; senescence; ubiquitylation (ubiquitination); protein degradation; hydrogen peroxide; brain and muscle ARNT-like 1 (BMAL1; ARNTL; MOP3); cell cycle regulation; circadian clock; proteasome; STIP1 homology and U-box-containing protein 1 (STUB1)	HUMAN FIBROBLASTS; CHIP CONTROLS; PROTEIN; TRANSCRIPTION; CLOCK; P53; COMPONENT; CANCER; UBIQUITYLATION; PROTEASOME	Cell senescence is one of the most important processes determining cell fate and is involved in many pathophysiological conditions, including cancer, neurodegenerative diseases, and other aging-associated diseases. It has recently been discovered that the E3 ubiquitin ligase STIP1 homology and U-box?containing protein 1 (STUB1 or CHIP) is up-regulated during the senescence of human fibroblasts and modulates cell senescence. However, the molecular mechanism underlying STUB1-controlled senescence is not clear. Here, using affinity purification and MS-based analysis, we discovered that STUB1 binds to brain and muscle ARNT-like 1 (BMAL1, also called aryl hydrocarbon receptor nuclear translocator?like protein 1 (ARNTL)). Through biochemical experiments, we confirmed the STUB1-BMAL1 interaction, identified their interaction domains, and revealed that STUB1 overexpression down-regulates BMAL1 protein levels through STUB1's enzymatic activity and that STUB1 knockdown increases BMAL1 levels. Further experiments disclosed that STUB1 enhances BMAL1 degradation, which is abolished upon proteasome inhibition. Moreover, we found that STUB1 promotes the formation of Lys-48?linked polyubiquitin chains on BMAL1, facilitating its proteasomal degradation. Interestingly, we also discovered that oxidative stress promotes STUB1 nuclear translocation and enhances its co-localization with BMAL1. STUB1 expression attenuates hydrogen peroxide?induced cell senescence, indicated by a reduced signal in senescence-associated ?-gal staining and decreased protein levels of two cell senescence markers, p53 and p21. BMAL1 knockdown diminishes this effect, and BMAL1 overexpression abolishes STUB1's effect on cell senescence. In summary, the results of our work reveal that the E3 ubiquitin ligase STUB1 ubiquitinates and degrades its substrate BMAL1 and thereby alleviates hydrogen peroxide?induced cell senescence.	[Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Ullah, Kifayat; Chen, Suping; Lu, Jiaqi; Wang, XiaoHui; Liu, Qing; Zhang, Yang; Long, Yaqiu; Xu, Guoqiang] Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; [Hu, Zhanhong] Soochow Univ, Affiliated Hosp 2, Dept Pharm, Suzhou 215004, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Hu, ZH (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Pharm, Suzhou 215004, Jiangsu, Peoples R China.; Xu, GQ (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China.	sdfeyhzh@163.com; gux2002@suda.edu.cn	Xiaohui, Wang/AFS-7746-2022	Xu, Guoqiang/0000-0002-4753-4769	National Key R&D Program of China [2019YFA0800400]; National Natural Science Foundation of China [31670833, 31700722]; Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences) [SYS201718]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX17_2040]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; National Center for International Research Grant [2017B01012]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences); Postgraduate Research and Practice Innovation Program of Jiangsu Province; Jiangsu Key Laboratory of Neuropsychiatric Diseases; National Center for International Research Grant; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by National Key R&D Program of China Grant 2019YFA0800400, National Natural Science Foundation of China Grants 31670833 and 31700722, Suzhou Bureau of Science and Technology (Basic Research in Medical and Health Sciences) Grant SYS201718, Postgraduate Research and Practice Innovation Program of Jiangsu Province Grant KYCX17_2040, Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003, National Center for International Research Grant 2017B01012, and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chen SP, 2018, FEBS J, V285, P2987, DOI 10.1111/febs.14595; Chen SP, 2018, J BIOL CHEM, V293, P11296, DOI 10.1074/jbc.RA117.001432; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Choppara S, 2018, J BIOL CHEM, V293, P16291, DOI 10.1074/jbc.RA118.005354; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fang LM, 2017, ACTA PHARMACOL SIN, V38, P1305, DOI 10.1038/aps.2017.25; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hou XO, 2015, ACTA PHARMACOL SIN, V36, P1300, DOI 10.1038/aps.2015.54; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.181; Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002; Liu BY, 2019, ONCOGENE, V38, P2501, DOI 10.1038/s41388-018-0605-5; Ma Q, 2015, ACTA PHARMACOL SIN, V36, P966, DOI 10.1038/aps.2015.48; Mavrogonatou E, 2020, SEMIN CANCER BIOL, V62, P182, DOI 10.1016/j.semcancer.2019.06.018; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakahata Y, 2018, CHRONOBIOL INT, V35, P730, DOI 10.1080/07420528.2018.1430038; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Seo J, 2016, NAT CELL BIOL, V18, P291, DOI 10.1038/ncb3314; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shang Y, 2014, BIOCHEM BIOPH RES CO, V446, P387, DOI 10.1016/j.bbrc.2014.02.124; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Sisoula C, 2011, MECH AGEING DEV, V132, P269, DOI 10.1016/j.mad.2011.04.003; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; VanPelt J, 2017, BBA-PROTEINS PROTEOM, V1865, P133, DOI 10.1016/j.bbapap.2016.11.005; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu GQ, 2013, CURR PHARM DESIGN, V19, P3315, DOI 10.2174/13816128113199990305; Zhang QQ, 2015, ACTA PHARMACOL SIN, V36, P1113, DOI 10.1038/aps.2015.36; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhang Y, 2011, ACTA PHARMACOL SIN, V32, P1199, DOI 10.1038/aps.2011.108; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	52	16	17	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4696	4708		10.1074/jbc.RA119.011280	http://dx.doi.org/10.1074/jbc.RA119.011280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32041778	hybrid, Green Published			2022-12-28	WOS:000524499700027
J	Li, HY; Zhang, WX; Zhao, KM; Zhao, D; Zheng, SL; Hu, Y				Li Huayi; Zhang Wenxin; Zhao Kunming; Zhao Dong; Zheng Shanliang; Hu Ying			A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; NF-?B (NF-?B); senescence; interleukin 6 (IL-6); cancer therapy; iASPP; inhibitor of senescence-associated secretion phenotype	NF-KAPPA-B; ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; DNA-DAMAGE; TUMOR-SUPPRESSOR; P53; PROMOTES; PROTEIN; NRF2	Cellular senescence is terminal cell cycle arrest that represents a prominent response to numerous anticancer therapies. The oncogene inhibitor of the apoptosis-stimulating protein of p53 (iASPP) plays essential roles in regulating cellular drug response by inhibiting apoptosis. However, whether or not it regulates chemotherapy-induced senescence (TIS) in cancer cells remains unclear. Here, using two commonly used cancer cell lines, HCT 116 and MCF-7, along with the xenograft mouse model, we found that iASPP inhibits senescence and also influences the senescence-associated secretory phenotype (SASP), which confers anticancer drug resistance independently of apoptosis. Mechanistically, iASPP is transcriptionally elevated by the p65 subunit of NF-?B in senescent cells and then translocates to the nucleus, where it binds p53 and NF-?Bp65. This binding inhibits their transcriptional activities toward p21 and the key SASP factors interleukin (IL)-6/IL-8, respectively, and subsequently prevents senescence. Of note, we observed that iASPP knockdown sensitizes apoptosis-resistant cancers to doxorubicin treatment by promoting senescence both in vitro and in vivo. We conclude that iASPP integrates the NF-?Bp65- and p53-signaling pathways and thereby regulates cell fate in response to TIS, leading to chemotherapy resistance. These findings suggest that iASPP inhibition might be a strategy that could help restore senescence in cancer cells and improve outcomes of chemotherapy-based therapies.	[Li Huayi; Zhang Wenxin; Zhao Kunming; Zhao Dong; Zheng Shanliang; Hu Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China; [Hu Ying] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; University Town of Shenzhen	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.; Hu, Y (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China.	huying@hit.edu.cn	Hu, Ying/ABG-2935-2021	Hu, Ying/0000-0003-2469-5604; Li, Huayi/0000-0002-0732-3246; Zhao, Dong/0000-0001-7214-6947	National Natural Science Foundation of China [31871389, 31301131, 31741084]; Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant [JCYJ20170811154452255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant	This work was supported by National Natural Science Foundation of China Grants 31871389, 31301131, and 31741084 and Basic Science Foundation of Science and Technology Innovation Commission in Shenzhen Grant JCYJ20170811154452255. The authors declare that they have no conflicts of interest with the contents of this article.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Falik-Zaccai TC, 2017, EMBO MOL MED, V9, P319, DOI 10.15252/emmm.201606523; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Gunaratna RT, 2019, ONCOGENE, V38, P3535, DOI 10.1038/s41388-018-0630-4; Hainaut P, 2009, LANCET ONCOL, V10, P913, DOI 10.1016/S1470-2045(09)70198-6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Herron BJ, 2005, HUM MOL GENET, V14, P667, DOI 10.1093/hmg/ddi063; Hu Y, 2015, ONCOTARGET, V6, P42478, DOI 10.18632/oncotarget.6478; Hussain S, 2019, J CELL BIOCHEM, V120, P14213, DOI 10.1002/jcb.28782; Jia YJ, 2014, FASEB J, V28, P2816, DOI 10.1096/fj.13-244632; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15208; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laska MJ, 2010, BBA-GEN SUBJECTS, V1800, P1231, DOI 10.1016/j.bbagen.2010.09.002; Li GL, 2011, MOL CELL BIOCHEM, V350, P193, DOI 10.1007/s11010-010-0698-9; Li Y, 2015, CELL MOL BIOL, V61, P2; Lu B, 2010, GASTROENTEROLOGY, V139, P2183, DOI 10.1053/j.gastro.2010.06.049; Lu M, 2016, CANCER CELL, V30, P822, DOI 10.1016/j.ccell.2016.09.019; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mohan S, 2018, BIOMED PHARMACOTHER, V108, P1866, DOI 10.1016/j.biopha.2018.10.019; Morris EV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.442; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Oronsky B, 2019, MOL PHARMACEUT, V16, P2929, DOI 10.1021/acs.molpharmaceut.9b00150; Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Rao SG, 2016, TRENDS CANCER, V2, P676, DOI 10.1016/j.trecan.2016.10.001; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; te Poele RH, 2002, CANCER RES, V62, P1876; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Xiong Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0520-6; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	55	7	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4049	4063		10.1074/jbc.RA119.011411	http://dx.doi.org/10.1074/jbc.RA119.011411			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32005663	Green Published, hybrid			2022-12-28	WOS:000527704400028
J	Venkatesh, J; Sekhar, SC; Cheriyan, VT; Muthu, M; Meister, P; Levi, E; Dzinic, S; Gauld, JW; Polin, LA; Rishi, AK				Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Meister, Paul; Levi, Edi; Dzinic, Sijana; Gauld, James W.; Polin, Lisa A.; Rishi, Arun K.			Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKK? protein enhances the anticancer effect of chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-?B transcription factor; high-throughput screening (HTS); small molecule; breast cancer; cytokine; CARP-1; CCAR1; NEMO; IKK?; p65; RelA	NF-KAPPA-B; ESSENTIAL MODULATOR NEMO; IKK-GAMMA; ACTIVATION; COMPLEX; GROWTH; IDENTIFICATION; INHIBITION; CCAR1; REQUIREMENT	NF-?B is a pro-inflammatory transcription factor that critically regulates immune responses and other distinct cellular pathways. However, many NF-?B?mediated pathways for cell survival and apoptosis signaling in cancer remain to be elucidated. Cell cycle and apoptosis regulatory protein 1 (CARP-1 or CCAR1) is a perinuclear phosphoprotein that regulates signaling induced by anticancer chemotherapy and growth factors. Although previous studies have reported that CARP-1 is a part of the NF-?B proteome, regulation of NF-?B signaling by CARP-1 and the molecular mechanism(s) involved are unclear. Here, we report that CARP-1 directly binds the NF-?B?activating kinase I?B kinase subunit ? (NEMO or NF-?B essential modulator) and regulates the chemotherapy-activated canonical NF-?B pathway. Importantly, blockade of NEMO?CARP-1 binding diminished NF-?B activation, indicated by reduced phosphorylation of its subunit p65/RelA by the chemotherapeutic agent adriamycin (ADR), but not NF-?B activation induced by tumor necrosis factor ? (TNF?), interleukin (IL)-1?, or epidermal growth factor. High-throughput screening of a chemical library yielded a small molecule inhibitor of NEMO?CARP-1 binding, termed selective NF-?B inhibitor 1 (SNI)-1). We noted that SNI-1 enhances chemotherapy-dependent growth inhibition of a variety of cancer cells, including human triple-negative breast cancer (TNBC) and patient-derived TNBC cells in vitro, and attenuates chemotherapy-induced secretion of the pro-inflammatory cytokines TNF?, IL-1?, and IL-8. SNI-1 also enhanced ADR or cisplatin inhibition of murine TNBC tumors in vivo and reduced systemic levels of pro-inflammatory cytokines. We conclude that inhibition of NEMO?CARP-1 binding enhances responses of cancer cells to chemotherapy.	[Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Levi, Edi; Rishi, Arun K.] Wayne State Univ, John D Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA; [Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Dzinic, Sijana; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Venkatesh, Jaganathan; Sekhar, Sreeja C.; Cheriyan, Vino T.; Muthu, Magesh; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI 48201 USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; [Meister, Paul; Gauld, James W.] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Sekhar, Sreeja C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cheriyan, Vino T.] LA State Univ Hlth Sci Ctr, Dept Biochem, Shreveport, LA 71103 USA; [Muthu, Magesh] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; University of Windsor; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Umea University	Rishi, AK (corresponding author), VAMC, Rm B4334,4646 John R, Detroit, MI 48201 USA.	Rishia@Karmanos.org	muthu, magesh/N-6987-2017	muthu, magesh/0000-0003-3311-8120; sekhar, sreeja/0000-0002-9827-5349	Department of Veterans Affairs; Wayne State University Molecular Therapeutics Seed Money Grant	Department of Veterans Affairs(US Department of Veterans Affairs); Wayne State University Molecular Therapeutics Seed Money Grant	This work was supported by a Department of Veterans Affairs merit review grant (to A. K. R.) and Wayne State University Molecular Therapeutics Seed Money Grant (to A. K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Case DA, 2014, AMBER 14; Cheriyan VT, 2017, ONCOTARGET, V8, P104928, DOI 10.18632/oncotarget.20650; Cheriyan VT, 2016, ONCOTARGET, V7, P73370, DOI 10.18632/oncotarget.12333; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Francois S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043335; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Hervy Martial, 2010, Genes Cancer, V1, P506; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Hooper C, 2014, J BIOL CHEM, V289, P33161, DOI 10.1074/jbc.M114.582478; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hwang B, 2015, J BIOL CHEM, V290, P17967, DOI 10.1074/jbc.M115.645960; Jackson SS, 2015, EXP CELL RES, V331, P58, DOI 10.1016/j.yexcr.2014.09.034; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lu CK, 2012, BIOCHEM BIOPH RES CO, V418, P307, DOI 10.1016/j.bbrc.2012.01.016; Martin AG, 2009, AGING-US, V1, P335, DOI 10.18632/aging.100026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Muthu M, 2015, J BIOMED NANOTECHNOL, V11, P1608, DOI 10.1166/jbn.2015.2099; Muthu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102567; Ou CY, 2014, J BIOL CHEM, V289, P17078, DOI 10.1074/jbc.M114.548081; Ou CY, 2009, J BIOL CHEM, V284, P20629, DOI 10.1074/jbc.M109.014332; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Picco Vincent, 2013, Genes Cancer, V4, P360, DOI 10.1177/1947601913486347; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rocha CRR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e478s; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sekhar SC, 2019, CANCERS, V11, DOI 10.3390/cancers11020221; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; van Raam BJ, 2013, CELL DEATH DIFFER, V20, P86, DOI 10.1038/cdd.2012.98; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Vyas D, 2014, ONCOTARGETS THER, V7, P1015, DOI 10.2147/OTT.S60114; Wang Wei, 2017, J Cancer Metastasis Treat, V3, P45, DOI 10.20517/2394-4722.2017.03; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wen SH, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0625-9; Wu GY, 2018, CANCER RES, V78, P6399, DOI 10.1158/0008-5472.CAN-18-2063; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	59	4	4	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3532	3552		10.1074/jbc.RA119.009898	http://dx.doi.org/10.1074/jbc.RA119.009898			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32024692	Green Published, hybrid			2022-12-28	WOS:000527725300014
J	Wu, XY; Schnitzler, GR; Gao, GF; Diamond, B; Baker, AR; Kaplan, B; Williamson, K; Westlake, L; Lorrey, S; Lewis, TA; Garvie, CW; Lange, M; Hayat, S; Seidel, H; Doench, J; Cherniack, AD; Kopitz, C; Meyerson, M; Greulich, H				Wu, Xiaoyun; Schnitzler, Gavin R.; Gao, Galen F.; Diamond, Brett; Baker, Andrew R.; Kaplan, Bethany; Williamson, Kaylyn; Westlake, Lindsay; Lorrey, Selena; Lewis, Timothy A.; Garvie, Colin W.; Lange, Martin; Hayat, Sikander; Seidel, Henrik; Doench, John; Cherniack, Andrew D.; Kopitz, Charlotte; Meyerson, Matthew; Greulich, Heidi			Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; cancer biology; cell death; phosphodiesterases; biomarker; AIP; DNMDP; PDE3A; PDE3B; SLFN12; protein-protein interaction; chaperone	WEB TOOL; PDE3A; PHOSPHORYLATION; EXPRESSION; CHOPCHOP; ISOFORMS; REGION; AIP	Cytotoxic molecules can kill cancer cells by disrupting critical cellular processes or by inducing novel activities. 6-(4-(Diethylamino)-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one (DNMDP) is a small molecule that kills cancer cells by generation of novel activity. DNMDP induces complex formation between phosphodiesterase 3A (PDE3A) and schlafen family member 12 (SLFN12) and specifically kills cancer cells expressing elevated levels of these two proteins. Here, we examined the characteristics and covariates of the cancer cell response to DNMDP. On average, the sensitivity of human cancer cell lines to DNMDP is correlated with PDE3A expression levels. However, DNMDP could also bind the related protein, PDE3B, and PDE3B supported DNMDP sensitivity in the absence of PDE3A expression. Although inhibition of PDE3A catalytic activity did not account for DNMDP sensitivity, we found that expression of the catalytic domain of PDE3A in cancer cells lacking PDE3A is sufficient to confer sensitivity to DNMDP, and substitutions in the PDE3A active site abolish compound binding. Moreover, a genome-wide CRISPR screen identified the aryl hydrocarbon receptor?interacting protein (AIP), a co-chaperone protein, as required for response to DNMDP. We determined that AIP is also required for PDE3A-SLFN12 complex formation. Our results provide mechanistic insights into how DNMDP induces PDE3A-SLFN12 complex formation, thereby killing cancer cells with high levels of PDE3A and SLFN12 expression.	[Wu, Xiaoyun; Schnitzler, Gavin R.; Gao, Galen F.; Diamond, Brett; Baker, Andrew R.; Kaplan, Bethany; Williamson, Kaylyn; Westlake, Lindsay; Lorrey, Selena; Cherniack, Andrew D.; Meyerson, Matthew; Greulich, Heidi] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Lewis, Timothy A.; Garvie, Colin W.] Broad Inst, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Doench, John] Broad Inst, Genet Perturbat Platform, Cambridge, MA 02142 USA; [Lange, Martin; Hayat, Sikander; Seidel, Henrik; Kopitz, Charlotte] Bayer AG, Res & Dev, Pharmaceut, D-13342 Berlin, Germany; [Cherniack, Andrew D.; Meyerson, Matthew; Greulich, Heidi] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Bayer AG; Harvard University; Dana-Farber Cancer Institute	Greulich, H (corresponding author), Broad Inst, 415 Main St, Cambridge, MA 02142 USA.	heidig@broadinstitute.org	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022; Cherniack, Andrew D./AAY-8132-2020	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Cherniack, Andrew D./0000-0003-0470-0111; Lorrey, Selena/0000-0001-5567-2830; Seidel, Henrik/0000-0001-7804-5143; Williamson, Kaylyn/0000-0002-3252-5050; Gao, Galen/0000-0003-3143-9270; Meyerson, Matthew/0000-0002-9133-8108; Hayat, Sikander/0000-0001-5919-8371	Bayer AG	Bayer AG(Bayer AG)	We thank Alex Burgin and Jon Goldstein for critical reading of the manuscript. This work was supported by funding from Bayer AG.	Ahmad F, 2015, J BIOL CHEM, V290, P6763, DOI 10.1074/jbc.M115.638585; An R, 2019, AM J CANCER RES, V9, P1905; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basson MD, 2018, CELL PHYSIOL BIOCHEM, V48, P1274, DOI 10.1159/000492019; Berrisch S, 2017, N-S ARCH PHARMACOL, V390, P269, DOI 10.1007/s00210-016-1328-1; Cartledge DM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00042; de Waal L, 2016, NAT CHEM BIOL, V12, P102, DOI [10.1038/NCHEMBIO.1984, 10.1038/nchembio.1984]; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Fryknas M, 2006, J BIOMOL SCREEN, V11, P457, DOI 10.1177/1087057106288048; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Hernandez-Ramirez LC, 2016, J CLIN ENDOCR METAB, V101, P3144, DOI 10.1210/jc.2016-1307; Hung SH, 2006, J BIOL CHEM, V281, P29236, DOI 10.1074/jbc.M606558200; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kenan Y, 2000, J BIOL CHEM, V275, P12331, DOI 10.1074/jbc.275.16.12331; Kovalenko PL, 2014, J SURG RES, V190, P177, DOI 10.1016/j.jss.2014.03.069; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Li DR, 2019, MOL CELL, V75, P1103, DOI 10.1016/j.molcel.2019.06.040; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nazir M, 2017, EXP CELL RES, V361, P308, DOI 10.1016/j.yexcr.2017.10.032; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Puck A, 2017, EUR J IMMUNOL, V47, P193, DOI 10.1002/eji.201646405; Pulkka OP, 2019, CLIN CANCER RES, V25, P1676, DOI 10.1158/1078-0432.CCR-18-0815; Rhead B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206511; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sun LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090627; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Vandenberghe P, 2017, ONCOTARGET, V8, P41026, DOI 10.18632/oncotarget.17010; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	36	8	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3431	3446		10.1074/jbc.RA119.011191	http://dx.doi.org/10.1074/jbc.RA119.011191			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005668	hybrid, Green Published			2022-12-28	WOS:000527725300006
J	Yang, H; Xiang, SY; Kazi, A; Sebti, SM				Yang, Hua; Xiang, Shengyan; Kazi, Aslamuzzaman; Sebti, Said M.			The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; GTPase Kras (KRAS); reactive oxygen species (ROS); redox signaling; RalB; TBK1	NF-KAPPA-B; NRF2; MECHANISMS; KINASE; PHOSPHORYLATION; CYTOTOXICITY; ASSOCIATION; EXPRESSION; BINDING; REDOX	In human cancer cells that harbor mutant KRAS and WT p53 (p53), KRAS contributes to the maintenance of low p53 levels. Moreover, KRAS depletion stabilizes and reactivates p53 and thereby inhibits malignant transformation. However, the mechanism by which KRAS regulates p53 is largely unknown. Recently, we showed that KRAS depletion leads to p53 Ser-15 phosphorylation (P-p53) and increases the levels of p53 and its target p21/WT p53-activated fragment 1 (WAF1)/CIP1. Here, using several human lung cancer cell lines, siRNA-mediated gene silencing, immunoblotting, quantitative RT-PCR, promoter?reporter assays, and reactive oxygen species (ROS) assays, we demonstrate that KRAS maintains low p53 levels by activating the NRF2 (NFE2-related factor 2)?regulated antioxidant defense system. We found that KRAS depletion led to down-regulation of NRF2 and its targets NQO1 (NAD(P)H quinone dehydrogenase 1) and SLC7A11 (solute carrier family 7 member 11), decreased the GSH/GSSG ratio, and increased ROS levels. We noted that the increase in ROS is required for increased P-p53, p53, and p21(Waf1/cip1) levels following KRAS depletion. Downstream of KRAS, depletion of RalB (RAS-like proto-oncogene B) and I?B kinase?related TANK-binding kinase 1 (TBK1) activated p53 in a ROS- and NRF2-dependent manner. Consistent with this, the I?B kinase inhibitor BAY11-7085 and dominant-negative mutant I?B?M inhibited NF-?B activity and increased P-p53, p53, and p21(Waf1/cip1) levels in a ROS-dependent manner. In conclusion, our findings uncover an important role for the NRF2-regulated antioxidant system in KRAS-mediated p53 suppression.	H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA.; Sebti, SM (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA.	Said.Sebti@vcuhealth.org			Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center [P30-CA076292]	Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center	This work was supported in part by the Molecular Genomics Facility at Moffitt Cancer Center, an National Cancer Institute Comprehensive Cancer Center (P30-CA076292). We thank Gina DeNicola (Moffitt Cancer Center) for critical reading of this manuscript and Rasa Hamilton for editorial assistance.	Adler E.M., 2011, SCI SIGNAL, V4, pec24; Atia A., 2014, J APPL PHARM SCI, V4, P118, DOI [DOI 10.7324/JAPS.2014.41220, 10.7324/JAPS.2014.41220]; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Berger N, 2007, EXP HEMATOL, V35, P1495, DOI 10.1016/j.exphem.2007.07.006; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen CG, 1996, MOL IMMUNOL, V33, P57, DOI 10.1016/0161-5890(95)00128-X; Chien YC, 2008, METHOD ENZYMOL, V438, P321, DOI 10.1016/S0076-6879(07)38022-1; Cruz VH, 2018, J CELL COMMUN SIGNAL, V12, P83, DOI 10.1007/s12079-017-0438-y; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Durand JK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090139; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Jung BJ, 2018, BIOMOL THER, V26, P57, DOI 10.4062/biomolther.2017.195; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitamura H, 2018, CANCER SCI, V109, P900, DOI 10.1111/cas.13537; Kong B, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00246; Koppula P, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0288-x; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tecleab A, 2014, J BIOL CHEM, V289, P31296, DOI 10.1074/jbc.M114.565796	35	14	14	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3055	3063		10.1074/jbc.RA119.011930	http://dx.doi.org/10.1074/jbc.RA119.011930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001619	hybrid, Green Published			2022-12-28	WOS:000519597300015
J	Chen, C; Li, CC; Liu, WC; Guo, F; Kou, X; Sun, S; Ye, TY; Li, SJ; Zhao, AM				Chen, Chao; Li, Congcong; Liu, Weichun; Guo, Feng; Kou, Xi; Sun, Si; Ye, Taiyang; Li, Shanji; Zhao, Aimin			Estrogen-induced FOS-like 1 regulates matrix metalloproteinase expression and the motility of human endometrial and decidual stromal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell invasion; estrogen; estrogen receptor; matrix metalloproteinase (MMP); decidualization; FOS-like 1; human decidual stromal cells; human endometrial stromal cells	VASCULAR DYSFUNCTION; PLACENTAL ISCHEMIA; C-JUN; FRA-1; PREGNANCY; MMP-9; HYPERTENSION; ACTIVATION; DEPOSITION; IMMUNE	The regulation mechanisms involved in matrix metalloproteinase (MMP) expression and the motility of human endometrial and decidual stromal cells (ESCs and DSCs, respectively) during decidualization remain unclear. DSCs show significant increased cell motility and expression of FOS-like 1 (FOSL1) and MMP1, MMP2, and MMP9 compared with ESCs, whereas lack of decidualization inducers leads to a rapid decrease in FOSL1 and MMP1 and MMP9 expression in DSCs in vitro. Therefore, we hypothesized that a link exists between decidualization inducers and FOSL1 in up-regulation of motility during decidualization. Based on the response of ESCs/DSCs to different decidualization systems in vitro, we found that progesterone (P4) alone had no significant effect and that 17?-estradiol (E2) significantly increased cell motility and FOSL1 and MMP1 and MMP9 expression at the mRNA and protein levels, whereas 8-bromo-cAMP significantly decreased cell motility and FOSL1 and MMP9 expression in the presence of P4. In addition, we showed that E2 triggered phosphorylation of estrogen receptor 1 (ESR1), which could directly bind to the promoter of FOSL1 in ESCs/DSCs. Additionally, we also revealed silencing of ESR1 expression by siRNA abrogated E2-induced FOSL1 expression at the transcript and protein levels. Moreover, silencing of FOSL1 expression by siRNA was able to block E2-induced MMP1 and MMP9 expression and cell motility in ESCs/DSCs. Taken together, our data suggest that, in addition to its enhancement of secretory function, the change in MMP expression and cell motility is another component of the decidualization of ESCs/DSCs, including estrogen-dependent MMP1 and MMP9 expression mediated by E2?ESR1?FOSL1 signaling.	[Chen, Chao; Li, Congcong; Liu, Weichun; Guo, Feng; Kou, Xi; Sun, Si; Ye, Taiyang; Li, Shanji; Zhao, Aimin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Obstet & Gynecol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Chen, Chao; Li, Congcong; Guo, Feng; Zhao, Aimin] Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Zhao, AM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Obstet & Gynecol, 160 Pujian Rd, Shanghai 200127, Peoples R China.	zamzkh0526@126.com	li, congcong/AAE-5664-2021	Ye, Taiyang/0000-0002-2640-1289	National Natural Science Foundation of China [81671481, 81871179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81671481 and 81871179. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SMJ, 2015, EXPERT OPIN THER TAR, V19, P1495, DOI 10.1517/14728222.2015.1067684; Anacker J., 2010, J REPROD IMMUNOL, V86, P79, DOI [10.1016/j.jri.2010.08.002, DOI 10.1016/J.JRI.2010.08.002]; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Babu RL, 2013, MOL CELL BIOCHEM, V380, P143, DOI 10.1007/s11010-013-1667-x; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen JJ, 2017, PROG MOL BIOL TRANSL, V148, P87, DOI 10.1016/bs.pmbts.2017.04.001; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Das A, 2012, J BIOL CHEM, V287, P19622, DOI 10.1074/jbc.M111.297663; Dong JC, 2002, REPRODUCTION, V123, P621, DOI 10.1530/reprod/123.5.621; Sosa SEY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071448; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentilini D, 2010, FERTIL STERIL, V93, P706, DOI 10.1016/j.fertnstert.2008.10.014; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Guo D, 2010, CIRC RES, V107, P1275, DOI 10.1161/CIRCRESAHA.110.229054; HAMAGUCHI M, 1990, OBSTET GYNECOL, V76, P783, DOI 10.1097/00006250-199011000-00011; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; IRWIN JC, 1989, FERTIL STERIL, V52, P761; Kent LN, 2011, MOL CELL BIOL, V31, P4801, DOI 10.1128/MCB.05780-11; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Lekontseva O, 2009, J HYPERTENS, V27, P1602, DOI 10.1097/HJH.0b013e32832c41b5; Li W, 2017, AM J PHYSIOL-HEART C, V313, pH491, DOI 10.1152/ajpheart.00207.2017; Li W, 2014, BIOCHEM PHARMACOL, V89, P370, DOI 10.1016/j.bcp.2014.03.017; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0; Palei ACT, 2013, CURR DRUG TARGETS, V14, P325; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; Russo Louise A, 2009, Reprod Biol Endocrinol, V7, P124, DOI 10.1186/1477-7827-7-124; Sahay AS, 2018, J CELL BIOCHEM, V119, P6657, DOI 10.1002/jcb.26849; Salmi A, 1996, MOL HUM REPROD, V2, P979, DOI 10.1093/molehr/2.12.979; Shah DA, 2015, BIOCHEM PHARMACOL, V95, P211, DOI 10.1016/j.bcp.2015.04.012; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Staun-Ram E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-135; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yinon Y, 2015, PLACENTA, V36, P121, DOI 10.1016/j.placenta.2014.12.008; Zhang X, 2007, MOL REPROD DEV, V74, P321, DOI 10.1002/mrd.20582; Zhao P, 2008, MOL IMMUNOL, V45, P2187, DOI 10.1016/j.molimm.2007.12.002; Zhu H, 2014, GENE, V551, P1, DOI 10.1016/j.gene.2014.08.047	44	15	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2248	2258		10.1074/jbc.RA119.010701	http://dx.doi.org/10.1074/jbc.RA119.010701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31937587	Green Published, hybrid			2022-12-28	WOS:000517330200009
J	Hou, YJ; Yang, WS; Hong, Y; Zhang, Y; Wang, DC; Li, DF				Hou, Yan-Jie; Yang, Wen-Si; Hong, Yuan; Zhang, Ying; Wang, Da-Cheng; Li, De-Feng			Structural insights into the mechanism of c-di-GMP?bound YcgR regulating flagellar motility in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); crystal structure; molecular motor; second messenger; cell signaling; structure-function; biofilm regulation; flagellar motility; MotA; multiple targets; PilZ domain	PILZ DOMAIN; MOLECULAR CLUTCH; MOTA PROTEIN; GMP; SCATTERING; STATOR; MACROMOLECULES; ROTATION; SEQUENCE; COMPLEX	The motile-sessile transition is critical for bacterial survival and growth. Cyclic-di-GMP (c-di-GMP) plays a central role in controlling this transition and regulating biofilm formation via various effectors. As an effector of c-di-GMP in Escherichia coli and related species, the PilZ domain?containing protein YcgR responds to elevated c-di-GMP concentrations and acts on the flagellar motor to suppress bacterial motility in a brakelike fashion, which promotes bacterial surface attachment. To date, several target proteins within the motor, MotA, FliG, and FliM, along with different regulatory mechanisms have been reported. However, how YcgR acts on these components remains unclear. Here, we report that activated YcgR stably binds to MotA at the MotA-FliG interface and thereby regulates bacterial swimming. Biochemical and structural analyses revealed that c-di-GMP rearranges the PilZ domain configuration, resulting in the formation of a MotA-binding patch consisting of an RXXXR motif and the C-tail helix ?3. Moreover, we noted that a conserved region in the YcgR-N domain, which is independent of MotA interaction, is necessary for motility regulation. On the basis of these findings, we infer that the YcgR-N domain is required for activity on other motor proteins. We propose that activated YcgR appends to MotA via its PilZ domain and thereby interrupts the MotA-FliG interaction and simultaneously interacts with other motor proteins via its YcgR-N domain to inhibit flagellar motility. Our findings suggest that the mode of interaction between YcgR and motor proteins may be shared by other PilZ family proteins.	[Hou, Yan-Jie; Yang, Wen-Si; Hong, Yuan; Zhang, Ying; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Li, De-Feng] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, DC (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.; Li, DF (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn; lidefeng@im.ac.cn		Li, De-Feng/0000-0002-8683-019X	National Natural Science Foundation of China [31700661, 31270792]; Ministry of Science and Technology of the People's Republic of China [2013CB911501, 2017YFA0504000]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; program Youth Innovation Promotion Association of the Chinese Academy of Sciences [2014079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); program Youth Innovation Promotion Association of the Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31700661 (to Y.-J. H.) and 31270792 (to D.-F. L.), Ministry of Science and Technology of the People's Republic of China Grants 2013CB911501 (to D.-F. L.) and 2017YFA0504000 (to D.-C. W.), Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08020202 (to D.-C. W.), and the program Youth Innovation Promotion Association of the Chinese Academy of Sciences Grant 2014079 (to D.-F. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Armitage JP, 2010, CELL, V141, P24, DOI 10.1016/j.cell.2010.03.023; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker AE, 2016, J BACTERIOL, V198, P1837, DOI 10.1128/JB.00196-16; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Bren A, 1998, J MOL BIOL, V278, P507, DOI 10.1006/jmbi.1998.1730; Brown MT, 2011, CURR OPIN MICROBIOL, V14, P734, DOI 10.1016/j.mib.2011.09.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEAN GE, 1984, J BACTERIOL, V159, P991, DOI 10.1128/JB.159.3.991-999.1984; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hou YJ, 2013, ACTA CRYSTALLOGR F, V69, P663, DOI 10.1107/S1744309113011937; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P10067, DOI 10.1073/pnas.1607503113; Subramanian S, 2017, P NATL ACAD SCI USA, V114, P13537, DOI 10.1073/pnas.1716231114; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takekawa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31526; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wang F, 2016, PROTEIN CELL, V7, P766, DOI 10.1007/s13238-016-0317-y; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07; ZHOU JD, 1995, J MOL BIOL, V251, P237, DOI 10.1006/jmbi.1995.0431; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	55	13	14	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					808	821		10.1074/jbc.RA119.009739	http://dx.doi.org/10.1074/jbc.RA119.009739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31836667	Green Published, hybrid			2022-12-28	WOS:000508382900012
J	Picciano, AL; Crane, BR				Picciano, Angela L.; Crane, Brian R.			A nitric oxide synthase-like protein from Synechococcus produces NO/NO3- from l-arginine and NADPH in a tetrahydrobiopterin- and Ca2+-dependent manner (vol 294, pg 10708, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIGMS NIH HHS [R35 GM122535] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Picciano AL, 2019, J BIOL CHEM, V294, P10708, DOI 10.1074/jbc.RA119.008399	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					897	897		10.1074/jbc.AAC119.012409	http://dx.doi.org/10.1074/jbc.AAC119.012409			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953250	Green Published, hybrid			2022-12-28	WOS:000508382900019
J	Yasukawa, K; Kinoshita, D; Yaku, K; Nakagawa, T; Koshiba, T				Yasukawa, Kai; Kinoshita, Daisuke; Yaku, Keisuke; Nakagawa, Takashi; Koshiba, Takumi			The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; microRNA (miRNA); innate immunity; signaling; metabolic regulation; RNA virus	DEPENDENT PROTEIN-KINASE; DRP1; PHOSPHORYLATION; NORMALIZATION; TRANSCRIPTS; PYRUVATE; TARGETS; RAB32	MicroRNAs (miRNAs) are small noncoding RNAs that suppress the expression of multiple genes and are involved in numerous biologic functions and disorders, including human diseases. Here, we report that two miRNAs, miR-302b and miR-372, target mitochondrial-mediated antiviral innate immunity by regulating mitochondrial dynamics and metabolic demand. Using human cell lines transfected with the synthetic analog of viral dsRNA, poly(I-C), or challenged with Sendai virus, we found that both miRNAs are up-regulated in the cells late after viral infection and ultimately terminate the production of type I interferons and inflammatory cytokines. We found that miR-302b and miR-372 are involved in dynamin-related protein 1 (DRP1)-dependent mitochondrial fragmentation and disrupt mitochondrial metabolism by attenuating solute carrier family 25 member 12 (SLC25A12), a member of the SLC25 family. Neutralizing the effects of the two miRNAs through specific inhibitors re-established the mitochondrial dynamics and the antiviral responses. We found that SLC25A12 contributes to regulating the antiviral response by inducing mitochondrial-related metabolite changes in the organelle. Structure?function analysis indicated that SLC25A12, as part of a prohibitin complex, associates with the mitochondrial antiviral-signaling protein in mitochondria, providing structural insight into the regulation of the mitochondrial-mediated antiviral response. Our results contribute to the understanding of how miRNAs modulate the innate immune response by altering mitochondrial dynamics and metabolic demand. Manipulating the activities of miR-302b and miR-372 may be a potential therapeutic approach to target RNA viruses.	[Yasukawa, Kai; Kinoshita, Daisuke; Koshiba, Takumi] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan; [Yasukawa, Kai] Mitsubishi Tanabe Pharma Corp, Modal Labs, Innovat Res Div, Fujisawa, Kanagawa 2518555, Japan; [Yaku, Keisuke; Nakagawa, Takashi] Univ Toyama, Grad Sch Med & Pharmaceut Sci Res, Dept Metab & Nutr, Toyama 9300194, Japan; [Nakagawa, Takashi] Univ Toyama, Frontier Res Core Life Sci, Toyama 9300194, Japan; [Koshiba, Takumi] Fukuoka Univ, Dept Chem, Fac Sci, Fukuoka 8140180, Japan	Kyushu University; Mitsubishi Tanabe Pharma Corporation; University of Toyama; University of Toyama; Fukuoka University	Koshiba, T (corresponding author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	koshiba@kyudai.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Koshiba, Takumi/0000-0001-8535-5043; Yaku, Keisuke/0000-0002-2420-4265	JSPS KAKENHI [17H03667, 17K19561, 18H04863]; Takeda Science Foundation; KANEKA Corp.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); KANEKA Corp.	This work was supported by JSPS KAKENHI Grants 17H03667, 17K19561, and 18H04863, the Takeda Science Foundation, and the KANEKA Corp. (to T. K.). Kai Yasukawa is affiliated with Mitsubishi Tanabe Pharma Corp.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alkan HF, 2018, CELL METAB, V28, P706, DOI 10.1016/j.cmet.2018.07.021; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen XY, 2017, J BIOL CHEM, V292, P21291, DOI 10.1074/jbc.M117.805937; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wan SF, 2016, ONCOTARGET, V7, P76667, DOI 10.18632/oncotarget.12395; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yaku K, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4205; Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037; Yarbrough ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5963; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoshinaka T, 2019, ISCIENCE, V19, P1065, DOI 10.1016/j.isci.2019.08.056; Yoshizumi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05808-w; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713	45	16	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					444	457		10.1074/jbc.RA119.010511	http://dx.doi.org/10.1074/jbc.RA119.010511			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31767682	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000507373600015
J	Dey, S; Bindu, S; Goyal, M; Pal, C; Alam, A; Iqbal, MS; Kumar, R; Sarkar, S; Bandyopadhyay, U				Dey, Sumanta; Bindu, Samik; Goyal, Manish; Pal, Chinmay; Alam, Athar; Iqbal, Mohd. Shameel; Kumar, Rahul; Sarkar, Souvik; Bandyopadhyay, Uday			Impact of intravascular hemolysis in malaria on liver dysfunction: Involvement of hepatic free heme overload, NF-kappa B activation, and neutrophil infiltration (vol 287, pg 26630, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Goyal, Manish/O-2183-2015; Iqbal, Mohd Shameel/AAD-9641-2021	Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561				Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20259	20259		10.1074/jbc.AAC119.012033	http://dx.doi.org/10.1074/jbc.AAC119.012033			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31882520	Green Published, hybrid			2022-12-28	WOS:000505005800035
J	Kuiper, EG; Dey, D; LaMore, PA; Owings, JP; Prezioso, SM; Goldberg, JB; Conn, GL				Kuiper, Emily G.; Dey, Debayan; LaMore, Paige A.; Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.; Conn, Graeme L.			Substrate recognition by the Pseudomonas aeruginosa EF-Tu?modifying methyltransferase EftM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; post-translational modification (PTM); protein methylation; Pseudomonas aeruginosa (P; aeruginosa); S-adenosylmethionine (SAM); substrate specificity; translation elongation factor; EF-Tu; EftM	POSTTRANSLATIONAL MODIFICATIONS; PROTEIN; PHOSPHORYLCHOLINE; MODULATION; GENERATION; CHROMATIN; SERVER; OMPB	The opportunistic bacterial pathogen Pseudomonas aeruginosa is a leading cause of serious infections in individuals with cystic fibrosis, compromised immune systems, or severe burns. P. aeruginosa adhesion to host epithelial cells is enhanced by surface-exposed translation elongation factor EF-Tu carrying a Lys-5 trimethylation, incorporated by the methyltransferase EftM. Thus, the EF-Tu modification by EftM may represent a target to prevent P. aeruginosa infections in vulnerable individuals. Here, we extend our understanding of EftM activity by defining the molecular mechanism by which it recognizes EF-Tu. Acting on the observation that EftM can bind to EF-Tu lacking its N-terminal peptide (encompassing the Lys-5 target site), we generated an EftM homology model and used it in protein/protein docking studies to predict EftM/EF-Tu interactions. Using site-directed mutagenesis of residues in both proteins, coupled with binding and methyltransferase activity assays, we experimentally validated the predicted protein/protein interface. We also show that EftM cannot methylate the isolated N-terminal EF-Tu peptide and that binding-induced conformational changes in EftM are likely needed to enable placement of the first 5?6 amino acids of EF-Tu into a conserved peptide-binding channel in EftM. In this channel, a group of residues that are highly conserved in EftM proteins position the N-terminal sequence to facilitate Lys-5 modification. Our findings reveal that EftM employs molecular strategies for substrate recognition common among both class I (Rossmann fold) and class II (SET domain) methyltransferases and pave the way for studies seeking a deeper understanding of EftM's mechanism of action on EF-Tu.	[Kuiper, Emily G.; Dey, Debayan; LaMore, Paige A.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA; [Kuiper, Emily G.; Conn, Graeme L.] Emory Univ, GDBBS, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA; [Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, GDBBS, Grad Program Microbiol & Mol Genet MMG, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, Emory Childrens Ctr Cyst Fibrosis Res, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Goldberg, Joanna B.; Conn, Graeme L.] Emory Univ, Sch Med, Emory Antibiot Resistance Ctr Arc, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Dey, Debayan/AAI-9790-2020	Dey, Debayan/0000-0002-0222-6092; Conn, Graeme/0000-0002-2419-380X	Cystic Fibrosis Foundation [GOLDBE17P0, DEY18F0]; NIAID from the National Institutes of Health [T32-AI106699]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106699] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIAID from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Cystic Fibrosis Foundation Grant GOLDBE17P0 (to J. B. G. and G. L. C.), Postdoctoral Fellowship DEY18F0 (to D. D.), and in part by NIAID Training Grant T32-AI106699 from the National Institutes of Health to the Antimicrobial Resistance and Therapeutic Discovery Training Program of Emory University (awarded to S. M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; Abeykoon AH, 2016, J BIOL CHEM, V291, P19962, DOI 10.1074/jbc.M116.723460; Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Alvarez-Venegas R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00065; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Burgie ES, 2008, BIOCHEMISTRY-US, V47, P3982, DOI 10.1021/bi800063j; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Clark SE, 2013, INFECT IMMUN, V81, P392, DOI 10.1128/IAI.01168-12; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Demirci H, 2008, STRUCTURE, V16, P1059, DOI 10.1016/j.str.2008.03.016; Bastos PAD, 2017, J PROTEOMICS, V152, P254, DOI 10.1016/j.jprot.2016.11.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garcia-Fontana C, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004849; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jurcik A, 2018, BIOINFORMATICS, V34, P3586, DOI 10.1093/bioinformatics/bty386; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Macek B, 2019, NAT REV MICROBIOL, V17, P651, DOI 10.1038/s41579-019-0243-0; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Owings JP, 2016, J BIOL CHEM, V291, P3280, DOI 10.1074/jbc.M115.706853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prezioso SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39331-x; Quentin D, 2018, NAT MICROBIOL, V3, P1142, DOI 10.1038/s41564-018-0238-z; Savic M, 2015, ANTIMICROB AGENTS CH, V59, P2807, DOI 10.1128/AAC.00056-15; Sharma G, 2015, NUCLEIC ACIDS RES, V43, P3922, DOI 10.1093/nar/gkv261; Smani Y, 2012, J BIOL CHEM, V287, P26901, DOI 10.1074/jbc.M112.344556; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Valencia-Sanchez MI, 2019, MOL CELL, V74, P1010, DOI 10.1016/j.molcel.2019.03.029; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Widjaja M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10644-z; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Yaseen I, 2018, EMBO J, V37, P183, DOI 10.15252/embj.201796918	39	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20109	20121		10.1074/jbc.RA119.011213	http://dx.doi.org/10.1074/jbc.RA119.011213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753919	Green Published, hybrid			2022-12-28	WOS:000505005800023
J	Roche-Hakansson, H; Vansarla, G; Marks, LR; Hakansson, AP				Roche-Hakansson, Hazeline; Vansarla, Goutham; Marks, Laura R.; Hakansson, Anders P.			The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; Streptococcus; antibiotics; lactic acid; metabolism; cell death; enzyme inactivation; energy metabolism; membrane function; alpha-lactalbumin; glycolysis; HAMLET (human alpha-lactalbumin made lethal to tumor cells); human milk; Streptococcus pneumoniae; oleic acid	ALPHA-LACTALBUMIN; OLEIC-ACID; ESCHERICHIA-COLI; GENOME SEQUENCE; ESSENTIAL GENES; TUMOR-CELLS; INHIBITORS; BACTERIAL; ALDOLASE; DEHYDROGENASE	HAMLET is a complex of human ?-lactalbumin (ALA) and oleic acid and kills several Gram-positive bacteria by a mechanism that bears resemblance to apoptosis in eukaryotic cells. To identify HAMLET's bacterial targets, here we used Streptococcus pneumoniae as a model organism and employed a proteomic approach that identified several potential candidates. Two of these targets were the glycolytic enzymes fructose bisphosphate aldolase (FBPA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Treatment of pneumococci with HAMLET immediately inhibited their ATP and lactate production, suggesting that HAMLET inhibits glycolysis. This observation was supported by experiments with recombinant bacterial enzymes, along with biochemical and bacterial viability assays, indicating that HAMLET's activity is partially inhibited by high glucose?mediated stimulation of glycolysis but enhanced in the presence of the glycolysis inhibitor 2-deoxyglucose. Both HAMLET and ALA bound directly to each glycolytic enzyme in solution and solid-phase assays and effectively inhibited their enzymatic activities. In contrast, oleic acid alone had little to no inhibitory activity. However, ALA alone also exhibited no bactericidal activity and did not block glycolysis in whole cells, suggesting a role for the lipid moiety in the internalization of HAMLET into the bacterial cells to reach its target(s). This was verified by inhibition of enzyme activity in whole cells after HAMLET but not ALA exposure. The results of this study suggest that part of HAMLET's antibacterial activity relates to its ability to target and inhibit glycolytic enzymes, providing an example of a natural antimicrobial agent that specifically targets glycolysis.	[Roche-Hakansson, Hazeline] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14203 USA; [Vansarla, Goutham; Hakansson, Anders P.] Lund Univ, Dept Translat Med, Div Expt Infect Med, 53 Inga Marie Nilsson St, SE-21428 Malmo, Sweden; [Marks, Laura R.] Washington Univ, Dept Med, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Roche-Hakansson, Hazeline] Allergan Pharmaceut Inc, Madison, NJ 07940 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Lund University; Barnes-Jewish Hospital; Washington University (WUSTL); AbbVie; Allergan	Hakansson, AP (corresponding author), Lund Univ, Dept Translat Med, Div Expt Infect Med, 53 Inga Marie Nilsson St, SE-21428 Malmo, Sweden.	anders_p.hakansson@med.lu.se	Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders P/0000-0002-2834-6009; Vansarla, Goutham/0000-0002-8622-355X; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; American Lung Association [RG-123721-N]; Swedish Medical Research Council (VR) [K2015-99X-22878-01-6, 2018-05947]; Alfred Osterlund Foundation (Malmo, Sweden); Royal Physiographic Society (Lund, Sweden)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); American Lung Association; Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Alfred Osterlund Foundation (Malmo, Sweden); Royal Physiographic Society (Lund, Sweden)	This work was supported by Bill and Melinda Gates Foundation Grant 53085, American Lung Association Grant RG-123721-N, Swedish Medical Research Council (VR) Grants K2015-99X-22878-01-6 and 2018-05947, the Alfred Osterlund Foundation (Malmo, Sweden) (to A. P. H.), and the Royal Physiographic Society (Lund, Sweden) (to G. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P202, DOI 10.1021/bi401022b; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; CORI GT, 1948, J BIOL CHEM, V173, P605; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Fang B, 2016, J DAIRY SCI, V99, P5991, DOI 10.3168/jds.2016-10971; Ferrin G, 2011, CURR PHARM DESIGN, V17, P2002, DOI 10.2174/138161211796904803; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Frislev HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15003-6; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gutowicz J, 2003, CELL MOL BIOL LETT, V8, P667; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2007, J BIOL CHEM, V282, P29521, DOI 10.1074/jbc.M703144200; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hewitt LF, 1932, BIOCHEM J, V26, P464, DOI 10.1042/bj0260464; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jensen PA, 2017, CELL REP, V20, P1705, DOI 10.1016/j.celrep.2017.07.062; Johnsborg O, 2009, J BACTERIOL, V191, P5859, DOI 10.1128/JB.00724-09; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Katebi AR, 2015, BIOCHEMISTRY-US, V54, P3543, DOI 10.1021/acs.biochem.5b00042; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Labbe G, 2012, J INORG BIOCHEM, V112, P49, DOI 10.1016/j.jinorgbio.2012.02.032; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LUNDHOLM L, 1963, ACTA PHYSIOL SCAND, V58, P243, DOI 10.1111/j.1748-1716.1963.tb02645.x; Marks LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063158; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; Martin WF, 2017, PROTOPLASMA, V254, P1823, DOI 10.1007/s00709-017-1095-y; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Meikle V, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01846-18; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Munch D, 2014, J BIOL CHEM, V289, P12063, DOI 10.1074/jbc.M113.537449; PAKOSKEY AM, 1965, J GEN MICROBIOL, V38, P73, DOI 10.1099/00221287-38-1-73; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ramsay EE, 2011, PHARM RES-DORDR, V28, P2731, DOI 10.1007/s11095-011-0584-5; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; SEYMOUR CB, 1988, RADIAT ENVIRON BIOPH, V27, P49, DOI 10.1007/BF01211109; Shai Y, 2006, CURR PROTEIN PEPT SC, V7, P479, DOI 10.2174/138920306779025620; SIMPSON WJ, 1991, J BIOLUM CHEMILUM, V6, P97, DOI 10.1002/bio.1170060207; Singh M, 2017, J PHYS CHEM B, V121, P3925, DOI 10.1021/acs.jpcb.7b00324; Song JH, 2005, MOL CELLS, V19, P365; SPEERT DP, 1979, INFECT IMMUN, V26, P1202, DOI 10.1128/IAI.26.3.1202-1210.1979; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Sun XS, 2011, OMICS, V15, P683, DOI 10.1089/omi.2010.0133; Sun XS, 2011, OMICS, V15, P477, DOI 10.1089/omi.2010.0113; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2002, ADV EXP MED BIOL, V503, P125; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tiwari K, 2016, COMB CHEM HIGH T SCR, V19, P667, DOI 10.2174/1386207319666160610080716; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yadav PK, 2013, BIOINFORMATION, V9, P158, DOI 10.6026/97320630009158	67	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19511	19522		10.1074/jbc.RA119.009930	http://dx.doi.org/10.1074/jbc.RA119.009930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31694917	Green Published, hybrid			2022-12-28	WOS:000504093200006
J	Tong, ZW; Liu, YH; Yu, XB; Martinez, JD; Xu, JM				Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.; Xu, Jianming			The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ER? and enhancing enhancer?promoter interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; steroid hormone receptor; transcription co-activator; gene expression; chromatin modification; histone modification; cancer biology; epigenetics; endometrial cancer; nuclear receptor co-activator 6 (NCOA6)	ACTIVATING SIGNAL COINTEGRATOR-2; RECEPTOR COACTIVATOR; BREAST-CANCER; DEPENDENT TRANSACTIVATION; BINDING PROTEIN; OVARIAN-CANCER; NUCLEAR-FACTOR; IDENTIFICATION; COMPLEX; ALPHA	Estrogen and its cognate receptor, ER?, regulate cell proliferation, differentiation, and carcinogenesis in the endometrium by controlling gene transcription. ER? requires co-activators to mediate transcription via mechanisms that are largely uncharacterized. Herein, using growth-regulating estrogen receptor binding 1 (GREB1) as an ER? target gene in Ishikawa cells, we demonstrate that nuclear receptor co-activator 6 (NCOA6) is essential for estradiol (E2)/ER??activated GREB1 transcription. We found that NCOA6 associates with the GREB1 promoter and enhancer in an E2-independent manner and that NCOA6 knockout reduces chromatin looping, enhancer?promoter interactions, and basal GREB1 expression in the absence of E2. In the presence of E2, ER? bound the GREB1 enhancer and also associated with its promoter, and p300, myeloid/lymphoid or mixed-lineage leukemia protein 4 (MLL4), and RNA polymerase II were recruited to the GREB1 enhancer and promoter. Consequently, the levels of the histone modifications H3K4me1/3, H3K9ac, and H3K27ac were significantly increased; enhancer and promoter regions were transcribed; and GREB1 mRNA was robustly transcribed. NCOA6 knockout reduced ER? recruitment and abolished all of the aforementioned E2-induced events, making GREB1 completely insensitive to E2 induction. We also found that GREB1-deficient Ishikawa cells are much more resistant to chemotherapy and that human endometrial cancers with low GREB1 expression predict poor overall survival. These results indicate that NCOA6 has an essential role in ER?-mediated transcription by increasing enhancer?promoter interactions through chromatin looping and by recruiting RNA polymerase II and the histone-code modifiers p300 and MLL4. Moreover, GREB1 loss may predict chemoresistance of endometrial cancer.	[Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA; [Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Xu, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	jxu@bcm.edu		Xu, Jianming/0000-0002-8208-9162	National Institutes of Health [R01 CA193455]; Cancer Prevention and Research Institute of Texas [RP150197]; NATIONAL CANCER INSTITUTE [R01CA193455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01 CA193455 and Cancer Prevention and Research Institute of Texas Grant RP150197 (to J. X.). The authors have declared a conflict of interest. J. X. is a shareholder of Coactigon, Inc. This company develops steroid receptor co-activator inhibitors, which are unrelated to the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bauerschlag DO, 2011, ONCOLOGY-BASEL, V80, P12, DOI 10.1159/000327746; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fung JN, 2015, HUM REPROD, V30, P1263, DOI 10.1093/humrep/dev051; Gao WW, 2018, MOL CELL, V70, P340, DOI 10.1016/j.molcel.2018.03.006; Ghosh MG, 2000, CANCER RES, V60, P6367; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hamilton KJ, 2017, CURR TOP DEV BIOL, V125, P109, DOI 10.1016/bs.ctdb.2016.12.005; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hong S, 2001, BIOCHEM BIOPH RES CO, V282, P1257, DOI 10.1006/bbrc.2001.4727; Horvath G, 2002, GYNECOL ONCOL, V84, P271, DOI 10.1006/gyno.2001.6509; Huang YT, 2014, ONCOL REP, V31, P1235, DOI 10.3892/or.2014.2976; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kong HJ, 2003, MOL CANCER RES, V1, P948; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; NISHIDA M, 1985, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V37, P1103; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Punyadeera C, 2003, J STEROID BIOCHEM, V84, P393, DOI 10.1016/S0960-0760(03)00061-X; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Taylor AH, 2002, ANTICANCER RES, V22, P3993; Tien JCY, 2009, INT J BIOL SCI, V5, P256; Wang L, 2015, CANCER CELL, V28, P240, DOI 10.1016/j.ccell.2015.07.005; Winuthayanon W, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120170; Wu YM, 2018, CANCER RES, V78, P671, DOI 10.1158/0008-5472.CAN-17-1327; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yasar P, 2017, REPROD MED BIOL, V16, P4, DOI 10.1002/rmb2.12006; Zhang H, 2004, CANCER RES, V64, P7169, DOI 10.1158/0008-5472.CAN-04-1176; Zhang H, 2003, ENDOCRINOLOGY, V144, P1435, DOI 10.1210/en.2002-0018; Zhang W, 2016, MOL NUTR FOOD RES, V60, P2387, DOI 10.1002/mnfr.201600048; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	57	4	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19667	19682		10.1074/jbc.RA119.010704	http://dx.doi.org/10.1074/jbc.RA119.010704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31744881	hybrid, Green Published			2022-12-28	WOS:000504093200018
J	Bankaitis, VA; Xie, ZG				Bankaitis, Vytas A.; Xie, Zhigang			The neural stem cell/carnitine malnutrition hypothesis: new prospects for effective reduction of autism risk?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTERMEDIATE PROGENITOR CELLS; FATTY-ACID OXIDATION; RADIAL GLIAL-CELLS; IRON-DEFICIENCY; CARNITINE SUPPLEMENTATION; PLASMA CARNITINE; SPECTRUM DISORDER; PREGNANT-WOMEN; INBORN-ERRORS; SELF-RENEWAL	Autism spectrum disorders (ASDs) are developmental neuropsychiatric disorders with heterogeneous etiologies. As the incidence of these disorders is rising, such disorders represent a major human health problem with escalating social cost. Although recent years witnessed advances in our understanding of the genetic basis of some dysmorphic ASDs, little progress has been made in translating the improved understanding into effective strategies for ASD management or minimization of general ASD risk. Here we explore the idea, described in terms of the neural stem cell (NSC)/carnitine malnutrition hypothesis, that an unappreciated risk factor for ASD is diminished capacity for carnitine-dependent long-chain fatty acid beta-oxidation in neural stem cells of the developing mammalian brain. The basic premise is that fetal carnitine status is a significant metabolic component in determining NSC vulnerability to derangements in their self-renewal program and, therefore, to fetal ASD risk. As fetal carnitine status exhibits a genetic component that relates to de novo carnitine biosynthesis and is sensitive to environmental and behavioral factors that affect maternal circulating carnitine levels, to which the fetus is exposed, we propose that reduced carnitine availability during gestation is a common risk factor that lurks beneath the genetically complex ASD horizon. One major prediction of the NSC/carnitine malnutrition hypothesis is that a significant component of ASD risk might be effectively managed from a public policy perspective by implementing a carnitine surveillance and dietary supplementation strategy for women planning pregnancies and for women in their first trimester of pregnancy. We argue that this prediction deserves serious clinical interrogation.	[Bankaitis, Vytas A.; Xie, Zhigang] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Bankaitis, Vytas A.] Texas A&M Univ, Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Bankaitis, Vytas A.] Texas A&M Univ, Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bankaitis, VA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA.	vytas@tamu.edu		Xie, Zhigang/0000-0002-7190-992X; bankaitis, vytas/0000-0002-1654-6759	Robert A. Welch Foundation [BE0017]	Robert A. Welch Foundation(The Welch Foundation)	This work was supported by the Robert A. Welch Foundation (award BE0017 to V. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bagni C, 2019, NEURON, V101, P1070, DOI 10.1016/j.neuron.2019.02.041; BARGENLOCKNER C, 1981, AM J OBSTET GYNECOL, V140, P412, DOI 10.1016/0002-9378(81)90035-1; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Beaudet AL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700012; Bourdin B, 2007, PLANT PHYSIOL BIOCH, V45, P926, DOI 10.1016/j.plaphy.2007.09.009; Brown A, 2014, MOL GENET METAB, V113, P278, DOI 10.1016/j.ymgme.2014.10.005; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; CEDERBLAD G, 1986, AM J CLIN NUTR, V44, P379, DOI 10.1093/ajcn/44.3.379; CEDERBLAD G, 1985, ACTA PAEDIATR SCAND, V74, P500, DOI 10.1111/j.1651-2227.1985.tb11017.x; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Cemeroglu AP, 2001, PEDIATR HEMAT ONCOL, V18, P491, DOI 10.1080/088800101753328457; Choi JW, 2003, ARCH DIS CHILD, V88, P791, DOI 10.1136/adc.88.9.791; Citak EC, 2006, PEDIATR HEMAT ONCOL, V23, P381, DOI 10.1080/08880010600646704; Clark RH, 2017, J PERINATOL, V37, P566, DOI 10.1038/jp.2016.253; Crawley JN, 2016, TRENDS GENET, V32, P139, DOI 10.1016/j.tig.2016.01.001; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; Donovan APA, 2017, J ANAT, V230, P4, DOI 10.1111/joa.12542; Eissa N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00304; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1; Geier DA, 2011, MED SCI MONITOR, V17, pPI15, DOI 10.12659/MSM.881792; Goin-Kochel R. P, 2019, GLOB PEDIAT HLTH, V6; GREGERSEN N, 1993, HUM HERED, V43, P342, DOI 10.1159/000154157; Hathcock JN, 2006, REGUL TOXICOL PHARM, V46, P23, DOI 10.1016/j.yrtph.2006.06.007; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Keller U, 2009, EUR J CLIN NUTR, V63, P1098, DOI 10.1038/ejcn.2009.36; Kerner J, 1998, ANNU REV NUTR, V18, P179, DOI 10.1146/annurev.nutr.18.1.179; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Krajcovicova-Kudlackova M, 2000, PHYSIOL RES, V49, P399; Latif A, 2002, AUTISM, V6, P103, DOI 10.1177/1362361302006001008; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leigh JP, 2015, J AUTISM DEV DISORD, V45, P4135, DOI 10.1007/s10803-015-2521-7; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lombard J, 1998, MED HYPOTHESES, V50, P497, DOI 10.1016/S0306-9877(98)90270-5; LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301, DOI 10.1093/ajcn/50.2.301; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Loomes R, 2017, J AM ACAD CHILD PSY, V56, P466, DOI 10.1016/j.jaac.2017.03.013; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lv JW, 2013, NEUROSCI BULL, V29, P773, DOI 10.1007/s12264-013-1382-3; Lymbery P, 2018, NATURE, V563, P325, DOI 10.1038/d41586-018-07384-z; Mak CM, 2013, CRIT REV CL LAB SCI, V50, P142, DOI 10.3109/10408363.2013.847896; MARZO A, 1994, GYNECOL ENDOCRINOL, V8, P115, DOI 10.3109/09513599409058032; Mazumdar S, 2010, HEALTH PLACE, V16, P539, DOI 10.1016/j.healthplace.2009.12.014; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Monfregola J, 2007, GENE, V395, P86, DOI 10.1016/j.gene.2007.02.012; Mostafa GA., 2005, INT J CHILD NEUROPSY, V2, P179; Mostafa GA, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-014-0048-2; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Myers SM, 2019, J AUTISM DEV DISORD, V49, P1455, DOI 10.1007/s10803-018-3834-0; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; Rashidi-Nezhad A, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-75; Raskind JY, 2000, ANN PHARMACOTHER, V34, P630; REBOUCHE CJ, 1992, FASEB J, V6, P3379, DOI 10.1096/fasebj.6.15.1464372; Ringseis R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-17; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Rubio JC, 1998, J NEUROL SCI, V155, P192; Sacco R, 2018, CURR OPIN NEUROBIOL, V48, P131, DOI 10.1016/j.conb.2017.12.005; Saffary R, 2011, J NEUROSCI, V31, P1427, DOI 10.1523/JNEUROSCI.4854-10.2011; Schiavone S, 2016, PHARMACOL RES, V107, P195, DOI 10.1016/j.phrs.2016.03.019; Schmidt RJ, 2014, AM J EPIDEMIOL, V180, P890, DOI 10.1093/aje/kwu208; Schoderbeck M, 1995, J PERINAT MED, V23, P477, DOI 10.1515/jpme.1995.23.6.477; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Sengupta Somini, 2019, NY TIMES; Shinawi M, 1998, NEUROLOGY, V50, P1869, DOI 10.1212/WNL.50.6.1869; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Stoll EA, 2015, STEM CELLS, V33, P2306, DOI 10.1002/stem.2042; Strandqvist A, 2016, JIMD REP, V28, P75, DOI 10.1007/8904_2015_505; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Sullivan JM, 2019, CURR OPIN NEUROBIOL, V59, P102, DOI 10.1016/j.conb.2019.04.011; Talian GC, 2007, PEDIATR RES, V62, P88, DOI 10.1203/PDR.0b013e3180676cca; Tang WHW, 2019, NAT REV CARDIOL, V16, P137, DOI 10.1038/s41569-018-0108-7; Tanzer F, 2001, INT J VITAM NUTR RES, V71, P66, DOI 10.1024/0300-9831.71.1.66; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vorstman JAS, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.4; Waisbren SE, 2013, DEV DISABIL RES REV, V17, P260, DOI 10.1002/ddrr.1119; Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013; Wu R, 2012, P NATL ACAD SCI USA, V109, P3259, DOI 10.1073/pnas.1119155109; Xie ZG, 2016, CELL REP, V14, P991, DOI 10.1016/j.celrep.2016.01.004; Yamasue H, 2019, CURR OPIN NEUROL, V32, P635, DOI 10.1097/WCO.0000000000000703; Ziats MN, 2015, AM J MED GENET A, V167, P2162, DOI 10.1002/ajmg.a.37144; Zwaigenbaum L, 2018, BMJ-BRIT MED J, V361, DOI [10.1136/bmj.k1674, 10.1136/hmj.k1674]	87	10	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19424	19435		10.1074/jbc.AW119.008137	http://dx.doi.org/10.1074/jbc.AW119.008137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	KP9CW	31699893	Green Published, hybrid			2022-12-28	WOS:000516527800037
J	Niu, JX; Shi, YL; Tan, GY; Yang, CH; Fan, MY; Pfeffer, LM; Wu, ZH				Niu, Jixiao; Shi, Yuling; Tan, Guangyun; Yang, Chuan He; Fan, Meiyun; Pfeffer, Lawrence M.; Wu, Zhao-Hui			RETRACTION: DNA damage induces NF-kappa B-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion (Retraction of Vol 287, Pg 21783, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					18015	18015		10.1074/jbc.W119.011598	http://dx.doi.org/10.1074/jbc.W119.011598			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31757802	Green Published, hybrid			2022-12-28	WOS:000504206800026
J	Martin, ER; Barbieri, A; Ford, RC; Robinson, RC				Martin, Eleanor R.; Barbieri, Alessandro; Ford, Robert C.; Robinson, Robert C.			In vivo crystals reveal critical features of the interaction between cystic fibrosis transmembrane conductance regulator (CFTR) and the PDZ2 domain of Na+/H+ exchange cofactor NHERF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; X-ray crystallography; molecular modeling; protein complex; protein crystallization; crystal structure; cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; ion channel; protein-protein interaction	SOLVATED INTERACTION ENERGY; FUNCTIONAL EXPRESSION; PROTEIN INTERACTIONS; BINDING AFFINITIES; STRUCTURAL BASIS; KINASE; PHOSPHORYLATION; COMPLEX; ACTIN; AUTOINHIBITION	Crystallization of recombinant proteins has been fundamental to our understanding of protein function, dysfunction, and molecular recognition. However, this information has often been gleaned under extremely nonphysiological protein, salt, and H+ concentrations. Here, we describe the development of a robust Inka1-Box (iBox)?PAK4cat system that spontaneously crystallizes in several mammalian cell types. The semi-quantitative assay described here allows the measurement of in vivo protein-protein interactions using a novel GFP-linked reporter system that produces fluorescent readouts from protein crystals. We combined this assay with in vitro X-ray crystallography and molecular dynamics studies to characterize the molecular determinants of the interaction between the PDZ2 domain of Na+/H+ exchange regulatory cofactor NHE-RF1 (NHERF1) and cystic fibrosis transmembrane conductance regulator (CFTR), a protein complex pertinent to the genetic disease cystic fibrosis. These experiments revealed the crystal structure of the extended PDZ domain of NHERF1 and indicated, contrary to what has been previously reported, that residue selection at positions ?1 and ?3 of the PDZ-binding motif influences the affinity and specificity of the NHERF1 PDZ2-CFTR interaction. Our results suggest that this system could be utilized to screen additional protein-protein interactions, provided they can be accommodated within the spacious iBox-PAK4cat lattice.	[Martin, Eleanor R.; Barbieri, Alessandro; Ford, Robert C.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Michael Smith Bldg, Manchester M13 9PL, Lancs, England; [Martin, Eleanor R.; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore; [Barbieri, Alessandro] ASTAR, Bioinformat Inst BII, Biopolis 138671, Singapore; [Robinson, Robert C.] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong 21210, Thailand; [Robinson, Robert C.] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Martin, Eleanor R.] Luxembourg Inst Hlth, 1A-B,Rue Thomas Edison, L-1445 Luxembourg, Luxembourg	University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Vidyasirimedhi Institute of Science & Technology; Okayama University; Luxembourg Institute of Health	Robinson, RC (corresponding author), ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore.; Robinson, RC (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan.	br.okayama.u@gmail.com	robinson, robert/G-9702-2011	robinson, robert/0000-0001-6367-6903; Martin, Eleanor/0000-0003-4707-697X; Barbieri, Alessandro/0000-0002-0135-9977; Ford, Robert/0000-0002-0958-1505	University of Manchester, United Kingdom; Agency for Science, Technology and Research (A*STAR), Singapore; Vidyasirimedhi Institute of Science and Technology (VISTEC)	University of Manchester, United Kingdom; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Vidyasirimedhi Institute of Science and Technology (VISTEC)	This work was supported by the University of Manchester, United Kingdom, the Agency for Science, Technology and Research (A*STAR), Singapore and by Vidyasirimedhi Institute of Science and Technology (VISTEC). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; [Anonymous], [No title captured]; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baskaran Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9681; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Case DA, 2014, AMBER 14; Cau Y, 2015, J CHEM INF MODEL, V55, P2611, DOI 10.1021/acs.jcim.5b00452; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chumnarnsilpa S, 2009, P NATL ACAD SCI USA, V106, P13719, DOI 10.1073/pnas.0812383106; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Holcomb J, 2014, BIOCHEM BIOPH RES CO, V448, P169, DOI 10.1016/j.bbrc.2014.04.085; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Houslay MD, 2009, BRIT J PHARMACOL, V158, P483, DOI 10.1111/j.1476-5381.2009.00359.x; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kim JY, 2004, J BIOL CHEM, V279, P10389, DOI 10.1074/jbc.M312871200; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Loureiro CA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1580; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Poli G, 2018, J ENZYM INHIB MED CH, V33, P956, DOI 10.1080/14756366.2018.1469017; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	64	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4464	4476		10.1074/jbc.RA119.012015	http://dx.doi.org/10.1074/jbc.RA119.012015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32014995	Green Published, hybrid			2022-12-28	WOS:000524499700009
J	Mader, J; Huber, J; Bonn, F; Dotsch, V; Rogov, VV; Bremm, A				Mader, Julia; Huber, Jessica; Bonn, Florian; Doetsch, Volker; Rogov, Vladimir V.; Bremm, Anja			Oxygen-dependent asparagine hydroxylation of the ubiquitin-associated (UBA) domain in Cezanne regulates ubiquitin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); ubiquitin; protein-protein interaction; nuclear magnetic resonance (NMR); posttranslational modification (PTM); Cezanne; FIH1; hydroxylation; UBA domain; deubiquitinase (DUB); OTU domain-containing protein 7B (OTUD7B)	STRUCTURAL BASIS; PHOSPHORYLATION; DIMERIZATION; ACTIVATION; PROTEINS; CBL	Deubiquitinases (DUBs) are vital for the regulation of ubiquitin signals, and both catalytic activity of and target recruitment by DUBs need to be tightly controlled. Here, we identify asparagine hydroxylation as a novel posttranslational modification involved in the regulation of Cezanne (also known as OTU domain?containing protein 7B (OTUD7B)), a DUB that controls key cellular functions and signaling pathways. We demonstrate that Cezanne is a substrate for factor inhibiting HIF1 (FIH1)- and oxygen-dependent asparagine hydroxylation. We found that FIH1 modifies Asn(35) within the uncharacterized N-terminal ubiquitin-associated (UBA)-like domain of Cezanne (UBA(Cez)), which lacks conserved UBA domain properties. We show that UBA(Cez) binds Lys(11)-, Lys(48)-, Lys(63)-, and Met(1)-linked ubiquitin chains in vitro, establishing UBA(Cez) as a functional ubiquitin-binding domain. Our findings also reveal that the interaction of UBA(Cez) with ubiquitin is mediated via a noncanonical surface and that hydroxylation of Asn(35) inhibits ubiquitin binding. Recently, it has been suggested that Cezanne recruitment to specific target proteins depends on UBA(Cez). Our results indicate that UBA(Cez) can indeed fulfill this role as regulatory domain by binding various ubiquitin chain types. They also uncover that this interaction with ubiquitin, and thus with modified substrates, can be modulated by oxygen-dependent asparagine hydroxylation, suggesting that Cezanne is regulated by oxygen levels.	[Mader, Julia; Bonn, Florian; Bremm, Anja] Goethe Univ Frankfurt, Inst Biochem 2, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Huber, Jessica; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Huber, Jessica; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Bremm, A (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bremm@em.uni-frankfurt.de	Bremm, Anja/AAI-3146-2021	Huber, Jessica/0000-0003-4269-5720; Bremm, Anja/0000-0003-1386-0926	German Research Foundation [BR 4268/2-1]; CRC/SFB 1177 on selective autophagy	German Research Foundation(German Research Foundation (DFG)); CRC/SFB 1177 on selective autophagy	This work was supported by German Research Foundation Grants BR 4268/2-1 (to A. B.) and CRC/SFB 1177 on selective autophagy (to F. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bonacci T, 2018, EMBO J, V37, DOI 10.15252/embj.201798701; Bremm A, 2014, EMBO REP, V15, P1268, DOI 10.15252/embr.201438850; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Garcia-Santisteban I, 2012, BIOCHEM J, V441, P209, DOI 10.1042/BJ20111300; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Ji YX, 2018, J CELL BIOCHEM, V119, P1979, DOI 10.1002/jcb.26359; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Moniz S, 2015, J CELL SCI, V128, P3082, DOI 10.1242/jcs.168864; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Price C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00054; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Walinda E, 2014, J BIOL CHEM, V289, P13890, DOI 10.1074/jbc.M114.555441; Wang B, 2017, NATURE, V545, P365, DOI 10.1038/nature22344; Wang L, 2017, NEW BIOTECHNOL, V38, P16, DOI 10.1016/j.nbt.2016.10.003; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	44	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2160	2174		10.1074/jbc.RA119.010315	http://dx.doi.org/10.1074/jbc.RA119.010315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31937588	Green Published, hybrid			2022-12-28	WOS:000517330200001
J	Panthu, B; Denolly, S; Faivre-Moskalenko, C; Ohlmann, T; Cosset, FL; Jalinot, P				Panthu, Baptiste; Denolly, Solene; Faivre-Moskalenko, Cendrine; Ohlmann, Theophile; Cosset, Francois-Loic; Jalinot, Pierre			Unlike for cellular mRNAs and other viral internal ribosome entry sites (IRESs), the eIF3 subunit e is not required for the translational activity of the HCV IRES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation control; hepatitis C virus (HCV); eukaryotic translation initiation; infection; ribosome; protein synthesis; eukaryotic initiation factor 3 (eIF3); host factor; in vitro reconstitution; internal ribosome entry site (IRES); viral infection	HEPATITIS-C; INITIATION-FACTOR; DEPENDENT TRANSLATION; DNA-REPAIR; VIRUS; PROTEIN; INTERACTS; BINDING; RECRUITMENT; MECHANISM	Viruses depend on the host cell translation machinery for their replication, and one common strategy is the presence of internal ribosome entry sites (IRESs) in the viral RNAs, using different sets of host translation initiation factors. The hepatitis C virus (HCV) IRES binds eukaryotic translation initiation factor 3 (eIF3), but the exact functional role of the eIF3 complex and of its subunits remains to be precisely defined. Toward this goal, here we focused on eIF3 subunit e. We used an in vitro assay combining a ribosome-depleted rabbit reticulocyte lysate and ribosomes prepared from HeLa or Huh-7.5 cells transfected with either control or eIF3e siRNAs. eIF3e silencing reduced translation mediated by the 5?UTR of various cellular genes and HCV-like IRESs. However, this effect was not observed with the bona fide HCV IRES. Silencing of eIF3e reduced the intracellular levels of the c, d, and l subunits of eIF3 and their association with the eIF3 core subunit a. A pulldown analysis of eIF3 subunits associated with the HCV IRES disclosed similar effects and that the a subunit is critical for binding to the HCV IRES. Carrying out HCV infections of control and eIF3e-silenced Huh-7.5 cells, we found that in agreement with the in vitro findings, eIF3e silencing does not reduce HCV replication and viral protein expression. We conclude that unlike for host cellular mRNAs, the entire eIF3 is not required for HCV RNA translation, favoring viral expression under conditions of low eIF3e levels.	[Panthu, Baptiste; Jalinot, Pierre] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5239,INSERM,U1210,LBMC, F-69007 Lyon, France; [Denolly, Solene; Ohlmann, Theophile; Cosset, Francois-Loic] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CIRI,INSERM,U1111,CNRS,UMR5308, F-69007 Lyon, France; [Faivre-Moskalenko, Cendrine] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5672,Lab Phys, 46 Allee Italie Site Jacques Monod, F-69007 Lyon, France; [Panthu, Baptiste] Hop Lyon Sud, CARMEN, INSERM, U1060,Sect 2, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jalinot, P (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5239,INSERM,U1210,LBMC, F-69007 Lyon, France.; Cosset, FL (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CIRI,INSERM,U1111,CNRS,UMR5308, F-69007 Lyon, France.	flcosset@ens-lyon.fr; pjalinot@ens-lyon.fr	ohlmann, Theophile/M-4463-2014; Carmen, Team2/Y-7383-2019	ohlmann, Theophile/0000-0002-2001-8916; Carmen, Team2/0000-0001-9867-5724; Panthu, Baptiste/0000-0001-9430-4061; Lab, Carmen/0000-0002-5935-3236; Denolly, Solene/0000-0003-1739-0079; Cosset, Francois-Loic/0000-0001-8842-3726	Ligue Nationale Contre le Cancer; French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS); European Research Council Grant [ERC2008-AdG-233130-HEPCENT]; LabEx Ecofect Grant [ANR-11-LABX-0048]	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS)(French National Research Agency (ANR)); European Research Council Grant(European Research Council (ERC)); LabEx Ecofect Grant	This work was supported by grants from the Ligue Nationale Contre le Cancer (to B. P, and P. J.), the French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS), European Research Council Grant ERC2008-AdG-233130-HEPCENT, and LabEx Ecofect Grant ANR-11-LABX-0048 (to S. D., C. F.-M., T. O., and F.-L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Angulo J, 2016, NUCLEIC ACIDS RES, V44, P1309, DOI 10.1093/nar/gkv1325; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Bradrick SS, 2007, RNA, V13, P1582, DOI 10.1261/rna.556107; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Cai Q, 2010, J MOL BIOL, V403, P185, DOI 10.1016/j.jmb.2010.07.054; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Deforges J, 2015, BIOCHIMIE, V114, P48, DOI 10.1016/j.biochi.2014.12.008; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Derry MC, 2006, COLD SPRING HARB SYM, V71, P537, DOI 10.1101/sqb.2006.71.061; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Hamad IAY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122471; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johnson AG, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1050; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Koev G, 2002, VIROLOGY, V297, P195, DOI 10.1006/viro.2002.1455; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Liu XF, 2018, VIROLOGY, V515, P11, DOI 10.1016/j.virol.2017.11.019; Lozano G, 2015, CURR OPIN VIROL, V12, P113, DOI 10.1016/j.coviro.2015.04.008; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Mengardi C, 2017, NUCLEIC ACIDS RES, V45, P4810, DOI 10.1093/nar/gkw1345; Morris C, 2016, CANCER RES, V76, P6054, DOI 10.1158/0008-5472.CAN-16-0723; Morris C, 2012, CANCER RES, V72, P2006, DOI 10.1158/0008-5472.CAN-11-2562; Morris-Desbois C, 2001, J BIOL CHEM, V276, P45988, DOI 10.1074/jbc.M104966200; Morris-Desbois C, 1999, J CELL SCI, V112, P3331; Neusiedler J, 2012, RNA, V18, P1163, DOI 10.1261/rna.032631.112; Niepmann M, 2013, CURR TOP MICROBIOL, V369, P143, DOI 10.1007/978-3-642-27340-7_6; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Panthu B, 2015, BIOCHEM J, V467, P387, DOI 10.1042/BJ20141498; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smith MD, 2016, STRUCTURE, V24, P886, DOI 10.1016/j.str.2016.02.024; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Walsh D, 2014, GENE DEV, V28, P835, DOI 10.1101/gad.236752.113; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	52	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1843	1856		10.1074/jbc.RA119.009502	http://dx.doi.org/10.1074/jbc.RA119.009502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31929110	Green Published, hybrid			2022-12-28	WOS:000517128200006
J	Gong, SS; Wang, XQ; Meng, FL; Cui, LM; Yi, QZ; Zhao, Q; Cang, XH; Cai, ZY; Mo, JQ; Liang, Y; Guan, MX				Gong, Shasha; Wang, Xiaoqiong; Meng, Feilong; Cui, Limei; Yi, Qiuzi; Zhao, Qiong; Cang, Xiaohui; Cai, Zhiyi; Mo, Jun Qin; Liang, Yong; Guan, Min-Xin			Overexpression of mitochondrial histidyl-tRNA synthetase restores mitochondrial dysfunction caused by a deafness-associated tRNA(His) mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hearing; transfer RNA (tRNA); mitochondrial respiratory chain complex; translation; mitochondrial membrane potential; mitochondrial DNA (mtDNA); reactive oxygen species (ROS); gene transfer; ATP; aminoacyl tRNA synthetase; aminoacylation; m; 12201T > C mutation; mitochondrial histidyl-tRNA synthetase; mitochondrial tRNA mutation; pathophysiology; deafness; rescue; oxidative phosphorylation system (OXPHOS)	12S RIBOSOMAL-RNA; DNA MUTATION; PHENOTYPIC MANIFESTATION; NUCLEAR MODIFIER; COMPLEX-I; M(1)G37 MODIFICATION; ALTERS; GENE; TRNA(SER(UCN)); AMINOACYLATION	The deafness-associated m.12201T>C mutation affects the A5-U68 base-pairing within the acceptor stem of mitochondrial tRNA(His). The primary defect in this mutation is an alteration in tRNA(His) aminoacylation. Here, we further investigate the molecular mechanism of the deafness-associated tRNA(His) 12201T>C mutation and test whether the overexpression of the human mitochondrial histidyl-tRNA synthetase gene (HARS2) in cytoplasmic hybrid (cybrid) cells carrying the m.12201T>C mutation reverses mitochondrial dysfunctions. Using molecular dynamics simulations, we demonstrate that the m.12201T>C mutation perturbs the tRNA(His) structure and function, supported by decreased melting temperature, conformational changes, and instability of mutated tRNA. We show that the m.12201T>C mutation-induced alteration of aminoacylation tRNA(His) causes mitochondrial translational defects and respiratory deficiency. We found that the transfer of HARS2 into the cybrids carrying the m.12201T>C mutation raises the levels of aminoacylated tRNA(His) from 56.3 to 75.0% but does not change the aminoacylation of other tRNAs. Strikingly, HARS2 overexpression increased the steady-state levels of tRNA(His) and of noncognate tRNAs, including tRNA(Ala), tRNA(Gln), tRNA(Glu), tRNA(Leu(UUR)), tRNA(Lys), and tRNA(Met), in cells bearing the m.12201T>C mutation. This improved tRNA metabolism elevated the efficiency of mitochondrial translation, activities of oxidative phosphorylation complexes, and respiration capacity. Furthermore, HARS2 overexpression markedly increased mitochondrial ATP levels and membrane potential and reduced production of reactive oxygen species in cells carrying the m.12201T>C mutation. These results indicate that HARS2 overexpression corrects the mitochondrial dysfunction caused by the tRNA(His) mutation. These findings provide critical insights into the pathophysiology of mitochondrial disease and represent a step toward improved therapeutic interventions for mitochondrial disorders.	[Gong, Shasha; Liang, Yong] Taizhou Univ, Taizhou Univ Hosp, Taizhou 318000, Zhejiang, Peoples R China; [Gong, Shasha; Meng, Feilong; Cui, Limei; Yi, Qiuzi; Zhao, Qiong; Cang, Xiaohui; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Xiaoqiong; Cai, Zhiyi] Taizhou Municipal Hosp, Dept Otolaryngol, Taizhou 318000, Zhejiang, Peoples R China; [Wang, Xiaoqiong] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Xiaoqiong] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325035, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Sch Med, Childrens Hosp, Div Med Genet & Genom, Hangzhou 310058, Zhejiang, Peoples R China; [Mo, Jun Qin] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pathol, San Diego, CA 92123 USA; [Guan, Min-Xin] Joint Inst Genet & Genom Med Zhejiang Univ & Univ, Hangzhou 310058, Zhejiang, Peoples R China	Taizhou University; Zhejiang University; Zhejiang University; Taizhou University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736	Ministry of Science and Technology of Zhejiang Province [2018C03026]; National Key Technologies R&D Program from the Ministry of Science and Technology of China [2014CB541704]; National Natural Science Foundation of China [81330024, 31671305, 81470685, 81500804]; Natural Science Foundation of Zhejiang Province, China [LY18C060003, LY18C050002]; Science and Technology Bureau of Taizhou City, Zhejiang Province, China [1901ky78]	Ministry of Science and Technology of Zhejiang Province; National Key Technologies R&D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Science and Technology Bureau of Taizhou City, Zhejiang Province, China	This work was supported by Ministry of Science and Technology of Zhejiang Province Grant 2018C03026; National Key Technologies R&D Program Grant 2014CB541704 from the Ministry of Science and Technology of China (to M. X. G.); National Natural Science Foundation of China Grants 81330024 (to M. X. G), 31671305, 81470685, and 81500804 (to S. S. G.); Natural Science Foundation of Zhejiang Province, China, Grants LY18C060003 (to S. S. G.) and LY18C050002 (to X. H. C.); and Science and Technology Bureau of Taizhou City, Zhejiang Province, China, Grant 1901ky78 (to S. S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Area-Gomez E, 2014, J CHILD NEUROL, V29, P1208, DOI 10.1177/0883073814539561; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cortes NG, 2012, HUM MUTAT, V33, P681, DOI 10.1002/humu.22023; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Fan WL, 2019, J BIOL CHEM, V294, P19292, DOI 10.1074/jbc.RA119.010598; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Grosjean H, 2016, NUCLEIC ACIDS RES, V44, P8020, DOI 10.1093/nar/gkw608; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hao R, 2005, NUCLEIC ACIDS RES, V33, P3606, DOI 10.1093/nar/gki677; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; Kuncha SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02204-w; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Toompuu M, 2002, J BIOL CHEM, V277, P22240, DOI 10.1074/jbc.M200338200; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Xue L, 2019, MITOCHONDRION, V46, P370, DOI 10.1016/j.mito.2018.10.001; Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zhao XX, 2018, INT J BIOL SCI, V14, P1437, DOI 10.7150/ijbs.27043; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028	70	12	12	7	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					940	954		10.1074/jbc.RA119.010998	http://dx.doi.org/10.1074/jbc.RA119.010998			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31819004	hybrid, Green Published			2022-12-28	WOS:000509949300005
J	Fili, N; Hari-Gupta, Y; Aston, B; dos Santos, A; Gough, RE; Alamad, B; Wang, L; Martin-Fernandez, ML; Toseland, CP				Fili, Natalia; Hari-Gupta, Yukti; Aston, Bjork; dos Santos, Alia; Gough, Rosemarie E.; Alamad, Bana; Wang, Lin; Martin-Fernandez, Marisa L.; Toseland, Christopher P.			Competition between two high- and low-affinity protein-binding sites in myosin VI controls its cellular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; gene expression; gene regulation; kinetics; biophysics	DOMAIN; NDP52; ACTIVATION; EXPRESSION; DISABLED-2; DEAFNESS	Myosin VI is involved in many cellular processes ranging from endocytosis to transcription. This multifunctional potential is achieved through alternative isoform splicing and through interactions of myosin VI with a diverse network of binding partners. However, the interplay between these two modes of regulation remains unexplored. To this end, we compared two different binding partners and their interactions with myosin VI by exploring the kinetic properties of recombinant proteins and their distribution in mammalian cells using fluorescence imaging. We found that selectivity for these binding partners is achieved through a high-affinity motif and a low-affinity motif within myosin VI. These two motifs allow competition among partners for myosin VI. Exploring how this competition affects the activity of nuclear myosin VI, we demonstrate the impact of a concentration-driven interaction with the low-affinity binding partner DAB2, finding that this interaction blocks the ability of nuclear myosin VI to bind DNA and its transcriptional activity in vitro. We conclude that loss of DAB2, a tumor suppressor, may enhance myosin VI?mediated transcription. We propose that the frequent loss of specific myosin VI partner proteins during the onset of cancer leads to a higher level of nuclear myosin VI activity.	[Fili, Natalia; dos Santos, Alia; Gough, Rosemarie E.; Toseland, Christopher P.] Univ Sheffield, Dept Oncol & Metab, Sheffield Canc Ctr, Sheffield S10 2RX, S Yorkshire, England; [Hari-Gupta, Yukti; Aston, Bjork; Alamad, Bana] Univ Kent, Sch Biosci, Canterbury CT2 7NZ, Kent, England; [Wang, Lin; Martin-Fernandez, Marisa L.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England	University of Sheffield; University of Kent; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Toseland, CP (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield Canc Ctr, Sheffield S10 2RX, S Yorkshire, England.	c.toseland@sheffield.ac.uk		Hari-Gupta, Yukti/0000-0002-8685-2153; Fili, Natalia/0000-0002-0898-0766; wang, lin/0000-0001-9141-5217; dos Santos, Alia/0000-0002-3176-8317; Gough, Rosemarie/0000-0002-5587-4683; martin-fernandez, marisa/0000-0001-5496-6300	Medical Research Council [MR/M020606/1]; Science and Technology Facilities Council [19130001]; MRC [MR/M020606/1, MR/M020606/2] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/M020606/1 and Science and Technology Facilities Council Grant 19130001. The authors declare that they have no conflicts of interest with the contents of this article.	Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Cook A, 2018, BIOCHEM BIOPH RES CO, V496, P820, DOI 10.1016/j.bbrc.2018.01.147; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Fili N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02050-w; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; KORIOTH F, 1995, J CELL BIOL, V130, P1, DOI 10.1083/jcb.130.1.1; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Mohiddin SA, 2004, J MED GENET, V41, P309, DOI 10.1136/jmg.2003.011973; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Postma M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000202; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Sternsdorf T, 1997, J CELL BIOL, V138, P435, DOI 10.1083/jcb.138.2.435; Toseland Christopher P, 2014, Exp Suppl, V105, P67, DOI 10.1007/978-3-0348-0856-9_4; Toseland Christopher P, 2014, Exp Suppl, V105, P49, DOI 10.1007/978-3-0348-0856-9_3; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wollscheid HP, 2016, NAT STRUCT MOL BIOL, V23, P300, DOI 10.1038/nsmb.3187; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101	27	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					337	347		10.1074/jbc.RA119.010142	http://dx.doi.org/10.1074/jbc.RA119.010142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744880	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000507373600007
J	Maeda, N; Maruhashi, T; Sugiura, D; Shimizu, K; Okazaki, IM; Okazaki, T				Maeda, Natsumi; Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku			Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; glucocorticoid; immunosuppression; immunology; T cell; T cell receptor (TCR); cytokine induction; coreceptor; immune checkpoint; PD-1	PD-1 EXPRESSION; RECEPTOR PD-1; ACTIVATION; EXHAUSTION; RESISTANCE; RESPONSES; PATHWAYS	The inhibitory co-receptor programmed cell death 1 (PD-1, Pdcd1) plays critical roles in the regulation of autoimmunity, anticancer immunity, and immunity against infections. Immunotherapies targeting PD-1 have revolutionized cancer management and instigated various trials of improved cancer immunotherapies. Moreover, extensive trials are underway to potentiate PD-1 function to suppress harmful immune responses. Here we found that both natural and synthetic glucocorticoids (GCs) up-regulate PD-1 on T cells without altering the expression levels of other co-receptors and cell surface molecules. GC-induced up-regulation of PD-1 depended on transactivation of PD-1 transcription mediated through the glucocorticoid receptor. We further found that a GC response element 2525 bp upstream of the transcription start site of Pdcd1 is responsible for GC-mediated transactivation. We also observed that in vivo administration of GCs significantly up-regulates PD-1 expression on tumor-infiltrating T cells. By analyzing T cells differing in PD-1 expression, we directly demonstrated that the amount of PD-1 on the cell surface correlates with its inhibitory effect. Accordingly, GCs potentiated the capacity of PD-1 to inhibit T cell activation, suggesting that this PD-1-mediated inhibition contributes, at least in part, to the anti-inflammatory and immunosuppressive effects of GCs. In light of the critical roles of PD-1 in the regulation of autoimmunity, we expect that the potentiation of PD-1 activity may offer a promising therapeutic strategy for managing inflammatory and autoimmune diseases. Our current findings provide a rationale for strategies seeking to enhance the inhibitory effect of PD-1 by increasing its expression level.	[Maeda, Natsumi; Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan; [Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan	Tokushima University; University of Tokyo	Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan.; Okazaki, T (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	tokazaki@iam.u-tokyo.ac.jp		Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Il-mi/0000-0001-8644-0100; Okazaki, Taku/0000-0003-4790-1925; Sugiura, Daisuke/0000-0002-3865-3889	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417, JP19H01029, 19K16694]; Katsunuma scholarship; Yoshimitsu Otsuka scholarship	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Katsunuma scholarship; Yoshimitsu Otsuka scholarship(Otsuka Pharmaceutical)	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development (JP18am0301007) and Grants-in-Aid by the Japan Society for the Promotion of Science JP18H05417, JP19H01029, and 19K16694. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Katsunuma and Yoshimitsu Otsuka scholarships.	Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boldizsar F, 2010, IMMUNOBIOLOGY, V215, P521, DOI 10.1016/j.imbio.2009.10.003; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Giles AJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0371-5; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Maeda TK, 2019, J BIOL CHEM, V294, P6017, DOI 10.1074/jbc.RA119.007455; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mizuno R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00630; Mizuno R, 2019, BIOCHEM BIOPH RES CO, V511, P491, DOI 10.1016/j.bbrc.2019.02.004; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Petrillo MG, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-35; Piemonti L, 1999, J IMMUNOL, V162, P6473; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Quatrini L, 2018, NAT IMMUNOL, V19, P954, DOI 10.1038/s41590-018-0185-0; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rocamora-Reverte L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00472; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Xia M, 1999, CELL MOL LIFE SCI, V55, P1649, DOI 10.1007/s000180050403; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2	39	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19896	19906		10.1074/jbc.RA119.010379	http://dx.doi.org/10.1074/jbc.RA119.010379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31723031	Green Published, hybrid			2022-12-28	WOS:000505005800007
J	Yoon, JH; Choudhury, JR; Prakash, L; Prakash, S				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya			Translesion synthesis DNA polymerases eta, iota, and nu promote mutagenic replication through the anticancer nucleoside cytarabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translesion synthesis; cytarabine; AraC; acute myeloid leukemia; AraC mutagenesis	ERROR-FREE REPLICATION; ACUTE MYELOID-LEUKEMIA; NUCLEOTIDE INCORPORATION; THYMINE GLYCOL; BYPASS; YEAST; ZETA; MECHANISM; LESION; REV1	Cytarabine (AraC) is the mainstay for the treatment of acute myeloid leukemia (AML). Although complete remission is observed in a large proportion of patients, relapse occurs in almost all the cases. The chemotherapeutic action of AraC derives from its ability to inhibit DNA synthesis by the replicative polymerases (Pols); the replicative Pols can insert AraCTP at the 3'-terminus of the nascent DNA strand, but they are blocked at extending synthesis from AraC. By extending synthesis from the 3'-terminal AraC and by replicating through AraC that becomes incorporated into DNA, translesion synthesis ( TLS) DNA Pols could reduce the effectiveness of AraC in chemotherapy. Here we identify the TLS Pols required for replicating through the AraC templating residue and determine their error-proneness. We provide evidence that TLS makes a consequential contribution to the replication of AraC damaged DNA, that TLS through AraC is conducted by three different pathways dependent upon Pol., Pol., and Pol., respectively, and that TLS by all these Pols incurs considerable mutagenesis. The prominent role of TLS in promoting proficient and mutagenic replication through AraC suggests that TLS inhibition in AML patients would increase the effectiveness of AraC chemotherapy; and by reducing mutation formation, TLS inhibition may dampen the emergence of drug resistant tumors and thereby the high incidence of relapse in AraC treated patients.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Choudhury, Jayati Roy] NASA, Johnson Space Ctr, Human Hlth & Performance Directorate, 2101 Nasa Pkwy, Houston, TX 77058 USA	University of Texas System; University of Texas Medical Branch Galveston; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Prakash, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	saprakas@utmb.edu		Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NIH [CA200575]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH Grant CA200575. We thank Robert Johnson for help with preparation of this manuscript.	American Cancer Society, 2018, CANC FACTS FIG 2018; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Cooper T. M, 2011, PRINCIPLES PRACTICE, P566; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fordham SE, 2015, LEUKEMIA, V29, P491, DOI 10.1038/leu.2014.284; Garg M, 2015, BLOOD, V126, P2491, DOI 10.1182/blood-2015-05-646240; Grant S, 1998, ADV CANCER RES, V72, P197; Greif PA, 2018, CLIN CANCER RES, V24, P1716, DOI 10.1158/1078-0432.CCR-17-2344; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HARRINGTON C, 1995, J BIOL CHEM, V270, P26664, DOI 10.1074/jbc.270.44.26664; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kadia TM, 2015, CL LYMPH MYELOM LEUK, V15, P139, DOI 10.1016/j.clml.2014.08.006; Kunz JB, 2015, HAEMATOLOGICA, V100, P1442, DOI 10.3324/haematol.2015.129692; Lichtman MA, 2013, BLOOD CELL MOL DIS, V50, P119, DOI 10.1016/j.bcmd.2012.10.005; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Magina KN, 2017, BLOOD, V130, P946, DOI 10.1182/blood-2017-04-777722; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MIKITA T, 1988, BIOCHEMISTRY-US, V27, P4698, DOI 10.1021/bi00413a018; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Perrino Fred W., 1999, Cell Biochemistry and Biophysics, V30, P331, DOI 10.1007/BF02738118; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30796-w; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Walter RB, 2015, LEUKEMIA, V29, P312, DOI 10.1038/leu.2014.242; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Yoon JH, 2019, GENE DEV, V33, P282, DOI 10.1101/gad.320531.118; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2018, J BIOL CHEM, V293, P2949, DOI 10.1074/jbc.RA117.000962; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	44	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19048	19054		10.1074/jbc.RA119.011381	http://dx.doi.org/10.1074/jbc.RA119.011381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31685662	hybrid, Green Published			2022-12-28	WOS:000516527800009
J	Bernhagen, J				Bernhagen, Juergen			Separating cytokine twins with a small molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						chemokine; cytokine; chemotaxis; immunology; inflammation; inhibition mechanism; protein conformation; macrophage; MIF	MIGRATION INHIBITORY FACTOR	The cytokine macrophage migration inhibitory factor (MIF) has been characterized as a key immunomodulator and mediator of various diseases. Small molecule inhibitors based on the conserved enzymatic pocket of MIF have been valuable in elucidating MIF mechanisms and developing translational strategies. In contrast, our mechanistic understanding of the MIF homolog MIF-2/d-dopachrome tautomerase (d-DT) and its clinical translation has been hampered, partly because MIF-2?selective inhibitors have been elusive. Here, Tilstam et al. characterize a small-molecule inhibitor selective for MIF-2 that interferes with receptor binding and cell signaling. That could be a promising therapeutic lead and a valuable research tool.	[Bernhagen, Juergen] LMU, KUM, Inst Stroke & Dementia Res ISD, Dept Vasc Biol, D-81377 Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Bernhagen, Juergen] Munich Heart Alliance, D-80802 Munich, Germany	University of Munich; University of Munich; Munich Heart Alliance	Bernhagen, J (corresponding author), LMU, KUM, Inst Stroke & Dementia Res ISD, Dept Vasc Biol, D-81377 Munich, Germany.; Bernhagen, J (corresponding author), Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany.; Bernhagen, J (corresponding author), Munich Heart Alliance, D-80802 Munich, Germany.	juergen.bernhagen@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [SFB1123-A3]; DFG under Germany's Excellence Strategy [EXC 2145, 390857198]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB1123-A3 and by DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy-ID 390857198) (to J. B.). The author declares that he has no conflicts of interest with the contents of this article.	Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Michelet C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100740; Pantouris G, 2018, BIOCHEMISTRY-US, V57, P3599, DOI 10.1021/acs.biochem.8b00344; Qi DK, 2014, J CLIN INVEST, V124, P3540, DOI 10.1172/JCI73061; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Tilstam PV, 2019, J BIOL CHEM, V294, P18522, DOI 10.1074/jbc.RA119.009860; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C	10	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18532	18533		10.1074/jbc.H119.011749	http://dx.doi.org/10.1074/jbc.H119.011749			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31811047	Green Published, hybrid			2022-12-28	WOS:000507618800002
J	Philips, EA; Garcia-Espana, A; Tocheva, AS; Ahearn, IM; Adam, KR; Pan, RM; Mor, A; Kong, XP				Philips, Elliot A.; Garcia-Espana, Antonio; Tocheva, Anna S.; Ahearn, Ian M.; Adam, Kieran R.; Pan, Ruimin; Mor, Adam; Kong, Xiang-Peng			The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; immunotherapy; T-cell biology; protein evolution; glycoprotein structure; immune checkpoint; immune receptors; ligands; PD-L2; programmed cell death protein 1 (PD-1); programmed death ligand 1 (PD-L1)	B7 FAMILY MOLECULES; IMMUNE-SYSTEM; LIGANDS; CELLS; IMMUNOTHERAPY; EXPRESSION; BLOCKADE; RECEPTOR; SAFETY	Programmed cell death protein 1 (PD-1) is an inhibitory receptor on T lymphocytes that is critical for modulating adaptive immunity. As such, it has been successfully exploited for cancer immunotherapy. Programmed death ligand 1 (PD-L1) and PD-L2 are ligands for PD-1; the former is ubiquitously expressed in inflamed tissues, whereas the latter is restricted to antigen-presenting cells. PD-L2 binds to PD-1 with 3-fold stronger affinity compared with PD-L1. To date, this affinity discrepancy has been attributed to a tryptophan (W110(PD-L2)) that is unique to PD-L2 and has been assumed to fit snuggly into a pocket on the PD-1 surface. Contrary to this model, using surface plasmon resonance to monitor real-time binding of recombinantly-expressed and -purified proteins, we found that W110(PD-L2) acts as an ?elbow? that helps shorten PD-L2 engagement with PD-1 and therefore lower affinity. Furthermore, we identified a ?latch? between the C and D ?-strands of the binding face as the source of the PD-L2 affinity advantage. We show that the 3-fold affinity advantage of PD-L2 is the consequence of these two opposing features, the W110(PD-L2) ?elbow? and a C?D region ?latch.? Interestingly, using phylogenetic analysis, we found that these features evolved simultaneously upon the emergence of placental mammals, suggesting that PD-L2?affinity tuning was part of the alterations to the adaptive immune system required for placental gestation.	[Philips, Elliot A.; Pan, Ruimin; Kong, Xiang-Peng] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Garcia-Espana, Antonio] Univ Rovira & Virgili, Res Unit, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, Tarragona 43005, Spain; [Tocheva, Anna S.; Adam, Kieran R.; Mor, Adam] Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA; [Ahearn, Ian M.] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10016 USA	New York University; Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Columbia University; New York University	Kong, XP (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA.; Mor, A (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA.	am5121@cumc.columbia.edu; xiangpeng.kong@nyulangone.org		Philips, Elliot/0000-0002-6407-1890; Adam, Kieran/0000-0003-0787-6868; Ahearn, Ian/0000-0002-2275-137X; Kong, Xiang-Peng/0000-0001-5773-2681	National Institutes of Health [T32AR069515, T32GM007308, R01AI125640]; Ministerio de Economia y Competitividad FIS Grant [PI16/00504]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad FIS Grant	This work was supported in part by National Institutes of Health Grants T32AR069515 (to E. A. P), T32GM007308 (to E. A. P), and R01AI125640 (to A. M.) and Ministerio de Economia y Competitividad FIS Grant PI16/00504 (to A. G.-E.). E. A. P., A. M., and X. P. K. are inventors on a pending patent application pertaining to this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hansen JD, 2009, MOL IMMUNOL, V46, P457, DOI 10.1016/j.molimm.2008.10.007; Hedges S. Blair, 2009, P309; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Liu L, 2017, P NATL ACAD SCI USA, V114, pE7282, DOI 10.1073/pnas.1616744114; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Petroff MG, 2010, AM J REPROD IMMUNOL, V63, P506, DOI 10.1111/j.1600-0897.2010.00841.x; Petroff MG, 2003, BIOL REPROD, V68, P1496, DOI 10.1095/biolreprod.102.010058; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Tang SG, 2019, P NATL ACAD SCI USA, V116, P24500, DOI 10.1073/pnas.1916916116; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Viricel C, 2015, J MOL GRAPH MODEL, V57, P131, DOI 10.1016/j.jmgm.2015.01.015; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017; Zhao YL, 2019, IMMUNITY, V51, P1059, DOI 10.1016/j.immuni.2019.11.003	34	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4372	4380		10.1074/jbc.AC119.011747	http://dx.doi.org/10.1074/jbc.AC119.011747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	31882544	hybrid, Green Published			2022-12-28	WOS:000524499700001
J	Broekelmann, TJ; Bodmer, NK; Mecham, RP				Broekelmann, Thomas J.; Bodmer, Nicholas K.; Mecham, Robert P.			Identification of the growth factor?binding sequence in the extracellular matrix protein MAGP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; transforming growth factor beta (TGF?); cell signaling; bone morphogenetic protein (BMP); growth factor; fibrillar; growth factor signaling; MFAP2; microfibril; microfibril associated glycoprotein (MAGP); TGF?; fibrillin; extracellular cellular matrix (ECM); protein-protein interaction	MICROFIBRIL-ASSOCIATED GLYCOPROTEIN-1; TGF-BETA ACTIVATION; TRANSFORMING GROWTH-FACTOR-BETA-1; TERNARY COMPLEX; BINDING DOMAIN; FIBRILLIN; TROPOELASTIN; FIBRONECTIN; COMPONENTS; ELASTIN	Microfibril-associated glycoprotein-1 (MAGP-1) is a component of vertebrate extracellular matrix (ECM) microfibrils that, together with the fibrillins, contributes to microfibril function. Many of the phenotypes associated with MAGP-1 gene inactivation are consistent with dysregulation of the transforming growth factor ? (TGF?)/bone morphogenetic protein (BMP) signaling system. We have previously shown that full-length MAGP-1 binds active TGF?-1 and some BMPs. The work presented here further defines the growth factor?binding domain of MAGP-1. Using recombinant domains and synthetic peptides, along with surface plasmon resonance analysis to measure the kinetics of the MAGP-1?TGF?-1 interaction, we localized the TGF?- and BMP-binding site in MAGP-1 to a 19-amino acid?long, highly acidic sequence near the N terminus. This domain was specific for binding active, but not latent, TGF?-1. Growth factor activity experiments revealed that TGF?-1 retains signaling activity when complexed with MAGP-1. Furthermore, when bound to fibrillin, MAGP-1 retained the ability to interact with TGF?-1, and active TGF?-1 did not bind fibrillin in the absence of MAGP-1. The absence of MAGP was sufficient to raise the amount of total TGF? stored in the ECM of cultured cells, suggesting that the MAGPs compete with the TGF? large latent complex for binding to microfibrils. Together, these results indicate that MAGP-1 plays an active role in TGF? signaling in the ECM.	[Broekelmann, Thomas J.; Bodmer, Nicholas K.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mecham, RP (corresponding author), Campus Box 8228,660 South Euclid Ave, St Louis, MO 63110 USA.	bmecham@wustl.edu			NHLBI, National Institutes of Health [R01 HL53325, R01 HL105314]; National Institutes of Health [T32 HL125241, T32 HL07317]; Ines Mandl Research Foundation	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ines Mandl Research Foundation	This work was supported by NHLBI, National Institutes of Health Grants R01 HL53325 and R01 HL105314 (to R. P. M.) and by National Institutes of Health Training Grants T32 HL125241 and T32 HL07317 (to N. K. B.), and also by the Ines Mandl Research Foundation (to R. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcaraz LB, 2014, J CELL BIOL, V205, P409, DOI 10.1083/jcb.201308031; Barbier M, 2014, AM J HUM GENET, V95, P736, DOI 10.1016/j.ajhg.2014.10.018; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Combs MD, 2013, J BIOL CHEM, V288, P28869, DOI 10.1074/jbc.M113.497727; Craft CS, 2018, MATRIX BIOL, V71-72, P100, DOI 10.1016/j.matbio.2018.03.006; Craft CS, 2014, DIABETES, V63, P1920, DOI 10.2337/db13-1604; Craft CS, 2012, J CELL BIOCHEM, V113, P93, DOI 10.1002/jcb.23331; Craft CS, 2010, J BIOL CHEM, V285, P23858, DOI 10.1074/jbc.M110.113019; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Davis EC, 2002, J STRUCT BIOL, V139, P65, DOI 10.1016/S1047-8477(02)00559-2; DAVISON IG, 1995, J EXP BIOL, V198, P2185; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; GOLDFISCHER S, 1985, TISSUE CELL, V17, P441, DOI 10.1016/0040-8166(85)90023-0; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson MH, 2006, J CHROMATOGR A, V1128, P125, DOI 10.1016/j.chroma.2006.06.050; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kurcinski M, 2019, BIOINFORMATICS, V35, P4170, DOI 10.1093/bioinformatics/btz185; Lee H, 2015, NUCLEIC ACIDS RES, V43, pW431, DOI 10.1093/nar/gkv495; Lee J, 2015, GLYCOBIOLOGY, V25, P1491, DOI 10.1093/glycob/cwv064; Liu YJ, 2004, J CLIN ENDOCR METAB, V89, P875, DOI 10.1210/jc.2003-030774; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Mazzieri R, 2000, METH MOL B, V142, P13; McConnell CJ, 1997, J PHYSIOL-LONDON, V499, P513, DOI 10.1113/jphysiol.1997.sp021945; Mecham RP, 2015, MATRIX BIOL, V47, P13, DOI 10.1016/j.matbio.2015.05.003; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moulin A, 2014, PROTEIN SCI, V23, P1698, DOI 10.1002/pro.2548; Murphy-Ullrich JE, 2018, MATRIX BIOL, V68-69, P28, DOI 10.1016/j.matbio.2017.12.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Smaldone S, 2016, J BONE MINER RES, V31, P86, DOI 10.1002/jbmr.2598; Stoilov I, 2018, METHOD CELL BIOL, V143, P133, DOI 10.1016/bs.mcb.2017.08.008; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 1999, BIOCHEM J, V340, P693, DOI 10.1042/0264-6021:3400693; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Tumbarello DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162698; Villain G, 2018, FEBS J, V285, P4394, DOI 10.1111/febs.14680; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Walji TA, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00087; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Weinbaum JS, 2010, MACROMOL BIOSCI, V10, P1338, DOI 10.1002/mabi.201000121; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhao B, 2018, J BIOL CHEM, V293, P1579, DOI 10.1074/jbc.M117.809657	66	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2687	2697		10.1074/jbc.RA119.010540	http://dx.doi.org/10.1074/jbc.RA119.010540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31988245	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000519969100014
J	Weidlich, D; Klostermeier, D				Weidlich, Daniela; Klostermeier, Dagmar			Functional interactions between gyrase subunits are optimized in a species-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; DNA gyrase; ATPase; DNA-protein interaction; DNA binding protein; decatenation; genome integrity; species specificity; subunit interaction; supercoiling mechanism; heterologous protein-protein interaction; GyrA; GyrB	COLI DNA-GYRASE; C-TERMINAL-DOMAIN; COMPLETE GENOME SEQUENCE; SUPERCOILING SET-POINT; BACILLUS-SUBTILIS DNA; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; II TOPOISOMERASE; ATPASE ACTIVITY; MECHANISM	DNA gyrase is a bacterial DNA topoisomerase that catalyzes ATP-dependent negative DNA supercoiling and DNA decatenation. The enzyme is a heterotetramer comprising two GyrA and two GyrB subunits. Its overall architecture is conserved, but species-specific elements in the two subunits are thought to optimize subunit interaction and enzyme function. Toward understanding the roles of these different elements, we compared the activities of Bacillus subtilis, Escherichia coli, and Mycobacterium tuberculosis gyrases and of heterologous enzymes reconstituted from subunits of two different species. We show that B. subtilis and E. coli gyrases are proficient DNA-stimulated ATPases and efficiently supercoil and decatenate DNA. In contrast, M. tuberculosis gyrase hydrolyzes ATP only slowly and is a poor supercoiling enzyme and decatenase. The heterologous enzymes are generally less active than their homologous counterparts. The only exception is a gyrase reconstituted from mycobacterial GyrA and B. subtilis GyrB, which exceeds the activity of M. tuberculosis gyrase and reaches the activity of the B. subtilis gyrase, indicating that the activities of enzymes containing mycobacterial GyrB are limited by ATP hydrolysis. The activity pattern of heterologous gyrases is in agreement with structural features present: B. subtilis gyrase is a minimal enzyme, and its subunits can functionally interact with subunits from other bacteria. In contrast, the specific insertions in E. coli and mycobacterial gyrase subunits appear to prevent efficient functional interactions with heterologous subunits. Understanding the molecular details of gyrase adaptations to the specific physiological requirements of the respective organism might aid in the development of species-specific gyrase inhibitors.	[Weidlich, Daniela; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany	University of Munster	Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	dagmar.klostermeier@uni-muenster.de			Deutsche Forschungsgemeinschaft [KL1153/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KL1153/9-1. The authors declare that they have no conflicts of interest with the contents of this article.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blower TR, 2016, P NATL ACAD SCI USA, V113, P1706, DOI 10.1073/pnas.1525047113; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; CHAMPOUX JJ, 1981, J BIOL CHEM, V256, P4805; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; DEPEW RE, 1978, J BIOL CHEM, V253, P511; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2016, NUCLEIC ACIDS RES, V44, P10354, DOI 10.1093/nar/gkw740; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Gubaev A, 2012, J BIOL CHEM, V287, P10916, DOI 10.1074/jbc.M111.308247; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hartmann S, 2017, J MOL BIOL, V429, P3717, DOI 10.1016/j.jmb.2017.10.005; Hashimi SM, 2008, ANTIMICROB AGENTS CH, V52, P1382, DOI 10.1128/AAC.01551-07; Hearnshaw SJ, 2015, ACTA CRYSTALLOGR D, V71, P996, DOI 10.1107/S1399004715002916; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Jude KM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt413; Klostermeier D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051489; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Lanz MA, 2014, J BIOL CHEM, V289, P12275, DOI 10.1074/jbc.M114.547745; LIU LF, 1979, J BIOL CHEM, V254, P1082; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Madhusudan K, 1995, MICROBIOL-SGM, V141, P3029, DOI 10.1099/13500872-141-12-3029; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; ORR E, 1982, J BACTERIOL, V151, P524, DOI 10.1128/JB.151.1.524-527.1982; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; PENG H, 1993, P NATL ACAD SCI USA, V90, P8571, DOI 10.1073/pnas.90.18.8571; Petrella S, 2019, STRUCTURE, V27, P579, DOI 10.1016/j.str.2019.01.004; Rovinskiy NS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030081; Rudolph MG, 2013, J MOL BIOL, V425, P2632, DOI 10.1016/j.jmb.2013.04.010; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Sengupta S, 2008, FEMS MICROBIOL LETT, V279, P40, DOI 10.1111/j.1574-6968.2007.01005.x; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Stelljes JT, 2018, NUCLEIC ACIDS RES, V46, P6773, DOI 10.1093/nar/gky470; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; SUGINO A, 1980, NUCLEIC ACIDS RES, V8, P3865, DOI 10.1093/nar/8.17.3865; Taneja B, 2007, P NATL ACAD SCI USA, V104, P14670, DOI 10.1073/pnas.0701989104; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; TSE YC, 1980, J BIOL CHEM, V255, P5560; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Wu LCC, 1995, ARCH BIOCHEM BIOPHYS, V324, P123, DOI 10.1006/abbi.1995.9919	66	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2299	2312		10.1074/jbc.RA119.010245	http://dx.doi.org/10.1074/jbc.RA119.010245			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953321	Green Published, hybrid			2022-12-28	WOS:000517330200013
J	Vester, K; Santos, KF; Kuropka, B; Weise, C; Wahl, MC				Vester, Karen; Santos, Karine F.; Kuropka, Benno; Weise, Christoph; Wahl, Markus C.			The inactive C-terminal cassette of the dual-cassette RNA helicase BRR2 both stimulates and inhibits the activity of the N-terminal helicase unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein conformation; ATPase; RNA helicase; RNA splicing; dual-cassette Ski2-like helicase; intramolecular regulation; nucleic acid-dependent nucleotide triphosphatase (NTPase); small nuclear ribonucleoprotein U5 subunit 200 (SNRNP200); superfamily 2 helicase; pre-mRNA splicing	PRE-MESSENGER-RNA; CRYO-EM STRUCTURE; SIGNAL COINTEGRATOR 1; BOX ATPASES; TRANSCRIPTION COACTIVATOR; MOLECULAR ARCHITECTURE; ACTIVATED SPLICEOSOME; ATP HYDROLYSIS; PROTEIN; MECHANISM	The RNA helicase bad response to refrigeration 2 homolog (BRR2) is required for the activation of the spliceosome before the first catalytic step of RNA splicing. BRR2 represents a distinct subgroup of Ski2-like nucleic acid helicases whose members comprise tandem helicase cassettes. Only the N-terminal cassette of BRR2 is an active ATPase and can unwind substrate RNAs. The C-terminal cassette represents a pseudoenzyme that can stimulate RNA-related activities of the N-terminal cassette. However, the molecular mechanisms by which the C-terminal cassette modulates the activities of the N-terminal unit remain elusive. Here, we show that N- and C-terminal cassettes adopt vastly different relative orientations in a crystal structure of BRR2 in complex with an activating domain of the spliceosomal Prp8 protein at 2.4 ? resolution compared with the crystal structure of BRR2 alone. Likewise, inspection of BRR2 structures within spliceosomal complexes revealed that the cassettes occupy different relative positions and engage in different intercassette contacts during different splicing stages. Engineered disulfide bridges that locked the cassettes in two different relative orientations had opposite effects on the RNA-unwinding activity of the N-terminal cassette, with one configuration enhancing and the other configuration inhibiting RNA unwinding compared with the unconstrained protein. Moreover, we found that differences in relative positioning of the cassettes strongly influence RNA-stimulated ATP hydrolysis by the N-terminal cassette. Our results indicate that the inactive C-terminal cassette of BRR2 can both positively and negatively affect the activity of the N-terminal helicase unit from a distance.	[Vester, Karen; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Dept Biochem, Struct Biochem Grp, Takustr 6, D-14195 Berlin, Germany; [Kuropka, Benno; Weise, Christoph] Free Univ Berlin, Dept Biochem, Prot Biochem Grp, Thielallee 63, D-14195 Berlin, Germany; [Wahl, Markus C.] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog Grp, Albert Einstein Str 15, D-12489 Berlin, Germany; [Santos, Karine F.] 4TEEN4 Pharmaceut GmbH, Neuendorfstr 15b, D-16761 Hennigsdorf, Germany	Free University of Berlin; Free University of Berlin; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Wahl, MC (corresponding author), Free Univ Berlin, Struct Biochem, Takustr 6, D-14195 Berlin, Germany.	markus.wahl@fu-berlin.de	; Wahl, Markus/D-6365-2017	Kuropka, Benno/0000-0001-5088-6346; Wahl, Markus/0000-0002-2811-5307; Weise, Christoph/0000-0002-5507-4694	Deutsche Forschungsgemeinschaft [TRR186/A15-1]; Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin	This work was supported by Deutsche Forschungsgemeinschaft Grant TRR186/A15-1 (to M. C. W.) and by a Dahlem International Network Post-Doc Fellowship from Freie Universitat Berlin (to K. F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Absmeier E, 2017, CELL CYCLE, V16, P100, DOI 10.1080/15384101.2016.1255384; Absmeier E, 2016, CELL CYCLE, V15, P3362, DOI 10.1080/15384101.2016.1249549; Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bowers HA, 2006, RNA, V12, P903, DOI 10.1261/rna.2323406; Brickner JR, 2017, NATURE, V551, P389, DOI 10.1038/nature24484; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cordin O, 2014, NUCLEIC ACIDS RES, V42, P13897, DOI 10.1093/nar/gku1238; Cvackova Z, 2014, HUM MUTAT, V35, P308, DOI 10.1002/humu.22481; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Davignon L, 2016, HUM MOL GENET, V25, P1559, DOI 10.1093/hmg/ddw033; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Henning LM, 2017, NUCLEIC ACIDS RES, V45, P7922, DOI 10.1093/nar/gkx535; Hoskins AA, 2016, ELIFE, V5, DOI 10.7554/eLife.14166; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Knierim E, 2016, AM J HUM GENET, V98, P473, DOI 10.1016/j.ajhg.2016.01.006; Koodathingal P, 2013, RNA BIOL, V10, P1073, DOI 10.4161/rna.25245; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13; Liang WW, 2015, GENE DEV, V29, P81, DOI 10.1101/gad.253708.114; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mojumdar A, 2017, J BIOL CHEM, V292, P4176, DOI 10.1074/jbc.M116.767954; Mozaffari-Jovin S, 2014, RNA BIOL, V11, P298, DOI 10.4161/rna.28353; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Putnam AA, 2015, MOL CELL, V59, P541, DOI 10.1016/j.molcel.2015.06.030; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2001, ACTA CRYSTALLOGR D, V57, P1695, DOI 10.1107/S0907444901013105; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Theuser M, 2016, P NATL ACAD SCI USA, V113, P7798, DOI 10.1073/pnas.1524616113; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; van Nues RW, 2001, GENETICS, V157, P1451; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; WOLFF T, 1993, GENE DEV, V7, P1377, DOI 10.1101/gad.7.7b.1377; Wollenhaupt J, 2018, BIOPHYS J, V114, P788, DOI 10.1016/j.bpj.2017.12.033; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yang F, 2013, NUCLEIC ACIDS RES, V41, P4660, DOI 10.1093/nar/gkt149; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yankiwski V, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-11; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhang X, 2013, EYE, V27, P1204, DOI 10.1038/eye.2013.137; Zhang XF, 2019, CELL RES, V29, P274, DOI 10.1038/s41422-019-0143-x; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033	75	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2097	2112		10.1074/jbc.RA119.010964	http://dx.doi.org/10.1074/jbc.RA119.010964			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31914407	hybrid, Green Published			2022-12-28	WOS:000517128200026
J	Joly, JH; Delfarah, A; Phung, PS; Parrish, S; Graham, NA				Joly, James H.; Delfarah, Alireza; Phung, Philip S.; Parrish, Sydney; Graham, Nicholas A.			A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; cancer biology; redox regulation; Warburg effect; metabolomics; L-cystine; NADPH; SLC7A11	OXIDATIVE STRESS; GLUTAMINE-METABOLISM; INDUCED CYTOTOXICITY; XCT ANTIPORTER; H2O2 MEDIATE; TUMOR-CELLS; DEPENDENCY; SULFOXIMINE; ACTIVATION; INHIBITION	Metabolic reprogramming in cancer cells can increase their dependence on metabolic substrates such as glucose. As such, the vulnerability of cancer cells to glucose deprivation creates an attractive opportunity for therapeutic intervention. Because it is not possible to starve tumors of glucose in vivo, here we sought to identify the mechanisms in glucose deprivation-induced cancer cell death and then designed inhibitor combinations to mimic glucose deprivation-induced cell death. Using metabolomic profiling, we found that cells undergoing glucose deprivation-induced cell death exhibited dramatic accumulation of intracellular L-cysteine and its oxidized dimer, L-cystine, and depletion of the antioxidant GSH. Building on this observation, we show that glucose deprivation-induced cell death is driven not by the lack of glucose, but rather by L-cystine import. Following glucose deprivation, the import of L-cystine and its subsequent reduction to L-cysteine depleted both NADPH and GSH pools, thereby allowing toxic accumulation of reactive oxygen species. Consistent with this model, we found that the glutamate/cystine antiporter (xCT) is required for increased sensitivity to glucose deprivation. We searched for glycolytic enzymes whose expression is essential for the survival of cancer cells with high xCT expression and identified glucose transporter type 1 (GLUT1). Testing a drug combination that co-targeted GLUT1 and GSH synthesis, we found that this combination induces synthetic lethal cell death in high xCT-expressing cell lines susceptible to glucose deprivation. These results indicate that co-targeting GLUT1 and GSH synthesis may offer a potential therapeutic approach for targeting tumors dependent on glucose for survival.	[Joly, James H.; Delfarah, Alireza; Phung, Philip S.; Parrish, Sydney; Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Graham, Nicholas A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Graham, NA (corresponding author), Univ Southern Calif, 3710 McClintock Ave,RTH 509, Los Angeles, CA 90089 USA.	nagraham@usc.edu	Delfarah, Alireza/AAN-2110-2020; Graham, Nicholas A./X-2738-2019; Graham, Nicholas/GYD-5066-2022	Graham, Nicholas A./0000-0002-6811-1941; Graham, Nicholas/0000-0002-6811-1941; Joly, James/0000-0003-3780-9412; Delfarah, Alireza/0000-0002-3192-5941	American Cancer Society [IRG-16-181-57]; Rose Hills Foundation; USC Provost's Office; Viterbi School of Engineering	American Cancer Society(American Cancer Society); Rose Hills Foundation; USC Provost's Office; Viterbi School of Engineering	This work supported by American Cancer Society Grant IRG-16-181-57, the Rose Hills Foundation, the USC Provost's Office, and the Viterbi School of Engineering. The authors declare that they have no conflicts of interest with the contents of this article.	Adams DJ, 2014, ACS CHEM BIOL, V9, P2247, DOI 10.1021/cb500347p; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Andringa KK, 2006, CANCER RES, V66, P1605, DOI 10.1158/0008-5472.CAN-05-3462; Arensman MD, 2019, P NATL ACAD SCI USA, V116, P9533, DOI 10.1073/pnas.1814932116; ARRICK BA, 1982, J BIOL CHEM, V257, P1231; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; Cairns RA, 2016, NAT REV CANCER, V16, P613, DOI 10.1038/nrc.2016.100; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delfarah A, 2019, J BIOL CHEM, V294, P10564, DOI 10.1074/jbc.RA118.005806; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ganapathy-Kanniappan S, 2012, ONCOTARGET, V3, P940, DOI 10.18632/oncotarget.623; Goji T, 2017, J BIOL CHEM, V292, P19721, DOI 10.1074/jbc.M117.814392; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; HAWKINS RA, 1992, J NUCL MED, V33, P339; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HIRONO I, 1961, GANN, V52, P39; Ho SM, 2017, STEM CELL REP, V9, P615, DOI 10.1016/j.stemcr.2017.06.012; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Jae HJ, 2009, KOREAN J RADIOL, V10, P596, DOI 10.3348/kjr.2009.10.6.596; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Krejsa CM, 2010, J BIOL CHEM, V285, P16116, DOI 10.1074/jbc.M110.116210; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Labak CM, 2016, AM J CANCER RES, V6, P1599; Lee HY, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam7893; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Leonard PG, 2016, NAT CHEM BIOL, V12, P1053, DOI [10.1038/NCHEMBIO.2195, 10.1038/nchembio.2195]; Lu WY, 2018, ANTIOXID REDOX SIGN, V28, P167, DOI 10.1089/ars.2017.7014; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miwa H, 2013, ONCOL REP, V29, P2053, DOI 10.3892/or.2013.2299; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Ottestad-Hansen S, 2018, GLIA, V66, P951, DOI 10.1002/glia.23294; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Priebe A, 2011, GYNECOL ONCOL, V122, P389, DOI 10.1016/j.ygyno.2011.04.024; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan Michelle, 2017, React Oxyg Species (Apex), V3, P47, DOI 10.20455/ros.2017.801; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Villablanca JG, 2016, PEDIATR BLOOD CANCER, V63, P1349, DOI 10.1002/pbc.25994; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	67	19	19	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1350	1365		10.1074/jbc.RA119.011471	http://dx.doi.org/10.1074/jbc.RA119.011471			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31914417	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000513822300015
J	Liu, MY; Saha, N; Gajan, A; Saadat, N; Gupta, SV; Pile, LA				Liu, Mengying; Saha, Nirmalya; Gajan, Ambikai; Saadat, Nadia; Gupta, Smiti V.; Pile, Lori A.			A complex interplay between SAM synthetase and the epigenetic regulator SIN3 controls metabolism and transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone modification; transcription; metabolism; glycolysis; tricarboxylic acid cycle; TCA cycle; Krebs cycle; gene regulation; epigenetics; chromatin; SAM synthetase; SIN3	DEACETYLASE COMPLEX; CHROMATIN; GENES; COREPRESSOR; METHYLATION; GLYCOLYSIS; EXPRESSION; PATHWAYS; DYNAMICS; SERINE	The SIN3 histone-modifying complex regulates the expression of multiple methionine catabolic genes, including SAM synthetase (Sam-S), as well as SAM levels. To further dissect the relationship between methionine catabolism and epigenetic regulation by SIN3, we sought to identify genes and metabolic pathways controlled by SIN3 and SAM synthetase (SAM-S) in Drosophila melanogaster. Using several approaches, including RNAi-mediated gene silencing, RNA-Seq? and quantitative RT-PCR?based transcriptomics, and ultra-high-performance LC-MS/MS? and GC/MS?based metabolomics, we found that, as a global transcriptional regulator, SIN3 impacted a wide range of genes and pathways. In contrast, SAM-S affected only a narrow range of genes and pathways. The expression and levels of additional genes and metabolites, however, were altered in Sin3A+Sam-S dual knockdown cells. This analysis revealed that SIN3 and SAM-S regulate overlapping pathways, many of which involve one-carbon and central carbon metabolisms. In some cases, the factors acted independently; in some others, redundantly; and for a third set, in opposition. Together, these results, obtained from experiments with the chromatin regulator SIN3 and the metabolic enzyme SAM-S, uncover a complex relationship between metabolism and epigenetic regulation.	[Liu, Mengying; Saadat, Nadia; Gupta, Smiti V.] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI 48202 USA; [Liu, Mengying; Saha, Nirmalya; Gajan, Ambikai; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Saha, Nirmalya] Univ Michigan, Dept Pathol, Michigan Med, Ann Arbor, MI 48109 USA; [Gajan, Ambikai] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Gajan, Ambikai] Karmanos Canc Inst, Detroit, MI 48201 USA; [Saadat, Nadia] Univ Detroit Mercy, Coll Engn & Sci, Detroit, MI 48221 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Detroit Mercy	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	loripile@wayne.edu	Saha, Nirmalya/AEF-3616-2022; Saadat, Nadia/AAP-5101-2020	Saadat, Nadia/0000-0001-8726-9245; Pile, Lori/0000-0002-7189-4828; SAHA, NIRMALYA/0000-0002-5624-8879	NIGMS, National Institutes of Health [R01GM088886]; Wayne State University	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wayne State University	This work was supported by NIGMS, National Institutes of Health Grant R01GM088886 and a Wayne State University research support grant (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bansal N, 2016, ADV CANCER RES, V130, P113, DOI 10.1016/bs.acr.2016.01.006; Bansal N, 2015, ONCOTARGET, V6, P34087, DOI 10.18632/oncotarget.6048; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Barnes VL, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-26; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Chaubal A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0188-y; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cluntun AA, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0135-3; Dai ZW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04426-y; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Ding W, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007812; Farias EF, 2010, P NATL ACAD SCI USA, V107, P11811, DOI 10.1073/pnas.1006737107; Fussl M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00461; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gonneaud A, 2015, FEBS LETT, V589, P2776, DOI 10.1016/j.febslet.2015.08.009; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim JA, 2018, MOL CELLS, V41, P264, DOI 10.14348/molcells.2018.0076; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; Kwon YJ, 2015, MOL CANCER THER, V14, P1824, DOI 10.1158/1535-7163.MCT-14-0980-T; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Larsson J, 1998, FEBS LETT, V427, P119, DOI 10.1016/S0014-5793(98)00408-6; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Lewis MJ, 2016, ONCOTARGET, V7, P78713, DOI 10.18632/oncotarget.12805; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Li WX, 2011, J PLANT PHYSIOL, V168, P1837, DOI 10.1016/j.jplph.2011.05.020; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu MY, 2017, J BIOL CHEM, V292, P1970, DOI 10.1074/jbc.M116.749754; Liu MY, 2016, G3-GENES GENOM GENET, V6, P121, DOI 10.1534/g3.115.024273; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Murray B, 2019, WORLD J GASTROENTERO, V25, P4300, DOI 10.3748/wjg.v25.i31.4300; Musselman LP, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163881; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Strekalova E, 2019, BREAST CANCER RES TR, V175, P39, DOI 10.1007/s10549-019-05146-7; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye CQ, 2019, MOL CELL, V73, P1115, DOI 10.1016/j.molcel.2019.01.012; Ye CQ, 2018, TRENDS ENDOCRIN MET, V29, P626, DOI 10.1016/j.tem.2018.06.002; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	59	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					375	389		10.1074/jbc.RA119.010032	http://dx.doi.org/10.1074/jbc.RA119.010032			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31776190	Green Published, hybrid			2022-12-28	WOS:000507373600010
J	Makou, E; Bailey, RG; Johnston, H; Parkin, JD; Hulme, AN; Hahner, G; Barlow, PN				Makou, Elisavet; Bailey, Richard G.; Johnston, Heather; Parkin, John D.; Hulme, Alison N.; Hahner, Georg; Barlow, Paul N.			Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						surface plasmon resonance (SPR); atomic force microscopy (AFM); complement system; protein-protein interaction; protein conformation; inflammation; single-molecule biophysics; C3b; factor H; immune response; molecular stretching; self-assembling monolayer; single-molecule analysis	FACTOR-H; ALTERNATIVE PATHWAY; BINDING-SITES; HOST RECOGNITION; APOPTOTIC CELLS; C3B; REGULATOR; COMPONENT; DISEASE; MODULES	Activation and suppression of the complement system compete on every serum-exposed surface, host or foreign. Potentially harmful outcomes of this competition depend on surface molecules through mechanisms that remain incompletely understood. Combining surface plasmon resonance (SPR) with atomic force microscopy (AFM), here we studied two complement system proteins at the single-molecule level: C3b, the proteolytically activated form of C3, and factor H (FH), the surface-sensing C3b-binding complement regulator. We used SPR to monitor complement initiation occurring through a positive-feedback loop wherein surface-deposited C3b participates in convertases that cleave C3, thereby depositing more C3b. Over multiple cycles of flowing factor B, factor D, and C3 over the SPR chip, we amplified C3b from ?20 to ?220 molecules??m(?2). AFM revealed C3b clusters of up to 20 molecules and solitary C3b molecules deposited up to 200 nm away from the clusters. A force of 0.17 ? 0.02 nanonewtons was needed to pull a single FH molecule, anchored to the AFM probe, from its complex with surface-attached C3b. The extent to which FH molecules stretched before detachment varied widely among complexes. Performing force-distance measurements with FH(D1119G), a variant lacking one of the C3b-binding sites and causing atypical hemolytic uremic syndrome, we found that it detached more uniformly and easily. In further SPR experiments, K-D values between FH and C3b on a custom-made chip surface were 5-fold tighter than on commercial chips and similar to those on erythrocytes. These results suggest that the chemistry at the surface on which FH acts drives conformational adjustments that are functionally critical.	[Makou, Elisavet; Johnston, Heather; Hulme, Alison N.; Barlow, Paul N.] Univ Edinburgh, EaStChem Sch Chem, Joseph Black Chem Bldg, Edinburgh EH9 3FJ, Midlothian, Scotland; [Bailey, Richard G.; Parkin, John D.; Hahner, Georg] Univ St Andrews, EaStChem Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JY, Midlothian, Scotland	University of Edinburgh; University of St Andrews; University of Edinburgh	Barlow, PN (corresponding author), Univ Edinburgh, EaStChem Sch Chem, Joseph Black Chem Bldg, Edinburgh EH9 3FJ, Midlothian, Scotland.; Hahner, G (corresponding author), Univ St Andrews, EaStChem Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	gh23@st-andrews.ac.uk; Paul.Barlow@ed.ac.uk		Hulme, Alison/0000-0002-4619-1506; Bailey, Richard/0000-0001-7367-766X	Leverhulme Trust [RPG-2015-109]	Leverhulme Trust(Leverhulme Trust)	This work was supported by Leverhulme Trust Grant RPG-2015-109. The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2015, BIOCHEM J, V465, P325, DOI 10.1042/BJ20141069; Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Blatt AZ, 2016, IMMUNOL REV, V274, P172, DOI 10.1111/imr.12466; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Chen ZA, 2016, MOL CELL PROTEOMICS, V15, P2730, DOI 10.1074/mcp.M115.056473; COCHRANE CG, 1968, J EXP MED, V127, P371, DOI 10.1084/jem.127.2.371; Dave S, 2004, INDIAN J MED RES, V119, P66; DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; de Jorge EG, 2018, MOL IMMUNOL, V102, P42, DOI 10.1016/j.molimm.2018.06.011; Harder MJ, 2016, J IMMUNOL, V196, P866, DOI 10.4049/jimmunol.1501919; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Harris CL, 2018, MOL IMMUNOL, V102, P89, DOI 10.1016/j.molimm.2018.06.008; Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Herbert AP, 2015, J IMMUNOL, V195, P4986, DOI 10.4049/jimmunol.1501388; Hovingh ES, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02004; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; Kassa E, 2019, EXPERT OPIN BIOL TH, V19, P335, DOI 10.1080/14712598.2019.1575358; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; Kerr H, 2017, J BIOL CHEM, V292, P13345, DOI 10.1074/jbc.M117.795088; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Lachmann PJ, 2018, IMMUNOBIOLOGY, V223, P519, DOI 10.1016/j.imbio.2018.02.001; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LAW SKA, 1981, BIOCHEMISTRY-US, V20, P7457, DOI 10.1021/bi00529a020; LEVINE RP, 1990, CURR TOP MICROBIOL, V153, P73; Loyet KM, 2012, INVEST OPHTH VIS SCI, V53, P6628, DOI 10.1167/iovs.12-9587; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; MARDINEY MR, 1968, AM J PATHOL, V53, P253; Martin M, 2016, IMMUNOL REV, V274, P218, DOI 10.1111/imr.12462; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Meri S, 2016, FEBS LETT, V590, P2418, DOI 10.1002/1873-3468.12284; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Muller-Eberhard H J, 1968, Adv Immunol, V8, P1, DOI 10.1016/S0065-2776(08)60464-2; MULLEREBERHARD HJ, 1967, J EXP MED, V125, P359, DOI 10.1084/jem.125.2.359; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Osborne AJ, 2018, J BIOL CHEM, V293, P17166, DOI 10.1074/jbc.RA118.004767; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; Park DH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01007; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2010, ADV EXP MED BIOL, V703, P25, DOI 10.1007/978-1-4419-5635-4_3; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; Pouw RB, 2019, BLOOD ADV, V3, P621, DOI 10.1182/bloodadvances.2018025692; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2016, IMMUNOL REV, V274, P152, DOI 10.1111/imr.12475; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; TACK BF, 1976, BIOCHEMISTRY-US, V15, P4513, DOI 10.1021/bi00665a028; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Warwick A, 2014, J CLIN MED, V3, P1234, DOI 10.3390/jcm3041234; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	73	1	1	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20148	20163		10.1074/jbc.RA119.010913	http://dx.doi.org/10.1074/jbc.RA119.010913			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719147	Green Published, hybrid			2022-12-28	WOS:000505005800026
J	Zani, A; Zhang, LZ; McMichael, TM; Kenney, AD; Chemudupati, M; Kwiek, JJ; Liu, SL; Yount, JS				Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Kwiek, Jesse J.; Liu, Shan-Lu; Yount, Jacob S.			Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; virus; trophoblast; membrane fusion; fusion protein; IFITM; IFITM1; IFITM2; IFITM3; influenza virus; restriction factor; Zika virus; interferon-induced transmembrane protein; syncytin; placenta; cell fusion	IN-VITRO DEVELOPMENT; ZIKA VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; HERV-W; GLYCOPROTEIN; EXPRESSION; PROTECTION; RESISTANCE; INFECTION	Type I interferon (IFN) induced by virus infections during pregnancy can cause placental damage, but the mechanisms and identities of IFN-stimulated genes that are involved in this damage remain under investigation. The IFN-induced transmembrane proteins (IFITMs) inhibit virus infections by preventing virus membrane fusion with cells and by inhibiting fusion of infected cells (syncytialization). Fusion of placental trophoblasts via expression of endogenous retroviral fusogens known as syncytins forms the syncytiotrophoblast, a multinucleated cell structure essential for fetal development. We found here that IFN blocks fusion of BeWo human placental trophoblasts. Stably expressed IFITM1, -2, and -3 also blocked fusion of these trophoblasts while making them more resistant to virus infections. Conversely, stable IFITM knockdowns in BeWo trophoblasts increased their spontaneous fusion and allowed fusion in the presence of IFN while also making the cells more susceptible to virus infection. We additionally found that exogenous expression of IFITMs in HEK293T cells blocked fusion with cells expressing syncytin-1 or syncytin-2, confirming the ability of IFITMs to block individual syncytin-mediated fusion. Overall, our data indicate that IFITMs inhibit trophoblast fusion and suggest that there may be a critical balance between these antifusogenic effects and the beneficial antiviral effects of IFITMs in virus infections during pregnancy.	[Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA; [Kwiek, Jesse J.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Kwiek, Jesse J.; Liu, Shan-Lu; Yount, Jacob S.] Ohio State Univ, Infect Dis Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA.	jacob.yount@osumc.edu		Kwiek, Jesse/0000-0003-4277-8315; Yount, Jacob/0000-0002-6128-4575	National Institutes of Health [AI130110, AI142256, AI112542]; National Science Foundation Graduate Research Fellowship Program; NIGMS, National Institutes of Health [GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130110, R21AI146690, R21AI142256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI130110 and AI142256 (to J. S. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the National Science Foundation Graduate Research Fellowship Program.; Supported by National Institutes of Health Training Grant AI112542 administered by the Ohio State University Infectious Diseases Institute.; Supported by NIGMS, National Institutes of Health, Training Grant GM068412 administered by the Ohio State University Biomedical Sciences Graduate Program.	Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Buchrieser J, 2019, SCIENCE, V365, P176, DOI 10.1126/science.aaw7733; Cameo M, 1999, HUM REPROD, V14, P959, DOI 10.1093/humrep/14.4.959; Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gauster M, 2010, PLACENTA, V31, P82, DOI 10.1016/j.placenta.2009.12.007; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Ihara Toshio, 1999, Congenital Anomalies, V39, P223, DOI 10.1111/j.1741-4520.1999.tb00562.x; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; McMichael TM, 2018, J INFECT DIS, V218, P1582, DOI 10.1093/infdis/jiy361; McMichael TM, 2017, J BIOL CHEM, V292, P21517, DOI 10.1074/jbc.M117.800482; Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Ozog S, 2019, BLOOD, V134, P1298, DOI 10.1182/blood.2019000040; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; Shi GL, 2018, P NATL ACAD SCI USA, V115, pE10069, DOI 10.1073/pnas.1811892115; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; ZUSMAN I, 1984, TERATOLOGY, V29, P405, DOI 10.1002/tera.1420290311	46	36	35	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19844	19851		10.1074/jbc.AC119.010611	http://dx.doi.org/10.1074/jbc.AC119.010611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31735710	Green Published, hybrid			2022-12-28	WOS:000505005800002
J	Johnson, D; Zhu, L; Landim-Vieira, M; Pinto, JR; Chalovich, JM				Johnson, Dylan; Zhu, Li; Landim-Vieira, Maicon; Pinto, Jose Renato; Chalovich, Joseph M.			Basic residues within the cardiac troponin T C terminus are required for full inhibition of muscle contraction and limit activation by calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tropomyosin; muscle physiology; fluorescence resonance energy transfer (FRET); cardiac muscle; troponin; ATPase activity; cross-bridge kinetics; high Ala; high activation TnT (HAHA TnT); states of actin; troponin T (TnT)	RABBIT SKELETAL-MUSCLE; MYOSIN SUBFRAGMENT-1; ATPASE ACTIVITY; RESTRICTIVE CARDIOMYOPATHY; COOPERATIVE BINDING; REGULATORY PROTEINS; CA2+ SENSITIVITY; ENERGY-TRANSFER; INACTIVE STATE; F-ACTIN	Striated muscle is activated by myosin- and actin-linked processes, with the latter being regulated through changes in the position of tropomyosin relative to the actin surface. The C-terminal region of cardiac troponin T (TnT), a tropomyosin-associated protein, is required for full TnT inactivation at low Ca2+ and for limiting its activation at saturating Ca2+. Here, we investigated whether basic residues in this TnT region are involved in these activities, whether the TnT C terminus undergoes Ca2+-dependent conformational changes, and whether these residues affect cardiac muscle contraction. We generated a human cardiac TnT variant in which we replaced seven C-terminal Lys and Arg residues with Ala and added a Cys residue at either position 289 or 275 to affix a fluorescent probe. At pCa 3.7, actin filaments containing high-alanine TnT had an elevated ATPase rate like that obtained when the last TnT 14 residues were deleted. Acrylodan-tropomyosin fluorescence changes and S1-actin binding kinetics revealed that at pCa 8, the high-alanine TnT-containing filaments did not enter the first inactive state. FRET analyses indicated that the C-terminal TnT region approached Cys-190 of tropomyosin as actin filaments transitioned to the inactive B state; that transition was abolished with high-alanine TnT. High-alanine TnT-containing cardiac muscle preparations had increased Ca2+ sensitivity of both steady-state isometric force and sinusoidal stiffness as well as increased maximum steady-state isometric force and sinusoidal stiffness. We conclude that C-terminal basic residues in cardiac TnT are critical for the regulation of cardiac muscle contraction.	[Johnson, Dylan; Zhu, Li; Chalovich, Joseph M.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, 600 Moye Blvd, Greenville, NC 27834 USA; [Landim-Vieira, Maicon; Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Johnson, Dylan] Univ North Florida, 1 UNF Dr, Jacksonville, FL 32224 USA	University of North Carolina; East Carolina University; State University System of Florida; Florida State University; State University System of Florida; University of North Florida	Chalovich, JM (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, 600 Moye Blvd, Greenville, NC 27834 USA.	chalovichj@ecu.edu	; Pinto, Jose R/H-2631-2017	Chalovich, Joseph/0000-0002-1243-4055; Landim-Vieira, Maicon/0000-0002-6696-8888; Pinto, Jose R/0000-0001-9092-4976	Brody School of Medicine at East Carolina University; National Institutes of Health [AR035216, HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	Brody School of Medicine at East Carolina University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Brody School of Medicine at East Carolina University as well as National Institutes of Health Grants AR035216 (to J. M. C.) and HL128683 (to J. R. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baxley T, 2017, BIOCHEMISTRY-US, V56, P2928, DOI 10.1021/acs.biochem.6b01092; Borrego-Diaz E, 2010, BIOPHYS J, V98, P2601, DOI 10.1016/j.bpj.2010.02.030; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Burhop J, 2001, J BIOL CHEM, V276, P20788, DOI 10.1074/jbc.M101110200; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; Chalovich JM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00377; Chalovich JM, 2012, J MUSCLE RES CELL M, V33, P493, DOI 10.1007/s10974-012-9305-x; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; EBASHI S, 1973, COLD SPRING HARB SYM, V37, P215, DOI 10.1101/SQB.1973.037.01.031; EISENBERG E, 1970, NATURE, V228, P1092, DOI 10.1038/2281092a0; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gonzalez-Martinez D, 2018, J MOL CELL CARDIOL, V123, P26, DOI 10.1016/j.yjmcc.2018.08.015; GREASER ML, 1971, J BIOL CHEM, V246, P4226; HASELGROVE JC, 1973, J MOL BIOL, V77, P549, DOI 10.1016/0022-2836(73)90222-2; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Hibbs RE, 2004, J BIOL CHEM, V279, P28483, DOI 10.1074/jbc.M403713200; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1981, BIOPHYS J, V35, P99, DOI 10.1016/S0006-3495(81)84777-7; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Johnson D, 2018, BIOPHYS J, V115, P702, DOI 10.1016/j.bpj.2018.06.028; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; McNamara James W, 2015, Biophys Rev, V7, P5, DOI 10.1007/s12551-014-0151-5; MIKI M, 1986, BIOCHIM BIOPHYS ACTA, V871, P137, DOI 10.1016/0167-4838(86)90166-4; MORRIS EP, 1984, BIOCHEMISTRY-US, V23, P2214, DOI 10.1021/bi00305a018; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2011, J BIOL CHEM, V286, P20901, DOI 10.1074/jbc.M111.234336; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SPUDICH JA, 1972, J MOL BIOL, V72, P619, DOI 10.1016/0022-2836(72)90180-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WILKINSON JM, 1972, BIOCHEM J, V127, P215, DOI 10.1042/bj1270215; Yengo CM, 2010, CURR OPIN PHARMACOL, V10, P731, DOI 10.1016/j.coph.2010.09.013; Zot HG, 2016, ARCH BIOCHEM BIOPHYS, V601, P97, DOI 10.1016/j.abb.2016.03.011	48	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19535	19545		10.1074/jbc.RA119.010966	http://dx.doi.org/10.1074/jbc.RA119.010966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712308	hybrid, Green Published			2022-12-28	WOS:000504093200008
J	Fan, WL; Zheng, J; Kong, WZ; Cui, LM; Aishanjiang, M; Yi, QZ; Wang, M; Cang, XH; Tang, XW; Chen, Y; Mo, JQ; Sondheimer, N; Ge, WZ; Guan, MX				Fan, Wenlu; Zheng, Jing; Kong, Wanzhong; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Wang, Min; Cang, Xiaohui; Tang, Xiaowen; Chen, Ye; Mo, Jun Qin; Sondheimer, Neal; Ge, Wanzhong; Guan, Min-Xin			Contribution of a mitochondrial tyrosyl-tRNA synthetase mutation to the phenotypic expression of the deafness-associated tRNA(Ser(UCN)) 7511A > G mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hearing loss; mitochondrial tRNA; mutation; tyrosyl-tRNA synthetase 2 (YARS2); pathophysiology; oxidative stress; tRNA(Ser(UCN)); maternally transmitted deafness; genetic disorder	12S RIBOSOMAL-RNA; NON-SYNDROMIC DEAFNESS; T7511C MUTATION; HEARING-LOSS; DNA MUTATION; SENSORINEURAL DEAFNESS; M(1)G37 MODIFICATION; BIOCHEMICAL-EVIDENCE; NUCLEAR MODIFIER; OXIDATIVE STRESS	Nuclear modifier genes have been proposed to modify the phenotypic expression of mitochondrial DNA mutations. Using a targeted exome sequencing approach, here we found that the p.191Gly>Val mutation in mitochondrial tyrosyl-tRNA synthetase 2 (YARS2) interacts with the tRNA(Ser(UCN)) 7511A>G mutation in causing deafness. Strikingly, members of a Chinese family bearing both YARS2 p.191Gly>Val and m.7511A>G mutations displayed much higher penetrance of deafness than those pedigrees carrying only the m.7511A>G mutation. The m.7511A>G mutation changed the A4:U69 base pairing to G4:U69 pairing at the aminoacyl acceptor stem of tRNA(Ser(UCN)) and perturbed tRNA(Ser(UCN)) structure and function, including an increased melting temperature, altered conformation, instability, and aberrant aminoacylation of mutant tRNA. Using lymphoblastoid cell lines derived from symptomatic and asymptomatic members of these Chinese families and control subjects, we show that cell lines harboring only the m.7511A>G or p.191Gly>Val mutation revealed relatively mild defects in tRNA(Ser(UCN)) or tRNA(Tyr) metabolism, respectively. However, cell lines harboring both m.7511A>G and p.191Gly>Val mutations displayed more severe defective aminoacylations and lower tRNA(Ser(UCN)) and tRNA(Tyr) levels, aberrant aminoacylation, and lower levels of other tRNAs, including tRNA(Thr), tRNALys, tRNA(Leu(UUR)), and tRNA(Ser(AGY)), than those in the cell lines carrying only the m.7511A>G or p.191Gly>Val mutation. Furthermore, mutant cell lines harboring both m.7511A>G and p.191Gly>Val mutations exhibited greater decreases in the levels of mitochondrial translation, respiration, and mitochondrial ATP and membrane potentials, along with increased production of reactive oxygen species. Our findings provide molecular-level insights into the pathophysiology of maternally transmitted deafness arising from the synergy between tRNA(Ser(UCN)) and mitochondrial YARS mutations.	[Fan, Wenlu; Zheng, Jing; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Cang, Xiaohui; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Sch Med, Div Med Genet & Genom, Hangzhou 310058, Zhejiang, Peoples R China; [Fan, Wenlu; Zheng, Jing; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Cang, Xiaohui; Chen, Ye; Ge, Wanzhong; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Fan, Wenlu; Kong, Wanzhong; Wang, Min; Tang, Xiaowen] Wenzhou Med Univ, Attardi Inst Biomed, Sch Life Sci & Lab Med, Wenzhou 325600, Zhejiang, Peoples R China; [Mo, Jun Qin] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pathol, San Diego, CA 92123 USA; [Sondheimer, Neal] Univ Toronto, Sch Med, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Sondheimer, Neal] Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Guan, Min-Xin] Zhejiang Univ, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ & Univ Toronto, Joint Inst Genet & Genome Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn	; Chen, Ye/D-1164-2015	Sondheimer, Neal/0000-0001-9982-5712; Chen, Ye/0000-0003-3671-2504; Guan, Min-Xin/0000-0001-5067-6736; Ge, Wanzhong/0000-0003-1334-2723	Ministry of Science and Technology of Zhejiang Province [2018C03026]; National Key Technologies RAMP;D Program from the Ministry of Science and Technology of China [2014CB541704]; National Natural Science Foundation of China [81330024, 31671305, 81470685]	Ministry of Science and Technology of Zhejiang Province; National Key Technologies RAMP;D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to patients and their family members for their participation. This work was supported by the Grant 2018C03026 from Ministry of Science and Technology of Zhejiang Province, the National Key Technologies R&D Program Grant 2014CB541704 from the Ministry of Science and Technology of China (to M.X.G.) and Grants 81330024, 31671305 and 81470685 from the National Natural Science Foundation of China (to M. X. G., Y.C., and J. Z., respectively).	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Ceriani F, 2016, P NATL ACAD SCI USA, V113, pE7194, DOI 10.1073/pnas.1616061113; Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Chong YE, 2018, P NATL ACAD SCI USA, V115, P7527, DOI 10.1073/pnas.1807109115; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kuncha SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02204-w; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; Li RH, 2005, BIOCHEM BIOPH RES CO, V328, P32, DOI 10.1016/j.bbrc.2004.12.140; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schwartzentruber J, 2014, HUM MUTAT, V35, P1285, DOI 10.1002/humu.22629; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Steiner RE, 2019, IUBMB LIFE, V71, P1150, DOI 10.1002/iub.2080; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; Sun LT, 2016, J AM CHEM SOC, V138, P12948, DOI 10.1021/jacs.6b07121; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhang QH, 2018, NUCLEIC ACIDS RES, V46, P10930, DOI 10.1093/nar/gky758; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028; Zhou XL, 2017, HUM MUTAT, V38, P1740, DOI 10.1002/humu.23335	69	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19292	19305		10.1074/jbc.RA119.010598	http://dx.doi.org/10.1074/jbc.RA119.010598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31685661	hybrid, Green Published			2022-12-28	WOS:000516527800028
J	Peng, Y; Wang, ZX; Wang, ZQ; Yu, F; Li, JW; Wong, JM				Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin			SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small ubiquitin-like modifier (SUMO); UBC9; PIAS; rDNA transcription; RNA polymerase I; upstream-binding factor (UBF); c-Myc; gene regulation; ribosome biogenesis	RIBOSOMAL-RNA GENES; POLYMERASE I TRANSCRIPTION; SUMO MODIFICATION; UBIQUITIN; NUCLEOLIN; SYSTEM; DNA	Ribosome biogenesis is critical for proliferating cells and requires the coordinated activities of three eukaryotic RNA polymerases. We recently showed that the small ubiquitin-like modifier (SUMO) system controls the global level of RNA polymerase II (Pol II)-controlled transcription in mammalian cells by regulating cyclin-dependent kinase 9 (CDK9) activity. Here, we present evidence that the SUMO system also plays a critical role in the control of Pol I transcription. Using an siRNA-based knockdown approach, we found that multiple SUMO E3 ligases of the protein inhibitor of activated STAT (PIAS) family are involved in SUMO-mediated repression of rDNA gene transcription. We demonstrate that endogenous SUMO represses rDNA transcription primarily by repressing upstream-binding factor (UBF) and proto-oncogene c-Myc (c-Myc) expression and that ectopic overexpression of SUMO-associated enzymes additionally represses rDNA transcription via c-Myc SUMOylation and its subsequent degradation. The results of our study reveal a critical role of SUMOylation in the control of rDNA transcription, uncover the underlying mechanisms involved, and indicate that the SUMO system coordinates Pol I- and Pol II-mediated transcription in mammalian cells.	[Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Fengxian Dist Cent Hosp, ECNU Joint Ctr Translat Med, Inst Biomed Sci,Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Yu, Fang] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Wong, Jiemin] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	East China Normal University; East China Normal University; State University System of Florida; University of Florida	Li, JW; Wong, JM (corresponding author), East China Normal Univ, Fengxian Dist Cent Hosp, ECNU Joint Ctr Translat Med, Inst Biomed Sci,Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Li, JW; Wong, JM (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X; Yu, Fang/0000-0001-9010-9461	Ministry of Science and Technology of China [2017YFA054201]; National Natural Science Foundation of China [31730048, 81530078, 31571325]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Cheng-Ming Chiang (University of Texas Southwestern Medical Center) for critical reading of the manuscript. We also thank members of Wong's lab for valuable discussion. This study is supported by grants from the Ministry of Science and Technology of China (2017YFA054201 to J.W.) and the National Natural Science Foundation of China (31730048, 81530078 and 31571325 to J.W.).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Chymkowitch P, 2017, P NATL ACAD SCI USA, V114, P1039, DOI 10.1073/pnas.1615093114; Chymkowitch P, 2015, BIOESSAYS, V37, P1095, DOI 10.1002/bies.201500065; Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gonzalez-Prieto R, 2015, CELL CYCLE, V14, P1859, DOI 10.1080/15384101.2015.1040965; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; Liang J, 2017, GENE DEV, V31, P802, DOI 10.1101/gad.296145.117; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rohira AD, 2013, J BIOL CHEM, V288, P19288, DOI 10.1074/jbc.M113.473744; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Shi G, 2014, J BIOL CHEM, P29700; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Sun XX, 2018, P NATL ACAD SCI USA, V115, P10983, DOI 10.1073/pnas.1802932115; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Yang Xiang-Jiao, 2013, F1000Prime Rep, V5, P45, DOI 10.12703/P5-45; Yu F, 2018, CELL RES, V28, P670, DOI 10.1038/s41422-018-0023-9; Zhang DY, 2015, J BIOL CHEM, V290, P4784, DOI 10.1074/jbc.M114.598219	43	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19155	19166		10.1074/jbc.RA119.010624	http://dx.doi.org/10.1074/jbc.RA119.010624			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694914	hybrid, Green Published			2022-12-28	WOS:000516527800017
J	Prakhar, P; Holla, S; Ghorpade, DS; Gilleron, M; Puzo, G; Udupa, V; Balaji, KN				Prakhar, Praveen; Holla, Sahana; Ghorpade, Devram Sampat; Gilleron, Martine; Puzo, Germain; Udupa, Vibha; Balaji, Kithiganahalli Narayanaswamy			Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators (vol 290, pg 26576, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Holla, Sahana/0000-0001-5186-0180; Prakhar, Praveen/0000-0001-8726-7397				Prakhar P, 2015, J BIOL CHEM, V290, P26576, DOI 10.1074/jbc.M115.662817	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19446	19446		10.1074/jbc.AAC119.011907	http://dx.doi.org/10.1074/jbc.AAC119.011907			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836673	Green Published, hybrid			2022-12-28	WOS:000516527800041
J	Zuo, XF; Kwon, SH; Janech, MG; Dang, YJ; Lauzon, SD; Fogelgren, B; Polgar, N; Lipschutz, JH				Zuo, Xiaofeng; Kwon, Sang-Ho; Janech, Michael G.; Dang, Yujing; Lauzon, Steven D.; Fogelgren, Ben; Polgar, Noemi; Lipschutz, Joshua H.			Primary cilia and the exocyst are linked to urinary extracellular vesicle production and content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicle; exocyst; GTPase; protein trafficking; exocyst complex; component 5 (EXOC5); ADP ribosylation factor 6 (ARF6); EPS8 like 2 (EPS8L2); primary cilia; ciliopathy	POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIOGENESIS; PKD1 GENE; PROTEIN; COMPLEX; MEMBRANE; ENCODES; SEC10; CDC42; INTERACTS	The recently proposed idea of "urocrine signaling" hypothesizes that small secreted extracellular vesicles (EVs) contain proteins that transmit signals to distant cells. However, the role of renal primary cilia in EV production and content is unclear. We previously showed that the exocyst, a highly conserved trafficking complex, is necessary for ciliogenesis; that it is present in human urinary EVs; that knockdown (KD) of exocyst complex component 5 (EXOC5), a central exocyst component, results in very short or absent cilia; and that human EXOC5 overexpression results in longer cilia. Here, we show that compared with control Madin-Darby canine kidney (MDCK) cells, EXOC5 overexpression increases and KD decreases EV numbers. Proteomic analyses of isolated EVs from EXOC5 control, KD, and EXOC5-overexpressing MDCK cells revealed significant alterations in protein composition. Using immunoblotting to specifically examine the expression levels of ADP ribosylation factor 6 (ARF6) and EPS8 like 2 (EPS8L2) in EVs, we found that EXOC5 KD increases ARF6 levels and decreases EPS8L2 levels, and that EXOC5 overexpression increases EPS8L2. Knockout of intraflagellar transport 88 (IFT88) confirmed that the changes in EV number/content were due to cilia loss: similar to EXOC5, the IFT88 loss resulted in very short or absent cilia, decreased EV numbers, increased EV ARF6 levels and decreased Eps8L2 levels compared with IFT88-rescued EVs. Compared with control animals, urine from proximal tubule-specific EXOC5-KO mice contained fewer EVs and had increased ARF6 levels. These results indicate that perturbations in exocyst and primary cilia affect EV number and protein content.	[Zuo, Xiaofeng; Dang, Yujing; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Kwon, Sang-Ho] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Janech, Michael G.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Lauzon, Steven D.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Fogelgren, Ben; Polgar, Noemi] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96813 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; University System of Georgia; Augusta University; College of Charleston; Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ South Carolina, Med, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.; Lipschutz, JH (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	Lipschut@musc.edu	Lauzon, Steve/ABC-3727-2020	Lauzon, Steve/0000-0002-4911-0636; Polgar, Noemi/0000-0002-8400-162X; Kwon, Sang-Ho/0000-0001-9074-4641	NCATS NIH HHS [UL1 TR001450] Funding Source: Medline; NIDDK NIH HHS [R01 DK117308, R01 DK120510, P30 DK074038] Funding Source: Medline; NIGMS NIH HHS [P20 GM103457, P30 GM131944, P20 GM113134] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK120510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113134] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baek JI, 2016, J BIOL CHEM, V291, P8632, DOI 10.1074/jbc.M115.688663; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Camici M, 2008, BIOMARK MED, V2, P613, DOI 10.2217/17520363.2.6.613; Chacon-Heszele MF, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12116; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; DeLay BD, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00143; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fogelgren B, 2014, AM J PHYSIOL-RENAL, V307, pF1334, DOI 10.1152/ajprenal.00032.2014; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Grantham JJ, 2001, CURR OPIN NEPHROL HY, V10, P533, DOI 10.1097/00041552-200107000-00008; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hogan MC, 2014, KIDNEY INT, V85, P1225, DOI 10.1038/ki.2013.422; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hurd TW, 2011, NEPHRON EXP NEPHROL, V118, pE9, DOI 10.1159/000320888; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Leon IR, 2013, MOL CELL PROTEOMICS, V12, P2992, DOI 10.1074/mcp.M112.025585; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lobo GP, 2017, J BIOL CHEM, V292, P14814, DOI 10.1074/jbc.M117.795674; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Polgar N, 2015, AM J PHYSIOL-CELL PH, V309, pC190, DOI 10.1152/ajpcell.00011.2015; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; USRDS, 2016, INC PREV PAT CHAR TR, V2; Wang J, 2014, CURR BIOL, V24, P519, DOI 10.1016/j.cub.2014.01.002; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2019, J BIOL CHEM, V294, P6710, DOI 10.1074/jbc.RA118.006527; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	65	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19099	19110		10.1074/jbc.RA119.009297	http://dx.doi.org/10.1074/jbc.RA119.009297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694916	hybrid, Green Published			2022-12-28	WOS:000516527800013
J	Huang, S; Benben, A; Green, R; Cheranda, N; Lee, G; Joseph, B; Keaveney, S; Wang, YQ				Huang, Shan; Benben, Alex; Green, Robert; Cheranda, Nina; Lee, Grace; Joseph, Benita; Keaveney, Shannon; Wang, Yuqi			Phosphorylation of the G? protein Gpa2 promotes protein kinase A signaling in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; protein phosphorylation; posttranslational modification (PTM); yeast; PKA; sporulation; protein kinase; cellular localization; glycogen synthase kinase; Gpa2; nutrient signaling	HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR GPR1; ALPHA-SUBUNIT; PHOSPHOLIPASE-C; PSEUDOHYPHAL DIFFERENTIATION; N-MYRISTOYLATION; GLOBAL ANALYSIS; CAMP PATHWAY; PHOS-TAG; ACTIVATION	Heterotrimeric G proteins are important molecular switches that facilitate transmission of a variety of signals from the outside to the inside of cells. G proteins are highly conserved, enabling study of their regulatory mechanisms in model organisms such as the budding yeast Saccharomyces cerevisiae. Gpa2 is a yeast G? protein that functions in the nutrient signaling pathway. Using Phos-tag, a highly specific phosphate binding tag for separating phosphorylated proteins, we found that Gpa2 undergoes phosphorylation and that its level of phosphorylation is markedly increased upon nitrogen starvation. We also observed that phosphorylation of Gpa2 depends on glycogen synthase kinase (GSK). Disrupting GSK activity diminishes Gpa2 phosphorylation levels in vivo, and the purified GSK isoforms Mck1 and Ygk3 are capable of phosphorylating Gpa2 in vitro. Functionally, phosphorylation enhanced plasma membrane localization of Gpa2 and promoted nitrogen starvation?induced activation of protein kinase A. Together, the findings of our study reveal a mechanism by which GSK- and nutrient-dependent phosphorylation regulates subcellular localization of Gpa2 and its ability to activate downstream signaling.	[Huang, Shan; Benben, Alex; Green, Robert; Cheranda, Nina; Lee, Grace; Joseph, Benita; Keaveney, Shannon; Wang, Yuqi] St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA.	yuqi.wang@slu.edu		Benben, Alex/0000-0003-4982-920X	NIGMS, National Institutes of Health [R15GM128047-01]; Knoedler undergraduate research funds from Saint Louis University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM128047] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Knoedler undergraduate research funds from Saint Louis University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R15GM128047-01 (to Y. W.) and Knoedler undergraduate research funds from Saint Louis University (to A. B., S. K., and B. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Donzeau M, 1999, MOL CELL BIOL, V19, P6110; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Flick JS, 1998, GENETICS, V148, P33; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Horinouchi T, 2016, METHODS MOL BIOL, V1397, P267, DOI 10.1007/978-1-4939-3353-2_18; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jin X, 2016, J BIOL CHEM, V291, P16231, DOI 10.1074/jbc.M115.713206; Kinoshita E, 2016, PROTEOMICS, V16, P1825, DOI 10.1002/pmic.201500494; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Li Y, 2013, J BIOL CHEM, V288, P11358, DOI 10.1074/jbc.M112.449751; Lo IC, 2015, DEV CELL, V33, P189, DOI 10.1016/j.devcel.2015.02.009; Lombardi MS, 2002, CRIT REV IMMUNOL, V22, P141; Lorenz MC, 2000, GENETICS, V154, P609; MITCHELL AP, 1990, MOL CELL BIOL, V10, P2104, DOI 10.1128/MCB.10.5.2104; Nazarko VY, 2008, CELL BIOL INT, V32, P502, DOI 10.1016/j.cellbi.2007.11.001; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sato M, 2013, CIRC J, V77, P2455, DOI 10.1253/circj.CJ-13-0705; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Weissgerber TL, 2017, J BIOL CHEM, V292, P20592, DOI 10.1074/jbc.RA117.000147; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; YOSHIDA M, 1990, MOL GEN GENET, V221, P176, DOI 10.1007/BF00261718; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhang P, 2015, LIFE SCI, V129, P35, DOI 10.1016/j.lfs.2015.02.029	44	3	3	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18836	18845		10.1074/jbc.RA119.009609	http://dx.doi.org/10.1074/jbc.RA119.009609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31690628	Green Published, hybrid			2022-12-28	WOS:000507618800027
J	Scott, HL; Buckner, N; Fernandez-Albert, F; Pedone, E; Postiglione, L; Shi, GY; Allen, N; Wong, LF; Magini, L; Marucci, L; O'Sullivan, GA; Cole, S; Powell, J; Maycox, P; Uney, JB				Scott, Helen L.; Buckner, Nicola; Fernandez-Albert, Francesc; Pedone, Elisa; Postiglione, Lorena; Shi, Gongyu; Allen, Nicholas; Wong, Liang-Fong; Magini, Lorenzo; Marucci, Lucia; O'Sullivan, Gregory A.; Cole, Sarah; Powell, Justin; Maycox, Peter; Uney, James B.			A dual druggable genome-wide siRNA and compound library screening approach identifies modulators of parkin recruitment to mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; parkin; ubiquitin; Parkinson disease; mitophagy; kenpaullone; genome screen; neurodegeneration; ubiquitin proteasome system (UPS)	CYCLIN-DEPENDENT KINASE-5; HIT SELECTION; UBIQUITIN; DISEASE; PINK1; PHOSPHORYLATION; ASSOCIATION; DYSFUNCTION; ACTIVATION; IMPORT	Genetic and biochemical evidence points to an association between mitochondrial dysfunction and Parkinson's disease (PD). PD-associated mutations in several genes have been identified and include those encoding PTEN-induced putative kinase 1 (PINK1) and parkin. To identify genes, pathways, and pharmacological targets that modulate the clearance of damaged or old mitochondria (mitophagy), here we developed a high-content imaging-based assay of parkin recruitment to mitochondria and screened both a druggable genome-wide siRNA library and a small neuroactive compound library. We used a multiparameter principal component analysis and an unbiased parameter-agnostic machine-learning approach to analyze the siRNA-based screening data. The hits identified in this analysis included specific genes of the ubiquitin proteasome system, and inhibition of ubiquitin-conjugating enzyme 2 N (UBE2N) with a specific antagonist, Bay 11-7082, indicated that UBE2N modulates parkin recruitment and downstream events in the mitophagy pathway. Screening of the compound library identified kenpaullone, an inhibitor of cyclin-dependent kinases and glycogen synthase kinase 3, as a modulator of parkin recruitment. Validation studies revealed that kenpaullone augments the mitochondrial network and protects against the complex I inhibitor MPP+. Finally, we used a microfluidics platform to assess the timing of parkin recruitment to depolarized mitochondria and its modulation by kenpaullone in real time and with single-cell resolution. We demonstrate that the high-content imaging-based assay presented here is suitable for both genetic and pharmacological screening approaches, and we also provide evidence that pharmacological compounds modulate PINK1-dependent parkin recruitment.	[Scott, Helen L.; Buckner, Nicola; Shi, Gongyu; Wong, Liang-Fong; Magini, Lorenzo; Uney, James B.] Univ Bristol, Bristol Med Sch, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England; [Pedone, Elisa; Postiglione, Lorena; Marucci, Lucia] Univ Bristol, Dept Engn & Math, Bristol BS8 1TD, Avon, England; [Pedone, Elisa; Postiglione, Lorena] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Fernandez-Albert, Francesc; O'Sullivan, Gregory A.; Powell, Justin] Takeda Cambridge Ltd, Cambridge Sci Pk, Cambridge CB4 0PZ, England; [Allen, Nicholas] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, Wales; [Marucci, Lucia] BrisSynBio, Bristol BS8 1QU, Avon, England; [Cole, Sarah; Maycox, Peter] Takeda Ventures Inc, 61 Aldwych, London WC2B 4A, England	University of Bristol; University of Bristol; University of Bristol; Cardiff University	Uney, JB (corresponding author), Univ Bristol, Bristol Med Sch, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	James.uney@bristol.ac.uk	Pedone, Elisa/AAP-7448-2020; Marucci, Lucia/P-1582-2016; Scott, Helen/A-6307-2009; O'Sullivan, Gregory/F-8355-2011	Pedone, Elisa/0000-0001-9467-8207; Marucci, Lucia/0000-0002-7553-6358; Fernandez-Albert, Francesc/0000-0001-5561-0701; Allen, Nicholas/0000-0003-4009-186X; Scott, Helen/0000-0003-2656-4034; O'Sullivan, Gregory/0000-0003-0428-041X; Buckner, Nikki/0000-0003-2842-9928	Takeda Cambridge Ltd.; Parkinson'sUK [K1411]; Biotechnology and Biological Sciences Research Council [BB/J016489/1, BB/R017883/1]; Medical Research Council [MR/N021444/1]; Engineering and Physical Sciences Research Council [EP/R041695/1]; BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre [BB/L01386X/1]; BBSRC [BB/J016489/1, BB/L01386X/1, BB/M017532/1, BB/R017883/1] Funding Source: UKRI; EPSRC [EP/R041695/1, EP/S01876X/1] Funding Source: UKRI; MRC [MR/N021444/1, 1813362] Funding Source: UKRI	Takeda Cambridge Ltd.; Parkinson'sUK(Parkinson's UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Takeda Cambridge Ltd., Parkinson'sUKGrant K1411 (to J. B. U.), Biotechnology and Biological Sciences Research Council Grants BB/J016489/1 and BB/R017883/1 (to J. B. U.), Medical Research Council Grant MR/N021444/1 (to L. M.), Engineering and Physical Sciences Research Council Grant EP/R041695/1 (to L. M.), and BrisSynBio, a BBSRC/EPSRC Synthetic Biology Research Centre, Grant BB/L01386X/1 (to L. M.). This work was funded in part by Takeda Cambridge Ltd. Francesc Fernandez-Albert, Gregory O'Sullivan, Sarah Cole, Justin Powell, and Peter Maycox were employees of Takeda Cambridge Ltd. at the time of the study.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; BRION JP, 1995, AM J PATHOL, V147, P1465; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Datler C, 2014, J CELL SCI, V127, P1816, DOI 10.1242/jcs.140467; Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Fracassi C, 2016, ACS SYNTH BIOL, V5, P296, DOI 10.1021/acssynbio.5b00141; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C., 2012, MCLUST VERSION 4 R N; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Golpich M, 2015, PHARMACOL RES, V97, P16, DOI 10.1016/j.phrs.2015.03.010; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Ivatt RM, 2014, P NATL ACAD SCI USA, V111, P8494, DOI 10.1073/pnas.1321207111; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kolnik M, 2012, LAB CHIP, V12, P4732, DOI 10.1039/c2lc40569e; Koyano F, 2019, EMBO REP, V20, DOI 10.15252/embr.201947728; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Langston JW, 2017, J PARKINSON DIS, V7, pS11, DOI 10.3233/JPD-179006; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Lesage Suzanne, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS66, DOI 10.1016/S1353-8020(11)70022-0; Levine AJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-4; Li DW, 2014, MOL MED REP, V9, P2043, DOI 10.3892/mmr.2014.2080; Liu YH, 2017, CELL REP, V20, P30, DOI 10.1016/j.celrep.2017.06.022; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; Mezzaroba L, 2019, NEUROTOXICOLOGY, V74, P230, DOI 10.1016/j.neuro.2019.07.007; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pedone E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12329-9; Peng J, 2016, MITOCHONDRION, V28, P49, DOI 10.1016/j.mito.2016.03.007; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Postiglione L, 2018, ACS SYNTH BIOL, V7, P2558, DOI 10.1021/acssynbio.8b00235; R Development Core Team, 2016, R LANG ENV STAT COMP; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Scott H, 2012, J BIOL CHEM, V287, P14726, DOI 10.1074/jbc.M111.326041; Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Villace P, 2017, SLAS DISCOV, V22, P67, DOI 10.1177/1087057116671498; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Yin Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00171; Yuan LM, 2017, NEUROSCI BULL, V33, P510, DOI 10.1007/s12264-017-0122-5; Yuan YS, 2013, GENE, V524, P133, DOI 10.1016/j.gene.2013.04.045; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zhang XD, 2011, OPTIMAL HIGH THROUGH; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	68	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3285	3300		10.1074/jbc.RA119.009699	http://dx.doi.org/10.1074/jbc.RA119.009699			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31911436	hybrid, Green Published			2022-12-28	WOS:000519597300032
J	Arias-Arias, JL; MacPherson, DJ; Hill, ME; Hardy, JA; Mora-Rodriguez, R				Arias-Arias, Jorge L.; MacPherson, Derek J.; Hill, Maureen E.; Hardy, Jeanne A.; Mora-Rodriguez, Rodrigo			A fluorescence-activatable reporter of flavivirus NS2B?NS3 protease activity enables live imaging of infection in single cells and viral plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; dengue virus (DENV); flavivirus; fluorescence; protease; cell-based reporter; internal cleavage; NS2B?NS3; plaque assay; Zika virus (ZIKV)	DENGUE-VIRUS; ANIMAL-MODELS; NS1	The genus Flavivirus in the family Flaviviridae comprises many medically important viruses, such as dengue virus (DENV), Zika virus (ZIKV), and yellow fever virus. The quest for therapeutic targets to combat flavivirus infections requires a better understanding of the kinetics of virus?host interactions during infections with native viral strains. However, this is precluded by limitations of current cell-based systems for monitoring flavivirus infection in living cells. In the present study, we report the construction of fluorescence-activatable sensors to detect the activities of flavivirus NS2B?NS3 serine proteases in living cells. The system consists of GFP-based reporters that become fluorescent upon cleavage by recombinant DENV-2/ZIKV proteases in vitro. A version of this sensor containing the flavivirus internal NS3 cleavage site linker reported the highest fluorescence activation in stably transduced mammalian cells upon DENV-2/ZIKV infection. Moreover, the onset of fluorescence correlated with viral protease activity. A far-red version of this flavivirus sensor had the best signal-to-noise ratio in a fluorescent Dulbecco's plaque assay, leading to the construction of a multireporter platform combining the flavivirus sensor with reporter dyes for detection of chromatin condensation and cell death, enabling studies of viral plaque formation with single-cell resolution. Finally, the application of this platform enabled the study of cell-population kinetics of infection and cell death by DENV-2, ZIKV, and yellow fever virus. We anticipate that future studies of viral infection kinetics with this reporter system will enable basic investigations of virus?host interactions and facilitate future applications in antiviral drug research to manage flavivirus infections.	[Arias-Arias, Jorge L.; Mora-Rodriguez, Rodrigo] Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica; [MacPherson, Derek J.; Hill, Maureen E.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Universidad Costa Rica; University of Massachusetts System; University of Massachusetts Amherst	Mora-Rodriguez, R (corresponding author), Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica.	rodrigo.morarodriguez@ucr.ac.cr		Hardy, Jeanne/0000-0002-3406-7997; Mora-Rodriguez, Rodrigo/0000-0001-7964-3575	Universidad de Costa Rica Project [VI-803-B9-505]; National Science Foundation [NSF CBET1511367]; International Centre for Genetic Engineering and Biotechnology Grant [CRP/CRI18-02]	Universidad de Costa Rica Project; National Science Foundation(National Science Foundation (NSF)); International Centre for Genetic Engineering and Biotechnology Grant	This work was supported by Universidad de Costa Rica Project VI-803-B9-505 (to J. L. A.-A. and R. M.-R.), National Science Foundation Grant NSF CBET1511367 (to J. A. H.), and International Centre for Genetic Engineering and Biotechnology Grant CRP/CRI18-02 (to R. M.-R). The authors declare that they have no conflicts of interest with the contents of this article.	Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817; Arias-Arias JL, 2018, AM J TROP MED HYG, V99, P1451, DOI 10.4269/ajtmh.18-0175; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99; Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Constant DA, 2018, P NATL ACAD SCI USA, V115, P10136, DOI 10.1073/pnas.1805195115; d'Herelle F., 1926, NATURE, V118, P183, DOI [10.2307/3901538, DOI 10.2307/3901538]; de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93; Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978; Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508; Hsieh MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188170; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12; Leavesley SJ, 2016, CYTOM PART A, V89A, P325, DOI 10.1002/cyto.a.22851; Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64; Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; LIPRANDI F, 1981, J GEN VIROL, V56, P363, DOI 10.1099/0022-1317-56-2-363; Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400; McFadden MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020095; Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; Nicholls SB, 2013, PROTEIN SCI, V22, P247, DOI 10.1002/pro.2188; Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648; Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514; Petrova E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010068; Reynolds ES, 2017, COMPARATIVE MED, V67, P232; Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Tamura T, 2018, J VIROL, V92, DOI 10.1128/JVI.01582-17; Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8; Wu P, 2013, BIOPHYS J, V104, P1605, DOI 10.1016/j.bpj.2013.01.058; Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013; Yakimovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138760; Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398	56	12	12	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2212	2226		10.1074/jbc.RA119.011319	http://dx.doi.org/10.1074/jbc.RA119.011319			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31919100	hybrid, Green Published			2022-12-28	WOS:000517330200006
J	Watanabe, S				Watanabe, Seiya			Characterization of L-2-keto-3-deoxyfuconate aldolases in a nonphosphorylating L-fucose metabolism pathway in anaerobic bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stereoselectivity; molecular evolution; substrate specificity; enzyme catalysis; enzyme mechanism; 2-keto-3-deoxysugar acid; aldolase; gene cluster; L-fucose metabolism; Veillonella ratti	ARCHAEON SULFOLOBUS-SOLFATARICUS; L-RHAMNOSE; ALTERNATIVE PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; L-LACTALDEHYDE; IDENTIFICATION; DEHYDROGENASE; PROMISCUITY; DEHYDRATASE	The genetic context in bacterial genomes and screening for potential substrates can help identify the biochemical functions of bacterial enzymes. The Gram-negative, strictly anaerobic bacterium Veillonella ratti possesses a gene cluster that appears to be related to L-fucose metabolism and contains a putative dihydrodipicolinate synthase/N-acetylneuraminate lyase protein (FucH). Here, screening of a library of 2-keto-3-deoxysugar acids with this protein and biochemical characterization of neighboring genes revealed that this gene cluster encodes enzymes in a previously unknown "route I" nonphosphorylating L-fucose pathway. Previous studies of other aldolases in the dihydrodipicolinate synthase/N-acetylneuraminate lyase protein superfamily used only limited numbers of compounds, and the approach reported here enabled elucidation of the substrate specificities and stereochemical selectivities of these aldolases and comparison of them with those of FucH. According to the aldol cleavage reaction, the aldolases were specific for (R)- and (S)-stereospecific groups at the C4 position of 2-keto-3-deoxysugar acid but had no structural specificity or preference of methyl groups at the C5 and C6 positions, respectively. This categorization corresponded to the (Re)- or (Si)-facial selectivity of the pyruvate enamine on the (glycer)aldehyde carbonyl in the aldol-condensation reaction. These properties are commonly determined by whether a serine or threonine residue is positioned at the equivalent position close to the active site(s), and site-directed mutagenesis markedly modified C4-OH preference and selective formation of a diastereomer. I propose that substrate specificity of 2-keto-3-deoxysugar acid aldolases was convergently acquired during evolution and report the discovery of another L-2-keto-3-deoxyfuconate aldolase involved in the same nonphosphorylating L-fucose pathway in Campylobacter jejuni.	[Watanabe, Seiya] Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan; [Watanabe, Seiya] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Watanabe, Seiya] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan	Ehime University; Ehime University; Ehime University	Watanabe, S (corresponding author), Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan.; Watanabe, S (corresponding author), Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan.; Watanabe, S (corresponding author), Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan.	irab@agr.ehime-u.ac.jp		Watanabe, Seiya/0000-0002-6530-9047				BALDOMA L, 1988, J BACTERIOL, V170, P416, DOI 10.1128/jb.170.1.416-421.1988; Bhaskar V, 2011, PROTEINS, V79, P1132, DOI 10.1002/prot.22949; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; DAHMS AS, 1974, BIOCHEM BIOPH RES CO, V60, P1433; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DAHMS AS, 1972, J BIOL CHEM, V247, P2238; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Hilditch S, 2007, J BIOL CHEM, V282, P26195, DOI 10.1074/jbc.M704401200; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lamble HJ, 2005, CHEM COMMUN, P124, DOI 10.1039/b413255f; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; MACGEE J, 1954, J BIOL CHEM, V210, P617; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; Moore S, 1940, J BIOL CHEM, V133, P293; Nunn CEM, 2010, J BIOL CHEM, V285, P33701, DOI 10.1074/jbc.M110.146332; Royer SF, 2010, J AM CHEM SOC, V132, P11753, DOI 10.1021/ja104412a; Shimada T, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx220; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; Watanabe S, 2008, J BIOL CHEM, V283, P20372, DOI 10.1074/jbc.M801065200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2019, MOL MICROBIOL, V112, P147, DOI 10.1111/mmi.14259; Watanabe S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36774-6; Watanabe S, 2009, FEBS J, V276, P1554, DOI 10.1111/j.1742-4658.2009.06885.x; Williams GJ, 2006, J AM CHEM SOC, V128, P16238, DOI 10.1021/ja065233q; Windle CL, 2014, CURR OPIN CHEM BIOL, V19, P25, DOI 10.1016/j.cbpa.2013.12.010; Wolf J, 2016, MOL MICROBIOL, V102, P882, DOI 10.1111/mmi.13498; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o	29	5	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1338	1349		10.1074/jbc.RA119.011854	http://dx.doi.org/10.1074/jbc.RA119.011854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31914410	Green Published, Bronze			2022-12-28	WOS:000513822300014
J	Pillai-Kastoori, L; Heaton, S; Shiflett, SD; Roberts, AC; Solache, A; Schutz-Geschwender, AR				Pillai-Kastoori, Lakshmi; Heaton, Sam; Shiflett, Steve D.; Roberts, Annabelle C.; Solache, Alejandra; Schutz-Geschwender, Amy R.			Antibody validation for Western blot: By the user, for the user	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; immunochemistry; antigen; western blot; protein domain; antibody validation; Immunoblot; irreproducibility crisis; Methodology; reproducibility	DETECTION CHEMISTRIES; SELECTING ANTIBODIES; PROTEIN ABUNDANCE; REPRODUCIBILITY; SPECIFICITY; TRANSPARENCY; CRISPR-CAS9; PERFORMANCE; EXPRESSION; CONFIDENCE	Well-characterized antibody reagents play a key role in the reproducibility of research findings, and inconsistent antibody performance leads to variability in Western blotting and other immunoassays. The current lack of clear, accepted standards for antibody validation and reporting of experimental details contributes to this problem. Because the performance of primary antibodies is strongly influenced by assay context, recommendations for validation and usage are unique to each type of immunoassay. Practical strategies are proposed for the validation of primary antibody specificity, selectivity, and reproducibility using Western blot analysis. The antibody should produce reproducible results within and between Western blotting experiments and the observed effect confirmed with a complementary or orthogonal method. Routine implementation of standardized antibody validation and reporting in immunoassays such as Western blotting may promote improved reproducibility across the global life sciences community.	[Pillai-Kastoori, Lakshmi; Shiflett, Steve D.; Schutz-Geschwender, Amy R.] LI COR Biosci, 4647 Super St, Lincoln, NE 68504 USA; [Heaton, Sam; Roberts, Annabelle C.; Solache, Alejandra] Abcam Plc, Discovery Dr,Cambridge Biomed Campus, Cambridge CB2 0AX, England		Pillai-Kastoori, L (corresponding author), LI COR Biosci, 4647 Super St, Lincoln, NE 68504 USA.	lakshmi.pillai@licor.com		Pillai, Lakshmi/0000-0002-8748-5658				Acharya Poulomi, 2017, F1000Res, V6, P851, DOI 10.12688/f1000research.11774.1; Ambroz K, 2011, METHODS MOL BIOL, V785, P13, DOI 10.1007/978-1-61779-286-1_2; Ambroz KLH, 2008, PROTEOMICS, V8, P2379, DOI 10.1002/pmic.200700676; Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; [Anonymous], 2017, Nature, V543, P288, DOI 10.1038/543288b; [Anonymous], 2017, NATURE, V546, P8; [Anonymous], 2016, NATURE, V533, P437, DOI 10.1038/533437a; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2013, CAS STAND LIF SCI RE; [Anonymous], [No title captured]; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Baker M, 2015, NATURE, V527, P545, DOI 10.1038/527545a; Bakkenist Christopher J, 2015, Oncoscience, V2, P542; Bandrowski AE, 2016, NEURON, V90, P434, DOI 10.1016/j.neuron.2016.04.030; Bass JJ, 2017, SCAND J MED SCI SPOR, V27, P4, DOI 10.1111/sms.12702; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bourbeillon J, 2010, NAT BIOTECHNOL, V28, P650, DOI 10.1038/nbt0710-650; Casadevall A, 2018, MBIO, V9, DOI 10.1128/mBio.00043-18; Casadevall A, 2016, MBIO, V7, DOI 10.1128/mBio.01902-16; Casadevall A, 2016, MBIO, V7, DOI 10.1128/mBio.01256-16; Chow KM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-48; Chu CS, 2017, METHODS MOL BIOL, V1550, P199, DOI 10.1007/978-1-4939-6747-6_15; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Couchman JR, 2009, J HISTOCHEM CYTOCHEM, V57, P7, DOI 10.1369/jhc.2008.952820; DENHOLLANDER N, 1989, J IMMUNOL METHODS, V122, P129, DOI 10.1016/0022-1759(89)90343-8; Edfors F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06642-y; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Freedman Leonard P, 2017, F1000Res, V6, P604, DOI 10.12688/f1000research.11334.1; Freedman LP, 2014, CANCER RES, V74, P4024, DOI 10.1158/0008-5472.CAN-14-0925; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Gilda JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135392; Gloriam DE, 2010, MOL CELL PROTEOMICS, V9, P1, DOI 10.1074/mcp.M900185-MCP200; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guilak F, 2017, J BIOMECH, V54, P1, DOI 10.1016/j.jbiomech.2017.01.044; Gupta A, 2006, MT SINAI J MED, V73, P673; Hewitt SM, 2014, J HISTOCHEM CYTOCHEM, V62, P693, DOI 10.1369/0022155414545224; HOFFMAN WL, 1989, ANAL BIOCHEM, V181, P318, DOI 10.1016/0003-2697(89)90250-9; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ivell R, 2014, ENDOCRINOLOGY, V155, P676, DOI 10.1210/en.2013-1971; Janes KA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005966; Jin S, 2016, ANAL CHEM, V88, P6703, DOI 10.1021/acs.analchem.6b00705; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jo YI, 2015, BBA-REV CANCER, V1856, P234, DOI 10.1016/j.bbcan.2015.09.003; Kiermer V, 2008, NAT METHODS, V5, P860, DOI 10.1038/nmeth1008-860; Kimple Michelle E, 2013, Curr Protoc Protein Sci, V73, DOI 10.1002/0471140864.ps0909s73; Koller A, 2005, ELECTROPHORESIS, V26, P2470, DOI 10.1002/elps.200500024; Kothari V, 2015, METHODS MOL BIOL, V1314, P27, DOI 10.1007/978-1-4939-2718-0_4; Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Lund-Johansen F, 2017, NAT METHODS, V14, P215, DOI 10.1038/nmeth.4192; Mackrill John J, 2004, Methods Mol Biol, V259, P47; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; McDonough AA, 2015, AM J PHYSIOL-CELL PH, V308, pC426, DOI 10.1152/ajpcell.00400.2014; Murano G, 1997, DEV BIOLOGICALS, V91, P3; Naegle K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1125; Nguyen, 2011, NAT METHODS, V8, pv, DOI [10.1038/nmeth.f.353, DOI 10.1038/NMETH.F.353]; Olds Will, 2016, F1000Res, V5, P308, DOI 10.12688/f1000research.8159.1; Pan WY, 2010, ANAL CHEM, V82, P3974, DOI 10.1021/ac1000493; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Plant AL, 2014, NAT METHODS, V11, P895, DOI 10.1038/nmeth.3076; Sanders BJ, 2016, ANAL METHODS-UK, V8, P7002, DOI [10.1039/c6ay01947a, 10.1039/C6AY01947A]; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sikorski K, 2018, NAT METHODS, V15, P909, DOI 10.1038/s41592-018-0179-8; Smale Stephen T, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5421; Smith KA, 2004, J CLIN PATHOL, V57, P912, DOI 10.1136/jcp.2003.014407; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Snapp Erik, 2005, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2104s27; Stirling A, 2002, PUBLIC HEALTH REP, V117, P521; Thirstrup K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10501-z; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6; Uhlen M, 2017, NAT METHODS, V14, P215, DOI 10.1038/nmeth.4194; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Verhoef LGGC, 2016, BBA-MOL CELL RES, V1863, P284, DOI 10.1016/j.bbamcr.2015.11.031; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weller MG, 2018, ANAL CHEM INSIGHTS, V13, DOI 10.1177/1177390118757462; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1233, DOI 10.1177/002215549904701002; Zhu ZF, 2012, ANAL CHIM ACTA, V709, P21, DOI 10.1016/j.aca.2011.10.022	88	23	23	8	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					926	939		10.1074/jbc.RA119.010472	http://dx.doi.org/10.1074/jbc.RA119.010472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31819006	Green Published, hybrid			2022-12-28	WOS:000509949300004
J	Sinitski, D; Gruner, K; Brandhofer, M; Kontos, C; Winkler, P; Reinstadler, A; Bourilhon, P; Xiao, ZP; Cool, R; Kapurniotu, A; Dekker, FJ; Panstruga, R; Bernhagen, J				Sinitski, Dzmitry; Gruner, Katrin; Brandhofer, Markus; Kontos, Christos; Winkler, Pascal; Reinstaedler, Anja; Bourilhon, Priscila; Xiao, Zhangping; Cool, Robbert; Kapurniotu, Aphrodite; Dekker, Frank J.; Panstruga, Ralph; Bernhagen, Juergen			Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CXC chemokine receptor type 4 (CXCR-4); chemokine; cellular immune response; migration; structure?function; inflammation; innate immunity; cytokine; protein conformation; plant defense; CD74; MIF	MIGRATION INHIBITORY FACTOR; PROTEIN SECONDARY STRUCTURE; D-DOPACHROME TAUTOMERASE; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; CHEMOKINE RECEPTORS; STRUCTURAL DETERMINANTS; INTERNATIONAL UNION; FACTOR MIF; D-DT	Human macrophage migration-inhibitory factor (MIF) is an evolutionarily-conserved protein that has both extracellular immune-modulating and intracellular cell-regulatory functions. MIF plays a role in various diseases, including inflammatory diseases, atherosclerosis, autoimmunity, and cancer. It serves as an inflammatory cytokine and chemokine, but also exhibits enzymatic activity. Secreted MIF binds to cell-surface immune receptors such as CD74 and CXCR4. Plants possess MIF orthologs but lack the associated receptors, suggesting functional diversification across kingdoms. Here, we characterized three MIF orthologs (termed MIF/d-dopachrome tautomerase?like proteins or MDLs) of the model plant Arabidopsis thaliana. Recombinant Arabidopsis MDLs (AtMDLs) share similar secondary structure characteristics with human MIF, yet only have minimal residual tautomerase activity using either p-hydroxyphenylpyruvate or dopachrome methyl ester as substrate. Site-specific mutagenesis suggests that this is due to a distinct amino acid difference at the catalytic cavity-defining residue Asn-98. Surprisingly, AtMDLs bind to the human MIF receptors CD74 and CXCR4. Moreover, they activate CXCR4-dependent signaling in a receptor-specific yeast reporter system and in CXCR4-expressing human HEK293 transfectants. Notably, plant MDLs exert dose-dependent chemotactic activity toward human monocytes and T cells. A small molecule MIF inhibitor and an allosteric CXCR4 inhibitor counteract this function, revealing its specificity. Our results indicate cross-kingdom conservation of the receptor signaling and leukocyte recruitment capacities of human MIF by its plant orthologs. This may point toward a previously unrecognized interplay between plant proteins and the human innate immune system.	[Sinitski, Dzmitry; Brandhofer, Markus; Bourilhon, Priscila; Bernhagen, Juergen] LMU, KUM, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Feodor Lynen Str 17, D-81377 Munich, Germany; [Gruner, Katrin; Winkler, Pascal; Reinstaedler, Anja; Panstruga, Ralph] Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Worringerweg 1, D-52056 Aachen, Germany; [Kontos, Christos; Kapurniotu, Aphrodite] TUM, Div Peptide Biochem, D-85354 Freising Weihenstephan, Germany; [Xiao, Zhangping; Cool, Robbert; Dekker, Frank J.] Univ Groningen, Div Chem & Pharmaceut Biol, NL-9713 AV Groningen, Netherlands; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany	University of Munich; RWTH Aachen University; Technical University of Munich; University of Groningen; University of Munich	Bernhagen, J (corresponding author), LMU, KUM, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Feodor Lynen Str 17, D-81377 Munich, Germany.; Panstruga, R (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Worringerweg 1, D-52056 Aachen, Germany.	panstruga@bio1.rwth-aachen.de; juergen.bernhagen@med.uni-muenchen.de	Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957; Xiao, Zhangping/0000-0003-0557-9843; Bourilhon, Priscila/0000-0002-0693-4467; Brandhofer, Markus/0000-0002-1629-8353; Cool, Robbert/0000-0002-9845-2202	Deutsche Forschungsgemeinschaft (DFG)Agence Nationale Recherche (ANR) [BE1977/10-1, PA861/15-1]; DFG [EXC 1010, SFB1123/A03]	Deutsche Forschungsgemeinschaft (DFG)Agence Nationale Recherche (ANR); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG)Agence Nationale Recherche (ANR) co-funded project "X-KINGDOM-MIFcross-kingdom analysis of macrophage migration inhibitory factor (MIF) functions," DFG Grants BE1977/10-1 (to J. B.) and PA861/15-1 (to R. P.), and DFG Grant within the framework of Munich Cluster for Systems Neurology EXC 1010 SyNergy, and in part by DFG Grant SFB1123/A03 (to A. K. and J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Alampour-Rajabi S, 2015, FASEB J, V29, P4497, DOI 10.1096/fj.15-273904; Assis DN, 2014, HEPATOLOGY, V59, P580, DOI 10.1002/hep.26664; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bloom J, 2016, EXPERT OPIN THER TAR, V20, P1463, DOI 10.1080/14728222.2016.1251582; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Burger JA, 2009, EXPERT OPIN INV DRUG, V18, P481, DOI [10.1517/13543780902804249 , 10.1517/13543780902804249]; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Clercq E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00276; de Souza HS, 2015, MUCOSAL IMMUNOL, V8, P1154, DOI 10.1038/mi.2015.6; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Feng ZM, 2013, FEBS J, V280, P3365, DOI 10.1111/febs.12328; Garcia AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05041-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kapurniotu A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00003; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kessans MR, 2010, PHARMACOTHERAPY, V30, P485, DOI 10.1592/phco.30.5.485; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koenen RR, 2011, EMBO MOL MED, V3, P713, DOI 10.1002/emmm.201100183; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Kok T, 2018, PROTEIN EXPRES PURIF, V148, P46, DOI 10.1016/j.pep.2018.03.008; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Lacy M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23554-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Michelet C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100740; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P601; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Naessens E, 2015, CURR BIOL, V25, P1898, DOI 10.1016/j.cub.2015.05.047; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Pantouris G, 2014, J MED CHEM, V57, P8652, DOI 10.1021/jm501168q; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Sachpatzidis A, 2003, J BIOL CHEM, V278, P896, DOI 10.1074/jbc.M204667200; Saini V, 2011, J BIOL CHEM, V286, P44145, DOI 10.1074/jbc.M111.298505; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Schmitz C, 2018, FASEB J, V32, P4428, DOI 10.1096/fj.201800058R; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Soares AR, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28275; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Sommerville C, 2013, J BIOL CHEM, V288, P12733, DOI 10.1074/jbc.M112.419911; Soppert J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009384; Sparkes A, 2017, IMMUNOBIOLOGY, V222, P473, DOI 10.1016/j.imbio.2016.10.006; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Sterkel AK, 2016, CELL HOST MICROBE, V19, P361, DOI 10.1016/j.chom.2016.02.001; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Szpakowska M, 2016, J LEUKOCYTE BIOL, V99, P893, DOI 10.1189/jlb.2MR0815-383R; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Troshin PV, 2011, BIOINFORMATICS, V27, P2001, DOI 10.1093/bioinformatics/btr304; Twu O, 2014, P NATL ACAD SCI USA, V111, P8179, DOI 10.1073/pnas.1321884111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	91	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					850	867		10.1074/jbc.RA119.009716	http://dx.doi.org/10.1074/jbc.RA119.009716			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31811089	Green Published, Bronze			2022-12-28	WOS:000508382900015
J	Singh, S; Ng, J; Nayak, D; Sivaraman, J				Singh, Sunil; Ng, Joel; Nayak, Digant; Sivaraman, J.			Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; E3 ubiquitin ligase; ubiquitylation (ubiquitination); crystal structure; structure-function; structural biology; protein degradation; post-translational modification (PTM); cancer; apoptosis-resistant E3 ligase 1 (AREL1); autopolyubiquitination; HECT domain; second mitochondria-derived activator of caspase (SMAC)	DOMAIN; ACTIVATION; REVEALS; APOPTOSIS; PROTEINS; AUTOUBIQUITINATION; POLYUBIQUITIN; OPTIMIZATION; RECOGNITION; ANTAGONISTS	The HECT E3 ligase family comprises three subfamilies: NEDD4 E3 ubiquitin protein ligase (NEDD4), HECT and RLD domain?containing E3 ubiquitin protein ligase (HERC), and ?other.? Most previous studies have focused on the NEDD4 subfamily. Apoptosis-resistant E3 ligase 1 (AREL1) belongs to ?other? subfamily HECT that inhibits apoptosis by ubiquitinating and degrading proapoptotic proteins. Here, we report the crystal structure of the extended HECT domain of AREL1 (amino acids (aa) 436?823) at 2.4 ? resolution and its ubiquitination of the proapoptotic protein second mitochondria-derived activator of caspase (SMAC). We found that the extended HECT domain adopts an inverted, T-shaped, bilobed conformation and harbors an additional loop (aa 567?573) absent in all other HECT members. We also show that the N-terminal extended region (aa 436?482) preceding the HECT domain is indispensable for its stability and activity and that without this region, the HECT domain becomes inactive. AREL1 ubiquitinated SMAC, primarily on Lys(62) and Lys(191). We solved the crystal structure of the tetrameric form of SMAC to 2.8 ? resolution, revealing the Lys(62) and Lys(191) locations. The AREL1 HECT domain assembled Lys(33)-, Lys(48)-, and Lys(63)-linked polyubiquitin chains. Moreover, E701A substitution in the AREL1 HECT domain substantially increased its autopolyubiquitination and SMAC ubiquitination activity, whereas deletion of the last three amino acids at the C terminus completely abrogated AREL1 autoubiquitination and reduced SMAC ubiquitination. Finally, an AREL1-specific ubiquitin variant inhibited SMAC ubiquitination in vitro. Our findings may assist in the development of AREL1 inhibitors that block its anti-apoptotic activity in cancer.	[Singh, Sunil; Ng, Joel; Nayak, Digant; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsjayar@nus.edu.sg	Nayak, Digant/AAJ-1823-2020; Singh, Sunil/AAC-6669-2022	Nayak, Digant/0000-0003-3680-0846; Singh, Sunil/0000-0002-2863-5492; Ng, Joel/0000-0003-1797-3071; J, Sivaraman/0000-0001-9781-5326	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI Grant [S10 RR029205]; United States Department of Energy User Facility [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI Grant; United States Department of Energy User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the beamline MX2 Australian Synchrotron, part of ANSTO, and NECAT beamline 24-ID-E at the Advanced Photon Source, Argonne National Laboratory. NECAT beamlines are funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-E beamline is funded by NIH-ORIP HEI Grant S10 RR029205. The Advanced Photon Source is a United States Department of Energy User Facility operated by Argonne National Laboratory under Contract DE-AC02-06CH11357. We acknowledge the Protein and Proteomics center (NUS) for MS proteomics data acquisition and deposition.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Courivaud T, 2015, J BIOL CHEM, V290, P21007, DOI 10.1074/jbc.M115.642314; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Goka ET, 2015, ONCOGENE, V34, P5395, DOI 10.1038/onc.2014.468; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim JB, 2013, J BIOL CHEM, V288, P12014, DOI 10.1074/jbc.M112.436113; Kozak S, 2016, J BIOMOL NMR, V64, P281, DOI 10.1007/s10858-016-0027-z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mannhold R, 2010, DRUG DISCOV TODAY, V15, P210, DOI 10.1016/j.drudis.2010.01.003; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mastrangelo E, 2015, BIOPHYS J, V108, P714, DOI 10.1016/j.bpj.2014.11.3471; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Mukherjee M, 2014, J BIOL CHEM, V289, P25611, DOI 10.1074/jbc.M114.592840; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nayak D, 2018, J MOL BIOL, V430, P1173, DOI 10.1016/j.jmb.2018.02.016; Nayak D, 2015, ONCOTARGET, V6, P34342, DOI 10.18632/oncotarget.5326; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prinz F, 2016, J BIOL CHEM, V291, P11252, DOI 10.1074/jbc.M115.702142; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shaw N., 2007, PROTOC EXCHANGE, DOI [10.1038/nprot.2007.287, DOI 10.1038/NPROT.2007.287]; Sluimer J, 2018, CELL MOL LIFE SCI, V75, P3121, DOI 10.1007/s00018-018-2848-2; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Su V, 2012, ARCH BIOCHEM BIOPHYS, V524, P16, DOI 10.1016/j.abb.2011.12.027; Tan KM, 2014, METHODS MOL BIOL, V1140, P189, DOI 10.1007/978-1-4939-0354-2_15; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Yan S, 2014, ONCOGENE, V33, P5424, DOI 10.1038/onc.2013.494; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005	53	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19934	19949		10.1074/jbc.RA119.010327	http://dx.doi.org/10.1074/jbc.RA119.010327			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732561	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000505005800010
J	Xu, YQ; Du, XM; Turner, N; Brown, AJ; Yang, HY				Xu, Yanqing; Du, Ximing; Turner, Nigel; Brown, Andrew J.; Yang, Hongyuan			Enhanced acyl-CoA: cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ACAT1; ACAT2; SOAT1; SOAT2; cholesterol; esterification; adipocytes; lipid droplets; adipogenesis; lipolysis; caveolin 1	INSIG-DEPENDENT UBIQUITINATION; BINDING PROTEIN; ADIPOSE-TISSUE; ACAT2; DEGRADATION; STEROL; EXPRESSION; COENZYME; ACCUMULATION; RECEPTOR	Cholesterol plays essential structural and signaling roles in mammalian cells, but too much cholesterol can cause cytotoxicity. Acyl-CoA: cholesterol acyltransferases 1 and 2 (ACAT1/2) convert cholesterol into its storage form, cholesteryl esters, regulating a key step in cellular cholesterol homeostasis. Adipose tissue can store > 50% of whole-body cholesterol. Interestingly, however, almost no ACAT activity is present in adipose tissue and most adipose cholesterol is stored in its free form. We therefore hypothesized that increased cholesterol esterification may have detrimental effects on adipose tissue function. Here, using several approaches, including protein overexpression, quantitative RT-PCR, immunofluorescence, and various biochemical assays, we found that ACAT1 expression is significantly increased in the adipose tissue of the ob/ob mice. We further demonstrated that ACAT1/2 overexpression partially inhibited the differentiation of 3T3-L1 preadipocytes. In mature adipocytes, increased ACAT activity reduced the size of lipid droplets (LDs) and inhibited lipolysis and insulin signaling. Paradoxically, the amount of free cholesterol increased on the surface of LDs in ACAT1/2 overexpressing adipocytes, accompanied by increased LD localization of caveolin-1. Moreover, cholesterol depletion in adipocytes by treating the cells with cholesterol-deficient media or beta-cyclodextrins induced changes in cholesterol distribution that were similar to those caused by ACAT1/2 overexpression. Our results suggest that ACAT1/2 overexpression increases the level of free cholesterol on the LD surface, thereby impeding adipocyte function. These findings provide detailed insights into the role of free cholesterol in LD and adipocyte function and suggest that ACAT inhibitors have potential utility for managing disorders associated with extreme obesity.	[Xu, Yanqing; Du, Ximing; Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Turner, Nigel] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brown, AJ; Yang, HY (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au; h.rob.yang@unsw.edu.au	Yang, Hongyuan/AAR-1326-2020; Turner, Nigel/H-7176-2013	Yang, Hongyuan/0000-0002-8482-6031; Turner, Nigel/0000-0002-0119-9328	National Health and Medical Research Council (NHMRC) of Australia [1141939, 1144726]; NHMRC Senior Research Fellowship [1058237]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank the Biomedical Imaging Facility at the UNSW Mark Wainwright Analytical Centre, Australia. This work is supported by project grants from the National Health and Medical Research Council (NHMRC) of Australia (1141939, and 1144726). H.Y. is supported by an NHMRC Senior Research Fellowship (1058237).	Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Farese RV, 1998, CURR OPIN LIPIDOL, V9, P119, DOI 10.1097/00041433-199804000-00007; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; Gao MM, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100989; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo DQ, 2016, ACTA BIOCH BIOPH SIN, V48, P990, DOI 10.1093/abbs/gmw095; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Koivuniemi A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002299; KRAUSE BR, 1984, J LIPID RES, V25, P97; Krishna A, 2019, BIOPHYS J, V116, P69, DOI 10.1016/j.bpj.2018.11.3127; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lam YY, 2011, OBES RES CLIN PRACT, V5, pE43, DOI 10.1016/j.orcp.2010.12.002; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103; Lee RG, 2000, J LIPID RES, V41, P1991; LITTLE MTE, 1992, AM J PHYSIOL, V262, pG599, DOI 10.1152/ajpgi.1992.262.4.G599; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mesmin B, 2016, BBA-MOL CELL BIOL L, V1861, P940, DOI 10.1016/j.bbalip.2016.02.024; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Prattes S, 2000, J CELL SCI, V113, P2977; Qin L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030429; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wang MY, 2016, BBA-MOL CELL BIOL L, V1861, P410, DOI 10.1016/j.bbalip.2016.02.018; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356; Zhu YY, 2018, J LIPID RES, V59, P820, DOI 10.1194/jlr.M081745	61	24	25	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19306	19321		10.1074/jbc.RA119.011160	http://dx.doi.org/10.1074/jbc.RA119.011160			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31727739	hybrid, Green Published			2022-12-28	WOS:000516527800029
J	Okamoto, K; Seimiya, H				Okamoto, Keiji; Seimiya, Hiroyuki			From the wings to the center stage of chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Telomere-binding protein TRF2 protects the linear chromosome ends, telomeres, from being recognized as damaged DNA. TRF2 also regulates gene expression outside telomeres, but the detailed mechanism has not been fully understood. Mukherjee and colleagues have employed ChIP-Seq and biochemical analyses to identify G-quadruplexes at gene promoters across the genome as nontelomeric TRF2-binding sites. TRF2 occupancy on such target sites leads to epigenetic gene repression, implicating TRF2?G-quadruplex interaction as a sophisticated regulator of gene expression.	[Okamoto, Keiji; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research	Seimiya, H (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 1358550, Japan.	hseimiya@jfcr.or.jp		Seimiya, Hiroyuki/0000-0003-3314-9736	Japan Society for the Promotion of Science KAKENHI [JP18K07252, JP18K19487, JP18H04633]; Japan Agency for Medical Research and Development (AMED); Nippon Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Nippon Foundation(Nippon Foundation)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP18K07252, JP18K19487, and JP18H04633; the Japan Agency for Medical Research and Development (AMED); and the Nippon Foundation. H. S. is a scientific advisor for MiRTeL Co. Ltd.	El Mai M, 2014, CELL REP, V9, P1047, DOI 10.1016/j.celrep.2014.09.038; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Hirashima K, 2013, MOL CELL BIOL, V33, P2988, DOI 10.1128/MCB.00136-13; Mukherjee AK, 2019, J BIOL CHEM, V294, P17709, DOI 10.1074/jbc.RA119.008687; Mukherjee AK, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007782; Nakamura T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03785-8; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Simonet T, 2011, CELL RES, V21, P1028, DOI 10.1038/cr.2011.40; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17723	17724		10.1074/jbc.H119.011587	http://dx.doi.org/10.1074/jbc.H119.011587			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31757801	Green Published, hybrid			2022-12-28	WOS:000504206800002
J	Bashiri, G; Nigon, LV; Jirgis, ENM; Ho, NAT; Stanborough, T; Dawes, SS; Baker, EN; Bulloch, EMM; Johnston, JM				Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.; Johnston, Jodie M.			Allosteric regulation of menaquinone (vitamin K-2) biosynthesis in the human pathogen Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; allosteric regulation; cooperativity; structural biology; vitamin K; feedback inhibition; 1; 4-dihydroxy-2-naphthoic acid (DHNA); menaquinone (vitamin K-2) biosynthesis; drug target; pyruvate oxidase (POX) enzymes; SEPHCHC synthase (MenD); thiamine diphosphate (ThDP)-dependent enzymes; allostery	ESCHERICHIA-COLI; MEND; DECARBOXYLASE; INHIBITORS; DISCOVERY; SYSTEM; 1,4-DIHYDROXY-2-NAPHTHOATE; IDENTIFICATION; THIOESTERASE; UBIQUINONE	Menaquinone (vitamin K-2) plays a vital role in energy generation and environmental adaptation in many bacteria, including the human pathogen Mycobacterium tuberculosis (Mtb). Although menaquinone levels are known to be tightly linked to the cellular redox/energy status of the cell, the regulatory mechanisms underpinning this phenomenon are unclear. The first committed step in menaquinone biosynthesis is catalyzed by MenD, a thiamine diphosphate?dependent enzyme comprising three domains. Domains I and III form the MenD active site, but no function has yet been ascribed to domain II. Here, we show that the last cytosolic metabolite in the menaquinone biosynthesis pathway, 1,4-dihydroxy-2-naphthoic acid (DHNA), binds to domain II of Mtb-MenD and inhibits its activity. Using X-ray crystallography of four apo- and cofactor-bound Mtb-MenD structures, along with several spectroscopy assays, we identified three arginine residues (Arg-97, Arg-277, and Arg-303) that are important for both enzyme activity and the feedback inhibition by DHNA. Among these residues, Arg-277 appeared to be particularly important for signal propagation from the allosteric site to the active site. This is the first evidence of feedback regulation of the menaquinone biosynthesis pathway in bacteria, identifying a protein-level regulatory mechanism that controls menaquinone levels within the cell and may therefore represent a good target for disrupting menaquinone biosynthesis in M. tuberculosis.	[Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.] Univ Auckland, Struct Biol Lab, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand; [Bashiri, Ghader; Nigon, Laura V.; Jirgis, Ehab N. M.; Dawes, Stephanie S.; Baker, Edward N.; Bulloch, Esther M. M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1010, New Zealand; [Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Johnston, Jodie M.] Univ Canterbury, Sch Phys & Chem Sci, BIC, Christchurch 8041, New Zealand; [Ho, Ngoc Anh Thu; Stanborough, Tamsyn; Johnston, Jodie M.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Christchurch 8041, New Zealand	University of Auckland; University of Auckland; University of Canterbury; University of Canterbury	Johnston, JM (corresponding author), Univ Canterbury, Sch Phys & Chem Sci, BIC, Christchurch 8041, New Zealand.; Johnston, JM (corresponding author), Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Christchurch 8041, New Zealand.	jodie.johnston@canterbury.ac.nz	; Bashiri, Ghader/R-4957-2017	Nigon, Laura/0000-0003-0577-2918; Bashiri, Ghader/0000-0002-5092-3749; Baker, Edward/0000-0003-2456-7661; Stanborough, Tamsyn/0000-0001-5945-2536; Ho, Thu/0000-0001-9291-8860; Bulloch, Esther/0000-0002-4262-1791	Marsden Fund grant from the Royal Society Te Aparangi [M1208]; Auckland Medical Research Foundation; Canterbury Medical Research Foundation; Biomolecular Interaction Centre	Marsden Fund grant from the Royal Society Te Aparangi; Auckland Medical Research Foundation; Canterbury Medical Research Foundation; Biomolecular Interaction Centre	This work was primarily supported by a Marsden Fund grant from the Royal Society Te Aparangi (M1208, to J. M. J., G. B., and E. M. M. B.), with additional funding support from the Auckland Medical Research Foundation (to L. V. N. and J. M. J.), the Canterbury Medical Research Foundation (to T. S. and J. M. J.), and the Biomolecular Interaction Centre (to J. M. J. and N. A. T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Magid Ahmed F, 2015, ACS Med Chem Lett, V6, P104, DOI 10.1021/ml5005365; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Balakrishnan A, 2013, J BIOL CHEM, V288, P21688, DOI 10.1074/jbc.M113.465419; Barak Z, 2012, ARCH BIOCHEM BIOPHYS, V519, P167, DOI 10.1016/j.abb.2011.11.025; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Chen GY, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12762; Chen GY, 2017, MBIO, V8, DOI 10.1128/mBio.00119-17; Chen MJ, 2013, J BACTERIOL, V195, P2768, DOI 10.1128/JB.00141-13; Dawson A, 2010, J MOL BIOL, V401, P253, DOI 10.1016/j.jmb.2010.06.025; Dawson A, 2008, J MOL BIOL, V384, P1353, DOI 10.1016/j.jmb.2008.10.048; Debnath J, 2012, J MED CHEM, V55, P3739, DOI 10.1021/jm201608g; Dhiman RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214958; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jirgis ENM, 2016, STRUCTURE, V24, P1167, DOI 10.1016/j.str.2016.04.018; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Koehn JT, 2018, ACS OMEGA, V3, P14889, DOI 10.1021/acsomega.8b02620; Konig S, 2009, J MOL CATAL B-ENZYM, V61, P100, DOI 10.1016/j.molcatb.2009.02.010; KONIG S, 1993, EUR BIOPHYS J BIOPHY, V22, P185; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Kurosu M, 2009, MED CHEM, V5, P197, DOI 10.2174/157340609787582882; Kutter S, 2009, J BIOL CHEM, V284, P12136, DOI 10.1074/jbc.M806228200; LINDQVIST Y, 1993, CURR OPIN STRUC BIOL, V3, P896, DOI 10.1016/0959-440X(93)90153-C; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mishra A, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708038; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Amit P, 2009, BIOCHEM BIOPH RES CO, V380, P797, DOI 10.1016/j.bbrc.2009.01.168; Puffal J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03145; Qin MM, 2018, BIOCHEM J, V475, P3651, DOI 10.1042/BCJ20180548; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rozewicki J, 2019, NUCLEIC ACIDS RES, V47, pW5, DOI 10.1093/nar/gkz342; Sogi KM, 2016, ACS INFECT DIS, V2, P800, DOI 10.1021/acsinfecdis.6b00106; Sukheja P, 2017, MBIO, V8, DOI 10.1128/mBio.02022-16; Upadhyay A, 2015, ACS CENTRAL SCI, V1, P292, DOI 10.1021/acscentsci.5b00212; van Beilen JWA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01339; Versees W, 2007, J BIOL CHEM, V282, P35269, DOI 10.1074/jbc.M706048200; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Vogel C, 2014, PROTEINS, V82, P2523, DOI 10.1002/prot.24615; Vogel C, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-24; Wagner T, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav9504; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; Ward MJ, 2004, APPL MICROBIOL BIOT, V63, P571, DOI 10.1007/s00253-003-1407-3; Wellington S, 2017, NAT CHEM BIOL, V13, P943, DOI [10.1038/NCHEMBIO.2420, 10.1038/nchembio.2420]; Werther T, 2010, FEBS J, V277, P2628, DOI [10.1111/j.1742-4658.2010.07673.x, 10.1111/j.1742-464X.2010.07673.x]; Widhalm JR, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.46; Widhalm JR, 2009, P NATL ACAD SCI USA, V106, P5599, DOI 10.1073/pnas.0900738106; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3759	3770		10.1074/jbc.RA119.012158	http://dx.doi.org/10.1074/jbc.RA119.012158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029475	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000527704400003
J	Stribny, J; Thines, L; Deschamps, A; Goffin, P; Morsomme, P				Stribny, Jiri; Thines, Louise; Deschamps, Antoine; Goffin, Philippe; Morsomme, Pierre			The human Golgi protein TMEM165 transports calcium and manganese in yeast and bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; calcium transport; manganese; Golgi; glycosylation; yeast; CDG; TMEM165	LACTOCOCCUS-LACTIS; DEFICIENCY; TRANSFORMATION; GLYCOSYLATION; MUTATIONS; MEMBRANE; DISORDER	Cases of congenital disorders of glycosylation (CDG) have been associated with specific mutations within the gene encoding the human Golgi TMEM165 (transmembrane protein 165), belonging to UPF0016 (uncharacterized protein family 0016), a family of secondary ion transporters. To date, members of this family have been reported to be involved in calcium, manganese, and pH homeostases. Although it has been suggested that TMEM165 has cation transport activity, direct evidence for its Ca2+- and Mn2+-transporting activities is still lacking. Here, we functionally characterized human TMEM165 by heterologously expressing it in budding yeast (Saccharomyces cerevisiae) and in the bacterium Lactococcus lactis. Protein production in these two microbial hosts was enhanced by codon optimization and truncation of the putatively autoregulatory N terminus of TMEM165. We show that TMEM165 expression in a yeast strain devoid of Golgi Ca2+ and Mn2+ transporters abrogates Ca2+- and Mn2+-induced growth defects, excessive Mn2+ accumulation in the cell, and glycosylation defects. Using bacterial cells loaded with the fluorescent Fura-2 probe, we further obtained direct biochemical evidence that TMEM165 mediates Ca2+ and Mn2+ influxes. We also used the yeast and bacterial systems to evaluate the impact of four disease-causing missense mutations identified in individuals with TMEM165-associated CDG. We found that a mutation leading to a E108G substitution within the conserved UPF0016 family motif significantly reduces TMEM165 activity. These results indicate that TMEM165 can transport Ca2+ and Mn2+, which are both required for proper protein glycosylation in cells. Our work also provides tools to better understand the pathogenicity of CDG-associated TMEM165 mutations.	[Stribny, Jiri; Thines, Louise; Deschamps, Antoine; Morsomme, Pierre] Catholic Univ Louvain, Louvain Inst Biomol Sci & Technol, B-1348 Louvain La Neuve, Belgium; [Goffin, Philippe] Univ Libre Bruxelles, Cellular & Mol Microbiol Lab, B-6041 Gosselies, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles	Morsomme, P (corresponding author), Catholic Univ Louvain, Louvain Inst Biomol Sci & Technol, B-1348 Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be		Stribny, Jiri/0000-0002-2449-3167; Morsomme, Pierre/0000-0001-7780-7230	Fonds National de la Recherche Scientifique [PDR-T.0206.16]	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	The work was supported by Fonds National de la Recherche Scientifique Grant PDR-T.0206.16. The authors declare that they have no conflicts of interest with the contents of this article.	Althoff SS, 2016, JIMD REP, V26, P21, DOI 10.1007/8904_2015_455; Colinet AS, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12729; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Demaegd D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100851; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dulary E, 2018, BBA-GEN SUBJECTS, V1862, P394, DOI 10.1016/j.bbagen.2017.11.006; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Frank J, 2019, NEW PHYTOL, V221, P866, DOI 10.1111/nph.15407; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Lebredonchel E, 2019, BIOCHIMIE, V165, P123, DOI 10.1016/j.biochi.2019.07.016; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2017, BIOCHEM J, V474, P1481, DOI 10.1042/BCJ20160910; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thines L, 2018, J BIOL CHEM, V293, P8048, DOI 10.1074/jbc.RA118.002324	22	17	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3865	3874		10.1074/jbc.RA119.012249	http://dx.doi.org/10.1074/jbc.RA119.012249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047108	Green Published, hybrid			2022-12-28	WOS:000527704400012
J	Doruk, YU; Yarparvar, D; Akyel, YK; Gul, S; Taskin, AC; Yilmaz, F; Baris, I; Ozturk, N; Turkay, M; Ozturk, N; Okyar, A; Kavakli, IH				Doruk, Yagmur Umay; Yarparvar, Darya; Akyel, Yasemin Kubra; Gul, Seref; Taskin, Ali Cihan; Yilmaz, Fatma; Baris, Ibrahim; Ozturk, Nuri; Turkay, Metin; Ozturk, Narin; Okyar, Alper; Kavakli, Ibrahim Halil			A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug design; circadian clock; gene expression; protein expression; drug development; transcription; transcription coregulator; brain and muscle Arnt-like protein-1 (BMAL1); circadian locomotor output cycles kaput (CLOCK); circadian regulation; circadian rhythm amplitude; gene regulation	DRUG; PROTEINS; INHIBITORS; ACTIVATORS; PACEMAKER; MICE	Proper function of many physiological processes requires a robust circadian clock. Disruptions of the circadian clock can result in metabolic diseases, mood disorders, and accelerated aging. Therefore, identifying small molecules that specifically modulate regulatory core clock proteins may potentially enable better management of these disorders. In this study, we applied a structure-based molecular-docking approach to find small molecules that specifically bind to the core circadian regulator, the transcription factor circadian locomotor output cycles kaput (CLOCK). We identified 100 candidate molecules by virtual screening of ?2 million small molecules for those predicted to bind closely to the interface in CLOCK that interacts with its transcriptional co-regulator, Brain and muscle Arnt-like protein-1 (BMAL1). Using a mammalian two-hybrid system, real-time monitoring of circadian rhythm in U2OS cells, and various biochemical assays, we tested these compounds experimentally and found one, named CLK8, that specifically bound to and interfered with CLOCK activity. We show that CLK8 disrupts the interaction between CLOCK and BMAL1 and interferes with nuclear translocation of CLOCK both in vivo and in vitro. Results from further experiments indicated that CLK8 enhances the amplitude of the cellular circadian rhythm by stabilizing the negative arm of the transcription/translation feedback loop without affecting period length. Our results reveal CLK8 as a tool for further studies of CLOCK's role in circadian rhythm amplitude regulation and as a potential candidate for therapeutic development to manage disorders associated with dampened circadian rhythms.	[Doruk, Yagmur Umay; Baris, Ibrahim; Kavakli, Ibrahim Halil] Koc Univ, Dept Mol Biol & Genet, Rumelifeneri Yolu, Istanbul, Turkey; [Yarparvar, Darya; Gul, Seref; Kavakli, Ibrahim Halil] Koc Univ, Dept Chem & Biol Engn, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey; [Turkay, Metin] Koc Univ, Dept Ind Engn, Rumelifeneri Yolu, Istanbul, Turkey; [Akyel, Yasemin Kubra; Ozturk, Narin; Okyar, Alper] Istanbul Univ, Dept Pharmacol, Fac Pharm, TR-34116 Istanbul, Turkey; [Taskin, Ali Cihan] Koc Univ, Embryo Manipulat Lab, Anim Res Facil, Res Ctr Translat Med, Rumelifeneri yolu, Istanbul, Turkey; [Yilmaz, Fatma; Ozturk, Nuri] Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey	Koc University; Koc University; Koc University; Istanbul University; Koc University; Gebze Technical University	Kavakli, IH (corresponding author), Koc Univ, Dept Chem & Biol Engn, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.; Kavakli, IH (corresponding author), Koc Univ, Dept Mol Biol, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.; Kavakli, IH (corresponding author), Koc Univ, Dept Genet, Rumelifeneri Yolu, TR-34450 Istanbul, Turkey.	hkavakli@ku.edu.tr	GUL, SEREF/AAR-3289-2020; Ozturk, Nuri/F-4140-2011; Turkay, Metin/F-9769-2011	GUL, SEREF/0000-0002-5613-1339; Ozturk, Nuri/0000-0001-5206-4127; Turkay, Metin/0000-0003-4769-6714; Doruk Polcyn, Yagmur Umay/0000-0002-3388-7803; Taskin, Ali Cihan/0000-0003-3196-821X; Kavakli, Ibrahim/0000-0001-6624-3505	Scientific and Technological Research Council of Turkey (TUBITAK KBAG) [118Z140]	Scientific and Technological Research Council of Turkey (TUBITAK KBAG)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK KBAG) Grant 118Z140 (to I. H. K). The authors declare that they have no conflicts of interest with the contents of this article.	Antoch MP, 2009, MUTAT RES-GEN TOX EN, V680, P109, DOI 10.1016/j.mrgentox.2009.07.015; Armutlu P, 2009, LETT DRUG DES DISCOV, V6, P337, DOI 10.2174/1570180810906050337; Brown SA, 2011, GERONTOLOGY, V57, P427, DOI 10.1159/000320673; Cakir B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031787; Chen Z, 2013, CELL MOL LIFE SCI, V70, P2985, DOI 10.1007/s00018-012-1207-y; Chun SK, 2014, ACS CHEM BIOL, V9, P1213, DOI 10.1021/cb5002872; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gaddameedhi S, 2012, CELL CYCLE, V11, P3481, DOI 10.4161/cc.21771; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gloston GF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00100; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hu Y, 2011, ONCOTARGET, V2, P1279; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kavakli IH, 2017, PHOTOCHEM PHOTOBIOL, V93, P93, DOI 10.1111/php.12669; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Korkmaz T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34433-4; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee Y, 2011, J BIOL CHEM, V286, P7033, DOI 10.1074/jbc.M110.207217; Li Y, 2016, BIOCHEM BIOPH RES CO, V472, P531, DOI 10.1016/j.bbrc.2016.03.010; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nishide S, 2008, EUR J NEUROSCI, V27, P2686, DOI 10.1111/j.1460-9568.2008.06231.x; Nohara K, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00035; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schroeder AM, 2013, TRENDS PHARMACOL SCI, V34, P605, DOI 10.1016/j.tips.2013.09.002; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TUREK FW, 1995, NEUROSCI BIOBEHAV R, V19, P53, DOI 10.1016/0149-7634(94)00030-5; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yagita K, 2009, ACTA HISTOCHEM CYTOC, V42, P89, DOI 10.1267/ahc.09015; Yoshitane H, 2012, EMBO REP, V13, P455, DOI 10.1038/embor.2012.37; Zee Phyllis C, 2013, Continuum (Minneap Minn), V19, P132, DOI 10.1212/01.CON.0000427209.21177.aa	46	23	24	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3518	3531		10.1074/jbc.RA119.011332	http://dx.doi.org/10.1074/jbc.RA119.011332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32019867	Green Published, hybrid			2022-12-28	WOS:000527725300013
J	Petrlova, J; Petruk, G; Huber, RG; McBurnie, EW; van der Plas, MJA; Bond, PJ; Puthia, M; Schmidtchen, A				Petrlova, Jitka; Petruk, Ganna; Huber, Roland G.; McBurnie, Eilish W.; van der Plas, Mariena J. A.; Bond, Peter J.; Puthia, Manoj; Schmidtchen, Artur			Thrombin-derived C-terminal fragments aggregate and scavenge bacteria and their proinflammatory products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); innate immunity; aggregation; thrombin; lipopolysaccharide (LPS); peptides; bacteria; endotoxin; Toll-like receptor (TLR); inflammation; host defense; thrombin-derived C-terminal peptide (TCP)	TOLL-LIKE RECEPTORS; ANTIMICROBIAL PEPTIDES; MICROBIOLOGY; PATHOGENESIS; PH	Thrombin-derived C-terminal peptides (TCPs), including a major 11-kDa fragment (TCP96), are produced through cleavage by human neutrophil elastase and aggregate lipopolysaccharide (LPS) and the Gram-negative bacterium Escherichia coli. However, the physiological roles of TCP96 in controlling bacterial infections and reducing LPS-induced inflammation are unclear. Here, using various biophysical methods, in silico molecular modeling, microbiological and cellular assays, and animal models, we examined the structural features and functional roles of recombinant TCP96 (rTCP96) in the aggregation of multiple bacteria and the Toll-like receptor (TLR) agonists they produce. We found that rTCP96 aggregates both Gram-negative and Gram-positive bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa, and their cell-wall components LPS, lipid A, and lipoteichoic acid (LTA). The Gram-negative bacteria E. coli and P. aeruginosa were particularly sensitive to aggregation-induced bacterial permeabilization and killing. As a proof of concept, we show that rTCP96 reduces LPS-induced NF-?B activation in human monocytes, as well as in mouse models of LPS-induced subcutaneous inflammation. Moreover, in a mouse model of subcutaneous inoculation with P. aeruginosa, rTCP96 reduced bacterial levels. Together, these results link TCP-mediated aggregation of endotoxins and bacteria in vitro to attenuation of inflammation and bacterial levels in vivo.	[Petrlova, Jitka; Petruk, Ganna; van der Plas, Mariena J. A.; Puthia, Manoj; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden; [Huber, Roland G.; McBurnie, Eilish W.; Bond, Peter J.] Bioinformat Inst A STAR, SG-138671 Singapore, Singapore; [McBurnie, Eilish W.] Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England; [van der Plas, Mariena J. A.] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, SG-117558 Singapore, Singapore; [Schmidtchen, Artur] Univ Copenhagen, Bispebjerg Hosp, Dept Biomed Sci, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark	Lund University; University of Southampton; University of Copenhagen; National University of Singapore; University of Copenhagen; Bispebjerg Hospital	Petrlova, J (corresponding author), Lund Univ, Div Dermatol & Venereol, Dept Clin Sci, SE-22184 Lund, Sweden.	jitka.petrlova@med.lu.se	van der Plas, Mariena/GYV-3702-2022; Petruk, Ganna/AAH-8559-2020; Huber, Roland G/AAG-6353-2019; Petruk, Ganna/AAE-8378-2022	Huber, Roland G/0000-0001-5093-5988; Petrlova, Jitka/0000-0002-7554-3945; Puthia, Manoj/0000-0001-6048-7234; Schmidtchen, Artur/0000-0001-9209-3141; van der Plas, Mariena/0000-0002-3233-2881; Bond, Peter/0000-0003-2900-098X	Swedish Research Council [2012-1883, 2017-02341]; Welander-Finsen Foundation; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Swedish Government Funds for Clinical Research (ALF); Lund University; Crafoord 2018-2019 Foundation; Osterlund Foundation; Johanssons Foundation; Soderberg 2019 Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Government Funds for Clinical Research (ALF); Lund University; Crafoord 2018-2019 Foundation; Osterlund Foundation; Johanssons Foundation; Soderberg 2019 Foundation	This work was supported by Swedish Research Council Projects 2012-1883 ative bacteria and the products LPS, lipid A, and LTA. Finally, and 2017-02341, the Welander-Finsen, Crafoord 2018-2019, Osterlund, Johanssons, and Soderberg 2019 Foundations, the Swedish Foundation for Strategic Research 2018-2020, the Knut and Alice Wallenberg Foundation, The Swedish Government Funds for Clinical Research (ALF), and Lund University 2019-2020. A. S. is a founder of in2cure AB, a company developing therapies based on thrombin-derived host defense peptides. The peptide GKY25 and variants are patent-protected.	Berendsen H. J. C. P., 1981, INTERMOLECULAR FORCE, V14, P341; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dancer SJ, 2015, J HOSP INFECT, V91, P292, DOI 10.1016/j.jhin.2015.08.017; GRINSTEIN S, 1991, CLIN BIOCHEM, V24, P241, DOI 10.1016/0009-9120(91)80014-T; Hansen FC, 2015, J IMMUNOL, V194, P5397, DOI 10.4049/jimmunol.1403009; Holdbrook DA, 2018, BBA-BIOMEMBRANES, V1860, P2374, DOI 10.1016/j.bbamem.2018.06.002; Huber RG, 2018, STRUCTURE, V26, P1151, DOI 10.1016/j.str.2018.04.007; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Kumar KVSH, 2009, ENDOCR PRACT, V15, P6, DOI 10.4158/EP.15.1.6; Laupland KB, 2014, CLIN MICROBIOL REV, V27, P647, DOI 10.1128/CMR.00002-14; Levine BG, 2011, J COMPUT PHYS, V230, P3556, DOI 10.1016/j.jcp.2011.01.048; Llewelyn MJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3418; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Nekoofar MH, 2009, INT ENDOD J, V42, P534, DOI 10.1111/j.1365-2591.2009.01550.x; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Petrlova J, 2017, P NATL ACAD SCI USA, V114, pE4213, DOI 10.1073/pnas.1619609114; Petrlova J, 2014, PROTEIN SCI, V23, P1559, DOI 10.1002/pro.2534; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Puthia M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6601; Risselada HJ, 2008, J PHYS CHEM B, V112, P7438, DOI 10.1021/jp0758519; Saleh K, 2015, DERMATOL SURG, V41, P537, DOI 10.1097/DSS.0000000000000364; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Torrent M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003005; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; van der Plas MJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11567; Wennberg CL, 2015, J CHEM THEORY COMPUT, V11, P5737, DOI 10.1021/acs.jctc.5b00726; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3417	3430		10.1074/jbc.RA120.012741	http://dx.doi.org/10.1074/jbc.RA120.012741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32034093	hybrid, Green Published			2022-12-28	WOS:000527725300005
J	Stewart, TM; Khomutov, M; Foley, JR; Guo, X; Holbert, CE; Dunston, TT; Schwartz, CE; Gabrielson, K; Khomutov, A; Casero, RA				Stewart, Tracy Murray; Khomutov, Maxim; Foley, Jackson R.; Guo, Xin; Holbert, Cassandra E.; Dunston, Tiffany T.; Schwartz, Charles E.; Gabrielson, Kathleen; Khomutov, Alexey; Casero, Robert A., Jr.			(R,R)-1,12-Dimethylspermine can mitigate abnormal spermidine accumulation in Snyder?Robinson syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; spermidine; neurodevelopment; neurological disease; osteoporosis; (R; R)-1; 12-dimethylspermine (Me2SPM); alpha-methylated polyamine; polyamine mimetic; Snyder?Robinson Syndrome; spermine synthase	LINKED MENTAL-RETARDATION; ALPHA-METHYL POLYAMINES; SYNTHASE DEFICIENCY; PUTRESCINE; MUTATION; LIVER; N-1-ACETYLTRANSFERASE; DERIVATIVES; METABOLISM; INDUCTION	Snyder?Robinson syndrome (SRS) is an X-linked intellectual disability syndrome caused by a loss-of-function mutation in the spermine synthase (SMS) gene. Primarily affecting males, the main manifestations of SRS include osteoporosis, hypotonic stature, seizures, cognitive impairment, and developmental delay. Because there is no cure for SRS, treatment plans focus on alleviating symptoms rather than targeting the underlying causes. Biochemically, the cells of individuals with SRS accumulate excess spermidine, whereas spermine levels are reduced. We recently demonstrated that SRS patient-derived lymphoblastoid cells are capable of transporting exogenous spermine and its analogs into the cell and, in response, decreasing excess spermidine pools to normal levels. However, dietary supplementation of spermine does not appear to benefit SRS patients or mouse models. Here, we investigated the potential use of a metabolically stable spermine mimetic, (R,R)-1,12-dimethylspermine (Me2SPM), to reduce the intracellular spermidine pools of SRS patient-derived cells. Me2SPM can functionally substitute for the native polyamines in supporting cell growth while stimulating polyamine homeostatic control mechanisms. We found that both lymphoblasts and fibroblasts from SRS patients can accumulate Me2SPM, resulting in significantly decreased spermidine levels with no adverse effects on growth. Me2SPM administration to mice revealed that Me2SPM significantly decreases spermidine levels in multiple tissues. Importantly, Me2SPM was detectable in brain tissue, the organ most affected in SRS, and was associated with changes in polyamine metabolic enzymes. These findings indicate that the (R,R)-diastereomer of 1,12-Me2SPM represents a promising lead compound in developing a treatment aimed at targeting the molecular mechanisms underlying SRS pathology.	[Stewart, Tracy Murray; Foley, Jackson R.; Holbert, Cassandra E.; Dunston, Tiffany T.; Casero, Robert A., Jr.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Rm 551, Baltimore, MD 21287 USA; [Khomutov, Maxim; Khomutov, Alexey] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Guo, Xin; Gabrielson, Kathleen] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA	Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Johns Hopkins University; Johns Hopkins Medicine; Greenwood Genetic Center	Casero, RA (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Rm 551, Baltimore, MD 21287 USA.	rcasero@jhmi.edu	, WaNgtJ/AAR-7045-2020; Stewart, Tracy Murray/B-6137-2017; Khomutov, Alex/G-2128-2015	Stewart, Tracy Murray/0000-0001-8679-6414; Khomutov, Maxim/0000-0003-2833-9834; Khomutov, Alex/0000-0001-6833-7855; Holbert, Cassandra/0000-0002-4869-1301	NCI, National Institutes of Health [R01CA204345, R01CA235863, P30CA006973, R21CA229582]; NINDS, National Institutes of Health [R01NS073854]; Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania [MDBR-18-127-SR, MDBR-20-135-SRS]; South Carolina Department of Disabilities and Special Needs; Russian Science Foundation [17-74-20049]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania; South Carolina Department of Disabilities and Special Needs; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by NCI, National Institutes of Health Grants R01CA204345 and R01CA235863 (to R. A. C.), P30CA006973 (to S. K. C. C. C.) and R21CA229582 (to K. G.) and NINDS, National Institutes of Health Grant R01NS073854 (to C. E. S.). This work was also supported by funding from the Million Dollar Bike Ride, Orphan Disease Center at the University of Pennsylvania Grants MDBR-18-127-SR (to R. A. C.) and MDBR-20-135-SRS (to R. A. C. and T. M. S.) and a grant from the South Carolina Department of Disabilities and Special Needs (to C. E. S.). Synthesis of 1,12-Me2SPM was supported by Russian Science Foundation Grant 17-74-20049 (to A. K.).	Albert JS, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0235-8; Arena JF, 1996, AM J MED GENET, V64, P50, DOI 10.1002/(SICI)1096-8628(19960712)64:1<50::AID-AJMG7>3.3.CO;2-4; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; CASERO RA, 1989, CANCER RES, V49, P3829; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Goodwin AC, 2011, METHODS MOL BIOL, V720, P173, DOI 10.1007/978-1-61779-034-8_10; Grigorenko NA, 2007, TETRAHEDRON, V63, P2257, DOI 10.1016/j.tet.2006.12.065; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Hyvonen MT, 2009, BIOCHEM J, V422, P321, DOI 10.1042/BJ20090737; Jarvinen A, 2005, J BIOL CHEM, V280, P6595, DOI 10.1074/jbc.M412788200; Jarvinen AJ, 2006, J MED CHEM, V49, P399, DOI 10.1021/jm050872h; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Khomutov M, 2019, J MED CHEM, V62, P11335, DOI 10.1021/acs.jmedchem.9b01666; Kim JI, 2015, SCIENCE, V350, P102, DOI 10.1126/science.aac4690; LAKANEN JR, 1992, J MED CHEM, V35, P724, DOI 10.1021/jm00082a013; Larcher L, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2019.103777; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; Murray-Stewart Tracy, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6040112; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peron A, 2013, AM J MED GENET A, V161, P2316, DOI 10.1002/ajmg.a.36116; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; SEILER N, 1981, Neurochemistry International, V3, P95, DOI 10.1016/0197-0186(81)90027-9; SEILER N, 1975, BIOCHEM J, V152, P201, DOI 10.1042/bj1520201; Sequerra EB, 2007, NEUROSCIENCE, V146, P489, DOI 10.1016/j.neuroscience.2007.01.062; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; Starks Rachel, 2018, Autops Case Rep, V8, pe2018031, DOI 10.4322/acr.2018.031; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; Til HP, 1997, FOOD CHEM TOXICOL, V35, P337, DOI 10.1016/S0278-6915(97)00121-X; Wang XJ, 2009, J BIOL CHEM, V284, P930, DOI 10.1074/jbc.M807758200; YANG JN, 1995, J CELL PHYSIOL, V165, P71, DOI 10.1002/jcp.1041650109; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008	43	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3247	3256		10.1074/jbc.RA119.011572	http://dx.doi.org/10.1074/jbc.RA119.011572			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996374	Green Published, hybrid			2022-12-28	WOS:000519597300029
J	Zheng, H; Li, HF; Zhang, JY; Fan, HL; Jia, LN; Ma, WQ; Ma, SQ; Wang, SH; You, H; Yin, ZN; Li, XD				Zheng, Han; Li, Haifeng; Zhang, Jingyuan; Fan, Hanlu; Jia, Lina; Ma, Wenqiang; Ma, Shuoqian; Wang, Shenghong; You, Hua; Yin, Zhinan; Li, Xiangdong			Serum amyloid A exhibits pH dependent antibacterial action and contributes to host defense against Staphylococcus aureus cutaneous infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); lipid-binding protein; Staphylococcus aureus (S; aureus); host defense; phospholipid vesicle; acute-phase proteins; bactericidal mechanism; cutaneous infection; serum amyloid A	HIGH-DENSITY-LIPOPROTEIN; EXPRESSION; BINDING; IMMUNE; SAA; MECHANISM; PROTEIN; PATHOGENESIS; VESICLES; CELLS	Serum amyloid A (SAA), one of the major highly conserved acute-phase proteins in most mammals, is predominantly produced by hepatocytes and also by a variety of cells in extrahepatic tissues. It is well-known that the expression of SAA is sharply increased in bacterial infections. However, the exact physiological function of SAA during bacterial infection remains unclear. Herein, we showed that SAA expression significantly increased in abscesses of Staphylococcus aureus cutaneous infected mice, which exert direct antibacterial effects by binding to the bacterial cell surface and disrupting the cell membrane in acidic conditions. Mechanically, SAA disrupts anionic liposomes by spontaneously forming small vesicles or micelles under acidic conditions. Especially, the N-terminal region of SAA is necessary for membrane disruption and bactericidal activity. Furthermore, we found that mice deficient in SAA1/2 were more susceptible to infection by S. aureus. In addition, the expression of SAA in infected skin was regulated by interleukin-6. Taken together, these findings support a key role of the SAA in host defense and may provide a novel therapeutic strategy for cutaneous bacterial infection.	[Zheng, Han; Li, Haifeng; Zhang, Jingyuan; Fan, Hanlu; Jia, Lina; Ma, Wenqiang; Ma, Shuoqian; Wang, Shenghong; Li, Xiangdong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China; [You, Hua; Li, Xiangdong] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou 511436, Peoples R China; [Yin, Zhinan] Jinan Univ, Guangdong Prov Key Lab Mol Immunol & Antibody Eng, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510310, Peoples R China	China Agricultural University; Guangzhou Medical University; Jinan University	Li, XD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China.; Li, XD (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou 511436, Peoples R China.	xiangdongli@cau.edu.cn	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022	Li, Xiangdong/0000-0003-2261-2393	National Science and Technology Major Project [2013ZX10004608]; National Key Research and Development Grant [2018YFC1004702]; National Natural Science Foundation of China [NSFC31970802, NSFC31071316, NSFC81261130024]; Natural Science Foundation of Beijing Grant [20G10613]; State Key Laboratory of Agrobiotechnology, China Agricultural University [2018SKLAB6-18]; project for Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant [2015SKLAB6-2]	National Science and Technology Major Project; National Key Research and Development Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Grant; State Key Laboratory of Agrobiotechnology, China Agricultural University; project for Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant	,,.This work was supported by National Science and Technology Major Project Grant 2013ZX10004608; National Key Research and Development Grant 2018YFC1004702; National Natural Science Foundation of China Grants NSFC31970802, NSFC31071316 and NSFC81261130024; Natural Science Foundation of Beijing Grant 20G10613; State Key Laboratory of Agrobiotechnology, China Agricultural University, Grant 2018SKLAB6-18; and project for Extramural Scientists of State Key Laboratory of Agrobiotechnology Grant 2015SKLAB6-2. The authors declare that they have no conflicts of interest with the contents of this article.	Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Erman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032933; Eyerich S, 2018, TRENDS IMMUNOL, V39, P315, DOI 10.1016/j.it.2018.02.004; Frame NM, 2017, J STRUCT BIOL, V200, P293, DOI 10.1016/j.jsb.2017.06.007; Frame NM, 2016, FEBS LETT, V590, P866, DOI 10.1002/1873-3468.12116; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Han CY, 2016, J CLIN INVEST, V126, P266, DOI 10.1172/JCI83475; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Hilliard KL, 2015, AM J RESP CELL MOL, V53, P378, DOI 10.1165/rcmb.2014-0195OC; Hirakura Y, 2002, AMYLOID, V9, P13, DOI 10.3109/13506120209072440; Jayaraman S, 2019, ELIFE, V8, DOI 10.7554/eLife.46630; Jayaraman S, 2017, P NATL ACAD SCI USA, V114, pE6507, DOI 10.1073/pnas.1707120114; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kovacevic N, 2015, FISH SHELLFISH IMMUN, V47, P942, DOI 10.1016/j.fsi.2015.10.041; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li CW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003918; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Malik E, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040067; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Morizane S, 2017, J INVEST DERMATOL, V137, P757, DOI 10.1016/j.jid.2016.10.016; Noborn F, 2012, J BIOL CHEM, V287, P25669, DOI 10.1074/jbc.M112.363895; Ohta S, 2009, CHEM PHYS LIPIDS, V162, P62, DOI 10.1016/j.chemphyslip.2009.07.008; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Propheter DC, 2017, P NATL ACAD SCI USA, V114, P11027, DOI 10.1073/pnas.1711395114; Quinton LJ, 2012, J CLIN INVEST, V122, P1758, DOI 10.1172/JCI59408; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reigstad CS, 2010, GUT MICROBES, V1, P55, DOI 10.4161/gmic.1.1.10514; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Tannock LR, 2018, J LIPID RES, V59, P339, DOI 10.1194/jlr.M080887; Torocsik D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198323; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Yu JH, 2017, FISH SHELLFISH IMMUN, V65, P267, DOI 10.1016/j.fsi.2017.04.021; Yu WP, 2014, J CLIN INVEST, V124, P2709, DOI 10.1172/JCI59901; Zhang GF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01503; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zheng MQ, 2016, INFECT IMMUN, V84, P782, DOI 10.1128/IAI.01268-15; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97	52	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2570	2581		10.1074/jbc.RA119.010626	http://dx.doi.org/10.1074/jbc.RA119.010626			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31819008	Green Published, hybrid			2022-12-28	WOS:000519969100004
J	Bhopatkar, AA; Uversky, VN; Rangachari, V				Bhopatkar, Anukool A.; Uversky, Vladimir N.; Rangachari, Vijayaraghavan			Granulins modulate liquid?liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43; TARDBP); ALS (Lou Gehrig disease); stress granule; protein?protein interaction; protein dynamic; intrinsically disordered protein; ALS; FTLD; Granulins; liquid?liquid phase separation; progranulin	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; DNA-BINDING PROTEIN; INTRINSIC DISORDER; EPITHELIN PRECURSOR; WEB SERVER; PROGRANULIN; RNA; PREDICTION; SEQUENCE	TAR DNA-binding protein 43 (TDP-43) has emerged as a key player in many neurodegenerative pathologies, including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Hallmarks of both FTLD and ALS are the toxic cytoplasmic inclusions of the prion-like C-terminal fragments of TDP-43 CTD (TDP-43 C-terminal domain), formed upon proteolytic cleavage of full-length TDP-43 in the nucleus and subsequent transport to the cytoplasm. Both full-length TDP-43 and its CTD are also known to form stress granules by coacervating with RNA in the cytoplasm during stress and may be involved in these pathologies. Furthermore, mutations in the PGRN gene, leading to haploinsufficiency and diminished function of progranulin (PGRN) protein, are strongly linked to FTLD and ALS. Recent reports have indicated that proteolytic processing of PGRN to smaller protein modules called granulins (GRNs) contributes to FTLD and ALS progression, with specific GRNs exacerbating TDP-43?induced cytotoxicity. Here we investigated the interactions between the proteolytic products of both TDP-43 and PGRN. Based on structural disorder and charge distributions, we hypothesized that GRN-3 and GRN-5 could interact with the TDP-43 CTD. We show that, under both reducing and oxidizing conditions, GRN-3 and GRN-5 interact with and differentially modulate TDP-43 CTD aggregation and/or liquid?liquid phase separation in vitro. GRN-3 promoted insoluble aggregates of the TDP-43 CTD while GRN-5 mediated liquid?liquid phase separation. These results constitute the first observation of an interaction between GRNs and TDP-43, suggesting a mechanism by which attenuated PGRN function could lead to familial FTLD or ALS.	[Bhopatkar, Anukool A.; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Lab New Methods Biol, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	University of Southern Mississippi; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Rangachari, V (corresponding author), Univ Southern Mississippi, 118 Coll Dr 5043, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	NIA, National Institutes of Health [1R56AG062292-01, RF1AG055088]; NIGMS, National Institutes of Health [R01GM120634, 8 P20 GM-103476-11]; National Science Foundation [CBET 1802793]; National Center for Research Resources, National Institutes of Health [5P20RR01647-11]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIA, National Institutes of Health Grants 1R56AG062292-01 (to V. R.) and RF1AG055088 (to V. N. U.), NIGMS, National Institutes of Health Grants R01GM120634 and 8 P20 GM-103476-11 (to V. R.), National Science Foundation Grant CBET 1802793 (to V. R.), and National Center for Research Resources, National Institutes of Health Grant 5P20RR01647-11 (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Babinchak WM, 2019, J BIOL CHEM, V294, P6306, DOI 10.1074/jbc.RA118.007222; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; Bhopatkar AA, 2019, BIOCHEM J, V476, P859, DOI 10.1042/BCJ20180916; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bocti C, 2006, DEMENT GERIATR COGN, V21, P364, DOI 10.1159/000091838; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Butler VJ, 2019, BIOCHEMISTRY-US, V58, P2670, DOI 10.1021/acs.biochem.9b00275; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cascella R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153685; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; Chornenkyy Y, 2019, LAB INVEST, V99, P993, DOI 10.1038/s41374-019-0196-y; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Cooper PN, 1996, NEUROPATH APPL NEURO, V22, P17, DOI 10.1046/j.1365-2990.1996.2398023.x; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; Das RK, 2015, CURR OPIN STRUC BIOL, V32, P102, DOI 10.1016/j.sbi.2015.03.008; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Dine E, 2018, CELL SYST, V6, P655, DOI 10.1016/j.cels.2018.05.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Elhaddaoui A, 1995, BIOSPECTROSCOPY, V1, P351, DOI 10.1002/bspy.350010506; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Fei JY, 2017, J CELL SCI, V130, P4180, DOI 10.1242/jcs.206854; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fukui T, 2000, J NEUROL SCI, V174, P111, DOI 10.1016/S0022-510X(00)00261-6; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Ghag G, 2017, PROTEIN SCI, V26, P1759, DOI 10.1002/pro.3212; Ghag G, 2016, PROTEIN ENG DES SEL, V29, P177, DOI 10.1093/protein/gzw005; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Guo L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024554; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00680; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; HULETTE CM, 1992, CLIN NEUROPATHOL, V11, P151; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Irwin DJ, 2015, ACTA NEUROPATHOL, V129, P469, DOI 10.1007/s00401-014-1380-1; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Khalfallah Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25767-0; Kitamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19230; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Mann JR, 2019, NEURON, V102, P321, DOI 10.1016/j.neuron.2019.01.048; Mao QW, 2017, J NEUROPATH EXP NEUR, V76, P957, DOI 10.1093/jnen/nlx085; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meng FC, 2017, CELL MOL LIFE SCI, V74, P3069, DOI 10.1007/s00018-017-2555-4; Meng Fanchi, 2017, Curr Protoc Protein Sci, V88, DOI 10.1002/cpps.28; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, BIOCOMPUT-PAC SYM, P176; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025; Prather LJ, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11040649; Rao BS, 2017, P NATL ACAD SCI USA, V114, pE9569, DOI 10.1073/pnas.1712396114; Robert PH, 1999, ENCEPHALE, V25, P612; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Santamaria N, 2017, CELL MOL LIFE SCI, V74, P1297, DOI 10.1007/s00018-016-2416-6; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uversky VN, 2017, AUTOPHAGY, V13, P2115, DOI 10.1080/15548627.2017.1384889; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	108	15	15	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2506	2519		10.1074/jbc.RA119.011501	http://dx.doi.org/10.1074/jbc.RA119.011501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31911437	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000517330200030
J	Lafita-Navarro, MC; Liano-Pons, J; Quintanilla, A; Varela, I; Blanco, R; Ourique, F; Bretones, G; Aresti, J; Molina, E; Carroll, P; Hurlin, P; Romero, OA; Sanchez-Cespedes, M; Eisenman, RN; Delgado, MD; Leon, J				Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Carroll, Patrick; Hurlin, Peter; Romero, Octavio A.; Sanchez-Cespedes, Montse; Eisenman, Robert N.; Delgado, M. Dolores; Leon, Javier			The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); proliferation; gene regulation; promoter; transcription; basic helix-loop-helix leucine zipper protein; MAX dimerization protein MLX; MAX network transcriptional repressor (MNT); MXD family; MYC-associated factor X (MAX)	MAX-INTERACTING PROTEIN; NERVE GROWTH-FACTOR; C-MYC; BHLHZIP PROTEIN; CYCLE CONTROL; E-BOX; DIFFERENTIATION; NETWORK; MLX; INDUCTION	The MAX network transcriptional repressor (MNT) is an MXD family transcription factor of the basic helix-loop-helix (bHLH) family. MNT dimerizes with another transcriptional regulator, MYC-associated factor X (MAX), and down-regulates genes by binding to E-boxes. MAX also dimerizes with MYC, an oncogenic bHLH transcription factor. Upon E-box binding, the MYC?MAX dimer activates gene expression. MNT also binds to the MAX dimerization protein MLX (MLX), and MNT?MLX and MNT?MAX dimers co-exist. However, all MNT functions have been attributed to MNT?MAX dimers, and no functions of the MNT?MLX dimer have been described. MNT's biological role has been linked to its function as a MYC oncogene modulator, but little is known about its regulation. We show here that MNT localizes to the nucleus of MAX-expressing cells and that MNT?MAX dimers bind and repress the MNT promoter, an effect that depends on one of the two E-boxes on this promoter. In MAX-deficient cells, MNT was overexpressed and redistributed to the cytoplasm. Interestingly, MNT was required for cell proliferation even in the absence of MAX. We show that in MAX-deficient cells, MNT binds to MLX, but also forms homodimers. RNA-sequencing experiments revealed that MNT regulates the expression of several genes even in the absence of MAX, with many of these genes being involved in cell cycle regulation and DNA repair. Of note, MNT?MNT homodimers regulated the transcription of some genes involved in cell proliferation. The tight regulation of MNT and its functionality even without MAX suggest a major role for MNT in cell proliferation.	[Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Delgado, M. Dolores; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain; [Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Delgado, M. Dolores; Leon, Javier] Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain; [Carroll, Patrick; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hurlin, Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children Res Ctr, Portland, OR 97239 USA; [Hurlin, Peter] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Knight Canc Inst, Portland, OR 97239 USA; [Romero, Octavio A.; Sanchez-Cespedes, Montse] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Genes & Canc Grp, Barcelona 08908, Spain; [Quintanilla, Andrea] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Ourique, Fabiana] Univ Fed Santa Catarina, Dept Biochem, BR-88040900 Florianopolis, SC, Brazil; [Bretones, Gabriel] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo 33003, Asturias, Spain; [Aresti, Julia] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9712 CP Groningen, Netherlands; [Sanchez-Cespedes, Montse] Josep Carreras Leukemia Res Inst, Campus ICO Germans Trias & Pujol, Barcelona 08916, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria; Fred Hutchinson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Edinburgh; Universidade Federal de Santa Catarina (UFSC); University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Groningen; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Leon, J (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain.; Leon, J (corresponding author), Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain.	leonj@unican.es	Leon, Javier/K-4615-2014; Varela, Ignacio/AAA-7680-2021; Sanchez-Cespedes, Montse/H-8485-2012; Romero, Octavio A./AAA-8078-2020; Bretones, Gabriel/AAB-4637-2021; Delgado, M. Dolores/K-9056-2014	Varela, Ignacio/0000-0002-0969-506X; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Romero, Octavio A./0000-0003-0229-6530; Bretones, Gabriel/0000-0002-1521-5544; Delgado, M. Dolores/0000-0003-4682-4040; Carroll, Patrick/0000-0001-8147-5750; MOLINA, Ester/0000-0002-5138-6826; Ourique, Fabiana/0000-0002-2663-4015; LIANO-PONS, Judit/0000-0001-8097-4750; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X	Agencia Estatal de Investigacion, Spanish Government [SAF2017-88026-R]; FEDER Program from the European Union; National Institutes of Health from NCI [CA57138/CA]; Shriners Hospitals for Children	Agencia Estatal de Investigacion, Spanish Government; FEDER Program from the European Union; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shriners Hospitals for Children	This work was supported by Grant SAF2017-88026-R from Agencia Estatal de Investigacion, Spanish Government (to J. L. and M. D. D.), funded in part by FEDER Program from the European Union, National Institutes of Health Grant CA57138/CA from NCI (to R. N. E.), and grants from Shriners Hospitals for Children (to P. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campbell KJ, 2017, CELL DEATH DIFFER, V24, P2117, DOI 10.1038/cdd.2017.131; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; CONACCISORRELL M, 2014, CSH PERSPECT MED, V4, DOI DOI 10.1101/CSHPERSPECT.A014357; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Lafita-Navarro MDC, 2016, ONCOTARGET, V7, P69536, DOI 10.18632/oncotarget.11766; Dezfouli S, 2006, MOL CELL BIOL, V26, P2080, DOI 10.1128/MCB.26.6.2080-2092.2006; Diolaiti D, 2015, BBA-GENE REGUL MECH, V1849, P484, DOI 10.1016/j.bbagrm.2014.05.016; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrandiz N, 2009, DNA REPAIR, V8, P390, DOI 10.1016/j.dnarep.2008.12.001; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Gallant P, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014324; Garcia-Sanz P, 2014, J BIOL CHEM, V289, P22221, DOI 10.1074/jbc.M113.538744; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Hurlin PJ, 1997, CURR TOP MICROBIOL, V224, P115; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Link JM, 2012, P NATL ACAD SCI USA, V109, P19685, DOI 10.1073/pnas.1206406109; MARUYAMA K, 1987, ONCOGENE, V1, P361; Mathsyaraja H, 2019, GENE DEV, V33, P1252, DOI 10.1101/gad.325878.119; Mauleon I, 2004, MOL CARCINOGEN, V39, P85, DOI 10.1002/mc.20000; Meroni G, 1997, EMBO J, V16, P2892, DOI 10.1093/emboj/16.10.2892; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nilsson JA, 2004, MOL CELL BIOL, V24, P1560, DOI 10.1128/MCB.24.4.1560-1569.2004; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Queva C, 1999, CELL GROWTH DIFFER, V10, P785; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Terragni J, 2011, J BIOL CHEM, V286, P36215, DOI 10.1074/jbc.M111.246116; Toyo-oka K, 2004, HUM MOL GENET, V13, P1057, DOI 10.1093/hmg/ddh116; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Walker W, 2005, J CELL BIOL, V169, P405, DOI 10.1083/jcb.200411013; Yang G, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020083	50	8	8	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2001	2017		10.1074/jbc.RA119.010389	http://dx.doi.org/10.1074/jbc.RA119.010389			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919096	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000517128200019
J	Olson, AK; Bouchard, B; Zhu, WZ; Chatham, JC; Des Rosiers, C				Olson, Aaron K.; Bouchard, Bertrand; Zhu, Wei Zhong; Chatham, John C.; Des Rosiers, Christine			First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose; glucose metabolism; carbohydrate metabolism; cardiac metabolism; O-linked N-acetylglucosamine (O-GlcNAc); post-translational modification (PTM); glucosamine; hexosamine biosynthesis pathway; metabolic flux; protein glycosylation; UDP-GlcNAc	PROTEIN O-GLCNACYLATION; LIQUID-CHROMATOGRAPHY; GLCNAC LEVELS; RAT-HEART; HYPERTROPHY; REPERFUSION; INHIBITION; GLUTAMINE; AMIDOTRANSFERASE; OVEREXPRESSION	The hexosamine biosynthesis pathway (HBP) branches from glycolysis and forms UDP-GlcNAc, the moiety for O-linked ?-GlcNAc (O-GlcNAc) post-translational modifications. An inability to directly measure HBP flux has hindered our understanding of the factors regulating protein O-GlcNAcylation. Our goals in this study were to (i) validate a LC-MS method that assesses HBP flux as UDP-GlcNAc (C-13)-molar percent enrichment (MPE) and concentration and (ii) determine whether glucose availability or workload regulate cardiac HBP flux. For (i), we perfused isolated murine working hearts with [U-C-13(6)]glucosamine (1, 10, 50, or 100 ?m), which bypasses the rate-limiting HBP enzyme. We observed a concentration-dependent increase in UDP-GlcNAc levels and MPE, with the latter reaching a plateau of 56.3 ? 2.9%. For (ii), we perfused isolated working hearts with [U-C-13(6)]glucose (5.5 or 25 mm). Glycolytic efflux doubled with 25 mm [U-C-13(6)]glucose; however, the calculated HBP flux was similar among the glucose concentrations at ?2.5 nmol/g of heart protein/min, representing ?0.003?0.006% of glycolysis. Reducing cardiac workload in beating and nonbeating Langendorff perfusions had no effect on the calculated HBP flux at ?2.3 and 2.5 nmol/g of heart protein/min, respectively. To the best of our knowledge, this is the first direct measurement of glucose flux through the HBP in any organ. We anticipate that these methods will enable foundational analyses of the regulation of HBP flux and protein O-GlcNAcylation. Our results suggest that in the healthy ex vivo perfused heart, HBP flux does not respond to acute changes in glucose availability or cardiac workload.	[Olson, Aaron K.] Univ Washington, Dept Pediat, Div Cardiol, Seattle, WA 98105 USA; [Olson, Aaron K.; Zhu, Wei Zhong] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Bouchard, Bertrand; Des Rosiers, Christine] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Bouchard, Bertrand; Des Rosiers, Christine] Univ Montreal, Dept Nutr, Montreal, PQ H1T 1C8, Canada; [Chatham, John C.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Universite de Montreal; Universite de Montreal; University of Alabama System; University of Alabama Birmingham	Olson, AK (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98101 USA.	Aaron.Olson@seattlechildrens.org		Olson, Aaron/0000-0002-5237-400X	NHLBI, National Institutes of Health [R01HL122546]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Grant R01HL122546 (to A. K. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Dassanayaka S, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0612-7; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Han J, 2013, ANAL CHEM, V85, P5965, DOI 10.1021/ac400769g; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Lauzier B, 2013, J MOL CELL CARDIOL, V55, P92, DOI 10.1016/j.yjmcc.2012.11.008; Lauzier B, 2011, AM J PHYSIOL-HEART C, V300, pH845, DOI 10.1152/ajpheart.01034.2010; Ledee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135262; Ledee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065532; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Mailleux F, 2016, BBA-MOL BASIS DIS, V1862, P2232, DOI 10.1016/j.bbadis.2016.08.012; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Nabeebaccus AA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96184; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Ruiz M, 2015, METHOD ENZYMOL, V561, P107, DOI 10.1016/bs.mie.2015.06.026; Standage SW, 2017, AM J PHYSIOL-HEART C, V312, pH239, DOI 10.1152/ajpheart.00457.2016; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; Vincent G, 2003, MOL CELL BIOCHEM, V242, P89, DOI 10.1023/A:1021189728877; Wakamatsu A, 2005, J SEP SCI, V28, P1823, DOI 10.1002/jssc.200400027; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yokoe S, 2010, GLYCOBIOLOGY, V20, P1217, DOI 10.1093/glycob/cwq071; Zhu WZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011260	42	36	36	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2018	2033		10.1074/jbc.RA119.010565	http://dx.doi.org/10.1074/jbc.RA119.010565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915250	hybrid, Green Published			2022-12-28	WOS:000517128200020
J	Froula, JM; Castellana-Cruz, M; Anabtawi, NM; Camino, JD; Chen, SW; Thrasher, DR; Freire, J; Yazdi, AA; Fleming, S; Dobson, CM; Kumita, JR; Cremades, N; Volpicelli-Daley, LA				Froula, Jessica M.; Castellana-Cruz, Marta; Anabtawi, Nadia M.; Camino, Jose D.; Chen, Serene W.; Thrasher, Drake R.; Freire, Jennifer; Yazdi, Allen A.; Fleming, Sheila; Dobson, Christopher M.; Kumita, Janet R.; Cremades, Nunilo; Volpicelli-Daley, Laura A.			Defining alpha-synuclein species responsible for Parkinson's disease phenotypes in mice (vol 294, pg 10392, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kumita, Janet/AAO-5254-2021	Thrasher, Drake/0000-0001-5610-8828				Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743	1	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1142	1142		10.1074/jbc.AAC119.012485	http://dx.doi.org/10.1074/jbc.AAC119.012485			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31980482	Green Published, hybrid			2022-12-28	WOS:000509949300020
J	Hegazy, YA; Fernando, CM; Tran, EJ				Hegazy, Youssef A.; Fernando, Chrishan M.; Tran, Elizabeth J.			The balancing act of R-loop biology: The good, the bad, and the ugly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA damage; DNA repair; RNA metabolism; DNA structure; genomic instability; DNA; RNA hybrid; DNA; RNA immunoprecipitation (DRIP); R-loops; RNA; transcription; gene expression; double-strand break (DSB); R-loop mapping; DNA secondary structure	CLASS SWITCH RECOMBINATION; TRANSCRIPTION ELONGATION; DNA DEAMINATION; STRANDED-DNA; YEAST SEN1; RNA; AID; REPLICATION; ANTIBODY; REPAIR	An R-loop is a three-stranded nucleic acid structure that consists of a DNA:RNA hybrid and a displaced strand of DNA. R-loops occur frequently in genomes and have significant physiological importance. They play vital roles in regulating gene expression, DNA replication, and DNA and histone modifications. Several studies have uncovered that R-loops contribute to fundamental biological processes in various organisms. Paradoxically, although they do play essential positive functions required for important biological processes, they can also contribute to DNA damage and genome instability. Recent evidence suggests that R-loops are involved in a number of human diseases, including neurological disorders, cancer, and autoimmune diseases. This review focuses on the molecular basis for R-loop?mediated gene regulation and genomic instability and briefly discusses methods for identifying R-loops in vivo. It also highlights recent studies indicating the role of R-loops in DNA double-strand break repair with an updated view of much-needed future goals in R-loop biology.	[Hegazy, Youssef A.; Tran, Elizabeth J.] Purdue Univ, Dept Biochem, BCHM A343,175 S Univ St, W Lafayette, IN 47907 USA; [Fernando, Chrishan M.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Tran, Elizabeth J.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tran, EJ (corresponding author), Purdue Univ, Dept Biochem, BCHM A343,175 S Univ St, W Lafayette, IN 47907 USA.	ejtran@purdue.edu	Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X; Hegazy, Youssef/0000-0002-9962-0108	NIGMS NIH HHS [R01 GM097332] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Brochu J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007668; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen L, 2017, MOL CELL, V68, P745, DOI 10.1016/j.molcel.2017.10.008; Chen PB, 2015, NAT STRUCT MOL BIOL, V22, P999, DOI 10.1038/nsmb.3122; CLOUD KG, 1995, MUTAT RES LETT, V347, P55, DOI 10.1016/0165-7992(95)90070-5; Cloutier SC, 2016, MOL CELL, V61, P393, DOI 10.1016/j.molcel.2015.12.024; Cohen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02894-w; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; DROLET M, 1994, J BIOL CHEM, V269, P2068; Dumelie JG, 2017, ELIFE, V6, DOI 10.7554/eLife.28306; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hartono SR, 2018, J MOL BIOL, V430, P272, DOI 10.1016/j.jmb.2017.12.016; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Jolly CJ, 2008, J EXP MED, V205, P509, DOI 10.1084/jem.20080356; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Konig F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178875; Lang KS, 2017, CELL, V170, P787, DOI 10.1016/j.cell.2017.07.044; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu WT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02893-x; Ma WK, 2013, J MOL BIOL, V425, P3824, DOI 10.1016/j.jmb.2013.05.016; Manzo SG, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1478-1; Masse E, 1999, J BIOL CHEM, V274, P16659, DOI 10.1074/jbc.274.23.16659; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; Mersaoui SY, 2019, EMBO J, V38, DOI 10.15252/embj.2018100986; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Morales JC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006107; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Ohtani N, 2004, NUCLEIC ACIDS RES, V32, P5809, DOI 10.1093/nar/gkh917; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Rossler OG, 2001, NUCLEIC ACIDS RES, V29, P2088, DOI 10.1093/nar/29.10.2088; Roy D, 2010, MOL CELL BIOL, V30, P146, DOI 10.1128/MCB.00897-09; Roy D, 2009, MOL CELL BIOL, V29, P3124, DOI 10.1128/MCB.00139-09; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; So CC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008101; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2006, TRENDS GENET, V22, P23, DOI 10.1016/j.tig.2005.11.002; Stolz R, 2019, P NATL ACAD SCI USA, V116, P6260, DOI 10.1073/pnas.1819476116; Sun QW, 2013, SCIENCE, V340, P619, DOI 10.1126/science.1234848; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Teng YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06586-3; THOMAS M, 1976, P NATL ACAD SCI USA, V73, P2294, DOI 10.1073/pnas.73.7.2294; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Vanoosthuyse Vincent, 2018, Noncoding RNA, V4, DOI 10.3390/ncrna4020009; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wahba L, 2013, MOL CELL, V50, P611, DOI 10.1016/j.molcel.2013.05.024; Wang IX, 2018, GENOME RES, V28, P1405, DOI 10.1101/gr.237362.118; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Yasuhara T, 2018, CELL, V175, P558, DOI 10.1016/j.cell.2018.08.056	85	37	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					905	913		10.1074/jbc.REV119.011353	http://dx.doi.org/10.1074/jbc.REV119.011353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31843970	hybrid, Green Published			2022-12-28	WOS:000509949300002
J	Wong, W; Crane, ED; Kuo, Y; Kim, A; Crane, JD				Wong, Wesley; Crane, Elizabeth D.; Kuo, Yikai; Kim, Austin; Crane, Justin D.			The exercise cytokine interleukin-15 rescues slow wound healing in aged mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						wound healing; aging; exercise; epidermis; STAT3; interleukin 15; re-epithelialization; skin barrier; tissue repair; trauma	CELLULAR SENESCENCE; OXIDATIVE STRESS; ALARMIN HMGB1; GROWTH-FACTOR; STEM-CELLS; HUMAN SKIN; INFLAMMATION; STAT3; PREVALENCE; METABOLISM	Impaired wound healing in elderly individuals increases infection risk and prolongs surgical recovery, but current treatment options are limited. Low doses of interleukin-15 (IL-15) that mimic exercise responses in the circulation improve skin structure and increase mitochondria in uninjured aged skin, suggesting that IL-15 is an essential mitochondrial signal for healing that is lost during aging. Here we used gene microarray analysis of old and young murine epidermal stem cells and demonstrate that aging results in a gene signature characteristic of bioenergetic dysfunction. Intravenous IL-15 treatment rescued chronological aging-induced healing defects and restored youthful wound closure in old, sedentary mice. Additionally, exercise-mediated improvements in the healing of aged skin depend upon circulating IL-15. We show that IL-15 induces signal transducer and activator of transcription 3 (STAT3) signaling characteristic of young animals, reduces markers of growth arrest, and increases keratinocyte and fibroblast growth. Moreover, exercise or exercise-mimicking IL-15 treatment rescued the age-associated decrease in epidermal mitochondrial complex IV activity. Overall, these results indicate that IL-15 or its analogs represent promising therapies for treating impaired wound healing in elderly patients.	[Wong, Wesley; Crane, Elizabeth D.; Kuo, Yikai; Kim, Austin; Crane, Justin D.] Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA	Northeastern University	Crane, JD (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA.	j.crane@northeastern.edu		Wong, Wesley/0000-0003-3333-6689; Kim, Austin/0000-0002-9675-9374; Crane, Justin/0000-0002-5380-5676	Northeastern University Provost's Office	Northeastern University Provost's Office	This work was supported by startup funding from the Northeastern University Provost's Office (to J. D. C.). J. D. C. is a co-holder of a patent involving the use of IL-15 as a therapy for skin disorders.	Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Birch-Machin MA, 2016, BRIT J DERMATOL, V175, P26, DOI 10.1111/bjd.14906; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; Carli F, 2005, CURR OPIN CLIN NUTR, V8, P23, DOI 10.1097/00075197-200501000-00005; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Davidson JM, 2013, ADV WOUND CARE, V2, P142, DOI 10.1089/wound.2012.0424; Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Eaglstein WH, 2012, WOUND REPAIR REGEN, V20, P793, DOI 10.1111/j.1524-475X.2012.00849.x; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emery CF, 2005, J GERONTOL A-BIOL, V60, P1432, DOI 10.1093/gerona/60.11.1432; Flanagan M, 2003, J Wound Care, V12, P189; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Frankel HC, 2012, ARCH DERMATOL, V148, P918, DOI 10.1001/archdermatol.2012.943; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; Gould Lisa, 2015, Wound Repair Regen, V23, P1, DOI 10.1111/wrr.12245; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Han G, 2017, ADV THER, V34, P599, DOI 10.1007/s12325-017-0478-y; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; HOLT DR, 1992, SURGERY, V112, P293; Horiuchi T, 2017, J BIOL CHEM, V292, P8436, DOI 10.1074/jbc.M116.769380; Jones AM, 2016, INT J MOL MED, V38, P679, DOI 10.3892/ijmm.2016.2687; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Margolis DJ, 2002, ANN EPIDEMIOL, V12, P321, DOI 10.1016/S1047-2797(01)00255-1; Naidoo K, 2018, EXP DERMATOL, V27, P124, DOI 10.1111/exd.13476; Park JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090245; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Quinn LS, 2010, EXP GERONTOL, V45, P106, DOI 10.1016/j.exger.2009.10.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/0600/2, DOI 10.1101/0600/2]; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Sorrentino JA, 2014, TRENDS MOL MED, V20, P375, DOI 10.1016/j.molmed.2014.04.004; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Swift ME, 1999, LAB INVEST, V79, P1479; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Uhl E, 2003, WOUND REPAIR REGEN, V11, P361, DOI 10.1046/j.1524-475X.2003.11508.x; Urabe H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2536; Vujic A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04083-1; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wang AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15901-9; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106	62	9	9	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20024	20038		10.1074/jbc.RA119.010740	http://dx.doi.org/10.1074/jbc.RA119.010740			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748415	hybrid, Green Published			2022-12-28	WOS:000505005800017
J	Gurjar, SA; Wheeler, JX; Wadhwa, M; Thorpe, R; Kimber, I; Derrick, JP; Dearman, RJ; Metcalfe, C				Gurjar, Shalom A.; Wheeler, Jun X.; Wadhwa, Meenu; Thorpe, Robin; Kimber, Ian; Derrick, Jeremy P.; Dearman, Rebecca J.; Metcalfe, Clive			The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; thioredoxin (Trx); monoclonal antibody; redox regulation; disulfide; antibody-dependent cellular cytotoxicity (ADCC); biotherapeutic; functional effects; safety and efficacy; disulfide bond; complement-dependent cytotoxicity (CDC)	HUMAN-IGG; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; IN-VITRO; TRASTUZUMAB; COMPLEX; BINDING; CELLS; FLEXIBILITY; MECHANISMS	Therapeutic mAbs are used to manage a wide range of cancers and autoimmune disorders. However, mAb-based treatments are not always successful, highlighting the need for a better understanding of the factors influencing mAb efficacy. Increased levels of oxidative stress associated with several diseases are counteracted by the activities of various oxidoreductase enzymes, such as thioredoxin (Trx), which also reduces allosteric disulfide bonds in proteins, including mAbs. Here, using an array of in vitro assays, we explored the functional effects of Trx-mediated reduction on the mechanisms of action of six therapeutic mAbs. We found that Trx reduces the interchain disulfide bonds of the mAbs, after which they remain intact but have altered function. In general, this reduction increased antigen-binding capacity, resulting in, for example, enhanced tumor necrosis factor (TNF) neutralization by two anti-TNF mAbs. Conversely, Trx reduction decreased the antiproliferative activity of an anti-tyrosine kinase-type cell-surface receptor HER2 mAb. In all of the mAbs, Fc receptor binding was abrogated by Trx activity, with significant loss in both complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) activity of the mAbs tested. We also confirmed that without alkylation, Trx-reduced interchain disulfide bonds reoxidize, and ADCC activity is restored. In summary, Trx-mediated reduction has a substantial impact on the functional effects of an mAb, including variable effects on antigen binding and Fc function, with the potential to significantly impact mAb efficacy in vivo.	[Gurjar, Shalom A.; Wadhwa, Meenu; Thorpe, Robin; Metcalfe, Clive] Natl Inst Biol Stand & Controls, Div Biotherapeut, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England; [Wheeler, Jun X.] Natl Inst Biol Stand & Controls, Div Technol Dev & Infrastruct, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England; [Kimber, Ian; Derrick, Jeremy P.; Dearman, Rebecca J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Lydia Becker Inst Immunol & Inflammat, Fac Biol Med & Hlth,Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Gurjar, Shalom A.] Oxford Genet, Medawar Ctr, Oxford Sci Pk,1 Robert Robinson Ave, Oxford OX4 4HG, England	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; University of Manchester	Metcalfe, C (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England.	clive.metcalfe@nibsc.org		Wadhwa, Meenu/0000-0002-2331-1093; Metcalfe, Clive/0000-0002-7856-8574	National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit)	National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit)	This paper is based on independent research commissioned and funded by the National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit). The views expressed in the publication are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR, the Department of Health, "arms-length" bodies, or other government departments. The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Burkitt W, 2010, PROTEIN SCI, V19, P826, DOI 10.1002/pro.362; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Ceccarelli J, 2008, INT J CANCER, V123, P1770, DOI 10.1002/ijc.23709; Curbo S, 2009, BIOCHEM BIOPH RES CO, V390, P1272, DOI 10.1016/j.bbrc.2009.10.134; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; ERICSON ML, 1992, LYMPHOKINE CYTOK RES, V11, P201; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Gurjar SA, 2017, J PHARMACEUT BIOMED, V143, P188, DOI 10.1016/j.jpba.2017.06.004; Heim K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.69; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255; Janeway C. J., 2001, IMMUNOBIOLOGY IMMUNE, P93; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Kohno T, 2007, J INVEST DERM SYMP P, V12, P5, DOI 10.1038/sj.jidsymp.5650034; Krayukhina E, 2017, MABS-AUSTIN, V9, P664, DOI 10.1080/19420862.2017.1297909; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu TB, 2018, CLIN RHEUMATOL, V37, P117, DOI 10.1007/s10067-017-3832-1; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Nahta Rita, 2012, ISRN Oncol, V2012, P428062, DOI 10.5402/2012/428062; PACE CN, 1988, J BIOL CHEM, V263, P11820; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PALMER JL, 1963, J BIOL CHEM, V238, P2393; Pellom ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081134; Perdriger A, 2009, BIOL-TARGETS THER, V3, P183; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Roux KH, 1997, J IMMUNOL, V159, P3372; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Saphire EO, 2003, ADV EXP MED BIOL, V535, P55; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sherrod SD, 2012, J PROTEOME RES, V11, P3467, DOI 10.1021/pr201240a; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stegmann M, 2013, EUR J IMMUNOL, V43, P15, DOI 10.1002/eji.201242849; Suzuki M, 2016, J BIOCHEM, V159, P67, DOI 10.1093/jb/mvv074; Suzuki M, 2013, BIOCHEM BIOPH RES CO, V436, P519, DOI 10.1016/j.bbrc.2013.05.137; Trexler-Schmidt M, 2010, BIOTECHNOL BIOENG, V106, P452, DOI 10.1002/bit.22699; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xie ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002543; Zhang AM, 2014, ANAL CHEM, V86, P3468, DOI 10.1021/ac404130a	57	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19616	19634		10.1074/jbc.RA119.010637	http://dx.doi.org/10.1074/jbc.RA119.010637			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727737	hybrid, Green Published			2022-12-28	WOS:000504093200014
J	Narayana, Y; Balaji, KN				Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy			NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages (vol 283, pg 12501, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19444	19444		10.1074/jbc.AAC119.011905	http://dx.doi.org/10.1074/jbc.AAC119.011905			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836671	hybrid, Green Published			2022-12-28	WOS:000516527800039
J	Su, LJ; Jiang, XF; Yang, C; Zhang, JH; Chen, B; Li, YM; Yao, SJ; Xie, Q; Gomez, H; Murugan, R; Peng, ZY				Su, Lianjiu; Jiang, Xiaofang; Yang, Cheng; Zhang, Jiahao; Chen, Bo; Li, Yiming; Yao, Shijie; Xie, Qin; Gomez, Hernando; Murugan, Raghavan; Peng, Zhiyong			Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ferroptosis; lipid peroxidation; panx1; ischemia/reperfusion; kidney injury; ROS; cell death; MAPK signaling	ACUTE KIDNEY INJURY; CELL-DEATH; IRON; METABOLISM; GLUTATHIONE; CYCLE; EXPRESSION; TRANSPORT; PATHWAYS; FORM	Renal ischemia/reperfusion injury (IRI) is a significant challenge in perioperative medicine and is related to oxidative programmed cell death. However, the role of ferroptosis, a newly discovered form of oxidative cell death, has not been evaluated widely. Pannexin 1 (PANX1), an ATP-releasing pathway family protein, has pro-apoptotic effects during kidney injury. Here, we demonstrate that PANX1 deletion protects against renal IRI by regulating ferroptotic cell death. Panx1-knockout mice subjected to renal IRI had decreased plasma creatinine, malondialdehyde (MDA) levels in kidney tissues, and tubular cell death (visible as decreased TUNEL-positive renal tubular cells) compared with wildtype (WT) mice. In cultured human kidney 2 (HK-2) cells, silenced Panx1 expression significantly attenuated ferroptotic lipid peroxidation and iron accumulation induced by the ferroptosis inducer erastin. Moreover, the Panx1 silencing significantly modulated ferroptosis-related protein expression. Furthermore, Panx1 deletion induced the expression of a cytoprotective chaperone, heme oxygenase-1 (HO-1), and inhibited ferroptinophagy via the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway. In summary, Panx1 deletion protects against renal IRI by attenuating MAPK/ERK activation in a ferroptotic pathway. Our findings provide critical insights into the role of PANX1 in ferroptotic cell death and highlight a potential therapeutic target for the management of acute kidney injury (AKI) during the perioperative period.	[Su, Lianjiu; Jiang, Xiaofang; Yang, Cheng; Zhang, Jiahao; Chen, Bo; Li, Yiming; Yao, Shijie; Xie, Qin; Peng, Zhiyong] Wuhan Univ, Zhongnan Hosp, Dept Crit Care Med, Wuhan 430071, Hubei, Peoples R China; [Gomez, Hernando; Murugan, Raghavan; Peng, Zhiyong] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Ctr Crit Nephrol, Pittsburgh, PA 15223 USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Peng, ZY (corresponding author), Wuhan Univ, Zhongnan Hosp, Crit Care Med, Wuhan 430000, Hubei, Peoples R China.	pengzy5@hotmail.com	Su, Lianjiu/AAA-2545-2022; Gomez, Hernando/ABB-4589-2020	Su, Lianjiu/0000-0001-6822-6602; 	National Natural Science Foundation of China [81560131]; Hubei Province Key Projects [WJ2017Z008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Key Projects	This project was supported by grant from National Natural Science Foundation of China [ZP, 81560131] and Hubei Province Key Projects [Z.P. WJ2017Z008]	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bauckman KA, 2016, AUTOPHAGY, V12, P850, DOI 10.1080/15548627.2016.1160176; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Chang LC, 2018, CANCER LETT, V416, P124, DOI 10.1016/j.canlet.2017.12.025; Cheloni G, 2013, CYTOM PART A, V83, P952, DOI 10.1002/cyto.a.22338; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Doll S, 2017, IUBMB LIFE, V69, P423, DOI 10.1002/iub.1616; Draganov D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16222; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Gu X, 2019, AM J TRANSL RES, V11, P3850; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jankowski J, 2018, J AM SOC NEPHROL, V29, P1887, DOI 10.1681/ASN.2017121306; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Li YM, 2019, BBA-MOL BASIS DIS, V1865, P558, DOI 10.1016/j.bbadis.2018.10.041; Lin L, 2018, MOL MED REP, V18, P3027, DOI 10.3892/mmr.2018.9282; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Makarenkova HP, 2018, J INFLAMM RES, V11, P273, DOI 10.2147/JIR.S128401; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Nissen JD, 2017, GLIA, V65, P474, DOI 10.1002/glia.23105; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Sang Q, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8731; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su LJ, 2018, BRIT J ANAESTH, V121, P350, DOI 10.1016/j.bja.2018.02.069; Su X, 2019, THERANOSTICS, V9, P4461, DOI 10.7150/thno.35219; Sun MZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06946-z; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Sun Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0794-4; Visarius TM, 1996, BIOCHEM PHARMACOL, V52, P259, DOI 10.1016/0006-2952(96)00203-1; Wang L, 2019, CELL DEATH DIFFER; Wang YH, 2019, AM J PHYSIOL-CELL PH, V317, pC68, DOI 10.1152/ajpcell.00117.2018; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xu J, 2018, J CELL PHYSIOL, V233, P2075, DOI 10.1002/jcp.25906; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; ZAGER RA, 1995, KIDNEY INT, V48, P1624, DOI 10.1038/ki.1995.457	45	84	88	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19395	19404		10.1074/jbc.RA119.010949	http://dx.doi.org/10.1074/jbc.RA119.010949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694915	hybrid, Green Published			2022-12-28	WOS:000516527800035
J	Walter, A; Unsleber, S; Rismondo, J; Jorge, AM; Peschel, A; Grundling, A; Mayer, C				Walter, Axel; Unsleber, Sandra; Rismondo, Jeanine; Jorge, Ana Maria; Peschel, Andreas; Gruendling, Angelika; Mayer, Christoph			Phosphoglycerol-type wall and lipoteichoic acids are enantiomeric polymers differentiated by the stereospecific glycerophosphodiesterase GlpQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						teichoic acid; cell wall; glycobiology; microbiology; Bacillus; Gram-positive bacteria; glycerolphosphate; lipoteichoic acid (LTA); stereochemistry; teichoicase; wall teichoic acid (WTA)	GRAM-POSITIVE BACTERIA; TEICHOIC-ACID; CELL-WALL; BACILLUS-SUBTILIS; D-ALANINE; PHOSPHODIESTERASE GDPD; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION	The cell envelope of Gram-positive bacteria generally comprises two types of polyanionic polymers linked to either peptidoglycan (wall teichoic acids; WTA) or to membrane glycolipids (lipoteichoic acids; LTA). In some bacteria, including Bacillus subtilis strain 168, both WTA and LTA are glycerolphosphate polymers yet are synthesized through different pathways and have distinct but incompletely understood morphogenetic functions during cell elongation and division. We show here that the exolytic sn-glycerol-3-phosphodiesterase GlpQ can discriminate between B. subtilis WTA and LTA. GlpQ completely degraded unsubstituted WTA, which lacks substituents at the glycerol residues, by sequentially removing glycerolphosphates from the free end of the polymer up to the peptidoglycan linker. In contrast, GlpQ could not degrade unsubstituted LTA unless it was partially precleaved, allowing access of GlpQ to the other end of the polymer, which, in the intact molecule, is protected by a connection to the lipid anchor. Differences in stereochemistry between WTA and LTA have been suggested previously on the basis of differences in their biosynthetic precursors and chemical degradation products. The differential cleavage of WTA and LTA by GlpQ reported here represents the first direct evidence that they are enantiomeric polymers: WTA is made of sn-glycerol-3-phosphate, and LTA is made of sn-glycerol-1-phosphate. Their distinct stereochemistries reflect the dissimilar physiological and immunogenic properties of WTA and LTA. It also enables differential degradation of the two polymers within the same envelope compartment in vivo, particularly under phosphate-limiting conditions, when B. subtilis specifically degrades WTA and replaces it with phosphate-free teichuronic acids.	[Walter, Axel; Unsleber, Sandra; Mayer, Christoph] Univ Tubingen, Microbiol Glycobiol, Interfac Inst Microbiol & Infect Med Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany; [Jorge, Ana Maria; Peschel, Andreas] Univ Tubingen, Infect Biol, Interfac Inst Microbiol & Infect Med Tubingen, D-72076 Tubingen, Germany; [Rismondo, Jeanine; Gruendling, Angelika] Imperial Coll London, Sect Mol Microbiol, London SW7 2AZ, England; [Rismondo, Jeanine; Gruendling, Angelika] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Rismondo, Jeanine] Georg August Univ Gottingen, Dept Gen Microbiol, GZMB, D-37077 Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Imperial College London; Imperial College London; University of Gottingen	Mayer, C (corresponding author), Univ Tubingen, Microbiol Glycobiol, Interfac Inst Microbiol & Infect Med Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.	christoph.mayer@uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851; Peschel, Andreas/0000-0002-3209-8626; Grundling, Angelika/0000-0002-6235-8687; Walter, Axel/0000-0001-9462-9712	Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC 2124]; MRC [MR/P011071/1, MR/P028225/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy (EXC 2124 Controlling Microbes to Fight Infections). The authors declare that they have no conflicts of interest with the contents of this article.	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; ARCHIBALD A, 1961, NATURE, V191, P570, DOI 10.1038/191570a0; ARMSTRONG JJ, 1959, NATURE, V184, P247, DOI 10.1038/184247a0; BADDILEY J, 1989, BIOESSAYS, V10, P207, DOI 10.1002/bies.950100607; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Bontemps-Gallo Sebastien, 2017, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0001-2017; Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; BROOKS D, 1971, J BACTERIOL, V107, P223, DOI 10.1128/JB.107.1.223-229.1971; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; CHILDS WC, 1980, J BACTERIOL, V143, P293, DOI 10.1128/JB.143.1.293-301.1980; DEBOER WR, 1976, EUR J BIOCHEM, V62, P1; Ellwood D. C., 1972, ADV MICROBIAL PHYSL, P82; ELLWOOD DC, 1969, BIOCHEM J, V111, P1; Fischer W., 1990, HDB LIPID RES, P123; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Gerlach D, 2018, NATURE, V563, P705, DOI 10.1038/s41586-018-0730-x; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Jorge AM, 2018, J BIOL CHEM, V293, P14916, DOI 10.1074/jbc.RA118.004584; Jorge AM, 2017, MOL MICROBIOL, V103, P229, DOI 10.1111/mmi.13552; Kho K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00017-18; Kluj RM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02725; Kohler T, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P75; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Matias VRF, 2008, J BACTERIOL, V190, P7414, DOI 10.1128/JB.00581-08; Mayer C, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.006; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Myers CL, 2016, J BIOL CHEM, V291, P26066, DOI 10.1074/jbc.M116.760447; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Pooley HM, 2000, MICROBIOL-SGM, V146, P797, DOI 10.1099/00221287-146-4-797; Potekhina NV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P745, DOI 10.1134/S0006297911070042; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Rismondo J., 2019, GTCA IS REQUIRED LTA, DOI [10.1101/2019.12.12.873851, DOI 10.1101/2019.12.12.873851]; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Romaniuk JAH, 2018, BIOCHEMISTRY-US, V57, P3966, DOI 10.1021/acs.biochem.8b00495; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; van Dalen R, 2019, MBIO, V10, DOI 10.1128/mBio.00330-19; van der Es D, 2017, CHEM SOC REV, V46, P1464, DOI 10.1039/c6cs00270f; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wood BM, 2018, J BIOL CHEM, V293, P17985, DOI 10.1074/jbc.RA118.004561; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	58	11	11	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4024	4034		10.1074/jbc.RA120.012566	http://dx.doi.org/10.1074/jbc.RA120.012566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047114	hybrid, Green Published			2022-12-28	WOS:000527704400026
J	Mayr, SJ; Roper, J; Schwarz, G				Mayr, Simon J.; Roeper, Juliane; Schwarz, Guenter			Alternative splicing of the bicistronic gene molybdenum cofactor synthesis 1 (MOCS1) uncovers a novel mitochondrial protein maturation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; iron-sulfur protein; mitochondrial transport; molybdenum; S-adenosylmethionine (SAM); molybdenum cofactor; radical SAM enzyme	DEFICIENCY TYPE-A; GENOMIC STRUCTURE; BIOSYNTHESIS; MUTATIONS; SEQUENCES; ENZYMES; RNA; PH	Molybdenum cofactor (Moco) biosynthesis is a highly conserved multistep pathway. The first step, the conversion of GTP to cyclic pyranopterin monophosphate (cPMP), requires the bicistronic gene molybdenum cofactor synthesis 1 (MOCS1). Alternative splicing of MOCS1 within exons 1 and 9 produces four different N-terminal and three different C-terminal products (type I?III). Type I splicing results in bicistronic transcripts with two open reading frames, of which only the first, MOCS1A, is translated, whereas type II/III splicing produces MOCS1AB proteins. Here, we first report the cellular localization of alternatively spliced human MOCS1 proteins. Using fluorescence microscopy, fluorescence spectroscopy, and cell fractionation experiments, we found that depending on the alternative splicing of exon 1, type I splice variants (MOCS1A) either localize to the mitochondrial matrix (exon 1a) or remain cytosolic (exon 1b). MOCS1A proteins required exon 1a for mitochondrial translocation, but fluorescence microscopy of MOCS1AB variants (types II and III) revealed that they were targeted to mitochondria independently of exon 1 splicing. In the latter case, cell fractionation experiments displayed that mitochondrial matrix import was facilitated via an internal motif overriding the N-terminal targeting signal. Within mitochondria, MOCS1AB underwent proteolytic cleavage resulting in mitochondrial matrix localization of the MOCS1B domain. In conclusion, MOCS1 produces two functional proteins, MOCS1A and MOCS1B, which follow different translocation routes before mitochondrial matrix import for cPMP biosynthesis involving both proteins. MOCS1 protein maturation provides a novel alternative splicing mechanism that ensures the coordinated mitochondrial targeting of two functionally related proteins encoded by a single gene.	[Mayr, Simon J.; Roeper, Juliane; Schwarz, Guenter] Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; [Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-5931 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zulpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021	Schwarz, Guenter/0000-0002-2118-9338; Mayr, Simon Julius/0000-0002-0465-1121	Deutsche Forschungsgemeinschaft (DFG) [SCHW 759/10-1/2, SFB1218]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SCHW 759/10-1/2 (to G. S. and S. J. M.) and SFB1218, B08 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arenas M, 2009, J INHERIT METAB DIS, V32, P560, DOI 10.1007/s10545-009-1151-7; Backes S, 2018, J CELL BIOL, V217, P1369, DOI 10.1083/jcb.201708044; Belaidi AA, 2013, BIOCHEM J, V450, P149, DOI 10.1042/BJ20121078; Ciofi-Baffoni S, 2018, METALLOMICS, V10, P49, DOI 10.1039/c7mt00269f; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gray TA, 2000, RNA, V6, P928, DOI 10.1017/S1355838200000182; Gross-Hardt S, 2002, MOL GENET METAB, V76, P340, DOI 10.1016/S1096-7192(02)00100-2; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hartmann B, 2016, ELIFE, V5, DOI 10.7554/eLife.16078; Hover BM, 2015, P NATL ACAD SCI USA, V112, P6347, DOI 10.1073/pnas.1500697112; Hover BM, 2015, J AM CHEM SOC, V137, P3352, DOI 10.1021/ja512997j; Judes A, 2015, FEBS LETT, V589, P904, DOI 10.1016/j.febslet.2015.02.024; Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028; Kugler S, 2007, AM J HUM GENET, V80, P291, DOI 10.1086/511281; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lu YM, 2013, AMINO ACIDS, V44, P597, DOI 10.1007/s00726-012-1380-1; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Mayr SJ, 2018, J INHERIT METAB DIS, V41, P187, DOI 10.1007/s10545-018-0138-7; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Reiss J, 2011, HUM MUTAT, V32, P10, DOI 10.1002/humu.21390; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schwahn BC, 2015, LANCET, V386, P1955, DOI 10.1016/S0140-6736(15)00124-5; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Veldman A, 2010, PEDIATRICS, V125, pE1249, DOI 10.1542/peds.2009-2192; Wuebbens MM, 2000, STRUCTURE, V8, P709, DOI 10.1016/S0969-2126(00)00157-X	37	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3029	3039		10.1074/jbc.RA119.010720	http://dx.doi.org/10.1074/jbc.RA119.010720			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996372	hybrid, Green Published			2022-12-28	WOS:000519597300013
J	Reyes-Vargas, E; Barker, AP; Zhou, ZM; He, X; Jensen, PE				Reyes-Vargas, Eduardo; Barker, Adam P.; Zhou, Zemin; He, Xiao; Jensen, Peter E.			HLA-DM catalytically enhances peptide dissociation by sensing peptide?MHC class II interactions throughout the peptide-binding cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; antigen processing; major histocompatibility complex (MHC); peptide interaction; kinetics; fluorescence anisotropy; catalysis; Michaelis-Menten; immunogenicity; immunology	MHC PROTEIN HLA-DR1; ANTIGEN PRESENTATION; INVARIANT CHAIN; CUTTING EDGE; HYDROGEN-BONDS; DR MOLECULES; CRYSTAL-STRUCTURE; COMPLEX; SUSCEPTIBILITY; EXCHANGE	Human leukocyte antigen-DM (HLA-DM) is an integral component of the major histocompatibility complex class II (MHCII) antigen-processing and -presentation pathway. HLA-DM shapes the immune system by differentially catalyzing peptide exchange on MHCII molecules, thereby editing the peptide-MHCII (pMHCII) repertoire by imposing a bias on the foreign and self-derived peptide cargos that are presented on the cell surface for immune surveillance and tolerance induction by CD4(+) T cells. To better understand DM selectivity, here we developed a real-time fluorescence anisotropy assay to delineate the pMHCII intrinsic stability, DM-binding affinity, and catalytic turnover, independent kinetic parameters of HLA-DM enzymatic activity. We analyzed prominent pMHCII contacts by differentiating the kinetic parameters in pMHCII homologs, observing that peptide interactions throughout the MHCII-binding cleft influence both the rate of peptide dissociation from the DM-pMHCII catalytic complex and the binding affinity of HLA-DM for a pMHCII. We show that the intrinsic stability of a pMHCII linearly correlates with DM catalytic turnover, but is nonlinearly correlated with its binding affinity. Surprisingly, interactions at the peptides N terminus up to and including MHCII position one (P1) anchor affected the catalytic turnover, suggesting that the active DM-pMHCII catalytic complex operates on pMHCII complexes with full peptide occupancy. Furthermore, interactions at the peptide C terminus modulated DM-binding affinity, suggesting distal communication between peptide interactions with the MHCII and the DM-pMHCII binding interface. Our results imply an intimate linkage between the DM-pMHCII interface and peptide-MHCII interactions throughout the peptide-binding cleft.	[Reyes-Vargas, Eduardo; Barker, Adam P.; Zhou, Zemin; He, Xiao; Jensen, Peter E.] Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84112 USA; [Barker, Adam P.; Jensen, Peter E.] ARUP Inst Clin & Expt Pathol, Dept Pathol, ARUP Labs, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	He, X; Jensen, PE (corresponding author), Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84112 USA.; Jensen, PE (corresponding author), ARUP Inst Clin & Expt Pathol, Dept Pathol, ARUP Labs, Salt Lake City, UT 84108 USA.	xiao.he@path.utah.edu; peter.jensen@path.utah.edu		Jensen, Peter/0000-0002-1639-8223; Reyes-Vargas, Eduardo/0000-0003-3984-9274; He, Xiao/0000-0002-9286-9859	University of Utah Endowed Chair Fund	University of Utah Endowed Chair Fund	This work was supported by the University of Utah Endowed Chair Fund (to P. E. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bandyopadhyay A, 2008, MOL IMMUNOL, V45, P1248, DOI 10.1016/j.molimm.2007.09.011; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Belmares MP, 2001, BIOCHEMISTRY-US, V40, P10284, DOI 10.1021/bi010156r; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; Ferrante A, 2015, J IMMUNOL, V195, P1251, DOI 10.4049/jimmunol.1402367; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; Jensen PE, 1999, IMMUNOL REV, V172, P229, DOI 10.1111/j.1600-065X.1999.tb01368.x; Jensen PE, 1997, BIOPOLYMERS, V43, P303; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Rosloniec EF, 2006, J IMMUNOL, V177, P3884, DOI 10.4049/jimmunol.177.6.3884; Runnels HA, 1997, MOL IMMUNOL, V34, P471, DOI 10.1016/S0161-5890(97)00043-6; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schulze MSED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069228; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Vacchino JF, 2001, J IMMUNOL, V166, P6680, DOI 10.4049/jimmunol.166.11.6680; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wieczorek M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13224; WOLF PR, 1995, NATURE, V376, P464, DOI 10.1038/376464a0; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Yin LS, 2014, J BIOL CHEM, V289, P23449, DOI 10.1074/jbc.M114.585539; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zhou ZM, 2017, EUR J IMMUNOL, V47, P314, DOI 10.1002/eji.201646656; Zhou ZM, 2016, EUR J IMMUNOL, V46, P834, DOI 10.1002/eji.201545942; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	58	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2959	2973		10.1074/jbc.RA119.010645	http://dx.doi.org/10.1074/jbc.RA119.010645			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31969393	Green Published, hybrid			2022-12-28	WOS:000519597300008
J	Navaratnarajah, CK; Generous, AR; Yousaf, I; Cattaneo, R				Navaratnarajah, Chanakha K.; Generous, Alex R.; Yousaf, Iris; Cattaneo, Roberto			Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						virology; virus entry; measles; receptor; negative-strand RNA virus; microbiology; infection; host-pathogen interaction; cell invasion; animal virus; morbillivirus; Nipah virus; paramyxovirus; pathogenesis; sialic acid	MEASLES-VIRUS HEMAGGLUTININ; ACTIVATION MOLECULE SLAM; SUBACUTE SCLEROSING-PANENCEPHALITIS; NIPAH-VIRUS; HENDRA-VIRUS; MEMBRANE-FUSION; ATTACHMENT PROTEIN; STALK DOMAIN; SIALIC-ACID; EPITHELIAL RECEPTOR	Research in the last decade has uncovered many new paramyxoviruses, airborne agents that cause epidemic diseases in animals including humans. Most paramyxoviruses enter epithelial cells of the airway using sialic acid as a receptor and cause only mild disease. However, others cross the epithelial barrier and cause more severe disease. For some of these viruses, the host receptors have been identified, and the mechanisms of cell entry have been elucidated. The tetrameric attachment proteins of paramyxoviruses have vastly different binding affinities for their cognate receptors, which they contact through different binding surfaces. Nevertheless, all input signals are converted to the same output: conformational changes that trigger refolding of trimeric fusion proteins and membrane fusion. Experiments with selectively receptor-blinded viruses inoculated into their natural hosts have provided insights into tropism, identifying the cells and tissues that support growth and revealing the mechanisms of pathogenesis. These analyses also shed light on diabolically elegant mechanisms used by morbilliviruses, including the measles virus, to promote massive amplification within the host, followed by efficient aerosolization and rapid spread through host populations. In another paradigm of receptor-facilitated severe disease, henipaviruses, including Nipah and Hendra viruses, use different members of one protein family to cause zoonoses. Specific properties of different paramyxoviruses, like neurotoxicity and immunosuppression, are now understood in the light of receptor specificity. We propose that research on the specific receptors for several newly identified members of the Paramyxoviridae family that may not bind sialic acid is needed to anticipate their zoonotic potential and to generate effective vaccines and antiviral compounds.	[Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Generous, Alex R.; Yousaf, Iris] Mayo Clin, Grad Sch Biomed Sci, Virol & Gene Therapy Track, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Cattaneo, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	cattaneo.roberto@mayo.edu		Navaratnarajah, Chanakha/0000-0002-4513-8412	Mayo Clinic Center for Biological Discovery grant	Mayo Clinic Center for Biological Discovery grant	This work was supported by a Mayo Clinic Center for Biological Discovery grant (to R. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ader N, 2013, J VIROL, V87, P314, DOI 10.1128/JVI.01826-12; Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; Ader-Ebert N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004880; Aguayo-Hiraldo PI, 2017, J INFECT DIS, V216, P153, DOI 10.1093/infdis/jix203; Aguilar HC, 2016, CURR CLIN MICROBIOL, V3, P142, DOI 10.1007/s40588-016-0040-8; Apte-Sengupta S, 2013, J VIROL, V87, P10401, DOI 10.1128/JVI.01547-13; Apte-Sengupta S, 2012, J BIOL CHEM, V287, P33026, DOI 10.1074/jbc.M112.373308; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Bender RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005641; Bennett KM, 2013, AM J RESP CELL MOL, V49, P680, DOI 10.1165/rcmb.2013-0002OC; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bose S, 2013, J VIROL, V87, P13520, DOI 10.1128/JVI.02123-13; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Bossart KN, 2013, ADV EXP MED BIOL, V790, P95, DOI 10.1007/978-1-4614-7651-1_6; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, J VIROL, V84, P6208, DOI 10.1128/JVI.00317-10; Brancati F, 2010, AM J HUM GENET, V87, P265, DOI 10.1016/j.ajhg.2010.07.003; Brindley MA, 2015, J VIROL, V89, P1230, DOI 10.1128/JVI.02754-14; Brindley MA, 2013, J VIROL, V87, P11693, DOI 10.1128/JVI.01945-13; Broder CC, 2016, VACCINE, V34, P3525, DOI 10.1016/j.vaccine.2016.03.075; CATTANEO R, 1987, EMBO J, V6, P681, DOI 10.1002/j.1460-2075.1987.tb04808.x; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Clayton BA, 2012, EMERG INFECT DIS, V18, P1983, DOI 10.3201/eid1812.120875; COLLINS PL, 1991, J VIROL, V65, P2362, DOI 10.1128/JVI.65.5.2362-2371.1991; Condack C, 2007, J INFECT DIS, V196, P541, DOI 10.1086/519689; Cortez KJ, 2001, J INFECT DIS, V184, P1093, DOI 10.1086/322041; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Delpeut S, 2017, J VIROL, V91, DOI 10.1128/JVI.02490-16; Desfosses A, 2019, P NATL ACAD SCI USA, V116, P4256, DOI 10.1073/pnas.1816417116; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Diederich S, 2008, VIROLOGY, V375, P391, DOI 10.1016/j.virol.2008.02.019; Dines M, 2015, NEUROBIOL LEARN MEM, V124, P62, DOI 10.1016/j.nlm.2015.07.003; Donohue RC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007605; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Du Pont V, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007995; Durbin AP, 2000, VACCINE, V18, P2462, DOI 10.1016/S0264-410X(99)00575-7; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Figueira TN, 2017, J VIROL, V91, DOI 10.1128/JVI.01554-16; Frenzke M, 2013, J VIROL, V87, P2526, DOI 10.1128/JVI.03037-12; Fukuhara H, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080761; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Generous AR, 2019, J CELL SCI, V132, DOI 10.1242/jcs.235507; Gui L, 2015, MBIO, V6, DOI 10.1128/mBio.02393-14; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Gutsche I, 2015, SCIENCE, V348, P704, DOI 10.1126/science.aaa5137; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hammond AL, 2001, J VIROL, V75, P2087, DOI 10.1128/JVI.75.5.2087-2096.2001; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2018, P NATL ACAD SCI USA, V115, P2496, DOI 10.1073/pnas.1718957115; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Herren M, 2018, J VIROL, V92, DOI 10.1128/JVI.00679-18; Hsu EC, 1997, J VIROL, V71, P6144, DOI 10.1128/JVI.71.8.6144-6154.1997; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Ke ZL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04058-2; Krumm SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008517; Kubota M, 2016, P NATL ACAD SCI USA, V113, P11579, DOI 10.1073/pnas.1608383113; Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x; Laing ED, 2019, P NATL ACAD SCI USA, V116, P20707, DOI 10.1073/pnas.1911773116; Laing ED, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0964-0; Laksono BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07515-0; Laksono BM, 2018, J VIROL, V92, DOI 10.1128/JVI.00131-18; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lecouturier V, 1996, J VIROL, V70, P4200, DOI 10.1128/JVI.70.7.4200-4204.1996; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Leonard VHJ, 2010, J VIROL, V84, P3413, DOI 10.1128/JVI.02304-09; Lieu KG, 2015, ANTIVIR RES, V124, P69, DOI 10.1016/j.antiviral.2015.09.017; Liu J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129629; Liu Q, 2015, J VIROL, V89, P1838, DOI 10.1128/JVI.02277-14; Liu Q, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003770; Ludlow M, 2013, J VIROL, V87, P4033, DOI 10.1128/JVI.03258-12; Maar D, 2012, J VIROL, V86, P6632, DOI 10.1128/JVI.00076-12; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Mateo M, 2014, CURR OPIN VIROL, V5, P16, DOI 10.1016/j.coviro.2014.01.004; Mateo M, 2013, J VIROL, V87, P9208, DOI 10.1128/JVI.01210-13; Mathieu C, 2015, J VIROL, V89, P1143, DOI 10.1128/JVI.02417-14; Maziarz RT, 2010, BIOL BLOOD MARROW TR, V16, pS166, DOI 10.1016/j.bbmt.2009.09.014; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Mire CE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30916; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Morens DM, 2011, J INFECT DIS, V204, P502, DOI 10.1093/infdis/jir327; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Navaratnarajah CK, 2016, J VIROL, V90, P68, DOI 10.1128/JVI.02253-15; Navaratnarajah CK, 2014, J VIROL, V88, P6158, DOI 10.1128/JVI.02846-13; Navaratnarajah CK, 2012, J BIOL CHEM, V287, P38543, DOI 10.1074/jbc.M112.410563; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Negrete OA, 2007, J VIROL, V81, P10804, DOI 10.1128/JVI.00999-07; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ottolini MG, 2002, J INFECT DIS, V186, P1713, DOI 10.1086/345834; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Pfaller CK, 2020, J VIROL, V94, DOI 10.1128/JVI.01733-19; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2015, VIROLOGY, V479, P331, DOI 10.1016/j.virol.2015.01.029; Plattet P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040112; Plemper RK, 2001, J BIOL CHEM, V276, P44239, DOI 10.1074/jbc.M105967200; PORTER DD, 1991, J VIROL, V65, P103, DOI 10.1128/JVI.65.1.103-111.1991; Pryce R, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900578; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; RICHARDSON C, 1986, VIROLOGY, V155, P508, DOI 10.1016/0042-6822(86)90212-6; Rima B, 2019, J GEN VIROL, V100, P1593, DOI 10.1099/jgv.0.001328; Roberts A.R.G.D.P., 2013, FIELDS VIROLOGY, V6th, P957; Rota PA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.49; Santiago C, 2002, J BIOL CHEM, V277, P32294, DOI 10.1074/jbc.M202973200; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Satterfield BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8483; Sawatsky B, 2012, J VIROL, V86, P3658, DOI 10.1128/JVI.06414-11; Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971; Schneider U, 2000, J VIROL, V74, P9928, DOI 10.1128/JVI.74.21.9928-9936.2000; Schomacker H, 2012, CURR OPIN VIROL, V2, P294, DOI 10.1016/j.coviro.2012.02.001; Schountz T, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030291; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh RK, 2019, VET QUART, V39, P26, DOI 10.1080/01652176.2019.1580827; Svitek N, 2014, J VIROL, V88, P2941, DOI 10.1128/JVI.03076-13; Takimoto T, 2000, VIROLOGY, V270, P208, DOI 10.1006/viro.2000.0263; Talekar A, 2013, J VIROL, V87, P13619, DOI 10.1128/JVI.02256-13; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Watanabe S, 2019, TRENDS MICROBIOL, V27, P164, DOI 10.1016/j.tim.2018.08.010; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Welch BD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003534; Wendorf KA, 2017, CLIN INFECT DIS, V65, P226, DOI 10.1093/cid/cix302; Wong KT, 2012, CURR TOP MICROBIOL, V359, P95, DOI 10.1007/82_2012_205; Wong KT, 2009, NEUROPATH APPL NEURO, V35, P296, DOI 10.1111/j.1365-2990.2008.00991.x; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wu H, 1996, P NATL ACAD SCI USA, V93, P15030, DOI 10.1073/pnas.93.26.15030; Wu WX, 2004, VIROLOGY, V325, P340, DOI 10.1016/j.virol.2004.05.013; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu K, 2008, P NATL ACAD SCI USA, V105, P9953, DOI 10.1073/pnas.0804797105; Xu K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003684; Xu K, 2012, SEMIN CELL DEV BIOL, V23, P116, DOI 10.1016/j.semcdb.2011.12.005; Xu R, 2013, MBIO, V4, DOI 10.1128/mBio.00803-13; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zeltina A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005390; Zhang XA, 2013, NAT STRUCT MOL BIOL, V20, P67, DOI 10.1038/nsmb.2432	155	31	32	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2771	2786		10.1074/jbc.REV119.009961	http://dx.doi.org/10.1074/jbc.REV119.009961			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31949044	Green Published, hybrid			2022-12-28	WOS:000519969100021
J	Mehta, SJK; Kumar, V; Mishra, RK				Mehta, Saurabh Jayesh Kumar; Kumar, Vimlesh; Mishra, Ram Kumar			Drosophila ELYS regulates Dorsal dynamics during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-?B transcription factor; nuclear envelope; nuclear pore; nuclear organization; nuclear translocation; nuclear structure; development; Drosophila; Drosophila genetics	NF-KAPPA-B; NUCLEAR-PORE COMPLEX; TRANSCRIPTION FACTORS; NUP107-160 COMPLEX; NUCLEOPORIN; CHROMATIN; ENVELOPE; APOPTOSIS; ORGANIZATION; DCP-1	Embryonic large molecule derived from yolk sac (ELYS) is a constituent protein of nuclear pores. It initiates assembly of nuclear pore complexes into functional nuclear pores toward the end of mitosis. Using cellular, molecular, and genetic tools, including fluorescence and Electron microscopy, quantitative PCR, and RNAi-mediated depletion, we report here that the ELYS ortholog (dElys) plays critical roles during Drosophila development. dElys localized to the nuclear rim in interphase cells, but during mitosis it was absent from kinetochores and enveloped chromatin. We observed that RNAi-mediated dElys depletion leads to aberrant development and, at the cellular level, to defects in the nuclear pore and nuclear lamina assembly. Further genetic analyses indicated that dElys depletion re-activates the Dorsal (NF-?B) pathway during late larval stages. Re-activated Dorsal caused untimely expression of the Dorsal target genes in the post-embryonic stages. We also demonstrate that activated Dorsal triggers apoptosis during later developmental stages by up-regulating the pro-apoptotic genes reaper and hid. The apoptosis induced by Reaper and Hid was probably the underlying cause for developmental abnormalities observed upon dElys depletion. Moreover, we noted that dElys has conserved structural features, but contains a noncanonical AT-hook?like motif through which it strongly binds to DNA. Together, our results uncover a novel epistatic interaction that regulates Dorsal dynamics by dElys during development.	[Mehta, Saurabh Jayesh Kumar; Mishra, Ram Kumar] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Nups & SUMO Biol Grp, Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India; [Kumar, Vimlesh] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Neurogenet Lab, Acad Bldg 3,Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal; Indian Institute of Science Education & Research (IISER) - Bhopal	Mishra, RK (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Nups & SUMO Biol Grp, Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India.	rkmishra@iiserb.ac.in	Mishra, Ram/AAJ-1538-2020; Mishra, Ram/ABA-6071-2020	Mishra, Ram/0000-0002-9528-0476; Mehta, Saurabh Jayesh Kumar/0000-0002-0474-2429; Kumar, Vimlesh/0000-0003-2206-4905	Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India [EMR/2016/001819]; Indian Institute of Science Education and Research-Bhopal; CSIR-UGC; IISER-Bhopal	Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India; Indian Institute of Science Education and Research-Bhopal; CSIR-UGC(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); IISER-Bhopal	This work was supported by an extramural grant from the Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India, Grant EMR/2016/001819 (to R. K. M.) and Intramural Funding from the Indian Institute of Science Education and Research-Bhopal. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CSIR-UGC and IISER-Bhopal.	Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Andlauer TFM, 2014, ELIFE, V3, DOI 10.7554/eLife.03895; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Banerjee HN, 2010, MOL CELL BIOCHEM, V343, P21, DOI 10.1007/s11010-010-0494-6; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bilokapic S, 2013, STRUCTURE, V21, P572, DOI 10.1016/j.str.2013.02.006; Buster Daniel W, 2010, J Vis Exp, DOI 10.3791/1982; Campbell K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007167; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cerveny KL, 2010, DEVELOPMENT, V137, P2107, DOI 10.1242/dev.047753; Choudhury SD, 2017, SYNAPSE, V71, DOI 10.1002/syn.21969; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DeVorkin L, 2014, J CELL BIOL, V205, P477, DOI 10.1083/jcb.201303144; Emtage JLT, 1997, J CELL SCI, V110, P911; Espin-Palazon R, 2016, EXP HEMATOL, V44, P519, DOI 10.1016/j.exphem.2016.03.010; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Fatima R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027822; Fernandez AG, 2006, CURR BIOL, V16, P1757, DOI 10.1016/j.cub.2006.07.071; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gao N, 2011, GASTROENTEROLOGY, V140, P1547, DOI 10.1053/j.gastro.2011.01.048; Genenncher B, 2016, PLANT PHYSIOL, V172, P1293, DOI 10.1104/pp.16.00832; Georgieva S, 2000, MOL CELL BIOL, V20, P1639, DOI 10.1128/MCB.20.5.1639-1648.2000; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gomez-Saldivar G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006131; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Gullaud M, 2003, CELL DEATH DIFFER, V10, P641, DOI 10.1038/sj.cdd.4401222; HAREL A, 1989, J CELL SCI, V94, P463; Hattersley N, 2016, DEV CELL, V38, P463, DOI 10.1016/j.devcel.2016.08.006; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Ilyin AA, 2017, NUCLEIC ACIDS RES, V45, P7666, DOI 10.1093/nar/gkx355; Johansen KM, 2004, METH MOL B, V247, P215; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Katsani KR, 2008, MOL BIOL CELL, V19, P3652, DOI 10.1091/mbc.E07-11-1162; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimura N, 2002, GENES CELLS, V7, P435, DOI 10.1046/j.1365-2443.2002.00529.x; Kuhn TM, 2019, J CELL BIOL, V218, P2945, DOI 10.1083/jcb.201807139; Lim HY, 2006, DEVELOPMENT, V133, P3529, DOI 10.1242/dev.02524; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Mimura Y, 2016, J CELL SCI, V129, P4200, DOI 10.1242/jcs.190678; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Okita K, 2003, BIOCHEM BIOPH RES CO, V305, P327, DOI 10.1016/S0006-291X(03)00772-1; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061; Park MH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020015; Parrott BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025087; Pascual-Garcia P, 2017, MOL CELL, V66, P63, DOI 10.1016/j.molcel.2017.02.020; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; RIEMER D, 1995, J CELL SCI, V108, P3189; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Sonneville R, 2015, CELL REP, V12, P405, DOI 10.1016/j.celrep.2015.06.046; Uv AE, 2000, GENE DEV, V14, P1945; Velentzas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080530; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Vollmer B, 2015, DEV CELL, V33, P717, DOI 10.1016/j.devcel.2015.04.027; Wagner N, 2004, J CELL SCI, V117, P2015, DOI 10.1242/jcs.01052; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yang XJ, 2015, MOL CELL BIOL, V35, P1110, DOI 10.1128/MCB.01181-14; Yokoyama H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4270; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	87	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2421	2437		10.1074/jbc.RA119.009451	http://dx.doi.org/10.1074/jbc.RA119.009451			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31941789	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000517330200023
J	Musilli, S; Abramowski, V; Roch, B; de Villartay, JP				Musilli, Stefania; Abramowski, Vincent; Roch, Benoit; de Villartay, Jean-Pierre			An in vivo study of the impact of deficiency in the DNA repair proteins PAXX and XLF on development and maturation of the hemolymphoid system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; immunology; lymphocyte; genetics; gene knockout; double-strand break; immunogenetics; immunoglobulin class switch recombination; lymphoma; V(D)J recombination	V(D)J RECOMBINATION; LETHALITY; XRCC4; MICE; MECHANISMS; EXPRESSION; PATHWAYS	Repair of DNA double-strand breaks by the nonhomologous end joining pathway is central for proper development of the adaptive immune system. This repair pathway involves eight factors, including XRCC4-like factor (XLF)/Cernunnos and the paralog of XRCC4 and XLF, PAXX nonhomologous end joining factor (PAXX). Xlf(?/?) and Paxx(?/?) mice are viable and exhibit only a mild immunophenotype. However, mice lacking both PAXX and XLF are embryonic lethal because postmitotic neurons undergo massive apoptosis in embryos. To decipher the roles of PAXX and XLF in both variable, diversity, and joining recombination and immunoglobulin class switch recombination, here, using Cre/lox-specific deletion to prevent double-KO embryonic lethality, we developed two mouse models of a conditional Xlf KO in a Paxx(?/?) background. Cre expressed under control of the iVav or CD21 promoter enabled Xlf deletion in early hematopoietic progenitors and splenic mature B cells, respectively. We demonstrate the XLF and PAXX interplay during variable, diversity, and joining recombination in vivo but not during class switch recombination, for which PAXX appeared to be fully dispensable. Xlf/Paxx double KO in hematopoietic progenitors resulted in a shorter lifespan associated with onset of thymic lymphomas, revealing a genome caretaking function of XLF/PAXX.	[Musilli, Stefania; Abramowski, Vincent; Roch, Benoit; de Villartay, Jean-Pierre] Univ Paris, Lab Genome Dynam Immune Syst, Imagine Inst, INSERM,UMR 1163, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	de Villartay, JP (corresponding author), INSERM, UMR1163, Inst Imagine, Equipe Labellisee La Ligue, 24 Bd Montparnasse, F-75015 Paris, France.	devillartay@gmail.com	de villartay, jeanpierre/H-9353-2017	de villartay, jeanpierre/0000-0001-5987-0463	INSERM; Institut National du Cancer [INCa PLBIO16-280]; La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE); AT-Europe Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National du Cancer(Institut National du Cancer (INCA) France); La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE); AT-Europe Foundation	This work was supported by grants from INSERM and the Institut National du Cancer (INCa PLBIO16-280) and by grants from La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE) and the AT-Europe Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the AT-Europe Foundation.	Abramowski V, 2018, CELL DEATH DIFFER, V25, P444, DOI 10.1038/cdd.2017.184; Arya R, 2017, TRENDS GENET, V33, P479, DOI 10.1016/j.tig.2017.04.006; Balmus G, 2016, GENE DEV, V30, P2152, DOI 10.1101/gad.290510.116; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Betermier M, 2020, TRENDS CELL BIOL, V30, P87, DOI 10.1016/j.tcb.2019.11.005; Bhargava R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04867-5; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; de Villartay JP, 2015, BRIT MED BULL, V114, P157, DOI 10.1093/bmb/ldv020; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; Deriano L, 2011, NATURE, V471, P119, DOI 10.1038/nature09755; Dewan A, 2018, FEBS OPEN BIO, V8, P442, DOI 10.1002/2211-5463.12380; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gago-Fuentes R, 2018, FEBS OPEN BIO, V8, P426, DOI 10.1002/2211-5463.12381; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Han L, 2008, J EXP MED, V205, P2745, DOI 10.1084/jem.20081623; Hung PJ, 2018, MOL CELL, V71, P332, DOI 10.1016/j.molcel.2018.06.018; Hung PJ, 2017, CELL CYCLE, V16, P286, DOI 10.1080/15384101.2016.1253640; Kumar V, 2016, P NATL ACAD SCI USA, V113, P10619, DOI 10.1073/pnas.1611882113; Kumar V, 2014, DNA REPAIR, V16, P11, DOI 10.1016/j.dnarep.2014.01.010; Lescale C, 2016, CELL REP, V16, P2967, DOI 10.1016/j.celrep.2016.08.069; Lescale C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10529; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Roch B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00443; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Takahashi K, 1997, J IMMUNOL, V159, P1557; Vera G, 2013, MOL CELL BIOL, V33, P701, DOI 10.1128/MCB.01057-12; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhao BL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11507-z	35	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2398	2406		10.1074/jbc.AC119.010924	http://dx.doi.org/10.1074/jbc.AC119.010924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31915249	hybrid, Green Published			2022-12-28	WOS:000517330200021
J	Gupta, A; Okesli-Armlovich, A; Morgens, D; Bassik, MC; Khosla, C				Gupta, Amita; Okesli-Armlovich, Aye; Morgens, David; Bassik, Michael C.; Khosla, Chaitan			A genome-wide analysis of targets of macrolide antibiotics in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; shRNA; drug action; mitochondria; natural product; erythromycin; josamycin; mitochondrial translation	ACTIVATED PROTEIN-KINASE; IN-VITRO; THERAPEUTIC STRATEGY; HUMAN NEUTROPHILS; STEM-CELLS; DNA-PK; MITOCHONDRIAL; INHIBITION; P38; EXPRESSION	Macrolide antibiotics, such as erythromycin and josamycin, are natural polyketide products harboring 14- to 16-membered macrocyclic lactone rings to which various sugars are attached. These antibiotics are used extensively in the clinic because of their ability to inhibit bacterial protein synthesis. More recently, some macrolides have been shown to also possess anti-inflammatory and other therapeutic activities in mammalian cells. To better understand the targets and effects of this drug class in mammalian cells, we used a genome-wide shRNA screen in K562 cancer cells to identify genes that modulate cellular sensitivity to josamycin. Among the most sensitizing hits were proteins involved in mitochondrial translation and the mitochondrial unfolded protein response, glycolysis, and the mitogen-activated protein kinase signaling cascade. Further analysis revealed that cells treated with josamycin or other antibacterial agents exhibited impaired oxidative phosphorylation and metabolic shifts to glycolysis. Interestingly, we observed that knockdown of the mitogen-activated protein kinase kinase kinase 4 (MAP3K4) gene, which contributes to p38 mitogen-activated protein kinase signaling, sensitized cells only to josamycin but not to other antibacterial agents. There is a growing interest in better characterizing the therapeutic effects and toxicities of antibiotics in mammalian cells to guide new applications in both cellular and clinical studies. To our knowledge, this is the first report of an unbiased genome-wide screen to investigate the effects of a clinically used antibiotic on human cells.	[Gupta, Amita; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Okesli-Armlovich, Aye; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Morgens, David; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Gupta, Amita; Okesli-Armlovich, Aye; Bassik, Michael C.; Khosla, Chaitan] Stanford Univ, Stanford Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Okesli-Armlovich, Aye] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Gilead Sciences	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X; Morgens, David/0000-0002-5005-0669	NIAID, National Institute of Health [U19-AI109662]; NIGMS, National Institutes of Health [R01-GM087934]; NIH, Director's New Innovator Award [1DP2HD084069-01]; Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H)	NIAID, National Institute of Health; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H)	This work was funded by NIAID, National Institute of Health grant U19-AI109662; NIGMS, National Institutes of Health Grant R01-GM087934; NIH, Director's New Innovator Award Grant 1DP2HD084069-01; and a seed grant from Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelghaffar H, 1997, J IMMUNOL, V159, P3995; Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Al-Furoukh N, 2015, BBA-MOL CELL RES, V1853, P2580, DOI 10.1016/j.bbamcr.2015.06.016; Arsic B, 2018, INT J ANTIMICROB AG, V51, P283, DOI 10.1016/j.ijantimicag.2017.05.020; Asano K, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/692352; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bearden DT, 1999, INFECT MED, V16, P480; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Borgeling Y, 2014, J BIOL CHEM, V289, P13, DOI 10.1074/jbc.M113.469239; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Chow S, 1996, CYTOMETRY, V24, P360; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Crosbie PAJ, 2009, EUR RESPIR J, V33, P171, DOI 10.1183/09031936.00042208; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Donath E, 2013, RESP MED, V107, P1385, DOI 10.1016/j.rmed.2013.05.004; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Jost M, 2018, ACS CHEM BIOL, V13, P366, DOI 10.1021/acschembio.7b00965; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; LABRO MT, 1990, J ANTIMICROB CHEMOTH, V26, P515, DOI 10.1093/jac/26.4.515; LABRO MT, 1991, EUR J CLIN MICROBIOL, V10, P124, DOI 10.1007/BF01964424; LABRO MT, 1989, J ANTIMICROB CHEMOTH, V24, P561, DOI 10.1093/jac/24.4.561; Lamb R, 2015, ONCOTARGET, V6, P14005, DOI 10.18632/oncotarget.4159; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Li CH, 2010, TOXICOL SCI, V116, P140, DOI 10.1093/toxsci/kfq085; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Matheny CJ, 2013, CHEM BIOL, V20, P1352, DOI 10.1016/j.chembiol.2013.09.014; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; MORIKAWA K, 1994, ANTIMICROB AGENTS CH, V38, P2643, DOI 10.1128/AAC.38.11.2643; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nadanaciva S, 2010, J BIOMOL SCREEN, V15, P937, DOI 10.1177/1087057110373547; Nagiec EE, 2005, ANTIMICROB AGENTS CH, V49, P3896, DOI 10.1128/AAC.49.9.3896-3902.2005; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]; Pillozzi S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.32; Poletti V, 2006, EUR RESPIR J, V28, P862, DOI 10.1183/09031936.06.00131805; Ribeiro CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005806; Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Shin HB, 2015, INT IMMUNOPHARMACOL, V27, P65, DOI 10.1016/j.intimp.2015.04.045; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Steel HC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/584262; Sugamata R, 2014, J ANTIBIOT, V67, P213, DOI 10.1038/ja.2013.132; Takase S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02016-4; Takizawa H, 1997, AM J RESP CRIT CARE, V156, P266, DOI 10.1164/ajrccm.156.1.9612065; van Nuffel AMT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.513; Villarino N, 2013, VET J, V198, P352, DOI 10.1016/j.tvjl.2013.07.032; Viluksela M, 1996, J ANTIMICROB CHEMOTH, V38, P465, DOI 10.1093/jac/38.3.465; Wingert S, 2016, STEM CELLS, V34, P699, DOI 10.1002/stem.2282; Wong EHC, 2014, LANCET RESP MED, V2, P657, DOI 10.1016/S2213-2600(14)70107-9; Yamanaka Y, 2001, BIOCHEM BIOPH RES CO, V287, P198, DOI 10.1006/bbrc.2001.5550; Zarogoulidis P, 2012, EUR J CLIN PHARMACOL, V68, P479, DOI 10.1007/s00228-011-1161-x; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103; Zuckerman JM, 2011, MED CLIN N AM, V95, P761, DOI 10.1016/j.mcna.2011.03.012	77	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2057	2067		10.1074/jbc.RA119.010770	http://dx.doi.org/10.1074/jbc.RA119.010770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915244	hybrid, Green Published			2022-12-28	WOS:000517128200023
J	Casado-Medrano, V; Barrio-Real, L; Gutierrez-Miranda, L; Gonzalez-Sarmiento, R; Velasco, EA; Kazanietz, MG; Caloca, MJ				Casado-Medrano, Victoria; Barrio-Real, Laura; Gutierrez-Miranda, Laura; Gonzalez-Sarmiento, Rogelio; Velasco, Eladio A.; Kazanietz, Marcelo G.; Caloca, Maria J.			Identification of a truncated beta 1-chimaerin variant that inactivates nuclear Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Rac (Rac GTPase); GTPase-activating protein (GAP); cell cycle; cell signaling; nucleus; 1-chimaerin; nuclear export signal (NES); nuclear localization; nuclear localization signal (NLS); splicing	GTPASE-ACTIVATING PROTEIN; CANCER CELL-PROLIFERATION; KINASE-C-DELTA; SUBCELLULAR-LOCALIZATION; CYCLIN D1; BETA-2-CHIMAERIN; GAP; BINDING; TRANSCRIPTION; MECHANISM	beta 1-chimaerin belongs to the chimaerin family of GTPase-activating proteins (GAPs) and is encoded by the CHN2 gene, which also encodes the beta 2- and beta 3-chimaerin isoforms. All chimaerin isoforms have a C1 domain that binds diacylglycerol as well as tumor-promoting phorbol esters and a catalytic GAP domain that inactivates the small GTPase Rac. Nuclear Rac has emerged as a key regulator of various cell functions, including cell division, and has a pathological role by promoting tumorigenesis and metastasis. However, how nuclear Rac is regulated has not been fully addressed. Here, using several approaches, including siRNA-mediated gene silencing, confocal microscopy, and subcellular fractionation, we identified a nuclear variant of beta 1-chimaerin, beta 1-Delta 7p-chimaerin, that participates in the regulation of nuclear Rac1. We show that beta 1-Delta 7p-chimaerin is a truncated variant generated by alternative splicing at a cryptic splice site in exon 7. We found that, unlike other chimaerin isoforms, beta 1-Delta 7p-chimaerin lacks a functional C1 domain and is not regulated by diacylglycerol. We found that beta 1-Delta 7p-chimaerin localizes to the nucleus via a nuclear localization signal in its N terminus. We also identified a key nuclear export signal in beta 1-chimaerin that is absent in beta 1-Delta 7p-chimaerin, causing nuclear retention of this truncated variant. Functionally analyses revealed that beta 1-Delta 7p-chimaerin inactivates nuclear Rac and negatively regulates the cell cycle. Our results provide important insights into the diversity of chimaerin Rac-GAP regulation and function and highlight a potential mechanism of nuclear Rac inactivation that may play significant roles in pathologies such as cancer.	[Casado-Medrano, Victoria; Gutierrez-Miranda, Laura; Velasco, Eladio A.; Caloca, Maria J.] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Barrio-Real, Laura; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Mol Med Unit, Biomed Res Inst Salamanca, Salamanca 37007, Spain; [Barrio-Real, Laura; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Inst Mol & Cellular Biol Canc, Biomed Res Inst Salamanca, Salamanca 37007, Spain; [Casado-Medrano, Victoria; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA; [Barrio-Real, Laura] Limelight Bio, 3401 Grays Ferry Ave, Philadelphia, PA 19146 USA; [Gutierrez-Miranda, Laura] Weizmann Inst Sci, Dept Regulat Biol, Max & Lillian Candiotty Bldg 210, IL-76100 Rehovot, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; University of Salamanca; University of Salamanca; University of Pennsylvania; Pennsylvania Medicine; Weizmann Institute of Science	Caloca, MJ (corresponding author), Inst Biol & Genet Mol, C Sanz & Fores S-N, Valladolid 47003, Spain.	mj.caloca@csic.es	Caloca, María-José/K-9357-2014; Casado-Medrano, Victoria/ABE-6429-2021; Velasco, Eladio Andres/D-1432-2016	Casado-Medrano, Victoria/0000-0002-6929-4559; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; Gutierrez-Miranda, Laura/0000-0002-3256-9416; Velasco, Eladio Andres/0000-0002-9682-5589	Castilla-Leon Autonomous Government (Consejeria de Educacion); P.O. FEDER 2014-2020 of Castilla-Leon from the CastillaLeon Autonomous Government (Consejeria de Educacion) [CSI242P18]; National Institutes of Health [R01-CA189765, R01-CA196232, R01-ES026023]	Castilla-Leon Autonomous Government (Consejeria de Educacion); P.O. FEDER 2014-2020 of Castilla-Leon from the CastillaLeon Autonomous Government (Consejeria de Educacion); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by the Castilla-Leon Autonomous Government (Consejeria de Educacion) (to M. J. C.) and Grant CSI242P18 (cofunded by P.O. FEDER 2014-2020 of Castilla-Leon) from the CastillaLeon Autonomous Government (Consejeria de Educacion) (to E. A. V.). M. G. K.'s laboratory is supported by National Institutes of Health Grants R01-CA189765, R01-CA196232, and R01-ES026023. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Barrio-Real L, 2013, J INVEST MED, V61, P1129, DOI 10.2310/JIM.0b013e3182a32ff9; Berenjeno IM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02002-4; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Casado-Medrano V, 2018, BIOCHEM SOC T, V46, P1003, DOI 10.1042/BST20170519; Casado-Medrano V, 2016, ONCOTARGET, V7, P28301, DOI 10.18632/oncotarget.8597; CLEVENGER CV, 1995, J BIOL CHEM, V270, P13246, DOI 10.1074/jbc.270.22.13246; Diamantopoulou Z, 2017, CANCER CELL, V31, P621, DOI 10.1016/j.ccell.2017.03.007; DONG JM, 1995, EUR J BIOCHEM, V227, P636, DOI 10.1111/j.1432-1033.1995.tb20183.x; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Fernandez N, 2000, ENDOCRINOLOGY, V141, P146, DOI 10.1210/en.141.1.146; Ferreiro JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102977; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gutierrez-Uzquiza A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2834; Hashimoto R, 2005, SCHIZOPHR RES, V73, P383, DOI 10.1016/j.schres.2004.01.017; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hinde E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04219; Janbandhu VC, 2010, J BIOL CHEM, V285, P17453, DOI 10.1074/jbc.M109.058974; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; Kazanietz MG, 2017, CANCER RES, V77, P5445, DOI 10.1158/0008-5472.CAN-17-1456; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; LEUNG T, 1994, J BIOL CHEM, V269, P12888; LEUNG T, 1993, J BIOL CHEM, V268, P3813; Maeda M, 2006, INT J MOL MED, V17, P559; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Menna PL, 2003, CANCER RES, V63, P2284; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Navarro-Lerida I, 2015, DEV CELL, V32, P318, DOI 10.1016/j.devcel.2014.12.019; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; Takeuchi S, 2009, FEBS LETT, V583, P1237, DOI 10.1016/j.febslet.2009.03.032; Vauchelles R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015400; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; YUAN SX, 1995, CANCER RES, V55, P3456; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919; Zubeldia-Brenner L, 2014, MOL BIOL REP, V41, P2067, DOI 10.1007/s11033-014-3055-3	69	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1300	1314		10.1074/jbc.RA119.008688	http://dx.doi.org/10.1074/jbc.RA119.008688			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31871052	hybrid, Green Published			2022-12-28	WOS:000513822300011
J	Gupta, A; Mahalakshmi, R				Gupta, Ankit; Mahalakshmi, Radhakrishnan			Single-residue physicochemical characteristics kinetically partition membrane protein self-assembly and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; protein aggregation; protein denaturation; ultraviolet-visible spectroscopy (UV-Vis spectroscopy); spectroscopy; molecular imaging; circular dichroism (CD); imaging; amyloid; neurodegeneration; cross-beta aggregates; self-association; thermal perturbation	DISEASE; AIL; OLIGOMERS	Ninety-five percent of all transmembrane proteins exist in kinetically trapped aggregation-prone states that have been directly linked to neurodegenerative diseases. Interestingly, the primary sequence almost invariably avoids off-pathway aggregate formation, by folding reliably into its native, thermodynamically stabilized structure. However, with the rising incidence of protein aggregation diseases, it is now important to understand the underlying mechanism(s) of membrane protein aggregation. Micromolecular physicochemical and biochemical alterations in the primary sequence that trigger the formation of macromolecular cross-beta aggregates can be measured only through combinatorial spectroscopic experiments. Here, we developed spectroscopic thermal perturbation with 117 experimental variables to assess how subtle protein sequence variations drive the molecular transition of the folded protein to oligomeric aggregates. Using the Yersinia pestis outer transmembrane beta-barrel Ail as a model, we delineated how a single-residue substitution that alters the membrane-anchoring ability of Ail significantly contributes to the kinetic component of Ail stability. We additionally observed a stabilizing role for interface aliphatics, and that interface aromatics physicochemically contribute to Ail self-assembly and aggregation. Moreover, our method identified the formation of structured oligomeric intermediates during Ail aggregation. We show that the self-aggregation tendency of Ail is offset by the evolution of a thermodynamically compromised primary sequence that balances folding, stability, and oligomerization. Our approach provides critical information on how subtle changes in protein primary sequence trigger cross-beta fibril formation, with insights that have direct implications for deducing the molecular progression of neurodegeneration and amyloidogenesis in humans.	[Gupta, Ankit; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal 462066, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Rm 324,III Floor,Block C,Acad Bldg 3, Bhopal 462066, India.	maha@iiserb.ac.in	Gupta, Ankit/AAP-7024-2021; Mahalakshmi, Radhakrishnan/B-3143-2008	Gupta, Ankit/0000-0001-5295-180X; Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Science and Engineering Research Board [SB/WEA-13/2016, EMR/2016/001774]; Wellcome Trust/DBT India Alliance Fellowship/Grant [IA/I/14/1/501305]; IISER Bhopal; Wellcome Trust/DBT India Alliance Intermediate Fellowship	Science and Engineering Research Board; Wellcome Trust/DBT India Alliance Fellowship/Grant; IISER Bhopal; Wellcome Trust/DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance)	This work was supported by Science and Engineering Research Board Awards SB/WEA-13/2016 and EMR/2016/001774, Wellcome Trust/DBT India Alliance Fellowship/Grant [IA/I/14/1/501305] awarded (to R. M.), a IISER Bhopal for research fellowship (to A. G.), and a Wellcome Trust/DBT India Alliance Intermediate Fellowship (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bandyopadhyay A, 2012, NAT CHEM BIOL, V8, P238, DOI [10.1038/NCHEMBIO.768, 10.1038/nchembio.768]; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Frederix PWJM, 2015, NAT CHEM, V7, P30, DOI [10.1038/NCHEM.2122, 10.1038/nchem.2122]; Friedland RP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006654; Gazit E, 2015, NAT CHEM, V7, P14, DOI 10.1038/nchem.2140; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gupta A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183097; Gupta A, 2019, J GEN PHYSIOL, V151, P489, DOI 10.1085/jgp.201812272; Gupta A, 2015, RSC ADV, V5, P1227, DOI 10.1039/c4ra11207e; Gupta A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06508; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Jain N, 2017, P NATL ACAD SCI USA, V114, P12184, DOI 10.1073/pnas.1708805114; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Kumar S, 2017, J PHYS CHEM B, V121, P7561, DOI 10.1021/acs.jpcb.7b03941; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Magri A, 2017, CURR MED CHEM, V24, P4470, DOI 10.2174/0929867324666170601073920; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Marassi FM, 2015, J BIOMOL NMR, V63, P59, DOI 10.1007/s10858-015-9963-2; Marshall KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30182; Mason TO, 2017, J AM CHEM SOC, V139, P16134, DOI 10.1021/jacs.7b00229; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Min D, 2015, NAT CHEM BIOL, V11, P981, DOI 10.1038/nchembio.1939; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Plesniak LA, 2011, BBA-BIOMEMBRANES, V1808, P482, DOI 10.1016/j.bbamem.2010.09.017; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818	39	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1181	1194		10.1074/jbc.RA119.011342	http://dx.doi.org/10.1074/jbc.RA119.011342			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31844019	Green Published, hybrid			2022-12-28	WOS:000513822300002
J	Kim, T; Stogios, PJ; Khusnutdinova, AN; Nemr, K; Skarina, T; Flick, R; Joo, JC; Mahadevan, R; Savchenko, A; Yakunin, AF				Kim, Taeho; Stogios, Peter J.; Khusnutdinova, Anna N.; Nemr, Kayla; Skarina, Tatiana; Flick, Robert; Joo, Jeong Chan; Mahadevan, Radhakrishnan; Savchenko, Alexei; Yakunin, Alexander F.			Rational engineering of 2-deoxyribose-5-phosphate aldolases for the biosynthesis of (R)-1,3-butanediol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); protein engineering; crystal structure; site-directed mutagenesis; biotechnology; 1; 3-butanediol; 2-deoxyribose-5-phosphate aldolase (DERA); acetaldehyde condensation; aldo-keto reductase; BH1352	ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 1,3-BUTANEDIOL; EFFICIENT; MECHANISM; SEQUENCE; SYSTEM; MODEL	Carbon?carbon bond formation is one of the most important reactions in biocatalysis and organic chemistry. In nature, aldolases catalyze the reversible stereoselective aldol addition between two carbonyl compounds, making them attractive catalysts for the synthesis of various chemicals. In this work, we identified several 2-deoxyribose-5-phosphate aldolases (DERAs) having acetaldehyde condensation activity, which can be used for the biosynthesis of (R)-1,3-butanediol (1,3BDO) in combination with aldo-keto reductases (AKRs). Enzymatic screening of 20 purified DERAs revealed the presence of significant acetaldehyde condensation activity in 12 of the enzymes, with the highest activities in BH1352 from Bacillus halodurans, TM1559 from Thermotoga maritima, and DeoC from Escherichia coli. The crystal structures of BH1352 and TM1559 at 1.40?2.50 ? resolution are the first full-length DERA structures revealing the presence of the C-terminal Tyr (Tyr(224) in BH1352). The results from structure-based site-directed mutagenesis of BH1352 indicated a key role for the catalytic Lys(155) and other active-site residues in the 2-deoxyribose-5-phosphate cleavage and acetaldehyde condensation reactions. These experiments also revealed a 2.5-fold increase in acetaldehyde transformation to 1,3BDO (in combination with AKR) in the BH1352 F160Y and F160Y/M173I variants. The replacement of the WT BH1352 by the F160Y or F160Y/M173I variants in E. coli cells expressing the DERA + AKR pathway increased the production of 1,3BDO from glucose five and six times, respectively. Thus, our work provides detailed insights into the molecular mechanisms of substrate selectivity and activity of DERAs and identifies two DERA variants with enhanced activity for in vitro and in vivo 1,3BDO biosynthesis.	[Kim, Taeho; Stogios, Peter J.; Khusnutdinova, Anna N.; Nemr, Kayla; Skarina, Tatiana; Flick, Robert; Mahadevan, Radhakrishnan; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada; [Joo, Jeong Chan] Korea Res Inst Chem Technol, Ctr Biobased Chem, Div Convergence Chem, Daejeon 34114, South Korea; [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Yakunin, Alexander F.] Bangor Univ, Sch Nat Sci, Ctr Environm Biotechnol, Bangor LL57 2UW, Gwynedd, Wales; [Kim, Taeho] LG Chem, Future Technol Ctr, Seoul 150721, South Korea	University of Toronto; Korea Research Institute of Chemical Technology (KRICT); University of Calgary; Bangor University; LG Chem	Yakunin, AF (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.	a.iakounine@utoronto.ca	Khusnutdinova, Anna/AAU-8164-2020	Joo, Jeong Chan/0000-0001-5393-7057; Yakunin, Alexander/0000-0003-0813-6490; Stogios, Peter/0000-0001-8663-1425	Natural Sciences and Engineering Research Council Strategic Network Grant IBN; Ontario Research Fund Research Excellence Grant BioCeB (Biochemicals from Cellulosic Biomass); Genome Canada, Genomics Applied Partnership Program	Natural Sciences and Engineering Research Council Strategic Network Grant IBN; Ontario Research Fund Research Excellence Grant BioCeB (Biochemicals from Cellulosic Biomass); Genome Canada, Genomics Applied Partnership Program(Genome Canada)	This work was supported by Natural Sciences and Engineering Research Council Strategic Network Grant IBN, Ontario Research Fund Research Excellence Grant BioCeB (Biochemicals from Cellulosic Biomass), and a grant from the Genome Canada, Genomics Applied Partnership Program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARBAS CF, 1990, J AM CHEM SOC, V112, P2013, DOI 10.1021/ja00161a064; Branden CI, 1991, CURR OPIN STRUC BIOL, V1, P978, DOI 10.1016/0959-440X(91)90094-A; Cao TP, 2016, J MICROBIOL, V54, P311, DOI 10.1007/s12275-016-6029-4; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; DeSantis G, 2003, BIOORGAN MED CHEM, V11, P43, DOI 10.1016/S0968-0896(02)00429-7; Dick M, 2016, CHEM SCI, V7, P4492, DOI 10.1039/c5sc04574f; Dick M, 2016, SCI REP-UK, V6, DOI 10.1038/srep17908; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GIJSEN HJM, 1994, J AM CHEM SOC, V116, P8422, DOI 10.1021/ja00097a082; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; Greenberg WA, 2004, P NATL ACAD SCI USA, V101, P5788, DOI 10.1073/pnas.0307563101; Gulevich AY, 2016, APPL BIOCHEM MICRO+, V52, P15, DOI 10.1134/S0003683816010051; Haridas M, 2018, APPL MICROBIOL BIOT, V102, P9959, DOI 10.1007/s00253-018-9392-8; Heine A, 2004, J MOL BIOL, V343, P1019, DOI 10.1016/j.jmb.2004.08.066; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; HOFFEE P, 1974, ARCH BIOCHEM BIOPHYS, V164, P736, DOI 10.1016/0003-9861(74)90087-3; Ichikawa N, 2005, J MOL CATAL A-CHEM, V231, P181, DOI 10.1016/j.molcata.2005.01.017; Ichikawa N, 2006, J MOL CATAL A-CHEM, V256, P106, DOI 10.1016/j.molcata.2006.04.057; Jennewein Stefan, 2006, Biotechnology Journal, V1, P537, DOI 10.1002/biot.200600020; Jiang YD, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0165-5; Jiao XC, 2017, BIOCHEM BIOPH RES CO, V482, P159, DOI 10.1016/j.bbrc.2016.11.020; Jiao XC, 2016, CATAL SCI TECHNOL, V6, P7094, DOI 10.1039/c6cy01085g; Jiao XC, 2015, CATAL SCI TECHNOL, V5, P4048, DOI 10.1039/c5cy00537j; Kataoka N, 2014, BIOSCI BIOTECH BIOCH, V78, P695, DOI 10.1080/09168451.2014.891933; Kim T, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03172-16; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu JJ, 2002, ANGEW CHEM INT EDIT, V41, P1404, DOI 10.1002/1521-3773(20020415)41:8<1404::AID-ANIE1404>3.0.CO;2-G; LOMAX MS, 1968, J BACTERIOL, V96, P501, DOI 10.1128/JB.96.2.501-514.1968; Ma H, 2016, CHEM SCI, V7, P1415, DOI 10.1039/c5sc03666f; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Mahrwald R, 1999, CHEM REV, V99, P1095, DOI 10.1021/cr980415r; Mahrwald R., 2004, MODEL ALDOL REACTION; Makshina EV, 2014, CHEM SOC REV, V43, P7917, DOI 10.1039/c4cs00105b; Matsuyama A, 2001, J MOL CATAL B-ENZYM, V11, P513, DOI 10.1016/S1381-1177(00)00032-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MUKAIYAMA T, 1982, ORG REACTIONS, V28, P203; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Muller M, 2005, ANGEW CHEM INT EDIT, V44, P362, DOI 10.1002/anie.200460852; Nemr K, 2018, METAB ENG, V48, P13, DOI 10.1016/j.ymben.2018.04.013; ORSINI F, 1989, J HETEROCYCLIC CHEM, V26, P837, DOI 10.1002/jhet.5570260360; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PRICER WE, 1960, J BIOL CHEM, V235, P1292; RACKER E, 1952, J BIOL CHEM, V196, P347; Sabra W, 2016, ADV BIOCHEM ENG BIOT, V155, P165, DOI 10.1007/10_2015_330; Sakuraba H, 2003, J BIOL CHEM, V278, P10799, DOI 10.1074/jbc.M212449200; Sakuraba H, 2007, APPL ENVIRON MICROB, V73, P7427, DOI 10.1128/AEM.01101-07; Schulte M, 2018, ACS CATAL, V8, P3971, DOI 10.1021/acscatal.7b04408; VALENTINHANSEN P, 1982, EUR J BIOCHEM, V125, P561, DOI 10.1111/j.1432-1033.1982.tb06719.x; Windle CL, 2014, CURR OPIN CHEM BIOL, V19, P25, DOI 10.1016/j.cbpa.2013.12.010; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412; Yamamoto H, 2002, BIOSCI BIOTECH BIOCH, V66, P925, DOI 10.1271/bbb.66.925; You ZY, 2013, J IND MICROBIOL BIOT, V40, P29, DOI 10.1007/s10295-012-1213-y	55	12	12	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					597	609		10.1074/jbc.RA119.011363	http://dx.doi.org/10.1074/jbc.RA119.011363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806708	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000507373600026
J	Merino, P; Diaz, A; Torre, ER; Yepes, M				Merino, Paola; Diaz, Ariel; Torre, Enrique R.; Yepes, Manuel			Urokinase-type plasminogen activator (uPA) regulates the expression and function of growth-associated protein 43 (GAP-43) in the synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						urokinase receptor; plasmin; plasminogen; synapse; protease; GAP-43	IN-SITU HYBRIDIZATION; KINASE-C SUBSTRATE; MESSENGER-RNA; NMDA RECEPTOR; NEURONAL MIGRATION; HUD BINDS; PROMOTES; LOCALIZATION; PHOSPHORYLATION; HIPPOCAMPAL	Growth-associated protein 43 (GAP-43) plays a central role in the formation of presynaptic terminals, synaptic plasticity, and axonal growth and regeneration. During development, GAP-43 is found in axonal extensions of most neurons. In contrast, in the mature brain, its expression is restricted to a few presynaptic terminals and scattered axonal growth cones. Urokinase-type plasminogen activator (uPA) is a serine proteinase that, upon binding to its receptor (uPAR), catalyzes the conversion of plasminogen into plasmin and activates signaling pathways that promote cell migration, proliferation, and survival. In the developing brain, uPA induces neuritogenesis and neuronal migration. In contrast, the expression and function of uPA in the mature brain are poorly understood. However, recent evidence reveals that different forms of injury induce release of uPA and expression of uPAR in neurons and that uPA/uPAR binding triggers axonal growth and synapse formation. Here we show that binding of uPA to uPAR induces not only the mobilization of GAP-43 from the axonal shaft to the presynaptic terminal but also its activation in the axonal bouton by PKC-induced calcium-dependent phosphorylation at Ser-41 (pGAP-43). We found that this effect requires open presynaptic N-methyl-d-aspartate receptors but not plasmin generation. Furthermore, our work reveals that, following its activation by uPA/uPAR binding, pGAP-43 colocalizes with presynaptic vesicles and triggers their mobilization to the synaptic release site. Together, these data reveal a novel role of uPA as an activator of the synaptic vesicle cycle in cerebral cortical neurons via its ability to induce presynaptic recruitment and activation of GAP-43.	[Merino, Paola; Diaz, Ariel; Torre, Enrique R.; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yepes, M (corresponding author), Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.	myepes@emory.edu	Díaz, Ariel/ABF-7295-2020	Díaz, Ariel/0000-0001-5677-5751; Yepes, Manuel/0000-0002-5224-9663; Merino, Paola/0000-0002-5203-4507	NINDS, National Institutes of Health [NS-NS091201]; VA MERIT Award [IO1BX003441]; American Heart Association [19POST34380009]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); VA MERIT Award(US Department of Veterans Affairs); American Heart Association(American Heart Association)	This work was supported in part by NINDS, National Institutes of Health Grant NS-NS091201 (to M. Y.), VA MERIT Award IO1BX003441 (to M. Y.), and American Heart Association Postdoctoral Fellowship Grant 19POST34380009 (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; [Anonymous], 1990, PROG BRAIN RES; [Anonymous], [No title captured]; Apel E D, 1992, Perspect Dev Neurobiol, V1, P3; Archinti M, 2011, CNS NEUROL DISORD-DR, V10, P271, DOI 10.2174/187152711794480393; Banerjee A, 2016, TRENDS NEUROSCI, V39, P26, DOI 10.1016/j.tins.2015.11.001; Baumgartel K, 2012, LEARN MEMORY, V19, P375, DOI 10.1101/lm.027201.112; BENDOTTI C, 1991, J NEUROSCI, V11, P600; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; CAMPAGNE MV, 1990, J NEUROCYTOL, V19, P948, DOI 10.1007/BF01186822; Cantallops I, 1999, J NEUROBIOL, V41, P208, DOI 10.1002/(SICI)1097-4695(19991105)41:2<208::AID-NEU4>3.3.CO;2-M; Casoli T, 2003, MICRON, V34, P415, DOI 10.1016/S0968-4328(03)00038-6; CHAN SY, 1986, J NEUROSCI, V6, P3618; CHAO HM, 1992, MOL CELL NEUROSCI, V3, P529, DOI 10.1016/1044-7431(92)90065-A; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cuadrado A, 2002, NUCLEIC ACIDS RES, V30, P2202, DOI 10.1093/nar/30.10.2202; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Deschenes-Furry J, 2007, J NEUROSCI, V27, P665, DOI 10.1523/JNEUROSCI.4626-06.2007; Diaz A, 2019, J CEREBR BLOOD F MET, V39, P2157, DOI 10.1177/0271678X18783653; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; DOKAS LA, 1991, PROG BRAIN RES, V89, P27; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fallini C, 2016, J NEUROSCI, V36, P3811, DOI 10.1523/JNEUROSCI.2396-15.2016; Gilder AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168418; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Holahan MR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00266; HUTTNER WB, 1979, P NATL ACAD SCI USA, V76, P5402, DOI 10.1073/pnas.76.10.5402; Irwin N, 2002, P NATL ACAD SCI USA, V99, P12427, DOI 10.1073/pnas.152457399; Jeanneret V, 2018, J CEREBR BLOOD F MET, V38, P1896, DOI 10.1177/0271678X18764495; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392; Leu BG, 2010, DEV NEUROBIOL, V70, P897, DOI 10.1002/dneu.20829; LIJNEN HR, 1986, J BIOL CHEM, V261, P1253; LIJNEN HR, 1987, EUR J BIOCHEM, V169, P359, DOI 10.1111/j.1432-1033.1987.tb13620.x; LIN LH, 1992, MOL BRAIN RES, V14, P147, DOI 10.1016/0169-328X(92)90024-6; Lino N, 2014, DEV DYNAM, V243, P676, DOI 10.1002/dvdy.24114; MCNAMARA RK, 1995, MOL BRAIN RES, V33, P22, DOI 10.1016/0169-328X(95)00083-5; Merino P, 2018, J BIOL CHEM, V293, P9234, DOI 10.1074/jbc.RA118.002534; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Neve RL, 1998, J NEUROSCI, V18, P7757; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; RAMAKERS GJA, 1991, INT J DEV NEUROSCI, V9, P215, DOI 10.1016/0736-5748(91)90042-K; RAO A, 1991, J NEUROSCI, V11, P2881; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Sainath R, 2015, DEV NEUROBIOL, V75, P757, DOI 10.1002/dneu.22246; Sanna MD, 2014, EXP NEUROL, V261, P343, DOI 10.1016/j.expneurol.2014.05.017; Semina E V, 2016, Ross Fiziol Zh Im I M Sechenova, V102, P881; Semina E, 2016, EUR J CELL BIOL, V95, P295, DOI 10.1016/j.ejcb.2016.05.003; SHEU FS, 1990, BIOCHEM BIOPH RES CO, V171, P1236, DOI 10.1016/0006-291X(90)90818-8; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; SNIPES GJ, 1987, J NEUROSCI, V7, P4066; Son H, 1997, CELL MOL NEUROBIOL, V17, P171, DOI 10.1023/A:1026361711588; Torre ER, 2010, MOL CELL NEUROSCI, V44, P135, DOI 10.1016/j.mcn.2010.03.003; Verkade P, 1996, NEUROSCIENCE, V71, P489, DOI 10.1016/0306-4522(95)00463-7; Verkade P, 1996, J NEUROCYTOL, V25, P583, DOI 10.1007/BF02284826; Weingarten J, 2014, MOL CELL NEUROSCI, V59, P106, DOI 10.1016/j.mcn.2014.02.003; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wu F, 2015, J CEREBR BLOOD F MET, V35, P1966, DOI 10.1038/jcbfm.2015.155; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Yepes M, 2016, NEUROSCIENCE, V319, P69, DOI 10.1016/j.neuroscience.2016.01.046	67	9	11	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					619	630		10.1074/jbc.RA119.010644	http://dx.doi.org/10.1074/jbc.RA119.010644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31819012	Green Published, hybrid			2022-12-28	WOS:000507373600028
J	Galvin, HD; Husain, M				Galvin, Henry D.; Husain, Matloob			Influenza A virus-induced host caspase and viral PA-X antagonize the antiviral host factor, histone deacetylase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; histone deacetylase 4 (HDAC4); innate immunity; host-pathogen interaction; signal transducers and activators of transcription 1 (STAT1); host defense; IFITM3; ISG15; PA; PA-X; viperin	CATHEPSIN-B CONTRIBUTES; PROTEIN ACETYLATION; MEDIATED DEGRADATION; SHUTOFF ACTIVITY; APOPTOSIS; INFECTION; RELEASE; EPIDEMIOLOGY; SUPPRESSION; RESISTANCE	Influenza A virus (IAV) effectively manipulates host machinery to replicate. There is a growing evidence that an optimal acetylation environment in the host cell is favorable to IAV proliferation and vice versa. The histone deacetylases (HDACs), a family of 18 host enzymes classified into four classes, are central to negatively regulating the acetylation level, hence the HDACs would not be favorable to IAV. Indeed, by using the RNAi and overexpression strategies, we found that human HDAC4, a class II member, possesses anti-IAV properties and is a component of host innate antiviral response. We discovered that IAV multiplication was augmented in HDAC4-depleted cells and abated in HDAC4-supplemented cells. Likewise, the expression of IFITM3, ISG15, and viperin, some of the critical markers of host anti-IAV response was abated in HDAC4-depleted cells and augmented in HDAC4-supplemented cells. In turn, IAV strongly antagonizes the HDAC4, by down-regulating its expression both at the mRNA level via viral RNA endonuclease PA-X and at the polypeptide level by inducing its cleavage via host caspase 3 in infected cells. Such HDAC4 polypeptide cleavage resulted in a ?30 kDa fragment that is also observed in some heterologous systems and may have a significant role in IAV replication.	[Galvin, Henry D.; Husain, Matloob] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand	University of Otago	Husain, M (corresponding author), Univ Otago, Dunedin 9054, New Zealand.	matloob.husain@otago.ac.nz	Husain, Matloob/AAN-7649-2020	Husain, Matloob/0000-0002-4413-6220	H. S. and J. C. Anderson Charitable Trust; University of Otago; Department of Microbiology and Immunology; School of Biomedical Sciences	H. S. and J. C. Anderson Charitable Trust; University of Otago; Department of Microbiology and Immunology; School of Biomedical Sciences	This work was supported by the H. S. and J. C. Anderson Charitable Trust, a University of Otago Ph.D. scholarship (to H. D. G.), and the Department of Microbiology and Immunology and the School of Biomedical Sciences (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen DY, 2016, VIROLOGY, V497, P146, DOI 10.1016/j.virol.2016.07.017; Chen H, 2019, J VIROL, V93, DOI 10.1128/JVI.01896-18; Chen XY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00320; Conrad RJ, 2016, ACS CHEM BIOL, V11, P669, DOI 10.1021/acschembio.5b00999; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Giese S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01112-3; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hatakeyama D, 2018, J BIOL CHEM, V293, P7126, DOI 10.1074/jbc.RA117.001683; Hayashi T, 2015, J VIROL, V89, P6442, DOI 10.1128/JVI.00319-15; Husain M, 2014, INFECT GENET EVOL, V28, P304, DOI 10.1016/j.meegid.2014.10.016; Husain M, 2014, J VIROL, V88, P11229, DOI 10.1128/JVI.00727-14; Husain M, 2009, FEBS LETT, V583, P2517, DOI 10.1016/j.febslet.2009.07.005; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jeng MY, 2015, CRIT REV BIOCHEM MOL, V50, P314, DOI 10.3109/10409238.2015.1061973; Khaperskyy DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005427; Kim H, 2018, VIRAL IMMUNOL, V31, P174, DOI 10.1089/vim.2017.0141; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; Liu N, 2017, ONCOTARGET, V8, P89315, DOI 10.18632/oncotarget.19167; Moon J, 2016, BIOCHEM BIOPH RES CO, V474, P428, DOI 10.1016/j.bbrc.2016.05.005; Nagesh PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01315; Nagesh PT, 2016, J VIROL, V90, P4614, DOI 10.1128/JVI.00126-16; Nutsford AN, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12989; Oishi K, 2018, CELL REP, V24, P851, DOI 10.1016/j.celrep.2018.06.078; Oishi K, 2018, VIROLOGY, V516, P71, DOI 10.1016/j.virol.2018.01.004; Ortiz JR, 2014, CRIT CARE MED, V42, P2325, DOI 10.1097/CCM.0000000000000545; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Paroni G, 2007, MOL CELL BIOL, V27, P6718, DOI 10.1128/MCB.00853-07; Petrie JG, 2016, CLIN INFECT DIS, V62, P448, DOI 10.1093/cid/civ952; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Song GY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00421; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Webster RG, 2014, ANN NY ACAD SCI, V1323, P115, DOI 10.1111/nyas.12462; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xue KS, 2018, TRENDS MICROBIOL, V26, P781, DOI 10.1016/j.tim.2018.02.007; Yang ZM, 2017, AM J PATHOL, V187, P781, DOI 10.1016/j.ajpath.2016.12.001; Zhou YL, 2017, EUR J IMMUNOL, V47, P1414, DOI 10.1002/eji.201746959	53	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20207	20221		10.1074/jbc.RA119.010650	http://dx.doi.org/10.1074/jbc.RA119.010650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31757810	Green Published, hybrid			2022-12-28	WOS:000505005800031
J	Zhu, Y; Li, HJ; Su, Q; Wen, J; Wang, YF; Song, W; Xie, YP; He, WR; Yang, Z; Jiang, K; Guo, HW				Zhu, Ying; Li, Hong-jiang; Su, Qi; Wen, Jing; Wang, Yuefan; Song, Wen; Xie, Yinpeng; He, Wenrong; Yang, Zhen; Jiang, Kai; Guo, Hongwei			A phenotype-directed chemical screen identifies ponalrestat as an inhibitor of the plant flavin monooxygenase YUCCA in auxin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; high-throughput screening (HTS); auxin; biosynthesis; enzyme inhibitor; ethylene; flavin-containing monooxygenase; ponalrestat; root growth regulator; YUCCA	ETHYLENE-INSENSITIVE MUTANTS; RESPONSE PATHWAY; SIGNALING PATHWAY; ARABIDOPSIS; TRYPTOPHAN; ACID; MECHANISM; GAS	Plant development is regulated by both synergistic and antagonistic interactions of different phytohormones, including a complex crosstalk between ethylene and auxin. For instance, auxin and ethylene synergistically control primary root elongation and root hair formation. However, a lack of chemical agents that specifically modulate ethylene or auxin production has precluded precise delineation of the contribution of each hormone to root development. Here, we performed a chemical genetic screen based on the recovery of root growth in ethylene-related Arabidopsis mutants with constitutive ?short root? phenotypes (eto1?2 and ctr1?1). We found that ponalrestat exposure recovers root elongation in these mutants in an ethylene signal?independent manner. Genetic and pharmacological investigations revealed that ponalrestat inhibits the enzymatic activity of the flavin-containing monooxygenase YUCCA, which catalyzes the rate-limiting step of the indole-3-pyruvic acid branch of the auxin biosynthesis pathway. In summary, our findings have identified a YUCCA inhibitor that may be useful as a chemical tool to dissect the distinct steps in auxin biosynthesis and in the regulation of root development.	[Zhu, Ying; Xie, Yinpeng; Jiang, Kai; Guo, Hongwei] Southern Univ Sci & Technol SUSTech, Inst Plant & Food Sci, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China; [Li, Hong-jiang] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, Minist Educ, Key Lab Bioorgan Chem & Mol Engn, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, BNLMS, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Wen, Jing; Song, Wen] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [He, Wenrong] Salk Inst Biol Studies, Plant Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Jiang, Kai] Southern Univ Sci & Technol SUSTech, SUSTech Acad Adv & Interdisciplinary Studies, Shenzhen 518055, Guangdong, Peoples R China; [Li, Hong-jiang] BioCentury Inc, Redwood City, CA 94065 USA; [Su, Qi] Johns Hopkins Univ, Dept Chem, 3400 N Charles St, Baltimore, MD 21218 USA; [Wen, Jing] North Sichuan Med Coll, Sch Pharm, Nanchong 637100, Peoples R China; [Wang, Yuefan] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Yang, Zhen] Peking Univ, State Key Lab Chem Oncogen, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Yang, Zhen] Peking Univ, Key Lab Chem Genom, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China	Southern University of Science & Technology; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Peking University; Max Planck Society; Salk Institute; Southern University of Science & Technology; Johns Hopkins University; North Sichuan Medical University; Johns Hopkins University; Peking University; University Town of Shenzhen; Peking University; University Town of Shenzhen	Jiang, K; Guo, HW (corresponding author), Southern Univ Sci & Technol SUSTech, Inst Plant & Food Sci, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China.; Jiang, K (corresponding author), Southern Univ Sci & Technol SUSTech, SUSTech Acad Adv & Interdisciplinary Studies, Shenzhen 518055, Guangdong, Peoples R China.	jiangk@sustech.edu.cn; guohw@sustech.edu.cn	Wang, Yuefan/AGO-1425-2022	Song, Wen/0000-0002-9498-2409; Wang, Yuefan/0000-0001-5731-6143; Jiang, Kai/0000-0001-9901-5293	National Natural Science Foundation of China [31570286, 91740203, 21907049]; Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06S172]; Shenzhen Sci-Tech Fund [KYTDPT20181011104005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Shenzhen Sci-Tech Fund	This work was supported by the National Natural Science Foundation of China Grants 31570286 and 91740203 (to H. G.) and Grant 21907049 (to K. J.), the Guangdong Innovative and Entrepreneurial Research Team Program Grant 2016ZT06S172 (to K. J.), and the Shenzhen Sci-Tech Fund Grant KYTDPT20181011104005 (to K. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeles F.B., 1992, PLANT BIOL ETHYL, P1, DOI [DOI 10.1016/B978-0-08-091628-6.50001-1, 10.1016/b978-0-08-091628-6.50001-1, DOI 10.1016/C2009-0-03226-7]; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen QG, 2014, PLANT CELL PHYSIOL, V55, P1072, DOI 10.1093/pcp/pcu039; CHUNG S, 1989, J BIOL CHEM, V264, P14775; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; Dejonghe W, 2017, PLANT PHYSIOL, V174, P5, DOI 10.1104/pp.16.01805; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; Hicks GR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00455; Jiang K, 2018, BIOSCI BIOTECH BIOCH, V82, P1265, DOI 10.1080/09168451.2018.1462693; Ju CL, 2015, PLANT PHYSIOL, V169, P85, DOI 10.1104/pp.15.00845; Kakei Y, 2015, PLANT J, V84, P827, DOI 10.1111/tpj.13032; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kubo Y, 2015, CHEM COMMUN, V51, P2005, DOI 10.1039/c4cc07712a; Lindell SD, 2009, BIOORGAN MED CHEM, V17, P4035, DOI 10.1016/j.bmc.2009.03.027; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mao JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005760; Martin YC, 2018, J COMPUT AID MOL DES, V32, P809, DOI 10.1007/s10822-018-0127-9; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Narukawa-Nara M, 2016, PLANT J, V87, P245, DOI 10.1111/tpj.13197; Nishimura T, 2014, PLANT J, V77, P352, DOI 10.1111/tpj.12399; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sriram D, 2010, CHEM BIOL DRUG DES, V75, P381, DOI 10.1111/j.1747-0285.2010.00947.x; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Thimann KV, 1938, PLANT PHYSIOL, V13, P437, DOI 10.1104/pp.13.3.437; Tsugafune S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14332-w; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104	48	8	9	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19923	19933		10.1074/jbc.RA119.010480	http://dx.doi.org/10.1074/jbc.RA119.010480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732559	hybrid, Green Published			2022-12-28	WOS:000505005800009
J	Irwin, MJ; Gupta, R; Gao, XZ; Cahill, KB; Chu, FX; Cote, RH				Irwin, Michael J.; Gupta, Richa; Gao, Xiong-Zhuo; Cahill, Karyn B.; Chu, Feixia; Cote, Rick H.			The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphodiesterases; G protein; phototransduction; allosteric regulation; mass spectrometry (MS); protein cross-linking; photoreceptor; integrative structural modeling; PDE6; transducin	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; INHIBITORY GAMMA-SUBUNIT; TRANSDUCIN ALPHA-SUBUNIT; CGMP-PHOSPHODIESTERASE; BINDING-SITES; TERMINAL REGION; GAF DOMAINS; IDENTIFICATION; GMP; PURIFICATION	Photoreceptor phosphodiesterase 6 (PDE6) is the central effector of the visual excitation pathway in both rod and cone photoreceptors, and PDE6 mutations that alter PDE6 structure or regulation can result in several human retinal diseases. The rod PDE6 holoenzyme consists of two catalytic subunits (P??) whose activity is suppressed in the dark by binding of two inhibitory ?-subunits (P?). Upon photoactivation of rhodopsin, the heterotrimeric G protein (transducin) is activated, resulting in binding of the activated transducin ?-subunit (Gt(?)) to PDE6, displacement of P? from the PDE6 active site, and enzyme activation. Although the biochemistry of this pathway is understood, a lack of detailed structural information about the PDE6 activation mechanism hampers efforts to develop therapeutic interventions for managing PDE6-associated retinal diseases. To address this gap, here we used a cross-linking MS-based approach to create a model of the entire interaction surface of P? with the regulatory and catalytic domains of P?? in its nonactivated state. Following reconstitution of PDE6 and activated Gt(?) with liposomes and identification of cross-links between Gt(?) and PDE6 subunits, we determined that the PDE6?Gt(?) protein complex consists of two Gt(?)-binding sites per holoenzyme. Each Gt(?) interacts with the catalytic domains of both catalytic subunits and induces major changes in the interaction sites of the P? subunit with the catalytic subunits. These results provide the first structural model for the activated state of the transducin?PDE6 complex during visual excitation, enhancing our understanding of the molecular etiology of inherited retinal diseases.	[Irwin, Michael J.; Gupta, Richa; Gao, Xiong-Zhuo; Cahill, Karyn B.; Chu, Feixia; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA; [Gao, Xiong-Zhuo] Biogen, 5000 Davis Dr, Res Triangle Pk, NC 27709 USA; [Cahill, Karyn B.] Envirologix Inc, 500 Riverside Ind Pkwy, Portland, ME 04103 USA	University System Of New Hampshire; University of New Hampshire; Biogen	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick/G-3363-2013	Cote, Rick/0000-0002-1573-6526	NEI, National Institutes of Health [R01 EY05798]; NIGMS, National Institutes of Health [P20 GM113131]; National Science Foundation [CLF 1307367]; NICHD, National Institutes of Health [R01 HD093783]; University of New Hampshire Collaborative Research Excellence grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD093783] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113131] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of New Hampshire Collaborative Research Excellence grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NEI, National Institutes of Health Grant R01 EY05798 (to R. H. C.), NIGMS, National Institutes of Health Grant P20 GM113131 (to R. H. C.), National Science Foundation Grant CLF 1307367 (to F. C.), NICHD, National Institutes of Health Grant R01 HD093783 (to F. C.), and University of New Hampshire Collaborative Research Excellence grant (to R. H. C. and F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkhammash HI, 2015, PHYS CHEM CHEM PHYS, V17, P15547, DOI 10.1039/c4cp05882h; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Baillie GS, 2019, NAT REV DRUG DISCOV, V18, P770, DOI 10.1038/s41573-019-0033-4; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Chu FX, 2019, J MOL BIOL, V431, P3677, DOI 10.1016/j.jmb.2019.07.035; Chu FX, 2018, METHODS, V144, P53, DOI 10.1016/j.ymeth.2018.05.023; Chu FX, 2010, MOL CELL PROTEOMICS, V9, P25, DOI 10.1074/mcp.M800555-MCP200; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; CUNNICK J, 1994, BIOCHEM J, V297, P87, DOI 10.1042/bj2970087; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Gulati S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4322; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lamb TD, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180076; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Maryam A, 2019, COMPUT STRUCT BIOTEC, V17, P378, DOI 10.1016/j.csbj.2019.03.004; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Milano SK, 2018, J BIOL CHEM, V293, P17941, DOI 10.1074/jbc.RA118.003746; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Omar F, 2019, P NATL ACAD SCI USA, V116, P13320, DOI 10.1073/pnas.1822113116; Pentia Dana C., 2005, V307, P125; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Power M, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.07.005; Qi C, 2019, SCIENCE, V364, P389, DOI 10.1126/science.aav0778; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; Ting T. D., 1993, PHOTORECEPTOR CELLS, P180; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Wang X, 2019, J BIOL CHEM, V294, P8351, DOI 10.1074/jbc.RA119.007520; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Wensel Theodore G., 2005, V307, P289; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang XJ, 2012, J BIOL CHEM, V287, P26312, DOI 10.1074/jbc.M112.377333; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406; Zhang ZX, 2015, J BIOL CHEM, V290, P17131, DOI 10.1074/jbc.A115.647636; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	62	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19486	19497		10.1074/jbc.RA119.011002	http://dx.doi.org/10.1074/jbc.RA119.011002			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690623	Green Published, hybrid			2022-12-28	WOS:000504093200004
J	Chen, YC; Sood, C; Francis, AC; Melikyan, GB; Dickson, RM				Chen, Yen-Cheng; Sood, Chetan; Francis, Ashwanth C.; Melikyan, Gregory B.; Dickson, Robert M.			Facile autofluorescence suppression enabling tracking of single viruses in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microscopy; Human Immunodeficiency Virus (HIV); membrane fusion; autofluorescence; optical modulation; photoswitchable fluorescent proteins; single virus tracking; synchronously amplified fluorescence image recovery (SAFIRe); live cell imaging	GREEN FLUORESCENT PROTEIN; IMAGING MICROSCOPY; CONTRAST; DISCRIMINATION; FLUOROPHORES; REDUCTION; FUSION; NADH; HIV; GFP	Live cell fluorescence imaging is the method of choice for studying dynamic processes, such as nuclear transport, vesicular trafficking, and virus entry and egress. However, endogenous cellular autofluorescence masks useful fluorescence signal, limiting the ability to reliably visualize low-abundance fluorescent proteins. Here, we employed synchronously amplified fluorescence image recovery (SAFIRe), which optically alters ground versus photophysical dark state populations within fluorescent proteins to modulate and selectively detect their background-free emission. Using a photoswitchable rsFastLime green fluorescent protein combined with a simple illumination and image-processing scheme, we demonstrate the utility of this approach for suppressing undesirable, unmodulatable fluorescence background. Significantly, we adapted this technique to different commercial wide-field and spinning-disk confocal microscopes, obtaining > 10-fold improvements in signal to background. SAFIRe allowed visualization of rsFastLime targeted to mitochondria by efficiently suppressing endogenous autofluorescence or overexpressed cytosolic unmodulatable EGFP. Suppression of the overlapping EGFP signal provided a means to perform multiplexed imaging of rsFastLime and spectrally overlapping fluorophores. Importantly, we used SAFIRe to reliably visualize and track single rsFastLime-labeled HIV-1 particles in living cells exhibiting high and uneven autofluorescence signals. Time-lapse SAFIRe imaging can be performed for an extended period of time to visualize HIV-1 entry into cells. SAFIRe should be broadly applicable for imaging live cell dynamics with commercial microscopes, even in strongly autofluorescent cells or cells expressing spectrally overlapping fluorescent proteins.	[Chen, Yen-Cheng; Dickson, Robert M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Chen, Yen-Cheng; Sood, Chetan; Francis, Ashwanth C.; Melikyan, Gregory B.] Emory Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Sood, Chetan] NanoView Biosci, Boston, MA 02135 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Children's Healthcare of Atlanta (CHOA)	Dickson, RM (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Melikyan, GB (corresponding author), Emory Sch Med, Dept Pediat, Atlanta, GA 30322 USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.	gmeliki@emory.edu; dickson@chemistry.gatech.edu	Francis, Ashwanth Christopher/N-5730-2018	Francis, Ashwanth Christopher/0000-0002-8663-2038; Chen, Yen-Cheng/0000-0001-5909-293X	NIH [R21EB020371, R01 AI1504535, R01 AI129862]; Vasser-Woolley foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vasser-Woolley foundation	The authors gratefully acknowledge the gift of the initial rsFastLime plasmid from C.J. Fahrni (Georgia Tech) and David Kabat (OHSU) for kindly providing CF3 cells. We also appreciate helpful discussions by Mariana Marin and other members of Melikyan laboratory. This work was supported by NIH R21EB020371 (RMD), the Vasser-Woolley foundation (RMD), the NIH R01 AI1504535 (GBM) and R01 AI129862 (GBM).	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chen YC, 2017, J PHYS CHEM LETT, V8, P733, DOI 10.1021/acs.jpclett.6b02816; Chen YC, 2015, J AM CHEM SOC, V137, P12764, DOI 10.1021/jacs.5b07871; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; Gatzogiannis E, 2011, J PHYS CHEM LETT, V2, P461, DOI 10.1021/jz2000134; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3326; Guo JQ, 2010, AGR ISSUES POLICIES, P1; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Hsiang JC, 2014, ACCOUNTS CHEM RES, V47, P1545, DOI 10.1021/ar400325y; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Icha J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700003; Jablonski AE, 2013, J AM CHEM SOC, V135, P16410, DOI 10.1021/ja405459b; Jablonski AE, 2012, J PHYS CHEM LETT, V3, P3585, DOI 10.1021/jz3016414; Knight AW, 2001, BIOPHOTONICS INT, V8, P42; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Querard J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00847-3; Querard J, 2015, ANGEW CHEM INT EDIT, V54, P2633, DOI 10.1002/anie.201408985; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Richards CI, 2010, J PHYS CHEM B, V114, P660, DOI 10.1021/jp909167j; Richards CI, 2009, J AM CHEM SOC, V131, P4619, DOI 10.1021/ja809785s; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Sood C, 2017, J BIOL CHEM, V292, P20196, DOI 10.1074/jbc.M117.818088; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Suddala KC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007532; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yan YL, 2011, BIOCHEM J, V433, P411, DOI 10.1042/BJ20100992; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	51	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19111	19118		10.1074/jbc.RA119.010268	http://dx.doi.org/10.1074/jbc.RA119.010268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694918	Green Published, hybrid			2022-12-28	WOS:000516527800014
J	Merkl, PE; Pilsl, M; Fremter, T; Schwank, K; Engel, C; Langst, G; Milkereit, P; Griesenbeck, J; Tschochner, H				Merkl, Philipp E.; Pilsl, Michael; Fremter, Tobias; Schwank, Katrin; Engel, Christoph; Laengst, Gernot; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert			RNA polymerase I (Pol I) passage through nucleosomes depends on Pol I subunits binding its lobe structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleolus; RNA polymerase II; RNA polymerase I; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); transcription; transcription elongation factor; RNA polymerase III; nucleosome; ribosome; chromatin; Rpa34; 5; Rpa49	TRANSCRIPTION INITIATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN TRANSCRIPTION; MOLECULAR-STRUCTURES; TOPOISOMERASE-I; ELONGATION RATE; CROSS-LINKING; PAF1 COMPLEX; ARCHITECTURE; TFIIF	RNA polymerase I (Pol I) is a highly efficient enzyme specialized in synthesizing most ribosomal RNAs. After nucleosome deposition at each round of rDNA replication, the Pol I transcription machinery has to deal with nucleosomal barriers. It has been suggested that Pol I?associated factors facilitate chromatin transcription, but it is unknown whether Pol I has an intrinsic capacity to transcribe through nucleosomes. Here, we used in vitro transcription assays to study purified WT and mutant Pol I variants from the yeast Saccharomyces cerevisiae and compare their abilities to pass a nucleosomal barrier with those of yeast Pol II and Pol III. Under identical conditions, purified Pol I and Pol III, but not Pol II, could transcribe nucleosomal templates. Pol I mutants lacking either the heterodimeric subunit Rpa34.5/Rpa49 or the C-terminal part of the specific subunit Rpa12.2 showed a lower processivity on naked DNA templates, which was even more reduced in the presence of a nucleosome. Our findings suggest that the lobe-binding subunits Rpa34.5/Rpa49 and Rpa12.2 facilitate passage through nucleosomes, suggesting possible cooperation among these subunits. We discuss the contribution of Pol I?specific subunit domains to efficient Pol I passage through nucleosomes in the context of transcription rate and processivity.	[Merkl, Philipp E.; Pilsl, Michael; Fremter, Tobias; Schwank, Katrin; Engel, Christoph; Laengst, Gernot; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert] Univ Regensburg, Lehrstuhl Biochem 3, RCB, D-93053 Regensburg, Germany; [Merkl, Philipp E.] Tech Univ Munich, Arcisstr 21, D-80333 Munich, Germany	University of Regensburg; Technical University of Munich	Milkereit, P; Griesenbeck, J; Tschochner, H (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, RCB, D-93053 Regensburg, Germany.	philipp.milkereit@ur.de; joachim.griesenbeck@ur.de; herbert.tschochner@ur.de		Engel, Christoph/0000-0001-8451-3599	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 960. The authors declare that they have no conflicts of interest with the contents of this article.	Albert B, 2011, J CELL BIOL, V192, P277, DOI 10.1083/jcb.201006040; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bintu L, 2011, NAT STRUCT MOL BIOL, V18, P1394, DOI 10.1038/nsmb.2164; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Burke D., 2000, METHODS YEAST GENETI; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Crickard JB, 2017, NUCLEIC ACIDS RES, V45, P6362, DOI 10.1093/nar/gkx220; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Darriere T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008157; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaykalova DA, 2015, P NATL ACAD SCI USA, V112, pE5787, DOI 10.1073/pnas.1508371112; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gout JF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701484; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kostrewa D, 2015, ACTA CRYSTALLOGR D, V71, P1850, DOI 10.1107/S1399004715012651; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luse DS, 2011, RNA BIOL, V8, P581, DOI 10.4161/rna.8.4.15389; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Merkl P, 2014, MOL CELL BIOL, V34, P3817, DOI 10.1128/MCB.00395-14; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Osheim Yvonne N., 2008, V464, P55; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sadian Y, 2017, EMBO J, V36, P2698, DOI 10.15252/embj.201796958; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanz-Murillo M, 2018, P NATL ACAD SCI USA, V115, P8972, DOI 10.1073/pnas.1802626115; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Scull CE, 2019, BIOCHEMISTRY-US, V58, P2116, DOI 10.1021/acs.biochem.8b01256; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Tafur L, 2019, ELIFE, V8, DOI 10.7554/eLife.43204; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Teves SS, 2014, TRENDS BIOCHEM SCI, V39, P577, DOI 10.1016/j.tibs.2014.10.004; Torreira E, 2017, ELIFE, V6, DOI [10.7554/eLife.20832.001, 10.7554/eLife.20832]; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wittner M, 2011, CELL, V145, P543, DOI 10.1016/j.cell.2011.03.051; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	73	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4782	4795		10.1074/jbc.RA119.011827	http://dx.doi.org/10.1074/jbc.RA119.011827			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32060094	hybrid, Green Published			2022-12-28	WOS:000526887000004
J	Horning, KJ; Joshi, P; Nitin, R; Balachandran, RC; Yanko, FM; Kim, K; Christov, P; Aschner, M; Sulikowski, GA; Weaver, CD; Bowman, AB				Horning, Kyle J.; Joshi, Piyush; Nitin, Rachana; Balachandran, Rekha C.; Yanko, Frank M.; Kim, Kwangho; Christov, Plamen; Aschner, Michael; Sulikowski, Gary A.; Weaver, C. David; Bowman, Aaron B.			Identification of a selective manganese ionophore that enables nonlethal quantification of cellular manganese	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; metal homeostasis; transport metal; neurobiology; neurodegenerative disease; calcium transport; calcimycin; ionomycin; ionophore; MESM	SLC39A8 DEFICIENCY; TRANSPORTER; HOMEOSTASIS; MUTATIONS; PARKINSONISM; DYSTONIA; SLC30A10; A23187; IRON; HYPERMANGANESEMIA	Available assays for measuring cellular manganese (Mn) levels require cell lysis, restricting longitudinal experiments and multiplexed outcome measures. Conducting a screen of small molecules known to alter cellular Mn levels, we report here that one of these chemicals induces rapid Mn efflux. We describe this activity and the development and implementation of an assay centered on this small molecule, named manganese-extracting small molecule (MESM). Using inductively-coupled plasma?MS, we validated that this assay, termed here ?manganese-extracting small molecule estimation route? (MESMER), can accurately assess Mn in mammalian cells. Furthermore, we found evidence that MESM acts as a Mn-selective ionophore, and we observed that it has increased rates of Mn membrane transport, reduced cytotoxicity, and increased selectivity for Mn over calcium compared with two established Mn ionophores, calcimycin (A23187) and ionomycin. Finally, we applied MESMER to test whether prior Mn exposures subsequently affect cellular Mn levels. We found that cells receiving continuous, elevated extracellular Mn accumulate less Mn than cells receiving equally-elevated Mn for the first time for 24 h, indicating a compensatory cellular homeostatic response. Use of the MESMER assay versus a comparable detergent lysis-based assay, cellular Fura-2 Mn extraction assay, reduced the number of cells and materials required for performing a similar but cell lethality-based experiment to 25% of the normally required sample size. We conclude that MESMER can accurately quantify cellular Mn levels in two independent cells lines through an ionophore-based mechanism, maintaining cell viability and enabling longitudinal assessment within the same cultures.	[Horning, Kyle J.; Joshi, Piyush; Nitin, Rachana; Bowman, Aaron B.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Balachandran, Rekha C.; Yanko, Frank M.; Bowman, Aaron B.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Kim, Kwangho; Christov, Plamen; Sulikowski, Gary A.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Kim, Kwangho; Sulikowski, Gary A.; Weaver, C. David] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sulikowski, Gary A.; Weaver, C. David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Vanderbilt University; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University	Bowman, AB (corresponding author), Purdue Univ, 550 Stadium Mall Dr,HAMP 1173A, W Lafayette, IN 47907 USA.	bowma117@purdue.edu		aschner, michael/0000-0002-2619-1656; Nitin, Rachana/0000-0002-3331-1580	NIH [1S10OD025281-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Panoptic plate reader was purchased from funds obtain through NIH Grant 1S10OD025281-01. The Panoptic is housed and managed in the Vanderbilt Institute of Chemical Biology's High-throughput Screen Facility.	Aydemir TB, 2018, J NUTR, V148, P174, DOI 10.1093/jn/nxx041; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Bakthavatsalam S, 2015, CHEM COMMUN, V51, P2605, DOI 10.1039/c4cc09542a; Banci L, 2013, METAL IONS LIFE SCI, V12, P1, DOI 10.1007/978-94-007-5561-1; Bichell TJV, 2017, BBA-MOL BASIS DIS, V1863, P1596, DOI 10.1016/j.bbadis.2017.02.013; Bowman AB, 2014, NEUROTOXICOLOGY, V41, P141, DOI 10.1016/j.neuro.2014.01.010; Bryan MR, 2018, NEUROTOXICOLOGY, V64, P185, DOI 10.1016/j.neuro.2017.07.026; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Das S, 2019, INORG CHEM, V58, P13724, DOI 10.1021/acs.inorgchem.9b01389; Delnooz CCS, 2013, MOVEMENT DISORD, V28, P685, DOI 10.1002/mds.25390; DENNY MF, 1993, TOXICOL APPL PHARM, V122, P222, DOI 10.1006/taap.1993.1191; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Freedman JC, 2012, CELL PHYSL SOURCE BO, P61, DOI DOI 10.1016/B978-0-12-387738-3.00004-4; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Haynes EN, 2015, ENVIRON HEALTH PERSP, V123, P1066, DOI 10.1289/ehp.1408993; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hernandez EH, 2006, NEUROTOXICOLOGY, V27, P333, DOI 10.1016/j.neuro.2005.09.003; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jin L, 2019, METALLOMICS, V11, P959, DOI 10.1039/c8mt00370j; Joshi P, 2019, NEUROTOXICOLOGY, V75, P148, DOI 10.1016/j.neuro.2019.09.007; Kalia K, 2008, NEUROTOXICOLOGY, V29, P466, DOI 10.1016/j.neuro.2008.02.012; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Koike A, 2017, LIFE SCI, V173, P80, DOI 10.1016/j.lfs.2016.12.006; Komagiri Y, 2011, CELL CALCIUM, V49, P35, DOI 10.1016/j.ceca.2010.11.006; Kumar KK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06801; Kumar KK, 2013, J BIOCHEM MOL TOXIC, V27, P42, DOI 10.1002/jbt.21457; Kumar KK, 2012, NEUROTOXICOLOGY, V33, P518, DOI 10.1016/j.neuro.2012.02.005; Kwakye Gunnar F, 2011, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1218s48; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; LICCIONE JJ, 1988, J PHARMACOL EXP THER, V247, P156; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; LOCKWICH T, 1993, MOL CELL BIOCHEM, V126, P143, DOI 10.1007/BF00925692; LUKACS GL, 1987, BIOCHEM J, V248, P609, DOI 10.1042/bj2480609; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; Morello M, 2008, NEUROTOXICOLOGY, V29, P60, DOI 10.1016/j.neuro.2007.09.001; Moynier F, 2017, SCI REP-UK, V7, DOI 10.1038/srep44255; OAKES SG, 1988, ANAL BIOCHEM, V169, P159, DOI 10.1016/0003-2697(88)90267-9; Pan Z, 2018, METHODS MOL BIOL, V1843, P55, DOI 10.1007/978-1-4939-8704-7_4; Park JH, 2018, GENET MED, V20, P259, DOI 10.1038/gim.2017.106; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; PFEIFFER DR, 1974, BIOCHEMISTRY-US, V13, P4007, DOI 10.1021/bi00716a029; PFEIFFER DR, 1979, FEBS LETT, V105, P360, DOI 10.1016/0014-5793(79)80649-3; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; REED PW, 1972, J BIOL CHEM, V247, P6970; Skulan J, 1999, P NATL ACAD SCI USA, V96, P13709, DOI 10.1073/pnas.96.24.13709; Stillwell W, 2016, INTRODUCTION TO BIOLOGICAL MEMBRANES: COMPOSITION, STRUCTURE AND FUNCTION, 2ND EDITION, P3, DOI 10.1016/B978-0-444-63772-7.00001-4; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Tidball AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150372; Tidball AM, 2015, HUM MOL GENET, V24, P1929, DOI 10.1093/hmg/ddu609; Torres-Agustin R, 2013, ENVIRON RES, V121, P39, DOI 10.1016/j.envres.2012.10.007; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Vollet Kaitlin, 2016, Curr Environ Health Rep, V3, P392, DOI 10.1007/s40572-016-0108-x; Williams BB, 2010, TOXICOL SCI, V117, P169, DOI 10.1093/toxsci/kfq174; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhao NN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121335; Zogzas CE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00115d; Zogzas Charles E, 2017, Adv Neurobiol, V18, P35, DOI 10.1007/978-3-319-60189-2_3	62	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3875	3890		10.1074/jbc.RA119.009781	http://dx.doi.org/10.1074/jbc.RA119.009781			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047113	Green Published, hybrid			2022-12-28	WOS:000527704400013
J	Chan, TO; Armen, RS; Yadav, S; Shah, S; Zhang, J; Tiegs, BC; Keny, N; Blumhof, B; Deshpande, DA; Rodeck, U; Penn, RB				Chan, Tung O.; Armen, Roger S.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Rodeck, Ulrich; Penn, Raymond B.			A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PKA; phosphatase; Akt PKB; serine; threonine protein kinase; signal transduction; structure?function; cAMP-dependent protein kinase; dephosphorylation; protein kinase B	TERMINAL TAIL; ATP-BINDING; AKT KINASES; PDK1; ACTIVATION; ADENOSINE; SITES; AUTOPHOSPHORYLATION; PHOSPHORYLATION; MYRISTYLATION	Phosphorylation of specific residues in the activation loops of AGC kinase group (protein kinase A, G, and C families) is required for activity of most of these kinases, including the catalytic subunit of PKA (PKAc). Although many phosphorylated AGC kinases are sensitive to phosphatase-mediated dephosphorylation, the PKAc activation loop uniquely resists dephosphorylation, rendering it ?constitutively? phosphorylated in cells. Previous biophysical experiments and structural modeling have suggested that the N-terminal myristoylation signal and the C-terminal FXXF motif in PKAc regulate its thermal stability and catalysis. Here, using site-directed mutagenesis, molecular modeling, and in cell-free and cell-based systems, we demonstrate that substitutions of either the PKAc myristoylation signal or the FXXF motif only modestly reduce phosphorylation and fail to affect PKAc function in cells. However, we observed that these two sites cooperate with an N-terminal FXXW motif to cooperatively establish phosphatase resistance of PKAc while not affecting kinase-dependent phosphorylation of the activation loop. We noted that this tripartite cooperative mechanism of phosphatase resistance is functionally relevant, as demonstrated by changes in morphology, adhesion, and migration of human airway smooth muscle cells transfected with PKAc variants containing amino acid substitutions in these three sites. These findings establish that three allosteric sites located at the PKAc N and C termini coordinately regulate the phosphatase sensitivity of this enzyme. This cooperative mechanism of phosphatase resistance of AGC kinase opens new perspectives toward therapeutic manipulation of kinase signaling in disease.	[Chan, Tung O.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Chan, Tung O.; Yadav, Santosh; Shah, Sushrut; Zhang, Jin; Tiegs, Brian C.; Keny, Nikhil; Blumhof, Brian; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Korman Resp Inst, Dept Med, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Armen, Roger S.] Thomas Jefferson Univ, Coll Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA; [Chan, Tung O.; Rodeck, Ulrich] Thomas Jefferson Univ, Sydney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Chan, TO (corresponding author), Thomas Jefferson Univ, Dept Med, 1020 Locust St,JAH Rm 543, Philadelphia, PA 19107 USA.	tung.chan@jefferson.edu	YADAV, SANTOSH KUMAR/AAU-6594-2020; Yadav, Santosh/GQZ-7569-2022	YADAV, SANTOSH KUMAR/0000-0001-7375-1698; Chan, Tung/0000-0001-6574-9555; Shah, Sushrut/0000-0002-4201-6532	American Heart Association research award; American Lung Association research award; W. W. Smith Charitable Trust medical research award; National Institutes of Health [RO1 HL58506]; U.S. Department of Defense [W81XWH-16-1-0679]	American Heart Association research award(American Heart Association); American Lung Association research award; W. W. Smith Charitable Trust medical research award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense)	This work was supported by an American Heart Association research award, an American Lung Association research award, and aW. W. Smith Charitable Trust medical research award (to T. O. C.), National Institutes of Health Grant RO1 HL58506 (to R. B. P.) and U.S. Department of Defense Grant W81XWH-16-1-0679 (to U. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bastidas AC, 2012, J MOL BIOL, V422, P215, DOI 10.1016/j.jmb.2012.05.021; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BECHTEL PJ, 1977, J BIOL CHEM, V252, P2691; BENNETT PA, 1993, J CELL SCI, V106, P891; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chan TO, 2015, BIOCHEM J, V471, P37, DOI 10.1042/BJ20150325; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; di Blasio L, 2015, J CELL SCI, V128, P863, DOI 10.1242/jcs.149294; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Heijerman HGM, 2019, LANCET, V394, P1940, DOI 10.1016/S0140-6736(19)32597-8; Herberg FW, 1997, PROTEIN SCI, V6, P569; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Koop A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-41; Langer T, 2005, FEBS LETT, V579, P4049, DOI 10.1016/j.febslet.2005.06.015; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Middleton PG, 2019, NEW ENGL J MED, V381, P1809, DOI 10.1056/NEJMoa1908639; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Rahaman O, 2011, J CHEM INF MODEL, V51, P2047, DOI 10.1021/ci1003009; Rettenmaier TJ, 2014, P NATL ACAD SCI USA, V111, P18590, DOI 10.1073/pnas.1415365112; Sakkal LA, 2017, J COMPUT CHEM, V38, P1209, DOI 10.1002/jcc.24728; Schulze JO, 2016, CELL CHEM BIOL, V23, P1193, DOI 10.1016/j.chembiol.2016.06.017; SHOJI S, 1979, J BIOL CHEM, V254, P6211; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; TONERWEBB J, 1992, J BIOL CHEM, V267, P25174; VERON M, 1993, P NATL ACAD SCI USA, V90, P10618, DOI 10.1073/pnas.90.22.10618; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348	49	0	0	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3316	3329		10.1074/jbc.RA119.010004	http://dx.doi.org/10.1074/jbc.RA119.010004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31964716	hybrid, Green Published			2022-12-28	WOS:000519597300034
J	Watanabe, Y; Tamura, Y; Kakuta, C; Watanabe, S; Endo, T				Watanabe, Yasunori; Tamura, Yasushi; Kakuta, Chika; Watanabe, Seiya; Endo, Toshiya			Structural basis for interorganelle phospholipid transport mediated by VAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); mitochondria; lipid transport; lipid-protein interaction; X-ray crystallography	INTRAMITOCHONDRIAL TRANSPORT; LIPID TRANSFER; YEAST; PHOSPHATIDYLSERINE; PROTEIN; UPS2-MDM35; MEMBRANES; INSIGHTS; TORPEDO; SUITE	Eukaryotic cells are compartmentalized to form organelles, whose functions rely on proper phospholipid and protein transport. Here we determined the crystal structure of human VAT-1, a cytosolic soluble protein that was suggested to transfer phosphatidylserine, at 2.2 ? resolution. We found that VAT-1 transferred not only phosphatidylserine but also other acidic phospholipids between membranes in vitro. Structure-based mutational analyses showed the presence of a possible lipid-binding cavity at the interface between the two subdomains, and two tyrosine residues in the flexible loops facilitated phospholipid transfer, likely by functioning as a gate to this lipid-binding cavity. We also found that a basic and hydrophobic loop with two tryptophan residues protruded from the molecule and facilitated binding to the acidic-lipid membranes, thereby achieving efficient phospholipid transfer.	[Watanabe, Yasunori; Watanabe, Seiya] Ehime Univ, Grad Sch Agr, Dept Biosci, Matsuyama, Ehime 7908566, Japan; [Watanabe, Yasunori; Kakuta, Chika; Endo, Toshiya] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Endo, Toshiya] Kyoto Sangyo Univ, Res Ctr Prot Dynam, Kita Ku, Kyoto 6038555, Japan; [Tamura, Yasushi] Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan; [Watanabe, Seiya] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan	Ehime University; Kyoto Sangyo University; Kyoto Sangyo University; Yamagata University; Ehime University	Endo, T (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	tendo@cc.kyoto-su.ac.jp	Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607; Watanabe, Yasunori/0000-0002-7846-680X; Watanabe, Seiya/0000-0002-6530-9047	Japan Society of the Promotion of Science KAKENHI [16K21473, 15H05595, 17H06414, 15H05705, 22227003]; Japan Science and Technology Agency (JST) CREST Grant [JPMJCR12M]; Takeda Science Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society of the Promotion of Science KAKENHI; Japan Science and Technology Agency (JST) CREST Grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Japan Society of the Promotion of Science KAKENHI Grants 16K21473 (to Y. W.), 15H05595 and 17H06414 (to Y. T.), and 15H05705 and 22227003 (to T. E.); a Japan Science and Technology Agency (JST) CREST Grant JPMJCR12M (to T. E.); a grant from the Takeda Science Foundation (to T. E.); and funds from the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Guo PC, 2011, J STRUCT BIOL, V176, P112, DOI 10.1016/j.jsb.2011.07.010; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Jeong H, 2017, P NATL ACAD SCI USA, V114, pE9502, DOI 10.1073/pnas.1715592114; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Junker M, 2015, TRAFFIC, V16, P1306, DOI 10.1111/tra.12336; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawano S, 2018, J CELL BIOL, V217, P959, DOI 10.1083/jcb.201704119; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; Kojima R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30777; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; LINIAL M, 1993, FEBS LETT, V315, P91, DOI 10.1016/0014-5793(93)81140-U; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Tamura Y, 2019, J BIOCHEM, V165, P115, DOI 10.1093/jb/mvy088; Tamura Y, 2017, ADV EXP MED BIOL, V997, P121, DOI 10.1007/978-981-10-4567-7_9; Tatsuta T, 2017, BBA-MOL CELL BIOL L, V1862, P81, DOI 10.1016/j.bbalip.2016.08.006; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsujita K, 2010, J BIOL CHEM, V285, P6781, DOI 10.1074/jbc.M109.057018; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001	40	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3257	3268		10.1074/jbc.RA119.011019	http://dx.doi.org/10.1074/jbc.RA119.011019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005660	hybrid, Green Published			2022-12-28	WOS:000519597300030
J	Andres, DA; Young, LEA; Veeranki, S; Hawkinson, TR; Levitan, BM; He, DH; Wang, C; Satin, J; Sun, RC				Andres, Douglas A.; Young, Lyndsay E. A.; Veeranki, Sudhakar; Hawkinson, Tara R.; Levitan, Bryana M.; He, Daheng; Wang, Chi; Satin, Jonathan; Sun, Ramon C.			Improved workflow for mass spectrometry?based metabolomics analysis of the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolomics; cardiac metabolism; glycogen; adrenergic receptor; gas chromatography-mass spectrometry (GC-MS); adrenergic receptor; Cardiac metabolism; GC-MS; Glycogen; Metabolomics	GLYCOGEN-SYNTHASE; RAT-HEART; MYOCARDIAL-METABOLISM; GLUCOSE-METABOLISM; CARDIAC METABOLISM; GLOBAL-ISCHEMIA; ATP HYDROLYSIS; INBORN-ERRORS; FATTY-ACID; FAILURE	MS-based metabolomics methods are powerful techniques to map the complex and interconnected metabolic pathways of the heart; however, normalization of metabolite abundance to sample input in heart tissues remains a technical challenge. Herein, we describe an improved GC-MS?based metabolomics workflow that uses insoluble protein?derived glutamate for the normalization of metabolites within each sample and includes normalization to protein-derived amino acids to reduce biological variation and detect small metabolic changes. Moreover, glycogen is measured within the metabolomics workflow. We applied this workflow to study heart metabolism by first comparing two different methods of heart removal: the Langendorff heart method (reverse aortic perfusion) and in situ freezing of mouse heart with a modified tissue freeze-clamp approach. We then used the in situ freezing method to study the effects of acute ?-adrenergic receptor stimulation (through isoproterenol (ISO) treatment) on heart metabolism. Using our workflow and within minutes, ISO reduced the levels of metabolites involved in glycogen metabolism, glycolysis, and the Krebs cycle, but the levels of pentose phosphate pathway metabolites and of many free amino acids remained unchanged. This observation was coupled to a 6-fold increase in phosphorylated adenosine nucleotide abundance. These results support the notion that ISO acutely accelerates oxidative metabolism of glucose to meet the ATP demand required to support increased heart rate and cardiac output. In summary, our MS-based metabolomics workflow enables improved quantification of cardiac metabolites and may also be compatible with other methods such as LC or capillary electrophoresis.	[Andres, Douglas A.; Young, Lyndsay E. A.; Veeranki, Sudhakar] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Levitan, Bryana M.; Satin, Jonathan] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; [He, Daheng; Wang, Chi] Univ Kentucky, Coll Med, Dept Biostat, Lexington, KY 40536 USA; [Andres, Douglas A.; Levitan, Bryana M.] Univ Kentucky, Coll Med, Gill Heart & Vasc Inst, Lexington, KY 40536 USA; [Andres, Douglas A.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Andres, Douglas A.; Veeranki, Sudhakar; Wang, Chi; Sun, Ramon C.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Hawkinson, Tara R.; Sun, Ramon C.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Sun, RC (corresponding author), Univ Kentucky, Coll Med, Dept Neurosci, Markey Canc Ctr, Lexington, KY 40536 USA.	ramon.sun@uky.edu	He, Daheng/AAR-1813-2021	sun, ramon/0000-0002-3009-1850; Young, Lyndsay/0000-0002-6873-5674	National Institutes of Health [HL131782, UL1TR001998]; American Heart Association [16GRNT27790094, 17SDG33670578]; American Cancer Society [16-182-28]; St. Baldrick's Career Development Award; University of Kentucky Markey Cancer Center; Saha Cardiovascular Research Center; Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); St. Baldrick's Career Development Award; University of Kentucky Markey Cancer Center; Saha Cardiovascular Research Center; Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center	This work was supported by National Institutes of Health Grant HL131782 (to D. A. A. and J. S.) and UL1TR001998 (to D. A. A., S. V., and R. C. S.); American Heart Association Grants 16GRNT27790094 (to D. A. A. and J. S.) and 17SDG33670578 (to S. V.); American Cancer Society Institutional Research Grant 16-182-28 (to R. C. S.); and a St. Baldrick's Career Development Award (to R. C. S.). This work was also supported by funding from the University of Kentucky Markey Cancer Center, the Saha Cardiovascular Research Center, and the Biostatistics and Bioinformatics Shared Resource Facility of the University of Kentucky Markey Cancer Center Grant P30CA177558. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN DG, 1985, J PHYSIOL-LONDON, V361, P185, DOI 10.1113/jphysiol.1985.sp015640; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2011, ADV STRUCTURAL SAFET; Barros LF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00027; Brewer MK, 2019, CELL METAB, V30, P689, DOI 10.1016/j.cmet.2019.07.002; CALDER PC, 1990, INT J BIOCHEM, V22, P847, DOI 10.1016/0020-711X(90)90288-E; CAMICI P, 1989, AM J PHYSIOL, V257, pE309, DOI 10.1152/ajpendo.1989.257.3.E309; Claudino WM, 2007, J CLIN ONCOL, V25, P2840, DOI 10.1200/JCO.2006.09.7550; DEEMS RO, 1991, BIOCHEM BIOPH RES CO, V174, P716, DOI 10.1016/0006-291X(91)91476-S; Deshpande P, 1999, J APPL PHYSIOL, V87, P203, DOI 10.1152/jappl.1999.87.1.203; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; FIOLET JWT, 1984, J MOL CELL CARDIOL, V16, P1023, DOI 10.1016/S0022-2828(84)80015-2; Ganna A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004801; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Guard BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127259; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Haukaas TH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00017; HEADRICK J, 1989, J MOL CELL CARDIOL, V21, P1089, DOI 10.1016/0022-2828(89)90687-1; HIBBS RG, 1963, ANAT REC, V147, P261, DOI 10.1002/ar.1091470209; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Ho JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148361; IBSEN KH, 1961, CANCER RES, V21, P829; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; JULIA PL, 1990, J THORAC CARDIOV SUR, V100, P879; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; KRASNOW N, 1964, AM J MED, V37, P514, DOI 10.1016/0002-9343(64)90065-8; Kuhara T, 2005, MASS SPECTROM REV, V24, P814, DOI 10.1002/mas.20038; LAZAR HL, 1980, SURGERY, V88, P702; LIEBERMAN J, 1983, LAB INVEST, V48, P711; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; MANCINI DM, 1992, CIRCULATION, V85, P1364, DOI 10.1161/01.CIR.85.4.1364; MASSAGUE J, 1978, BIOCHIM BIOPHYS ACTA, V543, P269, DOI 10.1016/0304-4165(78)90073-9; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Miller MJ, 2015, J INHERIT METAB DIS, V38, P1029, DOI 10.1007/s10545-015-9843-7; MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Moseley HNB, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301006; Opie L.H., 2004, HEART PHYSL CELL CIR, DOI 10.1161/01.CIR.0000143724.99618.; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Padron-Barthe L, 2018, J AM COLL CARDIOL, V71, P654, DOI 10.1016/j.jacc.2017.11.067; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; Quero A, 2014, J CHROMATOGR B, V970, P36, DOI 10.1016/j.jchromb.2014.08.040; Ramautar R, 2009, ELECTROPHORESIS, V30, P276, DOI 10.1002/elps.200800512; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Savorani F, 2013, FOOD RES INT, V54, P1131, DOI 10.1016/j.foodres.2012.12.025; Schonekess BO, 1997, J MOL CELL CARDIOL, V29, P2725, DOI 10.1006/jmcc.1997.0504; SHIPP JC, 1961, NATURE, V189, P1018, DOI 10.1038/1891018a0; Silva LP, 2013, ANAL CHEM, V85, P9536, DOI 10.1021/ac401559v; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; SMITH EL, 1954, J BIOL CHEM, V207, P501; SOBEL B, 1966, CIRC RES, V19, P1050, DOI 10.1161/01.RES.19.6.1050; SOLE MJ, 1979, CIRC RES, V45, P629, DOI 10.1161/01.RES.45.5.629; SONNTAG H, 1979, ANESTHESIOLOGY, V51, P204, DOI 10.1097/00000542-197909000-00005; STEWART RV, 1984, AM J CLIN PATHOL, V82, P411, DOI 10.1093/ajcp/82.4.411; STRICKLAND WG, 1980, DIABETES, V29, P617, DOI 10.2337/diabetes.29.8.617; Sun RC, 2019, CELL METAB, V30, P903, DOI 10.1016/j.cmet.2019.08.014; Sun RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01518-z; SVEDJEHOLM R, 1990, THORAC CARDIOV SURG, V38, P1, DOI 10.1055/s-2007-1013981; Taegtmeyer H, 1997, AM J CARDIOL, V80, pA3, DOI 10.1016/S0002-9149(97)00452-9; Tomita M, 2012, SCIENCE, V336, P990, DOI 10.1126/science.1223066; Trutschel D, 2015, METABOLOMICS, V11, P851, DOI 10.1007/s11306-014-0742-y; TSUGITA A, 1982, EUR J BIOCHEM, V124, P585, DOI 10.1111/j.1432-1033.1982.tb06634.x; WIESNER RJ, 1989, J MOL CELL CARDIOL, V21, P49, DOI 10.1016/0022-2828(89)91492-2; WILLIAMS BJ, 1966, MOL PHARMACOL, V2, P454; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Zarate E, 2017, METABOLITES, V7, DOI 10.3390/metabo7010001; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	79	10	10	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2676	2686		10.1074/jbc.RA119.011081	http://dx.doi.org/10.1074/jbc.RA119.011081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31980460	Green Published, hybrid			2022-12-28	WOS:000519969100013
J	Romero, C; Lambert, LJ; Sheffler, DJ; De Backer, LJS; Raveendra-Panickar, D; Celeridad, M; Grotegut, S; Rodiles, S; Holleran, J; Sergienko, E; Pasquale, EB; Cosford, NDP; Tautz, L				Romero, Celeste; Lambert, Lester J.; Sheffler, Douglas J.; De Backer, Laurent J. S.; Raveendra-Panickar, Dhanya; Celeridad, Maria; Grotegut, Stefan; Rodiles, Socorro; Holleran, John; Sergienko, Eduard; Pasquale, Elena B.; Cosford, Nicholas D. P.; Tautz, Lutz			A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tyrosine-protein phosphatase (tyrosine phosphatase); anticancer drug; drug discovery; protein drug interaction; small molecule; allosteric inhibitors; cellular target engagement; cellular thermal shift assay; PTPN11; SHP2	PROTEIN-TYROSINE PHOSPHATASES; CANCER; CELLS	The nonreceptor protein-tyrosine phosphatase (PTP) SHP2 is encoded by the proto-oncogene PTPN11 and is a ubiquitously expressed key regulator of cell signaling, acting on a number of cellular processes and components, including the Ras/Raf/Erk, PI3K/Akt, and JAK/STAT pathways and immune checkpoint receptors. Aberrant SHP2 activity has been implicated in all phases of tumor initiation, progression, and metastasis. Gain-of-function PTPN11 mutations drive oncogenesis in several leukemias and cause developmental disorders with increased risk of malignancy such as Noonan syndrome. Until recently, small molecule-based targeting of SHP2 was hampered by the failure of orthosteric active-site inhibitors to achieve selectivity and potency within a useful therapeutic window. However, new SHP2 allosteric inhibitors with excellent potency and selectivity have sparked renewed interest in the selective targeting of SHP2 and other PTP family members. Crucially, drug discovery campaigns focusing on SHP2 would greatly benefit from the ability to validate the cellular target engagement of candidate inhibitors. Here, we report a cellular thermal shift assay that reliably detects target engagement of SHP2 inhibitors. Using this assay, based on the DiscoverX InCell Pulse enzyme complementation technology, we characterized the binding of several SHP2 allosteric inhibitors in intact cells. Moreover, we demonstrate the robustness and reliability of a 384-well miniaturized version of the assay for the screening of SHP2 inhibitors targeting either WT SHP2 or its oncogenic E76K variant. Finally, we provide an example of the assay's ability to identify and characterize novel compounds with specific cellular potency for either WT or mutant SHP2.	[Romero, Celeste; Lambert, Lester J.; Sheffler, Douglas J.; De Backer, Laurent J. S.; Raveendra-Panickar, Dhanya; Celeridad, Maria; Cosford, Nicholas D. P.; Tautz, Lutz] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Canc Metab & Signaling Networks Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Grotegut, Stefan; Rodiles, Socorro; Holleran, John; Sergienko, Eduard] Sanford Burnham Prebys Med Discovery Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Tautz, L (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Canc Metab & Signaling Networks Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	tautz@sbpdiscovery.org	; Tautz, Lutz/M-9989-2014	Romero, Celeste/0000-0001-6232-392X; Tautz, Lutz/0000-0002-4075-6238	National Institutes of Health [1R21CA195422, 1R21NS067502]; NCI Experimental Therapeutics (NExT) Program [Leidos-16X113-SHP2]; Epstein Family Foundation Award; NCI Cancer Center Support Grant [P30CA030199]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Experimental Therapeutics (NExT) Program; Epstein Family Foundation Award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants 1R21CA195422 (to L. T.) and 1R21NS067502 (to E. B. P.), NCI Experimental Therapeutics (NExT) Program Grant Leidos-16X113-SHP2 (to L. T.), Epstein Family Foundation Award (to N. D. P. C.), and NCI Cancer Center Support Grant P30CA030199. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], 2019, US MAN INCELL PULS T; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Benjamin G., 2010, HDB CELL SIGNALING, P771; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen C.H.-T., 2018, Patent, Patent No. [US20180201623, 20180201623]; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Elson A, 2018, INT J BIOCHEM CELL B, V96, P135, DOI 10.1016/j.biocel.2017.09.013; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Gurzov EN, 2015, TRENDS ENDOCRIN MET, V26, P30, DOI 10.1016/j.tem.2014.10.004; Herr RJ, 2002, BIOORGAN MED CHEM, V10, P3379, DOI 10.1016/S0968-0896(02)00239-0; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; Lauriol J, 2015, SEMIN CELL DEV BIOL, V37, P73, DOI 10.1016/j.semcdb.2014.09.013; Lombroso Paul J, 2016, F1000Res, V5, DOI 10.12688/f1000research.8571.1; McNulty DE, 2018, SLAS DISCOV, V23, P34, DOI 10.1177/2472555217732014; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nichols RJ, 2018, NAT CELL BIOL, V20, P1064, DOI 10.1038/s41556-018-0169-1; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Scott LM, 2010, CURR PHARM DESIGN, V16, P1843; Senis YA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030569; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Sun X, 2018, LEUKEMIA, V32, P1246, DOI 10.1038/s41375-018-0020-5; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tautz L, 2015, J CLIN INVEST, V125, P2931, DOI 10.1172/JCI83192; Tautz L, 2015, BIOORGAN MED CHEM, V23, P2786, DOI 10.1016/j.bmc.2015.03.075; Tautz L, 2013, METHODS MOL BIOL, V1053, P223, DOI 10.1007/978-1-62703-562-0_14; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tsutsumi R, 2018, FEBS OPEN BIO, V8, P1405, DOI 10.1002/2211-5463.12493; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Yu ZH, 2018, CHEM REV, V118, P193, DOI 10.1021/acs.chemrev.7b00105; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003	46	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2601	2613		10.1074/jbc.RA119.010838	http://dx.doi.org/10.1074/jbc.RA119.010838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953320	Green Published, hybrid			2022-12-28	WOS:000519969100007
J	Ustinova, K; Novakova, Z; Saito, M; Meleshin, M; Mikesova, J; Kutil, Z; Baranova, P; Havlinova, B; Schutkowski, M; Matthias, P; Barinka, C				Ustinova, Kseniya; Novakova, Zora; Saito, Makoto; Meleshin, Marat; Mikesova, Jana; Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Schutkowski, Mike; Matthias, Patrick; Barinka, Cyril			The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; substrate specificity; protein-protein interaction; microtubule-associated protein (MAP); tubulin; intrinsically disordered protein; histone deacetylase 6 (HDAC6); protein motif; total internal reflection fluorescence (TIRF); cytoskeleton; post-translational modification	HISTONE; ACETYLATION; BRAIN; ACTIVATION; MECHANISMS; CLEARANCE; ISOTYPES; MEMORY; MOTORS; TAU	Histone deacetylase 6 (HDAC6) is a multidomain cytosolic enzyme having tubulin deacetylase activity that has been unequivocally assigned to the second of the tandem catalytic domains. However, virtually no information exists on the contribution of other HDAC6 domains on tubulin recognition. Here, using recombinant protein expression, site-directed mutagenesis, fluorimetric and biochemical assays, microscale thermophoresis, and total internal reflection fluorescence microscopy, we identified the N-terminal, disordered region of HDAC6 as a microtubule-binding domain and functionally characterized it to the single-molecule level. We show that the microtubule-binding motif spans two positively charged patches comprising residues Lys-32 to Lys-58. We found that HDAC6-microtubule interactions are entirely independent of the catalytic domains and are mediated by ionic interactions with the negatively charged microtubule surface. Importantly, a crosstalk between the microtubule-binding domain and the deacetylase domain was critical for recognition and efficient deacetylation of free tubulin dimers both in vitro and in vivo. Overall, our results reveal that recognition of substrates by HDAC6 is more complex than previously appreciated and that domains outside the tandem catalytic core are essential for proficient substrate deacetylation.	[Ustinova, Kseniya; Novakova, Zora; Mikesova, Jana; Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, BIOCEV, Inst Biotechnol, Prumyslova 595, Vestec 25250, Czech Republic; [Ustinova, Kseniya] Charles Univ Prague, Fac Nat Sci, Dept Biochem, Albertov 6, Prague 2, Czech Republic; [Saito, Makoto; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, D-06120 Halle, Germany; [Saito, Makoto; Matthias, Patrick] Univ Basel, Fac Sci, CH-4031 Basel, Switzerland	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague; Friedrich Miescher Institute for Biomedical Research; Martin Luther University Halle Wittenberg; University of Basel	Barinka, C (corresponding author), Vvi, Inst Biotechnol, Struct Biol Lab, Prumyslova 595, Vestec 25250, Czech Republic.	cyril.barinka@ibt.cas.cz	Saito, Makoto/GLR-4232-2022; Ustinova, Kseniya/AAO-7143-2021; Kutil, Zsofia/O-1096-2013; Novakova, Zora/G-8665-2014; Ustinova, Kseniya/L-7261-2017	Ustinova, Kseniya/0000-0001-6632-5850; Novakova, Zora/0000-0001-9804-6346; Ustinova, Kseniya/0000-0001-6632-5850; Matthias, Patrick/0000-0002-3927-1452; Barinka, Cyril/0000-0003-2751-3060; Saito, Makoto/0000-0001-8619-5176	Czech-BioImaging large RI projects (MEYS CR) [LM2015062, CZ.02.1.01/0.0/0.0/16_013/0001775]; MEYS CR [LM2015043]	Czech-BioImaging large RI projects (MEYS CR); MEYS CR	We thank I. Jelinkova for the excellent technical assistance, M. Hubalek for MS analysis, and A. Kozikowski for the gift of Nexturastat A. We acknowledge the Imaging Methods Core Facility at BIOCEV, institution supported by the Czech-BioImaging large RI projects (LM2015062 and CZ.02.1.01/0.0/0.0/16_013/0001775, funded by MEYS CR) and the Biophysics facility of CMS supported by MEYS CR (LM2015043) for their support with obtaining scientific data presented in this article.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Du YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123191; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hai Y, 2016, NAT CHEM BIOL, V12, P741, DOI 10.1038/nchembio.2134; Hansen BK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09024-0; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hard RL, 2010, BIOCHEMISTRY-US, V49, P10737, DOI 10.1021/bi101014s; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; HYMAN AA, 1991, J CELL SCI, P125; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kellogg EH, 2016, P NATL ACAD SCI USA, V113, P9430, DOI 10.1073/pnas.1609903113; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kozikowski AP, 2019, ACS CHEM NEUROSCI, V10, P1679, DOI 10.1021/acschemneuro.8b00600; Kutil Z, 2019, FASEB J, V33, P4035, DOI 10.1096/fj.201801680R; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Lernoux M, 2018, PHARMACOL RES, V129, P337, DOI 10.1016/j.phrs.2017.11.004; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Nahhas F, 2007, MOL CELL BIOCHEM, V303, P221, DOI 10.1007/s11010-007-9478-6; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saito M, 2019, NAT CHEM BIOL, V15, P51, DOI 10.1038/s41589-018-0180-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Thiede C, 2013, BIOPHYS J, V104, P432, DOI 10.1016/j.bpj.2012.11.3810; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13897-w; Wang Q, 2014, P NATL ACAD SCI USA, V111, P11347, DOI 10.1073/pnas.1403135111; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao ZQ, 2010, PROTEIN PEPTIDE LETT, V17, P555, DOI 10.2174/092986610791112620; Zhuang Y, 2010, BIOCHEM BIOPH RES CO, V392, P608, DOI 10.1016/j.bbrc.2010.01.091; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	65	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2614	2628		10.1074/jbc.RA119.011243	http://dx.doi.org/10.1074/jbc.RA119.011243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953325	Green Published, hybrid			2022-12-28	WOS:000519969100008
J	Thibeault, PE; LeSarge, JC; Arends, D; Fernandes, M; Chidiac, P; Stathopulos, PB; Luyt, LG; Ramachandran, R				Thibeault, Pierre E.; LeSarge, Jordan C.; Arends, D'Arcy; Fernandes, Michaela; Chidiac, Peter; Stathopulos, Peter B.; Luyt, Leonard G.; Ramachandran, Rithwik			Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein?coupled receptor (GPCR); bioluminescence; bioluminescence resonance energy transfer (BRET); mitogen-activated protein kinase (MAPK); arrestin; docking; platelet; biased signaling; G-protein; peptide; protease-activated receptor-4 (PAR4)	SECONDARY PREVENTION; TETHERED LIGAND; AGONIST RECOGNITION; COUPLED RECEPTORS; SPECIFICITY; PEPTIDE; MECHANISM; CLONING; REQUIREMENTS; ASSOCIATION	Proteinase-activated receptor (PAR)-4 is a member of the proteolytically-activated PAR family of G-protein?coupled receptors (GPCR) that represents an important target in the development of anti-platelet therapeutics. PARs are activated by proteolytic cleavage of their receptor N terminus by enzymes such as thrombin, trypsin, and cathepsin-G. This reveals the receptor-activating motif, termed the tethered ligand that binds intramolecularly to the receptor and triggers signaling. However, PARs are also activated by exogenous application of synthetic peptides derived from the tethered-ligand sequence. To better understand the molecular basis for PAR4-dependent signaling, we examined PAR4-signaling responses to a peptide library derived from the canonical PAR4-agonist peptide, AYPGKF-NH2, and we monitored activation of the G?(q/11)-coupled calcium-signaling pathway, ?-arrestin recruitment, and mitogen-activated protein kinase (MAPK) pathway activation. We identified peptides that are poor activators of PAR4-dependent calcium signaling but were fully competent in recruiting ?-arrestin-1 and -2. Peptides that were unable to stimulate PAR4-dependent calcium signaling could not trigger MAPK activation. Using in silico docking and site-directed mutagenesis, we identified Asp(230) in the extracellular loop-2 as being critical for PAR4 activation by both agonist peptide and the tethered ligand. Probing the consequence of biased signaling on platelet activation, we found that a peptide that cannot activate calcium signaling fails to cause platelet aggregation, whereas a peptide that is able to stimulate calcium signaling and is more potent for ?-arrestin recruitment triggered greater levels of platelet aggregation compared with the canonical PAR4 agonist peptide. These findings uncover molecular determinants critical for agonist binding and biased signaling through PAR4.	[Thibeault, Pierre E.; Arends, D'Arcy; Chidiac, Peter; Stathopulos, Peter B.; Ramachandran, Rithwik] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [LeSarge, Jordan C.; Fernandes, Michaela; Luyt, Leonard G.] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Luyt, Leonard G.] Univ Western Ontario, Dept Oncol, London, ON N6A 5C1, Canada; [Luyt, Leonard G.] Lawson Hlth Res Inst, London Reg Canc Program, London, ON N6C2R5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Ramachandran, R (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	rramach@uwo.ca	Ramachandran, Rithwik/N-7815-2015; Chidiac, Peter/L-5906-2015	Ramachandran, Rithwik/0000-0001-9557-9905; Chidiac, Peter/0000-0001-8365-6109; Thibeault, Pierre/0000-0002-3867-9819; Stathopulos, Peter B./0000-0002-0536-6656	Canadian Institutes of Health Research (CIHR) [376560]; Natural Sciences and Engineering Research Council of Canada; Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology; Canada Graduate Scholarship; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology; Canada Graduate Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by a Canadian Institutes of Health Research (CIHR) grant 376560 (to R. R.) and by grants from the Natural Sciences and Engineering Research Council of Canada (to L. G. L. and P. B. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Doctoral Queen Elizabeth II Graduate Scholarship in Science and Technology.; Recipient of a Canada Graduate Scholarship and an Ontario Graduate Scholarship.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2002, J PHARMACOL EXP THER, V302, P1046, DOI 10.1124/jpet.302.3.1046; Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Bar-Shavit R, 2016, METHOD CELL BIOL, V132, P341, DOI 10.1016/bs.mcb.2015.11.006; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Boitano S, 2011, J MED CHEM, V54, P1308, DOI 10.1021/jm1013049; Centellas DS, 2017, THROMB RES, V154, P84, DOI 10.1016/j.thromres.2017.04.006; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Chidiac P, 2016, METHODS, V92, P87, DOI 10.1016/j.ymeth.2015.08.011; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edelstein LC, 2014, BLOOD, V124, P3450, DOI 10.1182/blood-2014-04-572479; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Ferguson Stephen S. G., 2003, V237, P121; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; French SL, 2016, BRIT J PHARMACOL, V173, P2952, DOI 10.1111/bph.13455; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hoffmann W, 2019, ANGEW CHEM INT EDIT, V58, P8216, DOI 10.1002/anie.201813954; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Hollenberg MD, 2003, DRUG DEVELOP RES, V59, P336, DOI 10.1002/ddr.10301; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Kim BH, 2019, ACS PHARMACOL TRANSL, V2, P155, DOI 10.1021/acsptsci.8b00053; Lee H, 2015, NUCLEIC ACIDS RES, V43, pW431, DOI 10.1093/nar/gkv495; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; LIU LW, 1991, J BIOL CHEM, V266, P16977; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Miller MM, 2019, J MED CHEM, V62, P7400, DOI 10.1021/acs.jmedchem.9b00186; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Morrow DA, 2009, AM HEART J, V158, P335, DOI 10.1016/j.ahj.2009.06.027; Moschonas IC, 2017, PLATELETS, V28, P812, DOI 10.1080/09537104.2017.1282607; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ramachandran R, 2017, MOL PHARMACOL, V91, P287, DOI 10.1124/mol.116.106526; Rudinga GR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020573; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Seyedabadi M, 2019, PHARMACOL THERAPEUT, V200, P148, DOI 10.1016/j.pharmthera.2019.05.006; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tourdot BE, 2018, ARTERIOSCL THROM VAS, V38, P1632, DOI 10.1161/ATVBAHA.118.311112; Vanderboor C. M., 2019, PROTEINASE ACTIVATED, DOI [10.1101/746677, DOI 10.1101/746677]; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wilson SJ, 2018, ARTERIOSCL THROM VAS, V38, P448, DOI 10.1161/ATVBAHA.117.310104; Wong PC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5294; Woolley MJ, 2017, MOL CELL ENDOCRINOL, V449, P3, DOI 10.1016/j.mce.2016.11.023; Wu CC, 2000, BRIT J PHARMACOL, V130, P1289, DOI 10.1038/sj.bjp.0703437; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Young S. E., 2010, PROBE REPORTS NIH MO	73	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2520	2540		10.1074/jbc.RA119.011461	http://dx.doi.org/10.1074/jbc.RA119.011461			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31892516	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000517330200031
J	Zhuang, NN; Zhang, H; Li, LT; Wu, XX; Yang, C; Zhang, Y				Zhuang, Ningning; Zhang, Hao; Li, Lingting; Wu, Xiaoxian; Yang, Chen; Zhang, Yu			Crystal structures and biochemical analyses of the bacterial arginine dihydrolase ArgZ suggests a ?bond rotation? catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; nitrogen metabolism; enzyme structure; cyanobacteria; hydrolase; enzyme mechanism; arginine; arginine dihydrolase; arginine metabolism; cyanobacteria; ornithine?ammonia cycle	ENZYME; METABOLISM; PATHWAY; INTERMEDIATE; DIVERSITY; DEIMINASE; SUBSTRATE; COMPLEX	A recently discovered ornithine?ammonia cycle (OAC) serves as a conduit in the nitrogen storage and remobilization machinery in cyanobacteria. The OAC involves an arginine catabolic reaction catalyzed by the arginine dihydrolase ArgZ whose catalytic mechanism is unknown. Here we determined the crystal structures at 1.2?3.0 ? of unliganded ArgZ from the cyanobacterium Synechocystis sp. PCC6803 and of ArgZ complexed with its substrate arginine, a covalently linked reaction intermediate, or the reaction product ornithine. The structures reveal that a key residue, Asn(71), in the ArgZ active center functions as the determinant distinguishing ArgZ from other members of the guanidino group?modifying enzyme superfamily. The structures, along with biochemical evidence from enzymatic assays coupled with electrospray ionization MS techniques, further suggest that ArgZ-catalyzed conversion of arginine to ornithine, ammonia, and carbon dioxide consists of two successive cycles of amine hydrolysis. Finally, we show that arginine dihydrolases are broadly distributed among bacteria and metazoans, suggesting that the OAC may be frequently used for redistribution of nitrogen from arginine catabolism or nitrogen fixation.	[Zhuang, Ningning; Zhang, Hao; Li, Lingting; Wu, Xiaoxian; Yang, Chen; Zhang, Yu] Chinese Acad Sci, Key Lab Synthet Biol, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Zhang, Hao; Li, Lingting; Wu, Xiaoxian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, C; Zhang, Y (corresponding author), Chinese Acad Sci, Key Lab Synthet Biol, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.	chenyang@sibs.ac.cn; yzhang@sippe.ac.cn	Zhang, Yu/AAV-5722-2021	Zhang, Yu/0000-0002-1778-8389	National Key Research and Development Program of China [2018YFA0900700]; National Natural Science Foundation of China [31822001]; Leading Science Key Research Program of the Chinese Academy of Sciences [QYZDB-SSW-SMC005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Science Key Research Program of the Chinese Academy of Sciences	This work was supported by National Key Research and Development Program of China Grant 2018YFA0900700, National Natural Science Foundation of China Grant 31822001, and Leading Science Key Research Program of the Chinese Academy of Sciences Grant QYZDB-SSW-SMC005. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berthold CL, 2007, STRUCTURE, V15, P853, DOI 10.1016/j.str.2007.06.001; Botas A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00361; Burnat M, 2019, MOL MICROBIOL, V111, P883, DOI 10.1111/mmi.14203; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Kemper EL, 1998, EUR J BIOCHEM, V253, P720, DOI 10.1046/j.1432-1327.1998.2530720.x; Liao DI, 1998, STRUCTURE, V6, P23, DOI 10.1016/S0969-2126(98)00004-5; Linsky T, 2010, BBA-PROTEINS PROTEOM, V1804, P1943, DOI 10.1016/j.bbapap.2010.07.016; Linsky TW, 2008, CHEM BIOL, V15, P467, DOI 10.1016/j.chembiol.2008.03.012; Ma H, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13100969; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; SIMON JP, 1982, J BACTERIOL, V150, P1085, DOI 10.1128/JB.150.3.1085-1090.1982; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Stone EA, 2005, BIOCHEMISTRY-US, V44, P7069, DOI 10.1021/bi047407r; Stone EM, 2006, BIOCHEMISTRY-US, V45, P5618, DOI 10.1021/bi052595m; Tocilj A, 2005, J BIOL CHEM, V280, P15800, DOI 10.1074/jbc.M413833200; Wall LG, 2000, J PLANT GROWTH REGUL, V19, P167; Wang BH, 2015, J IND MICROBIOL BIOT, V42, P949, DOI 10.1007/s10295-015-1611-z; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wang Y, 2017, NUCLEIC ACIDS RES, V45, pW429, DOI 10.1093/nar/gkx349; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhang H, 2018, NAT CHEM BIOL, V14, P575, DOI 10.1038/s41589-018-0038-z	32	4	4	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2113	2124		10.1074/jbc.RA119.011752	http://dx.doi.org/10.1074/jbc.RA119.011752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31914412	Green Published, hybrid			2022-12-28	WOS:000517128200027
J	Broussard, A; Florwick, A; Desbiens, C; Nischan, N; Robertson, C; Guan, ZQ; Kohler, JJ; Wells, L; Boyce, M				Broussard, Alex; Florwick, Alyssa; Desbiens, Chelsea; Nischan, Nicole; Robertson, Corrina; Guan, Ziqiang; Kohler, Jennifer J.; Wells, Lance; Boyce, Michael			Human UDP-galactose 4 '-epimerase (GALE) is required for cell-surface glycome structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide metabolism; carbohydrate metabolism; galactose; glycobiology; glycoprotein; glycolipid; apoptosis; CD95 (APO-1/Fas); integrin; UDP-galactose 4 '-epimerase (GALE)	VERTEBRATE AMINO-SUGARS; O-LINKED GLYCOSYLATION; WHEAT-GERM-AGGLUTININ; ALPHA-5-BETA-1 INTEGRIN; N-ACETYLGALACTOSAMINE; GLCNAC TRANSFERASE; SERUM TRANSFERRIN; LELOIR PATHWAY; ER STRESS; EXPRESSION	Glycan biosynthesis relies on nucleotide sugars (NSs), abundant metabolites that serve as monosaccharide donors for glycosyltransferases. In vivo, signal-dependent fluctuations in NS levels are required to maintain normal cell physiology and are dysregulated in disease. However, how mammalian cells regulate NS levels and pathway flux remains largely uncharacterized. To address this knowledge gap, here we examined UDP-galactose 4'-epimerase (GALE), which interconverts two pairs of essential NSs. Using immunoblotting, flow cytometry, and LC-MS-based glycolipid and glycan profiling, we found that CRISPR/Cas9-mediated GALE deletion in human cells triggers major imbalances in NSs and dramatic changes in glycolipids and glycoproteins, including a subset of integrins and the cell-surface death receptor FS-7-associated surface antigen. In particular, we observed substantial decreases in total sialic acid, galactose, and GalNAc levels in glycans. These changes also directly impacted cell signaling, as GALE(-/-) cells exhibited FS-7-associated surface antigen ligand-induced apoptosis. Our results reveal a role of GALE-mediated NS regulation in death receptor signaling and may have implications for the molecular etiology of illnesses characterized by NS imbalances, including galactosemia and metabolic syndrome.	[Broussard, Alex; Florwick, Alyssa; Robertson, Corrina; Guan, Ziqiang; Boyce, Michael] Duke Univ, Dept Biochem, Durham, NC 27710 USA; [Desbiens, Chelsea; Wells, Lance] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Nischan, Nicole; Kohler, Jennifer J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wells, Lance] Complex Carbohydrate Res Ctr, Thermo Fisher Ctr Excellence Glycoprote, Durham, NC USA	Duke University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Boyce, M (corresponding author), Duke Univ, Dept Biochem, Durham, NC 27710 USA.	michael.boyce@duke.edu	Kohler, Jennifer/B-6589-2009	Kohler, Jennifer/0000-0001-5373-3329; Desbiens, Chelsea/0000-0003-2768-9306; Boyce, Michael/0000-0002-2729-4876; Wells, Lance/0000-0003-4956-5363	Rita Allen Foundation; NIGMS, National Institutes of Health [GM069338]; NEI, National Institutes of Health [EY023666]; Welch Foundation [I-1686]; German Academic Exchange Service	Rita Allen Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Welch Foundation(The Welch Foundation); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by a scholar award from the Rita Allen Foundation (to A. B. and M. B.); NIGMS, National Institutes of Health Grant GM069338 and NEI, National Institutes of Health Grant EY023666 (to Z. G.), Welch Foundation Grant I-1686 (to J. J. K.), and a postdoctoral fellowship from the German Academic Exchange Service (to N. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Blackburn JB, 2018, TRAFFIC, V19, P463, DOI 10.1111/tra.12564; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brokate-Llanos AM, 2014, GENETICS, V198, P1559, DOI 10.1534/genetics.114.170084; Broussard AC, 2019, MOL BIOL CELL, V30, P525, DOI 10.1091/mbc.E18-04-0247; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Charlwood J, 1998, GLYCOBIOLOGY, V8, P351, DOI 10.1093/glycob/8.4.351; Cox NJ, 2018, BIOCHEMISTRY-US, V57, P91, DOI 10.1021/acs.biochem.7b00870; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Esko JD., 2017, ESSENTIALS GLYCOBIOL; Freeze HH, 2017, ESSENTIALS GLYCOBIOL, V3rd; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fridovich-Keil J., 2016, GENEREVIEWS; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Fujita N, 2008, FEBS J, V275, P788, DOI 10.1111/j.1742-4658.2008.06246.x; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; GITZELMANN R, 1995, EUR J PEDIATR, V154, pS45, DOI 10.1007/BF02143803; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; HABERLAN.C, 1971, J NEUROPATH EXP NEUR, V30, P431, DOI 10.1097/00005072-197107000-00009; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; HENDERSON MJ, 1983, J INHERIT METAB DIS, V6, P17, DOI 10.1007/BF02391187; Hennet T, 2015, TRENDS BIOCHEM SCI, V40, P377, DOI 10.1016/j.tibs.2015.03.002; Hirahara Y, 2017, J NEUROCHEM, V140, P435, DOI 10.1111/jnc.13897; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Ichikawa M, 2014, J BIOL CHEM, V289, P6751, DOI 10.1074/jbc.M113.544064; Inamori K, 2018, J LIPID RES, V59, P1472, DOI 10.1194/jlr.M085753; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; JAEKEN J, 1992, LANCET, V340, P1472, DOI 10.1016/0140-6736(92)92664-2; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Ji ST, 2015, BIOCHEM BIOPH RES CO, V459, P189, DOI 10.1016/j.bbrc.2015.01.143; Jumbo-Lucioni P, 2014, DIS MODEL MECH, V7, P1365, DOI 10.1242/dmm.017137; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Liu Y, 2012, MOL GENET METAB, V106, P442, DOI 10.1016/j.ymgme.2012.05.025; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Marsico G, 2018, TRENDS CANCER, V4, P537, DOI 10.1016/j.trecan.2018.05.009; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Novelli G, 2000, MOL GENET METAB, V71, P62, DOI 10.1006/mgme.2000.3073; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Openo KK, 2006, AM J HUM GENET, V78, P89, DOI 10.1086/498985; Palavicini JP, 2016, J NEUROCHEM, V139, P40, DOI 10.1111/jnc.13738; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; PETRY K, 1991, BIOCHEM MED METAB B, V46, P93, DOI 10.1016/0885-4505(91)90054-O; Ranzinger R., 2017, GRITS TOOLBOX; Ryczko MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23043; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sanders RD, 2010, DIS MODEL MECH, V3, P628, DOI 10.1242/dmm.005058; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Schulz JM, 2005, J BIOL CHEM, V280, P13493, DOI 10.1074/jbc.M414045200; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Scott DW, 2012, ARTERIOSCL THROM VAS, V32, pE51, DOI 10.1161/ATVBAHA.112.253203; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Seo A, 2019, HUM MOL GENET, V28, P133, DOI 10.1093/hmg/ddy334; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Stibler H, 1997, ACTA PAEDIATR, V86, P1377, DOI 10.1111/j.1651-2227.1997.tb14917.x; Sturiale L, 2005, GLYCOBIOLOGY, V15, P1268, DOI 10.1093/glycob/cwj021; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Termini JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179949; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Varki A., 2017, ESSENTIALS GLYCOBIOL; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Walter JH, 1999, ARCH DIS CHILD, V80, P374, DOI 10.1136/adc.80.4.374; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; WITTING LA, 1972, CLIN CHIM ACTA, V37, P387, DOI 10.1016/0009-8981(72)90459-7; Yilmaz E., 2017, OBESITY LIPOTOXICITY, P261; Yoshihara T, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007545; Zhu Y, 2017, DIABETES, V66, P2789, DOI 10.2337/db17-0323; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	95	8	8	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1225	1239		10.1074/jbc.RA119.009271	http://dx.doi.org/10.1074/jbc.RA119.009271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31819007	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000513822300006
J	Cao, DY; Spivia, WR; Veiras, LC; Khan, Z; Peng, ZZ; Jones, AE; Bernstein, EA; Saito, S; Okwan-Duodu, D; Parker, SJ; Giani, JF; Divakaruni, AS; Van Eyk, JE; Bernstein, KE				Cao, Duo-Yao; Spivia, Weston R.; Veiras, Luciana C.; Khan, Zakir; Peng, Zhenzi; Jones, Anthony E.; Bernstein, Ellen A.; Saito, Suguru; Okwan-Duodu, Derick; Parker, Sarah J.; Giani, Jorge F.; Divakaruni, Ajit S.; Van Eyk, Jennifer E.; Bernstein, Kenneth E.			ACE overexpression in myeloid cells increases oxidative metabolism and cellular ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; mitochondria; macrophage; electron transport chain; neutrophil; angiotensin-converting enzyme (ACE); oxidative metabolism	ANGIOTENSIN-CONVERTING ENZYME; RESISTANT; DISCOVERY; SUCCINATE; GENE	Angiotensin-converting enzyme (ACE) affects blood pressure. In addition, ACE overexpression in myeloid cells increases their immune function. Using MS and chemical analysis, we identified marked changes of intermediate metabolites in ACE-overexpressing macrophages and neutrophils, with increased cellular ATP (1.7-3.0-fold) and Krebs cycle intermediates, including citrate, isocitrate, succinate, and malate (1.4-3.9-fold). Increased ATP is due to ACE C-domain catalytic activity; it is reversed by an ACE inhibitor but not by an angiotensin II AT1 receptor antagonist. In contrast, macrophages from ACE knockout (null) mice averaged only 28% of the ATP levels found in WT mice. ACE overexpression does not change cell or mitochondrial size or number. However, expression levels of the electron transport chain proteins NDUFB8 (complex I), ATP5A, and ATP5 beta (complex V) are significantly increased in macrophages and neutrophils, and COX1 and COX2 (complex IV) are increased in macrophages overexpressing ACE. Macrophages overexpressing ACE have increased mitochondrial membrane potential (24% higher), ATP production rates (29% higher), and maximal respiratory rates (37% higher) compared with WT cells. Increased cellular ATP underpins increased myeloid cell superoxide production and phagocytosis associated with increased ACE expression. Myeloid cells overexpressing ACE indicate the existence of a novel pathway in which myeloid cell function can be enhanced, with a key feature being increased cellular ATP.	[Cao, Duo-Yao; Veiras, Luciana C.; Khan, Zakir; Peng, Zhenzi; Bernstein, Ellen A.; Saito, Suguru; Okwan-Duodu, Derick; Giani, Jorge F.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA; [Spivia, Weston R.; Parker, Sarah J.; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Spivia, Weston R.; Parker, Sarah J.; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Adv Clin Biosyst Res Inst, Los Angeles, CA 90048 USA; [Khan, Zakir; Okwan-Duodu, Derick; Giani, Jorge F.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Parker, Sarah J.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Jones, Anthony E.; Divakaruni, Ajit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.; Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Pathol, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.	Kenneth.Bernstein@cshs.org	Saito, Suguru/AAQ-2679-2020	Cao, DuoYao/0000-0002-0455-4655; Saito, Suguru/0000-0003-2235-8866; Spivia, Weston/0000-0003-2764-7763	National Institutes of Health [P01HL129941, R01AI143599, R21AI114965, R01HL142672, R00HL128787, K99HL141638, T32DK007770, T32CA009056, P30DK063491, R01HL111362, R01HL132075]; American Heart Association (AHA) [17GRNT33661206, 16SDG30130015, 19CDA34760010]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association)	This work was supported by National Institutes of Health Grants P01HL129941 (to K. E. B.), R01AI143599(to K. E. B.),R21AI114965(to K. E. B.), R01HL142672(to J. F. G.), R00HL128787 (to S. J. P.), K99HL141638 (to D. O. D.), T32DK007770 (to L. C. V.), T32CA009056 (to A. E. J.), P30DK063491 (to J. F. G.), R01HL111362 (to J. E. V. E.), and R01HL132075 (to J. E. V. E.) and American Heart Association (AHA) Grants 17GRNT33661206 (to K. E. B.), 16SDG30130015 (to J. F. G.), and 19CDA34760010 (to Z. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Baudin B, 2002, CLIN CHEM LAB MED, V40, P256, DOI 10.1515/CCLM.2002.042; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bernstein KE, 2018, NAT REV NEPHROL, V14, P325, DOI 10.1038/nrneph.2018.15; Bernstein KE, 2014, J CLIN INVEST, V124, P1000, DOI 10.1172/JCI66541; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; BRICE EAW, 1995, CHEST, V107, P706, DOI 10.1378/chest.107.3.706; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Danilov SM, 2018, MOL GENET METAB, V123, P501, DOI 10.1016/j.ymgme.2018.02.007; Davies LC, 2019, J LEUKOCYTE BIOL, V105, P37, DOI 10.1002/JLB.4RI0518-195R; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Divakaruni AS, 2017, J CELL BIOL, V216, P1091, DOI 10.1083/jcb.201612067; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Khan Z, 2019, J BIOL CHEM, V294, P4368, DOI 10.1074/jbc.RA118.006275; Khan Z, 2017, BLOOD, V130, P328, DOI 10.1182/blood-2016-11-752006; LIEBERMAN J, 1977, ANN INTERN MED, V87, P422, DOI 10.7326/0003-4819-87-4-422; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Lin CT, 2011, FASEB J, V25, P1145, DOI 10.1096/fj.10-169433; Mentz RJ, 2013, INT J CARDIOL, V167, P1677, DOI 10.1016/j.ijcard.2012.10.007; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Ohishi M, 1997, J HYPERTENS, V15, P1295, DOI 10.1097/00004872-199715110-00014; Okwan-Duodu D, 2010, J BIOL CHEM, V285, P39051, DOI 10.1074/jbc.M110.163782; Olle EW, 2007, PROTEOM CLIN APPL, V1, P1212, DOI 10.1002/prca.200600906; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Romero N., 2017, IMPROVING QUANTIFICA; Saijonmaa O, 2007, AM J PHYSIOL-HEART C, V292, pH1917, DOI 10.1152/ajpheart.00920.2006; Semis M, 2019, ANAL CHEM, V91, P6440, DOI 10.1021/acs.analchem.8b03828; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; SKEGGS LT, 1993, HYPERTENSION, V21, P259, DOI 10.1161/01.HYP.21.2.259; Stotland A. B., 2019, MITOPLEX TARGETED MU, DOI [10.1101/820167, DOI 10.1101/820167]; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; WEINSTOCK JV, 1991, EUR J CLIN INVEST, V21, P145, DOI 10.1111/j.1365-2362.1991.tb01803.x	37	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1369	1384		10.1074/jbc.RA119.011244	http://dx.doi.org/10.1074/jbc.RA119.011244			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31871049	Green Published, Bronze			2022-12-28	WOS:000513822300019
J	Schaible, B; Crifo, B; Schaffer, K; Taylor, CT				Schaible, Bettina; Crifo, Bianca; Schaffer, Kirsten; Taylor, Cormac T.			The putative bacterial oxygen sensor Pseudomonas prolyl hydroxylase (PPHD) suppresses antibiotic resistance and pathogenicity in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; Pseudomonas aeruginosa (P. aeruginosa); virulence factor; antibiotic resistance; infectious disease	HYPOXIA-INDUCIBLE FACTOR; MULTIDRUG EFFLUX PUMPS; IMPACT	Pseudomonas aeruginosa is an extracellular opportunistic bacterial pathogen commonly associated with infectious complications in susceptible individuals, such as those with underlying diseases including HIV/AIDS and cystic fibrosis. Antibiotic resistance in multiple strains of P. aeruginosa is a rapidly developing clinical problem. We have previously demonstrated that the oxygen levels at the site of P. aeruginosa infection can strongly influence virulence and antibiotic resistance in this pathogen, although the oxygen-sensing and -signaling mechanisms underpinning this response have remained unknown. In this study, we investigated the potential role of the putative oxygen sensor Pseudomonas prolyl hydroxylase (PPHD) in the control of virulence and antibiotic resistance in P. aeruginosa. We found that a P. aeruginosa strain lacking PPHD (PAO310) exhibits increased virulence associated with increased bacterial motility. Furthermore, PPHD-deficient P. aeruginosa displayed enhanced antibiotic resistance against tetracycline through increased expression of the xenobiotic transporters mexEF-oprN and MexXY. Of note, the effect of the PPHD knockout on antibiotic resistance was phenocopied in bacteria exposed to atmospheric hypoxia. We conclude that PPHD is a putative bacterial oxygen sensor that may link microenvironmental oxygen levels to virulence and antibiotic resistance in P. aeruginosa.	[Schaible, Bettina; Crifo, Bianca; Taylor, Cormac T.] Univ Coll Dublin, Syst Biol Ireland, Conway Inst, Dublin 4, Ireland; [Schaible, Bettina; Crifo, Bianca; Taylor, Cormac T.] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Schaffer, Kirsten] St Vincents Univ Hosp, Dept Clin Microbiol, Elm Pk, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital	Taylor, CT (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie			Science Foundation Ireland; European Union [15/ERA-CSM/3267]; Irish Research Council [GOIPD/2016/593]; Enterprise Ireland [CS20182081]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland	This work was supported by grants from Science Foundation Ireland, the European Union Grant 15/ERA-CSM/3267, Irish Research Council Grant GOIPD/2016/593, and Enterprise Ireland Grant CS20182081. C. T. T. is a member of the Scientific Advisory Board of Akebia Therapeutics.	Cohen JI, 2010, INFECT DIS-SER, P13, DOI 10.1007/978-1-60761-512-5_2; Cullen L, 2015, MICROBIOL-SGM, V161, P1961, DOI 10.1099/mic.0.000155; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Dickinson Rebecca S, 2017, Wellcome Open Res, V2, P104, DOI 10.12688/wellcomeopenres.12871.1; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; Fernando DM, 2013, ANTIBIOTICS-BASEL, V2, P163, DOI 10.3390/antibiotics2010163; Fujitani S., PSEUDOMONAS AERUGINO, P15219; Haase VH, 2017, HEMODIAL INT, V21, pS110, DOI 10.1111/hdi.12567; Hickey C, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00357; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1732, DOI 10.1128/AAC.38.8.1732; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Locke LW, 2016, EUR RESPIR J, V47, P1392, DOI 10.1183/13993003.01880-2015; Perez-Osorio AC, 2010, J BACTERIOL, V192, P2991, DOI 10.1128/JB.01598-09; Pickel C, 2018, METHODS MOL BIOL, V1742, P1, DOI 10.1007/978-1-4939-7665-2_1; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Schaffer K, 2015, FEBS J, V282, P2260, DOI 10.1111/febs.13270; Schaible B, 2017, J INFECT DIS, V215, P1459, DOI 10.1093/infdis/jix139; Schaible B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056491; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; Schnicker NJ, 2017, BIOCHEMISTRY-US, V56, P5771, DOI [10.1021/acs.biochem.7b00601, 10.1021/ac]; Scotti JS, 2014, P NATL ACAD SCI USA, V111, P13331, DOI 10.1073/pnas.1409916111; Taylor CT, 2010, PHYSIOLOGY, V25, P272, DOI 10.1152/physiol.00029.2010; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wolloscheck D, 2018, ACS INFECT DIS, V4, P185, DOI 10.1021/acsinfecdis.7b00160; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	28	2	2	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1195	1201		10.1074/jbc.RA119.010033	http://dx.doi.org/10.1074/jbc.RA119.010033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31826919	hybrid, Green Published			2022-12-28	WOS:000513822300003
J	Hofman, ZLM; Clark, CC; Sanrattana, W; Nosairi, A; Parr, NMJ; Zivkovic, M; Krause, K; Mahnke, NA; Scheffel, J; Hack, CE; Maurer, M; de Maat, S; Maas, C				Hofman, Zonne L. M.; Clark, Chantal C.; Sanrattana, Wariya; Nosairi, Aziz; Parr, Naomi M. J.; Zivkovic, Minka; Krause, Karoline; Mahnke, Niklas A.; Scheffel, Joerg; Hack, C. Erik; Maurer, Marcus; de Maat, Steven; Maas, Coen			A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; serine protease; vascular biology; coagulation factor; enzyme mutation; autoinflammatory syndrome; bradykinin; factor XII; hereditary angioedema; kringle domain	HEREDITARY ANGIOEDEMA; ENHANCED SUSCEPTIBILITY; PLASMINOGEN-ACTIVATOR; PLASMA; GENE; AUTOACTIVATION; GENERATION; FIBRIN	Coagulation factor XII (FXII) drives production of the inflammatory peptide bradykinin. Pathological mutations in the F12 gene, which encodes FXII, provoke acute tissue swelling in hereditary angioedema (HAE). Interestingly, a recently identified F12 mutation, causing a W268R substitution, is not associated with HAE. Instead, FXII-W268R carriers experience cold-inducible urticarial rash, arthralgia, fever, and fatigue. Here, we aimed to investigate the molecular characteristics of the FXII-W268R variant. We expressed wild type FXII (FXII-WT), FXII-W268R, and FXII-T309R (which causes HAE), as well as other FXII variants in HEK293 freestyle cells. Using chromogenic substrate assays, immunoblotting, and ELISA, we analyzed expression media, cell lysates, and purified proteins for FXII activation. Recombinant FXII-W268R forms increased amounts of intracellular cleavage products that are also present in expression medium and display enzymatic activity. The active site?incapacitated variant FXII-W268R/S544A reveals that intracellular fragmentation is largely dependent on autoactivation. Purified FXII-W268R is highly sensitive to activation by plasma kallikrein and plasmin, compared with FXII-WT or FXII-T309R. Furthermore, binding studies indicated that the FXII-W268R variant leads to the exposure of a plasminogen-binding site that is cryptic in FXII-WT. In plasma, recombinant FXII-W268R spontaneously triggers high-molecular-weight kininogen cleavage. Our findings suggest that the W268R substitution influences FXII protein conformation and exposure of the activation loop, which is concealed in FXII-WT. This results in intracellular autoactivation and constitutive low-grade secretion of activated FXII. These findings help to explain the chronically increased contact activation in carriers of the FXII-W268R variant.	[Hofman, Zonne L. M.; Clark, Chantal C.; Sanrattana, Wariya; Nosairi, Aziz; Parr, Naomi M. J.; Zivkovic, Minka; de Maat, Steven; Maas, Coen] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Hack, C. Erik; Maurer, Marcus] Univ Med Ctr Utrecht, Lab Translat Immunol, NL-3584 CX Utrecht, Netherlands; [Krause, Karoline; Mahnke, Niklas A.; Scheffel, Joerg] Charite Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Maas, C (corresponding author), Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	cmaas4@umcutrecht.nl	Maurer, Marcus/ABG-2174-2020; Levi, Marcel/AAZ-8559-2020; Krause, Karoline/G-5218-2018	Maurer, Marcus/0000-0002-4121-481X; Zivkovic, Minka/0000-0003-4545-7939; Clark, Chantal/0000-0001-9614-7135; Maas, Coen/0000-0003-4593-0976; Sanrattana, Wariya/0000-0002-8731-8673; Krause, Karoline/0000-0001-9711-9654; Mahnke, Niklas Amadeus/0000-0002-2520-2990	Landsteiner Foundation for Blood Transfusion Research Grant [LSBR 1520]; Netherlands Thrombosis Foundation [2017-03]; Thai government; Utrecht University Medical Center	Landsteiner Foundation for Blood Transfusion Research Grant; Netherlands Thrombosis Foundation; Thai government; Utrecht University Medical Center	This work was supported by funds from the Landsteiner Foundation for Blood Transfusion Research Grant LSBR 1520 (to C. M.), The Netherlands Thrombosis Foundation Grant 2017-03 (to C. M.), the Alexandre Suermann Grant from the Utrecht University Medical Center (to Z. L. M. H.), and a grant from the Thai government (to W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], PEDIAT RHEUMATOLOGY; Beringer DX, 2013, ACTA CRYSTALLOGR F, V69, P94, DOI 10.1107/S1744309113000286; Bork K, 2011, CLIN IMMUNOL, V141, P31, DOI 10.1016/j.clim.2011.07.002; CASTELLINO FJ, 1987, J MOL EVOL, V26, P358, DOI 10.1007/BF02101155; Chinnaraj M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00281; Citarella F, 2000, THROMB HAEMOSTASIS, V84, P1057; Citarella F, 1997, BRIT J HAEMATOL, V99, P197, DOI 10.1046/j.1365-2141.1997.3513165.x; Clark CC, 2018, THROMB HAEMOSTASIS, V118, P471, DOI 10.1055/s-0038-1627460; de Maat S, 2019, J THROMB HAEMOST, V17, P183, DOI 10.1111/jth.14325; De Maat S, 2018, J THROMB HAEMOST, V16, P1674, DOI 10.1111/jth.14209; de Maat S, 2016, J THROMB HAEMOST, V14, P1498, DOI 10.1111/jth.13383; de Maat S, 2016, J ALLERGY CLIN IMMUN, V138, P1414, DOI 10.1016/j.jaci.2016.02.021; de Maat S, 2013, THROMB HAEMOSTASIS, V110, P458, DOI 10.1160/TH12-11-0792; Dementiev A, 2018, BLOOD ADV, V2, P549, DOI 10.1182/bloodadvances.2018016337; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; DORS DM, 1992, THROMB HAEMOSTASIS, V67, P644; Gelincik A, 2015, ANN ALLERG ASTHMA IM, V114, P154, DOI 10.1016/j.anai.2014.11.018; Hall SM, 2016, ACS CHEM NEUROSCI, V7, P1746, DOI 10.1021/acschemneuro.6b00258; Ivanov I, 2019, BLOOD, V133, P1152, DOI 10.1182/blood-2018-06-860270; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Kiss N, 2013, CLIN IMMUNOL, V149, P142, DOI 10.1016/j.clim.2013.08.001; Konings J, 2011, BLOOD, V118, P3942, DOI 10.1182/blood-2011-03-339572; Mahnke NA, 2018, EXP DERMATOL, V27, pE32; Mitchell JL, 2016, BLOOD, V128, P2834, DOI 10.1182/blood-2015-10-673285; Pathak M, 2015, J THROMB HAEMOST, V13, P580, DOI 10.1111/jth.12849; Pathak M, 2019, ACTA CRYSTALLOGR D, V75, P578, DOI 10.1107/S2059798319006910; RAVON DM, 1995, BLOOD, V86, P4134, DOI 10.1182/blood.V86.11.4134.bloodjournal86114134; Renne T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02011; SAMUEL M, 1992, J BIOL CHEM, V267, P19691; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; South K, 2014, P NATL ACAD SCI USA, V111, P18578, DOI 10.1073/pnas.1411979112; Stavrou EX, 2018, J CLIN INVEST, V128, P944, DOI 10.1172/JCI92880; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	34	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					363	374		10.1074/jbc.RA119.009788	http://dx.doi.org/10.1074/jbc.RA119.009788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771982	hybrid, Green Published			2022-12-28	WOS:000507373600009
J	Hsu, PJ; Shi, HL; Zhu, AC; Lu, ZK; Miller, N; Edens, BM; Ma, YC; He, C				Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.; He, Chuan			The RNA-binding protein FMRP facilitates the nuclear export of N-6-methyladenosine?containing mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA methylation; nuclear RNA; mouse; RNA metabolism; neurological disease; Fmr1 KO mice; FMRP; mouse brain; N6-methyladenosine (m6A); nuclear RNA export; fragile X mental retardation protein (FMRP); post-transcriptional modification; RNA-binding protein; gene regulation	MENTAL-RETARDATION PROTEIN; TRANSLATION	N-6-Methyladenosine (m(6)A) is the most abundant post-transcriptional mRNA modification in eukaryotes and exerts many of its effects on gene expression through reader proteins that bind specifically to m(6)A-containing transcripts. Fragile X mental retardation protein (FMRP), an RNA-binding protein, has previously been shown to affect the translation of target mRNAs and trafficking of mRNA granules. Loss of function of FMRP causes fragile X syndrome, the most common form of inherited intellectual disability in humans. Using HEK293T cells, siRNA-mediated gene knockdown, cytoplasmic and nuclear fractions, RNA-Seq, and LC-MS/MS analyses, we demonstrate here that FMRP binds directly to a collection of m(6)A sites on mRNAs. FMRP depletion increased mRNA m(6)A levels in the nucleus. Moreover, the abundance of FMRP targets in the cytoplasm relative to the nucleus was decreased in Fmr1-KO mice, an effect also observed in highly methylated genes. We conclude that FMRP may affect the nuclear export of m(6)A-modified RNA targets.	[Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; He, Chuan] Howard Hughes Med Inst, Dept Chem, Chevy Chase, MD 20815 USA; [Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; He, Chuan] Howard Hughes Med Inst, Inst Biophys Dynam, Chevy Chase, MD 20815 USA; [He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Hsu, Phillip J.] Univ Chicago, Med Scientist Training Program, Comm Immunol, Chicago, IL 60637 USA; [Zhu, Allen C.] Univ Chicago, Med Scientist Training Program, Comm Canc Biol, Chicago, IL 60637 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Neurol, Chicago, IL 60611 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Physiol, Chicago, IL 60611 USA; [He, Chuan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute	He, C (corresponding author), Howard Hughes Med Inst, Dept Chem, Chevy Chase, MD 20815 USA.; He, C (corresponding author), Howard Hughes Med Inst, Inst Biophys Dynam, Chevy Chase, MD 20815 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; He, C (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	ma@northwestern.edu; chuanhe@uchicago.edu	, WaNgtJ/AAR-7045-2020; Shi, Hailing/AAW-5351-2021	Shi, Hailing/0000-0001-7355-378X; Ma, Yongchao/0000-0002-2469-4356	Chicago Biomedical Consortium; National Institutes of Health Medical Scientist National Research Service Award [T32 GM007281]; National Institutes of Health [R01NS094564, R21NS106307]; Cure SMA; Hartwell Foundation	Chicago Biomedical Consortium; National Institutes of Health Medical Scientist National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure SMA; Hartwell Foundation	This work was supported by grants from the Chicago Biomedical Consortium (to Y. C. M. and C. H.). C. H. is a scientific founder of Accent Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Medical Scientist National Research Service Award T32 GM007281.; Supported by National Institutes of Health Grants R01NS094564 and R21NS106307, Cure SMA, and The Hartwell Foundation. To whom correspondence may be addressed. E-mail: ma@northwestern.edu.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BAKKER CE, 1994, CELL, V78, P23; Bresson S, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170270; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edens BM, 2019, CELL REP, V28, P845, DOI 10.1016/j.celrep.2019.06.072; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Feng Y, 1997, J NEUROSCI, V17, P1539; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Williams T, 2018, SEMIN CELL DEV BIOL, V75, P70, DOI 10.1016/j.semcdb.2017.08.054; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Zhang FR, 2018, HUM MOL GENET, V27, P3936, DOI 10.1093/hmg/ddy292; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	53	57	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19889	19895		10.1074/jbc.AC119.010078	http://dx.doi.org/10.1074/jbc.AC119.010078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753916	hybrid, Green Published			2022-12-28	WOS:000505005800006
J	Reynolds, HM; Zhang, LP; Tran, DT; Ten Hagen, KG				Reynolds, Hayley M.; Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.			Tango1 coordinates the formation of endoplasmic reticulum/Golgi docking sites to mediate secretory granule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; glycoprotein secretion; secretion; Golgi; COPII; Drosophila; endoplasmic reticulum (ER); MIA SH3 domain ER export Factor 3 (MIA3); O-glycosylation; salivary gland; secretory granules; Tango1	DROSOPHILA; BIOGENESIS; GLAND; MODEL	Regulated secretion is a conserved process occurring across diverse cells and tissues. Current models suggest that the conserved cargo receptor Tango1 mediates the packaging of collagen into large coat protein complex II (COPII) vesicles that move from the endoplasmic reticulum (ER) to the Golgi apparatus. However, how Tango1 regulates the formation of COPII carriers and influences the secretion of other cargo remains unknown. Here, through high-resolution imaging of Tango1, COPII, Golgi, and secretory cargo (mucins) in Drosophila larval salivary glands, we found that Tango1 forms ring-like structures that mediate the formation of COPII rings rather than vesicles. These COPII rings act as docking sites for the cis-Golgi. Moreover, we observed nascent secretory mucins emerging from the Golgi side of these Tango1?COPII?Golgi complexes, suggesting that these structures represent functional docking sites/fusion points between the ER exit sites and the Golgi. Loss of Tango1 disrupted the formation of COPII rings, the association of COPII with the cis-Golgi, mucin O-glycosylation, and secretory granule biosynthesis. Additionally, we identified a Tango1 self-association domain that is essential for formation of this structure. Our results provide evidence that Tango1 organizes an interaction site where secretory cargo is efficiently transferred from the ER to Golgi and then to secretory vesicles. These findings may explain how the loss of Tango1 can influence Golgi/ER morphology and affect the secretion of diverse proteins across many tissues.	[Reynolds, Hayley M.; Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA; [Tran, Duy T.] NIDCR, NIDCR Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov		Reynolds, Hayley/0000-0002-3077-5603	Intramural Research Program of the NIDCR, National Institutes of Health [Z01-DE000713]; NIDCR [DE000750-01]	Intramural Research Program of the NIDCR, National Institutes of Health; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grant Z01-DE000713 from the Intramural Research Program of the NIDCR, National Institutes of Health (to K. G. T. H.). This work was also supported in part by NIDCR Imaging Core Grant DE000750-01 (to D. T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Biyasheva A, 2001, DEV BIOL, V231, P234, DOI 10.1006/dbio.2000.0126; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Burgess J, 2012, DEVELOPMENT, V139, P3040, DOI 10.1242/dev.077644; Burgess J, 2011, MOL BIOL CELL, V22, P2094, DOI 10.1091/mbc.E11-01-0054; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ji S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05978-9; Ke HM, 2018, J GENET GENOMICS, V45, P299, DOI 10.1016/j.jgg.2018.05.002; KORGE G, 1977, DEV BIOL, V58, P339, DOI 10.1016/0012-1606(77)90096-3; Kurokawa K, 2019, J BIOCHEM, V165, P109, DOI 10.1093/jb/mvy080; Lerner DW, 2013, DEV CELL, V24, P159, DOI 10.1016/j.devcel.2012.12.005; Liu M, 2017, J CELL BIOL, V216, P1035, DOI 10.1083/jcb.201611088; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Maeda M, 2017, J CELL BIOL, V216, P1731, DOI 10.1083/jcb.201703084; McCaughey J, 2019, J CELL BIOL, V218, P929, DOI 10.1083/jcb.201806035; McCaughey J, 2018, HISTOCHEM CELL BIOL, V150, P119, DOI 10.1007/s00418-018-1689-2; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Petley-Ragan LM, 2016, J NEUROSCI, V36, P1151, DOI 10.1523/JNEUROSCI.1797-15.2016; Raote I, 2018, ELIFE, V7, DOI 10.7554/eLife.32723; Raote I, 2017, J CELL BIOL, V216, P901, DOI 10.1083/jcb.201608080; Rios-Barrera LD, 2017, P NATL ACAD SCI USA, V114, pE10389, DOI 10.1073/pnas.1711408114; Rousso T, 2016, NAT CELL BIOL, V18, P181, DOI 10.1038/ncb3288; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Santos AJM, 2016, J CELL BIOL, V213, P343, DOI 10.1083/jcb.201603072; Schnakenberg Sandra L, 2012, Spermatogenesis, V2, P224; Syed ZA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002850; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Tran DT, 2017, J CELL SCI, V130, P1355, DOI 10.1242/jcs.193425; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Wilson DG, 2011, J CELL BIOL, V194, P347, DOI 10.1083/jcb.2010071621942c; Yuan L, 2018, P NATL ACAD SCI USA, V115, pE12255, DOI 10.1073/pnas.1814810115; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951; Zhang LP, 2017, J BIOL CHEM, V292, P21231, DOI 10.1074/jbc.M117.809848; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	40	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19498	19510		10.1074/jbc.RA119.011063	http://dx.doi.org/10.1074/jbc.RA119.011063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690624	hybrid, Green Published			2022-12-28	WOS:000504093200005
J	Grifoll-Romero, L; Sainz-Polo, MA; Albesa-Jove, D; Guerin, ME; Biarnes, X; Planas, A				Grifoll-Romero, Laia; Angela Sainz-Polo, Maria; Albesa-Jove, David; Guerin, Marcelo E.; Biarnes, Xevi; Planas, Antoni			Structure-function relationships underlying the dual N-acetylmuramic and N-acetylglucosamine specificities of the bacterial peptidoglycan deacetylase PdaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peptidoglycan; cell wall; bacterial pathogenesis; crystal structure; ligand-docking simulations; deacetylase; specificity; chitooligosaccharides; N-acetylglucosamine; N-acetylmuramic acid	POLYSACCHARIDE DEACETYLASES; CARBOHYDRATE ESTERASE; BACILLUS-CEREUS; CELL-SHAPE; LACTAM; STABILITY; VIRULENCE; SOFTWARE; RESIDUES; HOMOLOG	Bacillus subtilis PdaC (BsPdaC) is a membrane-bound, multidomain peptidoglycan N-deacetylase acting on N-acetylmuramic (MurNAc) residues and conferring lysozyme resistance to modified cell wall peptidoglycans. BsPdaC contains a C-terminal family 4 carbohydrate esterase (CE4) catalytic domain, but unlike other MurNAc deacetylases, BsPdaC also has GlcNAc deacetylase activity on chitooligosaccharides (COSs), characteristic of chitin deacetylases. To uncover the molecular basis of this dual activity, here we determined the X-ray structure of the BsPdaC CE4 domain at 1.54 angstrom resolution and analyzed its mode of action on COS substrates. We found that the minimal substrate is GlcNAc(3) and that activity increases with the degree of glycan polymerization. COS deacetylation kinetics revealed that BsPdaC operates by a multiple-chain mechanism starting at the internal GlcNAc units and leading to deacetylation of all but the reducing-end GlcNAc residues. Interestingly, BsPdaC shares higher sequence similarity with the peptidoglycan GlcNAc deacetylase SpPgdaA than with other MurNAc deacetylases. Therefore, we used ligand-docking simulations to analyze the dual GlcNAc- and MurNAc-binding specificities of BsPdaC and compared them with those of SpPgdA and BsPdaA, representing peptidoglycan deacetylases highly specific for GlcNAc or MurNAc residues, respectively. BsPdaC retains the conserved Asp-His-His metal-binding triad characteristic of CE4 enzymes acting on GlcNAc residues, differing from MurNAc deacetylases that lack the metal-coordinating Asp residue. BsPdaC contains short loops similar to those in SpPgdA, resulting in an open binding cleft that can accommodate polymeric substrates. We propose that PdaC is the first member of a new subclass of peptidoglycan MurNAc deacetylases.	[Grifoll-Romero, Laia; Biarnes, Xevi; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Lab Biochem, Barcelona 08017, Spain; [Angela Sainz-Polo, Maria; Albesa-Jove, David; Guerin, Marcelo E.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk,Ed 801A, Derio 48160, Spain; [Albesa-Jove, David; Guerin, Marcelo E.] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Universitat Ramon Llull; Institut Quimic de Sarria; CIC bioGUNE; Basque Foundation for Science	Planas, A (corresponding author), Inst Quim Sarria, Via Augusta 390, Barcelona 08017, Spain.	antoni.planas@iqs.edu	PLANAS, ANTONI/I-4803-2015; Albesa-Jové, David/O-3822-2019; Albesa-Jové, David/F-5683-2016; Guerin, Marcelo/N-7245-2016	PLANAS, ANTONI/0000-0001-7073-3320; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Guerin, Marcelo/0000-0001-9524-3184	Severo Ochoa Excellence Accreditation from MINECO, Spain. [SEV-2016-0644]; AGAUR from the Generalitat de Catalunya [2017SGR-727]; IQS; MINECO under the "Juan de la Cierva Postdoctoral program" [FJCI-2015-25725];  [BFU2016-77427-C2-1-R];  [BFU2016-77427-C2-2-R];  [BFU2017-92223-EXP]	Severo Ochoa Excellence Accreditation from MINECO, Spain.; AGAUR from the Generalitat de Catalunya; IQS; MINECO under the "Juan de la Cierva Postdoctoral program"; ; ; 	Work supported by grants BFU2016-77427-C2-1-R (to A.P.), BFU2016-77427-C2-2-R (to M.E.G.), BFU2017-92223-EXP (to M.E.G.) and Severo Ochoa Excellence Accreditation SEV-2016-0644 (to M.E.G.) from MINECO, Spain., and AGAUR grant 2017SGR-727 (to A. P.) from the Generalitat de Catalunya. We gratefully acknowledge Diamond Light Source (proposal mx15304), ALBA and iNEXT (proposal numbers 1618/2538) for granting access to synchrotron radiation facilities. Laia Grifoll acknowledges a predoctoral contract from IQS, and Maria Angela Sainz-Polo acknowledges a postdoctoral contract from MINECO under the "Juan de la Cierva Postdoctoral program" (FJCI-2015-25725). We thank Dr. Hugo Aragunde for the sequencing of deacetylated COS and Prof. Bruno Moerschbacher and Dr. Stefan Cord-Landwehr, University of Munster, for his advice on MS/MS sequencing analysis. Montserrat Murcia is acknowledged for performing some of the docking simulations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Aragunde H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020412; ARAKI Y, 1971, BIOCHEM BIOPH RES CO, V42, P691, DOI 10.1016/0006-291X(71)90543-2; Arnaouteli S, 2015, J BIOL CHEM, V290, P13465, DOI 10.1074/jbc.M115.640029; Balomenou S, 2018, BIOORGAN MED CHEM, V26, P3845, DOI 10.1016/j.bmc.2018.06.045; Balomenou S, 2013, MOL MICROBIOL, V87, P867, DOI 10.1111/mmi.12137; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cord-Landwehr S, 2017, ANAL CHEM, V89, P2893, DOI 10.1021/acs.analchem.6b04183; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Giastas P, 2018, BIOCHEMISTRY-US, V57, P753, DOI 10.1021/acs.biochem.7b00919; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Grifoll-Romero L, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10040352; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi K, 2012, J BIOL CHEM, V287, P9765, DOI 10.1074/jbc.M111.329490; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk JE, 2015, J AM CHEM SOC, V137, P6987, DOI 10.1021/jacs.5b01607; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Bui NK, 2011, BIOCHEM PHARMACOL, V82, P43, DOI 10.1016/j.bcp.2011.03.028; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popham DL, 1996, P NATL ACAD SCI USA, V93, P15405, DOI 10.1073/pnas.93.26.15405; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	47	9	9	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19066	19080		10.1074/jbc.RA119.009510	http://dx.doi.org/10.1074/jbc.RA119.009510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690626	Green Published, hybrid			2022-12-28	WOS:000516527800011
J	Banwarth-Kuhn, M; Sindi, S				Banwarth-Kuhn, Mikahl; Sindi, Suzanne			How and why to build a mathematical model: A case study using prion aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						mathematical modeling; enzyme kinetics; protein aggregation; prion disease; computational biology; mathematical methods; numerical analysis; protein aggregation; differential equation; law of mass action	PATTERN-FORMATION; BIOLOGY; DYNAMICS; SCRAPIE; DISEASE; SYSTEMS; TRANSMISSION; MECHANISMS; PATHOLOGY; ONCOLOGY	Biological systems are inherently complex, and the increasing level of detail with which we are able to experimentally probe such systems continually reveals new complexity. Fortunately, mathematical models are uniquely positioned to provide a tool suitable for rigorous analysis, hypothesis generation, and connecting results from isolated in vitro experiments with results from in vivo and whole-organism studies. However, developing useful mathematical models is challenging because of the often different domains of knowledge required in both math and biology. In this work, we endeavor to provide a useful guide for researchers interested in incorporating mathematical modeling into their scientific process. We advocate for the use of conceptual diagrams as a starting place to anchor researchers from both domains. These diagrams are useful for simplifying the biological process in question and distinguishing the essential components. Not only do they serve as the basis for developing a variety of mathematical models, but they ensure that any mathematical formulation of the biological system is led primarily by scientific questions. We provide a specific example of this process from our own work in studying prion aggregation to show the power of mathematical models to synergistically interact with experiments and push forward biological understanding. Choosing the most suitable model also depends on many different factors, and we consider how to make these choices based on different scales of biological organization and available data. We close by discussing the many opportunities that abound for both experimentalists and modelers to take advantage of collaborative work in this field.	[Banwarth-Kuhn, Mikahl; Sindi, Suzanne] Univ Calif, Sch Nat Sci, Dept Appl Math, Merced, CA 95343 USA	University of California System; University of California Merced	Sindi, S (corresponding author), Univ Calif, Sch Nat Sci, Dept Appl Math, Merced, CA 95343 USA.	ssindi@ucmerced.edu			Joint Division of Mathematical Sciences (DMS)/NIGMS, National Institutes of Health, Initiative to Support Research at the Interface of the Biological and Mathematical Sciences [R01-GM126548]	Joint Division of Mathematical Sciences (DMS)/NIGMS, National Institutes of Health, Initiative to Support Research at the Interface of the Biological and Mathematical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Joint Division of Mathematical Sciences (DMS)/NIGMS, National Institutes of Health, Initiative to Support Research at the Interface of the Biological and Mathematical Sciences (Grant R01-GM126548). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Alber M, 2019, BIOPHYS J, V116, p323A, DOI 10.1016/j.bpj.2018.11.1751; Alber MS, 2003, IMA VOL MATH APPL, V134, P1; Allen L. J. S., 2007, INTRO MATH BIOL; Allen LJ., 2010, INTRO STOCHASTIC PRO; Alon U., 2006, INTRO SYSTEMS BIOL D; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; ALPER T, 1966, BIOCHEM BIOPH RES CO, V22, P278, DOI 10.1016/0006-291X(66)90478-5; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Anderson A., 2007, SINGLE CELL BASED MO; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; [Anonymous], [No title captured]; [Anonymous], 2012, CELLULAR AUTOMATA MO; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Apostolova LG, 2007, ARCH NEUROL-CHICAGO, V64, P1489, DOI 10.1001/archneur.64.10.1489; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Boon JP, 1996, PHYS REP, V273, P55, DOI 10.1016/0370-1573(95)00080-1; Brauer F., 2001, MATH MODELS POPULATI, V40; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; BROTHERSTON JG, 1968, J COMP PATHOL, V78, P9, DOI 10.1016/0021-9975(68)90107-2; Brown P, 2001, EMERG INFECT DIS, V7, P6, DOI 10.3201/eid0701.010102; Carbonell F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00037; Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Davis JK, 2016, J MATH BIOL, V72, P1555, DOI 10.1007/s00285-015-0921-0; Davis JK, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022109; de la Loza MCD, 2017, MECH DEVELOP, V144, P23, DOI 10.1016/j.mod.2016.10.003; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Deutsch A, 2017, MODEL SIMUL SCI ENG, P1, DOI 10.1007/978-1-4899-7980-3; Drasdo D, 2007, J STAT PHYS, V128, P287, DOI 10.1007/s10955-007-9289-x; Edelstein-Keshet L, 2005, MATH MODELS BIOL; Elliott A, 2018, PLANT PHYSIOL, V176, P94, DOI 10.1104/pp.17.01329; Fletcher AG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0519; Galle J, 2006, CYTOM PART A, V69A, P704, DOI 10.1002/cyto.a.20287; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Ghaffarizadeh A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005991; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Gou LK, 2019, GENETICS, V211, P731, DOI 10.1534/genetics.118.301609; Greer ML, 2006, J THEOR BIOL, V242, P598, DOI 10.1016/j.jtbi.2006.04.010; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hemmat M, 2019, BIOPHYS J, V116, p256A, DOI 10.1016/j.bpj.2018.11.1398; Herajy M, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0449-6; Hunter P, 2010, EMBO REP, V11, P350, DOI 10.1038/embor.2010.55; Hwang M, 2009, CELL MOL BIOENG, V2, P285, DOI 10.1007/s12195-009-0078-2; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klaips CL, 2014, ELIFE, V3, DOI 10.7554/eLife.04288; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Masel J, 1999, BIOPHYS CHEM, V77, P139, DOI 10.1016/S0301-4622(99)00016-2; McKenna MT, 2018, TRANSL ONCOL, V11, P732, DOI 10.1016/j.tranon.2018.03.009; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Michaelis L, 1913, BIOCHEM Z, V49, P333; Murray J.D., 2003, MATH BIOL, V1; Oliphant T. E., 2006, A GUIDE TO NUMPY; Olopade OI, 2008, CLIN CANCER RES, V14, P7988, DOI 10.1158/1078-0432.CCR-08-1211; Pathmanathan P, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036001; PATTISON IH, 1967, VET REC, V80, P2, DOI 10.1136/vr.80.1.2; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; RUBENSTEIN R, 1991, J INFECT DIS, V164, P29, DOI 10.1093/infdis/164.1.29; Sandersius SA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045007; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Sindi SS, 2009, CURR OPIN MICROBIOL, V12, P623, DOI 10.1016/j.mib.2009.09.003; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083962; Thompson PM, 2003, J NEUROSCI, V23, P994; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; Torres NV, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00354; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Van Liedekerke P, 2015, COMPUT PART MECH, V2, P401, DOI 10.1007/s40571-015-0082-3; Vilette D, 2018, CELL MOL LIFE SCI, V75, P2557, DOI 10.1007/s00018-018-2823-y; Wang H, 2019, CURR OPIN INFECT DIS, V32, P272, DOI 10.1097/QCO.0000000000000552; Wilkinson D.J, 2011, STOCHASTIC MODELLING; Wolf-Gladrow DA, 2004, LATTICE GAS CELLULAR; Xue WF, 2015, BIOPHYS J, V109, P1999, DOI 10.1016/j.bpj.2015.10.011; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Yankeelov TE, 2016, ANN BIOMED ENG, V44, P2626, DOI 10.1007/s10439-016-1691-6; Yankeelov TE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005686; Yvinec R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4772598	86	10	10	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5022	5035		10.1074/jbc.REV119.009851	http://dx.doi.org/10.1074/jbc.REV119.009851			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32005659	hybrid, Green Published			2022-12-28	WOS:000526887000024
J	Moonira, T; Chachra, SS; Ford, BE; Marin, S; Alshawi, A; Adam-Primus, NS; Arden, C; Al-Oanzi, ZH; Foretz, M; Viollet, B; Cascante, M; Agius, L				Moonira, Tabassum; Chachra, Shruti S.; Ford, Brian E.; Marin, Silvia; Alshawi, Ahmed; Adam-Primus, Natasha S.; Arden, Catherine; Al-Oanzi, Ziad H.; Foretz, Marc; Viollet, Benoit; Cascante, Marta; Agius, Loranne			Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; metformin; glycolysis; phosphofructokinase; hepatocyte; glucose 6-phosphate	GENE-EXPRESSION; FRUCTOSE 2,6-BISPHOSPHATE; INTRAVENOUS METFORMIN; REGULATORY PROTEIN; COMPLEX I; MITOCHONDRIAL; LIVER; GLUCOKINASE; GLUCONEOGENESIS; PHOSPHATE	The chronic effects of metformin on liver gluconeogenesis involve repression of the G6pc gene, which is regulated by the carbohydrate-response element?binding protein through raised cellular intermediates of glucose metabolism. In this study we determined the candidate mechanisms by which metformin lowers glucose 6-phosphate (G6P) in mouse and rat hepatocytes challenged with high glucose or gluconeogenic precursors. Cell metformin loads in the therapeutic range lowered cell G6P but not ATP and decreased G6pc mRNA at high glucose. The G6P lowering by metformin was mimicked by a complex 1 inhibitor (rotenone) and an uncoupler (dinitrophenol) and by overexpression of mGPDH, which lowers glycerol 3-phosphate and G6P and also mimics the G6pc repression by metformin. In contrast, direct allosteric activators of AMPK (A-769662, 991, and C-13) had opposite effects from metformin on glycolysis, gluconeogenesis, and cell G6P. The G6P lowering by metformin, which also occurs in hepatocytes from AMPK knockout mice, is best explained by allosteric regulation of phosphofructokinase-1 and/or fructose bisphosphatase-1, as supported by increased metabolism of [3-H-3]glucose relative to [2-H-3]glucose; by an increase in the lactate m2/m1 isotopolog ratio from [1,2-C-13(2)]glucose; by lowering of glycerol 3-phosphate an allosteric inhibitor of phosphofructokinase-1; and by marked G6P elevation by selective inhibition of phosphofructokinase-1; but not by a more reduced cytoplasmic NADH/NAD redox state. We conclude that therapeutically relevant doses of metformin lower G6P in hepatocytes challenged with high glucose by stimulation of glycolysis by an AMP-activated protein kinase?independent mechanism through changes in allosteric effectors of phosphofructokinase-1 and fructose bisphosphatase-1, including AMP, P-i, and glycerol 3-phosphate.	[Moonira, Tabassum; Chachra, Shruti S.; Ford, Brian E.; Alshawi, Ahmed; Adam-Primus, Natasha S.; Arden, Catherine; Al-Oanzi, Ziad H.; Agius, Loranne] Newcastle Univ, Med Sch, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Marin, Silvia; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, E-08007 Barcelona, Spain; [Marin, Silvia] Inst Salud Carlos III, CIBEREHD, Madrid 28029, Spain; [Marin, Silvia] Inst Salud Carlos III, Metabol Node INB Bioinformat Platform, Madrid 28029, Spain; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France; [Alshawi, Ahmed] Al Furat Al Awsat Tech Univ, Kufa Inst, Med Lab Tech Dept, Kufa, Iraq; [Al-Oanzi, Ziad H.] Jouf Univ, Med Lab Sci, POB 2014, Sakaka, Saudi Arabia	Newcastle University - UK; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Al-Furat Al-Awsat Technical University; Al Jouf University	Agius, L (corresponding author), Newcastle Univ, Med Sch, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	loranne.agius@ncl.ac.uk	CASCANTE, MARTA/AAG-4355-2022; Viollet, Benoit/O-6927-2017; Al-Oanzi, Ziad/AAI-4296-2020; Viollet, Benoit/N-2397-2019; Alshawi, Ahmed/J-1256-2019; CASCANTE, MARTA/AFK-5991-2022; Marin, Silvia/C-5492-2017; Ford, Brian E/G-5875-2010; FORETZ, Marc/O-7334-2017	CASCANTE, MARTA/0000-0002-2062-4633; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Alshawi, Ahmed/0000-0002-0328-3486; CASCANTE, MARTA/0000-0002-2062-4633; Marin, Silvia/0000-0003-0693-2207; Ford, Brian E/0000-0003-0543-4978; FORETZ, Marc/0000-0001-7017-9032	Diabetes UK [13/0004701]; Medical Research Council [MR/P002854/1]; Higher Committee for Education Development Iraq Grant 2015-2019; Agencia Catalana d'Ajuts Universitaris i de Recerca [2017SGR1033]; ICREA Foundation, Generalitat de Catalunya; MRC [MR/P002854/1] Funding Source: UKRI	Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Committee for Education Development Iraq Grant 2015-2019; Agencia Catalana d'Ajuts Universitaris i de Recerca; ICREA Foundation, Generalitat de Catalunya(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Diabetes UK Grant 13/0004701 and Medical Research Council Grant MR/P002854/1 (to L. A.). This work was also supported in part by a Higher Committee for Education Development Iraq Grant 2015-2019 (to A. A.) and by Agencia Catalana d'Ajuts Universitaris i de Recerca (2017SGR1033) and ICREA Foundation, Generalitat de Catalunya (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agius L, 2016, P NUTR SOC, V75, P10, DOI 10.1017/S0029665115002451; Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002; Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Al-Oanzi ZH, 2017, DIABETES OBES METAB, V19, P1078, DOI 10.1111/dom.12910; Alshawi A, 2019, J BIOL CHEM, V294, P2839, DOI 10.1074/jbc.RA118.006670; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; BERRY MN, 1994, EUR J BIOCHEM, V225, P557, DOI 10.1111/j.1432-1033.1994.00557.x; BONORA E, 1984, CURR MED RES OPIN, V9, P47, DOI 10.1185/03007998409109558; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Cameron AR, 2018, REDOX BIOL, V14, P187, DOI 10.1016/j.redox.2017.08.018; Chakera AJ, 2015, DIABETES CARE, V38, P1383, DOI 10.2337/dc14-2769; Christensen MMH, 2015, DIABETOLOGIA, V58, P2494, DOI 10.1007/s00125-015-3733-2; Codner GF, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0530-7; COOK DE, 1973, J BIOL CHEM, V248, P5272; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CRAWFORD JM, 1983, BIOCHEM J, V212, P595, DOI 10.1042/bj2120585; Dawed AY, 2017, DIABETOLOGIA, V60, P2231, DOI 10.1007/s00125-017-4404-2; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Dong Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21111446; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Glossmann HH, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172782; Grefhorst A, 2010, BIOCHEM J, V432, P249, DOI 10.1042/BJ20101225; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hampson LJ, 2005, DIABETES, V54, P617, DOI 10.2337/diabetes.54.3.617; Harndahl L, 2006, FEBS J, V273, P336, DOI 10.1111/j.1742-4658.2005.05067.x; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; HUE L, 1982, BIOCHEM J, V206, P359, DOI 10.1042/bj2060359; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; KATZ J, 1963, J BIOL CHEM, V238, P517; Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993; Kraev A, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-18; Li MQ, 2019, CELL METAB, V30, P508, DOI 10.1016/j.cmet.2019.05.018; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Marin S, 2004, BIOCHEM J, V381, P287, DOI 10.1042/BJ20031737; MCCUNE SA, 1989, BIOCHEM J, V259, P925, DOI 10.1042/bj2590925; MOYLE J, 1973, BIOCHEM J, V132, P571, DOI 10.1042/bj1320571; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; Neal A, 2015, TOXICOL SCI, V148, P594, DOI 10.1093/toxsci/kfv208; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Payne VA, 2005, DIABETES, V54, P1949, DOI 10.2337/diabetes.54.7.1949; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; SIES H, 1975, FEBS LETT, V54, P274, DOI 10.1016/0014-5793(75)80091-3; Stein BD, 2019, CELL REP, V29, P3331, DOI 10.1016/j.celrep.2019.10.117; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; SUM CF, 1992, DIABETIC MED, V9, P61, DOI 10.1111/j.1464-5491.1992.tb01716.x; THOMAS AP, 1981, BIOCHEM J, V198, P551, DOI 10.1042/bj1980551; VANSCHAFTINGEN E, 1984, BIOCHEM J, V222, P511, DOI 10.1042/bj2220511; VANSTAPEL F, 1990, BIOCHEM J, V266, P207, DOI 10.1042/bj2660207; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275	74	11	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3330	3346		10.1074/jbc.RA120.012533	http://dx.doi.org/10.1074/jbc.RA120.012533			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974165	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000519597300035
J	Winters, CM; Hong-Brown, LQ; Chiang, HL				Winters, Chelsea M.; Hong-Brown, Ly Q.; Chiang, Hui-Ling			Intracellular vesicle clusters are organelles that synthesize extracellular vesicle?associated cargo proteins in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; exosome (vesicle); extracellular vesicles; protein synthesis; gluconeogenesis; cell-cell communication; intracellular vesicle clusters; proteomics; vacuole import and degradation (Vid) pathway; CLICK chemistry; Saccharomyces cerevisiae; secreted protein	CRYPTOCOCCUS-NEOFORMANS; VACUOLE IMPORT; ACTIN PATCHES; VID VESICLES; EXOSOMES; DEGRADATION; ENDOCYTOSIS; FRUCTOSE-1,6-BISPHOSPHATASE; ASSOCIATION; SECRETION	Extracellular vesicles (EVs) play important roles in cell-cell communication. In budding yeast (Saccharomyces cerevisiae), EVs function as carriers to transport cargo proteins into the periplasm for storage during glucose starvation. However, intracellular organelles that synthesize these EV-associated cargo proteins have not been identified. Here, we investigated whether cytoplasmic organelles?called intracellular vesicle clusters (IVCs)?serve as sites for the synthesis of proteins targeted for secretion as EV-associated proteins. Using proteomics, we identified 377 IVC-associated proteins in yeast cells grown under steady-state low-glucose conditions, with the largest group being involved in protein translation. Isolated IVCs exhibited protein synthesis activities that required initiation and elongation factors. We have also identified 431 newly synthesized proteins on isolated IVCs. Expression of 103Q-GFP, a foreign protein with a long polyglutamine extension, resulted in distribution of this protein as large puncta that co-localized with IVC markers, including fructose-1,6-bisphosphatase (FBPase) and the vacuole import and degradation protein Vid24p. We did not observe this pattern in cycloheximide-treated cells or in cells lacking VID genes, required for IVC formation. The induction of 103Q-GFP on IVCs adversely affected total protein synthesis in intact cells and on isolated IVCs. This expression also decreased levels of EV-associated cargo proteins in the extracellular fraction without affecting the number of secreted EVs. Our results provide important insights into the functions of IVCs as sites for the synthesis of EV-associated proteins targeted for secretion to the periplasm.	[Winters, Chelsea M.; Hong-Brown, Ly Q.; Chiang, Hui-Ling] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	hchiang@pennstatehealth.psu.edu			NIGMS, National Institutes of Health [GM59480]; Penn State Gift Fund	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Penn State Gift Fund	This study was supported in part by NIGMS, National Institutes of Health Grant GM59480 and a Penn State Gift Fund (to H.-L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Tables S1-S4.	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Coleman BM, 2015, SEMIN CELL DEV BIOL, V40, P89, DOI 10.1016/j.semcdb.2015.02.007; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Giardina BJ, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23497; Giardina BJ, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-9; Giardina BJ, 2013, J BIOL CHEM, V288, P11636, DOI 10.1074/jbc.M112.419895; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Harischandra DS, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau4543; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Jalalian SH, 2019, ANAL BIOCHEM, V571, P1, DOI 10.1016/j.ab.2019.02.013; Kao CY, 2019, CURR OPIN BIOTECH, V60, P89, DOI 10.1016/j.copbio.2019.01.005; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Oliveira Debora L, 2010, Commun Integr Biol, V3, P533, DOI 10.4161/cib.3.6.12756; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Salehi M, 2018, J CELL PHYSIOL, V233, P6370, DOI 10.1002/jcp.26481; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stein K, 2017, BIOL CELL, V109, P190, DOI 10.1111/boc.201600060; Stein K, 2014, MEMBRANES-BASEL, V4, P608, DOI 10.3390/membranes4030608; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039463; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; Vilaca-Faria H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020118; Winters CM, 2017, DNA CELL BIOL, V36, P909, DOI 10.1089/dna.2017.3847; Winters CM, 2016, CURR PROTEIN PEPT SC, V17, P808, DOI 10.2174/1389203717666160226144457; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118	41	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2650	2663		10.1074/jbc.RA119.008612	http://dx.doi.org/10.1074/jbc.RA119.008612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974164	hybrid, Green Published			2022-12-28	WOS:000519969100011
J	Karsai, G; Lone, M; Kutalik, Z; Brenna, JT; Li, HD; Pan, DJ; von Eckardstein, A; Hornemann, T				Karsai, Gergely; Lone, Museer; Kutalik, Zoltan; Brenna, J. Thomas; Li, Hongde; Pan, Duojia; von Eckardstein, Arnold; Hornemann, Thorsten			FADS3 is a?14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; lipid metabolism; human genetics; single-nucleotide polymorphism (SNP); molecular cell biology; ceramide; genomics; fatty acid desaturase 3 (FADS3); GWAS	FATTY-ACIDS; ASSOCIATION; GENE; TRANSCRIPTS; EXPRESSION; DISEASE; MEMBERS; MICE	Sphingolipids (SLs) are structurally diverse lipids that are defined by the presence of a long-chain base (LCB) backbone. Typically, LCBs contain a single ?4E double bond (DB) (mostly d18:1), whereas the dienic LCB sphingadienine (d18:2) contains a second DB at the ?14Z position. The enzyme introducing the ?14Z DB is unknown. We analyzed the LCB plasma profile in a gender-, age-, and BMI-matched subgroup of the CoLaus cohort (n = 658). Sphingadienine levels showed a significant association with gender, being on average ?30% higher in females. A genome-wide association study (GWAS) revealed variants in the fatty acid desaturase 3 (FADS3) gene to be significantly associated with the plasma d18:2/d18:1 ratio (p = ?log 7.9). Metabolic labeling assays, FADS3 overexpression and knockdown approaches, and plasma LCB profiling in FADS3-deficient mice confirmed that FADS3 is a bona fide LCB desaturase and required for the introduction of the ?14Z double bond. Moreover, we showed that FADS3 is required for the conversion of the atypical cytotoxic 1-deoxysphinganine (1-deoxySA, m18:0) to 1-deoxysphingosine (1-deoxySO, m18:1). HEK293 cells overexpressing FADS3 were more resistant to m18:0 toxicity than WT cells. In summary, using a combination of metabolic profiling and GWAS, we identified FADS3 to be essential for forming ?14Z DB containing LCBs, such as d18:2 and m18:1. Our results unravel FADS3 as a ?14Z LCB desaturase, thereby disclosing the last missing enzyme of the SL de novo synthesis pathway.	[Karsai, Gergely; Lone, Museer; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Karsai, Gergely; Lone, Museer; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Zurich, CH-8091 Zurich, Switzerland; [Kutalik, Zoltan] Univ Lausanne, Univ Ctr Primary Care & Publ Hlth, CH-1010 Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Brenna, J. Thomas] Univ Texas Austin, Dept Chem, Dell Pediat Res Inst, Austin, TX 78723 USA; [Brenna, J. Thomas] Univ Texas Austin, Dept Pediat, Dell Pediat Res Inst, Austin, TX 78723 USA; [Brenna, J. Thomas] Univ Texas Austin, Dept Nutr, Dell Pediat Res Inst, Austin, TX 78723 USA; [Li, Hongde; Pan, Duojia] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Zurich; University Zurich Hospital; University of Zurich; University of Lausanne; Swiss Institute of Bioinformatics; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hornemann, T (corresponding author), Univ Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland.; Hornemann, T (corresponding author), Univ Zurich, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch	Li, Hongde/K-7347-2014; Colaus, PsyColaus/K-6607-2013; Kutalik, Zoltan/HHZ-5697-2022	Li, Hongde/0000-0003-1256-2513; Kutalik, Zoltan/0000-0001-8285-7523; Karsai, Gergely/0000-0002-6840-682X; Lone, Museer/0000-0001-9710-775X	Swiss National Foundation (SNF) [31003A/179371]; Swiss Life Foundation; Novartis Foundation; GlaxoSmith Kline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 33CS30-139468, 33CS30-148401]; Hurka	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Life Foundation; Novartis Foundation(Novartis); GlaxoSmith Kline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hurka	This work was supported by Swiss National Foundation (SNF) Grant 31003A/179371 and the Hurka and Swiss Life Foundation (to T. H.) and by the Novartis Foundation (to A. v. E.). The CoLaus study is supported by research grants from GlaxoSmith Kline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (Grants 33CSCO-122661, 33CS30-139468, and 33CS30-148401). The authors declare that they have no conflicts of interest with the contents of this article.	Alecu I, 2017, J LIPID RES, V58, P60, DOI 10.1194/jlr.M072421; Antiochos P, 2016, ATHEROSCLEROSIS, V244, P59, DOI 10.1016/j.atherosclerosis.2015.10.104; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Brenna JT, 2010, PROSTAG LEUKOTR ESS, V82, P281, DOI 10.1016/j.plefa.2010.02.011; Carreira AC, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100988; Chew WS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126925; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Gantner ML, 2019, NEW ENGL J MED, V381, P1422, DOI 10.1056/NEJMoa1815111; Hannich JT, 2019, NAT METAB, V1, P996, DOI 10.1038/s42255-019-0123-y; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Huynh K, 2019, CELL CHEM BIOL, V26, P71, DOI 10.1016/j.chembiol.2018.10.008; Karsai G, 2019, J CLIN INVEST, V129, P1229, DOI 10.1172/JCI124159; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kutalik Z, 2011, BIOSTATISTICS, V12, P1, DOI 10.1093/biostatistics/kxq039; Lone MA, 2019, BBA-MOL CELL BIOL L, V1864, P512, DOI 10.1016/j.bbalip.2018.12.013; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mwinyi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175776; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; Othman A, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000073; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; RENKONEN O, 1970, BIOCHIM BIOPHYS ACTA, V210, P190, DOI 10.1016/0005-2760(70)90078-0; RENKONEN O, 1969, J LIPID RES, V10, P687; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; Ryan E, 2017, J AM SOC MASS SPECTR, V28, P1406, DOI 10.1007/s13361-017-1668-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Steiner R, 2016, J LIPID RES, V57, P1194, DOI 10.1194/jlr.M067033; Storti F, 2019, ELIFE, V8, DOI 10.7554/eLife.45100; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Struckhoff AP, 2004, J PHARMACOL EXP THER, V309, P523, DOI 10.1124/jpet.103.062760; Sugawara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2906, DOI 10.1271/bbb.60318; Sutter I, 2015, ATHEROSCLEROSIS, V241, P539, DOI 10.1016/j.atherosclerosis.2015.05.037; Symolon H, 2004, J NUTR, V134, P1157, DOI 10.1093/jn/134.5.1157; Zhang JY, 2017, PROSTAG LEUKOTR ESS, V123, P25, DOI 10.1016/j.plefa.2017.07.001; Zhang TJ, 2015, J LIPID RES, V56, P1501, DOI 10.1194/jlr.M058750	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1889	1897		10.1074/jbc.AC119.011883	http://dx.doi.org/10.1074/jbc.AC119.011883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31862735	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000517128200010
J	Visootsat, A; Nakamura, A; Vignon, P; Watanabe, H; Uchihashi, T; Iino, R				Visootsat, Akasit; Nakamura, Akihiko; Vignon, Paul; Watanabe, Hiroki; Uchihashi, Takayuki; Iino, Ryota			Single-molecule imaging analysis reveals the mechanism of a high-catalytic-activity mutant of chitinase A from Serratia marcescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitinase; processivity; single-molecule biophysics; Serratia marcescens; chitin; biomass conversion; biotechnology; chitin degradation; high-speed atomic force microscopy; single-molecule fluorescence imaging	PROTEIN-CARBOHYDRATE INTERACTIONS; CELLOBIOHYDROLASE I; AROMATIC RESIDUES; PROCESSIVITY; BINDING; CEL7A; HYDROLYSIS; ALPHA; COCKTAILS; MOVEMENT	Chitin degradation is important for biomass conversion and has potential applications for agriculture, biotechnology, and the pharmaceutical industry. Chitinase A from the Gram-negative bacterium Serratia marcescens (SmChiA) is a processive enzyme that hydrolyzes crystalline chitin as it moves linearly along the substrate surface. In a previous study, the catalytic activity of SmChiA against crystalline chitin was found to increase after the tryptophan substitution of two phenylalanine residues (F232W and F396W), located at the entrance and exit of the substrate binding cleft of the catalytic domain, respectively. However, the mechanism underlying this high catalytic activity remains elusive. In this study, single-molecule fluorescence imaging and high-speed atomic force microscopy were applied to understand the mechanism of this high-catalytic-activity mutant. A reaction scheme including processive catalysis was used to reproduce the properties of SmChiA WT and F232W/F396W, in which all of the kinetic parameters were experimentally determined. High activity of F232W/F396W mutant was caused by a high processivity and a low dissociation rate constant after productive binding. The turnover numbers for both WT and F232W/F396W, determined by the biochemical analysis, were well-replicated using the kinetic parameters obtained from single-molecule imaging analysis, indicating the validity of the reaction scheme. Furthermore, alignment of amino acid sequences of 258 SmChiA-like proteins revealed that tryptophan, not phenylalanine, is the predominant amino acid at the corresponding positions (Phe-232 and Phe-396 for SmChiA). Our study will be helpful for understanding the kinetic mechanisms and further improvement of crystalline chitin hydrolytic activity of SmChiA mutants.	[Visootsat, Akasit; Nakamura, Akihiko; Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Funct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Visootsat, Akasit; Nakamura, Akihiko; Vignon, Paul; Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Vignon, Paul] Chim ParisTech, F-75231 Paris, France; [Watanabe, Hiroki; Uchihashi, Takayuki] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648601, Japan; [Watanabe, Hiroki; Uchihashi, Takayuki] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi 4448787, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Iino, R (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	iino@ims.ac.jp	Iino, Ryota/B-7746-2011; Uchihashi, Takayuki/D-5209-2011	Iino, Ryota/0000-0003-0110-5704; Uchihashi, Takayuki/0000-0002-0263-5312; VISOOTSAT, AKASIT/0000-0002-1258-6745; Nakamura, Akihiko/0000-0003-0409-5759	Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP18H05424, JP18H02418, JP18H04755]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Engine" JP18H05424 (to R. I.) and Grants-in-Aid for Scientific Research JP18H02418 and JP18H04755 (to R. I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BAMBARA RA, 1978, J BIOL CHEM, V253, P413; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Bonderoff JM, 2010, NUCLEIC ACIDS RES, V38, P7054, DOI 10.1093/nar/gkq566; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Deguchi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11907; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Einbu A, 2008, BIOMACROMOLECULES, V9, P1870, DOI 10.1021/bm8001123; Hamed I, 2016, TRENDS FOOD SCI TECH, V48, P40, DOI 10.1016/j.tifs.2015.11.007; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hu GH, 2002, BIOCHEMISTRY-US, V41, P7677, DOI 10.1021/bi0201926; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kawai F, 2018, ACS OMEGA, V3, P7715, DOI 10.1021/acsomega.8b00663; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Langner T, 2016, CURR GENET, V62, P243, DOI 10.1007/s00294-015-0530-x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu T, 2017, J BIOL CHEM, V292, P2080, DOI [10.1074/jbc.M116.755330, 10.1074/jbc.m116.755330]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Madhuprakash J, 2018, BIOCHEMISTRY-US, V57, P4325, DOI 10.1021/acs.biochem.8b00381; Mekasha S, 2017, PROCESS BIOCHEM, V56, P132, DOI 10.1016/j.procbio.2017.02.021; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; Nakamura A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06362-3; Nakamura A, 2018, PHYS CHEM CHEM PHYS, V20, P3010, DOI 10.1039/c7cp04606e; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Snoberger A, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00018; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sorlie M, 2012, BIOCATAL BIOTRANSFOR, V30, P353, DOI 10.3109/10242422.2012.676282; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; Williams SJ, 2001, TRENDS BIOTECHNOL, V19, P356, DOI 10.1016/S0167-7799(01)01699-7; Yan N, 2015, NATURE, V524, P155, DOI 10.1038/524155a; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	55	6	6	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1915	1925		10.1074/jbc.RA119.012078	http://dx.doi.org/10.1074/jbc.RA119.012078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31924658	hybrid, Green Published			2022-12-28	WOS:000517128200012
J	Nielsen, AL; Olsen, CA				Nielsen, Alexander L.; Olsen, Christian A.			Finding the gas pedal on a slow sirtuin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACTIVATION	The class III histone deacetylase sirtuin 6 (SIRT6) modulates numerous functions in the cell by deacetylating histone lysine residues. Interestingly, SIRT6's efficiency in in vitro experiments is far greater against substrates carrying long-chain fatty acyl modifications such as myristoylated lysine compared with acetylated counterparts, but the deacetylase activity can be stimulated by fatty acids and small-molecule allosteric modulators. A new study helps to explain this puzzling activation using a novel activator, thorough kinetic investigation, and mutagenesis studies. These data help elucidate the molecular requirements for activation of SIRT6 and provide a foundation for development of activators for therapeutic purposes.	[Olsen, Christian A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Parken 2, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Parken 2, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Olsen, CA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Biopharmaceut, Univ Parken 2, DK-2100 Copenhagen, Denmark.	cao@sund.ku.dk	Nielsen, Alexander Lund/AAJ-4395-2020	Nielsen, Alexander Lund/0000-0003-1195-0143; Olsen, Christian Adam/0000-0002-2953-8942	European Research Council [ERC-CoG-725172-SIRFUNCT]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Grant ERC-CoG-725172-SIRFUNCT. The authors declare that they have no conflicts of interest with the contents of this article.	Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Klein MA, 2020, J BIOL CHEM, V295, P1385, DOI 10.1074/jbc.RA119.011285; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tong Z, 2017, ACS CHEM BIOL, V12, P300, DOI 10.1021/acschembio.6b00954; Wang WW, 2019, J AM CHEM SOC, V141, P2462, DOI 10.1021/jacs.8b12083; You WJ, 2017, ANGEW CHEM INT EDIT, V56, P1007, DOI 10.1002/anie.201610082	10	0	0	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1400	1401		10.1074/jbc.H120.012534	http://dx.doi.org/10.1074/jbc.H120.012534			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	32005646	Green Published, hybrid			2022-12-28	WOS:000513822300021
J	Gao, XL; Tian, WJ; Liu, BF; Wu, JY; Xie, W; Shen, Q				Gao, Xue-Ling; Tian, Wen-Jia; Liu, Bofeng; Wu, Jingyi; Xie, Wei; Shen, Qin			High-mobility group nucleosomal binding domain 2 protects against microcephaly by maintaining global chromatin accessibility during corticogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural stem cell (NSC); neurogenesis; neurodevelopment; neurological disease; chromatin remodeling; chromatin assembly and disassembly; HMGN proteins; microcephaly; neural stem cells	TRANSCRIPTION FACTOR KLF7; PROTEINS; CELLS; DIFFERENTIATION; NEUROGENESIS; TRANSITIONS; PREVALENCE; EXPRESSION; LANDSCAPE; NEOCORTEX	The surface area of the human cerebral cortex undergoes dramatic expansion during late fetal development, leading to cortical folding, an evolutionary feature not present in rodents. Microcephaly is a neurodevelopmental disorder defined by an abnormally small brain, and many gene mutations have been found to be associated with primary microcephaly. However, mouse models generated by ablating primary microcephaly-associated genes often fail to recapitulate the severe loss of cortical surface area observed in individuals with this pathology. Here, we show that a mouse model with deficient expression of high-mobility group nucleosomal binding domain 2 (HMGN2) manifests microcephaly with reduced cortical surface area and almost normal radial corticogenesis, with a pattern of incomplete penetrance. We revealed that altered cleavage plane and mitotic delay of ventricular radial glia may explain the rising ratio of intermediate progenitor cells to radial glia and the displacement of neural progenitor cells in microcephalic mutant mice. These led to decreased self-renewal of the radial glia and reduction in lateral expansion. Furthermore, we found that HMGN2 protected corticogenesis by maintaining global chromatin accessibility mainly at promoter regions, thereby ensuring the correct regulation of the transcriptome. Our findings underscore the importance of the regulation of chromatin structure in cortical development and highlight a mouse model with critical insights into the etiology of microcephaly.	[Gao, Xue-Ling] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Gao, Xue-Ling; Tian, Wen-Jia; Shen, Qin] Tongji Univ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Minist Educ, Tongji Hosp,Sch Life Sci & Technol, Shanghai 200065, Peoples R China; [Gao, Xue-Ling; Tian, Wen-Jia; Shen, Qin] Tongji Univ, Sch Life Sci & Technol, Minist Educ, Frontier Sci Ctr Stem Cell Res, Shanghai 200092, Peoples R China; [Tian, Wen-Jia; Liu, Bofeng; Wu, Jingyi; Xie, Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Bofeng; Wu, Jingyi; Xie, Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China; [Shen, Qin] Tongji Univ, Brain & Spinal Cord Clin Res Ctr, Shanghai 200092, Peoples R China; [Wu, Jingyi] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wu, Jingyi] Harvard Med Sch, Boston, MA 02114 USA; [Wu, Jingyi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Peking University; Tongji University; Tongji University; Tsinghua University; Tsinghua University; Tongji University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shen, Q (corresponding author), Tongji Univ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Minist Educ, Tongji Hosp,Sch Life Sci & Technol, Shanghai 200065, Peoples R China.; Shen, Q (corresponding author), Tongji Univ, Sch Life Sci & Technol, Minist Educ, Frontier Sci Ctr Stem Cell Res, Shanghai 200092, Peoples R China.; Shen, Q (corresponding author), Tongji Univ, Brain & Spinal Cord Clin Res Ctr, Shanghai 200092, Peoples R China.	shenqin@tongji.edu.cn			National Science Foundation of China [31671068]; Ministry of Science and Technology of China [2019YFA0110102]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Science Foundation of China Grant 31671068 and Ministry of Science and Technology of China Grant 2019YFA0110102. The authors declare that they have no conflicts of interest with the contents of this article.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bhattacharya A, 2003, CANCER RES, V63, P8167; Brown SDM, 2018, NAT REV GENET, V19, P357, DOI 10.1038/s41576-018-0005-2; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen FY, 2012, J NEUROSCI METH, V207, P172, DOI 10.1016/j.jneumeth.2012.03.016; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; Deng T, 2017, NUCLEIC ACIDS RES, V45, P3031, DOI 10.1093/nar/gkw1222; Deng T, 2015, GENOME RES, V25, P1295, DOI 10.1101/gr.192229.115; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dupuis N, 2015, HUM MOL GENET, V24, P2771, DOI 10.1093/hmg/ddv038; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hu XL, 2017, NEURON, V95, P309, DOI 10.1016/j.neuron.2017.06.047; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056; Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kajimura D, 2007, GENE, V388, P34, DOI 10.1016/j.gene.2006.09.027; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kugler JE, 2012, BBA-GENE REGUL MECH, V1819, P652, DOI 10.1016/j.bbagrm.2012.01.013; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04122-x; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Moon BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02720-9; Mounier A, 2015, J NEUROSCI, V35, P11862, DOI 10.1523/JNEUROSCI.1001-15.2015; NEW JS, 1986, J HETEROCYCLIC CHEM, V23, P545, DOI 10.1002/jhet.5570230247; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Ozturk N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00005; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Singh S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00062; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006	62	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					468	480		10.1074/jbc.RA119.010616	http://dx.doi.org/10.1074/jbc.RA119.010616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31699896	Green Published, hybrid			2022-12-28	WOS:000507373600017
J	Blackburn, DM; Lazure, F; Corchado, AH; Perkins, TJ; Najafabadi, HS; Soleimani, VD				Blackburn, Darren M.; Lazure, Felicia; Corchado, Aldo H.; Perkins, Theodore J.; Najafabadi, Hamed S.; Soleimani, Vahab D.			High-resolution genome-wide expression analysis of single myofibers using SMART-Seq	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle; RNA; gene expression; molecular cell biology; molecular biology; SMART-Seq	MOUSE SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; STEM-CELLS; PROGENITORS; CHEMOKINE; EXERCISE; BINDING; NECDIN; RNA	Skeletal muscle is a heterogeneous tissue. Individual myofibers that make up muscle tissue exhibit variation in their metabolic and contractile properties. Although biochemical and histological assays are available to study myofiber heterogeneity, efficient methods to analyze the whole transcriptome of individual myofibers are lacking. Here, we report on a single-myofiber RNA-sequencing (smfRNA-Seq) approach to analyze the whole transcriptome of individual myofibers by combining single-fiber isolation with Switching Mechanism at 5? end of RNA Template (SMART) technology. Using smfRNA-Seq, we first determined the genes that are expressed in the whole muscle, including in nonmyogenic cells. We also analyzed the differences in the transcriptome of myofibers from young and old mice to validate the effectiveness of this new method. Our results suggest that aging leads to significant changes in the expression of metabolic genes, such as Nos1, and structural genes, such as Myl1, in myofibers. We conclude that smfRNA-Seq is a powerful tool to study developmental, disease-related, and age-related changes in the gene expression profile of skeletal muscle.	[Blackburn, Darren M.; Lazure, Felicia; Corchado, Aldo H.; Najafabadi, Hamed S.; Soleimani, Vahab D.] McGill Univ, Dept Human Genet, 3640 Rue Univ, Montreal, PQ H3A 0C7, Canada; [Blackburn, Darren M.; Lazure, Felicia; Najafabadi, Hamed S.] Jewish Gen Hosp, Lady Davis Inst Med Res, Mol & Regenerat Med Axis, Montreal, PQ H3T 1E2, Canada; [Perkins, Theodore J.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Perkins, Theodore J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	McGill University; Lady Davis Institute; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Soleimani, VD (corresponding author), McGill Univ, Dept Human Genet, 3640 Rue Univ, Montreal, PQ H3A 0C7, Canada.	Vahab.soleimani@mcgill.ca			Canadian Institute of Health Research [PJT-15087]; Natural Sciences and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research Grant PJT-15087 and a Natural Sciences and Engineering Research Council grant (to V. D. S.). We would like to acknowledge Compute Canada allocations (to H. S. N. and T. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	AbuSamra DB, 2017, BLOOD ADV, V1, P2799, DOI 10.1182/bloodadvances.2017004317; Alway SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00246; Ancel S, 2019, AGING-US, V11, P7331, DOI 10.18632/aging.102304; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baghdadi MB, 2018, NATURE, V557, P714, DOI 10.1038/s41586-018-0144-9; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Bird L, 2016, NAT REV IMMUNOL, V16, P204, DOI 10.1038/nri.2016.30; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Cui CY, 2019, AGING CELL, V18, DOI 10.1111/acel.13032; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fernandez-Verdejo R, 2017, BIOCHEM BIOPH RES CO, V492, P249, DOI 10.1016/j.bbrc.2017.08.059; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Guo QC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89206; HOOD DA, 1989, AM J PHYSIOL, V256, pC1092, DOI 10.1152/ajpcell.1989.256.5.C1092; Hwang AB, 2018, CURR TOP DEV BIOL, V126, P299, DOI 10.1016/bs.ctdb.2017.08.008; Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/NMETH.3885, 10.1038/nmeth.3885]; Jiang DS, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00133; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Nowak KJ, 2013, ACTA NEUROPATHOL, V125, P19, DOI 10.1007/s00401-012-1019-z; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Pette D, 1999, ACTA PHYSIOL SCAND, V166, P261; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ravenscroft G, 2018, HUM MOL GENET, V27, P4263, DOI 10.1093/hmg/ddy320; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thorley Matthew, 2015, J Neuromuscul Dis, V2, P205; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Waddell LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02246; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Yin J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04038-6; YOON SJ, 1992, P NATL ACAD SCI USA, V89, P12078, DOI 10.1073/pnas.89.24.12078	51	13	13	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20097	20108		10.1074/jbc.RA119.011506	http://dx.doi.org/10.1074/jbc.RA119.011506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753917	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000505005800022
J	Yoganand, KN; Muralidharan, M; Nimkar, S; Anand, B				Yoganand, Kakimani Nagarajan; Muralidharan, Manasasri; Nimkar, Siddharth; Anand, Baskaran			Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR-Cas; protein-nucleic acid interaction; protein-DNA interaction; Escherichia coli (E; coli); molecular biology; microbiology; bacterial immunity; Cas1-Cas2; exonuclease; prespacer processing; CRISPR adaptation; protospacer-adjacent motif (PAM); Cas1; Cas2; prespacer integration	SPACER ACQUISITION; HOST FACTOR; INTEGRATION; SEQUENCE; IMMUNITY; DEFENSE; TARGETS; GUIDE; ENDORIBONUCLEASE; CLASSIFICATION	Prokaryotes deploy CRISPR-Cas?based RNA-guided adaptive immunity to fend off mobile genetic elements such as phages and plasmids. During CRISPR adaptation, which is the first stage of CRISPR immunity, the Cas1-2 integrase complex captures invader-derived prespacer DNA and specifically integrates it at the leader-repeat junction as spacers. For this integration, several variants of CRISPR-Cas systems use Cas4 as an indispensable nuclease for selectively processing the protospacer adjacent motif (PAM) containing prespacers to a defined length. Surprisingly, however, a few CRISPR-Cas systems, such as type I-E, are bereft of Cas4. Despite the absence of Cas4, how the prespacers show impeccable conservation for length and PAM selection in type I-E remains intriguing. Here, using in vivo and in vitro integration assays, deep sequencing, and exonuclease footprinting, we show that Cas1-2/I-E?via the type I-E?specific extended C-terminal tail of Cas1?displays intrinsic affinity for PAM containing prespacers of variable length in Escherichia coli. Although Cas1-2/I-E does not prune the prespacers, its binding protects the prespacer boundaries from exonuclease action. This ensures the pruning of exposed ends by exonucleases to aptly sized substrates for integration into the CRISPR locus. In summary, our work reveals that in a few CRISPR-Cas variants, such as type I-E, the specificity of PAM selection resides with Cas1-2, whereas the prespacer processing is co-opted by cellular non-Cas exonucleases, thereby offsetting the need for Cas4.	[Yoganand, Kakimani Nagarajan; Muralidharan, Manasasri; Nimkar, Siddharth; Anand, Baskaran] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Anand, B (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, India.	banand@iitg.ac.in		KNR, Yoganand/0000-0001-8940-4084; , Anand/0000-0002-7125-4011	Department of Biotechnology (DBT) [BT/PR15925/NER/95/141/2015, BT/08/IYBA/2014/05]; Science and Engineering Research Board (SERB) [YSS/2014/000286]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Science and Engineering Research Board (SERB)	This work was supported by Department of Biotechnology (DBT) Grants BT/PR15925/NER/95/141/2015 and BT/08/IYBA/2014/05 and Science and Engineering Research Board (SERB) Grant YSS/2014/000286. The authors declare that they have no conflicts of interest with the contents of this article.	Almendros C, 2019, NUCLEIC ACIDS RES, V47, P5223, DOI 10.1093/nar/gkz217; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Gleditzsch D, 2019, RNA BIOL, V16, P504, DOI 10.1080/15476286.2018.1504546; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Grainy J, 2019, NUCLEIC ACIDS RES, V47, P7518, DOI 10.1093/nar/gkz548; Guerrero F, 2015, PROTEIN EXPRES PURIF, V116, P42, DOI 10.1016/j.pep.2015.08.019; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Jackson SA, 2019, CELL HOST MICROBE, V25, P250, DOI 10.1016/j.chom.2018.12.014; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Ka D, 2018, NUCLEIC ACIDS RES, V46, P9805, DOI 10.1093/nar/gky702; Kieper SN, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz129; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; Kim JG, 2019, NUCLEIC ACIDS RES, V47, P8632, DOI 10.1093/nar/gkz677; Kim S., 2019, SELECTIVE PRESPACER, DOI [10.1101/608976, DOI 10.1101/608976]; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lee H, 2019, ELIFE, V8, DOI 10.7554/eLife.44248; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2017, NUCLEIC ACIDS RES, V45, P4642, DOI 10.1093/nar/gkx229; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu T, 2017, NUCLEIC ACIDS RES, V45, P8978, DOI 10.1093/nar/gkx612; Makarova KS, 2018, CRISPR J, V1, P325, DOI 10.1089/crispr.2018.0033; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Moch C, 2017, NUCLEIC ACIDS RES, V45, P2714, DOI 10.1093/nar/gkw1309; Mohr G, 2018, MOL CELL, V72, P700, DOI 10.1016/j.molcel.2018.09.013; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Musharova O, 2019, MOL MICROBIOL, V111, P1558, DOI 10.1111/mmi.14237; Musharova O, 2018, MBIO, V9, DOI 10.1128/mBio.02169-18; Musharova O, 2017, NUCLEIC ACIDS RES, V45, P3297, DOI 10.1093/nar/gkx097; MUSKAVITCH KMT, 1982, J BIOL CHEM, V257, P2641; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Plateau P, 2019, J BIOL CHEM, V294, P11311, DOI 10.1074/jbc.RA119.007619; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Punetha A, 2018, P INDIAN NATL SCI AC, V84, P455, DOI 10.16943/ptinsa/2017/49241; Radovcic M, 2018, NUCLEIC ACIDS RES, V46, P10173, DOI 10.1093/nar/gky799; Rao CT, 2017, RNA, V23, P1525, DOI 10.1261/rna.062083.117; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wright AV, 2019, MOL CELL, V73, P727, DOI 10.1016/j.molcel.2018.12.015; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZF, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00747-18	93	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20039	20053		10.1074/jbc.RA119.009438	http://dx.doi.org/10.1074/jbc.RA119.009438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748409	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000505005800018
J	Tossounian, MA; Truong, ACK; Buts, L; Wahni, K; Mourenza, A; Leermakers, M; Vertommen, D; Mateos, LM; Volkov, AN; Messens, J				Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Mourenza, Alvaro; Leermakers, Martine; Vertommen, Didier; Mateos, Luis Mariano; Volkov, Alexander N.; Messens, Joris			Methionine sulfoxide reductase B from Corynebacterium diphtheriae catalyzes sulfoxide reduction via an intramolecular disulfide cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme structure; nuclear magnetic resonance (NMR); kinetics; redox regulation; biochemistry; hydrogen peroxide; methionine sulfoxide	MYCOBACTERIUM-TUBERCULOSIS; MYCOTHIOL PEROXIDASE; ARABIDOPSIS-THALIANA; ARSENATE REDUCTASE; OXIDIZED PROTEINS; OXIDATIVE STRESS; MECHANISM; THIOREDOXIN; GLUTATHIONE; RESIDUES	Corynebacterium diphtheriae is a human pathogen that causes diphtheria. In response to immune system-induced oxidative stress, C. diphtheriae expresses antioxidant enzymes, among which are methionine sulfoxide reductase (Msr) enzymes, which are critical for bacterial survival in the face of oxidative stress. Although some aspects of the catalytic mechanism of the Msr enzymes have been reported, several details still await full elucidation. Here, we solved the solution structure of C. diphtheriae MsrB (Cd-MsrB) and unraveled its catalytic and oxidation-protection mechanisms. Cd-MsrB catalyzes methionine sulfoxide reduction involving three redox-active cysteines. Using NMR heteronuclear single-quantum coherence spectra, kinetics, biochemical assays, and MS analyses, we show that the conserved nucleophilic residue Cys-122 is S-sulfenylated after substrate reduction, which is then resolved by a conserved cysteine, Cys-66, or by the nonconserved residue Cys-127. We noted that the overall structural changes during the disulfide cascade expose the Cys-122?Cys-66 disulfide to recycling through thioredoxin. In the presence of hydrogen peroxide, Cd-MsrB formed reversible intra- and intermolecular disulfides without losing its Cys-coordinated Zn2+, and only the nonconserved Cys-127 reacted with the low-molecular-weight (LMW) thiol mycothiol, protecting it from overoxidation. In summary, our structure-function analyses reveal critical details of the Cd-MsrB catalytic mechanism, including a major structural rearrangement that primes the Cys-122?Cys-66 disulfide for thioredoxin reduction and a reversible protection against excessive oxidation of the catalytic cysteines in Cd-MsrB through intra- and intermolecular disulfide formation and S-mycothiolation.	[Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Volkov, Alexander N.; Messens, Joris] VUB, VIB, Ctr Structural Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Wahni, Khadija; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Tossounian, Maria-Armineh; Truong, Anh-Co Khanh; Buts, Lieven; Wahni, Khadija; Volkov, Alexander N.; Messens, Joris] Vrije Univ Brussels, Struct Biol Brussels, B-1050 Brussels, Belgium; [Volkov, Alexander N.] Vrije Univ Brussels, Struct Biol Brussels, Jean Jeener NMR Ctr, B-1050 Brussels, Belgium; [Mourenza, Alvaro; Mateos, Luis Mariano] Univ Leon, Area Microbiol, Dept Mol Biol, E-24071 Leon, Spain; [Leermakers, Martine] Vrije Univ Brussels, Analyt Environm & Geochem AMGC, Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Truong, Anh-Co Khanh] VIB, Lab Angiogenesis & Vasc Metab, VIB Ctr Canc Biol, B-3000 Leuven, Belgium; [Truong, Anh-Co Khanh] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, Leuven Canc Inst, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universidad de Leon; Vrije Universiteit Brussel; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven	Messens, J (corresponding author), VUB, VIB, Ctr Structural Biol, B-1050 Brussels, Belgium.	joris.messens@vub.vib.be	Mourenza, Alvaro/AAA-5385-2020; Messens, Joris/AAH-3008-2020	Mourenza, Alvaro/0000-0003-4926-3891; Messens, Joris/0000-0002-2128-8264; Tossounian, Maria-Armineh/0000-0003-3679-7376; Volkov, Alexander/0000-0002-0103-059X; Truong, Anh-Co Khanh/0000-0002-9806-4293	Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant; Anaerobic Workstation Grant from FWO [1508316N]; Hercules Foundation [HERC16]; Vrije Universiteit Brussel [SRP34]	Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant; Anaerobic Workstation Grant from FWO; Hercules Foundation; Vrije Universiteit Brussel	This work was supported by the Vlaams Instituut voor Biotechnologie (VIB), a FWO Ph.D. fellowship grant (to M. A. T.), Hercules Foundation Grant HERC16, Anaerobic Workstation Grant 1508316N from FWO, and Strategic Research Programme Grant SRP34 of the Vrije Universiteit Brussel (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao ZB, 2018, BIOCHEM J, V475, P827, DOI 10.1042/BCJ20170929; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Chi BK, 2014, ANTIOXID REDOX SIGN, V20, P589, DOI 10.1089/ars.2013.5423; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; FRELINGER AL, 1986, ARCH BIOCHEM BIOPHYS, V244, P641, DOI 10.1016/0003-9861(86)90632-6; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee SH, 2014, J EXP BOT, V65, P5049, DOI 10.1093/jxb/eru270; Leermakers M, 2005, WATER AIR SOIL POLL, V166, P265, DOI 10.1007/s11270-005-6671-7; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lillig CH, 2013, BBA-GEN SUBJECTS, V1830, P3137, DOI 10.1016/j.bbagen.2013.02.019; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pedre B, 2015, MOL MICROBIOL, V96, P1176, DOI 10.1111/mmi.12998; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Saha SS, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw260; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Si MR, 2017, J GEN APPL MICROBIOL, V63, P280, DOI 10.2323/jgam.2017.01.005; Si MR, 2015, BIOCHEM J, V469, P45, DOI 10.1042/BJ20141080; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Tossounian MA, 2018, BBA-GEN SUBJECTS, V1862, P775, DOI 10.1016/j.bbagen.2017.10.007; Tossounian MA, 2015, J BIOL CHEM, V290, P11365, DOI 10.1074/jbc.M114.632596; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Volkov AN, 2013, BIOCHEMISTRY-US, V52, P2165, DOI 10.1021/bi400220w; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	64	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3664	3677		10.1074/jbc.RA119.012438	http://dx.doi.org/10.1074/jbc.RA119.012438			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31992594	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000527725300023
J	Ganz, P; Ijato, T; Porras-Murillo, R; Stuhrwohldt, N; Ludewig, U; Neuhauser, B				Ganz, Pascal; Ijato, Toyosi; Porras-Murillo, Romano; Stuehrwohldt, Nils; Ludewig, Uwe; Neuhaeuser, Benjamin			A twin histidine motif is the core structure for high-affinity substrate selection in plant ammonium transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ammonia; membrane transport; plant; substrate specificity; transporter; ammonium transporter; channel pore; ion transport; substrate deprotonation; twin-histidine motif	POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; AMTB; NH3; ARRANGEMENT; AMT/MEP/RH; MECHANISMS; FAMILY; ROOTS	Ammonium transporters (AMT), methylamine permeases (Mep), and the more distantly related rhesus factors (Rh) are trimeric membrane proteins present in all domains of life. AMT/Mep/Rhs are highly selective membrane proteins required for ammonium uptake or release, and they efficiently exclude the similarly sized K+ ion. Previously reported crystal structures have revealed that each transporter subunit contains a unique hydrophobic but occluded central pore, but it is unclear whether the base (NH3) or NH3 coupled with an H+ are transported. Here, using expression of two plant AMTs (AtAMT1;2 and AMT2) in budding yeast, we found that systematic replacements in the conserved twin-histidine motif, a hallmark of most AMT/Mep/Rh, alter substrate recognition, transport capacities, N isotope selection, and selectivity against K+. AMT-specific differences were found for histidine variants. Variants that completely lost ammonium N isotope selection, a feature likely associated with NH4+ deprotonation during passage, substantially transported K+ in addition to NH4+. Of note, the twin-histidine motif was not essential for ammonium transport. However, it conferred key AMT features, such as high substrate affinity and selectivity against alkali cations via an NH4 + deprotonation mechanism. Our findings indicate that the twin-His motif is the core structure responsible for substrate deprotonation and isotopic preferences in AMT pores and that decreased deprotonation capacity is associated with reduced selectivity against K+. We conclude that optimization for ammonium transport in plant AMT represents a compromise between substrate deprotonation for optimal selectivity and high substrate affinity and transport rates.	[Ganz, Pascal; Ijato, Toyosi; Porras-Murillo, Romano; Ludewig, Uwe; Neuhaeuser, Benjamin] Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany; [Stuehrwohldt, Nils] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Neuhauser, B (corresponding author), Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany.	benjamin.neuhaeuser@uni-hohenheim.de		Stuhrwohldt, Nils/0000-0003-4166-3786; Neuhauser, Benjamin/0000-0002-2391-0598; Porras-Murillo, Romano/0000-0002-3934-2206	University of Hohenheim; DFG [NE 1727/2-2]	University of Hohenheim; DFG(German Research Foundation (DFG))	We thank D. Schnell for technical experimental assistance, Dr. W. Armbruster for isotope analysis, Dr. F. Rubio (Murcia, Spain) for the W Delta 3 yeast strain, and Dr. M. Dynowski for help with the AtAMT1;2 model. Work in the laboratory was partially funded by the University of Hohenheim and the DFG (NE 1727/2-2).	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Ariz I, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3599; Bindel N, 2019, 820712 BIORXIV, DOI 10.1101/820712; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FINDENEGG GR, 1987, PLANT SOIL, V103, P239, DOI 10.1007/BF02370395; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Ganz P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53333-9; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Hall JA, 2013, J BIOL CHEM, V288, P14080, DOI 10.1074/jbc.M113.457952; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Haro R, 1999, MOL MICROBIOL, V31, P511, DOI 10.1046/j.1365-2958.1999.01192.x; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEINER D, 1981, BIOCHIM BIOPHYS ACTA, V639, P41, DOI 10.1016/0304-4173(81)90004-5; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ludewlg U, 2007, FEBS LETT, V581, P2301, DOI 10.1016/j.febslet.2007.03.034; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Mirandela GD, 2019, FASEB J, V33, P1989, DOI 10.1096/fj.201800782R; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Neuhauser B, 2014, CHANNELS, V8, P496, DOI 10.4161/19336950.2014.967618; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Palffy A, 2010, CONTEMP PHYS, V51, P471, DOI 10.1080/00107514.2010.493325; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; RODRIGUEZNAVARRO A, 1986, J GEN PHYSIOL, V87, P649, DOI 10.1085/jgp.87.5.649; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; van den Berg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11337; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	40	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3362	3370		10.1074/jbc.RA119.010891	http://dx.doi.org/10.1074/jbc.RA119.010891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988244	Green Published, hybrid			2022-12-28	WOS:000519597300037
J	Murakami, C; Hoshino, F; Sakai, H; Hayashi, Y; Yamashita, A; Sakane, F				Murakami, Chiaki; Hoshino, Fumi; Sakai, Hiromichi; Hayashi, Yasuhiro; Yamashita, Atsushi; Sakane, Fumio			Diacylglycerol kinase ? and sphingomyelin synthase?related protein functionally interact via their sterile ? motif domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol kinase (DGK; DAGK); diacylglycerol; phosphatidic acid; dimerization; phosphatidylethanolamine; lipid signaling; metabolism; signal transduction; second messenger; heterodimer; sphingomyelin synthase-related protein; sterile ? motif domain	MULTIPLE SEQUENCE ALIGNMENT; SAM DOMAIN; PHOSPHATIDIC-ACID; C ACTIVITY; DELTA; CERAMIDE; INSULIN; ACTIVATION; LOCALIZATION; EXPRESSION	The ? isozyme of diacylglycerol kinase (DGK?) plays critical roles in lipid signaling by converting diacylglycerol (DG) to phosphatidic acid (PA). We previously demonstrated that DGK? preferably phosphorylates palmitic acid (16:0)- and/or palmitoleic acid (16:1)-containing DG molecular species, but not arachidonic acid (20:4)-containing DG species, which are recognized as DGK substrates derived from phosphatidylinositol turnover, in high glucose-stimulated myoblasts. However, little is known about the origin of these DG molecular species. DGK? and two DG-generating enzymes, sphingomyelin synthase (SMS) 1 and SMS-related protein (SMSr), contain a sterile ? motif domain (SAMD). In this study, we found that SMSr?SAMD, but not SMS1?SAMD, co-immunoprecipitates with DGK??SAMD. Full-length DGK? co-precipitated with full-length SMSr more strongly than with SMS1. However, SAMD-deleted variants of SMSr and DGK? interacted only weakly with full-length DGK? and SMSr, respectively. These results strongly suggested that DGK? interacts with SMSr through their respective SAMDs. To determine the functional outcomes of the relationship between DGK? and SMSr, we used LC-MS/MS to investigate whether overexpression of DGK? and/or SMSr in COS-7 cells alters the levels of PA species. We found that SMSr overexpression significantly enhances the production of 16:0- or 16:1-containing PA species such as 14:0/16:0-, 16:0/16:0-, 16:0/18:1-, and/or 16:1/18:1-PA in DGK?-overexpressing COS-7 cells. Moreover, SMSr enhanced DGK? activity via their SAMDs in vitro. Taken together, these results strongly suggest that SMSr is a candidate DG-providing enzyme upstream of DGK? and that the two enzymes represent a new pathway independent of phosphatidylinositol turnover.	[Murakami, Chiaki; Hoshino, Fumi; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Sakai, Hiromichi] Shimane Univ, Org Res & Acad Informat, Interdisciplinary Ctr Sci Res, Dept Biosignaling & Radioisotope Expt, Izumo, Shimane 6938501, Japan; [Hayashi, Yasuhiro; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan	Chiba University; Shimane University; Teikyo University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp	Sakane, Fumio/H-2693-2017; Murakami, Chiaki/O-2622-2016	Sakane, Fumio/0000-0003-0857-0377; Murakami, Chiaki/0000-0003-3645-8382; Hoshino, Fumi/0000-0003-4213-0631	MEXT/JSPS KAKENHI [JP18J20003, 25116704, 26291017, 17H03650, 15K14470]; Japan Science and Technology Agency [AS251Z01788Q, AS2621643Q]; Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation; SENSHIN Medical Research Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported in part by MEXT/JSPS KAKENHI Grants JP18J20003 (to C. M.) and 25116704, 26291017, 17H03650, and 15K14470 (to F. S.), Japan Science and Technology Agency Grants AS251Z01788Q and AS2621643Q (to F. S.), the Futaba Electronic Memorial Foundation (to F. S.), the Ono Medical Research Foundation (to F. S.), the Japan Foundation for Applied Enzymology (to F. S.), the Food Science Institute Foundation (to F. S.), the Skylark Food Science Institute to (F. S.), the Hamaguchi Foundation for the Advancement of Biochemistry (to F. S.), the Daiichi-Sankyo Foundation of Life Science (to F. S.), the Terumo Life Science Foundation (to F. S.), the Asahi Group Foundation (to F. S.), the Japan Milk Academic Alliance (to F. S.), the Japan Food Chemical Research Foundation (to F. S.), and the SENSHIN Medical Research Foundation (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200; Bickert A, 2015, J LIPID RES, V56, P821, DOI 10.1194/jlr.M055269; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabukusta B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41290; Cabukusta B, 2016, J BIOL CHEM, V291, P24735, DOI 10.1074/jbc.M116.749812; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fang NB, 2003, J AGR FOOD CHEM, V51, P6676, DOI 10.1021/jf034793v; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hayashi Y, 2018, J BIOL CHEM, V293, P17505, DOI 10.1074/jbc.RA118.002048; Hayashi Y, 2017, J BIOL CHEM, V292, P1122, DOI 10.1074/jbc.M116.746602; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; HEYDRICK SJ, 1991, DIABETES, V40, P1707, DOI 10.2337/diabetes.40.12.1707; Honda S, 2019, LIPIDS, V54, P763, DOI 10.1002/lipd.12201; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kol M, 2017, J LIPID RES, V58, P962, DOI 10.1194/jlr.M076133; Komenoi S, 2019, BIOCHEM BIOPHYS REP, V19, DOI 10.1016/j.bbrep.2019.100660; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Massart J, 2019, TRENDS ENDOCRIN MET, V30, P603, DOI 10.1016/j.tem.2019.06.003; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Mizuno S, 2012, FEBS OPEN BIO, V2, P267, DOI 10.1016/j.fob.2012.08.006; Murakami C, 2017, ANAL BIOCHEM, V526, P43, DOI 10.1016/j.ab.2017.03.010; Murakami E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162997; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ogushi F, 2012, CHEM PHYS LETT, V522, P96, DOI 10.1016/j.cplett.2011.11.057; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rajakulendran T, 2008, P NATL ACAD SCI USA, V105, P2836, DOI 10.1073/pnas.0709705105; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sakane Fumio, 2018, Advances in Biological Regulation, V67, P101, DOI 10.1016/j.jbior.2017.09.003; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; Sato Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1170, DOI 10.1016/j.bbapap.2016.06.012; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Takeuchi M, 2012, BBA-MOL CELL RES, V1823, P2210, DOI 10.1016/j.bbamcr.2012.08.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaki A, 2019, J CELL BIOCHEM, V120, P10043, DOI 10.1002/jcb.28288; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	52	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2932	2947		10.1074/jbc.RA119.012369	http://dx.doi.org/10.1074/jbc.RA119.012369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31980461	Green Published, hybrid			2022-12-28	WOS:000519597300006
J	Walenna, NF; Kurihara, Y; Chou, B; Ishii, K; Soejima, T; Hiromatsu, K				Walenna, Nirwana Fitriani; Kurihara, Yusuke; Chou, Bin; Ishii, Kazunari; Soejima, Toshinori; Hiromatsu, Kenji			Chlamydia pneumoniae infection?induced endoplasmic reticulum stress causes fatty acid?binding protein 4 secretion in murine adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydia; bacteria; infection; adipocyte; fatty acid binding protein; endoplasmic reticulum stress (ER stress); lipolysis; unfolded protein response (UPR); oxidative stress; metabolic disorder	ACID-BINDING PROTEIN; INTRACELLULAR GROWTH; INSULIN-RESISTANCE; RISK-FACTOR; ER STRESS; ATHEROSCLEROSIS; MECHANISMS; FABP4; AP2	Fatty acid?binding protein 4 (FABP4) is predominantly expressed in adipocytes and macrophages and regulates metabolic and inflammatory pathways. FABP4 is secreted from adipocytes during lipolysis, and elevated circulating FABP4 levels are associated with obesity, metabolic disease, and cardiac dysfunction. We previously reported that the bacterial respiratory pathogen Chlamydia pneumoniae infects murine adipocytes and exploits host FABP4 to mobilize fat and replicate within adipocytes. However, whether C. pneumoniae induces FABP4 secretion from adipocytes has not been determined. Here, we show that FABP4 is actively secreted by murine adipocytes upon C. pneumoniae infection. Chemical inhibition of lipase activity and genetic deficiency of hormone-sensitive lipase blocked FABP4 secretion from C. pneumoniae?infected adipocytes. Mechanistically, C. pneumoniae infection induced endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), resulting in elevated levels of mitochondrial reactive oxygen species and cytosolic Ca2+. Of note, exposure to a mitochondrial reactive oxygen species?specific scavenger, MitoTEMPO, reduced FABP4 release from C. pneumoniae?infected adipocytes. Furthermore, treatment with azoramide, which protects cells against ER stress, decreased FABP4 release from C. pneumoniae?infected adipocytes. Using gene silencing of CHOP (C/EBP homologous protein), a central regulator of ER stress, we further validated the role of C. pneumoniae infection?induced ER stress/UPR in promoting FABP4 secretion. Overall, these results indicate that C. pneumoniae infection robustly induces FABP4 secretion from adipocytes by stimulating ER stress/UPR. Our findings shed additional light on the etiological link between C. pneumoniae infection and metabolic syndrome.	[Walenna, Nirwana Fitriani; Kurihara, Yusuke; Chou, Bin; Ishii, Kazunari; Soejima, Toshinori; Hiromatsu, Kenji] Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka 8140180, Japan; [Walenna, Nirwana Fitriani] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Higashi Ku, Fukuoka 8128582, Japan; [Walenna, Nirwana Fitriani] Hasanuddin Univ, Fac Med, Makassar, South Sulawesi, Indonesia	Fukuoka University; Kyushu University; Universitas Hasanuddin	Hiromatsu, K (corresponding author), Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	khiromatsu@fukuoka-u.ac.jp		Walenna, Nirwana Fitriani/0000-0002-3992-5604	Japan Society for the Promotion of Science [19K166590002]; Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 19K166590002. This work was also supported in part by an Indonesia Endowment Fund for Education scholarship from Ministry of Finance of the Republic of Indonesia (to N. F. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JL, 2005, NEW ENGL J MED, V352, P1706, DOI 10.1056/NEJMe058019; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Blessing E, 2000, INFECT IMMUN, V68, P7195, DOI 10.1128/IAI.68.12.7195-7197.2000; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Campbell LA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00034; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Fernandez-Real JM, 2006, DIABETES CARE, V29, P1058, DOI 10.2337/dc05-2068; Fu SN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9134; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; George Z, 2017, J INFECT DIS, V215, P456, DOI 10.1093/infdis/jiw569; Grayston JT, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu015; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Itoh R, 2014, BIOCHEM BIOPH RES CO, V452, P689, DOI 10.1016/j.bbrc.2014.08.128; Kajimoto K, 2012, ENDOCRINOLOGY, V153, P5629, DOI 10.1210/en.2012-1456; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Kralisch S, 2014, INT J OBESITY, V38, P1251, DOI 10.1038/ijo.2013.232; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Li SS, 2015, CRIT REV MICROBIOL, V41, P150, DOI 10.3109/1040841X.2013.813899; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pillich Helena, 2016, Mol Cell Pediatr, V3, P9, DOI 10.1186/s40348-016-0037-7; Schlottmann I, 2014, INT J OBESITY, V38, P1221, DOI 10.1038/ijo.2013.241; Suzuki T, 2017, CELL REP, V18, P2045, DOI 10.1016/j.celrep.2017.01.076; Villeneuve J, 2018, J CELL BIOL, V217, P649, DOI 10.1083/jcb.201705047; Walenna NF, 2018, BIOCHEM BIOPH RES CO, V495, P353, DOI 10.1016/j.bbrc.2017.11.005; Wang CM, 2009, J INFECT DIS, V200, P279, DOI 10.1086/599796; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112	44	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2713	2723		10.1074/jbc.RA119.010683	http://dx.doi.org/10.1074/jbc.RA119.010683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31992597	hybrid, Green Published			2022-12-28	WOS:000519969100016
J	Shaheen, ZR; Stafford, JD; Voss, MG; Oleson, BJ; Stancill, JS; Corbett, JA				Shaheen, Zachary R.; Stafford, Joshua D.; Voss, Michael G.; Oleson, Bryndon J.; Stancill, Jennifer S.; Corbett, John A.			The location of sensing determines the pancreatic ?-cell response to the viral mimetic dsRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; cytokine; beta cell; pathogen-associated molecular pattern (PAMP); diabetes; dsRNA; IL-1; poly(I; C); dsRNA sensors; type I interferon; IFN response; inducible nitric oxide synthase; innate immunity; autoimmune diabetes; picornavirus	DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; PROTEIN-KINASE PKR; NITRIC-OXIDE; ENCEPHALOMYOCARDITIS-VIRUS; BETA-CELLS; RIG-I; SUBCELLULAR-LOCALIZATION; GENE-TRANSCRIPTION	Viral infection is an environmental trigger that has been suggested to initiate pancreatic ?-cell damage, leading to the development of autoimmune diabetes. Viruses potently activate the immune system and can damage ? cells by either directly infecting them or stimulating the production of secondary effector molecules (such as proinflammatory cytokines) during bystander activation. However, how and where ? cells recognize viruses is unclear, and the antiviral responses that are initiated following virus recognition are incompletely understood. In this study, we show that the ?-cell response to dsRNA, a viral replication intermediate known to activate antiviral responses, is determined by the cellular location of sensing (intracellular versus extracellular) and differs from the cellular response to cytokine treatment. Using biochemical and immunological methods, we show that ? cells selectively respond to intracellular dsRNA by expressing type I interferons (IFNs) and inducing apoptosis, but that they do not respond to extracellular dsRNA. These responses differ from the activities of cytokines on ? cells, which are mediated by inducible nitric oxide synthase expression and ?-cell production of nitric oxide. These findings provide evidence that the antiviral activities of type I IFN production and apoptosis are elicited in ? cells via the recognition of intracellular viral replication intermediates and that ? cells lack the capacity to respond to extracellular viral intermediates known to activate innate immune responses.	[Shaheen, Zachary R.; Stafford, Joshua D.; Voss, Michael G.; Oleson, Bryndon J.; Stancill, Jennifer S.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Shaheen, Zachary R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Voss, Michael G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Oleson, Bryndon J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Stancill, Jennifer/0000-0002-1612-4695	National Institutes of Health [DK-052194, AI-44458]; F30 Fellowship [DK102363-01A1]; NIGMS, National Institutes of Health [T32-GM080202]; American Heart Association [17PRE32530001, 14PRE20380585]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F30 Fellowship; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C.); F30 Fellowship DK102363-01A1 (to Z. R. S.); NIGMS, National Institutes of Health, Training Grant T32-GM080202 (to Z. R. S.); and American Heart Association Grants 17PRE32530001 (to J. D. S.) and 14PRE20380585 (to B. J. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arnush M, 1998, J IMMUNOL, V160, P2684; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Broniowska KA, 2014, VITAM HORM, V95, P299, DOI 10.1016/B978-0-12-800174-5.00012-0; Carocci M, 2011, J VIROL, V85, P10741, DOI 10.1128/JVI.00394-11; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; Christmann BS, 2011, AM J PATHOL, V179, P2941, DOI 10.1016/j.ajpath.2011.08.012; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GOLD R, 1994, LAB INVEST, V71, P219; GORCZYCA W, 1993, LEUKEMIA, V7, P659; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Groppo R, 2007, J VIROL, V81, P13067, DOI 10.1128/JVI.00185-07; Groppo R, 2011, VIROLOGY, V410, P257, DOI 10.1016/j.virol.2010.11.002; Hato SV, 2007, CELL MICROBIOL, V9, P2921, DOI 10.1111/j.1462-5822.2007.01006.x; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Iordanov MS, 2001, MOL CELL BIOL, V21, P61, DOI 10.1128/MCB.21.1.61-72.2001; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jaeckel E, 2002, ANN NY ACAD SCI, V958, P7; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KAUFMAN DL, 1992, J CLIN INVEST, V89, P283, DOI 10.1172/JCI115573; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LACY PE, 1991, AM J PATHOL, V138, P1183; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Moran JM, 2005, J VIROL, V79, P10226, DOI 10.1128/JVI.79.16.10226-10236.2005; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Oleson BJ, 2018, ANTIOXID REDOX SIGN, V29, P1432, DOI 10.1089/ars.2017.7351; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Pham AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005489; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Romanova LI, 2009, J VIROL, V83, P7273, DOI 10.1128/JVI.00467-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shaheen ZR, 2019, AM J PHYSIOL-REG I, V316, pR525, DOI 10.1152/ajpregu.00019.2019; Shaheen ZR, 2015, BIOMOLECULES, V5, P1938, DOI 10.3390/biom5031938; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; VERGE CF, 1995, DIABETES, V44, P1176, DOI 10.2337/diabetes.44.10.1176; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoon JW, 2006, ANN NY ACAD SCI, V1079, P138, DOI 10.1196/annals.1375.021; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	77	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2385	2397		10.1074/jbc.RA119.010267	http://dx.doi.org/10.1074/jbc.RA119.010267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31915247	hybrid, Green Published			2022-12-28	WOS:000517330200020
J	Liang, YJ; Lu, XF				Liang, Yajing; Lu, Xuefeng			Structural insights into the catalytic mechanism of lovastatin hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; substrate specificity; protein engineering; carboxylesterase; polyketide; cholesterol-lowering drug; lovastatin hydrolase; monacolin J; simvastatin	SIMVASTATIN; ESTERASE; ENZYMES	The lovastatin hydrolase PcEST from the fungus Penicillium chrysogenum exhibits enormous potential for industrial-scale applications in single-step production of monacolin J, the key precursor for synthesis of the cholesterol-lowering drug simvastatin. This enzyme specifically and efficiently catalyzes the conversion of lovastatin to monacolin J but cannot hydrolyze simvastatin. Understanding the catalytic mechanism and the structure?function relationship of PcEST is therefore important for further lovastatin hydrolase screening, engineering, and commercial applications. Here, we solved four X-ray crystal structures, including apo PcEST (2.3 ?), PcEST in complex with monacolin J (2.48 ?), PcEST complexed with the substrate analog simvastatin (2.4 ?), and an inactivated PcEST variant (S57A) with the lovastatin substrate (2.3 ?). Structure-based biochemical analyses and mutagenesis assays revealed that the Ser(57) (nucleophile)?Tyr(170) (general base)?Lys(60) (general acid) catalytic triad, the hydrogen-bond network (Trp(344) and Tyr(127)) around the active site, and the specific substrate-binding tunnel together determine efficient and specific lovastatin hydrolysis by PcEST. Moreover, steric effects on nucleophilic attack caused by the 2?,2-dimethybutyryl group of simvastatin resulted in no activity of PcEST on simvastatin. On the basis of structural comparisons, we propose several indicators to define lovastatin esterases. Furthermore, using structure-guided enzyme engineering, we developed a PcEST variant, D106A, having improved solubility and thermostability, suggesting a promising application of this variant in industrial processes. To our knowledge, this is the first report describing the mechanism and structure?function relationship of lovastatin hydrolase and providing insights that may guide rapid screening and engineering of additional lovastatin esterase variants.	[Liang, Yajing; Lu, Xuefeng] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao 266101, Peoples R China; [Liang, Yajing; Lu, Xuefeng] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Peoples R China; [Lu, Xuefeng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266003, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Qingdao National Laboratory for Marine Science & Technology	Lu, XF (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, 189 Songling Rd, Qingdao 266101, Peoples R China.	lvxf@qibebt.ac.cn			National Natural Science Foundation of China [31700051]; Natural Science Foundation of Shandong Province [ZR2017BC065]; Science and Technology Service Network Initiative of the Chinese Academy of Sciences [KFJ-STS-ZDTP-031]; Shandong Taishan Scholarship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Service Network Initiative of the Chinese Academy of Sciences; Shandong Taishan Scholarship	This work was supported by National Natural Science Foundation of China Grant 31700051 (to Y. L.), Natural Science Foundation of Shandong Province Grant ZR2017BC065 (to Y. L.), Science and Technology Service Network Initiative of the Chinese Academy of Sciences Grant KFJ-STS-ZDTP-031, and a Shandong Taishan Scholarship (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Cha SS, 2016, BIOCHEM BIOPH RES CO, V478, P818, DOI 10.1016/j.bbrc.2016.08.031; Cha SS, 2013, PROTEINS, V81, P2045, DOI 10.1002/prot.24334; Chen LC, 2006, ENZYME MICROB TECH, V39, P1051, DOI 10.1016/j.enzmictec.2006.02.018; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102423; Gao X, 2009, CHEM BIOL, V16, P1064, DOI 10.1016/j.chembiol.2009.09.017; HOFFMAN WF, 1986, J MED CHEM, V29, P849, DOI 10.1021/jm00155a040; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang XN, 2017, METAB ENG, V42, P109, DOI 10.1016/j.ymben.2017.06.005; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; Liang B, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201800094; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morgan B., 2004, U. S. Patent, Patent No. 20080182303; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schimmel TG, 1997, APPL ENVIRON MICROB, V63, P1307, DOI 10.1128/AEM.63.4.1307-1311.1997; Wagner UG, 2002, PROTEIN SCI, V11, P467, DOI 10.1110/ps.33002; Xie XK, 2007, APPL ENVIRON MICROB, V73, P2054, DOI 10.1128/AEM.02820-06; Xie XK, 2006, CHEM BIOL, V13, P1161, DOI 10.1016/j.chembiol.2006.09.008; Yainoy S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061269	27	2	3	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1047	1055		10.1074/jbc.RA119.011936	http://dx.doi.org/10.1074/jbc.RA119.011936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31839596	Green Published, Bronze			2022-12-28	WOS:000509949300013
J	Hosford, CJ; Bui, AQ; Chappie, JS				Hosford, Christopher J.; Bui, Anthony Q.; Chappie, Joshua S.			The structure of the Thermococcus gammatolerans McrB N-terminal domain reveals a new mode of substrate recognition and specificity among McrB homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; DNA binding protein; protein-nucleic acid interaction; protein structure; RNA-protein interaction; structural biology; 6-methyladenosine; DNA binding; McrB; restriction system; YTH domain	RESTRICTION ENZYME MCRBC; YTH DOMAIN; M(6)A RNA; DNA; ENDONUCLEASE; BINDING; COMPLEX; RESOLUTION; MECHANISM; CLEAVAGE	McrBC is a two-component, modification-dependent restriction system that cleaves foreign DNA-containing methylated cytosines. Previous crystallographic studies have shown that Escherichia coli McrB uses a base-flipping mechanism to recognize these modified substrates with high affinity. The side chains stabilizing both the flipped base and the distorted duplex are poorly conserved among McrB homologs, suggesting that other mechanisms may exist for binding modified DNA. Here we present the structures of the Thermococcus gammatolerans McrB DNA-binding domain (Tg?185) both alone and in complex with a methylated DNA substrate at 1.68 and 2.27 ? resolution, respectively. The structures reveal that Tg?185 consists of a YT521-B homology (YTH) domain, which is commonly found in eukaryotic proteins that bind methylated RNA and is structurally unrelated to the E. coli McrB DNA-binding domain. Structural superposition and co-crystallization further show that Tg?185 shares a conserved aromatic cage with other YTH domains, which forms the binding pocket for a flipped-out base. Mutational analysis of this aromatic cage supports its role in conferring specificity for the methylated adenines, whereas an extended basic surface present in Tg?185 facilitates its preferential binding to duplex DNA rather than RNA. Together, these findings establish a new binding mode and specificity among McrB homologs and expand the biological roles of YTH domains.	[Hosford, Christopher J.; Bui, Anthony Q.; Chappie, Joshua S.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Chappie, JS (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	chappie@cornell.edu	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Bui, Anthony/0000-0002-6470-6294; Hosford, Christopher/0000-0001-5756-6505	Department of Energy Office of Science [DE-AC02-06CH11357]	Department of Energy Office of Science(United States Department of Energy (DOE))	We thank Dr. Eric Alani and Carol Manhart for advice and assistance with filter-binding assays, Drs. Eric Alani and Chris Fromme for critical reading of the manuscript, and the Northeastern Collaborative Access Team beamline staff at the Advanced Photon Source for assistance with remote X-ray data collection. Weadditionally thank Dr. Frederick Dyda for the generous use of a rotating anode home source for preliminary X-ray diffraction studies and cryo-protection optimization. This work used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; Arnold HP, 2000, VIROLOGY, V272, P409, DOI 10.1006/viro.2000.0375; Bair CL, 2007, J MOL BIOL, V366, P768, DOI 10.1016/j.jmb.2006.11.051; Baranyi U, 2000, MOL MICROBIOL, V35, P1168, DOI 10.1046/j.1365-2958.2000.01786.x; Borgaro JG, 2013, NUCLEIC ACIDS RES, V41, P4198, DOI 10.1093/nar/gkt102; Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2; Burman RW, 1999, AM J HUM GENET, V65, P1375, DOI 10.1086/302628; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Chen K, 2016, CELL CHEM BIOL, V23, P74, DOI 10.1016/j.chembiol.2015.11.007; Chotai KA, 1998, J MED GENET, V35, P472, DOI 10.1136/jmg.35.6.472; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gast FU, 1997, BIOL CHEM, V378, P975, DOI 10.1515/bchm.1997.378.9.975; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; HILL C, 1991, J BACTERIOL, V173, P4363, DOI 10.1128/JB.173.14.4363-4370.1991; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosford CJ, 2018, J BIOL CHEM, V293, P11758, DOI 10.1074/jbc.RA118.001888; Ishikawa K, 2010, DNA RES, V17, P325, DOI 10.1093/dnares/dsq027; JENTSCH S, 1983, J BACTERIOL, V156, P800, DOI 10.1128/JB.156.2.800-808.1983; Jolivet E, 2003, INT J SYST EVOL MICR, V53, P847, DOI 10.1099/ijs.0.02503-0; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Liao SH, 2018, GENOM PROTEOM BIOINF, V16, P99, DOI 10.1016/j.gpb.2018.04.002; Liu K, 2016, CURR PROTEIN PEPT SC, V17, P306, DOI 10.2174/1389203716666150901113553; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Luo GZ, 2017, NAT STRUCT MOL BIOL, V24, P503, DOI 10.1038/nsmb.3412; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; LURIA SE, 1952, J BACTERIOL, V64, P557, DOI 10.1128/JB.64.4.557-569.1952; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mullins EA, 2019, TRENDS BIOCHEM SCI, V44, P765, DOI 10.1016/j.tibs.2019.04.006; O'Driscoll J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-40; Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894; Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210; Papoulas O, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1208s36; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5236, DOI 10.1021/bi0156862; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Pieper U, 1999, J MOL BIOL, V292, P547, DOI 10.1006/jmbi.1999.3103; Pieper U, 1999, BIOL CHEM, V380, P1225, DOI 10.1515/BC.1999.155; Santoso B, 2000, J BIOL CHEM, V275, P1952, DOI 10.1074/jbc.275.3.1952; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Swiercz JP, 2013, NUCLEIC ACIDS RES, V41, P4171, DOI 10.1093/nar/gkt095; Szwagierczak A, 2011, NUCLEIC ACIDS RES, V39, P5149, DOI 10.1093/nar/gkr118; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang CY, 2016, NUCLEIC ACIDS RES, V44, P969, DOI 10.1093/nar/gkv1382; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Witte A, 1997, MOL MICROBIOL, V23, P603, DOI 10.1046/j.1365-2958.1997.d01-1879.x; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xu C, 2015, J BIOL CHEM, V290, P24902, DOI 10.1074/jbc.M115.680389; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Zagorskaite E, 2018, FEBS LETT, V592, P3335, DOI 10.1002/1873-3468.13244; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhao YL, 2019, MOL BIOTECHNOL, V61, P355, DOI 10.1007/s12033-018-00149-z; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	70	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					743	756		10.1074/jbc.RA119.010188	http://dx.doi.org/10.1074/jbc.RA119.010188			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31822563	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000508382900007
J	Sorensen, AB; Tuneew, I; Svensson, LA; Persson, E; Ostergaard, H; Overgaard, MT; Olsen, OH; Gandhi, PS				Sorensen, Anders B.; Tuneew, Inga; Svensson, L. Anders; Persson, Egon; Ostergaard, Henrik; Overgaard, Michael Toft; Olsen, Ole H.; Gandhi, Prafull S.			Beating tissue factor at its own game: Design and properties of a soluble tissue factor?independent coagulation factor VIIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; tissue factor; coagulation factor; trypsin; protein engineering; allosteric regulation; X-ray crystallography; inflammation; blood clotting; cofactor	ENHANCED CATALYTIC ACTIVITY; ACTIVE-SITE; ALLOSTERIC ACTIVATION; MEMBRANE-SURFACE; FACTOR-X; BINDING; COMPLEX; EXOSITE; ACID; LOOP	Two decades of research have uncovered the mechanism by which the complex of tissue factor (TF) and the plasma serine protease factor VIIa (FVIIa) mediates the initiation of blood coagulation. Membrane-anchored TF directly interacts with substrates and induces allosteric effects in the protease domain of FVIIa. These properties are also recapitulated by the soluble ectodomain of TF (sTF). At least two interdependent allosteric activation pathways originate at the FVIIa:sTF interface are proposed to enhance FVIIa activity upon sTF binding. Here, we sought to engineer an sTF-independent FVIIa variant by stabilizing both proposed pathways, with one pathway terminating at segment 215?217 in the activation domain and the other pathway terminating at the N terminus insertion site. To stabilize segment 215?217, we replaced the flexible 170 loop of FVIIa with the more rigid 170 loop from trypsin and combined it with an L163V substitution (FVIIa-VYT). The FVIIa-VYT variant exhibited 60-fold higher amidolytic activity than FVIIa, and displayed similar FX activation and antithrombin inhibition kinetics to the FVIIa.sTF complex. The sTF-independent activity of FVIIa-VYT was partly mediated by an increase in the N terminus insertion and, as shown by X-ray crystallography, partly by Tyr-172 inserting into a cavity in the activation domain stabilizing the S1 substrate-binding pocket. The combination with L163V likely drove additional changes in a delicate hydrogen-bonding network that further stabilized S1?S3 sites. In summary, we report the first FVIIa variant that is catalytically independent of sTF and provide evidence supporting the existence of two TF-mediated allosteric activation pathways.	[Sorensen, Anders B.; Tuneew, Inga; Svensson, L. Anders; Persson, Egon; Ostergaard, Henrik; Olsen, Ole H.; Gandhi, Prafull S.] Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark; [Sorensen, Anders B.; Overgaard, Michael Toft] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Olsen, Ole H.] Univ Copenhagen, Sect Metab Receptol, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark	Novo Nordisk; Aalborg University; Novo Nordisk Foundation; University of Copenhagen	Gandhi, PS (corresponding author), Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark.; Sorensen, AB (corresponding author), Evaxion Biotech, Bredgade 34E, DK-1260 Copenhagen K, Denmark.	abs@evaxion-biotech.com; pgan@novonordisk.com	Overgaard, Michael Toft/E-1354-2011	Overgaard, Michael Toft/0000-0002-1423-2481; Tuneew, Inga/0000-0002-8258-3857	Danish Agency for Science, Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program; Obelske Family Foundation	Danish Agency for Science, Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program; Obelske Family Foundation	Supported by grants from the Danish Agency for Science, Technology and Innovation and the Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program.; Supported by a grant from the Obelske Family Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Bjelke JR, 2007, FEBS LETT, V581, P71, DOI 10.1016/j.febslet.2006.11.079; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; Butenas S, 2009, ARTERIOSCL THROM VAS, V29, P1989, DOI 10.1161/ATVBAHA.108.177402; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freskgard PO, 1998, BIOCHEMISTRY-US, V37, P7203, DOI 10.1021/bi972847m; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; Hedner U, 2011, HAEMOPHILIA, V17, pE172, DOI 10.1111/j.1365-2516.2010.02352.x; Hedner U, 2015, BLOOD REV, V29, pS4, DOI 10.1016/S0268-960X(15)30002-3; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KELLEY RF, 1995, BIOCHEMISTRY-US, V34, P10383, DOI 10.1021/bi00033a009; Kirchhofer D, 2000, BIOCHEMISTRY-US, V39, P7380, DOI 10.1021/bi000182+; Larsen KS, 2010, J BIOL CHEM, V285, P19959, DOI 10.1074/jbc.M110.101030; Lee CJ, 2010, THROMB RES, V125, pS7, DOI 10.1016/j.thromres.2010.01.022; Lentz SR, 2014, J THROMB HAEMOST, V12, P1244, DOI 10.1111/jth.12634; Madsen JJ, 2015, J THROMB HAEMOST, V13, P262, DOI 10.1111/jth.12791; MANN KG, 1990, BLOOD, V76, P1; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; McCallum CD, 1997, J BIOL CHEM, V272, P30160, DOI 10.1074/jbc.272.48.30160; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISSEY JH, 1993, BLOOD, V81, P734; Nielsen AL, 2017, P NATL ACAD SCI USA, V114, P12454, DOI 10.1073/pnas.1618713114; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2002, EUR J BIOCHEM, V269, P5950, DOI 10.1046/j.1432-1033.2002.03323.x; PERSSON E, 1995, EUR J BIOCHEM, V234, P293, DOI 10.1111/j.1432-1033.1995.293_c.x; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, J BIOL CHEM, V276, P29195, DOI 10.1074/jbc.M102187200; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 2012, SEMIN THROMB HEMOST, V38, P274, DOI 10.1055/s-0032-1302442; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; Persson E, 2009, FEBS J, V276, P3099, DOI 10.1111/j.1742-4658.2009.07028.x; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Petrovan RJ, 2001, J BIOL CHEM, V276, P6616, DOI 10.1074/jbc.M004726200; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; RUF W, 1994, BIOCHEMISTRY-US, V33, P11631, DOI 10.1021/bi00204a026; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Soejima K, 2002, J BIOL CHEM, V277, P49027, DOI 10.1074/jbc.M203091200; Soejima K, 2001, J BIOL CHEM, V276, P17229, DOI 10.1074/jbc.M009206200; Song HJ, 2014, J BIOL CHEM, V289, P35388, DOI 10.1074/jbc.M114.614297; Sorensen AB, 2016, J BIOL CHEM, V291, P4671, DOI 10.1074/jbc.M115.698613; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734	60	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					517	528		10.1074/jbc.RA119.009183	http://dx.doi.org/10.1074/jbc.RA119.009183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31801825	Green Published, hybrid			2022-12-28	WOS:000507373600020
J	Kam, A; Loo, S; Fan, JS; Sze, SK; Yang, DW; Tam, JP				Kam, Antony; Loo, Shining; Fan, Jing-Song; Sze, Siu Kwan; Yang, Daiwen; Tam, James P.			Roseltide rT7 is a disulfide-rich, anionic, and cell-penetrating peptide that inhibits proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; cell-penetrating peptide (CPP); peptides; peptide chemical synthesis; enzyme inhibitor; protease inhibitor; structure-function; natural product; drug discovery; drug action; cystine-knot peptide; Hibiscus sabdariffa; plant peptide; proteasome inhibitor; roseltide rT7	NF-KAPPA-B; CRYSTAL-STRUCTURE; 20S PROTEASOME; KNOT; SYSTEM; ACTIVATION; EXPRESSION; PROTEIN; ICAM-1; EPOXOMICIN	Disulfide-rich plant peptides with molecular masses of 2?6 kDa represent an expanding class of peptidyl-type natural products with diverse functions. They are structurally compact, hyperstable, and underexplored as cell-penetrating agents that inhibit intracellular functions. Here, we report the discovery of an anionic, 34-residue peptide, the disulfide-rich roseltide rT7 from Hibiscus sabdariffa (of the Malvaceae family) that penetrates cells and inhibits their proteasomal activities. Combined proteomics and NMR spectroscopy revealed that roseltide rT7 is a cystine-knotted, six-cysteine hevein-like cysteine-rich peptide. A pair-wise comparison indicated that roseltide rT7 is >100-fold more stable against protease degradation than its S-alkylated analog. Confocal microscopy studies and cell-based assays disclosed that after roseltide rT7 penetrates cells, it causes accumulation of ubiquitinated proteins, inhibits human 20S proteasomes, reduces tumor necrosis factor-induced I?B? degradation, and decreases expression levels of intercellular adhesion molecule-1. Structure-activity studies revealed that roseltide rT7 uses a canonical substrate-binding mechanism for proteasomal inhibition enabled by an IIML motif embedded in its proline-rich and exceptionally long intercysteine loop 4. Taken together, our results provide mechanistic insights into a novel disulfide-rich, anionic, and cell-penetrating peptide, representing a potential lead for further development as a proteasomal inhibitor in anti-cancer or anti-inflammatory therapies.	[Kam, Antony; Loo, Shining; Sze, Siu Kwan; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Fan, Jing-Song; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	JPTam@ntu.edu.sg	Sze, Siu Kwan/AAO-3342-2020; Tam, James P/A-2176-2011; yang, daiwen/H-8408-2012; LOO, Shining/AAT-2864-2021	Sze, Siu Kwan/0000-0002-5652-1687; Tam, James P/0000-0003-4433-198X; yang, daiwen/0000-0002-6804-0071; LOO, Shining/0000-0002-2220-8297; Kam, Antony/0000-0003-2155-6887	Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC); AcRF Tier 3 funding [MOE2016-T3-1-003]	Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC)(Nanyang Technological University); AcRF Tier 3 funding	This work was supported in part by Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC) and AcRF Tier 3 funding Grant MOE2016-T3-1-003. The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Bax M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060581; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Bundy RE, 2005, ANTIOXID REDOX SIGN, V7, P14, DOI 10.1089/ars.2005.7.14; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Gao XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35179; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; Grawert MA, 2012, CHEM COMMUN, V48, P1364, DOI 10.1039/c1cc15273d; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; HANADA M, 1992, J ANTIBIOT, V45, P1746, DOI 10.7164/antibiotics.45.1746; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Huber EM, 2015, J AM CHEM SOC, V137, P7835, DOI 10.1021/jacs.5b03688; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Jha D, 2011, BIOCONJUGATE CHEM, V22, P319, DOI 10.1021/bc100045s; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kam A, 2019, J BIOL CHEM, V294, P4000, DOI 10.1074/jbc.RA118.006693; Kam A, 2014, INT J CARDIOL, V171, P231, DOI 10.1016/j.ijcard.2013.12.020; Kim KB, 1999, BIOORG MED CHEM LETT, V9, P3335, DOI 10.1016/S0960-894X(99)00612-5; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo SN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02162; Loo SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep39401; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Molesini B, 2017, BRIT J CLIN PHARMACO, V83, P63, DOI 10.1111/bcp.12932; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Northfield SE, 2014, EUR J MED CHEM, V77, P248, DOI 10.1016/j.ejmech.2014.03.011; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Pai P. P., 2017, TOXINS DRUG DISCOVER; Peraro L, 2018, ANGEW CHEM INT EDIT, V57, P11868, DOI 10.1002/anie.201801361; Pereira AR, 2012, CHEMBIOCHEM, V13, P810, DOI 10.1002/cbic.201200007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Nguyen QT, 2015, J BIOL CHEM, V290, P31138, DOI 10.1074/jbc.M115.654855; Riaz G, 2018, BIOMED PHARMACOTHER, V102, P575, DOI 10.1016/j.biopha.2018.03.023; Richardson Paul G, 2003, Cancer Control, V10, P361; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Tam JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33894-x; Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859; Winter MB, 2017, ELIFE, V6, DOI 10.7554/eLife.27364; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Yabe K, 2009, J BIOCHEM, V145, P217, DOI 10.1093/jb/mvn160; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	72	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19604	19615		10.1074/jbc.RA119.010796	http://dx.doi.org/10.1074/jbc.RA119.010796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727740	hybrid, Green Published			2022-12-28	WOS:000504093200013
J	Takayanagi, H; Hayase, J; Kamakura, S; Miyano, K; Chishiki, K; Yuzawa, S; Sumimoto, H				Takayanagi, Hiroki; Hayase, Junya; Kamakura, Sachiko; Miyano, Kei; Chishiki, Kanako; Yuzawa, Satoru; Sumimoto, Hideki			Intramolecular interaction in LGN, an adaptor protein that regulates mitotic spindle orientation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; cell division; cytoskeleton; G protein; mitosis; protein conformation; protein domain; protein motif; protein-protein interaction; nuclear mitotic apparatus protein (NuMA)	ASYMMETRIC CELL-DIVISION; STRUCTURAL BASIS; CORTICAL DYNEIN; GOLOCO MOTIF; NUMA; POLARITY; BINDING; CHROMOSOME; POSITION; MITOSIS	Proper mitotic spindle orientation requires that astral microtubules are connected to the cell cortex by the microtubule-binding protein NuMA, which is recruited from the cytoplasm. Cortical recruitment of NuMA is at least partially mediated via direct binding to the adaptor protein LGN. LGN normally adopts a closed conformation via an intramolecular interaction between its N-terminal NuMA-binding domain and its C-terminal region that contains four GoLoco (GL) motifs, each capable of binding to the membrane-anchored G?(i) subunit of heterotrimeric G protein. Here we show that the intramolecular association with the N-terminal domain in LGN involves GL3, GL4, and a region between GL2 and GL3, whereas GL1 and GL2 do not play a major role. This conformation renders GL1 but not the other GL motifs in a state easily accessible to G?(i). To interact with full-length LGN in a closed state, NuMA requires the presence of G?(i); both NuMA and G?(i) are essential for cortical recruitment of LGN in mitotic cells. In contrast, mInsc, a protein that competes with NuMA for binding to LGN and regulates mitotic spindle orientation in asymmetric cell division, efficiently binds to full-length LGN without G?(i) and induces its conformational change, enhancing its association with G?(i). In nonpolarized symmetrically dividing HeLa cells, disruption of the LGN?NuMA interaction by ectopic expression of mInsc results in a loss of cortical localization of NuMA during metaphase and anaphase and promotes mitotic spindle misorientation and a delayed anaphase progression. These findings highlight a specific role for LGN-mediated cell cortex recruitment of NuMA.	[Takayanagi, Hiroki; Hayase, Junya; Kamakura, Sachiko; Miyano, Kei; Chishiki, Kanako; Yuzawa, Satoru; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp		Yuzawa, Satoru/0000-0002-1031-5781	Ministry of Education, Culture, Sports, Science and Technology [JP26111009]; Japan Society for the Promotion of Science KAKENHI [JP18K06934]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" JP26111009 (to H. S.); and Japan Society for the Promotion of Science KAKENHI Grant JP18K06934 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bergstralh DT, 2017, DEVELOPMENT, V144, P1137, DOI 10.1242/dev.140764; Chapard C, 2014, J CELL SCI, V127, P5149, DOI 10.1242/jcs.152579; Chishiki K, 2017, GENES CELLS, V22, P293, DOI 10.1111/gtc.12477; Chishiki K, 2013, BIOCHEM BIOPH RES CO, V435, P414, DOI 10.1016/j.bbrc.2013.04.103; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Culurgioni S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03343-4; Culurgioni S, 2011, P NATL ACAD SCI USA, V108, P20998, DOI 10.1073/pnas.1113077108; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Iwakiri Y, 2013, BIOCHEM J, V451, P195, DOI 10.1042/BJ20121447; Izaki T, 2006, BIOCHEM BIOPH RES CO, V341, P1001, DOI 10.1016/j.bbrc.2006.01.050; Jia M, 2012, J BIOL CHEM, V287, P36766, DOI 10.1074/jbc.M112.391607; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kiyomitsu T, 2015, TRENDS CELL BIOL, V25, P286, DOI 10.1016/j.tcb.2014.12.003; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kotak S, 2014, EMBO J, V33, P1815, DOI 10.15252/embj.201488147; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Larson ME, 2017, MOL BIOL CELL, V28, P746, DOI 10.1091/mbc.E16-06-0355; Lazaro-Dieguez F, 2015, MOL BIOL CELL, V26, P1286, DOI 10.1091/mbc.E14-08-1330; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pan Z, 2013, STRUCTURE, V21, P1007, DOI 10.1016/j.str.2013.04.005; Pirovano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09999-w; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Seldin L, 2013, MOL BIOL CELL, V24, P3651, DOI 10.1091/mbc.E13-05-0277; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tuncay H, 2016, CELL MOL LIFE SCI, V73, P1195, DOI 10.1007/s00018-015-2116-7; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Williams SE, 2013, CURR OPIN CELL BIOL, V25, P749, DOI 10.1016/j.ceb.2013.08.003; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Zheng Z, 2014, MOL BIOL CELL, V25, P606, DOI 10.1091/mbc.E13-08-0474; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	55	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19655	19666		10.1074/jbc.RA119.011457	http://dx.doi.org/10.1074/jbc.RA119.011457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31732560	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000504093200017
J	Tripathi, A; Martinez, E; Obaidullah, AJ; Lete, MG; Lonnfors, M; Khan, D; Soni, KG; Mousley, CJ; Kellogg, GE; Bankaitis, VA				Tripathi, Ashutosh; Martinez, Elliott; Obaidullah, Ahmad J.; Lete, Marta G.; Lonnfors, Max; Khan, Danish; Soni, Krishnakant G.; Mousley, Carl J.; Kellogg, Glen E.; Bankaitis, Vytas A.			Functional Diversification of the Chemical Landscapes of Yeast Sec14-like Phosphatidylinositol Transfer Protein Lipid-Binding Cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol transfer proteins; phosphoinositide signaling; Sec14-domain; cavity mapping; squalene; sterols	SACCHAROMYCES-CEREVISIAE; POTENTIAL FUNCTIONS; METABOLISM; PHOSPHOINOSITIDES; PHOSPHOLIPIDS; BIOSYNTHESIS; DEGENERATION; PREDICTION; TRANSPORT; DOCKING	Phosphatidylinositol-transfer proteins (PITPs) are key regulators of lipid signaling in eukaryotic cells. These proteins both potentiate the activities of phosphatidylinositol (PtdIns) 4-OH kinases and help channel production of specific pools of PtdIns-4-phosphate (PtdIns4P) dedicated to specific biological outcomes. In this manner, PITPs represent a major contributor to the mechanisms by which the biological outcomes of phosphoinositide are diversified. The two-ligand priming model proposes that the engine by which Sec14-like PITPs potentiate PtdIns kinase activities is a heterotypic lipid exchange cycle where PtdIns is a common exchange substrate among the Sec14-like PITP family, but the second exchange ligand varies with the PITP. A major prediction of this model is that second-exchangeable ligand identity will vary from PITP to PITP. Thus, we used structural, computational and biochemical approaches to probe the diversities of the lipid-binding cavity microenvironments of the yeast Sec14-like PITPs. Using Sfh2 and Sfh3 as models, we demonstrate these represent PtdIns/squalene and PtdIns/ergosterol exchange proteins, respectively. The collective data report that yeast Sec14-like PITP lipid-binding pockets indeed define diverse chemical microenvironments that translate into differential ligand binding specificities across this protein family.	[Tripathi, Ashutosh; Lete, Marta G.; Lonnfors, Max; Soni, Krishnakant G.; Bankaitis, Vytas A.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Martinez, Elliott; Khan, Danish; Bankaitis, Vytas A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Obaidullah, Ahmad J.; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Obaidullah, Ahmad J.; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA; [Lonnfors, Max] Abo Akad Univ, Fac Sci & Engn, Dept Biosci, FI-20520 Turku, Finland; [Mousley, Carl J.] Curtin Univ, Fac Hlth Sci, CHIRI, Sch Biomed Sci, Bentley, WA 6102, Australia; [Bankaitis, Vytas A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Obaidullah, Ahmad J.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Virginia Commonwealth University; Virginia Commonwealth University; Abo Akademi University; Curtin University; Texas A&M University System; Texas A&M University College Station; King Saud University	Tripathi, A; Bankaitis, VA (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	tripathi@tamu.edu; vytas@tamu.edu	Lete, Marta G/C-3960-2017; OBAIDULLAH, AHMAD J./GQI-4663-2022; KHAN, DANISH/AAN-2493-2021; OBAIDULLAH, AHMAD JOMAH/ABD-2825-2020	Lete, Marta G/0000-0002-9654-7881; OBAIDULLAH, AHMAD J./0000-0002-7532-6318; KHAN, DANISH/0000-0002-0650-3990; bankaitis, vytas/0000-0002-1654-6759; Mousley, Carl/0000-0002-0192-7030	National Institutes of Health [R35 GM131804]; Robert A. Welch Foundation [BE-0017]; Basque Government; Sigrid Juselius Foundation; King Saud University; Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Basque Government(Basque Government); Sigrid Juselius Foundation(Sigrid Juselius Foundation); King Saud University(King Saud University); Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R35 GM131804 from the National Institutes of Health and BE-0017 from the Robert A. Welch Foundation to VAB. MGL and ML were supported by postdoctoral fellowships from the Basque Government and the Sigrid Juselius Foundation, respectively. A. J. O. acknowledges King Saud University for support of his graduate studies at Virginia Commonwealth University. The Laboratory for Molecular Simulation and High Performance Research Computing at Texas A&M University provided software, support, and computer time. We thank Kaitlyn McGrath for help with lipid transfer assays, and Pentti Somerharju (Helsinki) and J. Peter Slotte (Turku) for their generous gifts of fluorescent lipids.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alb JG, 2007, J LIPID RES, V48, P1857, DOI 10.1194/jlr.M700145-JLR200; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; [Anonymous], 2018, MOL OP ENV MOE; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Cha MK, 2003, J BIOL CHEM, V278, P34952, DOI 10.1074/jbc.M301819200; Christen M, 2015, J STRUCT BIOL, V190, P261, DOI 10.1016/j.jsb.2015.05.001; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Desfougeres T, 2008, BIOCHEM J, V409, P299, DOI 10.1042/BJ20071028; Ghosh R, 2015, MOL BIOL CELL, V26, P1764, DOI 10.1091/mbc.E14-10-1475; Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011; GORDESKY SE, 1973, BIOCHEM BIOPH RES CO, V50, P1027, DOI 10.1016/0006-291X(73)91509-X; Grabon A, 2015, BBA-MOL CELL BIOL L, V1851, P724, DOI 10.1016/j.bbalip.2014.12.011; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hoffman CS, 2015, GENETICS, V201, P403, DOI 10.1534/genetics.115.181503; Holic R, 2014, BBA-MOL CELL BIOL L, V1841, P1483, DOI 10.1016/j.bbalip.2014.07.014; Huang J, 2018, DEV CELL, V44, P378, DOI 10.1016/j.devcel.2017.12.026; Huang J, 2016, MOL BIOL CELL, V27, P2317, DOI 10.1091/mbc.E16-04-0221; Ile KE, 2010, TRAFFIC, V11, P1151, DOI 10.1111/j.1600-0854.2010.01085.x; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Khan D, 2016, J LIPID RES, V57, P650, DOI 10.1194/jlr.M066381; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Liebeschuetz JW, 2012, J COMPUT AID MOL DES, V26, P737, DOI 10.1007/s10822-012-9551-4; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Regnacq M, 2002, FEMS MICROBIOL LETT, V216, P165, DOI 10.1016/S0378-1097(02)01034-0; Ren JH, 2014, MOL BIOL CELL, V25, P712, DOI 10.1091/mbc.E13-11-0634; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2011, MOL BIOL CELL, V22, P892, DOI 10.1091/mbc.E10-11-0903; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SOMERHARJU P, 1982, CHEM PHYS LIPIDS, V30, P81, DOI 10.1016/0009-3084(82)90009-3; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Tripathi A, 2011, METHODS MOL BIOL, V716, P39, DOI 10.1007/978-1-61779-012-6_3; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Yang H, 2013, FEBS LETT, V587, P1610, DOI 10.1016/j.febslet.2013.04.009	55	5	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19081	19098		10.1074/jbc.RA119.011153	http://dx.doi.org/10.1074/jbc.RA119.011153			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690622	hybrid, Green Published			2022-12-28	WOS:000516527800012
J	Grolla, AA; Miggiano, R; Di Marino, D; Bianchi, M; Gori, A; Orsomando, G; Gaudino, F; Galli, U; Del Grosso, E; Mazzola, F; Angeletti, C; Guarneri, M; Torretta, S; Calabro, M; Boumya, S; Fan, XR; Colombo, G; Travelli, C; Rocchio, F; Aronica, E; Wohlschlegel, JA; Deaglio, S; Rizzi, M; Genazzani, AA; Garavaglia, S				Grolla, Ambra A.; Miggiano, Riccardo; Di Marino, Daniele; Bianchi, Michele; Gori, Alessandro; Orsomando, Giuseppe; Gaudino, Federica; Galli, Ubaldina; Del Grosso, Erika; Mazzola, Francesca; Angeletti, Carlo; Guarneri, Martina; Torretta, Simone; Calabro, Marta; Boumya, Sara; Fan, Xiaorui; Colombo, Giorgia; Travelli, Cristina; Rocchio, Francesca; Aronica, Eleonora; Wohlschlegel, James A.; Deaglio, Silvia; Rizzi, Menico; Genazzani, Armando A.; Garavaglia, Silvia			A nicotinamide phosphoribosyltransferase?GAPDH interaction sustains the stress-induced NMN/NAD(+) salvage pathway in the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; NAMPT; melanoma; nicotinamide adenine dinucleotide (NAD); metabolism; GAPDH; NAD compartmentalization; nucleus; nicotinamide mononucleotide (NMN); protein-protein interaction; cell stress; redox cycling; NMN; NAD plus salvage pathway	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH; METABOLISM; DYNAMICS; NAD(+); INSIGHTS; COMPLEX; DEATH; NAMPT	All cells require sustained intracellular energy flux, which is driven by redox chemistry at the subcellular level. NAD(+), its phosphorylated variant NAD(P)(+), and its reduced forms NAD(P)/NAD(P)H are all redox cofactors with key roles in energy metabolism and are substrates for several NAD-consuming enzymes (e.g. poly(ADP-ribose) polymerases, sirtuins, and others). The nicotinamide salvage pathway, constituted by nicotinamide mononucleotide adenylyltransferase (NMNAT) and nicotinamide phosphoribosyltransferase (NAMPT), mainly replenishes NAD(+) in eukaryotes. However, unlike NMNAT1, NAMPT is not known to be a nuclear protein, prompting the question of how the nuclear NAD(+) pool is maintained and how it is replenished upon NAD(+) consumption. In the present work, using human and murine cells; immunoprecipitation, pulldown, and surface plasmon resonance assays; and immunofluorescence, small-angle X-ray scattering, and MS-based analyses, we report that GAPDH and NAMPT form a stable complex that is essential for nuclear translocation of NAMPT. This translocation furnishes NMN to replenish NAD(+) to compensate for the activation of NAD-consuming enzymes by stressful stimuli induced by exposure to H2O2 or S-nitrosoglutathione and DNA damage inducers. These results indicate that by forming a complex with GAPDH, NAMPT can translocate to the nucleus and thereby sustain the stress-induced NMN/NAD(+) salvage pathway.	[Grolla, Ambra A.; Miggiano, Riccardo; Bianchi, Michele; Galli, Ubaldina; Del Grosso, Erika; Guarneri, Martina; Torretta, Simone; Calabro, Marta; Boumya, Sara; Colombo, Giorgia; Rocchio, Francesca; Rizzi, Menico; Genazzani, Armando A.; Garavaglia, Silvia] Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, I-28100 Novara, Italy; [Di Marino, Daniele] Polytech Univ Marche, Dept Life & Environm Sci, New York Marche Struct Biol Ctr NY MaSBiC, Via Brecce Bianche, I-60131 Ancona, Italy; [Gori, Alessandro] CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy; [Orsomando, Giuseppe; Mazzola, Francesca; Angeletti, Carlo] Polytech Univ Marche, Sect Biochem, Dept Clin Sci DISCO, Via Ranieri 67, I-60128 Ancona, Italy; [Gaudino, Federica; Deaglio, Silvia] Univ Turin, Dept Med Sci, Via Nizza 52, I-10126 Turin, Italy; [Fan, Xiaorui; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Travelli, Cristina] Univ Amsterdam, Amsterdam UMC, Dept Neuro Pathol, Amsterdam Neurosci, NL-1001 NK Amsterdam, Netherlands; [Aronica, Eleonora] Univ Pavia, Dept Pharmaceut Sci, Via Taramelli 12-14, I-27100 Pavia, Italy; [Deaglio, Silvia] Italian Inst Genom Med, Via Nizza 52, I-10126 Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Marche Polytechnic University; University of Turin; University of California System; University of California Los Angeles; University of Amsterdam; Vrije Universiteit Amsterdam; University of Pavia; Italian Institute for Genomic Medicine (IIGM)	Genazzani, AA; Garavaglia, S (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Largo Donegani 2, I-28100 Novara, Italy.	armando.genazzani@uniupo.it; silvia.garavaglia@uniupo.it	Rocchio, Francesca/AAA-6754-2019; Gori, Alessandro/A-1357-2019; del grosso, erika/ABH-9491-2022; Miggiano, Riccardo/AAO-7887-2020; Orsomando, Giuseppe/L-2120-2015; Di Marino, Daniele/ABB-2333-2020; Travelli, Cristina/AAA-9450-2022; Mazzola, Francesca/ADC-1197-2022; garavaglia, silvia/AIA-1816-2022	Rocchio, Francesca/0000-0002-2145-2642; del grosso, erika/0000-0002-2398-5944; MIGGIANO, Riccardo/0000-0002-2159-3314; Galli, Ubaldina/0000-0003-1126-0142; Colombo, Giorgia/0000-0002-8280-2589; grolla, ambra/0000-0003-0233-0700; garavaglia, silvia/0000-0001-8494-1729; Genazzani, Armando/0000-0003-1923-7430; Orsomando, Giuseppe/0000-0001-6640-097X	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG2018 21842]; PRIN 2017 CBNCYT from the Italian Ministry of Health; Fondazione Umberto Veronesi Grant 2018; SIF-Merck scholarship; Universita del Piemonte Orientale Grant FAR 2015	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); PRIN 2017 CBNCYT from the Italian Ministry of Health; Fondazione Umberto Veronesi Grant 2018; SIF-Merck scholarship; Universita del Piemonte Orientale Grant FAR 2015	This work was supported in part by Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG2018 21842 (to A. A. Genazzani), by PRIN 2017 CBNCYT from the Italian Ministry of Health (to A. A. Genazzani), by Fondazione Umberto Veronesi Grant 2018 (to A. A. Genazzani), and by a SIF-Merck scholarship (to A. A. Genazzani), and Universita del Piemonte Orientale Grant FAR 2015 (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Amici A, 2017, CELL CHEM BIOL, V24, P553, DOI 10.1016/j.chembiol.2017.03.010; Audrito V, 2020, SEMIN CELL DEV BIOL, V98, P192, DOI 10.1016/j.semcdb.2019.05.001; Bockwoldt M, 2019, P NATL ACAD SCI USA, V116, P15957, DOI 10.1073/pnas.1902346116; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Danshina PV, 2016, MOL HUM REPROD, V22, P410, DOI 10.1093/molehr/gaw016; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Di Marino D, 2015, J CHEM THEORY COMPUT, V11, P3401, DOI 10.1021/ct500431h; Di Marino D, 2014, J BIOMOL STRUCT DYN, V32, P337, DOI 10.1080/07391102.2013.768552; Donini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175815; Donini S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01057-z; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gaudino F, 2019, ANTIOXID REDOX SIGN, V31, P1150, DOI 10.1089/ars.2019.7799; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258; Grolla AA, 2016, BRIT J PHARMACOL, V173, P2182, DOI 10.1111/bph.13505; Grolla AA, 2015, PIGM CELL MELANOMA R, V28, P718, DOI 10.1111/pcmr.12420; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Maldi E, 2013, PIGM CELL MELANOMA R, V26, P144, DOI 10.1111/pcmr.12037; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; Mori V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113939; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Ryu KW, 2018, SCIENCE, V360, DOI 10.1126/science.aan5780; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover M.A., 2017, MOONLIGHTING PROTEIN, VVolume 8, P147; Svoboda P, 2019, J BIOL CHEM, V294, P8676, DOI 10.1074/jbc.RA118.003505; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wilsbacher JL, 2017, MOL CANCER THER, V16, P1236, DOI 10.1158/1535-7163.MCT-16-0819; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang RY, 2011, ANAL BIOCHEM, V412, P18, DOI 10.1016/j.ab.2010.12.035; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	50	15	16	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3635	3651		10.1074/jbc.RA119.010571	http://dx.doi.org/10.1074/jbc.RA119.010571			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31988240	Green Published, hybrid			2022-12-28	WOS:000527725300021
J	Wei, XM; Zhang, Y; Li, C; Ai, KT; Li, K; Li, HY; Yang, JL				Wei, Xiumei; Zhang, Yu; Li, Cheng; Ai, Kete; Li, Kang; Li, Huiying; Yang, Jialong			The evolutionarily conserved MAPK/Erk signaling promotes ancestral T-cell immunity in fish via c-Myc?mediated glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell; evolution; mitogen-activated protein kinase (MAPK); cellular immune response; glycolysis; adaptive immunity; ancestral T cells; immune regulation; MAPK; Erk; teleost	ACTIVATED PROTEIN-KINASES; MAP KINASES; FEEDBACK LOOP; DIFFERENTIATION; TRANSDUCTION; METABOLISM; FAMILY; MYC; TRANSLOCATION; TRANSCRIPTION	The mitogen-activated protein kinase (MAPK) cascade is an ancient and evolutionarily conserved signaling pathway involved in numerous physiological processes. Despite great advances in understanding MAPK-mediated regulation of adaptive immune responses in mammals, its contribution to T-cell immunity in early vertebrates remains unclear. Herein, we used Nile tilapia (Oreochromis niloticus) to investigate the regulatory roles of MAPK/extracellular signal?regulated kinase (Erk) signaling in ancestral T-cell immunity of jawed fish. We found that Nile tilapia possesses an evolutionarily conserved MAPK/Erk axis that is activated through a classical three-tier kinase cascade, involving sequential phosphorylation of RAF proto-oncogene serine/threonine-protein kinase (Raf), MAPK/Erk kinase 1/2 (Mek1/2), and Erk1/2. In Nile tilapia, MAPK/Erk signaling participates in adaptive immune responses during bacterial infection. Upon T-cell activation, the MAPK/Erk axis is robustly activated, and MAPK/Erk blockade by specific inhibitors severely impairs T-cell activation. Furthermore, signals from MAPK/Erk were indispensable for primordial T cells to proliferate and exert their effector functions. Mechanistically, activation of the MAPK/Erk axis promoted glycolysis via induction of the transcriptional regulator proto-oncogene c-Myc (c-Myc), to ensure the proper activation and proliferation of fish T cells. Our results reveal the regulatory mechanisms of MAPK/Erk signaling in T-cell immunity in fish and highlight a close link between immune signals and metabolic programs. We propose that regulation of T-cell immunity by MAPK/Erk is a basic and sophisticated strategy that evolved before the emergence of the tetrapod lineage. These findings shed light on the evolution of the adaptive immune system.	[Wei, Xiumei; Zhang, Yu; Li, Cheng; Ai, Kete; Li, Kang; Li, Huiying; Yang, Jialong] East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China; [Yang, Jialong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China	East China Normal University; Qingdao National Laboratory for Marine Science & Technology	Yang, JL (corresponding author), East China Normal Univ, Shanghai 200241, Peoples R China.	jlyang@bio.ecnu.edu.cn	kang, li/HCH-5087-2022	Yang, Jialong/0000-0002-3112-5012	National Natural Science Foundation of China [31972822, 31872591]; Shanghai Pujiang Program [18PJ1402700]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31972822 and 31872591, Shanghai Pujiang Program Grant 18PJ1402700, and the Fundamental Research Funds for the Central Universities (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li D, 2019, J BIOL CHEM, V294, P16440, DOI 10.1074/jbc.RA119.010247; Linke M, 2017, FEBS LETT, V591, P3089, DOI 10.1002/1873-3468.12711; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Menon MB, 2016, BIOCHEM J, V473, P2995, DOI 10.1042/BCJ20160672C; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Nakanishi Teruyuki, 2015, Biology-Basel, V4, P640, DOI 10.3390/biology4040640; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun JJ, 2016, J BIOL CHEM, V291, P7488, DOI 10.1074/jbc.M115.698134; Sun JJ, 2019, J IMMUNOL, V203, P1845, DOI 10.4049/jimmunol.1900238; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Takizawa F, 2016, J IMMUNOL, V196, P4522, DOI 10.4049/jimmunol.1600222; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Tripathi P, 2012, IMMUNOL CELL BIOL, V90, P676, DOI 10.1038/icb.2011.87; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; Wang LJ, 2018, FASEB J, V32, P875, DOI 10.1096/fj.201700672RR; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei XM, 2020, J IMMUNOL, V204, P569, DOI 10.4049/jimmunol.1901065; Wei XM, 2019, J IMMUNOL, V203, P1172, DOI 10.4049/jimmunol.1900008; Wei XM, 2019, FISH SHELLFISH IMMUN, V89, P281, DOI 10.1016/j.fsi.2019.04.003; Wei XM, 2019, FISH SHELLFISH IMMUN, V86, P507, DOI 10.1016/j.fsi.2018.11.072; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zhai W, 2018, BRIT J CANCER, V119, P591, DOI 10.1038/s41416-018-0196-5; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhou DA, 2017, J CELL MOL MED, V21, P2465, DOI 10.1111/jcmm.13168; Zhu LY, 2012, J IMMUNOL, V188, P5571, DOI 10.4049/jimmunol.1102259	70	17	19	10	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3000	3016		10.1074/jbc.RA119.012231	http://dx.doi.org/10.1074/jbc.RA119.012231			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996375	hybrid, Green Published			2022-12-28	WOS:000519597300011
J	Jureka, AS; Kleinpeter, AB; Tipper, JL; Harrod, KS; Petit, CM				Jureka, Alexander S.; Kleinpeter, Alex B.; Tipper, Jennifer L.; Harrod, Kevin S.; Petit, Chad M.			The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; viral protein; host?pathogen interaction; infectious disease; innate immunity; nuclear magnetic resonance (NMR); non-structural protein 1; NS1; RIG-I; TRIM25	VIRAL-RNA MOLECULES; DOUBLE-STRANDED-RNA; A VIRUS; UBIQUITIN LIGASE; STRUCTURAL BASIS; SEASONAL INFLUENZA; RECOGNITION; INTERFERON; IDENTIFICATION; PREFERENCE	A critical role of influenza A virus nonstructural protein 1 (NS1) is to antagonize the host cellular antiviral response. NS1 accomplishes this role through numerous interactions with host proteins, including the cytoplasmic pathogen recognition receptor, retinoic acid?inducible gene I (RIG-I). Although the consequences of this interaction have been studied, the complete mechanism by which NS1 antagonizes RIG-I signaling remains unclear. We demonstrated previously that the NS1 RNA-binding domain (NS1(RBD)) interacts directly with the second caspase activation and recruitment domain (CARD) of RIG-I. We also identified that a single strain-specific polymorphism in the NS1(RBD) (R21Q) completely abrogates this interaction. Here we investigate the functional consequences of an R21Q mutation on NS1's ability to antagonize RIG-I signaling. We observed that an influenza virus harboring the R21Q mutation in NS1 results in significant up-regulation of RIG-I signaling. In support of this, we determined that an R21Q mutation in NS1 results in a marked deficit in NS1's ability to antagonize TRIM25-mediated ubiquitination of the RIG-I CARDs, a critical step in RIG-I activation. We also observed that WT NS1 is capable of binding directly to the tandem RIG-I CARDs, whereas the R21Q mutation in NS1 significantly inhibits this interaction. Furthermore, we determined that the R21Q mutation does not impede the interaction between NS1 and TRIM25 or NS1(RBD)'s ability to bind RNA. The data presented here offer significant insights into NS1 antagonism of RIG-I and illustrate the importance of understanding the role of strain-specific polymorphisms in the context of this specific NS1 function.	[Jureka, Alexander S.; Kleinpeter, Alex B.; Petit, Chad M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; [Tipper, Jennifer L.; Harrod, Kevin S.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Sch Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Petit, CM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA.	cpetit@uab.edu	Kleinpeter, Alex/AAO-9289-2020	Kleinpeter, Alex/0000-0001-5630-1345; Jureka, Alexander/0000-0001-6839-1835	NCI, National Institutes of Health [1P30 CA-13148]; NCRR [1S10 RR022994-01A1]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Michaela Gack for kindly providing the pGST-2CARD and pEBG-GST empty vector, Dr. Adolfo Garcia-Sastre for providing the PR8 reverse genetics constructs, and Dr. Takashi Fujita for kindly providing the p125-Luc vector. We also thank the Placzek laboratory for technical assistance with collecting the fluorescence polarization anisotropy data. The Bruker 850-MHz and 600-MHz magnets used in this work were funded by NCI, National Institutes of Health Grants 1P30 CA-13148 and 1P30 CA-13148 and NCRR Grant 1S10 RR022994-01A1.	Askovich PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074863; Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Cheng JH, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0971-1; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jureka AS, 2015, STRUCTURE, V23, P2001, DOI 10.1016/j.str.2015.08.007; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007; Marc D, 2013, NUCLEIC ACIDS RES, V41, P434, DOI 10.1093/nar/gks979; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P896, DOI 10.1093/nar/gkv1299; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sanchez-Aparicio MT, 2018, J VIROL, V92, DOI 10.1128/JVI.01960-17; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	49	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1153	1164		10.1074/jbc.RA119.011410	http://dx.doi.org/10.1074/jbc.RA119.011410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31843969	Green Published, hybrid			2022-12-28	WOS:000509949300022
J	Farrington, CC; Yuan, E; Mazhar, S; Izadmehr, S; Hurst, L; Allen-Petersen, BL; Janghorban, M; Chung, E; Wolczanski, G; Galsky, M; Sears, R; Sangodkar, J; Narla, G				Farrington, Caroline C.; Yuan, Eric; Mazhar, Sahar; Izadmehr, Sudeh; Hurst, Lauren; Allen-Petersen, Brittany L.; Janghorban, Mahnaz; Chung, Eric; Wolczanski, Grace; Galsky, Matthew; Sears, Rosalie; Sangodkar, Jaya; Narla, Goutham			Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); protein phosphatase 2 (PP2A); protein degradation; breast cancer; oncogene; anticancer drug; small molecule; Burkitt Lymphoma; non?small cell lung cancer; small molecule activator of PP2A (SMAP)	BET BROMODOMAIN INHIBITION; C-MYC; LUNG-CANCER; BURKITTS-LYMPHOMA; ONCOGENIC MYC; PP2A; EXPRESSION; PATHWAY; TARGETS; OMOMYC	The tumor suppressor protein phosphatase 2A (PP2A) is a serine/threonine phosphatase whose activity is inhibited in most human cancers. One of the best-characterized PP2A substrates is MYC proto-oncogene basic helix?loop?helix transcription factor (MYC), whose overexpression is commonly associated with aggressive forms of this disease. PP2A directly dephosphorylates MYC, resulting in its degradation. To explore the therapeutic potential of direct PP2A activation in a diverse set of MYC-driven cancers, here we used biochemical assays, recombinant cell lines, gene expression analyses, and immunohistochemistry to evaluate a series of first-in-class small-molecule activators of PP2A (SMAPs) in Burkitt lymphoma, KRAS-driven non?small cell lung cancer, and triple-negative breast cancer. In all tested models of MYC-driven cancer, the SMAP treatment rapidly and persistently inhibited MYC expression through proteasome-mediated degradation, inhibition of MYC transcriptional activity, decreased cancer cell proliferation, and tumor growth inhibition. Importantly, we generated a series of cell lines expressing PP2A-dependent phosphodegron variants of MYC and demonstrated that the antitumorigenic activity of SMAPs depends on MYC degradation. Collectively, the findings presented here indicate a pharmacologically tractable approach to drive MYC degradation by using SMAPs for the management of a broad range of MYC-driven cancers.	[Farrington, Caroline C.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Mazhar, Sahar] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Yuan, Eric; Chung, Eric] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Izadmehr, Sudeh; Galsky, Matthew] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, Dept Med, New York, NY 10029 USA; [Hurst, Lauren; Wolczanski, Grace; Sangodkar, Jaya; Narla, Goutham] Univ Michigan, Dept Internal Med, Div Genet Med, Ann Arbor, MI 48105 USA; [Allen-Petersen, Brittany L.; Janghorban, Mahnaz; Sears, Rosalie] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; Oregon Health & Science University	Narla, G (corresponding author), Univ Michigan, Dept Internal Med, Div Genet Med, Ann Arbor, MI 48105 USA.	gnarla@med.umich.edu	Allen-Petersen, Brittany/AAC-8504-2020; Narla, Goutham/AAZ-5710-2020	Allen-Petersen, Brittany/0000-0002-7436-9412; Narla, Goutham/0000-0003-4098-4203; Hurst, Lauren/0000-0002-3016-9419	Young Scientist Foundation	Young Scientist Foundation	We acknowledge the contributions of Shirish Shenolikar for insight and critical evaluation of the work. We also thank Caitlin O'Connor for assistance with the manuscript. We acknowledge the support of the Young Scientist Foundation.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Allen-Petersen BL, 2019, BIODRUGS, V33, P539, DOI 10.1007/s40259-019-00370-5; Allen-Petersen BL, 2019, CANCER RES, V79, P209, DOI 10.1158/0008-5472.CAN-18-0717; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Arriazu E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00078; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Barfeld SJ, 2017, EBIOMEDICINE, V18, P83, DOI 10.1016/j.ebiom.2017.04.006; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Choi SK, 2016, ONCOL REP, V35, P1186, DOI 10.3892/or.2015.4410; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Escamilia-Powers JR, 2007, J BIOL CHEM, V282, P5432, DOI 10.1074/jbc.M611437200; Fallah Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030053; Farrell AS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01967-6; Farrell AS, 2014, MOL CANCER RES, V12, P924, DOI 10.1158/1541-7786.MCR-13-0542; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fukazawa T, 2010, ANTICANCER RES, V30, P4193; Giovannelli P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00492; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15182; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jung LA, 2017, ONCOGENE, V36, P1911, DOI 10.1038/onc.2016.354; Kastrinsky DB, 2015, BIOORGAN MED CHEM, V23, P6528, DOI 10.1016/j.bmc.2015.07.007; Kauko O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1093; Lambrecht C, 2018, ONCOGENE, V37, P544, DOI 10.1038/onc.2017.350; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee J, 2019, BREAST CANCER RES TR, V175, P339, DOI 10.1007/s10549-019-05166-3; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lustig LC, 2017, ONCOGENE, V36, P6830, DOI 10.1038/onc.2017.275; McClinch K, 2018, CANCER RES, V78, P2065, DOI 10.1158/0008-5472.CAN-17-0123; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nagaria TS, 2017, ONCOTARGET, V8, P80804, DOI 10.18632/oncotarget.20534; Neviani P, 2014, CLIN CANCER RES, V20, P2026, DOI 10.1158/1078-0432.CCR-14-0166; O'Connor CM, 2018, INT J BIOCHEM CELL B, V96, P182, DOI 10.1016/j.biocel.2017.10.008; Ohshima K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00219-3; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Pippa R, 2014, LEUKEMIA, V28, P1915, DOI 10.1038/leu.2014.141; Qu JK, 2017, ONCOTARGET, V8, P93998, DOI 10.18632/oncotarget.21501; Ramaswamy K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00016; Richard NP, 2016, ONCOTARGET, V7, P84214, DOI 10.18632/oncotarget.12394; RICHARDSON GE, 1993, SEMIN ONCOL, V20, P105; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Sangodkar J, 2017, J CLIN INVEST, V127, P2081, DOI 10.1172/JCI89548; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Sents W, 2017, CANCER RES, V77, P6825, DOI 10.1158/0008-5472.CAN-16-2911; Seo AN, 2014, BRIT J CANCER, V110, P2688, DOI 10.1038/bjc.2014.218; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sun XX, 2015, CELL CYCLE, V14, P3786, DOI 10.1080/15384101.2015.1093713; Togel L, 2016, MOL CANCER THER, V15, P1217, DOI 10.1158/1535-7163.MCT-15-0724; Tohme R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125693; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang E, 2019, ONCOGENE, V38, P140, DOI 10.1038/s41388-018-0421-y; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Yang AM, 2017, CANCER RES, V77, P6641, DOI 10.1158/0008-5472.CAN-16-3452; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang ZF, 2016, THERANOSTICS, V6, P219, DOI 10.7150/thno.13178	74	24	24	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					757	770		10.1074/jbc.RA119.011443	http://dx.doi.org/10.1074/jbc.RA119.011443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31822503	Green Published, hybrid			2022-12-28	WOS:000508382900008
J	Pham, KTM; Li, ZY				Pham, Kieu T. M.; Li, Ziyin			Regulated protein stabilization underpins the functional interplay among basal body components in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; centriole; microbiology; Trypanosoma brucei; trypanosome; basal body; centriole; flagellum; parasite; sleeping sickness; microtubule-organizing center; SAS-6; BLD10; BBP65; BBP164	9-FOLD SYMMETRY; CENTRIOLE BIOGENESIS; CARTWHEEL PROTEIN; MOLECULAR-BASIS; CELL-DIVISION; GAMMA-TUBULIN; PLK4; CPAP; LOCALIZATION; INTERDEPENDENCE	The basal body in the human parasite Trypanosoma brucei is structurally equivalent to the centriole in animals and functions in the nucleation of axonemal microtubules in the flagellum. T. brucei lacks many evolutionarily conserved centriolar protein homologs and constructs the basal body through unknown mechanisms. Two evolutionarily conserved centriole/basal body cartwheel proteins, TbSAS-6 and TbBLD10, and a trypanosome-specific protein, BBP65, play essential roles in basal body biogenesis in T. brucei, but how they cooperate in the regulation of basal body assembly remains elusive. Here using RNAi, endogenous epitope tagging, immunofluorescence microscopy, and 3D-structured illumination super-resolution microscopy, we identified a new trypanosome-specific protein named BBP164 and found that it has an essential role in basal body biogenesis in T. brucei. Further investigation of the functional interplay among BBP164 and the other three regulators of basal body assembly revealed that BBP164 and BBP65 are interdependent for maintaining their stability and depend on TbSAS-6 and TbBLD10 for their stabilization in the basal body. Additionally, TbSAS-6 and TbBLD10 are independent from each other and from BBP164 and BBP65 for maintaining their stability in the basal body. These findings demonstrate that basal body cartwheel proteins are required for stabilizing other basal body components and uncover that regulation of protein stability is an unusual control mechanism for assembly of the basal body in T. brucei.	[Pham, Kieu T. M.; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI118736, AI101437]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI118736 and AI101437 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN RD, 1969, J CELL BIOL, V40, P716, DOI 10.1083/jcb.40.3.716; Badjatia N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005498; Banterle N, 2017, ANNU REV CELL DEV BI, V33, P23, DOI 10.1146/annurev-cellbio-100616-060454; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Dang HQ, 2017, MBIO, V8, DOI [10.1128/mBio.02120-16, 10.1128/mbio.02120-16]; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dilbeck V, 1999, J CELL SCI, V112, P4687; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kratz AS, 2015, BIOL OPEN, V4, P370, DOI 10.1242/bio.201411023; Lacomble S, 2010, J CELL SCI, V123, P2884, DOI 10.1242/jcs.074161; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lozano-Nunez A, 2013, MOL BIOL CELL, V24, P1321, DOI 10.1091/mbc.E12-12-0846; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Mittal S, 2015, J BIOSCIENCES, V40, P863, DOI 10.1007/s12038-015-9570-0; Morgan GW, 2005, MOL CELL BIOL, V25, P3774, DOI 10.1128/MCB.25.9.3774-3783.2005; Moyer TC, 2015, J CELL BIOL, V209, P863, DOI 10.1083/jcb.201502088; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Park SY, 2014, NAT STRUCT MOL BIOL, V21, P696, DOI 10.1038/nsmb.2846; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Scott V, 1997, J CELL SCI, V110, P157; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thakur J, 2012, PLOS GENET, V8, P466, DOI 10.1371/journal.pgen.1002661; van Breugel M, 2014, ELIFE, V3, DOI 10.7554/eLife.01812; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2015, MOL MICROBIOL, V98, P667, DOI 10.1111/mmi.13149	66	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					729	742		10.1074/jbc.RA119.011352	http://dx.doi.org/10.1074/jbc.RA119.011352			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31819011	Green Published, hybrid			2022-12-28	WOS:000508382900006
J	Joshi, R; Qin, LG; Cao, X; Zhong, SS; Voss, C; Min, WP; Li, SSC				Joshi, Rakesh; Qin, Lyugao; Cao, Xuan; Zhong, Shanshan; Voss, Courtney; Min, Weiping; Li, Shawn S. C.			DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deleted in liver cancer 1 (DLC1); Ras homolog gene family; member A (RhoA); cell migration; cell proliferation; breast cancer; C2 domain; RhoGAP; SAM domain	GTPASE-ACTIVATING PROTEIN; TUMOR-SUPPRESSOR PROTEIN; EPHA2 RECEPTOR; GENE-EXPRESSION; MOTIF; RECOGNITION; APOPTOSIS	Deleted-in-liver cancer 1 (DLC1) exerts its tumor suppressive function mainly through the Rho-GTPase?activating protein (RhoGAP) domain. When activated, the domain promotes the hydrolysis of RhoA-GTP, leading to reduced cell migration. DLC1 is kept in an inactive state by an intramolecular interaction between its RhoGAP domain and the DLC1 sterile ? motif (SAM) domain. We have shown previously that this autoinhibited state of DLC1 may be alleviated by tensin-3 (TNS3) or PTEN. We show here that the TNS3/PTEN-DLC1 interactions are mediated by the C2 domains of the former and the SAM domain of the latter. Intriguingly, the DLC1 SAM domain was capable of binding to specific peptide motifs within the C2 domains. Indeed, peptides containing the binding motifs were highly effective in blocking the C2-SAM domain-domain interaction. Importantly, when fused to the tat protein-transduction sequence and subsequently introduced into cells, the C2 peptides potently promoted the RhoGAP function in DLC1, leading to decreased RhoA activation and reduced tumor cell growth in soft agar and migration in response to growth factor stimulation. To facilitate the development of the C2 peptides as potential therapeutic agents, we created a cyclic version of the TNS3 C2 domain-derived peptide and showed that this peptide readily entered the MDA-MB-231 breast cancer cells and effectively inhibited their migration. Our work shows, for the first time, that the SAM domain is a peptide-binding module and establishes the framework on which to explore DLC1 SAM domain-binding peptides as potential therapeutic agents for cancer treatment.	[Joshi, Rakesh; Qin, Lyugao; Zhong, Shanshan; Voss, Courtney; Li, Shawn S. C.] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Joshi, Rakesh; Min, Weiping] Western Univ, Dept Surg, London, ON N6A 5A5, Canada; [Joshi, Rakesh; Min, Weiping] Western Univ, Dept Pathol, London, ON N6A 5A5, Canada; [Joshi, Rakesh; Min, Weiping] Western Univ, Dept Oncol, London, ON N6A 5A5, Canada; [Cao, Xuan] Huazhong Univ Sci & Technol, Sch Basic Med, Tongji Med Coll, Wuhan 430030, Peoples R China	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Huazhong University of Science & Technology	Li, SSC (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada.; Min, WP (corresponding author), Western Univ, Dept Surg, London, ON N6A 5A5, Canada.; Min, WP (corresponding author), Western Univ, Dept Pathol, London, ON N6A 5A5, Canada.; Min, WP (corresponding author), Western Univ, Dept Oncol, London, ON N6A 5A5, Canada.	weiping.min@uwo.ca; sli@uwo.ca			Canadian Institute of Health Research; Canadian Cancer Society; Natural Science Foundation of Hubei Province, China [2016CFA053]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This work was supported, in part, by grants from the Canadian Institute of Health Research (to S. S. C. L.), the Canadian Cancer Society (to S. S. C. L.), and the Natural Science Foundation of Hubei Province, China Grant 2016CFA053 (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlbach CL, 2015, FUTURE MED CHEM, V7, P2121, DOI 10.4155/fmc.15.78; Andreu D, 1994, Methods Mol Biol, V35, P91; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Biron E, 2016, J STEROID BIOCHEM, V161, P36, DOI 10.1016/j.jsbmb.2015.07.006; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; Cao X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8721; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Heering J, 2009, EXP CELL RES, V315, P2505, DOI 10.1016/j.yexcr.2009.05.022; Howl J, 2009, EXPERT OPIN THER PAT, V19, P1329, DOI 10.1517/17530050902824829; Isidro-Llobet A, 2009, CHEM REV, V109, P2455, DOI 10.1021/cr800323s; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kaneko T, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-32; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Ko FCF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2604; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; Kwan JJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-34; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Low JSW, 2011, ONCOGENE, V30, P1923, DOI 10.1038/onc.2010.576; Mercurio FA, 2017, BBA-PROTEINS PROTEOM, V1865, P1095, DOI 10.1016/j.bbapap.2017.06.003; Mercurio FA, 2016, CURR MED CHEM, V23, P4718, DOI 10.2174/0929867323666161101100722; Mercurio FA, 2018, BIOORG CHEM, V80, P602, DOI 10.1016/j.bioorg.2018.07.013; Mercurio FA, 2012, BIOCHEMISTRY-US, V51, P2136, DOI 10.1021/bi300141h; MOSCOW JA, 1994, ONCOGENE, V9, P189; Myrdal PB, 2004, J PHARM SCI-US, V93, P1054, DOI 10.1002/jps.20025; Park JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036564; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Shi XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45084; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tripathi BK, 2017, J CELL BIOL, V216, P4255, DOI 10.1083/jcb.201703105; Tripathi BK, 2017, ONCOTARGET, V8, P27674, DOI 10.18632/oncotarget.16805; Tripathi BK, 2014, J CELL BIOL, V207, P627, DOI 10.1083/jcb.201405105; Ullmannova V, 2007, CANCER DETECT PREV, V31, P110, DOI 10.1016/j.cdp.2007.02.005; Ullmannova-Benson V, 2009, LEUKEMIA, V23, P383, DOI 10.1038/leu.2008.285; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yang XY, 2011, CANCER RES, V71, P2916, DOI 10.1158/0008-5472.CAN-10-2158; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	56	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					645	656		10.1074/jbc.RA119.011929	http://dx.doi.org/10.1074/jbc.RA119.011929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806702	Green Published, hybrid			2022-12-28	WOS:000507373600030
J	Maity, S; Muhamed, J; Sarikhani, M; Kumar, S; Ahamed, F; Spurthi, KM; Ravi, V; Jain, A; Khan, D; Arathi, BP; Desingu, PA; Sundaresan, NR				Maity, Sangeeta; Muhamed, Jaseer; Sarikhani, Mohsen; Kumar, Shweta; Ahamed, Faiz; Spurthi, Kondapalli Mrudula; Ravi, Venkatraman; Jain, Aditi; Khan, Danish; Arathi, Bangalore Prabhashankar; Desingu, Perumal Arumugam; Sundaresan, Nagalingam R.			Sirtuin 6 deficiency transcriptionally up-regulates TGF-? signaling and induces fibrosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; transforming growth factor beta (TGF-beta); fibrosis; aging; SMAD transcription factor; aging; aging-associated fibrosis; SIRT6 deacetylase; TGF-beta signaling; SMAD3; caloric restriction; cardiac disease; extracellular matrix (ECM)	GROWTH-FACTOR-BETA; CALORIE RESTRICTION; CELLULAR SENESCENCE; HEART-FAILURE; SMAD3; ACTIVATION; MECHANISMS; EXPRESSION; TGF-BETA-1; INFLAMMATION	Caloric restriction has been associated with increased life span and reduced aging-related disorders and reduces fibrosis in several diseases. Fibrosis is characterized by deposition of excess fibrous material in tissues and organs and is caused by aging, chronic stress, injury, or disease. Myofibroblasts are fibroblast-like cells that secrete high levels of extracellular matrix proteins, resulting in fibrosis. Histological studies have identified many-fold increases of myofibroblasts in aged organs where myofibroblasts are constantly generated from resident tissue fibroblasts and other cell types. However, it remains unclear how aging increases the generation of myofibroblasts. Here, using mouse models and biochemical assays, we show that sirtuin 6 (SIRT6) deficiency plays a major role in aging-associated transformation of fibroblasts to myofibroblasts, resulting in tissue fibrosis. Our findings suggest that SIRT6-deficient fibroblasts transform spontaneously to myofibroblasts through hyperactivation of transforming growth factor ? (TGF-?) signaling in a cell-autonomous manner. Importantly, we noted that SIRT6 haploinsufficiency is sufficient for enhancing myofibroblast generation, leading to multiorgan fibrosis and cardiac dysfunction in mice during aging. Mechanistically, SIRT6 bound to and repressed the expression of key TGF-? signaling genes by deacetylating SMAD family member 3 (SMAD3) and Lys-9 and Lys-56 in histone 3. SIRT6 binding to the promoters of genes in the TGF-? signaling pathway decreased significantly with age and was accompanied by increased binding of SMAD3 to these promoters. Our findings reveal that SIRT6 may be a potential candidate for modulating TGF-? signaling to reduce multiorgan fibrosis during aging and fibrosis-associated diseases.	[Maity, Sangeeta; Muhamed, Jaseer; Sarikhani, Mohsen; Kumar, Shweta; Ahamed, Faiz; Spurthi, Kondapalli Mrudula; Ravi, Venkatraman; Khan, Danish; Arathi, Bangalore Prabhashankar; Desingu, Perumal Arumugam; Sundaresan, Nagalingam R.] Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, Lab SB 02, Bengaluru 560012, Karnataka, India; [Jain, Aditi] Indian Inst Sci, Ctr BioSyst Sci & Engn, Bengaluru 560012, Karnataka, India; [Muhamed, Jaseer] Indian Council Med Res, Reg Occupat Hlth Ctr Southern, Bengaluru 562110, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Occupational Health (NIOH)	Sundaresan, NR (corresponding author), Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, Lab SB 02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Desingu, P./AGM-5446-2022; Desingu, Perumal/AGH-9777-2022; Ravi, Venkatraman/C-7967-2014	Desingu, P./0000-0003-4395-4472; Muhamed, Jaseer/0000-0001-5046-9438; Ravi, Venkatraman/0000-0002-1409-682X; Maity, Sangeeta/0000-0003-4426-1715	Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF); Department of Biotechnology Research Associateship; Dr. D. S. Kothari Postdoctoral fellowship (DKPDF); Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology [EMR/2014/000065]; Department of Biotechnology [BRB/10/1294/2014, MED/30/1454/2014]; Council for Scientific and Industrial Research [37(1646)/15/EMR-II]; Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Biotechnology Research Associateship; Dr. D. S. Kothari Postdoctoral fellowship (DKPDF); Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Supported by the Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF).; Supported by a Department of Biotechnology Research Associateship.; Supported by a Dr. D. S. Kothari Postdoctoral fellowship (DKPDF).; Recipient of the Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India. This author's laboratory is supported by research funding from the Department of Science and Technology (Grant EMR/2014/000065), the Department of Biotechnology (Grants BRB/10/1294/2014 and MED/30/1454/2014), the Council for Scientific and Industrial Research (Grant 37(1646)/15/EMR-II), and the Department of Biotechnology-Indian Institute of Science partnership program for advanced research.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Araki S, 2015, CIRCULATION, V132, P1081, DOI 10.1161/CIRCULATIONAHA.114.014821; Arteaga M, 2016, AM J PHYSIOL-GASTR L, V310, pG1155, DOI 10.1152/ajpgi.00271.2015; Bhardwaj A, 2016, P NATL ACAD SCI USA, V113, pE538, DOI 10.1073/pnas.1520045113; Biernacka A, 2011, AGING DIS, V2, P158; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Cappetta D, 2016, INT J CARDIOL, V205, P99, DOI 10.1016/j.ijcard.2015.12.008; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Davis J, 2014, J MOL CELL CARDIOL, V70, P9, DOI 10.1016/j.yjmcc.2013.10.019; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Harvey AE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094151, 10.1371/journal.pone.0101803]; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Huang XZ, 2014, J CELL BIOCHEM, V115, P996, DOI 10.1002/jcb.24748; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kashiwagi I, 2015, IMMUNITY, V43, P65, DOI 10.1016/j.immuni.2015.06.010; Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636; Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6; Kim S, 2013, AM J PATHOL, V183, P1758, DOI 10.1016/j.ajpath.2013.08.014; Knaapen P, 2006, RADIOLOGY, V240, P380, DOI 10.1148/radiol.2402051038; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; LAURENT GJ, 1993, THORAX, V48, P953, DOI 10.1136/thx.48.10.953; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li Rujun, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P67; Li ZY, 2016, AGING-US, V8, P2337, DOI 10.18632/aging.101050; Luo YX, 2017, EUR HEART J, V38, P1389, DOI 10.1093/eurheartj/ehw138; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Massague J, 2000, GENE DEV, V14, P627; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012; Ravi V, 2019, NUCLEIC ACIDS RES, V47, P9115, DOI 10.1093/nar/gkz648; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Ruiz-Torres MP, 1998, J AM SOC NEPHROL, V9, P782; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sarikhani M, 2018, ELIFE, V7, DOI 10.7554/eLife.32952; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sharma A, 2013, J BIOL CHEM, V288, P18439, DOI 10.1074/jbc.M112.405928; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tan KM, 2015, TRANSL RES, V165, P374, DOI 10.1016/j.trsl.2014.08.008; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Yamamoto T, 1999, CLIN IMMUNOL, V92, P6, DOI 10.1006/clim.1999.4720; Yan L, 2013, AGE, V35, P2177, DOI 10.1007/s11357-012-9508-5; Yang BH, 2012, CELL BIOL INT, V36, P105, DOI 10.1042/CBI20110268; Yao QP, 2014, INT J BIOCHEM CELL B, V49, P98, DOI 10.1016/j.biocel.2014.01.016; Zerr P, 2016, ANN RHEUM DIS, V75, P226, DOI 10.1136/annrheumdis-2014-205740; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003; Zhao GY, 2016, AGING-US, V8, P2308, DOI 10.18632/aging.101038; Zorrilla-Zubilete MA, 2018, J NEUROCHEM, V144, P128, DOI 10.1111/jnc.14243	69	33	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					415	434		10.1074/jbc.RA118.007212	http://dx.doi.org/10.1074/jbc.RA118.007212			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744885	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000507373600013
J	Frinder, J; Kahloon, MA; Zhang, YQ; Ahmed, YL; Sinning, I; Jaschke, A				Frinder, Jens; Kahloon, Masroor Ahmad; Zhang, Yaqing; Ahmed, Yasar Luqman; Sinning, Irmgard; Jaeschke, Andres			YvcI from Bacillus subtilis has in vitro RNA pyrophosphohydrolase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA degradation; RNA processing; RNA turnover; nucleic acid enzymology; metalloenzyme; manganese; Nudix hydrolase; pyrophosphohydrolase; ribonucleolytic decay; YvcI	MESSENGER-RNA; ESCHERICHIA-COLI; NUDIX HYDROLASES; DEGRADATION; SPECIFICITY; GENE; VERSATILE; PROTEINS; STATE; DAPF	RNA degradation is one of several ways for organisms to regulate gene expression. In bacteria, the removal of two terminal phosphate moieties as orthophosphate (Bacillus subtilis) or pyrophosphate (Escherichia coli) triggers ribonucleolytic decay of primary transcripts by 5?-monophosphate?dependent ribonucleases. In the soil-dwelling firmicute species B. subtilis, the RNA pyrophosphohydrolase BsRppH, a member of the Nudix family, triggers RNA turnover by converting primary transcripts to 5?-monophospate RNA. In addition to BsRppH, a source of redundant activity in B. subtilis has been proposed. Here, using recombinant protein expression and in vitro enzyme assays, we provide evidence for several additional RNA pyrophosphohydrolases, among them MutT, NudF, YmaB, and YvcI in B. subtilis. We found that in vitro, YvcI converts RNA 5?-di- and triphosphates into monophosphates in the presence of manganese at neutral to slightly acidic pH. It preferred G-initiating RNAs and required at least one unpaired nucleotide at the 5?-end of its substrates, with the 5?-terminal nucleotide determining whether primarily ortho- or pyrophosphate is released. Exchanges of catalytically important glutamate residues in the Nudix motif impaired or abolished the enzymatic activity of YvcI. In summary, the results of our extensive in vitro biochemical characterization raise the possibility that YvcI is an additional RNA pyrophosphohydrolase in B. subtilis.	[Frinder, Jens; Kahloon, Masroor Ahmad; Zhang, Yaqing; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Ahmed, Yasar Luqman; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Jaschke, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany.	jaeschke@uni-hd.de			Baden-Wurttemberg Stiftung Grant [BWST_NCRNA_045]; Deutsche Forschungsgemeinschaft [SPP 1784, Ja794/10-1]	Baden-Wurttemberg Stiftung Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Baden-Wurttemberg Stiftung Grant BWST_NCRNA_045] and in part by Deutsche Forschungsgemeinschaft Priority Program SPP 1784 Grant Ja794/10-1. The authors declare that they have no conflicts of interest with the contents of this article.	Akbar S, 1999, MICROBIOL-UK, V145, P1069, DOI 10.1099/13500872-145-5-1069; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Frindert J, 2018, CELL REP, V24, P1890, DOI 10.1016/j.celrep.2018.07.047; Fukushima T, 2003, J BIOCHEM, V133, P475, DOI 10.1093/jb/mvg062; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Hofer K, 2016, NAT CHEM BIOL, V12, P730, DOI 10.1038/nchembio.2132; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Huang FQ, 1997, P NATL ACAD SCI USA, V94, P8965, DOI 10.1073/pnas.94.17.8965; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Lee CR, 2014, NUCLEIC ACIDS RES, V42, P12746, DOI 10.1093/nar/gku926; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Liu SW, 2008, METHOD ENZYMOL, V448, P3, DOI 10.1016/S0076-6879(08)02601-3; Luciano DJ, 2017, MOL CELL, V67, P44, DOI 10.1016/j.molcel.2017.05.035; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Presecan E, 1997, MICROBIOL-SGM, V143, P3313, DOI 10.1099/00221287-143-10-3313; REDDY PS, 1994, EUR J BIOCHEM, V225, P737, DOI 10.1111/j.1432-1033.1994.00737.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; RICHAUD C, 1987, J BACTERIOL, V169, P1454, DOI 10.1128/jb.169.4.1454-1459.1987; Schwartz D, 2003, RNA, V9, P239, DOI 10.1261/rna.2171203; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Xu WL, 2004, J BACTERIOL, V186, P8380, DOI 10.1128/JB.186.24.8380-8384.2004	34	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19967	19977		10.1074/jbc.RA119.011485	http://dx.doi.org/10.1074/jbc.RA119.011485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740579	Green Published, hybrid			2022-12-28	WOS:000505005800012
J	Harikrishnan, V; Titus, AS; Cowling, RT; Kailasam, S				Harikrishnan, V; Titus, Allen Sam; Cowling, Randy T.; Kailasam, Shivakumar			Collagen receptor cross-talk determines ?-smooth muscle actin-dependent collagen gene expression in angiotensin II?stimulated cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; fibrosis; integrin; collagen; tyrosine-protein kinase (tyrosine kinase); cardiovascular disease; connective tissue; cardiac fibroblast; cardiac fibrosis; collagen type I; discoidin domain receptor 2; integrin-beta1; alpha-smooth muscle actin; tissue damage; gene regulation	INTEGRIN BETA-1; EXTRACELLULAR-MATRIX; AP-1; PROLIFERATION; MIGRATION; ADHESION; BETA-1-INTEGRIN; DIFFERENTIATION; TRANSCRIPTION; HYPERTENSION	Excessive collagen deposition by myofibroblasts during adverse cardiac remodeling leads to myocardial fibrosis that can compromise cardiac function. Unraveling the mechanisms underlying collagen gene expression in cardiac myofibroblasts is therefore an important clinical goal. The collagen receptors, discoidin domain receptor 2 (DDR2), a collagen-specific receptor tyrosine kinase, and integrin-?1, are reported to mediate tissue fibrosis. Here, we probed the role of DDR2?integrin-?1 cross-talk in the regulation of collagen ?1(I) gene expression in angiotensin II (Ang II)-stimulated cardiac fibroblasts. Results from gene silencing/overexpression approaches, electrophoretic mobility shift assays, and ChIP revealed that DDR2 acts via extracellular signal?regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK)-dependent transforming growth factor-?1 (TGF-?1) signaling to activate activator protein-1 (AP-1) that in turn transcriptionally enhances the expression of collagen-binding integrin-?1 in Ang II?stimulated cardiac fibroblasts. The DDR2?integrin-?1 link was also evident in spontaneously hypertensive rats and DDR2-knockout mice. Further, DDR2 acted via integrin-?1 to regulate ?-smooth muscle actin (?-SMA) and collagen type I expression in Ang II?exposed cardiac fibroblasts. Downstream of the DDR2?integrin-?1 axis, ?-SMA was found to regulate collagen ?1(I) gene expression via the Ca2+ channel, transient receptor potential cation channel subfamily C member 6 (TRPC6), and the profibrotic transcription factor, Yes-associated protein (YAP). This finding indicated that fibroblast-to-myofibroblast conversion is mechanistically coupled to collagen expression. The observation that collagen receptor cross-talk underlies ?-SMA?dependent collagen type I expression in cardiac fibroblasts expands our understanding of the complex mechanisms involved in collagen gene expression in the heart and may be relevant to cardiac fibrogenesis.	[Harikrishnan, V; Titus, Allen Sam; Kailasam, Shivakumar] Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Trivandrum 695011, Kerala, India; [Cowling, Randy T.] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA; [Harikrishnan, V] Govt India, Dept Biotechnol, Delhi, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); University of California System; University of California San Diego; Department of Biotechnology (DBT) India	Kailasam, S (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Trivandrum 695011, Kerala, India.	shivak@sctimst.ac.in	Titus, Allen/GSD-8138-2022	Titus, Allen/0000-0001-8149-3895	Department of Biotechnology, Government of India [BT/PR23486/BRB/10/1589/2017]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India, Research Grant BT/PR23486/BRB/10/1589/2017 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anupama V, 2016, J MOL CELL CARDIOL, V97, P295, DOI 10.1016/j.yjmcc.2016.05.010; BRILLA CG, 1993, EUR HEART J, V14, P57; Civitarese RA, 2016, AM J PHYSIOL-HEART C, V311, pH96, DOI 10.1152/ajpheart.00918.2015; Cowling RT, 2014, AM J PHYSIOL-HEART C, V307, pH773, DOI 10.1152/ajpheart.00142.2014; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/s2214-109x(17)30196-1, 10.1016/S2214-109X(17)30196-1]; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Follonier L, 2008, J CELL SCI, V121, P3305, DOI 10.1242/jcs.024521; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; George M, 2016, J MOL CELL CARDIOL, V90, P59, DOI 10.1016/j.yjmcc.2015.12.004; He XJ, 2017, P NATL ACAD SCI USA, V114, pE4582, DOI 10.1073/pnas.1621384114; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Jia SJ, 2018, AM J RESP CELL MOL, V59, P295, DOI 10.1165/rcmb.2017-0419OC; Jiang T, 2008, NEPHROLOGY, V13, P212, DOI 10.1111/j.1440-1797.2007.00913.x; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Kumaran C, 2002, AM J PHYSIOL-HEART C, V282, pH1855, DOI 10.1152/ajpheart.00747.2001; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lee HW, 2013, CLIN CANCER RES, V19, P5879, DOI 10.1158/1078-0432.CCR-13-1181; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Liu SX, 2013, J INVEST DERMATOL, V133, P899, DOI 10.1038/jid.2012.438; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Nichols TC, 1999, CIRC RES, V85, P1040; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Philip L, 2013, J MOL CELL CARDIOL, V62, P217, DOI 10.1016/j.yjmcc.2013.06.009; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Ren XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43259; Rockey DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077166; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Soto-Ribeiro M, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224493; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; WOOD EJ, 1983, BIOCHEM EDUC, V11, P82, DOI 10.1016/0307-4412(83)90068-7; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zablocki D, 2013, ANTIOXID REDOX SIGN, V19, P1095, DOI 10.1089/ars.2012.4588; Zhang BY, 2016, J PHARMACOL SCI, V132, P171, DOI 10.1016/j.jphs.2016.05.008; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276	60	24	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19723	19739		10.1074/jbc.RA119.009744	http://dx.doi.org/10.1074/jbc.RA119.009744			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31699892	Green Published, hybrid			2022-12-28	WOS:000504093200021
J	Singaravelu, R; Ahmed, N; Quan, C; Srinivasan, P; Ablenas, CJ; Roy, DG; Pezacki, JP				Singaravelu, Ragunath; Ahmed, Nadine; Quan, Curtis; Srinivasan, Prashanth; Ablenas, Christopher J.; Roy, Dominic G.; Pezacki, John Paul			A conserved miRNA-183 cluster regulates the innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); interferon; interferon regulatory factor (IRF); innate immunity; posttranscriptional regulation; antiviral signaling; IFN regulatory factor 3 (IRF3); miR-183 cluster; STAT1	MICRORNA; VIRUS; TRANSCRIPTION; ACTIVATION; EXPRESSION; TYROSINE; MIR-182; STAT1; TBK1; IRF3	Upon immune recognition of viruses, the mammalian innate immune response activates a complex signal transduction network to combat infection. This activation requires phosphorylation of key transcription factors regulating IFN production and signaling, including IFN regulatory factor 3 (IRF3) and STAT1. The mechanisms regulating these STAT1 and IRF3 phosphorylation events remain unclear. Here, using human and mouse cell lines along with gene microarrays, quantitative RT-PCR, viral infection and plaque assays, and reporter gene assays, we demonstrate that a microRNA cluster conserved among bilaterian animals, encoding miR-96, miR-182, and miR-183, regulates IFN signaling. In particular, we observed that the miR-183 cluster promotes IFN production and signaling, mediated by enhancing IRF3 and STAT1 phosphorylation. We also found that the miR-183 cluster activates the IFN pathway and inhibits vesicular stomatitis virus infection by directly targeting several negative regulators of IRF3 and STAT1 activities, including protein phosphatase 2A (PPP2CA) and tripartite motif?containing 27 (TRIM27). Overall, our work reveals an important role of the evolutionarily conserved miR-183 cluster in the regulation of mammalian innate immunity.	[Singaravelu, Ragunath; Roy, Dominic G.; Pezacki, John Paul] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Ahmed, Nadine; Quan, Curtis; Srinivasan, Prashanth; Ablenas, Christopher J.; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Pezacki, JP (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.; Pezacki, JP (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada.	John.Pezacki@uottawa.ca		Srinivasan, Prashanth/0000-0002-4898-2205; Roy, Dominic/0000-0002-6044-0118	Natural Sciences and Engineering Research Council [298496]; Canadian Institutes of Health Research [136807]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council Grant 298496 and Canadian Institutes of Health Research Grant 136807. University of Ottawa has filed a patent on the miR-183 cluster's immunomodulatory properties in the name of John Paul Pezacki and Ragunath Singaravelu.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YM, 2015, INT J CLIN EXP MED, V8, P18462; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Donatelli SS, 2014, P NATL ACAD SCI USA, V111, P4203, DOI 10.1073/pnas.1319269111; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; El Sobky SA, 2016, IMMUNOL LETT, V169, P52, DOI 10.1016/j.imlet.2015.10.013; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Mitchell AM, 2015, MBIO, V6, DOI 10.1128/mBio.02510-14; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Oussaief L, 2015, J VIROL, V89, P12178, DOI 10.1128/JVI.01757-15; Powdrill MH, 2016, CURR OPIN VIROL, V19, P71, DOI 10.1016/j.coviro.2016.07.005; Shanker V, 2013, J VIRAL HEPATITIS, V20, P612, DOI 10.1111/jvh.12083; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Singaravelu R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18529-x; Singaravelu R, 2015, NAT CHEM BIOL, V11, P988, DOI 10.1038/nchembio.1940; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tremblay N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005772; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu HS, 2014, J MOL MED, V92, P961, DOI 10.1007/s00109-014-1159-9; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108	36	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19785	19794		10.1074/jbc.RA119.010858	http://dx.doi.org/10.1074/jbc.RA119.010858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31694919	hybrid, Green Published			2022-12-28	WOS:000504093200025
J	Chaturvedi, R; Bansal, K; Narayana, Y; Kapoor, N; Sukumar, N; Togarsimalemath, SK; Chandra, N; Mishra, S; Ajitkumar, P; Joshi, B; Kotach, VM; Patil, SA; Balaji, KN				Chaturvedi, Rashmi; Bansal, Kushagra; Narayana, Yeddula; Kapoor, Nisha; Sukumar, Namineni; Togarsimalemath, Shambhuprasad Kotresh; Chandra, Nagasuma; Mishra, Saurabh; Ajitkumar, Parthasarathi; Joshi, Beenu; Kotach, Vishwa Mohan; Patil, Shripad A.; Balaji, Kithiganahalli Narayanaswamy			The multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stress (vol 285, pg 30389, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19445	19445		10.1074/jbc.AAC119.011906	http://dx.doi.org/10.1074/jbc.AAC119.011906			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836672	Green Published, hybrid			2022-12-28	WOS:000516527800040
J	Ito, T; Yamamoto, S; Yamaguchi, K; Sato, M; Kaneko, Y; Goto, S; Goto, Y; Narita, I				Ito, Toru; Yamamoto, Suguru; Yamaguchi, Keiichi; Sato, Mami; Kaneko, Yoshikatsu; Goto, Shin; Goto, Yuji; Narita, Ichiei			Inorganic polyphosphate potentiates lipopolysaccharide-induced macrophage inflammatory response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; lipopolysaccharide (LPS); infection; inflammation; micelle; polyphosphate; inflammatory response; LPS micelle formation	MOLECULE	Inorganic polyphosphate (polyP) is a linear polymer of orthophosphate units that are linked by phosphoanhydride bonds and is involved in various pathophysiological processes. However, the role of polyP in immune cell dysfunction is not well-understood. In this study, using several biochemical and cell biology approaches, including cytokine assays, immunofluorescence microscopy, receptor-binding assays with quartz crystal microbalance, and dynamic light scanning, we investigated the effect of polyP on in vitro lipopolysaccharide (LPS)-induced macrophage inflammatory response. PolyP up-regulated LPS-induced production of the inflammatory cytokines, such as tumor necrosis factor ?, interleukin-1?, and interleukin-6, in macrophages, and the effect was polyP dose? and chain length?dependent. However, orthophosphate did not exhibit this effect. PolyP enhanced the LPS-induced intracellular macrophage inflammatory signals. Affinity analysis revealed that polyP interacts with LPS, inducing formation of small micelles, and the polyP-LPS complex enhanced the binding affinity of LPS to Toll-like receptor 4 (TLR4) on macrophages. These results suggest that inorganic polyP plays a critical role in promoting inflammatory response by enhancing the interaction between LPS and TLR4 in macrophages.	[Ito, Toru; Yamamoto, Suguru; Sato, Mami; Kaneko, Yoshikatsu; Goto, Shin; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, 1-757 Asahimachi Dori, Niigata 9518510, Japan; [Yamaguchi, Keiichi; Goto, Yuji] Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan	Niigata University; Osaka University	Yamamoto, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	yamamots@med.niigata-u.ac.jp	Narita, Ichiei/G-5204-2017	Narita, Ichiei/0000-0001-7692-3096; Goto, Yuji/0000-0003-1221-1270; Sato, Mami/0000-0001-5292-8319; Yamamoto, Suguru/0000-0002-8279-2966				Bae JS, 2012, J THROMB HAEMOST, V10, P1145, DOI 10.1111/j.1538-7836.2012.04671.x; Biswas I, 2018, ARTERIOSCL THROM VAS, V38, P1868, DOI 10.1161/ATVBAHA.118.311165; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Dinarvand P, 2014, BLOOD, V123, P935, DOI 10.1182/blood-2013-09-529602; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hori Y, 2017, J AM SOC NEPHROL, V28, P1783, DOI 10.1681/ASN.2016060606; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Takakusagi Y, 2005, BIOORG MED CHEM LETT, V15, P4850, DOI 10.1016/j.bmcl.2005.07.017; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Verhoef JJF, 2017, BLOOD, V129, P1707, DOI 10.1182/blood-2016-08-734988; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	20	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4014	4023		10.1074/jbc.RA119.011763	http://dx.doi.org/10.1074/jbc.RA119.011763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32041779	Green Published, hybrid			2022-12-28	WOS:000527704400025
J	Min, KB; Yoon, SS				Min, Kyung Bae; Yoon, Sang Sun			Transcriptome analysis reveals that the RNA polymerase?binding protein DksA1 has pleiotropic functions in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa; quorum sensing; virulence factor; stress response; transcription regulation; DksA1; transcription factor; stringent response; gene regulation; polyamine metabolism; anaerobic respiration	GENE-EXPRESSION; LIFE-STYLE; PPGPP; VIRULENCE; BIOSYNTHESIS; INFECTIONS; INITIATION; REGULATOR; HIERARCHY; SIGNAL	The stringent response (SR) is a highly conserved stress response in bacteria. It is composed of two factors, (i) a nucleotide alarmone, guanosine tetra- and pentaphosphate ((p)ppGpp), and (ii) an RNA polymerase-binding protein, DksA, that regulates various phenotypes, including bacterial virulence. The clinically significant opportunistic bacterial pathogen Pseudomonas aeruginosa possesses two genes, dksA1 and dksA2, that encode DksA proteins. It remains elusive, however, which of these two genes plays a more important role in SR regulation. In this work, we compared genome-wide, RNA-Seq?based transcriptome profiles of ?dksA1, ?dksA2, and ?dksA1?dksA2 mutants to globally assess the effects of these gene deletions on transcript levels coupled with phenotypic analyses. The ?dksA1 mutant exhibited substantial defects in a wide range of phenotypes, including quorum sensing (QS), anaerobiosis, and motility, whereas the ?dksA2 mutant exhibited no significant phenotypic changes, suggesting that the dksA2 gene may not have an essential function in P. aeruginosa under the conditions used here. Of note, the ?dksA1 mutants displayed substantially increased transcription of genes involved in polyamine biosynthesis, and we also detected increased polyamine levels in these mutants. Because SAM is a shared precursor for the production of both QS autoinducers and polyamines, these findings suggest that DksA1 deficiency skews the flow of SAM toward polyamine production rather than to QS signaling. Together, our results indicate that DksA1, but not DksA2, controls many important phenotypes in P. aeruginosa. We conclude that DksA1 may represent a potential target whose inhibition may help manage recalcitrant P. aeruginosa infections.	[Min, Kyung Bae; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Min, Kyung Bae; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul 03722, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 03722, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea [2017M3A9F3041233, 2019R1A6A1A03032869]; Korean Government	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by National Research Foundation (NRF) of Korea Grants 2017M3A9F3041233 and 2019R1A6A1A03032869, funded by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Azriel S, 2016, INFECT IMMUN, V84, P375, DOI 10.1128/IAI.01135-15; Basu P, 2019, MICROBIOL-SGM, V165, P102, DOI 10.1099/mic.0.000743; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Chernish RN, 2003, CURR OPIN PULM MED, V9, P509, DOI 10.1097/00063198-200311000-00011; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chou HT, 2008, J BACTERIOL, V190, P1966, DOI 10.1128/JB.01804-07; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Furman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120746; Galan-Vasquez Edgardo, 2011, Microb Inform Exp, V1, P3, DOI 10.1186/2042-5783-1-3; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Gray MJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00664-18; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hammond JH, 2015, J BACTERIOL, V197, P2810, DOI 10.1128/JB.00182-15; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hwang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26223; Hwang W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37422-9; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Kim HY, 2018, J BIOL CHEM, V293, P5679, DOI [10.1074/jbc.RA117.000383, 10.1074/jbc.ra117.000383]; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee K, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01182-17; Lee K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw104; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Montravers P, 2016, ADV THER, V33, P151, DOI 10.1007/s12325-016-0293-x; Oh YT, 2015, J BIOL CHEM, V290, P13178, DOI 10.1074/jbc.M115.640466; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Parshin A, 2015, P NATL ACAD SCI USA, V112, pE6862, DOI 10.1073/pnas.1521365112; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Pletzer D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01867; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Pruitt BA, 1998, WORLD J SURG, V22, P135; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Ross W, 2016, MOL CELL, V62, P811, DOI 10.1016/j.molcel.2016.04.029; Ruparell A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33101; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Schafhauser J, 2014, J BACTERIOL, V196, P1641, DOI 10.1128/JB.01086-13; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Smale Stephen T, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5423; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Toyofuku M, 2018, ADV MICROB PHYSIOL, V72, P117, DOI 10.1016/bs.ampbs.2018.01.005; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797; Xu XH, 2016, MICROBIOL RES, V192, P84, DOI 10.1016/j.micres.2016.06.005; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	63	11	12	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3851	3864		10.1074/jbc.RA119.011692	http://dx.doi.org/10.1074/jbc.RA119.011692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047111	hybrid, Green Published			2022-12-28	WOS:000527704400011
J	Quin, C; Vicaretti, SD; Mohtarudin, NA; Garner, AM; Vollman, DM; Gibson, DL; Zandberg, WF				Quin, Candice; Vicaretti, Sara D.; Mohtarudin, Nina A.; Garner, Alexander M.; Vollman, Deanna M.; Gibson, Deanna L.; Zandberg, Wesley F.			Influence of sulfonated and diet-derived human milk oligosaccharides on the infant microbiome and immune markers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; oligosaccharide; microbiome; sialic acid; cytokine; diet; MS; capillary electrophoresis; prebiotic	N-GLYCOLYLNEURAMINIC ACID; SIALIC-ACID; GLYCAN; FECES; ACETYLLACTOSAMINE; MECHANISMS; GENERATION; EXPRESSION; MUCINS; GROWTH	Human milk oligosaccharides (HMOs) promote the development of the neonatal intestinal, immune, and nervous systems and has recently received considerable attention. Here we investigated how the maternal diet affects HMO biosynthesis and how any diet-induced HMO alterations influence the infant gut microbiome and immunity. Using capillary electrophoresis and MS-based analyses, we extracted and measured HMOs from breast milk samples and then correlated their levels with results from validated 24-h diet recall surveys and breast milk fatty acids. We found that fruit intake and unsaturated fatty acids in breast milk were positively correlated with an increased absolute abundance of numerous HMOs, including 16 sulfonated HMOs we identified here in humans for the first time. The diet-derived monosaccharide 5-N-glycolyl-neuraminic acid (Neu5Gc) was unambiguously detected in all samples. To gain insights into the potential impact of Neu5Gc on the infant microbiome, we used a constrained ordination approach and identified correlations between Neu5Gc levels and Bacteroides spp. in infant stool. However, Neu5Gc was not associated with marked changes in infant immune markers, in contrast with sulfonated HMOs, whose expression correlated with suppression of two major Th2 cytokines, IL-10 and IL-13. The findings of our work highlight the importance of maternal diet for HMO biosynthesis and provide as yet unexplored targets for future studies investigating interactions between HMOs and the intestinal microbiome and immunity in infants.	[Quin, Candice; Mohtarudin, Nina A.; Garner, Alexander M.; Vollman, Deanna M.; Gibson, Deanna L.] Univ British Columbia, IK Barber Sch Arts & Sci, Dept Biol, 1177 Res Rd, Kelowna, BC V1V 1V7, Canada; [Vicaretti, Sara D.; Zandberg, Wesley F.] Univ British Columbia, Dept Chem, IK Barber Sch Arts & Sci, 3247 Univ Way, Kelowna, BC V1V 1V7, Canada; [Gibson, Deanna L.] Fac Med, Dept Med, 317-2194 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Gibson, DL (corresponding author), Univ British Columbia, IK Barber Sch Arts & Sci, Dept Biol, 1177 Res Rd, Kelowna, BC V1V 1V7, Canada.; Zandberg, WF (corresponding author), Univ British Columbia, Dept Chem, IK Barber Sch Arts & Sci, 3247 Univ Way, Kelowna, BC V1V 1V7, Canada.	Deanna.Gibson@ubc.ca; wesley.zandberg@ubc.ca	Zandberg, Wesley/AAX-5568-2021; Gibson, Deanna L/CAF-4166-2022	Gibson, Deanna L/0000-0003-0052-7550; Hart, Gerald/0000-0001-7812-4351	Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Natural Sciences and Engineering Research Council of Canada; Crohn's and Colitis Canada; Bill and Melinda Gates Foundation; Canadian Foundation for Innovation John Evans Leaders Fund; BC Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Crohn's and Colitis Canada; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Foundation for Innovation John Evans Leaders Fund; BC Knowledge Development Fund(General Electric)	Supported by scholarships from the Canadian Institutes of Health Research and the Canadian Association of Gastroenterology.; Supported by Natural Sciences and Engineering Research Council of Canada undergraduate student research awards.; Supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant, Crohn's and Colitis Canada, and the Bill and Melinda Gates Foundation. To whom correspondence may be addressed. E-mail:Deanna.Gibson@ubc.ca.; Supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant, the Canadian Foundation for Innovation John Evans Leaders Fund, and the BC Knowledge Development Fund. To whom correspondence may be addressed. E-mail: wesley.zandberg@ubc.ca.	Albrecht S, 2011, CARBOHYD RES, V346, P2540, DOI 10.1016/j.carres.2011.08.009; Albrecht S, 2010, ELECTROPHORESIS, V31, P1264, DOI 10.1002/elps.200900646; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Blank D, 2012, ADV NUTR, V3, p440S, DOI 10.3945/an.111.001446; Bosch AM, 2011, J INHERIT METAB DIS, V34, P257, DOI 10.1007/s10545-010-9157-8; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Bum-Erdene K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20289; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen Y, 2014, BRIT J NUTR, V111, P332, DOI 10.1017/S0007114513002468; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Corfield AP, 1996, GLYCOCONJUGATE J, V13, P809, DOI 10.1007/BF00702345; Davis JCC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40466; Davis JCC, 2016, MOL CELL PROTEOMICS, V15, P2987, DOI 10.1074/mcp.M116.060665; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Estaki M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0189-7; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Guerardel Y, 1999, CARBOHYD RES, V320, P230, DOI 10.1016/S0008-6215(99)00153-6; Hasnain SZ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006218; He Y, 2014, MUCOSAL IMMUNOL, V7, P1326, DOI 10.1038/mi.2014.20; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hill DR, 2012, J BIOL CHEM, V287, P30610, DOI 10.1074/jbc.M112.356238; Jiang X, 2004, J INFECT DIS, V190, P1850, DOI 10.1086/425159; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim H, 2017, BRIT J NUTR, V117, P556, DOI [10.1017/S0007114517000253, 10.1017/s0007114517000253]; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lacomba R, 2011, INT DAIRY J, V21, P887, DOI 10.1016/j.idairyj.2011.05.008; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Mahajan VS, 2016, IMMUNOL REV, V269, P145, DOI 10.1111/imr.12344; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; McGuire MK, 2017, AM J CLIN NUTR, V105, P1086, DOI 10.3945/ajcn.116.139980; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Oliveros E, 2016, J NUTR BIOCHEM, V31, P20, DOI 10.1016/j.jnutbio.2015.12.014; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26423-3; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rohrig CH, 2017, CRIT REV FOOD SCI, V57, P1017, DOI 10.1080/10408398.2015.1040113; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Schwab C, 2011, FEMS MICROBIOL LETT, V315, P141, DOI 10.1111/j.1574-6968.2010.02185.x; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Smilowitz JT, 2014, ANNU REV NUTR, V34, P143, DOI 10.1146/annurev-nutr-071813-105721; Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016; Suzuki A, 2001, J BIOL CHEM, V276, P24388, DOI 10.1074/jbc.M103135200; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Torii T, 2000, GLYCOBIOLOGY, V10, P203, DOI 10.1093/glycob/10.2.203; Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g; Urashima T, 2018, TRENDS GLYCOSCI GLYC, V30, pSE51, DOI 10.4052/tigg.1734.1SE; Vicaretti SD, 2018, J AGR FOOD CHEM, V66, P8574, DOI 10.1021/acs.jafc.8b01041; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wylie AD, 2018, J AGR FOOD CHEM, V66, P8114, DOI 10.1021/acs.jafc.8b01042; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Yu Y, 2012, J BIOL CHEM, V287, P44784, DOI 10.1074/jbc.M112.425819	70	24	26	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4035	4048		10.1074/jbc.RA119.011351	http://dx.doi.org/10.1074/jbc.RA119.011351			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014993	Green Published, hybrid			2022-12-28	WOS:000527704400027
J	Goodall, KJ; Nguyen, A; McKenzie, C; Eckle, SBG; Sullivan, LC; Andrews, DM				Goodall, Katharine Jennifer; Nguyen, Angela; McKenzie, Craig; Eckle, Sidonia Barbara Guiomar; Sullivan, Lucy Catherine; Andrews, Daniel Mark			The murine CD94/NKG2 ligand, Qa-1(b), is a high-affinity, functional ligand for the CD8?? homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						major histocompatibility complex (MHC); innate immunity; lymphocyte; T-cell biology; cell biology; CD8aa; MHC class I antigen E (HLA-E); MHC-Ib; Qa-1b; T cell; TL; cell surface glycoprotein; MHC class I antigen E (HLA-E)	CLASS-IB MOLECULE; DELTA-T-CELLS; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; STRUCTURAL BASIS; DIFFERENTIAL EXPRESSION; CORECEPTOR FUNCTION; CRYSTAL-STRUCTURE; LEUKEMIA ANTIGEN; DENDRITIC CELLS; HLA-E	The immune co-receptor CD8 molecule (CD8) has two subunits, CD8? and CD8?, which can assemble into homo or heterodimers. Nonclassical (class-Ib) major histocompatibility complex (MHC) molecules (MHC-Ibs) have recently been identified as ligands for the CD8?? homodimer. This was demonstrated by the observation that histocompatibility 2, Q region locus 10 (H2-Q10) is a high-affinity ligand for CD8?? which also binds the MHC-Ib molecule H2-TL. This suggests that MHC-Ib proteins may be an extended source of CD8?? ligands. Expression of H2-T3/TL and H2-Q10 is restricted to the small intestine and liver, respectively, yet CD8??-containing lymphocytes are present more broadly. Therefore, here we sought to determine whether murine CD8?? binds only to tissue-specific MHC-Ib molecules or also to ubiquitously expressed MHC-Ib molecules. Using recombinant proteins and surface plasmon resonance?based binding assays, we show that the MHC-Ib family furnishes multiple binding partners for murine CD8??, including H2-T22 and the CD94/NKG2-A/B-activating NK receptor (NKG2) ligand Qa-1(b). We also demonstrate a hierarchy among MHC-Ib proteins with respect to CD8?? binding, in which Qa-1(b) > H2-Q10 > TL. Finally, we provide evidence that Qa-1(b) is a functional ligand for CD8??, distinguishing it from its human homologue MHC class I antigen E (HLA-E). These findings provide additional clues as to how CD8??-expressing cells are controlled in different tissues. They also highlight an unexpected immunological divergence of Qa-1(b)/HLA-E function, indicating the need for more robust studies of murine MHC-Ib proteins as models for human disease.	[Goodall, Katharine Jennifer; Nguyen, Angela; McKenzie, Craig; Andrews, Daniel Mark] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia; [Eckle, Sidonia Barbara Guiomar; Sullivan, Lucy Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Andrews, Daniel Mark] RMIT Univ, Bioproperties Pty Ltd, Bundoora Campus, Bundoora, Vic 3083, Australia	Monash University; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Goodall, KJ (corresponding author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	katharine.goodall@monash.edu	Eckle, Sidonia/O-8146-2014	Eckle, Sidonia/0000-0003-0766-171X; Sullivan, Lucy/0000-0003-2907-4989; Goodall, Katharine/0000-0001-5812-8515; Andrews, Dan/0000-0002-5896-7885; Nguyen, Angela/0000-0003-1610-515X	National Health and Medical Research Council (NHMRC) [APP1141950]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Grant APP1141950 (to L. C. S.).	Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Attinger A, 2005, J IMMUNOL, V174, P3501, DOI 10.4049/jimmunol.174.6.3501; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Colmenero P, 2007, J IMMUNOL, V179, P4608, DOI 10.4049/jimmunol.179.7.4608; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Della Chiesa M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00573; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Goodall KJ, 2019, IMMUNOL CELL BIOL, V97, P326, DOI 10.1111/imcb.12222; Goodall KJ, 2019, MOL IMMUNOL, V115, P31, DOI [10.1016/jmolimm.2018.05.001, 10.1016/j.molimm.2018.05.001]; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Kadivar M, 2016, J IMMUNOL, V197, P4584, DOI 10.4049/jimmunol.1601146; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kenna T, 2004, CLIN IMMUNOL, V113, P56, DOI 10.1016/j.clim.2004.05.003; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Khairallah C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004702; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; LEW AM, 1986, J IMMUNOL, V136, P254; Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; OHTSUKA K, 1994, CELL IMMUNOL, V153, P52, DOI 10.1006/cimm.1994.1005; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Olivares-Villagomez D, 2008, P NATL ACAD SCI USA, V105, P17931, DOI 10.1073/pnas.0808242105; SATO K, 1993, IMMUNOLOGY, V80, P380; Sipes SL, 1996, IMMUNOGENETICS, V45, P108, DOI 10.1007/s002510050178; Sullivan LC, 2017, J BIOL CHEM, V292, P21149, DOI 10.1074/jbc.M117.807719; Sullivan LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135972; Tang XL, 2007, J IMMUNOL, V178, P6043, DOI 10.4049/jimmunol.178.10.6043; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; TORRESNAGEL N, 1992, EUR J IMMUNOL, V22, P2841, DOI 10.1002/eji.1830221113; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WEI XH, 1990, HUM IMMUNOL, V29, P131, DOI 10.1016/0198-8859(90)90076-2; WU M, 1991, J EXP MED, V174, P213, DOI 10.1084/jem.174.1.213	52	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3239	3246		10.1074/jbc.RA119.010509	http://dx.doi.org/10.1074/jbc.RA119.010509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31992596	hybrid, Green Published			2022-12-28	WOS:000519597300028
J	Razai, AS; Eckelman, BP; Salvesen, GS				Razai, Amir S.; Eckelman, Brendan P.; Salvesen, Guy S.			Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; antibody; metalloprotease; protease inhibitor; single-domain antibody; sdAb; nanobody; matrix metalloproteinase; protease; MMP10; MMP3; antibody selectivity; camelid; orthosteric inhibitor	ALPHA-1-PROTEINASE INHIBITOR; THERAPEUTIC TARGETS; TISSUE INHIBITOR; NANOBODIES	Since their discovery, the matrix metalloproteinase (MMP) family proteases have been considered as therapeutic targets in numerous diseases and disorders. Unfortunately, clinical trials with MMP inhibitors have failed to yield any clinical benefits of these inhibitors. These failures were largely due to a lack of MMP-selective agents; accordingly, it has become important to identify a platform with which high selectivity can be achieved. To this end, we propose using MMP-targeting antibodies that can achieve high specificity in interactions with their targets. Using a scaffold of single-domain antibodies, here we raised a panel of MMP10-selective antibodies through immunization of llamas, a member of the camelid family, whose members generate conventional heavy/light-chain antibodies and also smaller antibodies lacking light-chain and CH1 domains. We report the generation of a highly selective and tightly binding MMP10 inhibitor (K-i < 2 nm). Using bio-layer interferometry?based binding assays, we found that this antibody interacts with the MMP10 active site. Activity assays demonstrated that the antibody selectively inhibits MMP10 over its closest relative, MMP3. The ability of a single-domain antibody to discriminate between the most conserved MMP pair via an active site?directed mechanism of inhibition reported here supports the potential of this antibody as a broadly applicable scaffold for the development of selective, tightly binding MMP inhibitors.	[Razai, Amir S.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Razai, Amir S.; Eckelman, Brendan P.] Inhibrx, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Salvesen, GS (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	Gsalvesen@sbpdiscovery.org			NIGMS, National Institutes of Health [GM-099040]; Academic/Industry Fellowship from Inhibrx	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Academic/Industry Fellowship from Inhibrx	This work was supported by NIGMS, National Institutes of Health, Grant GM-099040 (to G. S. S.) and an Academic/Industry Fellowship from Inhibrx (to A. S. R.). The authors declare the following financial relationships. Amir S. Razai and Guy S. Salvesen consult for Inhibrx, and Brendan P. Eckelman is employed by Inhibrx. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown PD, 1999, APMIS, V107, P174, DOI 10.1111/j.1699-0463.1999.tb01541.x; Buelens K, 2010, J THROMB HAEMOST, V8, P1302, DOI 10.1111/j.1538-7836.2010.03816.x; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Fingleton Barbara, 2008, P759, DOI 10.1007/978-0-387-69057-5_36; Gatto C, 1999, CLIN CANCER RES, V5, P3603; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Liotta L A, 1982, Cancer Metastasis Rev, V1, P277, DOI 10.1007/BF00124213; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Mariya T, 2016, ONCOTARGET, V7, P26806, DOI 10.18632/oncotarget.8645; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; MAST AE, 1991, J BIOL CHEM, V266, P15810; Mazurek SGN, 2011, J PHARMACOL TOX MET, V64, P89, DOI 10.1016/j.vascn.2011.02.002; Muyldermans S, 2001, J Biotechnol, V74, P277; Nagase H, 1999, ANN NY ACAD SCI, V878, P1, DOI 10.1111/j.1749-6632.1999.tb07670.x; Nagase H, 2002, ARTHRITIS RES THER, V4, pS51, DOI 10.1186/ar573; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Peterson JT, 2004, HEART FAIL REV, V9, P63, DOI 10.1023/B:HREV.0000011395.11179.af; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Revets H, 2005, EXPERT OPIN BIOL TH, V5, P111, DOI 10.1517/14712598.5.1.111; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Santamaria S, 2019, BRIT J PHARMACOL, V176, P52, DOI 10.1111/bph.14186; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2464	2472		10.1074/jbc.RA119.011712	http://dx.doi.org/10.1074/jbc.RA119.011712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953328	hybrid, Green Published			2022-12-28	WOS:000517330200026
J	Sastre, DE; Basso, LGM; Trastoy, B; Cifuente, JO; Contreras, X; Gueiros, F; de Mendoza, D; Navarro, MVAS; Guerin, ME				Sastre, Diego E.; Basso, Luis G. M.; Trastoy, Beatriz; Cifuente, Javier O.; Contreras, Xabier; Gueiros-Filho, Frederico; de Mendoza, Diego; Navarro, Marcos V. A. S.; Guerin, Marcelo E.			Membrane fluidity adjusts the insertion of the transacylase PlsX to regulate phospholipid biosynthesis in Gram-positive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid metabolism; enzyme mechanism; enzyme catalysis; enzyme mutation; enzyme structure; membrane binding; membrane fluidity; membrane insertion; phospholipid biosynthesis; protein-lipid interaction	BACILLUS-SUBTILIS; FATTY-ACID; CRYSTAL-STRUCTURE; ACP; PROTEINS; COMPLEX; MECHANISM; ENZYME; TEMPERATURE; MONOLAYERS	PlsX plays a central role in the coordination of fatty acid and phospholipid biosynthesis in Gram-positive bacteria. PlsX is a peripheral membrane acyltransferase that catalyzes the conversion of acyl-ACP to acyl-phosphate, which is in turn utilized by the polytopic membrane acyltransferase PlsY on the pathway of bacterial phospholipid biosynthesis. We have recently studied the interaction between PlsX and membrane phospholipids in vivo and in vitro, and observed that membrane association is necessary for the efficient transfer of acyl-phosphate to PlsY. However, understanding the molecular basis of such a channeling mechanism remains a major challenge. Here, we disentangle the binding and insertion events of the enzyme to the membrane, and the subsequent catalysis. We show that PlsX membrane binding is a process mostly mediated by phospholipid charge, whereas fatty acid saturation and membrane fluidity remarkably influence the membrane insertion step. Strikingly, the PlsX(L254E) mutant, whose biological functionality was severely compromised in vivo but remains catalytically active in vitro, was able to superficially bind to phospholipid vesicles, nevertheless, it loses the insertion capacity, strongly supporting the importance of membrane insertion in acyl-phosphate delivery. We propose a mechanism in which membrane fluidity governs the insertion of PlsX and thus regulates the biosynthesis of phospholipids in Gram-positive bacteria. This model may be operational in other peripheral membrane proteins with an unprecedented impact in drug discovery/development strategies.	[Sastre, Diego E.; Navarro, Marcos V. A. S.] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, Sao Carlos, SP, Brazil; [Basso, Luis G. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil; [Trastoy, Beatriz; Cifuente, Javier O.; Guerin, Marcelo E.] CIC BioGUNE Technol Pk Bizkaia, Struct Biol Unit, Derio 48160, Vizcaya, Spain; [Contreras, Xabier; Guerin, Marcelo E.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Contreras, Xabier] Univ Basque Country, CSIC, Inst Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain; [Contreras, Xabier] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Gueiros-Filho, Frederico] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil; [de Mendoza, Diego] Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; Basque Foundation for Science; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Universidade de Sao Paulo	Sastre, DE (corresponding author), Univ Sao Paulo, Ave Joao Dagnone 1100, BR-13563120 Sao Carlos, SP, Brazil.; Guerin, ME (corresponding author), CIC BioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio 48160, Spain.	diegosastre82@gmail.com; mrcguerin@cicbiogune.es	Basso, Luis GM/AAF-9872-2021; Trastoy, Beatriz/F-3692-2016; Basso, Luis GM/N-6692-2013; Cifuente, Javier O./AAC-5127-2019; Navarro, Marcos VAS/C-9141-2013; Cifuente, Javier/F-3874-2016; Gueiros-Filho, Frederico J./D-2160-2013; Guerin, Marcelo/N-7245-2016	Basso, Luis GM/0000-0003-1277-1008; Trastoy, Beatriz/0000-0002-2178-732X; Basso, Luis GM/0000-0003-1277-1008; Cifuente, Javier O./0000-0001-5420-121X; Cifuente, Javier/0000-0001-5420-121X; Gueiros-Filho, Frederico J./0000-0001-5425-2439; Contreras, Xabier/0000-0003-0875-634X; Guerin, Marcelo/0000-0001-9524-3184	Ministerio de Economia, Industria y Competitividad (MINECO) [BFU2016-77427-C2-2-R, BFU2017-92223-EXP, SEV-2016-0644]; Basque Government [KK-2019/00076]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/13411-1]; "Juan de la Cierva" post-doctoral contract from the MINECO [IJCI-2014-19206]; FAPESP [2016/05203-5, 2015/21583-0, 2014/00206-0]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)	Ministerio de Economia, Industria y Competitividad (MINECO); Basque Government(Basque Government); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Juan de la Cierva" post-doctoral contract from the MINECO; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Ministerio de Economia, Industria y Competitividad (MINECO) Contracts BFU2016-77427-C2-2-R and BFU2017-92223-EXP, and Severo Ochoa Excellence Accreditation SEV-2016-0644 (to M. E. G.), Grant KK-2019/00076 from the Basque Government (to M. E. G.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Postdoctoral Fellowship 2014/13411-1 (to D. E. S.), "Juan de la Cierva" post-doctoral contract IJCI-2014-19206 from the MINECO (to B. T.), FAPESP Grants 2016/05203-5 (to F. G.-F.) and 2015/21583-0 (to M. N.), FAPESP scholarship 2014/00206-0 (to L. G. M. B.), and a Career Investigator Award from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) (to D. d. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Altabe SG, 2003, J BACTERIOL, V185, P3228, DOI 10.1128/JB.185.10.3228-3231.2003; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bartucci R., 2013, SPIN LABELING EPR LI, DOI [10.1007/978-3-642-16712_594, DOI 10.1007/978-3-642-16712_594]; Basso LGM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37131; Basso Luis G Mansor, 2016, Biophys Rev, V8, P179, DOI 10.1007/s12551-016-0199-5; Beranova J, 2010, J BACTERIOL, V192, P4164, DOI 10.1128/JB.00384-10; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisselier E, 2012, LANGMUIR, V28, P9680, DOI 10.1021/la301135z; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Budil DE, 2006, J PHYS CHEM A, V110, P3703, DOI 10.1021/jp054738k; Calvez P, 2011, LANGMUIR, V27, P1373, DOI 10.1021/la104097n; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; de Mendoza D, 2014, ANNU REV MICROBIOL, V68, P101, DOI 10.1146/annurev-micro-091313-103612; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; HAWCO MW, 1981, BIOCHIM BIOPHYS ACTA, V646, P185, DOI 10.1016/0005-2736(81)90286-8; Jiang YP, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0562-8; Kim Y., 2009, Journal of Structural and Functional Genomics, V10, P157, DOI 10.1007/s10969-008-9052-9; Lella M, 2017, BIOCHEMISTRY-US, V56, P2971, DOI 10.1021/acs.biochem.7b00375; Loew C, 2011, LANGMUIR, V27, P10041, DOI 10.1021/la201027p; Lopez D, 2017, CURR OPIN MICROBIOL, V36, P76, DOI 10.1016/j.mib.2017.02.001; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Luckey M., 2008, MEMBRANE STRUCTURAL; Maloney FP, 2016, P NATL ACAD SCI USA, V113, P10316, DOI 10.1073/pnas.1607210113; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; Marsh D, 1981, Mol Biol Biochem Biophys, V31, P51; Marsh D, 1996, BBA-BIOMEMBRANES, V1279, P119, DOI 10.1016/0005-2736(95)00296-0; Martinez MA, 2010, BIOCHEMISTRY-US, V49, P3161, DOI 10.1021/bi100136n; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; Morozova D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002067; Muller A, 2016, P NATL ACAD SCI USA, V113, pE7077, DOI 10.1073/pnas.1611173113; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Parsons JB, 2015, MOL MICROBIOL, V96, P28, DOI 10.1111/mmi.12916; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Saita EA, 2015, BBA-BIOMEMBRANES, V1848, P1757, DOI 10.1016/j.bbamem.2015.04.005; Sajbidor J, 1997, CRIT REV BIOTECHNOL, V17, P87, DOI 10.3109/07388559709146608; Sastre DE, 2020, J BIOL CHEM, V295, P2148, DOI 10.1074/jbc.RA119.011147; Sastre DE, 2016, MOL MICROBIOL, V100, P621, DOI 10.1111/mmi.13337; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Siliakus MF, 2017, EXTREMOPHILES, V21, P651, DOI 10.1007/s00792-017-0939-x; Soderlund T, 2003, BIOPHYS J, V85, P2333, DOI 10.1016/S0006-3495(03)74657-8; Takada H, 2014, MOL MICROBIOL, V91, P242, DOI 10.1111/mmi.12457; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhang L, 2016, CELL RES, V26, P1330, DOI 10.1038/cr.2016.136; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zhao H, 2006, BBA-BIOMEMBRANES, V1758, P1461, DOI 10.1016/j.bbamem.2006.03.037	55	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2136	2147		10.1074/jbc.RA119.011122	http://dx.doi.org/10.1074/jbc.RA119.011122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31796629	hybrid, Green Published			2022-12-28	WOS:000517128200030
J	Klein, MA; Liu, C; Kuznetsov, VI; Feltenberger, JB; Tang, WP; Denu, JM				Klein, Mark A.; Liu, Can; Kuznetsov, Vyacheslav I.; Feltenberger, John B.; Tang, Weiping; Denu, John M.			Mechanism of activation for the sirtuin 6 protein deacylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; epigenetics; cancer; histone deacetylase (HDAC); histone; chromatin; activator; deacetylation; lifespan; longevity; SIRT6; long chain acyl substrate	HISTONE DEACETYLASE SIRT6; GENOMIC INSTABILITY; IMPROVES HEALTH; LIFE-SPAN; CHROMATIN; MICE; HOMEOSTASIS; SURVIVAL; REPAIR; LYSINE	The histone deacetylase sirtuin 6 (SIRT6) regulates numerous biological functions, including transcriptional repression, DNA repair, and telomere maintenance. Recombinant SIRT6 displays catalytic efficiencies 2 orders of magnitude greater for long-chain deacylation than deacetylation against peptide substrates; however, deacetylation can be enhanced by allosteric small-molecule activators. Here, we investigated the mechanisms of activated lysine deacetylation and enhanced long-chain acyl-group removal by SIRT6. Activity-based screening identified compounds that activated histone peptide deacetylation 18-48-fold. Chemical optimization based on structure-activity relationships yielded an activator with improved potency and selectivity for SIRT6. Using this novel activator, we conducted biochemical and kinetic analyses revealing that SIRT6 is activated via acceleration of a catalytic step occurring after substrate binding but before NAD(+) cleavage. We identified a SIRT6 variant, R65A, that maintains basal deacetylase activity but cannot be activated and failed to enhance long-chain deacylation. Additional biochemical studies revealed that Arg-65 is critical for activation by facilitating a conformational step that initiates chemical catalysis. This work suggests that SIRT6 activation of deacetylation involves a similar mechanism to improved catalysis as that of long-chain deacylation. The identification of novel SIRT6 activators and the molecular insights into activation and catalysis presented here provide a foundational understanding for physiological SIRT6 activation and for rational design of activating molecules.	[Klein, Mark A.; Kuznetsov, Vyacheslav I.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Klein, Mark A.; Kuznetsov, Vyacheslav I.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Liu, Can; Tang, Weiping] Univ Wisconsin, Sch Pharm, Madison, WI 53715 USA; [Feltenberger, John B.] Univ Wisconsin, Sch Pharm, Med Chem Ctr, Madison, WI 53715 USA; [Denu, John M.] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Denu, JM (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA.	john.denu@wisc.edu		Klein, Mark/0000-0002-6782-8502	National Institutes of Health [GM65386]; University of Wisconsin Institute for Clinical and Translational Research; NIGMS, National Institutes of Health, Chemistry-Biology Interface Training Program [T32GM008505]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Institute for Clinical and Translational Research; NIGMS, National Institutes of Health, Chemistry-Biology Interface Training Program	This work was supported by National Institutes of Health Grant GM65386 (to J. M. D.) and the University of Wisconsin Institute for Clinical and Translational Research. J. M. D is a consultant for FORGE Life Science, and cofounder of Galilei BioSciences.; Supported by NIGMS, National Institutes of Health, Chemistry-Biology Interface Training Program Grant T32GM008505.	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Dai H, 2018, PHARMACOL THERAPEUT, V188, P140, DOI 10.1016/j.pharmthera.2018.03.004; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Ferrer CM, 2018, GENE DEV, V32, P373, DOI 10.1101/gad.307330.117; Ghosh S, 2015, CELL REP, V13, P1396, DOI 10.1016/j.celrep.2015.10.006; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Iachettini S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1065-0; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Madsen AS, 2016, J BIOL CHEM, V291, P7128, DOI 10.1074/jbc.M115.668699; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Rahnasto-Rilla M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22388-5; Rahnasto-Rilla MK, 2017, MAR DRUGS, V15, DOI 10.3390/md15060190; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Shi YW, 2013, J PHYS CHEM LETT, V4, P491, DOI 10.1021/jz302015s; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202; Tian X, 2019, CELL, V177, P622, DOI 10.1016/j.cell.2019.03.043; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhang J, 2015, EUR REV MED PHARMACO, V19, P818; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	43	29	29	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1385	1399		10.1074/jbc.RA119.011285	http://dx.doi.org/10.1074/jbc.RA119.011285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31822559	Green Published, Bronze			2022-12-28	WOS:000513822300020
J	Gao, YR; Cao, DD; Ahn, HM; Swain, A; Hill, S; Ogilvie, C; Kurien, M; Rahmatullah, T; Liang, B				Gao, Yunrong; Cao, Dongdong; Ahn, Hyunjun Max; Swain, Anshuman; Hill, Shaylan; Ogilvie, Claire; Kurien, Matthew; Rahmatullah, Taha; Liang, Bo			In vitro trackable assembly of RNA-specific nucleocapsids of the respiratory syncytial virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						negative-strand RNA virus; RNA?protein interaction; chromatography; EM; protein assembly; genome replication; nucleocapsid (NC); nucleocapsid-like particle (NCLP); nucleoprotein (N); respiratory syncytial virus (RSV)	VESICULAR STOMATITIS-VIRUS; CRYSTAL-STRUCTURE; NUCLEOPROTEIN; REPLICATION; COMPLEX; PROTEIN; RULE; TRANSCRIPTION; SEQUENCES; GENETICS	The templates for transcription and replication by respiratory syncytial virus (RSV) polymerase are helical nucleocapsids (NCs), formed by viral RNAs that are encapsidated by the nucleoprotein (N). Proper NC assembly is vital for RSV polymerase to engage the RNA template for RNA synthesis. Previous studies of NCs or nucleocapsid-like particles (NCLPs) from RSV and other nonsegmented negative-sense RNA viruses have provided insights into the overall NC architecture. However, in these studies, the RNAs were either random cellular RNAs or average viral genomic RNAs. An in-depth mechanistic understanding of NCs has been hampered by lack of an in vitro assay that can track NC or NCLP assembly. Here we established a protocol to obtain RNA-free N protein (N-0) and successfully demonstrated the utility of a new assay for tracking assembly of N with RNA oligonucleotides into NCLPs. We discovered that the efficiency of the NCLP (N?RNA) assembly depends on the length and sequence of the RNA incorporated into NCLPs. This work provides a framework to generate purified N-0 and incorporate it with RNA into NCLPs in a controllable manner. We anticipate that our assay for in vitro trackable assembly of RSV-specific nucleocapsids may enable in-depth mechanistic analyses of this process.	[Gao, Yunrong; Cao, Dongdong; Ahn, Hyunjun Max; Swain, Anshuman; Hill, Shaylan; Ogilvie, Claire; Kurien, Matthew; Rahmatullah, Taha; Liang, Bo] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Liang, B (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	bo.liang@emory.edu		Liang, Bo/0000-0002-5617-9228; Cao, Dongdong/0000-0002-2031-9321; Ahn, Hyunjun/0000-0002-5353-4845; Gao, Yunrong/0000-0001-6787-2397	NIGMS, National Institute of Health [R01GM130950]; Emory University School of Medicine	NIGMS, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Emory University School of Medicine	This work was supported by NIGMS, National Institute of Health Grant R01GM130950 (to B. L.) and research startup funds from Emory University School of Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Bukreyev A, 1996, J VIROL, V70, P6634, DOI 10.1128/JVI.70.10.6634-6641.1996; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; Collins PL, 2013, FIELDS VIROLOGY, V1, P1087; Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Desfosses A, 2019, P NATL ACAD SCI USA, V116, P4256, DOI 10.1073/pnas.1816417116; Fearns R, 2002, J VIROL, V76, P1663, DOI 10.1128/JVI.76.4.1663-1672.2002; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Green TJ, 2011, J VIROL, V85, P2714, DOI 10.1128/JVI.01927-10; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Guryanov SG, 2016, J VIROL, V90, P2849, DOI 10.1128/JVI.02865-15; Gutsche I, 2015, SCIENCE, V348, P704, DOI 10.1126/science.aaa5137; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; Jamin M, 2017, ADV VIRUS RES, V97, P143, DOI 10.1016/bs.aivir.2016.09.001; Jorquera PA, 2017, EXPERT REV RESP MED, V11, P609, DOI 10.1080/17476348.2017.1338567; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Liuzzi M, 2005, J VIROL, V79, P13105, DOI 10.1128/JVI.79.20.13105-13115.2005; MacLellan K, 2007, J VIROL, V81, P9519, DOI 10.1128/JVI.00526-07; Milles S, 2016, ANGEW CHEM INT EDIT, V55, P9356, DOI 10.1002/anie.201602619; MINK MA, 1991, VIROLOGY, V185, P615, DOI 10.1016/0042-6822(91)90532-G; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; Noton SL, 2014, VIROLOGY, V462, P318, DOI 10.1016/j.virol.2014.05.032; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Ogino T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01490; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Samal SK, 1996, J VIROL, V70, P5075, DOI 10.1128/JVI.70.8.5075-5082.1996; Sengar A, 2014, BIOCHEMISTRY-US, V53, P7718, DOI 10.1021/bi500990v; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Sugita Y, 2018, NATURE, V563, P137, DOI 10.1038/s41586-018-0630-0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Wan W, 2017, NATURE, V551, P394, DOI 10.1038/nature24490; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868	41	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					883	895		10.1074/jbc.RA119.011602	http://dx.doi.org/10.1074/jbc.RA119.011602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31822560	hybrid, Green Published			2022-12-28	WOS:000508382900017
J	Spiering, MJ				Spiering, Martin J.			How to catch a HIF?the work of Gregg Semenza's lab on hypoxia-inducible factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ENHANCER					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	9	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					715	716		10.1074/jbc.CL119.012269	http://dx.doi.org/10.1074/jbc.CL119.012269			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953247	Green Published, hybrid			2022-12-28	WOS:000508382900004
J	Kim, D; Song, J; Jin, EJ				Kim, Dongkyun; Song, Jinsoo; Jin, Eun-Jung			RETRACTION: MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of Slug by targeting Mdm2. (Retraction of Vol 287, Pg 12501, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Kim D, 2012, J BIOL CHEM, V287, P12501, DOI 10.1074/jbc.M111.264382	1	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					668	668		10.1074/jbc.W119.012220	http://dx.doi.org/10.1074/jbc.W119.012220			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31924674	Green Published, hybrid			2022-12-28	WOS:000507373600033
J	Park, KC; Geleta, B; Leck, LYW; Paluncic, J; Chiang, SN; Jansson, PJ; Kovacevic, Z; Richardson, DR				Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.			Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; cancer biology; molecular pharmacology; receptor tyrosine kinase; hepatocyte growth factor (HGF); c-Met; hepatocyte growth factor receptor; MET proto-oncogene receptor tyrosine kinase (MET); N-myc downstream-regulated gene-1 (NDRG1); thiosemicarbazone	HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SELECTIVE ANTITUMOR-ACTIVITY; MITOGEN-INDUCIBLE GENE-6; RECEPTOR TYROSINE KINASE; IRON CHELATORS; METASTASIS SUPPRESSOR; REGULATED GENE-1; DOWN-REGULATION; UP-REGULATION	Considering the role of proto-oncogene c-Met (c-Met) in oncogenesis, we examined the effects of the metastasis suppressor, N-myc downstream-regulated gene-1 (NDRG1), and two NDRG1-inducing thiosemicarbazone-based agents, Dp44mT and DpC, on c-Met expression in DU145 and Huh7 cells. NDRG1 silencing without Dp44mT and DpC up-regulated c-Met expression, demonstrating that NDRG1 modulates c-Met levels. Dp44mT and DpC up-regulated NDRG1 by an iron-dependent mechanism and decreased c-Met levels, c-Met phosphorylation, and phosphorylation of its downstream effector, GRB2-associated binding protein 1 (GAB1). However, incubation with Dp44mT and DpC after NDRG1 silencing or silencing of the receptor tyrosine kinase inhibitor, mitogen-inducible gene 6 (MIG6), decreased c-Met and its phosphorylation, suggesting NDRG1- and MIG6-independent mechanism(s). Lysosomal inhibitors rescued the Dp44mT- and DpC-mediated c-Met down-regulation in DU145 cells. Confocal microscopy revealed that lysosomotropic agents and the thiosemicarbazones significantly increased co-localization between c-Met and lysosomal-associated membrane protein 2 (LAMP2). Moreover, generation of c-Met C-terminal fragment (CTF) and its intracellular domain (ICD) suggested metalloprotease-mediated cleavage. In fact, Dp44mT increased c-Met CTF while decreasing the ICD. Dp44mT and a ?-secretase inhibitor increased cellular c-Met CTF levels, suggesting that Dp44mT induces c-Met CTF levels by increasing metalloprotease activity. The broad metalloprotease inhibitors, EDTA and batimastat, partially prevented Dp44mT-mediated down-regulation of c-Met. In contrast, the ADAM inhibitor, TIMP metallopeptidase inhibitor 3 (TIMP-3), had no such effect, suggesting c-Met cleavage by another metalloprotease. Notably, Dp44mT did not induce extracellular c-Met shedding that could decrease c-Met levels. In summary, the thiosemicarbazones Dp44mT and DpC effectively inhibit oncogenic c-Met through lysosomal degradation and metalloprotease-mediated cleavage.	[Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan	University of Sydney; University of Sydney; Nagoya University	Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.; Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	zaklina.kovacevic@sydney.edu.au; d.richardson@med.usyd.edu.au	Geleta, Bekesho/AAC-5785-2022; Kovacevic, Zaklina/ABD-9581-2021; Jansson, Patric/AAC-4221-2022	Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Leck Yi Wen, Lionel/0000-0001-7589-6735; Wendimu, Bekesho Geleta/0000-0002-4546-9692; Chiang, Shannon/0000-0002-5043-9586; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia (NHMRC) [1060482]; Priority-driven Collaborative Cancer Research Scheme Grant - Cure Cancer Australia Foundation of Australia [1086449]; Cancer Australia; NHMRC/PdCCRS Cancer Australia Project Grant - NBCF [NHMRC APP1146599]; National Breast Cancer Foundation (NBCF) [IIRS-19-048]; Research Training Program Scholarship from the University of Sydney; Cancer Institute of New South Wales Career Development Fellowship [CDF171147]; NHMRC Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; NHMRC RD Wright Fellowship [APP1140447]; Cancer Institute New South Wales Career Development Fellowship [CDF171126]; NHMRC Senior Principal Research Fellowship [1062607]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Priority-driven Collaborative Cancer Research Scheme Grant - Cure Cancer Australia Foundation of Australia; Cancer Australia; NHMRC/PdCCRS Cancer Australia Project Grant - NBCF; National Breast Cancer Foundation (NBCF); Research Training Program Scholarship from the University of Sydney; Cancer Institute of New South Wales Career Development Fellowship; NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Fellowship; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development Fellowship; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1060482 (to D. R. R. and Z. K.) and Priority-driven Collaborative Cancer Research Scheme Grant 1086449 co-funded by the Cure Cancer Australia Foundation of Australia and Cancer Australia) (to Z. K.). This research was also supported by NHMRC/PdCCRS Cancer Australia Project Grant co-Funded by NBCF (NHMRC APP1146599) and National Breast Cancer Foundation (NBCF) grant support IIRS-19-048 (to D. R. R. and P. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Research Training Program Scholarship from the University of Sydney.; Recipient of Cancer Institute of New South Wales Career Development Fellowship CDF171147.; Supported by NHMRC Peter Doherty Early Career Fellowship 1037323, Cancer Institute New South Wales Early Career Fellowship 12-ECF2-17, NHMRC RD Wright Fellowship APP1140447, and Cancer Institute New South Wales Career Development Fellowship CDF171126. To whom correspondence may be addressed: Molecular Pharmacology and Pathology Program, Dept. of Pathology and Bosch Institute, Medical Foundation Bldg. (K25), University of Sydney, Sydney, New South Wales 2006, Australia. Tel.: 6129036-3026; E-mail: zaklina.kovacevic@sydney.edu.au.; Supported by NHMRC Senior Principal Research Fellowship 1062607. To whom correspondence may be addressed: Molecular Pharmacology and Pathology Program, Dept. of Pathology and Bosch Institute, Medical Foundation Bldg. (K25), University of Sydney, Sydney, New South Wales 2006, Australia. Tel.: 612-9036-3026; E-mail: d.richardson@med.usyd.edu.au.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Al-Akra L, 2018, J BIOL CHEM, V293, P3562, DOI 10.1074/jbc.M116.772699; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Ancot F, 2012, TRAFFIC, V13, P1261, DOI 10.1111/j.1600-0854.2012.01384.x; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bachleitner-Hofmann T, 2011, CLIN CANCER RES, V17, P122, DOI 10.1158/1078-0432.CCR-10-0253; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Ceci A, 2003, EXPERT OPIN PHARMACO, V4, P1763, DOI 10.1517/14656566.4.10.1763; Chalupsky K, 2013, FOLIA BIOL-PRAGUE, V59, P76; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Codony-Servat J, 1999, CANCER RES, V59, P1196; Copin MC, 2016, LUNG CANCER, V101, P59, DOI 10.1016/j.lungcan.2016.09.009; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; GALVANI AP, 1995, BIOCHEM PHARMACOL, V50, P959, DOI 10.1016/0006-2952(95)00219-P; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GIORDANO S, 1989, ONCOGENE, V4, P1383; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Krishan S, 2016, BBA-MOL CELL RES, V1863, P2916, DOI 10.1016/j.bbamcr.2016.09.011; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li PC, 2016, AM J TRANSL RES, V8, P5370; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; Ogunwobi OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063765; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Park KC, 2020, FREE RADICAL BIO MED, V157, P154, DOI 10.1016/j.freeradbiomed.2019.05.020; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; Peng M, 2010, IMMUNOLOGY, V130, P83, DOI 10.1111/j.1365-2567.2009.03215.x; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1994, J CELL PHYSIOL, V161, P160, DOI 10.1002/jcp.1041610119; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sahni S, 2019, BBA-MOL BASIS DIS, V1865, P1361, DOI 10.1016/j.bbadis.2019.02.008; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Schelter F, 2010, J BIOL CHEM, V285, P26335, DOI 10.1074/jbc.M110.106435; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sidarovich V, 2015, MOL PHARMACOL, V87, P513, DOI 10.1124/mol.114.095729; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	87	14	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					481	503		10.1074/jbc.RA119.011341	http://dx.doi.org/10.1074/jbc.RA119.011341			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744884	Green Published, hybrid			2022-12-28	WOS:000507373600018
J	Johnston, JR; Landim-Vieira, M; Marques, MA; de Oliveira, GAP; Gonzalez-Martinez, D; Moraes, AH; He, H; Iqbal, A; Wilnai, Y; Birk, E; Zucker, N; Silva, JL; Chase, PB; Pinto, JR				Johnston, Jamie R.; Landim-Vieira, Maicon; Marques, Mayra A.; de Oliveira, Guilherme A. P.; Gonzalez-Martinez, David; Moraes, Adolfo H.; He, Huan; Iqbal, Anwar; Wilnai, Yael; Birk, Einat; Zucker, Nili; Silva, Jerson L.; Chase, P. Bryant; Pinto, Jose Renato			The intrinsically disordered C terminus of troponin T binds to troponin C to modulate myocardial force generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac muscle; contractile protein; protein dynamic; structure?function; cardiovascular disease; cardiac muscle; cardiomyopathy; cross-bridges; NMR; troponin	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HUMAN CARDIAC TROPONIN; DILATED CARDIOMYOPATHY; THIN FILAMENT; FUNCTIONAL-CHARACTERIZATION; TENSION DEVELOPMENT; CA2+ SENSITIVITY; ATPASE ACTIVITY; NMR RELAXATION; RARE VARIANTS	Aberrant regulation of myocardial force production represents an early biomechanical defect associated with sarcomeric cardiomyopathies, but the molecular mechanisms remain poorly defined. Here, we evaluated the pathogenicity of a previously unreported sarcomeric gene variant identified in a pediatric patient with sporadic dilated cardiomyopathy, and we determined a molecular mechanism. Trio whole-exome sequencing revealed a de novo missense variant in TNNC1 that encodes a p.I4M substitution in the N-terminal helix of cardiac troponin C (cTnC). Reconstitution of this human cTnC variant into permeabilized porcine cardiac muscle preparations significantly decreases the magnitude and rate of isometric force generation at physiological Ca2+-activation levels. Computational modeling suggests that this inhibitory effect can be explained by a decrease in the rates of cross-bridge attachment and detachment. For the first time, we show that cardiac troponin T (cTnT), in part through its intrinsically disordered C terminus, directly binds to WT cTnC, and we find that this cardiomyopathic variant displays tighter binding to cTnT. Steady-state fluorescence and NMR spectroscopy studies suggest that this variant propagates perturbations in cTnC structural dynamics to distal regions of the molecule. We propose that the intrinsically disordered C terminus of cTnT directly interacts with the regulatory N-domain of cTnC to allosterically modulate Ca2+ activation of force, perhaps by controlling the troponin I switching mechanism of striated muscle contraction. Alterations in cTnC?cTnT binding may compromise contractile performance and trigger pathological remodeling of the myocardium.	[Johnston, Jamie R.; Landim-Vieira, Maicon; Gonzalez-Martinez, David; He, Huan; Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West Call St, Tallahassee, FL 32306 USA; [Marques, Mayra A.; de Oliveira, Guilherme A. P.; Iqbal, Anwar; Silva, Jerson L.] Univ Fed Rio Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Programa Biol Estrutural,Inst Nacl Biol Estrutura, BR-21941902 Rio De Janeiro, Brazil; [Moraes, Adolfo H.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil; [Chase, P. Bryant] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [He, Huan] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Wilnai, Yael] Dana Dwek Children COs Hosp, Tel Aviv Sourasky Med Ctr, Dept Pediat, IL-6423906 Israel, Israel; [Birk, Einat; Zucker, Nili] Tel Aviv Univ, Schneider Childrens Med Ctr, Dept Cardiol, IL-4920235 Petah Tiqwa, Israel	State University System of Florida; Florida State University; Universidade Federal de Minas Gerais; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	Marques, Mayra/AAN-3130-2021; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022; de Oliveira, Guilherme A. P./O-1192-2013; Pinto, Jose R/H-2631-2017	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Landim-Vieira, Maicon/0000-0002-6696-8888; Gonzalez-Martinez, David/0000-0003-1782-9133; Pinto, Jose R/0000-0001-9092-4976	American Heart Association [19PRE34380628]; National Institutes of Health from NHLBI [HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 19PRE34380628 (to J. R. J.) and National Institutes of Health Grant HL128683 from NHLBI (to J. R. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alves ML, 2017, CARDIOVASC RES, V113, P915, DOI 10.1093/cvr/cvx068; Baker AJ, 1998, AM J PHYSIOL-HEART C, V275, pH744, DOI 10.1152/ajpheart.1998.275.3.H744; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bing W, 1997, BIOCHEM J, V327, P335, DOI 10.1042/bj3270335; Blumenschein TMA, 2001, J BIOL CHEM, V276, P36606, DOI 10.1074/jbc.M105130200; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brunet NM, 2014, ARCH BIOCHEM BIOPHYS, V552, P11, DOI 10.1016/j.abb.2013.12.021; Burke MA, 2016, J AM COLL CARDIOL, V68, P2871, DOI 10.1016/j.jacc.2016.08.079; Cannata' A, 2019, EUR HEART J SUPPL, V21, pB90, DOI 10.1093/eurheartj/suz033; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; Chung JH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00562; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Deranek AE, 2019, PFLUG ARCH EUR J PHY, V471, P661, DOI 10.1007/s00424-019-02269-0; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gonzalez-Martinez D, 2018, J MOL CELL CARDIOL, V123, P26, DOI 10.1016/j.yjmcc.2018.08.015; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Johnson D, 2018, BIOPHYS J, V115, P702, DOI 10.1016/j.bpj.2018.06.028; Johnston JR, 2018, ONCOTARGET, V9, P1461, DOI 10.18632/oncotarget.22879; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kawai M, 2017, BIOPHYS J, V112, P1726, DOI 10.1016/j.bpj.2017.02.045; Khush K, 2018, J HEART LUNG TRANSPL, V37, pS341, DOI 10.1016/j.healun.2018.01.874; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 1999, BIOCHEMISTRY-US, V38, P5386, DOI 10.1021/bi981320m; Kowlessur D, 2012, J BIOL CHEM, V287, P42299, DOI 10.1074/jbc.M112.423459; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDESBERG A, 1994, AM J PHYSIOL, V266, pH1260, DOI 10.1152/ajpheart.1994.266.3.H1260; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; LIPARI G, 1982, NATURE, V300, P197, DOI 10.1038/300197a0; Lipshultz SE, 2019, CIRCULATION, V140, pE9, DOI 10.1161/CIR.0000000000000682; Loong CKP, 2013, CELL MOL BIOENG, V6, P183, DOI 10.1007/s12195-013-0269-8; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Marques MA, 2019, ARCH BIOCHEM BIOPHYS, V663, P95, DOI 10.1016/j.abb.2018.12.026; Marques MD, 2017, J BIOL CHEM, V292, P2379, DOI 10.1074/jbc.M116.765362; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Na I, 2016, BIOL CHEM, V397, P731, DOI 10.1515/hsz-2015-0303; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pejaver V, 2017, BIORXIV, DOI [10.1101/134981, DOI 10.1101/134981]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2011, J BIOL CHEM, V286, P34404, DOI 10.1074/jbc.M111.267211; Pinto JR, 2011, J BIOL CHEM, V286, P1005, DOI 10.1074/jbc.M110.168583; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Regnier M, 1999, BIOPHYS J, V76, P2664, DOI 10.1016/S0006-3495(99)77418-7; Repetti GG, 2019, CIRC RES, V124, P1536, DOI 10.1161/CIRCRESAHA.119.313569; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ripoll-Vera T, 2016, REV ESP CARDIOL, V69, P149, DOI 10.1016/j.rec.2015.06.025; Risi C, 2017, P NATL ACAD SCI USA, V114, P6782, DOI 10.1073/pnas.1700868114; Rossano JW, 2018, J HEART LUNG TRANSPL, V37, P1184, DOI 10.1016/j.healun.2018.07.018; Schmidt C, 2014, NAT PROTOC, V9, P2224, DOI 10.1038/nprot.2014.144; Schultheiss HP, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0084-1; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Solis C, 2018, BIOPHYS J, V115, P1762, DOI 10.1016/j.bpj.2018.08.033; Stehle R, 2010, J MOL CELL CARDIOL, V48, P843, DOI 10.1016/j.yjmcc.2009.12.020; Stevens CM, 2017, J BIOL CHEM, V292, P11915, DOI 10.1074/jbc.M116.770776; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; van der Velden J, 2019, PHYSIOL REV, V99, P381, DOI 10.1152/physrev.00040.2017; Veltri T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00777-6; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Williams MR, 2016, P NATL ACAD SCI USA, V113, P3257, DOI 10.1073/pnas.1519541113; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; WOLFF MR, 1995, CIRC RES, V76, P154, DOI 10.1161/01.RES.76.1.154; Zamora JE, 2016, PHYS CHEM CHEM PHYS, V18, P20691, DOI 10.1039/c6cp02610a	90	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20054	20069		10.1074/jbc.RA119.011177	http://dx.doi.org/10.1074/jbc.RA119.011177			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748410	Green Published, hybrid			2022-12-28	WOS:000505005800019
J	Emmanuel, JS; Sengupta, A; Gordon, ER; Noble, JT; Cruz-Vera, LR				Emmanuel, Jerusha Salome; Sengupta, Arnab; Gordon, Emily Roth; Noble, Joseph Thomas; Cruz-Vera, Luis Rogelio			The regulatory TnaC nascent peptide preferentially inhibits release factor 2-mediated hydrolysis of peptidyl-tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Regulatory nascent peptides; release factor; L-tryptophan; peptidyl transferase center; ribosomal arrest; gene regulation; translation termination; tnaC; GGQ tripeptide motif	TRYPTOPHANASE OPERON EXPRESSION; 23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; GGQ MOTIF; TRANSLATION; TERMINATION; INDUCTION; CODON; RF2; NUCLEOTIDES	The tnaC regulatory gene from the tna operon of Escherichia coli controls the transcription of its own operon through an attenuation mechanism relying on the accumulation of arrested ribosomes during inhibition of its own translation termination. This free L-Trp dependent mechanism of inhibition of translation termination remains unclear. Here, we analyzed the inhibitory effects of L-Trp on the function of two known E. coli translation termination factors, RF1 and RF2. Using a series of reporter genes, we found that the in vivo L-Trp sensitivity of tnaC gene expression is influenced by the identity of its stop codon, with the UGA stop codon producing higher expression efficiency of the tnaA-lacZ gene construct than the UAG stop codon. in vitro TnaC-peptidyl-tRNA accumulation and toeprinting assays confirmed that in the presence of L-Trp, the UGA stop codon generates higher accumulation of both TnaC-peptidyl-tRNA and arrested ribosomes than does the UAG stop codon. RF-mediated hydrolysis assays corroborated that L-Trp blocks RF2 function more than that of RF1. Mutational analyses disclosed that amino acids substitutions at the 246 and 256 residue positions surrounding the RF2-GGQ functional motif reduce L-Trp dependent expression of the tnaC(UGA) tnaA-lacZ construct and the ability of L-Trp to inhibit RF2-mediated cleavage of the TnaC-peptidyl-tRNA. Altogether, our results indicate that L-Trp preferentially blocks RF2 activity during translation termination of the tnaC gene. This inhibition depends on the identities of amino acid residues surrounding the RF2-GGQ functional motif.	[Emmanuel, Jerusha Salome; Sengupta, Arnab; Gordon, Emily Roth; Noble, Joseph Thomas; Cruz-Vera, Luis Rogelio] Univ Alabama, 301 Sparkman Dr, Huntsville, AL 35899 USA; [Sengupta, Arnab] North Carolina State Univ, Raleigh, NC 27695 USA; [Gordon, Emily Roth] HudsonAlpha Inst Biotechnol, Huntsville, AL USA	University of Alabama System; University of Alabama Huntsville; University of North Carolina; North Carolina State University; HudsonAlpha Institute for Biotechnology	Cruz-Vera, LR (corresponding author), Univ Alabama, 301 Sparkman Dr, Huntsville, AL 35899 USA.	luis.cruz-vera@uah.edu	Cruz-Vera, Luis Rogelio/AFV-2807-2022	Cruz-Vera, Luis Rogelio/0000-0002-4593-9957; Noble, Joseph/0000-0002-9261-4039; Emmanuel, Jerusha/0000-0002-8220-9558	Alabama Space Grant Consortium; National Science Foundation [MCB-1158271]; UAH RCEU program	Alabama Space Grant Consortium; National Science Foundation(National Science Foundation (NSF)); UAH RCEU program	We are grateful to Hani Zaher for the kind provision of the pETDuet plasmids and Karin Musier-Forsyth for provide us with L-PSA used in this study. We also thank Valerie Heurgue-Hamard for providing us with the VH1125 strain. Nora Vazquez-Laslop, Gabriel Guarneros, Frances Yap, and Tanya Sysoeva for their valuable critics regarding this version of the manuscript, and Yan Zhang and Carol Gross for their helpful discussion about their data on the expression of the tna operon under the expression of the RF2 A246 protein variant. We also want to thank previous anonymous reviewers for their observations that led us to improve the scientific content of this article. J. N. and L.R.C-V will like to tank the UAH RCEU program and Alabama Space Grant Consortium for supporting J.N. during the course of his work. This work was supported by National Science Foundation [MCB-1158271 to L.R.C-V].	Adio S, 2018, ELIFE, V7, DOI 10.7554/eLife.34252; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Burakovsky DE, 2010, RNA, V16, P1848, DOI 10.1261/rna.2185710; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; DEELEY MC, 1982, J BACTERIOL, V151, P942, DOI 10.1128/JB.151.2.942-951.1982; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GOLLNICK P, 1990, J BACTERIOL, V172, P3100, DOI 10.1128/jb.172.6.3100-3107.1990; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gong M, 2006, J BACTERIOL, V188, P1892, DOI 10.1128/JB.188.5.1892-1898.2006; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Konan KV, 1999, J BACTERIOL, V181, P1530, DOI 10.1128/JB.181.5.1530-1536.1999; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Martinez AK, 2014, NUCLEIC ACIDS RES, V42, P1245, DOI 10.1093/nar/gkt923; Martinez AK, 2012, NUCLEIC ACIDS RES, V40, P2247, DOI 10.1093/nar/gkr1052; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson WE, 2016, CELL REP, V17, P11, DOI 10.1016/j.celrep.2016.08.085; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; STEWART V, 1985, J BACTERIOL, V164, P731, DOI 10.1128/JB.164.2.731-740.1985; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; TIAN P, 2018, P NATL ACAD SCI US, V0115; Trappl K, 2016, J MOL BIOL, V428, P1333, DOI 10.1016/j.jmb.2016.01.021; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wood TK, 2011, TRENDS BIOTECHNOL, V29, P87, DOI 10.1016/j.tibtech.2010.11.001; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	43	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19224	19235		10.1074/jbc.RA119.011313	http://dx.doi.org/10.1074/jbc.RA119.011313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31712310	Green Published, hybrid			2022-12-28	WOS:000516527800022
J	Canalis, E; Grossman, TR; Carrer, M; Schilling, L; Yu, J				Canalis, Ernesto; Grossman, Tamar R.; Carrer, Michele; Schilling, Lauren; Yu, Jungeun			Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; osteoporosis; bone; Notch receptor; osteoclast; antisense oligonucleotides; bone resorption; cell fate; Hajdu-Cheney syndrome; osteoclastogenesis	BONE MASS; MUTATIONS; LIGAND; INHIBITION; KIDNEY; ACROOSTEOLYSIS; ARCHITECTURE; INCREASES; DISORDER; ANTIBODY	Notch receptors play critical roles in cell-fate decisions and in the regulation of skeletal development and bone remodeling. Gain?of?function NOTCH2 mutations can cause Hajdu-Cheney syndrome, an untreatable disease characterized by osteoporosis and fractures, craniofacial developmental abnormalities, and acro-osteolysis. We have previously created a mouse model harboring a point 6955C?T mutation in the Notch2 locus upstream of the PEST domain, and we termed this model Notch2(tm1.1Ecan). Heterozygous Notch2(tm1.1Ecan) mutant mice exhibit severe cancellous and cortical bone osteopenia due to increased bone resorption. In this work, we demonstrate that the subcutaneous administration of Notch2 antisense oligonucleotides (ASO) down-regulates Notch2 and the Notch target genes Hes-related family basic helix?loop?helix transcription factor with YRPW motif 1 (Hey1), Hey2, and HeyL in skeletal tissue from Notch2(tm1.1Ecan) mice. Results of microcomputed tomography experiments indicated that the administration of Notch2 ASOs ameliorates the cancellous osteopenia of Notch2(tm1.1Ecan) mice, and bone histomorphometry analysis revealed decreased osteoclast numbers in Notch2 ASO-treated Notch2(tm1.1Ecan) mice. Notch2 ASOs decreased the induction of mRNA levels of TNF superfamily member 11 (Tnfsf11, encoding the osteoclastogenic protein RANKL) in cultured osteoblasts and osteocytes from Notch2(tm1.1Ecan) mice. Bone marrow-derived macrophage cultures from the Notch2(tm1.1Ecan) mice displayed enhanced osteoclastogenesis, which was suppressed by Notch2 ASOs. In conclusion, Notch2(tm1.1Ecan) mice exhibit cancellous bone osteopenia that can be ameliorated by systemic administration of Notch2 ASOs.	[Canalis, Ernesto; Yu, Jungeun] UConn Hlth, Dept Orthopaed Surg, 263 Farmington Ave, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Canalis, Ernesto; Schilling, Lauren; Yu, Jungeun] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Grossman, Tamar R.; Carrer, Michele] Ionis Pharmaceut Inc, Carlsbad, CA 92010 USA	Ionis Pharmaceuticals, Inc.	Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, 263 Farmington Ave, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	canalis@uchc.edu		Carrer, Michele/0000-0002-6464-9584	National Institutes of Health from the NIDDK [DK045227]; National Institutes of Health from the NIAMS [AR076747]	National Institutes of Health from the NIDDK; National Institutes of Health from the NIAMS	This work was supported by National Institutes of Health Grant DK045227 (to E. C.) from the NIDDK and Grant AR076747 (to E. C.) from the NIAMS. T. R. G. and M. C. are employed by Ionis Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adami G, 2016, BONE, V92, P150, DOI 10.1016/j.bone.2016.08.025; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bennett CF, 2017, ANNU REV PHARMACOL, V57, P81, DOI 10.1146/annurev-pharmtox-010716-104846; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2018, METABOLISM, V80, P48, DOI 10.1016/j.metabol.2017.08.002; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2017, J CELL PHYSIOL, V232, P363, DOI 10.1002/jcp.25433; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Ilagan MXG, 2013, CANCER CELL, V23, P267, DOI 10.1016/j.ccr.2013.02.020; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; McCright B, 2001, DEVELOPMENT, V128, P491; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Murray SF, 2015, INVEST OPHTH VIS SCI, V56, P6362, DOI 10.1167/iovs.15-16400; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; NYE JS, 1994, DEVELOPMENT, V120, P2421; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Ryeom SW, 2011, J CLIN INVEST, V121, P508, DOI 10.1172/JCI45976; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakka S, 2017, J CLIN ENDOCR METAB, V102, P4163, DOI 10.1210/jc.2017-01102; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Shy ME, 2018, J CLIN INVEST, V128, P110, DOI 10.1172/JCI98617; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; Vollersen N, 2018, J BONE MINER RES, V33, P70, DOI 10.1002/jbmr.3283; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang FS, 2011, BONE, V49, P1080, DOI 10.1016/j.bone.2011.08.006; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Yorgan T, 2016, BONE, V87, P136, DOI 10.1016/j.bone.2016.04.012; Yu J, 2019, J BIOL CHEM, V294, P14203, DOI 10.1074/jbc.RA119.009824; Yu JG, 2020, J CELL PHYSIOL, V235, P210, DOI 10.1002/jcp.28960; Yu JG, 2018, AM J PATHOL, V188, P149, DOI 10.1016/j.ajpath.2017.09.010; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhao HT, 2018, J CLIN INVEST, V128, P359, DOI 10.1172/JCI96499; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5; Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344	78	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3952	3964		10.1074/jbc.RA119.011440	http://dx.doi.org/10.1074/jbc.RA119.011440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	31992595	hybrid, Green Published			2022-12-28	WOS:000527704400020
J	Hayes, ML; Santibanez, PI				Hayes, Michael L.; Santibanez, Paola I.			A plant pentatricopeptide repeat protein with a DYW-deaminase domain is sufficient for catalyzing C-to-U RNA editing in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA editing; mitochondria; organelle; metalloenzyme; metal ion-protein interaction; C-to-U editing; deaminase; DYW domain; pentatricopeptide repeat (PPR); PPR65	TRANSITION-STATE; IDENTIFICATION; ZINC; SITE; INVOLVEMENT; SUBSTRATE; REVEALS; BINDING; MOTIF	Pentatricopeptide repeat (PPR) proteins with C-terminal DYW domains are present in organisms that undergo C-to-U editing of organelle RNA transcripts. PPR domains act as specificity factors through electrostatic interactions between a pair of polar residues and the nitrogenous bases of an RNA target. DYW-deaminase domains act as the editing enzyme. Two moss (Physcomitrella patens) PPR proteins containing DYW-deaminase domains, PPR65 and PPR56, can convert Cs to Us in cognate, exogenous RNA targets co-expressed in Escherichia coli. We show here that purified, recombinant PPR65 exhibits robust editase activity on synthetic RNAs containing cognate, mitochondrial PpccmFC sequences in vitro, indicating that a PPR protein with a DYW domain is solely sufficient for catalyzing C-to-U RNA editing in vitro. Monomeric fractions possessed the highest conversion efficiency, and oligomeric fractions had reduced activity. Inductively coupled plasma (ICP)?MS analysis indicated a stoichiometry of two zinc ions per highly active PPR65 monomer. Editing activity was sensitive to addition of zinc acetate or the zinc chelators 1,10-o-phenanthroline and EDTA. Addition of ATP or nonhydrolyzable nucleotide analogs stimulated PPR65-catalyzed RNA-editing activity on PpccmFC substrates, indicating potential allosteric regulation of PPR65 by ATP. Unlike for bacterial cytidine deaminase, addition of two putative transition-state analogs, zebularine and tetrahydrouridine, failed to disrupt RNA-editing activity. RNA oligonucleotides with a single incorporated zebularine also did not disrupt editing in vitro, suggesting that PPR65 cannot bind modified bases due to differences in the structure of the active site compared with other zinc-dependent nucleotide deaminases.	[Hayes, Michael L.; Santibanez, Paola I.] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Hayes, ML (corresponding author), Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA.	mhayes3@calstatela.edu		Hayes, Michael/0000-0002-0210-0182	National Institutes of Health SCORE SC2 Grant [SC2 GM122718]; National Institutes of Health NIGMS [R25 GM61331]	National Institutes of Health SCORE SC2 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health SCORE SC2 Grant SC2 GM122718 (to M. L. H.) and National Institutes of Health NIGMS Grant R25 GM61331 to the RISE MS-to-Ph.D. program (to P. I. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bobik K, 2017, PLANT J, V91, P114, DOI 10.1111/tpj.13550; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Carlow D, 1998, BIOCHEMISTRY-US, V37, P11873, DOI 10.1021/bi980959n; Diaz MF, 2017, PLANT J, V92, P638, DOI 10.1111/tpj.13709; Gerke P, 2020, NEW PHYTOL, V225, P1974, DOI 10.1111/nph.16297; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Haudenschild BL, 2004, J AM CHEM SOC, V126, P11213, DOI 10.1021/ja0472073; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Krishnan A, 2018, P NATL ACAD SCI USA, V115, pE3201, DOI 10.1073/pnas.1720897115; Kvach MV, 2019, BIOCHEMISTRY-US, V58, P391, DOI 10.1021/acs.biochem.8b00858; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakajima Y, 2005, J PLANT PHYSIOL, V162, P1347, DOI 10.1016/j.jplph.2005.02.009; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Oldenkott B, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0328-3; Pham P, 2016, DNA REPAIR, V43, P48, DOI 10.1016/j.dnarep.2016.05.029; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sandoval R, 2019, PLANT J, V99, P1116, DOI 10.1111/tpj.14384; Schallenberg-Rudinger M, 2013, RNA BIOL, V10, P1549, DOI 10.4161/rna.25755; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Spears JL, 2011, J BIOL CHEM, V286, P20366, DOI 10.1074/jbc.M111.243568; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Takenaka M, 2003, J BIOL CHEM, V278, P47526, DOI 10.1074/jbc.M305341200; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wilkins MR, 1999, METH MOL B, V112, P531	37	27	29	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3497	3505		10.1074/jbc.RA119.011790	http://dx.doi.org/10.1074/jbc.RA119.011790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31996373	hybrid, Green Published			2022-12-28	WOS:000527725300011
J	Raetz, AG; Banda, DM; Ma, XY; Xu, GG; Rajavel, AN; McKibbin, PL; Lebrilla, CB; David, SS				Raetz, Alan G.; Banda, Douglas M.; Ma, Xiaoyan; Xu, Gege; Rajavel, Anisha N.; McKibbin, Paige L.; Lebrilla, Carlito B.; David, Sheila S.			The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; base excision repair (BER); mutY homolog (MUTYH); DNA methylation; DNA damage; DNA enzyme; DNA damage response; cancer biology; cancer chemoprevention; abasic sites	BASE-EXCISION-REPAIR; ADENINE GLYCOSYLASE ACTIVITY; INTERSTRAND CROSS-LINKS; SINGLE-STRAND BREAKS; ESCHERICHIA-COLI; METHYLATING AGENTS; ENDONUCLEASE ACTIVITIES; CATALYTIC MECHANISM; DUPLEX DNA; DAMAGE	Higher expression of the human DNA repair enzyme MUTYH has previously been shown to be strongly associated with reduced survival in a panel of 24 human lymphoblastoid cell lines exposed to the alkylating agent N-methyl-N?-nitro-N-nitrosoguanidine (MNNG). The molecular mechanism of MUTYH-enhanced MNNG cytotoxicity is unclear, because MUTYH has a well-established role in the repair of oxidative DNA lesions. Here, we show in mouse embryonic fibroblasts (MEFs) that this MNNG-dependent phenotype does not involve oxidative DNA damage and occurs independently of both O-6-methyl guanine adduct cytotoxicity and MUTYH-dependent glycosylase activity. We found that blocking of abasic (AP) sites abolishes higher survival of Mutyh-deficient (Mutyh(?/?)) MEFs, but this blockade had no additive cytotoxicity in WT MEFs, suggesting the cytotoxicity is due to MUTYH interactions with MNNG-induced AP sites. We found that recombinant mouse MUTYH tightly binds AP sites opposite all four canonical undamaged bases and stimulated apurinic/apyrimidinic endonuclease 1 (APE1)-mediated DNA incision. Consistent with these observations, we found that stable expression of WT, but not catalytically-inactive MUTYH, enhances MNNG cytotoxicity in Mutyh(?/?) MEFs and that MUTYH expression enhances MNNG-induced genomic strand breaks. Taken together, these results suggest that MUTYH enhances the rapid accumulation of AP-site intermediates by interacting with APE1, implicating MUTYH as a factor that modulates the delicate process of base-excision repair independently of its glycosylase activity.	[Raetz, Alan G.; Banda, Douglas M.; Ma, Xiaoyan; Xu, Gege; Rajavel, Anisha N.; McKibbin, Paige L.; Lebrilla, Carlito B.; David, Sheila S.] Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	David, SS (corresponding author), Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA.	ssdavid@ucdavis.edu	Lebrilla, Carlito Bangeles/ABE-6369-2020	Raetz, Alan/0000-0003-2039-3692; Lebrilla, Carlito/0000-0001-7190-5323; David, Sheila/0000-0001-5873-7935; Banda, Douglas/0000-0001-6198-2923	National Institutes of Health [2RO1CA067985, RO1GM049077]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants 2RO1CA067985 (to S. S. D.) and RO1GM049077 (to C. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Admiraal SJ, 2015, BIOCHEMISTRY-US, V54, P1849, DOI 10.1021/bi501491z; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Bai HB, 2007, J BACTERIOL, V189, P902, DOI 10.1128/JB.01513-06; Banda DM, 2017, FREE RADICAL BIO MED, V107, P202, DOI 10.1016/j.freeradbiomed.2017.01.008; Bobola MS, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00176; Caimi PF, 2017, ONCOTARGET, V8, P79864, DOI 10.18632/oncotarget.20094; Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413; Cheadle JP, 2007, DNA REPAIR, V6, P274, DOI 10.1016/j.dnarep.2006.11.001; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fouquerel E, 2014, DNA REPAIR, V23, P27, DOI 10.1016/j.dnarep.2014.09.004; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Giovannini S, 2019, NUCLEIC ACIDS RES, V47, P9132, DOI 10.1093/nar/gkz624; Grasso F, 2015, ONCOTARGET, V6, P7481, DOI 10.18632/oncotarget.3037; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Hahm SH, 2011, BMB REP, V44, P352, DOI 10.5483/BMBRep.2011.44.5.352; Hwang BJ, 2014, DNA REPAIR, V13, P10, DOI 10.1016/j.dnarep.2013.10.011; Jansson K, 2008, MUTAT RES-FUND MOL M, V644, P48, DOI 10.1016/j.mrfmmm.2008.07.001; Jansson K, 2013, ENVIRON MOL MUTAGEN, V54, P327, DOI 10.1002/em.21784; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Kundu S, 2009, DNA REPAIR, V8, P1400, DOI 10.1016/j.dnarep.2009.09.009; Laverty DJ, 2017, ACS CHEM BIOL, V12, P1584, DOI 10.1021/acschembio.7b00211; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Leipold MD, 2000, BIOCHEMISTRY-US, V39, P14984, DOI 10.1021/bi0017982; Lim PX, 2015, J BIOL CHEM, V290, P14826, DOI 10.1074/jbc.M114.630640; Lipton L, 2003, CANCER RES, V63, P7595; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu LL, 2003, MOL CANCER THER, V2, P1061; Liu LL, 1996, CANCER RES, V56, P5375; Lu AL, 1996, J BIOL CHEM, V271, P24138, DOI 10.1074/jbc.271.39.24138; Luke AM, 2010, MUTAT RES-FUND MOL M, V694, P65, DOI 10.1016/j.mrfmmm.2010.08.008; Luncsford PJ, 2013, DNA REPAIR, V12, P1043, DOI 10.1016/j.dnarep.2013.09.007; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Manuel RC, 2004, J BIOL CHEM, V279, P46930, DOI 10.1074/jbc.M403944200; Markkanen Enni, 2013, Frontiers in Genetics, V4, P18, DOI 10.3389/fgene.2013.00018; Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046; Mazouzi A, 2017, MOL CELL, V68, P797, DOI 10.1016/j.molcel.2017.10.021; MCGOLDRICK JP, 1995, MOL CELL BIOL, V15, P989; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Mohni KN, 2019, CELL, V176, P144, DOI 10.1016/j.cell.2018.10.055; Mullins EA, 2013, METHODS, V64, P59, DOI 10.1016/j.ymeth.2013.07.020; Mutamba JT, 2011, DNA REPAIR, V10, P1282, DOI 10.1016/j.dnarep.2011.10.008; Nakamura J, 2000, J BIOL CHEM, V275, P5323, DOI 10.1074/jbc.275.8.5323; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Pastoriza-Gallego M, 2007, MUTAGENESIS, V22, P343, DOI 10.1093/mutage/gem024; Pope MA, 2005, DNA REPAIR, V4, P315, DOI 10.1016/j.dnarep.2004.10.003; Pope MA, 2005, DNA REPAIR, V4, P91, DOI 10.1016/j.dnarep.2004.08.004; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Prystay L, 2001, J BIOMOL SCREEN, V6, P141, DOI 10.1177/108705710100600304; Quinones JL, 2016, DNA REPAIR, V44, P103, DOI 10.1016/j.dnarep.2016.05.014; Raetz AG, 2019, DNA REPAIR, V80, P16, DOI 10.1016/j.dnarep.2019.05.005; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rothwell DG, 1996, NUCLEIC ACIDS RES, V24, P4217, DOI 10.1093/nar/24.21.4217; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Shen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151026; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Tang JB, 2011, NEURO-ONCOLOGY, V13, P471, DOI 10.1093/neuonc/nor011; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Tominaga Y, 2004, NUCLEIC ACIDS RES, V32, P3198, DOI 10.1093/nar/gkh642; Troll CJ, 2014, MUTAT RES-FUND MOL M, V763, P64, DOI 10.1016/j.mrfmmm.2014.03.007; TSAIWU JJ, 1992, P NATL ACAD SCI USA, V89, P8779, DOI 10.1073/pnas.89.18.8779; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; VANHOUTEN B, 1987, J BACTERIOL, V169, P540, DOI 10.1128/jb.169.2.540-545.1987; Williams SD, 1998, NUCLEIC ACIDS RES, V26, P5123, DOI 10.1093/nar/26.22.5123; Williams SD, 1999, BIOCHEMISTRY-US, V38, P15417, DOI 10.1021/bi992013z; Williams SD, 2000, BIOCHEMISTRY-US, V39, P10098, DOI 10.1021/bi0004652; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Woods RD, 2016, NUCLEIC ACIDS RES, V44, P801, DOI 10.1093/nar/gkv1469; Wright PM, 1999, J BIOL CHEM, V274, P29011, DOI 10.1074/jbc.274.41.29011; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xie YL, 2008, CARCINOGENESIS, V29, P722, DOI 10.1093/carcin/bgn033; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743; Yang K, 2018, P NATL ACAD SCI USA, V115, pE11212, DOI 10.1073/pnas.1813338115; Yang ZY, 2017, NUCLEIC ACIDS RES, V45, P6275, DOI 10.1093/nar/gkx394; Zharkov DO, 1998, BIOCHEMISTRY-US, V37, P12384, DOI 10.1021/bi981066y	93	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3692	3707		10.1074/jbc.RA119.010497	http://dx.doi.org/10.1074/jbc.RA119.010497			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32001618	hybrid, Green Published			2022-12-28	WOS:000527725300025
J	Krainer, G; Schenkel, M; Hartmann, A; Ravamehr-Lake, D; Deber, CM; Schlierf, M				Krainer, Georg; Schenkel, Mathias; Hartmann, Andreas; Ravamehr-Lake, Dorna; Deber, Charles M.; Schlierf, Michael			CFTR transmembrane segments are impaired in their conformational adaptability by a pathogenic loop mutation and dynamically stabilized by Lumacaftor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; single-molecule biophysics; membrane protein; protein misfolding; helical packing; lumacaftor; pharmacological corrector; single-molecule F?rster resonance energy transfer (FRET)	SINGLE-MOLECULE FRET; CONDUCTANCE REGULATOR; EXTRACELLULAR LOOP; FOLDING DEFECTS; PROTEIN; DOMAIN; CORRECTORS; RECEPTOR; RATHER	The cystic fibrosis transmembrane conductance regulator (CFTR) is an ion channel protein that is defective in individuals with cystic fibrosis (CF). To advance the rational design of CF therapies, it is important to elucidate how mutational defects in CFTR lead to its impairment and how pharmacological compounds interact with and alter CFTR. Here, using a helical-hairpin construct derived from CFTR's transmembrane (TM) helices 3 and 4 (TM3/4) and their intervening loop, we investigated the structural effects of a patient-derived CF-phenotypic mutation, E217G, located in the loop region of CFTR's membrane-spanning domain. Employing a single-molecule FRET assay to probe the folding status of reconstituted hairpins in lipid bilayers, we found that the E217G hairpin exhibits an altered adaptive packing behavior stemming from an additional GXXXG helix?helix interaction motif created in the mutant hairpin. This observation suggested that the misfolding and functional defects caused by the E217G mutation arise from an impaired conformational adaptability of TM helical segments in CFTR. The addition of the small-molecule corrector Lumacaftor exerts a helix stabilization effect not only on the E217G mutant hairpin, but also on WT TM3/4 and other mutations in the hairpin. This finding suggests a general mode of action for Lumacaftor through which this corrector efficiently improves maturation of various CFTR mutants.	[Krainer, Georg; Schenkel, Mathias; Hartmann, Andreas; Schlierf, Michael] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Tatzberg 41, D-01307 Dresden, Germany; [Ravamehr-Lake, Dorna; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Med, 686 Bay St, Toronto, ON M5G 0A4, Canada; [Ravamehr-Lake, Dorna; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Schlierf, Michael] Tech Univ Dresden, Cluster Excellence Phys Life, D-01062 Dresden, Germany	Technische Universitat Dresden; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Technische Universitat Dresden	Schlierf, M (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Tatzberg 41, D-01307 Dresden, Germany.; Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Med, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Krainer, G (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gk422@ch.cam.ac.uk; deber@sickkids.ca; michael.schlierf@tu-dresden.de	Krainer, Georg/AAW-4764-2020; Schlierf, Michael/F-5343-2012	Krainer, Georg/0000-0002-9626-7636; Schenkel, Mathias/0000-0003-2125-4045; Schlierf, Michael/0000-0002-6209-2364	European Social Fund; Free State of Saxony; Boehringer Ingelheim Foundation (BIS); Deutsche Forschungsgemeinschaft (DFG) [SCHL 1896/3-1]; Cystic Fibrosis Canada	European Social Fund(European Social Fund (ESF)); Free State of Saxony; Boehringer Ingelheim Foundation (BIS); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cystic Fibrosis Canada	This work was supported by a scholarship of the European Social Fund and the Free State of Saxony (to M. Schenkel), an Exploration Grant of the Boehringer Ingelheim Foundation (BIS) (to M. Schlierf), Deutsche Forschungsgemeinschaft (DFG) Grant SCHL 1896/3-1 (to M. Schlierf), and a grant from Cystic Fibrosis Canada (to C. M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baroni D, 2014, EUR BIOPHYS J BIOPHY, V43, P341, DOI 10.1007/s00249-014-0956-y; Chang YH, 2018, BBA-BIOMEMBRANES, V1860, P1092, DOI 10.1016/j.bbamem.2018.01.003; Cheung JC, 2008, BIOCHEMISTRY-US, V47, P1465, DOI 10.1021/bi702209s; Du K, 1997, BIOCHEM BIOPH RES CO, V230, P289, DOI 10.1006/bbrc.1996.5949; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Frotscher E, 2018, ACS OMEGA, V3, P12026, DOI 10.1021/acsomega.8b01609; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Hammerle MM, 2001, J BIOL CHEM, V276, P14848, DOI 10.1074/jbc.M011017200; Hellenkamp B, 2018, NAT METHODS, V15, P669, DOI 10.1038/s41592-018-0085-0; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim JH, 1996, MOL PHARMACOL, V49, P683; Kim JM, 2001, J MOL BIOL, V308, P409, DOI 10.1006/jmbi.2001.4603; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Krainer G, 2019, CURR OPIN STRUC BIOL, V58, P124, DOI 10.1016/j.sbi.2019.05.025; Krainer G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0153-0; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Kucerka N, 2009, BIOPHYS J, V97, P1926, DOI 10.1016/j.bpj.2009.06.050; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Laselva O, 2018, MOL PHARMACOL, V93, P612, DOI 10.1124/mol.118.111799; Lee JH, 2003, HUM MOL GENET, V12, P2321, DOI 10.1093/hmg/ddg243; Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Loo TW, 2014, BIOCHEM PHARMACOL, V88, P46, DOI 10.1016/j.bcp.2013.12.027; Loo TW, 2013, BIOCHEMISTRY-US, V52, P5161, DOI 10.1021/bi4008758; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mijnders M, 2017, CURR OPIN PHARMACOL, V34, P83, DOI 10.1016/j.coph.2017.09.014; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Nadeau VG, 2016, BIOPOLYMERS, V106, P37, DOI 10.1002/bip.22765; Nadeau VG, 2013, BIOCHEMISTRY-US, V52, P2419, DOI 10.1021/bi400187w; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Pedemonte N, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00175; Rath A, 2009, BIOCHEMISTRY-US, V48, P3036, DOI 10.1021/bi900184j; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Soranno A, 2012, P NATL ACAD SCI USA, V109, P17800, DOI 10.1073/pnas.1117368109; Tastan O, 2009, BIOPHYS J, V96, P2299, DOI 10.1016/j.bpj.2008.12.3894; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Therien AG, 2002, PROTEIN EXPRES PURIF, V25, P81, DOI 10.1006/prep.2001.1612; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115	49	7	9	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1985	1991		10.1074/jbc.AC119.011360	http://dx.doi.org/10.1074/jbc.AC119.011360			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31882543	Green Published, hybrid			2022-12-28	WOS:000517128200017
J	Round, P; Das, S; Wu, TS; Wahala, K; Van Petegem, F; Hammond, GL				Round, Phillip; Das, Samir; Wu, Tsung-Sheng; Wahala, Kristiina; Van Petegem, Filip; Hammond, Geoffrey L.			Molecular interactions between sex hormone-binding globulin and nonsteroidal ligands that enhance androgen activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid; testosterone; ligand-binding protein; hormone; crystal structure; free testosterone; SHBG; sex hormone-binding globulin (SHBG); ligand binding; hormone bioavailability; nonsteroidal ligand; anabolic compound	STEROID-BINDING; CRYSTAL-STRUCTURE; TESTOSTERONE; RESOLUTION; CLEARANCE; TRANSPORT; LIGNANS; SHBG	Sex hormone-binding globulin (SHBG) determines the equilibrium between free and protein-bound androgens and estrogens in the blood and regulates their access to target tissues. Using crystallographic approaches and radiolabeled competitive binding-capacity assays, we report here how two nonsteroidal compounds bind to human SHBG, and how they influence androgen activity in cell culture. We found that one of these compounds, (-)3,4-divanillyltetrahydrofuran (DVT), present in stinging nettle root extracts and used as a nutraceutical, binds SHBG with relatively low affinity. By contrast, a synthetic compound, 3-(1H-imidazol-1-ylmethyl)-2phenyl-1H-indole (IPI), bound SHBG with an affinity similar to that of testosterone and estradiol. Crystal structures of SHBG in complex with DVT or IPI at 1.71-1.80 angstrom resolutions revealed their unique orientations in the SHBG ligand-binding pocket and suggested opportunities for the design of other nonsteroidal ligands of SHBG. As observed for estradiol but not testosterone, IPI binding to SHBG was reduced by similar to 20-fold in the presence of zinc, whereas DVT binding was almost completely lost. Estradiol-dependent fibulin-2 interactions with SHBG similarly occurred for IPI-bound SHBG, but not with DVT-bound SHBG. Both DVT and IPI increased the activity of testosterone in a cell culture androgen reporter system by competitively displacing testosterone from SHBG. These findings indicate how nonsteroidal ligands of SHBG maybe designed to modulate the bioavailability of sex steroids.	[Round, Phillip; Wu, Tsung-Sheng; Hammond, Geoffrey L.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z4, Canada; [Das, Samir; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Wahala, Kristiina] Univ Helsinki, Dept Biochem & Dev Biol, SF-00100 Helsinki, Finland; [Wahala, Kristiina] Univ Helsinki, Dept Chem, Helsinki 00100, Finland	University of British Columbia; University of British Columbia; University of Helsinki; University of Helsinki	Hammond, GL (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z4, Canada.	geoffrey.hammond@ubc.ca		Hammond, Geoffrey/0000-0002-4639-7336; Wahala, Kristiina/0000-0003-4082-8622	Canadian Institutes of Health Research Grant [MOP 15261]; Canada Research Chair in Reproductive Health Tier 1	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Reproductive Health Tier 1	This work was supported by the Canadian Institutes of Health Research Grant MOP 15261 (to G. L. H.) and the Canada Research Chair in Reproductive Health Tier 1 (to G. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Avvakumov GV, 2010, MOL CELL ENDOCRINOL, V316, P13, DOI 10.1016/j.mce.2009.09.005; Avvakumov GV, 2000, J BIOL CHEM, V275, P25920, DOI 10.1074/jbc.M004484200; Avvakumov GV, 2002, J BIOL CHEM, V277, P45219, DOI 10.1074/jbc.M207762200; Avvakumov GV, 2001, J BIOL CHEM, V276, P34453, DOI 10.1074/jbc.M106274200; BOCCHINFUSO WP, 1994, BIOCHEMISTRY-US, V33, P10622, DOI 10.1021/bi00201a008; Campana C, 2016, J STEROID BIOCHEM, V156, P17, DOI 10.1016/j.jsbmb.2015.11.005; Cousin P, 1999, J STEROID BIOCHEM, V70, P115, DOI 10.1016/S0960-0760(99)00101-6; Cousin P, 1998, J CLIN ENDOCR METAB, V83, P235, DOI 10.1210/jc.83.1.235; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; Grishkovskaya I, 2002, J BIOL CHEM, V277, P32086, DOI 10.1074/jbc.M203999200; Grishkovskaya I, 2002, J MOL BIOL, V318, P621, DOI 10.1016/S0022-2836(02)00169-9; Hammond GL, 2016, J ENDOCRINOL, V230, pR13, DOI 10.1530/JOE-16-0070; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Hazarika J, 2019, J APPL TOXICOL, V39, P1002, DOI 10.1002/jat.3789; Hong EJ, 2011, MOL ENDOCRINOL, V25, P269, DOI 10.1210/me.2010-0483; Janne M, 1998, MOL ENDOCRINOL, V12, P123; Jury HH, 2000, J STEROID BIOCHEM, V75, P167, DOI 10.1016/S0960-0760(00)00168-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald TJ, 2011, CLIN CHIM ACTA, V412, P1999, DOI 10.1016/j.cca.2011.06.028; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ng KM, 2006, J BIOL CHEM, V281, P15853, DOI 10.1074/jbc.M512370200; Pohjoispaa M, 2013, MOLECULES, V18, P13124, DOI 10.3390/molecules181113124; Schottner M, 1998, J NAT PROD, V61, P119, DOI 10.1021/np9701743; Schottner M, 1997, PLANTA MED, V63, P529, DOI 10.1055/s-2006-957756; Sheikh IA, 2019, REPROD TOXICOL, V83, P46, DOI 10.1016/j.reprotox.2018.11.003; Sheikh IA, 2017, ECOTOX ENVIRON SAFE, V135, P284, DOI 10.1016/j.ecoenv.2016.10.005; Wu TS, 2014, MOL ENDOCRINOL, V28, P1026, DOI 10.1210/me.2014-1058	32	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1202	1211		10.1074/jbc.RA119.011051	http://dx.doi.org/10.1074/jbc.RA119.011051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31852737	Green Published, Bronze			2022-12-28	WOS:000513822300004
J	Iwamoto, M; Saso, W; Nishioka, K; Ohashi, H; Sugiyama, R; Ryo, A; Ohki, M; Yun, JH; Park, SY; Ohshima, T; Suzuki, R; Aizaki, H; Muramatsu, M; Matano, T; Iwami, S; Sureau, C; Wakita, T; Watashi, K				Iwamoto, Masashi; Saso, Wakana; Nishioka, Kazane; Ohashi, Hirofumi; Sugiyama, Ryuichi; Ryo, Akihide; Ohki, Mio; Yun, Ji-Hye; Park, Sam-Yong; Ohshima, Takayuki; Suzuki, Ryosuke; Aizaki, Hideki; Muramatsu, Masamichi; Matano, Tetsuro; Iwami, Shingo; Sureau, Camille; Wakita, Takaji; Watashi, Koichi			The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis B virus (HBV; Hep B); epidermal growth factor receptor (EGFR); infection; endocytosis; virus entry; entry; sodium taurocholate cotransporting polypeptide (NTCP); endosomal sorting complex required for transport (ESCRT); viral translocation; receptor tyrosine kinase	EGF RECEPTOR; C VIRUS; ACTIVATION; INTERNALIZATION; INFECTION; PATHWAY	Sodium taurocholate cotransporting polypeptide (NTCP) is expressed at the surface of human hepatocytes and functions as an entry receptor of hepatitis B virus (HBV). Recently, we have reported that epidermal growth factor receptor (EGFR) is involved in NTCP-mediated viral internalization during the cell entry process. Here, we analyzed which function of EGFR is essential for mediating HBV internalization. In contrast to the reported crucial function of EGFR-downstream signaling for the entry of hepatitis C virus (HCV), blockade of EGFR-downstream signaling proteins, including mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), and signal transducer and activator of transcription (STAT), had no or only minor effects on HBV infection. Instead, deficiency of EGFR endocytosis resulting from either a deleterious mutation in EGFR or genetic knockdown of endocytosis adaptor molecules abrogated internalization of HBV via NTCP and prevented viral infection. EGFR activation triggered a time-dependent relocalization of HBV preS1 to the early and late endosomes and to lysosomes in concert with EGFR transport. Suppression of EGFR ubiquitination by site-directed mutagenesis or by knocking down two EGFR-sorting molecules, signal-transducing adaptor molecule (STAM) and lysosomal protein transmembrane 4? (LAPTM4B), suggested that EGFR transport to the late endosome is critical for efficient HBV infection. Cumulatively, these results support the idea that the EGFR endocytosis/sorting machinery drives the translocation of NTCP-bound HBV from the cell surface to the endosomal network, which eventually enables productive viral infection.	[Iwamoto, Masashi; Saso, Wakana; Nishioka, Kazane; Ohashi, Hirofumi; Sugiyama, Ryuichi; Suzuki, Ryosuke; Aizaki, Hideki; Muramatsu, Masamichi; Wakita, Takaji; Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Iwamoto, Masashi; Iwami, Shingo] Kyushu Univ, Fac Sci, Dept Biol, Math Biol Lab, Fukuoka 8128581, Japan; [Saso, Wakana; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan; [Saso, Wakana; Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Nishioka, Kazane; Ohashi, Hirofumi; Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 2360004, Japan; [Ohki, Mio; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, Yokohama, Kanagawa 2300045, Japan; [Yun, Ji-Hye] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus, Tokushima, Kagawa 7692193, Japan; [Iwami, Shingo; Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama 3320012, Japan; [Iwami, Shingo; Watashi, Koichi] JST, MIRAI, Saitama 3320012, Japan; [Sureau, Camille] Inst Natl Transfus Sanguine, Lab Virol Mol, F-75739 Paris, France; [Watashi, Koichi] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto 6068507, Japan	National Institute of Infectious Diseases (NIID); Kyushu University; National Institute of Infectious Diseases (NIID); University of Tokyo; Tokyo University of Science; Yokohama City University; Yokohama City University; Yonsei University; Tokushima Bunri University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University	Watashi, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	kwatashi@nih.go.jp		OHSHIMA, Takayuki/0000-0002-1501-6430; Iwamoto, Masashi/0000-0002-0419-4485	Japan Society for the Promotion of Science KAKENHI [JP17H04085, JP19K16672, JP19J21455]; Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST) MIRAI program; Japan Agency for Medical Research and Development (AMED) [JP19fk0310114j0003, JP19fk0310101j1003, JP19fk0310103j0203, JP19fm0208019j0003, JP19fk0210036j0002]; Takeda Science Foundation; Yasuda Medical Foundation; Smoking Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mitsui Life Social Welfare Foundation; Kyushu University Qdai-jump Research Program	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST) MIRAI program; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yasuda Medical Foundation; Smoking Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mitsui Life Social Welfare Foundation; Kyushu University Qdai-jump Research Program	This study was supported in part by Japan Society for the Promotion of Science KAKENHI Grants JP17H04085, JP19K16672, and JP19J21455; the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) and MIRAI program; Japan Agency for Medical Research and Development (AMED) Grants JP19fk0310114j0003, JP19fk0310101j1003, JP19fk0310103j0203, JP19fm0208019j0003, and JP19fk0210036j0002; the Takeda Science Foundation; the Yasuda Medical Foundation; the Smoking Research Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Mitsui Life Social Welfare Foundation; and the Kyushu University Qdai-jump Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	Bakker J, 2017, J CELL SCI, V130, P4087, DOI 10.1242/jcs.209197; Daffis S, 2021, HEPATOLOGY, V73, P53, DOI 10.1002/hep.31255; Di Domenico M, 2017, ONCOTARGET, V8, P36869, DOI 10.18632/oncotarget.16300; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Fukano K, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03257; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iwamoto M, 2019, P NATL ACAD SCI USA, V116, P8487, DOI 10.1073/pnas.1811064116; Iwamoto M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11015-4; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Liu L, 2011, TRAFFIC, V12, P201, DOI 10.1111/j.1600-0854.2010.01141.x; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; Miyakawa Kei, 2018, Oncotarget, V9, P23681, DOI 10.18632/oncotarget.25348; Nishimura Y, 2007, HISTOCHEM CELL BIOL, V127, P541, DOI 10.1007/s00418-007-0281-y; Song M, 2018, J VIROL, V92, DOI 10.1128/JVI.01771-17; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Watashi K, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021378; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zheng K, 2014, REV MED VIROL, V24, P274, DOI 10.1002/rmv.1796; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	28	33	34	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					800	807		10.1074/jbc.AC119.010366	http://dx.doi.org/10.1074/jbc.AC119.010366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31836663	Green Published, hybrid			2022-12-28	WOS:000508382900011
J	Anderson, EM; Sychantha, D; Brewer, D; Clarke, AJ; Geddes-McAlister, J; Khursigara, CM				Anderson, Erin M.; Sychantha, David; Brewer, Dyanne; Clarke, Anthony J.; Geddes-McAlister, Jennifer; Khursigara, Cezar M.			Peptidoglycomics reveals compositional changes in peptidoglycan between biofilm- and planktonic-derived Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptidoglycan; Pseudomonas aeruginosa (P; aeruginosa); biofilm; microbiology; mass spectrometry (MS); bacterial cell wall; murine; peptidoglycomics; planktonic; sacculi	D-AMINO ACIDS; BETA-LACTAM RESISTANCE; BACTERIAL-CELL-WALL; LYTIC TRANSGLYCOSYLASES; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; VI SECRETION; CLONING; MUREIN; GROWTH	Peptidoglycan (PG) is a critical component of the bacterial cell wall and is composed of a repeating ?-1,4?linked disaccharide of N-acetylglucosamine and N-acetylmuramic acid appended with a highly conserved stem peptide. In Gram-negative bacteria, PG is assembled in the cytoplasm and exported into the periplasm where it undergoes considerable maturation, modification, or degradation depending on the growth phase or presence of environmental stressors. These modifications serve important functions in diverse processes, including PG turnover, cell elongation/division, and antibiotic resistance. Conventional methods for analyzing PG composition are complex and time-consuming. We present here a streamlined MS-based method that combines differential analysis with statistical 1D annotation approaches to quantitatively compare PGs produced in planktonic- and biofilm-cultured Pseudomonas aeruginosa. We identified a core assembly of PG that is present in high abundance and that does not significantly differ between the two growth states. We also identified an adaptive PG assembly that is present in smaller amounts and fluctuates considerably between growth states in response to physiological changes. Biofilm-derived adaptive PG exhibited significant changes compared with planktonic-derived PG, including amino acid substitutions of the stem peptide and modifications that indicate changes in the activity of amidases, deacetylases, and lytic transglycosylases. The results of this work also provide first evidence of de-N-acetylated muropeptides from P. aeruginosa. The method developed here offers a robust and reproducible workflow for accurately determining PG composition in samples that can be used to assess global PG fluctuations in response to changing growth conditions or external stimuli.	[Anderson, Erin M.; Sychantha, David; Clarke, Anthony J.; Geddes-McAlister, Jennifer; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Brewer, Dyanne; Geddes-McAlister, Jennifer; Khursigara, Cezar M.] Univ Guelph, Mass Spectrometry Facil, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Geddes-McAlister, J; Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	jgeddesm@uoguelph.ca; ckhursig@uoguelph.ca		Khursigara, Cezar/0000-0001-9263-7604	Canadian Institutes of Health Research Operating Grants [PJT 156111, PJT 156353]; Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada	This work was supported by Canadian Institutes of Health Research Operating Grants PJT 156111 (to C. M. K.) and PJT 156353 (to A. J. C.) and a scholarship from the Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada (to E. M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Asmar AT, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern M, 2017, ANAL BIOANAL CHEM, V409, P551, DOI 10.1007/s00216-016-9857-5; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BRAUN V, 1972, EUR J BIOCHEM, V28, P51, DOI 10.1111/j.1432-1033.1972.tb01883.x; Brott AS, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030094; CAPARROS M, 1992, J BACTERIOL, V174, P5549; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Chang JD, 2018, BIOCHEMISTRY-US, V57, P1274, DOI 10.1021/acs.biochem.7b01207; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Crepin S, 2018, MOL MICROBIOL, V109, P745, DOI 10.1111/mmi.14000; de Jonge BLM, 2002, ANTIMICROB AGENTS CH, V46, P3151, DOI 10.1128/AAC.46.10.3151-3155.2002; deJonge BLM, 1996, ANTIMICROB AGENTS CH, V40, P1498, DOI 10.1128/AAC.40.6.1498; Dhar S, 2018, J MED MICROBIOL, V67, P1, DOI 10.1099/jmm.0.000636; Dik DA, 2017, CRIT REV BIOCHEM MOL, V52, P503, DOI 10.1080/10409238.2017.1337705; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Espaillat A, 2016, J AM CHEM SOC, V138, P9193, DOI 10.1021/jacs.6b04430; Fisher JF, 2014, BIOORG CHEM, V56, P41, DOI 10.1016/j.bioorg.2014.05.011; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grohs P, 2000, J BACTERIOL, V182, P6228, DOI 10.1128/JB.182.21.6228-6232.2000; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; Herlihey Francesca A, 2017, Adv Exp Med Biol, V925, P41, DOI 10.1007/5584_2016_52; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Hugonnet JE, 2016, ELIFE, V5, DOI 10.7554/eLife.19469; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lee M, 2017, ANGEW CHEM INT EDIT, V56, P2735, DOI 10.1002/anie.201611279; Lee M, 2016, ANGEW CHEM INT EDIT, V55, P6882, DOI [10.1002/anie.201601693, 10.1002/anie.201608482]; Legaree BA, 2007, J ANTIMICROB CHEMOTH, V59, P411, DOI 10.1093/jac/dkl536; LIAO XW, 1995, ANTIMICROB AGENTS CH, V39, P1871, DOI 10.1128/AAC.39.8.1871; Liao XW, 1997, J BACTERIOL, V179, P1490, DOI 10.1128/jb.179.5.1490-1496.1997; Lupoli TJ, 2011, J AM CHEM SOC, V133, P10748, DOI 10.1021/ja2040656; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Meirelles LA, 2018, MOL MICROBIOL, V110, P995, DOI 10.1111/mmi.14132; Monteiro C, 2011, J BACTERIOL, V193, P6443, DOI 10.1128/JB.00425-11; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Moya B, 2008, ANTIMICROB AGENTS CH, V52, P3694, DOI 10.1128/AAC.00172-08; Neudorf KD, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx035; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Park AJ, 2015, J PROTEOME RES, V14, P4524, DOI 10.1021/acs.jproteome.5b00262; Park AJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00464; Park AJ, 2014, MOL CELL PROTEOMICS, V13, P1095, DOI 10.1074/mcp.M113.033985; Peters K, 2018, P NATL ACAD SCI USA, V115, P10786, DOI 10.1073/pnas.1809285115; Pomin V. H., 2012, J GLYCOMICS LIPIDOMI, V2, p1000e102, DOI [10.4172/2153-0637.1000e102, DOI 10.4172/2153-0637.1000E102]; Priyadarshini R, 2007, J BACTERIOL, V189, P5334, DOI 10.1128/JB.00415-07; Putty S, 2013, ANAL BIOCHEM, V442, P166, DOI 10.1016/j.ab.2013.07.045; QUINTELA JC, 1995, FEMS MICROBIOL LETT, V125, P95, DOI 10.1016/0378-1097(94)00479-B; Ramon-Perez ML, 2014, J MED MICROBIOL, V63, P1369, DOI 10.1099/jmm.0.075796-0; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Rivera I, 2016, MICROB DRUG RESIST, V22, P470, DOI 10.1089/mdr.2016.0083; Ropy A, 2015, ANTIMICROB AGENTS CH, V59, P3925, DOI 10.1128/AAC.05150-14; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; Sanchez CJ, 2014, ANTIMICROB AGENTS CH, V58, P4353, DOI 10.1128/AAC.02468-14; Schaub RE, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2438; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; She PF, 2015, MICROB PATHOGENESIS, V86, P38, DOI 10.1016/j.micpath.2015.07.009; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Sychantha D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02332; Takacs CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057579; Teo ACK, 2015, ANTIBIOTICS-BASEL, V4, P495, DOI 10.3390/antibiotics4040495; Tolker-Nielsen T, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0001-2014; Torrens G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01868; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van der Aart LT, 2018, J BACTERIOL, V200, DOI [10.1128/JB.0020-18, 10.1128/JB.00290-18]; Vermassen A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00331; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Wheeler R, 2014, CELL MICROBIOL, V16, P1014, DOI 10.1111/cmi.12304; WIENTJES FB, 1991, J BACTERIOL, V173, P7684, DOI 10.1128/jb.173.23.7684-7691.1991; Zhang WL, 2013, J AM CHEM SOC, V135, P4950, DOI 10.1021/ja400970n	90	11	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					504	516		10.1074/jbc.RA119.010505	http://dx.doi.org/10.1074/jbc.RA119.010505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771981	Green Published, hybrid			2022-12-28	WOS:000507373600019
J	Pal, C; Bindu, S; Dey, S; Alam, A; Goyal, M; Iqbal, MS; Sarkar, S; Kumar, R; Halder, KK; Debnath, MC; Adhikari, S; Bandyopadhyay, U				Pal, Chinmay; Bindu, Samik; Dey, Sumanta; Alam, Athar; Goyal, Manish; Iqbal, Mohd. Shameel; Sarkar, Souvik; Kumar, Rahul; Halder, Kamal Krishna; Debnath, Mita Chatterjee; Adhikari, Susanta; Bandyopadhyay, Uday			RETRACTION: Tryptamine-gallic acid hybrid prevents non-steroidal anti-inflammatory drug-induced gastropathy: Correction of mitochondrial dysfunction and inhibition of apoptosis in gastric mucosal cells (Retraction Article, vol 287, pg 3495, 2012) (Retraction of Vol 287, Pg 3495, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Iqbal, Mohd Shameel/AAD-9641-2021	Iqbal, Mohd Shameel/0000-0002-0353-3561				Pal C, 2012, J BIOL CHEM, V287, P3495, DOI 10.1074/jbc.M111.307199	1	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20261	20261		10.1074/jbc.W119.012035	http://dx.doi.org/10.1074/jbc.W119.012035			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31882522	Green Published, hybrid			2022-12-28	WOS:000505005800037
J	Sian, TCCLK; Indumathy, S; Halim, H; Greule, A; Cryle, MJ; Bowness, P; Rossjohn, J; Gras, S; Purcell, AW; Schittenhelm, RB				Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Bowness, Paul; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.			Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; major histocompatibility complex (MHC); crystallography; arthritis; single-nucleotide polymorphism (SNP); Ankylosing spondylitis; HLA heavy chain homodimers; HLA-B*27; 03; HLA-B27; X-ray crystallography	HLA CLASS-I; HLA-B-ASTERISK-27 SUBTYPES; MONOCLONAL-ANTIBODIES; IMGT/HLA DATABASE; HLA-B27; SUSCEPTIBILITY; RECOGNITION; KIR3DL2; CELLS; EXPRESSION	Expression of human leukocyte antigen (HLA)-B27 is strongly associated with predisposition toward ankylosing spondylitis (AS) and other spondyloarthropathies. However, the exact involvement of HLA-B27 in disease initiation and progression remains unclear. The homodimer theory, which proposes that HLA-B27 heavy chains aberrantly form homodimers, is a central hypothesis that attempts to explain the role of HLA-B27 in disease pathogenesis. Here, we examined the ability of the eight most prevalent HLA-B27 allotypes (HLA-B*27:02 to HLA-B*27:09) to form homodimers. We observed that HLA-B*27:03, a disease-associated HLA-B27 subtype, showed a significantly reduced ability to form homodimers compared with all other allotypes, including the non-disease-associated/protective allotypes HLA-B*27:06 and HLA-B*27:09. We used X-ray crystallography and site-directed mutagenesis to unravel the molecular and structural mechanisms in HLA-B*27:03 that are responsible for its compromised ability to form homodimers. We show that polymorphism at position 59, which differentiates HLA-B*27:03 from all other allotypes, is responsible for its compromised ability to form homodimers. Indeed, histidine 59 in HLA-B*27:03 leads to a series of local conformational changes that act in concert to reduce the accessibility of the nearby cysteine 67, an essential amino acid residue for the formation of HLA-B27 homodimers. Considered together, the ability of both protective and disease-associated HLA-B27 allotypes to form homodimers and the failure of HLA-B*27:03 to form homodimers challenge the role of HLA-B27 homodimers in AS pathoetiology. Rather, this work implicates other features, such as peptide binding and antigen presentation, as pivotal mechanisms for disease pathogenesis.	[Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Greule, Anja; Cryle, Max J.] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, Monash Prote & Metabol Facil, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Bowness, Paul] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Windmill Rd, Oxford OX3 7LD, England; [Schittenhelm, Ralf B.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; European Molecular Biology Laboratory (EMBL); Monash University; Monash University; Monash University; Nuffield Orthopaedic Centre; University of Oxford; Cardiff University	Gras, S; Purcell, AW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Schittenhelm, RB (corresponding author), Monash Univ, Monash Prote & Metabol Facil, Biomed Discovery Inst, Clayton, Vic 3800, Australia.	Stephanie.gras@monash.edu; anthony.purcell@monash.edu; ralf.schittenhelm@monash.edu	Bowness, Paul/AAH-2484-2019; Purcell, Anthony/AAH-1942-2019; Cryle, Max/H-7656-2017; Rossjohn, Jamie/F-9032-2013	Purcell, Anthony/0000-0003-0532-8331; Schittenhelm, Ralf/0000-0001-8738-1878; Abd Halim, Noor Hanim/0000-0002-3502-9351; Cryle, Max/0000-0002-9739-6157; Rossjohn, Jamie/0000-0002-2020-7522; Lim Kam Sian, Terry/0000-0001-7038-1214	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) [1085017]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC) Project 1085017. The authors declare that they have no conflicts of interest with the contents of this article.	Allen RL, 1999, J IMMUNOL, V162, P5045; Antoniou AN, 2004, J BIOL CHEM, V279, P8895, DOI 10.1074/jbc.M311757200; Armas JB, 1999, TISSUE ANTIGENS, V53, P237, DOI 10.1034/j.1399-0039.1999.530303.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Ben Radhia K, 2008, JOINT BONE SPINE, V75, P172, DOI 10.1016/j.jbspin.2007.05.020; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Bowness P, 2015, ANNU REV IMMUNOL, V33, P29, DOI 10.1146/annurev-immunol-032414-112110; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bricogne G., 2017, BUSTER VERSION 1 7 6; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2011, BRIEF FUNCT GENOMICS, V10, P249, DOI 10.1093/bfgp/elr023; Cauli A, 2013, RHEUMATOLOGY, V52, P1952, DOI 10.1093/rheumatology/ket219; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; Colbert RA, 2004, CURR MOL MED, V4, P21, DOI 10.2174/1566524043479293; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giquel B, 2007, ARTHRITIS RHEUM, V56, P2232, DOI 10.1002/art.22725; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnes JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8708; Khan MA, 2000, CURR OPIN RHEUMATOL, V12, P235, DOI 10.1097/00002281-200007000-00001; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Khan Muhammad Asim, 2010, Curr Rheumatol Rep, V12, P337, DOI 10.1007/s11926-010-0126-x; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lin H, 2017, RHEUMATOL INT, V37, P1267, DOI 10.1007/s00296-017-3741-2; Liu X, 2010, RHEUMATOL INT, V30, P587, DOI 10.1007/s00296-009-1018-0; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Makhadiyeva D, 2012, IMMUNOLOGY, V135, P133, DOI 10.1111/j.1365-2567.2011.03518.x; McHugh K, 2014, ANN RHEUM DIS, V73, P763, DOI 10.1136/annrheumdis-2012-203080; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reveille JD, 2011, AM J MED SCI, V341, P284, DOI 10.1097/MAJ.0b013e31820f8c99; Reveille JD, 2009, ADV EXP MED BIOL, V649, P159; Robinson J, 2016, HUM IMMUNOL, V77, P233, DOI 10.1016/j.humimm.2016.01.020; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Schittenhelm RB, 2014, TISSUE ANTIGENS, V83, P174, DOI 10.1111/tan.12282; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241; Wong-Baeza I, 2013, J IMMUNOL, V190, P3216, DOI 10.4049/jimmunol.1202926; Yu HC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4016802; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	57	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20185	20195		10.1074/jbc.RA119.010257	http://dx.doi.org/10.1074/jbc.RA119.010257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740583	Green Published, hybrid			2022-12-28	WOS:000505005800029
J	Song, KH; Park, YY; Kee, HJ; Hong, CY; Lee, YS; Ahn, SW; Kim, HJ; Lee, K; Kook, H; Lee, IK; Choi, HS				Song, Kwang-Hoon; Park, Yun-Yong; Kee, Hae Jin; Hong, Cheol Yi; Lee, Yong-Soo; Ahn, Seung-Won; Kim, Hye-Jin; Lee, Keesook; Kook, Hyun; Lee, In-Kyu; Choi, Heung-Sik			RETRACTION: Withdrawal: Orphan nuclear receptor Nur77 induces zinc finger protein GIOT-1 gene expression, and GIOT-1 acts as a novel corepressor of orphan nuclear receptor SF-1 via recruitment of HDAC2 (Retraction of Vol 281, Pg 15605, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021	Kook, Hyun/0000-0002-0740-1806				Song KH, 2006, J BIOL CHEM, V281, P15605, DOI 10.1074/jbc.M505937200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19448	19448		10.1074/jbc.W119.011940	http://dx.doi.org/10.1074/jbc.W119.011940			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836675	Green Published, hybrid			2022-12-28	WOS:000516527800043
J	Trautz, B; Wiedemann, H; Luchtenborg, C; Pierini, V; Kranich, J; Glass, B; Krausslich, HG; Brocker, T; Pizzato, M; Ruggieri, A; Brugger, B; Fackler, OT				Trautz, Birthe; Wiedemann, Hanna; Luchtenborg, Christian; Pierini, Virginia; Kranich, Jan; Glass, Barbel; Krausslich, Hans-Georg; Brocker, Thomas; Pizzato, Massimo; Ruggieri, Alessia; Brugger, Britta; Fackler, Oliver T.			The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles (vol 292, pg 13702, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Kranich, Jan/0000-0002-9928-4132				Trautz B, 2017, J BIOL CHEM, V292, P13702, DOI 10.1074/jbc.M117.797332	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18951	18951		10.1074/jbc.AAC119.011798	http://dx.doi.org/10.1074/jbc.AAC119.011798			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31811051	Green Published, hybrid			2022-12-28	WOS:000507618800039
J	Cao, TX; Sujkowski, A; Cobb, T; Wessells, RJ; Jin, JP				Cao, Tianxin; Sujkowski, Alyson; Cobb, Tyler; Wessells, Robert J.; Jin, Jian-Ping			The glutamic acid-rich?long C-terminal extension of troponin T has a critical role in insect muscle functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						troponin; Drosophila; molecular evolution; muscle physiology; invertebrate; contractile protein; tropomyosin; calcium homeostasis; striated muscle; TnT	NH2-TERMINAL VARIABLE REGION; SKELETAL-MUSCLE; LENGTH DEPENDENCE; PROTEIN; EXPRESSION; ISOFORMS; BINDING; CONTRACTION; EVOLUTION; FORCE	The troponin complex regulates the Ca2+ activation of myofilaments during striated muscle contraction and relaxation. Troponin genes emerged 500?700 million years ago during early animal evolution. Troponin T (TnT) is the thin-filament?anchoring subunit of troponin. Vertebrate and invertebrate TnTs have conserved core structures, reflecting conserved functions in regulating muscle contraction, and they also contain significantly diverged structures, reflecting muscle type- and species-specific adaptations. TnT in insects contains a highly-diverged structure consisting of a long glutamic acid?rich C-terminal extension of ?70 residues with unknown function. We found here that C-terminally truncated Drosophila TnT (TpnT?CD70) retains binding of tropomyosin, troponin I, and troponin C, indicating a preserved core structure of TnT. However, the mutant TpnT(CD70) gene residing on the X chromosome resulted in lethality in male flies. We demonstrate that this X-linked mutation produces dominant-negative phenotypes, including decreased flying and climbing abilities, in heterozygous female flies. Immunoblot quantification with a TpnT-specific mAb indicated expression of TpnT?CD70 in vivo and normal stoichiometry of total TnT in myofilaments of heterozygous female flies. Light and EM examinations revealed primarily normal sarcomere structures in female heterozygous animals, whereas Z-band streaming could be observed in the jump muscle of these flies. Although TpnT?CD70-expressing flies exhibited lower resistance to cardiac stress, their hearts were significantly more tolerant to Ca2+ overloading induced by high-frequency electrical pacing. Our findings suggest that the Glu-rich long C-terminal extension of insect TnT functions as a myofilament Ca2+ buffer/reservoir and is potentially critical to the high-frequency asynchronous contraction of flight muscles.	[Cao, Tianxin; Sujkowski, Alyson; Cobb, Tyler; Wessells, Robert J.; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, 5374 Scott Hall,540 E Canfield, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 5374 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	jjin@med.wayne.edu		Sujkowski, Alyson/0000-0002-9909-9279; Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL127691, HL138007, AG059683]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL127691 and HL138007 (to J.-P. J.) and AG059683 (to R. J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alayari Nakissa N, 2009, J Vis Exp, DOI 10.3791/1423; Alex A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500639; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Biesiadecki BJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/421701; Bullard B, 2011, J MUSCLE RES CELL M, V32, P303, DOI 10.1007/s10974-011-9278-1; Cao TX, 2019, ARCH BIOCHEM BIOPHYS, V666, P40, DOI 10.1016/j.abb.2019.03.013; Chakraborty K, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2860; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Damschroder D, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3037; Domingo A, 1998, J MUSCLE RES CELL M, V19, P393, DOI 10.1023/A:1005349704790; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; FRIDEN J, 1992, MED SCI SPORT EXER, V24, P521; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hanft LM, 2010, J PHYSIOL-LONDON, V588, P2891, DOI 10.1113/jphysiol.2010.190504; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2007, ARCH BIOCHEM BIOPHYS, V466, P1, DOI 10.1016/j.abb.2007.07.021; Jin JP, 1998, GENE, V214, P121, DOI 10.1016/S0378-1119(98)00214-5; JIN JP, 1995, J BIOL CHEM, V270, P6908; Jin JP, 2001, J MOL EVOL, V52, P103, DOI 10.1007/s002390010139; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kagawa H, 2007, ADV EXP MED BIOL, V592, P153; Liu R, 2017, BIOCHEMISTRY-US, V56, P5526, DOI 10.1021/acs.biochem.7b00794; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; Ogut O, 1999, AM J PHYSIOL-CELL PH, V276, pC1162, DOI 10.1152/ajpcell.1999.276.5.C1162; Rassier DE, 2017, AM J PHYSIOL-CELL PH, V313, pC134, DOI 10.1152/ajpcell.00050.2017; Robinson P, 2018, J BIOL CHEM, V293, P10487, DOI 10.1074/jbc.RA118.002081; Rothwell Wendy F, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4825; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Wang J, 1998, BIOCHEMISTRY-US, V37, P14519, DOI 10.1021/bi9812322; Wang J, 1997, GENE, V193, P105, DOI 10.1016/S0378-1119(97)00100-5; Wang X, 2005, J BIOL CHEM, V280, P13241, DOI 10.1074/jbc.M413696200; WANG ZY, 1990, J BIOL CHEM, V265, P4953; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Xiao YS, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2606; YANAGIDA T, 1985, NATURE, V316, P366, DOI 10.1038/316366a0; Zhang ZL, 2004, BIOCHEMISTRY-US, V43, P2645, DOI 10.1021/bi035067o	44	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3794	3807		10.1074/jbc.RA119.012014	http://dx.doi.org/10.1074/jbc.RA119.012014			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32024695	hybrid, Green Published			2022-12-28	WOS:000527704400007
J	Li, X; Kong, LM; Yang, QH; Duan, AZ; Ju, XM; Cai, BC; Chen, L; An, T; Li, Y				Li, Xue; Kong, Lingmei; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Cai, Bicheng; Chen, Lin; An, Tao; Li, Yan			Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small molecule; deubiquitylation (deubiquitination); Wnt signaling; pharmacology; enzyme inhibitor; ?-catenin; parthenolide; ubiquitination; USP7; Wnt signaling; ubiquitin-specific peptidase 7; colorectal cancer; proteasome system; protein homeostasis; deubiquitinating activity	NF-KAPPA-B; BETA-CATENIN; MULTIPLE-MYELOMA; DNA METHYLATION; PROMOTES; DEUBIQUITINATION; STABILIZATION; SYSTEM; TARGET; TRANSCRIPTION	It has been well-established that the deubiquitinating enzyme ubiquitin-specific peptidase 7 (USP7) supports cancer growth by up-regulating multiple cellular pathways, including Wnt/?-catenin signaling. Therefore, considerable efforts are directed at identifying and developing USP7 inhibitors. Here, we report that sesquiterpene lactone parthenolide (PTL) inhibits USP7 activity, assessed with deubiquitinating enzyme activity assays, including fluorogenic Ub-AMC/Ub-Rho110, Ub-VME/PA labeling, and Di-Ub hydrolysis assays. Further investigations using cellular thermal shift (CETSA), surface plasmon resonance (SPR), and mass spectrum (MS) assays revealed that PTL directly interacts with USP7. Consistent with the role of USP7 in stimulating Wnt signaling and carcinogenesis, PTL treatment inhibited the activity of Wnt signaling partly by destabilizing ?-catenin. Moreover, using cell viability assays, we found that PTL suppresses the proliferation of colorectal cancer cells and induces apoptosis in these cells. Additionally, we examined the effects of two other sesquiterpene lactones (costunolide and ?-santonin) on USP7 and Wnt signaling and found that ?-methylene-?-butyrolactone may provide a scaffold for future USP7 inhibitors. In summary, our findings reveal that PTL inhibits USP7 activity, identifying a potential mechanism by which PTL suppresses Wnt/?-catenin signaling. We further suggest that sesquiterpene lactones might represent a suitable scaffold for developing USP7 inhibitors and indicate that PTL holds promise as an anticancer agent targeting aberrant USP7/Wnt signaling.	[Li, Xue; Kong, Lingmei; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Cai, Bicheng; Chen, Lin; An, Tao; Li, Yan] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China; [Li, Xue; Yang, Qihong; Duan, Aizhu; Ju, Xiaoman; Chen, Lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Kong, Lingmei; An, Tao; Li, Yan] Chinese Acad Sci, Yunnan Key Lab Nat Med Chem, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	An, T; Li, Y (corresponding author), Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China.; An, T; Li, Y (corresponding author), Chinese Acad Sci, Yunnan Key Lab Nat Med Chem, Kunming Inst Bot, Kunming 650201, Yunnan, Peoples R China.	antao@mail.kib.ac.cn; liyanb@mail.kib.ac.cn			Young Scientists Fund of National Science Foundation of China [81803587, 81603161]; National Natural Science Foundation of China [81773783]; Project of Science and Technology of Yunnan Province [2019FD054]; West Light Foundation of the Chinese Academy of Sciences; Youth Innovation Promotion Association CAS; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences	Young Scientists Fund of National Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Yunnan Province; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association CAS; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Young Scientists Fund of National Science Foundation of China Grant 81803587 (to T. A.); the National Natural Science Foundation of China Grant 81773783 (to Y. L.); the Young Scientists Fund of National Science Foundation of China Grant 81603161 (to L. K.); the Project of Science and Technology of Yunnan Province Grant 2019FD054 (to T. A.); the West Light Foundation of the Chinese Academy of Sciences (to T. A. and L. K.); and Youth Innovation Promotion Association CAS (to L. K.). The work was also supported by the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences (to T. A. and L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agathanggelou A, 2017, BLOOD, V130, P156, DOI 10.1182/blood-2016-12-758219; Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; An T, 2017, BIOCHEM PHARMACOL, V131, P29, DOI 10.1016/j.bcp.2017.02.011; Berdan CA, 2019, CELL CHEM BIOL, V26, P1027, DOI 10.1016/j.chembiol.2019.03.016; Cai JB, 2015, HEPATOLOGY, V61, P1603, DOI 10.1002/hep.27682; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Franqui-Machin R, 2018, J CLIN INVEST, V128, P2877, DOI 10.1172/JCI98765; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Greenblatt MB, 2016, P NATL ACAD SCI USA, V113, pE1226, DOI 10.1073/pnas.1600813113; Gupta I, 2018, FRONT GENET, V9, DOI [10.3389/fgene.2018.00336, 10.3389/fgene.2018.00409]; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Inoue D, 2015, LEUKEMIA, V29, P2257, DOI 10.1038/leu.2015.90; Jackson PA, 2017, J MED CHEM, V60, P839, DOI 10.1021/acs.jmedchem.6b00788; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin Q, 2019, CLIN CANCER RES, V25, P222, DOI 10.1158/1078-0432.CCR-18-1740; Kim JC, 2018, AM J CANCER RES, V8, P1823; Kong FC, 2015, J HUAZHONG U SCI-MED, V35, P343, DOI 10.1007/s11596-015-1435-0; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lee MJ, 2019, J MED CHEM, V62, P4444, DOI 10.1021/acs.jmedchem.8b01943; Lei AH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00422; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Liu M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061478; Liu YC, 2017, INTEST RES, V15, P174, DOI 10.5217/ir.2017.15.2.174; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Ma XJ, 2018, AM J CANCER RES, V8, P2284; Merin NM, 2015, PHARMACEUTICALS-BASE, V8, P1, DOI 10.3390/ph8010001; Nguyen Hoa Hong, 2019, Cell Physiol Biochem, V53, P157, DOI 10.33594/000000127; Novellasdemunt L, 2017, CELL REP, V21, P612, DOI 10.1016/j.celrep.2017.09.072; Poondla N, 2019, BMB REP, V52, P181, DOI 10.5483/BMBRep.2019.52.3.048; Pozhidaeva A, 2019, DNA REPAIR, V76, P30, DOI 10.1016/j.dnarep.2019.02.005; Rawat R, 2019, CURR OPIN CELL BIOL, V58, P85, DOI 10.1016/j.ceb.2019.02.008; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Shan HZ, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0028-3; Sheridan C, 2015, NAT BIOTECHNOL, V33, P1115, DOI 10.1038/nbt1115-1115; Shi JD, 2015, MOL CELL BIOL, V35, P3301, DOI 10.1128/MCB.00373-15; Song J, 2015, MOL CANCER RES, V13, P969, DOI 10.1158/1541-7786.MCR-13-0644; Sun XH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08334-7; Tavana O, 2017, J MOL CELL BIOL, V9, P45, DOI 10.1093/jmcb/mjw049; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Wu CM, 2018, CELL DEATH DIFFER, V25, P1855, DOI 10.1038/s41418-018-0138-z; Wu J, 2018, J MED CHEM, V61, P422, DOI 10.1021/acs.jmedchem.7b00498; Yang B, 2016, ONCOTARGET, V7, P79501, DOI 10.18632/oncotarget.12819; Zhou ZZ, 2015, DEV CELL, V34, P58, DOI 10.1016/j.devcel.2015.05.016; Zhu XL, 2018, J BIOL CHEM, V293, P5335, DOI 10.1074/jbc.M117.819300; Zhu YH, 2020, CELL DEATH DIFFER, V27, P1316, DOI 10.1038/s41418-019-0417-3	57	22	24	7	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3576	3589		10.1074/jbc.RA119.011396	http://dx.doi.org/10.1074/jbc.RA119.011396			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32029476	Green Published, hybrid			2022-12-28	WOS:000527725300017
J	Ramachandran, A; Summerville, L; Learn, BA; DeBell, L; Bailey, S				Ramachandran, Anita; Summerville, Lesley; Learn, Brian A.; DeBell, Lily; Bailey, Scott			Processing and integration of functionally oriented prespacers in the Escherichia coli CRISPR system depends on bacterial host exonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; CRISPR-RNA (crRNA); DNA; deoxyribonuclease (DNase); integrase; 3'-5' exonuclease; bacterial immunity; DnaQ; prespacer processing; primed adaptation; protospacer adjacent motif (PAM)	SPACER ACQUISITION; MECHANISTIC BASIS; EPSILON-SUBUNIT; DNA; IMMUNITY; REPEATS; PAM; RESISTANCE; ESTABLISH; PROTEINS	CRISPR-Cas systems provide bacteria with adaptive immunity against viruses. During spacer adaptation, the Cas1-Cas2 complex selects fragments of foreign DNA, called prespacers, and integrates them into CRISPR arrays in an orientation that provides functional immunity. Cas4 is involved in both the trimming of prespacers and the cleavage of protospacer adjacent motif (PAM) in several type I CRISPR-Cas systems, but how the prespacers are processed in systems lacking Cas4, such as the type I-E and I-F systems, is not understood. In Escherichia coli, which has a type I-E system, Cas1-Cas2 preferentially selects prespacers with 3? overhangs via specific recognition of a PAM, but how these prespacers are integrated in a functional orientation in the absence of Cas4 is not known. Using a biochemical approach with purified proteins, as well as integration, prespacer protection, sequencing, and quantitative PCR assays, we show here that the bacterial 3??5? exonucleases DnaQ and ExoT can trim long 3? overhangs of prespacers and promote integration in the correct orientation. We found that trimming by these exonucleases results in an asymmetric intermediate, because Cas1-Cas2 protects the PAM sequence, which helps to define spacer orientation. Our findings implicate the E. coli host 3??5? exonucleases DnaQ and ExoT in spacer adaptation and reveal a mechanism by which spacer orientation is defined in E. coli.	[Ramachandran, Anita; Summerville, Lesley; Learn, Brian A.; DeBell, Lily; Bailey, Scott] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Bailey, Scott] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Bailey, S (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu		Bailey, Scott/0000-0003-1953-7089	National Institutes of Health [GM097330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM097330 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Hamdan S, 2000, J STRUCT BIOL, V131, P164, DOI 10.1006/jsbi.2000.4291; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hsiao YY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001803; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lee H, 2019, ELIFE, V8, DOI 10.7554/eLife.44248; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Modell JW, 2017, NATURE, V544, P101, DOI 10.1038/nature21719; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Shiimori M, 2017, NUCLEIC ACIDS RES, V45, P11281, DOI 10.1093/nar/gkx839; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shiriaeva AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12417-w; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	50	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3403	3414		10.1074/jbc.RA119.012196	http://dx.doi.org/10.1074/jbc.RA119.012196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31914418	Green Published, hybrid			2022-12-28	WOS:000527725300003
J	Seki, T; Kanagawa, M; Kobayashi, K; Kowa, H; Yahata, N; Maruyama, K; Iwata, N; Inoue, H; Toda, T				Seki, Tsuneyoshi; Kanagawa, Motoi; Kobayashi, Kazuhiro; Kowa, Hisatomo; Yahata, Naoki; Maruyama, Kei; Iwata, Nobuhisa; Inoue, Haruhisa; Toda, Tatsushi			Galectin 3?binding protein suppresses amyloid-? production by modulating ?-cleavage of amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; induced pluripotent stem cell (iPS cell) (iPSC); amyloid-beta (AB); amyloid precursor protein (APP); lectin; beta-secretase 1 (BACE1); microarray; neurodegeneration; galectin 3?binding protein (GAL3BP); glycophosphatidylinositol-specific phospholipase D1 (GPLD1)	ALZHEIMERS-DISEASE; A-BETA; ANCHORED PROTEINS; CELL BIOLOGY; SECRETASE; HYPOTHESIS; A-BETA-40; PEPTIDES; MUTATION; TARGETS	Alzheimer's disease (AD) is the most common type of dementia, and its pathogenesis is associated with accumulation of ?-amyloid (A?) peptides. A? is produced from amyloid precursor protein (APP) that is sequentially cleaved by ?- and ?-secretases. Therefore, APP processing has been a target in therapeutic strategies for managing AD; however, no effective treatment of AD patients is currently available. Here, to identify endogenous factors that modulate A? production, we performed a gene microarray?based transcriptome analysis of neuronal cells derived from human induced pluripotent stem cells, because A? production in these cells changes during neuronal differentiation. We found that expression of the glycophosphatidylinositol-specific phospholipase D1 (GPLD1) gene is associated with these changes in A? production. GPLD1 overexpression in HEK293 cells increased the secretion of galectin 3?binding protein (GAL3BP), which suppressed A? production in an AD model, neuroglioma H4 cells. Mechanistically, GAL3BP suppressed A? production by directly interacting with APP and thereby inhibiting APP processing by ?-secretase. Furthermore, we show that cells take up extracellularly added GAL3BP via endocytosis and that GAL3BP is localized in close proximity to APP in endosomes where amyloidogenic APP processing takes place. Taken together, our results indicate that GAL3BP may be a suitable target of AD-modifying drugs in future therapeutic strategies for managing AD.	[Seki, Tsuneyoshi; Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Kowa, Hisatomo] Kobe Univ, Dept Rehabil Sci, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Yahata, Naoki] Fujita Hlth Univ, Dept Anat 1, Sch Med, Toyoake, Aichi 4701192, Japan; [Maruyama, Kei] Saitama Med Univ, Dept Pharmacol, Fac Med, Saitama 3500495, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Genome Based Drug Discovery, Nagasaki 8528521, Japan; [Yahata, Naoki; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Inoue, Haruhisa] RIKEN BioResource Res Ctr BRC, IPSC Based Drug Discovery & Dev Team, Kyoto 6190238, Japan; [Inoue, Haruhisa] RIKEN Ctr Adv Intelligence Project AIP, Med Risk Avoidance Based iPS Cells Team, Kyoto 6068507, Japan; [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan	Kobe University; Kobe University; Fujita Health University; Saitama Medical University; Nagasaki University; Kyoto University; RIKEN; RIKEN; University of Tokyo	Toda, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan.	toda@m.u-tokyo.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science (JSPS) [17H06421]; CREST	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant 17H06421 (to M. K.) and by CREST (to H. I., N. I., and T. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arbor S, 2017, NEURAL REGEN RES, V12, P207, DOI 10.4103/1673-5374.200800; Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Ashraf GM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00430; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Darcissac ECA, 2001, CLIN EXP IMMUNOL, V126, P287, DOI 10.1046/j.1365-2249.2001.01670.x; Deeg MA, 2001, J LIPID RES, V42, P442; Deeg MA, 2012, BBA-MOL CELL BIOL L, V1821, P381, DOI 10.1016/j.bbalip.2011.12.009; Deroo EP, 2015, BLOOD, V125, P1813, DOI 10.1182/blood-2014-04-569939; Grassadonia A, 2013, DIS MARKERS, V2013, P747, DOI 10.1155/2013/214595; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122120; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Klein AM, 1999, ANN NY ACAD SCI, V893, P314, DOI 10.1111/j.1749-6632.1999.tb07845.x; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Ooi A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00300; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Sambamurti K, 1999, J BIOL CHEM, V274, P26810, DOI 10.1074/jbc.274.38.26810; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; SCALLON BJ, 1991, SCIENCE, V252, P446, DOI 10.1126/science.2017684; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang XX, 2015, AM J ALZHEIMERS DIS, V30, P729, DOI 10.1177/1533317513495107; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788	48	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3678	3691		10.1074/jbc.RA119.008703	http://dx.doi.org/10.1074/jbc.RA119.008703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31996371	Green Published, hybrid			2022-12-28	WOS:000527725300024
J	Chen, A; Arora, PD; Lai, CC; Copeland, JW; Moraes, TF; McCulloch, CA; Lavoie, B; Wilde, A				Chen, Anan; Arora, Pam D.; Lai, Christine C.; Copeland, John W.; Moraes, Trevor F.; McCulloch, Christopher A.; Lavoie, Brigitte; Wilde, Andrew			The scaffold-protein IQGAP1 enhances and spatially restricts the actin-nucleating activity of Diaphanous-related formin 1 (DIAPH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; formin; Rho (Rho GTPase); cytoskeleton; cell signaling; actin nucleation; Diaphanous-related formin 1 (DIAPH1); Flightless-I (Fli-I); IQ motif containing GTPase-activating protein 1 (IQGAP1)	FLIGHTLESS I; AURORA-B; PHOSPHORYLATION; MDIA1; RHO; BINDING; ORGANIZATION; ARCHITECTURE; MIGRATION	The actin cytoskeleton is a dynamic array of filaments that undergoes rapid remodeling to drive many cellular processes. An essential feature of filament remodeling is the spatio-temporal regulation of actin filament nucleation. One family of actin filament nucleators, the Diaphanous-related formins, is activated by the binding of small G-proteins such as RhoA. However, RhoA only partially activates formins, suggesting that additional factors are required to fully activate the formin. Here we identify one such factor, IQ motif containing GTPase activating protein-1 (IQGAP1), which enhances RhoA-mediated activation of the Diaphanous-related formin (DIAPH1) and targets DIAPH1 to the plasma membrane. We find that the inhibitory intramolecular interaction within DIAPH1 is disrupted by the sequential binding of RhoA and IQGAP1. Binding of RhoA and IQGAP1 robustly stimulates DIAPH1-mediated actin filament nucleation in vitro. In contrast, the actin capping protein Flightless-I, in conjunction with RhoA, only weakly stimulates DIAPH1 activity. IQGAP1, but not Flightless-I, is required to recruit DIAPH1 to the plasma membrane where actin filaments are generated. These results indicate that IQGAP1 enhances RhoA-mediated activation of DIAPH1 in vivo. Collectively these data support a model where the combined action of RhoA and an enhancer ensures the spatio-temporal regulation of actin nucleation to stimulate robust and localized actin filament production in vivo.	[Chen, Anan; Lai, Christine C.; Moraes, Trevor F.; Wilde, Andrew] Univ Toronto, Dept Biochem, Toronto, ON M5G 1M1, Canada; [Arora, Pam D.; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Toronto, ON M5G 1M1, Canada; [Lavoie, Brigitte; Wilde, Andrew] Univ Toronto, Dept Mol Genet, 661 Univ Ave, Toronto, ON M5G 1M1, Canada; [Copeland, John W.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Ottawa	Wilde, A (corresponding author), Univ Toronto, Dept Mol Genet, 661 Univ Ave, Toronto, ON M5G 1M1, Canada.	andrew.wilde@utoronto.ca		Wilde, Andrew/0000-0002-9812-3847	Canadian Institutes of Health Research (CIHR) [PJT 148575]; Tier 1 Canada Research Chair [MOP-36332]; CIHR [MOP-36332]; National Science and Engineering Research Council [RGPIN-2018-06546]; Cancer Research Society [24154]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research Society	This work was supported by Canadian Institutes of Health Research (CIHR) Grant PJT 148575 (to A. W.), a Tier 1 Canada Research Chair and CIHR Grant MOP-36332 (to C. A. M.), National Science and Engineering Research Council Grant RGPIN-2018-06546 (to T. F. M.), and Cancer Research Society Grant 24154 (to J. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Arora PD, 2017, J CELL SCI, V130, P2196, DOI 10.1242/jcs.201665; Arora PD, 2015, MOL BIOL CELL, V26, P2279, DOI 10.1091/mbc.E14-11-1536; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brenig J, 2015, J BIOL CHEM, V290, P14314, DOI 10.1074/jbc.M114.621946; Chen A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01231-x; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Floyd S, 2013, J CELL SCI, V126, P2845, DOI 10.1242/jcs.123232; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Greseth MD, 2017, MOL CELL PROTEOMICS, V16, pS124, DOI 10.1074/mcp.M116.065003; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Mohammad I, 2012, FASEB J, V26, P3260, DOI 10.1096/fj.11-202051; Nezami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012992; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pogoutse AK, 2016, ANAL BIOCHEM, V501, P35, DOI 10.1016/j.ab.2016.02.001; Renshaw MJ, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130190; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sakamoto S, 2012, J CELL SCI, V125, P108, DOI 10.1242/jcs.087411; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Staus DP, 2011, BIOCHEM J, V439, P57, DOI 10.1042/BJ20101700; VOGT TF, 1993, P NATL ACAD SCI USA, V90, P5554, DOI 10.1073/pnas.90.12.5554; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Zhou Q, 2017, HYPERTENSION, V69, P1070, DOI 10.1161/HYPERTENSIONAHA.116.08662	37	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3134	3147		10.1074/jbc.RA119.010476	http://dx.doi.org/10.1074/jbc.RA119.010476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005666	hybrid, Green Published			2022-12-28	WOS:000519597300020
J	Coombes, D; Davies, JS; Newton-Vesty, MC; Horne, CR; Setty, TG; Subramanian, R; Moir, JWB; Friemann, R; Panjikar, S; Griffin, MDW; North, RA; Dobson, RCJ				Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; Setty, Thanuja G.; Subramanian, Ramaswamy; Moir, James W. B.; Friemann, Rosmarie; Panjikar, Santosh; Griffin, Michael D. W.; North, Rachel A.; Dobson, Renwick C. J.			The basis for non-canonical ROK family function in the N-acetylmannosamine kinase from the pathogen Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); X-ray crystallography; analytical ultracentrifugation; small-angle X-ray scattering (SAXS); structural biology; N-aceytlmannosamine kinase; repressor; open reading frame; kinase; ROK protein family; sialic acid; sugar kinase	X-RAY DIFFRACTION; SIALIC-ACID CATABOLISM; MOLECULAR REPLACEMENT; ESCHERICHIA-COLI; ACETYLNEURAMINATE LYASE; CRYSTAL-STRUCTURES; BACILLUS-SUBTILIS; GLUCOSE KINASE; PURIFICATION; CRYSTALLIZATION	In environments where glucose is limited, some pathogenic bacteria metabolize host-derived sialic acid as a nutrient source. N-Acetylmannosamine kinase (NanK) is the second enzyme of the bacterial sialic acid import and degradation pathway and adds phosphate to N-acetylmannosamine using ATP to prime the molecule for future pathway reactions. Sequence alignments reveal that Gram-positive NanK enzymes belong to the Repressor, ORF, Kinase (ROK) family, but many lack the canonical Zn-binding motif expected for this function, and the sugar-binding EXGH motif is altered to EXGY. As a result, it is unclear how they perform this important reaction. Here, we study the Staphylococcus aureus NanK (SaNanK), which is the first characterization of a Gram-positive NanK. We report the kinetic activity of SaNanK along with the ligand?free, N-acetylmannosamine?bound and substrate analog GlcNAc?bound crystal structures (2.33, 2.20, and 2.20 ? resolution, respectively). These demonstrate, in combination with small-angle X-ray scattering, that SaNanK is a dimer that adopts a closed conformation upon substrate binding. Analysis of the EXGY motif reveals that the tyrosine binds to the N-acetyl group to select for the ?boat? conformation of N-acetylmannosamine. Moreover, SaNanK has a stacked arginine pair coordinated by negative residues critical for thermal stability and catalysis. These combined elements serve to constrain the active site and orient the substrate in lieu of Zn binding, representing a significant departure from canonical NanK binding. This characterization provides insight into differences in the ROK family and highlights a novel area for antimicrobial discovery to fight Gram-positive and S. aureus infections.	[Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; North, Rachel A.; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; North, Rachel A.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Setty, Thanuja G.; Subramanian, Ramaswamy] NCBS, Inst Stem Cell Biol & Regenerat Med, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India; [Setty, Thanuja G.] Univ Trans Disciplinary Hlth Sci & Technol TDU, Bangalore 560064, Karnataka, India; [Moir, James W. B.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Friemann, Rosmarie] Sahlgrens Univ Hosp, Dept Clin Microbiol, Guldhedsgatan 10A, S-41346 Gothenburg, Sweden; [Friemann, Rosmarie] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, S-40530 Gothenburg, Sweden; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Panjikar, Santosh] Australian Synchrotron, ANSTO, Clayton, Vic 3168, Australia; [Griffin, Michael D. W.; Dobson, Renwick C. J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Canterbury; University of Canterbury; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of York - UK; Sahlgrenska University Hospital; University of Gothenburg; Monash University; Australian Nuclear Science & Technology Organisation; University of Melbourne	Dobson, RCJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand.; North, RA (corresponding author), POB 4800, Christchurch 8140, New Zealand.	rachel.north@dbb.su.se; renwick.dobson@canterbury.ac.nz	North, Rachel/W-3575-2019; Dobson, Renwick/AAZ-7020-2021; Friemann, Rosmarie/C-1018-2008; Panjikar, Santosh/D-2709-2012	North, Rachel/0000-0001-5011-1567; Dobson, Renwick/0000-0002-5506-4939; Friemann, Rosmarie/0000-0002-5633-2894; Gangisetty, Thanuja/0000-0002-3162-8138; Subramanian, Ramaswamy/0000-0002-6709-190X; Griffin, Michael/0000-0001-9845-7735; Coombes, David/0000-0001-6384-2617; Davies, James/0000-0003-4029-1650; Panjikar, Santosh/0000-0001-7429-3879; Horne, Christopher R./0000-0003-1318-514X	New Zealand Royal Society Marsden Fund [UOC1506]; Ministry of Business, Innovation and Employment Smart Ideas Grant [UOCX1706]; Biomolecular Interactions Centre (University of Canterbury); Australian Research Council [FT140100544]; University of Canterbury; DBT-Indo Swedish Grant [BT/IN/SWEDEN/06/SR/2017-18]; Council of Scientific and Industrial Research (CSIR); Swedish Governmental Agency for Innovation Systems (VINNOVA) [2017-00180]; Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg; Erskine distinguished Visiting Fellowship	New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Ministry of Business, Innovation and Employment Smart Ideas Grant; Biomolecular Interactions Centre (University of Canterbury); Australian Research Council(Australian Research Council); University of Canterbury; DBT-Indo Swedish Grant; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg; Erskine distinguished Visiting Fellowship	This work was supported by in part by New Zealand Royal Society Marsden Fund contract UOC1506, Ministry of Business, Innovation and Employment Smart Ideas Grant UOCX1706, and the Biomolecular Interactions Centre (University of Canterbury) (to R. C. J. D.), Australian Research Council Future Fellowship project FT140100544 (to M. D. W. G.), University of Canterbury Doctoral Scholarships (to D. C. and R. A. N.), New Zealand Royal Society Marsden Fund contract UOC1506 (to R. A. N.), DBT-Indo Swedish Grant BT/IN/SWEDEN/06/SR/2017-18 (to R. S. and T. G. S.), a Senior Research fellowship from the Council of Scientific and Industrial Research (CSIR) (to T. G. S.), Swedish Governmental Agency for Innovation Systems (VINNOVA) Grant 2017-00180 (to R. F.) and the Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg (to R. F.), and an Erskine distinguished Visiting Fellowship (to J. W. B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abergel C, 2013, ACTA CRYSTALLOGR D, V69, P2167, DOI 10.1107/S0907444913015291; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Caing-Carlsson R, 2017, ACTA CRYSTALLOGR F, V73, P356, DOI 10.1107/S2053230X17007439; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conejo MS, 2010, J MOL EVOL, V70, P545, DOI 10.1007/s00239-010-9351-1; Coombes D, 2019, BIOCHEM SOC T, V47, P1533, DOI 10.1042/BST20180626; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P129; Davies JS, 2019, FEBS LETT, V593, P52, DOI 10.1002/1873-3468.13289; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Griffin MDW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040318; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Imriskova I, 2005, RES MICROBIOL, V156, P361, DOI 10.1016/j.resmic.2004.11.001; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kakkar T, 2000, J PHARMACOL EXP THER, V293, P861; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larion M, 2007, BIOCHEMISTRY-US, V46, P13564, DOI 10.1021/bi700924d; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Martinez J, 2012, J BIOL CHEM, V287, P13656, DOI 10.1074/jbc.M111.318170; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mesak LR, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-6; Miyazono K, 2012, J BACTERIOL, V194, P607, DOI 10.1128/JB.06173-11; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nocek B, 2011, J MOL BIOL, V406, P325, DOI 10.1016/j.jmb.2010.12.021; North RA, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00233; North Rachel A, 2018, Biophys Rev, V10, P219, DOI 10.1007/s12551-017-0343-x; North RA, 2016, FEBS LETT, V590, P4414, DOI 10.1002/1873-3468.12462; North RA, 2014, ACTA CRYSTALLOGR F, V70, P650, DOI 10.1107/S2053230X14007171; North RA, 2013, ACTA CRYSTALLOGR F, V69, P306, DOI 10.1107/S1744309113003060; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Pelissier MC, 2014, J BIOL CHEM, V289, P35215, DOI 10.1074/jbc.M114.604272; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plumbridge J, 2015, J MOL MICROB BIOTECH, V25, P154, DOI 10.1159/000369583; Ringborg RH, 2016, REACT CHEM ENG, V1, P10, DOI 10.1039/c5re00045a; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skarlatos P, 1998, J BACTERIOL, V180, P3222, DOI 10.1128/JB.180.12.3222-3226.1998; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thompson J, 2002, J BIOL CHEM, V277, P34310, DOI 10.1074/jbc.M206397200; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vergne-Vaxelaire C, 2018, APPL MICROBIOL BIOT, V102, P5569, DOI 10.1007/s00253-018-9018-1; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wahlgren WY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04045-7; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	62	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3301	3315		10.1074/jbc.RA119.010526	http://dx.doi.org/10.1074/jbc.RA119.010526			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31949045	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000519597300033
J	Rathkey, JK; Xiao, TS; Abbott, DW				Rathkey, Joseph K.; Xiao, Tsan S.; Abbott, Derek W.			Human polymorphisms in GSDMD alter the inflammatory response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; inflammasome; genetics; inflammation; genetic polymorphism; SNP	GASDERMIN-D; ACTIVE CASPASE-1; PYROPTOSIS; PORE; MECHANISM; DRIVEN	Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation than the majority of other gene families. However, the phenotypic implications of this genetic variation are not well understood, with effects ranging from hypomorphic to silent to hyperfunctioning. In this work, we study the functional consequences of this variation by investigating polymorphisms in gasdermin D, the key pyroptotic effector protein. We find that, although SNPs affecting potential posttranslational modifications did not affect gasdermin D function or pyroptosis, polymorphisms disrupting sites predicted to be structurally important dramatically alter gasdermin D function. The manner in which these polymorphisms alter function varies from conserving normal pyroptotic function to inhibiting caspase cleavage to disrupting oligomerization and pore formation. Further, downstream of inflammasome activation, polymorphisms that cause loss of gasdermin D function convert inflammatory pyroptotic cell death into immunologically silent apoptotic cell death. These findings suggest that human genetic variation can alter mechanisms of cell death in inflammation.	[Rathkey, Joseph K.; Xiao, Tsan S.; Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Abbott, DW (corresponding author), Rm 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Xiao, Tsan/I-7616-2013	Xiao, Tsan/0000-0001-9688-475X; Abbott, Derek/0000-0003-4387-8094	NIDDK, National Institutes of Health [P01-DK091222]; NIGMS, National Institutes of Health [R01GM086550]; National Institutes of Health [R21AR069908, R01GM127609]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIDDK, National Institutes of Health Grant P01-DK091222 (to D. W. A.); NIGMS, National Institutes of Health Grant R01GM086550 (to D. W. A.); and National Institutes of Health Grants R21AR069908 and R01GM127609 (to T. S. X.).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Chirieleison SM, 2017, J BIOL CHEM, V292, P9666, DOI 10.1074/jbc.M117.781500; Chirieleison SM, 2016, J IMMUNOL, V196, P4291, DOI 10.4049/jimmunol.1502631; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lei XB, 2017, J VIROL, V91, DOI 10.1128/JVI.01069-17; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Newton K, 2019, NATURE, V575, P679, DOI 10.1038/s41586-019-1752-8; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Rathkey JK, 2017, J BIOL CHEM, V292, P14649, DOI 10.1074/jbc.M117.797217; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi PL, 2015, BIOCHEM J, V468, P325, DOI 10.1042/BJ20150204; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115	28	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3228	3238		10.1074/jbc.RA119.010604	http://dx.doi.org/10.1074/jbc.RA119.010604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988247	hybrid, Green Published			2022-12-28	WOS:000519597300027
J	Gray, MW; Gopalan, V				Gray, Michael W.; Gopalan, Venkat			Piece by piece: Building a ribozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ribonuclease P (RNase P); ribozyme (catalytic RNA) (RNA enzyme); evolution; ribosome; enzyme catalysis; ribonucleoprotein complex	23S RIBOSOMAL-RNA; RIBONUCLEASE-P RNA; STRUCTURAL BASIS; MITOCHONDRIAL-DNA; CRYSTAL-STRUCTURE; CATALYTIC CORE; MESSENGER-RNA; EF-TU; SUBUNIT; CLEAVAGE	The ribosome and RNase P are cellular ribonucleoprotein complexes that perform peptide bond synthesis and phosphodiester bond cleavage, respectively. Both are ancient biological assemblies that were already present in the last universal common ancestor of all life. The large subunit rRNA in the ribosome and the RNA subunit of RNase P are the ribozyme components required for catalysis. Here, we explore the idea that these two large ribozymes may have begun their evolutionary odyssey as an assemblage of RNA ?fragments? smaller than the contemporary full-length versions and that they transitioned through distinct stages along a pathway that may also be relevant for the evolution of other non-coding RNAs.	[Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Gray, Michael W.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada; [Gopalan, Venkat] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Gopalan, Venkat] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	Dalhousie University; Dalhousie University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gray, MW (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.; Gray, MW (corresponding author), Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada.; Gopalan, V (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Gopalan, V (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.	m.w.gray@dal.ca; gopalan.5@osu.edu		Gopalan, Venkat/0000-0002-3016-2719	Canadian Institutes of Health Research [MOP-4124, MOP-11212]; Natural Sciences and Engineering Research Council of Canada [A8387]; National Institutes of Health [GM-120582, NS-096600]; US-Israel Binational Science Foundation [2015157]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by Canadian Institutes of Health Research Grants MOP-4124 and MOP-11212 and Natural Sciences and Engineering Research Council of Canada Grant A8387 (to M. W. G.) and National Institutes of Health Grants GM-120582 and NS-096600 and US-Israel Binational Science Foundation Grant 2015157 (to V. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Altman S., 1999, RNA WORLD, P351; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; BOER PH, 1988, CURR GENET, V14, P583, DOI 10.1007/BF00434084; BOER PH, 1988, CELL, V55, P399, DOI 10.1016/0092-8674(88)90026-8; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; BOWMAN CM, 1971, P NATL ACAD SCI USA, V68, P964, DOI 10.1073/pnas.68.5.964; CAMPBELL DA, 1987, J MOL BIOL, V196, P113, DOI 10.1016/0022-2836(87)90514-6; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; Chambliss G., 1980, RIBOSOMES STRUCTURE, P357; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Chan PP, 2012, RNA BIOL, V9, P1155, DOI 10.4161/rna.21502; Chen WY, 2010, NUCLEIC ACIDS RES, V38, P8316, DOI 10.1093/nar/gkq668; CLARK CG, 1987, J MOL EVOL, V25, P343, DOI 10.1007/BF02603119; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Copley SD, 2007, BIOORG CHEM, V35, P430, DOI 10.1016/j.bioorg.2007.08.001; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Daniels CJ, 2019, RNA, V25, P286, DOI 10.1261/rna.068379.118; Davis JH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0181; Ellis JC, 2009, RNA BIOL, V6, P362, DOI 10.4161/rna.6.4.9241; ENDO Y, 1982, J BIOL CHEM, V257, P9054; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Feagin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038320; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Fox GF, 2004, MOL B INT U, P92; FRANK DN, 1994, BIOCHEMISTRY-US, V33, P10800, DOI 10.1021/bi00201a030; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fujii K, 2018, MOL CELL, V72, P1013, DOI 10.1016/j.molcel.2018.11.023; Garcia-Ortega L, 2010, NUCLEIC ACIDS RES, V38, P4108, DOI 10.1093/nar/gkq151; Gopalan V, 2007, P NATL ACAD SCI USA, V104, P2031, DOI 10.1073/pnas.0611193104; Gray M. W., 1996, RIBOSOMAL RNA STRUCT, P49; GRAY MW, 1990, RIBOSOME, P589; Gray MW, 1995, TRACING BIOLOGICAL EVOLUTION IN PROTEIN AND GENE STRUCTURES, P65; GRAY MW, 1981, MOL CELL BIOL, V1, P347, DOI 10.1128/MCB.1.4.347; Green CJ, 1996, NUCLEIC ACIDS RES, V24, P1497, DOI 10.1093/nar/24.8.1497; GUERRIERTAKADA C, 1992, P NATL ACAD SCI USA, V89, P1266, DOI 10.1073/pnas.89.4.1266; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Gutell R.R., 1992, ORIGIN EVOLUTION CEL, P243; GUTELL RR, 1994, NUCLEIC ACIDS RES, V22, P3502, DOI 10.1093/nar/22.17.3502; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Harris ME, 1997, RNA, V3, P561; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HEINONEN TY, 1987, J BIOL CHEM, V262, P2879; Hsiao CL, 2009, MOL BIOL EVOL, V26, P2415, DOI 10.1093/molbev/msp163; Hsiao CL, 2009, NUCLEIC ACIDS RES, V37, P3134, DOI 10.1093/nar/gkp119; Hury J, 2006, ORIGINS LIFE EVOL B, V36, P421, DOI 10.1007/s11084-006-9011-z; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; Jarrous N, 2010, NUCLEIC ACIDS RES, V38, P7885, DOI 10.1093/nar/gkq701; Kachouri R, 2005, RNA, V11, P1064, DOI 10.1261/rna.2130705; KENNEDY TD, 1981, J BIOL CHEM, V256, P5802; Kikovska E, 2012, NUCLEIC ACIDS RES, V40, P2224, DOI 10.1093/nar/gkr1001; KIKUCHI Y, 1993, NUCLEIC ACIDS RES, V21, P4685, DOI 10.1093/nar/21.20.4685; KIKUCHI Y, 1995, J BIOCHEM-TOKYO, V117, P197, DOI 10.1093/oxfordjournals.jbchem.a124710; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Krupkin M, 2011, PHILOS T R SOC B, V366, P2972, DOI 10.1098/rstb.2011.0146; Lai LB, 2010, P NATL ACAD SCI USA, V107, P22493, DOI 10.1073/pnas.1013969107; Lan PF, 2018, SCIENCE, V362, P657, DOI 10.1126/science.aat6678; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; LEFFERS H, 1988, J MOL BIOL, V204, P507, DOI 10.1016/0022-2836(88)90351-8; Lehmann J, 2013, NUCLEIC ACIDS RES, V41, P5494, DOI 10.1093/nar/gkt219; Loria A, 1999, BIOCHEMISTRY-US, V38, P8612, DOI 10.1021/bi990691f; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Loria A, 1996, RNA, V2, P551; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Mao CH, 2009, RNA BIOL, V6, P355, DOI 10.4161/rna.6.4.9172; Marquez SM, 2005, RNA, V11, P739, DOI 10.1261/rna.7211705; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Noller H.F., 1993, RNA WORLD, P137; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Petrov AS, 2015, P NATL ACAD SCI USA, V112, P15396, DOI 10.1073/pnas.1509761112; Pulukkunat DK, 2008, NUCLEIC ACIDS RES, V36, P4172, DOI 10.1093/nar/gkn360; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Robertson MP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003608; Saurer M, 2019, SCIENCE, V365, P1144, DOI 10.1126/science.aaw5570; SCHIMMEL P, 1994, P NATL ACAD SCI USA, V91, P11283, DOI 10.1073/pnas.91.24.11283; Schimmel P, 1998, P NATL ACAD SCI USA, V95, P10351, DOI 10.1073/pnas.95.18.10351; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHIMMEL P, 1995, CELL, V81, P983, DOI 10.1016/S0092-8674(05)80002-9; SCHNARE MN, 1990, J MOL BIOL, V215, P73, DOI 10.1016/S0022-2836(05)80096-8; SCHNARE MN, 1990, J MOL BIOL, V215, P85, DOI 10.1016/S0022-2836(05)80097-X; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Seif ER, 2003, RNA, V9, P1073, DOI 10.1261/rna.5880403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SENIOR BW, 1971, P NATL ACAD SCI USA, V68, P959, DOI 10.1073/pnas.68.5.959; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shi YG, 2017, J MOL BIOL, V429, P2640, DOI 10.1016/j.jmb.2017.07.010; SHUSTER EO, 1988, CELL, V55, P41, DOI 10.1016/0092-8674(88)90007-4; Siegel RW, 1996, RNA, V2, P452; Smallman DS, 1996, BBA-GENE STRUCT EXPR, V1305, P1, DOI 10.1016/0167-4781(95)00204-9; Smith TF, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-16; Spencer DF, 2011, MOL GENET GENOMICS, V285, P19, DOI 10.1007/s00438-010-0585-9; SPENCER DF, 1987, EMBO J, V6, P1063, DOI 10.1002/j.1460-2075.1987.tb04859.x; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; Sun FJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-153; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WISE CA, 1991, J BIOL CHEM, V266, P19154; Woese C. R., 1972, EXOBIOLOGY, P301; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Wu J, 2018, CELL, V175, P1393, DOI 10.1016/j.cell.2018.10.003; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zimmerman E, 2009, CHEMBIOCHEM, V10, P63, DOI 10.1002/cbic.200800554; Zwieb C, 2010, ARCHAEA, V2010, DOI 10.1155/2010/485051	122	15	15	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2313	2323		10.1074/jbc.REV119.009929	http://dx.doi.org/10.1074/jbc.REV119.009929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953324	Green Published, hybrid			2022-12-28	WOS:000517330200014
J	Mikkelsen, JH; Runager, K; Andersen, CBF				Mikkelsen, Jakob H.; Runager, Kasper; Andersen, Christian B. F.			The human protein haptoglobin inhibits IsdH-mediated heme-sequestering by Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); hemoglobin; inhibitor; infection; iron; Haptoglobin; Hemoglobin; iron; IsdH; Staphylococcus aureus	HEMOGLOBIN RECEPTOR; SURFACE PROTEIN; NUTRITIONAL IMMUNITY; STRUCTURAL BASIS; IRON; BINDING; DOMAIN; IDENTIFICATION; NEAT; ISDH/HARA	Iron is an essential nutrient for all living organisms. To acquire iron, many pathogens have developed elaborate systems to steal it from their hosts. The iron acquisition system in the opportunistic pathogen Staphylococcus aureus comprises nine proteins, called iron-regulated surface determinants (Isds). The Isd components enable S. aureus to extract heme from hemoglobin (Hb), transport it into the bacterial cytoplasm, and ultimately release iron from the porphyrin ring. IsdB and IsdH act as hemoglobin receptors and are known to actively extract heme from extracellular Hb. To limit microbial pathogenicity during infection, host organisms attempt to restrict the availability of nutrient metals at the host?pathogen interface. The human acute phase protein haptoglobin (Hp) protects the host from oxidative damage by clearing hemoglobin that has leaked from red blood cells and also restricts the availability of extracellular Hb-bound iron to invading pathogens. To investigate whether Hp serves an additional role in nutritional immunity through a direct inhibition of IsdH-mediated iron acquisition, here we measured heme extraction from the Hp?Hb complex by UV-visible spectroscopy and determined the crystal structure of the Hp?Hb?IsdH complex at 2.9 ? resolution. We found that Hp strongly inhibits IsdH-mediated heme extraction and that Hp binding prevents local unfolding of the Hb heme pocket, leaving IsdH unable to wrest the heme from Hb. Furthermore, we noted that the Hp?Hb binding appears to trap IsdH in an initial state before heme transfer. Our findings provide insights into Hp-mediated IsdH inhibition and the dynamics of IsdH-mediated heme extraction.	[Mikkelsen, Jakob H.; Runager, Kasper; Andersen, Christian B. F.] Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark	Aarhus University	Andersen, CBF (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	cbfa@biomed.au.dk		Mikkelsen, Jakob Hauge/0000-0002-2914-3297; Andersen, Christian Brix Folsted/0000-0001-6182-2436				ADAMS EC, 1969, BIOCHEM J, V115, P441, DOI 10.1042/bj1150441; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Andrade MA, 2002, GENOME BIOL, V3; BANERJEE R, 1976, EUR J BIOCHEM, V67, P349, DOI 10.1111/j.1432-1033.1976.tb10698.x; BOLTON W, 1970, NATURE, V228, P551, DOI 10.1038/228551a0; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; BUNN HF, 1968, J BIOL CHEM, V243, P465; CHIANCONE E, 1968, J BIOL CHEM, V243, P1212; CHIANCONE E, 1968, J MOL BIOL, V34, P347, DOI 10.1016/0022-2836(68)90258-1; Conroy BS, 2019, BIOMETALS, V32, P409, DOI 10.1007/s10534-019-00188-2; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; FANELLI AR, 1958, BIOCHIM BIOPHYS ACTA, V30, P608, DOI 10.1016/0006-3002(58)90108-2; FRANCIS RT, 1985, INT J BIOCHEM, V17, P767, DOI 10.1016/0020-711X(85)90262-9; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katnik Iwona, 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P45; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lane-Serff H, 2014, ELIFE, V3, DOI 10.7554/eLife.05553; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2007, BIOCHEMISTRY-US, V46, P12777, DOI 10.1021/bi7009585; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; SHIM BS, 1965, NATURE, V207, P1264, DOI 10.1038/2071264a0; Sjodt M, 2018, J BIOL CHEM, V293, P6942, DOI 10.1074/jbc.RA117.000803; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Stodkilde K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6487; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	53	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1781	1791		10.1074/jbc.RA119.011612	http://dx.doi.org/10.1074/jbc.RA119.011612			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31819010	Green Published, hybrid			2022-12-28	WOS:000517128200002
J	Andres, SN; Li, ZMM; Erie, DA; Williams, RS				Andres, Sara N.; Li, Zimeng M.; Erie, Dorothy A.; Williams, R. Scott			Ctp1 protein-DNA filaments promote DNA bridging and DNA double-strand break repair (vol 294, pg 3312, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NCI NIH HHS [P30 CA016086] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andres SN, 2019, J BIOL CHEM, V294, P3312, DOI 10.1074/jbc.RA118.006759	1	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					896	896		10.1074/jbc.AAC119.012364	http://dx.doi.org/10.1074/jbc.AAC119.012364			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953249	Green Published, hybrid			2022-12-28	WOS:000508382900018
J	Aldahl, J; Mi, JQ; Pineda, A; Kim, WK; Olson, A; Hooker, E; He, YF; Yu, EJ; Le, V; Lee, DH; Geradts, J; Sun, ZJ				Aldahl, Joseph; Mi, Jiaqi; Pineda, Ariana; Kim, Won Kyung; Olson, Adam; Hooker, Erika; He, Yongfeng; Yu, Eun-Jeong; Le, Vien; Lee, Dong-Hoon; Geradts, Joseph; Sun, Zijie			Aberrant activation of hepatocyte growth factor/MET signaling promotes ?-catenin?mediated prostatic tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostate cancer; hepatocyte growth factor; scatter factor (HGF; SF); Wnt signaling; beta-catenin (B-catenin); mouse; cell signaling; MET proto-oncogene receptor tyrosine kinase (MET); metastasis; transgenic mice; tumorigenesis	BETA-CATENIN; ANDROGEN RECEPTOR; C-MET; INTRAEPITHELIAL NEOPLASIA; GENE-EXPRESSION; GASTRIC-CANCER; METASTASIS; PATHWAY; CELLS; THERAPY	Co-occurrence of aberrant hepatocyte growth factor (HGF)/MET proto-oncogene receptor tyrosine kinase (MET) and Wnt/?-catenin signaling pathways has been observed in advanced and metastatic prostate cancers. This co-occurrence positively correlates with prostate cancer progression and castration-resistant prostate cancer development. However, the biological consequences of these abnormalities in these disease processes remain largely unknown. Here, we investigated the aberrant activation of HGF/MET and Wnt/?-catenin cascades in prostate tumorigenesis by using a newly generated mouse model in which both murine Met transgene and stabilized ?-catenin are conditionally co-expressed in prostatic epithelial cells. These compound mice displayed accelerated prostate tumor formation and invasion compared with their littermates that expressed only stabilized ?-catenin. RNA-Seq and quantitative RT-PCR analyses revealed increased expression of genes associated with tumor cell proliferation, progression, and metastasis. Moreover, Wnt signaling pathways were robustly enriched in prostate tumor samples from the compound mice. ChIP-qPCR experiments revealed increased ?-catenin recruitment within the regulatory regions of the Myc gene in tumor cells of the compound mice. Interestingly, the occupancy of MET on the Myc promoter also appeared in the compound mouse tumor samples, implicating a novel role of MET in ?-catenin?mediated transcription. Results from implanting prostate graft tissues derived from the compound mice and controls into HGF-transgenic mice further uncovered that HGF induces prostatic oncogenic transformation and cell growth. These results indicate a role of HGF/MET in ?-catenin?mediated prostate cancer cell growth and progression and implicate a molecular mechanism whereby nuclear MET promotes aberrant Wnt/?-catenin signaling?mediated prostate tumorigenesis.	[Aldahl, Joseph; Mi, Jiaqi; Pineda, Ariana; Kim, Won Kyung; Olson, Adam; Hooker, Erika; He, Yongfeng; Yu, Eun-Jeong; Le, Vien; Lee, Dong-Hoon; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Geradts, Joseph] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Rm 2311,Beckman Bldg, Duarte, CA 91010 USA.	zjsun@coh.org	Mi, Jiaqi/GVU-4732-2022; He, Yongfeng/AAR-8257-2020; le, vien/GWV-7308-2022	Mi, Jiaqi/0000-0002-6537-7795; Lee, Dong-Hoon/0000-0001-7466-6997; Hooker, Erika/0000-0002-4515-4041; Olson, Adam W./0000-0003-3118-0393; Aldahl, Joseph/0000-0001-9664-5644	National Institutes of Health [R01CA070297, R01CA166894, R01DK104941]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01CA070297, R01CA166894, and R01DK104941. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Barrett RT, 2015, ECOL EVOL, V5, P1306, DOI 10.1002/ece3.1438; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cannistraci A, 2017, ONCOGENE, V36, P3718, DOI 10.1038/onc.2016.505; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang Wei-Chao, 2010, Int J Proteomics, V2010, P726968, DOI 10.1155/2010/726968; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Chen K, 2011, CANCER BIOL THER, V12, P1114, DOI 10.4161/cbt.12.12.18435; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chimento A, 2012, MOL CELL ENDOCRINOL, V355, P49, DOI 10.1016/j.mce.2012.01.017; Chlenski A, 2001, PROSTATE, V47, P66; Cotney Justin L, 2015, Cold Spring Harb Protoc, V2015, P191, DOI 10.1101/pdb.prot084848; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P211, DOI 10.3322/caac.21555; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Gupta S, 2017, CLIN CANCER RES, V23, P1346, DOI 10.1158/1078-0432.CCR-16-1211; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jeffers M, 1999, ONCOGENE, V18, P5120, DOI 10.1038/sj.onc.1202902; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kasai S, 1996, BIOCHEM BIOPH RES CO, V228, P646, DOI 10.1006/bbrc.1996.1710; Katoh M, 2003, INT J MOL MED, V11, P683; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Kozakowski N, 2014, TARGET ONCOL, V9, P359, DOI 10.1007/s11523-013-0298-1; Kurashige Junji, 2013, Fukuoka Acta Medica, V104, P344; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Lee SH, 2015, STEM CELLS, V33, P3356, DOI 10.1002/stem.2096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mi JQ, 2018, J BIOL CHEM, V293, P20123, DOI 10.1074/jbc.RA118.005395; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Murillo-Garzon V, 2017, NAT REV UROL, V14, P683, DOI 10.1038/nrurol.2017.144; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rotinen M, 2018, NAT MED, V24, P1887, DOI 10.1038/s41591-018-0241-1; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sasnauskiene A, 2014, MED LITH, V50, P14, DOI 10.1016/j.medici.2014.05.002; Sathyanarayana UG, 2003, CLIN CANCER RES, V9, P6395; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Singh V, 2015, OMICS, V19, P688, DOI 10.1089/omi.2015.0121; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Truica CI, 2000, CANCER RES, V60, P4709; Vadnais C, 2014, BIOL OPEN, V3, P937, DOI 10.1242/bio.20148193; van Leenders GJLH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026753; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Watanabe M, 1999, CANCER LETT, V141, P173, DOI 10.1016/S0304-3835(99)00102-0; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wu Xiuzhong, 2001, Journal of UOEH, V23, P23; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Xie YQ, 2014, MOL ENDOCRINOL, V28, P1629, DOI 10.1210/me.2014-1078; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yu EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174357; Zhang YW, 2005, ONCOGENE, V24, P101, DOI 10.1038/sj.onc.1208181; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	75	5	5	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					631	644		10.1074/jbc.RA119.011137	http://dx.doi.org/10.1074/jbc.RA119.011137			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31819003	Green Published, hybrid			2022-12-28	WOS:000507373600029
J	Oo, A; Kim, DH; Schinazi, RF; Kim, B				Oo, Adrian; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			Viral protein X reduces the incorporation of mutagenic noncanonical rNTPs during lentivirus reverse transcription in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); SAM domain and HD domain-containing protein 1 (SAMHD1); macrophage; nucleotide; lentivirus; dNTPs; HIV-1; macrophages; rNTPs; Vpx	HUMAN-IMMUNODEFICIENCY-VIRUS; AICARDI-GOUTIERES-SYNDROME; DNA; SAMHD1; RIBONUCLEOTIDES; REPLICATION; KINETICS; TYPE-1; INFECTION; RESTRICTION	Unlike activated CD4+ T cells, nondividing macrophages have an extremely small dNTP pool, which restricts HIV-1 reverse transcription. However, rNTPs are equally abundant in both of these cell types and reach much higher concentrations than dNTPs. The greater difference in concentration between dNTPs and rNTPs in macrophages results in frequent misincorporation of noncanonical rNTPs during HIV-1 reverse transcription. Here, we tested whether the highly abundant SAM domain? and HD domain?containing protein 1 (SAMHD1) deoxynucleoside triphosphorylase in macrophages is responsible for frequent rNTP incorporation during HIV-1 reverse transcription. We also assessed whether Vpx (viral protein X), an accessory protein of HIV-2 and some simian immunodeficiency virus strains that targets SAMHD1 for proteolytic degradation, can counteract the rNTP incorporation. Results from biochemical simulation of HIV-1 reverse transcriptase?mediated DNA synthesis confirmed that rNTP incorporation is reduced under Vpx-mediated dNTP elevation. Using HIV-1 vector, we further demonstrated that dNTP pool elevation by Vpx or deoxynucleosides in human primary monocyte-derived macrophages reduces noncanonical rNTP incorporation during HIV-1 reverse transcription, an outcome similarly observed with the infectious HIV-1 89.6 strain. Furthermore, the simian immunodeficiency virus mac239 strain, encoding Vpx, displayed a much lower level of rNTP incorporation than its ?Vpx mutant in macrophages. Finally, the amount of rNMPs incorporated in HIV-1 proviral DNAs remained unchanged for ?2 weeks in macrophages. These findings suggest that noncanonical rNTP incorporation is regulated by SAMHD1 in macrophages, whereas rNMPs incorporated in HIV-1 proviral DNA remain unrepaired. This suggests a potential long-term DNA damage impact of SAMHD1-mediated rNTP incorporation in macrophages.	[Oo, Adrian; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kim, Dong-Hyun] Kyung Hee Univ, Dept Pharm, Seoul 02447, South Korea; [Kim, Baek] Childrens Healthcare Atlanta, Ctr Drug Discovery, Atlanta, GA 30322 USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr Drug Discovery, 1760 Haygood Dr NE,Hlth Sci Res Bldg E432, Atlanta, GA 30322 USA.	baek.kim@emory.edu	Oo, Adrian/ABB-6800-2021; Kim, Dong-Hyun/AAJ-8795-2020	Oo, Adrian/0000-0002-2469-5391; 	National Institutes of Health [AI136581, AI150451, MH116695]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI136581 (to B. K.), AI150451 (to B. K.), and MH116695 (to R. F. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abmayr S. M., 2001, CURRENT PROTOCOLS PH, V12, P121311, DOI [10.1002/0471141755.ph1203s12, DOI 10.1002/0471141755.PH1203S12]; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; COLLIN M, 1994, VIROLOGY, V200, P114, DOI 10.1006/viro.1994.1169; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Daddacha W, 2013, J BIOL CHEM, V288, P12522, DOI 10.1074/jbc.M113.458398; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; HOFFMANN JS, 1993, CANCER RES, V53, P2895; Hollenbaugh JA, 2015, VIROLOGY, V485, P313, DOI 10.1016/j.virol.2015.08.006; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jinks-Robertson S, 2015, NAT STRUCT MOL BIOL, V22, P176, DOI 10.1038/nsmb.2981; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim SS, 2001, J VIROL, V75, P2288, DOI 10.1128/JVI.75.5.2288-2300.2001; Koh KD, 2015, NAT METHODS, V12, P251, DOI [10.1038/NMETH.3259, 10.1038/nmeth.3259]; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Mahboubi B, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0452-z; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moore JM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006733; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Sudhir Ambekar S., 2017, GLOBAL J PHARM PHARM, V3, DOI [10.19080/GJPPS.2017.03.555613, DOI 10.19080/GJPPS.2017.03.555613]; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110	38	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					657	666		10.1074/jbc.RA119.011466	http://dx.doi.org/10.1074/jbc.RA119.011466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806704	Green Published, hybrid			2022-12-28	WOS:000507373600031
J	Zhang, JH; Xie, ZL; Dong, YZ; Wang, SX; Liu, C; Zou, MH				Zhang, Junhua; Xie, Zhonglin; Dong, Yunzhou; Wang, Shuangxi; Liu, Chao; Zou, Ming-Hui			Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. (Withdrawal of Vol 283, Pg 27452, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Chi Y, 2011, J PHARMACOL EXP THER, V339, P257, DOI 10.1124/jpet.111.183020; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200	2	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					670	670		10.1074/jbc.W119.012218	http://dx.doi.org/10.1074/jbc.W119.012218			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31924676	Green Published, hybrid			2022-12-28	WOS:000507373600035
J	Zou, MH; Hou, XY; Shi, CM; Kirkpatrick, S; Liu, F; Goldman, MH; Cohen, RA				Zou, Ming-Hui; Hou, Xiu-Yun; Shi, Chao-Mei; Kirkpatrick, Stacy; Liu, Feng; Goldman, Mitchell H.; Cohen, Richard A.			Activation of 5 '-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells: Role of peroxynitrite (Withdrawal of Vol 278, Pg 34003, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal														/0000-0002-1070-6408				Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	1	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					18016	18016		10.1074/jbc.W119.011600	http://dx.doi.org/10.1074/jbc.W119.011600			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31757803	Green Published, hybrid			2022-12-28	WOS:000504206800027
J	Kinoshita, R; Homma, Y; Fukuda, M				Kinoshita, Riko; Homma, Yuta; Fukuda, Mitsunori			Rab35?GEFs, DENND1A and folliculin differentially regulate podocalyxin trafficking in two- and three-dimensional epithelial cell cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell polarity; epithelial cell; guanine nucleotide exchange factor (GEF); membrane trafficking; Rab; small GTPase; 3D cell culture; podocalyxin; tissue development	RAB GTPASES; CONNECDENN; DOMAIN; FAMILY; POLARITY; PROTEIN; GEFS	Polarized epithelial cells have functionally distinct apical and basolateral membranes through which they communicate with external and internal bodily environments, respectively. The establishment and maintenance of this asymmetric structure depend on polarized trafficking of specific cargos, but the precise molecular mechanism is incompletely understood. We previously showed that Rab35, a member of the Rab family small GTPases, differentially regulates the trafficking of an apical cargo, podocalyxin (PODXL), in two-dimensional (2D) and three-dimensional (3D) Madin?Darby canine kidney (MDCK) II cell cultures through specific interactions with two distinct effectors, OCRL inositol polyphosphate-5-phosphatase (OCRL) and ArfGAP with coiled-coil, ankyrin repeat and pleckstrin homology domains 2 (ACAP2), respectively. However, whether the upstream regulators of Rab35 also differ depending on the culture conditions remains completely unknown. Here, we investigated four known guanine nucleotide exchange factors (GEFs) of Rab35, namely DENN domain?containing 1A (DENND1A), DENND1B, DENND1C, and folliculin (FLCN), and demonstrate that DENND1A and FLCN exhibit distinct requirements for Rab35-dependent PODXL trafficking under the two culture conditions. In 3D cell cultures, only DENDN1A-knockout cysts exhibited the inverted localization of PODXL similar to that of Rab35-knockout cysts. Moreover, the DENN domain, harboring GEF activity toward Rab35, was required for proper PODXL trafficking to the apical membrane. By contrast, FLCN-knockdown cells specifically accumulated PODXL in actin-rich structures similar to the Rab35-knockdown cells in 2D cell cultures. Our findings indicate that two distinct functional cascades of Rab35, the FLCN-Rab35-OCRL and the DENND1A-Rab35-ACAP2 axes, regulate PODXL trafficking in 2D and 3D MDCK II cell cultures, respectively.	[Kinoshita, Riko; Homma, Yuta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Integrat Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Homma, Y; Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Integrat Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	y-homma@biology.tohoku.ac.jp; nori@tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Homma, Yuta/T-3089-2018	Fukuda, MItsunori/0000-0002-8620-5853; Homma, Yuta/0000-0002-3676-6089	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18K14692]; MEXT [19H03220]; Japan Science and Technology Agency (JST) CREST [JPMJCR17H4]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grant-in-Aid for Young Scientists 18K14692 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to Y. H.); Grant-in-Aid for Scientific Research (B) 19H03220 from MEXT (to M. F.); and Japan Science and Technology Agency (JST) CREST Grant JPMJCR17H4 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Cauvin C, 2016, CURR BIOL, V26, P120, DOI 10.1016/j.cub.2015.11.040; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cheng SY, 2015, J CELL BIOL, V210, P485, DOI 10.1083/jcb.201501038; Etoh K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226977; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Haley R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007558; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kinoshita R., 2020, METHODS MOL BIOL; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Kulasekaran G, 2015, J BIOL CHEM, V290, P17999, DOI 10.1074/jbc.M115.636712; Lamber EP, 2019, CURR OPIN CELL BIOL, V59, P34, DOI 10.1016/j.ceb.2019.03.004; Laviolette LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15866; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mrozowska Paulina S, 2016, Small GTPases, V7, P231; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nishikimi A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005199; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roman-Fernandez A, 2016, TRAFFIC, V17, P1244, DOI 10.1111/tra.12417; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yasuda Takao, 2015, Methods Mol Biol, V1298, P127, DOI 10.1007/978-1-4939-2569-8_11; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zheng JC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00688	44	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3652	3663		10.1074/jbc.RA119.011646	http://dx.doi.org/10.1074/jbc.RA119.011646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31992598	Green Published, hybrid			2022-12-28	WOS:000527725300022
J	Scull, CE; Clarke, AM; Lucius, AL; Schneider, DA				Scull, Catherine E.; Clarke, Andrew M.; Lucius, Aaron L.; Schneider, David Alan			Downstream sequence-dependent RNA cleavage and pausing by RNA polymerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; RNA polymerase I; enzyme kinetics; rRNA; transcription regulation; NET-seq	TRANSCRIPTION ELONGATION; NUCLEOTIDE INCORPORATION; BACILLUS-SUBTILIS; DYNAMICS; HAIRPIN; TRANSLOCATION; RESIDUES; FIDELITY; SUBUNIT; BINDING	The sequence of the DNA template has long been thought to influence the rate of transcription by DNA-dependent RNA polymerases, but the influence of DNA sequence on transcription elongation properties of eukaryotic RNA polymerase I (Pol I) from Saccharomyces cerevisiae has not been defined. In this study, we observe changes in dinucleotide production, transcription elongation complex stability, and Pol I pausing in vitro in response to downstream DNA. In vitro studies demonstrate that AT-rich downstream DNA enhances pausing by Pol I and inhibits Pol I nucleolytic cleavage activity. Analysis of Pol I native elongating transcript sequencing data in Saccharomyces cerevisiae suggests that these downstream sequence elements influence Pol I in vivo. Native elongating transcript sequencing studies reveal that Pol I occupancy increases as downstream AT content increases and decreases as downstream GC content increases. Collectively, these data demonstrate that the downstream DNA sequence directly impacts the kinetics of transcription elongation prior to the sequence entering the active site of Pol I both in vivo and in vitro.	[Scull, Catherine E.; Clarke, Andrew M.; Schneider, David Alan] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Lucius, Aaron L.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	dschneid@uab.edu		Lucius, Aaron/0000-0001-8636-5411; Schneider, David/0000-0003-0635-5091; Scull, Catherine/0000-0002-7084-5485	National Institutes of Health [GM084946, GM008111]; National Science Foundation [MCB-1817749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This study was supported by National Institutes of Health Grant GM084946 (to D. A. S.) and T32 Grant GM008111 (to C. E. S.). This work was also funded by National Science Foundation Grant MCB-1817749 (to A. L. L. and D. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appling FD, 2018, BIOPHYS J, V114, P2507, DOI 10.1016/j.bpj.2018.04.015; Appling FD, 2017, BIOCHEMISTRY-US, V56, P5654, DOI 10.1021/acs.biochem.7b00370; Appling FD, 2015, BIOPHYS J, V109, P2382, DOI 10.1016/j.bpj.2015.10.037; Bengtsson H., 2021, MATRIXSTATS FUNCTION; Cabrera-Ostertag IJ, 2013, NUCLEIC ACIDS RES, V41, P7501, DOI 10.1093/nar/gkt517; Clarke AM, 2018, P NATL ACAD SCI USA, V115, pE11633, DOI 10.1073/pnas.1809421115; Czyz A, 2014, MBIO, V5, DOI 10.1128/mBio.00931-14; Ederth J, 2006, J MOL BIOL, V356, P1163, DOI 10.1016/j.jmb.2005.11.080; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Gabizon R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05344-9; Hannan RD, 2013, EXPERT OPIN THER TAR, V17, P873, DOI 10.1517/14728222.2013.818658; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Holmes SF, 2003, J BIOL CHEM, V278, P35597, DOI 10.1074/jbc.M304496200; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kang JY, 2018, MOL CELL, V69, P802, DOI 10.1016/j.molcel.2018.01.018; Kassambara A, 2017, GGPUBR GGPLOT2 BASED, DOI DOI 10.1038/132817A0; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Larson MH, 2012, P NATL ACAD SCI USA, V109, P6555, DOI 10.1073/pnas.1200939109; LEE DN, 1990, J BIOL CHEM, V265, P15145; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Mills EW, 2017, SCIENCE, V358, DOI 10.1126/science.aan2755; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Palangat M, 2004, J MOL BIOL, V341, P429, DOI 10.1016/j.jmb.2004.06.009; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider DA, 2012, METHODS MOL BIOL, V809, P579, DOI 10.1007/978-1-61779-376-9_37; Scull CE, 2019, TRENDS GENET, V35, P724, DOI 10.1016/j.tig.2019.07.002; Scull CE, 2019, BIOCHEM J, V476, P2209, DOI 10.1042/BCJ20190207; Scull CE, 2019, BIOCHEMISTRY-US, V58, P2116, DOI 10.1021/acs.biochem.8b01256; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tafur L, 2019, ELIFE, V8, DOI 10.7554/eLife.43204; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Viktorovskaya OV, 2013, CELL REP, V4, P974, DOI 10.1016/j.celrep.2013.07.044; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Wickham H., 2019, DPLYR GRAMMAR DATA M, P1; Wickham H., 2019, DEVTOOLS TOOLS MAKE, DOI [DOI 10.1093/NAR/GKQ537, 10.1093/nar/gkq537]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilke C.O., 2020, COWPLOT STREAMLINED; Windgassen TA, 2014, NUCLEIC ACIDS RES, V42, P12707, DOI 10.1093/nar/gku997	51	8	8	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1288	1299		10.1074/jbc.RA119.011354	http://dx.doi.org/10.1074/jbc.RA119.011354			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31843971	hybrid, Green Published			2022-12-28	WOS:000513822300010
J	Zhang, XJ; MacDonald, BT; Gao, HL; Shamashkin, M; Coyle, AJ; Martinez, RV; He, X				Zhang, Xinjun; MacDonald, Bryan T.; Gao, Huilan; Shamashkin, Michael; Coyle, Anthony J.; Martinez, Robert V.; He, Xi			Characterization of Tiki, a new family of Wnt-specific metalloproteases (vol 291, pg 2435, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Zhang XJ, 2016, J BIOL CHEM, V291, P2435, DOI 10.1074/jbc.M115.677807	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1367	1367		10.1074/jbc.AAC120.012554	http://dx.doi.org/10.1074/jbc.AAC120.012554			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	32005644	Green Published, hybrid			2022-12-28	WOS:000513822300017
J	Li, JY; Wang, YY; Shao, T; Fan, DD; Lin, AF; Xiang, LX; Shao, JZ				Li, Jiang-Yuan; Wang, Yue-Yi; Shao, Tong; Fan, Dong-Dong; Lin, Ai-Fu; Xiang, Li-Xin; Shao, Jian-Zhong			The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1? maturation and gasdermin E?mediated pyroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; NLRP3; inflammasome; interleukin 1? (IL-1?); innate immunity; apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC); caspase; gasdermin E (GSDME); pattern recognition receptor; pyroptosis	CASPASE-1 AUTOPROTEOLYSIS; CELL-DEATH; ACTIVATION; PROTEIN; BINDING; IL-1-BETA; RECEPTORS; MECHANISM; CLEAVAGE; IMMUNITY	The NLR family pyrin domain containing 3 (NLRP3) inflammasome is one of the best-characterized inflammasomes in humans and other mammals. However, knowledge about the NLRP3 inflammasome in nonmammalian species remains limited. Here, we report the molecular and functional identification of an NLRP3 homolog (DrNLRP3) in a zebrafish (Danio rerio) model. We found that DrNLRP3's overall structural architecture was shared with mammalian NLRP3s. It initiates a classical inflammasome assembly for zebrafish inflammatory caspase (DrCaspase-A/-B) activation and interleukin 1? (DrIL-1?) maturation in an apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC)-dependent manner, in which DrNLRP3 organizes DrASC into a filament that recruits DrCaspase-A/-B by homotypic pyrin domain (PYD)?PYD interactions. DrCaspase-A/-B activation in the DrNLRP3 inflammasome occurred in two steps, with DrCaspase-A being activated first and DrCaspase-B second. DrNLRP3 also directly activated full-length DrCaspase-B and elicited cell pyroptosis in a gasdermin E (GSDME)-dependent but ASC-independent manner. These two events were tightly coordinated by DrNLRP3 to ensure efficient IL-1? secretion for the initiation of host innate immunity. By knocking down DrNLRP3 in zebrafish embryos and generating a DrASC-knockout (DrASC(?/?)) fish clone, we characterized the function of the DrNLRP3 inflammasome in anti-bacterial immunity in vivo. The results of our study disclosed the origin of the NLRP3 inflammasome in teleost fish, providing a cross-species understanding of the evolutionary history of inflammasomes. Our findings also indicate that the NLRP3 inflammasome may coordinate inflammatory cytokine processing and secretion through a GSDME-mediated pyroptotic pathway, uncovering a previously unrecognized regulatory function of NLRP3 in both inflammation and cell pyroptosis.	[Li, Jiang-Yuan; Wang, Yue-Yi; Shao, Tong; Fan, Dong-Dong; Lin, Ai-Fu; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310058, Peoples R China; [Shao, Jian-Zhong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China	Zhejiang University; Qingdao National Laboratory for Marine Science & Technology	Xiang, LX; Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, 866 YuHangTang Rd, Hangzhou 310058, Peoples R China.	xianglx@zju.edu.cn; shaojz@zju.edu.cn		Li, Jiang-Yuan/0000-0002-2147-5908	National Natural Science Foundation of China [31630083, 31572641]; National Key Research and Development Program of China [2016YFA0101001, 2018YFD0900503, 2018YFD0900505]; Stem Cell and Translational Research; Open Fund of the Laboratory for Marine Biology and Biotechnology; Qingdao National Laboratory for Marine Science and Technology, Qingdao, China [OF2017NO02]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering; Zhejiang Major Special Program of Breeding Grant [2016C02055-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Stem Cell and Translational Research; Open Fund of the Laboratory for Marine Biology and Biotechnology; Qingdao National Laboratory for Marine Science and Technology, Qingdao, China; Open Funding Project of the State Key Laboratory of Bioreactor Engineering; Zhejiang Major Special Program of Breeding Grant	This work was supported by National Natural Science Foundation of China Grants 31630083 and 31572641; National Key Research and Development Program of China Grants 2018YFD0900503 and 2018YFD0900505; Stem Cell and Translational Research; National Key Research and Development Program of China Grant 2016YFA0101001; the Open Fund of the Laboratory for Marine Biology and Biotechnology; Qingdao National Laboratory for Marine Science and Technology, Qingdao, China, Grant OF2017NO02; the Open Funding Project of the State Key Laboratory of Bioreactor Engineering; and the Zhejiang Major Special Program of Breeding Grant 2016C02055-4. The authors declare that they have no conflicts of interest with the contents of this article.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Angosto D, 2012, INNATE IMMUN-LONDON, V18, P815, DOI 10.1177/1753425912441956; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bracha D, 2018, CELL, V175, P1467, DOI 10.1016/j.cell.2018.10.048; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Feng SY, 2018, J MOL BIOL, V430, P3068, DOI 10.1016/j.jmb.2018.07.002; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gorfu G, 2014, MBIO, V5, DOI 10.1128/mBio.01117-13; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Howe K, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160009; Huang N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15057; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Koussounadis AI, 2004, CURR PHARM DESIGN, V10, P3857, DOI 10.2174/1381612043382585; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kuri P, 2017, J CELL BIOL, V216, P2891, DOI 10.1083/jcb.201703103; Li JY, 2018, J IMMUNOL, V201, P1946, DOI 10.4049/jimmunol.1800498; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Li YJ, 2017, CELL MOL IMMUNOL, V14, P80, DOI 10.1038/cmi.2016.50; Liang JJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15732; Liu JQ, 2017, HUM GENET, V136, P1, DOI 10.1007/s00439-016-1739-6; Liu YY, 2019, CELL MOL IMMUNOL, V16, P611, DOI 10.1038/s41423-018-0165-1; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Masumoto J, 2003, J BIOL CHEM, V278, P4268, DOI 10.1074/jbc.M203944200; Meunier E, 2017, TRENDS IMMUNOL, V38, P744, DOI 10.1016/j.it.2017.04.005; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Osipovitch Mikhail, 2015, Journal of Structural and Functional Genomics, V16, P101, DOI 10.1007/s10969-015-9199-0; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Reis MIR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050450; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; Shao T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01204; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sun LB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1761-4; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Winsor N, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13079; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Xu XG, 2016, J IMMUNOL, V196, P1686, DOI 10.4049/jimmunol.1501736; Yang DH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04984-1; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	67	44	44	10	62	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1120	1141		10.1074/jbc.RA119.011751	http://dx.doi.org/10.1074/jbc.RA119.011751			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31852739	Bronze, Green Published			2022-12-28	WOS:000509949300019
J	Halpert, JR				Halpert, James R.			So many roads traveled: A career in science and administration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						pharmacology; toxicology; chemical biology; cytochrome P450; structure-function; CYP2B enzymes	RAT-LIVER CYTOCHROME-P-450; SUBSTRATE RECOGNITION SITES; AMINO-ACID-SEQUENCE; ACTIVE-SITE; PRESYNAPTIC NEUROTOXIN; DIRECTED MUTAGENESIS; SUICIDE INACTIVATION; OXYGEN-AFFINITY; LIGAND-BINDING; RED-CELLS	I have traveled many roads during my career. After spending my first 19 years in Los Angeles, I became somewhat of an academic nomad, studying and/or working in six universities in the United States and three in Sweden. In chronological order, I have a B.A. in Scandinavian languages and literature from UCLA, a Ph.D. in biochemistry from Uppsala University, and an M.S. in toxicology from the Karolinska Institute. I have been in schools of natural science, pharmacy, and medicine and have worked in multiple basic science departments and one clinical department. I have served as a research-track and tenured faculty member, department chair, associate dean, and dean. My research has spanned toxinology, biochemistry, toxicology, and pharmacology. Through all the moves, I have gained much and lost some. For the past 40 years, my interest has been cytochrome P450 structure-function and structure-activity relationships. My lab has focused on CYP2B enzymes using X-ray crystallography, site-directed mutagenesis, deuterium-exchange MS, isothermal titration calorimetry, and computational methods in conjunction with a variety of functional assays. This comprehensive approach has enabled detailed understanding of the structural basis of the remarkable substrate promiscuity of CYP2B enzymes. We also have investigated the mechanisms of CYP3A4 allostery using biophysical and advanced spectroscopic techniques, and discovered a pivotal role of P450-P450 interactions and of multiple-ligand binding. A major goal of this article is to provide lessons that may be useful to scientists in the early and middle stages of their careers and those more senior scientists contemplating an administrative move.	[Halpert, James R.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA	University of Connecticut	Halpert, JR (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	james.halpert@uconn.edu			National Institutes of Health [ES00151, ES003619, ES004995, GM54995]; National Science Foundation [IOS-1461359]; PhRMA Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation	The research described was supported by National Institutes of Health Grants ES00151, ES003619, ES004995, and GM54995; by National Science Foundation Grant IOS-1461359; and by a Starter Grant and Faculty Development Award from the PhRMA Foundation. I thank the many members of my research group, friends, and colleagues whom I was not able to mention in the text.	BRANN EG, 1973, SCIENCE, V179, P593, DOI 10.1126/science.179.4073.593; CIACCIO PJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P319, DOI 10.1016/0167-4781(91)90072-T; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; DUIGNAN DB, 1987, ARCH BIOCHEM BIOPHYS, V255, P290, DOI 10.1016/0003-9861(87)90396-1; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; Gay SC, 2011, BIOCHEMISTRY-US, V50, P4903, DOI 10.1021/bi200482g; Gay SC, 2010, BIOCHEMISTRY-US, V49, P8709, DOI 10.1021/bi100914z; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; HAAPARANTA T, 1983, CANCER RES, V43, P5131; HALPERT J, 1980, MOL PHARMACOL, V17, P427; HALPERT J, 1979, J BIOL CHEM, V254, P7434; HALPERT J, 1983, MOL PHARMACOL, V23, P445; HALPERT J, 1976, FEBS LETT, V61, P72, DOI 10.1016/0014-5793(76)80174-3; HALPERT J, 1975, J BIOL CHEM, V250, P6990; HALPERT J, 1976, J BIOL CHEM, V251, P7343; HALPERT J, 1980, J BIOL CHEM, V255, P1080; HALPERT J, 1981, BIOCHEM PHARMACOL, V30, P875, DOI 10.1016/S0006-2952(81)80010-X; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; HALPERT JR, 1985, J BIOL CHEM, V260, P8397; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; HASLER JA, 1994, MOL PHARMACOL, V46, P338; He YA, 1997, BIOCHEMISTRY-US, V36, P8831, DOI 10.1021/bi970182i; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; KAMATAKI T, 1976, MOL PHARMACOL, V12, P933; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Kobayashi Y, 1998, BIOCHEMISTRY-US, V37, P6679, DOI 10.1021/bi9731450; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Lee SC, 2013, P NATL ACAD SCI USA, V110, pE1203, DOI 10.1073/pnas.1221442110; Liu JB, 2016, BIOCHEMISTRY-US, V55, P1997, DOI 10.1021/acs.biochem.5b01330; MACGEOCH C, 1984, J BIOL CHEM, V259, P5433; Muralidhara BK, 2007, J AM CHEM SOC, V129, P2015, DOI 10.1021/ja066303w; Neal RA, 1996, ANNU REV PHARMACOL, V36, P35; OSKI FA, 1972, SCIENCE, V175, P1372, DOI 10.1126/science.175.4028.1372; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P2123, DOI 10.1021/bi101797v; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shah MB, 2017, ACS CHEM BIOL, V12, P1204, DOI 10.1021/acschembio.7b00056; Shah Manish B, 2016, Mol Pharmacol, V89, P435, DOI 10.1124/mol.115.102111; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Spatzenegger M, 2001, MOL PHARMACOL, V59, P475, DOI 10.1124/mol.59.3.475; STEVENS JC, 1988, MOL PHARMACOL, V33, P103; Strobel SM, 1997, BIOCHEMISTRY-US, V36, P11697, DOI 10.1021/bi9710176; SZKLARZ GD, 1995, BIOCHEMISTRY-US, V34, P14312, DOI 10.1021/bi00044a008; Wilderman PR, 2014, TOXICOL APPL PHARM, V274, P393, DOI 10.1016/j.taap.2013.12.005; Wilderman PR, 2012, CURR DRUG METAB, V13, P167; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	51	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					822	832		10.1074/jbc.X119.012206	http://dx.doi.org/10.1074/jbc.X119.012206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31953248	Green Published, hybrid			2022-12-28	WOS:000508382900013
J	Nair, SK; Jez, JM				Nair, Satish K.; Jez, Joseph M.			Natural product biosynthesis: What's next? An introduction to the JBC Reviews Thematic Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						biosynthesis; drug discovery; natural product biosynthesis; plant; bacteria; fungi; biopharmaceuticals; chemical diversity; specialized metabolism		The diversity of natural products not only fascinates us intellectually, but also provides an armamentarium against the microbes that threaten our health. The increased prevalence of pathogens that are resistant to one or more classes of available medicines continues to be a growing global threat. As drug-resistant pathogens erode the effectiveness of the current reserve of antibiotics and antifungals, methodological advances open additional avenues for discovery of new classes of drugs, as well as novel derivatives of existing (and proven) classes of compounds. In this Thematic Review Series, we aim to provide a snapshot of the current state of the art in natural product discovery. The reviews in this series encapsulate convergent approaches toward the identification of different classes of primary and specialized metabolites, including nonribosomal peptides, polyketides, and ribosomally synthesized and post-translationally modified peptides, from all kingdoms of life. Traction in unraveling new and diverse classes of molecules has come largely from the academic sector, which ensures availability of methods and data sets. Such knowledge is needed to thwart serious threats to human health and calls to mind the proverb praemonitus praemunitus (forewarned is forearmed).	[Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL)	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Nair, SK (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.; Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	snair@illinois.edu; jjez@wustl.edu	Nair, Satish/AAY-2510-2021					Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Hunter P, 2008, EMBO REP, V9, P838, DOI 10.1038/embor.2008.160; Hutchings MI, 2019, CURR OPIN MICROBIOL, V51, P72, DOI 10.1016/j.mib.2019.10.008; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li YY, 2020, J BIOL CHEM, V295, P34, DOI 10.1074/jbc.REV119.006545; Maeda HA, 2019, J BIOL CHEM, V294, P16549, DOI 10.1074/jbc.REV119.006132; Marschall E, 2019, J BIOL CHEM, V294, P18769, DOI 10.1074/jbc.REV119.006349; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]; Morita H, 2019, J BIOL CHEM, V294, P15121, DOI 10.1074/jbc.REV119.006129; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Steele AD, 2019, J BIOL CHEM, V294, P16567, DOI 10.1074/jbc.REV119.006514; Torres JP, 2019, J BIOL CHEM, V294, P17684, DOI 10.1074/jbc.REV119.006130; Wurtzel ET, 2016, SCIENCE, V353, P1232, DOI 10.1126/science.aad2062	13	2	2	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					335	336		10.1074/jbc.REV119.011586	http://dx.doi.org/10.1074/jbc.REV119.011586			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31806701	Green Published, hybrid			2022-12-28	WOS:000507373600006
J	Rao, DM; Shackleford, MT; Bordeaux, EK; Sottnik, JL; Ferguson, RL; Yamamoto, TM; Wellberg, EA; Bitler, BG; Sikora, MJ				Rao, Deviyani M.; Shackleford, Madeleine T.; Bordeaux, Evelyn K.; Sottnik, Joseph L.; Ferguson, Rebecca L.; Yamamoto, Tomomi M.; Wellberg, Elizabeth A.; Bitler, Benjamin G.; Sikora, Matthew J.			Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; Wnt pathway; protein secretion; cancer biology; cell signaling; cell growth; glycoprotein secretion; breast cancer; ovarian cancer; PORCN; WNT3A; WNT4	BETA-CATENIN; LOBULAR CARCINOMA; STEM-CELLS; PROTEINS; PATHWAY; PROGESTERONE; IDENTIFICATION; ENDOMETRIOSIS; INHIBITION; EXPRESSION	Porcupine O-acyltransferase (PORCN) is considered essential for Wnt secretion and signaling. However, we observed that PORCN inhibition does not phenocopy the effects of WNT4 knockdown in WNT4-dependent breast cancer cells. This suggests a unique relationship between PORCN and WNT4 signaling. To examine the role of PORCN in WNT4 signaling, here we overexpressed WNT4 or WNT3A in breast cancer, ovarian cancer, and fibrosarcoma cell lines. Conditioned media from these lines and co-culture systems were used to assess the dependence of Wnt secretion and activity on the critical Wnt secretion proteins PORCN and Wnt ligand secretion (WLS) mediator. We observed that WLS is universally required for Wnt secretion and paracrine signaling. In contrast, the dependence of WNT3A secretion and activity on PORCN varied across the cell lines, and WNT4 secretion was PORCN-independent in all models. Surprisingly, WNT4 did not exhibit paracrine activity in any tested context. Absent the expected paracrine activity of secreted WNT4, we identified cell-autonomous Wnt signaling activation by WNT4 and WNT3A, independent of PORCN or Wnt secretion. The PORCN-independent, cell-autonomous Wnt signaling demonstrated here may be critical in WNT4-driven cellular contexts or in those that are considered to have dysfunctional Wnt signaling.	[Rao, Deviyani M.; Shackleford, Madeleine T.; Bordeaux, Evelyn K.; Sottnik, Joseph L.; Ferguson, Rebecca L.; Wellberg, Elizabeth A.; Sikora, Matthew J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Yamamoto, Tomomi M.; Bitler, Benjamin G.] Univ Colorado, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sikora, MJ (corresponding author), Mail Stop 8104,Res Complex 1 South,Rm 5117, Aurora, CO 80045 USA.	matthew.sikora@cuanschutz.edu	Wellberg, Elizabeth/AFQ-6450-2022	Shackleford, Madeleine/0000-0003-2599-1747; Bordeaux, Evelyn/0000-0001-9264-0205; Sottnik, Joseph/0000-0002-0263-3608; Sikora, Matthew/0000-0003-2915-7442; Bitler, Benjamin/0000-0002-5809-5271; Rao, Deviyani/0000-0002-6923-4492	National Institutes of Health [T32 GM007635, R00 CA193734, R00 CA194318]; Cancer League of Colorado, Inc.; NATIONAL CANCER INSTITUTE [K99CA193734, R00CA193734, R00CA194318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R00 CA193734 (to M. J. S.) and R00 CA194318 (to B. G. B.), a grant from the Cancer League of Colorado, Inc. (to M. J. S.), and by National Institutes of Health Grant T32 GM007635 (to E. K. B.). This manuscript was posted as a pre-print on bioRxiv (73). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal P, 2017, BLOOD, V129, P1008, DOI 10.1182/blood-2016-05-714089; Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Caprioli A, 2015, DEV BIOL, V406, P222, DOI 10.1016/j.ydbio.2015.08.017; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen QH, 2012, J CELL SCI, V125, P2224, DOI 10.1242/jcs.098368; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dissanayake Samudra K., 2008, V468, P157, DOI 10.1007/978-1-59745-249-6_12; Galli LM, 2018, DEV BIOL, V439, P53, DOI 10.1016/j.ydbio.2018.04.025; Galli LM, 2016, EXP CELL RES, V347, P171, DOI 10.1016/j.yexcr.2016.07.028; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Hayashi M, 2017, ONCOTARGET, V8, P78265, DOI 10.18632/oncotarget.19432; Itaranta P, 2006, DEV BIOL, V293, P473, DOI 10.1016/j.ydbio.2006.02.019; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Kurita Yayoi, 2019, Kurume Med J, V65, P55, DOI 10.2739/kurumemedj.MS652008; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Mafra F, 2015, J ASSIST REPROD GEN, V32, P1359, DOI 10.1007/s10815-015-0523-1; Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Moti N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212711; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Powell JE, 2016, HUM MOL GENET, V25, P5046, DOI 10.1093/hmg/ddw320; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Prunskaite-Hyyrylainen R, 2016, HUM MOL GENET, V25, P1059, DOI 10.1093/hmg/ddv621; Pryde JG, 1998, METH MOL B, V88, P23; Rahmioglu N, 2015, HUM MOL GENET, V24, P1185, DOI 10.1093/hmg/ddu516; Rajaram RD, 2015, EMBO J, V34, P641, DOI 10.15252/embj.201490434; Rao D. M., 2019, ESTROGEN CONTROLS MT, DOI [10.1101/684530, DOI 10.1101/684530]; Rao DM, 2018, WNT4 WNT3A ACTIVATE, DOI [10.1101/333906, DOI 10.1101/333906]; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Richards MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092159; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Sikora MJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0748-7; Sikora MJ, 2014, CANCER RES, V74, P1463, DOI 10.1158/0008-5472.CAN-13-2779; Speer KF, 2019, CELL REP, V26, P875, DOI 10.1016/j.celrep.2018.12.104; Strochlic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029976; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052; Yamamoto T. M., 2018, TARGETING WNT SIGNAL, DOI [10.1101/378463, DOI 10.1101/378463]; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665; Zheng Y, 2016, OSTEOPOROSIS INT, V27, P1805, DOI 10.1007/s00198-015-3457-7; Zmuda JM, 2011, OSTEOPOROSIS INT, V22, P1079, DOI 10.1007/s00198-010-1296-0	72	12	14	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19950	19966		10.1074/jbc.RA119.009615	http://dx.doi.org/10.1074/jbc.RA119.009615			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740580	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000505005800011
J	Li, XH; Lee, JH				Li, Xi-Hui; Lee, Joon-Hee			Quorum sensing-dependent post-secretional activation of extracellular proteases in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; protease; metalloprotease; protein processing; protein secretion; protein?protein interaction; inhibition mechanism; microbial pathogenesis	ACTIVE-SITE HIS-223; PROTEIN SECRETION; LASA PROTEASE; ELASTASE; PROPEPTIDE; SYSTEM; IDENTIFICATION; PURIFICATION; SUBSTITUTION; SPECIFICITY	Pseudomonas aeruginosa secretes multiple proteases that are implicated in its pathogenesis, and most of them are regulated by quorum sensing (QS). In this study, we found that the activities of three major extracellular proteases, protease IV (PIV), elastase A (LasA), and elastase B (LasB), are reduced considerably when expressed in a QS mutant (MW1). PIV and LasA expressed in MW1 exhibited little activity, even when purified, and their activities were inhibited by noncleavage or binding of their propeptides. LasB was activated by a QS-dependent factor, indicating that, unlike what has been proposed previously, LasB is not autoactivated. When LasB was relieved from inhibition, it activated PIV, which then sequentially processed pro-LasA to mature LasA. When activated, LasB was not inhibited by exogenous addition of its propeptide, but LasA and PIV were inhibited by their propeptides, even after prior activation. These differences may be explained by the fact that LasB can degrade its own propeptide but PIV and LasA cannot. We also found that, although PIV is the preferred LasA-activating factor, LasB can also partially activate LasA. Overall, LasB, PIV, and LasA were activated postsecretionally in a cascading manner in which the initial activation of LasB was controlled tightly by QS at the protein level in addition to the well-known transcriptional control of these proteases by QS. Interestingly, human elastase also activated LasA, indicating that the activation cascade is triggered by host factors during infection. In summary, a QS-induced proteolytic cascade activates secreted proteases from P. aeruginosa.	[Li, Xi-Hui; Lee, Joon-Hee] Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 609735, South Korea	Pusan National University	Lee, JH (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 609735, South Korea.	joonhee@pusan.ac.kr			National Research Foundation of Korea - Korean government [NRF-2019R1A2C1010087]; National Research Foundation of Korea [2017M3A9E4078553]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (NRF-2019R1A2C1010087). This work was also supported by a grant from the National Research Foundation of Korea (2017M3A9E4078553). The authors declare that they have no conflicts of interest with the contents of this article.	AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bradshaw JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00212-18, 10.1128/msphere.00212-18]; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; ChaponHerve V, 1997, MOL MICROBIOL, V24, P1169, DOI 10.1046/j.1365-2958.1997.4271794.x; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dolly JO, 2006, EUR J NEUROL, V13, P1, DOI 10.1111/j.1468-1331.2006.01648.x; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gustin JK, 1996, J BACTERIOL, V178, P6608, DOI 10.1128/jb.178.22.6608-6617.1996; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoge R., 2010, CURR RES TECHNOL ED, P383; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; KESSLER E, 1994, J BIOL CHEM, V269, P22726; Lee JH, 2006, MOL MICROBIOL, V59, P602, DOI 10.1111/j.1365-2958.2005.04960.x; MCIVER K, 1991, J BACTERIOL, V173, P7781, DOI 10.1128/jb.173.24.7781-7789.1991; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MCIVER KS, 1993, J BACTERIOL, V175, P4008, DOI 10.1128/JB.175.13.4008-4015.1993; Oh J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03733-6; PARK S, 1995, MOL MICROBIOL, V16, P263, DOI 10.1111/j.1365-2958.1995.tb02298.x; Park SJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P8, DOI 10.1006/abbi.1998.0787; Park SJ, 2014, MOL MICROBIOL, V94, P1298, DOI 10.1111/mmi.12830; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; RUST L, 1994, METHOD ENZYMOL, V235, P554; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	33	20	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19635	19644		10.1074/jbc.RA119.011047	http://dx.doi.org/10.1074/jbc.RA119.011047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727738	hybrid, Green Published			2022-12-28	WOS:000504093200015
J	Semmler, S; Gagne, M; Garg, P; Pickles, SR; Baudouin, C; Hamon-Keromen, E; Destroismaisons, L; Khalfallah, Y; Chaineau, M; Caron, E; Bayne, AN; Trempe, JF; Cashman, NR; Star, AT; Haqqani, AS; Durcan, TM; Meiering, EM; Robertson, J; Grandvaux, N; Plotkin, SS; McBride, HM; Velde, CV				Semmler, Sabrina; Gagne, Myriam; Garg, Pranav; Pickles, Sarah R.; Baudouin, Charlotte; Hamon-Keromen, Emeline; Destroismaisons, Laurie; Khalfallah, Yousra; Chaineau, Mathilde; Caron, Elise; Bayne, Andrew N.; Trempe, Jean-Francois; Cashman, Neil R.; Star, Alexandra T.; Haqqani, Arsalan S.; Durcan, Thomas M.; Meiering, Elizabeth M.; Robertson, Janice; Grandvaux, Nathalie; Plotkin, Steven S.; McBride, Heidi M.; Vande Velde, Christine			TNF receptor?associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); superoxide dismutase (SOD); protein misfolding; mitochondria; TNF receptor?associated factor (TRAF); ubiquitin; protein aggregation	NF-KAPPA-B; AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SOD1; PARKINSONS-DISEASE; MOUSE MODEL; ATYPICAL UBIQUITINATION; MONOCLONAL-ANTIBODY; INDUCED ACTIVATION; IN-VIVO; TRAF6	Amyotrophic lateral sclerosis (ALS) is a fatal disease, characterized by the selective loss of motor neurons leading to paralysis. Mutations in the gene encoding superoxide dismutase 1 (SOD1) are the second most common cause of familial ALS, and considerable evidence suggests that these mutations result in an increase in toxicity due to protein misfolding. We previously demonstrated in the SOD1(G93A) rat model that misfolded SOD1 exists as distinct conformers and forms deposits on mitochondrial subpopulations. Here, using SOD1(G93A) rats and conformation-restricted antibodies specific for misfolded SOD1 (B8H10 and AMF7-63), we identified the interactomes of the mitochondrial pools of misfolded SOD1. This strategy identified binding proteins that uniquely interacted with either AMF7-63 or B8H10-reactive SOD1 conformers as well as a high proportion of interactors common to both conformers. Of this latter set, we identified the E3 ubiquitin ligase TNF receptor?associated factor 6 (TRAF6) as a SOD1 interactor, and we determined that exposure of the SOD1 functional loops facilitates this interaction. Of note, this conformational change was not universally fulfilled by all SOD1 variants and differentiated TRAF6 interacting from TRAF6 noninteracting SOD1 variants. Functionally, TRAF6 stimulated polyubiquitination and aggregation of the interacting SOD1 variants. TRAF6 E3 ubiquitin ligase activity was required for the former but was dispensable for the latter, indicating that TRAF6-mediated polyubiquitination and aggregation of the SOD1 variants are independent events. We propose that the interaction between misfolded SOD1 and TRAF6 may be relevant to the etiology of ALS.	[Semmler, Sabrina; Chaineau, Mathilde; Durcan, Thomas M.; McBride, Heidi M.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Bayne, Andrew N.; Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2B4, Canada; [Chaineau, Mathilde; Durcan, Thomas M.; McBride, Heidi M.] McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada; [Semmler, Sabrina; Gagne, Myriam; Pickles, Sarah R.; Baudouin, Charlotte; Hamon-Keromen, Emeline; Destroismaisons, Laurie; Khalfallah, Yousra; Caron, Elise; Grandvaux, Nathalie; Vande Velde, Christine] CHU Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Gagne, Myriam; Pickles, Sarah R.; Grandvaux, Nathalie; Vande Velde, Christine] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Khalfallah, Yousra; Vande Velde, Christine] Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada; [Garg, Pranav; Plotkin, Steven S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Baudouin, Charlotte] Catholic Univ Louvain, B-1348 Louvain La Neuve, Belgium; [Hamon-Keromen, Emeline] Univ Paris 06, F-75005 Paris, France; [Cashman, Neil R.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V6T 2B5, Canada; [Cashman, Neil R.] Brain Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6T 2B5, Canada; [Star, Alexandra T.; Haqqani, Arsalan S.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Meiering, Elizabeth M.] Univ Waterloo, Guelph Waterloo Ctr Grad Work Chem & Biochem, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Robertson, Janice] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 0S8, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of British Columbia; Universite Catholique Louvain; UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; Vancouver Coastal Health Research Institute; National Research Council Canada; University of Guelph; University of Waterloo; Guelph-Waterloo Centre for Graduate Work in Chemistry & Biochemistry; University of Toronto	Velde, CV (corresponding author), Univ Montreal, Dept Neurosci, CHU Montreal, Ctr Rech, 900 St Denis,R09-442, Montreal, PQ H2X 0A9, Canada.	c.vande.velde@umontreal.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021; Plotkin, Steven/AAO-3257-2020	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Plotkin, Steven/0000-0001-8998-877X; Semmler, Sabrina/0000-0001-7422-9068	ALS Society of Canada; Muscular Dystrophy Association; Frick Foundation for ALS Research; Rare Disease Foundation	ALS Society of Canada; Muscular Dystrophy Association(Muscular Dystrophy Association); Frick Foundation for ALS Research; Rare Disease Foundation	This work was supported by grants from the ALS Society of Canada (to C. V. V.), the Muscular Dystrophy Association (to C. V. V.), the Frick Foundation for ALS Research (to C. V. V.), and the Rare Disease Foundation (to S. S. and C. V. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Broering TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061210; Broom HR, 2016, BIOCHEMISTRY-US, V55, P519, DOI 10.1021/acs.biochem.5b01187; Broom HR, 2015, PROTEIN SCI, V24, P2081, DOI 10.1002/pro.2803; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chung JY, 2013, LAB INVEST, V93, P663, DOI 10.1038/labinvest.2013.60; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Doyle CM, 2016, BIOCHEMISTRY-US, V55, P1346, DOI 10.1021/acs.biochem.5b01133; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Fang J, 2018, CELL REP, V22, P1250, DOI 10.1016/j.celrep.2018.01.013; Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Goslin K., 1998, CULTURING NERVE CELL, P339; Granatiero V, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020036; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Khalfallah Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25767-0; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lee NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02096; Lim GGY, 2015, J BIOL CHEM, V290, P16882, DOI 10.1074/jbc.M114.622399; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Maier M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah3924; Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Min Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00094; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ouali Alami N, 2018, EMBO J, V37, DOI 10.15252/embj.201798697; Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Peng XB, 2018, J PHYS CHEM B, V122, P11662, DOI 10.1021/acs.jpcb.8b07680; Pickles S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0313-8; Pickles Sarah, 2014, J Vis Exp, P51887, DOI 10.3791/51887; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Pickles S, 2012, AMYOTROPH LATERAL SC, V13, P333, DOI 10.3109/17482968.2012.648645; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Rengachari S, 2018, P NATL ACAD SCI USA, V115, pE601, DOI 10.1073/pnas.1718426115; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruegsegger C, 2016, ACTA NEUROPATHOL, V131, P427, DOI 10.1007/s00401-015-1510-4; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Schimmack G, 2017, ELIFE, V6, DOI 10.7554/eLife.22416; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi ZB, 2015, J BIOL CHEM, V290, P26811, DOI 10.1074/jbc.M115.666578; Strickson S, 2017, P NATL ACAD SCI USA, V114, pE3481, DOI 10.1073/pnas.1702367114; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Takeuchi S, 2010, J NEUROPATH EXP NEUR, V69, P1044, DOI 10.1097/NEN.0b013e3181f4a90a; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tarr IS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44765-4; Tenekeci U, 2016, MOL CELL, V62, P943, DOI 10.1016/j.molcel.2016.05.017; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Velde CV, 2008, P NATL ACAD SCI USA, V105, P4022, DOI 10.1073/pnas.0712209105; Velde CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022031; Vilotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035051; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wang KZQ, 2010, J CELL BIOCHEM, V110, P763, DOI 10.1002/jcb.22589; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wright GSA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27691; Yan R, 2013, CELL SIGNAL, V25, P1769, DOI 10.1016/j.cellsig.2013.05.015; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhao BB, 2019, VACCINE, V37, P4920, DOI 10.1016/j.vaccine.2019.07.044; Zucchelli S, 2011, J BIOL CHEM, V286, P25108, DOI 10.1074/jbc.M110.187591; Zucchelli S, 2010, HUM MOL GENET, V19, P3759, DOI 10.1093/hmg/ddq290	103	10	10	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3808	3825		10.1074/jbc.RA119.011215	http://dx.doi.org/10.1074/jbc.RA119.011215			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029478	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000527704400008
J	Aleisa, FA; Sakashita, K; Lee, JM; AbuSamra, DB; Al Alwan, B; Nozue, S; Tehseen, M; Hamdan, SM; Habuchi, S; Kusakabe, T; Merzaban, JS				Aleisa, Fajr A.; Sakashita, Kosuke; Lee, Jae Man; AbuSamra, Dina B.; Al Alwan, Bader; Nozue, Shuho; Tehseen, Muhammad; Hamdan, Samir M.; Habuchi, Satoshi; Kusakabe, Takahiro; Merzaban, Jasmeen S.			Functional binding of E-selectin to its ligands is enhanced by structural features beyond its lectin domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell adhesion; glycoprotein structure; kinetics; glycobiology; carbohydrate-binding protein; dimerization; binding kinetics; complement regulatory repeats; E-selectin; short consensus repeats; silkworm expression; adhesion; glycoprotein; conformational extension; homing; silkworm expression	LEUKOCYTE ADHESION MOLECULE-1; P-SELECTIN; CELL-ADHESION; GLYCOPROTEIN LIGAND-1; CARBOHYDRATE LIGAND; SURFACE ADHESION; HOMING RECEPTOR; EXPRESSION; RECOGNITION; FLOW	Selectins are key to mediating interactions involved in cellular adhesion and migration, underlying processes such as immune responses, metastasis, and transplantation. Selectins are composed of a lectin domain, an epidermal growth factor (EGF)-like domain, multiple short consensus repeats (SCRs), a transmembrane domain, and a cytoplasmic tail. It is well-established that the lectin and EGF domains are required to mediate interactions with ligands; however, the contributions of the other domains in mediating these interactions remain obscure. Using various E-selectin constructs produced in a newly developed silkworm-based expression system and several assays performed under both static and physiological flow conditions, including flow cytometry, glycan array analysis, surface plasmon resonance, and cell-rolling assays, we show here that a reduction in the number of SCR domains is correlated with a decline in functional E-selectin binding to hematopoietic cell E- and/or L-selectin ligand (HCELL) and P-selectin glycoprotein ligand-1 (PSGL-1). Moreover, the binding was significantly improved through E-selectin dimerization and by a substitution (A28H) that mimics an extended conformation of the lectin and EGF domains. Analyses of the association and dissociation rates indicated that the SCR domains, conformational extension, and dimerization collectively contribute to the association rate of E-selectin?ligand binding, whereas just the lectin and EGF domains contribute to the dissociation rate. These findings provide the first evidence of the critical role of the association rate in functional E-selectin?ligand interactions, and they highlight that the SCR domains have an important role that goes beyond the structural extension of the lectin and EGF domains.	[Aleisa, Fajr A.; Sakashita, Kosuke; AbuSamra, Dina B.; Al Alwan, Bader; Nozue, Shuho; Tehseen, Muhammad; Hamdan, Samir M.; Habuchi, Satoshi; Merzaban, Jasmeen S.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia; [Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Lab Insect Genome Sci, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan	King Abdullah University of Science & Technology; Kyushu University	Merzaban, JS (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia.	Jasmeen.Merzaban@kaust.edu.sa	; Merzaban, Jasmeen/V-3147-2018; Habuchi, Satoshi/N-6037-2018	Hamdan, Samir/0000-0001-5192-1852; Merzaban, Jasmeen/0000-0002-7276-2907; Aleisa, Fajr/0000-0001-6403-374X; Habuchi, Satoshi/0000-0002-6663-2807; Al Alwan, Bader/0000-0001-6075-3889; Tehseen, Muhammad/0000-0001-9834-2372	King Abdullah University of Science and Technology (KAUST);  [OCRF-2014-CRG3-2276]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); 	This research was supported by a King Abdullah University of Science and Technology (KAUST) Faculty Baseline Research Funding Program (to J. S. M.) and by a Competitive Research Grant (OCRF-2014-CRG3-2276) (to J. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AbuSamra DB, 2015, J BIOL CHEM, V290, P21213, DOI 10.1074/jbc.M114.629451; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; ALON R, 1995, J IMMUNOL, V154, P5356; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barkalow FJ, 2000, BLOOD, V96, P3070; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Carlson GE, 2013, JOVE-J VIS EXP, DOI 10.3791/50604; COLLINS T, 1991, J BIOL CHEM, V266, P2466; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; ERBE DV, 1993, J CELL BIOL, V120, P1227, DOI 10.1083/jcb.120.5.1227; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Fuhlbrigge RC, 2002, J IMMUNOL, V168, P5645, DOI 10.4049/jimmunol.168.11.5645; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; GENG JG, 1992, J BIOL CHEM, V267, P19846; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Isshiki M, 2002, J CELL SCI, V115, P475; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; Kato T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01630-6; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Levy O, 2013, JOVE-J VIS EXP, DOI 10.3791/50866; LI SH, 1994, J BIOL CHEM, V269, P4431; Ling X, 2003, ACTA BIOCH BIOPH SIN, V35, P567; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Masuda A, 2015, J ASIA-PAC ENTOMOL, V18, P175, DOI 10.1016/j.aspen.2015.01.006; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Patel KD, 1995, J CELL BIOL, V131, P1893, DOI 10.1083/jcb.131.6.1893; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Rocheleau AD, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0060-x; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2009, METHODS MOL BIOL, V536, P343, DOI 10.1007/978-1-59745-542-8_36; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Schwizer D, 2012, CHEM-EUR J, V18, P1342, DOI 10.1002/chem.201102884; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; WATSON SR, 1991, J CELL BIOL, V115, P235, DOI 10.1083/jcb.115.1.235; Wiese Georg, 2009, J Vis Exp, DOI 10.3791/1009; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.jbiotec.2006.07.012; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057202	77	7	7	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3719	3733		10.1074/jbc.RA119.010910	http://dx.doi.org/10.1074/jbc.RA119.010910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31949047	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000527725300027
J	Huang, XL; Duddy, OP; Silpe, JE; Paczkowski, JE; Cong, JP; Henke, BR; Bassler, BL				Huang, Xiuliang; Duddy, Olivia P.; Silpe, Justin E.; Paczkowski, Jon E.; Cong, Jianping; Henke, Brad R.; Bassler, Bonnie L.			Mechanism underlying autoinducer recognition in the Vibrio cholerae DPO-VqmA quorum-sensing pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; Vibrio cholerae; crystallography; bacteria; gene regulation; 3; 5-dimethyl-pyrazin-2-ol (DPO); autoinducer; binding; N-alanyl-aminoacetone (Ala-AA); VqmA	CONTROLS BIOFILM FORMATION; PAS DOMAINS; REGULATOR; VIRULENCE; BINDING; LIGAND; SIGNAL; SPECIFICITY; ACTIVATION; GLYOXYLATE	Quorum sensing is a bacterial communication process whereby bacteria produce, release, and detect extracellular signaling molecules called autoinducers to coordinate collective behaviors. In the pathogen Vibrio cholerae, the quorum-sensing autoinducer 3,5-dimethyl-pyrazin-2-ol (DPO) binds the receptor and transcription factor VqmA. The DPO-VqmA complex activates transcription of vqmR, encoding the VqmR small RNA, which represses genes required for biofilm formation and virulence factor production. Here, we show that VqmA is soluble and properly folded and activates basal-level transcription of its target vqmR in the absence of DPO. VqmA transcriptional activity is increased in response to increasing concentrations of DPO, allowing VqmA to drive the V. cholerae quorum-sensing transition at high cell densities. We solved the DPO-VqmA crystal structure to 2.0 ? resolution and compared it with existing structures to understand the conformational changes VqmA undergoes upon DNA binding. Analysis of DPO analogs showed that a hydroxyl or carbonyl group at the 2?-position is critical for binding to VqmA. The proposed DPO precursor, a linear molecule, N-alanyl-aminoacetone (Ala-AA), also bound and activated VqmA. Results from site-directed mutagenesis and competitive ligand-binding analyses revealed that DPO and Ala-AA occupy the same binding site. In summary, our structure-function analysis identifies key features required for VqmA activation and DNA binding and establishes that, whereas VqmA binds two different ligands, VqmA does not require a bound ligand for folding or basal transcriptional activity. However, bound ligand is required for maximal activity.	[Huang, Xiuliang; Duddy, Olivia P.; Silpe, Justin E.; Paczkowski, Jon E.; Cong, Jianping; Henke, Brad R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Huang, Xiuliang; Henke, Brad R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bassler, Bonnie L.] Optimol Consulting LLC, Cary, NC 27513 USA; [Paczkowski, Jon E.] Wadsworth Ctr, New York State Dept Hlth, Div Genet, Albany, NY 12201 USA	Princeton University; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab 329, Princeton, NJ 08544 USA.	bbassler@princeton.edu	; Silpe, Justin/B-6956-2013	Duddy, Olivia/0000-0002-6221-7841; Bassler, Bonnie/0000-0002-0043-746X; Silpe, Justin/0000-0002-6264-8553; HUANG, XIULIANG/0000-0002-1596-4617	DOE Office of Science [DE-SC0012704]; NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant [P41GM111244]; DOE Office of Biological and Environmental Research Grant [KP1605010]	DOE Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant; DOE Office of Biological and Environmental Research Grant(United States Department of Energy (DOE))	We thank Dr. Phillip Jeffrey of the Macromolecular Crystallography Core Facility, Dr. Saw Kyin of the Proteomics and Mass Spectrometry Core Facility, and Dr. Venu Vandasvasi of the Biophysics Core Facility, all at Princeton University, for expert assistance. We thank Dr. Frederick Hughson for thoughtful discussions. We thank the Bassler group for insight into the research. This research used resources FMX and AMX of the National Synchrotron Light Source II, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under Contract DE-SC0012704. The Life Science Biomedical Technology Research resource is primarily supported by NIGMS, National Institutes of Health, through Biomedical Technology Research Resource P41 Grant P41GM111244 and by DOE Office of Biological and Environmental Research Grant KP1605010. The authors received expert technical support from Dr. Martin Fuchs and Dr. Jean Jakoncic of the NSLS II FMX and AMX beamlines.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bundy BM, 2002, P NATL ACAD SCI USA, V99, P7693, DOI 10.1073/pnas.102605799; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Collier LS, 1998, J BACTERIOL, V180, P2493, DOI 10.1128/JB.180.9.2493-2501.1998; EBERHARD A, 1986, ARCH MICROBIOL, V146, P35, DOI 10.1007/BF00690155; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerdt JP, 2017, ACS CHEM BIOL, V12, P2457, DOI 10.1021/acschembio.7b00458; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Herzog R, 2019, NUCLEIC ACIDS RES, V47, P3171, DOI 10.1093/nar/gky1320; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Joyce MG, 2010, ACTA CRYSTALLOGR D, V66, P358, DOI 10.1107/S0907444909053074; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Ke XB, 2015, MOL MICROBIOL, V95, P127, DOI 10.1111/mmi.12852; KURIHARA T, 1991, J HETEROCYCLIC CHEM, V28, P1557, DOI 10.1002/jhet.5570280616; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; McCready AR, 2019, P NATL ACAD SCI USA, V116, P245, DOI 10.1073/pnas.1817239116; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MUKHERJEE JJ, 1987, J BIOL CHEM, V262, P14441; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Papenfort K, 2017, NAT CHEM BIOL, V13, P551, DOI [10.1038/NCHEMBIO.2336, 10.1038/nchembio.2336]; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silpe JE, 2019, CELL, V176, P268, DOI 10.1016/j.cell.2018.10.059; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652; Wu H, 2019, BIOCHEM BIOPH RES CO, V520, P399, DOI 10.1016/j.bbrc.2019.10.063; Wu H, 2019, J BIOL CHEM, V294, P2580, DOI 10.1074/jbc.RA118.006082; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	48	15	16	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2916	2931		10.1074/jbc.RA119.012104	http://dx.doi.org/10.1074/jbc.RA119.012104			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31964715	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000519597300005
J	Muller, YA; Hage, S; Alkhashrom, S; Hollriegl, T; Weigert, S; Dolles, S; Hof, K; Walzer, SA; Egerer-Sieber, C; Conrad, M; Holst, S; Losing, J; Sonntag, E; Sticht, H; Eichler, J; Marschall, M				Muller, Yves A.; Haege, Sigrun; Alkhashrom, Sewar; Hoellriegl, Tobias; Weigert, Sebastian; Dolles, Simon; Hof, Kerstin; Walzer, Sascha A.; Egerer-Sieber, Claudia; Conrad, Marcus; Holst, Stephanie; Loesing, Josephine; Sonntag, Eric; Sticht, Heinrich; Eichler, Jutta; Marschall, Manfred			High-resolution crystal structures of two prototypical ?- and ?-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; structure-function; energetics; confocal microscopy; crystal structure; alanine scan; Epstein-Barr virus; Human cytomegalovirus; nuclear egress complex; Protein-protein interactions	CYTOMEGALOVIRUS PUL50; WEB SERVER; PROTEIN; INFECTION; INSIGHTS; FEATURES; LAMINA; DOMAIN	Herpesviruses uniquely express two essential nuclear egress-regulating proteins forming a heterodimeric basic structure of the nuclear egress complex (core NEC). These core NECs serve as a hexameric lattice-structured platform for capsid docking and recruit viral and cellular NEC-associated factors that jointly exert nuclear lamina- and membrane-rearranging functions (multicomponent NEC). Here, we report the X-ray structures of ?- and ?-herpesvirus core NECs obtained through an innovative recombinant expression strategy based on NEC-hook::NEC-groove protein fusion constructs. This approach yielded the first structure of ?-herpesviral core NEC, namely the 1.56 ? structure of Epstein-Barr virus (EBV) BFRF1?BFLF2, as well as an increased resolution 1.48 ? structure of human cytomegalovirus (HCMV) pUL50-pUL53. Detailed analysis of these structures revealed that the prominent hook segment is absolutely required for core NEC formation and contributes approximately 80% of the interaction surface of the globular domains of NEC proteins. Moreover, using HCMV::EBV hook domain swap constructs, computational prediction of the roles of individual hook residues for binding, and quantitative binding assays with synthetic peptides presenting the HCMV- and EBV-specific NEC hook sequences, we characterized the unique hook-into-groove NEC interaction at various levels. Although the overall physicochemical characteristics of the protein interfaces differ considerably in these ?- and ?-herpesvirus NECs, the binding free energy contributions of residues displayed from identical positions are similar. In summary, the results of our study reveal critical details of the molecular mechanism of herpesviral NEC interactions and highlight their potential as an antiviral drug target.	[Muller, Yves A.; Hoellriegl, Tobias; Weigert, Sebastian; Hof, Kerstin; Walzer, Sascha A.; Egerer-Sieber, Claudia] Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany; [Haege, Sigrun; Loesing, Josephine; Sonntag, Eric; Marschall, Manfred] Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Alkhashrom, Sewar; Dolles, Simon; Holst, Stephanie; Eichler, Jutta] Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Med Chem, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Conrad, Marcus; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany.; Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Ctr, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	yves.muller@fau.de; manfred.marschall@fau.de	Eichler, Jutta/H-7847-2018; Muller, Yves/R-5397-2016	Eichler, Jutta/0000-0001-6683-9456; Muller, Yves/0000-0003-0519-8928; Weigert, Sebastian/0000-0002-0469-1545	Deutsche Forschungsgemeinschaft [MA 1289/8-1, EI 423/4-1, MU 1477/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 1289/8-1, EI 423/4-1, and MU 1477/10-1 (to Y. A. M., J. E., and M. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], [No title captured]; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bailer SM, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040046; Bigalke JM, 2015, EMBO J, V34, P2921, DOI 10.15252/embj.201592359; Bigalke JM, 2015, J VIROL, V89, P9150, DOI 10.1128/JVI.02530-14; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Diewald B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102908; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gross A, 2015, CHEMBIOCHEM, V16, P446, DOI 10.1002/cbic.201402545; Hellberg T, 2016, ADV VIRUS RES, V94, P81, DOI 10.1016/bs.aivir.2015.10.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jha HC, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010018; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kumar KSD, 2015, J APPL CRYSTALLOGR, V48, P939, DOI 10.1107/S1600576715006287; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lye MF, 2015, EMBO J, V34, P2937, DOI 10.15252/embj.201592651; Marschall M, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1934; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2012, J BIOL CHEM, V287, P24004, DOI 10.1074/jbc.M111.331207; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sonntag E, 2016, J GEN VIROL, V97, P1676, DOI 10.1099/jgv.0.000495; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Walzer SA, 2015, J BIOL CHEM, V290, P27452, DOI 10.1074/jbc.C115.686527; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeev-Ben-Mordehai T, 2015, CELL REP, V13, P2645, DOI 10.1016/j.celrep.2015.11.008	35	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3189	3201		10.1074/jbc.RA119.011546	http://dx.doi.org/10.1074/jbc.RA119.011546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31980459	Green Published, hybrid			2022-12-28	WOS:000519597300024
J	Takeishi, Y; Fujikane, R; Ritake, M; Obayashi, Y; Sekiguchi, M; Hidaka, M				Takeishi, Yukimasa; Fujikane, Ryosuke; Ritake, Mihoko; Obayashi, Yuko; Sekiguchi, Mutsuo; Hidaka, Masumi			SMARCAD1-mediated recruitment of the DNA mismatch repair protein MutL? to MutS? on damaged chromatin induces apoptosis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; chromatin remodeling; DNA damage response; DNA mismatch repair; mutL homolog 1 (MLH1); CRISPR; Cas9; N-methyl-N-nitrosourea; O6-methylguanine; SMARCAD1; DNA damage signaling; O6-methylguanine; SMARCAD1	ALKYLATION-INDUCED APOPTOSIS; GENE; MICE; O-6-METHYLGUANINE; METHYLTRANSFERASE; INSTABILITY; EXPRESSION; TOLERANT; HOMOLOG; FUN30	The mismatch repair (MMR) complex is composed of MutS? (MSH2-MSH6) and MutL? (MLH1-PMS2) and specifically recognizes mismatched bases during DNA replication. O-6-Methylguanine is produced by treatment with alkylating agents, such as N-methyl-N-nitrosourea (MNU), and during DNA replication forms a DNA mismatch (i.e. an O-6-methylguanine/thymine pair) and induces a G/C to A/T transition mutation. To prevent this outcome, cells carrying this DNA mismatch are eliminated by MMR-dependent apoptosis, but the underlying molecular mechanism is unclear. In this study, we provide evidence that the chromatin-regulatory and ATP-dependent nucleosome-remodeling protein SMARCAD1 is involved in the induction of MMR-dependent apoptosis in human cells. Unlike control cells, SMARCAD1-knockout cells (?SMARCAD1) were MNU-resistant, and the appearance of a sub-G(1) population and caspase-9 activation were significantly suppressed in the ?SMARCAD1 cells. Furthermore, the MNU-induced mutation frequencies were increased in these cells. Immunoprecipitation analyses revealed that the recruitment of MutL? to chromatin-bound MutS?, observed in SMARCAD1-proficient cells, is suppressed in ?SMARCAD1 cells. Of note, the effect of SMARCAD1 on the recruitment of MutL? exclusively depended on the ATPase activity of the protein. On the basis of these findings, we propose that SMARCAD1 induces apoptosis via its chromatin-remodeling activity, which helps recruit MutL? to MutS? on damaged chromatin.	[Takeishi, Yukimasa; Obayashi, Yuko; Sekiguchi, Mutsuo; Hidaka, Masumi] Fukuoka Dent Coll, Adv Sci Res Ctr, Fukuoka 8140193, Japan; [Fujikane, Ryosuke; Ritake, Mihoko; Obayashi, Yuko; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka 8140193, Japan; [Ritake, Mihoko] Fukuoka Dent Coll, Dept Oral Growth & Dev, Fukuoka 8140193, Japan; [Ritake, Mihoko] Fukuoka Dent Coll, Dept Oral & Maxillofacial Surg, Fukuoka 8140193, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Hidaka, M (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	hidaka@college.fdcnet.ac.jp		Fujikane, Ryosuke/0000-0002-6621-3848; Takeishi, Yukimasa/0000-0001-9049-3117	Private University Research Branding Project; Japan Society for the Promotion of Science (JSPS) KAKENHI [16K18428]; JSPS KAKENHI [25241012, 26830085]; MEXT; MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 [S1411042]; Fukuoka Foundation for Sound Health Cancer Research Fund	Private University Research Branding Project; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017; Fukuoka Foundation for Sound Health Cancer Research Fund	This work was supported by the Private University Research Branding Project (to R. F.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Young Scientist (B) Grant 16K18428 (to Y. T.), JSPS KAKENHI Grant-in-Aid for Young Scientist (B) Grant 26830085 (to R. F.), JSPS KAKENHI Grant-in-Aid for Scientific Research (A) Grant 25241012 (to M.H.), MEXT-Grants-in-Aid and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, Grant S1411042 (to M. S. and M. H.), and the Fukuoka Foundation for Sound Health Cancer Research Fund (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; AQUILINA G, 1994, P NATL ACAD SCI USA, V91, P8905, DOI 10.1073/pnas.91.19.8905; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Chen Z, 2016, MOL CELL PROTEOMICS, V15, P1299, DOI [10.1074/mcp.M115.056093, 10.1074/mcp.M115.056093 ]; Cleynen I, 2008, INT J ONCOL, V32, P289; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Davis BM, 1997, CANCER RES, V57, P5093; Densham RM, 2016, NAT STRUCT MOL BIOL, V23, P647, DOI 10.1038/nsmb.3236; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fujikane R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31714; Fujikane R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044817; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; Hayashida G, 2019, EXP CELL RES, V377, P24, DOI 10.1016/j.yexcr.2019.02.020; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; Kadyrova LY, 2016, J BIOL CHEM, V291, P27298, DOI 10.1074/jbc.M116.760561; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Maze R, 1996, P NATL ACAD SCI USA, V93, P206, DOI 10.1073/pnas.93.1.206; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Qin XS, 1999, ONCOGENE, V18, P4394, DOI 10.1038/sj.onc.1202798; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Sakumi K, 1997, CANCER RES, V57, P2415; Sanada M, 2007, CARCINOGENESIS, V28, P2657, DOI 10.1093/carcin/bgm188; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Sirbu BM, 2013, J BIOL CHEM, V288, P31458, DOI 10.1074/jbc.M113.511337; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; Taneja N, 2017, MOL CELL, V66, P50, DOI 10.1016/j.molcel.2017.02.006; Terui R, 2018, GENE DEV, V32, P806, DOI 10.1101/gad.310995.117; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tominaga Y, 1997, CARCINOGENESIS, V18, P889, DOI 10.1093/carcin/18.5.889; Wu JX, 1999, MOL CELL BIOL, V19, P8292	50	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1056	1065		10.1074/jbc.RA119.008854	http://dx.doi.org/10.1074/jbc.RA119.008854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31843968	hybrid, Green Published			2022-12-28	WOS:000509949300014
J	Salimi, H; Johnson, J; Flores, MG; Zhang, MS; O'Malley, Y; Houtman, JC; Schlievert, PM; Haim, H				Salimi, Hamid; Johnson, Jacklyn; Flores, Manuel G.; Zhang, Michael S.; O'Malley, Yunxia; Houtman, Jon C.; Schlievert, Patrick M.; Haim, Hillel			The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); virus entry; membrane lipid; antibody; protein conformation; protein stability; cholesterol; vaccine development; lipid raft; envelope glycoproteins; surface-acting agent	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRION-ASSOCIATED CHOLESTEROL; HUMAN MONOCLONAL-ANTIBODY; GP41 CYTOPLASMIC TAIL; CD4-BOUND CONFORMATION; VAGINAL TRANSMISSION; PLASMA-MEMBRANE; CRAC SEGMENT; GP120; PROTEIN	The envelope glycoproteins (Envs) of HIV-1 are embedded in the cholesterol-rich lipid membrane of the virus. Chemical depletion of cholesterol from HIV-1 particles inactivates their infectivity. We observed that diverse HIV-1 strains exhibit a range of sensitivities to such treatment. Differences in sensitivity to cholesterol depletion could not be explained by variation in Env components known to interact with cholesterol, including the cholesterol-recognition motif and cytoplasmic tail of gp41. Using antibody-binding assays, measurements of virus infectivity, and analyses of lipid membrane order, we found that depletion of cholesterol from HIV-1 particles decreases the conformational stability of Env. It enhances exposure of partially cryptic epitopes on the trimer and increases sensitivity to structure-perturbing treatments such as antibodies and cold denaturation. Substitutions in the cholesterol-interacting motif of gp41 induced similar effects as depletion of cholesterol. Surface-acting agents, which are incorporated into the virus lipid membrane, caused similar effects as disruption of the Env-cholesterol interaction. Furthermore, substitutions in gp120 that increased structural stability of Env (i.e. induced a ?closed? conformation of the trimer) increased virus resistance to cholesterol depletion and to the surface-acting agents. Collectively, these results indicate a critical contribution of the viral membrane to the stability of the Env trimer and to neutralization resistance against antibodies. Our findings suggest that the potency of poorly neutralizing antibodies, which are commonly elicited in vaccinated individuals, may be markedly enhanced by altering the lipid composition of the viral membrane.	[Salimi, Hamid; Johnson, Jacklyn; Flores, Manuel G.; Zhang, Michael S.; O'Malley, Yunxia; Houtman, Jon C.; Schlievert, Patrick M.; Haim, Hillel] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	University of Iowa	Haim, H (corresponding author), Univ Iowa, Dept Microbiol & Immunol, 51 Newton Rd,3-770 BSB, Iowa City, IA 52242 USA.	Hillel-haim@uiowa.edu		Haim, Hillel/0000-0002-6071-5089; Houtman, Jon/0000-0002-5307-9854	University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award; Department of Microbiology and Immunology, the University of Iowa	University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award; Department of Microbiology and Immunology, the University of Iowa	This work was supported by the University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award (to H. H.) as well as a Development Grant from the Department of Microbiology and Immunology, the University of Iowa (to H. H.). Dr. Schlievert is co-founder of a small business, Hennepin Life Sciences, which has licensed a patent awarded to the University of Minnesota for the development of glycerol monolaurate (GML) to treat vaginal bacterial infections. Dr. Schlievert receives no salary or consulting support from Hennepin Life Sciences, although he does have stock in the company. Dr. Schlievert is a co-inventor on the above GML patent awarded to the University of Minnesota. The title of this patent is Compositions and Methods for Controlling Infections (US 8796332 B2). The authors confirm that the patent and stock do not alter adherence to all Journal of Biological Chemistry policies on sharing data and materials. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Alexandre KB, 2016, VIROLOGY, V497, P69, DOI 10.1016/j.virol.2016.07.004; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Ambrose Z, 2008, J VIROL, V82, P6591, DOI 10.1128/JVI.02730-07; [Anonymous], 1998, NUMBERING POSITIONS; Apel-Paz M, 2003, LANGMUIR, V19, P591, DOI 10.1021/la020723r; Arriaga LR, 2017, ADV COLLOID INTERFAC, V247, P514, DOI 10.1016/j.cis.2017.07.007; Ball C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049792; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Bourinbaiar AS, 1996, AIDS, V10, P558, DOI 10.1097/00002030-199605000-00024; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Bromfield EG, 2014, REPRODUCTION, V147, P153, DOI 10.1530/REP-13-0393; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; DeLeon O, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001549; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Etemad-Moghadam B, 2002, VACCINE, V20, P1934, DOI 10.1016/S0264-410X(02)00072-5; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Freitas MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015756; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Greenwood AI, 2008, BBA-BIOMEMBRANES, V1778, P1120, DOI 10.1016/j.bbamem.2008.01.008; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; HAFFAR OK, 1991, VIROLOGY, V180, P439, DOI 10.1016/0042-6822(91)90054-F; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2013, J VIROL, V87, P1884, DOI 10.1128/JVI.02765-12; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hammonds J, 2003, VIROLOGY, V314, P636, DOI 10.1016/S0042-6822(03)00467-7; HATCH WC, 1992, J IMMUNOL, V148, P3055; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Johnson J, 2017, J VIROL, V91, DOI 10.1128/JVI.00174-17; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kawano N, 2011, J LIPIDS, V2011, DOI 10.1155/2011/264706; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114; Kirtane AR, 2017, J PHARM SCI-US, V106, P1821, DOI 10.1016/j.xphs.2017.03.030; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Mayr LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01590; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McGee K, 2014, J VIROL, V88, P21, DOI 10.1128/JVI.01558-13; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Munro JB, 2015, J VIROL, V89, P5752, DOI 10.1128/JVI.03187-14; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nieto-Garai JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01983; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Paladino S, 2002, INT J MED MICROBIOL, V291, P439; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Schwarzer R, 2014, CELL MICROBIOL, V16, P1565, DOI 10.1111/cmi.12314; Sezgin E, 2014, LANGMUIR, V30, P8160, DOI 10.1021/la501226v; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Sundaram RVK, 2016, BIOCHEMISTRY-US, V55, P447, DOI 10.1021/acs.biochem.5b00936; Tedbury PR, 2014, TRENDS MICROBIOL, V22, P372, DOI 10.1016/j.tim.2014.04.012; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; Yang ST, 2016, CHEM PHYS LIPIDS, V199, P136, DOI 10.1016/j.chemphyslip.2016.05.003; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; Yuan W, 2006, J VIROL, V80, P6725, DOI 10.1128/JVI.00118-06; Zhang MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30225	115	25	26	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					348	362		10.1074/jbc.RA119.009481	http://dx.doi.org/10.1074/jbc.RA119.009481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31757809	Green Published, hybrid			2022-12-28	WOS:000507373600008
J	Shi, JF; Hu, XY; Guo, Y; Wang, LH; Ji, J; Li, JQ; Zhang, ZR				Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong			A technique for delineating the unfolding requirements for substrate entry into retrotranslocons during endoplasmic reticulum?associated degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER-associated degradation; ER quality control; E3 ubiquitin ligase; protein misfolding; ubiquitylation (ubiquitination); membrane enzyme; dihydrofolate reductase; ER-to-cytosol transport; retrotranslocation; tunable folding domain; unfolded substrate	DIHYDROFOLATE-REDUCTASE; PROTEIN-DEGRADATION; UBIQUITIN; RETICULUM; PROTEASOME; ERAD; COMPLEX; BINDING; IMPORT; DOMAIN	The endoplasmic reticulum?associated degradation (ERAD) pathway mediates the endoplasmic reticulum?to?cytosol retrotranslocation of defective proteins through protein complexes called retrotranslocons. Defective proteins usually have complex conformations and topologies, and it is unclear how ERAD can thread these conformationally diverse protein substrates through the retrotranslocons. Here, we investigated the substrate conformation flexibility necessary for transport via retrotranslocons on the ERAD-L, ERAD-M, and HIV-encoded protein Vpu-hijacked ERAD branches. To this end, we appended various ERAD substrates with specific domains whose conformations were tunable in flexibility or tightness by binding to appropriate ligands. With this technique, we could define the capacity of specific retrotranslocons in disentangling very tight, less tight but well-folded, and unstructured conformations. The Hrd1 complex, the retrotranslocon on the ERAD-L branch, permitted the passage of substrates with a proteinase K?resistant tight conformation, whereas the E3 ligase gp78-mediated ERAD-M allowed passage only of nearly completely disordered but not well-folded substrates and thus may have the least unfoldase activity. Vpu-mediated ERAD, containing a potential retrotranslocon, could unfold well-folded substrates for successful retrotranslocation. However, substrate retrotranslocation in Vpu-mediated ERAD was blocked by enhanced conformational tightness of the substrate. On the basis of these findings, we propose a mechanism underlying polypeptide movement through the endoplasmic reticulum membrane. We anticipate that our biochemical system paves the way for identifying the factors necessary for the retrotranslocation of membrane proteins.	[Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China; [Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, ZR (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China.	zrzhang@sioc.ac.cn		ZHANG, ZAIRONG/0000-0001-9768-0548	National Key RAMP;D Program of China [2016YFA0501903]; National Natural Science Foundation of China [31670780]	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2016YFA0501903 and National Natural Science Foundation of China Grant 31670780. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; [Anonymous], 2019, SCIENCE; ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Berner N, 2018, ANNU REV BIOCHEM, V87, P751, DOI 10.1146/annurev-biochem-062917-012749; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; ENDO T, 1994, EUR J BIOCHEM, V225, P403, DOI 10.1111/j.1432-1033.1994.00403.x; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ganesan I, 2018, PLANT CELL, V30, P2161, DOI 10.1105/tpc.18.00427; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Jain P, 2018, CELL REP, V22, P2493, DOI 10.1016/j.celrep.2018.01.091; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Liu Y, 2019, NAT MICROBIOL, V4, P813, DOI 10.1038/s41564-019-0372-2; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013; Morito D, 2015, MOL CELL, V59, P335, DOI 10.1016/j.molcel.2015.06.010; Needham PG, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033928; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Petris G, 2014, J BIOL CHEM, V289, P1, DOI 10.1074/jbc.M113.512368; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salvador N, 2000, J BIOL CHEM, V275, P27447; SASSO SP, 1994, BBA-PROTEIN STRUCT M, V1207, P74, DOI 10.1016/0167-4838(94)90053-1; Schoebel S, 2017, NATURE, V548, P352, DOI 10.1038/nature23314; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	55	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20084	20096		10.1074/jbc.RA119.010019	http://dx.doi.org/10.1074/jbc.RA119.010019			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748412	Green Published, hybrid			2022-12-28	WOS:000505005800021
J	Komazin, G; Maybin, M; Woodard, RW; Scior, T; Schwudke, D; Schombel, U; Gisch, N; Mamat, U; Meredith, TC				Komazin, Gloria; Maybin, Michael; Woodard, Ronald W.; Scior, Thomas; Schwudke, Dominik; Schombel, Ursula; Gisch, Nicolas; Mamat, Uwe; Meredith, Timothy C.			Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endotoxin; lipopolysaccharide (LPS); metabolic endotoxemia; intestinal alkaline phosphatase; Toll-like receptor (TLR); lipid A; systemic inflammation; metabolic syndrome; gut microbiome; intestinal flora	ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; ACID-DEFICIENT MUTANT; LIPID-A PRECURSORS; SALMONELLA-TYPHIMURIUM; DEACYLATED LIPOPOLYSACCHARIDE; ENTEROCYTE MICROVILLUS; METABOLIC ENDOTOXEMIA; POLYMYXIN RESISTANCE; CRYSTAL-STRUCTURE; GUT MICROBIOTA	Lipopolysaccharide (LPS) from the Gram-negative bacterial outer membrane potently activates the human innate immune system. LPS is recognized by the Toll-like receptor 4/myeloid differentiation factor-2 (TLR4/MD2) complex, leading to the release of pro-inflammatory cytokines. Alkaline phosphatase (AP) is currently being investigated as an anti-inflammatory agent for detoxifying LPS through dephosphorylating lipid A, thus providing a potential treatment for managing both acute (sepsis) and chronic (metabolic endotoxemia) pathologies wherein aberrant TLR4/MD2 activation has been implicated. Endogenous LPS preparations are chemically heterogeneous, and little is known regarding the LPS chemotype substrate range of AP. Here, we investigated the activity of AP on a panel of structurally defined LPS chemotypes isolated from Escherichia coli and demonstrate that calf intestinal AP (cIAP) has only minimal activity against unmodified enteric LPS chemotypes. Inorganic phosphate was only released from a subset of LPS chemotypes harboring spontaneously labile phosphoethanolamine (PEtN) modifications connected through phosphoanhydride bonds. We demonstrate that the spontaneously hydrolyzed O-phosphorylethanolamine is the actual substrate for AP. We found that the 1- and 4'-lipid A phosphate groups critical in TLR4/MD2 signaling become susceptible to hydrolysis only after de-O-acylation of ester linked primary acyl chains on lipid A. Furthermore, PEtN modifications on lipid A specifically enhanced hTLR4 agonist activity of underacylated LPS preparations. Computational binding models are proposed to explain the limitation of AP substrate specificity imposed by the acylation state of lipid A, and the mechanism of PEtN in enhancing hTLR4/MD2 signaling.	[Komazin, Gloria; Maybin, Michael; Meredith, Timothy C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scior, Thomas] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Puebla 72000, Mexico; [Schwudke, Dominik; Schombel, Ursula; Gisch, Nicolas] Leibniz Lung Ctr, Res Ctr Borstel, Bioanalyt Chem Prior Res Area Infect, D-23845 Borstel, Germany; [Mamat, Uwe] Leibniz Lung Ctr, Res Ctr Borstel, Cellular Microbiol, Prior Res Area Infect, D-23845 Borstel, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Benemerita Universidad Autonoma de Puebla; Forschungszentrum Borstel; Forschungszentrum Borstel	Meredith, TC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	txm50@psu.edu	Thomas, alias Tom Scior/AAM-9189-2020; Schwudke, Dominik/B-3478-2013; Meredith, Timothy/X-2713-2019	Thomas, alias Tom Scior/0000-0003-2196-2682; Schwudke, Dominik/0000-0002-1379-9451; Meredith, Timothy/0000-0002-1901-6841; Gisch, Nicolas/0000-0003-3260-5269	National Institutes of Health Grants NAID [R21 AI138152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI138152] Funding Source: NIH RePORTER	National Institutes of Health Grants NAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants NAID R21 AI138152 (to TCM). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bilski J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9074601; Moreira APB, 2012, NUTR HOSP, V27, P382, DOI [10.1590/S0212-16112012000200007, 10.3305/nh.2012.27.2.5543]; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Chen HD, 2013, ANNU REV MICROBIOL, V67, P83, DOI 10.1146/annurev-micro-092412-155751; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; DALNOGARE AR, 1990, J IMMUNOL, V144, P1404; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duseja A, 2014, CLIN LIVER DIS, V18, P59, DOI 10.1016/j.cld.2013.09.002; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002; Fawley J, 2016, J SURG RES, V202, P225, DOI 10.1016/j.jss.2015.12.008; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Ghosh K, 2013, J STRUCT BIOL, V184, P182, DOI 10.1016/j.jsb.2013.09.017; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gorelik A, 2018, P NATL ACAD SCI USA, V115, pE896, DOI 10.1073/pnas.1719834115; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Gregg KA, 2017, MBIO, V8, DOI [10.1128/mBio.00492-17, 10.1128/mbio.00492-17]; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; HARKNESS DR, 1968, ARCH BIOCHEM BIOPHYS, V126, P513, DOI 10.1016/0003-9861(68)90436-0; Henderson JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50623; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HULETT FM, 1991, J BIOL CHEM, V266, P1077; JANSSON PE, 1981, EUR J BIOCHEM, V115, P571; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Klein G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020356; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kutschera A, 2019, SCIENCE, V364, P178, DOI 10.1126/science.aau1279; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LEHRER S, 1972, INFECT IMMUN, V6, P928, DOI 10.1128/IAI.6.6.928-933.1972; Linder CH, 2009, BONE, V45, P987, DOI 10.1016/j.bone.2009.07.009; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Maldonado RF, 2016, FEMS MICROBIOL REV, V40, P480, DOI 10.1093/femsre/fuw007; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Malo MS, 2014, AM J PHYSIOL-GASTR L, V306, pG826, DOI 10.1152/ajpgi.00357.2013; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moss AK, 2013, AM J PHYSIOL-GASTR L, V304, pG597, DOI 10.1152/ajpgi.00455.2012; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Neves AL, 2013, J MOL ENDOCRINOL, V51, pR51, DOI 10.1530/JME-13-0079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Peters E, 2015, BRIT J PHARMACOL, V172, P4932, DOI 10.1111/bph.13261; Pettengill M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175936; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piya MK, 2013, CURR OPIN LIPIDOL, V24, P78, DOI 10.1097/MOL.0b013e32835b4431; Poelstra K, 1997, AM J PATHOL, V151, P1163; POHLMAN TH, 1987, J EXP MED, V165, P1393, DOI 10.1084/jem.165.5.1393; Rader BA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00897; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Renzi F, 2016, INFECT IMMUN, V84, P550, DOI 10.1128/IAI.01006-15; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; RICK PD, 1977, J BIOL CHEM, V252, P4904; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; ROSNER MR, 1979, J BIOL CHEM, V254, P5906; Schromm AB, 1998, J IMMUNOL, V161, P5464; Scior T, 2007, DRUG DESIGN RES PERS, P675; Scior T, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302012; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; STRAIN SM, 1983, J BIOL CHEM, V258, P2906; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Sunden F, 2016, J AM CHEM SOC, V138, P14273, DOI 10.1021/jacs.6b06186; Thompson M., 2004, ACS M PHIL PA; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tuin A, 2006, AM J PHYSIOL-GASTR L, V290, pG377, DOI 10.1152/ajpgi.00147.2005; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; WANG MH, 1991, INFECT IMMUN, V59, P4655, DOI 10.1128/IAI.59.12.4655-4664.1991; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391; Yang WH, 2018, CELL HOST MICROBE, V24, P500, DOI 10.1016/j.chom.2018.09.011; Yang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00314; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Zariri A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36575; Zariri A, 2015, EXPERT REV VACCINES, V14, P861, DOI 10.1586/14760584.2015.1026808; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	120	7	8	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19405	19423		10.1074/jbc.RA119.010836	http://dx.doi.org/10.1074/jbc.RA119.010836			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31704704	Green Published, hybrid			2022-12-28	WOS:000516527800036
J	Miller, MS; Douglass, J; Hwang, MS; Skora, AD; Murphy, M; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Zhou, SB; Gabelli, SB				Miller, Michelle S.; Douglass, Jacqueline; Hwang, Michael S.; Skora, Andrew D.; Murphy, Michael; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin; Gabelli, Sandra B.			An engineered antibody fragment targeting mutant beta-catenin via major histocompatibility complex I neoantigen presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; ANTI-P185HER2 ANTIBODY; NEURAL-NETWORKS; CANCER; GENERATION; MUTATIONS; THERAPY; PEPTIDE; CELLS	Mutations in CTNNB1, the gene encoding beta-catenin, are common in colon and liver cancers, the most frequent mutation affecting Ser-45 in beta-catenin. Peptides derived from WT beta-catenin have previously been shown to be presented on the cell surface as part of major histocompatibility complex (MHC) class I, suggesting an opportunity for targeting this common driver gene mutation with antibody-based therapies. Here, crystal structures of both the WT and S45F mutant peptide bound to HLA-A*03:01 at 2.20 and 2.45 angstrom resolutions, respectively, confirmed the accessibility of the phenylalanine residue for antibody recognition. Phage display was then used to identify single-chain variable fragment clones that selectively bind the S45F mutant peptide presented in HLA-A*03:01 and have minimal WT or other off-target binding. Following the initial characterization of five clones, we selected a single clone, E10, for further investigation. We developed a computational model of the binding of E10 to the mutant peptide-bound HLA-A3, incorporating data from affinity maturation as initial validation. In the future, our model may be used to design clones with maintained specificity and higher affinity. Such derivatives could be adapted into either cell-based (CAR-T) or protein-based (bispecific T-cell engagers) therapies to target cancer cells harboring the S45F mutation in CTNNB1.	[Miller, Michelle S.; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Douglass, Jacqueline; Hwang, Michael S.; Skora, Andrew D.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin] Johns Hopkins Univ, Sch Med, Ludwig Ctr, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Murphy, Michael] GE Healthcare Life Sci, Marlborough, MA 01752 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Skora, Andrew D.] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; General Electric; Johns Hopkins University; Eli Lilly	Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	gabelli@jhmi.edu	; Gabelli, Sandra/A-3705-2008	Miller, Michelle/0000-0003-1972-4503; Gabelli, Sandra/0000-0003-1205-5204	Lustgarten Foundation; BKI Cancer Genetics and Genomics Research Program; United States Department of Defense Grant [CDMRP BC151831]; National Institutes of Health [CA062924, P30 CA006973]; Virginia and D. K. Ludwig Fund for Cancer Research; Commonwealth Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Lustgarten Foundation; BKI Cancer Genetics and Genomics Research Program; United States Department of Defense Grant(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Fund for Cancer Research; Commonwealth Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Lustgarten Foundation (to B. V.), the BKI Cancer Genetics and Genomics Research Program (to B. V.), United States Department of Defense Grant CDMRP BC151831 (to S. B. G.), and National Institutes of Health Grants CA062924 (to S. B. G.), P30 CA006973 (to B. V.), The Virginia and D. K. Ludwig Fund for Cancer Research (to B. V. and K. W. K.) and the Commonwealth Fund (to S. Z.). B. V., K. W. K., and N. P. are founders of, hold equity in, and are consultants to Thrive Earlier Detection and Personal Genome Diagnostics. K. W. K. and N. P. are on the Board of Directors of Thrive Earlier Detection. S. Z. is a founder of, holds equity in, and serves as a consultant to Personal Genome Diagnostics, holds equity in Thrive Earlier Detection, and has a research agreement with BioMed Valley Discoveries. K. W. K and B. V. are consultants to Sysmex, Eisai, and CAGE Pharma and hold equity in CAGE Pharma. B. V. is also a consultant to Nexus, and K. W. K., B. V., S. Z., and N. P. are consultants to and hold equity in NeoPhore. Sysmex, Qiagen, Invitae, Personal Genome Diagnostics, PapGene, Thrive Earlier Detection, BioMed Valley Discoveries, Pierce Biotechnology, Horizon Discovery, Life Technologies, as well as other companies, have licensed previously described technologies from Johns Hopkins University. B. V., K. W. K., S. Z., and N. P. are inventors on some of these technologies. Licenses to these technologies are or will be associated with equity or royalty payments to the inventors as well as to Johns Hopkins University. Patent applications on the work described in this paper have or may be filed by Johns Hopkins University. The terms of all these arrangements are being managed by Johns Hopkins University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman J. D, 2003, CURR PROTOC IMMUNOL; ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Catrow JL, 2015, J MED CHEM, V58, P4678, DOI 10.1021/acs.jmedchem.5b00223; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Cui C, 2018, TRENDS BIOCHEM SCI, V43, P623, DOI 10.1016/j.tibs.2018.06.003; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Dietrich L, 2017, CELL CHEM BIOL, V24, P958, DOI 10.1016/j.chembiol.2017.06.013; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fiskus W, 2015, LEUKEMIA, V29, P1267, DOI 10.1038/leu.2014.340; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Granados DP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4600; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Hagen T, 2002, BIOCHEM BIOPH RES CO, V294, P324, DOI 10.1016/S0006-291X(02)00485-0; Hahne G, 2013, BIOORGAN MED CHEM, V21, P4020, DOI 10.1016/j.bmc.2013.02.050; Hsieh TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19156; Huang Z, 2014, ACS CHEM BIOL, V9, P193, DOI 10.1021/cb400795x; Hwang SY, 2016, CELL REP, V16, P28, DOI 10.1016/j.celrep.2016.05.071; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaleli NE, 2019, PROTEINS, V87, P607, DOI 10.1002/prot.25685; Kandel RA, 2018, CANCER TREAT REV, V66, P74, DOI 10.1016/j.ctrv.2018.04.005; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kasper B, 2016, ANN SURG ONCOL, V23, P1924, DOI 10.1245/s10434-016-5132-4; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Lazar AJF, 2008, AM J PATHOL, V173, P1518, DOI 10.2353/ajpath.2008.080475; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Trufero JM, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0474-0; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004; Sankar K, 2018, PROTEINS, V86, P1147, DOI 10.1002/prot.25594; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneider JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06845-3; Shin SH, 2017, EBIOMEDICINE, V25, P22, DOI 10.1016/j.ebiom.2017.09.029; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Skora AD, 2015, P NATL ACAD SCI USA, V112, P9967, DOI 10.1073/pnas.1511996112; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Wang Xiaolei, 2015, Biochem Biophys Rep, V3, P169; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu BX, 2013, ACS CHEM BIOL, V8, P524, DOI 10.1021/cb300564v; Yu J, 2015, GUT, V64, P636, DOI 10.1136/gutjnl-2013-306620; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zhang SH, 2011, MOL IMMUNOL, V49, P395, DOI 10.1016/j.molimm.2011.08.015; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551	71	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19322	19334		10.1074/jbc.RA119.010251	http://dx.doi.org/10.1074/jbc.RA119.010251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690625	Green Published, hybrid			2022-12-28	WOS:000516527800030
J	Kuan, YC; Takahashi, Y; Maruyama, T; Shimizu, M; Yamauchi, Y; Sato, R				Kuan Yen-Chou; Takahashi, Yu; Maruyama, Takashi; Shimizu, Makoto; Yamauchi, Yoshio; Sato, Ryuichiro			Ring finger protein 5 activates sterol regulatory element?binding protein 2 (SREBP2) to promote cholesterol biosynthesis via inducing polyubiquitination of SREBP chaperone SCAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; E3 ubiquitin ligase; endoplasmic reticulum (ER); lipid metabolism; polyubiquitin chain; post-translational modification (PTM); ring finger protein 5 (RNF5); SREBP chaperone (SCAP); sterol regulatory element-binding protein (SREBP)	HAMSTER OVARY CELLS; LIPID-METABOLISM; BINDING PROTEIN; UBIQUITIN LIGASE; DEGRADATION; INSIG-1; HOMEOSTASIS; STABILITY; KINASE; RNF5	Sterol regulatory element?binding protein 2 (SREBP2) is the master transcription factor that regulates cholesterol metabolism. SREBP2 activation is regulated by SREBP chaperone SCAP. Here we show that ring finger protein 5 (RNF5), an endoplasmic reticulum-anchored E3 ubiquitin ligase, mediates the Lys-29?linked polyubiquitination of SCAP and thereby activates SREBP2. RNF5 knockdown inhibited SREBP2 activation and reduced cholesterol biosynthesis in human hepatoma cells, and RNF5 overexpression activated SREBP2. Mechanistic studies revealed that RNF5 binds to the transmembrane domain of SCAP and ubiquitinates the Lys-305 located in cytosolic loop 2 of SCAP. Moreover, the RNF5-mediated ubiquitination enhanced an interaction between SCAP luminal loop 1 and loop 7, a crucial event for SREBP2 activation. Notably, an overexpressed K305R SCAP variant failed to restore the SREBP2 pathway in SCAP-deficient cell lines. These findings define a new mechanism by which an ubiquitination-induced SCAP conformational change regulates cholesterol biosynthesis.	[Kuan Yen-Chou; Takahashi, Yu; Maruyama, Takashi; Yamauchi, Yoshio; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Food Biochem Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Nutri Life Sci Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Kuan Yen-Chou] Natl Taiwan Univ, Dept Hort & Landscape Architecture, Coll Bioresources & Agr, 1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan	University of Tokyo; University of Tokyo; National Taiwan University	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Kuan, Yen-Chou/0000-0001-6870-0685	JSPS KAKENHI [15H05781, 17F17100]; Japanese Agency for Medical Research and Development [16gm0910008h0001]; Cross-ministerial Strategic Innovation Promotion Program [14533567]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Agency for Medical Research and Development; Cross-ministerial Strategic Innovation Promotion Program	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 15H05781, Cross-ministerial Strategic Innovation Promotion Program Grant 14533567, Japanese Agency for Medical Research and Development Grant 16gm0910008h0001 (to R. S.), and a JSPS KAKENHI Grant-in-Aid for JSPS Fellows 17F17100 (to Y.-C. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Asano L, 2017, CELL CHEM BIOL, V24, P207, DOI 10.1016/j.chembiol.2016.12.017; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Cheng CM, 2015, CANCER CELL, V28, P569, DOI 10.1016/j.ccell.2015.09.021; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Feng X, 2019, AUTOPHAGY, V15, P1130, DOI 10.1080/15548627.2019.1570063; Fujita Y, 2018, CELL REP, V24, P3296, DOI 10.1016/j.celrep.2018.08.057; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Jiang LY, 2018, J BIOL CHEM, V293, P4047, DOI 10.1074/jbc.RA117.001260; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kuan YC, 2017, J BIOL CHEM, V292, P3016, DOI 10.1074/jbc.M116.767277; Kuang ES, 2013, TRENDS BIOCHEM SCI, V38, P453, DOI 10.1016/j.tibs.2013.06.008; Lee JH, 2014, HEPATOLOGY, V60, P844, DOI 10.1002/hep.27011; Lee JH, 2018, P NATL ACAD SCI USA, V115, pE12228, DOI 10.1073/pnas.1813458115; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li Y, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-019-09525-y, 10.1038/s41467-019-12385-1]; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Miyata S, 2015, J BIOL CHEM, V290, P20565, DOI 10.1074/jbc.M115.656975; Nucifora FC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11792; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shao W, 2016, J LIPID RES, V57, P1564, DOI 10.1194/jlr.M069583; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singh R, 2018, J CLIN INVEST, V128, P3129, DOI 10.1172/JCI96060; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Yu DH, 2018, J LIPID RES, V59, P1745, DOI 10.1194/jlr.P084269; Zhang L, 2017, ELIFE, V6, DOI 10.7554/eLife.28766.001; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	43	14	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3918	3928		10.1074/jbc.RA119.011849	http://dx.doi.org/10.1074/jbc.RA119.011849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32054686	Green Published, hybrid			2022-12-28	WOS:000527704400016
J	Braunstein, I; Engelman, R; Yitzhaki, O; Ziv, T; Galardon, E; Benhar, M				Braunstein, Ilana; Engelman, Rotem; Yitzhaki, Ofer; Ziv, Tamar; Galardon, Erwan; Benhar, Moran			Opposing effects of polysulfides and thioredoxin on apoptosis through caspase persulfidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; redox regulation; cell signaling; thioredoxin; cancer; caspases; depersulfidation; hydrogen sulfide (H2S); polysulfides; protein persulfidation; sulfhydration	HYDROGEN-SULFIDE; CANCER CELLS; ACTIVATION; GASOTRANSMITTER; NITROSYLATION; INHIBITION; MECHANISMS; REDUCTASE; SULFUR	Hydrogen sulfide has been implicated in a large number of physiological processes including cell survival and death, encouraging research into its mechanisms of action and therapeutic potential. Results from recent studies suggest that the cellular effects of hydrogen sulfide are mediated in part by sulfane sulfur species, including persulfides and polysulfides. In the present study, we investigated the apoptosis-modulating effects of polysulfides, especially on the caspase cascade, which mediates the intrinsic apoptotic pathway. Biochemical analyses revealed that organic or synthetic polysulfides strongly and rapidly inhibit the enzymatic activity of caspase-3, a major effector protease in apoptosis. We attributed the caspase-3 inhibition to persulfidation of its catalytic cysteine. In apoptotically stimulated HeLa cells, short-term exposure to polysulfides triggered the persulfidation and deactivation of cleaved caspase-3. These effects were antagonized by the thioredoxin/thioredoxin reductase system (Trx/TrxR). Trx/TrxR restored the activity of polysulfide-inactivated caspase-3 in vitro, and TrxR inhibition potentiated polysulfide-mediated suppression of caspase-3 activity in situ. We further found that under conditions of low TrxR activity, early cell exposure to polysulfides leads to enhanced persulfidation of initiator caspase-9 and decreases apoptosis. Notably, we show that the proenzymes procaspase-3 and -9 are basally persulfidated in resting (unstimulated) cells and become depersulfidated during their processing and activation. Inhibition of TrxR attenuated the depersulfidation and activation of caspase-9. Taken together, our results reveal that polysulfides target the caspase-9/3 cascade and thereby suppress cancer cell apoptosis, and highlight the role of Trx/TrxR-mediated depersulfidation in enabling caspase activation.	[Braunstein, Ilana; Engelman, Rotem; Yitzhaki, Ofer; Benhar, Moran] Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-3200003 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Fac Biol, IL-31096 Haifa, Israel; [Galardon, Erwan] Univ Paris 05, Sorbonne Paris Cite, UMR 8601, CNRS, F-75006 Paris, France	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Benhar, M (corresponding author), Technion Israel Inst Technol, Dept Biochem, Rappaport Inst Res Med Sci, Fac Med, IL-3200003 Haifa, Israel.	benhar@technion.ac.il	Benhar, Moran/AAV-5764-2020; Galardon, Erwan/K-1063-2018	Benhar, Moran/0000-0002-7094-3456; Ziv, Tamar/0000-0003-4299-7454; Yitzhaki, Ofer/0000-0002-4508-8208; Galardon, Erwan/0000-0002-4371-6119	Israel Science Foundation [1574/14]; Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant [86607114]	Israel Science Foundation(Israel Science Foundation); Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant	This work was supported by Israel Science Foundation Grant 1574/14 (to M. B.) and Allen and Jewell Prince Center for Neurodegenerative Diseases of the Brain Grant 86607114 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Artaud I, 2014, CHEMBIOCHEM, V15, P2361, DOI 10.1002/cbic.201402312; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Cao X, 2019, ANTIOXID REDOX SIGN, V31, P1, DOI 10.1089/ars.2017.7058; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P723, DOI 10.1016/j.bcp.2011.12.019; Choi YH, 2017, BIOMED PHARMACOTHER, V94, P63, DOI 10.1016/j.biopha.2017.07.055; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Engelman R, 2016, FREE RADICAL BIO MED, V97, P375, DOI 10.1016/j.freeradbiomed.2016.06.032; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Fu L, 2020, ANTIOXID REDOX SIGN, V33, P1061, DOI 10.1089/ars.2019.7777; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Fukuto JM, 2018, FEBS LETT, V592, P2140, DOI 10.1002/1873-3468.13090; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Johnson CR, 2004, APOPTOSIS, V9, P423, DOI 10.1023/B:APPT.0000031457.90890.13; Kimura H, 2020, BRIT J PHARMACOL, V177, P720, DOI 10.1111/bph.14579; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14774; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Munchberg U, 2007, ORG BIOMOL CHEM, V5, P1505, DOI 10.1039/b703832a; Murata T, 2014, EXP CELL RES, V320, P247, DOI 10.1016/j.yexcr.2013.10.023; Nagy P, 2015, METHOD ENZYMOL, V554, P3, DOI 10.1016/bs.mie.2014.11.036; Olson KR, 2019, FREE RADICAL BIO MED, V140, P74, DOI 10.1016/j.freeradbiomed.2019.01.020; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Paul BD, 2015, TRENDS BIOCHEM SCI, V40, P687, DOI 10.1016/j.tibs.2015.08.007; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rose P, 2005, WORLD J GASTROENTERO, V11, P3990, DOI 10.3748/wjg.v11.i26.3990; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Stafford WC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf7444; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Toohey JI, 2014, MOLECULES, V19, P12789, DOI 10.3390/molecules190812789; Vitvitsky V, 2018, ACS CHEM BIOL, V13, P2300, DOI 10.1021/acschembio.8b00463; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Yuan S, 2017, ANTIOXID REDOX SIGN, V27, P634, DOI 10.1089/ars.2017.7096; Zhang TL, 2019, CELL CHEM BIOL, V26, P686, DOI 10.1016/j.chembiol.2019.02.003; Zhen YL, 2015, INT J ONCOL, V46, P2194, DOI 10.3892/ijo.2015.2914	48	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3590	3600		10.1074/jbc.RA119.012357	http://dx.doi.org/10.1074/jbc.RA119.012357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32041780	hybrid, Green Published			2022-12-28	WOS:000527725300018
J	Korasick, DA; Kandoth, PK; Tanner, JJ; Mitchum, MG; Beamer, LJ				Korasick, David A.; Kandoth, Pramod K.; Tanner, John J.; Mitchum, Melissa G.; Beamer, Lesa J.			Impaired folate binding of serine hydroxymethyltransferase 8 from soybean underlies resistance to the soybean cyst nematode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; X-ray crystallography; plant defense; folate; ligand-binding protein; host-pathogen interaction; disease resistance; Glycine max; quantitative trait loci (QTL); serine hydroxymethyltransferase 8 (SHMT8); soybean cyst nematode	BACILLUS-STEAROTHERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INHIBITORS; GLYCINE; ENZYME; SHMT; MECHANISM; POLYGLUTAMYLATION; COMPLEX	Management of the agricultural pathogen soybean cyst nematode (SCN) relies on the use of SCN-resistant soybean cultivars, a strategy that has been failing in recent years. An underutilized source of resistance in the soybean genotype Peking is linked to two polymorphisms in serine hydroxy-methyltransferase 8 (SHMT8). SHMT is a pyridoxal 5?-phosphate?dependent enzyme that converts l-serine and (6S)-tetrahydrofolate to glycine and 5,10-methylenetetrahydrofolate. Here, we determined five crystal structures of the 1884-residue SHMT8 tetramers from the SCN-susceptible cultivar (cv.) Essex and the SCN-resistant cv. Forrest (whose resistance is derived from the SHMT8 polymorphisms in Peking); the crystal structures were determined in complex with various ligands at 1.4?2.35 ? resolutions. We find that the two Forrest-specific polymorphic substitutions (P130R and N358Y) impact the mobility of a loop near the entrance of the (6S)-tetrahydrofolate?binding site. Ligand-binding and kinetic studies indicate severely reduced affinity for folate and dramatically impaired enzyme activity in Forrest SHMT8. These findings imply widespread effects on folate metabolism in soybean cv. Forrest that have implications for combating the widespread increase in virulent SCN.	[Korasick, David A.; Tanner, John J.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA; [Tanner, John J.; Beamer, Lesa J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Kandoth, Pramod K.] Natl Agrifood Biotechnol Inst, Mohali 140308, Punjab, India; [Mitchum, Melissa G.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Mitchum, Melissa G.] Univ Georgia, Inst Plant Breeding Genet & Genom, Ctr Appl Genet Technol, Athens, GA 30602 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	beamerl@missouri.edu		Tanner, John/0000-0001-8314-113X; Beamer, Lesa/0000-0001-5689-200X; Korasick, David/0000-0002-6337-2085	NIGMS, National Institutes of Health [9 P41 GM103622]; National Institute of Food and Agriculture Award from the U.S. Department of Agriculture National Institute of Food and Agriculture [2019-67012-29653]; Missouri Soybean Mercchanising Council Project [258]; University of Missouri Bond Life Sciences Center	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Food and Agriculture Award from the U.S. Department of Agriculture National Institute of Food and Agriculture; Missouri Soybean Mercchanising Council Project; University of Missouri Bond Life Sciences Center	This work was supported by Grant 9 P41 GM103622 from the NIGMS, National Institutes of Health. This work was also supported by National Institute of Food and Agriculture Award 2019-67012-29653 from the U.S. Department of Agriculture National Institute of Food and Agriculture (to D. A. K.), the Missouri Soybean Mercchanising Council Project 258 (to M. G. M.), and by a seed grant from the University of Missouri Bond Life Sciences Center (to M. G. M., J. J. T., and L. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen TW, 2017, PLANT HLTH PROG, V18, P19, DOI 10.1094/PHP-RS-16-0066; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Chitnumsub P, 2014, ACTA CRYSTALLOGR D, V70, P3177, DOI 10.1107/S1399004714023128; Contestabile R, 2000, BIOCHEMISTRY-US, V39, P7492, DOI 10.1021/bi000032z; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Ducker GS, 2017, P NATL ACAD SCI USA, V114, P11404, DOI 10.1073/pnas.1706617114; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FLORINI JR, 1957, BIOCHIM BIOPHYS ACTA, V25, P575, DOI 10.1016/0006-3002(57)90529-2; Fu TF, 2003, J BIOL CHEM, V278, P2645, DOI 10.1074/jbc.M210649200; Giardina G, 2018, FEBS J, V285, P3238, DOI 10.1111/febs.14610; Goverse A, 2014, ANNU REV PHYTOPATHOL, V52, P243, DOI 10.1146/annurev-phyto-102313-050118; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lakhssassi N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37815-w; Lightfoot David A, 2008, Int J Plant Genomics, V2008, P793158, DOI 10.1155/2008/793158; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; McCarville MT, 2017, PLANT HLTH PROG, V18, P146, DOI [10.1094/php-rs-16-0062, 10.1094/PHP-RS-16-0062]; Mehrshahi P, 2010, PLANT J, V64, P267, DOI 10.1111/j.1365-313X.2010.04336.x; Nonaka H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08833-7; Pai VR, 2009, BIOCHEM J, V418, P635, DOI 10.1042/BJ20081739; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Patil GB, 2019, PLANT BIOTECHNOL J, V17, P1595, DOI 10.1111/pbi.13086; Pinthong C, 2014, FEBS J, V281, P2570, DOI 10.1111/febs.12803; Ruszkowski M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56043-4; Ruszkowski M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00584; Sah S, 2015, BIOCHEMISTRY-US, V54, P3504, DOI 10.1021/acs.biochem.5b00400; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; Schwertz G, 2018, CHEMMEDCHEM, V13, P931, DOI 10.1002/cmdc.201800053; Schwertz G, 2017, CHEM-EUR J, V23, P14345, DOI 10.1002/chem.201703244; Schwertz G, 2017, J MED CHEM, V60, P4840, DOI 10.1021/acs.jmedchem.7b00008; Sopitthummakhun K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-194; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Tramonti A, 2018, BIOCHEMISTRY-US, V57, P6984, DOI 10.1021/acs.biochem.8b01074; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; Ubonprasert S, 2019, J BIOL CHEM, V294, P10490, DOI 10.1074/jbc.RA119.007454; ULEVITCH RJ, 1977, BIOCHEMISTRY-US, V16, P5342, DOI 10.1021/bi00643a027; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Witschel MC, 2015, J MED CHEM, V58, P3117, DOI 10.1021/jm501987h; Wu XY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00998; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3708	3718		10.1074/jbc.RA119.012256	http://dx.doi.org/10.1074/jbc.RA119.012256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32014996	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000527725300026
J	Xu, Y; Cantwell, L; Molosh, AI; Plant, LD; Gazgalis, D; Fitz, SD; Dustrude, ET; Yang, YH; Kawano, T; Garai, S; Noujaim, SF; Shekhar, A; Logothetis, DE; Thakur, GA				Xu, Yu; Cantwell, Lucas; Molosh, Andrei I.; Plant, Leigh D.; Gazgalis, Dimitris; Fitz, Stephanie D.; Dustrude, Erik T.; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Noujaim, Sami F.; Shekhar, Anantha; Logothetis, Diomedes E.; Thakur, Ganesh A.			The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoinositide; medicinal chemistry; potassium channel; small molecule; neurophysiology; basolateral amygdala; GIRK channels; PIP2; specific activator	RECTIFYING POTASSIUM CHANNELS; SODIUM-DEPENDENT ACTIVATION; MUSCARINIC K+ CHANNEL; BETA-GAMMA; G-PROTEINS; STRUCTURAL ELEMENTS; SUBUNIT; MECHANISMS; INSIGHTS; AMYGDALA	G-protein?gated inwardly-rectifying K+ (GIRK) channels are targets of G(i/o)-protein?signaling systems that inhibit cell excitability. GIRK channels exist as homotetramers (GIRK2 and GIRK4) or heterotetramers with nonfunctional homomeric subunits (GIRK1 and GIRK3). Although they have been implicated in multiple conditions, the lack of selective GIRK drugs that discriminate among the different GIRK channel subtypes has hampered investigations into their precise physiological relevance and therapeutic potential. Here, we report on a highly-specific, potent, and efficacious activator of brain GIRK1/2 channels. Using a chemical screen and electrophysiological assays, we found that this activator, the bromothiophene-substituted small molecule GAT1508, is specific for brain-expressed GIRK1/2 channels rather than for cardiac GIRK1/4 channels. Computational models predicted a GAT1508-binding site validated by experimental mutagenesis experiments, providing insights into how urea-based compounds engage distant GIRK1 residues required for channel activation. Furthermore, we provide computational and experimental evidence that GAT1508 is an allosteric modulator of channel?phosphatidylinositol 4,5-bisphosphate interactions. Through brain-slice electrophysiology, we show that subthreshold GAT1508 concentrations directly stimulate GIRK currents in the basolateral amygdala (BLA) and potentiate baclofen-induced currents. Of note, GAT1508 effectively extinguished conditioned fear in rodents and lacked cardiac and behavioral side effects, suggesting its potential for use in pharmacotherapy for post-traumatic stress disorder. In summary, our findings indicate that the small molecule GAT1508 has high specificity for brain GIRK1/2 channel subunits, directly or allosterically activates GIRK1/2 channels in the BLA, and facilitates fear extinction in a rodent model.	[Xu, Yu; Cantwell, Lucas; Plant, Leigh D.; Gazgalis, Dimitris; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Logothetis, Diomedes E.; Thakur, Ganesh A.] Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA; [Xu, Yu; Cantwell, Lucas; Plant, Leigh D.; Gazgalis, Dimitris; Yang, Yuchen; Kawano, Takeharu; Garai, Sumanta; Logothetis, Diomedes E.; Thakur, Ganesh A.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Molosh, Andrei I.; Fitz, Stephanie D.; Dustrude, Erik T.; Shekhar, Anantha] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indiana Clin & Translat Sci Inst, Dept Psychiat, Indianapolis, IN 46202 USA; [Noujaim, Sami F.] Univ S Florida, Mol Pharmacol & Physiol, Tampa, FL 33612 USA	Northeastern University; Northeastern University; Indiana University System; Indiana University Bloomington; State University System of Florida; University of South Florida	Logothetis, DE; Thakur, GA (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA.; Logothetis, DE; Thakur, GA (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Shekhar, A (corresponding author), Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indiana Clin & Translat Sci Inst, Dept Psychiat, Indianapolis, IN 46202 USA.	ashekhar@iu.edu; d.logothetis@northeastern.edu; g.thakur@northeastern.edu	Yang, Yuchen/GZK-6062-2022; Xu, Yu/AAM-8492-2021	Garai, Sumanta/0000-0003-4071-8490; Molosh, Andrei/0000-0001-6451-7912; Plant, Leigh/0000-0002-1622-1655	National Institutes of Health [R01-EY024717, R01-HL059949-21, R01-HL059949-22, R01-MH052619, R01-MH065702, UL1-TR001108, R21-HL138064, R01-HL129136]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01-EY024717 (to G. A. T.), R01-HL059949-21 and R01-HL059949-22 (to D. E. L.), and R01-MH052619, R01-MH065702, UL1-TR001108 (to A. S), R21-HL138064, and R01-HL129136 (to S.F.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 2015, INT REV NEUROBIOL, V123, P27, DOI 10.1016/bs.irn.2015.06.001; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Days E, 2010, PROBE REPORTS NIH MO; de Velasco EMF, 2015, INT REV NEUROBIOL, V123, P201, DOI 10.1016/bs.irn.2015.05.011; Doupnik CA, 2015, INT REV NEUROBIOL, V123, P87, DOI 10.1016/bs.irn.2015.05.010; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Glaaser IW, 2015, INT REV NEUROBIOL, V123, P117, DOI 10.1016/bs.irn.2015.05.014; Ha J, 2018, J BIOL CHEM, V293, P3546, DOI 10.1074/jbc.RA117.001679; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hickey AL, 2014, J PHYS CHEM A, V118, P3678, DOI 10.1021/jp502475e; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Johnson PL, 2015, PHARMACOL BIOCHEM BE, V138, P174, DOI 10.1016/j.pbb.2015.09.021; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee Y, 2008, NEUROPSYCHOPHARMACOL, V33, P2586, DOI 10.1038/sj.npp.1301674; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Li LP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0208-5; Liao YJ, 1996, J NEUROSCI, V16, P7137; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin FY, 2017, J PHYS CHEM B, V121, P6813, DOI 10.1021/acs.jpcb.7b04198; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2015, INT REV NEUROBIOL, V123, P1, DOI 10.1016/bs.irn.2015.05.013; Logothetis DE, 2015, ANNU REV PHYSIOL, V77, P81, DOI 10.1146/annurev-physiol-021113-170358; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2015, INT REV NEUROBIOL, V123, P161, DOI 10.1016/bs.irn.2015.05.009; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Manteghi AA, 2014, J CLIN PSYCHOPHARM, V34, P240, DOI 10.1097/JCP.0000000000000089; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mase Y, 2012, J BIOL CHEM, V287, P19537, DOI 10.1074/jbc.M112.353888; Mayfield J, 2015, INT REV NEUROBIOL, V123, P279, DOI 10.1016/bs.irn.2015.05.016; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Mirshahi Tooraj, 2002, Mol Interv, V2, P289, DOI 10.1124/mi.2.5.289; Molosh AI, 2014, NAT NEUROSCI, V17, P1583, DOI 10.1038/nn.3822; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Scholfield MR, 2017, BIOCHEMISTRY-US, V56, P2794, DOI 10.1021/acs.biochem.7b00022; Schr?dinger LLC, 2019, SCHROD REL IND FIT D; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sosulina L, 2008, MOL CELL NEUROSCI, V39, P491, DOI 10.1016/j.mcn.2008.08.002; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o; Takemoto Y, 2018, FASEB J, V32, P1778, DOI 10.1096/fj.201700349R; Tipps ME, 2015, INT REV NEUROBIOL, V123, P239, DOI 10.1016/bs.irn.2015.05.012; Weigl LG, 2001, MOL PHARMACOL, V60, P282, DOI 10.1124/mol.60.2.282; Wen WD, 2014, BIOORG MED CHEM LETT, V24, P5102, DOI 10.1016/j.bmcl.2014.08.061; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wieting JM, 2017, ACS CHEM NEUROSCI, V8, P1873, DOI 10.1021/acschemneuro.7b00217; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Wydeven N, 2012, P NATL ACAD SCI USA, V109, P21492, DOI 10.1073/pnas.1212019110; Xu Y, 2015, BIOPHYS J, V108, P62, DOI 10.1016/j.bpj.2014.10.059; Yamakura T, 2001, ANESTHESIOLOGY, V95, P144, DOI 10.1097/00000542-200107000-00025; Yow TT, 2011, BRIT J PHARMACOL, V163, P1017, DOI 10.1111/j.1476-5381.2011.01315.x; Zarzoso M, 2013, CARDIOVASC RES, V99, P566, DOI 10.1093/cvr/cvt081; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	80	12	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3614	3634		10.1074/jbc.RA119.011527	http://dx.doi.org/10.1074/jbc.RA119.011527			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31953327	Green Published, hybrid			2022-12-28	WOS:000527725300020
J	Diaz-Jimenez, D; Petrillo, MG; Busada, J; Hermoso, MA; Cidlowski, JA				Diaz-Jimenez, David; Grazia Petrillo, Maria; Busada, Jonathan; Hermoso, Marcela A.; Cidlowski, John A.			Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; glucocorticoid; migration; macrophage; gene expression; immunology; inflammation; chromatin remodeling; nuclear receptor; dipeptidyl peptidase-4 (DPP4); DPP4 inhibitors; linagliptin; sitagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; TUMOR-ASSOCIATED MACROPHAGES; GENE-EXPRESSION; IN-VITRO; MIGRATION; INSULIN; DIFFERENTIATION; ACTIVATION; MONOCYTES; METFORMIN	Glucocorticoids are potent endogenous anti-inflammatory molecules, and their cognate receptor, glucocorticoid receptor (GR), is expressed in nearly all immune cells. Macrophages are heterogeneous immune cells having a central role in both tissue homeostasis and inflammation and also play a role in the pathogenesis of some inflammatory diseases. Paradoxically, glucocorticoids have only a limited efficacy in controlling the resolution of these macrophage-related diseases. Here, we report that the transcriptomes of monocyte-like THP-1 cells and macrophage-like THP-1 cells (THP1-M?) have largely conserved gene expression patterns. In contrast, the differentiation to THP1-M? significantly altered the sensitivity of gene transcription to glucocorticoids. Among glucocorticoid-regulated genes, we identified the exopeptidase dipeptidyl peptidase-4 (DPP4) as a critical glucocorticoid-responsive gene in THP1-M?. We found that GR directly induces DPP4 gene expression by binding to two glucocorticoid-responsive elements (GREs) within the DPP4 promoter. Additionally, we show that glucocorticoid-induced DPP4 expression is blocked by the GR antagonist RU-486 and by GR siRNA transfection and that DPP4 enzyme activity is reduced by DPP4 inhibitors. Of note, glucocorticoids highly stimulated macrophage mobility; unexpectedly, DPP4 mediated the glucocorticoid-induced macrophage migration, and siRNA-mediated knockdowns of GR and DPP4 blocked dexamethasone-induced THP1-M? migration. Moreover, glucocorticoid-induced DPP4 activation was also observed in proinflammatory M1-polarized murine macrophages, as well as peritoneal macrophages, and was associated with increased macrophage migration. Our results indicate that glucocorticoids directly up-regulate DPP4 expression and thereby induce migration in macrophages, potentially explaining why glucocorticoid therapy is less effective in controlling macrophage-dominated inflammatory disorders.	[Diaz-Jimenez, David; Grazia Petrillo, Maria; Busada, Jonathan; Cidlowski, John A.] NIEHS, Mol Endocrinol Grp, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Diaz-Jimenez, David; Hermoso, Marcela A.] Univ Chile, Fac Med, Inst Biomed Sci, Lab Innate Immun,Disciplinary Program Immunol, Santiago 8380000, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Universidad de Chile	Cidlowski, JA (corresponding author), NIEHS, NIH, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Hermoso, Marcela A./AAF-6893-2021; Cidlowski, John/G-2548-2019	Hermoso, Marcela A./0000-0002-7936-7571; Petrillo, Maria Grazia/0000-0001-5999-9355; Cidlowski, John/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health [1ZIAES090057]; NIH Research Program [37432]; NIGMS, NIH [1Fi2GM123974]; FONDECYT [1170648];  [CONICYT-PFCHA/Doctorado Nacional/2015/21150264]	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); 	This work was supported by Intramural Research Program of the NIEHS, National Institutes of Health, Grant 1ZIAES090057. This work was also supported by CONICYT-PFCHA/Doctorado Nacional/2015/21150264 and a supplemental predoctoral fellowship of the NIH Research Program (Grant 37432) (to D. D. J.), a postdoctoral research associate (PRAT) fellowship from NIGMS, NIH (Grant 1Fi2GM123974) (to J. T. B.), and FONDECYT Grant 1170648 (to M. A. H.).	Angsana J, 2016, EUR J IMMUNOL, V46, P1592, DOI 10.1002/eji.201546262; Apostolopoulos D, 2017, RHEUMATOLOGY, V56, P114, DOI 10.1093/rheumatology/kew406; Ayoub S, 2008, NAT CLIN PRACT RHEUM, V4, P98, DOI 10.1038/ncprheum0701; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blauenfeldt T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01456; Broxmeyer HE, 2016, STEM CELLS DEV, V25, P575, DOI 10.1089/scd.2016.0026; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Crowley MJ, 2017, DIABETES CARE, V40, P1787, DOI 10.2337/dc17-1528; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; de Lange P, 2001, CANCER RES, V61, P3937; Desmet SJ, 2017, J CLIN INVEST, V127, P1136, DOI 10.1172/JCI88886; Diaz J, 2014, J CELL SCI, V127, P2401, DOI 10.1242/jcs.141689; Fen ZG, 2016, DIABETES, V65, P2966, DOI 10.2337/db16-0317; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Guo B, 2017, NAT MED, V23, P424, DOI 10.1038/nm.4298; Heideveld E, 2018, HAEMATOLOGICA, V103, P395, DOI 10.3324/haematol.2017.179341; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Herrera C, 2001, J BIOL CHEM, V276, P19532, DOI 10.1074/jbc.M004586200; Hiromura M, 2018, BIOCHEM BIOPH RES CO, V495, P223, DOI 10.1016/j.bbrc.2017.11.016; Ishiguro Y, 2006, CLIN IMMUNOL, V120, P335, DOI 10.1016/j.clim.2006.05.010; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jewell CM, 2016, AM J PHYSIOL-ENDOC M, V311, pE741, DOI 10.1152/ajpendo.00105.2016; Koenen M, 2018, ANN RHEUM DIS, V77, P1610, DOI 10.1136/annrheumdis-2017-212762; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Liao XD, 2018, P NATL ACAD SCI USA, V115, pE4661, DOI 10.1073/pnas.1720065115; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Necela BM, 2004, J BIOL CHEM, V279, P39279, DOI 10.1074/jbc.M405489200; Ou SM, 2017, HEART, V103, P414, DOI 10.1136/heartjnl-2016-309687; Rohrborn D, 2016, BIOCHEM BIOPH RES CO, V471, P348, DOI 10.1016/j.bbrc.2016.02.019; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Takahashi H, 2019, J DIABETES INVEST, V10, P714, DOI 10.1111/jdi.12922; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; van Genugten RE, 2014, EUR J ENDOCRINOL, V170, P429, DOI 10.1530/EJE-13-0610; Vilsboll T, 2019, DIABETES CARE, V42, P1464, DOI 10.2337/dc18-1988; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Yata Y, 2017, INTERNAL MED, V56, P2555, DOI 10.2169/internalmedicine.8296-16; Yen FS, 2018, DIABETES RES CLIN PR, V140, P279, DOI 10.1016/j.diabres.2018.04.012; Zhong JX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00477; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	51	18	19	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3213	3227		10.1074/jbc.RA119.010894	http://dx.doi.org/10.1074/jbc.RA119.010894			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31988243	hybrid, Green Published			2022-12-28	WOS:000519597300026
J	Eckmair, B; Jin, CS; Karlsson, NG; Abed-Navandi, D; Wilson, IBH; Paschinger, K				Eckmair, Barbara; Jin, Chunsheng; Karlsson, Niclas G.; Abed-Navandi, Daniel; Wilson, Iain B. H.; Paschinger, Katharina			Glycosylation at an evolutionary nexus: the brittle star Ophiactis savignyi expresses both vertebrate and invertebrate N-glycomic features	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycomics; N-linked glycosylation; glycosylation; MS; deuterostomes; echinoderms; invertebrate evolution; N-glycans	SIALIC ACIDS; LINKED OLIGOSACCHARIDES; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ASTERIAS-RUBENS; DICTYOSTELIUM-DISCOIDEUM; ACETYLNEURAMINIC ACID; SPECIES RECOGNITION; POLYSIALIC ACID; IDENTIFICATION	Echinoderms are among the most primitive deuterostomes and have been used as model organisms to understand chordate biology because of their close evolutionary relationship to this phylogenetic group. However, there are almost no data available regarding the N-glycomic capacity of echinoderms, which are otherwise known to produce a diverse set of species-specific glycoconjugates, including ones heavily modified by fucose, sulfate, and sialic acid residues. To increase the knowledge of diversity of carbohydrate structures within this phylum, here we conducted an in-depth analysis of N-glycans from a brittle star (Ophiactis savignyi) as an example member of the class Ophiuroidea. To this end, we performed a multi-step N-glycan analysis by HPLC and various exoglyosidase and chemical treatments in combination with MALDI-TOF MS and MS/MS. Using this approach, we found a wealth of hybrid and complex oligosaccharide structures reminiscent of those in higher vertebrates as well as some classical invertebrate glycan structures. 70% of these N-glycans were anionic, carrying either sialic acid, sulfate, or phosphate residues. In terms of glycophylogeny, our data position the brittle star between invertebrates and vertebrates and confirm the high diversity of N-glycosylation in lower organisms.	[Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng; Karlsson, Niclas G.] Gothenburg Univ, Inst Biomed, S-40530 Gothenburg, Sweden; [Abed-Navandi, Daniel] Haus Meeres Aqua Terra Zoo, A-1060 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg	Paschinger, K (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	katharina.paschinger@boku.ac.at	Karlsson, Niclas/G-5235-2013; Wilson, Iain/B-3326-2009	Karlsson, Niclas/0000-0002-3045-2628; Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136; Eckmair, Barbara/0000-0003-0818-867X	Austrian Science Fund [P25058, W1224]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P25058 (to K. P.) and W1224 (to B. E.).	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BERGWERFF AA, 1992, BIOCHIMIE, V74, P25, DOI 10.1016/0300-9084(92)90181-D; Biermann CH, 2004, EVOL DEV, V6, P353, DOI 10.1111/j.1525-142X.2004.04043.x; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; CORFIELD AP, 1981, BIOCHEM J, V197, P293, DOI 10.1042/bj1970293; de Haan N, 2015, ANAL CHEM, V87, P8284, DOI 10.1021/acs.analchem.5b02426; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; FARACHCARSON MC, 1989, J CELL BIOL, V109, P1289, DOI 10.1083/jcb.109.3.1289; GALILI U, 1988, J BIOL CHEM, V263, P17755; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Handa-Narumi M, 2018, CELL STRUCT FUNCT, V43, P141, DOI 10.1247/csf.18009; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-258; HEIFETZ A, 1979, J BIOL CHEM, V254, P6119; Higuchi R, 2007, J NAT MED-TOKYO, V61, P367, DOI 10.1007/s11418-007-0171-6; HOSHI M, 1975, BIOCHIM BIOPHYS ACTA, V388, P152; Hykollari A, 2017, METHODS MOL BIOL, V1503, P167, DOI 10.1007/978-1-4939-6493-2_13; Hykollari A, 2014, ELECTROPHORESIS, V35, P2116, DOI 10.1002/elps.201300612; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Ijuin T, 1996, GLYCOCONJUGATE J, V13, P401, DOI 10.1007/BF00731473; Inagaki M, 2005, CHEM PHARM BULL, V53, P1551, DOI 10.1248/cpb.53.1551; Inagaki M, 2001, CHEM PHARM BULL, V49, P1521, DOI 10.1248/cpb.49.1521; Jin CS, 2015, J PROTEOME RES, V14, P3239, DOI 10.1021/acs.jproteome.5b00232; KABAKOFF B, 1990, J CELL BIOL, V111, P391, DOI 10.1083/jcb.111.2.391; KABAKOFF B, 1992, DEV BIOL, V150, P294, DOI 10.1016/0012-1606(92)90243-A; Kelm A, 1998, EUR J BIOCHEM, V251, P874, DOI 10.1046/j.1432-1327.1998.2510874.x; Kisa F, 2006, CHEM PHARM BULL, V54, P1293, DOI 10.1248/cpb.54.1293; Kitazume S, 1996, J BIOL CHEM, V271, P6694, DOI 10.1074/jbc.271.12.6694; KitazumeKawaguchi S, 1997, P NATL ACAD SCI USA, V94, P3650, DOI 10.1073/pnas.94.8.3650; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KLEINEIDAM RG, 1990, BIOL CHEM H-S, V371, P715, DOI 10.1515/bchm3.1990.371.2.715; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kurz S, 2015, J PROTEOMICS, V126, P172, DOI 10.1016/j.jprot.2015.05.030; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu JN, 2015, J BIOTECHNOL, V199, P77, DOI 10.1016/j.jbiotec.2015.02.017; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; McGovern TM, 2003, P ROY SOC B-BIOL SCI, V270, P2517, DOI 10.1098/rspb.2003.2529; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Minamisawa T, 2005, RAPID COMMUN MASS SP, V19, P1788, DOI 10.1002/rcm.1985; Minowa MT, 1998, J BIOL CHEM, V273, P11556, DOI 10.1074/jbc.273.19.11556; Miyata S, 2004, GLYCOBIOLOGY, V14, P827, DOI 10.1093/glycob/cwh100; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; Miyata S, 2011, GLYCOBIOLOGY, V21, P1596, DOI 10.1093/glycob/cwr081; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; Paschinger K, 2019, PARASITOLOGY, V146, P1733, DOI 10.1017/S0031182019000398; Paschinger K, 2016, GLYCOCONJUGATE J, V33, P273, DOI 10.1007/s10719-016-9650-x; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; PAULSON JC, 1984, EUR J BIOCHEM, V140, P523, DOI 10.1111/j.1432-1033.1984.tb08133.x; Petit D, 2015, MOL BIOL EVOL, V32, P906, DOI 10.1093/molbev/msu395; Pomin VH, 2010, GLYCOCONJUGATE J, V27, P1, DOI 10.1007/s10719-009-9251-z; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; PROKAZOVA NV, 1981, EUR J BIOCHEM, V115, P671; Sahar U, 2017, MOL REPROD DEV, V84, P401, DOI 10.1002/mrd.22794; Santos GRC, 2017, GLYCOBIOLOGY, V27, P625, DOI 10.1093/glycob/cwx031; SCHLENZKA W, 1993, BIOCHIM BIOPHYS ACTA, V1161, P131, DOI 10.1016/0167-4838(93)90206-7; Stanton R, 2017, BBA-GEN SUBJECTS, V1861, P699, DOI 10.1016/j.bbagen.2017.01.009; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Torii T, 2014, GLYCOCONJUGATE J, V31, P671, DOI 10.1007/s10719-014-9566-2; Vanbeselaere J, 2020, J BIOL CHEM, V295, P3159, DOI 10.1074/jbc.RA119.011701; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Vilela-Silva ACES, 2008, INT J DEV BIOL, V52, P551, DOI 10.1387/ijdb.072531av; WARREN L, 1964, BIOCHIM BIOPHYS ACTA, V83, P129, DOI 10.1016/0926-6526(64)90062-X; Yamada K, 2003, CHEM PHARM BULL, V51, P46, DOI 10.1248/cpb.51.46; Yamakawa N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06950-3; Zueva O, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-017-0247-4	70	8	8	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3173	3188		10.1074/jbc.RA119.011703	http://dx.doi.org/10.1074/jbc.RA119.011703			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001617	Green Published, hybrid			2022-12-28	WOS:000519597300023
J	Rege, NK; Liu, M; Dhayalan, B; Chen, YS; Smith, NA; Rahimi, L; Sun, JH; Guo, H; Yang, YW; Haataja, L; Phillips, NFB; Whittaker, J; Smith, B; Arvan, P; Ismail-Beigi, F; Weiss, MA				Rege, Nischay K.; Liu, Ming; Dhayalan, Balamurugan; Chen, Yen Shan; Smith, Nicholas A.; Rahimi, Leili; Sun, Jinhong; Guo, Huan; Yang, Yanwu; Haataja, Leena; Phillips, Nelson F. B.; Whittaker, Jonathan; Smith, Brian; Arvan, Peter; Ismail-Beigi, Faramarz; Weiss, Michael A.			?Register-shift? insulin analogs uncover constraints of proteotoxicity in protein evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein structure; molecular evolution; hormone; peptide biosynthesis; protein biosynthesis	PHENYLALANINE-B25 SIDE-CHAIN; MUTANT HUMAN INSULIN; ENDOPLASMIC-RETICULUM; STRUCTURAL SWITCH; IN-VIVO; ACTIVE CONFORMATION; BETA-CELL; IGF-I; RECEPTOR; PROINSULIN	Globular protein sequences encode not only functional structures (the native state) but also protein foldability, i.e. a conformational search that is both efficient and robustly minimizes misfolding. Studies of mutations associated with toxic misfolding have yielded insights into molecular determinants of protein foldability. Of particular interest are residues that are conserved yet dispensable in the native state. Here, we exploited the mutant proinsulin syndrome (a major cause of permanent neonatal-onset diabetes mellitus) to investigate whether toxic misfolding poses an evolutionary constraint. Our experiments focused on an invariant aromatic motif (Phe(B24)?Phe(B25)?Tyr(B26)) with complementary roles in native self-assembly and receptor binding. A novel class of mutations provided evidence that insulin can bind to the insulin receptor (IR) in two different modes, distinguished by a ?register shift? in this motif, as visualized by molecular dynamics (MD) simulations. Register-shift variants are active but defective in cellular foldability and exquisitely susceptible to fibrillation in vitro. Indeed, expression of the corresponding proinsulin variant induced endoplasmic reticulum stress, a general feature of the mutant proinsulin syndrome. Although not present among vertebrate insulin and insulin-like sequences, a prototypical variant ([Gly(B24)]insulin) was as potent as WT insulin in a rat model of diabetes. Although in MD simulations the shifted register of receptor engagement is compatible with the structure and allosteric reorganization of the IR-signaling complex, our results suggest that this binding mode is associated with toxic misfolding and so is disallowed in evolution. The implicit threat of proteotoxicity limits sequence variation among vertebrate insulins and insulin-like growth factors.	[Rege, Nischay K.; Rahimi, Leili; Phillips, Nelson F. B.; Whittaker, Jonathan; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Rahimi, Leili; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Liu, Ming] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin 300052, Peoples R China; [Liu, Ming; Sun, Jinhong; Guo, Huan; Haataja, Leena; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48105 USA; [Smith, Nicholas A.; Smith, Brian] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Dhayalan, Balamurugan; Chen, Yen Shan; Yang, Yanwu; Weiss, Michael A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Tianjin Medical University; University of Michigan System; University of Michigan; La Trobe University; Indiana University System; Indiana University Bloomington	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Smith, Brian J/F-8282-2011; Smith, Nicholas/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Dhayalan, Balamurugan/0000-0001-6002-1207; Smith, Nicholas/0000-0001-8894-4249; Rahimi, Leili/0000-0002-3908-8324	National Institutes of Health [R01 DK040949, R01 DK48280]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01 DK040949 (to M. A. W.) and R01 DK48280 (to P. A.). M. A. W. has equity in Thermalin, Inc. (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N. F. B. P. is a consultant to Thermalin, Inc. F. I.-B. has equity in Thermalin, Inc., and is a consultant to COVANCE, Sanofi, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arunagiri A, 2019, ELIFE, V8, DOI 10.7554/eLife.44532; Attri AK, 2010, BIOPHYS CHEM, V148, P23, DOI 10.1016/j.bpc.2010.02.001; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CHAN SJ, 1987, P NATL ACAD SCI USA, V84, P2194, DOI 10.1073/pnas.84.8.2194; Chan SJ, 2000, AM ZOOL, V40, P213; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2000, AM ZOOL, V40, P200; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Glidden MD, 2018, J BIOL CHEM, V293, P47, DOI 10.1074/jbc.M117.808626; Greenfield JR, 2004, CLIN DERMATOL, V22, P289, DOI 10.1016/j.clindermatol.2004.01.011; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; HUA QX, 1992, BIOCHEMISTRY-US, V31, P11940, DOI 10.1021/bi00162a037; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2018, DIABETES OBES METAB, V20, P28, DOI 10.1111/dom.13378; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Liu M, 2010, J BIOL CHEM, V285, P30989, DOI 10.1074/jbc.M110.152645; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Raile K, 2011, EUR J ENDOCRINOL, V165, P255, DOI 10.1530/EJE-11-0208; RIBEL U, 1990, DIABETES, V39, P1033, DOI 10.2337/diabetes.39.9.1033; ROY M, 1989, J BIOL CHEM, V264, P19081; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; STEINER DF, 1968, DIABETES, V17, P309; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Subbian E., 2015, ADV BIOSCI BIOTECHNO, V06, P73; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; THOMAS GJ, 1990, BIOCHEMISTRY-US, V29, P4181, DOI 10.1021/bi00469a022; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Upton Z, 1998, COMP BIOCHEM PHYS B, V121, P35, DOI 10.1016/S0305-0491(98)10111-6; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; VINIK A, 1988, HORM METAB RES, V20, P1, DOI 10.1055/s-2007-1010736; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; WANG CC, 1991, TRENDS BIOCHEM SCI, V16, P279, DOI 10.1016/0968-0004(91)90114-B; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weiss MA, 2018, DIABETES OBES METAB, V20, P51, DOI 10.1111/dom.13402; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Westermark P, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P3, DOI 10.1533/9781845690878.1.1; Wright J, 2013, J BIOL CHEM, V288, P31010, DOI 10.1074/jbc.M113.510065; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; YU MH, 1984, P NATL ACAD SCI-BIOL, V81, P6584, DOI 10.1073/pnas.81.21.6584; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	122	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3080	3098		10.1074/jbc.RA119.011389	http://dx.doi.org/10.1074/jbc.RA119.011389			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005662	Green Published, hybrid			2022-12-28	WOS:000519597300017
J	Kim, L; Kwon, DH; Heo, J; Park, MR; Song, HK				Kim, Leehyeon; Kwon, Do Hoon; Heo, Jiwon; Park, Mi Rae; Song, Hyun Kyu			Use of the LC3B-fusion technique for biochemical and structural studies of proteins involved in the N-degron pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein crystallization; ubiquitylation (ubiquitination); protein degradation; autophagy; p62 (sequestosome 1(SQSTM1)); LC3B; N-end rule; NTAQ1; PRT1; UBR box	END RULE PATHWAY; SUMO FUSION TECHNOLOGY; TERMINAL AMIDASE; SUBSTRATE RECOGNITION; UBIQUITIN LIGASE; EXPRESSION; COMPONENT; SPECIFICITY; PHOSPHORYLATION; AUTOPHAGY	The N-degron pathway, formerly the N-end rule pathway, is a protein degradation process that determines the half-life of proteins based on their N-terminal residues. In contrast to the well-established in vivo studies over decades, in vitro studies of this pathway, including biochemical characterization and high-resolution structures, are relatively limited. In this study, we have developed a unique fusion technique using microtubule-associated protein 1A/1B light chain 3B, a key marker protein of autophagy, to tag the N terminus of the proteins involved in the N-degron pathway, which enables high yield of homogeneous target proteins with variable N-terminal residues for diverse biochemical studies including enzymatic and binding assays and substrate identification. Intriguingly, crystallization showed a markedly enhanced probability, even for the N-degron complexes. To validate our results, we determined the structures of select proteins in the N-degron pathway and compared them with the Protein Data Bank?deposited proteins. Furthermore, several biochemical applications of this technique were introduced. Therefore, this technique can be used as a general tool for the in vitro study of the N-degron pathway.	[Kim, Leehyeon; Kwon, Do Hoon; Heo, Jiwon; Park, Mi Rae; Song, Hyun Kyu] Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea	Korea University	Song, HK (corresponding author), Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea.	hksong@korea.ac.kr	Sood, Anoop Kumar/A-7344-2013; Song, Hyun Kyu/D-6763-2016	Sood, Anoop Kumar/0000-0001-5702-4108; Song, Hyun Kyu/0000-0001-5684-4059; Kim, Leehyeon/0000-0002-1266-7828	International Collaborative Research Program of the Institute for Protein Research, Osaka University [ICR-17-05]	International Collaborative Research Program of the Institute for Protein Research, Osaka University	We thank the staff at Beamlines 5C and 11C, Pohang Accelerator Laboratory, Republic of Korea and Beamline BL-17A, Photon Factory, Japan, for help with X-ray data collection. This work was performed in part under the International Collaborative Research Program of the Institute for Protein Research, Osaka University Grant ICR-17-05. Diffraction data were collected at the Osaka University Beamline BL44XU at SPring-8 (Harima, Japan) under Proposal 2019A6973.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Dong C, 2018, NAT CHEM BIOL, V14, P466, DOI 10.1038/s41589-018-0036-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Hondred D, 1999, PLANT PHYSIOL, V119, P713, DOI 10.1104/pp.119.2.713; Hwang CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024925; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JM, 2018, SCIENCE, V362, P1019, DOI 10.1126/science.aat0174; Kim MK, 2016, P NATL ACAD SCI USA, V113, P12438, DOI 10.1073/pnas.1612620113; Kobe B, 2015, ACTA CRYSTALLOGR F, V71, P861, DOI 10.1107/S2053230X15011061; Kwon DH, 2019, AUTOPHAGY, V15, P180, DOI 10.1080/15548627.2018.1532264; Kwon DH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05825-x; Kwon DH, 2017, BIOCHEM BIOPH RES CO, V490, P1093, DOI 10.1016/j.bbrc.2017.06.173; Kwon DH, 2017, AUTOPHAGY, V13, P70, DOI 10.1080/15548627.2016.1243199; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Munoz-Escobar J, 2017, STRUCTURE, V25, P719, DOI 10.1016/j.str.2017.03.004; Nishimura K, 2013, PLANT CELL, V25, P2276, DOI 10.1105/tpc.113.112557; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Park MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111142; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Satakarni M, 2011, PROTEIN EXPRES PURIF, V78, P113, DOI 10.1016/j.pep.2011.04.015; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; UHLEN M, 1990, METHOD ENZYMOL, V185, P129; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang XH, 2016, PROTEIN J, V35, P115, DOI 10.1007/s10930-016-9654-1; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	57	8	8	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2590	2600		10.1074/jbc.RA119.010912	http://dx.doi.org/10.1074/jbc.RA119.010912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31919097	hybrid, Green Published			2022-12-28	WOS:000519969100006
J	Cope, NJ; Novak, B; Liu, ZW; Cavallo, M; Gunderwala, AY; Connolly, M; Wang, ZH				Cope, Nicholas J.; Novak, Borna; Liu, Zhiwei; Cavallo, Maria; Gunderwala, Amber Y.; Connolly, Matthew; Wang, Zhihong			Analyses of the oncogenic BRAF(D594G) variant reveal a kinase-independent function of BRAF in activating MAPK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; protein kinase; Raf kinase; dimerization; ATP; allosteric inhibitor; ATP-competitive inhibitor; P-loop; paradoxical activation; DFG motif; autophosphorylation; molecular dynamics; 14?3-3 protein; peptide inhibitor; allosteric activation; cancer; kinase signaling	RAF INHIBITORS; PATHWAY; MUTATIONS; MECHANISM; DOMAIN; CRAF; MUTANTS; SIDE	Class 3 mutations in B-Raf proto-oncogene, Ser/Thr kinase (BRAF), that result in kinase-impaired or kinase-dead BRAF have the highest mutation frequency in BRAF gene in lung adenocarcinoma. Several studies have reported that kinase-dead BRAF variants amplify mitogen-activated protein kinase (MAPK) signaling by dimerizing with and activating WT C-Raf proto-oncogene, Ser/Thr kinase (CRAF). However, the structural and functional principles underlying their activation remain elusive. Herein, using cell biology and various biochemical approaches, we established that variant BRAF(D594G), a kinase-dead representative of class 3 mutation-derived BRAF variants, has a higher dimerization potential as compared with WT BRAF. Molecular dynamics simulations uncovered that the D594G substitution orients the ?C-helix toward the IN position and extends the activation loop within the kinase domain, shifting the equilibrium toward the active, dimeric conformation, thus priming BRAF(D594G) as an effective allosteric activator of CRAF. We found that B/CRAF heterodimers are the most thermodynamically stable RAF dimers, suggesting that RAF heterodimers, and not homodimers, are the major players in determining the amplitude of MAPK signaling in cells. Additionally, we show that BRAF(D594G):CRAF heterodimers bypass autoinhibitory P-loop phosphorylation, which might contribute to longer duration of MAPK pathway signaling in cancer cells. Last, we propose that the dimer interface of the BRAF(D594G):CRAF heterodimer may represent a promising target in the design of novel anticancer therapeutics.	[Cope, Nicholas J.; Novak, Borna; Liu, Zhiwei; Cavallo, Maria; Gunderwala, Amber Y.; Connolly, Matthew; Wang, Zhihong] Univ Sci, Dept Chem & Biochem, Philadelphia, PA 19104 USA		Wang, ZH (corresponding author), Univ Sci, Dept Chem & Biochem, Philadelphia, PA 19104 USA.	z.wang@usciences.edu	Zhiwei, Liu/HGC-1226-2022		W. W. Smith Charitable Fund; NIGMS, National Institutes of Health [1R15GM128099-01]; Spiers Fellowship	W. W. Smith Charitable Fund; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spiers Fellowship	This work was supported by the W. W. Smith Charitable Fund and NIGMS, National Institutes of Health, Grant 1R15GM128099-01 (to Z. W.) and the Spiers Fellowship (to N. J. C. and A. Y. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Carter J, 2015, AM J CLIN PATHOL, V144, P620, DOI 10.1309/AJCP85ATMJOZOUDJ; Case DA., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cope N, 2019, CHEMBIOCHEM, V20, P2850, DOI 10.1002/cbic.201900266; Cope N, 2018, CHEMBIOCHEM, V19, P1988, DOI 10.1002/cbic.201800359; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Grasso M, 2018, J MED CHEM, V61, P5034, DOI 10.1021/acs.jmedchem.8b00499; Grasso M, 2016, ACS CHEM BIOL, V11, P2876, DOI 10.1021/acschembio.6b00529; Gunderwala AY, 2019, ACS CHEM BIOL, V14, P1471, DOI 10.1021/acschembio.9b00191; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; Kondo Y, 2019, SCIENCE, V366, P109, DOI 10.1126/science.aay0543; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nieto P, 2017, NATURE, V548, P239, DOI 10.1038/nature23297; Noeparast Amir, 2018, Oncotarget, V9, P16110, DOI 10.18632/oncotarget.24576; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qjn J, 2012, J MED CHEM, V55, P5220, DOI 10.1021/jm3004416; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZL, 2019, AGING-US, V11, P7187, DOI 10.18632/aging.102244; Weber CK, 2001, CANCER RES, V61, P3595; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yuan JM, 2018, J BIOL CHEM, V293, P14276, DOI 10.1074/jbc.RA118.004597; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	44	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2407	2420		10.1074/jbc.RA119.011536	http://dx.doi.org/10.1074/jbc.RA119.011536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31929109	Green Published, hybrid			2022-12-28	WOS:000517330200022
J	Koeller, CM; Tiengwe, C; Schwartz, KJ; Bangs, JD				Koeller, Carolina M.; Tiengwe, Calvin; Schwartz, Kevin J.; Bangs, James D.			Steric constraints control processing of glycosylphosphatidylinositol anchors in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; transferrin; glycosylphosphatidylinositol (GPI anchor); trypanosome; N-linked glycosylation; glycosylphosphatidylinositol processing; kinetoplastid protozoa; N-glycan processing; transferrin receptor; trypanosome	VARIANT SURFACE GLYCOPROTEIN; POLY-N-ACETYLLACTOSAMINE; TRANSFERRIN RECEPTOR; MEMBRANE ANCHOR; LINKED OLIGOSACCHARIDES; GENE-EXPRESSION; PROTEIN P67; GLYCOSYLATION; BIOSYNTHESIS; TRAFFICKING	The transferrin receptor (TfR) of the bloodstream form (BSF) of Trypanosoma brucei is a heterodimer comprising glycosylphosphatidylinositol (GPI)-anchored expression site?associated gene 6 (ESAG6 or E6) and soluble ESAG7. Mature E6 has five N-glycans, consisting of three oligomannose and two unprocessed paucimannose structures. Its GPI anchor is modified by the addition of 4?6 ?-galactose residues. TfR binds tomato lectin (TL), specific for N-acetyllactosamine (LacNAc) repeats, and previous studies have shown transport-dependent increases in E6 size consistent with post-glycan processing in the endoplasmic reticulum. Using pulse-chase radiolabeling, peptide-N-glycosidase F treatment, lectin pulldowns, and exoglycosidase treatment, we have now investigated TfR N-glycan and GPI processing. E6 increased ?5 kDa during maturation, becoming reactive with both TL and Erythrina cristagalli lectin (ECL, terminal LacNAc), indicating synthesis of poly-LacNAc on paucimannose N-glycans. This processing was lost after exoglycosidase treatment and after RNAi-based silencing of TbSTT3A, the oligosaccharyltransferase that transfers paucimannose structures to nascent secretory polypeptides. These results contradict previous structural studies. Minor GPI processing was also observed, consistent with ?-galactose addition. However, increasing the spacing between E6 protein and the GPI ?-site (aa 4?7) resulted in extensive post-translational processing of the GPI anchor to a form that was TL/ECL-reactive, suggesting the addition of LacNAc structures, confirmed by identical assays with BiPNHP, a non-N-glycosylated GPI-anchored reporter. We conclude that BSF trypanosomes can modify GPIs by generating structures reminiscent of those present in insect-stage trypanosomes and that steric constraints, not stage-specific expression of glycosyltransferases, regulate GPI processing.	[Koeller, Carolina M.; Tiengwe, Calvin; Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Schwartz, Kevin J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Tiengwe, Calvin] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Wisconsin System; University of Wisconsin Madison; Imperial College London	Bangs, JD (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	jdbangs@buffalo.edu	Tiengwe, Calvin/AAH-6658-2020; Koeller, Carolina/ABB-1968-2021	Tiengwe, Calvin/0000-0002-3742-6502; Koeller, Carolina/0000-0002-1919-7582; Bangs, James/0000-0001-7903-6521	NIAID, National Institutes of Health [R01 AI035739]; Jacobs School of Medicine and Biomedical Sciences	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jacobs School of Medicine and Biomedical Sciences	This work was supported by NIAID, National Institutes of Health, Grant R01 AI035739 and funds from the Jacobs School of Medicine and Biomedical Sciences (to J. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander DL, 2002, J CELL SCI, V115, P3253; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; Damerow M, 2016, J BIOL CHEM, V291, P13834, DOI 10.1074/jbc.M116.733246; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 2017, ESSENTIALS GLYCOBIOL, P2015, DOI DOI 10.1101/GLYC0BIOLOGY.3E.012; Haanstra JR, 2016, BBA-MOL CELL RES, V1863, P1038, DOI 10.1016/j.bbamcr.2015.09.015; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelley RJ, 1995, MOL BIOCHEM PARASIT, V74, P167, DOI 10.1016/0166-6851(95)02493-X; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Maier A, 1996, FEBS LETT, V396, P87, DOI 10.1016/0014-5793(96)01073-3; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; MAYOR S, 1992, J BIOL CHEM, V267, P754; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2007, MOL BIOCHEM PARASIT, V151, P220, DOI 10.1016/j.molbiopara.2006.11.001; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Oguri S, 2005, GLYCOCONJUGATE J, V22, P453, DOI 10.1007/s10719-005-5329-4; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PaturiauxHanocq F, 1997, BIOCHEM J, V324, P885, DOI 10.1042/bj3240885; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Schwartz KJ, 2013, EUKARYOT CELL, V12, P132, DOI 10.1128/EC.00293-12; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; STEVERDING D, 1994, EUR J CELL BIOL, V64, P78; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Tiengwe C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006366; Tiengwe C, 2016, CELL MICROBIOL, V18, P1673, DOI 10.1111/cmi.12605; Umaer K, 2018, TRAFFIC, V19, P406, DOI 10.1111/tra.12565; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Welburn SC, 2016, TRENDS PARASITOL, V32, P230, DOI 10.1016/j.pt.2015.11.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zitzmann N, 2000, GLYCOBIOLOGY, V10, P243, DOI 10.1093/glycob/10.3.243	53	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2227	2238		10.1074/jbc.RA119.010847	http://dx.doi.org/10.1074/jbc.RA119.010847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932305	Green Published, hybrid			2022-12-28	WOS:000517330200007
J	Yoshida, H; Aoki, M; Komiya, A; Endo, Y; Kawabata, K; Nakamura, T; Sakai, S; Sayo, T; Okada, Y; Takahashi, Y				Yoshida, Hiroyuki; Aoki, Mika; Komiya, Aya; Endo, Yoko; Kawabata, Keigo; Nakamura, Tomomi; Sakai, Shingo; Sayo, Tetsuya; Okada, Yasunori; Takahashi, Yoshito			HYBID (alias KIAA1199/CEMIP) and hyaluronan synthase coordinately regulate hyaluronan metabolism in histamine-stimulated skin fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; skin; hyaluronan; mast cell; histamine; cell signaling; catabolism; hyaluronan synthase; KIAA1199; HYBID; photoaging	EXPRESSION; INFLAMMATION; RECEPTORS; DEGRADATION; TRYPTASE; GENE	The immune-regulatory compound histamine is involved in the metabolism of the essential skin component hyaluronan (HA). We previously reported that histamine up-regulates the expression of HYBID (hyaluronan-binding protein involved in hyaluronan depolymerization, also called CEMIP or KIAA1199), which plays a key role in HA degradation. However, no information is available about histamine's effects on HA synthase (HAS) expression, the molecular sizes of HA species produced, and histamine receptors and their signaling pathways in skin fibroblasts. Moreover, histamine's effects on photoaged skin remain elusive. Here, we show that histamine increases HA degradation by up-regulating HYBID and down-regulating HAS2 in human skin fibroblasts in a dose- and time-dependent manner and thereby decreases the total amounts and sizes of newly produced HA. Histamine H1 blocker abrogated the histamine effects on HYBID up-regulation, HAS2 suppression, and HA degradation. Histamine H1 agonist exhibited effects on HA levels, composition, and breakdown similar to those of histamine. Of note, blockade of protein kinase C? or PI3K?Akt signaling abolished histamine-mediated HYBID stimulation and HAS2 suppression, respectively. Immunohistochemical experiments revealed a significant ?2-fold increase in tryptase-positive mast cells in photoaged skin, where HYBID and HAS2 expression levels were increased and decreased, respectively, compared with photoprotected skin. These results indicate that histamine controls HA metabolism by up-regulating HYBID and down-regulating HAS2 via distinct signaling pathways downstream of histamine receptor H1. They further suggest that histamine may contribute to photoaged skin damage by skewing HA metabolism toward degradation.	[Yoshida, Hiroyuki; Aoki, Mika; Komiya, Aya; Endo, Yoko; Kawabata, Keigo; Nakamura, Tomomi; Sayo, Tetsuya; Takahashi, Yoshito] Kao Corp, Dept Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan; [Sakai, Shingo] Kao Corp, Dept Hlth Beauty Prod Res, Odawara, Kanagawa 2500002, Japan; [Okada, Yasunori] Juntendo Univ, Grad Sch Med, Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan	KAO Corporation; KAO Corporation; Juntendo University	Yoshida, H (corresponding author), Kao Corp, Dept Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan.; Okada, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan.	yoshida.hiroyuki2@kao.com; ya-okada@juntendo.ac.jp						BHAWAN J, 1992, AM J DERMATOPATH, V14, P224, DOI 10.1097/00000372-199206000-00008; BHAWAN J, 1995, J CUTAN PATHOL, V22, P154, DOI 10.1111/j.1600-0560.1995.tb01399.x; Bosset S, 2003, BRIT J DERMATOL, V149, P826, DOI 10.1046/j.1365-2133.2003.05456.x; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Gebhardt C, 2010, J INVEST DERMATOL, V130, P141, DOI 10.1038/jid.2009.210; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; JOHNSON CL, 1990, AM J PHYSIOL, V258, pC533, DOI 10.1152/ajpcell.1990.258.3.C533; Kim MS, 2009, BRIT J DERMATOL, V160, P393, DOI 10.1111/j.1365-2133.2008.08838.x; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAVKER RM, 1988, J INVEST DERMATOL, V90, P325, DOI 10.1111/1523-1747.ep12456193; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; Nagaoka A, 2015, J BIOL CHEM, V290, P30910, DOI 10.1074/jbc.M115.673566; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Rojas IG, 2004, J ORAL PATHOL MED, V33, P567, DOI 10.1111/j.1600-0714.2004.00242.x; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Toyoda M, 2005, BRIT J DERMATOL, V153, P13, DOI 10.1111/j.1365-2133.2005.06965.x; Toyoda M, 2001, J DERMATOL SCI, V27, pS32; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149; Yoshida H, 2018, BRIT J DERMATOL, V179, P136, DOI 10.1111/bjd.16335; Yoshida H, 2018, SKIN RES TECHNOL, V24, P562, DOI 10.1111/srt.12467; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110	30	8	8	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2483	2494		10.1074/jbc.RA119.010457	http://dx.doi.org/10.1074/jbc.RA119.010457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949043	Green Published, hybrid			2022-12-28	WOS:000517330200028
J	Sherekar, M; Han, SW; Ghirlando, R; Messing, S; Drew, M; Rabara, D; Waybright, T; Juneja, P; O'Neill, H; Stanley, CB; Bhowmik, D; Ramanathan, A; Subramaniam, S; Nissley, DV; Gillette, W; McCormick, F; Esposito, D				Sherekar, Mukul; Han, Sae-Won; Ghirlando, Rodolfo; Messing, Simon; Drew, Matthew; Rabara, Dana; Waybright, Timothy; Juneja, Puneet; O'Neill, Hugh; Stanley, Christopher B.; Bhowmik, Debsindhu; Ramanathan, Arvind; Subramaniam, Sriram; Nissley, Dwight, V; Gillette, William; McCormick, Frank; Esposito, Dominic			Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase-activating protein (GAP); dimerization; Ras protein; GTPase Kras (KRAS); cell signaling; cancer; mitogen-activated protein kinase pathway; neurofibromin; NF1	GENE-PRODUCT NEUROFIBROMIN; GAP-RELATED DOMAIN; SEDIMENTATION-VELOCITY; NEUTRON-SCATTERING; TYPE-1 PROTEIN; RAS; ULTRACENTRIFUGATION; SOLUBILITY; EXPRESSION; MUTATIONS	Neurofibromin is a tumor suppressor encoded by the NF1 gene, which is mutated in Rasopathy disease neurofibromatosis type I. Defects in NF1 lead to aberrant signaling through the RAS?mitogen-activated protein kinase pathway due to disruption of the neurofibromin GTPase-activating function on RAS family small GTPases. Very little is known about the function of most of the neurofibromin protein; to date, biochemical and structural data exist only for its GAP domain and a region containing a Sec-PH motif. To better understand the role of this large protein, here we carried out a series of biochemical and biophysical experiments, including size-exclusion chromatography?multiangle light scattering (SEC-MALS), small-angle X-ray and neutron scattering, and analytical ultracentrifugation, indicating that full-length neurofibromin forms a high-affinity dimer. We observed that neurofibromin dimerization also occurs in human cells and likely has biological and clinical implications. Analysis of purified full-length and truncated neurofibromin variants by negative-stain EM revealed the overall architecture of the dimer and predicted the potential interactions that contribute to the dimer interface. We could reconstitute structures resembling high-affinity full-length dimers by mixing N- and C-terminal protein domains in vitro. The reconstituted neurofibromin was capable of GTPase activation in vitro, and co-expression of the two domains in human cells effectively recapitulated the activity of full-length neurofibromin. Taken together, these results suggest how neurofibromin dimers might form and be stabilized within the cell.	[Sherekar, Mukul; Messing, Simon; Drew, Matthew; Rabara, Dana; Waybright, Timothy; Nissley, Dwight, V; Gillette, William; McCormick, Frank; Esposito, Dominic] NCI RAS Initiat, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Han, Sae-Won; McCormick, Frank] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Han, Sae-Won] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 03080, South Korea; [Ghirlando, Rodolfo] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Juneja, Puneet] Emory Univ, Robert P Apkarian Integrated Electron Microscopy, Atlanta, GA 30322 USA; [O'Neill, Hugh; Stanley, Christopher B.; Bhowmik, Debsindhu] Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA; [Ramanathan, Arvind] Argonne Natl Lab, Lemont, IL 60439 USA; [Subramaniam, Sriram] Frederick Natl Lab Canc Res, POB B, Frederick, MD 21702 USA; [Subramaniam, Sriram] Univ British Columbia, Life Sci Ctr, Dept Biochem, Columbia, BC V6T 1Z3, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Seoul National University (SNU); Seoul National University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Emory University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of British Columbia	Esposito, D (corresponding author), Frederick Natl Lab Canc Res, POB B, Frederick, MD 21702 USA.	dom.esposito@nih.gov	Juneja, Puneet/ABC-2748-2020; Juneja, Puneet/ABF-2997-2020; Stanley, Christopher/AAC-2732-2022; Juneja, Puneet/HHC-1232-2022	Stanley, Christopher/0000-0002-4226-7710; Juneja, Puneet/0000-0002-6774-2821; O'Neill, Hugh/0000-0003-2966-5527; Esposito, Dominic/0000-0002-9987-1687; Subramaniam, Sriram/0000-0003-4231-4115; Gillette, William/0000-0002-8592-3642; Juneja, Puneet/0000-0002-8934-4509	National Institutes of Health under NCI [HHSN261200800001E]; Intramural Research Program of the NIDDK	National Institutes of Health under NCI; Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part by National Institutes of Health under NCI Contract HHSN261200800001E and the Intramural Research Program of the NIDDK. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agamasu C, 2019, BIOPHYS J, V116, P1049, DOI 10.1016/j.bpj.2019.02.004; Anastasaki C, 2015, HUM MOL GENET, V24, P3518, DOI 10.1093/hmg/ddv103; Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029; Bonneau F, 2009, PROTEIN EXPRES PURIF, V65, P30, DOI 10.1016/j.pep.2008.12.001; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Carnes RM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090650; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; De Schepper S, 2006, J INVEST DERMATOL, V126, P653, DOI 10.1038/sj.jid.5700087; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Eisfeld AK, 2018, LEUKEMIA, V32, P2536, DOI 10.1038/s41375-018-0147-4; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Hakimi MA, 2002, J BIOL CHEM, V277, P36909, DOI 10.1074/jbc.C200434200; Heller WT, 2014, J APPL CRYSTALLOGR, V47, P1238, DOI 10.1107/S1600576714011285; Izawa I, 1996, FEBS LETT, V382, P53, DOI 10.1016/0014-5793(96)00137-8; Kiuru M, 2017, LAB INVEST, V97, P146, DOI 10.1038/labinvest.2016.142; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Li CJ, 2001, DEV BRAIN RES, V130, P231, DOI 10.1016/S0165-3806(01)00190-0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mehalko JL, 2016, J BIOTECHNOL, V238, P1, DOI [10.1016/j.jbiotec.2016.002, 10.1016/j.jbiotec.2016.09.002]; Mellert K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24310-5; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Philpott C, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0109-3; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Redig AJ, 2016, CLIN CANCER RES, V22, P3148, DOI 10.1158/1078-0432.CCR-15-2377; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Talsania K, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020079; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor T, 2017, METHODS MOL BIOL, V1586, P65, DOI 10.1007/978-1-4939-6887-9_5; Upadhyaya M, 1997, HUM GENET, V99, P88; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Welti S, 2011, HUM MUTAT, V32, P191, DOI 10.1002/humu.21405; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; XU NZ, 1994, ONCOGENE, V9, P597; Yang HW, 2018, ACTA PHARMACOL SIN, V39, P1837, DOI 10.1038/s41401-018-0079-6; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011	46	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1105	1119		10.1074/jbc.RA119.010934	http://dx.doi.org/10.1074/jbc.RA119.010934			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31836666	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000509949300018
J	Zhang, WJ; Yang, Y; Dong, ZZ; Shi, Z; Zhang, JT				Zhang, Wenji; Yang, Yang; Dong, Zizheng; Shi, Zhi; Zhang, Jian-Ting			Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; FUNCTIONAL RESCUE; 4-PHENYLBUTYRATE THERAPY; CYSTIC-FIBROSIS; OLIGOMERIZATION; PROTEINS; DOMAIN; PURIFICATION; INHIBITION; EXPRESSION	ATP-binding cassette (ABC) subfamily G member 2 (ABCG2) belongs to the ABC transporter superfamily and has been implicated in multidrug resistance of cancers. Although the structure and function of ABCG2 have been extensively studied, little is known about its biogenesis and the regulation thereof. In this study, using mutagenesis and several biochemical analyses, we show that the positive charges in the vicinity of the RKR motif downstream of the ABC signature drive trafficking of nascent ABCG2 out of the endoplasmic reticulum (ER) onto plasma membranes. Substitutions of and naturally occurring single-nucleotide polymorphisms within these positively charged residues disabled the trafficking of ABCG2 out of the ER. A representative ABCG2 variant in which the RKR motif had been altered underwent increased ER stress?associated degradation. We also found that unlike WT ABCG2, genetic ABCG2 RKR variants have disrupted normal maturation and do not reduce accumulation of the anticancer drug mitoxantrone and no longer confer resistance to the drug. We conclude that the positive charges downstream of the ABC signature motif critically regulate ABCG2 trafficking and maturation. We propose that single-nucleotide polymorphisms of these residues reduce ABCG2 expression via ER stress?associated degradation pathway and may contribute to reduced cancer drug resistance, improving the success of cancer chemotherapy.	[Zhang, Wenji; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Wenji; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA; [Zhang, Wenji; Yang, Yang; Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China; [Zhang, Wenji; Yang, Yang; Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Inst Biomed,Natl Engn Res Ctr Genet Med, Guangzhou 510632, Guangdong, Peoples R China; [Dong, Zizheng; Zhang, Jian-Ting] Univ Toledo, Coll Med & Life Sci, Dept Canc Biol, 3000 Arlington Ave, Toledo, OH 43614 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Jinan University; Jinan University; University System of Ohio; University of Toledo	Zhang, JT (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Canc Biol, 3000 Arlington Ave, Toledo, OH 43614 USA.; Shi, Z (corresponding author), Jinan Univ, Dept Cell Biol, 601 Huangpu Ave W, Guangzhou 510632, Guangdong, Peoples R China.	tshizhi@jnu.edu.cn; jianting.zhang@utoledo.edu		Shi, Zhi/0000-0002-8328-0305; Zhang, Wenji/0000-0003-1500-6627				Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Basseville A, 2012, CANCER RES, V72, P3642, DOI 10.1158/0008-5472.CAN-11-2008; Basseville Agnes, 2011, F1000 Biol Rep, V3, P23, DOI 10.3410/B3-23; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; HOLMBERG SRM, 1990, CIRC RES, V67, P272, DOI 10.1161/01.RES.67.2.272; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Iram SH, 2014, BBA-BIOMEMBRANES, V1838, P756, DOI 10.1016/j.bbamem.2013.11.002; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Lee YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24013; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu XA, 2012, APOPTOSIS, V17, P1039, DOI 10.1007/s10495-012-0744-z; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mo W, 2012, BIOCHEMISTRY-US, V51, P3634, DOI 10.1021/bi300301a; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Ni Zhanglin, 2010, Int J Biochem Mol Biol, V1, P1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Peng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015276; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Pomozi V, 2017, J INVEST DERMATOL, V137, P595, DOI 10.1016/j.jid.2016.10.035; Qi Q, 2013, ONCOGENE, V32, P1030, DOI 10.1038/onc.2012.109; Qiu JG, 2015, ONCOTARGET, V6, P15494, DOI 10.18632/oncotarget.3820; Reddy SS, 2019, CHEM-BIOL INTERACT, V306, P70, DOI 10.1016/j.cbi.2019.04.009; Ren XQ, 2004, MOL PHARMACOL, V65, P1536, DOI 10.1124/mol.65.6.1536; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Shneider BL, 2016, J PEDIATR GASTR NUTR, V62, P424, DOI 10.1097/MPG.0000000000001082; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; Stacchini A, 2012, CYTOM PART B-CLIN CY, V82B, P280, DOI [10.1002/cyto.b.21026, 10.1002/cyto.b.21034, 10.1002/cyto.b.21029, 10.1002/cyto.b.21036, 10.1002/cyto.b.21028]; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang WJ, 2018, BIOCHEM BIOPH RES CO, V503, P408, DOI 10.1016/j.bbrc.2018.06.157	50	4	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20222	20232		10.1074/jbc.RA119.008347	http://dx.doi.org/10.1074/jbc.RA119.008347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719146	hybrid, Green Published			2022-12-28	WOS:000505005800032
J	Tachiyama, S; Chang, YJ; Muthuramalingam, M; Hu, B; Barta, ML; Picking, WL; Liu, J; Picking, WD				Tachiyama, Shoichi; Chang, Yunjie; Muthuramalingam, Meenakumari; Hu, Bo; Barta, Michael L.; Picking, Wendy L.; Liu, Jun; Picking, William D.			The cytoplasmic domain of MxiG interacts with MxiK and directs assembly of the sorting platform in the Shigella type III secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MxiG; MxiK; type III secretion; Shigella; sorting platform; protein-protein interactions; cryo-electron tomography; virulence factor; effector protein	STRUCTURAL INSIGHTS; PROTEIN SECRETION; FLAGELLAR MOTOR; VISUALIZATION; FLEXNERI; COMPLEX; EXPORT; RECONSTRUCTION; ARCHITECTURE; ATPASE	Many Gram-negative bacteria use type III secretion systems (T3SSs) to inject virulence effector proteins into eukaryotic cells. The T3SS apparatus (T3SA) is structurally conserved among diverse bacterial pathogens and consists of a cytoplasmic sorting platform, an envelope-spanning basal body, and an extracellular needle with tip complex. The sorting platform is essential for effector recognition and powering secretion. Studies using bacterial "minicells" have revealed an unprecedented level of structural detail of the sorting platform; however, many of the structure-function relationships within this complex remain enigmatic. Here, we report on improved cryo-electron tomographic approaches to enhance the resolution of the Shigella T3SA sorting platform (at <= 2nm resolution) done in concert with biochemical and genetic methods to define the sorting platform interactome and interactions with the T3SA inner-membrane ring (IR). We observed that the sorting platform consists of "pods" with six-fold symmetry that interact with the Spa47 ATPase via radial extensions comprising MxiN. Most importantly, MxiK maintained an interaction with the IR via specific interactions with the cytoplasmic domain of the IR protein MxiG (MxiGC), which is a noncanonical forkhead-associated domain, and that MxiK has an elongated structure that interacts with the IR via MxiGC. T4 lysozyme-mediated insertional mutagenesis of MxiK revealed its orientation within the sorting platform and enabled disruption of interactions with its binding partners, which abolished sorting platform assembly. Finally, a comparison with the homologous interactions in the Salmonella T3SS sorting platform revealed clear differences in th`eir IR-sorting platform interfaces that have possible mechanistic implications.	[Tachiyama, Shoichi; Picking, William D.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Chang, Yunjie; Liu, Jun] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06516 USA; [Chang, Yunjie; Liu, Jun] Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA; [Muthuramalingam, Meenakumari; Barta, Michael L.] Univ Kansas, Higuchi Biosci Ctr, Lawrence, KS 66047 USA; [Hu, Bo] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Picking, Wendy L.; Picking, William D.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA; [Barta, Michael L.] Catalent Pharma Solut, Kansas City, MO 64137 USA	University of Kansas; Yale University; Yale University; University of Kansas; University of Texas System; University of Texas Health Science Center Houston; University of Kansas	Picking, WD (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.; Liu, J (corresponding author), Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06516 USA.	jliu@yale.edu; picking@ku.edu		Muthuramalingam, Meenakumari/0000-0001-5635-325X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123351] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI123351] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agulleiro JI, 2015, J STRUCT BIOL, V189, P147, DOI 10.1016/j.jsb.2014.11.009; ANDREWS GP, 1992, INFECT IMMUN, V60, P3287, DOI 10.1128/IAI.60.8.3287-3295.1992; Barison N, 2012, FASEB J, V26, P1717, DOI 10.1096/fj.11-197160; Barta ML, 2018, PROTEIN SCI, V27, P1392, DOI 10.1002/pro.3428; Barta ML, 2017, J BIOL CHEM, V292, P16677, DOI 10.1074/jbc.M117.802231; Bergeron JRC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003307; BI E, 1990, J BACTERIOL, V172, P5610, DOI 10.1128/jb.172.10.5610-5616.1990; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burgess JL, 2016, J BIOL CHEM, V291, P25837, DOI 10.1074/jbc.M116.755256; Case HB, 2018, BIOCHEMISTRY-US, V57, P2266, DOI 10.1021/acs.biochem.8b00070; Cherradi Y, 2014, MICROBIOL-SGM, V160, P130, DOI 10.1099/mic.0.071712-0; Choudhari SP, 2013, PROTEIN SCI, V22, P666, DOI 10.1002/pro.2249; Dickenson NE, 2013, PROTEIN SCI, V22, P614, DOI 10.1002/pro.2245; Diepold A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15940; Diepold A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002039; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Galan JE, 2018, CELL, V172, P1306, DOI 10.1016/j.cell.2018.01.034; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Hu J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06298-8; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kotloff KL, 2018, LANCET, V391, P801, DOI 10.1016/S0140-6736(17)33296-8; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhlen L, 2018, NAT STRUCT MOL BIOL, V25, P583, DOI 10.1038/s41594-018-0086-9; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lee PC, 2015, TRENDS MICROBIOL, V23, P296, DOI 10.1016/j.tim.2015.01.012; Majewski DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08477-7; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattock E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00064; McDowell MA, 2011, J BIOL CHEM, V286, P30606, DOI 10.1074/jbc.M111.243865; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Winkler H, 2009, J STRUCT BIOL, V165, P64, DOI 10.1016/j.jsb.2008.10.004; Zhao YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01434; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu SW, 2017, METHODS MOL BIOL, V1593, P229, DOI 10.1007/978-1-4939-6927-2_18	49	11	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19184	19196		10.1074/jbc.RA119.009125	http://dx.doi.org/10.1074/jbc.RA119.009125			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699894	Green Published, hybrid			2022-12-28	WOS:000516527800019
J	Mancl, JM; Suarez, C; Liang, WGG; Kovar, DR; Tang, WJ				Mancl, Jordan M.; Suarez, Cristian; Liang, Wenguang G.; Kovar, David R.; Tang, Wei-Jen			Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; bacterial pathogenesis; bacterial toxin; protein-protein interaction; Pseudomonas aeruginosa; host-pathogen interaction; cytoskeleton; virulence factor; actin bundling; exoenzyme Y (ExoY); host-microbe interactions	F-ACTIN; CYCLASE TOXIN; EPITHELIAL-CELLS; NUCLEOTIDYL CYCLASE; BINDING PROTEINS; STRUCTURAL BASIS; CROSS-LINKING; EXOY; COMPLEX; CYTOSKELETON	Pseudomonas aeruginosa uses a type III secretion system (T3SS) to inject cytotoxic effector proteins into host cells. The promiscuous nucleotidyl cyclase, exoenzyme Y (ExoY), is one of the most common effectors found in clinical P. aeruginosa isolates. Recent studies have revealed that the nucleotidyl cyclase activity of ExoY is stimulated by actin filaments (F-actin) and that ExoY alters actin cytoskeleton dynamics in vitro, via an unknown mechanism. The actin cytoskeleton plays an important role in numerous key biological processes and is targeted by many pathogens to gain competitive advantages. We utilized total internal reflection fluorescence microscopy, bulk actin assays, and EM to investigate how ExoY impacts actin dynamics. We found that ExoY can directly bundle actin filaments with high affinity, comparable with eukaryotic F-actin?bundling proteins, such as fimbrin. Of note, ExoY enzymatic activity was not required for F-actin bundling. Bundling is known to require multiple actin-binding sites, yet small-angle X-ray scattering experiments revealed that ExoY is a monomer in solution, and previous data suggested that ExoY possesses only one actin-binding site. We therefore hypothesized that ExoY oligomerizes in response to F-actin binding and have used the ExoY structure to construct a dimer-based structural model for the ExoY?F-actin complex. Subsequent mutational analyses suggested that the ExoY oligomerization interface plays a crucial role in mediating F-actin bundling. Our results indicate that ExoY represents a new class of actin-binding proteins that modulate the actin cytoskeleton both directly, via F-actin bundling, and indirectly, via actin-activated nucleotidyl cyclase activity.	[Mancl, Jordan M.; Liang, Wenguang G.; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Suarez, Cristian; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Tang, WJ (corresponding author), Univ Chicago, Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@bsd.uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995; Mancl, Jordan/0000-0003-3368-6275	National Institutes of Health [GM121964]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM121964 (20). As a result, many bacteria have evolved virulence factors (to W.-J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Belyy A, 2018, J BIOL CHEM, V293, P19785, DOI 10.1074/jbc.RA118.003784; Belyy A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13582; Benanti EL, 2015, CELL, V161, P348, DOI 10.1016/j.cell.2015.02.044; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Chatterjee M, 2016, INT J MED MICROBIOL, V306, P48, DOI 10.1016/j.ijmm.2015.11.004; Christensen JR, 2017, ELIFE, V6, DOI 10.7554/eLife.23152; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Cowell BA, 2005, FEMS MICROBIOL LETT, V250, P71, DOI 10.1016/j.femsle.2005.06.044; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FLEISZIG SMJ, 1995, INFECT IMMUN, V63, P4072, DOI 10.1128/IAI.63.10.4072-4077.1995; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hritonenko V, 2011, MICROB PATHOGENESIS, V51, P305, DOI 10.1016/j.micpath.2011.08.001; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Khanppnavar B, 2018, BBA-GEN SUBJECTS, V1862, P2090, DOI 10.1016/j.bbagen.2018.05.021; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Li YJ, 2016, MOL BIOL CELL, V27, P1821, DOI 10.1091/mbc.E16-01-0010; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Morrow KA, 2015, AM J PHYSIOL-LUNG C, V309, pL1199, DOI 10.1152/ajplung.00165.2015; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tanaka K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04290-w; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Winkelman JD, 2016, CURR BIOL, V26, P2697, DOI 10.1016/j.cub.2016.07.080; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zimmermann D, 2016, METHODS MOL BIOL, V1369, P151, DOI 10.1007/978-1-4939-3145-3_12	57	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3506	3517		10.1074/jbc.RA119.012320	http://dx.doi.org/10.1074/jbc.RA119.012320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32019868	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000527725300012
J	Dumbrepatil, AB; Zegalia, KA; Sajja, K; Kennedy, RT; Marsh, ENG				Dumbrepatil, Arti B.; Zegalia, Kelcie A.; Sajja, Keerthi; Kennedy, Robert T.; Marsh, E. Neil G.			Targeting viperin to the mitochondrion inhibits the thiolase activity of the trifunctional enzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inhibitor; enzyme degradation; metabolic regulation; metalloenzyme; mitochondria; innate immunity; fatty acid oxidation; cytomegalovirus; HADHB thiolase; mitochondrial trifunctional protein; radical SAM enzyme; viperin	ANTIVIRAL PROTEIN VIPERIN; RADICAL SAM ENZYME; IMMUNE-RESPONSES; INNATE IMMUNITY; QUALITY-CONTROL; VIRAL EVASION	Understanding the mechanisms by which viruses evade host cell immune defenses is important for developing improved antiviral therapies. In an unusual twist, human cytomegalovirus co-opts the antiviral radical SAM enzyme viperin (virus-inhibitory protein, endoplasmic reticulum?associated, interferon-inducible) to enhance viral infectivity. This process involves translocation of viperin to the mitochondrion, where it binds the ?-subunit (HADHB) of the mitochondrial trifunctional enzyme complex that catalyzes thiolysis of ?-ketoacyl?CoA esters as part of fatty acid ?-oxidation. Here we investigated how the interaction between these two enzymes alters their activities and affects cellular ATP levels. Experiments with purified enzymes indicated that viperin inhibits the thiolase activity of HADHB, but, unexpectedly, HADHB activates viperin, leading to synthesis of the antiviral nucleotide 3?-deoxy-3?,4?-didehydro-CTP. Measurements of enzyme activities in lysates prepared from transfected HEK293T cells expressing these enzymes mirrored the findings obtained with purified enzymes. Thus, localizing viperin to mitochondria decreased thiolase activity, and coexpression of HADHB significantly increased viperin activity. Furthermore, targeting viperin to mitochondria also increased the rate at which HADHB is retrotranslocated out of mitochondria and degraded, providing an additional mechanism by which viperin reduces HADHB activity. Targeting viperin to mitochondria decreased cellular ATP levels by more than 50%, consistent with the enzyme disrupting fatty acid catabolism. These results provide biochemical insight into the mechanism by which human cytomegalovirus subverts viperin; they also provide a biochemical rationale for viperin's recently discovered role in regulating thermogenesis in adipose tissues.	[Dumbrepatil, Arti B.; Zegalia, Kelcie A.; Sajja, Keerthi; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Marsh, Neil/G-7553-2016	Zegalia, Kelcie/0000-0003-0389-134X; Dumbrepatil, Arti/0000-0002-0105-9667; Marsh, Neil/0000-0003-1713-1683	National Institutes of Health [GM 093088, DK 046960]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants GM 093088 (to A. B. D., K. S., and E. N. G. M.) and DK 046960 (to K. A. Z. and R. T. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Broderick WE, 2019, J BIOL INORG CHEM, V24, P769, DOI 10.1007/s00775-019-01706-w; Chakravarti A, 2018, J BIOL CHEM, V293, P14122, DOI 10.1074/jbc.RA118.003998; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Dumbrepatil AB, 2019, J BIOL CHEM, V294, P6888, DOI 10.1074/jbc.RA119.007719; Duschene Kaitlin S, 2012, Biomol Concepts, V3, P255; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2017, FEBS LETT, V591, P2394, DOI 10.1002/1873-3468.12769; Eom J, 2019, P NATL ACAD SCI USA, V116, P17419, DOI 10.1073/pnas.1904480116; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Hee JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172236; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Iannello A, 2006, J LEUKOCYTE BIOL, V79, P16, DOI 10.1189/jlb.0705397; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/jvi.02054-17, 10.1128/JVI.02054-17]; Pang HR, 2018, METHOD ENZYMOL, V606, P485, DOI 10.1016/bs.mie.2018.04.014; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Rettberg L, 2018, METHOD ENZYMOL, V606, P341, DOI 10.1016/bs.mie.2018.04.009; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang SC, 2018, NAT PROD REP, V35, P707, DOI 10.1039/c7np00059f; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wang YY, 2018, METHOD ENZYMOL, V606, P199, DOI 10.1016/bs.mie.2018.05.018; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Yokoyama K, 2018, NAT PROD REP, V35, P660, DOI 10.1039/c8np00006a; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047	49	12	12	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2839	2849		10.1074/jbc.RA119.011526	http://dx.doi.org/10.1074/jbc.RA119.011526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31980458	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000519969100025
J	Ebert, SM; Bullard, SA; Basisty, N; Marcotte, GR; Skopec, ZP; Dierdorff, JM; Al-Zougbi, A; Tomcheck, KC; DeLau, AD; Rathmacher, JA; Bodine, SC; Schilling, B; Adams, CM				Ebert, Scott M.; Bullard, Steven A.; Basisty, Nathan; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Schilling, Birgit; Adams, Christopher M.			Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBP?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle atrophy; skeletal muscle; muscle; protein?protein interaction; protein?DNA interaction; gene regulation; activating transcription factor 4 (ATF4); basic leucine zipper transcription factor (bZIP); CCAAT enhancer-binding protein ? (C; EBP?); growth arrest and DNA damage-inducible ? (Gadd45?)	LEUCINE-ZIPPER; DNA-BINDING; GENE-EXPRESSION; GADD45A EXPRESSION; PROTEIN; PATHWAY; FAMILY; PHOSPHORYLATION; IDENTIFICATION; MASS	Skeletal muscle atrophy is a highly-prevalent and debilitating condition that remains poorly understood at the molecular level. Previous work found that aging, fasting, and immobilization promote skeletal muscle atrophy via expression of activating transcription factor 4 (ATF4) in skeletal muscle fibers. However, the direct biochemical mechanism by which ATF4 promotes muscle atrophy is unknown. ATF4 is a member of the basic leucine zipper transcription factor (bZIP) superfamily. Because bZIP transcription factors are obligate dimers, and because ATF4 is unable to form highly-stable homodimers, we hypothesized that ATF4 may promote muscle atrophy by forming a heterodimer with another bZIP family member. To test this hypothesis, we biochemically isolated skeletal muscle proteins that associate with the dimerization- and DNA-binding domain of ATF4 (the bZIP domain) in mouse skeletal muscle fibers in vivo. Interestingly, we found that ATF4 forms at least five distinct heterodimeric bZIP transcription factors in skeletal muscle fibers. Furthermore, one of these heterodimers, composed of ATF4 and CCAAT enhancer-binding protein ? (C/EBP?), mediates muscle atrophy. Within skeletal muscle fibers, the ATF4?C/EBP? heterodimer interacts with a previously unrecognized and evolutionarily conserved ATF?C/EBP composite site in exon 4 of the Gadd45a gene. This three-way interaction between ATF4, C/EBP?, and the ATF?C/EBP composite site activates the Gadd45a gene, which encodes a critical mediator of muscle atrophy. Together, these results identify a biochemical mechanism by which ATF4 induces skeletal muscle atrophy, providing molecular-level insights into the etiology of skeletal muscle atrophy.	[Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Internal Med, Iowa City, IA 52242 USA; [Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Bodine, Sue C.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Ebert, Scott M.; Bullard, Steven A.; Marcotte, George R.; Skopec, Zachary P.; Dierdorff, Jason M.; Al-Zougbi, Asma; Tomcheck, Kristin C.; DeLau, Austin D.; Rathmacher, Jacob A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Ebert, Scott M.; Bodine, Sue C.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA; [Basisty, Nathan; Schilling, Birgit] Buck Inst Res Aging, Novato, CA 94945 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Buck Institute for Research on Aging	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu	Basisty, Nathan B/J-9294-2014	Basisty, Nathan B/0000-0001-6173-1139; Marcotte, George/0000-0002-9162-135X; Adams, Christopher/0000-0002-5795-7212	NIH [1S10 OD016281]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Peter Snyder and Daryl Granner for critical review of the manuscript. We also acknowledge support from the NIH shared instrumentation grant for the TripleTOF system at the Buck Institute (1S10 OD016281 to the Buck Institute).	Ampofo E, 2013, BBA-MOL CELL RES, V1833, P439, DOI 10.1016/j.bbamcr.2012.10.025; Bagheri-Yarmand R, 2015, J BIOL CHEM, V290, P11749, DOI 10.1074/jbc.M114.619833; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Basisty N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800123; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bullard SA, 2016, J BIOL CHEM, V291, P17496, DOI 10.1074/jbc.M116.740308; Cohen DM, 2015, ELIFE, V4, DOI 10.7554/eLife.06821; Collins BC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00249-5; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, P83; Ebert SM, 2019, PHYSIOLOGY, V34, P232, DOI 10.1152/physiol.00003.2019; Ebert SM, 2015, J BIOL CHEM, V290, P25497, DOI 10.1074/jbc.M115.681445; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gombart AF, 2007, J LEUKOCYTE BIOL, V81, P1535, DOI 10.1189/jlb.0806516; Hirsch N, 2015, PERSPECT BIOL MED, V58, P182, DOI 10.1353/pbm.2015.0026; Huggins CJ, 2016, MOL CELL BIOL, V36, P693, DOI 10.1128/MCB.00911-15; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Inoue Y, 2017, FEBS LETT, V591, P3682, DOI 10.1002/1873-3468.12869; Jiang HY, 2007, J BIOL CHEM, V282, P3755, DOI 10.1074/jbc.M606461200; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Pons J, 2007, PEPTIDES, V28, P2253, DOI 10.1016/j.peptides.2007.09.016; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465; Rodriguez-Martinez JA, 2017, ELIFE, V6, DOI 10.7554/elife.19272.001; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Segatto M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01645-7; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sun DS, 1996, GENOMICS, V36, P54, DOI 10.1006/geno.1996.0425; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang GX, 2019, MOL CELL, V74, P844, DOI 10.1016/j.molcel.2019.03.021; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	65	22	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2787	2803		10.1074/jbc.RA119.012095	http://dx.doi.org/10.1074/jbc.RA119.012095			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31953319	Green Published, hybrid			2022-12-28	WOS:000519969100022
J	Loreti, M; Shi, DL; Carron, C				Loreti, Mafalda; Shi, De-Li; Carron, Cmence			The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during Xenopus development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						STAT3; polycomb; embryo; Xenopus; post-translational modification (PTM); DSCR6; embryonic axis patterning; Ezh2; mesoderm	CELL-ADHESION MOLECULE; GENE-EXPRESSION; COMPLEX PRC2; TARGET GENES; POLYCOMB; METHYLATION; ZEBRAFISH; SPECIFICATION; ACTIVATION; INDUCTION	Embryonic cell fate specification and axis patterning requires integration of several signaling pathways that orchestrate region-specific gene expression. The transcription factor signal transducer and activator of transcription 3 (Stat3) plays important roles during early development, but it is unclear how Stat3 is activated. Here, using Xenopus as a model, we analyzed the post-translational regulation and functional consequences of Stat3 activation in dorsoventral axis patterning. We show that Stat3 phosphorylation, lysine methylation, and transcriptional activity increase before gastrulation and induce ventral mesoderm formation. Down syndrome critical region gene 6 (DSCR6), a RIPPLY family member that induces dorsal mesoderm by releasing repressive polycomb group proteins from chromatin, bound to the Stat3 C-terminal region and antagonized its transcriptional and ventralizing activities by interfering with its lysine methylation. Enhancer of zeste 2 polycomb-repressive complex 2 subunit (Ezh2) also bound to this region; however, its methyltransferase activity was required for Stat3 methylation and activation. Loss of Ezh2 resulted in dorsalization of ventral mesoderm and formation of a secondary axis. Furthermore, interference with Ezh2 phosphorylation also prevented Stat3 lysine methylation and transcriptional activity. Thus, inhibition of either Ezh2 phosphorylation or Stat3 lysine methylation compensated for the absence of DSCR6 function. These results reveal that DSCR6 and Ezh2 critically and post-translationally regulate Stat3 transcriptional activity. Ezh2 promotes Stat3 activation in ventral mesoderm formation independently of epigenetic regulation, whereas DSCR6 specifies dorsal fate by counteracting this ventralizing activity. This antagonism helps pattern the mesoderm along the dorsoventral axis, representing a critical facet of cell identity regulation during development.	[Loreti, Mafalda; Shi, De-Li; Carron, Cmence] Sorbonne Univ, CNRS, Dev Biol Lab, UMR7622,IBPS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Shi, DL; Carron, C (corresponding author), Sorbonne Univ, CNRS, Dev Biol Lab, UMR7622,IBPS, F-75005 Paris, France.	de-li.shi@upmc.fr; clemence.carron_homo@upmc.fr	Carron, Clémence/AAG-6304-2021; Shi, De-Li/AAG-1807-2021	Shi, Deli/0000-0002-6104-9137; Carron, Clemence/0000-0002-8776-7380	Centre National de la Recherche Scientifique (CNRS); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc); Ministere de l'Enseignement Superieur et de la Recherche; the Sorbonne Universite	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); the Sorbonne Universite	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Sorbonne Universite, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (Gefluc), and a Doctoral Fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Barnett MW, 2001, MECH DEVELOP, V102, P157, DOI 10.1016/S0925-4773(01)00304-5; Besser D, 1999, MOL CELL BIOL, V19, P1401; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao JM, 2012, MECH DEVELOP, V129, P263, DOI 10.1016/j.mod.2012.07.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Carron C, 2016, WIRES DEV BIOL, V5, P150, DOI 10.1002/wdev.217; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheng XN, 2019, EXP CELL RES, V381, P112, DOI 10.1016/j.yexcr.2019.04.033; Cheng XN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01552-x; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Dasgupta M, 2014, J BIOL CHEM, V289, P30763, DOI 10.1074/jbc.M114.603894; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Deevy O, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.181354; Diaz HDM, 2014, GENESIS, V52, P849, DOI 10.1002/dvg.22804; Faust C, 1998, DEVELOPMENT, V125, P4495; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Guanizo AC, 2018, GROWTH FACTORS, V36, P1, DOI 10.1080/08977194.2018.1473393; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hong JY, 2012, J CELL SCI, V125, P561, DOI 10.1242/jcs.086173; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; Jalvy S, 2019, DEV BIOL, V447, P200, DOI 10.1016/j.ydbio.2018.12.020; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Li HY, 2013, DEVELOPMENT, V140, P4903, DOI 10.1242/dev.098319; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Li HY, 2006, DEV BIOL, V290, P470, DOI 10.1016/j.ydbio.2005.11.020; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Pan YM, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0561-z; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Shan YL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00668-4; Shao M, 2009, DEVELOPMENT, V136, P2121, DOI 10.1242/dev.032649; Stark GR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028555; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Tien CL, 2015, DEVELOPMENT, V142, P722, DOI 10.1242/dev.111997; Volkel P, 2015, AM J TRANSL RES, V7, P175; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Yu YX, 2017, STEM CELL REP, V9, P752, DOI 10.1016/j.stemcr.2017.07.016; Zhang T, 2014, DEVELOPMENT, V141, P4332, DOI 10.1242/dev.104885; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	58	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2724	2735		10.1074/jbc.RA119.010719	http://dx.doi.org/10.1074/jbc.RA119.010719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31996376	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000519969100017
J	McDonald, IM; Grant, GD; East, MP; Gilbert, TSK; Wilkerson, EM; Goldfarb, D; Beri, J; Herring, LE; Vaziri, C; Cook, JG; Emanuele, MJ; Graves, LM				McDonald, Ian M.; Grant, Gavin D.; East, Michael P.; Gilbert, Thomas S. K.; Wilkerson, Emily M.; Goldfarb, Dennis; Beri, Joshua; Herring, Laura E.; Vaziri, Cyrus; Cook, Jeanette Gowen; Emanuele, Michael J.; Graves, Lee M.			Mass spectrometry?based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); cell cycle; protein kinase; inhibitor; cell proliferation; G2; M checkpoint; kinome profiling; maternal embryonic leucine zipper kinase (MELK); mitotic delay; multiplexed kinase inhibitor beads; mass spectrometry (MIB; MS); inhibitor selectivity; NVS-MELK8a; AMPK family	LEUCINE-ZIPPER KINASE; THERAPEUTIC TARGET; BREAST-CANCER; CYCLE; PHOSPHORYLATION; PROLIFERATION; KINOME; GROWTH; CHECKPOINT; DISCOVERY	The maternal embryonic leucine zipper kinase (MELK) has been implicated in the regulation of cancer cell proliferation. RNAi-mediated MELK depletion impairs growth and causes G(2)/M arrest in numerous cancers, but the mechanisms underlying these effects are poorly understood. Furthermore, the MELK inhibitor OTSSP167 has recently been shown to have poor selectivity for MELK, complicating the use of this inhibitor as a tool compound to investigate MELK function. Here, using a cell-based proteomics technique called multiplexed kinase inhibitor beads/mass spectrometry (MIB/MS), we profiled the selectivity of two additional MELK inhibitors, NVS-MELK8a (8a) and HTH-01-091. Our results revealed that 8a is a highly selective MELK inhibitor, which we further used for functional studies. Resazurin and crystal violet assays indicated that 8a decreases triple-negative breast cancer cell viability, and immunoblotting revealed that impaired growth is due to perturbation of cell cycle progression rather than induction of apoptosis. Using double-thymidine synchronization and immunoblotting, we observed that MELK inhibition delays mitotic entry, which was associated with delayed activation of Aurora A, Aurora B, and cyclin-dependent kinase 1 (CDK1). Following this delay, cells entered and completed mitosis. Using live-cell microscopy of cells harboring fluorescent proliferating cell nuclear antigen, we confirmed that 8a significantly and dose-dependently lengthens G(2) phase. Collectively, our results provide a rationale for using 8a as a tool compound for functional studies of MELK and indicate that MELK inhibition delays mitotic entry, likely via transient G(2)/M checkpoint activation.	[McDonald, Ian M.; East, Michael P.; Gilbert, Thomas S. K.; Wilkerson, Emily M.; Beri, Joshua; Herring, Laura E.; Emanuele, Michael J.; Graves, Lee M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Grant, Gavin D.; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Vaziri, Cyrus] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [McDonald, Ian M.; Grant, Gavin D.; East, Michael P.; Vaziri, Cyrus; Cook, Jeanette Gowen; Emanuele, Michael J.; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gilbert, Thomas S. K.; Wilkerson, Emily M.; Beri, Joshua; Herring, Laura E.; Graves, Lee M.] Univ N Carolina, UNC Michael Hooker Prote Core Facil, Chapel Hill, NC 27599 USA; [Goldfarb, Dennis] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Goldfarb, Dennis] Washington Univ, Sch Med, Inst Informat, St Louis, MO 63110 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL)	Graves, LM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Grant, Gavin/0000-0002-8958-2056; Gilbert, Thomas/0000-0002-6833-6788; Goldfarb, Dennis/0000-0002-1584-5423	National Institutes of Health [R01 CA199064, GM083024, GM102413, T32 CA009156]; UNC Dissertation Completion Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Dissertation Completion Fellowship	This work was supported by National Institutes of Health Grants R01 CA199064 (to L. M. G.), GM083024 and GM102413 (to J. G. C.), and T32 CA009156 (to G. D. G.). This work was also supported in part by a UNC Dissertation Completion Fellowship (to I. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642; Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Boutard N, 2019, BIOORG MED CHEM LETT, V29, P607, DOI 10.1016/j.bmcl.2018.12.051; Chartrain I, 2013, BIOL OPEN, V2, P1037, DOI 10.1242/bio.20136080; Chlenski A, 2019, MOL CANCER THER, V18, P507, DOI 10.1158/1535-7163.MCT-18-0819; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Chung SY, 2012, ONCOTARGET, V3, P1629; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Currie CE, 2018, CURR BIOL, V28, pR929, DOI 10.1016/j.cub.2018.07.040; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Edupuganti R, 2017, BIOORGAN MED CHEM, V25, P2609, DOI 10.1016/j.bmc.2017.03.018; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Giuliano CJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32838; Grant GD, 2018, CELL CYCLE, V17, P2496, DOI 10.1080/15384101.2018.1547001; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Graves PR, 2019, ACS CHEM BIOL, V14, P1020, DOI 10.1021/acschembio.9b00222; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Guan S, 2018, ONCOTARGET, V9, P2591, DOI 10.18632/oncotarget.23515; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Janostiak R, 2017, CELL REP, V21, P2829, DOI 10.1016/j.celrep.2017.11.033; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Krulikas LJ, 2018, SLAS DISCOV, V23, P850, DOI 10.1177/2472555218773045; Le Page Y, 2011, J CELL SCI, V124, P958, DOI 10.1242/jcs.069567; Li S, 2016, ONCOTARGET, V7, P6266, DOI 10.18632/oncotarget.6673; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meraldi P, 2019, EMBO J, V38, DOI 10.15252/embj.2019101912; Minata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092546; Mirey G, 2005, CELL CYCLE, V4, P806, DOI 10.4161/cc.4.6.1716; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Offenburger SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04375-4; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Pitner MK, 2017, EXPERT OPIN THER TAR, V21, P849, DOI 10.1080/14728222.2017.1363183; Raaijmakers JA, 2018, CELL REP, V22, P1424, DOI 10.1016/j.celrep.2018.01.034; Rodriguez-Rodriguez JA, 2018, CURR BIOL, V28, P3422, DOI 10.1016/j.cub.2018.10.006; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Toure BB, 2016, J MED CHEM, V59, P4711, DOI 10.1021/acs.jmedchem.6b00052; Wang YB, 2018, ISCIENCE, V9, P149, DOI 10.1016/j.isci.2018.10.015; Wang YB, 2016, P NATL ACAD SCI USA, V113, P9810, DOI 10.1073/pnas.1606862113; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Xia HP, 2016, CANCER LETT, V383, P85, DOI 10.1016/j.canlet.2016.09.017; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zhang G, 2019, EMBO J, V38, DOI 10.15252/embj.2018100977; Zhang Y, 2018, ONCOGENE, V37, P5520, DOI 10.1038/s41388-018-0333-x	69	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2359	2374		10.1074/jbc.RA119.011083	http://dx.doi.org/10.1074/jbc.RA119.011083			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31896573	Green Published, hybrid			2022-12-28	WOS:000517330200018
J	Laursen, L; Karlsson, E; Gianni, S; Jemth, P				Laursen, Louise; Karlsson, Elin; Gianni, Stefano; Jemth, Per			Functional interplay between protein domains in a supramodular structure involving the postsynaptic density protein PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; protein conformation; protein?protein interaction; conformational change; kinetics; CXXC repeat?containing interactor of PDZ3 domain (CRIPT); postsynaptic density protein; PSD-95; supertertiary structure; supramodule	3RD PDZ DOMAIN; SUPERTERTIARY STRUCTURE; LIGAND-BINDING; ORGANIZATION; RECOGNITION; SUGGESTS; EXPLORER; TANDEM	Cell scaffolding and signaling are governed by protein?protein interactions. Although a particular interaction is often defined by two specific domains binding to each other, this interaction often occurs in the context of other domains in multidomain proteins. How such adjacent domains form supertertiary structures and modulate protein?protein interactions has only recently been addressed and is incompletely understood. The postsynaptic density protein PSD-95 contains a three-domain supramodule, denoted PSG, which consists of PDZ, Src homology 3 (SH3), and guanylate kinase-like domains. The PDZ domain binds to the C terminus of its proposed natural ligand, CXXC repeat?containing interactor of PDZ3 domain (CRIPT), and results from previous experiments using only the isolated PDZ domain are consistent with the simplest scenario for a protein?protein interaction; namely, a two-state mechanism. Here we analyzed the binding kinetics of the PSG supramodule with CRIPT. We show that PSG binds CRIPT via a more complex mechanism involving two conformational states interconverting on the second timescale. Both conformational states bound a CRIPT peptide with similar affinities but with different rates, and the distribution of the two conformational states was slightly shifted upon CRIPT binding. Our results are consistent with recent structural findings of conformational changes in PSD-95 and demonstrate how conformational transitions in supertertiary structures can shape the ligand-binding energy landscape and modulate protein?protein interactions.	[Laursen, Louise; Karlsson, Elin; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, S-75123 Uppsala, Sweden; [Gianni, Stefano] Sapienza Univ Roma, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Gianni, Stefano] Sapienza Univ Roma, CNR, Ist Biol & Patol Mol, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy	Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, S-75123 Uppsala, Sweden.; Gianni, S (corresponding author), Sapienza Univ Roma, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy.; Gianni, S (corresponding author), Sapienza Univ Roma, CNR, Ist Biol & Patol Mol, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.	Stefano.Gianni@uniroma1.it; Per.Jemth@imbim.uu.se		Laursen, Louise/0000-0001-7758-4487; Karlsson, Elin/0000-0001-5526-4968; Jemth, Per/0000-0003-1516-7228	European Union's Horizon 2020 Research and Innovation Program under Marie Sklodowska-Curie Grant [675341]; Swedish Research Council [201604965]	European Union's Horizon 2020 Research and Innovation Program under Marie Sklodowska-Curie Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded in part by the European Union's Horizon 2020 Research and Innovation Program under Marie Sklodowska-Curie Grant Agreement 675341 (to S. G. and P. J.) and by Swedish Research Council Grant 201604965 (to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Bagshaw CR, 2017, BIOMOLECULAR KINETIC; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Erlendsson S, 2019, ELIFE, V8, DOI 10.7554/eLife.39180; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Ivarsson Y, 2019, CURR OPIN STRUC BIOL, V54, P26, DOI 10.1016/j.sbi.2018.09.009; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Pascoe HG, 2015, P NATL ACAD SCI USA, V112, P14852, DOI 10.1073/pnas.1508931112; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Rademacher N, 2019, ELIFE, V8, DOI 10.7554/eLife.41299; Rademacher N, 2013, CHEM BIOL, V20, P1044, DOI 10.1016/j.chembiol.2013.06.016; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Zeng ML, 2018, J MOL BIOL, V430, P69, DOI 10.1016/j.jmb.2017.11.003; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0175-17.2017	30	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1992	2000		10.1074/jbc.RA119.011050	http://dx.doi.org/10.1074/jbc.RA119.011050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31831623	hybrid, Green Published			2022-12-28	WOS:000517128200018
J	Witham, CM; Dassanayake, HG; Paxman, AL; Stevens, KLP; Baklous, L; White, PF; Black, AL; Steuart, RFL; Stirling, CJ; Schulz, BL; Mousley, CJ				Witham, Christopher M.; Dassanayake, Hasindu G.; Paxman, Aleshanee L.; Stevens, Kofi L. P.; Baklous, Lamprini; White, Paris F.; Black, Amy L.; Steuart, Robert F. L.; Stirling, Colin J.; Schulz, Benjamin L.; Mousley, Carl J.			The conserved C-terminus of Sss1p is required to maintain the endoplasmic reticulum permeability barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic reticulum?associated protein degradation (ERAD); translocation; gating; endoplasmic reticulum stress (ER stress); Sec61 complex; Sss1p; Sec61?; translocon gating; Sec61p; Sec61?	POSTTRANSLATIONAL PROTEIN-TRANSPORT; PREPRO-ALPHA-FACTOR; TRANSLOCATION CHANNEL; SIGNAL PEPTIDE; SEC PROTEINS; IN-VITRO; YEAST; RECOGNITION; MEMBRANE; COMPLEX	The endoplasmic reticulum (ER) is the entry point to the secretory pathway and major site of protein biogenesis. Translocation of secretory and integral membrane proteins across or into the ER membrane occurs via the evolutionarily conserved Sec61 complex, a heterotrimeric channel that comprises the Sec61p/Sec61?, Sss1p/Sec61?, and Sbh1p/Sec61? subunits. In addition to forming a protein-conducting channel, the Sec61 complex also functions to maintain the ER permeability barrier, preventing the mass free flow of essential ER-enriched molecules and ions. Loss in Sec61 integrity is detrimental and implicated in the progression of disease. The Sss1p/Sec61? C terminus is juxtaposed to the key gating module of Sec61p/Sec61?, and we hypothesize it is important for gating the ER translocon. The ER stress response was found to be constitutively induced in two temperature-sensitive sss1 mutants (sss1(ts)) that are still proficient to conduct ER translocation. A screen to identify intergenic mutations that allow for sss1(ts) cells to grow at 37 ?C suggests the ER permeability barrier to be compromised in these mutants. We propose the extreme C terminus of Sss1p/Sec61? is an essential component of the gating module of the ER translocase and is required to maintain the ER permeability barrier.	[Witham, Christopher M.; Dassanayake, Hasindu G.; Paxman, Aleshanee L.; Stevens, Kofi L. P.; Baklous, Lamprini; White, Paris F.; Black, Amy L.; Mousley, Carl J.] Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA 6102, Australia; [Witham, Christopher M.; Stevens, Kofi L. P.; Baklous, Lamprini; Black, Amy L.; Steuart, Robert F. L.; Mousley, Carl J.] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Stirling, Colin J.] Univ Manchester, Sch Biol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Schulz, Benjamin L.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Stirling, Colin J.] Flinders Univ S Australia, Sturt Rd, Bedford Pk, SA 5042, Australia	Curtin University; Curtin University; University of Manchester; University of Queensland; Flinders University South Australia	Mousley, CJ (corresponding author), Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA 6102, Australia.; Mousley, CJ (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia.	Carl.Mousley@curtin.edu.au		Witham, Christopher/0000-0002-1626-6714; Mousley, Carl/0000-0002-0192-7030	Curtin University Schools of Pharmacy and Biomedical Science and Graduate Research School	Curtin University Schools of Pharmacy and Biomedical Science and Graduate Research School	We thank Curtin University Schools of Pharmacy and Biomedical Science and Graduate Research School for providing funds for graduate research.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085519; DAVIS CD, 1990, J NUTR, V120, P507, DOI 10.1093/jn/120.5.507; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Falcone D, 2011, BIOCHEM J, V436, P291, DOI 10.1042/BJ20101865; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Hansen SL, 2006, J ANIM SCI, V84, P3375, DOI 10.2527/jas.2005-667; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jensen RE, 1999, CURR BIOL, V9, pR779, DOI 10.1016/S0960-9822(00)80012-3; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Ponsero AJ, 2017, MOL CELL, V67, P962, DOI 10.1016/j.molcel.2017.08.012; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; ROTHBLATT JA, 1986, EMBO J, V5, P1031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wilkinson BM, 2010, J BIOL CHEM, V285, P32671, DOI 10.1074/jbc.M110.128256; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 1997, EMBO J, V16, P4549, DOI 10.1093/emboj/16.15.4549; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	49	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2125	2134		10.1074/jbc.RA119.010378	http://dx.doi.org/10.1074/jbc.RA119.010378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31848225	Green Published, hybrid			2022-12-28	WOS:000517128200028
J	Zhang, CF; Huang, H; Chen, Z; Zhang, ZY; Lu, WW; Qiu, MS				Zhang, Chengfu; Huang, Hao; Chen, Zhen; Zhang, Zunyi; Lu, Wenwen; Qiu, Mengsheng			The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oligodendrocyte; neurobiology; neurodifferentiation; neurodevelopment; genetics; chicken; differentiation; electroporation; oligodendrocyte; spinal cord	SPINAL-CORD; NK-2 HOMEODOMAIN; GENERATION; ORIGIN; MYELIN; DNA; PROGENITORS; EXPRESSION; REPRESSION; BINDING	The homeodomain protein NK2 homeobox 2 (NKX2-2) is a transcription factor that plays a critical role in the control of cell fate specification and differentiation in many tissues. In the developing central nervous system, this developmentally important transcription factor functions as a transcriptional repressor that governs oligodendrocyte (OL) differentiation and myelin gene expression, but the roles of various NKX2-2 structural domains in this process are unclear. In this study, using in situ hybridization, immunofluorescence, and coimmunoprecipitation, we determined the structural domains that mediate the repressive functions of murine NKX2-2 and identified the transcriptional corepressors that interact with it in OL cells. Through in ovo electroporation in embryonic chicken spinal cords, we demonstrate that the N-terminal Tinman domain and C-terminal domain synergistically promote OL differentiation by recruiting distinct transcriptional corepressors, including enhancer of split Groucho 3 (GRG3), histone deacetylase 1 (HDAC1), and DNA methyltransferase 3 ? (DNMT3A). We also observed that the NK2-specific domain suppresses the function of the C-terminal domain in OL differentiation. These findings delineate the distinct NKX2-2 domains and their roles in OL differentiation and suggest that NKX2-2 regulates differentiation by repressing gene expression via multiple cofactors and molecular mechanisms.	[Zhang, Chengfu; Qiu, Mengsheng] Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Zhang, Chengfu; Huang, Hao; Chen, Zhen; Zhang, Zunyi; Lu, Wenwen; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Life Sci, Key Lab Organ Dev & Regenerat Zhejiang Prov, 16 Xuelin St, Hangzhou 311121, Peoples R China	Zhejiang University; Hangzhou Normal University	Qiu, MS (corresponding author), Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.; Qiu, MS (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Key Lab Organ Dev & Regenerat Zhejiang Prov, 16 Xuelin St, Hangzhou 311121, Peoples R China.	m0qiu001@yahoo.com			National Natural Science Foundation of China [31572224, 31771621, 31900703]; Natural Science Founda-tion of Zhejiang Province [LQ15C070001, LQ19C090001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Founda-tion of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grants 31572224, 31771621, and 31900703 and Natural Science Founda-tion of Zhejiang Province Grants LQ15C070001 and LQ19C090001. The authors declare that they have no conflicts of interest with the contents of this article.	Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Chandran S, 1998, GLIA, V24, P382, DOI 10.1002/(SICI)1098-1136(199812)24:4<382::AID-GLIA3>3.0.CO;2-5; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen HM, 2018, J CANCER, V9, P3067, DOI 10.7150/jca.26382; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Egawa N, 2019, GLIA, V67, P718, DOI 10.1002/glia.23567; Fu H, 2002, DEVELOPMENT, V129, P681; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; He L, 2013, NEUROSCI BULL, V29, P129, DOI 10.1007/s12264-013-1318-y; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hessabi B, 2000, BIOCHEM BIOPH RES CO, V270, P695, DOI 10.1006/bbrc.2000.2491; Huang H, 2018, J NEUROSCI, V38, P9829, DOI 10.1523/JNEUROSCI.0154-18.2018; Huang H, 2013, NEUROSCI BULL, V29, P155, DOI 10.1007/s12264-013-1314-2; Ishii A, 2014, J NEUROSCI, V34, P16031, DOI 10.1523/JNEUROSCI.3360-14.2014; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Moyon S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0336-16.2017; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Soula C, 2001, DEVELOPMENT, V128, P1369; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; TSAO DHH, 1994, BIOCHEMISTRY-US, V33, P15053, DOI 10.1021/bi00254a014; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Wei Q, 2005, J BIOL CHEM, V280, P16284, DOI 10.1074/jbc.M500491200; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhu Q, 2014, DEVELOPMENT, V141, P548, DOI 10.1242/dev.095323	34	9	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1879	1888		10.1074/jbc.RA119.011163	http://dx.doi.org/10.1074/jbc.RA119.011163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31932307	hybrid, Green Published			2022-12-28	WOS:000517128200009
J	Liao, YJ; Duan, B; Zhang, YF; Zhang, XM; Xia, B				Liao, Yangjie; Duan, Bo; Zhang, Yufei; Zhang, Xinmin; Xia, Bin			Excessive ER-phagy mediated by the autophagy receptor FAM134B results in ER stress, the unfolded protein response, and cell death in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell death; endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); endoplasmic reticulum (ER); Bcl-xL inhibitor; ER-phagy; FAM134B; reticulophagy regulator 1 (RETREG1); Z36	DIFFERENTIAL EXPRESSION ANALYSIS; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; DEGRADATION; DISCOVERY	Autophagy is typically a prosurvival cellular process that promotes the turnover of long-lived proteins and damaged organelles, but it can also induce cell death. We have previously reported that the small molecule Z36 induces autophagy along with autophagic cell death in HeLa cells. In this study, we analyzed differential gene expression in Z36-treated HeLa cells and found that Z36-induced endoplasmic reticulum?specific autophagy (ER-phagy) results in ER stress and the unfolded protein response (UPR). This result is in contrast to the common notion that autophagy is generally activated in response to ER stress and the UPR. We demonstrate that Z36 up-regulates the expression levels of FAM134B, LC3, and Atg9, which together mediate excessive ER-phagy, characterized by forming increased numbers of autophagosomes with larger sizes. We noted that the excessive ER-phagy accelerates ER degradation and impairs ER homeostasis and thereby triggers ER stress and the UPR as well as ER-phagy?dependent cell death. Interestingly, overexpression of FAM134B alone in HeLa cells is sufficient to impair ER homeostasis and cause ER stress and cell death. These findings suggest a mechanism involving FAM134B activity for ER-phagy to promote cell death.	[Liao, Yangjie; Duan, Bo; Zhang, Yufei; Xia, Bin] Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Zhang, Xinmin] BioInfoRx Inc, Madison, WI 53719 USA	Peking University	Xia, B (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	binxia@pku.edu.cn	Xia, Bin/O-1160-2016; Zhang, yufei/HHC-7375-2022	Xia, Bin/0000-0002-2197-6403; Duan, Bo/0000-0003-0018-4092	Ministry of Science and Technology of China [2016YFA0501200, 2012CB910703]; National Natural Science Foundation of China [91013011]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0501200 and 2012CB910703 (to B. X.) and National Natural Science Foundation of China Grant 91013011 (to B. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; Deegan S, 2014, BIOCHEM BIOPH RES CO, V451, P367, DOI 10.1016/j.bbrc.2014.07.111; Denton D, 2015, IMMUNOL CELL BIOL, V93, P35, DOI 10.1038/icb.2014.85; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fregno Ilaria, 2018, F1000Res, V7, P454, DOI 10.12688/f1000research.13968.1; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Islam F, 2018, J CELL PHYSIOL, V233, P4479, DOI 10.1002/jcp.26384; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Jin MY, 2014, FEBS LETT, V588, P2457, DOI 10.1016/j.febslet.2014.06.015; Jin MY, 2014, CURR BIOL, V24, P1314, DOI 10.1016/j.cub.2014.04.048; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kuang Y, 2016, AUTOPHAGY, V12, P2363, DOI 10.1080/15548627.2016.1238552; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin J, 2009, AUTOPHAGY, V5, P314, DOI 10.4161/auto.5.3.7888; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Liu Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.183; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Svenning S, 2013, ESSAYS BIOCHEM, V55, P79, DOI [10.1042/bse0550079, 10.1042/BSE0550079]; Tian SH, 2010, AUTOPHAGY, V6, P1032, DOI 10.4161/auto.6.8.13336; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamamoto A, 2011, NEUROBIOL DIS, V43, P17, DOI 10.1016/j.nbd.2010.08.015; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	49	32	33	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20009	20023		10.1074/jbc.RA119.008709	http://dx.doi.org/10.1074/jbc.RA119.008709			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748416	hybrid, Green Published			2022-12-28	WOS:000505005800016
J	Aljohani, A; Khan, MI; Bonneville, A; Guo, CA; Jeffery, J; O'Neill, L; Syed, DN; Lewis, SA; Burhans, M; Mukhtar, H; Ntambi, JM				Aljohani, Ahmed; Khan, Mohammad Imran; Bonneville, Abram; Guo, Changan; Jeffery, Justin; O'Neill, Lucas; Syed, Deeba Nadeem; Lewis, Sarah A.; Burhans, Maggie; Mukhtar, Hasan; Ntambi, James M.			Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1??FGF21 axis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; carbohydrate metabolism; fibroblast growth factor (FGF); glucose metabolism; glucose transport; lipid metabolism; liver metabolism; obesity; liver; lipid signaling; glucose transporters; insulin sensitivity; heptokine-FGF21; liver?adipocyte cross-talk; monounsaturated fatty acids; stearoyl-CoA desaturase-1	GROWTH-FACTOR 21; NONALCOHOLIC FATTY LIVER; GLUT4 TRANSLOCATION; INSULIN SENSITIVITY; METABOLIC SYNDROME; GENE-EXPRESSION; PROTECTS MICE; ACID; FGF21; ASSOCIATION	Increased carbohydrate consumption increases hepatic de novo lipogenesis, which has been linked to the development of chronic metabolic diseases, including obesity, hepatic steatosis, and insulin resistance. Stearoyl CoA desaturase 1 (SCD1) is a critical lipogenic enzyme that catalyzes the synthesis of two monounsaturated fatty acids, oleate and palmitoleate, from the saturated fatty acids stearate and palmitate, respectively. SCD1-deficient mouse models are protected against diet-induced adiposity, hepatic steatosis, and hyperglycemia. However, the mechanism of this protection by SCD1 deficiency is unclear. Using liver-specific SCD1 knockout (LKO) mice fed a high-carbohydrate, low-fat diet, we show that hepatic SCD1 deficiency increases systemic glucose uptake. Hepatic SCD1 deficiency enhanced glucose transporter type 1 (GLUT1) expression in the liver and also up-regulated GLUT4 and adiponectin expression in adipose tissue. The enhanced glucose uptake correlated with increased liver expression and elevated plasma levels of fibroblast growth factor 21 (FGF21), a hepatokine known to increase systemic insulin sensitivity and regulate whole-body lipid metabolism. Feeding LKO mice a triolein-supplemented but not tristearin-supplemented high-carbohydrate, low-fat diet reduced FGF21 expression and plasma levels. Consistently, SCD1 inhibition in primary hepatocytes induced FGF21 expression, which was repressed by treatment with oleate but not palmitoleate. Moreover, deletion of the transcriptional coactivator PPAR? coactivator 1? (PGC-1?) reduced hepatic and plasma FGF21 and white adipocyte tissue-specific GLUT4 expression and raised plasma glucose levels in LKO mice. These results suggest that hepatic oleate regulates glucose uptake in adipose tissue either directly or partially by modulating the hepatic PGC-1??FGF21 axis.	[Aljohani, Ahmed] Univ Wisconsin, Sch Med & Publ Hlth, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53706 USA; [Khan, Mohammad Imran; Syed, Deeba Nadeem; Mukhtar, Hasan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA; [Aljohani, Ahmed] King Saud bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Riyadh 11481, Saudi Arabia; [Khan, Mohammad Imran] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia; [Bonneville, Abram; Guo, Changan; O'Neill, Lucas; Lewis, Sarah A.; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Burhans, Maggie; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Jeffery, Justin] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.; Ntambi, JM (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	james.ntambi@wisc.edu	Khan, Mohammad Dr/B-2030-2019; Khan, Mohammad Imran/AAH-3327-2020; Aljohani, Ahmed/HHD-3455-2022	Lewis, Sarah/0000-0002-5568-955X	National Institutes of Health [R01 DK062388, DK118093]; American Diabetes Association Grant [7-13-BS118]; Department of Agriculture [W2005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK118093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); Department of Agriculture; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK062388 and DK118093, American Diabetes Association Grant 7-13-BS118, and Department of Agriculture Hatch Grant W2005 (to J. M. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; de Souza CO, 2017, J CELL PHYSIOL, V232, P2168, DOI 10.1002/jcp.25715; Disselhorst JA, 2010, J NUCL MED, V51, P610, DOI 10.2967/jnumed.109.068858; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008; Forney LA, 2018, APPL PHYSIOL NUTR ME, V43, P123, DOI 10.1139/apnm-2017-0404; Fueger BJ, 2006, J NUCL MED, V47, P999; Garcia-Mendoza MG, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0703-7; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Jeyakumar SM, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-27; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu MY, 2018, CELL PHYSIOL BIOCHEM, V45, P1423, DOI 10.1159/000487568; Liu XQ, 2016, J HEPATOL, V65, P103, DOI 10.1016/j.jhep.2016.03.001; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; RANDLE PJ, 1963, LANCET, V1, P785; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Tan CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18366; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	44	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19475	19485		10.1074/jbc.RA119.009868	http://dx.doi.org/10.1074/jbc.RA119.009868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690632	hybrid, Green Published			2022-12-28	WOS:000504093200003
J	Kim, HG; Hwang, SY; Aaronson, SA; Mandinova, A; Lee, SW				Kim, Hyung-Gu; Hwang, So-Young; Aaronson, Stuart A.; Mandinova, Anna; Lee, Sam W.			DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. (Withdrawal of Vol 286, Pg 17672, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612	1	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18950	18950		10.1074/jbc.W119.011784	http://dx.doi.org/10.1074/jbc.W119.011784			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31811050	Green Published, hybrid			2022-12-28	WOS:000507618800038
J	Ji, HH; Ostap, EM				Ji, Huan-Hong; Ostap, E. Michael			The regulatory protein 14-3-3? binds to the IQ motifs of myosin-IC independent of phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; cell motility; 14-3-3 protein; cytoskeleton; calmodulin (CaM); 14-3-3?; cell signaling; molecular motor; myo1c; myosin-IC	CALMODULIN-BINDING; EQUILIBRIUM-ANALYSIS; CALCIUM REGULATION; STRUCTURAL BASIS; MOTOR; INSULIN; CA2+; MEMBRANE; EXOCYTOSIS; RECEPTORS	Myosin-IC (Myo1c) has been proposed to function in delivery of glucose transporter type 4 (GLUT4)?containing vesicles to the plasma membrane in response to insulin stimulation. Current evidence suggests that, upon insulin stimulation, Myo1c is phosphorylated at Ser(701), leading to binding of the signaling protein 14-3-3?. Biochemical and functional details of the Myo1c?14-3-3? interaction have yet to be described. Using recombinantly expressed proteins and mass spectrometry?based analyses to monitor Myo1c phosphorylation, along with pulldown, fluorescence binding, and additional biochemical assays, we show here that 14-3-3? is a dimer and, consistent with previous work, that it binds to Myo1c in the presence of calcium. This interaction was associated with dissociation of calmodulin (CaM) from the IQ motif in Myo1c. Surprisingly, we found that 14-3-3? binds to Myo1c independent of Ser(701) phosphorylation in vitro. Additionally, in contrast to previous reports, we did not observe Myo1c Ser(701) phosphorylation by Ca2+/CaM-dependent protein kinase II (CaMKII), although CaMKII phosphorylated four other Myo1c sites. The presence of 14-3-3? had little effect on the actin-activated ATPase or motile activities of Myo1c. Given these results, it is unlikely that 14-3-3? acts as a cargo adaptor for Myo1c-powered transport; rather, we propose that 14-3-3? binds Myo1c in the presence of calcium and stabilizes the calmodulin-dissociated, nonmotile myosin.	Univ Penn, Dept Physiol, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Engn Mechanobiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ostap, EM (corresponding author), Penn Muscle Inst, 700A Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	ostap@pennmedicine.upenn.edu			NIGMS, National Institutes of Health [R37 GM057247]; National Science Foundation CMMI Grant [15-48571]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation CMMI Grant(National Science Foundation (NSF))	This work was supported by NIGMS, National Institutes of Health Grant R37 GM057247 (to E. M. O.) and National Science Foundation CMMI Grant 15-48571 (to E. M. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen Z, 2015, CURR OPIN CHEM BIOL, V28, P115, DOI 10.1016/j.cbpa.2015.07.001; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Ge Q, 2012, J BIOL CHEM, V287, P41914, DOI 10.1074/jbc.M112.418855; Gillespie PG, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-31; Greenberg MJ, 2017, METHODS MOL BIOL, V1486, P483, DOI 10.1007/978-1-4939-6421-5_19; Greenberg MJ, 2013, TRENDS CELL BIOL, V23, P81, DOI 10.1016/j.tcb.2012.10.008; Gupta K, 2015, J BIOL CHEM, V290, P20185, DOI 10.1074/jbc.M115.667279; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; HOWE CL, 1983, J CELL BIOL, V97, P974, DOI 10.1083/jcb.97.4.974; Lanner JT, 2008, CURR OPIN PHARMACOL, V8, P339, DOI 10.1016/j.coph.2008.01.006; Lewis JH, 2012, BIOPHYS J, V102, P2799, DOI 10.1016/j.bpj.2012.05.014; Lin TM, 2005, J BIOL CHEM, V280, P41562, DOI 10.1074/jbc.M508653200; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McIntosh BB, 2016, J CELL SCI, V129, P2689, DOI 10.1242/jcs.186403; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Phillips KR, 2006, J NEUROSCI, V26, P10777, DOI 10.1523/JNEUROSCI.1847-06.2006; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; SWANLJUNGCOLLINS H, 1991, J BIOL CHEM, V266, P1312; Tang N, 2007, J MUSCLE RES CELL M, V28, P285, DOI 10.1007/s10974-007-9124-7; TRYBUS KM, 1994, J CELL BIOL, V124, P963, DOI 10.1083/jcb.124.6.963; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	43	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3749	3756		10.1074/jbc.RA119.011227	http://dx.doi.org/10.1074/jbc.RA119.011227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	31811090	hybrid, Green Published			2022-12-28	WOS:000527704400001
J	Zhang, H; Shen, Z; Lin, YM; Zhang, J; Zhang, YW; Liu, PH; Zeng, H; Yu, ML; Chen, XY; Ning, LG; Mao, XL; Cen, L; Yu, CH; Xu, CF				Zhang, Hong; Shen, Zhe; Lin, Yiming; Zhang, Jie; Zhang, Yuwei; Liu, Peihao; Zeng, Hang; Yu, Mengli; Chen, Xueyang; Ning, Longgui; Mao, Xinli; Cen, Li; Yu, Chaohui; Xu, Chengfu			Vitamin D receptor targets hepatocyte nuclear factor 4? and mediates protective effects of vitamin D in nonalcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin D; nuclear receptor; liver metabolism; lipid metabolism; insulin resistance; gene regulation; hepatic steatosis; hepatocyte nuclear factor 4? (HNF4?); metabolic syndrome; nonalcoholic fatty liver disease (NAFLD)	TRANSCRIPTION FACTOR; GENE-EXPRESSION; D DEFICIENCY; OBESITY; STEATOHEPATITIS; PATHOGENESIS; METABOLISM; RESISTANCE; HISTOLOGY; FIBROSIS	Epidemiological studies have suggested a link between vitamin D deficiency and increased risk for nonalcoholic fatty liver disease (NAFLD); however, the underlying mechanisms have remained unclear. Here, using both clinical samples and experimental rodent models along with several biochemical approaches, we explored the specific effects and mechanisms of vitamin D deficiency in NAFLD pathology. Serum vitamin D levels were significantly lower in individuals with NAFLD and in high-fat diet (HFD)-fed mice than in healthy controls and chow-fed mice, respectively. Vitamin D supplementation ameliorated HFD-induced hepatic steatosis and insulin resistance in mice. Hepatic expression of vitamin D receptor (VDR) was up-regulated in three models of NAFLD, including HFD-fed mice, methionine/choline-deficient diet (MCD)-fed mice, and genetically obese (ob/ob) mice. Liver-specific VDR deletion significantly exacerbated HFD- or MCD-induced hepatic steatosis and insulin resistance and also diminished the protective effect of vitamin D supplementation on NAFLD. Mechanistic experiments revealed that VDR interacted with hepatocyte nuclear factor 4 ? (HNF4?) and that overexpression of HNF4? improved HFD-induced NAFLD and metabolic abnormalities in liver-specific VDR-knockout mice. These results suggest that vitamin D ameliorates NAFLD and metabolic abnormalities by activating hepatic VDR, leading to its interaction with HNF4?. Our findings highlight a potential value of using vitamin D for preventing and managing NAFLD by targeting VDR.	[Zhang, Hong; Shen, Zhe; Lin, Yiming; Zhang, Jie; Zhang, Yuwei; Liu, Peihao; Zeng, Hang; Yu, Mengli; Chen, Xueyang; Ning, Longgui; Mao, Xinli; Cen, Li; Yu, Chaohui; Xu, Chengfu] Zhejiang Univ, Coll Med, Dept Gastroenterol, Affiliated Hosp 1, Hangzhou 310003, Peoples R China; [Mao, Xinli] Taizhou Hosp Zhejiang Prov, Dept Gastroenterol, Linhai 317000, Peoples R China	Zhejiang University	Yu, CH; Xu, CF (corresponding author), Zhejiang Univ, Coll Med, Dept Gastroenterol, Affiliated Hosp 1, Hangzhou 310003, Peoples R China.	zyyyych@zju.edu.cn; xiaofu@zju.edu.cn	Xu, Cheng/GXH-4815-2022; Shen, Zhe/CVP-6409-2022	Xu, Cheng/0000-0003-1000-733X; 	National Key R&D Program of China [2017YFC0908900, 2018YFA0109800]; National Natural Science Foundation of China [81570523, 81700485, 81722009, 81770573, U180321]; Key Research and Development Program of Zhejiang Province Grant [2020C03033]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Zhejiang Province Grant	This work was supported by National Key R&D Program of China Grants 2017YFC0908900 and 2018YFA0109800, National Natural Science Foundation of China Grants 81570523, 81700485, 81722009, 81770573, and U180321, and Key Research and Development Program of Zhejiang Province Grant 2020C03033. The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666; Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Baciu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189223; Bagamasbad P, 2011, GEN COMP ENDOCR, V170, P3, DOI 10.1016/j.ygcen.2010.03.013; Barchetta I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0638-y; Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bozic M, 2016, J HEPATOL, V65, P748, DOI 10.1016/j.jhep.2016.05.031; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cave MC, 2016, BBA-GENE REGUL MECH, V1859, P1083, DOI 10.1016/j.bbagrm.2016.03.002; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dasarathy J, 2014, LIVER INT, V34, pE118, DOI 10.1111/liv.12312; Della Corte C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168216; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dwivedi PP, 2000, J BIOL CHEM, V275, P47, DOI 10.1074/jbc.275.1.47; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Finck BN, 2018, DIABETES, V67, P2485, DOI 10.2337/dbi18-0024; Geldenhuys S, 2014, DIABETES, V63, P3759, DOI 10.2337/db13-1675; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Grammatiki M, 2019, HORM-INT J ENDOCRINO, V18, P37, DOI 10.1007/s42000-018-0063-z; Han SX, 2009, DRUG METAB DISPOS, V37, P469, DOI 10.1124/dmd.108.025155; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P1567, DOI 10.1016/j.bbadis.2019.03.007; Jais A, 2017, J CLIN INVEST, V127, P24, DOI 10.1172/JCI88878; Kitson MT, 2016, GUT, V65, DOI 10.1136/gutjnl-2015-310417; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Li J, 2015, J BIOL CHEM, V290, P24021, DOI 10.1074/jbc.M115.645200; Li M, 2018, GUT, V67, P2169, DOI 10.1136/gutjnl-2017-313778; Li YY, 2016, HEPATOLOGY, V63, P1860, DOI 10.1002/hep.28472; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nelson JE, 2016, AM J GASTROENTEROL, V111, P852, DOI 10.1038/ajg.2016.51; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Nobili V, 2015, GUT, V64, P698, DOI 10.1136/gutjnl-2014-308175; Pedigo NG, 2005, ONCOGENE, V24, P2654, DOI 10.1038/sj.onc.1208336; ROSS TK, 1993, P NATL ACAD SCI USA, V90, P9257, DOI 10.1073/pnas.90.20.9257; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Wan LY, 2015, MOLECULES, V20, P12389, DOI 10.3390/molecules200712389; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Watt MJ, 2019, ENDOCR REV, V40, P1367, DOI 10.1210/er.2019-00034; Wei Z, 2018, CELL, V173, P1135, DOI 10.1016/j.cell.2018.04.013; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wong VWS, 2016, LANCET GASTROENTEROL, V1, P56, DOI 10.1016/S2468-1253(16)30011-5; Xiao L, 2010, ADV DRUG DELIVER REV, V62, P1316, DOI 10.1016/j.addr.2010.07.006; Xie LF, 2016, J HEPATOL, V65, P113, DOI 10.1016/j.jhep.2016.03.008; Xu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8466; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhou F, 2019, HEPATOLOGY, V70, P1119, DOI 10.1002/hep.30702	57	25	26	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3891	3905		10.1074/jbc.RA119.011487	http://dx.doi.org/10.1074/jbc.RA119.011487			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32051143	hybrid, Green Published			2022-12-28	WOS:000527704400014
J	Iburg, M; Puchkov, D; Rosas-Brugada, IU; Bergemann, L; Rieprecht, U; Kirstein, J				Iburg, Manuel; Puchkov, Dmytro; Rosas-Brugada, Irving U.; Bergemann, Linda; Rieprecht, Ulrike; Kirstein, Janine			The noncanonical small heat shock protein HSP-17 from Caenorhabditis elegans is a selective protein aggregase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; protein folding; chaperone; small heat shock protein (sHsp); Caenorhabditis elegans (C; elegans); protein aggregates; proteostasis; selective protein aggregase	ALPHA-B-CRYSTALLIN; CHAPERONE PATHWAY; ESCHERICHIA-COLI; SEQUESTRATION; DISAGGREGATION; FIBRILS; DISEASE; STRESS; HSP110; LINE	Small heat shock proteins (sHsps) are conserved, ubiquitous members of the proteostasis network. Canonically, they act as ?holdases? and buffer unfolded or misfolded proteins against aggregation in an ATP-independent manner. Whereas bacteria and yeast each have only two sHsps in their genomes, this number is higher in metazoan genomes, suggesting a spatiotemporal and functional specialization in higher eukaryotes. Here, using recombinantly expressed and purified proteins, static light-scattering analysis, and disaggregation assays, we report that the noncanonical sHsp HSP-17 of Caenorhabditis elegans facilitates aggregation of model substrates, such as malate dehydrogenase (MDH), and inhibits disaggregation of luciferase in vitro. Experiments with fluorescently tagged HSP-17 under the control of its endogenous promoter revealed that HSP-17 is expressed in the digestive and excretory organs, where its overexpression promotes the aggregation of polyQ proteins and of the endogenous kinase KIN-19. Systemic depletion of hsp-17 shortens C. elegans lifespan and severely reduces fecundity and survival upon prolonged heat stress. HSP-17 is an abundant protein exhibiting opposing chaperone activities on different substrates, indicating that it is a selective protein aggregase with physiological roles in development, digestion, and osmoregulation.	[Iburg, Manuel; Puchkov, Dmytro; Rosas-Brugada, Irving U.; Bergemann, Linda; Rieprecht, Ulrike; Kirstein, Janine] Forschungsverbund Berlin eV, Leibniz Res Inst Mol Pharmacol, R Roessle Str 10, D-13125 Berlin, Germany; [Kirstein, Janine] Univ Bremen, Fac Cell Biol 2, Leobener Str, D-28359 Bremen, Germany; [Rosas-Brugada, Irving U.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bergemann, Linda] Lab Berlin Charite Vivantes GmbH, Fachbereich Humangenet, Sylter Str 2, D-13353 Berlin, Germany	Technical University of Berlin; University of Bremen; University of Toronto; Labor Berlin - Charite Vivantes GmbH	Kirstein, J (corresponding author), Univ Bremen, Fac Cell Biol 2, Leobener Str, D-28359 Bremen, Germany.	kirstein@uni-bremen.de		Iburg, Manuel/0000-0002-1073-9023; Kirstein, Janine/0000-0003-4990-2497; Puchkov, Dmytro/0000-0001-8341-4847	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]	National Institutes of Health Office of Research Infrastructure Programs	We acknowledge Della David (DZNE Tubingen) for providing strain DCD214, the Leube laboratory (RWTH Aachen) for strain BJ49, Richard Morimoto (Northwestern University, Evanston, IL) for sharing strain iQ85, and the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440), for providing additional strains. We thank Ellen Malovrh for cloning the hsp-12.6 construct. We thank Alice Baumann (FMP Berlin) for support in carrying out QTof experiments. We also acknowledge Johannes Buchner and Martin Haslbeck (TU Munich) for discussion.	Aevermann BD, 2008, GENETICA, V133, P307, DOI 10.1007/s10709-007-9215-9; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrigo A., 2015, BIG BOOK SMALL HEAT, P155; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; El Mouridi S, 2017, G3-GENES GENOM GENET, V7, P1429, DOI 10.1534/g3.117.040824; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Ezemaduka AN, 2017, J NEMATOL, V49, P334, DOI 10.21307/jofnem-2017-081; Ezemaduka AN, 2014, J BACTERIOL, V196, P2004, DOI 10.1128/JB.01473-14; Feleciano DR, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00009; Grousl T, 2018, J CELL BIOL, V217, P1269, DOI 10.1083/jcb.201708116; Hantke I, 2019, MOL MICROBIOL, V111, P423, DOI 10.1111/mmi.14164; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Ho CT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12868-1; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Mohri-Shiomi A, 2008, J BIOL CHEM, V283, P194, DOI 10.1074/jbc.M707956200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Oliveira AO, 2016, HUM MOL GENET, V25, P1677, DOI 10.1093/hmg/ddw028; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saarikangas J, 2015, ELIFE, V4, DOI 10.7554/eLife.06197; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scior A, 2018, EMBO J, V37, P282, DOI 10.15252/embj.201797212; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stiernagle Theresa, 2006, WormBook, P1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811	58	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3064	3079		10.1074/jbc.RA119.011185	http://dx.doi.org/10.1074/jbc.RA119.011185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32001616	Green Published, hybrid			2022-12-28	WOS:000519597300016
J	Stopschinski, BE; Thomas, TL; Nadji, S; Darvish, E; Fan, LF; Holmes, BB; Modi, AR; Finnell, JG; Kashmer, O; Estill-Terpack, S; Mirbaha, H; Luu, HS; Diamond, MI				Stopschinski, Barbara E.; Thomas, Talitha L.; Nadji, Sourena; Darvish, Eric; Fan, Linfeng; Holmes, Brandon B.; Modi, Anuja R.; Finnell, Jordan G.; Kashmer, Omar; Estill-Terpack, Sandi; Mirbaha, Hilda; Luu, Hung S.; Diamond, Marc, I			A synthetic heparinoid blocks Tau aggregate cell uptake and amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; heparan sulfate; Tau protein (Tau); tauopathy; heparin-binding protein; neurodegeneration; neurodegenerative disease; heparin; glycosaminoglycan	MOLECULAR-WEIGHT HEPARIN; PENTOSAN POLYSULFATE; SULFATE; PROTEIN; ANTITHROMBIN; BINDING; SCRAPIE; GLYCOSAMINOGLYCAN; PROPAGATION; ACTIVATION	Tau aggregation underlies neurodegeneration in Alzheimer's disease and related tauopathies. We and others have proposed that transcellular propagation of pathology is mediated by Tau prions, which are ordered protein assemblies that faithfully replicate in vivo and cause specific biological effects. The prion model predicts the release of aggregates from a first-order cell and subsequent uptake into a second-order cell. The assemblies then serve as templates for their own replication, a process termed ?seeding.? We have previously observed that heparan sulfate proteoglycans on the cell surface mediate the cellular uptake of Tau aggregates. This interaction is blocked by heparin, a sulfated glycosaminoglycan. Indeed, heparin-like molecules, or heparinoids, have previously been proposed as a treatment for PrP prion disorders. However, heparin is not ideal for managing chronic neurodegeneration, because it is difficult to synthesize in defined sizes, may have poor brain penetration because of its negative charge, and is a powerful anticoagulant. Therefore, we sought to generate an oligosaccharide that would bind Tau and block its cellular uptake and seeding, without exhibiting anticoagulation activity. We created a compound, SN7?13, from pentasaccharide units and tested it in a range of assays that measured direct binding of Tau to glycosaminoglycans and inhibition of Tau uptake and seeding in cells. SN7?13 does not inhibit coagulation, binds Tau with low nanomolar affinity, and inhibits cellular Tau aggregate propagation similarly to standard porcine heparin. This synthetic heparinoid could facilitate the development of agents to treat tauopathy.	[Stopschinski, Barbara E.; Thomas, Talitha L.; Holmes, Brandon B.; Modi, Anuja R.; Finnell, Jordan G.; Kashmer, Omar; Estill-Terpack, Sandi; Mirbaha, Hilda; Diamond, Marc, I] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Luu, Hung S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Childrens Hlth, Dallas, TX 75390 USA; [Stopschinski, Barbara E.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany; [Nadji, Sourena; Darvish, Eric] PharmaRen Discovery LLC, Berkeley, MO 63134 USA; [Fan, Linfeng] Shanghai Acana Pharmtech Co Ltd, Berkeley, MO 63134 USA; [Holmes, Brandon B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; RWTH Aachen University; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, NL10 120,6000 Harry Hines Blvd, Dallas, TX 75390 USA.	marc.diamond@utsouthwestern.edu		Luu, Hung S/0000-0003-2001-4031; Holmes, Brandon/0000-0002-1153-840X	Texas Institute for Brain Injury and Repair; Peter O'Donnell Jr. Brain Institute; Haggerty Center for Research on Brain Injury and Repair in Stroke	Texas Institute for Brain Injury and Repair; Peter O'Donnell Jr. Brain Institute; Haggerty Center for Research on Brain Injury and Repair in Stroke	We thank Baovy Pham (Departments of Pathology, Children's Medical Center Dallas) for performing the coagulation assays for the spiking study; Denise Ramirez (Whole Brain Microscopy Facility at University of Texas Southwestern Medical Center) for assistance with slide scanning (the Whole Brain Microscopy Facility is supported by the Texas Institute for Brain Injury and Repair and the Peter O'Donnell Jr. Brain Institute); and Eric Plautz (Neuro-Models Facility Core at University of Texas Southwestern Medical Center) for help with animal surgery (the Neuro-Models Facility Core is supported by the Texas Institute for Brain Injury and Repair and the Haggerty Center for Research on Brain Injury and Repair in Stroke).	Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Dudas B, 2008, NEURODEGENER DIS, V5, P200, DOI 10.1159/000113702; Dudas B, 2002, NEUROBIOL AGING, V23, P97, DOI 10.1016/S0197-4580(01)00255-X; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fareed J, 2000, SEMIN THROMB HEMOST, V26, P5, DOI 10.1055/s-2000-9498; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; GlaxoSmithKline, 2009, AR PRESCR INF 2009; Hemker HC, 2016, J THROMB HAEMOST, V14, P2329, DOI 10.1111/jth.13555; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kaufman SK, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0442-8; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Lapierre F, 1996, GLYCOBIOLOGY, V6, P355, DOI 10.1093/glycob/6.3.355; Leveugle B, 1998, J NEUROCHEM, V70, P736; LEVEUGLE B, 1994, NEUROREPORT, V5, P1389, DOI 10.1097/00001756-199406000-00025; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Ma Q, 2002, THROMB RES, V105, P447, DOI 10.1016/S0049-3848(02)00050-6; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Naini SMA, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00163; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Payal Parth Patel C. M., 2013, EFFICIENT SCALABLE P; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; PETITOU M, 1991, SEMIN THROMB HEMOST, V17, P143; Rainov NG, 2007, EXPERT OPIN BIOL TH, V7, P713, DOI 10.1517/14712598.7.5.713; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Schonberger O, 2003, BIOCHEM BIOPH RES CO, V312, P473, DOI 10.1016/j.bbrc.2003.10.150; Shafiei SS, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00083; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Sourena Nadji J. T. S., 2015, PROCESS PREPARING FO; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Teruya K, 2015, BIOCHEM BIOPH RES CO, V460, P989, DOI 10.1016/j.bbrc.2015.03.139; Timmer NM, 2010, NEUROBIOL DIS, V40, P340, DOI 10.1016/j.nbd.2010.06.008; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Walzer M, 2002, EUR J PHARMACOL, V445, P211, DOI 10.1016/S0014-2999(02)01759-4; Wang P, 2018, CHEM COMMUN, V54, P10120, DOI 10.1039/c8cc05072d; Weiss RJ, 2017, ORG BIOMOL CHEM, V15, P5656, DOI 10.1039/c7ob01058c; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024	54	14	14	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2974	2983		10.1074/jbc.RA119.010353	http://dx.doi.org/10.1074/jbc.RA119.010353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974166	hybrid, Green Published			2022-12-28	WOS:000519597300009
J	Su, VL; Simon, B; Draheim, KM; Calderwood, DA				Su, Valerie L.; Simon, Bertrand; Draheim, Kyle M.; Calderwood, David A.			Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cerebral cavernous malformation; cell compartmentalization; KRIT1 (Krev interaction trapped); nuclear translocation; nuclear transport; phosphorylation; ICAP1 (integrin cytoplasmic domain-associated protein-1); nuclear import; nucleocytoplasmic shuttling; phosphoprotein	CEREBRAL CAVERNOUS MALFORMATIONS; DOMAIN-ASSOCIATED PROTEIN; CYTOPLASMIC DOMAIN; ANKYRIN REPEAT; CELL-ADHESION; INTEGRIN; KRIT1; KINASE; LOCALIZATION; MECHANISM	Nuclear accumulation of the small phosphoprotein integrin cytoplasmic domain?associated protein-1 (ICAP1) results in recruitment of its binding partner, Krev/Rap1 interaction trapped-1 (KRIT1), to the nucleus. KRIT1 loss is the most common cause of cerebral cavernous malformation, a neurovascular dysplasia resulting in dilated, thin-walled vessels that tend to rupture, increasing the risk for hemorrhagic stroke. KRIT1's nuclear roles are unknown, but it is known to function as a scaffolding or adaptor protein at cell-cell junctions and in the cytosol, supporting normal blood vessel integrity and development. As ICAP1 controls KRIT1 subcellular localization, presumably influencing KRIT1 function, in this work, we investigated the signals that regulate ICAP1 and, hence, KRIT1 nuclear localization. ICAP1 contains a nuclear localization signal within an unstructured, N-terminal region that is rich in serine and threonine residues, several of which are reportedly phosphorylated. Using quantitative microscopy, we revealed that phosphorylation-mimicking substitutions at Ser-10, or to a lesser extent at Ser-25, within this N-terminal region inhibit ICAP1 nuclear accumulation. Conversely, phosphorylation-blocking substitutions at these sites enhanced ICAP1 nuclear accumulation. We further demonstrate that p21-activated kinase 4 (PAK4) can phosphorylate ICAP1 at Ser-10 both in vitro and in cultured cells and that active PAK4 inhibits ICAP1 nuclear accumulation in a Ser-10?dependent manner. Finally, we show that ICAP1 phosphorylation controls nuclear localization of the ICAP1-KRIT1 complex. We conclude that serine phosphorylation within the ICAP1 N-terminal region can prevent nuclear ICAP1 accumulation, providing a mechanism that regulates KRIT1 localization and signaling, potentially influencing vascular development.	[Su, Valerie L.; Simon, Bertrand; Draheim, Kyle M.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.; Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	david.calderwood@yale.edu		Su, Valerie/0000-0003-2919-0162; Calderwood, David/0000-0002-0791-4142	National Institutes of Health [R01NS085078, GM007324, F31HL143831]; American Heart Association [18POST33960340]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants R01NS085078 (to D. A. C.) and GM007324 and F31HL143831 (to V. L. S.) and American Heart Association Grant 18POST33960340 (to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Degani S, 2002, J CELL BIOL, V156, P377, DOI 10.1083/jcb.200108030; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; DiStefano PV, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582304; Draheim KM, 2017, J BIOL CHEM, V292, P1884, DOI 10.1074/jbc.M116.762393; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fisher OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8937; Fisher OS, 2015, J BIOL CHEM, V290, P2842, DOI 10.1074/jbc.M114.616433; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077818; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08373-4; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Ha BH, 2015, J BIOL CHEM, V290, P12975, DOI 10.1074/jbc.R115.650416; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Kadry YA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221184; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kurth JH, 1994, AM J HUM GENET S3, V55, pA15; Lisowska J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216093; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Lopez-Ramirez MA, 2019, BLOOD, V133, P193, DOI 10.1182/blood-2018-06-856062; Lopez-Ramirez MA, 2017, J EXP MED, V214, P3331, DOI 10.1084/jem.20171178; MARCHUK DA, 1995, GENOMICS, V28, P311, DOI 10.1006/geno.1995.1147; Marzo S, 2014, EUR J HISTOCHEM, V58, P62, DOI 10.4081/ejh.2014.2358; MCCORMICK WF, 1966, J NEUROSURG, V24, P807, DOI 10.3171/jns.1966.24.4.0807; Miller CJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006540; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Millon-Fremillon A, 2013, J BIOL CHEM, V288, P20248, DOI 10.1074/jbc.M113.455956; Morse EM, 2016, J CELL SCI, V129, P380, DOI 10.1242/jcs.177493; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nekrasova T, 2012, TRANSGENIC RES, V21, P797, DOI 10.1007/s11248-011-9578-7; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Stroeken PJM, 2006, J CELL PHYSIOL, V208, P620, DOI 10.1002/jcp.20699; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang R, 2015, J STRUCT BIOL, V192, P449, DOI 10.1016/j.jsb.2015.10.006; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	68	6	6	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3269	3284		10.1074/jbc.RA119.009794	http://dx.doi.org/10.1074/jbc.RA119.009794			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32005669	hybrid, Green Published			2022-12-28	WOS:000519597300031
J	Vanbeselaere, J; Jin, CS; Eckmair, B; Wilson, IBH; Paschinger, K				Vanbeselaere, Jorick; Jin, Chunsheng; Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina			Sulfated and sialylated N-glycans in the echinoderm Holothuria atra reflect its marine habitat and phylogeny	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycomics; glycosylation; N-linked glycosylation; glycobiology; MS; evolution; echinoderm; lollyfish; N-glycans; N-glycome	STRUCTURAL-ANALYSIS; ACETYLNEURAMINIC ACID; LINKED GLYCANS; OLIGOSACCHARIDES; CONSTITUENTS; GANGLIOSIDE; DERIVATIVES; ANTICANCER; CANCER; CHAINS	Among the earliest deuterostomes, the echinoderms are an evolutionary important group of ancient marine animals. Within this phylum, the holothuroids (sea cucumbers) are known to produce a wide range of glycoconjugate biopolymers with apparent benefits to health; therefore, they are of economic and culinary interest throughout the world. Other than their highly modified glycosaminoglycans (e.g. fucosylated chondroitin sulfate and fucoidan), nothing is known about their protein-linked glycosylation. Here we used multistep N-glycan fractionation to efficiently separate anionic and neutral N-glycans before analyzing the N-glycans of the black sea cucumber (Holothuria atra) by MS in combination with enzymatic and chemical treatments. These analyses showed the presence of various fucosylated, phosphorylated, sialylated, and multiply sulfated moieties as modifications of oligomannosidic, hybrid, and complex-type N-glycans. The high degree of sulfation and fucosylation parallels the modifications observed previously on holothuroid glycosaminoglycans. Compatible with its phylogenetic position, H. atra not only expresses vertebrate motifs such as sulfo? and sialyl?Lewis A epitopes but displays a high degree of anionic substitution of its glycans, as observed in other marine invertebrates. Thus, as for other echinoderms, the phylum- and order-specific aspects of this species' N-glycosylation reveal both invertebrate- and vertebrate-like features.	[Vanbeselaere, Jorick; Eckmair, Barbara; Wilson, Iain B. H.; Paschinger, Katharina] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Jin, Chunsheng] Gothenburg Univ, Sahlgrenska Acad, Inst Biomed, S-40530 Gothenburg, Sweden	University of Natural Resources & Life Sciences, Vienna; University of Gothenburg	Wilson, IBH (corresponding author), Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009	Wilson, Iain/0000-0001-8996-1518; Eckmair, Barbara/0000-0003-0818-867X; Paschinger, Katharina/0000-0002-3594-7136; Vanbeselaere, Jorick/0000-0002-1949-4835	Austrian Science Fund [P25058, P29466]; European Commission [PITN-GA-2013-608295]	Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Austrian Science Fund Grants P25058 (to K. P.) and P29466 (to I. B. H. W.) and European Commission Grant PITN-GA-2013-608295 (to J. V.).	Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Cabrera G, 2016, GLYCOBIOLOGY, V26, P230, DOI 10.1093/glycob/cwv096; Correia-Da-Silva M, 2017, SEMIN CANCER BIOL, V46, P55, DOI 10.1016/j.semcancer.2017.03.011; Dolmatov Igor Yu, 2014, ScientificWorldJournal, V2014, P527234, DOI 10.1155/2014/527234; Dragosits M, 2014, APPL MICROBIOL BIOT, V98, P3553, DOI 10.1007/s00253-013-5192-3; Eckmair B, 2020, J BIOL CHEM, V295, P3173, DOI 10.1074/jbc.RA119.011703; Eckmair B, 2016, MOL CELL PROTEOMICS, V15, P573, DOI 10.1074/mcp.M115.051573; Engle DD, 2019, SCIENCE, V364, P1156, DOI 10.1126/science.aaw3145; Gonzalez-Wanguemert M, 2014, OCEAN COAST MANAGE, V92, P87, DOI 10.1016/j.ocecoaman.2014.02.014; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Guerardel Y, 2012, GLYCOBIOLOGY, V22, P479, DOI 10.1093/glycob/cwr155; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harvey DJ, 2010, J MASS SPECTROM, V45, P528, DOI 10.1002/jms.1736; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hykollari A, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.08.002; Hykollari A, 2017, METHODS MOL BIOL, V1503, P167, DOI 10.1007/978-1-4939-6493-2_13; Hykollari A, 2016, MOL CELL PROTEOMICS, V15, P73, DOI 10.1074/mcp.M115.055061; Hykollari A, 2013, J PROTEOME RES, V12, P1173, DOI 10.1021/pr300806b; Ishimizu T, 1999, EUR J BIOCHEM, V263, P624, DOI 10.1046/j.1432-1327.1999.00499.x; Janakiram NB, 2015, MAR DRUGS, V13, P2909, DOI 10.3390/md13052909; Jimenez-Castells C, 2016, GLYCOBIOLOGY, V26, P1297, DOI 10.1093/glycob/cww051; Karamanos NK, 1996, BIOCHIMIE, V78, P171, DOI 10.1016/0300-9084(96)89502-2; Kisa F, 2006, CHEM PHARM BULL, V54, P1293, DOI 10.1248/cpb.54.1293; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Mertsalov IB, 2016, BIOCHEM J, V473, P1905, DOI 10.1042/BCJ20160347; Miyagawa S, 2014, GLYCOBIOLOGY, V24, P125, DOI 10.1093/glycob/cwt088; Mou JJ, 2017, INT J BIOL MACROMOL, V98, P208, DOI 10.1016/j.ijbiomac.2017.01.123; MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216; Murakami T, 2007, GLYCOCONJUGATE J, V24, P195, DOI 10.1007/s10719-006-9026-8; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982, DOI 10.1093/oxfordjournals.jbchem.a123700; Paschinger K, 2020, GLYCOCONJUGATE J, V37, P27, DOI 10.1007/s10719-019-09874-2; Paschinger K, 2019, PARASITOLOGY, V146, P1733, DOI 10.1017/S0031182019000398; Paschinger K, 2016, GLYCOCONJUGATE J, V33, P273, DOI 10.1007/s10719-016-9650-x; SCHLENZKA W, 1993, BIOCHIM BIOPHYS ACTA, V1161, P131, DOI 10.1016/0167-4838(93)90206-7; Silchenko AS, 2016, NAT PROD COMMUN, V11, P741; Stanton R, 2017, BBA-GEN SUBJECTS, V1861, P699, DOI 10.1016/j.bbagen.2017.01.009; Taguchi T, 1996, EUR J BIOCHEM, V238, P357, DOI 10.1111/j.1432-1033.1996.0357z.x; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yamada K, 2002, CHEM PHARM BULL, V50, P1467, DOI 10.1248/cpb.50.1467; Yamada K, 2001, CHEM PHARM BULL, V49, P447, DOI 10.1248/cpb.49.447; Yamakawa N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06950-3; YAMASHITA K, 1977, J BIOL CHEM, V252, P5408; Yan S, 2015, ELECTROPHORESIS, V36, P1314, DOI 10.1002/elps.201400528; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113	53	8	8	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3159	3172		10.1074/jbc.RA119.011701	http://dx.doi.org/10.1074/jbc.RA119.011701			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31969392	hybrid, Green Published			2022-12-28	WOS:000519597300022
J	Dai, SB; Horton, JR; Wilkinson, AW; Gozani, O; Zhang, X; Cheng, XD				Dai, Shaobo; Horton, John R.; Wilkinson, Alex W.; Gozani, Or; Zhang, Xing; Cheng, Xiaodong			An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S-adenosylmethionine (SAM); protein methylation; structural biology; enzyme catalysis; enzyme kinetics; histidine; glutamine methylation; histidine methylation; lysine methylation	SUBSTRATE-SPECIFICITY; HEMK2 PROTEIN; DOMAIN; CHROMATIN; IDENTIFICATION; EXPRESSION; DIM-5	Most characterized SET domain (SETD) proteins are protein lysine methyltransferases, but SETD3 was recently demonstrated to be a protein (i.e. actin) histidine-N-3 methyltransferase. Human SETD3 shares a high structural homology with two known protein lysine methyltransferases?human SETD6 and the plant LSMT?but differs in the residues constituting the active site. In the SETD3 active site, Asn(255) engages in a unique hydrogen-bonding interaction with the target histidine of actin that likely contributes to its >1300-fold greater catalytic efficiency (k(cat)/K-m) on histidine than on lysine. Here, we engineered active-site variants to switch the SETD3 target specificity from histidine to lysine. Substitution of Asn(255) with phenylalanine (N255F), together with substitution of Trp(273) with alanine (W273A), generated an active site mimicking that of known lysine methyltransferases. The doubly substituted SETD3 variant exhibited a 13-fold preference for lysine over histidine. We show, by means of X-ray crystallography, that the two target nitrogen atoms?the N-3 atom of histidine and the terminal ?-amino nitrogen of lysine?occupy the same position and point toward and are within a short distance of the incoming methyl group of SAM for a direct methyl transfer during catalysis. In contrast, SETD3 and its Asn(255) substituted derivatives did not methylate glutamine (another potentially methylated amino acid). However, the glutamine-containing peptide competed with the substrate peptide, and glutamine bound in the active site, but too far away from SAM to be methylated. Our results provide insight into the structural parameters defining the target amino acid specificity of SET enzymes.	[Dai, Shaobo; Horton, John R.; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Texas System; UTMD Anderson Cancer Center; Stanford University	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	xzhang21@mdanderson.org; xcheng5@mdanderson.org	Horton, John R/ABB-4770-2020	Dai, Shaobo/0000-0002-1629-4483; Cheng, Xiaodong/0000-0002-6967-6362; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [GM114306, GM133051]; Cancer Prevention and Research Institute of Texas Grant [RR160029]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant	This work was supported by National Institutes of Health Grants GM114306 (to X. C.) and GM133051 (to O. G.) and Cancer Prevention and Research Institute of Texas Grant RR160029 (to X. C.). X. C. is a CPRIT Scholar in Cancer Research. O. G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Coward J. K., 1977, BIOCH ADENOSYLMETHIO, P127; Dai SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11554-6; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Diep J, 2019, NAT MICROBIOL, V4, P2523, DOI 10.1038/s41564-019-0551-1; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Guo Q, 2019, ELIFE, V8, DOI 10.7554/eLife.43676; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; Kudithipudi S, 2012, BIOCHIMIE, V94, P2212, DOI 10.1016/j.biochi.2012.04.024; Kusevic D, 2016, J BIOL CHEM, V291, P6124, DOI 10.1074/jbc.M115.711952; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; Levy D, 2019, CELL MOL LIFE SCI, V76, P2873, DOI 10.1007/s00018-019-03142-0; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger E, 2019, NAT STRUCT MOL BIOL, V26, P361, DOI 10.1038/s41594-019-0219-9; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shechter D, 2019, CELL MOL LIFE SCI, V76, P2871, DOI 10.1007/s00018-019-03141-1; Tolsma TO, 2019, ESSAYS BIOCHEM, V63, P89, DOI 10.1042/EBC20180067; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Wood K, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010011; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0119-5; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936	39	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2582	2589		10.1074/jbc.RA119.012319	http://dx.doi.org/10.1074/jbc.RA119.012319			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31911441	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000519969100005
J	Pawlik, G; Renne, MF; Kol, MA; de Kroon, AIPM				Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.			The topology of the ER-resident phospholipid methyltransferase Opi3 of Saccharomyces cerevisiae is consistent with in trans catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid metabolism; cysteine-mediated cross-linking; membrane enzyme; yeast; S-adenosylmethionine (SAM); cysteine scanning; in trans catalysis; membrane topology; phosphatidylethanolamine N-methyltransferase (PEMT); phospholipid N-methyltransferase (PLMT)	CROSS-PATHWAY REGULATION; N-METHYLTRANSFERASES; MEMBRANE-PROTEINS; CONTACT SITES; PHOSPHATIDYLCHOLINE; METHYLATION; MECHANISM; MEMBER; GENE; WEB	Phospholipid N-methyltransferases (PLMTs) synthesize phosphatidylcholine by methylating phosphatidylethanolamine using S-adenosylmethionine as a methyl donor. Eukaryotic PLMTs are integral membrane enzymes located in the endoplasmic reticulum (ER). Recently Opi3, a PLMT of the yeast Saccharomyces cerevisiae was proposed to perform in trans catalysis, i.e. while localized in the ER, Opi3 would methylate lipid substrates located in the plasma membrane at membrane contact sites. Here, we tested whether the Opi3 active site is located at the cytosolic side of the ER membrane, which is a prerequisite for in trans catalysis. The membrane topology of Opi3 (and its human counterpart, phosphatidylethanolamine N-methyltransferase, expressed in yeast) was addressed by topology prediction algorithms and by the substituted cysteine accessibility method. The results of these analyses indicated that Opi3 (as well as phosphatidylethanolamine N-methyltransferase) has an N-out C-in topology and contains four transmembrane domains, with the fourth forming a re-entrant loop. On the basis of the sequence conservation between the C-terminal half of Opi3 and isoprenyl cysteine carboxyl methyltransferases with a solved crystal structure, we identified amino acids critical for Opi3 activity by site-directed mutagenesis. Modeling of the structure of the C-terminal part of Opi3 was consistent with the topology obtained by the substituted cysteine accessibility method and revealed that the active site faces the cytosol. In conclusion, the location of the Opi3 active site identified here is consistent with the proposed mechanism of in trans catalysis, as well as with conventional catalysis in cis.	[Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Pawlik, Grzegorz] Liposoma BV, Sci Pk 408, NL-1098 XH Amsterdam, Netherlands; [Renne, Mike F.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kol, Matthijs A.] Univ Osnabruck, Dept Biol Chem, Mol Cell Biol Div, D-49076 Osnabruck, Germany	Utrecht University; Utrecht University; University of Oxford; University Osnabruck	de Kroon, AIPM (corresponding author), Univ Utrecht, Dept Membrane Biochem & Biophys, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.i.p.m.dekroon@uu.nl		de Kroon, Anton/0000-0003-1209-756X; Renne, Mike/0000-0003-0508-2298	Focus en Massa Program Membrane proteins of Utrecht University	Focus en Massa Program Membrane proteins of Utrecht University	This work was supported by the Focus en Massa Program Membrane proteins of Utrecht University. The authors declare that they have no conflicts of interest with the contents of this article.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boumann HA, 2004, J BIOL CHEM, V279, P40314, DOI 10.1074/jbc.M406517200; Brooks CL, 2013, PROTEIN SCI, V22, P425, DOI 10.1002/pro.2223; Danne L, 2015, MOL MICROBIOL, V95, P313, DOI 10.1111/mmi.12870; DAUM G, 1982, J BIOL CHEM, V257, P3028; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Diver MM, 2018, NATURE, V553, P526, DOI 10.1038/nature25439; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Henrich E, 2018, BIOCHEMISTRY-US, V57, P5780, DOI 10.1021/acs.biochem.8b00807; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Holzl G, 2019, ANNU REV PLANT BIOL, V70, P51, DOI 10.1146/annurev-arplant-050718-100202; Hoffmann PC, 2017, BIOL CELL, V109, P400, DOI 10.1111/boc.201700031; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Janssen MJFW, 2002, FEBS LETT, V513, P197, DOI 10.1016/S0014-5793(02)02298-6; Kanipes MI, 1997, BBA-LIPID LIPID MET, V1348, P134, DOI 10.1016/S0005-2760(97)00121-5; Keogh MR, 2009, J BIOL CHEM, V284, P15439, DOI 10.1074/jbc.M109.005991; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; MCGRAW P, 1989, GENETICS, V122, P317; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Morita S, 2010, BIOCHEM J, V432, P387, DOI 10.1042/BJ20100490; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Pundir Sangya, 2016, Curr Protoc Bioinformatics, V53, DOI 10.1002/0471250953.bi0129s53; Quon E, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003864; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sadhua MJ, 2014, MOL BIOL CELL, V25, P1653, DOI 10.1091/mbc.E13-12-0755; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; SUMMERS EF, 1988, GENETICS, V120, P909; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Ye CQ, 2017, MOL CELL, V66, P180, DOI 10.1016/j.molcel.2017.02.026	51	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2473	2482		10.1074/jbc.RA119.011102	http://dx.doi.org/10.1074/jbc.RA119.011102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932304	Green Published, hybrid			2022-12-28	WOS:000517330200027
J	Porter, JJ; Jang, HS; Haque, MM; Stuehr, DJ; Mehl, RA				Porter, Joseph J.; Jang, Hyo Sang; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.; Mehl, Ryan A.			Tyrosine nitration on calmodulin enhances calcium-dependent association and activation of nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; reactive nitrogen species (RNS); calmodulin (CaM); nitric-oxide synthase; post-translational modification (PTM); calcium regulation; endothelial nitric-oxide synthase (eNOS); nitroTyrosine; ox-PTM; tyrosine nitration	STRUCTURAL BASIS; PHOSPHORYLATION; BINDING; PEPTIDES; DYNAMICS; ENOS	Production of reactive oxygen species caused by dysregulated endothelial nitric-oxide synthase (eNOS) activity is linked to vascular dysfunction. eNOS is a major target protein of the primary calcium-sensing protein calmodulin. Calmodulin is often modified by the main biomarker of nitroxidative stress, 3-nitrotyrosine (nitroTyr). Despite nitroTyr being an abundant post-translational modification on calmodulin, the mechanistic role of this modification in altering calmodulin function and eNOS activation has not been investigated. Here, using genetic code expansion to site-specifically nitrate calmodulin at its two tyrosine residues, we assessed the effects of these alterations on calcium binding by calmodulin and on binding and activation of eNOS. We found that nitroTyr?calmodulin retains affinity for eNOS under resting physiological calcium concentrations. Results from in vitro eNOS assays with calmodulin nitrated at Tyr-99 revealed that this nitration reduces nitric-oxide production and increases eNOS decoupling compared with WT calmodulin. In contrast, calmodulin nitrated at Tyr-138 produced more nitric oxide and did so more efficiently than WT calmodulin. These results indicate that the nitroTyr post-translational modification, like tyrosine phosphorylation, can impact calmodulin sensitivity for calcium and reveal Tyr site-specific gain or loss of functions for calmodulin-induced eNOS activation.	[Porter, Joseph J.; Jang, Hyo Sang; Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44195 USA; [Haque, Mohammad Mahfuzul] Jamia Millia Islamia, Dept Biotechnol, Maulana Mohammad Ali Jauhar Marg, New Delhi 110025, India	Oregon State University; Cleveland Clinic Foundation; Jamia Millia Islamia	Mehl, RA (corresponding author), Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg,2750 SW Campus Way, Corvallis, OR 97331 USA.	Ryan.Mehl@oregonstate.edu		Jang, Hyo Sang/0000-0003-0460-9924; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [RGM114653A]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant RGM114653A (to R. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Boo YC, 2007, NITRIC OXIDE-BIOL CH, V16, P306, DOI 10.1016/j.niox.2006.09.004; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; Corti C, 1999, EUR J BIOCHEM, V262, P790, DOI 10.1046/j.1432-1327.1999.00441.x; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379; Haque MM, 2016, J BIOL CHEM, V291, P23047, DOI 10.1074/jbc.M116.737361; JOYAL JL, 1994, J BIOL CHEM, V269, P30039; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Mukherjea P, 1996, PROTEIN SCI, V5, P468; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Piazza M, 2014, BIOCHEMISTRY-US, V53, P1241, DOI 10.1021/bi401466s; Piazza M, 2012, BIOCHEMISTRY-US, V51, P3651, DOI 10.1021/bi300327z; Porter JJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7607463; Radi R, 2018, P NATL ACAD SCI USA, V115, P5839, DOI 10.1073/pnas.1804932115; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rhoads TW, 2013, J AM SOC MASS SPECTR, V24, P115, DOI 10.1007/s13361-012-0500-1; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Smallwood HS, 2007, BIOCHEMISTRY-US, V46, P10498, DOI 10.1021/bi7009713; Smallwood HS, 2003, CHEM RES TOXICOL, V16, P95, DOI 10.1021/tx025566a; Spratt DE, 2008, BIOCHEMISTRY-US, V47, P12006, DOI 10.1021/bi801418s; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Villalobo A, 2018, BIOCHEM J, V475, P4011, DOI 10.1042/BCJ20180755; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009	35	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2203	2211		10.1074/jbc.RA119.010999	http://dx.doi.org/10.1074/jbc.RA119.010999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31914408	Green Published, hybrid			2022-12-28	WOS:000517330200005
J	Robinson, PJ; Kanemura, S; Cao, XF; Bulleid, NJ				Robinson, Philip J.; Kanemura, Shingo; Cao, Xiaofei; Bulleid, Neil J.			Protein secondary structure determines the temporal relationship between folding and disulfide formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); protein disulfide isomerase; protein secretion; protein folding; protein structure; folded precursor model; nascent chain; protein homeostasis; protein translocation; quasi-stochastic model	REDUCTASE; RIBOSOME; BONDS; ISOMERIZATION; GLYCOPROTEIN; CLEAVAGE; SYSTEM; FORM	How and when disulfide bonds form in proteins relative to the stage of their folding is a fundamental question in cell biology. Two models describe this relationship: the folded precursor model, in which a nascent structure forms before disulfides do, and the quasi-stochastic model, where disulfides form prior to folding. Here we investigated oxidative folding of three structurally diverse substrates, ?2-microglobulin, prolactin, and the disintegrin domain of ADAM metallopeptidase domain 10 (ADAM10), to understand how these mechanisms apply in a cellular context. We used a eukaryotic cell-free translation system in which we could identify disulfide isomers in stalled translation intermediates to characterize the timing of disulfide formation relative to translocation into the endoplasmic reticulum and the presence of non-native disulfides. Our results indicate that in a domain lacking secondary structure, disulfides form before conformational folding through a process prone to nonnative disulfide formation, whereas in proteins with defined secondary structure, native disulfide formation occurs after partial folding. These findings reveal that the nascent protein structure promotes correct disulfide formation during cotranslational folding.	[Robinson, Philip J.; Cao, Xiaofei; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Kanemura, Shingo] Kwansei Gakuin Univ, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan	University of Glasgow; Kwansei Gakuin University	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Kanemura, Shingo/0000-0002-7012-8179; Robinson, Philip/0000-0003-2576-5010; Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [103720]; Royal Society [IE140492]; Chinese Scholarship Council; BBSRC [BB/D00764X/1, BB/P017665/1, BB/M017656/1, BB/L00593X/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Chinese Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Wellcome Trust Grant 103720 and Royal Society Grant IE140492. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Chinese Scholarship Council award.	BAILEY CA, 1989, P NATL ACAD SCI USA, V86, P22, DOI 10.1073/pnas.86.1.22; BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Fass D, 2018, CHEM REV, V118, P293, DOI 10.1021/acs.chemrev.7b00123; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lv JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20014-y; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Robinson PJ, 2017, J BIOL CHEM, V292, P6978, DOI 10.1074/jbc.M117.780742; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Singh RR, 2002, BBA-PROTEIN STRUCT M, V1597, P280, DOI 10.1016/S0167-4838(02)00301-1; Spurway TD, 2001, J BIOL CHEM, V276, P15975, DOI 10.1074/jbc.M010128200; Thommen M, 2017, CURR OPIN STRUC BIOL, V42, P83, DOI 10.1016/j.sbi.2016.11.020; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]	34	7	7	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2438	2448		10.1074/jbc.RA119.011983	http://dx.doi.org/10.1074/jbc.RA119.011983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953323	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000517330200024
J	Durand, L; Duval, S; Evagelidis, A; Guillemot, J; Dianati, V; Sikorska, E; Schu, P; Day, R; Seidah, NG				Durand, Lorelei; Duval, Stephanie; Evagelidis, Alexandra; Guillemot, Johann; Dianati, Vahid; Sikorska, Emilia; Schu, Peter; Day, Robert; Seidah, Nabil G.			The motif EXEXXXL in the cytosolic tail of the secretory human proprotein convertase PC7 regulates its trafficking and cleavage activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						shedding; trafficking; protease; protein dynamic; convertase; adaptor protein 2 (AP-2); cell sorting; cytosolic tail (CT); proprotein convertase type 7; transferrin receptor 1(TfR1)	FURIN; MEMBRANE; BINDING; AP-1; COMPLEMENTARY; INHIBITION; EXPRESSION; BIOLOGY; GROWTH; CELLS	Many secretory proteins are activated by cleavage at specific sites. The proprotein convertases (PCs) form a family of nine secretory subtilisin-like serine proteases, seven of which cleave at specific basic residues within the trans-Golgi network, granules, or at the cell surface/endosomes. The seventh member, PC7, is a type-I transmembrane (TM) protein with a 97-residue?long cytosolic tail (CT). PC7 sheds human transferrin receptor 1 (hTfR1) into soluble shTfR1 in endosomes. To better understand the physiological roles of PC7, here we focused on the relationship between the CT-regulated trafficking of PC7 and its ability to shed hTfR1. Deletion of the TMCT resulted in soluble PC7 and loss of its hTfR1 shedding activity. Extensive CT deletions and mutagenesis analyses helped us zoom in on three residues in the CT, namely Glu-719, Glu-721, and Leu-725, that are part of a novel motif, EXEXXXL725, critical for PC7 activity on hTfR1. NMR studies of two 14-mer peptides mimicking this region of the CT and its Ala variants revealed that the three exposed residues are on the same side of the molecule. This led to the identification of adaptor protein 2 (AP-2) as a protein that recognizes the EXEXXXL725 motif, thus representing a potentially new regulator of PC7 trafficking and cleavage activity. Immunocytochemistry of the subcellular localization of PC7 and its Ala variants of Leu-725 and Glu-719 and Glu-721 revealed that Leu-725 enhances PC7 localization to early endosomes and that, together with Glu-719 and Glu-721, it increases the endosomal activity of PC7 on hTfR1.	[Durand, Lorelei; Duval, Stephanie; Evagelidis, Alexandra; Seidah, Nabil G.] Univ Montreal, Clin Res Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Guillemot, Johann] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, CIRI,INSERM,U1111,CNRS,UMR5308,Team Pathogenesis, F-69100 Villeurbanne, France; [Dianati, Vahid; Day, Robert] Inst Pharmacol Sherbrooke, Dept Surg, Div Urol, Sherbrooke, PQ J1H 5N4, Canada; [Dianati, Vahid; Day, Robert] Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Sikorska, Emilia] Univ Gdansk, Fac Chem, PL-80233 Gdansk, Poland; [Schu, Peter] Univ Med Ctr, Dept Cellular Biochem, Humboldtallee 23, D-37073 Gottingen, Germany	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Fahrenheit Universities; University of Gdansk; University of Gottingen	Seidah, NG (corresponding author), Clin Res Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Guillemot, Johann/O-1066-2013; Seidah, Nabil/I-3596-2013	Guillemot, Johann/0000-0002-5902-9188; Seidah, Nabil/0000-0001-6503-9342; Sikorska, Emilia/0000-0001-7851-6371; Dianati, Vahid/0000-0001-6883-6574; Schu, Peter/0000-0001-7169-1097	Canadian Institutes of Health Research Foundation Scheme [148363]; Canada Research Chair [950-231335]	Canadian Institutes of Health Research Foundation Scheme(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institutes of Health Research Foundation Scheme 148363 and Canada Research Chair 950-231335. The authors declare that they have no conflicts of interest with the contents of this article.	Ashraf Y, 2018, ATHEROSCLEROSIS SUPP, V32, P56, DOI 10.1016/j.atherosclerosissup.2018.04.169; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baltes J, 2014, J CELL SCI, V127, P3477, DOI 10.1242/jcs.146886; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chamberland JP, 2016, J CELL SCI, V129, P2625, DOI 10.1242/jcs.173708; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Dacks JB, 2017, CURR OPIN CELL BIOL, V47, P108, DOI 10.1016/j.ceb.2017.04.001; Declercq J, 2017, EUR J CELL BIOL, V96, P432, DOI 10.1016/j.ejcb.2017.03.010; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Dongiovanni P, 2019, J LIPID RES, V60, P1144, DOI 10.1194/jlr.P090449; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Gavenonis J, 2014, NAT CHEM BIOL, V10, P716, DOI [10.1038/NCHEMBIO.1580, 10.1038/nchembio.1580]; Ginefra P, 2018, CELL REP, V22, P2176, DOI 10.1016/j.celrep.2018.02.005; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Guardia CM, 2018, CURR OPIN NEUROBIOL, V51, P103, DOI 10.1016/j.conb.2018.02.021; Guillemot J, 2014, FEBS OPEN BIO, V4, P741, DOI 10.1016/j.fob.2014.08.004; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medigeshi GR, 2008, TRAFFIC, V9, P121, DOI 10.1111/j.1600-0854.2007.00672.x; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Rajan SG, 2018, GENESIS, V56, DOI 10.1002/dvg.23214; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah Nabil G, 2017, Glob Cardiol Sci Pract, V2017, pe201702, DOI 10.21542/gcsp.2017.2; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Senturker S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039380; Sergeeva OA, 2019, P NATL ACAD SCI USA, V116, P1279, DOI 10.1073/pnas.1812588116; Shi X, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00559; Susan-Resiga D, 2017, J BIOL CHEM, V292, P1573, DOI 10.1074/jbc.M116.769430; Tie HC, 2017, JOVE-J VIS EXP, DOI 10.3791/55996; Turpeinen H, 2013, J BIOL CHEM, V288, P36610, DOI 10.1074/jbc.M113.453183; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Voelz VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000281; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	51	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2068	2083		10.1074/jbc.RA119.011775	http://dx.doi.org/10.1074/jbc.RA119.011775			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915245	hybrid, Green Published			2022-12-28	WOS:000517128200024
J	Westerfield, JM; Barrera, FN				Westerfield, Justin M.; Barrera, Francisco N.			Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein?protein interaction; receptor tyrosine kinase; oligomerization; transmembrane domain; epidermal growth factor receptor (EGFR); T-cell receptor (TCR); integrin; ?-helical; cell signaling; conformational change; transmembrane receptor	EPIDERMAL-GROWTH-FACTOR; T-CELL-RECEPTOR; PROTEIN-PROTEIN INTERACTIONS; HELIX-HELIX INTERACTIONS; E5 TRANSFORMING PROTEIN; EPHA2 TYROSINE KINASE; AMINO-ACID-SEQUENCE; PDGF BETA-RECEPTOR; IN-VITRO; SIGNAL-TRANSDUCTION	Single-pass membrane receptors contain extracellular domains that respond to external stimuli and transmit information to intracellular domains through a single transmembrane (TM) ?-helix. Because membrane receptors have various roles in homeostasis, signaling malfunctions of these receptors can cause disease. Despite their importance, there is still much to be understood mechanistically about how single-pass receptors are activated. In general, single-pass receptors respond to extracellular stimuli via alterations in their oligomeric state. The details of this process are still the focus of intense study, and several lines of evidence indicate that the TM domain (TMD) of the receptor plays a central role. We discuss three major mechanistic hypotheses for receptor activation: ligand-induced dimerization, ligand-induced rotation, and receptor clustering. Recent observations suggest that receptors can use a combination of these activation mechanisms and that technical limitations can bias interpretation. Short peptides derived from receptor TMDs, which can be identified by screening or rationally developed on the basis of the structure or sequence of their targets, have provided critical insights into receptor function. Here, we explore recent evidence that, depending on the target receptor, TMD peptides cannot only inhibit but also activate target receptors and can accommodate novel, bifunctional designs. Furthermore, we call for more sharing of negative results to inform the TMD peptide field, which is rapidly transforming into a suite of unique tools with the potential for future therapeutics.	[Westerfield, Justin M.; Barrera, Francisco N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Barrera, FN (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	fbarrera@utk.edu		Westerfield, Justin/0000-0002-3937-5833; Barrera, Francisco N./0000-0002-5200-7891	National Institutes of Health [R01GM120642]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM120642. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Alberts B., 2008, MOL BIOL CELL, P1539; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Ali M, 2005, BIOCONJUGATE CHEM, V16, P1556, DOI 10.1021/bc050127j; Ali M, 2001, LETT PEPT SCI, V8, P289, DOI 10.1023/A:1016277622317; Ali M, 2001, LETT PEPT SCI, V8, P227; Ali M, 2006, INT J PEPT RES THER, V12, P261, DOI 10.1007/s10989-006-9025-4; Alto LT, 2017, METHODS MOL BIOL, V1493, P1, DOI 10.1007/978-1-4939-6448-2_1; Alves DS, 2018, ELIFE, V7, DOI 10.7554/eLife.36645; Amon MA, 2006, BBA-MOL CELL RES, V1763, P879, DOI 10.1016/j.bbamcr.2006.04.013; Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; Anderson SM, 2017, J AM CHEM SOC, V139, P15774, DOI 10.1021/jacs.7b07505; Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; Anikeeva N, 2019, J IMMUNOL, V202, P591, DOI 10.4049/jimmunol.1801196; Arbely E, 2004, J AM CHEM SOC, V126, P5362, DOI 10.1021/ja049826h; Arndt-Jovin DJ, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a008961; Arpel A, 2016, ONCOTARGET, V7, P54723, DOI 10.18632/oncotarget.10101; Arpel A, 2014, CELL REP, V8, P1714, DOI 10.1016/j.celrep.2014.07.044; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Bagnard D., 2002, U. S. Patent, Patent No. [6417168 B1, 6417168]; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Barker FG, 2001, INT J RADIAT ONCOL, V51, P410, DOI 10.1016/S0360-3016(01)01609-1; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Benej M, 2013, NEOPLASMA, V60, P111, DOI 10.4149/neo_2013_015; Bennasroune A, 2005, CELL MOL LIFE SCI, V62, P2124, DOI 10.1007/s00018-005-5226-9; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; BERGMAN P, 1988, ONCOGENE, V2, P453; Bessman NJ, 2014, CELL REP, V9, P1306, DOI 10.1016/j.celrep.2014.10.010; Bloch E, 2019, J BIOL CHEM, V294, P18796, DOI 10.1074/jbc.RA119.010229; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bocharov EV, 2018, BBA-GEN SUBJECTS, V1862, P1410, DOI 10.1016/j.bbagen.2018.03.022; Bocharov EV, 2017, BIOCHEMISTRY-US, V56, P1697, DOI 10.1021/acs.biochem.6b01085; Bocharov EV, 2017, BBA-BIOMEMBRANES, V1859, P561, DOI 10.1016/j.bbamem.2016.10.024; Bocharov EV, 2016, BBA-BIOMEMBRANES, V1858, P1254, DOI 10.1016/j.bbamem.2016.02.023; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; Botta J, 2019, J BIOL CHEM, V294, P16587, DOI 10.1074/jbc.RA119.009160; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bublil EM, 2016, BIOCHEMISTRY-US, V55, P5520, DOI 10.1021/acs.biochem.6b00450; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Cammett TJ, 2010, P NATL ACAD SCI USA, V107, P3447, DOI 10.1073/pnas.0915057107; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CAO HN, 1992, J BIOL CHEM, V267, P20489; Caputo GA, 2008, BIOCHEMISTRY-US, V47, P8600, DOI 10.1021/bi800687h; Carles-Kinch K, 2002, CANCER RES, V62, P2840; CARPENTER CD, 1991, J BIOL CHEM, V266, P5750; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; CASTEN LA, 1988, J IMMUNOL, V140, P404; CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; Chen ZW, 2018, P NATL ACAD SCI USA, V115, pE5696, DOI 10.1073/pnas.1719961115; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; COHEN BD, 1993, J VIROL, V67, P5303, DOI 10.1128/JVI.67.9.5303-5311.1993; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; Collier S, 2006, SCAND J IMMUNOL, V64, P388, DOI 10.1111/j.1365-3083.2006.01806.x; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cristian L, 2003, P NATL ACAD SCI USA, V100, P14772, DOI 10.1073/pnas.2536751100; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Cymer F, 2008, CURR MED CHEM, V15, P779, DOI 10.2174/092986708783955545; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Deacon JC, 2015, ARCH BIOCHEM BIOPHYS, V565, P40, DOI 10.1016/j.abb.2014.11.002; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DELISI C, 1980, Q REV BIOPHYS, V13, P201, DOI 10.1017/S0033583500001657; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Fink A, 2013, J IMMUNOL, V190, P6410, DOI 10.4049/jimmunol.1202033; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; FRATTALI AL, 1991, J BIOL CHEM, V266, P9829; Freeman-Cook LL, 2005, ONCOGENE, V24, P7756, DOI 10.1038/sj.onc.1209039; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; FURTHMAYR H, 1976, BIOCHEMISTRY-US, V15, P1137, DOI 10.1021/bi00650a028; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Godfroy JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048875; Gollner GP, 2000, GENE THER, V7, P1000, DOI 10.1038/sj.gt.3301183; Gomez-Soler M, 2019, J BIOL CHEM, V294, P8791, DOI 10.1074/jbc.RA119.008213; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grau B, 2017, CELL STRESS, V1, P90, DOI 10.15698/cst2017.11.111; Greene AC, 2014, BIOPHYS J, V106, P2196, DOI 10.1016/j.bpj.2014.03.043; Greene M. L., 2015, U. S. Patent, Patent No. [8956622 B2, 8956622]; Gullick WJ, 2001, BREAST CANCER RES, V3, P390, DOI 10.1186/bcr328; Gumustekin M, 2012, PATHOL ONCOL RES, V18, P209, DOI 10.1007/s12253-011-9430-7; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hasan M, 2019, J MEMBRANE BIOL, V252, P357, DOI 10.1007/s00232-019-00075-4; He L, 2019, ISCIENCE, V17, P167, DOI 10.1016/j.isci.2019.06.027; He L, 2017, ELIFE, V6, DOI 10.7554/eLife.27701; He LJ, 2011, J MOL BIOL, V412, P43, DOI 10.1016/j.jmb.2011.07.004; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hedger G, 2016, BBA-BIOMEMBRANES, V1858, P2390, DOI 10.1016/j.bbamem.2016.02.037; Heim EN, 2015, P NATL ACAD SCI USA, V112, pE4717, DOI 10.1073/pnas.1514230112; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Hortiguela V, 2018, NANO LETT, V18, P629, DOI 10.1021/acs.nanolett.7b04904; HORWITZ BH, 1988, MOL CELL BIOL, V8, P4071, DOI 10.1128/MCB.8.10.4071; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Huynh NT, 2003, IMMUNOLOGY, V108, P458, DOI 10.1046/j.1365-2567.2003.01614.x; ISHIZAKA K, 1959, J IMMUNOL, V83, P116; Jones G, 1999, J NEUROSCI, V19, P3376; JONG SMJ, 1991, J VIROL, V65, P180, DOI 10.1128/JVI.65.1.180-189.1991; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; Karabadzhak AG, 2017, P NATL ACAD SCI USA, V114, pE7262, DOI 10.1073/pnas.1705622114; KASHLES O, 1988, P NATL ACAD SCI USA, V85, P9567, DOI 10.1073/pnas.85.24.9567; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Klasener K, 2014, ELIFE, V3, DOI 10.7554/eLife.02069; Kobus FJ, 2005, BIOCHEMISTRY-US, V44, P1464, DOI 10.1021/bi048076l; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kozer N, 2013, MOL BIOSYST, V9, P1849, DOI 10.1039/c3mb70073a; Kuchler-Bopp S, 2018, J TISSUE ENG REGEN M, V12, pE2151, DOI 10.1002/term.2648; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Landsteiner K, 1924, J EXP MED, V39, P631, DOI 10.1084/jem.39.5.631; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee J, 2014, J BIOL CHEM, V289, P19769, DOI 10.1074/jbc.M114.578641; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Lin QQ, 2013, J BIOL CHEM, V288, P1340, DOI 10.1074/jbc.M112.415596; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOFTS FJ, 1993, ONCOGENE, V8, P2813; Lohmuller T, 2013, NANO LETT, V13, P3059, DOI 10.1021/nl400874v; LONGO N, 1992, J BIOL CHEM, V267, P12416; Lorent JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01328-3; Ma YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15100; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Maehle AH, 2009, ENDEAVOUR, V33, P134, DOI 10.1016/j.endeavour.2009.09.001; Mahnke K, 2003, NAT BIOTECHNOL, V21, P903, DOI 10.1038/nbt842; Maity PC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005887; Mall S, 2001, BIOCHEMISTRY-US, V40, P12379, DOI 10.1021/bi011075y; Manni S, 2014, STRUCTURE, V22, P1077, DOI 10.1016/j.str.2014.05.010; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; Marlatt SA, 2011, PROTEIN ENG DES SEL, V24, P311, DOI 10.1093/protein/gzq112; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; MASSAGUE J, 1980, P NATL ACAD SCI-BIOL, V77, P7137, DOI 10.1073/pnas.77.12.7137; Matsushita C, 2013, P NATL ACAD SCI USA, V110, P1646, DOI 10.1073/pnas.1215207110; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Mattoon D, 2001, ONCOGENE, V20, P3824, DOI 10.1038/sj.onc.1204523; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; METZGER H, 1992, J IMMUNOL, V149, P1477; MEYER AN, 1994, P NATL ACAD SCI USA, V91, P4634, DOI 10.1073/pnas.91.11.4634; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Moser C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113482; Mohan K, 2019, SCIENCE, V364, P750, DOI 10.1126/science.aav7532; Monshipouri M, 2000, J MOL NEUROSCI, V14, P69, DOI 10.1385/JMN:14:1-2:069; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Mravic M, 2019, SCIENCE, V363, P1418, DOI 10.1126/science.aav7541; Mravic M, 2018, PROTEIN ENG DES SEL, V31, P181, DOI 10.1093/protein/gzy014; Mueller BK, 2014, P NATL ACAD SCI USA, V111, pE888, DOI 10.1073/pnas.1319944111; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9; Nash A, 2015, BBA-BIOMEMBRANES, V1848, P1248, DOI 10.1016/j.bbamem.2015.02.020; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Nguyen VP, 2019, J CONTROL RELEASE, V298, P142, DOI 10.1016/j.jconrel.2019.02.010; Nguyen VP, 2015, BIOCHEMISTRY-US, V54, P6567, DOI 10.1021/acs.biochem.5b00856; NILSON LA, 1995, J VIROL, V69, P5869, DOI 10.1128/JVI.69.9.5869-5874.1995; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Paul MD, 2019, CYTOKINE GROWTH F R, V49, P23, DOI 10.1016/j.cytogfr.2019.10.004; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PETTI L, 1994, J VIROL, V68, P3582, DOI 10.1128/JVI.68.6.3582-3592.1994; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Ptacek JB, 2007, P NATL ACAD SCI USA, V104, P11945, DOI 10.1073/pnas.0704348104; Raguine L, 2013, CHEM BIOL DRUG DES, V81, P167, DOI 10.1111/cbdd.12080; RATCLIFFE MJH, 1992, J IMMUNOL, V148, P1643; Rath A, 2007, BIOPOLYMERS, V88, P217, DOI 10.1002/bip.20668; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Saadipour K, 2017, J BIOL CHEM, V292, P16594, DOI 10.1074/jbc.M117.788729; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Saito T, 2004, ONCOL REP, V11, P605; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schaupp A, 2014, J CELL BIOL, V204, P409, DOI 10.1083/jcb.201305037; SCHECHTER Y, 1979, NATURE, V278, P835, DOI 10.1038/278835a0; Scheideman EH, 2012, J VIROL, V86, P10281, DOI 10.1128/JVI.00910-12; SCHLEGEL R, 1986, SCIENCE, V233, P464, DOI 10.1126/science.3014660; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger Joseph, 2014, Cold Spring Harb Perspect Biol, V6, DOI 10.1101/cshperspect.a008912; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shandler SJ, 2011, J AM CHEM SOC, V133, P12378, DOI 10.1021/ja204215f; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Sharonov GV, 2014, J BIOL CHEM, V289, P14955, DOI 10.1074/jbc.M114.558783; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shaw A, 2014, NAT METHODS, V11, P841, DOI [10.1038/NMETH.3025, 10.1038/nmeth.3025]; Shi XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45084; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shmuel-Galia L, 2016, EMBO J, V35, P685, DOI 10.15252/embj.201592649; Sigalov AB, 2010, CELL ADHES MIGR, V4, P255, DOI 10.4161/cam.4.2.10746; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Singh DR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0017-7; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Slivka PF, 2008, ACS CHEM BIOL, V3, P402, DOI 10.1021/cb800049w; Slusky J. S., 2009, V22, P315; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Stabley D, 2013, INTEGR BIOL-UK, V5, P659, DOI 10.1039/c3ib20239a; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Stone MB, 2017, ELIFE, V6, DOI 10.7554/eLife.19891; Stone TA, 2017, BBA-BIOMEMBRANES, V1859, P577, DOI 10.1016/j.bbamem.2016.08.013; Stoneman MR, 2019, NAT METHODS, V16, P493, DOI 10.1038/s41592-019-0408-9; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Talbert-Slagle K, 2009, VIROLOGY, V384, P345, DOI 10.1016/j.virol.2008.09.033; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Taylor MJ, 2017, CELL, V169, P108, DOI 10.1016/j.cell.2017.03.006; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; TOMITA M, 1975, P NATL ACAD SCI USA, V72, P2964, DOI 10.1073/pnas.72.8.2964; Toulmay A, 2013, J CELL BIOL, V202, P35, DOI 10.1083/jcb.201301039; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; Uchikawa E, 2019, ELIFE, V8, DOI 10.7554/eLife.48630; Velghe AI, 2014, ONCOGENE, V33, P2568, DOI 10.1038/onc.2013.218; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang XM, 2002, CLIN IMMUNOL, V105, P199, DOI 10.1006/clim.2002.5270; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wyatt LC, 2018, P NATL ACAD SCI USA, V115, pE2811, DOI 10.1073/pnas.1715350115; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; YANG YC, 1985, NATURE, V318, P575, DOI 10.1038/318575a0; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Yin H, 2016, ANNU REV BIOMED ENG, V18, P51, DOI 10.1146/annurev-bioeng-092115-025322; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g; You M, 2007, BIOCHEMISTRY-US, V46, P11039, DOI 10.1021/bi700986n; Zeng XF, 2017, BIOCHEMISTRY-US, V56, P2076, DOI 10.1021/acs.biochem.6b00909; Zhang K., 2019, ANGEW CHEM, V131, P4840; Zhang SQ, 2015, STRUCTURE, V23, P527, DOI 10.1016/j.str.2015.01.009; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	300	17	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1792	1814		10.1074/jbc.REV119.009457	http://dx.doi.org/10.1074/jbc.REV119.009457			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31879273	Green Published, hybrid			2022-12-28	WOS:000517128200003
J	Wang, HB; Loerke, D; Bruns, C; Muller, R; Koch, PA; Puchkov, D; Schultz, C; Haucke, V				Wang, Haibin; Loerke, Dinah; Bruns, Caroline; Mueller, Rainer; Koch, Philipp-Alexander; Puchkov, Dmytro; Schultz, Carsten; Haucke, Volker			Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clathrin; endocytosis; phosphoinositide; phosphatidylinositol kinase (PI kinase); phosphatidylinositol phosphatase; endosome; lysosome; mTOR complex (mTORC); imaging; nutrient signaling	PHOSPHOINOSITIDE CONVERSION; CLATHRIN; PX; COINCIDENCE; RECRUITMENT; PI(3,4)P-2; ACTIVATION; MECHANISM	Phosphoinositides play crucial roles in intracellular membrane dynamics and cell signaling, with phosphatidylinositol (PI) 3-phosphates being the predominant phosphoinositide lipids at endosomes and lysosomes, whereas PI 4-phosphates, such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), are enriched at the cell surface including sites of endocytosis. How PI 4-phosphates and PI 3-phosphates are dynamically interconverted within the endocytic pathway and how this is controlled in space and time remains poorly understood. Here, combining live imaging, genome engineering, and acute chemical and genetic manipulations, we found that local synthesis of PI(3,4)P-2 by phosphatidylinositol 3-kinase C2? at plasma membrane clathrin-coated pits is spatially segregated from its hydrolysis by the PI(3,4)P-2-specific inositol polyphosphate 4-phosphatase 4A (INPP4A). We observed that INPP4A is dispensable for clathrin-mediated endocytosis and is undetectable in endocytic clathrin-coated pits. Instead, we found that INPP4A partially localizes to endosomes and that loss of INPP4A in HAP1 cancer cells perturbs signaling via AKT kinase and mTOR complex 1. These results reveal a function for INPP4-mediated PI(3,4)P-2 hydrolysis in local regulation of growth factor and nutrient signals at endosomes in cancer cells. They further suggest a model whereby synthesis and turnover of PI(3,4)P-2 are spatially segregated within the endocytic pathway to couple endocytic membrane traffic to growth factor and nutrient signaling.	[Wang, Haibin; Bruns, Caroline; Koch, Philipp-Alexander; Puchkov, Dmytro; Haucke, Volker] Leibniz Forsch Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Loerke, Dinah] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Mueller, Rainer; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Schultz, Carsten] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97239 USA; [Haucke, Volker] Free Univ Berlin, Fac Biol Chem & Pharm, D-14195 Berlin, Germany; [Wang, Haibin] Chinese Acad Sci, Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China	University of Denver; European Molecular Biology Laboratory (EMBL); Oregon Health & Science University; Free University of Berlin; Chinese Academy of Sciences; Institute of Biophysics, CAS	Haucke, V (corresponding author), Leibniz Forsch Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.; Haucke, V (corresponding author), Free Univ Berlin, Fac Biol Chem & Pharm, D-14195 Berlin, Germany.	haucke@fmp-berlin.de		Mueller, Rainer/0000-0003-3464-494X; Puchkov, Dmytro/0000-0001-8341-4847; Koch, Philipp Alexander/0000-0003-0543-7482; Haucke, Volker/0000-0003-3119-6993; Loerke, Dinah/0000-0002-2068-0408; Bruns, Caroline/0000-0003-4849-2107	Deutsche Forschungsgemeinschaft [TRR 186/TP 08]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant TRR 186/TP 08 (to V. H. and C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Almeida-Souza L, 2018, CELL, V174, P325, DOI 10.1016/j.cell.2018.05.020; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; Campa CC, 2018, NAT CHEM BIOL, V14, P801, DOI 10.1038/s41589-018-0086-4; Daste F, 2017, J CELL BIOL, V216, P3745, DOI 10.1083/jcb.201704061; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Goulden BD, 2019, J CELL BIOL, V218, P1066, DOI 10.1083/jcb.201809026; Gulluni F, 2019, TRENDS CELL BIOL, V29, P339, DOI 10.1016/j.tcb.2019.01.001; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; He KM, 2017, NATURE, V552, P410, DOI 10.1038/nature25146; Hong Z, 2017, J CELL BIOL, V216, P4217, DOI 10.1083/jcb.201611073; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Laguerre A, 2018, CURR OPIN CELL BIOL, V53, P97, DOI 10.1016/j.ceb.2018.06.013; Lehmann M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5775; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Lo WT, 2017, DEV CELL, V43, P522, DOI 10.1016/j.devcel.2017.10.019; Loerke D, 2011, TRAFFIC, V12, P815, DOI 10.1111/j.1600-0854.2011.01197.x; Malek M, 2017, MOL CELL, V68, P566, DOI 10.1016/j.molcel.2017.09.024; Marat AL, 2017, SCIENCE, V356, P968, DOI 10.1126/science.aaf8310; Naguib A, 2015, MOL CELL, V58, P255, DOI 10.1016/j.molcel.2015.03.011; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Rosselli-Murai LK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208926; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Schoneberg J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15873; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Tiosano D, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008088; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wallroth A, 2019, NAT CELL BIOL, V21, P1093, DOI 10.1038/s41556-019-0377-3; Wang HB, 2018, MOL CELL, V71, P343, DOI 10.1016/j.molcel.2018.06.042; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	47	9	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1091	1104		10.1074/jbc.RA119.011774	http://dx.doi.org/10.1074/jbc.RA119.011774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31831620	Green Published, hybrid			2022-12-28	WOS:000509949300017
J	Powers, NE; Swartzwelter, B; Marchetti, C; de Graaf, DM; Lerchner, A; Schlapschy, M; Datar, R; Binder, U; Edwards, CK; Skerra, A; Dinarello, CA				Powers, Nicholas E.; Swartzwelter, Benjamin; Marchetti, Carlo; de Graaf, Dennis M.; Lerchner, Alexandra; Schlapschy, Martin; Datar, Rajiv; Binder, Uli; Edwards, Carl K., III; Skerra, Arne; Dinarello, Charles A.			PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; drug delivery; inflammation; innate immunity; interleukin 1 (IL-1); intrinsically-disordered protein; leukocyte; pharmacokinetics; half-life extension; IL-22; PASylation	PLASMA HALF-LIFE; INTERLEUKIN-1; ANAKINRA; INFLAMMATION; DISEASE; PHARMACOKINETICS; VACUOLATION; PEGYLATION; IL-1-BETA; INHIBITOR	Interleukin-1 (IL-1) is a key mediator of inflammation and immunity. Naturally-occurring IL-1 receptor antagonist (IL-1Ra) binds and blocks the IL-1 receptor-1 (IL-1R1), preventing signaling. Anakinra, a recombinant form of IL-1Ra, is used to treat a spectrum of inflammatory diseases. However, anakinra is rapidly cleared from the body and requires daily administration. To create a longer-lasting alternative, PASylated IL-1Ra (PAS?IL-1Ra) has been generated by in-frame fusion of a long, defined-length, N-terminal Pro/Ala/Ser (PAS) random-coil polypeptide with IL-1Ra. Here, we compared the efficacy of two PAS?IL-1Ra molecules, PAS600?IL-1Ra and PAS800?IL-1Ra (carrying 600 and 800 PAS residues, respectively), with that of anakinra in mice. PAS600?IL-1Ra displayed markedly extended blood plasma levels 3 days post-administration, whereas anakinra was undetectable after 24 h. We also studied PAS600?IL-1Ra and PAS800?IL-1Ra for efficacy in monosodium urate (MSU) crystal-induced peritonitis. 5 days post-administration, PAS800?IL-1Ra significantly reduced leukocyte influx and inflammatory markers in MSU-induced peritonitis, whereas equimolar anakinra administered 24 h before MSU challenge was ineffective. The 6-h pretreatment with equimolar anakinra or PAS800?IL-1Ra before MSU challenge similarly reduced inflammatory markers. In cultured A549 lung carcinoma cells, anakinra, PAS600?IL-1Ra, and PAS800-IL-Ra reduced IL-1??induced IL-6 and IL-8 levels with comparable potency. In human peripheral blood mononuclear cells, these molecules suppressed Candida albicans?induced production of the cancer-promoting cytokine IL-22. Surface plasmon resonance analyses revealed significant binding between PAS?IL-1Ra and IL-1R1, although with a slightly lower affinity than anakinra. These results validate PAS?IL-1Ra as an active IL-1 antagonist with marked in vivo potency and a significantly extended half-life compared with anakinra.	[Powers, Nicholas E.; Swartzwelter, Benjamin; Marchetti, Carlo; de Graaf, Dennis M.; Dinarello, Charles A.] Univ Colorado, Dept Med, Rm 10480A,Anschutz Med Campus,12700 East 17 Ave, Aurora, CO 80045 USA; [de Graaf, Dennis M.; Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Lerchner, Alexandra; Binder, Uli] XL Prot GmbH, Lise Meitner Str 30, D-85354 Freising Weihenstephan, Germany; [Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany; [Datar, Rajiv; Edwards, Carl K., III] DNX Biopharmaceut Inc, San Diego, CA 92121 USA; [Powers, Nicholas E.] CNR, Inst Prot Biochem, I-80131 Naples, Italy	University of Colorado System; University of Colorado Anschutz Medical Campus; Radboud University Nijmegen; Technical University of Munich; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Powers, NE (corresponding author), Univ Colorado, Dept Med, Rm 10480A,Anschutz Med Campus,12700 East 17 Ave, Aurora, CO 80045 USA.; Powers, NE (corresponding author), CNR, Inst Prot Biochem, I-80131 Naples, Italy.	nicholas.e.powers@CUAnschutz.edu	Skerra, Arne/A-2269-2013	Binder, Uli/0000-0002-9658-0630; de Graaf, Dennis/0000-0002-9198-7159; Skerra, Arne/0000-0002-5717-498X; Powers, Nicholas/0000-0002-5403-4324; Swartzwelter, Benjamin/0000-0002-6283-5199	National Institutes of Health [AI015614]; Interleukin Foundation; DNX Biopharmaceuticals, Inc., San Diego, CA	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interleukin Foundation; DNX Biopharmaceuticals, Inc., San Diego, CA	This work was supported by National Institutes of Health Grant AI015614 (to C. A. D.), the Interleukin Foundation (to N. E. P.), and by DNX Biopharmaceuticals, Inc., San Diego, CA. C. K. E., III, and R. D. are shareholders in DNX Biopharmaceuticals, Inc., and A. S., M. S., and U. B. are shareholders of XLprotein GmbH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Aouba A, 2015, MEDIAT INFLAMM, V2015, P1, DOI 10.1155/2015/792173; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; Binder U, 2017, CURR OPIN COLLOID IN, V31, P10, DOI 10.1016/j.cocis.2017.06.004; Breibeck J, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23069; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Campion GV, 1996, ARTHRITIS RHEUM, V39, P1092, DOI 10.1002/art.1780390704; Cavalli G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00148; Cesare S. D., 2013, BIOPROCESS INT, V11, P30; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; Dayer JM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00293; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; DINARELLO CA, 1974, J EXP MED, V139, P1369, DOI 10.1084/jem.139.6.1369; Dinarello CA, 2019, NAT REV RHEUMATOL, V15, P612, DOI 10.1038/s41584-019-0277-8; Doeleman MJH, 2019, RHEUMATOLOGY, V58, P1839, DOI 10.1093/rheumatology/kez030; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Everett BM, 2019, CIRCULATION, V139, P1289, DOI 10.1161/CIRCULATIONAHA.118.038010; Everett BM, 2018, J AM COLL CARDIOL, V71, P2392, DOI 10.1016/j.jacc.2018.03.002; Fleischmann R, 2004, EXPERT OPIN BIOL TH, V4, P1333, DOI 10.1517/14712598.4.8.1333; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; Gebauer M, 2018, BIOORGAN MED CHEM, V26, P2882, DOI 10.1016/j.bmc.2017.09.016; Grevich S, 2017, ADOLESC HEALTH MED T, V8, P125, DOI 10.2147/AHMT.S109495; Griffiths K, 2019, MABS-AUSTIN, V11, P1331, DOI 10.1080/19420862.2019.1626652; Harari D, 2014, J BIOL CHEM, V289, P29014, DOI 10.1074/jbc.M114.602474; Harrold LR, 2010, CHRONIC ILLN, V6, P263, DOI 10.1177/1742395310378761; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kuhn N, 2016, BIOCONJUGATE CHEM, V27, P2359, DOI 10.1021/acs.bioconjchem.6b00369; Langin M, 2018, NATURE, V564, P430, DOI 10.1038/s41586-018-0765-z; Lane T., 2015, PEDIAT RHEUMATOL ONL, V13, pO65, DOI [10.1186/1546-0096-13-S1-O65, DOI 10.1186/1546-0096-13-S1-O65]; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mahmood I, 2004, J PHARM SCI-US, V93, P177, DOI 10.1002/jps.10531; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Mantovani A, 2018, IMMUNOL REV, V281, P57, DOI 10.1111/imr.12614; Marchetti C, 2015, J CARDIOVASC PHARM, V66, P1, DOI 10.1097/FJC.0000000000000247; Markota A, 2018, HUM VACC IMMUNOTHER, V14, P2012, DOI 10.1080/21645515.2018.1461300; Mendler CT, 2015, MABS-AUSTIN, V7, P96, DOI 10.4161/19420862.2014.985522; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Morath V, 2015, MOL PHARMACEUT, V12, P1431, DOI 10.1021/mp5007147; Nganou-Makamdop K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007246; Ortiz-Sanjuan F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001554; Perez-Ruiz F, 2018, THER CLIN RISK MANAG, V14, P793, DOI 10.2147/TCRM.S162956; Ramirez J, 2018, EXPERT OPIN DRUG SAF, V17, P727, DOI 10.1080/14740338.2018.1486819; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rudmann DG, 2013, TOXICOL PATHOL, V41, P970, DOI 10.1177/0192623312474726; Ruscitti P, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002901; Schiff M, 2017, RHEUMATOL THER, V4, P445, DOI 10.1007/s40744-017-0080-4; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Sobowale OA, 2016, STROKE, V47, P2160, DOI 10.1161/STROKEAHA.115.010001; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Szekely Y, 2018, CARDIOL THER, V7, P25, DOI 10.1007/s40119-018-0104-3; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Wadhwa M, 2015, BIOLOGICALS, V43, P298, DOI 10.1016/j.biologicals.2015.06.004; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xia YC, 2019, ANTIVIR RES, V161, P134, DOI 10.1016/j.antiviral.2018.11.003; Xie R, 2019, EUR J DRUG METAB PH, V44, P353, DOI 10.1007/s13318-018-0523-5	67	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					868	882		10.1074/jbc.RA119.010340	http://dx.doi.org/10.1074/jbc.RA119.010340			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31819009	Green Published, hybrid			2022-12-28	WOS:000508382900016
J	Kim, D; Song, J; Kim, S; Park, HM; Chun, CH; Sonn, J; Jin, EJ				Kim, Dongkyun; Song, Jinsoo; Kim, Sunhyo; Park, Hyang Mi; Chun, Churl-Hong; Sonn, Jungkyung; Jin, Eun-Jung			RETRACTION: MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts. (Retraction of Vol 285, Pg 26900, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Kim D, 2010, J BIOL CHEM, V285, P26900, DOI 10.1074/jbc.M110.115105	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					669	669		10.1074/jbc.W119.012221	http://dx.doi.org/10.1074/jbc.W119.012221			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31924675	Green Published, hybrid			2022-12-28	WOS:000507373600034
J	Datta, P; Hendrickson, B; Brendalen, S; Ruffcorn, A; Seo, SJ				Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin			The myosin-tail homology domain of centrosomal protein 290 is essential for protein confinement between the inner and outer segments in photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer segment; connecting cilium; ciliary gate; gatekeeper; diffusion barrier; cilia; retinal degeneration; photoreceptor; intracellular trafficking; genetic disease	INTRAFLAGELLAR TRANSPORT; TRANSITION ZONE; MEMBRANE-PROTEINS; HCN1 CHANNELS; CEP290; ROD; MUTATIONS; GENE; CILIA; TRAFFICKING	Mutations in the centrosomal protein 290 (CEP290) gene cause various ciliopathies involving retinal degeneration. CEP290 proteins localize to the ciliary transition zone and are thought to act as a gatekeeper that controls ciliary protein trafficking. However, precise roles of CEP290 in photoreceptors and pathomechanisms of retinal degeneration in CEP290-associated ciliopathies are not sufficiently understood. Using conditional Cep290 mutant mice, in which the C-terminal myosin-tail homology domain of CEP290 is disrupted after the connecting cilium is assembled, we show that this domain is essential for protein confinement between the inner and the outer segments. Upon disruption of the myosin-tail homology domain, inner segment plasma membrane proteins, including syntaxin 3 (STX3), synaptosome-associated protein 25 (SNAP25), and interphotoreceptor matrix proteoglycan 2 (IMPG2), rapidly accumulated in the outer segment. In contrast, localization of endomembrane proteins was not altered. Trafficking and confinement of most outer segment-resident proteins appeared to be unaffected or only minimally affected in Cep290 mutant mice. One notable exception was rhodopsin (RHO), which severely mislocalized to inner segments during the initial stage of degeneration. Similar mislocalization phenotypes were observed in Cep290(rd16) mice. These results suggest that a failure of protein confinement at the connecting cilium and consequent accumulation of inner segment membrane proteins in the outer segment, along with insufficient RHO delivery, is part of the disease mechanisms that cause retinal degeneration in CEP290-associated ciliopathies. Our study provides insights into the pathomechanisms of retinal degenerations associated with compromised ciliary gates.	[Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin] Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin] Univ Iowa, Inst Vis Res, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Seo, SJ (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	seongjin-seo@uiowa.edu		Datta, Poppy/0000-0003-4989-0975; Seo, Seongjin/0000-0002-7908-3210	NATIONAL EYE INSTITUTE [R01EY022616, R21EY027431, P30EY025580] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022616, R21 EY027431, P30 EY025580] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baehr W., 2018, PROG RETIN EYE RES; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Barny I., 2018, HUM MOL GENET; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dilan TL, 2018, HUM MOL GENET, V27, P283, DOI 10.1093/hmg/ddx399; Drivas TG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5370; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garcia-Gonzalo FR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028134; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Hallett MA, 1996, J CELL SCI, V109, P1803; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hsu Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007057; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JOHNSON LV, 1984, CURR EYE RES, V3, P969, DOI 10.3109/02713688409167215; KAMPS KMP, 1982, BIOCHIM BIOPHYS ACTA, V687, P296, DOI 10.1016/0005-2736(82)90558-2; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Lessieur EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213960; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Meunier I, 2014, OPHTHALMOLOGY, V121, P2406, DOI 10.1016/j.ophtha.2014.06.028; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Murga-Zamalloa CA, 2011, J BIOL CHEM, V286, P28276, DOI 10.1074/jbc.M111.237560; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Pan Y, 2015, CELL MOL LIFE SCI, V72, P833, DOI 10.1007/s00018-014-1705-1; Rachel RA, 2015, HUM MOL GENET, V24, P3775, DOI 10.1093/hmg/ddv123; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Roosing S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080208; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Seo S, 2017, HUM MOL GENET, V26, pR75, DOI 10.1093/hmg/ddx163; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Shimada H, 2017, CELL REP, V20, P384, DOI 10.1016/j.celrep.2017.06.045; Smith TS, 2013, CELL MOL LIFE SCI, V70, P4603, DOI 10.1007/s00018-013-1403-4; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van Huet RAC, 2014, INVEST OPHTH VIS SCI, V55, P3939, DOI 10.1167/iovs.14-14129; Wiegering A, 2018, EMBO J, V37, DOI 10.15252/embj.201797791; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Yang TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14096; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	74	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19119	19136		10.1074/jbc.RA119.009712	http://dx.doi.org/10.1074/jbc.RA119.009712			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694913	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000516527800015
J	McKibben, KM; Rhoades, E				McKibben, Kristen M.; Rhoades, Elizabeth			Independent tubulin binding and polymerization by the proline-rich region of tau is regulated by tau's N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; Tau protein (Tau); Alzheimer disease; microtubule-associated protein (MAP); single-molecule biophysics; cytoskeleton; tauopathy; tubulin polymerization; single-molecule FRET; fluorescence correlation spectroscopy (FCS)	MICROTUBULE-BINDING; SINGLE-MOLECULE; PROTEIN; PHOSPHORYLATION; ISOFORMS; BRAIN; IDENTIFICATION; DISEASE; FACES; JAWS	Tau is an intrinsically disordered, microtubule-associated protein that has a role in regulating microtubule dynamics. Despite intensive research, the molecular mechanisms of tau-mediated microtubule polymerization are poorly understood. Here, we used single-molecule fluorescence to investigate the role of tau's N-terminal domain (NTD) and proline-rich region (PRR) in regulating interactions of tau with soluble tubulin. We assayed both full-length tau isoforms and truncated variants for their ability to bind soluble tubulin and stimulate microtubule polymerization. We found that tau's PRR is an independent tubulin-binding domain that has tubulin polymerization capacity. In contrast to the relatively weak interactions with tubulin mediated by sites distributed throughout tau's microtubule-binding repeats (MTBR), resulting in heterogeneous tau:tubulin complexes, the PRR bound tubulin tightly and stoichiometrically. Moreover, we demonstrate that interactions between the PRR and MTBR are reduced by the NTD through a conserved conformational ensemble. On the basis of these results, we propose that tau's PRR can serve as a core tubulin-binding domain, whereas the MTBR enhances polymerization capacity by increasing the local tubulin concentration. Moreover, the NTD appears to negatively regulate tubulin-binding interactions of both of these domains. The findings of our study draw attention to a central role for the PRR in tau function and provide mechanistic insight into tau-mediated polymerization of tubulin.	[McKibben, Kristen M.; Rhoades, Elizabeth] Univ Penn, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Rhoades, Elizabeth] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rhoades, E (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	elizabeth.rhoades@sas.upenn.edu			NIH Institutional Training Grant [T32 GM071399]; NIH [AG053951]	NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank: H.Y.J Fung, S. Wickramasinghe, I. Yannatos and H. Merens for assistance during the various tubulin purifications; the Chenoweth Lab for use of their fluorimeter; the Svitkina Lab for the use of their TEM microscope and C. Yang for assistance with the microscope and insightful suggestions. This work was supported by NIH Institutional Training Grant T32 GM071399 (to K.M.) and NIH Grant AG053951 (to E.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Chung PJ, 2015, P NATL ACAD SCI USA, V112, pE6416, DOI 10.1073/pnas.1513172112; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Elbaum-Garfinkle S, 2014, P NATL ACAD SCI USA, V111, P6311, DOI 10.1073/pnas.1315983111; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fauquant C., 2011, J BIOL CHEM; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Gigant B, 2014, J AM CHEM SOC, V136, P12615, DOI 10.1021/ja504864m; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Iwata M, 2019, MOL BIOL CELL, V30, P2441, DOI 10.1091/mbc.E19-03-0183; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Li XH, 2017, BIOPHYS J, V112, P2567, DOI 10.1016/j.bpj.2017.05.006; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; Mandell JW, 1996, J NEUROSCI, V16, P5727; Melo AM, 2016, P NATL ACAD SCI USA, V113, P14336, DOI 10.1073/pnas.1610137113; Metskas LA, 2015, J AM CHEM SOC, V137, P11962, DOI 10.1021/jacs.5b04471; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Niewidok B, 2016, MOL BIOL CELL, V27, P3537, DOI 10.1091/mbc.E16-06-0402; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Preuss U, 1997, J CELL SCI, V110, P789; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Trzeciakiewicz H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44102; Vemu A, 2018, SCIENCE, V361, DOI 10.1126/science.aau1504; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	55	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19381	19394		10.1074/jbc.RA119.010172	http://dx.doi.org/10.1074/jbc.RA119.010172			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699899	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000516527800034
J	Han, HT; Chen, N; Huang, XG; Liu, B; Tian, JK; Lei, HT				Han, Haote; Chen, Na; Huang, Xionggao; Liu, Bing; Tian, Jingkui; Lei, Hetian			Phosphoinositide 3-kinase delta inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells (vol 294, pg 15408, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Han, Haote; Chen, Na; Huang, Xionggao; Liu, Bing; Lei, Hetian] Hainan Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Haikou 570102, Hainan, Peoples R China	Hainan Medical University	Han, HT (corresponding author), Hainan Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Haikou 570102, Hainan, Peoples R China.			Lei, Hetian/0000-0003-4091-1936				Han HT, 2019, J BIOL CHEM, V294, P15408, DOI 10.1074/jbc.RA119.010130	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18517	18517		10.1074/jbc.AAC119.011662	http://dx.doi.org/10.1074/jbc.AAC119.011662			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31784478	Green Published, hybrid			2022-12-28	WOS:000505547900043
J	Abeliovich, H				Abeliovich, Hagai			New gadget in the membrane trafficking toolbox: A novel inhibitor of SNARE priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN; IDENTIFICATION; FUSION	NSF (N-ethylmaleimide sensitive factor) and its yeast counterpart Sec18 are highly conserved homohexameric proteins that play vital roles in eukaryotic membrane trafficking. Sec18 functions by disrupting SNARE complexes formed in cis, on the same membrane. However, the molecular mechanisms of this process are poorly understood, in large part due to the lack of selective, reversible inhibitors. A new study by Sparks et al. now reports a small molecule that appears to selectively inhibit Sec18 action in an in vitro assay. Their finding now paves the way to elucidate further details of Sec18-mediated SNARE priming.	[Abeliovich, Hagai] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Abeliovich, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Food Sci, IL-76100 Rehovot, Israel.	hagai.abeliovich@mail.huji.ac.il						BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Ryu JK, 2016, BIOPOLYMERS, V105, P518, DOI 10.1002/bip.22854; Sparks RP, 2019, J BIOL CHEM, V294, P17168, DOI 10.1074/jbc.RA119.008865; Starr ML, 2019, J BIOL CHEM, V294, P3100, DOI 10.1074/jbc.RA118.006552; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61	11	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17186	17187		10.1074/jbc.H119.011334	http://dx.doi.org/10.1074/jbc.H119.011334			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31732684	hybrid, Green Published			2022-12-28	WOS:000503173500002
J	Han, XJ; Chen, HH; Gong, H; Tang, XQ; Huang, N; Xu, WT; Tai, HR; Zhang, GC; Zhao, TT; Gong, CH; Wang, S; Yang, Y; Xiao, HY				Han, Xiaojuan; Chen, Honghan; Gong, Hui; Tang, Xiaoqiang; Huang, Ning; Xu, Weitong; Tai, Haoran; Zhang, Gongchang; Zhao, Tingting; Gong, Chuhui; Wang, Shuang; Yang, Yu; Xiao, Hengyi			Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress?induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; senescence; DNA damage; autophagy; NF-kappaB (NF-KB); autolysosome; cGAS-STING pathway; cytosolic chromatin fragment (CCF); senescence-associated secretory phenotype (SASP)	CYCLIC GMP-AMP; SECRETORY PHENOTYPE; DNASE-II; CGAS; 2ND-MESSENGER; INFLAMMATION; EXPRESSION	Oxidative stress-induced DNA damage, the senescence-associated secretory phenotype (SASP), and impaired autophagy all are general features of senescent cells. However, the cross-talk among these events and processes is not fully understood. Here, using NIH3T3 cells exposed to hydrogen peroxide stress, we show that stress-induced DNA damage provokes the SASP largely via cytosolic chromatin fragment (CCF) formation, which activates a cascade comprising cGMP-AMP synthase (cGAS), stimulator of interferon genes protein (STING), NF-?B, and SASP, and that autolysosomal function inhibits this cascade. We found that CCFs accumulate in senescent cells with activated cGAS-STING-NF-?B signaling, promoting SASP and cellular senescence. We also present evidence that the persistent accumulation of CCFs in prematurely senescent cells is partially associated with a defect in DNA-degrading activity in autolysosomes and reduced abundance of activated DNase 2?. Intriguingly, we found that metformin- or rapamycin-induced activation of autophagy significantly lessened the size and levels of CCFs and repressed the activation of the cGAS-STING-NF-?B-SASP cascade and cellular senescence. These effects of autophagy activators indicated that autolysosomal function contributes to CCF clearance and SASP suppression, further supported by the fact that the lysosome inhibitor bafilomycin A1 blocked the role of autophagy-mediated CCF clearance and senescence repression.	[Han, Xiaojuan; Chen, Honghan; Gong, Hui; Huang, Ning; Xu, Weitong; Tai, Haoran; Zhang, Gongchang; Zhao, Tingting; Gong, Chuhui; Wang, Shuang; Yang, Yu; Xiao, Hengyi] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Aging Res,Natl Clin Res Ctr Geriatr, 1 Keyuan 4 Rd,Gaopeng Ave, Chengdu 610041, Peoples R China; [Han, Xiaojuan] Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian 710049, Peoples R China; [Han, Xiaojuan] Xian Med Univ, Inst Basic & Translat Med, Xian 710049, Peoples R China; [Tang, Xiaoqiang] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, MOE,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Tai, Haoran] Chengdu Med Coll, Dept Anat & Histol & Embryol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu 610031, Peoples R China	Sichuan University; Xi'an Medical University; Xi'an Medical University; Sichuan University; Chengdu Medical College	Xiao, HY (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Aging Res,Natl Clin Res Ctr Geriatr, 1 Keyuan 4 Rd,Gaopeng Ave, Chengdu 610041, Peoples R China.	hengyix@scu.edu.cn	Tang, Xiaoqiang/G-4319-2013	Tang, Xiaoqiang/0000-0003-1314-3417	National Natural Science Foundation of China [81771511]; National Key R&D Program of China [2018YFC2000400]; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University [Z2018B04]; Young Talent Found of the University Association for Science and technology in Shaanxi, China [20190308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University; Young Talent Found of the University Association for Science and technology in Shaanxi, China	This work is supported by National Natural Science Foundation of China Grant 81771511; National Key R&D Program of China Grant 2018YFC2000400; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Grant Z2018B04, and the Young Talent Found of the University Association for Science and technology in Shaanxi, China 20190308. The authors declare that they have no conflicts of interest with the contents of this article.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Ohkouchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059148; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143; Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	37	28	28	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4451	4463		10.1074/jbc.RA119.010734	http://dx.doi.org/10.1074/jbc.RA119.010734			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32047109	Green Published, hybrid			2022-12-28	WOS:000524499700008
J	Aranha, MP; Penfound, TA; Spencer, JA; Agarwal, R; Baudry, J; Dale, JB; Smith, JC				Aranha, Michelle P.; Penfound, Thomas A.; Spencer, Jay A.; Agarwal, Rupesh; Baudry, Jerome; Dale, James B.; Smith, Jeremy C.			Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein?derived peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S; pyogenes); structural biology; bioinformatics; vaccine development; humoral response; vaccine; coiled coil; cross-reactive epitope; heptad site identity; M proteins; multivalent vaccine	IMMUNOGENICITY; PROTEINS; PYOGENES; SAFETY; NORTH	Group A streptococcus (Strep A) surface M protein, an ?-helical coiled-coil dimer, is a vaccine target and a major determinant of streptococcal virulence. The sequence-variable N-terminal region of the M protein defines the M type and also contains epitopes that promote opsonophagocytic killing of streptococci. Recent reports have reported considerable cross-reactivity among different M types, suggesting the prospect of identifying cross-protective epitopes that would constitute a broadly protective multivalent vaccine against Strep A isolates. Here, we have used a combination of immunological assays, structural biology, and cheminformatics to construct a recombinant M protein?based vaccine that included six Strep A M peptides that were predicted to elicit antisera that would cross-react with an additional 15 nonvaccine M types of Strep A. Rabbit antisera against this recombinant vaccine cross-reacted with 10 of the 15 nonvaccine M peptides. Two of the five nonvaccine M peptides that did not cross-react shared high sequence identity (?50%) with the vaccine peptides, implying that high sequence identity alone was insufficient for cross-reactivity among the M peptides. Additional structural analyses revealed that the sequence identity at corresponding polar helical-wheel heptad sites between vaccine and nonvaccine peptides accurately distinguishes cross-reactive from non?cross-reactive peptides. On the basis of these observations, we developed a scoring algorithm based on the sequence identity at polar heptad sites. When applied to all epidemiologically important M types, this algorithm should enable the selection of a minimal number of M peptide?based vaccine candidates that elicit broadly protective immunity against Strep A.	[Aranha, Michelle P.; Agarwal, Rupesh; Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Agarwal, Rupesh] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Aranha, Michelle P.; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA; [Penfound, Thomas A.; Dale, James B.] Univ Tennessee, Div Infect Dis, Dept Med, Hlth Sci Ctr, Memphis, TN 38163 USA; [Spencer, Jay A.; Baudry, Jerome] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Huntsville	Aranha, MP (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	maranha@utk.edu	Aranha, Michelle/ABC-6512-2020	Aranha, Michelle/0000-0002-8230-5726; Agarwal, Rupesh/0000-0003-1029-2281	National Institutes of Health [AI-R01AI132117]; University of Tennessee Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Research Foundation	This work was supported by National Institutes of Health Grant AI-R01AI132117. J. B. D. is the inventor of certain technologies related to the development of Strep A vaccines. The technology has been licensed from the University of Tennessee Research Foundation to Vaxent, LLC, of which J. B. D. is a member and Chief Scientific Officer. All other authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; Buffalo CZ, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.155, 10.1038/NMICROBIOL.2016.155]; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Dale JB, 2017, VACCINE, V35, P19, DOI 10.1016/j.vaccine.2016.11.065; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; Dale JB, 2016, STREPTOCOCCUS PYOGEN; Davies MR, 2019, NAT GENET, V51, P1035, DOI 10.1038/s41588-019-0417-8; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Frost HR, 2017, CLIN INFECT DIS, V65, P1523, DOI 10.1093/cid/cix599; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Haggar A, 2012, J CLIN MICROBIOL, V50, P1626, DOI 10.1128/JCM.06697-11; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Steer AC, 2016, VACCINE, V34, P2953, DOI 10.1016/j.vaccine.2016.03.073; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Vekemans J, 2019, CLIN INFECT DIS, V69, P877, DOI 10.1093/cid/ciy1143; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545	34	3	3	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3826	3836		10.1074/jbc.RA119.011258	http://dx.doi.org/10.1074/jbc.RA119.011258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029479	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000527704400009
J	Singh, S; Szlachta, K; Manukyan, A; Raimer, HM; Dinda, M; Bekiranov, S; Wang, YH				Singh, Sandeep; Szlachta, Karol; Manukyan, Arkadi; Raimer, Heather M.; Dinda, Manikarna; Bekiranov, Stefan; Wang Yuh-Hwa			Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; DNA topoisomerase; DNA transcription; transcription regulation; DNA sequencing; DNA damage; gene expression; DNA double-stranded breaks; HeLa cells; RNA polymerase II promoter-proximal pausing; topoisomerase inhibitors; topoisomerase I and II	TOPOISOMERASE-II; EUKARYOTIC TOPOISOMERASES; CLEAVAGE; MUTATION; HOTSPOTS; HAIRPIN	DNA double-stranded breaks (DSBs) are strongly associated with active transcription, and promoter-proximal pausing of RNA polymerase II (Pol II) is a critical step in transcriptional regulation. Mapping the distribution of DSBs along actively expressed genes and identifying the location of DSBs relative to pausing sites can provide mechanistic insights into transcriptional regulation. Using genome-wide DNA break mapping/sequencing techniques at single-nucleotide resolution in human cells, we found that DSBs are preferentially located around transcription start sites of highly transcribed and paused genes and that Pol II promoter-proximal pausing sites are enriched in DSBs. We observed that DSB frequency at pausing sites increases as the strength of pausing increases, regardless of whether the pausing sites are near or far from annotated transcription start sites. Inhibition of topoisomerase I and II by camptothecin and etoposide treatment, respectively, increased DSBs at the pausing sites as the concentrations of drugs increased, demonstrating the involvement of topoisomerases in DSB generation at the pausing sites. DNA breaks generated by topoisomerases are short-lived because of the religation activity of these enzymes, which these drugs inhibit; therefore, the observation of increased DSBs with increasing drug doses at pausing sites indicated active recruitment of topoisomerases to these sites. Furthermore, the enrichment and locations of DSBs at pausing sites were shared among different cell types, suggesting that Pol II promoter-proximal pausing is a common regulatory mechanism. Our findings support a model in which topoisomerases participate in Pol II promoter-proximal pausing and indicated that DSBs at pausing sites contribute to transcriptional activation.	[Singh, Sandeep; Szlachta, Karol; Manukyan, Arkadi; Raimer, Heather M.; Dinda, Manikarna; Bekiranov, Stefan; Wang Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wang, YH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	yw4b@virginia.edu	DINDA, MANIKARNA/ABB-2631-2021	Singh, Sandeep/0000-0001-5361-4303; Raimer Young, Heather/0000-0002-7415-6011	NIGMS, National Institutes of Health [RO1GM101192, T32GM008136]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants RO1GM101192 (to Y.-H. W.) and T32GM008136 (to H. M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEEN MD, 1984, J MOL BIOL, V180, P515, DOI 10.1016/0022-2836(84)90025-1; Bigioni M, 1996, BIOCHEMISTRY-US, V35, P153, DOI 10.1021/bi951736p; Bunch H, 2016, GENOMICS, V108, P64, DOI 10.1016/j.ygeno.2016.07.003; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canela A, 2019, MOL CELL, V75, P252, DOI 10.1016/j.molcel.2019.04.030; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; D'Alessandro G, 2017, J MOL BIOL, V429, P3215, DOI 10.1016/j.jmb.2016.11.002; Dellino GI, 2019, NAT GENET, V51, P1011, DOI 10.1038/s41588-019-0421-z; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; FROELICHAMMON SJ, 1994, J BIOL CHEM, V269, P7719; Gittens WH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12802-5; Gothe HJ, 2019, MOL CELL, V75, P267, DOI 10.1016/j.molcel.2019.05.015; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jonstrup AT, 2008, NUCLEIC ACIDS RES, V36, P6165, DOI 10.1093/nar/gkn640; Kaiser VB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006207; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kellner WA, 2015, GENOME RES, V25, P1600, DOI 10.1101/gr.189068.114; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Mills WE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020534; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schwer B, 2016, P NATL ACAD SCI USA, V113, P2258, DOI 10.1073/pnas.1525564113; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Spence JM, 2005, CHROMOSOME RES, V13, P637, DOI 10.1007/s10577-005-1003-8; Szlachta K, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6436-0; Szlachta K, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1463-8; Tanwar VS, 2019, MUTAT RES-REV MUTAT, V780, P61, DOI 10.1016/j.mrrev.2018.02.002; Tchasovnikarova IA, 2017, NAT GENET, V49, P1035, DOI 10.1038/ng.3878; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984	40	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3990	4000		10.1074/jbc.RA119.011665	http://dx.doi.org/10.1074/jbc.RA119.011665			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32029477	Green Published, hybrid			2022-12-28	WOS:000527704400023
J	Homma, K; Takahashi, H; Tsuburaya, N; Naguro, I; Fujisawa, T; Ichijo, H				Homma, Kengo; Takahashi, Hiromitsu; Tsuburaya, Naomi; Naguro, Isao; Fujisawa, Takao; Ichijo, Hidenori			Genome-wide siRNA screening reveals that DCAF4-mediated ubiquitination of optineurin stimulates autophagic degradation of Cu,Zn-superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); proteostasis; autophagy; protein misfolding; protein aggregation; DDB1 and CUL4 associated factor 4 (DCAF4); genome-wide siRNA screen; superoxide dismutase 1 (SOD1)	MOTOR-NEURON DEATH; ALS-LINKED SOD1; STATISTICAL-METHODS; WILD-TYPE; MUTATIONS; DISEASE; ASTROCYTES; PROTEINS; GENES; MICE	Cu, Zn superoxide dismutase (SOD1) is one of the genes implicated in the devastating neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Although the precise mechanisms of SOD1 mutant (SOD1(mut))-induced motoneuron toxicity are still unclear, defects in SOD1 proteostasis are known to have a critical role in ALS pathogenesis. We previously reported that the SOD1(mut) adopts a conformation that exposes a Derlin-1?binding region (DBR) and that DBR-exposed SOD1 interacts with Derlin-1, leading to motoneuron death. We also found that an environmental change, i.e. zinc depletion, induces a conformational change in WT SOD1 (SOD1(WT)) to the DBR-exposed conformation, suggesting the presence of an equilibrium state between the DBR-masked and DBR-exposed states even with SOD1(WT). Here, we conducted a high-throughput screening based on time-resolved FRET to further investigate the SOD1(WT) conformational change, and we used a genome-wide siRNA screen to search for regulators of SOD1 proteostasis. This screen yielded 30 candidate genes that maintained an absence of the DBR-exposed SOD1(WT) conformation. Among these genes was one encoding DDB1- and CUL4-associated factor 4 (DCAF4), a substrate receptor of the E3 ubiquitin?protein ligase complex. Of note, we found that DCAF4 mediates the ubiquitination of an ALS-associated protein and autophagy receptor, optineurin (OPTN), and facilitates autophagic degradation of DBR-exposed SOD1. In summary, our screen identifies DCAF4 as being required for proper proteostasis of DBR-exposed SOD1, which may have potential relevance for the development of therapies for managing ALS.	[Homma, Kengo; Takahashi, Hiromitsu; Tsuburaya, Naomi; Naguro, Isao; Fujisawa, Takao; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Homma, Kengo] TMDU, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU)	Homma, K (corresponding author), TMDU, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kenx5.homma@gmail.com		Fujisawa, Takao/0000-0001-7401-5457; Homma, Kengo/0000-0002-6609-9272; Naguro, Isao/0000-0002-0338-8026	Japanese Society for the Promotion of Science; MEXT [25221302, JP18H03995, 16K18513, JP18H02569, 18K15358]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED) [JP17gm5010001, JP19gm5010001]; Kowa Life Science Foundation; SERIKA Fund; Tokyo Biochemical Research Foundation [161000000310]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kowa Life Science Foundation; SERIKA Fund; Tokyo Biochemical Research Foundation	This work was supported by Grants-in-aid for Scientific Research from the Japanese Society for the Promotion of Science; MEXT Grants 25221302 and JP18H03995 (to H. I.), 16K18513 (to K. H.), JP18H02569 (to I. N.) and 18K15358 (to T. F.); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (to H. I.); Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED) Grant JP17gm5010001 and JP19gm5010001 (to H. I.); the Kowa Life Science Foundation (to T. F.); the SERIKA Fund (to T. F.); and Grant-in-aid from the Tokyo Biochemical Research Foundation Grant 161000000310 (to K. H.). A portion of this study resulted from "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to H. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; Ferraiuolo L, 2016, P NATL ACAD SCI USA, V113, pE6496, DOI 10.1073/pnas.1607496113; Fujisawa T, 2015, NEUROBIOL DIS, V82, P478, DOI 10.1016/j.nbd.2015.08.010; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Homma K, 2013, MOL CELL, V52, P75, DOI 10.1016/j.molcel.2013.08.038; Nguyen HP, 2018, TRENDS GENET, V34, P404, DOI 10.1016/j.tig.2018.03.001; Ikenaka K, 2012, INT J MOL SCI, V13, P1225, DOI 10.3390/ijms13011225; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imamura K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf3962; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Markovinovic A, 2017, PROG NEUROBIOL, V154, P1, DOI 10.1016/j.pneurobio.2017.04.005; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Tsuburaya N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05127-2; Watanabe K, 2018, CELL REP, V22, P2809, DOI 10.1016/j.celrep.2018.02.045; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhai JB, 2015, J NEUROSCI, V35, P9088, DOI 10.1523/JNEUROSCI.5032-13.2015	35	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3148	3158		10.1074/jbc.RA119.010239	http://dx.doi.org/10.1074/jbc.RA119.010239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32014991	Green Published, hybrid			2022-12-28	WOS:000519597300021
J	Tetley, GJN; Murphy, NP; Bonetto, S; Ivanova-Berndt, G; Revell, J; Mott, HR; Cooley, RN; Owen, D				Tetley, George J. N.; Murphy, Natasha P.; Bonetto, Stephane; Ivanova-Berndt, Gabriela; Revell, Jefferson; Mott, Helen R.; Cooley, R. Neil; Owen, Darerca			The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; CDC42; peptide conformation; nuclear magnetic resonance (NMR); GTPase Kras (KRAS); drug discovery; cyclic peptide; cell proliferation; cell signaling; cell migration; biologics; cancer therapeutics; drug discovery	RHO; BINDING; ACTIVATION; MODEL; PHOSPHORYLATION; INHIBITORS; COMPLEXES; GTPASES; KRAS; BACK	Aberrant Ras signaling drives 30% of cancers, and inhibition of the Rho family small GTPase signaling has been shown to combat Ras-driven cancers. Here, we present the discovery of a 16-mer cyclic peptide that binds to Cdc42 with nanomolar affinity. Affinity maturation of this sequence has produced a panel of derived candidates with increased affinity and modulated specificity for other closely-related small GTPases. The structure of the tightest binding peptide was solved by NMR, and its binding site on Cdc42 was determined. Addition of a cell-penetrating sequence allowed the peptides to access the cell interior and engage with their target(s), modulating signaling pathways. In Ras-driven cancer cell models, the peptides have an inhibitory effect on proliferation and show suppression of both invasion and motility. As such, they represent promising candidates for Rho-family small GTPase inhibitors and therapeutics targeting Ras-driven cancers. Our data add to the growing literature demonstrating that peptides are establishing their place in the biologics arm of drug discovery.	[Tetley, George J. N.; Murphy, Natasha P.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Bonetto, Stephane; Ivanova-Berndt, Gabriela; Cooley, R. Neil] Isogenica Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England; [Revell, Jefferson] MedImmune, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England; [Tetley, George J. N.] ImmTune Therapies Ltd, 51 Eastcheap, London EC3M 1JP, England; [Bonetto, Stephane] Agenus UK Ltd, 315 Sci Pk, Cambridge CB4 0WG, England; [Ivanova-Berndt, Gabriela] Bicycle Therapeut Ltd, B900 Babraham Res Campus, Cambridge CB22 3AT, England; [Cooley, R. Neil] Abzena, Babraham Res Campus, Cambridge CB22 3AT, England	University of Cambridge; Isogenica Limited; AstraZeneca; Medimmune; Agenus Inc; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Mott, HR; Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	hrm28@cam.ac.uk; do202@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Tetley, George/0000-0002-7134-7066	MRC CASE Studentship [MR/K017101/1]; BBSRC DTP iCASE Studentship [BB/M011194/1]; short-term Glover Research Fund Fellowship	MRC CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC DTP iCASE Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); short-term Glover Research Fund Fellowship	This work was supported by MRC CASE Studentship MR/K017101/1 (to D. O. and R. N. C.), BBSRC DTP iCASE Studentship Grant BB/M011194/1 (to D. O. and J. R.), and a short-term Glover Research Fund Fellowship (to G. J. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2018, LANG ENV STAT COMP; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Campbell LJ, 2015, BIOCHEMISTRY-US, V54, P1380, DOI 10.1021/bi501530u; Chakraborty A, 2018, BIOCHEM SOC T, V46, P1303, DOI 10.1042/BST20170529; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Galande AK, 2001, LETT PEPT SCI, V8, P247, DOI 10.1023/A:1016285331403; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Heard KR, 2013, J MED CHEM, V56, P8339, DOI 10.1021/jm400423p; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hubbard S. J., 1993, NACCESS; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; LeCher Julia C., 2017, BioMolecular Concepts, V8, P131, DOI 10.1515/bmc-2017-0023; Li SQ, 2018, NAT REV CANCER, V18, P767, DOI 10.1038/s41568-018-0076-6; Lim YT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208273; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mahendrarajah N, 2017, CELL SIGNAL, V39, P9, DOI 10.1016/j.cellsig.2017.07.014; Mahendrarajah N, 2016, J CANCER RES CLIN, V142, P2263, DOI 10.1007/s00432-016-2229-x; Martinek TA, 2012, CHEM SOC REV, V41, P687, DOI 10.1039/c1cs15097a; McCormick F, 2018, ANNU REV CANC BIOL, V2, P81, DOI 10.1146/annurev-cancerbio-050216-122010; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Mott HR, 2019, SEMIN CANCER BIOL, V54, P149, DOI 10.1016/j.semcancer.2018.01.001; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2018, BIOCHEM SOC T, V46, P1289, DOI 10.1042/BST20170570; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Qian ZQ, 2016, BIOCHEMISTRY-US, V55, P2601, DOI 10.1021/acs.biochem.6b00226; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Santra S, 2011, J AM CHEM SOC, V133, P16680, DOI 10.1021/ja207463b; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Spencer-Smith R, 2019, SEMIN CANCER BIOL, V54, P138, DOI 10.1016/j.semcancer.2017.12.005; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tetley GJN, 2018, J BIOL CHEM, V293, P15136, DOI 10.1074/jbc.RA118.003290; Tetley GJN, 2017, J BIOL CHEM, V292, P11361, DOI 10.1074/jbc.M117.789883; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang K, 2014, INT J NANOMED, V9, P4991, DOI 10.2147/IJN.S72560; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200	65	8	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2866	2884		10.1074/jbc.RA119.010077	http://dx.doi.org/10.1074/jbc.RA119.010077			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31959628	Green Published, hybrid			2022-12-28	WOS:000519969100027
J	Bozzi, AT; McCabe, AL; Barnett, BC; Gaudet, R				Bozzi, Aaron T.; McCabe, Anne L.; Barnett, Benjamin C.; Gaudet, Rachelle			Transmembrane helix 6b links proton and metal release pathways and drives conformational change in an Nramp-family transition metal transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proton transport; transport metal; transporter; metal homeostasis; membrane transport; manganese; conformational change; conformational cycle; cysteine accessibility; divalent metal transporter 1 (DMT1); MntH; natural resistance-associated macrophage protein (Nramp)	X-RAY STRUCTURES; MICROCYTIC ANEMIA; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; IRON TRANSPORT; MECHANISM; MUTATION; RESISTANCE; RESIDUES; LEUT	The natural resistance-associated macrophage protein (Nramp) family encompasses transition metal and proton cotransporters that are present in many organisms from bacteria to humans. Recent structures of Deinococcus radiodurans Nramp (DraNramp) in multiple conformations revealed the intramolecular rearrangements required for alternating access of the metal-binding site to the external or cytosolic environment. Here, using recombinant proteins and metal transport and cysteine accessibility assays, we demonstrate that two parallel cytoplasm-accessible networks of conserved hydrophilic residues in DraNramp, one lining the wide intracellular vestibule for metal release and the other forming a narrow proton transport pathway, are essential for metal transport. We further show that mutagenic or posttranslational modifications of transmembrane helix (TM) 6b, which structurally links these two pathways, impede normal conformational cycling and metal transport. TM6b contains two highly conserved histidines, His(232) and His(237). We found that different mutagenic perturbations of His(232), just below the metal-binding site along the proton exit route, differentially affect DraNramp's conformational state, suggesting that His(232) serves as a pivot point for conformational changes. In contrast, any replacement of His(237), lining the metal exit route, locked the transporter in a transport-inactive outward-closed state. We conclude that these two histidines, and TM6b more broadly, help trigger the bulk rearrangement of DraNramp to the inward-open state upon metal binding and facilitate return of the empty transporter to an outward-open state upon metal release.	[Bozzi, Aaron T.; McCabe, Anne L.; Barnett, Benjamin C.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA; [Bozzi, Aaron T.] Alex Pharmaceut, 100 Coll St, New Haven, CT 06510 USA; [McCabe, Anne L.] Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, 885 Washington St, Boston, MA 02111 USA; [Barnett, Benjamin C.] UNC Sch Med, 321 S Columbia St, Chapel Hill, NC 27599 USA	Harvard University; Tufts University; University of North Carolina School of Medicine	Gaudet, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	; Gaudet, Rachelle/I-4133-2014	McCabe, Anne/0000-0002-3607-5368; Gaudet, Rachelle/0000-0002-9177-054X	National Institutes of Health [R01GM120996]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by National Institutes of Health Grant R01GM120996 (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardou-Jacquet E, 2011, BLOOD CELL MOL DIS, V47, P243, DOI 10.1016/j.bcmd.2011.07.004; Beaumont C, 2006, BLOOD, V107, P4168, DOI 10.1182/blood-2005-10-4269; Blanco E, 2009, BLOOD CELL MOL DIS, V43, P199, DOI 10.1016/j.bcmd.2009.05.003; Bozzi AT, 2019, J GEN PHYSIOL, V151, P1413, DOI 10.1085/jgp.201912428; Bozzi AT, 2019, ELIFE, V8, DOI 10.7554/eLife.41124; Bozzi AT, 2016, STRUCTURE, V24, P2102, DOI 10.1016/j.str.2016.09.017; Bozzi AT, 2016, P NATL ACAD SCI USA, V113, P10310, DOI 10.1073/pnas.1607734113; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chaloupka R, 2005, BIOCHEMISTRY-US, V44, P726, DOI 10.1021/bi048014v; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200; Courville P, 2008, J BIOL CHEM, V283, P9651, DOI 10.1074/jbc.M709906200; Cunrath O, 2019, SCIENCE, V366, P995, DOI 10.1126/science.aax7898; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Ehrnstorfer IA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14033; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Grouleff J, 2015, BIOPHYS J, V108, P1390, DOI 10.1016/j.bpj.2015.02.010; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haemig HAH, 2004, J MEMBRANE BIOL, V201, P97, DOI 10.1007/s00232-004-0711-x; Haemig HAH, 2010, BIOCHEMISTRY-US, V49, P4662, DOI 10.1021/bi100320y; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lam-Yuk-Tseung S, 2005, BLOOD CELL MOL DIS, V35, P212, DOI 10.1016/j.bcmd.2005.05.008; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lam-Yuk-Tseung S, 2006, BLOOD CELL MOL DIS, V36, P347, DOI 10.1016/j.bcmd.2006.01.011; LeVine MV, 2019, P NATL ACAD SCI USA, V116, P15947, DOI 10.1073/pnas.1903020116; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; Li JY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051430; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Perez C, 2013, BIOL CHEM, V394, P641, DOI 10.1515/hsz-2012-0336; Pujol-Gimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06446-y; Rudnick G, 2019, J GEN PHYSIOL, V151, P1339, DOI 10.1085/jgp.201912464; Senguen FT, 2012, BIOCHEMISTRY-US, V51, P6182, DOI 10.1021/bi300698h; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Shin JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004429; Shu HY, 2010, AFR J BIOTECHNOL, V9, P2742; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]	60	6	6	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1212	1224		10.1074/jbc.RA119.011336	http://dx.doi.org/10.1074/jbc.RA119.011336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31882536	Green Published, Bronze			2022-12-28	WOS:000513822300005
J	Soliman, C; Chua, JX; Vankemmelbeke, M; McIntosh, RS; Guy, AJ; Spendlove, I; Durrant, LG; Ramsland, PA				Soliman, Caroline; Chua, Jia Xin; Vankemmelbeke, Mireille; McIntosh, Richard S.; Guy, Andrew J.; Spendlove, Ian; Durrant, Lindy G.; Ramsland, Paul A.			The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; cancer; glycobiology; carbohydrate structure; carbohydrate-binding protein; structural biology; post-translational modification (PTM); anti-cancer antibody; antibody-based tumor targeting; carbohydrate-binding antibody; glycolipid antigen; stage-specific embryonic antigen; glycosphingolipid; immunotherapy	MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; BREAST-CANCER; STEM-CELLS; SSEA-4; GANGLIOSIDE; RECOGNITION; EXPRESSION; MELANOMA; GLYCOSYLATION	Cancer remains a leading cause of morbidity and mortality worldwide, requiring ongoing development of targeted therapeutics such as monoclonal antibodies. Carbohydrates on embryonic cells are often highly expressed in cancer and are therefore attractive targets for antibodies. Stage-specific embryonic antigen-4 (SSEA-4) is one such glycolipid target expressed in many cancers, including breast and ovarian carcinomas. Here, we defined the structural basis for recognition of SSEA-4 by a novel monospecific chimeric antibody (ch28/11). Five X-ray structures of ch28/11 Fab complexes with the SSEA-4 glycan headgroup, determined at 1.5?2.7 ? resolutions, displayed highly similar three-dimensional structures indicating a stable binding mode. The structures also revealed that by adopting a horseshoe-shaped conformation in a deep groove, the glycan headgroup likely sits flat against the membrane to allow the antibody to interact with SSEA-4 on cancer cells. Moreover, we found that the terminal sialic acid of SSEA-4 plays a dominant role in dictating the exquisite specificity of the ch28/11 antibody. This observation was further supported by molecular dynamics simulations of the ch28/11-glycan complex, which show that SSEA-4 is stabilized by its terminal sialic acid, unlike SSEA-3, which lacks this sialic acid modification. These high-resolution views of how a glycolipid interacts with an antibody may help to advance a new class of cancer-targeting immunotherapy.	[Soliman, Caroline; Guy, Andrew J.; Ramsland, Paul A.] RMIT Univ, Sch Sci, Melbourne, Vic 3083, Australia; [Chua, Jia Xin; Vankemmelbeke, Mireille; McIntosh, Richard S.; Spendlove, Ian; Durrant, Lindy G.] Univ Nottingham, Acad Dept Clin Oncol, Sch Med, Div Canc & Stem Cells, City Hosp Campus, Nottingham NG7 2RD, England; [Chua, Jia Xin; Vankemmelbeke, Mireille; Durrant, Lindy G.] Univ Nottingham, Scancell Ltd, Acad Dept Clin Oncol, City Hosp Campus, Nottingham NG7 2RD, England; [Ramsland, Paul A.] Monash Univ, Cent Clin Sch, Dept Immunol, Melbourne, Vic 3800, Australia; [Ramsland, Paul A.] Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic 3084, Australia	Royal Melbourne Institute of Technology (RMIT); Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ramsland, PA (corresponding author), RMIT Univ, Sch Sci, Plenty Rd, Bundoora, Vic 3083, Australia.	paul.ramsland@rmit.edu.au		Ramsland, Paul/0000-0002-2107-2738; Spendlove, Ian/0000-0002-7480-3768; Soliman, Caroline/0000-0003-2714-5341; Vankemmelbeke, Mireille/0000-0002-8100-813X; Guy, Andrew/0000-0003-0376-2329	LIEF Grant [LE170100200]; Consortium for Functional Glycomics Grants [GM62116, GM098791]; MRC [MR/M015564/1] Funding Source: UKRI	LIEF Grant; Consortium for Functional Glycomics Grants; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the ACRF detector. This research was also undertaken using the Linkage Infrastructure, Equipment, and Facilities (LIEF) HPC-GPGPU Facility hosted at the University of Melbourne. This facility was established with the assistance of LIEF Grant LE170100200. The glycan array screening resources were provided by Consortium for Functional Glycomics Grants GM62116 and GM098791.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Ahmed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063359; Aloia A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0652-6; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bernardi A, 2019, SOFTWAREX, V10, DOI 10.1016/j.softx.2019.100241; Casanas A, 2016, ACTA CRYSTALLOGR D, V72, P1036, DOI 10.1107/S2059798316012304; Chang WW, 2008, P NATL ACAD SCI USA, V105, P11667, DOI 10.1073/pnas.0804979105; Chua JX, 2015, CLIN CANCER RES, V21, P2963, DOI 10.1158/1078-0432.CCR-14-3030; Copoiu L, 2020, NUCLEIC ACIDS RES, V48, pD368, DOI 10.1093/nar/gkz860; da Silva AWS, 2012, BMC RES NOTES, V5, DOI 10.1186/1756-0500-5-367; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Dhar C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00807; Dhillon S, 2015, DRUGS, V75, P923, DOI 10.1007/s40265-015-0399-5; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Durrant LG, 2012, CLIN EXP IMMUNOL, V167, P206, DOI 10.1111/j.1365-2249.2011.04516.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan ZC, 1999, J MOL RECOGNIT, V12, P19, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y; Galizia G, 2007, ONCOGENE, V26, P3654, DOI 10.1038/sj.onc.1210381; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horwacik I, 2015, MOL CELL PROTEOMICS, V14, P2577, DOI 10.1074/mcp.M115.052720; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski MJ, 1999, J BIOL CHEM, V274, P5597, DOI 10.1074/jbc.274.9.5597; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Krengel U, 2004, J BIOL CHEM, V279, P5597, DOI 10.1074/jbc.M311693200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lou YW, 2014, P NATL ACAD SCI USA, V111, P2482, DOI 10.1073/pnas.1400283111; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Markham A, 2016, DRUGS, V76, P1227, DOI 10.1007/s40265-016-0618-8; MEEZAN E, 1969, BIOCHEMISTRY-US, V8, P2518, DOI 10.1021/bi00834a039; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noto Z, 2013, ORAL ONCOL, V49, P787, DOI 10.1016/j.oraloncology.2013.04.012; NUDELMAN E, 1982, J BIOL CHEM, V257, P2752; Parameswaran R, 2013, J EXP MED, V210, P805, DOI 10.1084/jem.20121482; Parte SC, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0439-3; Pento JT, 2017, ANTICANCER RES, V37, P5935, DOI 10.21873/anticanres.12040; Pichla SL, 1997, J STRUCT BIOL, V119, P6, DOI 10.1006/jsbi.1997.3857; Scott AM, 2001, J CLIN ONCOL, V19, P3976, DOI 10.1200/JCO.2001.19.19.3976; Sivasubramaniyan K, 2015, GLYCOBIOLOGY, V25, P902, DOI 10.1093/glycob/cwv032; Soliman C, 2018, J BIOL CHEM, V293, P5079, DOI 10.1074/jbc.RA117.001170; Soliman C, 2017, CURR OPIN STRUC BIOL, V44, P1, DOI 10.1016/j.sbi.2016.10.009; Suzuki S, 2016, JPN J CLIN ONCOL, V46, P191, DOI 10.1093/jjco/hyv201; Talavera A, 2009, MOL IMMUNOL, V46, P3466, DOI 10.1016/j.molimm.2009.07.032; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang SG, 2020, IEEE T CLOUD COMPUT, V8, P1122, DOI 10.1109/TCC.2016.2603504; Wang Z, 2012, GLYCOBIOLOGY, V22, P930, DOI 10.1093/glycob/cws061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37004; Zhang T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00090	56	6	6	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1009	1020		10.1074/jbc.RA119.011518	http://dx.doi.org/10.1074/jbc.RA119.011518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31831622	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000509949300010
J	An, ZB; Wang, H; Song, P; Zhang, M; Geng, XM; Zou, MH				An, Zhibo; Wang, Hong; Song, Ping; Zhang, Miao; Geng, Xuemei; Zou, Ming-Hui			Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: A role for oxidant stress (Withdrawal of Vol 282, Pg 26793, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Cheng PY, 2007, BIOCHEM PHARMACOL, V74, P1758, DOI 10.1016/j.bcp.2007.08.004	2	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					667	667		10.1074/jbc.W119.012217	http://dx.doi.org/10.1074/jbc.W119.012217			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31924673	Green Published, hybrid			2022-12-28	WOS:000507373600032
J	Salazar, ML; Jimenez, JM; Villar, J; Rivera, M; Baez, M; Manubens, A; Becker, MI				Salazar, Michelle L.; Jimenez, Jose M.; Villar, Javiera; Rivera, Maira; Baez, Mauricio; Manubens, Augusto; Becker, Maria Ines			N-Glycosylation of mollusk hemocyanins contributes to their structural stability and immunomodulatory properties in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; carbohydrate function; protein stability; humoral response; cytokine induction; glycoprotein; immunotherapy; mollusk hemocyanin; quaternary structure; secondary structure	KEYHOLE LIMPET HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; PROTEIN GLYCOSYLATION; CARBOHYDRATE MOIETY; ELECTRON-MICROSCOPY; ANTIBODY-RESPONSES; GLYCAN STRUCTURES; TUMOR-DEVELOPMENT; DENDRITIC CELLS; SUBUNIT	Hemocyanins are widely used as carriers, adjuvants, and nonspecific immunostimulants in cancer because they promote Th1 immunity in mammals. Hemocyanins also interact with glycan-recognizing innate immune receptors on antigen-presenting cells, such as the C-type lectin immune receptors mannose receptor (MR), macrophage galactose lectin (MGL), and the Toll-like receptors (TLRs), stimulating proinflammatory cytokine secretion. However, the role of N-linked oligosaccharides on the structural and immunological properties of hemocyanin is unclear. Mollusk hemocyanins, such as Concholepas concholepas (CCH), Fissurella latimarginata (FLH), and Megathura crenulata (KLH), are oligomeric glycoproteins with complex dodecameric quaternary structures and heterogeneous glycosylation patterns, primarily consisting of mannose-rich N-glycans. Here, we report that enzyme-catalyzed N-deglycosylation of CCH, FLH, and KLH disrupts their quaternary structure and impairs their immunogenic effects. Biochemical analyses revealed that the deglycosylation does not change hemocyanin secondary structure but alters their refolding mechanism and dodecameric structure. Immunochemical analyses indicated decreased binding of N-deglycosylated hemocyanins to the MR and MGL receptors and TLR4 and reduced endocytosis concomitant with an impaired production of tumor necrosis factor ?, and interleukins 6 and 12 (IL-6 and IL-12p40, respectively) in macrophages. Evaluating the function of N-deglycosylated hemocyanins in the humoral immune response and their nonspecific antitumor effects in the B16F10 melanoma model, we found that compared with native hemocyanins N-deglycosylated hemocyanins elicited reduced antibody titers, as well as partially diminished antitumor effects and altered carrier activities. In conclusion, the glycan content of hemocyanins is, among other structural characteristics, critically required for their immunological activities and should be considered in biomedical applications.	[Salazar, Michelle L.; Jimenez, Jose M.; Villar, Javiera; Becker, Maria Ines] Fdn Ciencia & Tecnol El Desarrollo FUCITED, Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile; [Rivera, Maira; Baez, Mauricio] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago 8380494, Chile; [Manubens, Augusto; Becker, Maria Ines] Biosonda Corp, Dept Invest & Desarrollo, Santiago 7750269, Chile; [Salazar, Michelle L.] Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile	Universidad de Chile	Becker, MI (corresponding author), Fdn Ciencia & Tecnol El Desarrollo FUCITED, Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile.	marianes.becker@fucited.cl		Rivera, Maira/0000-0002-2771-9248; Villar, Javiera/0000-0002-8581-4155	FONDEQUIP [EQM140151]; FONDECYT [1191153, 1151337]; CONICYT-CHILE National Ph.D. Fellowship [CONICYT-PCHA/Doctorado Nacional/2013-21130683]	FONDEQUIP; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-CHILE National Ph.D. Fellowship	This work was supported in part by FONDECYT Grant 1151337 (to M. I. B.), FONDEQUIP EQM140151 and FONDECYT Grant 1191153 (to M. B.), and CONICYT-CHILE National Ph.D. Fellowship CONICYT-PCHA/Doctorado Nacional/2013-21130683 (to J. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonova O, 2014, Z NATURFORSCH C, V69, P325, DOI 10.5560/ZNC.2013-0148; Arancibia S., 2012, BLADDER CANC FROM BA, P221, DOI [10.5772/28281, DOI 10.5772/28281]; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; Chia J, 2016, BBA-GEN SUBJECTS, V1860, P1623, DOI 10.1016/j.bbagen.2016.03.008; Cornelissen LAM, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020026; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Dolashka P, 2010, CARBOHYD RES, V345, P2361, DOI 10.1016/j.carres.2010.08.005; Dolashka-Angelova P, 2003, BBA-PROTEINS PROTEOM, V1646, P77, DOI 10.1016/S1570-9639(02)00549-6; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Etxebarria J, 2012, ACS CHEM BIOL, V7, P1729, DOI 10.1021/cb300262x; Fierz W, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00551; Freeze Hudson H, 2008, Curr Protoc Immunol, VChapter 8, DOI [10.1002/0471140864.ps1204s62, 10.1002/0471142727.mb1713as89, 10.1002/0471142735.im0815s83]; Gai ZQ, 2015, STRUCTURE, V23, P2204, DOI 10.1016/j.str.2015.09.008; Garcia Villalobos J., 2016, THESIS UPSEHU LEIOA, P1; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gesheva V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0034-3; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GLADHAUG IP, 1990, J CELL PHYSIOL, V143, P188, DOI 10.1002/jcp.1041430126; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Harris JR, 2000, MICRON, V31, P1, DOI 10.1016/S0968-4328(99)00059-1; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jayaprakash NG, 2017, BIOCHEM J, V474, P2333, DOI 10.1042/BCJ20170111; Jimenez JM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01136; Kawai R, 2013, J IMMUNOTOXICOL, V10, P40, DOI 10.3109/1547691X.2012.691122; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lingg N, 2012, BIOTECHNOL J, V7, P1462, DOI 10.1002/biot.201200078; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Roman JJM, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7076942; Oyelaran O, 2010, PROTEOM CLIN APPL, V4, P285, DOI 10.1002/prca.200900130; Palacios M, 2018, EUR J MED CHEM, V150, P74, DOI 10.1016/j.ejmech.2018.02.082; Peixoto A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00380; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Rodriguez E, 2018, NAT REV IMMUNOL, V18, P204, DOI 10.1038/nri.2018.3; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; SIEZEN RJ, 1974, J MOL BIOL, V90, P77; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Sotillo J, 2014, PARASITOLOGY, V141, P1333, DOI 10.1017/S0031182014000596; SPIRO RG, 1964, J BIOL CHEM, V239, P567; Staudacher Erika, 2009, Curr Top Biochem Res, V11, P29; Stoeva S, 1999, BBA-PROTEIN STRUCT M, V1435, P94, DOI 10.1016/S0167-4838(99)00198-3; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Van Die I., 2010, HDB GLYCOMICS; Varki A., 2009, ESSENTIALS GLYCOBIOL; Velkova L, 2010, COMP BIOCHEM PHYS B, V157, P16, DOI 10.1016/j.cbpb.2010.04.012; Velkova L, 2017, CARBOHYD RES, V449, P1, DOI 10.1016/j.carres.2017.06.012; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WALSH MT, 1990, BIOCHEMISTRY-US, V29, P6250, DOI 10.1021/bi00478a020; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhang PQ, 2016, DRUG DISCOV TODAY, V21, P740, DOI 10.1016/j.drudis.2016.01.006; Zhang ZH, 2019, FEBS LETT, V593, P820, DOI 10.1002/1873-3468.13367; Zheng LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151801; Zhong TY, 2016, J IMMUNOL, V196, P4650, DOI 10.4049/jimmunol.1501156; Zou GZ, 2018, J BIOL CHEM, V293, P19277, DOI 10.1074/jbc.RA118.005294; Zou X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43560	80	14	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19546	19564		10.1074/jbc.RA119.009525	http://dx.doi.org/10.1074/jbc.RA119.009525			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31719148	Green Published, hybrid			2022-12-28	WOS:000504093200009
J	Wortham, AM; Goldman, DC; Chen, JX; Fleming, WH; Zhang, AS; Enns, CA				Wortham, Aaron M.; Goldman, Devorah C.; Chen Juxing; Fleming, William H.; Zhang An-Sheng; Enns, Caroline A.			Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; iron; erythropoiesis; erythropoietin; transferrin; metal homeostasis; metabolic regulation; erythropoiesis; erythropoietin; hereditary hemochromatosis; iron overload; transferrin receptor-2	PROGENITORS BFU-E; ERYTHROID-DIFFERENTIATION; HEPCIDIN EXPRESSION; DEPENDENT INDUCTION; DISTINCT STAGES; MICE LEADS; GENE; ERYTHROFERRONE; TFR2; HFE	Transferrin receptor 2 (TFR2) is a transmembrane protein expressed mainly in hepatocytes and in developing erythroid cells and is an important focal point in systemic iron regulation. Loss of TFR2 function results in a rare form of the iron-overload disease hereditary hemochromatosis. Although TFR2 in the liver has been shown to be important for regulating iron homeostasis in the body, TFR2's function in erythroid progenitors remains controversial. In this report, we analyzed TFR2-deficient mice in the presence or absence of iron overload to distinguish between the effects caused by a high iron load and those caused by loss of TFR2 function. Analysis of bone marrow from TFR2-deficient mice revealed a reduction in the early burst-forming unit?erythroid and an expansion of late-stage erythroblasts that was independent of iron overload. Spleens of TFR2-deficient mice displayed an increase in colony-forming unit?erythroid progenitors and in all erythroblast populations regardless of iron overload. This expansion of the erythroid compartment coincided with increased erythroferrone (ERFE) expression and serum erythropoietin (EPO) levels. Rescue of hepatic TFR2 expression normalized hepcidin expression and the total cell count of the bone marrow and spleen, but it had no effect on erythroid progenitor frequency. On the basis of these results, we propose a model of TFR2's function in murine erythropoiesis, indicating that deficiency in this receptor is associated with increased erythroid development and expression of EPO and ERFE in extrahepatic tissues independent of TFR's role in the liver.	[Wortham, Aaron M.; Chen Juxing; Zhang An-Sheng; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Goldman, Devorah C.; Fleming, William H.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Chen Juxing] Novus Int Inc, St Charles, MO 63304 USA	Oregon Health & Science University; Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu		Enns, Caroline/0000-0002-5852-3766	National Institutes of Health [R01DK072166, R37-DK054488, R01DK109694, R01DK102791]; American Heart Association [11POST5250029]; Collins Medical Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Collins Medical Trust	This work was supported by National Institutes of Health Grants R01DK072166, R37-DK054488, R01DK109694, and R01DK102791, American Heart Association Grant 11POST5250029, and a Collins Medical Trust grant (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chloupkova M, 2010, BLOOD CELL MOL DIS, V44, P28, DOI 10.1016/j.bcmd.2009.09.004; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Doty RT, 2015, J CLIN INVEST, V125, P4681, DOI 10.1172/JCI83054; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; Fillebeen C, 2019, BLOOD, V133, P344, DOI 10.1182/blood-2018-05-850404; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Grover A, 2014, J EXP MED, V211, P181, DOI 10.1084/jem.20131189; HEATH DS, 1976, BLOOD, V47, P777; Hirano I, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00451-16; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Jiang XK, 2016, BLOOD CELL MOL DIS, V58, P45, DOI 10.1016/j.bcmd.2016.02.005; JOHNSON CS, 1983, AM J CLIN PATHOL, V80, P31, DOI 10.1093/ajcp/80.1.31; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Joshi R, 2015, MOL GENET GENOM MED, V3, P221, DOI 10.1002/mgg3.136; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; Kim A, 2015, CURR OPIN HEMATOL, V22, P199, DOI 10.1097/MOH.0000000000000132; Kleven MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194728; Koulnis M, 2014, ADV EXP MED BIOL, V844, P37, DOI 10.1007/978-1-4939-2095-2_3; LANDSCHULZ KT, 1992, BLOOD, V79, P2749; LEONARD JP, 1988, BLOOD, V72, P1492; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Nai A, 2014, HAEMATOLOGICA, V99, P1016, DOI 10.3324/haematol.2013.103143; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Oshima K, 2017, LAB INVEST, V97, P555, DOI 10.1038/labinvest.2017.11; Pagani A, 2015, HAEMATOLOGICA, V100, P461, DOI 10.3324/haematol.2014.118521; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Rauner M, 2019, NAT METAB, V1, P111, DOI 10.1038/s42255-018-0005-8; Rishi G, 2016, AM J HEMATOL, V91, P812, DOI 10.1002/ajh.24417; Roetto A, 2010, BLOOD, V115, P3382, DOI 10.1182/blood-2009-09-240960; Salgia RJ, 2015, CLIN LIVER DIS, V19, P187, DOI 10.1016/j.cld.2014.09.011; Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Storti F, 2014, HAEMATOLOGICA, V99, pE45, DOI 10.3324/haematol.2013.102707; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Wallace DF, 2015, BRIT J HAEMATOL, V168, P891, DOI 10.1111/bjh.13225; WALLERSTEIN RO, 1987, WESTERN J MED, V146, P443	60	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3906	3917		10.1074/jbc.RA119.010535	http://dx.doi.org/10.1074/jbc.RA119.010535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32054685	hybrid, Green Published			2022-12-28	WOS:000527704400015
J	Meng, DL; Yang, QM; Wang, HY; Melick, CH; Navlani, R; Frank, AR; Jewell, JL				Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.			Glutamine and asparagine activate mTORC1 independently of Rag GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; glutamine; mTOR complex (mTORC); metabolism; signal transduction; ADP-ribosylation factor 1 (Arf1); asparagine; glutamine; mTORC1; Rag GTPase; amino acid sensing; v-ATPase; lysosome; metabolic regulation	TUBEROUS SCLEROSIS COMPLEX; AMINO-ACID SUFFICIENCY; TUMOR-SUPPRESSOR; REGULATES MTOR; DIRECT TARGET; GAP ACTIVITY; PROTEIN; METABOLISM; MECHANISM; UPSTREAM	Nutrient sensing by cells is crucial, and when this sensing mechanism is disturbed, human disease can occur. mTOR complex 1 (mTORC1) senses amino acids to control cell growth, metabolism, and autophagy. Leucine, arginine, and methionine signal to mTORC1 through the well-characterized Rag GTPase signaling pathway. In contrast, glutamine activates mTORC1 through a Rag GTPase?independent mechanism that requires ADP-ribosylation factor 1 (Arf1). Here, using several biochemical and genetic approaches, we show that eight amino acids filter through the Rag GTPase pathway. Like glutamine, asparagine signals to mTORC1 through Arf1 in the absence of the Rag GTPases. Both the Rag-dependent and Rag-independent pathways required the lysosome and lysosomal function for mTORC1 activation. Our results show that mTORC1 is differentially regulated by amino acids through two distinct pathways.	[Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA; [Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Meng, Delong; Yang, Qianmei; Wang, Huanyu; Melick, Chase H.; Navlani, Rishika; Frank, Anderson R.; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jewell, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA.	Jenna.Jewell@UTSouthwestern.edu		Wang, Huanyu/0000-0003-3981-3394; Meng, Delong/0000-0001-5183-4564; Frank, Anderson/0000-0003-2239-9975; Jewell, Jenna/0000-0002-8021-9453; Melick, Chase/0000-0003-3977-9886	CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant [RR150032]; CPRIT High-Impact/High-Risk Research Award [RP160713]; Welch Foundation [I-1927]; 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS) [ACS-IRG-17-174-13]; National Institutes of Health [R01GM129097-01]	CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant; CPRIT High-Impact/High-Risk Research Award; Welch Foundation(The Welch Foundation); 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS)(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by CPRIT Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant RR150032; CPRIT High-Impact/High-Risk Research Award RP160713; Welch Foundation Grant I-1927; the 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society (ACS) Institutional Research Grant ACS-IRG-17-174-13; and National Institutes of Health Grant R01GM129097-01 (to J. L. J.). TheX authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRAME EG, 1958, J CLIN INVEST, V37, P1710, DOI 10.1172/JCI103763; Gomes AP, 2015, CURR OPIN BIOTECH, V34, P110, DOI 10.1016/j.copbio.2014.12.007; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kim A, 2015, MOL BIOL CELL, V26, P4631, DOI 10.1091/mbc.E15-08-0581; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Luo M, 2018, CELL METAB, V27, P947, DOI 10.1016/j.cmet.2018.04.012; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Pavlova NN, 2018, CELL METAB, V27, P428, DOI 10.1016/j.cmet.2017.12.006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; STEIN WH, 1954, J BIOL CHEM, V211, P915; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Tanigawa M, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00075-17; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Ukai H, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007334; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2017, NATURE, V543, P438, DOI 10.1038/nature21423; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	66	67	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2890	2899		10.1074/jbc.AC119.011578	http://dx.doi.org/10.1074/jbc.AC119.011578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32019866	Green Published, hybrid			2022-12-28	WOS:000519597300001
J	Meng, YX; Sheen, C; Magon, NJ; Hampton, MB; Dobson, RCJ				Meng, Yanxiang; Sheen, Campbell; Magon, Nicholas J.; Hampton, Mark B.; Dobson, Renwick C. J.			Structure-function analyses of alkylhydroperoxidase D from Streptococcus pneumoniae reveal an unusual three-cysteine active site architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; oxidative stress; X-ray crystallography; analytical ultracentrifugation; small-angle X-ray scattering (SAXS); electron transfer; alkylhydroperoxidase D; liquid chromatography-mass spectrometry (LC-MS; MS); redox switch; Streptococcus pneumoniae	ALKYL HYDROPEROXIDE REDUCTASE; ANTIOXIDANT DEFENSE SYSTEM; PYRUVATE OXIDASE; NADH OXIDASE; AHPD; MACROMOLECULES; THIOREDOXIN; SCATTERING; APOPTOSIS; VIRULENCE	During aerobic growth, the Gram-positive facultative anaerobe and opportunistic human pathogen Streptococcus pneumoniae generates large amounts of hydrogen peroxide that can accumulate to millimolar concentrations. The mechanism by which this catalase-negative bacterium can withstand endogenous hydrogen peroxide is incompletely understood. The enzyme alkylhydroperoxidase D (AhpD) has been shown to contribute to pneumococcal virulence and oxidative stress responses in vivo. We demonstrate here that SpAhpD exhibits weak thiol-dependent peroxidase activity and, unlike the previously reported Mycobacterium tuberculosis AhpC/D system, SpAhpD does not mediate electron transfer to SpAhpC. A 2.3-? resolution crystal structure revealed several unusual structural features, including a three-cysteine active site architecture that is buried in a deep pocket, in contrast to the two-cysteine active site found in other AhpD enzymes. All single-cysteine SpAhpD variants remained partially active, and LC-MS/MS analyses revealed that the third cysteine, Cys-163, formed disulfide bonds with either of two cysteines in the canonical Cys-78-X?X-Cys-81 motif. We observed that SpAhpD formed a dimeric quaternary structure both in the crystal and in solution, and that the highly conserved Asn-76 of the AhpD core motif is important for SpAhpD folding. In summary, SpAhpD is a weak peroxidase and does not transfer electrons to AhpC, and therefore does not fit existing models of bacterial AhpD antioxidant defense mechanisms. We propose that it is unlikely that SpAhpD removes peroxides either directly or via AhpC, and that SpAhpD cysteine oxidation may act as a redox switch or mediate electron transfer with other thiol proteins.	[Meng, Yanxiang; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Meng, Yanxiang; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand; [Sheen, Campbell] Univ Canterbury, Callaghan Innovat, Christchurch 8041, New Zealand; [Magon, Nicholas J.; Hampton, Mark B.] Univ Otago, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8011, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Canterbury; University of Canterbury; University of Canterbury; University of Otago; University of Melbourne	Dobson, RCJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 8041, New Zealand.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand.; Hampton, MB (corresponding author), Univ Otago, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8011, New Zealand.; Dobson, RCJ (corresponding author), Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	mark.hampton@otago.ac.nz; renwick.dobson@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021; Hampton, Mark/A-8490-2008	Dobson, Renwick/0000-0002-5506-4939; Hampton, Mark/0000-0002-7349-3729; Meng, Yanxiang/0000-0001-7447-9788	New Zealand Royal Society Marsden Fund [UOC1506]; Health Research Council of New Zealand; AINSE Honours Scholarship 2018; University of Otago; University of Canterbury	New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); AINSE Honours Scholarship 2018; University of Otago; University of Canterbury	This work was supported by New Zealand Royal Society Marsden Fund contract UOC1506 (to R. C. J. D.), the Health Research Council of New Zealand (to M. B. H.), and AINSE Honours Scholarship 2018, University of Canterbury Summer Scholarship 2017/2018, and University of Otago Summer Scholarship 2018/2019 (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Clontech Laboratories Inc.-Takara Bio USA, 2015, HD CLON PLUS CLON CO; DeLano W.L, PYMOL MOL GRAPHICS S; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Hajaj B, 2012, INFECT IMMUN, V80, P4333, DOI 10.1128/IAI.00126-12; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; Hong EJ, 2019, J BIOCHEM, V165, P197, DOI 10.1093/jb/mvy097; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kamariah N, 2015, BBA-BIOENERGETICS, V1847, P1139, DOI 10.1016/j.bbabio.2015.06.011; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishiyama Y, 2001, J BACTERIOL, V183, P2431, DOI 10.1128/JB.183.8.2431-2438.2001; Nunn CM, 2002, J BIOL CHEM, V277, P20033, DOI 10.1074/jbc.M200864200; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Paterson GK, 2006, MICROB PATHOGENESIS, V40, P152, DOI 10.1016/j.micpath.2005.12.003; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; PERRY FE, 1993, THORAX, V48, P364, DOI 10.1136/thx.48.4.364; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shrivastava AK, 2015, FUNCT INTEGR GENOMIC, V15, P77, DOI 10.1007/s10142-014-0407-y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winther JR, 2014, BBA-GEN SUBJECTS, V1840, P838, DOI 10.1016/j.bbagen.2013.03.031; Wong CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05354-5; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yesilkaya H, 2013, TRENDS MICROBIOL, V21, P187, DOI 10.1016/j.tim.2013.01.004	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2984	2999		10.1074/jbc.RA119.012226	http://dx.doi.org/10.1074/jbc.RA119.012226			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31974167	hybrid, Green Published			2022-12-28	WOS:000519597300010
J	Li, FKK; Rosell, FI; Gale, RT; Simorre, JP; Brown, ED; Strynadka, NCJ				Li, Franco K. K.; Rosell, Federico I.; Gale, Robert T.; Simorre, Jean-Pierre; Brown, Eric D.; Strynadka, Natalie C. J.			Crystallographic analysis of Staphylococcus aureus LcpA, the primary wall teichoic acid ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; teichoic acid; peptidoglycan; gram-positive bacteria; Staphylococcus aureus (S; aureus); Bacillus; X-ray crystallography; oligomerization; LytR?CpsA?Psr; size-exclusion chromatography with multiangle light scattering	CPSA-PSR PROTEINS; CELL-WALL; PEPTIDOGLYCAN; BIOSYNTHESIS; POLYSACCHARIDE; FEATURES; REVEALS; FAMILY; GENE	Gram-positive bacteria, including major clinical pathogens such as Staphylococcus aureus, are becoming increasingly drug-resistant. Their cell walls are composed of a thick layer of peptidoglycan (PG) modified by the attachment of wall teichoic acid (WTA), an anionic glycopolymer that is linked to pathogenicity and regulation of cell division and PG synthesis. The transfer of WTA from lipid carriers to PG, catalyzed by the LytR?CpsA?Psr (LCP) enzyme family, offers a unique extracellular target for the development of new anti-infective agents. Inhibitors of LCP enzymes have the potential to manage a wide range of bacterial infections because the target enzymes are implicated in the assembly of many other bacterial cell wall polymers, including capsular polysaccharide of streptococcal species and arabinogalactan of mycobacterial species. In this study, we present the first crystal structure of S. aureus LcpA with bound substrate at 1.9 ? resolution and those of Bacillus subtilis LCP enzymes, TagT, TagU, and TagV, in the apo form at 1.6?2.8 ? resolution. The structures of these WTA transferases provide new insight into the binding of lipid-linked WTA and enable assignment of the catalytic roles of conserved active-site residues. Furthermore, we identified potential subsites for binding the saccharide core of PG using computational docking experiments, and multiangle light-scattering experiments disclosed novel oligomeric states of the LCP enzymes. The crystal structures and modeled substrate-bound complexes of the LCP enzymes reported here provide insights into key features linked to substrate binding and catalysis and may aid the structure-guided design of specific LCP inhibitors.	[Li, Franco K. K.; Rosell, Federico I.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Li, Franco K. K.; Rosell, Federico I.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z4, Canada; [Simorre, Jean-Pierre] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Simorre, Jean-Pierre] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38000 Grenoble, France	University of British Columbia; University of British Columbia; McMaster University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Strynadka, NCJ (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Li, Franco/0000-0001-7318-9754; simorre, jean-pierre/0000-0002-7943-1342	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Howard Hughes Medical Institute International Senior Scholar program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Canada Research Chairs program; Joint Programming Initiative on Antimicrobial Resistance	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Senior Scholar program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Canada Research Chairs program(Canada Research Chairs); Joint Programming Initiative on Antimicrobial Resistance	This work was supported by the Natural Sciences and Engineering Research Council (to F. K. K. L.), the Canadian Institutes of Health Research (to R. T. G., N. C. J. S., and E. D. B.), the Howard Hughes Medical Institute International Senior Scholar program (to N. C. J. S.), the Canada Foundation for Innovation (to N. C. J. S. and E. D. B.), the British Columbia Knowledge Development Fund (to N. C. J. S.), the Canada Research Chairs program (tier 1; to N. C. J. S. and E. D. B.), and the Joint Programming Initiative on Antimicrobial Resistance (to J.-P. S). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Baumgart M, 2016, J BACTERIOL, V198, P3045, DOI 10.1128/JB.00406-16; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Caveney NA, 2018, CURR OPIN STRUC BIOL, V53, P45, DOI 10.1016/j.sbi.2018.05.002; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Gale RT, 2017, CELL CHEM BIOL, V24, P1537, DOI 10.1016/j.chembiol.2017.09.006; Grzegorzewicz AE, 2016, J BIOL CHEM, V291, P18867, DOI 10.1074/jbc.M116.739227; Harrison J, 2016, MBIO, V7, DOI 10.1128/mBio.00972-16; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kim H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204375; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Malm S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22012-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misawa Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005061; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Rausch M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09356-x; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Riley JG, 2005, GLYCOBIOLOGY, V15, P605, DOI 10.1093/glycob/cwi038; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Schaefer K, 2018, J AM CHEM SOC, V140, P2442, DOI 10.1021/jacs.7b13551; Schaefer K, 2017, NAT CHEM BIOL, V13, P396, DOI 10.1038/nchembio.2302; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Siegel SD, 2019, MBIO, V10, DOI 10.1128/mBio.01580-18; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weissgerber TL, 2017, J BIOL CHEM, V292, P20592, DOI 10.1074/jbc.RA117.000147	43	13	13	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2629	2639		10.1074/jbc.RA119.011469	http://dx.doi.org/10.1074/jbc.RA119.011469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969390	hybrid, Green Published			2022-12-28	WOS:000519969100009
J	Marivin, A; Maziarz, M; Zhao, JY; DiGiacomo, V; Calvo, IO; Mann, EA; Ear, J; Blanco-Canosa, JB; Ross, EM; Ghosh, P; Garcia-Marcos, M				Marivin, Arthur; Maziarz, Marcin; Zhao, Jingyi; DiGiacomo, Vincent; Olmos Calvo, Isabel; Mann, Emily A.; Ear, Jason; Blanco-Canosa, Juan B.; Ross, Elliott M.; Ghosh, Pradipta; Garcia-Marcos, Mikel			DAPLE protein inhibits nucleotide exchange on G?(s) and G?(q) via the same motif that activates G?i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; G-protein?coupled receptor (GPCR); guanine nucleotide?exchange factor (GEF); G protein; protein?protein interaction; cell signaling; G?-binding and -activating (GBA); guanine nucleotide dissociation inhibitor (GDI)	G-ALPHA-S; HETEROTRIMERIC G-PROTEINS; DISSOCIATION INHIBITOR; COUPLED RECEPTORS; REGULATORY MOTIF; DRUG DISCOVERY; GOLOCO MOTIF; SUBUNIT; STATE; RGS	Besides being regulated by G-protein?coupled receptors, the activity of heterotrimeric G proteins is modulated by many cytoplasmic proteins. GIV/Girdin and DAPLE (Dvl-associating protein with a high frequency of leucine) are the best-characterized members of a group of cytoplasmic regulators that contain a G?-binding and -activating (GBA) motif and whose dysregulation underlies human diseases, including cancer and birth defects. GBA motif?containing proteins were originally reported to modulate G proteins by binding G? subunits of the G(i/o) family (G?(i)) over other families (such as G(s), G(q/11), or G(12/13)), and promoting nucleotide exchange in vitro. However, some evidence suggests that this is not always the case, as phosphorylation of the GBA motif of GIV promotes its binding to G?(s) and inhibits nucleotide exchange. The G-protein specificity of DAPLE and how it might affect nucleotide exchange on G proteins besides G?(i) remain to be investigated. Here, we show that DAPLE's GBA motif, in addition to G?(i), binds efficiently to members of the G(s) and G(q/11) families (G?(s) and G?(q), respectively), but not of the G(12/13) family (G?(12)) in the absence of post-translational phosphorylation. We pinpointed Met-1669 as the residue in the GBA motif of DAPLE that diverges from that in GIV and enables better binding to G?(s) and G?(q). Unlike the nucleotide-exchange acceleration observed for G?(i), DAPLE inhibited nucleotide exchange on G?(s) and G?(q). These findings indicate that GBA motifs have versatility in their G-protein?modulating effect, i.e. they can bind to G? subunits of different classes and either stimulate or inhibit nucleotide exchange depending on the G-protein subtype.	[Marivin, Arthur; Maziarz, Marcin; Zhao, Jingyi; DiGiacomo, Vincent; Olmos Calvo, Isabel; Mann, Emily A.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA; [Ear, Jason; Ghosh, Pradipta] Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; [Blanco-Canosa, Juan B.] CSIC, Inst Adv Chem Catalonia IQAC, Dept Biol Chem, ES-08034 Barcelona, Spain; [Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Dallas, TX 75390 USA; [DiGiacomo, Vincent] DeepBiome Therapeut, Cambridge, MA 02139 USA; [Olmos Calvo, Isabel] Med Univ Vienna, Div Rheumatol, A-1090 Vienna, Austria	Boston University; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Vienna	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu	Zhao, Jingyi/AAG-3799-2019; Blanco-Canosa, Juan B./H-4544-2015	Zhao, Jingyi/0000-0002-3125-2716; Blanco-Canosa, Juan B./0000-0001-5738-6993	National Institutes of Health [CA100768, CA160911, R01GM108733, R01GM136132, R01GM030355]; American Cancer Society-Funding Hope Postdoctoral Fellowship [PF-19-084-01-CDD]; Hartwell Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Funding Hope Postdoctoral Fellowship; Hartwell Foundation	This work was supported by National Institutes of Health Grants R01GM108733 and R01GM136132 (to M. G.-M.), American Cancer Society-Funding Hope Postdoctoral Fellowship PF-19-084-01-CDD (to M. M.), a postdoctoral fellowship from the Hartwell Foundation (to V. D.), National Institutes of Health Grant R01GM030355 (to E. M. R.), and National Institutes of Health Grants CA100768 and CA160911 (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Acharya BR, 2018, DEV CELL, V47, P439, DOI 10.1016/j.devcel.2018.09.016; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; DiGiacomo V, 2018, BIOCHEMISTRY-US, V57, P255, DOI 10.1021/acs.biochem.7b00845; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Ear J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48420-w; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gupta V, 2016, P NATL ACAD SCI USA, V113, pE5721, DOI 10.1073/pnas.1609502113; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Johnston CA, 2005, FEBS LETT, V579, P5746, DOI 10.1016/j.febslet.2005.09.059; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kalogriopoulos NA, 2019, P NATL ACAD SCI USA, V116, P16394, DOI 10.1073/pnas.1906658116; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Leyme A, 2014, J BIOL CHEM, V289, P21818, DOI 10.1074/jbc.M114.549790; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Marivin A, 2019, MOL BIOL CELL, V30, P1900, DOI 10.1091/mbc.E19-02-0091; Marivin A, 2019, J CELL BIOL, V218, P1743, DOI 10.1083/jcb.201811174; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Maziarz M, 2018, J BIOL CHEM, V293, P16964, DOI 10.1074/jbc.RA118.003580; Meyer TN, 2002, J BIOL CHEM, V277, P24855, DOI 10.1074/jbc.C200240200; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; Navaratnarajah P, 2017, J BIOL CHEM, V292, P16788, DOI 10.1074/jbc.M117.809673; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Parag-Sharma K, 2016, J BIOL CHEM, V291, P27098, DOI 10.1074/jbc.M116.764431; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Ritchie Benjamin J, 2013, J Mol Signal, V8, P3, DOI 10.1186/1750-2187-8-3; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ross EM, 2002, METHOD ENZYMOL, V344, P601; Saha C, 2001, BIOCHEM BIOPH RES CO, V285, P250, DOI 10.1006/bbrc.2001.5154; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; UEDA N, 1994, J BIOL CHEM, V269, P4388; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756	85	6	6	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2270	2284		10.1074/jbc.RA119.011648	http://dx.doi.org/10.1074/jbc.RA119.011648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949046	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000517330200011
J	Uno, S; Masuya, T; Shinzawa-Itoh, K; Lasham, J; Haapanen, O; Shiba, T; Inaoka, DK; Sharma, V; Murai, M; Miyoshi, H				Uno, Shinpei; Masuya, Takahiro; Shinzawa-Itoh, Kyoko; Lasham, Jonathan; Haapanen, Outi; Shiba, Tomoo; Inaoka, Daniel Ken; Sharma, Vivek; Murai, Masatoshi; Miyoshi, Hideto			Oversized ubiquinones as molecular probes for structural dynamics of the ubiquinone reaction site in mitochondrial respiratory complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; complex I; ubiquinone; chemical biology; respiratory chain; proton pump	PINPOINT CHEMICAL-MODIFICATION; 49 KDA; CRYSTAL-STRUCTURE; INNER MEMBRANE; PROTON PUMP; NADH; REDUCTION; OXIDOREDUCTASE; MECHANISM; BINDING	NADH-quinone oxidoreductase (complex I) couples electron transfer from NADH to quinone with proton translocation across the membrane. Quinone reduction is a key step for energy transmission from the site of quinone reduction to the remotely located proton-pumping machinery of the enzyme. Although structural biology studies have proposed the existence of a long and narrow quinone-access channel, the physiological relevance of this channel remains debatable. We investigated here whether complex I in bovine heart submitochondrial particles (SMPs) can catalytically reduce a series of oversized ubiquinones (OS-UQs), which are highly unlikely to transit the narrow channel because their side chain includes a bulky ?block? that is ?13 ? across. We found that some OS-UQs function as efficient electron acceptors from complex I, accepting electrons with an efficiency comparable with ubiquinone-2. The catalytic reduction and proton translocation coupled with this reduction were completely inhibited by different quinone-site inhibitors, indicating that the reduction of OS-UQs takes place at the physiological reaction site for ubiquinone. Notably, the proton-translocating efficiencies of OS-UQs significantly varied depending on their side-chain structures, suggesting that the reaction characteristics of OS-UQs affect the predicted structural changes of the quinone reaction site required for triggering proton translocation. These results are difficult to reconcile with the current channel model; rather, the access path for ubiquinone may be open to allow OS-UQs to access the reaction site. Nevertheless, contrary to the observations in SMPs, OS-UQs were not catalytically reduced by isolated complex I reconstituted into liposomes. We discuss possible reasons for these contradictory results.	[Uno, Shinpei; Masuya, Takahiro; Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Shinzawa-Itoh, Kyoko] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Lasham, Jonathan; Haapanen, Outi; Sharma, Vivek] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Sharma, Vivek] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Shiba, Tomoo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto 6068585, Japan; [Inaoka, Daniel Ken] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Mol Infect Dynam, Nagasaki 8528523, Japan; [Inaoka, Daniel Ken] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan	Kyoto University; University of Hyogo; University of Helsinki; University of Helsinki; Kyoto Institute of Technology; Nagasaki University; Nagasaki University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Inaoka, Daniel Ken/GMX-4344-2022; Sharma, Vivek/CAG-0014-2022; Lasham, Jonathan/AAX-8331-2021	Inaoka, Daniel Ken/0000-0002-9791-927X; Lasham, Jonathan/0000-0001-6393-9654; Murai, Masatoshi/0000-0001-6601-2854; Haapanen, Outi/0000-0002-1958-8997; Sharma, Vivek/0000-0002-8838-3151; Miyoshi, Hideto/0000-0002-1792-554X; Masuya, Takahiro/0000-0003-4950-0527	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP18H02147, JP19K22278, JP18K05458]; Academy of Finland [294652]; University of Helsinki; Sigrid Juselius Foundation; doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Finland(Academy of Finland); University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP18H02147 and JP19K22278 (to H. M.) and JP18K05458 (to M. M.), by the Academy of Finland (294652), the University of Helsinki and the Sigrid Juselius Foundation grants (to V. S.), and by the doctoral program in chemistry and molecular sciences (CHEMS) of the University of Helsinki funding (to O. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2016, J BIOL CHEM, V291, P15491, DOI 10.1074/jbc.M116.718510; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Banba A, 2019, J BIOL CHEM, V294, P6550, DOI 10.1074/jbc.RA119.007687; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brookes PS, 1997, J MEMBRANE BIOL, V155, P167, DOI 10.1007/s002329900168; Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y; Cermakova P, 2019, PARASITE, V26, DOI 10.1051/parasite/2019017; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galassi VV, 2015, BBA-BIOENERGETICS, V1847, P1560, DOI 10.1016/j.bbabio.2015.08.001; Gamiz-Hernandez AP, 2017, J AM CHEM SOC, V139, P16282, DOI 10.1021/jacs.7b08486; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Haapanen O, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00221; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jones AJY, 2017, J BIOL CHEM, V292, P4987, DOI 10.1074/jbc.M116.771899; Jones AJY, 2016, ANGEW CHEM INT EDIT, V55, P728, DOI 10.1002/anie.201507332; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kido Y, 2010, BBA-BIOENERGETICS, V1797, P443, DOI 10.1016/j.bbabio.2009.12.021; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Masuya T, 2017, BIOCHEMISTRY-US, V56, P4279, DOI 10.1021/acs.biochem.7b00612; Masuya T, 2016, BIOSCI BIOTECH BIOCH, V80, P1464, DOI 10.1080/09168451.2016.1179095; Masuya T, 2014, BIOCHEMISTRY-US, V53, P7816, DOI 10.1021/bi501342w; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; Murai M, 2015, BIOCHEMISTRY-US, V54, P2739, DOI 10.1021/acs.biochem.5b00187; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Okuda K, 2016, BIOCHEMISTRY-US, V55, P470, DOI 10.1021/acs.biochem.5b01090; Parey K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9484; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Shiba T, 2019, BBA-BIOENERGETICS, V1860, P375, DOI 10.1016/j.bbabio.2019.03.008; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shimada S, 2018, PROTEIN EXPRES PURIF, V150, P33, DOI 10.1016/j.pep.2018.04.015; Shintou K, 2007, BIOPHYS J, V93, P3900, DOI 10.1529/biophysj.107.108399; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Uno SP, 2019, J BIOL CHEM, V294, P679, DOI 10.1074/jbc.RA118.006056; Warnau J, 2018, P NATL ACAD SCI USA, V115, pE8413, DOI 10.1073/pnas.1805468115; Wikstrom M, 2015, CHEM REV, V115, P2196, DOI 10.1021/cr500448t; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu X, 2012, WIRES COMPUT MOL SCI, V2, P167, DOI 10.1002/wcms.74; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	65	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2449	2463		10.1074/jbc.RA119.012347	http://dx.doi.org/10.1074/jbc.RA119.012347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31953326	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000517330200025
J	He, YM; Wang, SY; Tong, JF; Jiang, SY; Yang, Y; Zhang, ZB; Xu, YJ; Zeng, YY; Cao, BY; Moran, MF; Mao, XL				He, Yuanming; Wang, Siyu; Tong, Jiefei; Jiang, Shuoyi; Yang, Ye; Zhang, Zubin; Xu, Yujia; Zeng, Yuanying; Cao, Biyin; Moran, Michael F.; Mao, Xinliang			The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multiple myeloma; deubiquitylation (deubiquitination); cancer; transcription factor; anticancer drug	MULTIPLE-MYELOMA; C-MAF; UBIQUITINATION; APOPTOSIS; MIGRATION	The Maf proteins, including c-Maf, MafA, and MafB, are critical transcription factors in myelomagenesis. Previous studies demonstrated that Maf proteins are processed by the ubiquitin?proteasome pathway, but the mechanisms remain elusive. This study applied MS to identify MafB ubiquitination-associated proteins and found that the ubiquitin-specific protease USP7 was present in the MafB interactome. Moreover, USP7 also interacted with c-Maf and MafA and blocked their polyubiquitination and degradation. Consistently, knockdown of USP7 resulted in Maf protein degradation along with increased polyubiquitination levels. The action of USP7 thus promoted Maf transcriptional activity as evidenced by luciferase assays and by the up-regulation of the expression of Maf-modulated genes. Furthermore, USP7 was up-regulated in myeloma cells, and it was negatively associated with the survival of myeloma patients. USP7 promoted myeloma cell survival, and when it was inhibited by its specific inhibitor P5091, myeloma cell lines underwent apoptosis. These results therefore demonstrated that USP7 is a deubiquitinase of Maf proteins and promotes MM cell survival in association with Maf stability. Given the significance of USP7 and Maf proteins in myeloma genesis, targeting the USP7/Maf axle is a potential strategy to the precision therapy of MM.	[He, Yuanming; Wang, Siyu; Jiang, Shuoyi; Zhang, Zubin; Xu, Yujia; Cao, Biyin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China; [He, Yuanming; Jiang, Shuoyi; Mao, Xinliang] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou & Guangdong Key Lab Prot Modificat & De, Guangzhou 511436, Peoples R China; [Tong, Jiefei; Moran, Michael F.] Univ Toronto, Hosp Sick Children, Dept Mol Genet, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Yang, Ye] Nanjing Univ Tradit Med, Sch Basic Med, Nanjing 210023, Peoples R China; [Zeng, Yuanying] Suzhou Municipal Hosp, Dept Oncol, Suzhou 215100, Peoples R China; [Mao, Xinliang] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou Inst Cardiovasc Dis, Guangzhou 510260, Peoples R China; [Mao, Xinliang] Guangzhou Med Univ, Affiliated Hosp 2, Dept Hematol, Guangzhou 510260, Peoples R China	Soochow University - China; Guangzhou Medical University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Nanjing University of Chinese Medicine; Guangzhou Medical University; Guangzhou Medical University	Cao, BY; Mao, XL (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.; Zeng, YY (corresponding author), Suzhou Municipal Hosp, Dept Oncol, Suzhou 215100, Peoples R China.	zengyuanying@163.com; caobiyin@suda.edu.cn; xinliangmao@suda.edu.cn	Lang, Ming/HIK-0758-2022; Moran, Michael/GYD-3631-2022; yang, yang/GWB-9426-2022; YANG, YE/F-4987-2015	YANG, YE/0000-0003-0228-5102	National Natural Science Foundation of China [81320108023, 81770154, 81770215]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for NeuroPsycho-Diseases [BK2013003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for NeuroPsycho-Diseases	This work was supported in part by National Natural Science Foundation of China Grants 81320108023 and 81770154 (to X. M.) and 81770215 (to B. C.), by the Priority Academic Program Development of Jiangsu Higher Education Institutions (to B. C.), and by Jiangsu Key Laboratory for NeuroPsycho-Diseases Grant BK2013003 (to B. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ao NN, 2017, COMB CHEM HIGH T SCR, V20, P403, DOI 10.2174/1386207320666170710124746; Biswas K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03020-6; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chen GD, 2014, INT J BIOCHEM CELL B, V57, P157, DOI 10.1016/j.biocel.2014.10.024; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Drach J, 1998, BLOOD, V92, P802, DOI 10.1182/blood.V92.3.802.415a17_802_809; Du YY, 2018, J BIOL CHEM, V293, P5847, DOI 10.1074/jbc.RA117.000972; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Jiang L, 2017, J BIOL CHEM, V292, P13296, DOI 10.1074/jbc.M117.780130; Kocoglu M, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9010003; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Li T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.197; Ling X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-8; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lu J, 2012, ONCOGENE, V31, P3647, DOI 10.1038/onc.2011.538; Nakasone MA, 2017, STRUCTURE, V25, P1839, DOI 10.1016/j.str.2017.10.007; Neri P, 2011, BLOOD, V117, P6202, DOI 10.1182/blood-2010-06-292243; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qiang YW, 2016, BLOOD, V128, P2919, DOI 10.1182/blood-2016-03-706077; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Tavana O, 2017, J MOL CELL BIOL, V9, P45, DOI 10.1093/jmcb/mjw049; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; Tong JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064817; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Vicente-Duenas C, 2012, CELL CYCLE, V11, P3896, DOI 10.4161/cc.22186; Vicente-Duenas C, 2012, EMBO J, V31, P3704, DOI 10.1038/emboj.2012.227; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Wang SY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.450; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203; Zhou J, 2018, MED CHEM, V14, P3, DOI 10.2174/1573406413666171020115539; Zhu QZ, 2015, CELL CYCLE, V14, P1413, DOI 10.1080/15384101.2015.1007785	41	25	25	2	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2084	2096		10.1074/jbc.RA119.010724	http://dx.doi.org/10.1074/jbc.RA119.010724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31822558	hybrid, Green Published			2022-12-28	WOS:000517128200025
J	Han, NC; Bullwinkle, TJ; Loeb, KF; Faull, KF; Mohler, K; Rinehart, J; Ibba, M				Han, Nien-Ching; Bullwinkle, Tammy J.; Loeb, Kaeli F.; Faull, Kym F.; Mohler, Kyle; Rinehart, Jesse; Ibba, Michael			The mechanism of beta-N-methylamino-l-alanine inhibition of tRNA aminoacylation and its impact on misincorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; protein synthesis; translation; transfer RNA (tRNA); amino acid; beta-N-methylamino-L-alanine (BMAA); nonproteinogenic amino acid (NPA); alanyl-tRNA synthetase (AlaRS); amyotrophic lateral sclerosis (ALS); neurodegeneration and cyanotoxin	AMYOTROPHIC-LATERAL-SCLEROSIS; AMINO-ACID; CYANOBACTERIAL NEUROTOXINS; NEURODEGENERATIVE DISEASE; PARKINSONISM-DEMENTIA; EDITING ACTIVITY; SYNTHETASE; BMAA; PROTEIN; MISTRANSLATION	beta-N-methylamino-L-alanine (BMAA) is a nonproteinogenic amino acid that has been associated with neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD). BMAA has been found in human protein extracts; however, the mechanism by which it enters the proteome is still unclear. It has been suggested that BMAA is misincorporated at serine codons during protein synthesis, but direct evidence of its cotranslational incorporation is currently lacking. Here, using LC-MS-purified BMAA and several biochemical assays, we sought to determine whether any aminoacyl-tRNA synthetase (aaRS) utilizes BMAA as a substrate for aminoacylation. Despite BMAA's previously predicted misincorporation at serine codons, following a screen for amino acid activation in ATP/PPi exchange assays, we observed that BMAA is not a substrate for human seryl-tRNA synthetase (SerRS). Instead, we observed that BMAA is a substrate for human alanyl-tRNA synthetase (AlaRS) and can form BMAA-tRNA(Ala) by escaping from the intrinsic AlaRS proofreading activity. Furthermore, we found that BMAA inhibits both the cognate amino acid activation and the editing functions of AlaRS. Our results reveal that, in addition to being misincorporated during translation, BMAA may be able to disrupt the integrity of protein synthesis through multiple different mechanisms.	[Han, Nien-Ching; Bullwinkle, Tammy J.; Loeb, Kaeli F.; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43220 USA; [Faull, Kym F.] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, David Geffen Sch Med,Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Mohler, Kyle; Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Mohler, Kyle; Rinehart, Jesse] Yale Univ, Syst Biol Inst, New Haven, CT 06520 USA	University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Yale University	Ibba, M (corresponding author), 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu		Rinehart, Jesse/0000-0003-4839-4005	National Science Foundation [MCB-1715840]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1715840 (to M. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Al-Sammak MA, 2014, TOXINS, V6, P488, DOI 10.3390/toxins6020488; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beri J, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700161; Berntzon L, 2013, MAR DRUGS, V11, P3091, DOI 10.3390/md11083091; Bullwinkle T, 2014, ANNU REV GENET, V48, P149, DOI 10.1146/annurev-genet-120213-092101; Caller TA, 2012, AMYOTROPH LATERAL SC, V13, P25, DOI 10.3109/17482968.2011.621436; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Davis DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213346; DIXON M, 1979, ENZYMES, P332; Downing S, 2011, TOXICON, V58, P187, DOI 10.1016/j.toxicon.2011.05.017; DUNCAN MW, 1990, NEUROLOGY, V40, P767, DOI 10.1212/WNL.40.5.767; Dunlop RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075376; Esterhuizen M, 2008, ECOTOX ENVIRON SAFE, V71, P309, DOI 10.1016/j.ecoenv.2008.04.010; Glover WB, 2014, AMINO ACIDS, V46, P2553, DOI 10.1007/s00726-014-1812-1; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Holman KM, 2017, RNA, V23, P1685, DOI 10.1261/rna.061069.117; Jiang LY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06931; Kapur M, 2018, TRENDS GENET, V34, P218, DOI 10.1016/j.tig.2017.12.007; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Lu JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6650; Masseret E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083406; Mohler K, 2017, BBA-GEN SUBJECTS, V1861, P3081, DOI 10.1016/j.bbagen.2017.01.025; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Mohler K, 2017, NUCLEIC ACIDS RES, V45, P3985, DOI 10.1093/nar/gkx077; MULDER D W, 1954, U S Armed Forces Med J, V5, P1724; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Vo MN, 2018, NATURE, V557, P510, DOI 10.1038/s41586-018-0137-8; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Pawar KI, 2017, ELIFE, V6, DOI 10.7554/eLife.24001; Popova AA, 2018, ENV MICROBIOL REP, V10, P369, DOI 10.1111/1758-2229.12647; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Singh SP, 2011, WORLD J MICROB BIOT, V27, P1225, DOI 10.1007/s11274-010-0571-8; Song Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02201-z; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Torbick N, 2018, NEUROTOX RES, V33, P199, DOI 10.1007/s12640-017-9740-y; van Onselen R, 2018, TOXICON, V143, P74, DOI 10.1016/j.toxicon.2018.01.011; van Onselen R, 2017, TOXINS, V9, DOI 10.3390/toxins9120400; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; WEISS JH, 1989, NEURON, V3, P321, DOI 10.1016/0896-6273(89)90256-0; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j	51	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1402	1410		10.1074/jbc.RA119.011714	http://dx.doi.org/10.1074/jbc.RA119.011714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31862734	Green Published, Bronze			2022-12-28	WOS:000513822300022
J	Li, YX; Ramachandran, S; Nguyen, TTT; Stalnecker, CA; Cerione, RA; Erickson, JW				Li, Yunxing; Ramachandran, Sekar; Nguyen, Thuy-Tien T.; Stalnecker, Clint A.; Cerione, Richard A.; Erickson, Jon W.			The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutaminase; protein self-assembly; tryptophan; fluorescence; substrate specificity; cancer; small molecule; conformational change; CB-839; fluorescence quenching; glutamine metabolism; glutaminolysis; quaternary structure	KIDNEY-TYPE GLUTAMINASE; TRYPTOPHAN FLUORESCENCE; CONFORMATIONAL-CHANGES; MECHANISM; INHIBITION; METABOLISM; PROTEINS; COMPLEX; SWITCH	The glutaminase C (GAC) isoform of mitochondrial glutaminase is overexpressed in many cancer cells and therefore represents a potential therapeutic target. Understanding the regulation of GAC activity has been guided by the development of spectroscopic approaches that measure glutaminase activity in real time. Previously, we engineered a GAC protein (GAC(F327W)) in which a tryptophan residue is substituted for phenylalanine in an activation loop to explore the role of this loop in enzyme activity. We showed that the fluorescence emission of Trp-327 is enhanced in response to activator binding, but quenched by inhibitors of the BPTES class that bind to the GAC tetramer and contact the activation loop, thereby constraining it in an inactive conformation. In the present work, we took advantage of a tryptophan substitution at position 471, proximal to the GAC catalytic site, to examine the conformational coupling between the activation loop and the substrate-binding cleft, separated by similar to 16 angstrom. Comparison of glutamine binding in the presence or absence of the BPTES analog CB-839 revealed a reciprocal relationship between the constraints imposed on the activation loop position and the affinity of GAC for substrate. Binding of the inhibitor weakened the affinity of GAC for glutamine, whereas activating anions such as P-i increased this affinity. These results indicate that the conformations of the activation loop and the substrate-binding cleft in GAC are allosterically coupled and that this coupling determines substrate affinity and enzymatic activity and explains the activities of CB-839, which is currently in clinical trials.	[Li, Yunxing; Ramachandran, Sekar; Nguyen, Thuy-Tien T.; Stalnecker, Clint A.; Cerione, Richard A.; Erickson, Jon W.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Ramachandran, Sekar; Cerione, Richard A.; Erickson, Jon W.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Li, Yunxing] Silicon Therapeut, 51 D St,Suite 205, Boston, MA 02210 USA; [Stalnecker, Clint A.] Lineberger Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368; Stalnecker, Clint/0000-0002-0570-4416; Nguyen, Thuy-Tien/0000-0003-1676-733X	National Institutes of Health [R01 GM122575, R01 CA201402, U54 CA210184]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 GM122575, R01 CA201402, and U54 CA210184 (to R. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; ANTONNY B, 1991, BIOCHEMISTRY-US, V30, P8287, DOI 10.1021/bi00098a002; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Katt WP, 2014, DRUG DISCOV TODAY, V19, P450, DOI 10.1016/j.drudis.2013.10.008; LEE FS, 1989, BIOCHEMISTRY-US, V28, P219, DOI 10.1021/bi00427a030; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Moon CP, 2011, METHOD ENZYMOL, V492, P189, DOI 10.1016/B978-0-12-381268-1.00018-5; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; SHAPIRO RA, 1982, BIOCHEM J, V207, P561, DOI 10.1042/bj2070561; Stalnecker C. A., 2016, THESIS; Stalnecker CA, 2017, J BIOL CHEM, V292, P6095, DOI 10.1074/jbc.M116.758219; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Swain SD, 1997, J BIOL CHEM, V272, P29502, DOI 10.1074/jbc.272.47.29502; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836	27	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1328	1337		10.1074/jbc.RA119.010314	http://dx.doi.org/10.1074/jbc.RA119.010314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	31871054	Bronze, Green Published			2022-12-28	WOS:000513822300013
J	Tripathi, A; Martinez, E; Obaidullah, AJ; Lete, MG; Lonnfors, M; Khan, D; Soni, KG; Mousley, CJ; Kellogg, GE; Bankaitis, VA				Tripathi, Ashutosh; Martinez, Elliott; Obaidullah, Ahmad J.; Lete, Marta G.; Lonnfors, Max; Khan, Danish; Soni, Krishnakant G.; Mousley, Carl J.; Kellogg, Glen E.; Bankaitis, Vytas A.			Functional diversification of the chemical landscapes of yeast Sec14-like phosphatidylinositol transfer protein lipid-binding cavities (vol 294, pg 19081, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Lete, Marta G.] Univ Basque Country, Inst Biofis, CSIC, Leioa, Spain; [Lete, Marta G.] Univ Basque Country, Leioa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country			OBAIDULLAH, AHMAD J./GQI-4663-2022; OBAIDULLAH, AHMAD JOMAH/ABD-2825-2020	OBAIDULLAH, AHMAD J./0000-0002-7532-6318; Mousley, Carl/0000-0002-0192-7030; Khan, Danish/0000-0002-0650-3990				Aziz M, 2019, J BIOL CHEM, V294, P7419, DOI 10.1074/jbc.RA118.006672	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2020	295	5					1368	1368		10.1074/jbc.AAC120.012555	http://dx.doi.org/10.1074/jbc.AAC120.012555			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KM0QP	32005645	hybrid, Green Published			2022-12-28	WOS:000513822300018
J	Eill, GJ; Sinha, A; Morawskr, M; Viapiano, MS; Matthews, RT				Eill, Geoffrey J.; Sinha, Ashis; Morawskr, Markus; Viapiano, Mariano S.; Matthews, Russell T.			The protein tyrosine phosphatase RPTP?/phosphacan is critical for perineuronal net structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; extracellular matrix; hyaluronan; synaptic plasticity; tenascin; aggrecan; perineuronal net (PNN); phosphacan; protein tyrosine phosphatase receptor type Z1 (PTPRZ1); tenascin-R; neuronal plasticity; extracellular matrix (ECM); chondroitin sulfate proteoglycan	CHONDROITIN SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; TENASCIN-R; FUNCTIONAL RECOVERY; HYALURONAN SYNTHASE; NEURITE OUTGROWTH; PREFRONTAL CORTEX; MICE DEFICIENT; LINK PROTEIN; RAT-BRAIN	Perineuronal nets (PNNs) are conspicuous neuron-specific substructures within the extracellular matrix of the central nervous system that have generated an explosion of interest over the last decade. These reticulated structures appear to surround synapses on the cell bodies of a subset of the neurons in the central nervous system and play key roles in both developmental and adult-brain plasticity. Despite the interest in these structures and compelling demonstrations of their importance in regulating plasticity, their precise functional mechanisms remain elusive. The limited mechanistic understanding of PNNs is primarily because of an incomplete knowledge of their molecular composition and structure and a failure to identify PNN-specific targets. Thus, it has been challenging to precisely manipulate PNNs to rigorously investigate their function. Here, using mouse models and neuronal cultures, we demonstrate a role of receptor protein tyrosine phosphatase zeta (RPTP?) in PNN structure. We found that in the absence of RPTP?, the reticular structure of PNNs is lost and phenocopies the PNN structural abnormalities observed in tenascin-R knockout brains. Furthermore, we biochemically analyzed the contribution of RPTP? to PNN formation and structure, which enabled us to generate a more detailed model for PNNs. We provide evidence for two distinct kinds of interactions of PNN components with the neuronal surface, one dependent on RPTP? and the other requiring the glycosaminoglycan hyaluronan. We propose that these findings offer important insight into PNN structure and lay important groundwork for future strategies to specifically disrupt PNNs to precisely dissect their function.	[Eill, Geoffrey J.; Sinha, Ashis; Viapiano, Mariano S.; Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Viapiano, Mariano S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA; [Morawskr, Markus] Univ Leipzig, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Leipzig University	Matthews, RT (corresponding author), 750 East Adams St, Syracuse, NY 13210 USA.	matthewr@upstate.edu	Morawski, Markus/X-2977-2019; Morawski, Markus/D-4877-2011	Morawski, Markus/0000-0002-3817-5186	NINDS, National Institutes of Health [NS069660]; German Research Foundation (DFG) [Mo2249/2-1, Mo2249/2-2]; Alzheimer-Forschung-Inititiative (AFI) [18072]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); German Research Foundation (DFG)(German Research Foundation (DFG)); Alzheimer-Forschung-Inititiative (AFI)	This work was supported by NINDS, National Institutes of Health Grant NS069660 (to R. T. M.) and by the German Research Foundation (DFG) Priority Program 1608 "Ultrafast and temporally precise information processing: Normal and dysfunctional hearing" Mo2249/2-1, Mo2249/2-2 (to M. M.) and the Alzheimer-Forschung-Inititiative (AFI) 18072 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2019, OXFORD HDB AUDITORY, DOI DOI 10.1093/OXFORDHB/9780190849061.013.12; Arnst N, 2016, BRAIN RES, V1648, P214, DOI 10.1016/j.brainres.2016.07.020; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; BARNEA G, 1994, J BIOL CHEM, V269, P14349; Bekku Y, 2003, MOL CELL NEUROSCI, V24, P148, DOI 10.1016/S1044-7431(03)00133-7; Blosa M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2828536; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dwyer CA, 2015, J BIOL CHEM, V290, P10256, DOI 10.1074/jbc.M114.614099; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Garwood J, 1999, J NEUROSCI, V19, P3888; Giamanco KA, 2012, NEUROSCIENCE, V218, P367, DOI 10.1016/j.neuroscience.2012.05.055; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; GRUMET M, 1994, J BIOL CHEM, V269, P12142; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Haunso A, 2000, BRAIN RES, V864, P142, DOI 10.1016/S0006-8993(00)02173-9; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; HOCKFIELD S, 1983, P NATL ACAD SCI-BIOL, V80, P5758, DOI 10.1073/pnas.80.18.5758; John N, 2006, MOL CELL NEUROSCI, V31, P774, DOI 10.1016/j.mcn.2006.01.011; Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Lander C, 1997, J NEUROSCI, V17, P1928; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032747; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mauney SA, 2013, BIOL PSYCHIAT, V74, P427, DOI 10.1016/j.biopsych.2013.05.007; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; Monslow J, 2003, INT J BIOCHEM CELL B, V35, P1272, DOI 10.1016/S1357-2725(03)00048-7; Morawski M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0046; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Pantazopoulos H, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.128; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Rowlands D, 2018, J NEUROSCI, V38, P10102, DOI 10.1523/JNEUROSCI.1122-18.2018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Slaker M, 2015, J NEUROSCI, V35, P4190, DOI 10.1523/JNEUROSCI.3592-14.2015; Suttkus A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.25; Tsifrina E, 1999, AM J PATHOL, V155, P1625, DOI 10.1016/S0002-9440(10)65478-8; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2003, J BIOL CHEM, V278, P33239, DOI 10.1074/jbc.M303480200; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Xue YX, 2014, J NEUROSCI, V34, P6647, DOI 10.1523/JNEUROSCI.5390-13.2014; Yang S, 2015, EXP NEUROL, V265, P48, DOI 10.1016/j.expneurol.2014.11.013; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	59	11	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					955	968		10.1074/jbc.RA119.010830	http://dx.doi.org/10.1074/jbc.RA119.010830			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31822561	Green Published, hybrid			2022-12-28	WOS:000509949300006
J	Howard, MJ; Cavanaugh, NA; Batra, VK; Shock, DD; Beard, WA; Wilson, SH				Howard, Michael J.; Cavanaugh, Nisha A.; Batra, Vinod K.; Shock, David D.; Beard, William A.; Wilson, Samuel H.			DNA polymerase ? nucleotide-stabilized template misalignment fidelity depends on local sequence context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA synthesis; DNA structure; kinetics; mutagenesis; X-ray crystallography; base excision repair; DNA repair; mutagenesis mechanism; polymerase fidelity; structure?function	BETA; BINDING; DOMAIN; MUTAGENESIS	DNA polymerase ? has two DNA-binding domains that interact with the opposite sides of short DNA gaps. These domains contribute two activities that modify the 5? and 3? margins of gapped DNA during base excision repair. DNA gaps greater than 1 nucleotide (nt) pose an architectural and logistical problem for the two domains to interact with their respective DNA termini. Here, crystallographic and kinetic analyses of 2-nt gap-filling DNA synthesis revealed that the fidelity of DNA synthesis depends on local sequence context. This was due to template dynamics that altered which of the two template nucleotides in the gap served as the coding nucleotide. We observed that, when a purine nucleotide was in the first coding position, DNA synthesis fidelity was similar to that observed with a 1-nt gap. However, when the initial templating nucleotide was a pyrimidine, fidelity was decreased. If the first templating nucleotide was a cytidine, there was a significantly higher probability that the downstream template nucleotide coded for the incoming nucleotide. This dNTP-stabilized misalignment reduced base substitution and frameshift deletion fidelities. A crystal structure of a binary DNA product complex revealed that the cytidine in the first templating site was in an extrahelical position, permitting the downstream template nucleotide to occupy the coding position. These results indicate that DNA polymerase ? can induce a strain in the DNA that modulates the position of the coding nucleotide and thereby impacts the identity of the incoming nucleotide. Our findings demonstrate that ?correct? DNA synthesis can result in errors when template dynamics induce coding ambiguity.	[Howard, Michael J.; Cavanaugh, Nisha A.; Batra, Vinod K.; Shock, David D.; Beard, William A.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA; [Howard, Michael J.] Illumina Inc, San Diego, CA 92121 USA; [Cavanaugh, Nisha A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Illumina; Sanford Burnham Prebys Medical Discovery Institute	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel/E-6644-2019	Wilson, Samuel/0000-0002-1702-5293	Intramural Research Program, NIEHS, National Institutes of Health [Z01-ES050158, Z01ES050161]; National Institutes of Health [U19CA105010]	Intramural Research Program, NIEHS, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by Intramural Research Program, NIEHS, National Institutes of Health Grants Z01-ES050158 and Z01ES050161 (to S. H. W.) and in association with National Institutes of Health Grant U19CA105010 (to S. H. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2016, STRUCTURE, V24, P1863, DOI 10.1016/j.str.2016.08.006; Batra VK, 2005, STRUCTURE, V13, P1225, DOI 10.1016/j.str.2005.05.010; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2014, J BIOL CHEM, V289, P31411, DOI 10.1074/jbc.M114.607432; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Bebenek K, 2003, J BIOL CHEM, V278, P34685, DOI 10.1074/jbc.M305705200; Efrati E, 1997, J BIOL CHEM, V272, P2559; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; KUMAR A, 1990, J BIOL CHEM, V265, P2124; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Moon AF, 2015, P NATL ACAD SCI USA, V112, pE4530, DOI 10.1073/pnas.1505798112; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Ray S, 2018, NUCLEIC ACIDS RES, V46, P242, DOI 10.1093/nar/gkx1147; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200	29	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					529	538		10.1074/jbc.RA119.010594	http://dx.doi.org/10.1074/jbc.RA119.010594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31801827	Green Published, hybrid			2022-12-28	WOS:000507373600021
J	Mazurkewich, S; Poulsen, JCN; Lo Leggio, L; Larsbrink, J				Mazurkewich, Scott; Poulsen, Jens-Christian N.; Lo Leggio, Leila; Larsbrink, Johan			Structural and biochemical studies of the glucuronoyl esterase OtCE15A illuminate its interaction with lignocellulosic components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; enzyme mutation; enzyme kinetics; carbohydrate processing; cell wall; alpha; beta-hydrolase; carbohydrate-active enzymes; catalytic triad; glucuronoyl esterase; lignin-carbohydrate complexes; glucuronoxylan; biomass	CATALYTIC TRIAD; HALOALKANE DEHALOGENASE; INSIGHTS; ENZYMES; ACID; DOMAIN; XYLAN; MASS; TOOL	Glucuronoyl esterases (GEs) catalyze the cleavage of ester linkages between lignin and glucuronic acid moieties on glucuronoxylan in plant biomass. As such, GEs represent promising biochemical tools in industrial processing of these recalcitrant resources. However, details on how GEs interact and catalyze degradation of their natural substrates are sparse, calling for thorough enzyme structure-function studies. Presented here is a structural and mechanistic investigation of the bacterial GE OtCE15A. GEs belong to the carbohydrate esterase family 15 (CE15), which is in turn part of the larger ?/?-hydrolase superfamily. GEs contain a Ser-His-Asp/Glu catalytic triad, but the location of the catalytic acid in GEs has been shown to be variable, and OtCE15A possesses two putative catalytic acidic residues in the active site. Through site-directed mutagenesis, we demonstrate that these residues are functionally redundant, possibly indicating the evolutionary route toward new functionalities within the family. Structures determined with glucuronate, in both native and covalently bound intermediate states, and galacturonate provide insights into the catalytic mechanism of CE15. A structure of OtCE15A with the glucuronoxylooligosaccharide 2(3)-(4-O-methyl-?-d-glucuronyl)-xylotriose (commonly referred to as XUX) shows that the enzyme can indeed interact with polysaccharides from the plant cell wall, and an additional structure with the disaccharide xylobiose revealed a surface binding site that could possibly indicate a recognition mechanism for long glucuronoxylan chains. Collectively, the results indicate that OtCE15A, and likely most of the CE15 family, can utilize esters of glucuronoxylooligosaccharides and support the proposal that these enzymes work on lignin-carbohydrate complexes in plant biomass.	[Mazurkewich, Scott; Larsbrink, Johan] Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Dept Biol & Biol Engn, Div Ind Biotechnol, SE-41296 Gothenburg, Sweden; [Poulsen, Jens-Christian N.; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, Univ Pk, DK-2100 Copenhagen O, Denmark; [Poulsen, Jens-Christian N.] Univ Copenhagen, Integrat Struct Biol, ISBUC, Copenhagen, Denmark	Chalmers University of Technology; University of Copenhagen; University of Copenhagen	Lo Leggio, L (corresponding author), Univ Copenhagen, Dept Chem, Univ Pk, DK-2100 Copenhagen O, Denmark.; Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Kemivagen 10, SE-41296 Gothenburg, Sweden.	leila@chem.ku.dk; johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013; Lo Leggio, Leila/B-4287-2015	Larsbrink, Johan/0000-0001-8386-2914; Lo Leggio, Leila/0000-0002-5135-0882; Mazurkewich, Scott/0000-0002-9238-0615	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center; Novo Nordisk Foundation [NNF17OC0027698]; Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT	The work performed at Chalmers University of Technology was supported by the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center. Funding for collaborative work between Chalmers University of Technology and Copenhagen University was provided by the Novo Nordisk Foundation (NNF17OC0027698, Biotechnology-based Synthesis and Production Research). Funding for synchrotron travels was provided in part by the Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baath JA, 2019, J BIOL CHEM, V294, P6635, DOI 10.1074/jbc.RA119.007831; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; Baath JA, 2016, FEBS LETT, V590, P2611, DOI 10.1002/1873-3468.12290; Biely P, 2016, APPL ENVIRON MICROB, V82, P7014, DOI 10.1128/AEM.02396-16; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17677-4; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Huynh H, 2018, APPL MICROBIOL BIOT, V102, P2191, DOI 10.1007/s00253-018-8739-5; Hynkova K, 1999, FEBS LETT, V446, P177, DOI 10.1016/S0014-5793(99)00199-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krooshof GH, 1997, BIOCHEMISTRY-US, V36, P9571, DOI 10.1021/bi971014t; Kulkarni AR, 2012, GLYCOBIOLOGY, V22, P439, DOI 10.1093/glycob/cwr117; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mosbech C, 2019, APPL MICROBIOL BIOT, V103, P4065, DOI 10.1007/s00253-019-09797-w; Mosbech C, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1075-2; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Singh MK, 2016, BIOCHEM BIOPH RES CO, V476, P63, DOI 10.1016/j.bbrc.2016.05.061; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Vincent F, 2003, J MOL BIOL, V330, P593, DOI 10.1016/S0022-2836(03)00632-6; Winkler R, 2010, RAPID COMMUN MASS SP, V24, P285, DOI 10.1002/rcm.4384; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	11	11	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19978	19987		10.1074/jbc.RA119.011435	http://dx.doi.org/10.1074/jbc.RA119.011435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740581	hybrid, Green Published			2022-12-28	WOS:000505005800013
J	Qu, XX; Liu, Y; Cao, DY; Chen, JH; Liu, Z; Ji, HR; Chen, YW; Zhang, WJ; Zhu, P; Xiao, DY; Li, XH; Shou, WN; Chen, HY				Qu, Xiuxia; Liu, Ying; Cao, Dayan; Chen, Jinghai; Liu, Zhuo; Ji, Hongrui; Chen, Yuwen; Zhang, Wenjun; Zhu, Ping; Xiao, Deyong; Li, Xiaohui; Shou, Weinian; Chen, Hanying			BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); SMAD transcription factor; STAT transcription factor; heart failure; cell death; fibrosis	BONE MORPHOGENETIC PROTEIN-10; POLY(ADP-RIBOSE) POLYMERASE; FIBROBLAST PROLIFERATION; HEART-DISEASE; INHIBITION; EXPRESSION; FAMILY; MYOCARDIUM; APOPTOSIS; FIBROSIS	Bone morphogenetic protein 10 (BMP10) is a cardiac peptide growth factor belonging to the transforming growth factor ? superfamily that critically controls cardiovascular development, growth, and maturation. It has been shown that BMP10 elicits its intracellular signaling through a receptor complex of activin receptor-like kinase 1 with morphogenetic protein receptor type II or activin receptor type 2A. Previously, we generated and characterized a transgenic mouse line expressing BMP10 from the ?-myosin heavy chain gene promoter and found that these mice have normal cardiac hypertrophic responses to both physiological and pathological stimuli. In this study, we report that these transgenic mice exhibit significantly reduced levels of cardiomyocyte apoptosis and cardiac fibrosis in response to a prolonged administration of the ?-adrenoreceptor agonist isoproterenol. We further confirmed this cardioprotective function with a newly generated conditional Bmp10 transgenic mouse line, in which Bmp10 was activated in adult hearts by tamoxifen. Moreover, the intraperitoneal administration of recombinant human BMP10 was found to effectively protect hearts from injury, suggesting potential therapeutic utility of using BMP10 to prevent heart failure. Gene profiling and biochemical analyses indicated that BMP10 activates the SMAD-mediated canonical pathway and, unexpectedly, also the signal transducer and activator of transcription 3 (STAT3)?mediated signaling pathway both in vivo and in vitro. Additional findings further supported the notion that BMP10's cardioprotective function likely is due to its dual activation of SMAD- and STAT3-regulated signaling pathways, promoting cardiomyocyte survival and suppressing cardiac fibrosis.	[Qu, Xiuxia] Jiangnan Univ, Wuxi Sch Med, Wuxi 214122, Jiangsu, Peoples R China; [Qu, Xiuxia; Liu, Ying; Liu, Zhuo; Ji, Hongrui; Chen, Yuwen; Zhang, Wenjun; Zhu, Ping; Xiao, Deyong; Shou, Weinian; Chen, Hanying] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Cao, Dayan; Li, Xiaohui] Army Med Univ, Coll Pharm, Inst Mat Med, Chongqing 400038, Peoples R China; [Cao, Dayan; Li, Xiaohui] Army Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China; [Chen, Jinghai] Zhejiang Univ, Affiliate Hosp 2, Inst Translat Med, Sch Med,Dept Cardiol, Hangzhou 310029, Zhejiang, Peoples R China; [Ji, Hongrui] Harbin Univ Sci & Technol, Sch Chem & Environm Engn, Harbin 150040, Heilongjiang, Peoples R China; [Qu, Xiuxia] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Guangzhou 510100, Guangdong, Peoples R China; [Xiao, Deyong] Fountain Valley Inst Life Sci, Dalian 116023, Liaoning, Peoples R China; [Xiao, Deyong] Fountain Valley Biotechnol Inc, Dalian 116023, Liaoning, Peoples R China	Jiangnan University; Indiana University System; Indiana University Bloomington; Army Medical University; Army Medical University; Zhejiang University; Harbin University of Science & Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Shou, WN; Chen, HY (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Li, XH (corresponding author), Army Med Univ, Coll Pharm, Inst Mat Med, Chongqing 400038, Peoples R China.; Li, XH (corresponding author), Army Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China.	lps008@aliyun.com; wshou@iu.edu; hanchen@iu.edu		cao, dayan/0000-0001-7648-3668	National Institutes of Health [R01HL145060, R01HL81092, P01HL134599, P01HL85098]; Indiana University Showalter Research Trust Fund; National Science Foundation China Projects of International Cooperation and Exchanges [81720102004]; National Science Foundation China [81570279, 81974019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL145060, P01HL134599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Showalter Research Trust Fund; National Science Foundation China Projects of International Cooperation and Exchanges; National Science Foundation China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants R01HL145060, R01HL81092, P01HL134599, and P01HL85098 (to W. S.), a grant from the Indiana University Showalter Research Trust Fund (to H. C.), and National Science Foundation China Projects of International Cooperation and Exchanges Grant 81720102004 and National Science Foundation China Grants 81570279 and 81974019 (to P. Z.) to support P. Z. as a visiting Scholar in Shou Lab. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bryson BL, 2017, CELL CYCLE, V16, P319, DOI 10.1080/15384101.2016.1259037; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Maruyama S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008441; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakano N, 2007, AM J PHYSIOL-HEART C, V293, pH3396, DOI 10.1152/ajpheart.00311.2007; Nakayama T, 2000, CELL MOL LIFE SCI, V57, P943, DOI 10.1007/PL00000736; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Ning BB, 2017, ACTA PHARMACOL SIN, V38, P331, DOI 10.1038/aps.2016.142; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ooi JYY, 2017, RNA BIOL, V14, P500, DOI 10.1080/15476286.2016.1181251; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Piotrowska I., 2007, THESIS; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Somi S, 2004, ANAT REC PART A, V279A, P579, DOI 10.1002/ar.a.20052; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Valkov N, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00065; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wang J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050749; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zhang WJ, 2016, CIRCULATION, V133, P48, DOI 10.1161/CIRCULATIONAHA.115.017472; Zhang WJ, 2011, J BIOL CHEM, V286, P36820, DOI 10.1074/jbc.M111.279679; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	43	14	14	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19877	19888		10.1074/jbc.RA119.010943	http://dx.doi.org/10.1074/jbc.RA119.010943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31712309	Green Published, hybrid			2022-12-28	WOS:000505005800005
J	Buchanan, BW; Mehrtash, AB; Broshar, CL; Runnebohm, AM; Snow, BJ; Scanameo, LN; Hochstrasser, M; Rubenstein, EM				Buchanan, Bryce W.; Mehrtash, Adrian B.; Broshar, Courtney L.; Runnebohm, Avery M.; Snow, Brian J.; Scanameo, Laura N.; Hochstrasser, Mark; Rubenstein, Eric M.			Endoplasmic reticulum stress differentially inhibits endoplasmic reticulum and inner nuclear membrane protein quality control degradation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); endoplasmic reticulum?associated protein degradation (ERAD); E3 ubiquitin ligase; Saccharomyces cerevisiae; protein translocation; yeast genetics; inner nuclear membrane-associated degradation (INMAD); protein quality control; Ste24; translocon	UBIQUITIN LIGASE DOA10; IN-VIVO DEGRADATION; ER STRESS; SACCHAROMYCES-CEREVISIAE; YEAST; PROTEASOME; RETROTRANSLOCATION; GENE; TRANSPORTER; ELONGATION	Endoplasmic reticulum (ER) stress occurs when the abundance of unfolded proteins in the ER exceeds the capacity of the folding machinery. Despite the expanding cadre of characterized cellular adaptations to ER stress, knowledge of the effects of ER stress on cellular physiology remains incomplete. We investigated the impact of ER stress on ER and inner nuclear membrane protein quality control mechanisms in Saccharomyces cerevisiae. We analyzed the turnover of substrates of four ubiquitin ligases (Doa10, Rkr1/Ltn1, Hrd1, and the Asi complex) and the metalloprotease Ste24 in induced models of ER stress. ER stress did not substantially impact Doa10 or Rkr1 substrates. However, Hrd1-mediated destruction of a protein that aberrantly engages the translocon (Deg1-Sec62) and substrates with luminal degradation signals was markedly impaired by ER stress; by contrast, Hrd1-dependent degradation of proteins with intramembrane degrons was largely unperturbed by ER stress. ER stress impaired the degradation of one of two Asi substrates analyzed and caused a translocon-clogging Ste24 substrate to accumulate in a form consistent with persistent translocon occupation. Degradation of Deg1-Sec62 in the absence of stress and stabilization during ER stress were independent of four ER stress?sensing pathways. Our results indicate ER stress differentially impacts degradation of protein quality control substrates, including those mediated by the same ubiquitin ligase. These observations suggest the existence of additional regulatory mechanisms dictating substrate selection during ER stress.	[Buchanan, Bryce W.; Broshar, Courtney L.; Runnebohm, Avery M.; Snow, Brian J.; Scanameo, Laura N.; Rubenstein, Eric M.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Mehrtash, Adrian B.; Hochstrasser, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Buchanan, Bryce W.] Indiana Univ Sch Med, Ctr Med Educ, Muncie, IN 47306 USA; [Runnebohm, Avery M.] Eli Lilly & Co, Diabet & Complicat Therapeut Area, Indianapolis, IN 46225 USA; [Snow, Brian J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA	Ball State University; Yale University; Yale University; Indiana University System; Eli Lilly; University of Wisconsin System; University of Wisconsin Madison	Rubenstein, EM (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	emrubenstein@bsu.edu		Hochstrasser, Mark/0000-0002-1131-5484; Runnebohm, Avery/0000-0001-6798-6407; Rubenstein, Eric/0000-0003-4983-1430	Ball State University ASPiRE Research Awards; Ball State University Department of Biology Sigma Zeta research award; National Institutes of Health [GM111713, GM046904]; Ball State University Faculty Advance research award; Indiana Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R15GM111713, R37GM046904] Funding Source: NIH RePORTER	Ball State University ASPiRE Research Awards; Ball State University Department of Biology Sigma Zeta research award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball State University Faculty Advance research award; Indiana Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Ball State University ASPiRE Research Awards (to B. W. B., C. L. B., and A. M. R.), a Ball State University Department of Biology Sigma Zeta research award (to B. J. S.), National Institutes of Health Grant GM046904 (to M. H.), a Ball State University Faculty Advance research award (to E. M. R.), an Indiana Academy of Science senior research grant (to E. M. R.), and National Institutes of Health Grant GM111713 (to E. M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Babour A, 2010, CELL, V142, P256, DOI 10.1016/j.cell.2010.06.006; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Boban M, 2014, J CELL SCI, V127, P3603, DOI 10.1242/jcs.153163; Buchanan BW, 2016, JOVE-J VIS EXP, DOI 10.3791/53975; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Crowder JJ, 2015, J BIOL CHEM, V290, P18454, DOI 10.1074/jbc.M115.663559; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Engle SM, 2017, PEERJ, V5, DOI 10.7717/peerj.3728; Fabre B, 2019, BIOCHEM BIOPH RES CO, V517, P188, DOI 10.1016/j.bbrc.2019.07.040; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Guthrie C., 2004, GUIDE YEAST GENETICS, P1; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hirata R, 2013, J BIOL CHEM, V288, P37057, DOI 10.1074/jbc.M113.518340; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kadowaki H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25724-x; Kadowaki H, 2015, CELL REP, V13, P944, DOI 10.1016/j.celrep.2015.09.047; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Kim Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00030; Koch BA, 2019, J CELL BIOL, V218, P839, DOI 10.1083/jcb.201808024; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Neal S, 2018, MOL CELL, V69, P306, DOI 10.1016/j.molcel.2017.12.012; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Pierre N, 2014, BIOCHEM BIOPH RES CO, V450, P459, DOI 10.1016/j.bbrc.2014.05.143; Pina FJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06970; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Ruggiano A, 2016, EMBO J, V35, P1644, DOI 10.15252/embj.201593106; Ryu HY, 2016, GENE DEV, V30, P1881, DOI 10.1101/gad.282194.116; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; SIKORSKI RS, 1989, GENETICS, V122, P19; Smoyer CJ, 2019, CURR GENET, V65, P1099, DOI 10.1007/s00294-019-00971-1; Sozen E, 2017, REDOX BIOL, V12, P456, DOI 10.1016/j.redox.2017.02.025; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szoradi T, 2018, MOL CELL, V70, P1025, DOI 10.1016/j.molcel.2018.04.027; Takenokuchi M, 2015, ANTICANCER RES, V35, P3307; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Utecht KN, 2008, AM J HEALTH-SYST PH, V65, P1221, DOI 10.2146/ajhp070272; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Watts SG, 2015, JOVE-J VIS EXP, DOI 10.3791/52428; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Wu HX, 2014, BIOSCIENCE REP, V34, P321, DOI 10.1042/BSR20140058; Xiang CC, 2017, APOPTOSIS, V22, P1, DOI 10.1007/s10495-016-1296-4	97	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19814	19830		10.1074/jbc.RA119.010295	http://dx.doi.org/10.1074/jbc.RA119.010295			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723032	hybrid, Green Published			2022-12-28	WOS:000504093200028
J	Jiang, LY; Dai, SY; Li, J; Liang, XJ; Qu, LZ; Chen, XJ; Guo, M; Chen, ZC; Chen, L; Wei, HD; Chen, YH				Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng			Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; protein crystallization; protein?DNA interaction; protein?protein interaction; dimerization; crystal structure; gene regulation; nuclear receptor subfamily 4 group A member 2; Nur-responsive elements; transcription factor	HETERODIMERIZATION; MECHANISM; SUBFAMILY; SOFTWARE; DOMAIN; PHENIX; CELL	Proteins of nuclear receptor subfamily 4 group A (NR4A), including NR4A1/NGFI-B, NR4A2/Nurr1, and NR4A3/NOR-1, are nuclear transcription factors that play important roles in metabolism, apoptosis, and proliferation. NR4A proteins recognize DNA response elements as monomers or dimers to regulate the transcription of a variety of genes involved in multiple biological processes. In this study, we determined two crystal structures of the NR4A2 DNA-binding domain (NR4A2-DBD) bound to two Nur-responsive elements: an inverted repeat and an everted repeat at 2.6?2.8 ? resolution. The structures revealed that two NR4A2-DBD molecules bind independently to the everted repeat, whereas two other NR4A2-DBD molecules form a novel dimer interface on the inverted repeat. Moreover, substitution of the interfacial residue valine 298 to lysine as well as mutation of DNA bases involved in the interactions abolished the dimerization. Overall, our structural, biochemical, and bioinformatics analyses provide a molecular basis for the binding of the NR4A2 protein dimers to NurREs and advance our understanding of the dimerization specificity of nuclear receptors.	[Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng] Cent S Univ, Dept Oncol, Struct Biol Lab, NHC Key Lab Canc Prote,Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Chen, Lin] Univ Southern Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Chen, Lin] Univ Southern Calif, Mol & Computat Biol Program, Dept Chem, Los Angeles, CA 90089 USA	Central South University; University of Southern California; University of Southern California	Wei, HD; Chen, YH (corresponding author), Cent S Univ, Dept Oncol, Struct Biol Lab, NHC Key Lab Canc Prote,Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	hudiewei18@163.com; yonghenc@163.com		dai, shuyan/0000-0002-8484-634X	National Natural Science Foundation of China [81372904, 81570537, 81272971]; Science and Technology Department of Hunan Province [2015SK2037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	This work was supported by National Natural Science Foundation of China Grants 81372904 and 81570537 (to Y. C.) and 81272971 (to Z. C.) and the Science and Technology Department of Hunan Province Grant 2015SK2037 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berwick DC, 2014, J MOL CELL BIOL, V6, P3, DOI 10.1093/jmcb/mjt037; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen XJ, 2019, NUCLEIC ACIDS RES, V47, P3752, DOI 10.1093/nar/gkz077; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li J, 2017, ACTA BIOCH BIOPH SIN, V49, P792, DOI 10.1093/abbs/gmx079; Li J, 2017, BIOCHEMISTRY-US, V56, P3745, DOI 10.1021/acs.biochem.7b00211; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Osz J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08216; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Scheepstra M, 2017, ACS CHEM NEUROSCI, V8, P2065, DOI 10.1021/acschemneuro.7b00216; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Shigeishi H, 2011, CANCER LETT, V307, P227, DOI 10.1016/j.canlet.2011.04.008; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang J, 2013, ASIAN PAC J CANCER P, V14, P2023, DOI 10.7314/APJCP.2013.14.3.2023; Wu DC, 2018, CHEM COMMUN, V54, P12089, DOI 10.1039/c8cc07546h; Yan Ningning, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P345, DOI 10.11817/j.issn.1672-7347.2015.04.001; Yin K, 2017, MOL CANCER RES, V15, P1184, DOI 10.1158/1541-7786.MCR-17-0002; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhang L, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9363461; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	46	12	12	6	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19795	19803		10.1074/jbc.RA119.010730	http://dx.doi.org/10.1074/jbc.RA119.010730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723028	Green Published, hybrid			2022-12-28	WOS:000504093200026
J	Masui, K; Harachi, M; Ikegami, S; Yang, HJ; Onizuka, H; Yong, WH; Cloughesy, TF; Muragaki, Y; Kawamata, T; Arai, N; Komori, T; Cavenee, WK; Mischel, PS; Shibata, N				Masui, Kenta; Harachi, Mio; Ikegami, Shiro; Yang, Huijun; Onizuka, Hiromi; Yong, William H.; Cloughesy, Timothy F.; Muragaki, Yoshihiro; Kawamata, Takakazu; Arai, Nobutaka; Komori, Takashi; Cavenee, Webster K.; Mischel, Paul S.; Shibata, Noriyuki			mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); histone acetylation; glucose metabolism; acetyl coenzyme A (acetyl-CoA); iron metabolism; glioblastoma	MALIGNANT GLIOMAS; GLIAL PROGENITORS; HISTONE H3; CANCER; ACETYLATION; CHROMATIN; GENES; STEM; TRANSCRIPTION; HALLMARKS	In cancer, aberrant growth factor receptor signaling reprograms cellular metabolism and global gene transcription to drive aggressive growth, but the underlying mechanisms are not well-understood. Here we show that in the highly lethal brain tumor glioblastoma (GBM), mTOR complex 2 (mTORC2), a critical core component of the growth factor signaling system, couples acetyl-CoA production with nuclear translocation of histone-modifying enzymes including pyruvate dehydrogenase and class IIa histone deacetylases to globally alter histone acetylation. Integrated analyses in orthotopic mouse models and in clinical GBM samples reveal that mTORC2 controls iron metabolisms via histone H3 acetylation of the iron-related gene promoter, promoting tumor cell survival. These results nominate mTORC2 as a critical epigenetic regulator of iron metabolism in cancer.	[Masui, Kenta; Harachi, Mio; Onizuka, Hiromi; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; [Muragaki, Yoshihiro; Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Ikegami, Shiro; Yang, Huijun; Cavenee, Webster K.; Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yong, William H.; Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Henry Singleton Brain Tumor Program, Los Angeles, CA 90095 USA; [Yong, William H.; Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Lab Neuropathol, Setagaya Ku, Tokyo 1568506, Japan; [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Neuropathol, Tokyo 1830042, Japan; [Cavenee, Webster K.; Mischel, Paul S.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Tokyo Women's Medical University; Tokyo Women's Medical University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; University of California System; University of California San Diego; University of California System; University of California San Diego	Masui, K (corresponding author), Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan.	masui-kn@twmu.ac.jp	Cloughesy, Timothy Francis/AGV-1013-2022; Ikegami, Shiro/GLS-7614-2022; MURAGAKI, YOSHIHIRO/AAZ-9863-2021		National Institutes of Health NINDS [NS73831]; Defeat GBM Research Collaborative; National Institutes of Health NCI [CA119347]; Ben and Catherine Ivy Foundation; Ziering Family Foundation in memory of Sigi Ziering; Takeda Science Foundation; Japan Society for the Promotion of Science KAKENHI Grant [19K07649]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073831] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defeat GBM Research Collaborative; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben and Catherine Ivy Foundation; Ziering Family Foundation in memory of Sigi Ziering; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Grant NS73831, the Defeat GBM Research Collaborative, a subsidiary of National Brain Tumor Society, National Institutes of Health NCI Grant CA119347, the Ben and Catherine Ivy Foundation, the Ziering Family Foundation in memory of Sigi Ziering, a Grant-in-Aid from Takeda Science Foundation, and Japan Society for the Promotion of Science KAKENHI Grant 19K07649. P.S.M. is a scientific co-founder and consultant for Pretzel Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu YC, 2017, MOL CELL, V67, P128, DOI 10.1016/j.molcel.2017.05.030; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao YX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01127; Harachi M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103267; Hirayama T, 2019, METALLOMICS, V11, P111, DOI 10.1039/c8mt00212f; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu F, 2015, MOL CELL, V60, P307, DOI 10.1016/j.molcel.2015.09.002; Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059; Masui K, 2019, NEUROPATHOLOGY, V39, P3, DOI 10.1111/neup.12535; Masui K, 2015, P NATL ACAD SCI USA, V112, P9406, DOI 10.1073/pnas.1511759112; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Seibel Philipp N, 2006, BMC BIOINFORMATICS, V7, DOI [10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-109]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615; Villa GR, 2016, CANCER CELL, V30, P683, DOI 10.1016/j.ccell.2016.09.008; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19740	19751		10.1074/jbc.RA119.011519	http://dx.doi.org/10.1074/jbc.RA119.011519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712311	hybrid, Green Published			2022-12-28	WOS:000504093200022
J	Bansal, K; Trinath, J; Chakravortty, D; Patil, SA; Balaji, KN				Bansal, Kushagra; Trinath, Jamma; Chakravortty, Dipshikha; Patil, Shripad A.; Balaji, Kithiganahalli Narayanaswamy			RETRACTION: Withdrawal: Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling (Retraction of Vol 286, Pg 37032, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414	1	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19450	19450		10.1074/jbc.W119.011944	http://dx.doi.org/10.1074/jbc.W119.011944			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31836677	hybrid, Green Published			2022-12-28	WOS:000516527800045
J	Jauss, B; Petriman, NA; Drepper, F; Franz, L; Sachelaru, I; Welte, T; Steinberg, R; Warscheid, B; Koch, HG				Jauss, Benjamin; Petriman, Narcis-Adrian; Drepper, Friedel; Franz, Lisa; Sachelaru, Ilie; Welte, Thomas; Steinberg, Ruth; Warscheid, Bettina; Koch, Hans-Georg			Non-competitive binding of PpiD and YidC to the SecYEG translocon expands the global view on the SecYEG interactome in E. coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SecYEG translocon; interaction proteomics; YidC; PpiD; protein cross-linking; protein translocation; quantitative affinity purification mass spectrometry (qAP-MS); protein-protein interaction	SIGNAL-RECOGNITION PARTICLE; MEMBRANE-PROTEIN INSERTION; GRAM-NEGATIVE BACTERIA; CRYO-EM STRUCTURE; ESCHERICHIA-COLI; INNER MEMBRANE; TRANSMEMBRANE HELICES; MOLECULAR CHAPERONE; MASS-SPECTROMETRY; SRP RECEPTOR	The SecYEG translocon constitutes the major protein transport channel in bacteria and transfers an enormous variety of different secretory and inner-membrane proteins. The minimal core of the SecYEG translocon consists of three inner-membrane proteins, SecY, SecE, and SecG, which, together with appropriate targeting factors, are sufficient for protein transport in vitro. However, in vivo the SecYEG translocon has been shown to associate with multiple partner proteins, likely allowing the SecYEG translocon to process its diverse substrates. To obtain a global view on SecYEG plasticity in Escherichia coli, here we performed a quantitative interaction proteomic analysis, which identified several known SecYEG-interacting proteins, verified the interaction of SecYEG with quality-control proteins, and revealed several previously unknown putative SecYEG interacting proteins. Surprisingly, we found that the chaperone complex PpiD/YfgM is the most prominent interaction partner of SecYEG. Detailed analyses of the PpiD-SecY interaction by site-directed cross-linking revealed that PpiD and the established SecY partner protein YidC use almost completely overlapping binding sites on SecY. Both PpiD and YidC contacted the lateral gate, the plug domain, and the periplasmic cavity of SecY. However, quantitative MS and cross-linking analyses revealed that despite having almost identical binding sites, their binding to SecY is noncompetitive. This observation suggests that the SecYEG translocon forms different substrate-independent subassemblies in which SecYEG either associates with YidC or with the PpiD/YfgM complex. In summary, the results of this study indicate that the PpiD/YfgM chaperone complex is a primary interaction partner of the SecYEG translocon.	[Jauss, Benjamin; Petriman, Narcis-Adrian; Franz, Lisa; Sachelaru, Ilie; Welte, Thomas; Steinberg, Ruth; Koch, Hans-Georg] Albert Ludwigs Univ Freiburg, ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany; [Petriman, Narcis-Adrian; Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Fac Biol, Inst Biol Biochem & Funct Prote 2, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Signalling Res Ctr BIOSS, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, CIBSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Albert Ludwigs Univ Freiburg, ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Steinberg, Ruth/0000-0003-4108-6085; Warscheid, Bettina/0000-0001-5096-1975; Petriman, Narcis Adrian/0000-0002-3189-7530; Koch, Hans-Georg/0000-0001-5913-0334; Drepper, Friedel/0000-0002-2043-5795; Welte, Thomas/0000-0003-4583-9216	German Science Foundation (DFG) [KO2184/8-1, KO2184/8-2, 403222702, SFB 1381, 390939984]; Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School; Konrad-Adenauer-Foundation; FF-Nord Fellowship	German Science Foundation (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School; Konrad-Adenauer-Foundation; FF-Nord Fellowship	We thank Bettina Knapp for technical assistance in LC/MS analyses and Dan Daley and Gunnar von Heijne (University Stockholm) for antibodies, strains and plasmids. This work was supported by the German Science Foundation (DFG grants KO2184/8-1 & 8-2 to HGK, Project-ID 403222702, SFB 1381 to HGK and BW, and the Excellence Strategy (CIBBS-EXC-2189 Project ID 390939984 to BW), the Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School and the Konrad-Adenauer-Foundation to BJ and by an FF-Nord Fellowship to RS.	Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Banerjee T, 2017, J BIOL CHEM, V292, P19693, DOI 10.1074/jbc.RA117.000130; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Botte M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38399; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; Carlson ML, 2019, ELIFE, V8, DOI 10.7554/eLife.46615; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Chan A, 2016, EUR J CELL BIOL, V95, P585, DOI 10.1016/j.ejcb.2016.10.004; Chorev DS, 2018, SCIENCE, V362, P829, DOI 10.1126/science.aau0976; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Cymer F, 2015, J BIOL CHEM, V290, P10208, DOI 10.1074/jbc.M115.641555; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; de Keyzer J, 2007, FEBS LETT, V581, P1859, DOI 10.1016/j.febslet.2007.03.081; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Draycheva A, 2016, MOL MICROBIOL, V102, P152, DOI 10.1111/mmi.13452; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Furst M, 2018, BBA-MOL CELL RES, V1865, P273, DOI 10.1016/j.bbamcr.2017.10.012; Ge Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6263; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gotzke H, 2015, MOL CELL PROTEOMICS, V14, P216, DOI 10.1074/mcp.M114.043216; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris ME, 2009, METHOD ENZYMOL, V468, P127, DOI 10.1016/S0076-6879(09)68007-1; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ismail N, 2015, NAT STRUCT MOL BIOL, V22, P145, DOI 10.1038/nsmb.2940; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Jomaa A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15470; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Knyazev D. G, 2018, J MEMBRANE BIOL; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Komar J, 2016, BIOCH J; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn A, 2016, ECOSAL PLUS, DOI [10.1128/ecosalplus.esp-0012-2016, DOI 10.1128/ECOSALPLUS.ESP-0012-2016, 10 .1128/ecosalplus.ESP-0012-2016., DOI 10.1128/EC0SALPLUS.ESP-0012-2016]; Kuhn P, 2015, J CELL BIOL, V211, P91, DOI 10.1083/jcb.201502103; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petriman NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19019-w; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; Sachelaru I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00109-8; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Stull F, 2018, ECOSAL PLUS, V8; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Zhang XX, 2012, J PROTEOME RES, V11, P1454, DOI 10.1021/pr200846y; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	97	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19167	19183		10.1074/jbc.RA119.010686	http://dx.doi.org/10.1074/jbc.RA119.010686			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699901	Green Published, hybrid			2022-12-28	WOS:000516527800018
J	Crowe, A; Henderson, MJ; Anderson, J; Titus, SA; Zakharov, A; Simeonov, A; Buist, A; Delay, C; Moechars, D; Trojanowski, JQ; Lee, VMY; Brunden, KR				Crowe, Alex; Henderson, Mark J.; Anderson, Johnathon; Titus, Steven A.; Zakharov, Alexey; Simeonov, Anton; Buist, Arjan; Delay, Charlotte; Moechars, Diederik; Trojanowski, John Q.; Lee, Virginia M. -Y.; Brunden, Kurt R.			Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); Alzheimer disease; aggregation; inhibitor; drug screening; neurodegeneration; drug discovery; amyloid plaque; neurotoxicity	ALZHEIMERS-DISEASE; HYPOTHETICAL MODEL; CORTICAL-NEURONS; AGGREGATION; PATHOLOGY; PROTEIN; MICROTUBULES; FIBRILLIZATION; INHIBITORS; DEMENTIA	The hallmark pathological features of Alzheimer's disease (AD) brains are senile plaques, comprising ?-amyloid (A?) peptides, and neuronal inclusions formed from tau protein. These plaques form 10?20 years before AD symptom onset, whereas robust tau pathology is more closely associated with symptoms and correlates with cognitive status. This temporal sequence of AD pathology development, coupled with repeated clinical failures of A?-directed drugs, suggests that molecules that reduce tau inclusions have therapeutic potential. Few tau-directed drugs are presently in clinical testing, in part because of the difficulty in identifying molecules that reduce tau inclusions. We describe here two cell-based assays of tau inclusion formation that we employed to screen for compounds that inhibit tau pathology: a HEK293 cell-based tau overexpression assay, and a primary rat cortical neuron assay with physiological tau expression. Screening a collection of ?3500 pharmaceutical compounds with the HEK293 cell tau aggregation assay, we obtained only a low number of hit compounds. Moreover, these compounds generally failed to inhibit tau inclusion formation in the cortical neuron assay. We then screened the Prestwick library of mostly approved drugs in the cortical neuron assay, leading to the identification of a greater number of tau inclusion inhibitors. These included four dopamine D2 receptor antagonists, with D2 receptors having previously been suggested to regulate tau inclusions in a Caenorhabditis elegans model. These results suggest that neurons, the cells most affected by tau pathology in AD, are very suitable for screening for tau inclusion inhibitors.	[Crowe, Alex; Anderson, Johnathon; Trojanowski, John Q.; Lee, Virginia M. -Y.; Brunden, Kurt R.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA; [Henderson, Mark J.; Titus, Steven A.; Zakharov, Alexey; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Buist, Arjan; Delay, Charlotte; Moechars, Diederik] Janssen Pharmaceut NV, Janssen Res & Dev, Dept Neurosci, B-2340 Beerse, Belgium	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Johnson & Johnson; Janssen Pharmaceuticals	Brunden, KR (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA.	kbrunden@upenn.edu		Henderson, Mark/0000-0001-8590-7338	Janssen Pharmaceutica NV; National Center for Advancing Translational Sciences, National Institutes of Health	Janssen Pharmaceutica NV(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Janssen Pharmaceutica NV and in part by the Intramural Research Program, National Center for Advancing Translational Sciences, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Bhat RV, 2018, J ALZHEIMERS DIS, V64, pS547, DOI 10.3233/JAD-179934; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; CHIVERS JK, 1988, J PHARM PHARMACOL, V40, P415, DOI 10.1111/j.2042-7158.1988.tb06306.x; Cho H, 2016, NEUROLOGY, V87, P375, DOI 10.1212/WNL.0000000000002892; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Crowe A, 2009, BIOCHEMISTRY-US, V48, P7732, DOI 10.1021/bi9006435; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2016, J BIOL CHEM, V291, P13175, DOI 10.1074/jbc.M115.712083; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hanseeuw BJ, 2019, JAMA NEUROL, V76, P915, DOI 10.1001/jamaneurol.2019.1424; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrington CR, 2015, J BIOL CHEM, V290, P10862, DOI 10.1074/jbc.M114.616029; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Honson NS, 2007, NEUROBIOL DIS, V28, P251, DOI 10.1016/j.nbd.2007.07.018; Hoskin JL, 2019, EXPERT OPIN INV DRUG, V28, P545, DOI 10.1080/13543784.2019.1619694; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Khanna MR, 2016, ALZHEIMERS DEMENT, V12, P1051, DOI 10.1016/j.jalz.2016.06.006; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Koppel Jeremy, 2016, Alzheimers Dement (N Y), V2, P121, DOI 10.1016/j.trci.2016.05.003; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kow RL, 2018, BIOL PSYCHIAT, V83, P438, DOI 10.1016/j.biopsych.2017.06.007; Lane RF, 2012, ADV PHARMACOL, V64, P213, DOI 10.1016/B978-0-12-394816-8.00007-6; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Lim S, 2014, COMPUT STRUCT BIOTEC, V12, P7, DOI 10.1016/j.csbj.2014.09.011; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McCormick AV, 2013, BIOL PSYCHIAT, V73, P464, DOI 10.1016/j.biopsych.2012.08.027; Medda X, 2016, J BIOMOL SCREEN, V21, P804, DOI 10.1177/1087057116638029; Merrick SE, 1997, J NEUROSCI, V17, P5726; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2019, NEUROBIOL AGING, V76, P24, DOI 10.1016/j.neurobiolaging.2018.11.026; Pickhardt M, 2017, CURR ALZHEIMER RES, V14, P742, DOI 10.2174/1567205014666170202103136; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tell V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00189; Titus Steven A, 2012, Curr Chem Genomics, V6, P79, DOI 10.2174/1875397301206010079; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wagner U, 1996, J CELL SCI, V109, P1537; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	68	6	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4001	4013		10.1074/jbc.RA119.010532	http://dx.doi.org/10.1074/jbc.RA119.010532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32034092	Green Published, hybrid			2022-12-28	WOS:000527704400024
J	Toda, A; Nishikawa, Y; Tanaka, H; Yagi, T; Kurisu, G				Toda, Akiyuki; Nishikawa, Yosuke; Tanaka, Hideaki; Yagi, Toshiki; Kurisu, Genji			The complex of outer-arm dynein light chain-1 and the microtubule-binding domain of the ? heavy chain shows how axonemal dynein tunes ciliary beating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynein; molecular motor; X-ray crystallography; structural biology; protein complex; axonemal dynein; light chain; cilium; flagellum; axoneme	CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURE; COILED-COIL; CHLAMYDOMONAS; ARCHITECTURE; ATPASE	Axonemal dynein is a microtubule-based molecular motor that drives ciliary/flagellar beating in eukaryotes. In axonemal dynein, the outer-arm dynein (OAD) complex, which comprises three heavy chains (?, ?, and ?), produces the main driving force for ciliary/flagellar motility. It has recently been shown that axonemal dynein light chain-1 (LC1) binds to the microtubule-binding domain (MTBD) of OAD?, leading to a decrease in its microtubule-binding affinity. However, it remains unclear how LC1 interacts with the MTBD and controls the microtubule-binding affinity of OAD?. Here, we have used X-ray crystallography and pulldown assays to examine the interaction between LC1 and the MTBD, identifying two important sites of interaction in the MTBD. Solving the LC1-MTBD complex from Chlamydomonas reinhardtii at 1.7 ? resolution, we observed that one site is located in the H5 helix and that the other is located in the flap region that is unique to some axonemal dynein MTBDs. Mutational analysis of key residues in these sites indicated that the H5 helix is the main LC1-binding site. We modeled the ternary structure of the LC1-MTBD complex bound to microtubules based on the known dynein-microtubule complex. This enabled us to propose a structural basis for both formations of the ternary LC1-MTBD-microtubule complex and LC1-mediated tuning of MTBD binding to the microtubule, suggesting a molecular model for how axonemal dynein senses the curvature of the axoneme and tunes ciliary/flagellar beating.	[Toda, Akiyuki; Kurisu, Genji] Osaka Univ, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Toda, Akiyuki; Nishikawa, Yosuke; Tanaka, Hideaki; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Yagi, Toshiki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Hiroshima 7270023, Japan; [Nishikawa, Yosuke] Daiichi Sankyo RD Novare Co Ltd, Dept Organ Synth, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan	Osaka University; Osaka University; Daiichi Sankyo Company Limited	Kurisu, G (corresponding author), Osaka Univ, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan.; Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp	Tanaka, Hideaki/AGY-8426-2022; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Yagi, Toshiki/0000-0002-1379-460X	 [17J07553];  [18H02390]	; 	This work was supported by a Grant-in-Aid for JSPS Fellows Number 17J07553 (to A. T.) and a Grant-in-Aid for Scientific Research B number 18H02390 (to G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Ichikawaa M, 2015, MOL BIOL CELL, V26, P4236, DOI 10.1091/mbc.E15-05-0289; Kato YS, 2014, STRUCTURE, V22, P1628, DOI 10.1016/j.str.2014.08.021; Kikushima K, 2008, BIOPHYS J, V94, P4014, DOI 10.1529/biophysj.107.123083; King SM, 2012, J BIOL CHEM, V287, P3108, DOI 10.1074/jbc.M111.286211; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lacey SE, 2019, ELIFE, V8, DOI 10.7554/eLife.47145; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lin JF, 2018, SCIENCE, V360, DOI 10.1126/science.aar1968; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Nair R, 2009, NEW BIOTECHNOL, V26, P282, DOI 10.1016/j.nbt.2009.08.002; Nishikawa Y, 2016, J MOL BIOL, V428, P1886, DOI 10.1016/j.jmb.2015.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Pigino G, 2012, J STRUCT BIOL, V178, P199, DOI 10.1016/j.jsb.2012.02.012; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Toda Akiyuki, 2018, Biophys Rev, V10, P677, DOI 10.1007/s12551-018-0402-y; Uchimura S, 2015, J CELL BIOL, V208, P211, DOI 10.1083/jcb.201407039; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Yamaguchi S, 2015, BIOPHYS J, V108, P872, DOI 10.1016/j.bpj.2014.12.038	32	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3982	3989		10.1074/jbc.RA119.011541	http://dx.doi.org/10.1074/jbc.RA119.011541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32014992	Green Published, hybrid			2022-12-28	WOS:000527704400022
J	Kang, CY; Huang, IH; Chou, CC; Wu, TY; Chang, JC; Hsiao, YY; Cheng, CH; Tsai, WJ; Hsu, KC; Wang, SY				Kang, Chia-Yu; Huang, I-Hsiu; Chou, Chi-Chi; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Hsiao, Yu-Yuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Hsu, Kai-Cheng; Wang, Shuying			Functional analysis of Clostridium difficile sortase B reveals key residues for catalytic activity and substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; fluorescence resonance energy transfer (FRET); protein structure; substrate specificity; protein chemistry; protein purification; protein sorting; Clostridium difficile; crystal structure; cysteine transpeptidase; sortase B; substrate specificity	STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; CELL-WALL; SORTING SIGNAL; A TRANSPEPTIDASE; UNITED-STATES; INFECTION; RECOGNITION; ENZYME; SRTB	Most of Gram-positive bacteria anchor surface proteins to the peptidoglycan cell wall by sortase, a cysteine transpeptidase that targets proteins displaying a cell wall sorting signal. Unlike other bacteria, Clostridium difficile, the major human pathogen responsible for antibiotic-associated diarrhea, has only a single functional sortase (SrtB). Sortase's vital importance in bacterial virulence has been long recognized, and C. difficile sortase B (Cd-SrtB) has become an attractive therapeutic target for managing C. difficile infection. A better understanding of the molecular activity of Cd-SrtB may help spur the development of effective agents against C. difficile infection. In this study, using site-directed mutagenesis, biochemical and biophysical tools, LC-MS/MS, and crystallographic analyses, we identified key residues essential for Cd-SrtB catalysis and substrate recognition. To the best of our knowledge, we report the first evidence that a conserved serine residue near the active site participates in the catalytic activity of Cd-SrtB and also SrtB from Staphylococcus aureus. The serine residue indispensable for SrtB activity may be involved in stabilizing a thioacyl-enzyme intermediate because it is neither a nucleophilic residue nor a substrate-interacting residue, based on the LC-MS/MS data and available structural models of SrtB?substrate complexes. Furthermore, we also demonstrated that residues 163?168 located on the ?6/?7 loop of Cd-SrtB dominate specific recognition of the peptide substrate PPKTG. The results of this work reveal key residues with roles in catalysis and substrate specificity of Cd-SrtB.	[Kang, Chia-Yu; Huang, I-Hsiu; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Kang, Chia-Yu; Huang, I-Hsiu; Wu, Tsai-Yu; Chang, Jyun-Cyuan; Cheng, Cheng-Hsuan; Tsai, Wei-Jiun; Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Chou, Chi-Chi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Hsiao, Yu-Yuan] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu 300, Taiwan; [Hsu, Kai-Cheng] Taipei Med Univ, Grad Inst Canc Mol Biol & Drug Discovery, Coll Med Sci & Technol, Taipei 110, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Wang, SY (corresponding author), Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan.; Wang, SY (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan.; Wang, SY (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan.	sswang23@mail.ncku.edu.tw	Huang, I-Hsiu/CAF-2125-2022; Chou, Chi-Chi/X-6053-2019; wang, shuying/HHZ-4516-2022; Hsiao, Yu-Yuan/AAA-7408-2022	Huang, I-Hsiu/0000-0001-9667-0612; Chou, Chi-Chi/0000-0002-7862-7757; Hsiao, Yu-Yuan/0000-0002-9648-5879	Taiwan Protein Project [AS-KPQ-109-TPP2]; Ministry of Science and Technology of Taiwan [106-2320-B-006-010, 107-2320-B-006-048, 108-2320-B006-012]	Taiwan Protein Project; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Taiwan Protein Project Grant AS-KPQ-109-TPP2 and by Grants 106-2320-B-006-010, 107-2320-B-006-048, and 108-2320-B006-012 from the Ministry of Science and Technology of Taiwan (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asempa TE, 2017, CLIN INTERV AGING, V12, P1799, DOI 10.2147/CIA.S149089; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cole SA, 2015, CLIN COLON RECT SURG, V28, P65, DOI 10.1055/s-0035-1547333; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dubberke ER, 2008, INFECT CONT HOSP EP, V29, pS81, DOI 10.1086/591065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Honda H, 2014, ANAEROBE, V25, P5, DOI 10.1016/j.anaerobe.2013.10.004; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Roshan N, 2018, ANAEROBE, V49, P103, DOI 10.1016/j.anaerobe.2018.01.003; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; Yin JC, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00160; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	54	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3734	3745		10.1074/jbc.RA119.011322	http://dx.doi.org/10.1074/jbc.RA119.011322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32005667	hybrid, Green Published			2022-12-28	WOS:000527725300028
J	Carr, RM; Duran, PAR; Tolosa, EJ; Ma, CC; Oseini, AM; Moser, CD; Banini, BA; Huang, JB; Asumda, F; Dhanasekaran, R; Graham, RP; Toruner, MD; Safgren, SL; Almada, LL; Wang, SQ; Patnaik, MM; Roberts, LR; Fernandez-Zapico, ME				Carr, Ryan M.; Duran, Paola A. Romecin; Tolosa, Ezequiel J.; Ma, Chenchao; Oseini, Abdul M.; Moser, Catherine D.; Banini, Bubu A.; Huang, Jianbo; Asumda, Faizal; Dhanasekaran, Renumathy; Graham, Rondell P.; Toruner, Merih D.; Safgren, Stephanie L.; Almada, Luciana L.; Wang, Shaoqing; Patnaik, Mrinal M.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.			The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; carcinogenesis; STAT transcription factor; gene transcription; gene regulation; GLI1; promoter conformation; STAT3; SULF2; tumorigenesis	HEPATOCELLULAR-CARCINOMA; FACTOR GLI1; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; DOUBLE-BLIND; SORAFENIB; ACTIVATION; INHIBITION; THERAPY	The expression of the extracellular sulfatase SULF2 has been associated with increased hepatocellular carcinoma (HCC) growth and poor patient survival. However, the molecular mechanisms underlying SULF2-associated tumor growth remain unclear. To address this gap, here we developed a transgenic mouse overexpressing Sulf2 in hepatocytes under the control of the transthyretin promoter. In this model, Sulf2 overexpression potentiated diethylnitrosamine-induced HCC. Further analysis indicated that the transcription factor GLI family zinc finger 1 (GLI1) mediates Sulf2 expression during HCC development. A cross of the Sulf2-overexpressing with Gli1-knockout mice revealed that Gli1 inactivation impairs SULF2-induced HCC. Transcriptomic analysis revealed that Sulf2 overexpression is associated with signal transducer and activator of transcription 3 (STAT3)-specific gene signatures. Interestingly, the Gli1 knockout abrogated SULF2-mediated induction of several STAT3 target genes, including suppressor of cytokine signaling 2/3 (Socs2/3); Pim-1 proto-oncogene, Ser/Thr kinase (Pim1); and Fms-related tyrosine kinase 4 (Flt4). Human orthologs were similarly regulated by SULF2, dependent on intact GLI1 and STAT3 functions in HCC cells. SULF2 overexpression promoted a GLI1-STAT3 interaction and increased GLI1 and STAT3 enrichment at the promoters of their target genes. Interestingly, the SULF2 overexpression resulted in GLI1 enrichment at select STAT3 consensus sites, and vice versa. siRNA-mediated STAT3 or GLI1 knockdown reduced promoter binding of GLI1 and STAT3, respectively. Finally, chromatin-capture PCR confirmed long-range co-regulation of SOCS2 and FLT3 through changes in promoter conformation. These findings define a mechanism whereby SULF2 drives HCC by stimulating formation of a GLI1-STAT3 transcriptional complex.	[Carr, Ryan M.; Duran, Paola A. Romecin; Tolosa, Ezequiel J.; Toruner, Merih D.; Safgren, Stephanie L.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA; [Graham, Rondell P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55902 USA; [Patnaik, Mrinal M.] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA; [Ma, Chenchao; Oseini, Abdul M.; Moser, Catherine D.; Banini, Bubu A.; Huang, Jianbo; Asumda, Faizal; Dhanasekaran, Renumathy; Wang, Shaoqing; Roberts, Lewis R.] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Roberts, LR (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA.; Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Dept Oncol, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA.	roberts.lewis@mayo.edu; fernandez-zapico.martin@mayo.edu	Tolosa, Ezequiel J/AAD-9799-2019	Tolosa, Ezequiel J/0000-0001-5167-0782; Roberts, Lewis/0000-0001-7885-8574; Romecin Duran, Paola Alejandra/0000-0001-6890-5883; Graham, Rondell/0000-0002-8686-4867; Carr, Ryan/0000-0001-5762-367X; Huang, Jianbo/0000-0002-1662-2969	NCI, National Institutes of Health [CA165076, CA136526]; Mayo Clinic Pancreatic SPORE [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Mayo Clinic Hepatobiliary SPORE [P50 CA210964]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo Clinic Hepatobiliary SPORE	This work was supported by NCI, National Institutes of Health, Grant CA136526, Mayo Clinic Pancreatic SPORE P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology P30 DK84567 (to M. E. F.-Z.); NCI, National Institutes of Health, Grant CA165076 (to M. E. F.-Z. and L. R. R.), and Mayo Clinic Hepatobiliary SPORE P50 CA210964 (to L.R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Brault L, 2012, BRIT J CANCER, V107, P491, DOI 10.1038/bjc.2012.272; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Chen G, 2017, CANCER RES, V77, P632, DOI 10.1158/0008-5472.CAN-15-2556; Davey HW, 1999, J BIOL CHEM, V274, P35331, DOI 10.1074/jbc.274.50.35331; Dhanasekaran R, 2015, HEPATOLOGY, V61, P1269, DOI 10.1002/hep.27658; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Geng LY, 2017, ONCOTARGET, V8, P48701, DOI 10.18632/oncotarget.9792; Parra RG, 2016, BIOINFORMATICS, V32, P1229, DOI 10.1093/bioinformatics/btv726; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Han Hui, 2013, Frontiers in Genetics, V4, P224, DOI 10.3389/fgene.2013.00224; Hsu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103629; Ke JQ, 2018, ONCOL LETT, V16, P4577, DOI 10.3892/ol.2018.9165; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lau AHY, 2012, PROSTAG LEUKOTR ESS, V86, P119, DOI 10.1016/j.plefa.2011.12.002; Li SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25754; Lin YW, 2016, J INNATE IMMUN, V8, P97, DOI 10.1159/000433539; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nault JC, 2017, GASTROENTEROLOGY, V152, P880, DOI 10.1053/j.gastro.2016.11.042; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Qin HW, 2016, J NEUROSCI, V36, P5144, DOI 10.1523/JNEUROSCI.4658-15.2016; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Rodriguez-Barrueco R, 2015, GENE DEV, V29, P1631, DOI 10.1101/gad.262642.115; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Sirkisoon SR, 2018, ONCOGENE, V37, P2502, DOI 10.1038/s41388-018-0132-4; Tang AC, 2017, J INFECT DIS, V215, P293, DOI 10.1093/infdis/jiw516; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Wu KJ, 2015, CELL SIGNAL, V27, P2515, DOI 10.1016/j.cellsig.2015.09.014; Yang JD, 2011, GENE CHROMOSOME CANC, V50, P122, DOI 10.1002/gcc.20838; Yun M, 2015, CELL PHYSIOL BIOCHEM, V35, P1821, DOI 10.1159/000373993; Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628; Zhang Y, 2013, CELL BIOCHEM BIOPHYS, V67, P575, DOI 10.1007/s12013-013-9544-5; Zheng X, 2013, GENE CHROMOSOME CANC, V52, P225, DOI 10.1002/gcc.22022; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhu AX, 2015, LANCET ONCOL, V16, P859, DOI 10.1016/S1470-2045(15)00050-9	46	6	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2698	2712		10.1074/jbc.RA119.011146	http://dx.doi.org/10.1074/jbc.RA119.011146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31988246	hybrid, Green Published			2022-12-28	WOS:000519969100015
J	Sekine, Y; Lindborg, JA; Strittmatter, SM				Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.			A proteolytic C-terminal fragment of Nogo-A (reticulon-4A) is released in exosomes and potently inhibits axon regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; regeneration; exosome (vesicle); -secretase 1 (BACE1); oligodendrocyte; NgR1; Nogo; Nogo receptor; reticulon; spinal cord injury	MYELIN-ASSOCIATED GLYCOPROTEIN; BACE1 ACTIVITY; RECEPTOR; IDENTIFICATION; OUTGROWTH; LIGAND; EXPRESSION; PROTEINS; GROWTH; RNA	Glial signals are known to inhibit axonal regeneration and functional recovery after mammalian central nervous system trauma, including spinal cord injury. Such signals include membrane-associated proteins of the oligodendrocyte plasma membrane and astrocyte-derived, matrix-associated proteins. Here, using cell lines and primary cortical neuron cultures, recombinant protein expression, immunoprecipitation and immunoblot assays, transmission EM of exosomes, and axon regeneration assays, we explored the secretion and activity of the myelin-associated neurite outgrowth inhibitor Nogo-A and observed exosomal release of a 24-kDa C-terminal Nogo-A fragment from cultured cells. We found that the cleavage site in this 1192-amino-acid-long fragment is located between amino acids 961?971. We also detected a Nogo-66 receptor (NgR1)?interacting Nogo-66 domain on the exosome surface. Enzyme inhibitor treatment and siRNA knockdown revealed that ?-secretase 1 (BACE1) is the protease responsible for Nogo-A cleavage. Functionally, exosomes with the Nogo-66 domain on their surface potently inhibited axonal regeneration of mechanically injured cerebral cortex neurons from mice. Production of this fragment was observed in the exosomal fraction from neuronal tissue lysates after spinal cord crush injury of mice. We also noted that, relative to the exosomal marker Alix, a Nogo-immunoreactive, 24-kDa protein is enriched in exosomes 2-fold after injury. We conclude that membrane-associated Nogo-A produced in oligodendrocytes is processed proteolytically by BACE1, is released via exosomes, and is a potent diffusible inhibitor of regenerative growth in NgR1-expressing axons.	[Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Sekine, Yuichi] Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan	Yale University; Yale University; Wakayama Medical University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, CNNR Program, 295 Congress Ave,BCMM 436, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Sekine, Yuichi/S-8813-2019; Strittmatter, Stephen/F-5739-2011	Sekine, Yuichi/0000-0002-2861-603X; Strittmatter, Stephen/0000-0001-8188-3092	NINDS, National Institutes of Health [R35NS097283]; Falk Medical Research Trust Transformative Research Award	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Falk Medical Research Trust Transformative Research Award	This work was supported by NINDS, National Institutes of Health Grant R35NS097283 and a Falk Medical Research Trust Transformative Research Award (to S. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S.M.S. is a cofounder of ReNetX Bio, which seeks to develop NgR1-based therapeutics.	Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frohlich D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0510; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Huber AB, 2002, J NEUROSCI, V22, P3553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Raissi AJ, 2013, MOL CELL NEUROSCI, V57, P23, DOI 10.1016/j.mcn.2013.08.004; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sekine Y, 2019, J NEUROSCI, V39, P3204, DOI 10.1523/JNEUROSCI.2996-18.2019; Sekine Y, 2018, CELL REP, V23, P415, DOI 10.1016/j.celrep.2018.03.058; Sekine Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4180; Sharoar MG, 2017, REV NEUROSCIENCE, V28, P145, DOI 10.1515/revneuro-2016-0054; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Teng FYH, 2008, J CELL PHYSIOL, V216, P303, DOI 10.1002/jcp.21434; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	35	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2175	2183		10.1074/jbc.RA119.009896	http://dx.doi.org/10.1074/jbc.RA119.009896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31748413	Green Published, hybrid			2022-12-28	WOS:000517330200002
J	Tempelhagen, L; Ayer, A; Culham, DE; Stocker, R; Wood, JM				Tempelhagen, Laura; Ayer, Anita; Culham, Doreen E.; Stocker, Roland; Wood, Janet M.			Cultivation at high osmotic pressure confers ubiquinone 8?independent protection of respiration on Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						respiration; cardiolipin; trehalose; ubiquinone; stress; coenzyme Q; LacY; osmotolerance; ProP; proteoliposomes	TRANSPORTER PROP; FLUORESCENCE ANISOTROPY; LIQUID-CHROMATOGRAPHY; CARDIOLIPIN SYNTHASE; ELECTRON-TRANSPORT; COILED-COIL; MEMBRANE; ACCUMULATION; ACTIVATION; TREHALOSE	Ubiquinone 8 (coenzyme Q8 or Q8) mediates electron transfer within the aerobic respiratory chain, mitigates oxidative stress, and contributes to gene expression in Escherichia coli. In addition, Q8 was proposed to confer bacterial osmotolerance by accumulating during growth at high osmotic pressure and altering membrane stability. The osmolyte trehalose and membrane lipid cardiolipin accumulate in E. coli cells cultivated at high osmotic pressure. Here, Q8 deficiency impaired E. coli growth at low osmotic pressure and rendered growth osmotically sensitive. The Q8 deficiency impeded cellular O-2 uptake and also inhibited the activities of two proton symporters, the osmosensing transporter ProP and the lactose transporter LacY. Q8 supplementation decreased membrane fluidity in liposomes, but did not affect ProP activity in proteoliposomes, which is respiration-independent. Liposomes and proteoliposomes prepared with E. coli lipids were used for these experiments. Similar oxygen uptake rates were observed for bacteria cultivated at low and high osmotic pressures. In contrast, respiration was dramatically inhibited when bacteria grown at the same low osmotic pressure were shifted to high osmotic pressure. Thus, respiration was restored during prolonged growth of E. coli at high osmotic pressure. Of note, bacteria cultivated at low and high osmotic pressures had similar Q8 concentrations. The protection of respiration was neither diminished by cardiolipin deficiency nor conferred by trehalose overproduction during growth at low osmotic pressure, but rather might be achieved by Q8-independent respiratory chain remodeling. We conclude that osmotolerance is conferred through Q8-independent protection of respiration, not by altering physical properties of the membrane.	[Tempelhagen, Laura; Culham, Doreen E.; Wood, Janet M.] Univ Guelph, Dept Mol & Cellular Biol, 488 Gordon St, Guelph, ON N1G 2W1, Canada; [Ayer, Anita; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW 2010, Australia; [Ayer, Anita; Stocker, Roland] Univ New South Wales Med, St Vincents Clin Sch, Kensington, NSW 2050, Australia	University of Guelph; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Wood, JM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 488 Gordon St, Guelph, ON N1G 2W1, Canada.	jwood@uoguelph.ca	Stocker, Roland/AAV-4489-2021	Ayer, Anita/0000-0002-7073-2835	Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05160]; Australian Research Council [DP170101453]; National Health and Medical Research Council of Australia [1052616, 1111632]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN-2017-05160 (to J. M. W.), Australian Research Council Grant DP170101453 (to R. S. and A. A.), and a Program and a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia (Grants 1052616 and 1111632) (to R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ALEMOHAMMAD MM, 1974, J GEN MICROBIOL, V82, P125, DOI 10.1099/00221287-82-1-125; Altendorf Karlheinz, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.5.4.5; Arias-Cartin R, 2012, BBA-BIOENERGETICS, V1817, P1937, DOI 10.1016/j.bbabio.2012.04.005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BROWN ED, 1992, J BIOL CHEM, V267, P13086; Caputo Gregory A, 2013, Methods Mol Biol, V974, P279, DOI 10.1007/978-1-62703-275-9_13; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; Clarke CF, 2014, NAT CHEM BIOL, V10, P242, DOI 10.1038/nchembio.1478; CRANE FL, 1959, BIOCHIM BIOPHYS ACTA, V32, P73, DOI 10.1016/0006-3002(59)90554-2; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Culham DE, 2000, J MOL RECOGNIT, V13, P309, DOI 10.1002/1099-1352(200009/10)13:5<309::AID-JMR505>3.3.CO;2-I; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2018, BIOPHYS J, V115, P2152, DOI 10.1016/j.bpj.2018.10.023; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Eriksson EK, 2019, BBA-BIOMEMBRANES, V1861, P1388, DOI 10.1016/j.bbamem.2019.04.008; Eriksson EK, 2018, BBA-BIOMEMBRANES, V1860, P1205, DOI 10.1016/j.bbamem.2018.02.015; Galassi VV, 2015, BBA-BIOENERGETICS, V1847, P1560, DOI 10.1016/j.bbabio.2015.08.001; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez VA, 2015, BBA-BIOMEMBRANES, V1848, P2233, DOI 10.1016/j.bbamem.2015.05.002; HOUSSIN C, 1991, BIOCHIM BIOPHYS ACTA, V1056, P76, DOI 10.1016/S0005-2728(05)80075-1; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; JemiolaRzeminska M, 1996, CHEM PHYS LIPIDS, V79, P55, DOI 10.1016/0009-3084(95)02507-3; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Kaback HR, 2019, J GEN PHYSIOL, V151, P878, DOI 10.1085/jgp.201912377; KATES M, 1982, METHOD ENZYMOL, V88, P98; KATSIKAS H, 1982, BIOCHIM BIOPHYS ACTA, V689, P363, DOI 10.1016/0005-2736(82)90270-X; LENTZ BR, 1989, CHEM PHYS LIPIDS, V50, P171, DOI 10.1016/0009-3084(89)90049-2; Loiseau L, 2017, J BIOL CHEM, V292, P11937, DOI 10.1074/jbc.M117.789164; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; Magalon A, 2016, BBA-BIOENERGETICS, V1857, P198, DOI 10.1016/j.bbabio.2015.10.015; Maximov S, 2014, BBA-BIOMEMBRANES, V1838, P1288, DOI 10.1016/j.bbamem.2013.12.017; MCMANUS DC, 1993, ARCH BIOCHEM BIOPHYS, V304, P367, DOI 10.1006/abbi.1993.1363; MEURY J, 1994, FEMS MICROBIOL LETT, V121, P281, DOI 10.1016/0378-1097(94)90304-2; Miller J. H., 1972, EXPT MOL GENETICS, P433; MILNER JL, 1988, J BIOL CHEM, V263, P14900; Murdock L, 2014, APPL ENVIRON MICROB, V80, P5366, DOI 10.1128/AEM.01138-14; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Okada K, 1998, EUR J BIOCHEM, V255, P52, DOI 10.1046/j.1432-1327.1998.2550052.x; ONDARROA M, 1986, BIOSCIENCE REP, V6, P783, DOI 10.1007/BF01117101; Orozco D, 2007, J AOAC INT, V90, P1227; Pilizota T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035205; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Romantsov T, 2018, MOL MICROBIOL, V107, P623, DOI 10.1111/mmi.13904; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sevin DC, 2014, NAT CHEM BIOL, V10, P266, DOI 10.1038/nchembio.1437; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Skowronek M, 1996, BBA-BIOMEMBRANES, V1280, P115, DOI 10.1016/0005-2736(95)00264-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Sousa PMF, 2012, MICROBIOL-SGM, V158, P2408, DOI 10.1099/mic.0.056531-0; Sousa PMF, 2011, BIOCHIMIE, V93, P418, DOI 10.1016/j.biochi.2010.10.014; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Van Gelder K, 2018, PLANT CELL PHYSIOL, V59, P2350, DOI 10.1093/pcp/pcy157; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; White GF, 2000, BBA-BIOMEMBRANES, V1468, P175, DOI 10.1016/S0005-2736(00)00255-8; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815	77	7	7	7	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					981	993		10.1074/jbc.RA119.011549	http://dx.doi.org/10.1074/jbc.RA119.011549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31826918	Green Published, hybrid			2022-12-28	WOS:000509949300008
J	Wang, W; Xiang, P; Chew, WS; Torta, F; Bandla, A; Lopez, V; Seow, WL; Lam, BWS; Chang, JK; Wong, PY; Chayaburakul, K; Ong, WY; Wenk, MR; Sundar, R; Herr, DR				Wang, Wei; Xiang, Ping; Chew, Wee Siong; Torta, Federico; Bandla, Aishwarya; Lopez, Violeta; Seow, Wei Lun; Lam, Brenda Wan Shing; Chang, Jing Kai; Wong, Peiyan; Chayaburakul, Kanokporn; Ong, Wei-Yi; Wenk, Markus R.; Sundar, Raghav; Herr, Deron R.			Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroprotection; pharmacology; sphingosine 1-phosphate (S1P); G-protein?coupled receptor; glial cell; cancer; anticancer drug; chemotherapy; cisplatin; glial satellite cells; neuropathy; oxaliplatin	PERIPHERAL NEUROPATHY; CISPLATIN; CELLS; NEPHROTOXICITY; MAINTENANCE; THERAPY; PAIN	Platinum-based therapeutics are used to manage many forms of cancer, but frequently result in peripheral neuropathy. Currently, the only option available to attenuate chemotherapy-induced neuropathy is to limit or discontinue this treatment. Sphingosine 1-phosphate (S1P) is a lipid-based signaling molecule involved in neuroinflammatory processes by interacting with its five cognate receptors: S1P(1?5). In this study, using a combination of drug pharmacodynamic analysis in human study participants, disease modeling in rodents, and cell-based assays, we examined whether S1P signaling may represent a potential target in the treatment of chemotherapy-induced neuropathy. To this end, we first investigated the effects of platinum-based drugs on plasma S1P levels in human cancer patients. Our analysis revealed that oxaliplatin treatment specifically increases one S1P species, d16:1 S1P, in these patients. Although d16:1 S1P is an S1P(2) agonist, it has lower potency than the most abundant S1P species (d18:1 S1P). Therefore, as d16:1 S1P concentration increases, it is likely to disproportionately activate proinflammatory S1P(1) signaling, shifting the balance away from S1P(2). We further show that a selective S1P(2) agonist, CYM-5478, reduces allodynia in a rat model of cisplatin-induced neuropathy and attenuates the associated inflammatory processes in the dorsal root ganglia, likely by activating stress-response proteins, including ATF3 and HO-1. Cumulatively, the findings of our study suggest that the development of a specific S1P(2) agonist may represent a promising therapeutic approach for the management of chemotherapy-induced neuropathy.	[Wang, Wei; Xiang, Ping; Chew, Wee Siong; Seow, Wei Lun; Lam, Brenda Wan Shing; Chang, Jing Kai; Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 119228, Singapore; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Lipid Incubator SLING, Singapore 119228, Singapore; [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119228, Singapore; [Lopez, Violeta] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Singapore 119228, Singapore; [Wong, Peiyan] Natl Univ Singapore, Yong Loo Lin Sch Med, Neurosci Phenotyping Core, Singapore 119228, Singapore; [Ong, Wei-Yi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119228, Singapore; [Sundar, Raghav] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore; [Bandla, Aishwarya; Sundar, Raghav] Natl Univ Singapore, 1 Inst Hlth, Singapore 119077, Singapore; [Ong, Wei-Yi] Natl Univ Singapore, Neurobiol & Ageing Res Programme, Singapore 119077, Singapore; [Chayaburakul, Kanokporn] Rangsit Univ, Fac Sci, Anat Unit, Pathum Thani 12000, Thailand; [Sundar, Raghav] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore 119074, Singapore; [Herr, Deron R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Rangsit University; National University of Singapore; California State University System; San Diego State University	Herr, DR (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 119228, Singapore.; Sundar, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore.; Sundar, R (corresponding author), Natl Univ Singapore, 1 Inst Hlth, Singapore 119077, Singapore.; Sundar, R (corresponding author), Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore 119074, Singapore.; Herr, DR (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	raghav_sundar@nuhs.edu.sg; phcdrh@nus.edu.sg	Bandla, Aishwarya/AAQ-5441-2020; Bandla, Aishwarya/AAN-5685-2020; Sundar, Raghav/GRS-0649-2022; Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896; Wong, Peiyan/0000-0003-3734-2461; Torta, Federico/0000-0001-7545-7484; Bandla, Aishwarya/0000-0002-6705-1318; Sundar, Raghav/0000-0001-9423-1368	Ministry of Education, Singapore [T1-2013Sep-09]; National University Health System Grants [NUHSRO/2014/085/AF-Partner/01, NUHSRO/2017/064/Bridging/02]; National Medical Research Council [NMRC/CG/M009/2017_NUH/NUHS]	Ministry of Education, Singapore(Ministry of Education, Singapore); National University Health System Grants; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Ministry of Education, Singapore, Grant T1-2013Sep-09 (to D. R. H.), by National University Health System Grants NUHSRO/2014/085/AF-Partner/01 (to D. R. H.) and NUHSRO/2017/064/Bridging/02 (to D. R. H.), and by National Medical Research Council, Grant NMRC/CG/M009/2017_NUH/NUHS (to P. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Akman T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/167235; Areti A, 2014, REDOX BIOL, V2, P289, DOI 10.1016/j.redox.2014.01.006; Authier N, 2003, EXP NEUROL, V182, P12, DOI 10.1016/S0014-4886(03)00003-7; Bruno G, 2018, CELL SIGNAL, V45, P110, DOI 10.1016/j.cellsig.2018.02.001; Burla B, 2018, METHODS MOL BIOL, V1730, P135, DOI 10.1007/978-1-4939-7592-1_11; Catarzi S, 2007, BBA-GEN SUBJECTS, V1770, P872, DOI 10.1016/j.bbagen.2007.01.008; Cencetti F, 2019, BBA-MOL CELL RES, V1866, P554, DOI 10.1016/j.bbamcr.2018.12.007; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Colevas AD, 2015, HEAD NECK-J SCI SPEC, V37, P1102, DOI 10.1002/hed.23714; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; Grabski AD, 2009, ARTERIOSCL THROM VAS, V29, P1644, DOI 10.1161/ATVBAHA.109.191965; Gutierrez-Gutierrez G, 2010, CLIN TRANSL ONCOL, V12, P81, DOI 10.1007/S12094-010-0474-z; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Herr DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24541; Herr DR, 2013, J BIOL CHEM, V288, P29882, DOI 10.1074/jbc.M113.510099; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Janes K, 2014, J BIOL CHEM, V289, P21082, DOI 10.1074/jbc.M114.569574; Joseph EK, 2009, J PAIN, V10, P534, DOI 10.1016/j.jpain.2008.12.003; Karasawa T, 2015, TOXICOL LETT, V237, P219, DOI 10.1016/j.toxlet.2015.06.012; KATO R, 1992, TOXICOL LETT, V64-5, P661, DOI 10.1016/0378-4274(92)90245-F; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Kelley MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106485; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Li HR, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e43; Li YY, 2020, J CELL PHYSIOL, V235, P3864, DOI 10.1002/jcp.29280; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Lu C, 2006, DRUG METAB DISPOS, V34, P1600, DOI 10.1124/dmd.106.010793; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Molassiotis A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5302-4; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Pace A, 2010, NEUROLOGY, V74, P762, DOI 10.1212/WNL.0b013e3181d5279e; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sastry J, 2005, PEDIATR HEMAT ONCOL, V22, P441, DOI 10.1080/08880010590964381; Satsu H, 2013, BIOORGAN MED CHEM, V21, P5373, DOI 10.1016/j.bmc.2013.06.012; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Stockstill K, 2018, J EXP MED, V215, P1301, DOI 10.1084/jem.20170584; Takuwa N., 2010, CARDIOVASC; Thirunavukkarasan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186334; Tran C, 2020, J NEUROCHEM, V153, P173, DOI 10.1111/jnc.14917; Troupiotis-Tsailaki A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02104-5; Wang W, 2019, FASEB J, V33, P7180, DOI 10.1096/fj.201801635R; Wong KM, 2017, NEURAL REGEN RES, V12, P518, DOI 10.4103/1673-5374.205000; Zhou T, 2006, ACTA NEUROBIOL EXP, V66, P105	53	21	21	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					1143	1152		10.1074/jbc.RA119.011699	http://dx.doi.org/10.1074/jbc.RA119.011699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31882542	hybrid, Green Published			2022-12-28	WOS:000509949300021
J	Hojo, H; Yashiro, Y; Noda, Y; Ogami, K; Yamagishi, R; Okada, S; Hoshino, S; Suzuki, T				Hojo, Hiroaki; Yashiro, Yuka; Noda, Yuta; Ogami, Koichi; Yamagishi, Ryota; Okada, Shunpei; Hoshino, Shin-ichi; Suzuki, Tsutomu			The RNA-binding protein QKI-7 recruits the poly(A) polymerase GLD-2 for 3? adenylation and selective stabilization of microRNA-122	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); RNA binding protein; post-transcriptional regulation; polyadenylation; hepatocyte; miRNA metabolism	PIWI-INTERACTING RNAS; C VIRUS-RNA; MESSENGER-RNA; MAMMALIAN MICRORNAS; PRE-MICRORNA; QUAKING; URIDYLATION; DEGRADATION; METHYLATION; BIOGENESIS	MicroRNA-122 (miR-122) is highly expressed in hepatocytes, where it plays an important role in regulating cholesterol and fatty acid metabolism, and it is also a host factor required for hepatitis C virus replication. miR-122 is selectively stabilized by 3? adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2 (also known as PAPD4 or TENT2). However, it is unclear how GLD-2 specifically stabilizes miR-122. Here, we show that QKI7 KH domain-containing RNA binding (QKI-7), one of three isoforms of the QKI proteins, which are members of the signal transduction and activation of RNA (STAR) family of RNA-binding proteins, is involved in miR-122 stabilization. QKI down-regulation specifically decreased the steady-state level of mature miR-122, but did not affect the pre-miR-122 level. We also found that QKI-7 uses its C-terminal region to interact with GLD-2 and its QUA2 domain to associate with the RNA-induced silencing complex protein Argonaute 2 (Ago2), indicating that the GLD-2?QKI-7 interaction recruits GLD-2 to Ago2. QKI-7 exhibited specific affinity to miR-122 and significantly promoted GLD-2?mediated 3? adenylation of miR-122 in vitro. Taken together, our findings indicate that miR-122 binds Ago2?interacting QKI-7, which recruits GLD-2 for 3? adenylation and stabilization of miR-122.	[Hojo, Hiroaki; Yashiro, Yuka; Noda, Yuta; Okada, Shunpei; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Ogami, Koichi; Yamagishi, Ryota; Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan	University of Tokyo; Nagoya City University	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	Ogami, Koichi/K-1160-2019; Suzuki, Tsutomu/J-1776-2015	Ogami, Koichi/0000-0001-9380-9666; Suzuki, Tsutomu/0000-0002-9731-1731; Hoshino, Shinichi/0000-0001-6135-7896	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and the Japan Society for the Promotion of Science (JSPS) (to T. S.), and the Program on the Innovative Development and the Application of New Drugs for Hepatitis B from the Japan Agency for Medical Research and Development (AMED) (to S.-i. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Akay A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130151; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boele J, 2014, P NATL ACAD SCI USA, V111, P11467, DOI 10.1073/pnas.1317751111; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; D'Ambrogio A, 2012, CELL REP, V2, P1537, DOI 10.1016/j.celrep.2012.10.023; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Katoh T, 2015, NUCLEIC ACIDS RES, V43, P7521, DOI 10.1093/nar/gkv669; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim GW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005714; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lee M, 2014, MOL CELL, V56, P696, DOI 10.1016/j.molcel.2014.10.011; Li ZZ, 2000, J NEUROSCI, V20, P4944; Li ZZ, 2002, JPN J CANCER RES, V93, P167, DOI 10.1111/j.1349-7006.2002.tb01255.x; Nakel K, 2015, P NATL ACAD SCI USA, V112, P8614, DOI 10.1073/pnas.1504648112; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ren GD, 2014, P NATL ACAD SCI USA, V111, P6365, DOI 10.1073/pnas.1405083111; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarnow P, 2016, ANNU REV VIROL, V3, P309, DOI 10.1146/annurev-virology-110615-042409; Shingu T, 2017, NAT GENET, V49, P75, DOI 10.1038/ng.3711; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012824; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Yamagishi R, 2016, NUCLEIC ACIDS RES, V44, P2475, DOI 10.1093/nar/gkw118; Yoon JH, 2015, GENE DEV, V29, P1599, DOI 10.1101/gad.263749.115; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051	56	14	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					390	402		10.1074/jbc.RA119.011617	http://dx.doi.org/10.1074/jbc.RA119.011617			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31792053	Green Published, hybrid			2022-12-28	WOS:000507373600011
J	Maity, P; Bindu, S; Choubey, V; Alam, A; Mitra, K; Goyal, M; Dey, S; Guha, M; Pal, C; Bandyopadhyay, U				Maity, Pallab; Bindu, Samik; Choubey, Vinay; Alam, Athar; Mitra, Kalyan; Goyal, Manish; Dey, Sumanta; Guha, Mithu; Pal, Chinmay; Bandyopadhyay, Uday			RETRACTION: Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal (Retraction Article, vol 283, pg 14391, 2008) (Retraction of Vol 283, Pg 14391, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20260	20260		10.1074/jbc.W119.012034	http://dx.doi.org/10.1074/jbc.W119.012034			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31882521	hybrid, Green Published			2022-12-28	WOS:000505005800036
J	Tian, SJ; Jia, WM; Lu, M; Zhao, J; Sun, XL				Tian, Shijiao; Jia, Wenming; Lu, Mei; Zhao, Juan; Sun, Xiulian			Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin resistance; insulin receptor substrate 1 (IRS-1); DYRK1A; Alzheimer disease; diabetes; neurodegenerative disease; brain neuron; db; db mouse; metabolic disorder	PANCREATIC BETA-CELL; INTRANASAL INSULIN; RECEPTOR SUBSTRATE-1; ALZHEIMERS-DISEASE; FUNCTIONAL-LINK; DOWN-SYNDROME; DYRK1A; INHIBITION; DEGRADATION; COGNITION	Insulin resistance in the brain is a pathological mechanism that is shared between Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM). Although aberrant expression and phosphorylation of insulin receptor substrate 1 (IRS-1) contribute to insulin resistance, the underlying mechanism remains elusive. In this study, we used several approaches, including adeno-associated virus-based protein overexpression, immunoblotting, immunoprecipitation, immunohistochemistry, and in situ proximal ligation assays, to investigate the function of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) in IRS-1 regulation and the downstream insulin signaling in neurons. We found that DYRK1A overexpression up-regulated IRS-1 expression by slowing turnover of the IRS-1 protein. We further observed that DYRK1A directly interacted with IRS-1 and phosphorylated IRS-1's multiple serine residues. Of note, DYRK1A and IRS-1 were coordinately up-regulated in the prefrontal cortex of db/db mice brain. Furthermore, DYRK1A overexpression ameliorated chronic high insulin-induced insulin resistance in SH-SY5Y cells as well as in primary rat neurons. These findings suggest that DYRK1A protects against insulin resistance in the brain by elevating IRS-1 expression.	[Tian, Shijiao] Shandong Univ, Qilu Hosp, Dept Neurol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Tian, Shijiao; Sun, Xiulian] Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Jia, Wenming; Zhao, Juan] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, NHC Key Lab Otorhinolaryngol, 44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Lu, Mei] Shandong Univ, Qilu Hosp, Dept Geriatr, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Sun, Xiulian] Shandong Univ, Qilu Hosp, Chinese Natl Hlth Commiss, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.; Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Chinese Natl Hlth Commiss, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China [91849130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 91849130. The authors declare that they have no conflicts of interest with the contents of this article.	Abbassi R, 2015, PHARMACOL THERAPEUT, V151, P87, DOI 10.1016/j.pharmthera.2015.03.004; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Belke Darrell D, 2012, Methods Mol Biol, V933, P47, DOI 10.1007/978-1-62703-068-7_4; Branca C, 2017, AGING CELL, V16, P1146, DOI 10.1111/acel.12648; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Fratantonio D, 2017, BBA-MOL CELL BIOL L, V1862, P351, DOI 10.1016/j.bbalip.2016.12.008; Hu Yusheng, 2015, MATH PROBL ENG, V1, P1, DOI DOI 10.1145/2835596.2835613; Jeong H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18081-8; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; LEROITH D, 1989, J MOL NEUROSCI, V1, P3, DOI 10.1007/BF02896850; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172985; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu Q, 2016, J BIOL CHEM, V291, P26399, DOI 10.1074/jbc.M116.717553; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martins IVA, 2017, J ALZHEIMERS DIS, V55, P915, DOI 10.3233/JAD-160640; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Novak V, 2014, DIABETES CARE, V37, P751, DOI 10.2337/dc13-1672; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Rachdi L, 2014, CELL CYCLE, V13, P2221, DOI 10.4161/cc.29250; Rachdi L, 2014, DIABETOLOGIA, V57, P960, DOI 10.1007/s00125-014-3174-3; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Shi LJ, 2017, BEHAV BRAIN RES, V327, P65, DOI 10.1016/j.bbr.2017.03.032; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Wang P, 2019, CELL METAB, V29, P638, DOI 10.1016/j.cmet.2018.12.005; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Wang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07655-1; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang H, 2015, DIABETES, V64, P1025, DOI 10.2337/db14-1000; Zhang JY, 2017, DIABETES RES CLIN PR, V124, P41, DOI 10.1016/j.diabres.2016.10.024	54	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20164	20176		10.1074/jbc.RA119.010809	http://dx.doi.org/10.1074/jbc.RA119.010809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31723029	Green Published, hybrid			2022-12-28	WOS:000505005800027
J	Barrows, JK; Long, DT				Barrows, John K.; Long, David T.			Cell-free transcription in Xenopus egg extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasmid; Xenopus; transcription; histone; RNA processing; cell-free system; gene regulation; genome activation; in vitro assay; nucleoplasmic extract	CHROMOSOMAL DNA-REPLICATION; RNA POLYMERASE-II; DIVERGENT TRANSCRIPTION; CHROMATIN-STRUCTURE; MECHANISM; INITIATION; RECONSTITUTION; INHIBITION	Soluble extracts prepared from Xenopus eggs have been used extensively to study various aspects of cellular and developmental biology. During early egg development, transcription of the zygotic genome is suppressed. As a result, traditional extracts derived from unfertilized and early stage eggs possess little or no intrinsic transcriptional activity. In this study, we show that Xenopus nucleoplasmic extract (NPE) supports robust transcription of a chromatinized plasmid substrate. Although prepared from eggs in a transcriptionally inactive state, the process of making NPE resembles some aspects of egg fertilization and early embryo development that lead to transcriptional activation. With this system, we observed that promoter-dependent recruitment of transcription factors and RNA polymerase II leads to conventional patterns of divergent transcription and pre-mRNA processing, including intron splicing and 3? cleavage and polyadenylation. We also show that histone density controls transcription factor binding and RNA polymerase II activity, validating a mechanism proposed to regulate genome activation during development. Together, these results establish a new cell-free system to study the regulation, initiation, and processing of mRNA transcripts.	[Barrows, John K.; Long, David T.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Long, DT (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	longdt@musc.edu		Long, David/0000-0001-9232-0316; Barrows, John/0000-0003-0906-1574	National Institutes of Health [R35 GM119512]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [TL1 TR001451, UL1 TR001450]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450, TL1TR001451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35 GM119512 (to D. T. L.) and National Center for Advancing Translational Sciences (NCATS), National Institutes of Health Grants TL1 TR001451 and UL1 TR001450 (to J. K. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amodeo AA, 2015, P NATL ACAD SCI USA, V112, pE1086, DOI 10.1073/pnas.1413990112; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; BLOW JJ, 1990, J CELL SCI, V95, P383; Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cross MK, 2009, DIS MODEL MECH, V2, P541, DOI 10.1242/dmm.002022; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; FELIX MA, 1990, NATURE, V346, P379, DOI 10.1038/346379a0; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Fullbright G, 2016, MOL CELL BIOL, V36, P2983, DOI 10.1128/MCB.00434-16; Gillespie PJ, 2012, METHODS, V57, P203, DOI 10.1016/j.ymeth.2012.03.029; Hashimoto Y, 2011, METHODS MOL BIOL, V745, P437, DOI 10.1007/978-1-61779-129-1_25; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HUTCHISON CJ, 1989, J CELL SCI, P197; Hyde AS, 2016, METHODS MOL BIOL, V1481, P101, DOI 10.1007/978-1-4939-6393-5_11; INOUE N, 1991, J BACTERIOL, V173, P1208, DOI 10.1128/jb.173.3.1208-1214.1991; Jimeno-Gonzalez S, 2016, TRANSCR-AUSTIN, V7, P63, DOI 10.1080/21541264.2016.1168507; Jones C. Michael, 2008, V461, P385, DOI 10.1007/978-1-60327-483-8_28; Joseph SR, 2017, ELIFE, V6, DOI 10.7554/eLife.23326; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; LENO GH, 1991, METHOD CELL BIOL, V36, P561; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu Z J, 1990, DNA Seq, V1, P125, DOI 10.3109/10425179009016040; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Maresca Thomas J., 2006, V322, P459; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; Nagai S, 2017, P NATL ACAD SCI USA, V114, P1536, DOI 10.1073/pnas.1620312114; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Read A, 2018, ENDOCR-RELAT CANCER, V25, pR467, DOI 10.1530/ERC-18-0068; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Srinivasan SV, 2011, METHODS MOL BIOL, V782, P119, DOI 10.1007/978-1-61779-273-1_10; Tanny JC, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/21541264.2014.988093; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; TOYODA T, 1992, DEV BIOL, V153, P150, DOI 10.1016/0012-1606(92)90099-3; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang WL, 2016, INT J DEV BIOL, V60, P315, DOI 10.1387/ijdb.160161ds; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Wu RA, 2019, NATURE, V567, P267, DOI 10.1038/s41586-019-1002-0; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zierhut C, 2014, NAT STRUCT MOL BIOL, V21, P617, DOI 10.1038/nsmb.2845	61	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19645	19654		10.1074/jbc.RA119.011350	http://dx.doi.org/10.1074/jbc.RA119.011350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31732562	hybrid, Green Published			2022-12-28	WOS:000504093200016
J	Sun, LF; Liu, Y; Wang, J; Huang, LD; Yang, Y; Cheng, XY; Fan, YZ; Zhu, MX; Liang, H; Tian, Y; Wang, HS; Guo, CR; Yu, Y				Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Fan, Ying-Zhe; Zhu, Michael X.; Liang, Hong; Tian, Yun; Wang, Heng-Shan; Guo, Chang-Run; Yu, Ye			Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purinergic receptor; allosteric regulation; gating; conformational change; molecular dynamics; ATP-evoked current; ATP-gated ion channel; left flipper domain; LF domain; ATP-evoked current	GATED ION CHANNELS; MOLECULAR-MECHANISM; EXPRESSION; P2X(5); ACTIVATION; CLONING; MUSCLE; LOCALIZATION; ANTAGONIST; DEFINE	Although the extracellular ATP-gated cation channel purinergic receptor P2X5 is widely expressed in heart, skeletal muscle, and immune and nervous systems in mammals, little is known about its functions and channel-gating activities. This lack of knowledge is due to P2X5's weak ATP responses in several mammalian species, such as humans, rats, and mice. WT human P2X5 (hP2X5(?328?349)) does not respond to ATP, whereas a full-length variant, hP2X5 (hP2X5-FL), containing exon 10 encoding the second hP2X5 transmembrane domain (TM2), does. However, although rat P2X5 (rP2X5) has a full-length TM2, ATP induces only weak currents in rP2X5, which prompted us to investigate the mechanism underlying this small ATP response. Here, we show that single replacements of specific rP2X5 residues with the corresponding residues in hP2X5 (S191F or F195H) significantly enhance the current amplitude of rP2X5. Using a combination of engineered disulfide cross-linking, single-channel recording, and molecular modeling, we interrogated the effects of S191F and F195H substitutions on the allostery of the left flipper (LF) domain. On the basis of our findings, we propose that the bound ATP-induced distinct allostery of the LF domain with that of other functional subtypes has caused the weak ATP response of rP2X5 receptors. The findings of our study provide the prerequisite for future transgenic studies on the physiological and pathological functions of P2X5 receptors.	[Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol & Pharmacol, Shanghai 200025, Peoples R China; [Liang, Hong; Wang, Heng-Shan] Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China; [Guo, Chang-Run; Yu, Ye] China Pharmaceut Univ, Dept Basic Med & Clin Pharm, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200026, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangxi Normal University; China Pharmaceutical University; University of Texas System; University of Texas Health Science Center Houston; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol & Pharmacol, Shanghai 200025, Peoples R China.; Wang, HS (corresponding author), Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China.; Guo, CR; Yu, Y (corresponding author), China Pharmaceut Univ, Dept Basic Med & Clin Pharm, Nanjing 210009, Jiangsu, Peoples R China.; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	hshwang2002@163.com; crguocpu@126.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Yu, Ye/0000-0002-4054-8543	Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China [31971146, 81603409, 31971042, 21977021, 31900808, 31570832, 31170787, 31400707, 81703677]; National Postdoctoral Program for Innovative Talents Grant [BX201700306]; China Postdoctoral Science Foundation [2018M632127]; Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China [2014CB910300/02]; National Excellent Young Scientist Foundation of China [31222018]; Hunan Provincial Natural Science Foundation of China [2018JJ1012]; Science and Technology Department of Hunan Province [2018RS3086]	Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Program for Innovative Talents Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Department of Hunan Province	This study was supported by Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China, Grants 31971146, 81603409, 31971042, 21977021, 31900808, 31570832, 31170787, 31400707, and 81703677; National Postdoctoral Program for Innovative Talents Grant BX201700306; China Postdoctoral Science Foundation Grant 2018M632127; the Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China Grant 2014CB910300/02; National Excellent Young Scientist Foundation of China Grant 31222018; Hunan Provincial Natural Science Foundation of China Grant 2018JJ1012; and Science and Technology Department of Hunan Province Grant 2018RS3086. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; ADAMS L, 1995, J CELL BIOL, V131, P1341, DOI 10.1083/jcb.131.5.1341; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen L, 2016, PURINERG SIGNAL, V12, P79, DOI 10.1007/s11302-015-9481-4; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Compan V, 2012, J NEUROSCI, V32, P4284, DOI 10.1523/JNEUROSCI.6332-11.2012; Cox JA, 2001, GENE, V270, P145, DOI 10.1016/S0378-1119(01)00484-X; Cremlyn R. J., 1996, AN INTRODUCTION TO O, P7; Geuder K I, 1992, Dev Immunol, V2, P69, DOI 10.1155/1992/40576; Groschel-Stewart U, 1999, CELL TISSUE RES, V296, P599, DOI 10.1007/s004410051321; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jensik PJ, 2001, AM J PHYSIOL-CELL PH, V281, pC954, DOI 10.1152/ajpcell.2001.281.3.C954; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kotnis S, 2010, MOL PHARMACOL, V77, P953, DOI 10.1124/mol.110.063636; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le KT, 1999, J BIOL CHEM, V274, P15415, DOI 10.1074/jbc.274.22.15415; Le KT, 1997, FEBS LETT, V418, P195, DOI 10.1016/S0014-5793(97)01380-X; Li B, 2018, SCI BULL, V63, P1616, DOI 10.1016/j.scib.2018.11.016; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Meyer MP, 1999, DEV DYNAM, V216, P442, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<442::AID-DVDY12>3.0.CO;2-Z; Niu YY, 2016, J BIOL CHEM, V291, P7571, DOI 10.1074/jbc.M115.710251; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Saul A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00250; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Stephan G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03728-5; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Surprenant A, 2000, J AUTONOM NERV SYST, V81, P249, DOI 10.1016/S0165-1838(00)00123-5; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Verkhratsky A, 2014, ADV NEUROBIOL, V11, P55, DOI 10.1007/978-3-319-08894-5_4; Wang J, 2018, P NATL ACAD SCI USA, V115, P4939, DOI 10.1073/pnas.1800907115; Wang J, 2017, J BIOL CHEM, V292, P7619, DOI 10.1074/jbc.M116.771121; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Yang XN, 2017, J BIOL CHEM, V292, P21662, DOI 10.1074/jbc.M117.814707; Zhao WS, 2016, J BIOL CHEM, V291, P7990, DOI 10.1074/jbc.M115.711127; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	56	6	6	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19589	19603		10.1074/jbc.RA119.009959	http://dx.doi.org/10.1074/jbc.RA119.009959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727741	hybrid, Green Published			2022-12-28	WOS:000504093200012
J	Morris, DL; Kastner, DW; Johnson, S; Strub, MP; He, Y; Bleck, CKE; Lee, DY; Tjandra, N				Morris, Daniel L.; Kastner, David W.; Johnson, Sabrina; Strub, Marie-Paule; He, Yi; Bleck, Christopher K. E.; Lee, Duck-Yeon; Tjandra, Nico			Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; BCL-2-associated X apoptosis regulator (BAX); humanin; fibers; electron microscopy; conformational change; beta-sheet; protein aggregation; fibrillation	RETRACTED ARTICLE. SEE; CELL-DEATH; BH3-ONLY PROTEINS; PEPTIDE HUMANIN; RESCUE FACTOR; PG 480; ACTIVATION; BINDING; ANALOG; BIM	The mitochondrial, or intrinsic, apoptosis pathway is regulated mainly by members of the B-cell lymphoma 2 (BCL-2) protein family. BCL-2-associated X apoptosis regulator (BAX) plays a pivotal role in the initiation of mitochondria-mediated apoptosis as one of the factors causing mitochondrial outer-membrane permeabilization (MOMP). Of current interest are endogenous BAX ligands that inhibit its MOMP activity. Mitochondrial-derived peptides (MDPs) are a recently identified class of mitochondrial retrograde signaling molecules and are reported to be potent apoptosis inhibitors. Among them, humanin (HN), has been shown to suppress apoptosis by inhibiting BAX translocation to the mitochondrial outer membrane, but the molecular mechanism of this interaction is unknown. Here, using recombinant protein expression, along with light-scattering, CD, and fluorescence spectroscopy, we report that HN and BAX can form fibers together in vitro. Results from negative stain EM experiments suggest that BAX undergoes secondary and tertiary structural rearrangements and incorporates into the fibers, and that its membrane-associating C-terminal helix is important for the fibrillation process. Additionally, HN mutations known to alter its anti-apoptotic activity affect fiber morphology. Our findings reveal for the first time a potential mechanism by which BAX can be sequestered by fibril formation, which can prevent it from initiating MOMP and committing the cell to apoptosis.	[Morris, Daniel L.; Kastner, David W.; Johnson, Sabrina; Strub, Marie-Paule; He, Yi; Tjandra, Nico] NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, 50 South Dr, Bethesda, MD 20814 USA; [Strub, Marie-Paule; He, Yi] NHLBI, Prot Express Facil, Biochem & Biophys Ctr, NIH, 50 South Dr, Bethesda, MD 20814 USA; [Bleck, Christopher K. E.] NHLBI, Electron Microscopy Core Facil, NIH, 14 Serv Rd West, Bethesda, MD 20892 USA; [Lee, Duck-Yeon] NHLBI, Biochem Core Facil, NIH, 50 South Dr, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, 50 South Dr,Room 3503, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov	Kastner, David W./ABC-1599-2021	Kastner, David W./0000-0002-7766-4249; Bleck, Christopher/0000-0003-1029-3444; Morris, Daniel/0000-0001-5274-0172				Alsanousi N, 2016, BIOCHEM BIOPH RES CO, V477, P647, DOI 10.1016/j.bbrc.2016.06.114; Arakawa T, 2006, J PEPT SCI, V12, P639, DOI 10.1002/psc.773; Arakawa T, 2014, MOL MED REP, V9, P375, DOI 10.3892/mmr.2013.1797; Arakawa T, 2011, INT J BIOL MACROMOL, V49, P93, DOI 10.1016/j.ijbiomac.2011.04.003; Arisaka F, 2009, PROTEIN PEPTIDE LETT, V16, P132, DOI 10.2174/092986609787316225; Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Benaki D, 2005, BIOCHEM BIOPH RES CO, V329, P152, DOI 10.1016/j.bbrc.2005.01.100; Benaki D, 2007, COLLECT S SER, V9, P5; Benaki D, 2006, BIOCHEM BIOPH RES CO, V349, P634, DOI 10.1016/j.bbrc.2006.08.087; Bilinovich SM, 2014, J MOL BIOL, V426, P1753, DOI 10.1016/j.jmb.2014.01.007; Brahmbhatt H, 2016, BIOCHEM J, V473, P1073, DOI 10.1042/BCJ20160118; Choi JY, 2007, CHEM BIOL DRUG DES, V70, P383, DOI 10.1111/j.1747-0285.2007.00576.x; Chu Q, 2015, CRIT REV BIOCHEM MOL, V50, P134, DOI 10.3109/10409238.2015.1016215; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Edlich F, 2018, BIOCHEM BIOPH RES CO, V500, P26, DOI 10.1016/j.bbrc.2017.06.190; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Esckilsen D, 2016, 47 CENTR REG M AM CH; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gahl RF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.593897; Garner TP, 2019, NAT CHEM BIOL, V15, P322, DOI 10.1038/s41589-018-0223-0; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gong ZW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00210; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hayashi K, 2012, AMINO ACIDS, V42, P2293, DOI 10.1007/s00726-011-0971-6; He Y, 2020, PROTEIN EXPRES PURIF, V165, DOI 10.1016/j.pep.2019.105501; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hirano A, 2011, INT J BIOL MACROMOL, V48, P360, DOI 10.1016/j.ijbiomac.2010.12.017; Hirano A, 2010, INT J BIOL MACROMOL, V46, P375, DOI 10.1016/j.ijbiomac.2010.01.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Kale J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745235; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kita Y, 2008, PROTEIN PEPTIDE LETT, V15, P510, DOI 10.2174/092986608784567555; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma J, 2016, ANAL CHEM, V88, P3967, DOI 10.1021/acs.analchem.6b00191; Ma JH, 2012, P NATL ACAD SCI USA, V109, P20901, DOI 10.1073/pnas.1217094110; Ma ZW, 2018, ACTA PHARMACOL SIN, V39, P1012, DOI 10.1038/aps.2017.169; Maftei M, 2012, J PEPT SCI, V18, P373, DOI 10.1002/psc.2404; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Niu X, 2017, CELL CHEM BIOL, V24, P493, DOI 10.1016/j.chembiol.2017.03.011; Pistolesi S, 2009, BIOCHEMISTRY-US, V48, P5026, DOI 10.1021/bi900187s; Pritz JR, 2017, NAT CHEM BIOL, V13, P961, DOI [10.1038/NCHEMBIO.2433, 10.1038/nchembio.2433]; Ramirez-Galicia G, 2005, COLLECT S SER, V8, P62; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rojo-Dominguez A, 2007, PROTEIN PEPTIDE LETT, V14, P618; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xin MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5935; Yagisawa R, 2008, CHEM PHYS LETT, V455, P293, DOI 10.1016/j.cplett.2008.02.109; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zapala B, 2010, PHARMACOL REP, V62, P767, DOI 10.1016/S1734-1140(10)70337-6; Zarse K, 2015, CELL METAB, V21, P355, DOI 10.1016/j.cmet.2015.02.013; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	68	17	18	6	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19055	19065		10.1074/jbc.RA119.011297	http://dx.doi.org/10.1074/jbc.RA119.011297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690630	hybrid, Green Published			2022-12-28	WOS:000516527800010
J	Steimle, BL; Smith, FM; Kosman, DJ				Steimle, Brittany L.; Smith, Frances M.; Kosman, Daniel J.			The solute carriers ZIP8 and ZIP14 regulate manganese accumulation in brain microvascular endothelial cells and control brain manganese levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood-brain barrier; human brain microvascular endothelial cells; manganese transport; ZIP8; SLC39A8; ZIP14; SLC39A14; metal homeostasis; neurotoxicity; capillary bed	METAL-ION TRANSPORTER; BOUND IRON UPTAKE; ZINC TRANSPORTER; FUNCTIONAL-PROPERTIES; TRANSFERRIN RECEPTOR; SLC39A8 DEFICIENCY; MEMBRANE; BARRIER; DEPOSITION; MUTATIONS	Manganese (Mn) supports numerous neuronal functions but in excess is neurotoxic. Consequently, regulation of Mn flux at the blood-brain barrier (BBB)(1) is critical to brain homeostasis. However, the molecular pathways supporting the transcellular trafficking of divalent Mn ions within the microvascular capillary endothelial cells (BMVECs) that constitute the BBB have not been examined. In this study, we have determined that Zrt- and Irt-like protein 8 (ZIP8) and ZIP14 support Mn2+-uptake by BMVECs and that neither DMT1 nor an endocytosis-dependent pathway play any significant role in Mn2+-uptake. Specifically, siRNA-mediated knockdown of ZIP8 and ZIP14 coincided with a decrease in Mn uptake, and kinetic analyses revealed that Mn uptake depends on pH and bicarbonate and is up-regulated by lipopolysaccharide (LPS), all biochemical markers of ZIP8 or ZIP14 activity. Mn2+-uptake also was associated with cell-surface membrane presentation of ZIP8 and ZIP14, as indicated by membrane protein biotinylation. Importantly, surface ZIP8 and ZIP14 biotinylation, and Mn2+-uptake experiments together revealed that these transporters support Mn-uptake at both the apical, blood and basal, brain sides of BMVECs. This indicated that at in the BMVECs of the BBB, these two transporters support a bi-directional Mn2+ flux. We conclude that BMVECs play a critical role in controlling manganese homeostasis in the brain.	[Steimle, Brittany L.; Smith, Frances M.; Kosman, Daniel J.] SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 955 Main St,Suite 4102, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 955 Main St,Suite 4102, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682; , Brittany/0000-0003-3638-8767; Smith, Frances M./0000-0001-5479-4692	National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA [RO3NS095063, RO1NS102337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337] Funding Source: NIH RePORTER	National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mitchell Knutson for generously sharing unpublished data and providing valuable suggestions about this project. We thank also our colleague Ms. Danielle Bailey who shared her ZIP8 and ZIP14 qPCR efficiency data presented in Fig. S1. This work was supported by grants RO3NS095063 and RO1NS102337 from the National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA to DJK. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Aydemir TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048679; Barar J, 2016, BIOIMPACTS, V6, P225, DOI 10.15171/bi.2016.30; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bowers K, 2018, TRAFFIC, V19, P813, DOI 10.1111/tra.12602; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chtourou Y, 2011, NEUROCHEM RES, V36, P1546, DOI 10.1007/s11064-011-0483-5; Coffey R, 2017, AM J PHYSIOL-CELL PH, V312, pC169, DOI 10.1152/ajpcell.00116.2016; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Ding DL, 2014, BIOMETALS, V27, P731, DOI 10.1007/s10534-014-9765-0; Dlouhy AC, 2019, J BIOL CHEM, V294, P4202, DOI 10.1074/jbc.RA118.005142; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Fitsanakis VA, 2005, J NEUROSCI RES, V81, P235, DOI 10.1002/jnr.20560; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gunter TE, 2013, NEUROTOXICOLOGY, V34, P118, DOI 10.1016/j.neuro.2012.10.018; Gupta RC, 2014, BIOMARKERS IN TOXICOLOGY, P1; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Ji CY, 2015, J NEUROCHEM, V133, P668, DOI 10.1111/jnc.13040; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Marti-Sanchez L, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0758-x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Park JH, 2018, GENET MED, V20, P259, DOI 10.1038/gim.2017.106; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Pyle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169531; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riley LG, 2017, J INHERIT METAB DIS, V40, P261, DOI 10.1007/s10545-016-0010-6; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; SUAREZ N, 1995, TOXICOL IN VITRO, V9, P717, DOI 10.1016/0887-2333(95)00062-D; Szpetnar M, 2016, NEUROCHEM RES, V41, P2129, DOI 10.1007/s11064-016-1928-7; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; Thompson KJ, 2018, AM J PHYSIOL-GASTR L, V315, pG351, DOI 10.1152/ajpgi.00103.2018; Troche C, 2016, AM J PHYSIOL-ENDOC M, V310, pE258, DOI 10.1152/ajpendo.00421.2015; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wahlberg K, 2018, NEUROTOXICOLOGY, V64, P103, DOI 10.1016/j.neuro.2017.09.003; Wahlberg KE, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00664; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Worzfeld T, 2016, J CEREBR BLOOD F MET, V36, P340, DOI 10.1177/0271678X15608644; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yokel Robert A, 2004, Res Rep Health Eff Inst, P7; Zhang RX, 2016, HUM MOL GENET, V25, P4117, DOI 10.1093/hmg/ddw236; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111	65	16	18	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19197	19208		10.1074/jbc.RA119.009371	http://dx.doi.org/10.1074/jbc.RA119.009371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699897	Green Published, hybrid			2022-12-28	WOS:000516527800020
J	Dhawan, K; Naslavsky, N; Caplan, S				Dhawan, Kanika; Naslavsky, Naava; Caplan, Steve			Sorting nexin 17 (SNX17) links endosomal sorting to Eps15 homology domain protein 1 (EHD1)?mediated fission machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; sorting; sorting nexin (SNX); trafficking; vesicles; receptor recycling; receptor endocytosis; receptor; intracellular trafficking; endocytosis; endosomal fission; Eps15 homology domain protein 1 (EHD1); LDL receptor?related protein 1 (LRP1); retromer; sorting nexin 17 (SNX17)	TERMINAL EH-DOMAIN; ENDOCYTIC TRAFFICKING; PLASMA-MEMBRANE; WASH COMPLEX; RETROMER; RECEPTOR; FAMILY; RME-1; TAIL; RECOGNITION	Following endocytosis, receptors that are internalized to sorting endosomes are sorted to different pathways, in part by sorting nexin (SNX) proteins. Notably, SNX17 interacts with a multitude of receptors in a sequence-specific manner to regulate their recycling. However, the mechanisms by which SNX17-labeled vesicles that contain sorted receptors bud and undergo vesicular fission from the sorting endosomes remain elusive. Recent studies suggest that a dynamin-homolog, Eps15 homology domain protein 1, catalyzes fission and releases endosome-derived vesicles for recycling to the plasma membrane. However, the mechanism by which EHD1 is coupled to various receptors and regulates their recycling remains unknown. Here we sought to characterize the mechanism by which EHD1 couples with SNX17 to regulate recycling of SNX17-interacting receptors. We hypothesized that SNX17 couples receptors to the EHD1 fission machinery in mammalian cells. Coimmunoprecipitation experiments and in vitro assays provided evidence that EHD1 and SNX17 directly interact. We also found that inducing internalization of a SNX17 cargo receptor, low-density lipoprotein receptor?related protein 1 (LRP1), led to recruitment of cytoplasmic EHD1 to endosomal membranes. Moreover, surface rendering and quantification of overlap volumes indicated that SNX17 and EHD1 partially colocalize on endosomes and that this overlap further increases upon LRP1 internalization. Additionally, SNX17-containing endosomes were larger in EHD1-depleted cells than in WT cells, suggesting that EHD1 depletion impairs SNX17-mediated endosomal fission. Our findings help clarify our current understanding of endocytic trafficking, providing significant additional insight into the process of endosomal fission and connecting the sorting and fission machineries.	[Dhawan, Kanika; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu		Dhawan, Kanika/0000-0002-6267-0312	National Institutes of Health [1R01GM123557, P20 GM103427]; Nebraska Department of Health and Human Services Grant [2019-41]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services Grant	This work was supported by National Institutes of Health Grants 1R01GM123557 and P20 GM103427 (to S. C.) and Nebraska Department of Health and Human Services Grant 2019-41 (to N. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen KE, 2019, TRAFFIC, V20, P465, DOI 10.1111/tra.12649; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Deo R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07586-z; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai Rajesh, 2011, Small GTPases, V2, P259; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Giridharan Sai Srinivas Panapakkam, 2012, Commun Integr Biol, V5, P384, DOI 10.4161/cib.20064; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Jia ZG, 2014, PROTEINS, V82, P2332, DOI 10.1002/prot.24593; Kamerkar SC, 2019, BIOCHEMISTRY-US, V58, P65, DOI 10.1021/acs.biochem.8b00925; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10939; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Melo AA, 2017, P NATL ACAD SCI USA, V114, P5629, DOI 10.1073/pnas.1614075114; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216499; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135; Osborne DG, 2015, J IMMUNOL, V194, P4555, DOI 10.4049/jimmunol.1402734; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Wang J, 2018, TRAFFIC, V19, P578, DOI 10.1111/tra.12574; Xie SW, 2018, MOL BIOL CELL, V29, P2622, DOI 10.1091/mbc.E18-04-0241; Xu Y, 2004, MOL MEMBR BIOL, V21, P269, DOI 10.1080/09687680410001716871; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047; Zhang J, 2012, TRAFFIC, V13, P745, DOI 10.1111/j.1600-0854.2012.01334.x	64	13	13	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3837	3850		10.1074/jbc.RA119.011368	http://dx.doi.org/10.1074/jbc.RA119.011368			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32041776	Green Published, hybrid			2022-12-28	WOS:000527704400010
J	Caon, I; Bartolini, B; Moretto, P; Parnigoni, A; Carava, E; Vitale, DL; Alaniz, L; Viola, M; Karousou, E; De Luca, G; Hascall, VC; Passi, A; Vigetti, D				Caon, Ilaria; Bartolini, Barbara; Moretto, Paola; Parnigoni, Arianna; Carava, Elena; Vitale, Daiana L.; Alaniz, Laura; Viola, Manuela; Karousou, Evgenia; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto; Vigetti, Davide			Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-?B and expression of the long-noncoding RNA HAS2?AS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; sirtuin 1 (SIRT1); long-noncoding RNA (long ncRNA; lncRNA); inflammation; extracellular matrix; epigenetics; metabolic regulation; glycosaminoglycan; sirtuin; HAS2; HAS2?AS1; SMC	SMOOTH-MUSCLE-CELLS; KAPPA-B; EXTRACELLULAR-MATRIX; TNF-ALPHA; POSTTRANSLATIONAL REGULATION; ATHEROSCLEROSIS; RESVERATROL; ACTIVATION; PROTEIN; TRANSCRIPTION	Hyaluronan (HA) is one of the most prevalent glycosaminoglycans of the vascular extracellular matrix (ECM). Abnormal HA accumulation within blood vessel walls is associated with tissue inflammation and is prominent in most vascular pathological conditions such as atherosclerosis and restenosis. Hyaluronan synthase 2 (HAS2) is the main hyaluronan synthase enzyme involved in HA synthesis and uses cytosolic UDP-glucuronic acid and UDP-GlcNAc as substrates. The synthesis of UDP-glucuronic acid can alter the NAD(+)/NADH ratio via the enzyme UDP-glucose dehydrogenase, which oxidizes the alcohol group at C6 to the COO? group. Here, we show that HAS2 expression can be modulated by sirtuin 1 (SIRT1), the master metabolic sensor of the cell, belonging to the class of NAD(+)-dependent deacetylases. Our results revealed the following. 1) Treatments of human aortic smooth muscle cells (AoSMCs) with SIRT1 activators (SRT1720 and resveratrol) inhibit both HAS2 expression and accumulation of pericellular HA coats. 2) Tumor necrosis factor ? (TNF?) induced HA-mediated monocyte adhesion and AoSMC migration, whereas SIRT1 activation prevented immune cell recruitment and cell motility by reducing the expression levels of the receptor for HA-mediated motility, RHAMM, and the HA-binding protein TNF-stimulated gene 6 protein (TSG6). 3) SIRT1 activation prevented nuclear translocation of NF-?B (p65), which, in turn, reduced the levels of HAS2?AS1, a long-noncoding RNA that epigenetically controls HAS2 mRNA expression. In conclusion, we demonstrate that both HAS2 expression and HA accumulation by AoSMCs are down-regulated by the metabolic sensor SIRT1.	[Caon, Ilaria; Bartolini, Barbara; Moretto, Paola; Parnigoni, Arianna; Carava, Elena; Viola, Manuela; Karousou, Evgenia; De Luca, Giancarlo; Passi, Alberto; Vigetti, Davide] Univ Insubria, Dept Med & Surg, Via JH Dunant 5, I-21100 Varese, Italy; [Vitale, Daiana L.; Alaniz, Laura] Univ Nacl Noroeste Pcia Bs As, Lab Microambiente Tumoral, CIBA, Ctr Invest & Transferencia Noroeste Pcia Bs As CI, Junin, Argentina; [Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA	University of Insubria; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Cleveland Clinic Foundation	Vigetti, D (corresponding author), Univ Insubria, Dept Med & Surg, Via JH Dunant 5, I-21100 Varese, Italy.	Davide.vigetti@uninsubria.it	Alaniz, Laura/AAM-2676-2020	Alaniz, Laura/0000-0002-6070-6078; Parnigoni, Arianna/0000-0002-1822-4120; Vitale, Daiana L./0000-0001-5593-9101	Universita degli Studi dell'Insubria; MIUR [PRIN 2017T8CMCY]	Universita degli Studi dell'Insubria; MIUR(Ministry of Education, Universities and Research (MIUR))	Supported by the Universita degli Studi dell'Insubria as postdoc fellows (assegno di ricerca junior).; Recipient of a fellowship supported by MIUR Grant PRIN 2017T8CMCY (to E. K.).	Badi I, 2018, ARTERIOSCL THROM VAS, V38, P2079, DOI 10.1161/ATVBAHA.118.311298; Baggenstoss BA, 2017, GLYCOBIOLOGY, V27, P154, DOI 10.1093/glycob/cww089; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caon I, 2020, SEMIN CANCER BIOL, V62, P9, DOI 10.1016/j.semcancer.2019.07.007; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Chen YX, 2015, BIOCHEM BIOPH RES CO, V465, P732, DOI 10.1016/j.bbrc.2015.08.066; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; Day AJ, 2019, MATRIX BIOL, V78-79, P60, DOI 10.1016/j.matbio.2018.01.011; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Filpa V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18020-7; Fischer JW, 2019, MATRIX BIOL, V78-79, P324, DOI 10.1016/j.matbio.2018.03.003; Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Heldin P, 2019, MATRIX BIOL, V78-79, P100, DOI 10.1016/j.matbio.2018.01.017; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou E, 2017, MATRIX BIOL, V59, P3, DOI 10.1016/j.matbio.2016.10.001; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Kolliopoulos C, 2019, MATRIX BIOL, V80, P29, DOI 10.1016/j.matbio.2018.09.002; Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Levesque MC, 1996, J IMMUNOL, V156, P1557; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P103, DOI 10.1093/abbs/gmq104; Lin QQ, 2016, MED SCI MONIT BASIC, V22, P165, DOI 10.12659/MSMBR.901909; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Manou D, 2019, METHODS MOL BIOL, V1952, P1, DOI 10.1007/978-1-4939-9133-4_1; de Mera RMMF, 2019, MATRIX BIOL, V80, P85, DOI 10.1016/j.matbio.2018.10.004; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Moretto P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/167283; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Passi A, 2019, FEBS J, V286, P2937, DOI 10.1111/febs.14847; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramprasath VR, 2010, EUR J CLIN NUTR, V64, P660, DOI 10.1038/ejcn.2010.77; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Saikia P, 2017, HEPATOLOGY, V66, P602, DOI 10.1002/hep.29144; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Siiskonen H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00043; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Sobuz SU, 2019, BBA-MOL CELL RES, V1866, P1355, DOI 10.1016/j.bbamcr.2019.05.001; Spinelli FM, 2019, FEBS J, V286, P3433, DOI 10.1111/febs.14871; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Thompson AM, 2014, AM J PHYSIOL-HEART C, V307, pH533, DOI 10.1152/ajpheart.00871.2013; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, FEBS J, V281, P4980, DOI 10.1111/febs.12938; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, ADV CANCER RES, V123, P95, DOI 10.1016/B978-0-12-800092-2.00004-6; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Viola Manuela, 2015, Int J Cell Biol, V2015, P208303, DOI 10.1155/2015/208303; Viola M, 2017, GLYCOCONJUGATE J, V34, P411, DOI 10.1007/s10719-016-9735-6; Viola M, 2016, CURR MED CHEM, V23, P2958, DOI 10.2174/0929867323666160607104602; Viola M, 2015, GLYCOCONJUGATE J, V32, P93, DOI 10.1007/s10719-015-9586-6; Viola M, 2013, J BIOL CHEM, V288, P29595, DOI 10.1074/jbc.M113.508341; Vitale Daiana L, 2018, Oncotarget, V9, P36585, DOI 10.18632/oncotarget.26379; Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yu X, 2015, CELL DEATH DIFFER, V22, P1170, DOI 10.1038/cdd.2014.206; Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003; Zhang P, 2016, TRANSPL P, V48, P3378, DOI 10.1016/j.transproceed.2016.10.023; Zhu GQ, 2017, MOL CARCINOGEN, V56, P2210, DOI 10.1002/mc.22674; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]	94	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3485	3496		10.1074/jbc.RA119.011982	http://dx.doi.org/10.1074/jbc.RA119.011982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31932306	Green Published, hybrid			2022-12-28	WOS:000527725300010
J	Irie, K; Nagai, T; Mizuno, K				Irie, Kazuki; Nagai, Tomoaki; Mizuno, Kensaku			Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; yes-associated protein (YAP); NDR (nuclear Dbf2-related) kinase; protein kinase; phosphorylation; cancer; cell signaling; Furry (FRY); gene knockout; large tumor suppressor kinase (LATS)	CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; SIGNALING PATHWAY; DROSOPHILA; GROWTH; YAP/TAZ; PHOSPHORYLATION; MORPHOGENESIS; INACTIVATION	The Hippo signaling pathway suppresses cell proliferation and tumorigenesis. In the canonical Hippo pathway, large tumor suppressor kinases 1/2 (LATS1/2) phosphorylate the transcriptional coactivator yes-associated protein (YAP) and thereby suppress its nuclear localization and co-transcriptional activity. Nuclear Dbf2-related kinases 1/2 (NDR1/2), which are closely related to LATS1/2, also phosphorylate and inactivate YAP by suppressing its nuclear localization. Furry (FRY) is a cytoplasmic protein that associates with NDR1/2 and activates them, but its role in the nuclear/cytoplasmic localization of YAP remains unknown. Here, we constructed FRY-knockout cell lines to examine the role of FRY in YAP's cytoplasmic localization. FRY depletion markedly increased YAP nuclear localization and decreased NDR1/2 kinase activity and YAP phosphorylation levels, but did not affect LATS1/2 kinase activity. This indicated that FRY suppresses YAP's nuclear localization by promoting its phosphorylation via NDR1/2 activation. NDR1/2 depletion also promoted YAP nuclear localization, but depletion of both FRY and NDR1/2 increased the number of cells with YAP nuclear localization more strongly than did depletion of NDR1/2 alone, suggesting that FRY suppresses YAP nuclear localization by a mechanism in addition to NDR1/2 activation. Co-precipitation assays revealed that Fry uses its N-terminal 1?2400-amino-acid-long region to bind to YAP. Expression of full-length FRY or its 1?2400 N-terminal fragment restored YAP cytoplasmic localization in FRY-knockout cells. Taken together, these results suggest that FRY plays a crucial role in YAP cytoplasmic retention by promoting YAP phosphorylation via NDR1/2 kinase activation and by binding to YAP, leading to its cytoplasmic sequestration.	[Irie, Kazuki; Nagai, Tomoaki; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Mol & Chem Life Sci, Sendai, Miyagi 9808578, Japan; [Mizuno, Kensaku] Tohoku Univ, Inst Liberal Arts & Sci, Sendai, Miyagi 9808576, Japan	Tohoku University; Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Mol & Chem Life Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp		Irie, Kazuki/0000-0002-7553-6948	MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research [15H04347, 18H02398]	MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research	This work was supported by MEXT/Japan Society for the Promotion of Science (JSPS) Grants for Scientific Research 15H04347 and 18H02398 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cong JL, 2001, DEVELOPMENT, V128, P2793; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hirata D, 2002, EMBO J, V21, P4863, DOI 10.1093/emboj/cdf495; Ikeda M, 2012, J BIOL CHEM, V287, P27670, DOI 10.1074/jbc.M112.378968; Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7781; Liu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01279; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nagai T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183030; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070930; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharif AAD, 2018, SEMIN CANCER BIOL, V48, P104, DOI 10.1016/j.semcancer.2017.04.010; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Xiong S, 2018, STRUCTURE, V26, P1101, DOI 10.1016/j.str.2018.05.014; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	41	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3017	3028		10.1074/jbc.RA119.010783	http://dx.doi.org/10.1074/jbc.RA119.010783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31996378	Green Published, hybrid			2022-12-28	WOS:000519597300012
J	Kawaguchi, M; Dashzeveg, N; Cao, Y; Jia, YZ; Liu, X; Shen, Y; Liu, HP				Kawaguchi, Madoka; Dashzeveg, Nurmaa; Cao, Yue; Jia, Yuzhi; Liu, Xia; Shen, Yang; Liu, Huiping			Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; metastasis; protein domain; protein-protein interaction; mutagenesis; homophilic interactions; circulating tumor cell; P21-activated kinase 2 (PAK2); machine learning; protein docking; cancer; cell-cell aggregation; tumor cell cluster	CANCER STEM-CELLS; GLYCOSYLATION; METASTASES; ADHESION; BINDING	CD44 molecule (CD44) is a well-known surface glycoprotein on tumor-initiating cells or cancer stem cells. However, its utility as a therapeutic target for managing metastases remains to be fully evaluated. We previously demonstrated that CD44 mediates homophilic interactions for circulating tumor cell (CTC) cluster formation, which enhances cancer stemness and metastatic potential in association with an unfavorable prognosis. Furthermore, CD44 self-interactions activate the P21-activated kinase 2 (PAK2) signaling pathway. Here, we further examined the biochemical properties of CD44 in homotypic tumor cell aggregation. The standard CD44 form (CD44s) mainly assembled as intercellular homodimers (trans-dimers) in tumor clusters rather than intracellular dimers (cis-dimers) present in single cells. Machine learning?based computational modeling combined with experimental mutagenesis tests revealed that the extracellular Domains I and II of CD44 are essential for its trans-dimerization and predicted high-score residues to be required for dimerization. Substitutions of 10 these residues in Domain I (Ser-45, Glu-48, Phe-74, Cys-77, Arg-78, Tyr-79, Ile-88, Arg-90, Asn-94, and Cys-97) or 5 residues in Domain II (Ile-106, Tyr-155, Val-156, Gln-157, and Lys-158) abolished CD44 dimerization and reduced tumor cell aggregation in vitro. Importantly, the substitutions in Domain II dramatically inhibited lung colonization in mice. The CD44 dimer-disrupting substitutions decreased downstream PAK2 activation without affecting the interaction between CD44 and PAK2, suggesting that PAK2 activation in tumor cell clusters is CD44 trans-dimer?dependent. These results shed critical light on the biochemical mechanisms of CD44-mediated tumor cell cluster formation and may help inform the development of therapeutic strategies to prevent tumor cluster formation and block cluster-mediated metastases.	[Kawaguchi, Madoka; Dashzeveg, Nurmaa; Jia, Yuzhi; Liu, Xia; Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Kawaguchi, Madoka] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto 6068501, Japan; [Cao, Yue; Shen, Yang] Texas A&M Univ, Dept Elect & Comp Engn, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA; [Liu, Xia] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Dept Med, Hematol Oncol Div, Chicago, IL 60611 USA; [Liu, Huiping] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Kyoto University; Texas A&M University System; Texas A&M University College Station; University of Kentucky; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Liu, X; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.; Shen, Y (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, TEES AgriLife Ctr Bioinformat & Genom Syst Engn, College Stn, TX 77843 USA.; Liu, X (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Hematol Oncol Div, Chicago, IL 60611 USA.; Liu, HP (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	xli369@uky.edu; YShen@tamu.edu; huiping.liu@northwestern.edu	Shen, Yang/A-7939-2012	Shen, Yang/0000-0002-1703-7796; Liu, Huiping/0000-0003-4822-7995	Susan G. Komen Foundation Grant [CCR18548501, CCR15332826]; American Cancer Society [ACS127951-RSG-15-025-01-CSM]; National Institutes of Health [1R01CA245699, R00CA160638, R35GM124952]; DHA, Department of Defense [W81XWH-16-1-0021]; Northwestern University Start-Up Grant	Susan G. Komen Foundation Grant(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHA, Department of Defense; Northwestern University Start-Up Grant	This work was supported by Susan G. KomenFoundation Grant CCR18548501 (to X. L.) and CCR15332826 (to H. L.); American Cancer Society Grant ACS127951-RSG-15-025-01-CSM (to H. L.); National Institutes of Health Grants 1R01CA245699 and R00CA160638 (to H. L.) and R35GM124952 (to Y. S.); DHA, Department of Defense Grant W81XWH-16-1-0021 (to H. L.); and Northwestern University Start-Up Grant (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the United States Government.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azevedo R, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-018-9198-9; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Cao Y., 2019, ARXIV190200067, DOI [10.1101/537035, DOI 10.1101/537035]; Chen HR, 2017, PROTEINS, V85, P544, DOI 10.1002/prot.25212; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gkountela S, 2019, CELL, V176, P98, DOI 10.1016/j.cell.2018.11.046; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Inoue K, 2015, GENET EPIGENETICS, V7, P19, DOI 10.4137/GEG.S35500; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu X, 2019, CANCER DISCOV, V9, P96, DOI 10.1158/2159-8290.CD-18-0065; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliwa T, 2015, BIOINFORMATICS, V31, P151, DOI 10.1093/bioinformatics/btv252; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prochazka L, 2014, CELL SIGNAL, V26, P2234, DOI 10.1016/j.cellsig.2014.07.011; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Slomiany MG, 2009, CLIN CANCER RES, V15, P7593, DOI 10.1158/1078-0432.CCR-09-2317; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang HH, 2019, GENE DEV, V33, P166, DOI 10.1101/gad.319889.118; ZHOU DFH, 1989, J IMMUNOL, V143, P3390; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	37	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2640	2649		10.1074/jbc.RA119.010252	http://dx.doi.org/10.1074/jbc.RA119.010252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31969394	Green Published, hybrid			2022-12-28	WOS:000519969100010
J	Li, J; Zhang, Y; Soubias, O; Khago, D; Chao, FA; Li, YF; Shaw, K; Byrd, RA				Li, Jess; Zhang, Yue; Soubias, Olivier; Khago, Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd, R. Andrew			Optimization of sortase A ligation for flexible engineering of complex protein systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sortase A; GTPase-activating protein (GAP); post-translational modification (PTM); cyclic peptide; protein engineering; cyclic proteins; lipidated proteins; nanodisc; segmental labeling; segmental labeling; sortase; protein tagging; protein ligation; SrtA; intrinsically disordered region; structural biology	STAPHYLOCOCCUS-AUREUS SORTASE; MOTILITY FACTOR-RECEPTOR; MEDIATED LIGATIONS; ARF FAMILY; GP78; ACTIVATION; INHIBITORS; DOMAIN; GENE	Engineering and bioconjugation of proteins is a critically valuable tool that can facilitate a wide range of biophysical and structural studies. The ability to orthogonally tag or label a domain within a multidomain protein may be complicated by undesirable side reactions to noninvolved domains. Furthermore, the advantages of segmental (or domain-specific) isotopic labeling for NMR, or deuteration for neutron scattering or diffraction, can be realized by an efficient ligation procedure. Common methods?expressed protein ligation, protein trans-splicing, and native chemical ligation?each have specific limitations. Here, we evaluated the use of different variants of Staphylococcus aureus sortase A for a range of ligation reactions and demonstrate that conditions can readily be optimized to yield high efficiency (i.e. completeness of ligation), ease of purification, and functionality in detergents. These properties may enable joining of single domains into multidomain proteins, lipidation to mimic posttranslational modifications, and formation of cyclic proteins to aid in the development of nanodisc membrane mimetics. We anticipate that the method for ligating separate domains into a single functional multidomain protein reported here may enable many applications in structural biology.	[Li, Jess; Zhang, Yue; Soubias, Olivier; Khago, Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd, R. Andrew] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, POB B,Bldg 538,Rm 110, Frederick, MD 21702 USA; [Li, Yifei] Fosun Pharmaceut Co Ltd, 1289 Yishan Rd, Shanghai, Peoples R China; [Shaw, Katherine] Apic Bio Inc, 700 Main St North, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Byrd, RA (corresponding author), NCI, Struct Biophys Lab, Ctr Canc Res, NIH, POB B,Bldg 538,Rm 110, Frederick, MD 21702 USA.	byrdra@mail.nih.gov	Li, Yifei/GYA-2567-2022; Byrd, R. Andrew/F-8042-2015	Byrd, R. Andrew/0000-0003-3625-4232; Chao, Fa-An/0000-0001-5215-8545; Soubias, Olivier/0000-0003-4819-2753; Khago, Domarin/0000-0001-5676-6804; Zhang, Yue/0000-0003-4367-4470; Li, Jess/0000-0001-7708-8555; Shaw, Katherine/0000-0001-7906-5672	Intramural Research Program of NCI, National Institutes of Health [ZIA BC 011419, ZIA BC 011131, ZIA BC 011132]	Intramural Research Program of NCI, National Institutes of Health	The research was supported by the Intramural Research Program of NCI, National Institutes of Health, Projects ZIA BC 011419, ZIA BC 011131, and ZIA BC 011132. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antos John M, 2017, Curr Protoc Protein Sci, V89, DOI 10.1002/cpps.38; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chakrabarti KS, 2017, STRUCTURE, V25, P794, DOI 10.1016/j.str.2017.03.016; Chan AH, 2013, CHEM BIOL DRUG DES, V82, P418, DOI 10.1111/cbdd.12167; Chao FA, 2019, J AM CHEM SOC, V141, P11881, DOI 10.1021/jacs.9b02602; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Chen JH, 2018, J MOL BIOL, V430, P2275, DOI 10.1016/j.jmb.2018.06.012; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31899; Chin JW, 2017, NATURE, V550, P53, DOI 10.1038/nature24031; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Freiburger L, 2015, J BIOMOL NMR, V63, P1, DOI 10.1007/s10858-015-9981-0; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hirakawa H, 2015, BIOTECHNOL J, V10, P1487, DOI 10.1002/biot.201500012; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Josts I, 2018, STRUCTURE, V26, P1072, DOI 10.1016/j.str.2018.05.007; Kobashigawa Y, 2009, J BIOMOL NMR, V43, P145, DOI 10.1007/s10858-008-9296-5; Li YF, 2019, BIOCHEMISTRY-US, V58, P1423, DOI 10.1021/acs.biochem.8b01323; Liu S, 2012, STRUCTURE, V20, P2138, DOI 10.1016/j.str.2012.09.020; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Mejuch T, 2016, BIOCONJUGATE CHEM, V27, P1771, DOI 10.1021/acs.bioconjchem.6b00261; Michel E, 2015, METHOD ENZYMOL, V565, P389, DOI 10.1016/bs.mie.2015.05.028; Miehling J, 2018, CHEMBIOCHEM, V19, P1927, DOI 10.1002/cbic.201800345; Mikula KM, 2018, J BIOMOL NMR, V71, P225, DOI 10.1007/s10858-018-0175-4; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nasr ML, 2017, NAT METHODS, V14, P49, DOI [10.1038/NMETH.4079, 10.1038/nmeth.4079]; Nikghalb KD, 2018, CHEMBIOCHEM, V19, P185, DOI 10.1002/cbic.201700517; Nikic I, 2015, NAT PROTOC, V10, P780, DOI 10.1038/nprot.2015.045; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Raltchev K, 2018, CHEM-EUR J, V24, P5493, DOI 10.1002/chem.201800812; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Refaei MA, 2011, J BIOMOL NMR, V49, P3, DOI 10.1007/s10858-010-9464-2; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Row RD, 2015, CHEM COMMUN, V51, P12548, DOI 10.1039/c5cc04657b; Sakamoto S, 2019, ANAL SCI, V35, P5, DOI 10.2116/analsci.18R003; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Spicer CD, 2013, CHEM COMMUN, V49, P2747, DOI 10.1039/c3cc38824g; Spicer CD, 2012, J AM CHEM SOC, V134, P800, DOI 10.1021/ja209352s; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Williams FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154607; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o	58	18	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2664	2675		10.1074/jbc.RA119.012039	http://dx.doi.org/10.1074/jbc.RA119.012039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31974162	hybrid, Green Published			2022-12-28	WOS:000519969100012
J	Pascolutti, R; Erlandson, SC; Burri, DJ; Zheng, S; Kruse, AC				Pascolutti, Roberta; Erlandson, Sarah C.; Burri, Dominique J.; Zheng, Sanduo; Kruse, Andrew C.			Mapping and engineering the interaction between adiponectin and T-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; crystallography; protein engineering; cadherin; adipokine	MOLECULAR-WEIGHT ADIPONECTIN; CONSERVED LYSINE RESIDUES; CELL-ADHESION MOLECULE; YEAST SURFACE DISPLAY; COLLAGENOUS DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; RECEPTOR; PLASMA; ACRP30/ADIPONECTIN	Adiponectin is a highly abundant protein hormone secreted by adipose tissue. It elicits diverse biological responses, including anti-diabetic, anti-inflammatory, anti-tumor, and anti-atherosclerotic effects. Adiponectin consists of a globular domain and a collagen-like domain, and it occurs in three major oligomeric forms that self-assemble: trimers, hexamers, and high-molecular-weight oligomers. Adiponectin has been reported to bind to two seven-transmembrane domain receptors, AdipoR1 and AdipoR2, as well as to the protein T-cadherin, which is highly expressed in the cardiovascular system and binds only the high-molecular-weight form of adiponectin. The molecular mechanisms underlying this specificity remain unclear. Here we used a combination of X-ray crystallography and protein engineering to define the details of adiponectin's interaction with T-cadherin. We found that T-cadherin binds to the globular domain of adiponectin, relying on structural stabilization of this domain by bound metal ions. Moreover, we show that the adiponectin globular domain can be engineered to enhance its binding affinity for T-cadherin. These results help to define the molecular basis for the interaction between adiponectin and T-cadherin, and our engineered globular domain variants may be useful tools for further investigating adiponectin's functions.	[Pascolutti, Roberta; Erlandson, Sarah C.; Zheng, Sanduo; Kruse, Andrew C.] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Burri, Dominique J.] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA; [Zheng, Sanduo] Natl Inst Biol Sci Beijing, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institute of Biological Sciences, Beijing	Kruse, AC (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	andrew_kruse@hms.harvard.edu		Kruse, Andrew/0000-0002-1467-1222	National Institutes of Health [DP5OD021345]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant DP5OD021345 (to A. C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Fukuda S, 2017, J BIOL CHEM, V292, P7840, DOI 10.1074/jbc.M117.780734; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Inoue T, 2007, AM J CARDIOL, V100, P569, DOI 10.1016/j.amjcard.2007.03.062; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kita S, 2019, ELIFE, V8, DOI 10.7554/eLife.48675; Koenen TB, 2008, BIOCHEM BIOPH RES CO, V376, P164, DOI 10.1016/j.bbrc.2008.08.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; REID KBM, 1982, BIOCHEM J, V203, P559, DOI 10.1042/bj2030559; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Richards AA, 2010, MOL ENDOCRINOL, V24, P229, DOI 10.1210/me.2009-0133; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sjodt M, 2018, NATURE, V556, P118, DOI 10.1038/nature25985; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wilson DS., 2000, CURRENT PROTOCOLS MO, V51, DOI DOI 10.1002/0471142727.MB0803S51; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Ye J, 2019, ADIPONECTIN RELATED, V117, DOI [10.1101/776690, DOI 10.1101/776690]; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	51	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2749	2759		10.1074/jbc.RA119.010970	http://dx.doi.org/10.1074/jbc.RA119.010970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31915248	Green Published, hybrid			2022-12-28	WOS:000519969100019
J	Koendjbiharie, JG; Hon, S; Pabst, M; Hooftman, R; Stevenson, DM; Cui, JX; Amador-Noguez, D; Lynd, LR; Olson, DG; van Kranenburg, R				Koendjbiharie, Jeroen G.; Hon, Shuen; Pabst, Martin; Hooftman, Robert; Stevenson, David M.; Cui, Jingxuan; Amador-Noguez, Daniel; Lynd, Lee R.; Olson, Daniel G.; van Kranenburg, Richard			The pentose phosphate pathway of cellulolytic clostridia relies on 6-phosphofructokinase instead of transaldolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pentose phosphate pathway (PPP); phosphofructokinase; mass spectrometry (MS); enzyme kinetics; bacterial metabolism; Clostridium thermocellum; Clostridium thermosuccinogenes; pyrophosphate; sedoheptulose 1; 7-bisphosphate; transaldolase	DEPENDENT 6-PHOSPHOFRUCTOKINASES; PHOSPHOFRUCTOKINASE; ALDOLASE; GLYCOLYSIS; OXIDATION; KINASE	The genomes of most cellulolytic clostridia do not contain genes annotated as transaldolase. Therefore, for assimilating pentose sugars or for generating C-5 precursors (such as ribose) during growth on other (non-C-5) substrates, they must possess a pathway that connects pentose metabolism with the rest of metabolism. Here we provide evidence that for this connection cellulolytic clostridia rely on the sedoheptulose 1,7-bisphosphate (SBP) pathway, using pyrophosphate-dependent phosphofructokinase (PPi-PFK) instead of transaldolase. In this reversible pathway, PFK converts sedoheptulose 7-phosphate (S7P) to SBP, after which fructose-bisphosphate aldolase cleaves SBP into dihydroxyacetone phosphate and erythrose 4-phosphate. We show that PPi-PFKs of Clostridium thermosuccinogenes and Clostridium thermocellum indeed can convert S7P to SBP, and have similar affinities for S7P and the canonical substrate fructose 6-phosphate (F6P). By contrast, (ATP-dependent) PfkA of Escherichia coli, which does rely on transaldolase, had a very poor affinity for S7P. This indicates that the PPi-PFK of cellulolytic clostridia has evolved the use of S7P. We further show that C. thermosuccinogenes contains a significant SBP pool, an unusual metabolite that is elevated during growth on xylose, demonstrating its relevance for pentose assimilation. Last, we demonstrate that a second PFK of C. thermosuccinogenes that operates with ATP and GTP exhibits unusual kinetics toward F6P, as it appears to have an extremely high degree of cooperative binding, resulting in a virtual on/off switch for substrate concentrations near its K-? value. In summary, our results confirm the existence of an SBP pathway for pentose assimilation in cellulolytic clostridia.	[Koendjbiharie, Jeroen G.; van Kranenburg, Richard] Corbion, NL-4206 AC Gorinchem, Netherlands; [Hon, Shuen; Lynd, Lee R.; Olson, Daniel G.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Hon, Shuen; Cui, Jingxuan; Amador-Noguez, Daniel; Lynd, Lee R.; Olson, Daniel G.] Oak Ridge Natl Lab, Ctr Bioenergy Innovat, Oak Ridge, TN 37830 USA; [Pabst, Martin] Delft Univ Technol, Cell Syst Engn, NL-2629 HZ Delft, Netherlands; [Hooftman, Robert; van Kranenburg, Richard] Wageningen Univ & Res, Microbiol Lab, NL-6708 WE Wageningen, Netherlands; [Stevenson, David M.; Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Cui, Jingxuan; Lynd, Lee R.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; United States Department of Energy (DOE); Oak Ridge National Laboratory; Delft University of Technology; Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison; Dartmouth College	van Kranenburg, R (corresponding author), Corbion, NL-4206 AC Gorinchem, Netherlands.; van Kranenburg, R (corresponding author), Wageningen Univ & Res, Microbiol Lab, NL-6708 WE Wageningen, Netherlands.	richard.van.kranenburg@corbion.com	Olson, Daniel/F-2058-2011; Koendjbiharie, Jeroen Girwar/AIF-4314-2022; Pabst, Martin/GOH-1766-2022; Lynd, Lee R/N-1260-2013	Olson, Daniel/0000-0001-5393-6302; Koendjbiharie, Jeroen Girwar/0000-0001-9047-8507; Pabst, Martin/0000-0001-9897-0723; Lynd, Lee R/0000-0002-5642-668X; Hon, Shuen/0000-0003-2146-0105; van Kranenburg, Richard/0000-0001-5856-1546	European Union Marie Sklodowska-Curie Innovative Training Networks (ITN) [642068]	European Union Marie Sklodowska-Curie Innovative Training Networks (ITN)	This work was supported by European Union Marie Sklodowska-Curie Innovative Training Networks (ITN) Contract 642068 (to J. G. K.) Lee R. Lynd is a founder of Enchi Corporation, which has a financial interest in C. thermocellum.	Alves AMCR, 2001, J BACTERIOL, V183, P7231, DOI 10.1128/JB.183.24.7231-7240.2001; Bapteste E, 2003, GENE, V318, P185, DOI 10.1016/S0378-1119(03)00797-2; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; Dash S, 2019, METAB ENG, V55, P161, DOI 10.1016/j.ymben.2019.06.006; Dash S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0792-2; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; KARADSHEH NS, 1973, BIOCHIM BIOPHYS ACTA, V327, P66, DOI 10.1016/0005-2744(73)90104-6; Khmelenina VN, 2011, METHOD ENZYMOL, P1, DOI 10.1016/B978-0-12-386905-0.00001-2; Koeck DE, 2016, J BIOTECHNOL, V237, P35, DOI 10.1016/j.jbiotec.2016.08.020; Koendjbiharie JG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01162; Koendjbiharie JG, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00363-18; LAMED R, 1980, J BACTERIOL, V144, P569, DOI 10.1128/JB.144.2.569-578.1980; Liu LX, 2012, J BACTERIOL, V194, P5413, DOI 10.1128/JB.00713-12; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B; Munir RI, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0711-x; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Olson DG, 2017, METAB ENG, V39, P169, DOI 10.1016/j.ymben.2016.11.011; Olson W.J., 2018, DUAL METABOLOMIC PRO, DOI DOI 10.1101/463075; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Plugge CM, 2005, METHOD ENZYMOL, V397, P3, DOI 10.1016/S0076-6879(05)97001-8; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Rozova ON, 2012, BIOCHEMISTRY-MOSCOW+, V77, P288, DOI 10.1134/S0006297912030078; Rydzak T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-214; Sander K, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0960-4; Sato S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-51; Sautner V, 2015, BIOCHEMISTRY-US, V54, P4475, DOI 10.1021/acs.biochem.5b00283; Schatschneider S, 2018, ANAL CHEM, V90, P4470, DOI 10.1021/acs.analchem.7b04758; Schellenberg JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-567; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; Sharma A., 2019, EL MAVEN, DOI [10.5281/zendo.3583792, DOI 10.5281/ZENDO.3583792]; Sund CJ, 2015, MICROBIOL-SGM, V161, P430, DOI 10.1099/mic.0.000008; SUSSKIND BM, 1982, BIOCHEM J, V204, P191, DOI 10.1042/bj2040191; Suzuki R, 2010, J BIOL CHEM, V285, P34279, DOI 10.1074/jbc.M110.156281; Tian L, 2016, APPL ENVIRON MICROB, V82, P7134, DOI 10.1128/AEM.02130-16; Tindall BJ, 2019, INT J SYST EVOL MICR, V69, P3927, DOI 10.1099/ijsem.0.003685; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; WEIMBERG R, 1961, J BIOL CHEM, V236, P629; Xiong W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.187, 10.1038/nplants.2015.187]; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zhang X, 2018, INT J SYST EVOL MICR, V68, P3197, DOI 10.1099/ijsem.0.002966; Zhou JL, 2013, APPL ENVIRON MICROB, V79, P3000, DOI 10.1128/AEM.04037-12	46	10	10	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1867	1878		10.1074/jbc.RA119.011239	http://dx.doi.org/10.1074/jbc.RA119.011239			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31871051	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000517128200008
J	Kowalsky, AH; Namkoong, S; Mettetal, E; Park, HW; Kazyken, D; Fingar, DC; Lee, JH				Kowalsky, Allison Ho; Namkoong, Sim; Mettetal, Eric; Park, Hwan-Woo; Kazyken, Dubek; Fingar, Diane C.; Lee, Jun Hee			The GATOR2?mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); Akt PKB; signal transduction; liver metabolism; insulin resistance	INSULIN-RESISTANCE; INHIBIT MTORC1; SESTRINS; COMPLEX; METABOLISM; AKT/PKB; TSC2; PHOSPHORYLATION; REGULATOR; RAPAMYCIN	Sestrins represent a family of stress-inducible proteins that prevent the progression of many age- and obesity-associated disorders. Endogenous Sestrins maintain insulin-dependent AKT Ser/Thr kinase (AKT) activation during high-fat diet?induced obesity, and overexpressed Sestrins activate AKT in various cell types, including liver and skeletal muscle cells. Although Sestrin-mediated AKT activation improves metabolic parameters, the mechanistic details underlying such improvement remain elusive. Here, we investigated how Sestrin2, the Sestrin homolog highly expressed in liver, induces strong AKT activation. We found that two known targets of Sestrin2, mTOR complex (mTORC) 1 and AMP-activated protein kinase, are not required for Sestrin2-induced AKT activation. Rather, phosphoinositol 3-kinase and mTORC2, kinases upstream of AKT, were essential for Sestrin2-induced AKT activation. Among these kinases, mTORC2 catalytic activity was strongly up-regulated upon Sestrin2 overexpression in an in vitro kinase assay, indicating that mTORC2 may represent the major link between Sestrin2 and AKT. As reported previously, Sestrin2 interacted with mTORC2; however, we found here that this interaction occurs indirectly through GATOR2, a pentameric protein complex that directly interacts with Sestrin2. Deleting or silencing WDR24 (WD repeat domain 24), the GATOR2 component essential for the Sestrin2?GATOR2 interaction, or WDR59, the GATOR2 component essential for the GATOR2?mTORC2 interaction, completely ablated Sestrin2-induced AKT activation. We also noted that Sestrin2 also directly binds to the pleckstrin homology domain of AKT and induces AKT translocation to the plasma membrane. These results uncover a signaling mechanism whereby Sestrin2 activates AKT through GATOR2 and mTORC2.	[Kowalsky, Allison Ho; Namkoong, Sim; Mettetal, Eric; Park, Hwan-Woo; Lee, Jun Hee] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kazyken, Dubek; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Namkoong, Sim] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 24341, Gangwon, South Korea; [Park, Hwan-Woo] Konyang Univ, Coll Med, Dept Cell Biol, Myunggok Med Res Inst, Daejeon 35365, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kangwon National University; Konyang University	Lee, JH (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leeju@umich.edu	Park, Hwan-Woo/D-2358-2014	Park, Hwan-Woo/0000-0001-8029-2004; Lee, Jun Hee/0000-0002-2200-6011; Kazyken, Dubek/0000-0001-8530-3390	National Institutes of Health [R01DK102850, R01DK111465, T32GM008322, T32AG000114, F31DK117610, P30AG024824, P30AR069620, P30DK034933, P30DK089503, P30CA046592]; University of Michigan through the Dean's Organogenesis Fellowship; University of Michigan through Biomedical and Life Science Summer Fellowship; University of Michigan through MCubed Scholar Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan through the Dean's Organogenesis Fellowship; University of Michigan through Biomedical and Life Science Summer Fellowship; University of Michigan through MCubed Scholar Fellowship	This work was supported by National Institutes of Health Grants R01DK102850 and R01DK111465 (to J. H. L.); T32GM008322, T32AG000114, and F31DK117610 (to A. H. K.); and P30AG024824, P30AR069620, P30DK034933, P30DK089503, and P30CA046592. This work was also supported by the University of Michigan through the Dean's Organogenesis Fellowship (to S. N.) and the Biomedical and Life Science Summer Fellowship and MCubed Scholar Fellowship (to E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Dai JM, 2018, CANCER MED-US, V7, P5691, DOI 10.1002/cam4.1826; Deng WB, 2016, J CLIN INVEST, V126, P2941, DOI 10.1172/JCI87715; Ehninger D, 2014, CELL MOL LIFE SCI, V71, P4325, DOI 10.1007/s00018-014-1677-1; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Ho A, 2016, TRENDS BIOCHEM SCI, V41, P621, DOI 10.1016/j.tibs.2016.04.005; Horbinski C, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-2; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2012, METHODS MOL BIOL, V821, P75, DOI 10.1007/978-1-61779-430-8_6; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang MH, 2020, HEPATOLOGY, V71, P76, DOI 10.1002/hep.30820; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Kim M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13442-5; Kim M, 2015, INT J MOL SCI, V16, P7015, DOI 10.3390/ijms16047015; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Segales J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13832-9; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang Li-Ping, 2003, Methods Mol Med, V83, P127; Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011; Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397	50	22	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1769	1780		10.1074/jbc.RA119.010857	http://dx.doi.org/10.1074/jbc.RA119.010857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915252	Green Published, hybrid			2022-12-28	WOS:000517128200001
J	Hans, F; Glasebach, H; Kahle, PJ				Hans, Friederike; Glasebach, Hanna; Kahle, Philipp J.			Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); ubiquitylation (ubiquitination); protein aggregation; RNA splicing; stress granule; oxidative stress; protein kinase; signal transduction; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); frontotemporal dementia; osmotic shock	DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA; 43 KDA; SARCOMA FUS; RECRUITMENT; MODULATION; MUTATIONS; INSIGHTS	Insoluble, hyperubiquitylated TAR DNA-binding protein of 43 kDa (TDP-43) in the central nervous system characterizes frontotemporal dementia and ALS in many individuals with these neurodegenerative diseases. The causes for neuropathological TDP-43 aggregation are unknown, but it has been suggested that stress granule (SG) formation is important in this process. Indeed, in human embryonic kidney HEK293E cells, various SG-forming conditions induced very strong TDP-43 ubiquitylation, insolubility, and reduced splicing activity. Osmotic stress?induced SG formation and TDP-43 ubiquitylation occurred rapidly and coincided with colocalization of TDP-43 and SG markers. Washout experiments confirmed the rapid dissolution of SGs, accompanied by normalization of TDP-43 ubiquitylation and solubility. Surprisingly, interference with the SG process using a protein kinase R?like endoplasmic reticulum kinase inhibitor (GSK2606414) or the translation blocker emetine did not prevent TDP-43 ubiquitylation and insolubility. Thus, parallel pathways may lead to pathological TDP-43 modifications independent of SG formation. Using a panel of kinase inhibitors targeting signaling pathways of the osmotic shock inducer sorbitol, we could largely rule out the stress-activated and extracellular signal?regulated protein kinase modules and glycogen synthase kinase 3?. For arsenite, but not for sorbitol, quenching oxidative stress with N-acetylcysteine did suppress both SG formation and TDP-43 ubiquitylation and insolubility. Thus, sodium arsenite appears to promote SG formation and TDP-43 modifications via oxidative stress, but sorbitol stimulates TDP-43 ubiquitylation and insolubility via a novel pathway(s) independent of SG formation. In conclusion, pathological TDP-43 modifications can be mediated via multiple distinct pathways for which SGs are not essential.	[Hans, Friederike; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Glasebach, Hanna; Kahle, Philipp J.] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, Dept Neurodegenerat, German Ctr Neurodegenerat Dis, Otfried Muller Str 27, D-72076 Tubingen, Germany.; Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Fac Med, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de		Kahle, Philipp/0000-0002-8587-1731	NOMIS Foundation; German Research Foundation (DFG) [KA1675/3-2]; German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	NOMIS Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	This work was supported by the NOMIS Foundation, German Research Foundation (DFG) Grant KA1675/3-2, the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, and the Hertie Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00423, 10.3389/fncel.2015.00423]; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bounedjah O, 2012, J BIOL CHEM, V287, P2446, DOI 10.1074/jbc.M111.292748; Brocker Chad, 2012, Biomol Concepts, V3, P345; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Chew J, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0310-z; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dardis A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0325-4; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamann I, 2013, REDOX BIOL, V1, P104, DOI 10.1016/j.redox.2012.11.010; Hans F, 2018, J BIOL CHEM, V293, P16083, DOI 10.1074/jbc.RA118.003440; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; Hock EM, 2018, CELL REP, V24, P987, DOI 10.1016/j.celrep.2018.06.094; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jo M, 2019, BIOCHEM BIOPH RES CO, V513, P925, DOI 10.1016/j.bbrc.2019.04.088; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Lee YC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0479-4; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Mackenzie IRA, 2016, J NEUROCHEM, V138, P54, DOI 10.1111/jnc.13588; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mann JR, 2019, NEURON, V102, P321, DOI 10.1016/j.neuron.2019.01.048; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; Mihevc SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33996; Moujalled D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067433; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pena-Oyarzun D, 2017, ONCOTARGET, V8, P55984, DOI 10.18632/oncotarget.18995; Plescher M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13828; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ryu HW, 2017, CELL STRESS CHAPERON, V22, P253, DOI 10.1007/s12192-017-0763-3; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wobst HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177181; Wolozin B, 2019, NEURON, V102, P265, DOI 10.1016/j.neuron.2019.03.041; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yuan HX, 2015, GENE DEV, V29, P2362, DOI 10.1101/gad.265116.115; Zhang PP, 2019, ELIFE, V8, DOI 10.7554/eLife.39578; Zhou XY, 2016, BBA-GEN SUBJECTS, V1860, P2037, DOI 10.1016/j.bbagen.2016.05.032	69	19	19	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					673	689		10.1074/jbc.RA119.010617	http://dx.doi.org/10.1074/jbc.RA119.010617			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31780563	Green Published, hybrid			2022-12-28	WOS:000508382900001
J	Buhrke, D; Gourinchas, G; Muller, M; Michael, N; Hildebrandt, P; Winkler, A				Buhrke, David; Gourinchas, Geoffrey; Mueller, Melanie; Michael, Norbert; Hildebrandt, Peter; Winkler, Andreas			Distinct chromophore?protein environments enable asymmetric activation of a bacteriophytochrome-activated diguanylate cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; allosteric regulation; cyclic di-GMP (c-di-GMP); crystallography; infrared spectroscopy (IR spectroscopy); asymmetry; GGDEF; photoconversion; phytochrome; symmetry	RESONANCE RAMAN ANALYSIS; PHYTOCHROME AGP1; PFR STATE; FTIR; HETEROGENEITY; SPECTROSCOPY; REVEALS; BATHY; PHOTOCONVERSION; MECHANISM	Sensing of red and far-red light by bacteriophytochromes involves intricate interactions between their bilin chromophore and the protein environment. The light-triggered rearrangements of the cofactor configuration and eventually the protein conformation enable bacteriophytochromes to interact with various protein effector domains for biological modulation of diverse physiological functions. Excitation of the holoproteins by red or far-red light promotes the photoconversion to their far-red light?absorbing Pfr state or the red light-absorbing Pr state, respectively. Because prototypical bacteriophytochromes have a parallel dimer architecture, it is generally assumed that symmetric activation with two Pfr state protomers constitutes the signaling-active species. However, the bacteriophytochrome from Idiomarina species A28L (IsPadC) has recently been reported to enable long-range signal transduction also in asymmetric dimers containing only one Pfr protomer. By combining crystallography, hydrogen?deuterium exchange coupled to MS, and vibrational spectroscopy, we show here that Pfr of IsPadC is in equilibrium with an intermediate ?Pfr-like? state that combines features of Pfr and Meta-R states observed in other bacteriophytochromes. We also show that structural rearrangements in the N-terminal segment (NTS) can stabilize this Pfr-like state and that the PHY-tongue conformation of IsPadC is partially uncoupled from the initial changes in the NTS. This uncoupling enables structural asymmetry of the overall homodimeric assembly and allows signal transduction to the covalently linked physiological diguanylate cyclase output module in which asymmetry might play a role in the enzyme-catalyzed reaction. The functional differences to other phytochrome systems identified here highlight opportunities for using additional red-light sensors in artificial sensor?effector systems.	[Buhrke, David; Michael, Norbert; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, Sekr PC14,Str 17 Juni 135, D-10623 Berlin, Germany; [Gourinchas, Geoffrey; Winkler, Andreas] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Mueller, Melanie] Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany; [Winkler, Andreas] BioTechMed Graz, A-8010 Graz, Austria	Technical University of Berlin; Graz University of Technology; Max Planck Society	Buhrke, D (corresponding author), Tech Univ Berlin, Inst Chem, Sekr PC14,Str 17 Juni 135, D-10623 Berlin, Germany.; Winkler, A (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.; Winkler, A (corresponding author), BioTechMed Graz, A-8010 Graz, Austria.	david.buhrke@campus.tu-berlin.de; andreas.winkler@tugraz.at	Buhrke, David/HDO-6394-2022; Hildebrandt, Peter/J-5658-2014; Gourinchas, Geoffrey/AAF-7377-2021; Gourinchas, Geoffrey/D-1277-2017	Hildebrandt, Peter/0000-0003-1030-5900; Gourinchas, Geoffrey/0000-0003-2543-3518; Buhrke, David/0000-0003-0294-9183; Winkler, Andreas/0000-0001-6221-9671	Project CALIPSOplus under EU Framework Programme for Research and Innovation HORIZON 2020 [730872]; Austrian Science Fund through the Ph.D. Program "DK Molecular Enzymology"; Austrian Science Fund (FWF) [P32022]; Deutsche Forschungsgemeinschaft [SFB1078 (B6)]; Cluster of Excellence "UniSysCat	Project CALIPSOplus under EU Framework Programme for Research and Innovation HORIZON 2020; Austrian Science Fund through the Ph.D. Program "DK Molecular Enzymology"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "UniSysCat	This work was supported by Project CALIPSOplus under Grant Agreement 730872 from the EU Framework Programme for Research and Innovation HORIZON 2020 and parts of this work were supported by the Austrian Science Fund through the Ph.D. Program "DK Molecular Enzymology" (to G. G.) and by the Austrian Science Fund (FWF) P32022 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Deutsche Forschungsgemeinschaft Grant SFB1078 (B6) and the Cluster of Excellence "UniSysCat."	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Anders K, 2015, CURR OPIN STRUC BIOL, V35, P7, DOI 10.1016/j.sbi.2015.07.005; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Buhrke D, 2018, CHEMPHYSCHEM, V19, P566, DOI 10.1002/cphc.201701311; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; EILFELD P, 1985, Z NATURFORSCH C, V40, P109; Escobar FV, 2017, PHOTOCHEM PHOTOBIOL, V93, P724, DOI 10.1111/php.12742; Escobar FV, 2017, J PHYS CHEM B, V121, P47, DOI 10.1021/acs.jpcb.6b09600; Escobar FV, 2015, NAT CHEM, V7, P423, DOI [10.1038/NCHEM.2225, 10.1038/nchem.2225]; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gourinchas G, 2019, CURR OPIN STRUC BIOL, V57, P72, DOI 10.1016/j.sbi.2019.02.005; Gourinchas G, 2019, J BIOL CHEM, V294, P4498, DOI 10.1074/jbc.RA118.007260; Gourinchas G, 2018, ELIFE, V7, DOI 10.7554/eLife.34815; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Hallberg ZF, 2019, ELIFE, V8, DOI 10.7554/eLife.43959; Hao YX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11930-2; HILDEBRANDT P, 1992, BIOCHEMISTRY-US, V31, P7957, DOI 10.1021/bi00149a029; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim PW, 2014, BIOCHEMISTRY-US, V53, P4601, DOI 10.1021/bi5005359; Kirpich JS, 2018, J PHYS CHEM LETT, V9, P3454, DOI 10.1021/acs.jpclett.8b01133; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lim S, 2018, P NATL ACAD SCI USA, V115, P4387, DOI 10.1073/pnas.1720682115; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu JK, 2017, ELIFE, V6, DOI 10.7554/eLife.26985; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nagano S, 2016, J BIOL CHEM, V291, P20674, DOI 10.1074/jbc.M116.739136; Nieder JB, 2009, J AM CHEM SOC, V131, P69, DOI 10.1021/ja8058292; Piwowarski P, 2010, CHEMPHYSCHEM, V11, P1207, DOI 10.1002/cphc.200901008; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Salewski J, 2013, J BIOL CHEM, V288, P16800, DOI 10.1074/jbc.M113.457531; Schmidt A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07392-7; Schwinte P, 2008, BIOPHYS J, V95, P1256, DOI 10.1529/biophysj.108.131441; Spillane KM, 2009, J AM CHEM SOC, V131, P13946, DOI 10.1021/ja905822m; Stensitzki T, 2017, PHOTOCHEM PHOTOBIOL, V93, P703, DOI 10.1111/php.12743; Stojkovic EA, 2014, J PHYS CHEM LETT, V5, P2512, DOI 10.1021/jz501189t; Takala H, 2018, J BIOL CHEM, V293, P8161, DOI 10.1074/jbc.RA118.001794; Takala H, 2016, STRUCT DYNAM-US, V3, DOI 10.1063/1.4961911; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Takiden A, 2017, PHOTOCHEM PHOTOBIOL, V93, P713, DOI 10.1111/php.12737; THUMMLER F, 1981, Z NATURFORSCH C, V36, P440; van Thor JJ, 2005, J PHYS CHEM B, V109, P20597, DOI 10.1021/jp052323t; Velazquez Escobar F. J, 2015, THESIS; von Stetten D., 2008, THESIS; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200	53	9	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					539	551		10.1074/jbc.RA119.011915	http://dx.doi.org/10.1074/jbc.RA119.011915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31801828	Green Published, hybrid			2022-12-28	WOS:000507373600022
J	McNamar, R; Abu-Adas, Z; Rothblum, K; Knutson, BA; Rothblum, LI				McNamar, Rachel; Abu-Adas, Zakaria; Rothblum, Katrina; Knutson, Bruce A.; Rothblum, Lawrence, I			Conditional depletion of the RNA polymerase I subunit PAF53 reveals that it is essential for mitosis and enables identification of functional domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						auxin; nucleolus; RNA polymerase I; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); DNA-binding protein	SACCHAROMYCES-CEREVISIAE ENCODES; RIBOSOMAL DNA-TRANSCRIPTION; GROWTH-DEPENDENT REGULATION; CELL-CYCLE; TIF-IA; RDNA TRANSCRIPTION; FACTOR UBF; PREINITIATION COMPLEX; PROTEIN-STRUCTURE; A49 SUBUNIT	Our knowledge of the mechanism of rDNA transcription has benefited from the combined application of genetic and biochemical techniques in yeast. Nomura's laboratory (Nogi, Y., Vu, L., and Nomura, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 7026?7030 and Nogi, Y., Yano, R., and Nomura, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 3962?3966) developed a system in yeast to identify genes essential for ribosome biogenesis. Such systems have allowed investigators to determine whether a gene was essential and to determine its function in rDNA transcription. However, there are significant differences in both the structures and components of the transcription apparatus and the patterns of regulation between mammals and yeast. Thus, there are significant deficits in our understanding of mammalian rDNA transcription. We have developed a system combining CRISPR/Cas9 and an auxin-inducible degron that enables combining a ?genetics-like?approach with biochemistry to study mammalian rDNA transcription. We now show that the mammalian orthologue of yeast RPA49, PAF53, is required for rDNA transcription and mitotic growth. We have studied the domains of the protein required for activity. We have found that the C-terminal, DNA-binding domain (tandem-winged helix), the heterodimerization, and the linker domain were essential. Analysis of the linker identified a putative helix?turn?helix (HTH) DNA-binding domain. This HTH constitutes a second DNA-binding domain within PAF53. The HTH of the yeast and mammalian orthologues is essential for function. In summary, we show that an auxin-dependent degron system can be used to rapidly deplete nucleolar proteins in mammalian cells, that PAF53 is necessary for rDNA transcription and cell growth, and that all three PAF53 domains are necessary for its function.	[McNamar, Rachel; Abu-Adas, Zakaria; Rothblum, Katrina; Rothblum, Lawrence, I] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Knutson, Bruce A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Rothblum, LI (corresponding author), Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA.	Irothblu@ouhsc.edu		McNamar, Rachel/0000-0001-5422-5617	National Institutes of Health [GM069841, HL077814, 5R03DE027785]; OCAST Grant [HR15-166]; Carol Baldwin Research Foundation; University of Oklahoma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE027785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST Grant; Carol Baldwin Research Foundation; University of Oklahoma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants GM069841 (to L. I. R.), HL077814 (to L. I. R.), and 5R03DE027785 (to B. A. K.), OCAST Grant HR15-166 (to L. I. R.), the Carol Baldwin Research Foundation (to B. A. K.), and by the University of Oklahoma (to L. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Albert B, 2016, MOL CELL, V64, P720, DOI 10.1016/j.molcel.2016.10.003; Aprikian P, 2001, MOL CELL BIOL, V21, P4847, DOI 10.1128/MCB.21.15.4847-4855.2001; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bertomeu T, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00302-17; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bier M, 2004, FEBS LETT, V564, P41, DOI 10.1016/S0014-5793(04)00311-4; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; BUSCH H, 1963, CANCER RES, V23, P313; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cavanaugh AH, 2008, GENE EXPRESSION, V14, P131; Chedin S, 2007, CELL CYCLE, V6, P11, DOI 10.4161/cc.6.1.3649; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Farley-Barnes KI, 2018, CELL REP, V22, P1923, DOI 10.1016/j.celrep.2018.01.056; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Filby A, 2016, METHODS MOL BIOL, P71, DOI 10.1007/978-1-4939-3302-0_5; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Green MR, 2012, MOL CLONING LAB MANU, V1; Hamdane N, 2015, ONCOTARGET, V6, P27519, DOI 10.18632/oncotarget.4823; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130, DOI 10.1152/ajpcell.1998.275.1.C130; Hannan KM, 1998, FRONT BIOSCI, V3, P376, DOI [10.2741/A282, DOI 10.2741/A282]; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; Hannan RD, 2013, EXPERT OPIN THER TAR, V17, P873, DOI 10.1517/14728222.2013.818658; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; Hirschler-Laszkiewicz I, 2003, J BIOL CHEM, V278, P18953, DOI 10.1074/jbc.M301093200; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Hu T, 2009, BIOTECHNOL LETT, V31, P353, DOI 10.1007/s10529-008-9882-3; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; Hung SS, 2017, GENE, V612, P36, DOI 10.1016/j.gene.2016.12.015; Jackobel AJ, 2018, TRANSCR-AUSTIN, V9, P255, DOI 10.1080/21541264.2017.1416268; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Keys DA, 1996, GENE DEV, V10, P887, DOI 10.1101/gad.10.7.887; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Ma HH, 2013, MOL BIOL CELL, V24, P1334, DOI 10.1091/mbc.E12-12-0881; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Montgomery T. S. H., 1898, J MORPHOL, V15, P265, DOI DOI 10.1002/JMOR.1050150204; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; Morgado-Palacin L, 2014, CARCINOGENESIS, V35, P2822, DOI 10.1093/carcin/bgu220; Nakagawa K, 2003, GENES GENET SYST, V78, P199, DOI 10.1266/ggs.78.199; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Penrod Y, 2015, GENE, V556, P61, DOI 10.1016/j.gene.2014.09.022; Penrod Y, 2012, BIOCHEMISTRY-US, V51, P6519, DOI 10.1021/bi300408q; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Philippi A, 2010, NUCLEIC ACIDS RES, V38, P5315, DOI 10.1093/nar/gkq264; Pianese G., 1896, BEITR PATHOL ANAT AL, V142, P1; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rebello RJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020071; Rebello RJ, 2016, CLIN CANCER RES, V22, P5539, DOI 10.1158/1078-0432.CCR-16-0124; RIGGS DL, 1995, J BIOL CHEM, V270, P6205, DOI 10.1074/jbc.270.11.6205; Rothblum K, 2014, MOL CANCER RES, V12, P1586, DOI 10.1158/1541-7786.MCR-14-0229; Rothblum LI, 2017, GENE, V612, P55, DOI 10.1016/j.gene.2016.12.023; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russo A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010140; Sakai D, 2009, INT J BIOCHEM CELL B, V41, P1229, DOI 10.1016/j.biocel.2008.10.026; Sambrook J., 2006, CONDENSED PROTOCOLS; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlosser A, 2002, PROTEOMICS, V2, P911, DOI 10.1002/1615-9861(200207)2:7<911::AID-PROT911>3.0.CO;2-K; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; Schneider DA, 2004, P NATL ACAD SCI USA, V101, P15112, DOI 10.1073/pnas.0406746101; Seither P, 1997, CHROMOSOMA, V106, P216, DOI 10.1007/s004120050242; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Stepanchick A, 2013, J BIOL CHEM, V288, P9135, DOI 10.1074/jbc.M112.444265; Stephan F, 2004, J BIOL CHEM, V279, P25251, DOI 10.1074/jbc.M401867200; Tafur L, 2019, ELIFE, V8, DOI 10.7554/eLife.43204; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Taylor NMI, 2013, NUCLEIC ACIDS RES, V41, P9183, DOI 10.1093/nar/gkt664; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16273; Warner JR, 2015, RNA, V21, P758, DOI 10.1261/rna.050435.115; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wei YY, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00105-17; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Yamamoto K, 2004, MOL CELL BIOL, V24, P6338, DOI 10.1128/MCB.24.14.6338-6349.2004; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuan FW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0572-3; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao QS, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0369-1	126	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19907	19922		10.1074/jbc.RA119.009902	http://dx.doi.org/10.1074/jbc.RA119.009902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31727736	Green Published, hybrid			2022-12-28	WOS:000505005800008
J	Wu, PT; Su, WR; Li, CL; Hsieh, JL; Ma, CH; Wu, CL; Kuo, LC; Jou, IM; Chen, SY				Wu, Po-Ting; Su, Wei-Ren; Li, Chia-Lung; Hsieh, Jeng-Long; Ma, Ching-Hou; Wu, Chao-Liang; Kuo, Li-Chieh; Jou, I-Ming; Chen, Shih-Yao			Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; tendon; cytokine induction; inflammation; matrix metalloproteinase (MMP); CD44; tendinopathy	ROTATOR CUFF; PROGENITOR CELLS; TENDON CELLS; HYALURONAN; IL-1-BETA; TEARS; VIVO	Apoptosis has emerged as a primary cause of tendinopathy. CD44 signaling pathways exert anti-apoptotic and -inflammatory effects on tumor cells, chondrocytes, and fibroblast-like synoviocytes. The aim of this study was to examine the association among CD44, apoptosis, and inflammation in tendinopathy. Expression of CD44 and apoptotic cell numbers in tendon tissue from patients with long head of biceps (LHB) tendinopathy were determined according to the histological grades of tendinopathy. Primary tenocytes from Achilles tendon of Sprague?Dawley rats 1 week after collagenase injection were cultured with an antagonizing antibody against CD44. Treatment responses were determined by evaluating cell viability and expression of tendon-related proliferation markers, inflammatory mediators, and apoptosis. The expression of CD44 and apoptosis were positively correlated with the severity of tendinopathy in the human LHB tendinopathy. Furthermore, CD44 expression and apoptotic cells were co-stained in tendinopathic tendon. Blocking the CD44 signaling pathways in rat primary tenocytes by OX-50 induced cell apoptosis and the elevated levels of cleaved caspase-3. Furthermore, they had decreased cell viability and expression of collagen type I, type III, tenomodulin, and phosphorylated AKT. In contrast, there were elevated levels of inflammatory mediators, including interleukin (IL)-1?, IL-6, tumor necrosis factor-?, cyclooxygenase-2, and phosphorylated NF-?B, as well as matrix metalloproteinase (MMP) family members including MMP-1, -3, -9, and -13 in tenocytes upon OX-50 treatment. This study is the first to demonstrate the association of CD44 and apoptosis in tendinopathy. Our data imply that CD44 may play a role in tendinopathy via regulating apoptosis, inflammation, and extracellular matrix homeostasis.	[Wu, Po-Ting; Su, Wei-Ren] Natl Cheng Kung Univ, Coll Med, Dept Orthopaed, Tainan, Taiwan; [Wu, Po-Ting; Su, Wei-Ren; Li, Chia-Lung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Orthopaed, Tainan, Taiwan; [Wu, Po-Ting] Natl Cheng Kung Univ, Coll Engn, Dept Biomed Engn, Tainan, Taiwan; [Wu, Po-Ting; Li, Chia-Lung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Orthopaed, Dou Liou Branch,Coll Med, Touliu, Yunlin, Taiwan; [Wu, Po-Ting; Kuo, Li-Chieh] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Hsieh, Jeng-Long; Chen, Shih-Yao] Chung Hwa Univ Med Technol, Coll Nursing, Dept Nursing, Tainan, Taiwan; [Ma, Ching-Hou; Jou, I-Ming] E Da Hosp, Dept Orthoped, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Ma, Ching-Hou; Jou, I-Ming] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Wu, Chao-Liang] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Occupat Therapy, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, 1 Univ Rd, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chung Hua University; E-Da Hospital; I Shou University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Jou, IM (corresponding author), E Da Hosp, Dept Orthoped, 1 Yida Rd, Kaohsiung 82445, Taiwan.; Chen, SY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Internal Med, 1 Univ Rd, Tainan 70101, Taiwan.	jming@mail.ncku.edu.tw; leonlai50@gmail.com	su, wei/GZM-3986-2022; Chen, Shih-Yao/GXM-5182-2022; Kuo, Li-Chieh/ABC-3826-2021	Chen, Shih-Yao/0000-0003-4929-855X; Kuo, Li-Chieh/0000-0001-7728-0096; Wu, Po-Ting/0000-0001-5534-8993	Ministry of Science and Technology, Taiwan [MOST 106-2622-E-006-029-CC2, MOST 108-2314-B-006-037-MY3, MOST 107-2314-B-006-065-MY3, MOST 105-2622-E-650-001-CC2]; National Cheng Kung University Hospital (Tainan, Taiwan) [NCKUH-10802005, NCKUEDA 10605]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital (Tainan, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan, Grants MOST 106-2622-E-006-029-CC2, MOST 108-2314-B-006-037-MY3, MOST 107-2314-B-006-065-MY3, and MOST 105-2622-E-650-001-CC2 and National Cheng Kung University Hospital (Tainan, Taiwan) Grants NCKUH-10802005, and NCKUEDA 10605. The authors declare that they have no conflicts of interest with the contents of this article.	Anand V, 2019, J CANCER RES CLIN, V145, P2649, DOI 10.1007/s00432-019-03024-9; Arnoczky SP, 2004, J ORTHOPAED RES, V22, P328, DOI 10.1016/S0736-0266(03)00185-2; Benson RT, 2010, J BONE JOINT SURG BR, V92B, P448, DOI 10.1302/0301-620X.92B3.23074; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Del Buono A, 2011, INT J IMMUNOPATH PH, V24, P45, DOI 10.1177/03946320110241S209; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Durgam S, 2016, TISSUE ENG PART C-ME, V22, P801, DOI [10.1089/ten.tec.2016.0152, 10.1089/ten.TEC.2016.0152]; Egerbacher M, 2008, CLIN ORTHOP RELAT R, V466, P1562, DOI 10.1007/s11999-008-0274-8; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Hiraoka N, 2011, J ORTHOP RES, V29, P354, DOI 10.1002/jor.21240; Hsieh JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204603; Ji RR, 2009, TRENDS PHARMACOL SCI, V30, P336, DOI 10.1016/j.tips.2009.04.002; Lakemeier S, 2011, KNEE SURG SPORT TR A, V19, P1760, DOI 10.1007/s00167-010-1367-y; Lian O, 2007, AM J SPORT MED, V35, P605, DOI 10.1177/0363546506295702; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Liu SL, 2017, CANCER RES, V77, P3791, DOI 10.1158/0008-5472.CAN-16-2545; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Longo UG, 2009, SPORTS MED ARTHROSC, V17, P112, DOI 10.1097/JSA.0b013e3181a3d625; Lotz M, 1999, OSTEOARTHR CARTILAGE, V7, P389, DOI 10.1053/joca.1998.0220; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Mobasheri A, 2013, HISTOL HISTOPATHOL, V28, P955, DOI 10.14670/HH-28.955; Mongkhon JM, 2014, INFLAMM RES, V63, P691, DOI 10.1007/s00011-014-0742-4; Nell EM, 2012, J ORTHOP RES, V30, P1719, DOI 10.1002/jor.22144; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Pearce CJ, 2009, AM J SPORT MED, V37, P2440, DOI 10.1177/0363546509340264; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Riley Graham, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008963; Shakibaei M, 2011, HISTOL HISTOPATHOL, V26, P1173, DOI 10.14670/HH-26.1173; Song JM, 2019, MOL CARCINOGEN, V58, P321, DOI 10.1002/mc.22930; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Wu PT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40840; Wu PT, 2014, J SHOULDER ELB SURG, V23, P1099, DOI 10.1016/j.jse.2013.11.013; Yoshida M, 2008, BIOMED RES-TOKYO, V29, P47, DOI 10.2220/biomedres.29.47; Yuan J, 2002, J ORTHOP RES, V20, P1372, DOI 10.1016/S0736-0266(02)00075-X; Zhang KR, 2015, BIOCHEM BIOPH RES CO, V463, P667, DOI 10.1016/j.bbrc.2015.05.122	36	12	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20177	20184		10.1074/jbc.RA119.009675	http://dx.doi.org/10.1074/jbc.RA119.009675			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732563	hybrid, Green Published			2022-12-28	WOS:000505005800028
J	Chen, JH; Zhang, J; Shaik, NF; Yi, B; Wei, X; Yang, XF; Naik, UP; Summer, R; Yan, GJ; Xu, XY; Sun, JX				Chen, Jihui; Zhang, Jian; Shaik, Noor F.; Yi, Bing; Wei, Xin; Yang, Xiao-Feng; Naik, Ulhas P.; Summer, Ross; Yan, Guijun; Xu, Xinyun; Sun, Jianxin			The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; endothelium; nitric oxide synthase; nitric oxide; gene regulation; diabetes; histone acetylase; endothelial cells; endothelial nitric oxide synthase (eNOS); cytoskeleton; histone deacetylase 6 (HDCA6); stroke; cardiovascular disorder; tubulin acetylation inducer (tubacin); inflammation	MESSENGER-RNA STABILITY; TRACT-BINDING PROTEIN; POSTTRANSCRIPTIONAL REGULATION; BLOOD-FLOW; CEREBRAL-ISCHEMIA; HDAC6 INHIBITOR; DOWN-REGULATION; SHEAR-STRESS; MICE; TUBULIN	Endothelial nitric oxide (NO) synthase (eNOS) plays a critical role in the maintenance of blood vessel homeostasis. Recent findings suggest that cytoskeletal dynamics play an essential role in regulating eNOS expression and activation. Here, we sought to test whether modulation of cytoskeletal dynamics through pharmacological regulation of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation affects eNOS expression and endothelial function in vitro and in vivo. We found that tubulin acetylation inducer (tubacin), a compound that appears to selectively inhibit HDAC6 activity, dramatically increased eNOS expression in several different endothelial cell lines, as determined by both immunoblotting and NO production assays. Mechanistically, we found that these effects were not mediated by tubacin's inhibitory effect on HDAC6 activity, but rather were due to its ability to stabilize eNOS mRNA transcripts. Consistent with these findings, tubacin also inhibited proinflammatory cytokine-induced degradation of eNOS transcripts and impairment of endothelium-dependent relaxation in the mouse aorta. Furthermore, we found that tubacin-induced up-regulation in eNOS expression in vivo is associated with improved endothelial function in diabetic db/db mice and with a marked attenuation of ischemic brain injury in a murine stroke model. Our findings indicate that tubacin exhibits potent eNOS-inducing effects and suggest that this compound might be useful for the prevention or management of endothelial dysfunction?associated cardiovascular diseases.	[Chen, Jihui; Yi, Bing; Summer, Ross; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA; [Shaik, Noor F.; Naik, Ulhas P.] Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA; [Chen, Jihui; Zhang, Jian; Wei, Xin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200092, Peoples R China; [Yang, Xiao-Feng] Temple Univ, Ctr Metab Dis Res, Lewis Katz Sch Med, Philadelphia, PA 19107 USA; [Yan, Guijun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Reprod Med Ctr, Nanjing 210023, Jiangsu, Peoples R China; [Xu, Xinyun] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gen Surg, Shanghai 200003, Peoples R China	Jefferson University; Jefferson University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nanjing University; Naval Medical University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu		Wei, Xin/0000-0002-5272-1665; Shaik, Noor/0000-0002-9336-4238; Chen, Jihui/0000-0002-9819-9921	National Institutes of Health [R01 HL103869, R01GM123047]; American Heart Association Established Investigator Award [16EIA27710023]; Chinese Natural Science Foundation [81672927]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113188, R01HL132399, R01HL103869, R01HL138749, R01HL147565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL103869 and R01GM123047 and American Heart Association Established Investigator Award 16EIA27710023 (to J. S.) and Chinese Natural Science Foundation Grant 81672927 (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Babic I, 2009, MOL CELL BIOL, V29, P5564, DOI 10.1128/MCB.00590-09; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Chen M, 2016, CARDIOVASC RES, V109, P141, DOI 10.1093/cvr/cvv250; DALKARA T, 1994, AM J PHYSIOL, V267, pH678, DOI 10.1152/ajpheart.1994.267.2.H678; Damaskos C, 2017, ANTICANCER RES, V37, P35, DOI 10.21873/anticanres.11286; Dekker FJ, 2014, DRUG DISCOV TODAY, V19, P654, DOI 10.1016/j.drudis.2013.11.012; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Fernandez-Barrera J, 2018, CELL MOL LIFE SCI, V75, P3181, DOI 10.1007/s00018-018-2855-3; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jung SB, 2010, CIRC RES, V107, P877, DOI 10.1161/CIRCRESAHA.110.222968; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Martinez-Gonzalez J, 2001, ARTERIOSCL THROM VAS, V21, P804, DOI 10.1161/01.ATV.21.5.804; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Mayanagi K, 2008, J CEREBR BLOOD F MET, V28, P1927, DOI 10.1038/jcbfm.2008.81; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Olzscha Heidi, 2015, Critical Reviews in Oncogenesis, V20, P1; Pasyukova EG, 2017, MECH AGEING DEV, V166, P6, DOI 10.1016/j.mad.2017.08.008; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Searles CD, 2004, CIRC RES, V95, P488, DOI 10.1161/01.RES.0000138953.21377.80; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Su YC, 2002, AM J PHYSIOL-LUNG C, V282, pL1183, DOI 10.1152/ajplung.00388.2001; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Wang XX, 2018, EUR J MED CHEM, V143, P1406, DOI 10.1016/j.ejmech.2017.10.040; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Xiao ZS, 1997, J CELL PHYSIOL, V171, P205, DOI 10.1002/(SICI)1097-4652(199705)171:2<205::AID-JCP11>3.3.CO;2-3; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xue C, 1996, J HISTOCHEM CYTOCHEM, V44, P463, DOI 10.1177/44.5.8627003; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Yang PH, 2013, DRUG DISCOV THER, V7, P233, DOI 10.5582/ddt.2013.v7.6.233; Yi B, 2015, ARTERIOSCL THROM VAS, V35, P2153, DOI 10.1161/ATVBAHA.115.305750; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; You XH, 2018, J BIOL CHEM, V293, P14001, DOI 10.1074/jbc.RA118.003099; Zhang F, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0030-4; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	58	11	12	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19565	19576		10.1074/jbc.RA119.011317	http://dx.doi.org/10.1074/jbc.RA119.011317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31719145	hybrid, Green Published			2022-12-28	WOS:000504093200010
J	Wakabayashi, S; Morihara, H; Yokoe, S; Nakagawa, T; Moriwaki, K; Tomoda, K; Asahi, M				Wakabayashi, Shigeo; Morihara, Hirofumi; Yokoe, Shunichi; Nakagawa, Takatoshi; Moriwaki, Kazumasa; Tomoda, Kiichiro; Asahi, Michio			Overexpression of Na+/H+ exchanger 1 specifically induces cell death in human iPS cells via sustained activation of the Rho kinase ROCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						induced pluripotent stem cell (iPS cell) (iPSC); sodium?proton exchange; Rho (Rho-GTPase); pH regulation; cell death; cell differentiation; protein kinase; cell motility; NHE1; ROCK	PLURIPOTENT STEM-CELLS; H+ EXCHANGER; BINDING; CYTOSKELETON; DOWNSTREAM; INHIBITOR; PROTEIN; NHE1; PH	Understanding the specific properties of human induced pluripotent stem cells (iPSCs) is important for quality control of iPSCs. Having incidentally discovered that overexpression of plasma membrane Na+/H+ exchanger 1 (NHE1) induces cell death in iPSCs, we investigated the mechanism of NHE1-induced cell death. Doxycycline-induced NHE1 overexpression arrested cell growth, and nearly all cells were killed by a necrotic process within 72 h. NHE1 overexpression led to sustained activation of Rho-associated coiled-coil kinase (ROCK), accompanied by dramatic changes in cell shape, cell elongation, and swelling of peripheral cells in iPSC colonies, as well as marked stress fiber formation. The ROCK inhibitor Y27632 reduced NHE1-induced cell death. ROCK-dependent phenotypes were suppressed by a loss-of-function mutation of NHE1 and inhibited by an inhibitor of NHE1 activity, indicating that NHE1-mediated transport activity is required. Moreover, ROCK was activated by trimethylamine treatment?mediated cytosolic alkalinization and accumulated in the plasma membrane near NHE1 in peripheral iPSCs of cell colonies. By contrast, cell death did not occur in mesendoderm-like cells that had differentiated from iPSCs, indicating that the NHE1-mediated effects were specific for iPSCs. These results suggest that NHE1 overexpression specifically induces death of iPSCs via sustained ROCK activation, probably caused by an increase in local pH near NHE1. Finally, monensin, a Na+/H+ exchange ionophore, selectively killed iPSCs, suggesting that monensin could help eliminate iPSCs that remain after differentiation, a strategy that might be useful for improving regenerative medicine.	[Wakabayashi, Shigeo; Morihara, Hirofumi; Yokoe, Shunichi; Nakagawa, Takatoshi; Moriwaki, Kazumasa; Tomoda, Kiichiro; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Wakabayashi, S (corresponding author), Osaka Med Coll, Fac Med, Dept Pharmacol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	pha047@osaka-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [17K08551, 17K07246]; Novartis; OMC Internal Research Grant; Suzuki Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis(Novartis); OMC Internal Research Grant; Suzuki Memorial Foundation	This work was supported by Grant-in-Aid for Scientific Research C 17K08551 (to S. W.) and 17K07246 (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology, Suzuki Memorial Foundation (to K. T. and M. A.), Novartis Research Grants (to K. T. and M. A.), and OMC Internal Research Grant (to K. T. and M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Benning N, 1996, PFLUG ARCH EUR J PHY, V432, P126, DOI 10.1007/s004240050114; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gao W, 2014, CELL PHYSIOL BIOCHEM, V33, P185, DOI 10.1159/000356661; Hisamitsu T, 2012, MOL CELL BIOL, V32, P3265, DOI 10.1128/MCB.00145-12; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huetsch JC, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13698; Julian Linda, 2014, Small GTPases, V5, pe29846, DOI 10.4161/sgtp.29846; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kime C, 2016, P NATL ACAD SCI USA, V113, P12478, DOI 10.1073/pnas.1608564113; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Monet M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28008; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Rangel-Mata F, 2007, BIOCHEM BIOPH RES CO, V352, P264, DOI 10.1016/j.bbrc.2006.11.015; Shimada-Shimizu N, 2014, MOL PHARMACOL, V85, P18, DOI 10.1124/mol.113.089268; SWEATT JD, 1986, J BIOL CHEM, V261, P8667; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Truebestein Linda, 2016, Small GTPases, V7, P82, DOI 10.1080/21541248.2016.1173770; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Vanneste M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38019-y; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2013, J MOL CELL CARDIOL, V61, P68, DOI 10.1016/j.yjmcc.2013.02.007; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wen WY, 2008, J BIOL CHEM, V283, P26263, DOI 10.1074/jbc.M803417200; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200	42	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19577	19588		10.1074/jbc.RA119.010329	http://dx.doi.org/10.1074/jbc.RA119.010329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723030	Green Published, hybrid			2022-12-28	WOS:000504093200011
J	[Anonymous]				[Anonymous]			Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif (Expression of Concern of Vol 280, Pg 16019, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17708	17708		10.1074/jbc.EC119.011524	http://dx.doi.org/10.1074/jbc.EC119.011524			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31732686	Green Published, hybrid			2022-12-28	WOS:000503173500044
